-DOCSTART- -X- -X- O

Identification NN B-NP O
of IN B-PP O
APC2 NN B-NP O
, , O O
a DT B-NP O
homologue NN I-NP O
of IN B-PP O
the DT B-NP O
adenomatous JJ I-NP B-Disease
polyposis NN I-NP I-Disease
coli NN I-NP I-Disease
tumour NN I-NP I-Disease
suppressor NN I-NP O
. . O O

The DT B-NP O
adenomatous JJ I-NP B-Disease
polyposis NN I-NP I-Disease
coli NN I-NP I-Disease
( ( O I-Disease
APC NN B-NP I-Disease
) ) O I-Disease
tumour NN B-NP I-Disease
- HYPH B-NP O
suppressor NN I-NP O
protein NN I-NP O
controls VBZ B-VP O
the DT B-NP O
Wnt NN I-NP O
signalling NN I-NP O
pathway NN I-NP O
by IN B-PP O
forming VBG B-VP O
a DT B-NP O
complex NN I-NP O
with IN B-PP O
glycogen NN B-NP O
synthase NN I-NP O
kinase NN I-NP O
3beta NN I-NP O
( ( O O
GSK NN B-NP O
- HYPH B-NP O
3beta NN I-NP O
) ) O O
, , O O
axin NN B-NP O
/ SYM B-NP O
conductin NN I-NP O
and CC I-NP O
betacatenin NN I-NP O
. . O O

Complex NN B-NP O
formation NN I-NP O
induces VBZ B-VP O
the DT B-NP O
rapid JJ I-NP O
degradation NN I-NP O
of IN B-PP O
betacatenin NN B-NP O
. . O O

In IN B-PP O
colon NN B-NP B-Disease
carcinoma NN I-NP I-Disease
cells NNS I-NP O
, , O O
loss NN B-NP O
of IN B-PP O
APC NN B-NP O
leads VBZ B-VP O
to TO B-PP O
the DT B-NP O
accumulation NN I-NP O
of IN B-PP O
betacatenin NN B-NP O
in IN B-PP O
the DT B-NP O
nucleus NN I-NP O
, , O O
where WRB B-ADVP O
it PRP B-NP O
binds VBZ B-VP O
to TO B-PP O
and CC O O
activates VBZ B-VP O
the DT B-NP O
Tcf NN I-NP O
- HYPH B-NP O
4 CD I-NP O
transcription NN I-NP O
factor NN I-NP O
( ( O O
reviewed VBN B-VP O
in IN B-PP O
[ ( B-NP O
1 CD I-NP O
] ) O O
[ ( O O
2 CD B-NP O
] ) O O
) ) O O
. . O O

Here RB B-ADVP O
, , O O
we PRP B-NP O
report VBP B-VP O
the DT B-NP O
identification NN I-NP O
and CC I-NP O
genomic JJ I-NP O
structure NN I-NP O
of IN B-PP O
APC NN B-NP O
homologues NNS I-NP O
. . O O

Mammalian JJ B-NP O
APC2 NN I-NP O
, , O O
which WDT B-NP O
closely RB B-ADVP O
resembles VBZ B-VP O
APC NN B-NP O
in IN B-PP O
overall JJ B-NP O
domain NN I-NP O
structure NN I-NP O
, , O O
was VBD B-VP O
functionally RB I-VP O
analyzed VBN I-VP O
and CC O O
shown VBN B-VP O
to TO I-VP O
contain VB I-VP O
two CD B-NP O
SAMP NN I-NP O
domains NNS I-NP O
, , O O
both DT B-NP O
of IN B-PP O
which WDT B-NP O
are VBP B-VP O
required VBN I-VP O
for IN B-PP O
binding VBG B-VP O
to TO B-PP O
conductin NN B-NP O
. . O O

Like IN B-PP O
APC NN B-NP O
, , O O
APC2 NN B-NP O
regulates VBZ B-VP O
the DT B-NP O
formation NN I-NP O
of IN B-PP O
active JJ B-NP O
betacatenin NN I-NP O
- HYPH B-NP O
Tcf NN I-NP O
complexes NNS I-NP O
, , O O
as IN B-SBAR O
demonstrated VBN B-VP O
using VBG B-VP O
transient JJ B-NP O
transcriptional JJ I-NP O
activation NN I-NP O
assays NNS I-NP O
in IN B-PP O
APC NN B-NP O
- HYPH B-NP O
/ SYM I-NP O
- HYPH I-NP O
colon NN I-NP B-Disease
carcinoma NN I-NP I-Disease
cells NNS I-NP O
. . O O

Human JJ B-NP O
APC2 NN I-NP O
maps VBZ B-VP O
to TO B-PP O
chromosome NN B-NP O
19p13 CD I-NP O
. . O O

3 LS B-LST O
. . O O

APC NN B-NP O
and CC I-NP O
APC2 NN I-NP O
may MD B-VP O
therefore RB I-VP O
have VB I-VP O
comparable JJ B-NP O
functions NNS I-NP O
in IN B-PP O
development NN B-NP O
and CC I-NP O
cancer NN I-NP B-Disease
. . O O

A DT B-NP O
common JJ I-NP O
MSH2 NN I-NP O
mutation NN I-NP O
in IN B-PP O
English JJ B-NP O
and CC I-NP O
North JJ I-NP O
American JJ I-NP O
HNPCC NN I-NP B-Disease
families NNS I-NP O
: : O O
origin NN B-NP O
, , O O
phenotypic JJ B-NP O
expression NN I-NP O
, , O O
and CC O O
sex NN B-NP O
specific JJ I-NP O
differences NNS I-NP O
in IN B-PP O
colorectal JJ B-NP B-Disease
cancer NN I-NP I-Disease
. . O O

The DT B-NP O
frequency NN I-NP O
, , O O
origin NN B-NP O
, , O O
and CC O O
phenotypic JJ B-NP O
expression NN I-NP O
of IN B-PP O
a DT B-NP O
germline NN I-NP O
MSH2 NN I-NP O
gene NN I-NP O
mutation NN I-NP O
previously RB B-VP O
identified VBN I-VP O
in IN B-PP O
seven CD B-NP O
kindreds NNS I-NP O
with IN B-PP O
hereditary JJ B-NP B-Disease
non AFX I-NP I-Disease
- HYPH I-NP I-Disease
polyposis NN I-NP I-Disease
cancer NN I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
HNPCC NN B-NP B-Disease
) ) O O
was VBD B-VP O
investigated VBN I-VP O
. . O O

The DT B-NP O
mutation NN I-NP O
( ( O O
A NN B-NP O
- SYM O O
- HYPH O O
> SYM O O
T NN B-NP O
at IN B-PP O
nt943 NN B-NP O
+ SYM B-NP O
3 CD I-NP O
) ) O O
disrupts VBZ B-VP O
the DT B-NP O
3 CD I-NP O
splice NN I-NP O
site NN I-NP O
of IN B-PP O
exon NN B-NP O
5 CD I-NP O
leading VBG B-VP O
to TO B-PP O
the DT B-NP O
deletion NN I-NP O
of IN B-PP O
this DT B-NP O
exon NN I-NP O
from IN B-PP O
MSH2 NN B-NP O
mRNA NN I-NP O
and CC O O
represents VBZ B-VP O
the DT B-NP O
only RB I-NP O
frequent JJ I-NP O
MSH2 NN I-NP O
mutation NN I-NP O
so RB B-VP O
far RB I-VP O
reported VBN I-VP O
. . O O

Although IN B-SBAR O
this DT B-NP O
mutation NN I-NP O
was VBD B-VP O
initially RB I-VP O
detected VBN I-VP O
in IN B-PP O
four CD B-NP O
of IN B-PP O
33 CD B-NP O
colorectal JJ I-NP B-Disease
cancer NN I-NP I-Disease
families NNS I-NP O
analysed VBN B-VP O
from IN B-PP O
eastern JJ B-NP O
England NNP I-NP O
, , O O
more RBR B-NP O
extensive JJ I-NP O
analysis NN I-NP O
has VBZ B-VP O
reduced VBN I-VP O
the DT B-NP O
frequency NN I-NP O
to TO B-PP O
four CD B-NP O
of IN B-PP O
52 CD B-NP O
( ( O O
8 CD B-NP O
% NN I-NP O
) ) I-NP O
English JJ I-NP O
HNPCC NN I-NP B-Disease
kindreds NNS I-NP O
analysed VBN B-VP O
. . O O

In IN B-PP O
contrast NN B-NP O
, , O O
the DT B-NP O
MSH2 NN I-NP O
mutation NN I-NP O
was VBD B-VP O
identified VBN I-VP O
in IN B-PP O
10 CD B-NP O
of IN B-PP O
20 CD B-NP O
( ( O O
50 CD B-NP O
% NN I-NP O
) ) O O
separately RB B-ADVP O
identified VBD B-VP O
colorectal JJ B-NP B-Disease
families NNS I-NP O
from IN B-PP O
Newfoundland NNP B-NP O
. . O O

To TO B-VP O
investigate VB I-VP O
the DT B-NP O
origin NN I-NP O
of IN B-PP O
this DT B-NP O
mutation NN I-NP O
in IN B-PP O
colorectal JJ B-NP B-Disease
cancer NN I-NP I-Disease
families NNS I-NP O
from IN B-PP O
England NNP B-NP O
( ( O O
n NN B-NP O
= SYM B-VP O
4 CD B-NP O
) ) O O
, , O O
Newfoundland NNP B-NP O
( ( O O
n NN B-NP O
= SYM B-VP O
10 CD B-NP O
) ) O O
, , O O
and CC O O
the DT B-NP O
United NNP I-NP O
States NNP I-NP O
( ( O O
n NN B-NP O
= SYM B-VP O
3 CD B-NP O
) ) O O
, , O O
haplotype NN B-NP O
analysis NN I-NP O
using VBG B-VP O
microsatellite NN B-NP O
markers NNS I-NP O
linked VBN B-VP O
to TO B-PP O
MSH2 NN B-NP O
was VBD B-VP O
performed VBN I-VP O
. . O O

Within IN B-PP O
the DT B-NP O
English NNP I-NP O
and CC I-NP O
US NNP I-NP O
families NNS I-NP O
there EX B-NP O
was VBD B-VP O
little JJ B-NP O
evidence NN I-NP O
for IN B-PP O
a DT B-NP O
recent JJ I-NP O
common JJ I-NP O
origin NN I-NP O
of IN B-PP O
the DT B-NP O
MSH2 NN I-NP O
splice NN I-NP O
site NN I-NP O
mutation NN I-NP O
in IN B-PP O
most JJS B-NP O
families NNS I-NP O
. . O O

In IN B-PP O
contrast NN B-NP O
, , O O
a DT B-NP O
common JJ I-NP O
haplotype NN I-NP O
was VBD B-VP O
identified VBN I-VP O
at IN B-PP O
the DT B-NP O
two CD I-NP O
flanking NN I-NP O
markers NNS I-NP O
( ( O O
CA5 NN B-NP O
and CC O O
D2S288 NN B-NP O
) ) O O
in IN B-PP O
eight CD B-NP O
of IN B-PP O
the DT B-NP O
Newfoundland NNP I-NP O
families NNS I-NP O
. . O O

These DT B-NP O
findings NNS I-NP O
suggested VBD B-VP O
a DT B-NP O
founder NN I-NP O
effect NN I-NP O
within IN B-PP O
Newfoundland NNP B-NP O
similar JJ B-ADJP O
to TO B-PP O
that DT B-NP O
reported VBN B-VP O
by IN B-PP O
others NNS B-NP O
for IN B-PP O
two CD B-NP O
MLH1 NN I-NP O
mutations NNS I-NP O
in IN B-PP O
Finnish JJ B-NP O
HNPCC NN I-NP B-Disease
families NNS I-NP O
. . O O

We PRP B-NP O
calculated VBD B-VP O
age NN B-NP O
related JJ I-NP O
risks NNS I-NP O
of IN B-PP O
all DT B-NP O
, , O O
colorectal JJ B-NP B-Disease
, , I-NP I-Disease
endometrial JJ I-NP I-Disease
, , O I-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancers NNS I-NP I-Disease
in IN B-PP O
nt943 NN B-NP O
+ SYM O O
3 CD B-NP O
A NN I-NP O
- SYM B-NP O
- HYPH I-NP O
> SYM I-NP O
T NN I-NP O
MSH2 NN I-NP O
mutation NN I-NP O
carriers NNS I-NP O
( ( O O
n NN B-NP O
= SYM B-VP O
76 CD B-NP O
) ) O O
for IN B-PP O
all DT B-NP O
patients NNS I-NP O
and CC B-PP O
for IN B-PP O
men NNS B-NP O
and CC I-NP O
women NNS I-NP O
separately RB B-ADVP O
. . O O

For IN B-PP O
both DT B-NP O
sexes NNS I-NP O
combined VBN B-VP O
, , O O
the DT B-NP O
penetrances NNS I-NP O
at IN B-PP O
age NN B-NP O
60 CD B-NP O
years NNS I-NP O
for IN B-PP O
all DT B-NP O
cancers NNS I-NP B-Disease
and CC B-PP O
for IN B-PP O
colorectal JJ B-NP B-Disease
cancer NN I-NP I-Disease
were VBD B-VP O
0 CD B-NP O
. . O O

86 CD B-NP O
and CC I-NP O
0 CD I-NP O
. . O O

57 CD B-NP O
, , O O
respectively RB B-ADVP O
. . O O

The DT B-NP O
risk NN I-NP O
of IN B-PP O
colorectal JJ B-NP B-Disease
cancer NN I-NP I-Disease
was VBD B-VP O
significantly RB B-ADJP O
higher JJR I-ADJP O
( ( O O
p NN B-NP O
< SYM B-ADJP O
0 CD B-NP O
. . I-NP O

01 CD I-NP O
) ) O O
in IN B-PP O
males NNS B-NP O
than IN B-PP O
females NNS B-NP O
( ( O O
0 CD B-NP O
. . O O

63 CD B-NP O
v IN B-PP O
0 CD B-NP O
. . O O

30 CD B-NP O
and CC I-NP O
0 CD I-NP O
. . O O

84 CD B-NP O
v IN B-PP O
0 CD B-NP O
. . I-NP O

44 CD I-NP O
at IN B-PP O
ages NNS B-NP O
50 CD B-NP O
and CC I-NP O
60 CD I-NP O
years NNS I-NP O
, , O O
respectively RB B-ADVP O
) ) O O
. . O O

For IN B-PP O
females NNS B-NP O
there EX B-NP O
was VBD B-VP O
a DT B-NP O
high JJ I-NP O
risk NN I-NP O
of IN B-PP O
endometrial JJ B-NP B-Disease
cancer NN I-NP I-Disease
( ( O O
0 CD B-NP O
. . O O

5 CD B-NP O
at IN B-PP O
age NN B-NP O
60 CD B-NP O
years NNS I-NP O
) ) O O
and CC O O
premenopausal JJ B-NP B-Disease
ovarian JJ I-NP I-Disease
cancer NN I-NP I-Disease
( ( O O
0 CD B-NP O
. . I-NP O

2 CD I-NP O
at IN B-PP O
50 CD B-NP O
years NNS I-NP O
) ) O O
. . O O

These DT B-NP O
intersex JJ I-NP O
differences NNS I-NP O
in IN B-PP O
colorectal JJ B-NP B-Disease
cancer NN I-NP I-Disease
risks NNS I-NP O
have VBP B-VP O
implications NNS B-NP O
for IN B-PP O
screening NN B-NP O
programmes NNS I-NP O
and CC B-PP O
for IN B-PP O
attempts NNS B-NP O
to TO B-VP O
identify VB I-VP O
colorectal JJ B-NP B-Disease
cancer NN I-NP I-Disease
susceptibility NN I-NP O
modifiers NNS I-NP O
. . O O

Age NN B-NP O
of IN B-PP O
onset NN B-NP O
in IN B-PP O
Huntington NNP B-NP B-Disease
disease NN I-NP I-Disease
: : O O
sex NN B-NP O
specific JJ I-NP O
influence NN I-NP O
of IN B-PP O
apolipoprotein NN B-NP O
E NN I-NP O
genotype NN I-NP O
and CC O O
normal JJ B-NP O
CAG NN I-NP O
repeat NN I-NP O
length NN I-NP O
. . O O

Age NN B-NP O
of IN B-PP O
onset NN B-NP O
( ( O O
AO NN B-NP O
) ) O O
of IN B-PP O
Huntington NNP B-NP B-Disease
disease NN I-NP I-Disease
( ( O O
HD NN B-NP B-Disease
) ) O O
is VBZ B-VP O
known VBN I-VP O
to TO I-VP O
be VB I-VP O
correlated VBN I-VP O
with IN B-PP O
the DT B-NP O
length NN I-NP O
of IN B-PP O
an DT B-NP O
expanded VBN I-NP O
CAG NN I-NP O
repeat NN I-NP O
in IN B-PP O
the DT B-NP O
HD NN I-NP B-Disease
gene NN I-NP O
. . O O

Apolipoprotein NN B-NP O
E NN I-NP O
( ( O O
APOE NN B-NP O
) ) O O
genotype NN B-NP O
, , O O
in IN B-PP O
turn NN B-NP O
, , O O
is VBZ B-VP O
known VBN I-VP O
to TO I-VP O
influence VB I-VP O
AO NN B-NP O
in IN B-PP O
Alzheimer NNP B-NP B-Disease
disease NN I-NP I-Disease
, , O O
rendering VBG B-VP O
the DT B-NP O
APOE NN I-NP O
gene NN I-NP O
a DT B-NP O
likely JJ I-NP O
candidate NN I-NP O
to TO B-VP O
affect VB I-VP O
AO NN B-NP O
in IN B-PP O
other JJ B-NP O
neurological JJ I-NP B-Disease
diseases NNS I-NP I-Disease
too RB B-ADVP O
. . O O

We PRP B-NP O
therefore RB B-ADVP O
determined VBD B-VP O
APOE NN B-NP O
genotype NN I-NP O
and CC O O
normal JJ B-NP O
CAG NN I-NP O
repeat NN I-NP O
length NN I-NP O
in IN B-PP O
the DT B-NP O
HD NN I-NP B-Disease
gene NN I-NP O
for IN B-PP O
138 CD B-NP O
HD NN I-NP B-Disease
patients NNS I-NP O
who WP B-NP O
were VBD B-VP O
previously RB I-VP O
analysed VBN I-VP O
with IN B-PP O
respect NN B-NP O
to TO B-PP O
CAG NN B-NP O
repeat NN I-NP O
length NN I-NP O
. . O O

Genotyping VBG B-VP O
for IN B-PP O
APOE NN B-NP O
was VBD B-VP O
performed VBN I-VP O
blind JJ B-ADJP O
to TO B-PP O
clinical JJ B-NP O
information NN I-NP O
. . O O

In IN B-PP O
addition NN B-NP O
to TO B-PP O
highlighting VBG B-VP O
the DT B-NP O
effect NN I-NP O
of IN B-PP O
the DT B-NP O
normal JJ I-NP O
repeat NN I-NP O
length NN I-NP O
upon IN B-PP O
AO NN B-NP O
in IN B-PP O
maternally RB B-NP O
inherited VBN I-NP O
HD NN I-NP B-Disease
and CC B-PP O
in IN B-PP O
male JJ B-NP O
patients NNS I-NP O
, , O O
we PRP B-NP O
show VBP B-VP O
that IN B-SBAR O
the DT B-NP O
APOE NN I-NP O
epsilon2epsilon3 NN I-NP O
genotype NN I-NP O
is VBZ B-VP O
associated VBN I-VP O
with IN B-PP O
significantly RB B-NP O
earlier JJR I-NP O
AO NN I-NP O
in IN B-PP O
males NNS B-NP O
than IN B-PP O
in IN B-PP O
females NNS B-NP O
. . O O

Such PDT B-NP O
a DT I-NP O
sex NN I-NP O
difference NN I-NP O
in IN B-PP O
AO NN B-NP O
was VBD B-VP O
not RB O O
apparent JJ B-ADJP O
for IN B-PP O
any DT B-NP O
of IN B-PP O
the DT B-NP O
other JJ I-NP O
APOE NNP I-NP O
genotypes NNS I-NP O
. . O O

Our PRP$ B-NP O
findings NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
subtle JJ B-NP O
differences NNS I-NP O
in IN B-PP O
the DT B-NP O
course NN I-NP O
of IN B-PP O
the DT B-NP O
neurodegeneration NN I-NP B-Disease
in IN B-PP O
HD NN B-NP B-Disease
may MD B-VP O
allow VB I-VP O
interacting VBG I-VP O
genes NNS B-NP O
to TO B-VP O
exert VB I-VP O
gender NN B-NP O
specific JJ I-NP O
effects NNS I-NP O
upon IN B-PP O
AO NN B-NP O
. . O O

Familial JJ B-NP B-Disease
deficiency NN I-NP I-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
seventh JJ I-NP I-Disease
component NN I-NP I-Disease
of IN B-PP I-Disease
complement NN B-NP I-Disease
associated VBN B-VP O
with IN B-PP O
recurrent JJ B-NP O
bacteremic JJ I-NP B-Disease
infections NNS I-NP I-Disease
due JJ B-ADJP I-Disease
to TO B-PP I-Disease
Neisseria NNP B-NP I-Disease
. . O O

The DT B-NP O
serum NN I-NP O
of IN B-PP O
a DT B-NP O
29 CD I-NP O
- HYPH I-NP O
year NN I-NP O
old JJ I-NP O
woman NN I-NP O
with IN B-PP O
a DT B-NP O
recent JJ I-NP O
episode NN I-NP O
of IN B-PP O
disseminated VBN B-NP B-Disease
gonococcal JJ I-NP I-Disease
infection NN I-NP I-Disease
and CC O O
a DT B-NP O
history NN I-NP O
of IN B-PP O
meningococcal JJ B-NP B-Disease
meningitis NN I-NP I-Disease
and CC I-NP O
arthritis NN I-NP B-Disease
as IN B-PP O
a DT B-NP O
child NN I-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
lack VB I-VP O
serum NN B-NP O
hemolytic JJ I-NP O
complement NN I-NP O
activity NN I-NP O
. . O O

The DT B-NP O
seventh JJ I-NP O
component NN I-NP O
of IN B-PP O
complement NN B-NP O
( ( O O
C7 NN B-NP O
) ) O O
was VBD B-VP O
not RB I-VP O
detected VBN I-VP O
by IN B-PP O
functional JJ B-NP O
or CC I-NP O
immunochemical JJ I-NP O
assays NNS I-NP O
, , O O
whereas IN O O
other JJ B-NP O
components NNS I-NP O
were VBD B-VP O
normal JJ B-ADJP O
by IN B-PP O
hemolytic JJ B-NP O
and CC I-NP O
immunochemical JJ I-NP O
assessment NN I-NP O
. . O O

Her PRP$ B-NP O
fresh JJ I-NP O
serum NN I-NP O
lacked VBD B-VP O
complement NN B-NP O
- HYPH O O
mediated VBN B-NP O
bactericidal JJ I-NP O
activity NN I-NP O
against IN B-PP O
Neisseria NNP B-NP O
gonorrhoeae NNP I-NP O
, , O O
but CC O O
the DT B-NP O
addition NN I-NP O
of IN B-PP O
fresh JJ B-NP O
normal JJ I-NP O
serum NN I-NP O
or CC O O
purified VBN B-NP O
C7 NN I-NP O
restored VBD B-VP O
bactericidal JJ B-NP O
activity NN I-NP O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
hemolytic JJ B-NP O
activity NN I-NP O
. . O O

The DT B-NP O
absence NN I-NP B-Disease
of IN B-PP I-Disease
functional JJ B-NP I-Disease
C7 NN I-NP I-Disease
activity NN I-NP O
could MD B-VP O
not RB I-VP O
be VB I-VP O
accounted VBN I-VP O
for IN B-PP O
on IN B-PP O
the DT B-NP O
basis NN I-NP O
of IN B-PP O
an DT B-NP O
inhibitor NN I-NP O
. . O O

Opsonization NN B-NP O
and CC I-NP O
generation NN I-NP O
of IN B-PP O
chemotactic JJ B-NP O
activity NN I-NP O
functioned VBD B-VP O
normally RB B-ADVP O
. . O O

Complete JJ B-NP B-Disease
absence NN I-NP I-Disease
of IN B-PP I-Disease
C7 NN B-NP I-Disease
was VBD B-VP O
also RB I-VP O
found VBN I-VP O
in IN B-PP O
one CD B-NP O
sibling NN I-NP O
who WP B-NP O
had VBD B-VP O
the DT B-NP O
clinical JJ I-NP O
syndrome NN I-NP O
of IN B-PP O
meningococcal JJ B-NP B-Disease
meningitis NN I-NP I-Disease
and CC I-NP O
arthritis NN I-NP B-Disease
as IN B-PP O
a DT B-NP O
child NN I-NP O
and CC B-PP O
in IN B-PP O
this DT B-NP O
siblings NNS I-NP O
clinically RB B-ADVP O
well RB B-NP O
eight CD I-NP O
- HYPH I-NP O
year NN I-NP O
- HYPH B-NP O
old JJ I-NP O
son NN I-NP O
. . O O

HLA NN B-NP O
histocompatibility NN I-NP O
typing NN I-NP O
of IN B-PP O
the DT B-NP O
family NN I-NP O
members NNS I-NP O
did VBD B-VP O
not RB I-VP O
demonstrate VB I-VP O
evidence NN B-NP O
for IN B-PP O
genetic JJ B-NP O
linkage NN I-NP O
of IN B-PP O
C7 NN B-NP B-Disease
deficiency NN I-NP I-Disease
with IN B-PP O
the DT B-NP O
major JJ I-NP O
histocompatibility NN I-NP O
loci NNS I-NP O
. . O O

This DT B-NP O
report NN I-NP O
represents VBZ B-VP O
the DT B-NP O
first JJ I-NP O
cases NNS I-NP O
of IN B-PP O
C7 NN B-NP B-Disease
deficiency NN I-NP I-Disease
associated VBN B-VP O
with IN B-PP O
infectious JJ B-NP O
complications NNS I-NP O
and CC O O
suggests VBZ B-VP O
that IN B-SBAR O
bactericidal JJ B-NP O
activity NN I-NP O
may MD B-VP O
be VB I-VP O
important JJ B-ADJP O
in IN B-PP O
host NN B-NP O
defense NN I-NP O
against IN B-PP O
bacteremic JJ B-NP B-Disease
neisseria NN I-NP I-Disease
infections NNS I-NP I-Disease
. . O O

Increased VBN B-NP O
incidence NN I-NP O
of IN B-PP O
cancer NN B-NP B-Disease
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
cartilage NN B-NP B-Disease
- HYPH B-NP I-Disease
hair NN I-NP I-Disease
hypoplasia NN I-NP I-Disease
. . O O

OBJECTIVE NN B-NP O
Previous JJ I-NP O
reports NNS I-NP O
have VBP B-VP O
suggested VBN I-VP O
an DT B-NP O
increased VBN I-NP O
risk NN I-NP O
of IN B-PP O
cancer NN B-NP B-Disease
among IN B-PP O
patients NNS B-NP O
with IN B-PP O
cartilage NN B-NP B-Disease
- HYPH B-NP I-Disease
hair NN I-NP I-Disease
hypoplasia NN I-NP I-Disease
( ( O O
CHH NN B-NP B-Disease
) ) O O
. . O O

This DT B-NP O
study NN I-NP O
was VBD B-VP O
carried VBN I-VP O
out RP B-PRT O
to TO B-VP O
further RB I-VP O
evaluate VB I-VP O
this DT B-NP O
risk NN I-NP O
among IN B-PP O
patients NNS B-NP O
with IN B-PP O
CHH NN B-NP B-Disease
and CC O O
their PRP$ B-NP O
first JJ I-NP O
- HYPH I-NP O
degree NN I-NP O
relatives NNS I-NP O
. . O O

STUDY NN B-NP O
DESIGN NNP B-NP O
One CD I-NP O
hundred CD I-NP O
twenty CD I-NP O
- HYPH O O
two CD B-NP O
patients NNS I-NP O
with IN B-PP O
CHH NN B-NP B-Disease
were VBD B-VP O
identified VBN I-VP O
through IN B-PP O
2 CD B-NP O
countrywide JJ I-NP O
epidemiologic JJ I-NP O
surveys NNS I-NP O
in IN B-PP O
1974 CD B-NP O
and CC O O
in IN B-PP O
1986 CD B-NP O
. . O O

Their PRP$ B-NP O
parents NNS I-NP O
and CC O O
nonaffected JJ B-NP O
siblings NNS I-NP O
were VBD B-VP O
identified VBN I-VP O
through IN B-PP O
the DT B-NP O
Population NNP I-NP O
Register NNP I-NP O
Center NNP I-NP O
. . O O

This DT B-NP O
cohort NN I-NP O
underwent VBD B-VP O
follow VB I-VP O
- HYPH O O
up RP B-PRT O
for IN B-PP O
cancer NN B-NP B-Disease
incidence NN I-NP O
through IN B-PP O
the DT B-NP O
Finnish NNP I-NP O
Cancer NNP I-NP O
Registry NNP I-NP O
to TO B-PP O
the DT B-NP O
end NN I-NP O
of IN B-PP O
1995 CD B-NP O
. . O O

RESULTS NNS B-NP O
A DT B-NP O
statistically RB I-NP O
significant JJ I-NP O
excess JJ I-NP O
risk NN I-NP O
of IN B-PP O
cancer NN B-NP B-Disease
was VBD B-VP O
seen VBN I-VP O
among IN B-PP O
the DT B-NP O
patients NNS I-NP O
with IN B-PP O
CHH NN B-NP B-Disease
( ( O O
standardized JJ B-NP O
incidence NN I-NP O
ratio NN I-NP O
6 CD I-NP O
. . I-NP O

9 CD I-NP O
, , I-NP O
95 CD I-NP O
% NN I-NP O
confidence NN I-NP O
interval NN I-NP O
2 CD I-NP O
. . I-NP O

3 CD I-NP O
to TO B-PP O
16 CD B-NP O
) ) O O
, , O O
which WDT B-NP O
was VBD B-VP O
mainly RB B-ADJP O
attributable JJ I-ADJP O
to TO B-PP O
non AFX B-NP B-Disease
- HYPH I-NP I-Disease
Hodgkins NNP I-NP I-Disease
lymphoma NN I-NP I-Disease
( ( O O
standardized JJ B-NP O
incidence NN I-NP O
ratio NN I-NP O
90 CD I-NP O
, , I-NP O
95 CD I-NP O
% NN I-NP O
confidence NN I-NP O
interval NN I-NP O
18 CD B-NP O
to TO I-NP O
264 CD I-NP O
) ) O O
. . O O

In IN B-PP O
addition NN B-NP O
, , O O
a DT B-NP O
significant JJ I-NP O
excess JJ I-NP O
risk NN I-NP O
of IN B-PP O
basal JJ B-NP B-Disease
cell NN I-NP I-Disease
carcinoma NN I-NP I-Disease
was VBD B-VP O
seen VBN I-VP O
( ( O O
standardized JJ B-NP O
incidence NN I-NP O
ratio NN I-NP O
35 CD I-NP O
, , O O
95 CD B-NP O
% NN I-NP O
confidence NN I-NP O
interval NN I-NP O
7 CD I-NP O
. . O O

2 CD B-NP O
to TO B-PP O
102 CD B-NP O
) ) O O
. . O O

The DT B-NP O
cancer NN I-NP B-Disease
incidence NN I-NP O
among IN B-PP O
the DT B-NP O
siblings NNS I-NP O
or CC O O
the DT B-NP O
parents NNS I-NP O
did VBD B-VP O
not RB I-VP O
differ VB I-VP O
from IN B-PP O
the DT B-NP O
average JJ I-NP O
cancer NN I-NP B-Disease
incidence NN I-NP O
in IN B-PP O
the DT B-NP O
Finnish JJ I-NP O
population NN I-NP O
. . O O

CONCLUSIONS NNS B-NP O
This DT B-NP O
study NN I-NP O
confirms VBZ B-VP O
an DT B-NP O
increased VBN I-NP O
risk NN I-NP O
of IN B-PP O
cancer NN B-NP B-Disease
, , O O
especially RB B-ADVP O
non AFX B-NP B-Disease
- HYPH I-NP I-Disease
Hodgkins NNP I-NP I-Disease
lymphoma NN I-NP I-Disease
, , O O
probably RB B-ADVP O
attributable JJ B-ADJP O
to TO B-PP O
defective JJ B-NP O
immunity NN I-NP O
, , O O
among IN B-PP O
patients NNS B-NP O
with IN B-PP O
CHH NN B-NP B-Disease
. . O O

Genotype NN B-NP O
and CC I-NP O
phenotype NN I-NP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
dihydropyrimidine NN B-NP B-Disease
dehydrogenase NN I-NP I-Disease
deficiency NN I-NP I-Disease
. . O O

Dihydropyrimidine NN B-NP B-Disease
dehydrogenase NN I-NP I-Disease
( ( O I-Disease
DPD NN B-NP I-Disease
) ) O I-Disease
deficiency NN B-NP I-Disease
is VBZ B-VP O
an DT B-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
disease NN I-NP I-Disease
characterised VBN B-VP O
by IN B-PP O
thymine NN B-NP O
- HYPH B-NP O
uraciluria NN I-NP O
in IN B-PP O
homozygous JJ B-NP O
deficient JJ I-NP O
patients NNS I-NP O
and CC O O
has VBZ B-VP O
been VBN I-VP O
associated VBN I-VP O
with IN B-PP O
a DT B-NP O
variable JJ I-NP O
clinical JJ I-NP O
phenotype NN I-NP O
. . O O

In IN B-SBAR O
order NN O O
to TO B-VP O
understand VB I-VP O
the DT B-NP O
genetic JJ I-NP O
and CC I-NP O
phenotypic JJ I-NP O
basis NN I-NP O
for IN B-PP O
DPD NN B-NP B-Disease
deficiency NN I-NP I-Disease
, , O O
we PRP B-NP O
have VBP B-VP O
reviewed VBN I-VP O
17 CD B-NP O
families NNS I-NP O
presenting VBG B-VP O
22 CD B-NP O
patients NNS I-NP O
with IN B-PP O
complete JJ B-NP O
deficiency NN I-NP B-Disease
of IN B-PP I-Disease
DPD NN B-NP I-Disease
. . O O

In IN B-PP O
this DT B-NP O
group NN I-NP O
of IN B-PP O
patients NNS B-NP O
, , O O
7 CD B-NP O
different JJ I-NP O
mutations NNS I-NP O
have VBP B-VP O
been VBN I-VP O
identified VBN I-VP O
, , O O
including VBG B-PP O
2 CD B-NP O
deletions NNS I-NP O
[ ( O O
295 CD B-NP O
- HYPH I-NP O
298delTCAT NN I-NP O
, , I-NP O
1897delC NN I-NP O
] ) O O
, , O O
1 CD B-NP O
splice NN I-NP O
- HYPH B-NP O
site NN I-NP O
mutation NN I-NP O
[ ( I-NP O
IVS14 NN I-NP O
+ SYM I-NP O
1G NN I-NP O
> SYM I-NP O
A NN I-NP O
) ) O O
] ) O O
and CC O O
4 CD B-NP O
missense JJ I-NP O
mutations NNS I-NP O
( ( O O
85T NN B-NP O
> SYM I-NP O
C NN I-NP O
, , O O
703C NN B-NP O
> SYM I-NP O
T NNP I-NP O
, , O O
2658G NN B-NP O
> SYM I-NP O
A NN I-NP O
, , O O
2983G NN B-NP O
> SYM B-VP O
T NN B-NP O
) ) O O
. . O O

Analysis NN B-NP O
of IN B-PP O
the DT B-NP O
prevalence NN I-NP O
of IN B-PP O
the DT B-NP O
various JJ I-NP O
mutations NNS I-NP O
among IN B-PP O
DPD NN B-NP B-Disease
patients NNS I-NP O
has VBZ B-VP O
shown VBN I-VP O
that IN B-SBAR O
the DT B-NP O
G NN I-NP O
- SYM B-VP O
- HYPH B-NP O
> SYM I-NP O
A NN I-NP O
point NN I-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
invariant JJ I-NP O
splice NN I-NP O
donor NN I-NP O
site NN I-NP O
is VBZ B-VP O
by IN B-PP O
far RB B-ADVP O
the DT B-NP O
most RBS I-NP O
common JJ I-NP O
( ( O O
52 CD B-NP O
% NN I-NP O
) ) O O
, , O O
whereas IN O O
the DT B-NP O
other JJ I-NP O
six CD I-NP O
mutations NNS I-NP O
are VBP B-VP O
less RBR I-VP O
frequently RB I-VP O
observed VBN I-VP O
. . O O

A DT B-NP O
large JJ I-NP O
phenotypic JJ I-NP O
variability NN I-NP O
has VBZ B-VP O
been VBN I-VP O
observed VBN I-VP O
, , O O
with IN B-PP O
convulsive JJ B-NP B-Disease
disorders NNS I-NP I-Disease
, , O O
motor NN B-NP B-Disease
retardation NN I-NP I-Disease
and CC O O
mental JJ B-NP B-Disease
retardation NN I-NP I-Disease
being VBG B-VP O
the DT B-NP O
most RBS I-NP O
abundant JJ I-NP O
manifestations NNS I-NP O
. . O O

A DT B-NP O
clear JJ I-NP O
correlation NN I-NP O
between IN B-PP O
the DT B-NP O
genotype NN I-NP O
and CC I-NP O
phenotype NN I-NP O
has VBZ B-VP O
not RB I-VP O
been VBN I-VP O
established VBN I-VP O
. . O O

An DT B-NP O
altered VBN I-NP O
beta SYM I-NP O
- HYPH I-NP O
alanine NN I-NP O
, , I-NP O
uracil NN I-NP O
and CC I-NP O
thymine NN I-NP O
homeostasis NN I-NP O
might MD B-VP O
underlie VB I-VP O
the DT B-NP O
various JJ I-NP O
clinical JJ I-NP B-Disease
abnormalities NNS I-NP I-Disease
encountered VBN B-VP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
DPD NN B-NP B-Disease
deficiency NN I-NP I-Disease
. . O O

Fibroblast NN B-NP O
growth NN I-NP O
factor NN I-NP O
homologous JJ I-NP O
factor NN I-NP O
2 CD I-NP O
( ( O O
FHF2 NN B-NP O
) ) O O
: : O O
gene NN B-NP O
structure NN I-NP O
, , O O
expression NN B-NP O
and CC O O
mapping NN B-NP O
to TO B-PP O
the DT B-NP O
Borjeson NNP I-NP B-Disease
- HYPH I-NP I-Disease
Forssman NNP I-NP I-Disease
- HYPH I-NP I-Disease
Lehmann NNP I-NP I-Disease
syndrome NN I-NP I-Disease
region NN I-NP O
in IN B-PP O
Xq26 NN B-NP O
delineated VBN B-VP O
by IN B-PP O
a DT B-NP O
duplication NN I-NP O
breakpoint NN I-NP O
in IN B-PP O
a DT B-NP O
BFLS NN I-NP B-Disease
- HYPH B-NP O
like JJ I-NP O
patient NN I-NP O
. . O O

Borjeson NNP B-NP B-Disease
- HYPH B-NP I-Disease
Forssman NNP I-NP I-Disease
- HYPH I-NP I-Disease
Lehmann NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
BFLS NN B-NP B-Disease
) ) O O
is VBZ B-VP O
a DT B-NP O
syndromal JJ I-NP O
X NN I-NP B-Disease
- HYPH B-VP I-Disease
linked VBN B-NP I-Disease
mental JJ I-NP I-Disease
retardation NN I-NP I-Disease
, , O O
which WDT B-NP O
maps VBZ B-VP O
by IN B-PP O
linkage NN B-NP O
to TO B-PP O
the DT B-NP O
q26 NN I-NP O
region NN I-NP O
of IN B-PP O
the DT B-NP O
human JJ I-NP O
X NN I-NP O
chromosome NN I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
identified VBN I-VP O
a DT B-NP O
male JJ I-NP O
patient NN I-NP O
with IN B-PP O
BFLS NN B-NP B-Disease
- HYPH B-NP O
like JJ I-NP O
features NNS I-NP O
and CC O O
a DT B-NP O
duplication NN I-NP O
, , O O
46 CD B-NP O
, , O O
Y NN B-NP O
, , O O
dup NN B-NP O
( ( O O
X NN B-NP O
) ) O O
( ( O O
q26q28 NN B-NP O
) ) O O
, , O O
inherited VBN B-VP O
from IN B-PP O
his PRP$ B-NP O
phenotypically RB I-NP O
normal JJ I-NP O
mother NN I-NP O
. . O O

Fluorescence NN B-NP O
in FW B-NP O
situ FW I-NP O
hybridisation NN I-NP O
using VBG B-VP O
yeast NN B-NP O
artificial JJ I-NP O
chromosome NN I-NP O
clones NNS I-NP O
from IN B-PP O
Xq26 NN B-NP O
localised VBD B-VP O
the DT B-NP O
duplication NN I-NP O
breakpoint NN I-NP O
to TO B-PP O
an DT B-NP O
approximately RB I-NP O
400 CD I-NP O
- HYPH I-NP O
kb NN I-NP O
interval NN I-NP O
in IN B-PP O
the DT B-NP O
Xq26 NN I-NP O
. . O O

3 CD B-NP O
region NN I-NP O
between IN B-PP O
DXS155 NN B-NP O
and CC I-NP O
DXS294 NN I-NP O
/ SYM B-NP O
DXS730 NN I-NP O
. . O O

Database NN B-NP O
searches NNS I-NP O
and CC O O
analysis NN B-NP O
of IN B-PP O
available JJ B-NP O
genomic JJ I-NP O
DNA NN I-NP O
sequence NN I-NP O
from IN B-PP O
the DT B-NP O
region NN I-NP O
revealed VBD B-VP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
the DT B-NP O
fibroblast NN I-NP O
growth NN I-NP O
factor NN I-NP O
homologous JJ I-NP O
factor NN I-NP O
gene NN I-NP O
, , O O
FHF2 NN B-NP O
, , O O
within IN B-PP O
the DT B-NP O
duplication NN I-NP O
breakpoint NN I-NP O
interval NN I-NP O
. . O O

The DT B-NP O
gene NN I-NP O
structure NN I-NP O
of IN B-PP O
FHF2 NN B-NP O
was VBD B-VP O
determined VBN I-VP O
and CC O O
two CD B-NP O
new JJ I-NP O
exons NNS I-NP O
were VBD B-VP O
identified VBN I-VP O
, , O O
including VBG B-PP O
a DT B-NP O
new JJ I-NP O
5 CD I-NP O
end NN I-NP O
exon NN I-NP O
, , O O
1B NN B-NP O
. . O O

FHF2 NN B-NP O
is VBZ B-VP O
a DT B-NP O
large JJ I-NP O
gene NN I-NP O
extending VBG B-VP O
over IN B-PP O
approximately RB B-NP O
200 CD I-NP O
kb NN I-NP O
in IN B-PP O
Xq26 NN B-NP O
. . O O

3 CD B-NP O
and CC O O
is VBZ B-VP O
composed VBN I-VP O
of IN B-PP O
at IN B-NP O
least JJS I-NP O
seven CD I-NP O
exons NNS I-NP O
. . O O

It PRP B-NP O
shows VBZ B-VP O
tissue NN B-NP O
- HYPH B-NP O
specific JJ I-NP O
alternative JJ I-NP O
splicing NN I-NP O
and CC O O
alternative JJ B-NP O
transcription NN I-NP O
starts NNS I-NP O
. . O O

Northern NN B-NP O
blot NN I-NP O
hybridisation NN I-NP O
showed VBD B-VP O
highest JJS B-NP O
expression NN I-NP O
in IN B-PP O
brain NN B-NP O
and CC O O
skeletal JJ B-NP O
muscle NN I-NP O
. . O O

The DT B-NP O
FHF2 NN I-NP O
gene NN I-NP O
localisation NN I-NP O
and CC I-NP O
tissue NN I-NP O
- HYPH B-NP O
specific JJ I-NP O
expression NN I-NP O
pattern NN I-NP O
suggest VBP B-VP O
it PRP B-NP O
to TO B-VP O
be VB I-VP O
a DT B-NP O
candidate NN I-NP O
gene NN I-NP O
for IN B-PP O
familial JJ B-NP O
cases NNS I-NP O
of IN B-PP O
the DT B-NP O
BFLS NN I-NP B-Disease
syndrome NN I-NP I-Disease
and CC O O
other JJ B-NP O
syndromal JJ I-NP O
and CC I-NP O
non AFX I-NP O
- HYPH I-NP O
specific JJ I-NP O
forms NNS I-NP O
of IN B-PP O
X NN B-NP B-Disease
- HYPH B-VP I-Disease
linked VBN B-NP I-Disease
mental JJ I-NP I-Disease
retardation NN I-NP I-Disease
mapping VBG B-VP O
to TO B-PP O
the DT B-NP O
region NN I-NP O
. . O O

Germline NN B-NP O
E NN I-NP O
- HYPH B-NP O
cadherin NN I-NP O
gene NN I-NP O
( ( O O
CDH1 NN B-NP O
) ) O O
mutations NNS B-NP O
predispose VBP B-VP O
to TO B-PP O
familial JJ B-NP B-Disease
gastric JJ I-NP I-Disease
cancer NN I-NP I-Disease
and CC O O
colorectal JJ B-NP B-Disease
cancer NN I-NP I-Disease
. . O O

Inherited VBN B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
E NN I-NP O
- HYPH B-NP O
cadherin NN I-NP O
gene NN I-NP O
( ( O O
CDH1 NN B-NP O
) ) O O
were VBD B-VP O
described VBN I-VP O
recently RB B-ADVP O
in IN B-PP O
three CD B-NP O
Maori NNP I-NP O
kindreds NNS I-NP O
with IN B-PP O
familial JJ B-NP B-Disease
gastric JJ I-NP I-Disease
cancer NN I-NP I-Disease
. . O O

Familial JJ B-NP B-Disease
gastric JJ I-NP I-Disease
cancer NN I-NP I-Disease
is VBZ B-VP O
genetically RB B-ADJP O
heterogeneous JJ I-ADJP O
and CC O O
it PRP B-NP O
is VBZ B-VP O
not RB O O
clear JJ B-ADJP O
what WDT B-NP O
proportion NN I-NP O
of IN B-PP O
gastric JJ B-NP B-Disease
cancer NN I-NP I-Disease
susceptibility NN I-NP O
in IN B-PP O
non AFX B-NP O
- HYPH I-NP O
Maori NNP I-NP O
populations NNS I-NP O
is VBZ B-VP O
due IN B-PP O
to TO B-PP O
germline NN B-NP O
CDH1 NN I-NP O
mutations NNS I-NP O
. . O O

Therefore RB B-ADVP O
, , O O
we PRP B-NP O
screened VBD B-VP O
eight CD B-NP O
familial JJ I-NP B-Disease
gastric JJ I-NP I-Disease
cancer NN I-NP I-Disease
kindreds NNS I-NP O
of IN B-PP O
British JJ B-NP O
and CC I-NP O
Irish JJ I-NP O
origin NN I-NP O
for IN B-PP O
germline NN B-NP O
CDH1 NN I-NP O
mutations NNS I-NP O
, , O O
by IN B-PP O
SSCP NN B-NP O
analysis NN I-NP O
of IN B-PP O
all DT B-NP O
16 CD I-NP O
exons NNS I-NP O
and CC I-NP O
flanking NN I-NP O
sequences NNS I-NP O
. . O O

Each DT B-NP O
family NN I-NP O
contained VBD B-VP O
( ( O O
i NNS B-NP O
) ) O O
two CD B-NP O
cases NNS I-NP O
of IN B-PP O
gastric JJ B-NP B-Disease
cancer NN I-NP I-Disease
in IN B-PP O
first JJ B-NP O
degree NN I-NP O
relatives NNS I-NP O
with IN B-PP O
one CD B-NP O
affected VBN B-VP O
before IN B-PP O
age NN B-NP O
50 CD B-NP O
years NNS I-NP O
; : O O
or CC O O
( ( O O
ii NNS B-NP O
) ) O O
three CD B-NP O
or CC I-NP O
more JJR I-NP O
cases NNS I-NP O
of IN B-PP O
gastric JJ B-NP B-Disease
cancer NN I-NP I-Disease
. . O O

Novel JJ B-NP O
germline NN I-NP O
CDH1 NN I-NP O
mutations NNS I-NP O
( ( O O
a DT B-NP O
nonsense NN I-NP O
and CC O O
a DT B-NP O
splice NN I-NP O
site NN I-NP O
) ) O O
were VBD B-VP O
detected VBN I-VP O
in IN B-PP O
two CD B-NP O
families NNS I-NP O
( ( O O
25 CD B-NP O
% NN I-NP O
) ) O O
. . O O

Both DT B-NP O
mutations NNS I-NP O
were VBD B-VP O
predicted VBN I-VP O
to TO B-VP O
truncate VB I-VP O
the DT B-NP O
E NN I-NP O
- HYPH B-NP O
cadherin NN I-NP O
protein NN I-NP O
in IN B-PP O
the DT B-NP O
signal NN I-NP O
peptide NN I-NP O
domain NN I-NP O
. . O O

In IN B-PP O
one CD B-NP O
family NN I-NP O
there EX B-NP O
was VBD B-VP O
evidence NN B-NP O
of IN B-PP O
non AFX B-NP O
- HYPH I-NP O
penetrance NN I-NP O
and CC I-NP O
susceptibility NN I-NP O
to TO B-PP O
both CC O O
gastric JJ B-NP B-Disease
and CC I-NP I-Disease
colorectal JJ I-NP I-Disease
cancer NN I-NP I-Disease
; : O O
thus RB B-ADVP O
, , O O
in IN B-PP O
addition NN B-NP O
to TO B-PP O
six CD B-NP O
cases NNS I-NP O
of IN B-PP O
gastric JJ B-NP B-Disease
cancer NN I-NP I-Disease
, , O O
a DT B-NP O
CDH1 NN I-NP O
mutation NN I-NP O
carrier NN I-NP O
developed VBD B-VP O
colorectal JJ B-NP B-Disease
cancer NN I-NP I-Disease
at IN B-PP O
age NN B-NP O
30 CD B-NP O
years NNS I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
confirmed VBN I-VP O
that IN B-SBAR O
germline NN B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
CDH1 NN I-NP O
gene NN I-NP O
cause VBP B-VP O
familial JJ B-NP B-Disease
gastric JJ I-NP I-Disease
cancer NN I-NP I-Disease
in IN B-PP O
non AFX B-NP O
- HYPH I-NP O
Maori NNP I-NP O
populations NNS I-NP O
. . O O

However RB B-ADVP O
, , O O
only RB B-NP O
a DT I-NP O
minority NN I-NP O
of IN B-PP O
familial JJ B-NP O
gastric JJ I-NP B-Disease
cancers NNS I-NP I-Disease
can MD B-VP O
be VB I-VP O
accounted VBN I-VP O
for IN B-PP O
by IN B-PP O
CDH1 NN B-NP O
mutations NNS I-NP O
. . O O

Loss NN B-NP O
of IN B-PP O
E NN B-NP O
- HYPH B-NP O
cadherin NN I-NP O
function NN I-NP O
has VBZ B-VP O
been VBN I-VP O
implicated VBN I-VP O
in IN B-PP O
the DT B-NP O
pathogenesis NN I-NP O
of IN B-PP O
sporadic JJ B-NP O
colorectal JJ I-NP B-Disease
and CC I-NP I-Disease
other JJ I-NP I-Disease
cancers NNS I-NP I-Disease
, , O O
and CC O O
our PRP$ B-NP O
findings NNS I-NP O
provide VBP B-VP O
evidence NN B-NP O
that IN B-SBAR O
germline NN B-NP O
CDH1 NN I-NP O
mutations NNS I-NP O
predispose VBP B-VP O
to TO B-PP O
early JJ B-NP O
onset NN I-NP O
colorectal JJ I-NP B-Disease
cancer NN I-NP I-Disease
. . O O

Thus RB B-ADVP O
, , O O
CDH1 NN B-NP O
should MD B-VP O
be VB I-VP O
investigated VBN I-VP O
as IN B-PP O
a DT B-NP O
cause NN I-NP O
of IN B-PP O
inherited VBN B-NP O
susceptibility NN I-NP O
to TO B-PP O
both CC O O
gastric JJ B-NP B-Disease
and CC I-NP I-Disease
colorectal JJ I-NP I-Disease
cancers NNS I-NP I-Disease
. . O O

A DT B-NP O
zinc NN I-NP O
finger NN I-NP O
truncation NN I-NP O
of IN B-PP O
murine JJ B-NP O
WT1 NN I-NP O
results VBZ B-VP O
in IN B-PP O
the DT B-NP O
characteristic JJ I-NP O
urogenital JJ I-NP B-Disease
abnormalities NNS I-NP I-Disease
of IN B-PP O
Denys NNP B-NP B-Disease
- HYPH I-NP I-Disease
Drash NNP I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

The DT B-NP O
Wilms NNP I-NP B-Disease
tumor NN I-NP I-Disease
- HYPH B-NP O
suppressor NN I-NP O
gene NN I-NP O
, , O O
WT1 NN B-NP O
, , O O
plays VBZ B-VP O
a DT B-NP O
key JJ I-NP O
role NN I-NP O
in IN B-PP O
urogenital JJ B-NP O
development NN I-NP O
, , O O
and CC O O
WT1 NN B-NP B-Disease
dysfunction NN I-NP I-Disease
is VBZ B-VP O
implicated VBN I-VP O
in IN B-PP O
both CC O O
neoplastic JJ O B-Disease
( ( O O
Wilms NNP B-NP B-Disease
tumor NN I-NP I-Disease
, , O O
mesothelioma NN B-NP B-Disease
, , O O
leukemias NNS B-NP B-Disease
, , O O
and CC O O
breast NN B-NP B-Disease
cancer NN I-NP I-Disease
) ) O O
and CC O O
nonneoplastic JJ B-NP B-Disease
( ( O O
glomerulosclerosis NN B-NP B-Disease
) ) O O
disease NN B-NP O
. . O O

The DT B-NP O
analysis NN I-NP O
of IN B-PP O
diseases NNS B-NP O
linked VBN B-VP O
specifically RB B-ADVP O
with IN B-PP O
WT1 NN B-NP O
mutations NNS I-NP O
, , O O
such JJ B-PP O
as IN I-PP O
Denys NNPS B-NP B-Disease
- HYPH I-NP I-Disease
Drash NN I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
DDS NN B-NP B-Disease
) ) O O
, , O O
can MD B-VP O
provide VB I-VP O
valuable JJ B-NP O
insight NN I-NP O
concerning VBG B-VP O
the DT B-NP O
role NN I-NP O
of IN B-PP O
WT1 NN B-NP O
in IN B-PP O
development NN B-NP O
and CC I-NP O
disease NN I-NP O
. . O O

DDS NN B-NP B-Disease
is VBZ B-VP O
a DT B-NP O
rare JJ I-NP O
childhood NN I-NP O
disease NN I-NP O
characterized VBN B-VP O
by IN B-PP O
a DT B-NP O
nephropathy NN I-NP B-Disease
involving VBG B-VP O
mesangial JJ B-NP B-Disease
sclerosis NN I-NP I-Disease
, , O O
XY NN B-NP O
pseudohermaphroditism NN I-NP B-Disease
, , O O
and CC O O
/ SYM B-NP O
or CC O O
Wilms NNP B-NP B-Disease
tumor NN I-NP I-Disease
( ( O O
WT NN B-NP B-Disease
) ) O O
. . O O

DDS NN B-NP B-Disease
patients NNS I-NP O
are VBP B-VP O
constitutionally RB B-ADJP O
heterozygous JJ I-ADJP O
for IN B-PP O
exonic JJ B-NP O
point NN I-NP O
mutations NNS I-NP O
in IN B-PP O
WT1 NN B-NP O
, , O O
which WDT B-NP O
include VBP B-VP O
mutations NNS B-NP O
predicted VBN B-VP O
to TO B-VP O
truncate VB I-VP O
the DT B-NP O
protein NN I-NP O
within IN B-PP O
the DT B-NP O
C NN I-NP O
- HYPH B-NP O
terminal JJ I-NP O
zinc NN I-NP O
finger NN I-NP O
( ( O O
ZF NN B-NP O
) ) O O
region NN B-NP O
. . O O

We PRP B-NP O
report VBP B-VP O
that IN B-SBAR O
heterozygosity NN B-NP O
for IN B-PP O
a DT B-NP O
targeted VBN I-NP O
murine JJ I-NP O
Wt1 NN I-NP O
allele NN I-NP O
, , O O
Wt1 NN B-NP O
( ( O O
tmT396 NN B-NP O
) ) O O
, , O O
which WDT B-NP O
truncates VBZ B-VP O
ZF3 NN B-NP O
at IN B-PP O
codon NN B-NP O
396 CD I-NP O
, , O O
induces VBZ B-VP O
mesangial JJ B-NP B-Disease
sclerosis NN I-NP I-Disease
characteristic JJ B-ADJP O
of IN B-PP O
DDS NN B-NP B-Disease
in IN B-PP O
adult JJ B-NP O
heterozygous JJ I-NP O
and CC I-NP O
chimeric JJ I-NP O
mice NNS I-NP O
. . O O

Male JJ B-NP B-Disease
genital JJ I-NP I-Disease
defects NNS I-NP I-Disease
also RB B-ADVP O
were VBD B-VP O
evident JJ B-ADJP O
and CC O O
there EX B-NP O
was VBD B-VP O
a DT B-NP O
single JJ I-NP O
case NN I-NP O
of IN B-PP O
Wilms NNP B-NP B-Disease
tumor NN I-NP I-Disease
in IN B-PP O
which WDT B-NP O
the DT B-NP O
transcript NN I-NP O
of IN B-PP O
the DT B-NP O
nontargeted JJ I-NP O
allele NN I-NP O
showed VBD B-VP O
an DT B-NP O
exon NN I-NP O
9 CD I-NP O
skipping NN I-NP O
event NN I-NP O
, , O O
implying VBG B-VP O
a DT B-NP O
causal JJ I-NP O
link NN I-NP O
between IN B-PP O
Wt1 NN B-NP B-Disease
dysfunction NN I-NP I-Disease
and CC O O
Wilms NNP B-NP B-Disease
tumorigenesis NN I-NP I-Disease
in IN B-PP O
mice NNS B-NP O
. . O O

However RB B-ADVP O
, , O O
the DT B-NP O
mutant JJ I-NP O
WT1 NN I-NP O
( ( O O
tmT396 NN B-NP O
) ) O O
protein NN B-NP O
accounted VBD B-VP O
for IN B-PP O
only RB B-NP O
5 CD I-NP O
% NN I-NP O
of IN B-PP O
WT1 NN B-NP O
in IN B-PP O
both CC B-NP O
heterozygous JJ I-NP O
embryonic JJ I-NP O
stem NN I-NP O
cells NNS I-NP O
and CC O O
the DT B-NP O
WT NN I-NP B-Disease
. . O O

This DT B-NP O
has VBZ B-VP O
implications NNS B-NP O
regarding VBG B-VP O
the DT B-NP O
mechanism NN I-NP O
by IN B-PP O
which WDT B-NP O
the DT B-NP O
mutant JJ I-NP O
allele NN I-NP O
exerts VBZ B-VP O
its PRP$ B-NP O
effect NN I-NP O
. . O O

Mechanism NN B-NP O
of IN B-PP O
increased VBN B-NP O
iron NN I-NP O
absorption NN I-NP O
in IN B-PP O
murine JJ B-NP O
model NN I-NP O
of IN B-PP O
hereditary JJ B-NP B-Disease
hemochromatosis NN I-NP I-Disease
: : O O
increased VBN B-NP O
duodenal JJ I-NP O
expression NN I-NP O
of IN B-PP O
the DT B-NP O
iron NN I-NP O
transporter NN I-NP O
DMT1 NN I-NP O
. . O O

Hereditary JJ B-NP B-Disease
hemochromatosis NN I-NP I-Disease
( ( O O
HH NN B-NP B-Disease
) ) O O
is VBZ B-VP O
a DT B-NP O
common JJ I-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
disorder NN I-NP I-Disease
characterized VBN B-VP O
by IN B-PP O
tissue NN B-NP O
iron NN I-NP O
deposition NN I-NP O
secondary JJ B-ADJP O
to TO B-PP O
excessive JJ B-NP O
dietary JJ I-NP O
iron NN I-NP O
absorption NN I-NP O
. . O O

We PRP B-NP O
recently RB B-ADVP O
reported VBD B-VP O
that IN B-SBAR O
HFE NN B-NP O
, , O O
the DT B-NP O
protein NN I-NP O
defective JJ B-ADJP O
in IN B-PP O
HH NN B-NP B-Disease
, , O O
was VBD B-VP O
physically RB I-VP O
associated VBN I-VP O
with IN B-PP O
the DT B-NP O
transferrin NN I-NP O
receptor NN I-NP O
( ( O O
TfR NN B-NP O
) ) O O
in IN B-PP O
duodenal JJ B-NP O
crypt NN I-NP O
cells NNS I-NP O
and CC O O
proposed VBD B-VP O
that IN B-SBAR O
mutations NNS B-NP O
in IN B-PP O
HFE NN B-NP O
attenuate VBP B-VP O
the DT B-NP O
uptake NN I-NP O
of IN B-PP O
transferrin NN B-NP O
- HYPH O O
bound VBN B-NP O
iron NN I-NP O
from IN B-PP O
plasma NN B-NP O
by IN B-PP O
duodenal JJ B-NP O
crypt NN I-NP O
cells NNS I-NP O
, , O O
leading VBG B-VP O
to TO B-PP O
up RB B-ADVP O
- HYPH O O
regulation NN B-NP O
of IN B-PP O
transporters NNS B-NP O
for IN B-PP O
dietary JJ B-NP O
iron NN I-NP O
. . O O

Here RB B-ADVP O
, , O O
we PRP B-NP O
tested VBD B-VP O
the DT B-NP O
hypothesis NN I-NP O
that IN B-SBAR O
HFE NN B-NP O
- HYPH O O
/ SYM O O
- HYPH O O
mice NNS B-NP O
have VBP B-VP O
increased VBN I-VP O
duodenal JJ B-NP O
expression NN I-NP O
of IN B-PP O
the DT B-NP O
divalent JJ I-NP O
metal NN I-NP O
transporter NN I-NP O
( ( O O
DMT1 NN B-NP O
) ) O O
. . O O

By IN B-PP O
4 CD B-NP O
weeks NNS I-NP O
of IN B-PP O
age NN B-NP O
, , O O
the DT B-NP O
HFE NN I-NP O
- HYPH O O
/ SYM O O
- HYPH O O
mice NNS B-NP O
demonstrated VBD B-VP O
iron NN B-NP O
loading NN I-NP O
when WRB B-ADVP O
compared VBN B-PP O
with IN B-PP O
HFE NN B-NP O
+ SYM B-NP O
/ SYM B-VP O
+ SYM B-NP O
littermates NNS I-NP O
, , O O
with IN B-PP O
elevated VBN B-NP O
transferrin NN I-NP O
saturations NNS I-NP O
( ( O O
68 CD B-NP O
. . O O

4 CD B-NP O
% NN I-NP O
vs NNS I-NP O
. . O O

49 CD B-NP O
. . O O

8 CD B-NP O
% NN I-NP O
) ) O O
and CC O O
elevated JJ B-NP O
liver NN I-NP O
iron NN I-NP O
concentrations NNS I-NP O
( ( O O
985 CD B-NP O
micrograms NNS I-NP O
vs CC O O
. . O O

381 CD B-NP O
micrograms NNS I-NP O
) ) O O
. . O O

By IN B-PP O
using VBG B-VP O
Northern JJ B-NP O
blot NN I-NP O
analyses NNS I-NP O
, , O O
we PRP B-NP O
quantitated VBD B-VP O
duodenal JJ B-NP O
expression NN I-NP O
of IN B-PP O
both DT B-NP O
classes NNS I-NP O
of IN B-PP O
DMT1 NN B-NP O
transcripts NNS I-NP O
one CD B-NP O
containing VBG B-VP O
an DT B-NP O
iron NN I-NP O
responsive JJ I-NP O
element NN I-NP O
( ( O O
IRE NN B-NP O
) ) O O
, , O O
called VBN B-VP O
DMT1 NN B-NP O
( ( O O
IRE NN B-NP O
) ) O O
, , O O
and CC O O
one CD B-NP O
containing VBG B-VP O
no DT B-NP O
IRE NN I-NP O
, , O O
called VBN B-VP O
DMT1 NN B-NP O
( ( O O
non AFX O O
- HYPH O O
IRE NN B-NP O
) ) O O
. . O O

The DT B-NP O
positive JJ I-NP O
control NN I-NP O
for IN B-PP O
DMT1 NN B-NP O
up RB B-ADVP O
- HYPH B-NP O
regulation NN I-NP O
was VBD B-VP O
a DT B-NP O
murine JJ I-NP O
model NN I-NP O
of IN B-PP O
dietary JJ B-NP B-Disease
iron NN I-NP I-Disease
deficiency NN I-NP I-Disease
that WDT B-NP O
demonstrated VBD B-VP O
greatly RB B-NP O
increased VBN I-NP O
levels NNS I-NP O
of IN B-PP O
duodenal JJ B-NP O
DMT1 NN I-NP O
( ( O O
IRE NN B-NP O
) ) O O
mRNA NN B-NP O
. . O O

HFE NN B-NP O
- HYPH O O
/ SYM O O
- HYPH O O
mice NNS B-NP O
also RB B-ADVP O
demonstrated VBD B-VP O
an DT B-NP O
increase NN I-NP O
in IN B-PP O
duodenal JJ B-NP O
DMT1 NN I-NP O
( ( O O
IRE NN B-NP O
) ) O O
mRNA NN B-NP O
( ( O O
average NN B-NP O
7 CD I-NP O
. . O O

7 CD B-NP O
- HYPH O O
fold RB B-ADVP O
) ) O O
, , O O
despite IN B-PP O
their PRP$ B-NP O
elevated VBN I-NP O
transferrin NN I-NP O
saturation NN I-NP O
and CC O O
hepatic JJ B-NP O
iron NN I-NP O
content NN I-NP O
. . O O

Duodenal JJ B-NP O
expression NN I-NP O
of IN B-PP O
DMT1 NN B-NP O
( ( O O
non AFX O O
- HYPH B-NP O
IRE NN I-NP O
) ) O O
was VBD B-VP O
not RB I-VP O
increased VBN I-VP O
, , O O
nor CC O O
was VBD B-VP O
hepatic JJ B-NP O
expression NN I-NP O
of IN B-PP O
DMT1 NN B-NP O
increased VBD B-VP O
. . O O

These DT B-NP O
data NNS I-NP O
support VBP B-VP O
the DT B-NP O
model NN I-NP O
for IN B-PP O
HH NN B-NP O
in IN B-PP O
which WDT B-NP O
HFE NN B-NP O
mutations NNS I-NP O
lead VBP B-VP O
to TO B-PP O
inappropriately RB B-NP O
low JJ I-NP O
crypt NN I-NP O
cell NN I-NP O
iron NN I-NP O
, , O O
with IN B-PP O
resultant JJ B-NP O
stabilization NN I-NP O
of IN B-PP O
DMT1 NN B-NP O
( ( O O
IRE NN B-NP O
) ) O O
mRNA NN B-NP O
, , O O
up RB B-ADVP O
- HYPH B-NP O
regulation NN I-NP O
of IN B-PP O
DMT1 NN B-NP O
, , O O
and CC O O
increased VBN B-NP O
absorption NN I-NP O
of IN B-PP O
dietary JJ B-NP O
iron NN I-NP O
. . O O

Neurophysiologic JJ B-NP O
follow VB B-VP O
- HYPH O O
up RP B-PRT O
of IN B-PP O
long JJ B-NP O
- HYPH I-NP O
term NN I-NP O
dietary JJ I-NP O
treatment NN I-NP O
in IN B-PP O
adult NN B-NP O
- HYPH B-NP O
onset NN I-NP O
adrenoleukodystrophy NN I-NP B-Disease
. . O O

OBJECTIVE NN B-NP O
To TO B-VP O
monitor VB I-VP O
the DT B-NP O
effects NNS I-NP O
of IN B-PP O
dietary JJ B-NP O
treatment NN I-NP O
in IN B-PP O
adult NN B-NP O
- HYPH O O
onset NN B-NP O
adrenoleukodystrophy NN I-NP B-Disease
( ( O O
ALD NN B-NP B-Disease
) ) O O
by IN B-PP O
means NNS B-NP O
of IN B-PP O
somatosensory JJ B-NP O
evoked JJ I-NP O
potentials NNS I-NP O
( ( O O
SEPs NNS B-NP O
) ) O O
and CC O O
motor NN B-NP O
evoked VBN I-NP O
potentials NNS I-NP O
( ( O O
MEPs NNS B-NP O
) ) O O
. . O O

BACKGROUND NN B-NP O
SEPs NNS I-NP O
and CC I-NP O
MEPs NNS I-NP O
have VBP B-VP O
proved VBN I-VP O
useful JJ B-ADJP O
in IN B-PP O
revealing VBG B-VP O
signs NNS B-NP O
of IN B-PP O
progressively RB B-NP O
severe JJ I-NP O
, , I-NP O
central JJ I-NP O
dying NN I-NP B-Disease
- HYPH B-NP I-Disease
back JJ I-NP I-Disease
axonopathy NN I-NP I-Disease
in IN B-PP O
early JJ B-NP O
stages NNS I-NP O
of IN B-PP O
adult JJ B-NP O
- HYPH I-NP O
onset NN I-NP O
ALD NN I-NP B-Disease
. . O O

METHODS NNS B-NP O
Eight CD B-NP O
patients NNS I-NP O
with IN B-PP O
adult JJ B-NP O
- HYPH I-NP O
onset NN I-NP O
ALD NN I-NP B-Disease
underwent VBD B-VP O
clinical JJ B-NP O
examination NN I-NP O
, , I-NP O
brain NN I-NP O
and CC I-NP O
spine NN I-NP O
MRI NN I-NP O
, , O O
and CC O O
SEP NN B-NP O
and CC I-NP O
MEP NN I-NP O
studies NNS I-NP O
before IN B-PP O
and CC I-PP O
after IN I-PP O
3 CD B-NP O
years NNS I-NP O
of IN B-PP O
Lorenzos NNP B-NP O
oil NN I-NP O
dietary JJ I-NP O
therapy NN I-NP O
. . O O

RESULTS NNS B-NP O
Before IN B-PP O
treatment NN B-NP O
, , O O
brain NN B-NP O
MRI NN I-NP O
was VBD B-VP O
normal JJ B-ADJP O
in IN B-PP O
five CD B-NP O
patients NNS I-NP O
. . O O

Three CD B-NP O
of IN B-PP O
these DT B-NP O
patients NNS I-NP O
had VBD B-VP O
pure JJ B-NP O
spinal JJ I-NP B-Disease
SEP NN I-NP I-Disease
abnormalities NNS I-NP I-Disease
and CC B-PP O
in IN B-PP O
the DT B-NP O
remaining VBG I-NP O
two CD I-NP O
patients NNS I-NP O
SEPs NNS I-NP O
showed VBD B-VP O
signs NNS B-NP O
of IN B-PP O
involvement NN B-NP O
of IN B-PP O
both CC O O
the DT B-NP O
spinal JJ I-NP O
and CC I-NP O
cerebral JJ I-NP O
somatosensory JJ I-NP O
tracts NNS I-NP O
. . O O

After IN B-PP O
treatment NN B-NP O
, , O O
the DT B-NP O
three CD I-NP O
patients NNS I-NP O
with IN B-PP O
pure JJ B-NP O
spinal JJ I-NP B-Disease
abnormalities NNS I-NP I-Disease
showed VBD B-VP O
clinical JJ B-NP O
and CC I-NP O
neurophysiologic JJ I-NP O
worsening NN I-NP O
, , O O
whereas IN O O
the DT B-NP O
two CD I-NP O
patients NNS I-NP O
with IN B-PP O
a DT B-NP O
more RBR I-NP O
advanced JJ I-NP O
stage NN I-NP O
of IN B-PP O
disease NN B-NP O
( ( O O
exhibited VBN B-VP O
by IN B-PP O
SEPs NNS B-NP O
) ) O O
showed VBD B-VP O
substantially RB B-NP O
unchanged JJ I-NP O
clinical JJ I-NP O
and CC I-NP O
neurophysiologic JJ I-NP O
features NNS I-NP O
. . O O

The DT B-NP O
patients NNS I-NP O
with IN B-PP O
abnormal JJ B-NP O
brain NN I-NP O
MRI NN I-NP O
at IN B-PP O
the DT B-NP O
onset NN I-NP O
of IN B-PP O
treatment NN B-NP O
showed VBD B-VP O
clinical JJ B-NP O
and CC I-NP O
neurophysiologic JJ I-NP O
worsening NN I-NP O
. . O O

CONCLUSIONS NNS B-NP O
Lorenzos NNS I-NP O
oil NN I-NP O
therapy NN I-NP O
had VBD B-VP O
no DT B-NP O
effect NN I-NP O
on IN B-PP O
patients NNS B-NP O
with IN B-PP O
evidence NN B-NP O
of IN B-PP O
inflammatory JJ B-NP B-Disease
brain NN I-NP I-Disease
lesions NNS I-NP I-Disease
. . O O

Moreover RB B-ADVP O
, , O O
in IN B-PP O
patients NNS B-NP O
without IN B-PP O
clear JJ B-NP O
signs NNS I-NP O
of IN B-PP O
inflammatory JJ B-NP O
damage NN I-NP O
, , O O
this DT B-NP O
treatment NN I-NP O
does VBZ B-VP O
not RB I-VP O
modify VB I-VP O
significantly RB B-ADVP O
the DT B-NP O
natural JJ I-NP O
course NN I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
. . O O

However RB B-ADVP O
, , O O
because IN B-SBAR O
effective JJ B-NP O
treatments NNS I-NP O
should MD B-VP O
begin VB I-VP O
before IN B-SBAR O
the DT B-NP O
onset NN I-NP O
of IN B-PP O
severe JJ B-NP O
neurologic JJ I-NP O
symptoms NNS I-NP O
, , I-NP O
SEPs NNS I-NP O
and CC I-NP O
MEPs NNS I-NP O
should MD B-VP O
be VB I-VP O
considered VBN I-VP O
to TO B-VP O
evaluate VB I-VP O
the DT B-NP O
effectiveness NN I-NP O
of IN B-PP O
other JJ B-NP O
experimental JJ I-NP O
treatments NNS I-NP O
in IN B-PP O
the DT B-NP O
patient NN I-NP O
with IN B-PP O
a DT B-NP O
negative JJ I-NP O
brain NN I-NP O
MRI NN I-NP O
. . O O

GCH1 NN B-NP O
mutation NN I-NP O
in IN B-PP O
a DT B-NP O
patient NN I-NP O
with IN B-PP O
adult NN B-NP O
- HYPH B-NP O
onset NN I-NP O
oromandibular JJ I-NP B-Disease
dystonia NN I-NP I-Disease
. . O O

The DT B-NP O
authors NNS I-NP O
report VBP B-VP O
a DT B-NP O
mutation NN I-NP O
in IN B-PP O
exon NN B-NP O
5 CD I-NP O
of IN B-PP O
GCH1 NN B-NP O
in IN B-PP O
a DT B-NP O
patient NN I-NP O
with IN B-PP O
adult NN B-NP O
- HYPH B-NP O
onset NN I-NP O
oromandibular JJ I-NP B-Disease
dystonia NN I-NP I-Disease
and CC O O
no DT B-NP O
obvious JJ I-NP O
family NN I-NP O
history NN I-NP O
of IN B-PP O
dystonia NN B-NP B-Disease
. . O O

The DT B-NP O
patient NN I-NP O
responded VBD B-VP O
positively RB B-ADVP O
to TO B-PP O
treatment NN B-NP O
with IN B-PP O
L NN B-NP O
- HYPH B-NP O
dopa NN I-NP O
. . O O

These DT B-NP O
findings NNS I-NP O
demonstrate VBP B-VP O
that IN B-SBAR O
GCH1 NN B-NP O
mutations NNS I-NP O
must MD B-VP O
be VB I-VP O
considered VBN I-VP O
even RB B-ADVP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
dystonic JJ B-NP B-Disease
symptoms NNS I-NP O
not RB O O
typical JJ B-ADJP O
of IN B-PP O
dopa NN B-NP B-Disease
- HYPH B-NP I-Disease
responsive JJ I-NP I-Disease
dystonia NN I-NP I-Disease
. . O O

Germline NN B-NP O
mutations NNS I-NP O
of IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
in IN B-PP O
Korean JJ B-NP O
familial JJ I-NP B-Disease
adenomatous JJ I-NP I-Disease
polyposis NN I-NP I-Disease
patients NNS I-NP O
. . O O

We PRP B-NP O
extensively RB B-ADVP O
analyzed VBD B-VP O
genomic JJ B-NP O
DNA NN I-NP O
and CC O O
messenger NN B-NP O
RNA NN I-NP O
( ( O O
mRNA NN B-NP O
) ) O O
from IN B-PP O
62 CD B-NP O
unrelated JJ I-NP O
Korean JJ I-NP O
patients NNS I-NP O
with IN B-PP O
familial JJ B-NP B-Disease
adenomatous JJ I-NP I-Disease
polyposis NN I-NP I-Disease
( ( O O
FAP NN B-NP B-Disease
) ) O O
for IN B-PP O
identification NN B-NP O
of IN B-PP O
germline NN B-NP O
adenomatous JJ I-NP B-Disease
polyposis NN I-NP I-Disease
coli NN I-NP I-Disease
( ( O O
APC NN B-NP B-Disease
) ) O O
gene NN B-NP O
mutations NNS I-NP O
. . O O

We PRP B-NP O
adopted VBD B-VP O
both CC O O
single JJ B-NP O
- HYPH I-NP O
strand NN I-NP O
conformation NN I-NP O
polymorphism NN I-NP O
( ( O O
SSCP NN B-NP O
) ) O O
analysis NN B-NP O
and CC O O
a DT B-NP O
method NN I-NP O
of IN B-PP O
analysis NN B-NP O
involving VBG B-VP O
the DT B-NP O
reverse JJ I-NP O
transcription NN I-NP O
- HYPH B-NP O
polymerase NN I-NP O
chain NN I-NP O
reaction NN I-NP O
( ( O O
RT NN B-NP O
- HYPH B-NP O
PCR NN I-NP O
) ) O O
followed VBN B-VP O
by IN B-PP O
a DT B-NP O
protein NN I-NP O
truncation NN I-NP O
test NN I-NP O
( ( O O
PTT NN B-NP O
) ) O O
. . O O

DNA NN B-NP O
sequencing NN I-NP O
confirmed VBD B-VP O
all DT B-NP O
alterations NNS I-NP O
represented VBN B-VP O
by IN B-PP O
aberrant JJ B-NP O
bands NNS I-NP O
. . O O

Germline NN B-NP O
mutations NNS I-NP O
were VBD B-VP O
identified VBN I-VP O
in IN B-PP O
38 CD B-NP O
patients NNS I-NP O
( ( O O
61 CD B-NP O
% NN I-NP O
) ) O O
. . O O

Nineteen CD B-NP O
of IN B-PP O
the DT B-NP O
detected VBN I-NP O
mutations NNS I-NP O
were VBD B-VP O
presumed VBN I-VP O
to TO I-VP O
be VB I-VP O
novel JJ B-ADJP O
, , O O
thus RB B-ADVP O
emphasizing VBG B-VP O
the DT B-NP O
heterogeneity NN I-NP O
of IN B-PP O
the DT B-NP O
mutational JJ I-NP O
spectrum NN I-NP O
in IN B-PP O
Korean JJ B-NP O
FAP NN I-NP B-Disease
patients NNS I-NP O
. . O O

In IN B-PP O
the DT B-NP O
initial JJ I-NP O
48 CD I-NP O
patients NNS I-NP O
, , O O
SSCP NN B-NP O
analysis NN I-NP O
was VBD B-VP O
followed VBN I-VP O
by IN B-PP O
PTT NN B-NP O
for IN B-PP O
those DT B-NP O
patients NNS I-NP O
for IN B-PP O
whom WP B-NP O
no DT B-NP O
detectable JJ I-NP O
mutations NNS I-NP O
were VBD B-VP O
found VBN I-VP O
by IN B-PP O
SSCP NN B-NP O
. . O O

Using VBG B-VP O
this DT B-NP O
combined VBN I-NP O
approach NN I-NP O
, , O O
we PRP B-NP O
identified VBD B-VP O
germline NN B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
mutations NNS I-NP O
in IN B-PP O
29 CD B-NP O
of IN B-PP O
the DT B-NP O
48 CD I-NP O
FAP NN I-NP B-Disease
patients NNS I-NP O
( ( O O
60 CD B-NP O
% NN I-NP O
) ) O O
, , O O
including VBG B-PP O
6 CD B-NP O
patients NNS I-NP O
in IN B-PP O
whom WP B-NP O
SSCP NN B-NP O
analysis NN I-NP O
failed VBD B-VP O
to TO I-VP O
distinguish VB I-VP O
the DT B-NP O
mutant JJ I-NP O
allele NN I-NP O
. . O O

In IN B-PP O
the DT B-NP O
14 CD I-NP O
later JJ I-NP O
patients NNS I-NP O
, , O O
we PRP B-NP O
identified VBD B-VP O
truncating VBG I-VP O
mutations NNS B-NP O
in IN B-PP O
9 CD B-NP O
patients NNS I-NP O
( ( O O
64 CD B-NP O
% NN I-NP O
) ) O O
using VBG B-VP O
PTT NN B-NP O
only RB B-ADVP O
. . O O

Our PRP$ B-NP O
results NNS I-NP O
confirm VBP B-VP O
that IN B-SBAR O
the DT B-NP O
mutation NN I-NP O
detection NN I-NP O
rate NN I-NP O
with IN B-PP O
PTT NN B-NP O
was VBD B-VP O
superior JJ B-ADJP O
to TO B-PP O
that DT B-NP O
with IN B-PP O
SSCP NN B-NP O
, , O O
and CC O O
suggest VBP B-VP O
that IN B-SBAR O
PTT NN B-NP O
would MD B-VP O
be VB I-VP O
a DT B-NP O
more RBR I-NP O
practical JJ I-NP O
screening NN I-NP O
method NN I-NP O
to TO B-VP O
detect VB I-VP O
germline NN B-NP O
mutations NNS I-NP O
of IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
in IN B-PP O
FAP NN B-NP B-Disease
patients NNS I-NP O
. . O O

Molecular JJ B-NP O
epidemiology NN I-NP O
of IN B-PP O
C9 NN B-NP B-Disease
deficiency NN I-NP I-Disease
heterozygotes NNS I-NP O
with IN B-PP O
an DT B-NP O
Arg95Stop NN I-NP O
mutation NN I-NP O
of IN B-PP O
the DT B-NP O
C9 NN I-NP O
gene NN I-NP O
in IN B-PP O
Japan NNP B-NP O
. . O O

Deficiency NN B-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
ninth JJ I-NP I-Disease
component NN I-NP I-Disease
of IN B-PP I-Disease
human JJ B-NP I-Disease
complement NN I-NP I-Disease
( ( O O
C9 NN B-NP O
) ) O O
is VBZ B-VP O
the DT B-NP O
most RBS I-NP O
common JJ I-NP O
complement NN I-NP B-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
Japan NNP B-NP O
, , O O
with IN B-PP O
an DT B-NP O
incidence NN I-NP O
of IN B-PP O
approximately RB B-NP O
one CD I-NP O
homozygote NN I-NP O
in IN B-PP O
1000 CD B-NP O
, , O O
but CC O O
is VBZ B-VP O
very RB B-ADJP O
rare JJ I-ADJP O
in IN B-PP O
other JJ B-NP O
countries NNS I-NP O
. . O O

Genetic JJ B-NP O
analyses NNS I-NP O
of IN B-PP O
Japanese JJ B-NP O
C9 NN I-NP B-Disease
deficiency NN I-NP I-Disease
have VBP B-VP O
shown VBN I-VP O
that IN B-SBAR O
a DT B-NP O
C NN I-NP O
- HYPH B-ADJP O
to TO B-PP O
- HYPH B-NP O
T NN I-NP O
transition NN I-NP O
leading VBG B-VP O
to TO B-PP O
TGA NN B-NP O
stop NN I-NP O
codon NN I-NP O
for IN B-PP O
Arg95 NN B-NP O
in IN B-PP O
exon NN B-NP O
4 CD I-NP O
of IN B-PP O
the DT B-NP O
C9 NN I-NP O
gene NN I-NP O
( ( O O
Arg95Stop NN B-NP O
) ) O O
is VBZ B-VP O
common JJ B-ADJP O
in IN B-PP O
Japanese JJ B-NP O
C9 NN I-NP B-Disease
deficiency NN I-NP I-Disease
. . O O

To TO B-VP O
determine VB I-VP O
the DT B-NP O
prevalence NN I-NP O
of IN B-PP O
heterozygous JJ B-NP O
carriers NNS I-NP O
of IN B-PP O
the DT B-NP O
Arg95Stop NN I-NP O
mutation NN I-NP O
in IN B-PP O
a DT B-NP O
Japanese JJ I-NP O
population NN I-NP O
, , O O
we PRP B-NP O
collected VBD B-VP O
DNA NN B-NP O
samples NNS I-NP O
from IN B-PP O
300 CD B-NP O
individuals NNS I-NP O
in IN B-PP O
two CD B-NP O
of IN B-PP O
the DT B-NP O
four CD I-NP O
main JJ I-NP O
islands NNS I-NP O
of IN B-PP O
Japan NNP B-NP O
. . O O

Heterozygote NN B-NP O
detection NN I-NP O
was VBD B-VP O
performed VBN I-VP O
with IN B-PP O
an DT B-NP O
allele NN I-NP O
- HYPH B-NP O
specific JJ I-NP O
polymerase NN I-NP O
chain NN I-NP O
reaction NN I-NP O
( ( O O
PCR NN B-NP O
) ) O O
system NN B-NP O
designed VBN B-VP O
to TO B-VP O
detect VB I-VP O
exclusively RB B-ADVP O
only RB B-NP O
one CD I-NP O
of IN B-PP O
the DT B-NP O
normal JJ I-NP O
and CC I-NP O
mutant JJ I-NP O
alleles NNS I-NP O
, , O O
followed VBN B-VP O
by IN B-PP O
confirmation NN B-NP O
with IN B-PP O
PCR NN B-NP O
/ SYM B-NP O
single JJ I-NP O
- HYPH I-NP O
strand NN I-NP O
conformation NN I-NP O
polymorphism NN I-NP O
( ( O O
SSCP NN B-NP O
) ) O O
analysis NN B-NP O
and CC O O
direct JJ B-NP O
sequencing NN I-NP O
. . O O

Twenty CD B-NP O
individuals NNS I-NP O
were VBD B-VP O
heterozygous JJ B-ADJP O
for IN B-PP O
the DT B-NP O
Arg95Stop NN I-NP O
mutation NN I-NP O
. . O O

None NN B-NP O
was VBD B-VP O
homozygous JJ B-ADJP O
. . O O

The DT B-NP O
prevalence NN I-NP O
of IN B-PP O
carriers NNS B-NP O
of IN B-PP O
the DT B-NP O
Arg95Stop NN I-NP O
mutation NN I-NP O
was VBD B-VP O
6 CD B-NP O
. . O O

7 CD B-NP O
% NN I-NP O
( ( O O
20 CD B-NP O
/ SYM I-NP O
300 CD I-NP O
) ) O O
. . O O

An DT B-NP O
estimated VBN I-NP O
frequency NN I-NP O
( ( O O
0 CD B-NP O
. . O O

12 CD B-NP O
% NN I-NP O
) ) O O
of IN B-PP O
complete JJ B-NP O
C9 NN I-NP B-Disease
deficiency NN I-NP I-Disease
due JJ B-ADJP O
to TO B-PP O
homozygous JJ B-NP O
Arg95Stop NN I-NP O
mutation NN I-NP O
was VBD B-VP O
consistent JJ B-ADJP O
with IN B-PP O
frequencies NNS B-NP O
determined VBN B-VP O
by IN B-PP O
serological JJ B-NP O
studies NNS I-NP O
The DT B-NP O
hereditary JJ I-NP B-Disease
hemochromatosis NN I-NP I-Disease
protein NN I-NP O
, , O O
HFE NN B-NP O
, , O O
specifically RB B-ADVP O
regulates VBZ B-VP O
transferrin NN B-NP O
- HYPH O O
mediated VBN B-NP O
iron NN I-NP O
uptake NN I-NP O
in IN B-PP O
HeLa NN B-NP O
cells NNS I-NP O
. . O O

HFE NN B-NP O
is VBZ B-VP O
the DT B-NP O
protein NN I-NP O
product NN I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
mutated VBN B-VP O
in IN B-PP O
the DT B-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
disease NN I-NP I-Disease
hereditary JJ I-NP B-Disease
hemochromatosis NN I-NP I-Disease
( ( O O
Feder NNP B-NP O
, , O O
J NNP B-NP O
. . O O

N NN B-NP O
. NN I-NP O

, , O O
Gnirke NNP B-NP O
, , O O
A NNP B-NP O
. . O O

, , O O
Thomas NNP B-NP O
, , O O
W NNP B-NP O
. . O O

, , O O
Tsuchihashi NNP B-NP O
, , O O
Z NNP B-NP O
. . O O

, , O O
Ruddy NNP B-NP O
, , O O
D NNP B-NP O
. . O O

A DT B-NP O
. NN I-NP O

, , O O
Basava NNP B-NP O
, , O O
A NNP B-NP O
. . O O

, , O O
Dormishian NNP B-NP O
, , O O
F NNP B-NP O
. . O O

, , O O
Domingo NNP B-NP O
, , O O
R NNP B-NP O
. . O O

J NNP B-NP O
. NN I-NP O

, , O O
Ellis NNP B-NP O
, , O O
M NNP B-NP O
. . O O

C NN B-NP O
. NN I-NP O

, , O O
Fullan NNP B-NP O
, , O O
A NNP B-NP O
. . O O

, , O O
Hinton NNP B-NP O
, , O O
L NNP B-NP O
. . O O

M NN B-NP O
. NN I-NP O

, , O O
Jones NNP B-NP O
, , O O
N NNP B-NP O
. . O O

L NN B-NP O
. NN I-NP O

, , O O
Kimmel NNP B-NP O
, , O O
B NNP B-NP O
. . O O

E NN B-NP O
. NN I-NP O

, , O O
Kronmal NNP B-NP O
, , O O
G NNP B-NP O
. . O O

S NN B-NP O
. NN I-NP O

, , O O
Lauer NNP B-NP O
, , O O
P NNP B-NP O
. . O O

, , O O
Lee NNP B-NP O
, , O O
V NNP B-NP O
. . O O

K NN B-NP O
. NN I-NP O

, , O O
Loeb NNP B-NP O
, , O O
D NNP B-NP O
. . O O

B NN B-NP O
. NN I-NP O

, , O O
Mapa NNP B-NP O
, , O O
F NNP B-NP O
. . O O

A DT B-NP O
. NN I-NP O

, , O O
McClelland NNP B-NP O
, , O O
E NNP B-NP O
. . O O

, , O O
Meyer NNP B-NP O
, , O O
N NNP B-NP O
. . O O

C NN B-NP O
. NN I-NP O

, , O O
Mintier NNP B-NP O
, , O O
G NNP B-NP O
. . O O

A DT B-NP O
. NN I-NP O

, , O O
Moeller NNP B-NP O
, , O O
N NNP B-NP O
. . O O

, , O O
Moore NNP B-NP O
, , O O
T NN B-NP O
. NN I-NP O

, , O O
Morikang NNP B-NP O
, , O O
E NNP B-NP O
. . O O

, , O O
Prasss NNP B-NP O
, , O O
C NNP B-NP O
. . O O

E NN B-NP O
. NN I-NP O

, , O O
Quintana NNP B-NP O
, , O O
L NNP B-NP O
. . O O

, , O O
Starnes NNP B-NP O
, , O O
S NNP B-NP O
. . O O

M NN B-NP O
. NN I-NP O

, , O O
Schatzman NNP B-NP O
, , O O
R NNP B-NP O
. . O O

C NN B-NP O
. NN I-NP O

, , O O
Brunke NNP B-NP O
, , O O
K NNP B-NP O
. . O O

J NNP B-NP O
. NN I-NP O

, , O O
Drayna NNP B-NP O
, , O O
D NNP B-NP O
. . O O

T NN B-NP O
. NN I-NP O

, , O O
Risch NN B-NP O
, , O O
N NN B-NP O
. . O O

J NNP B-NP O
. NN I-NP O

, , O O
Bacon NNP B-NP O
, , O O
B NNP B-NP O
. . O O

R NN B-NP O
. NN I-NP O

, , O O
and CC O O
Wolff NNP B-NP O
, , O O
R NNP B-NP O
. . O O

R NN B-NP O
. . O O

( ( O O
1996 CD B-NP O
) ) O O
Nat NNP B-NP O
. . O O

Genet NNP B-NP O
. . O O

13 CD B-NP O
, , I-NP O
399 CD I-NP O
- HYPH I-NP O
408 CD I-NP O
) ) O O
. . O O

At IN B-PP O
the DT B-NP O
cell NN I-NP O
surface NN I-NP O
, , O O
HFE NN B-NP O
complexes NNS I-NP O
with IN B-PP O
transferrin NN B-NP O
receptor NN I-NP O
( ( O O
TfR NN B-NP O
) ) O O
, , O O
increasing VBG B-VP O
the DT B-NP O
dissociation NN I-NP O
constant NN I-NP O
of IN B-PP O
transferrin NN B-NP O
( ( O O
Tf NN B-NP O
) ) O O
for IN B-PP O
its PRP$ B-NP O
receptor NN I-NP O
10 CD I-NP O
- HYPH O O
fold RB O O
( ( O O
Gross NNP B-NP O
, , O O
C NNP B-NP O
. . O O

N NN B-NP O
. NN I-NP O

, , O O
Irrinki NNP B-NP O
, , O O
A NNP B-NP O
. . O O

, , O O
Feder NNP B-NP O
, , O O
J NNP B-NP O
. . I-NP O

N NNP I-NP O
. NN I-NP O

, , O O
and CC O O
Enns NNP B-NP O
, , O O
C NNP B-NP O
. . I-NP O

A NNP I-NP O
. . O O

( ( O O
1998 CD B-NP O
) ) O O
J NNP B-NP O
. . I-NP O

Biol NNP I-NP O
. . I-NP O

Chem NNP I-NP O
. . I-NP O

273 CD I-NP O
, , I-NP O
22068 CD I-NP O
- HYPH B-NP O
22074 CD I-NP O
; : O O
Feder NNP B-NP O
, , O O
J NNP B-NP O
. . I-NP O

N NNP I-NP O
. . O O

, , O O
Penny NNP B-NP O
, , O O
D NNP B-NP O
. . I-NP O

M NNP I-NP O
. . O O

, , O O
Irrinki NNP B-NP O
, , O O
A NNP B-NP O
. . O O

, , O O
Lee NNP B-NP O
, , O O
V NNP B-NP O
. . I-NP O

K NNP I-NP O
. NNP I-NP O

, , O O
Lebron NNP B-NP O
, , O O
J NNP B-NP O
. . I-NP O

A NNP I-NP O
. . O O

, , O O
Watson NNP B-NP O
, , O O
N NNP B-NP O
. . O O

, , O O
Tsuchihashi NNP B-NP O
, , O O
Z NNP B-NP O
. . O O

, , O O
Sigal NNP B-NP O
, , O O
E NNP B-NP O
. . O O

, , O O
Bjorkman NNP B-NP O
, , O O
P NNP B-NP O
. . I-NP O

J NNP I-NP O
. NN I-NP O

, , O O
and CC O O
Schatzman NNP B-NP O
, , O O
R NNP B-NP O
. . I-NP O

C NNP I-NP O
. . O O

( ( O O
1998 CD B-NP O
) ) O O
Proc NNP B-NP O
. . I-NP O

Natl NNP I-NP O
. . O O

Acad NN B-NP O
. . O O

Sci NNS B-NP O
. . O O

U NNP B-NP O
S NNP I-NP O
A NNP I-NP O
95 CD I-NP O
, , I-NP O
1472 CD I-NP O
- HYPH I-NP O
1477 CD I-NP O
) ) O O
. . O O

HFE NN B-NP O
does VBZ B-VP O
not RB I-VP O
remain VB I-VP O
at IN B-PP O
the DT B-NP O
cell NN I-NP O
surface NN I-NP O
, , O O
but CC O O
traffics NNS B-NP O
with IN B-PP O
TfR NN B-NP O
to TO B-PP O
Tf NN B-NP O
- HYPH B-NP O
positive JJ I-NP O
internal JJ I-NP O
compartments NNS I-NP O
( ( O O
Gross NNP B-NP O
et FW I-NP O
al FW I-NP O
. FW I-NP O

, , O O
1998 CD B-NP O
) ) O O
. . O O

Using VBG B-VP O
a DT B-NP O
HeLa NN I-NP O
cell NN I-NP O
line NN I-NP O
in IN B-PP O
which WDT B-NP O
the DT B-NP O
expression NN I-NP O
of IN B-PP O
HFE NN B-NP O
is VBZ B-VP O
controlled VBN I-VP O
by IN B-PP O
tetracycline NN B-NP O
, , O O
we PRP B-NP O
show VBP B-VP O
that IN B-SBAR O
the DT B-NP O
expression NN I-NP O
of IN B-PP O
HFE NN B-NP O
reduces VBZ B-VP O
55Fe NN B-NP O
uptake NN I-NP O
from IN B-PP O
Tf NN B-NP O
by IN B-PP O
33 CD B-NP O
% NN I-NP O
but CC O O
does VBZ B-VP O
not RB I-VP O
affect VB I-VP O
the DT B-NP O
endocytic JJ I-NP O
or CC I-NP O
exocytic JJ I-NP O
rates NNS I-NP O
of IN B-PP O
TfR NN B-NP O
cycling NN I-NP O
. . O O

Therefore RB B-ADVP O
, , O O
HFE NN B-NP O
appears VBZ B-VP O
to TO I-VP O
reduce VB I-VP O
cellular JJ B-NP O
acquisition NN I-NP O
of IN B-PP O
iron NN B-NP O
from IN B-PP O
Tf NN B-NP O
within IN B-PP O
endocytic JJ B-NP O
compartments NNS I-NP O
. . O O

HFE NN B-NP O
specifically RB B-ADVP O
reduces VBZ B-VP O
iron NN B-NP O
uptake NN I-NP O
from IN B-PP O
Tf NN B-NP O
, , O O
as IN B-SBAR O
non AFX O O
- HYPH B-NP O
Tf NN I-NP O
- HYPH B-NP O
mediated VBN I-NP O
iron NN I-NP O
uptake NN I-NP O
from IN B-PP O
Fe NN B-NP O
- HYPH B-NP O
nitrilotriacetic JJ I-NP O
acid NN I-NP O
is VBZ B-VP O
not RB I-VP O
altered VBN I-VP O
. . O O

These DT B-NP O
results NNS I-NP O
explain VBP B-VP O
the DT B-NP O
decreased VBN I-NP O
ferritin NN I-NP O
levels NNS I-NP O
seen VBN B-VP O
in IN B-PP O
our PRP$ B-NP O
HeLa NN I-NP O
cell NN I-NP O
system NN I-NP O
and CC O O
demonstrate VBP B-VP O
the DT B-NP O
specific JJ I-NP O
control NN I-NP O
of IN B-PP O
HFE NN B-NP O
over IN B-PP O
the DT B-NP O
Tf NN I-NP O
- HYPH B-VP O
mediated VBN B-NP O
pathway NN I-NP O
of IN B-PP O
iron NN B-NP O
uptake NN I-NP O
. . O O

These DT B-NP O
results NNS I-NP O
also RB B-ADVP O
have VBP B-VP O
implications NNS B-NP O
for IN B-PP O
the DT B-NP O
understanding NN I-NP O
of IN B-PP O
cellular JJ B-NP O
iron NN I-NP O
homeostasis NN I-NP O
in IN B-PP O
organs NNS B-NP O
such JJ B-PP O
as IN I-PP O
the DT B-NP O
liver NN I-NP O
, , O O
pancreas NN B-NP O
, , O O
heart NN B-NP O
, , O O
and CC O O
spleen NN B-NP O
that WDT B-NP O
are VBP B-VP O
iron NN B-NP O
loaded VBN B-VP O
in IN B-PP O
hereditary JJ B-NP B-Disease
hemochromatotic JJ I-NP I-Disease
individuals NNS I-NP O
lacking VBG B-VP O
functional JJ B-NP O
HFE NN I-NP O
. . O O

Mutation NN B-NP O
and CC I-NP O
haplotype NN I-NP O
studies NNS I-NP O
of IN B-PP O
familial JJ B-NP B-Disease
Mediterranean JJ I-NP I-Disease
fever NN I-NP I-Disease
reveal VBP B-VP O
new JJ B-NP O
ancestral JJ I-NP O
relationships NNS I-NP O
and CC O O
evidence NN B-NP O
for IN B-PP O
a DT B-NP O
high JJ I-NP O
carrier NN I-NP O
frequency NN I-NP O
with IN B-PP O
reduced VBN B-NP O
penetrance NN I-NP O
in IN B-PP O
the DT B-NP O
Ashkenazi NNP I-NP O
Jewish JJ I-NP O
population NN I-NP O
. . O O

Familial JJ B-NP B-Disease
Mediterranean JJ I-NP I-Disease
fever NN I-NP I-Disease
( ( O O
FMF NN B-NP B-Disease
) ) O O
is VBZ B-VP O
a DT B-NP O
recessive JJ I-NP B-Disease
disorder NN I-NP I-Disease
characterized VBN B-VP O
by IN B-PP O
episodes NNS B-NP O
of IN B-PP O
fever NN B-NP O
with IN B-PP O
serositis NN B-NP B-Disease
or CC I-NP O
synovitis NN I-NP B-Disease
. . O O

The DT B-NP O
FMF NN I-NP B-Disease
gene NN I-NP O
( ( O O
MEFV NN B-NP O
) ) O O
was VBD B-VP O
cloned VBN I-VP O
recently RB B-ADVP O
, , O O
and CC O O
four CD B-NP O
missense JJ I-NP O
mutations NNS I-NP O
were VBD B-VP O
identified VBN I-VP O
. . O O

Here RB B-ADVP O
we PRP B-NP O
present VBP B-VP O
data NNS B-NP O
from IN B-PP O
non AFX B-NP O
- HYPH I-NP O
Ashkenazi NN I-NP O
Jewish JJ I-NP O
and CC I-NP O
Arab JJ I-NP O
patients NNS I-NP O
in IN B-PP O
whom WP B-NP O
we PRP B-NP O
had VBD B-VP O
not RB I-VP O
originally RB I-VP O
found VBN I-VP O
mutations NNS B-NP O
and CC B-PP O
from IN B-PP O
a DT B-NP O
new JJ I-NP O
, , I-NP O
more RBR I-NP O
ethnically RB I-NP O
diverse JJ I-NP O
panel NN I-NP O
. . O O

Among IN B-PP O
90 CD B-NP O
symptomatic JJ I-NP O
mutation NN I-NP O
- HYPH B-NP O
positive JJ I-NP O
individuals NNS I-NP O
, , O O
11 CD B-NP O
mutations NNS I-NP O
accounted VBD B-VP O
for IN B-PP O
79 CD B-NP O
% NN I-NP O
of IN B-PP O
carrier NN B-NP O
chromosomes NNS I-NP O
. . O O

Of IN B-PP O
the DT B-NP O
two CD I-NP O
mutations NNS I-NP O
that WDT B-NP O
are VBP B-VP O
novel JJ B-ADJP O
, , O O
one CD B-NP O
alters VBZ B-VP O
the DT B-NP O
same JJ I-NP O
residue NN I-NP O
( ( O O
680 CD B-NP O
) ) O O
as IN B-PP O
a DT B-NP O
previously RB I-NP O
known VBN I-NP O
mutation NN I-NP O
, , O O
and CC O O
the DT B-NP O
other JJ I-NP O
( ( O O
P369S NN B-NP O
) ) O O
is VBZ B-VP O
located VBN I-VP O
in IN B-PP O
exon NN B-NP O
3 CD I-NP O
. . O O

Consistent JJ B-ADJP O
with IN B-PP O
another DT B-NP O
recent JJ I-NP O
report NN I-NP O
, , O O
the DT B-NP O
E148Q NN I-NP O
mutation NN I-NP O
was VBD B-VP O
observed VBN I-VP O
in IN B-PP O
patients NNS B-NP O
of IN B-PP O
several JJ B-NP O
ethnicities NNS I-NP O
and CC B-PP O
on IN B-PP O
multiple JJ B-NP O
microsatellite NN I-NP O
haplotypes NNS I-NP O
, , O O
but CC O O
haplotype NN B-NP O
data NNS I-NP O
indicate VBP B-VP O
an DT B-NP O
ancestral JJ I-NP O
relationships NNS I-NP O
between IN B-PP O
non AFX B-NP O
- HYPH I-NP O
Jewish JJ I-NP O
Italian NNP I-NP O
and CC I-NP O
Ashkenazi NNP I-NP O
Jewish NNP I-NP O
patients NNS I-NP O
with IN B-PP O
FMF NN B-NP B-Disease
and CC O O
other JJ B-NP O
affected VBN I-NP O
populations NNS I-NP O
. . O O

Among IN B-PP O
approximately RB B-NP O
200 CD I-NP O
anonymous JJ I-NP O
Ashkenazi NNP I-NP O
Jewish JJ I-NP O
DNA NN I-NP O
samples NNS I-NP O
, , O O
the DT B-NP O
MEFV NN I-NP O
carrier NN I-NP O
frequency NN I-NP O
was VBD B-VP O
21 CD B-NP O
% NN I-NP O
, , O O
with IN B-PP O
E148Q NN B-NP O
the DT B-NP O
most RBS I-NP O
common JJ I-NP O
mutation NN I-NP O
. . O O

Several JJ B-NP O
lines NNS I-NP O
of IN B-PP O
evidence NN B-NP O
indicate VBP B-VP O
reduced VBN B-NP O
penetrance NN I-NP O
among IN B-PP O
Ashkenazi NNP B-NP O
Jews NNP I-NP O
, , O O
especially RB B-ADVP O
for IN B-PP O
E148Q NN B-NP O
, , O O
P369S NN B-NP O
, , O O
and CC O O
K695R NN B-NP O
. . O O

Nevertheless RB B-ADVP O
, , O O
E148Q NN B-NP O
helps VBZ B-VP O
account VB I-VP O
for IN B-PP O
recessive JJ B-NP O
inheritance NN I-NP O
in IN B-PP O
an DT B-NP O
Ashkenazi NNP I-NP O
family NN I-NP O
previously RB B-VP O
reported VBN I-VP O
as IN B-PP O
an DT B-NP O
unusual JJ I-NP O
case NN I-NP O
of IN B-PP O
dominantly RB B-NP O
inherited VBN I-NP O
FMF NN I-NP B-Disease
. . O O

The DT B-NP O
presence NN I-NP O
of IN B-PP O
three CD B-NP O
frequent JJ I-NP O
MEFV NN I-NP O
mutations NNS I-NP O
in IN B-PP O
multiple JJ B-NP O
Mediterranean JJ I-NP O
populations NNS I-NP O
strongly RB B-VP O
suggests VBZ I-VP O
a DT B-NP O
heterozygote JJ I-NP O
advantage NN I-NP O
in IN B-PP O
this DT B-NP O
geographic JJ I-NP O
region NN I-NP O
. . O O

Autoimmune JJ B-NP B-Disease
lymphoproliferative JJ I-NP I-Disease
syndrome NN I-NP I-Disease
with IN B-PP O
defective JJ B-NP O
Fas NN I-NP O
: : O O
genotype NN B-NP O
influences VBZ B-VP O
penetrance NN B-NP O
. . O O

Autoimmune JJ B-NP B-Disease
lymphoproliferative JJ I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
ALPS NN B-NP B-Disease
) ) O O
is VBZ B-VP O
a DT B-NP O
disorder NN I-NP B-Disease
of IN B-PP I-Disease
lymphocyte NN B-NP I-Disease
homeostasis NN I-NP I-Disease
and CC O I-Disease
immunological JJ B-NP I-Disease
tolerance NN I-NP I-Disease
. . O O

Most JJS B-NP O
patients NNS I-NP O
have VBP B-VP O
a DT B-NP O
heterozygous JJ I-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
APT1 NN I-NP O
gene NN I-NP O
, , O O
which WDT B-NP O
encodes VBZ B-VP O
Fas NN B-NP O
( ( O O
CD95 NN B-NP O
, , O O
APO NN B-NP O
- HYPH B-NP O
1 CD I-NP O
) ) O O
, , O O
mediator NN B-NP O
of IN B-PP O
an DT B-NP O
apoptotic JJ I-NP O
pathway NN I-NP O
crucial JJ B-ADJP O
to TO B-PP O
lymphocyte NN B-NP O
homeostasis NN I-NP O
. . O O

Of IN B-PP O
17 CD B-NP O
unique JJ I-NP O
APT1 NN I-NP O
mutations NNS I-NP O
in IN B-PP O
unrelated JJ B-NP O
ALPS NN I-NP B-Disease
probands NNS I-NP O
, , O O
12 CD B-NP O
( ( O O
71 CD B-NP O
% NN I-NP O
) ) O O
occurred VBD B-VP O
in IN B-PP O
exons NNS B-NP O
7 CD B-NP O
- HYPH I-NP O
9 CD I-NP O
, , O O
which WDT B-NP O
encode VBP B-VP O
the DT B-NP O
intracellular JJ I-NP O
portion NN I-NP O
of IN B-PP O
Fas NN B-NP O
. . O O

In FW B-ADVP O
vitro FW I-ADVP O
, , O O
activated VBN B-NP O
lymphocytes NNS I-NP O
from IN B-PP O
all DT B-NP O
17 CD I-NP O
patients NNS I-NP O
showed VBD B-VP O
apoptotic JJ B-NP O
defects NNS I-NP O
when WRB B-ADVP O
exposed VBN B-VP O
to TO B-PP O
an DT B-NP O
anti AFX I-NP O
- HYPH I-NP O
Fas NN I-NP O
agonist NN I-NP O
monoclonal JJ I-NP O
antibody NN I-NP O
. . O O

Similar JJ B-NP O
defects NNS I-NP O
were VBD B-VP O
found VBN I-VP O
in IN B-PP O
a DT B-NP O
Fas NN I-NP O
- HYPH B-NP O
negative JJ I-NP O
cell NN I-NP O
line NN I-NP O
transfected VBN B-VP O
with IN B-PP O
cDNAs NNS B-NP O
bearing VBG B-VP O
each DT B-NP O
of IN B-PP O
the DT B-NP O
mutations NNS I-NP O
. . O O

In IN B-PP O
cotransfection NN B-NP O
experiments NNS I-NP O
, , O O
Fas NN B-NP O
constructs NNS I-NP O
with IN B-PP O
either CC O O
intra AFX B-NP O
- HYPH I-NP O
or CC I-NP O
extracellular JJ I-NP O
mutations NNS I-NP O
caused VBD B-VP O
dominant JJ B-NP O
inhibition NN I-NP O
of IN B-PP O
apoptosis NN B-NP O
mediated VBN B-VP O
by IN B-PP O
wild JJ B-NP O
- HYPH I-NP O
type NN I-NP O
Fas NN I-NP O
. . O O

Two CD B-NP O
missense JJ I-NP O
Fas NN I-NP O
variants NNS I-NP O
, , B-NP O
not RB I-NP O
restricted JJ I-ADJP O
to TO B-PP O
patients NNS B-NP O
with IN B-PP O
ALPS NN B-NP B-Disease
, , O O
were VBD B-VP O
identified VBN I-VP O
. . O O

Variant NN B-NP O
A NN I-NP O
( ( O O
- SYM O O
1 CD O O
) ) O O
T NN B-NP O
at IN B-PP O
the DT B-NP O
Fas NN I-NP O
signal NN I-NP O
- HYPH B-NP O
sequence NN I-NP O
cleavage NN I-NP O
site NN I-NP O
, , O O
which WDT B-NP O
mediates VBZ B-VP O
apoptosis NN B-NP O
less RBR B-ADVP O
well RB I-ADVP O
than IN B-PP O
wild JJ B-NP O
- HYPH I-NP O
type NN I-NP O
Fas NN I-NP O
and CC O O
is VBZ B-VP O
partially RB B-ADJP O
inhibitory JJ I-ADJP O
, , O O
was VBD B-VP O
present JJ B-ADJP O
in IN B-PP O
13 CD B-NP O
% NN I-NP O
of IN B-PP O
African JJ B-NP O
American JJ I-NP O
alleles NNS I-NP O
. . O O

Among IN B-PP O
the DT B-NP O
ALPS NN I-NP B-Disease
- HYPH B-VP O
associated VBN B-NP O
Fas NN I-NP O
mutants NNS I-NP O
, , O O
dominant JJ B-NP O
inhibition NN I-NP O
of IN B-PP O
apoptosis NN B-NP O
was VBD B-VP O
much RB B-ADJP O
more RBR I-ADJP O
pronounced JJ I-ADJP O
in IN B-PP O
mutants NNS B-NP O
affecting VBG B-VP O
the DT B-NP O
intracellular JJ I-NP O
, , O O
versus IN B-PP O
extracellular JJ B-ADJP O
, , O O
portion NN B-NP O
of IN B-PP O
the DT B-NP O
Fas NN I-NP O
receptor NN I-NP O
. . O O

Mutations NNS B-NP O
causing VBG B-VP O
disruption NN B-NP O
of IN B-PP O
the DT B-NP O
intracellular JJ I-NP O
Fas NN I-NP O
death NN I-NP O
domain NN I-NP O
also RB B-ADVP O
showed VBD B-VP O
a DT B-NP O
higher JJR I-NP O
penetrance NN I-NP O
of IN B-PP O
ALPS NN B-NP B-Disease
phenotype NN I-NP O
features NNS I-NP O
in IN B-PP O
mutation NN B-NP O
- HYPH O O
bearing VBG B-VP O
relatives NNS B-NP O
. . O O

Significant JJ B-NP O
ALPS NN I-NP B-Disease
- HYPH B-VP O
related VBN B-NP O
morbidity NN I-NP O
occurred VBD B-VP O
in IN B-PP O
44 CD B-NP O
% NN I-NP O
of IN B-PP O
relatives NNS B-NP O
with IN B-PP O
intracellular JJ B-NP O
mutations NNS I-NP O
, , O O
versus IN B-ADVP O
0 CD B-NP O
% NN I-NP O
of IN B-PP O
relatives NNS B-NP O
with IN B-PP O
extracellular JJ B-NP O
mutations NNS I-NP O
. . O O

Thus RB B-ADVP O
, , O O
the DT B-NP O
location NN I-NP O
of IN B-PP O
mutations NNS B-NP O
within IN B-PP O
APT1 NN B-NP O
strongly RB B-ADVP O
influences VBZ B-VP O
the DT B-NP O
development NN I-NP O
and CC O O
the DT B-NP O
severity NN I-NP O
of IN B-PP O
ALPS NN B-NP B-Disease
. . O O

Multicentric JJ B-NP O
origin NN I-NP O
of IN B-PP O
hemochromatosis NN B-NP B-Disease
gene NN I-NP O
( ( O O
HFE NN B-NP O
) ) O O
mutations NNS B-NP O
. . O O

Genetic JJ B-NP B-Disease
hemochromatosis NN I-NP I-Disease
( ( O O
GH NN B-NP B-Disease
) ) O O
is VBZ B-VP O
believed VBN I-VP O
to TO I-VP O
be VB I-VP O
a DT B-NP O
disease NN I-NP O
restricted VBN B-VP O
to TO B-PP O
those DT B-NP O
of IN B-PP O
European JJ B-NP O
ancestry NN I-NP O
. . O O

In IN B-PP O
northwestern JJ B-NP O
Europe NNP I-NP O
, , O O
> SYM B-NP O
80 CD I-NP O
% NN I-NP O
of IN B-PP O
GH NN B-NP B-Disease
patients NNS I-NP O
are VBP B-VP O
homozygous JJ B-ADJP O
for IN B-PP O
one CD B-NP O
mutation NN I-NP O
, , O O
the DT B-NP O
substitution NN I-NP O
of IN B-PP O
tyrosine NN B-NP O
for IN B-PP O
cysteine NN B-NP O
at IN B-PP O
position NN B-NP O
282 CD I-NP O
( ( O O
C282Y NN B-NP O
) ) O O
in IN B-PP O
the DT B-NP O
unprocessed JJ I-NP O
protein NN I-NP O
. . O O

In IN B-PP O
a DT B-NP O
proportion NN I-NP O
of IN B-PP O
GH NN B-NP B-Disease
patients NNS I-NP O
, , O O
two CD B-NP O
mutations NNS I-NP O
are VBP B-VP O
present JJ B-ADJP O
, , O O
C282Y NN B-NP O
and CC I-NP O
H63D NN I-NP O
. . O O

The DT B-NP O
clinical JJ I-NP O
significance NN I-NP O
of IN B-PP O
this DT B-NP O
second JJ I-NP O
mutation NN I-NP O
is VBZ B-VP O
such JJ B-ADJP O
that IN B-SBAR O
it PRP B-NP O
appears VBZ B-VP O
to TO I-VP O
predispose VB I-VP O
1 CD B-NP O
% NN I-NP O
- HYPH I-NP O
2 CD I-NP O
% NN I-NP O
of IN B-PP O
compound NN B-NP O
heterozygotes NNS I-NP O
to TO B-PP O
expression NN B-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
. . O O

The DT B-NP O
distribution NN I-NP O
of IN B-PP O
the DT B-NP O
two CD I-NP O
mutations NNS I-NP O
differ VBP B-VP O
, , O O
C282Y NN B-NP O
being VBG B-VP O
limited VBN I-VP O
to TO B-PP O
those DT B-NP O
of IN B-PP O
northwestern JJ B-NP O
European JJ I-NP O
ancestry NN I-NP O
and CC I-NP O
H63D NN I-NP O
being VBG B-VP O
found VBN I-VP O
at IN B-PP O
allele NN B-NP O
frequencies NNS I-NP O
> SYM O O
5 CD B-NP O
% NN I-NP O
, , O O
in IN B-PP O
Europe NNP B-NP O
, , O O
in IN B-PP O
countries NNS B-NP O
bordering VBG B-VP O
the DT B-NP O
Mediterranean NNP I-NP O
, , O O
in IN B-PP O
the DT B-NP O
Middle NNP I-NP O
East NNP I-NP O
, , O O
and CC O O
in IN B-PP O
the DT B-NP O
Indian JJ I-NP O
subcontinent NN I-NP O
. . O O

The DT B-NP O
C282Y NN I-NP O
mutation NN I-NP O
occurs VBZ B-VP O
on IN B-PP O
a DT B-NP O
haplotype NN I-NP O
that WDT B-NP O
extends VBZ B-VP O
< SYM B-NP O
/ SYM B-NP O
= SYM B-VP O
6 CD B-NP O
Mb NN I-NP O
, , O O
suggesting VBG B-VP O
that IN B-SBAR O
this DT B-NP O
mutation NN I-NP O
has VBZ B-VP O
arisen VBN I-VP O
during IN B-PP O
the DT B-NP O
past JJ I-NP O
2 CD I-NP O
, , I-NP O
000 CD I-NP O
years NNS I-NP O
. . O O

The DT B-NP O
H63D NN I-NP O
mutation NN I-NP O
is VBZ B-VP O
older JJR B-ADJP O
and CC O O
does VBZ B-VP O
not RB I-VP O
occur VB I-VP O
on IN B-PP O
such PDT B-NP O
a DT I-NP O
large JJ I-NP O
extended VBN I-NP O
haplotype NN I-NP O
, , O O
the DT B-NP O
haplotype NN I-NP O
in IN B-PP O
this DT B-NP O
case NN I-NP O
extending VBG B-VP O
< SYM B-NP O
/ SYM B-NP O
= SYM B-VP O
700 CD B-NP O
kb NN I-NP O
. . O O

Here RB B-ADVP O
we PRP B-NP O
report VBP B-VP O
the DT B-NP O
finding NN I-NP O
of IN B-PP O
the DT B-NP O
H63D NN I-NP O
and CC I-NP O
C282Y NN I-NP O
mutations NNS I-NP O
on IN B-PP O
new JJ B-NP O
haplotypes NNS I-NP O
. . O O

In IN B-PP O
Sri NNP B-NP O
Lanka NNP I-NP O
we PRP B-NP O
have VBP B-VP O
found VBN I-VP O
H63D NN B-NP O
on IN B-PP O
three CD B-NP O
new JJ I-NP O
haplotypes NNS I-NP O
and CC O O
have VBP B-VP O
found VBN I-VP O
C282Y NN B-NP O
on IN B-PP O
one CD B-NP O
new JJ I-NP O
haplotype NN I-NP O
, , O O
demonstrating VBG B-VP O
that IN B-SBAR O
these DT B-NP O
mutations NNS I-NP O
have VBP B-VP O
arisen VBN I-VP O
independently RB B-ADVP O
on IN B-PP O
this DT B-NP O
island NN I-NP O
. . O O

These DT B-NP O
results NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
the DT B-NP O
HFE NN I-NP O
gene NN I-NP O
has VBZ B-VP O
been VBN I-VP O
the DT B-NP O
subject NN I-NP O
of IN B-PP O
selection NN B-NP O
pressure NN I-NP O
. . O O

These DT B-NP O
selection NN I-NP O
pressures NNS I-NP O
could MD B-VP O
be VB I-VP O
due JJ B-ADVP O
to TO B-PP O
infectious JJ B-NP B-Disease
diseases NNS I-NP I-Disease
, , O O
environmental JJ B-NP O
conditions NNS I-NP O
, , O O
or CC O O
other JJ B-NP O
genetic JJ I-NP B-Disease
disorders NNS I-NP I-Disease
such JJ B-PP O
as IN I-PP O
anemia NN B-NP B-Disease
. . O O

A DT B-NP O
retrospective JJ I-NP O
anonymous JJ I-NP O
pilot NN I-NP O
study NN I-NP O
in IN B-PP O
screening NN B-NP O
newborns NNS I-NP O
for IN B-PP O
HFE NN B-NP O
mutations NNS I-NP O
in IN B-PP O
Scandinavian JJ B-NP O
populations NNS I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
retrospectively RB I-VP O
analyzed VBN I-VP O
837 CD B-NP O
random JJ I-NP O
anonymized VBN B-VP O
dried VBD B-VP O
blood NN B-NP O
spot NN I-NP O
( ( O O
DBS NN B-NP O
) ) O O
samples NNS B-NP O
from IN B-PP O
neonatal JJ B-NP O
screening NN I-NP O
programs NNS I-NP O
in IN B-PP O
Scandinavia NNP B-NP O
for IN B-PP O
mutations NNS B-NP O
in IN B-PP O
HFE NN B-NP O
, , O O
the DT B-NP O
candidate NN I-NP O
gene NN I-NP O
for IN B-PP O
hemochromatosis NN B-NP B-Disease
. . O O

We PRP B-NP O
have VBP B-VP O
found VBN I-VP O
C282Y NN B-NP O
allele NN I-NP O
frequencies NNS I-NP O
of IN B-PP O
2 CD B-NP O
. . O O

3 CD B-NP O
% NN I-NP O
( ( O O
+ SYM B-NP O
2 CD I-NP O
. SYM I-NP O

0 CD I-NP O
% NN I-NP O
) ) O O
( ( O O
- SYM B-NP O
1 CD I-NP O
. SYM I-NP O

3 CD I-NP O
% NN I-NP O
) ) O O
in IN B-PP O
Greenland NNP B-NP O
, , O O
4 CD B-NP O
. . O O

5 CD B-NP O
% NN I-NP O
+ SYM B-NP O
/ SYM B-VP O
- SYM B-NP O
1 CD I-NP O
. . O O

9 CD B-NP O
% NN I-NP O
in IN B-PP O
Iceland NNP B-NP O
, , O O
5 CD B-NP O
. . O O

1 CD B-NP O
% NN I-NP O
+ SYM O O
/ SYM O O
- SYM B-NP O
2 CD B-NP O
. . O O

3 CD B-NP O
% NN I-NP O
in IN B-PP O
the DT B-NP O
Faeroe NNP I-NP O
Islands NNP I-NP O
, , O O
and CC O O
8 CD B-NP O
. . O O

2 CD B-NP O
% NN I-NP O
+ SYM B-NP O
/ SYM B-NP O
- SYM B-VP O
2 CD B-NP O
. . O O

7 CD B-NP O
% NN I-NP O
in IN B-PP O
Denmark NNP B-NP O
. . O O

The DT B-NP O
high JJ I-NP O
prevalence NN I-NP O
of IN B-PP O
HFE NN B-NP O
mutations NNS I-NP O
in IN B-PP O
Denmark NNP B-NP O
suggests VBZ B-VP O
that IN B-SBAR O
population NN B-NP O
screening NN I-NP O
for IN B-PP O
the DT B-NP O
C282Y NN I-NP O
mutation NN I-NP O
could MD B-VP O
be VB I-VP O
highly RB B-ADJP O
advantageous JJ I-ADJP O
in IN B-PP O
terms NNS B-NP O
of IN B-PP O
preventive JJ B-NP O
health NN I-NP O
care NN I-NP O
. . O O

Long JJ B-NP O
- HYPH I-NP O
term NN I-NP O
follow VB B-VP O
- HYPH O O
up RP B-PRT O
evaluation NN B-NP O
of IN B-PP O
C282Y NN B-NP O
homozygotes NNS I-NP O
and CC O O
H63D NN B-NP O
/ SYM I-NP O
C282Y NN I-NP O
compound NN I-NP O
heterozygotes NNS I-NP O
will MD B-VP O
give VB I-VP O
an DT B-NP O
indication NN I-NP O
of IN B-PP O
the DT B-NP O
penetrance NN I-NP O
of IN B-PP O
the DT B-NP O
mutations NNS I-NP O
. . O O

Identification NN B-NP O
of IN B-PP O
the DT B-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
alkaptonuria NN I-NP B-Disease
mouse NN I-NP O
model NN I-NP O
. . O O

Alkaptonuria NN B-NP B-Disease
( ( O O
aku NN B-NP B-Disease
) ) O O
, , O O
an DT B-NP O
inborn JJ I-NP B-Disease
error NN I-NP I-Disease
of IN B-PP I-Disease
metabolism NN B-NP I-Disease
caused VBN B-VP O
by IN B-PP O
the DT B-NP O
loss NN I-NP O
of IN B-PP O
homogentisate NN B-NP O
1 CD I-NP O
, , I-NP O
2 CD I-NP O
- HYPH I-NP O
dioxygenase NN B-NP O
( ( O O
HGD NN B-NP O
) ) O O
, , O O
has VBZ B-VP O
been VBN I-VP O
described VBN I-VP O
in IN B-PP O
a DT B-NP O
mouse NN I-NP O
model NN I-NP O
created VBN B-VP O
by IN B-PP O
ethylnitrosourea NN B-NP O
mutagenesis NN I-NP O
but CC O O
the DT B-NP O
mutation NN I-NP O
in IN B-PP O
these DT B-NP O
mice NNS I-NP O
has VBZ B-VP O
not RB I-VP O
previously RB I-VP O
been VBN I-VP O
identified VBN I-VP O
. . O O

We PRP B-NP O
used VBD B-VP O
RT NN B-NP O
- HYPH B-NP O
PCR NN I-NP O
to TO B-VP O
amplify VB I-VP O
the DT B-NP O
Hgd NN I-NP O
cDNA NN I-NP O
from IN B-PP O
Hgd NN B-NP O
( ( O O
aku NN B-NP O
) ) O O
/ SYM O O
Hgd NN B-NP O
( ( O O
aku NN B-NP O
) ) O O
mice NNS B-NP O
. . O O

Two CD B-NP O
products NNS I-NP O
shorter JJR B-ADJP O
than IN B-PP O
the DT B-NP O
wild JJ I-NP O
- HYPH I-NP O
type NN I-NP O
product NN I-NP O
were VBD B-VP O
amplified VBN I-VP O
. . O O

Restriction NN B-NP O
mapping NN I-NP O
and CC O O
DNA NN B-NP O
sequencing NN I-NP O
were VBD B-VP O
then RB I-VP O
used VBN I-VP O
to TO B-VP O
identify VB I-VP O
the DT B-NP O
Hgd NN I-NP O
( ( O O
aku NN B-NP O
) ) O O
mouse NN B-NP O
mutation NN I-NP O
, , O O
found VBN B-VP O
to TO I-VP O
be VB I-VP O
a DT B-NP O
single JJ I-NP O
base NN I-NP O
change NN I-NP O
in IN B-PP O
a DT B-NP O
splice NN I-NP O
donor NN I-NP O
consensus NN I-NP O
sequence NN I-NP O
, , O O
causing VBG B-VP O
exon NN B-NP O
skipping NN I-NP O
and CC I-NP O
frame NN I-NP O
- HYPH B-NP O
shifted VBN I-NP O
products NNS I-NP O
. . O O

This DT B-NP O
base NN I-NP O
change NN I-NP O
allowed VBD B-VP O
us PRP B-NP O
to TO B-VP O
create VB I-VP O
a DT B-NP O
non AFX I-NP O
- HYPH I-NP O
radioactive JJ I-NP O
genotyping NN I-NP O
assay NN I-NP O
for IN B-PP O
this DT B-NP O
allele NN I-NP O
. . O O

Non AFX B-NP B-Disease
- HYPH I-NP I-Disease
syndromic JJ I-NP I-Disease
hearing NN I-NP I-Disease
loss NN I-NP I-Disease
associated VBN B-VP O
with IN B-PP O
enlarged JJ B-NP B-Disease
vestibular JJ I-NP I-Disease
aqueduct NN I-NP I-Disease
is VBZ B-VP O
caused VBN I-VP O
by IN B-PP O
PDS NN B-NP B-Disease
mutations NNS I-NP O
. . O O

Enlarged JJ B-NP B-Disease
vestibular JJ I-NP I-Disease
aqueduct NN I-NP I-Disease
( ( O O
EVA NN B-NP B-Disease
) ) O O
, , O O
known VBN B-VP O
as IN B-PP O
the DT B-NP O
most RBS I-NP O
common JJ I-NP O
form NN I-NP O
of IN B-PP O
inner JJ B-NP B-Disease
ear NN I-NP I-Disease
abnormality NN I-NP I-Disease
, , O O
has VBZ B-VP O
recently RB I-VP O
been VBN I-VP O
of IN B-PP O
particular JJ B-NP O
genetic JJ I-NP O
interest NN I-NP O
because IN B-SBAR O
this DT B-NP O
anomaly RB B-ADVP O
is VBZ B-VP O
inherited VBN I-VP O
in IN B-PP O
a DT B-NP O
recessive JJ I-NP O
manner NN I-NP O
. . O O

The DT B-NP O
locus NN I-NP O
for IN B-PP O
non AFX B-NP B-Disease
- HYPH I-NP I-Disease
syndromic JJ I-NP I-Disease
sensorineural JJ I-NP I-Disease
hearing NN I-NP I-Disease
loss NN I-NP I-Disease
with IN B-PP O
EVA NN B-NP B-Disease
has VBZ B-VP O
been VBN I-VP O
mapped VBN I-VP O
to TO B-PP O
the DT B-NP O
same JJ I-NP O
chromosomal JJ I-NP O
region NN I-NP O
, , O O
7q31 CD B-NP O
, , O O
as IN B-SBAR O
the DT B-NP O
Pendred NNP I-NP B-Disease
syndrome NN I-NP I-Disease
locus NN I-NP O
. . O O

In IN B-PP O
the DT B-NP O
present JJ I-NP O
study NN I-NP O
, , O O
seven CD B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
PDS NN I-NP B-Disease
gene NN I-NP O
( ( O O
PDS NN B-NP O
) ) O O
, , O O
the DT B-NP O
gene NN I-NP O
responsible JJ B-ADJP O
for IN B-PP O
Pendred NNP B-NP B-Disease
syndrome NN I-NP I-Disease
, , O O
have VBP B-VP O
been VBN I-VP O
found VBN I-VP O
in IN B-PP O
families NNS B-NP O
of IN B-PP O
non AFX B-NP B-Disease
- HYPH I-NP I-Disease
syndromic JJ I-NP I-Disease
sensorineural JJ I-NP I-Disease
hearing NN I-NP I-Disease
loss NN I-NP I-Disease
with IN B-PP O
EVA NN B-NP B-Disease
. . O O

One CD B-NP O
family NN I-NP O
is VBZ B-VP O
homozygous JJ B-ADJP O
, , O O
three CD B-NP O
families NNS I-NP O
are VBP B-VP O
compound NN B-NP O
heterozygotes NNS I-NP O
, , O O
and CC O O
two CD B-NP O
families NNS I-NP O
are VBP B-VP O
heterozygous JJ B-ADJP O
but CC B-PP O
with IN B-PP O
no DT B-NP O
other JJ I-NP O
mutation NN I-NP O
detected VBN B-VP O
. . O O

The DT B-NP O
present JJ I-NP O
results NNS I-NP O
provide VBP B-VP O
evidence NN B-NP O
that IN B-SBAR O
mutations NNS B-NP O
in IN B-PP O
PDS NN B-NP O
cause VBP B-VP O
both CC O O
syndromic JJ B-ADJP B-Disease
and CC O I-Disease
non AFX B-NP I-Disease
- HYPH I-NP I-Disease
syndromic JJ I-NP I-Disease
hearing NN I-NP I-Disease
loss NN I-NP I-Disease
. . O O

. . O O

Mutational JJ B-NP O
analysis NN I-NP O
and CC I-NP O
genotype NN I-NP O
- HYPH B-NP O
phenotype NN I-NP O
correlation NN I-NP O
of IN B-PP O
29 CD B-NP O
unrelated JJ I-NP O
Japanese JJ I-NP O
patients NNS I-NP O
with IN B-PP O
X NN B-NP B-Disease
- HYPH O I-Disease
linked VBN B-NP I-Disease
adrenoleukodystrophy NN I-NP I-Disease
. . O O

BACKGROUND NN B-NP O
X NN I-NP B-Disease
- HYPH O I-Disease
linked VBN B-VP I-Disease
adrenoleukodystrophy NN B-NP I-Disease
( ( O O
ALD NN B-NP B-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
inherited VBN I-NP B-Disease
disease NN I-NP I-Disease
characterized VBN B-VP O
by IN B-PP O
progressive JJ B-NP O
neurologic JJ I-NP B-Disease
dysfunction NN I-NP I-Disease
, , O O
occasionally RB B-VP O
associated VBN I-VP O
with IN B-PP O
adrenal JJ B-NP B-Disease
insufficiency NN I-NP I-Disease
. . O O

The DT B-NP O
classic JJ I-NP O
form NN I-NP O
of IN B-PP O
ALD NN B-NP B-Disease
usually RB B-ADVP O
has VBZ B-VP O
onset NN B-NP O
in IN B-PP O
childhood NN B-NP O
( ( O O
childhood NN B-NP B-Disease
cerebral JJ I-NP I-Disease
ALD NN I-NP I-Disease
) ) O O
, , O O
with IN B-PP O
rapid JJ B-NP O
neurologic JJ I-NP B-Disease
deterioration NN I-NP I-Disease
leading VBG B-VP O
to TO B-PP O
a DT B-NP O
vegetative JJ I-NP O
state NN I-NP O
. . O O

Adult JJ B-NP O
- HYPH I-NP O
onset NN I-NP O
cerebral JJ I-NP B-Disease
ALD NN I-NP I-Disease
also RB B-ADVP O
presents VBZ B-VP O
with IN B-PP O
rapidly RB B-NP O
progressive JJ I-NP O
neurologic JJ I-NP B-Disease
dysfunction NN I-NP I-Disease
. . O O

Milder JJR B-NP O
phenotypes NNS I-NP O
such JJ B-PP O
as IN I-PP O
adrenomyeloneuropathy NN B-NP B-Disease
and CC I-NP O
Addison NN I-NP B-Disease
disease NN I-NP I-Disease
only RB B-ADVP O
also RB I-ADVP O
have VBP B-VP O
been VBN I-VP O
recognized VBN I-VP O
. . O O

Despite IN B-PP O
discovery NN B-NP O
of IN B-PP O
the DT B-NP O
causative JJ I-NP O
gene NN I-NP O
, , O O
a DT B-NP O
molecular JJ I-NP O
basis NN I-NP O
for IN B-PP O
the DT B-NP O
diverse JJ I-NP O
clinical JJ I-NP O
presentations NNS I-NP O
remains VBZ B-VP O
to TO I-VP O
be VB I-VP O
elucidated VBN I-VP O
. . O O

OBJECTIVES NNS B-NP O
To TO B-VP O
conduct VB I-VP O
mutational JJ B-NP O
analyses NNS I-NP O
in IN B-PP O
29 CD B-NP O
Japanese JJ I-NP O
patients NNS I-NP O
with IN B-PP O
ALD NN B-NP B-Disease
from IN B-PP O
29 CD B-NP O
unrelated JJ I-NP O
families NNS I-NP O
, , O O
to TO B-VP O
obtain VB I-VP O
knowledge NN B-NP O
of IN B-PP O
the DT B-NP O
spectrum NN I-NP O
of IN B-PP O
mutations NNS B-NP O
in IN B-PP O
this DT B-NP O
gene NN I-NP O
, , O O
and CC O O
to TO B-VP O
study VB I-VP O
genotype NN B-NP O
- HYPH B-NP O
phenotype NN I-NP O
correlations NNS I-NP O
in IN B-PP O
Japanese JJ B-NP O
patients NNS I-NP O
. . O O

METHODS NNS B-NP O
The DT B-NP O
29 CD I-NP O
patients NNS I-NP O
comprised VBD B-VP O
13 CD B-NP O
patients NNS I-NP O
with IN B-PP O
childhood NN B-NP B-Disease
cerebral JJ I-NP I-Disease
ALD NN I-NP I-Disease
, , O O
11 CD B-NP O
patients NNS I-NP O
with IN B-PP O
adult JJ B-NP O
- HYPH I-NP O
onset NN I-NP O
cerebral JJ I-NP B-Disease
ALD NN I-NP I-Disease
, , O O
and CC O O
5 CD B-NP O
patients NNS I-NP O
with IN B-PP O
adrenomyeloneuropathy NN B-NP B-Disease
. . O O

We PRP B-NP O
conducted VBD B-VP O
detailed JJ B-NP O
mutational JJ I-NP O
analyses NNS I-NP O
of IN B-PP O
29 CD B-NP O
unrelated JJ I-NP O
Japanese JJ I-NP O
patients NNS I-NP O
with IN B-PP O
ALD NN B-NP B-Disease
by IN B-PP O
genomic JJ B-NP O
Southern JJ I-NP O
blot NN I-NP O
analysis NN I-NP O
and CC O O
direct JJ B-NP O
nucleotide NN I-NP O
sequence NN I-NP O
analysis NN I-NP O
of IN B-PP O
reverse JJ B-NP O
transcriptase NN I-NP O
- HYPH I-NP O
polymerase NN I-NP O
chain NN I-NP O
reaction NN I-NP O
products NNS I-NP O
derived VBN B-VP O
from IN B-PP O
total JJ B-NP O
RNA NN I-NP O
that WDT B-NP O
was VBD B-VP O
extracted VBN I-VP O
from IN B-PP O
cultured VBN B-NP O
skin NN I-NP O
fibroblasts NNS I-NP O
, , O O
lymphoblastoid JJ B-NP O
cells NNS I-NP O
, , O O
or CC O O
peripheral JJ B-NP O
blood NN I-NP O
leukocytes NNS I-NP O
. . O O

RESULTS NNS B-NP O
Three CD B-NP O
patients NNS I-NP O
with IN B-PP O
adult JJ B-NP O
- HYPH I-NP O
onset NN I-NP O
cerebral JJ I-NP B-Disease
ALD NN I-NP I-Disease
were VBD B-VP O
identified VBN I-VP O
as IN B-PP O
having VBG B-VP O
large JJ B-NP O
genomic JJ I-NP O
rearrangements NNS I-NP O
. . O O

The DT B-NP O
remaining VBG I-NP O
26 CD I-NP O
patients NNS I-NP O
were VBD B-VP O
identified VBN I-VP O
as IN B-PP O
having VBG B-VP O
21 CD B-NP O
independent JJ I-NP O
mutations NNS I-NP O
, , O O
including VBG B-PP O
12 CD B-NP O
novel JJ I-NP O
mutations NNS I-NP O
resulting VBG B-VP O
in IN B-PP O
small JJ B-NP O
nucleotide NN I-NP O
alterations NNS I-NP O
in IN B-PP O
the DT B-NP O
ALD NN I-NP B-Disease
gene NN I-NP O
. . O O

Eighteen CD B-NP O
( ( O O
69 CD B-NP O
% NN I-NP O
) ) O O
of IN B-PP O
26 CD B-NP O
mutations NNS I-NP O
were VBD B-VP O
missense JJ B-NP O
mutations NNS I-NP O
. . O O

Most JJS B-NP O
missense JJ I-NP O
mutations NNS I-NP O
involved VBD B-VP O
amino NN B-NP O
acids NNS I-NP O
conserved VBN B-VP O
in IN B-PP O
homologous JJ B-NP O
gene NN I-NP O
products NNS I-NP O
, , O O
including VBG B-PP O
PMP70 NN B-NP O
, , O O
mALDRP NN B-NP O
, , O O
and CC O O
Pxa1p NN B-NP O
. . O O

The DT B-NP O
AG NNP I-NP O
dinucleotide NN I-NP O
deletion NN I-NP O
at IN B-PP O
position NN B-NP O
1081 CD I-NP O
- HYPH I-NP O
1082 CD I-NP O
, , O O
which WDT B-NP O
has VBZ B-VP O
been VBN I-VP O
reported VBN I-VP O
previously RB B-ADVP O
to TO B-VP O
be VB I-VP O
the DT B-NP O
most RBS I-NP O
common JJ I-NP O
mutation NN I-NP O
in IN B-PP O
white JJ B-NP O
patients NNS I-NP O
( ( O O
12 CD B-NP O
% NN I-NP O
- HYPH O O
17 CD B-NP O
% NN I-NP O
) ) O O
, , O O
was VBD B-VP O
also RB I-VP O
identified VBN I-VP O
as IN B-PP O
the DT B-NP O
most RBS I-NP O
common JJ I-NP O
mutation NN I-NP O
in IN B-PP O
Japanese JJ B-NP O
patients NNS I-NP O
( ( O O
12 CD B-NP O
% NN I-NP O
) ) O O
. . O O

All DT B-NP O
phenotypes NNS I-NP O
were VBD B-VP O
associated VBN I-VP O
with IN B-PP O
mutations NNS B-NP O
resulting VBG B-VP O
in IN B-PP O
protein NN B-NP O
truncation NN I-NP O
or CC O O
subtle JJ B-NP O
amino JJ I-NP O
acid NN I-NP O
changes NNS I-NP O
. . O O

There EX B-NP O
were VBD B-VP O
no DT B-NP O
differences NNS I-NP O
in IN B-PP O
phenotypic JJ B-NP O
expressions NNS I-NP O
between IN B-PP O
missense JJ B-NP O
mutations NNS I-NP O
involving VBG B-VP O
conserved VBN B-NP O
amino JJ I-NP O
acids NNS I-NP O
and CC O O
those DT B-NP O
involving VBG B-VP O
nonconserved JJ B-NP O
amino NN I-NP O
acids NNS I-NP O
. . O O

CONCLUSIONS NNS B-NP O
There EX B-NP O
are VBP B-VP O
no DT B-NP O
obvious JJ I-NP O
correlations NNS I-NP O
between IN B-PP O
the DT B-NP O
phenotypes NNS I-NP O
of IN B-PP O
patients NNS B-NP O
with IN B-PP O
ALD NN B-NP B-Disease
and CC O O
their PRP$ B-NP O
genotypes NNS I-NP O
, , O O
suggesting VBG B-VP O
that IN B-SBAR O
other JJ B-NP O
genetic JJ I-NP O
or CC I-NP O
environmental JJ I-NP O
factors NNS I-NP O
modify VBP B-VP O
the DT B-NP O
phenotypic JJ I-NP O
expressions NNS I-NP O
of IN B-PP O
ALD NN B-NP B-Disease
. . O O

. . O O

A DT B-NP O
common JJ I-NP O
human JJ I-NP O
skin NN I-NP B-Disease
tumour NN I-NP I-Disease
is VBZ B-VP O
caused VBN I-VP O
by IN B-PP O
activating VBG B-VP O
mutations NNS B-NP O
in IN B-PP O
beta SYM B-NP O
- HYPH B-NP O
catenin NN I-NP O
. . O O

WNT NN B-NP O
signalling NN I-NP O
orchestrates VBZ B-VP O
a DT B-NP O
number NN I-NP O
of IN B-PP O
developmental JJ B-NP O
programs NNS I-NP O
. . O O

In IN B-PP O
response NN B-NP O
to TO B-PP O
this DT B-NP O
stimulus NN I-NP O
, , O O
cytoplasmic JJ B-NP O
beta SYM I-NP O
- HYPH I-NP O
catenin NN I-NP O
( ( O O
encoded VBN B-VP O
by IN B-PP O
CTNNB1 NN B-NP O
) ) O O
is VBZ B-VP O
stabilized VBN I-VP O
, , O O
enabling VBG B-VP O
downstream JJ B-NP O
transcriptional JJ I-NP O
activation NN I-NP O
by IN B-PP O
members NNS B-NP O
of IN B-PP O
the DT B-NP O
LEF NN I-NP O
/ SYM B-NP O
TCF NN I-NP O
family NN I-NP O
. . O O

One CD B-NP O
of IN B-PP O
the DT B-NP O
target NN I-NP O
genes NNS I-NP O
for IN B-PP O
beta SYM B-NP O
- HYPH B-NP O
catenin NN I-NP O
/ SYM B-NP O
TCF NN I-NP O
encodes VBZ B-VP O
c NN B-NP O
- HYPH I-NP O
MYC NN I-NP O
, , O O
explaining VBG B-VP O
why WRB B-ADVP O
constitutive JJ B-NP O
activation NN I-NP O
of IN B-PP O
the DT B-NP O
WNT NN I-NP O
pathway NN I-NP O
can MD B-VP O
lead VB I-VP O
to TO B-PP O
cancer NN B-NP B-Disease
, , O O
particularly RB B-ADVP O
in IN B-PP O
the DT B-NP O
colon NN I-NP O
. . O O

Most JJS B-NP O
colon NN I-NP B-Disease
cancers NNS I-NP I-Disease
arise VBP B-VP O
from IN B-PP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
gene NN I-NP O
encoding VBG B-VP O
adenomatous JJ B-NP B-Disease
polyposis NN I-NP I-Disease
coli NN I-NP I-Disease
( ( O O
APC NN B-NP B-Disease
) ) O O
, , O O
a DT B-NP O
protein NN I-NP O
required VBN B-VP O
for IN B-PP O
ubiquitin NN B-NP O
- HYPH O O
mediated VBN B-NP O
degradation NN I-NP O
of IN B-PP O
beta SYM B-NP O
- HYPH O O
catenin NN B-NP O
, , O O
but CC O O
a DT B-NP O
small JJ I-NP O
percentage NN I-NP O
of IN B-PP O
colon NN B-NP B-Disease
and CC O I-Disease
some DT B-NP I-Disease
other JJ I-NP I-Disease
cancers NNS I-NP I-Disease
harbour VBP B-VP O
beta SYM B-NP O
- HYPH B-NP O
catenin NN I-NP O
- HYPH O O
stabilizing VBG B-VP O
mutations NNS B-NP O
. . O O

Recently RB B-ADVP O
, , O O
we PRP B-NP O
discovered VBD B-VP O
that IN B-SBAR O
transgenic JJ B-NP O
mice NNS I-NP O
expressing VBG B-VP O
an DT B-NP O
activated VBN I-NP O
beta SYM I-NP O
- HYPH I-NP O
catenin NN I-NP O
are VBP B-VP O
predisposed VBN I-VP O
to TO B-PP O
developing VBG B-VP O
skin NN B-NP B-Disease
tumours NNS I-NP I-Disease
resembling VBG B-VP O
pilomatricomas NNS B-NP B-Disease
. . O O

Given VBN B-VP O
that IN B-SBAR O
the DT B-NP O
skin NN I-NP O
of IN B-PP O
these DT B-NP O
adult JJ I-NP O
mice NNS I-NP O
also RB B-ADVP O
exhibits VBZ B-VP O
signs NNS B-NP O
of IN B-PP O
de FW B-NP O
novo FW I-NP O
hair NN I-NP O
- HYPH B-NP O
follicle NN I-NP O
morphogenesis NN I-NP O
, , O O
we PRP B-NP O
wondered VBD B-VP O
whether IN B-SBAR O
human JJ B-NP O
pilomatricomas NNS I-NP B-Disease
might MD B-VP O
originate VB I-VP O
from IN B-PP O
hair NN B-NP O
matrix NN I-NP O
cells NNS I-NP O
and CC O O
whether IN B-SBAR O
they PRP B-NP O
might MD B-VP O
possess VB I-VP O
beta SYM B-NP O
- HYPH B-NP O
catenin NN I-NP O
- HYPH O O
stabilizing VBG B-VP O
mutations NNS B-NP O
. . O O

Here RB B-ADVP O
, , O O
we PRP B-NP O
explore VBP B-VP O
the DT B-NP O
cell NN I-NP O
origin NN I-NP O
and CC I-NP O
aetiology NN I-NP O
of IN B-PP O
this DT B-NP O
common JJ I-NP O
human JJ I-NP O
skin NN I-NP B-Disease
tumour NN I-NP I-Disease
. . O O

We PRP B-NP O
found VBD B-VP O
nuclear JJ B-NP O
LEF NN I-NP O
- HYPH B-NP O
1 CD I-NP O
in IN B-PP O
the DT B-NP O
dividing VBG I-NP O
tumour NN I-NP B-Disease
cells NNS I-NP O
, , O O
providing VBG B-VP O
biochemical JJ B-NP O
evidence NN I-NP O
that IN B-SBAR O
pilomatricomas NNS B-NP B-Disease
are VBP B-VP O
derived VBN I-VP O
from IN B-PP O
hair NN B-NP O
matrix NN I-NP O
cells NNS I-NP O
. . O O

At IN B-NP O
least JJS I-NP O
75 CD I-NP O
% NN I-NP O
of IN B-PP O
these DT B-NP O
tumours NNS I-NP B-Disease
possess VBP B-VP O
mutations NNS B-NP O
affecting VBG B-VP O
the DT B-NP O
amino JJ I-NP O
- HYPH I-NP O
terminal JJ I-NP O
segment NN I-NP O
, , O O
normally RB B-ADVP O
involved VBN B-VP O
in IN B-PP O
phosphorylation NN B-NP O
- HYPH B-NP O
dependent JJ I-NP O
, , I-NP O
ubiquitin NN I-NP O
- HYPH I-NP O
mediated VBN B-NP O
degradation NN I-NP O
of IN B-PP O
the DT B-NP O
protein NN I-NP O
. . O O

This DT B-NP O
percentage NN I-NP O
of IN B-PP O
CTNNB1 NN B-NP O
mutations NNS I-NP O
is VBZ B-VP O
greater JJR B-ADJP O
than IN B-PP O
in IN B-PP O
all DT B-NP O
other JJ I-NP O
human JJ I-NP O
tumours NNS I-NP B-Disease
examined VBN B-VP O
thus RB B-ADVP O
far RB I-ADVP O
, , O O
and CC O O
directly RB B-VP O
implicates VBZ I-VP O
beta SYM B-NP O
- HYPH I-NP O
catenin NN I-NP O
/ SYM I-NP O
LEF NN I-NP O
misregulation NN I-NP O
as IN B-PP O
the DT B-NP O
major JJ I-NP O
cause NN I-NP O
of IN B-PP O
hair NN B-NP O
matrix NN I-NP O
cell NN I-NP O
tumorigenesis NN I-NP O
in IN B-PP O
humans NNS B-NP O
. . O O

. . O O

The DT B-NP O
Pendred NNP I-NP B-Disease
syndrome NN I-NP I-Disease
gene NN I-NP O
encodes VBZ B-VP O
a DT B-NP O
chloride NN I-NP O
- HYPH I-NP O
iodide NN I-NP O
transport NN I-NP O
protein NN I-NP O
. . O O

Pendred VBN B-NP B-Disease
syndrome NN I-NP I-Disease
is VBZ B-VP O
the DT B-NP O
most RBS I-NP O
common JJ I-NP O
form NN I-NP O
of IN B-PP O
syndromic JJ B-NP B-Disease
deafness NN I-NP I-Disease
and CC O O
characterized VBN B-VP O
by IN B-PP O
congenital JJ B-NP O
sensorineural JJ I-NP B-Disease
hearing NN I-NP I-Disease
loss NN I-NP I-Disease
and CC I-NP O
goitre NN I-NP B-Disease
. . O O

This DT B-NP O
disorder NN I-NP O
was VBD B-VP O
mapped VBN I-VP O
to TO B-PP O
chromosome NN B-NP O
7 CD I-NP O
and CC O O
the DT B-NP O
gene NN I-NP O
causing VBG B-VP O
Pendred VBN B-NP B-Disease
syndrome NN I-NP I-Disease
( ( O O
PDS NN B-NP B-Disease
) ) O O
was VBD B-VP O
subsequently RB I-VP O
identified VBN I-VP O
by IN B-PP O
positional JJ B-NP O
cloning NN I-NP O
. . O O

PDS NN B-NP O
encodes VBZ B-VP O
a DT B-NP O
putative JJ I-NP O
transmembrane JJ I-NP O
protein NN I-NP O
designated VBN B-VP O
pendrin NN B-NP O
. . O O

Pendrin NN B-NP O
is VBZ B-VP O
closely RB B-ADJP O
related JJ I-ADJP O
to TO B-PP O
a DT B-NP O
family NN I-NP O
of IN B-PP O
sulfate NN B-NP O
transport NN I-NP O
proteins NNS I-NP O
that WDT B-NP O
includes VBZ B-VP O
the DT B-NP O
rat NN I-NP O
sulfate NN I-NP O
- HYPH O O
anion NN B-NP O
transporter NN I-NP O
( ( O O
encoded VBN B-VP O
by IN B-PP O
Sat NNP B-NP O
- HYPH B-NP O
1 CD I-NP O
; : O O
29 CD B-NP O
% NN I-NP O
amino JJ I-NP O
acid NN I-NP O
sequence NN I-NP O
identity NN I-NP O
) ) O O
, , O O
the DT B-NP O
human JJ I-NP O
diastrophic JJ I-NP B-Disease
dysplasia NN I-NP I-Disease
sulfate NN I-NP O
transporter NN I-NP O
( ( O O
encoded VBN B-VP O
by IN B-PP O
DTD NN B-NP O
; : O O
32 CD B-NP O
% NN I-NP O
) ) O O
and CC O O
the DT B-NP O
human JJ I-NP O
sulfate NN I-NP O
transporter NN I-NP O
downregulated VBN B-VP O
in IN B-PP O
adenoma NN B-NP B-Disease
( ( O O
encoded VBN B-VP O
by IN B-PP O
DRA NN B-NP O
; : O O
45 CD B-NP O
% NN I-NP O
) ) O O
. . O O

On IN B-PP O
the DT B-NP O
basis NN I-NP O
of IN B-PP O
this DT B-NP O
homology NN I-NP O
and CC O O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
a DT B-NP O
slightly RB I-NP O
modified VBN I-NP O
sulfate NN I-NP O
- HYPH I-NP O
transporter NN I-NP O
signature NN I-NP O
sequence NN I-NP O
comprising VBG B-VP O
its PRP$ B-NP O
putative JJ I-NP O
second JJ I-NP O
transmembrane JJ I-NP O
domain NN I-NP O
, , O O
pendrin NN B-NP O
has VBZ B-VP O
been VBN I-VP O
proposed VBN I-VP O
to TO I-VP O
function VB I-VP O
as IN B-PP O
a DT B-NP O
sulfate NN I-NP O
transporter NN I-NP O
. . O O

We PRP B-NP O
were VBD B-VP O
unable JJ B-ADJP O
to TO B-VP O
detect VB I-VP O
evidence NN B-NP O
of IN B-PP O
sulfate NN B-NP O
transport NN I-NP O
following VBG B-PP O
the DT B-NP O
expression NN I-NP O
of IN B-PP O
pendrin NN B-NP O
in IN B-PP O
Xenopus NNP B-NP O
laevis NNP I-NP O
oocytes NNS I-NP O
by IN B-PP O
microinjection NN B-NP O
of IN B-PP O
PDS NN B-NP O
cRNA NN I-NP O
or CC B-PP O
in IN B-PP O
Sf9 NN B-NP O
cells NNS I-NP O
following VBG B-PP O
infection NN B-NP O
with IN B-PP O
PDS NN B-NP O
- HYPH B-NP O
recombinant JJ I-NP O
baculovirus NN I-NP O
. . O O

The DT B-NP O
rates NNS I-NP O
of IN B-PP O
transport NN B-NP O
for IN B-PP O
iodide NN B-NP O
and CC I-NP O
chloride NN I-NP O
were VBD B-VP O
significantly RB I-VP O
increased VBN I-VP O
following VBG B-PP O
the DT B-NP O
expression NN I-NP O
of IN B-PP O
pendrin NN B-NP O
in IN B-PP O
both DT B-NP O
cell NN I-NP O
systems NNS I-NP O
. . O O

Our PRP$ B-NP O
results NNS I-NP O
demonstrate VBP B-VP O
that IN B-SBAR O
pendrin NN B-NP O
functions VBZ B-VP O
as IN B-PP O
a DT B-NP O
transporter NN I-NP O
of IN B-PP O
chloride NN B-NP O
and CC I-NP O
iodide NN I-NP O
, , B-NP O
but CC I-NP O
not RB I-NP O
sulfate NN B-NP O
, , O O
and CC O O
may MD B-VP O
provide VB I-VP O
insight NN B-NP O
into IN B-PP O
thyroid JJ B-NP O
physiology NN I-NP O
and CC O O
the DT B-NP O
pathophysiology NN I-NP O
of IN B-PP O
Pendred NNP B-NP B-Disease
syndrome NN I-NP I-Disease
. . O O

. . O O

HFE NN B-NP O
mutations NNS I-NP O
analysis NN I-NP O
in IN B-PP O
711 CD B-NP O
hemochromatosis NN I-NP B-Disease
probands NNS I-NP O
: : O O
evidence NN B-NP O
for IN B-PP O
S65C NN B-NP O
implication NN I-NP O
in IN B-PP O
mild JJ B-NP O
form NN I-NP O
of IN B-PP O
hemochromatosis NN B-NP B-Disease
. . O O

Hereditary JJ B-NP B-Disease
hemochromatosis NN I-NP I-Disease
( ( O O
HH NN B-NP B-Disease
) ) O O
is VBZ B-VP O
a DT B-NP O
common JJ I-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
genetic JJ I-NP I-Disease
disorder NN I-NP I-Disease
of IN B-PP O
iron NN B-NP O
metabolism NN I-NP O
. . O O

The DT B-NP O
HFE NN I-NP O
candidate NN I-NP O
gene NN I-NP O
encoding VBG B-VP O
an DT B-NP O
HLA NN I-NP O
class NN I-NP O
I CD I-NP O
- HYPH B-NP O
like JJ I-NP O
protein NN I-NP O
involved VBN B-VP O
in IN B-PP O
HH NN B-NP B-Disease
was VBD B-VP O
identified VBN I-VP O
in IN B-PP O
1996 CD B-NP O
. . O O

Two CD B-NP O
missense JJ I-NP O
mutations NNS I-NP O
have VBP B-VP O
been VBN I-VP O
described VBN I-VP O
C282Y NN B-NP O
, , O O
accounting VBG B-VP O
for IN B-PP O
80 CD B-NP O
% NN I-NP O
to TO B-PP O
90 CD B-NP O
% NN I-NP O
of IN B-PP O
HH NN B-NP B-Disease
chromosomes NNS I-NP O
, , O O
and CC O O
H63D NN B-NP O
, , O O
which WDT B-NP O
is VBZ B-VP O
associated VBN I-VP O
with IN B-PP O
a DT B-NP O
milder JJR I-NP O
form NN I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
representing VBG B-VP O
40 CD B-NP O
% NN I-NP O
to TO I-NP O
70 CD I-NP O
% NN I-NP O
of IN B-PP O
non AFX B-NP O
- HYPH I-NP O
C282Y NN I-NP O
HH NN I-NP B-Disease
chromosomes NNS I-NP O
. . O O

We PRP B-NP O
report VBP B-VP O
here RB B-ADVP O
on IN B-PP O
the DT B-NP O
analysis NN I-NP O
of IN B-PP O
C282Y NN B-NP O
, , O O
H63D NN B-NP O
, , O O
and CC O O
the DT B-NP O
193A NN I-NP O
- SYM B-VP O
- SYM B-NP O
> SYM I-NP O
T NN I-NP O
substitution NN I-NP O
leading VBG B-VP O
to TO B-PP O
the DT B-NP O
S65C NN I-NP O
missense JJ I-NP O
substitution NN I-NP O
in IN B-PP O
a DT B-NP O
large JJ I-NP O
series NN I-NP O
of IN B-PP O
probands NNS B-NP O
and CC I-NP O
controls NNS I-NP O
. . O O

The DT B-NP O
results NNS I-NP O
confirm VBP B-VP O
that IN B-SBAR O
the DT B-NP O
C282Y NN I-NP O
substitution NN I-NP O
was VBD B-VP O
the DT B-NP O
main JJ I-NP O
mutation NN I-NP O
involved VBN B-VP O
in IN B-PP O
hemochromatosis NN B-NP B-Disease
, , O O
accounting VBG B-VP O
for IN B-PP O
85 CD B-NP O
% NN I-NP O
of IN B-PP O
carrier NN B-NP O
chromosomes NNS I-NP O
, , O O
whereas IN O O
the DT B-NP O
H63D NN I-NP O
substitution NN I-NP O
represented VBD B-VP O
39 CD B-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
HH NN I-NP B-Disease
chromosomes NNS I-NP O
that WDT B-NP O
did VBD B-VP O
not RB I-VP O
carry VB I-VP O
the DT B-NP O
C282Y NN I-NP O
mutation NN I-NP O
. . O O

In IN B-PP O
addition NN B-NP O
, , O O
our PRP$ B-NP O
screening NN I-NP O
showed VBD B-VP O
that IN B-SBAR O
the DT B-NP O
S65C NN I-NP O
substitution NN I-NP O
was VBD B-VP O
significantly RB I-VP O
enriched VBN I-VP O
in IN B-PP O
probands NNS B-NP O
with IN B-PP O
at IN B-NP O
least JJS I-NP O
one CD I-NP O
chromosome NN I-NP O
without IN B-PP O
an DT B-NP O
assigned VBN I-NP O
mutation NN I-NP O
. . O O

This DT B-NP O
substitution NN I-NP O
accounted VBD B-VP O
for IN B-PP O
7 CD B-NP O
. . O O

8 CD B-NP O
% NN I-NP O
of IN B-PP O
HH NN B-NP B-Disease
chromosomes NNS I-NP O
that WDT B-NP O
were VBD B-VP O
neither DT B-NP O
C282Y NN I-NP O
nor CC I-NP O
H63D NN I-NP O
. . O O

This DT B-NP O
enrichment NN I-NP O
of IN B-PP O
S65C NN B-NP O
among IN B-PP O
HH NN B-NP B-Disease
chromosomes NNS I-NP O
suggests VBZ B-VP O
that IN B-SBAR O
the DT B-NP O
S65C NN I-NP O
substitution NN I-NP O
is VBZ B-VP O
associated VBN I-VP O
with IN B-PP O
the DT B-NP O
mild JJ I-NP O
form NN I-NP O
of IN B-PP O
hemochromatosis NN B-NP B-Disease
. . O O

Germline NN B-NP O
BRCA1 NN I-NP O
alterations NNS I-NP O
in IN B-PP O
a DT B-NP O
population NN I-NP O
- HYPH O O
based VBN B-NP O
series NN I-NP O
of IN B-PP O
ovarian JJ B-NP B-Disease
cancer NN I-NP I-Disease
cases NNS I-NP O
. . O O

The DT B-NP O
objective NN I-NP O
of IN B-PP O
this DT B-NP O
study NN I-NP O
was VBD B-VP O
to TO I-VP O
provide VB I-VP O
more RBR B-NP O
accurate JJ I-NP O
frequency NN I-NP O
estimates NNS I-NP O
of IN B-PP O
breast NN B-NP B-Disease
cancer NN I-NP I-Disease
susceptibility NN I-NP O
gene NN I-NP O
1 CD I-NP O
( ( O O
BRCA1 NN B-NP O
) ) O O
germline NN B-NP O
alterations NNS I-NP O
in IN B-PP O
the DT B-NP O
ovarian JJ I-NP B-Disease
cancer NN I-NP I-Disease
population NN I-NP O
. . O O

To TO B-VP O
achieve VB I-VP O
this DT B-NP O
, , O O
we PRP B-NP O
determined VBD B-VP O
the DT B-NP O
prevalence NN I-NP O
of IN B-PP O
BRCA1 NN B-NP O
alterations NNS I-NP O
in IN B-PP O
a DT B-NP O
population NN I-NP O
- HYPH O O
based VBN B-NP O
series NN I-NP O
of IN B-PP O
consecutive JJ B-NP O
ovarian JJ I-NP B-Disease
cancer NN I-NP I-Disease
cases NNS I-NP O
. . O O

This DT B-NP O
is VBZ B-VP O
the DT B-NP O
first JJ I-NP O
population NN I-NP O
- HYPH B-VP O
based VBN B-NP O
ovarian JJ I-NP B-Disease
cancer NN I-NP I-Disease
study NN I-NP O
reporting VBG B-VP O
BRCA1 NN B-NP O
alterations NNS I-NP O
derived VBN B-VP O
from IN B-PP O
a DT B-NP O
comprehensive JJ I-NP O
screen NN I-NP O
of IN B-PP O
the DT B-NP O
entire JJ I-NP O
coding VBG I-NP O
region NN I-NP O
. . O O

One CD B-NP O
hundred CD I-NP O
and CC I-NP O
seven CD I-NP O
ovarian JJ I-NP B-Disease
cancer NN I-NP I-Disease
cases NNS I-NP O
were VBD B-VP O
analyzed VBN I-VP O
for IN B-PP O
BRCA1 NN B-NP O
alterations NNS I-NP O
using VBG B-VP O
the DT B-NP O
RNase NN I-NP O
mismatch NN I-NP O
cleavage NN I-NP O
assay NN I-NP O
followed VBN B-VP O
by IN B-PP O
direct JJ B-NP O
sequencing NN I-NP O
. . O O

Two CD B-NP O
truncating VBG I-NP O
mutations NNS I-NP O
, , O O
962del4 CD B-NP O
and CC I-NP O
3600del11 CD I-NP O
, , O O
were VBD B-VP O
identified VBN I-VP O
. . O O

Both DT B-NP O
patients NNS I-NP O
had VBD B-VP O
a DT B-NP O
family NN I-NP O
history NN I-NP O
of IN B-PP O
breast NN B-NP B-Disease
or CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
. . O O

Several JJ B-NP O
novel NN I-NP O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
previously RB B-NP O
reported VBN I-NP O
uncharacterized JJ I-NP O
variants NNS I-NP O
were VBD B-VP O
also RB I-VP O
identified VBN I-VP O
, , O O
some DT B-NP O
of IN B-PP O
which WDT B-NP O
were VBD B-VP O
associated VBN I-VP O
with IN B-PP O
a DT B-NP O
family NN I-NP O
history NN I-NP O
of IN B-PP O
cancer NN B-NP B-Disease
. . O O

The DT B-NP O
frequency NN I-NP O
distribution NN I-NP O
of IN B-PP O
common JJ B-NP O
polymorphisms NNS I-NP O
was VBD B-VP O
determined VBN I-VP O
in IN B-PP O
the DT B-NP O
91 CD I-NP O
Caucasian JJ I-NP O
cancer NN I-NP B-Disease
cases NNS I-NP O
in IN B-PP O
this DT B-NP O
series NN I-NP O
and CC O O
24 CD B-NP O
sister NN I-NP O
controls NNS I-NP O
using VBG B-VP O
allele NN B-NP O
- HYPH B-NP O
specific JJ I-NP O
amplification NN I-NP O
. . O O

The DT B-NP O
rare JJ I-NP O
form NN I-NP O
of IN B-PP O
the DT B-NP O
Q356R NN I-NP O
polymorphism NN I-NP O
was VBD B-VP O
significantly RB B-ADVP O
( ( O O
P NN B-NP O
= SYM B-VP O
0 CD B-NP O
. . O O

03 CD O O
) ) O O
associated VBN B-VP O
with IN B-PP O
a DT B-NP O
family NN I-NP O
history NN I-NP O
of IN B-PP O
ovarian JJ B-NP B-Disease
cancer NN I-NP I-Disease
, , O O
suggesting VBG B-VP O
that IN B-SBAR O
this DT B-NP O
polymorphism NN I-NP O
may MD B-VP O
influence VB I-VP O
ovarian JJ B-NP B-Disease
cancer NN I-NP I-Disease
risk NN I-NP O
. . O O

In IN B-PP O
summary NN B-NP O
, , O O
our PRP$ B-NP O
data NNS I-NP O
suggest VBP B-VP O
a DT B-NP O
role NN I-NP O
for IN B-PP O
some DT B-NP O
uncharacterized JJ I-NP O
variants NNS I-NP O
and CC O O
rare JJ B-NP O
forms NNS I-NP O
of IN B-PP O
polymorphisms NNS B-NP O
in IN B-PP O
determining VBG B-VP O
ovarian JJ B-NP B-Disease
cancer NN I-NP I-Disease
risk NN I-NP O
, , O O
and CC O O
highlight VBP B-VP O
the DT B-NP O
necessity NN I-NP O
to TO B-VP O
screen VB I-VP O
for IN B-PP O
missense JJ B-NP O
alterations NNS I-NP O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
truncating VBG B-VP O
mutations NNS B-NP O
in IN B-PP O
this DT B-NP O
population NN I-NP O
. . O O

Adrenoleukodystrophy NN B-NP O
- HYPH B-PP O
related VBN B-NP O
protein NN I-NP O
can MD B-VP O
compensate VB I-VP O
functionally RB B-ADVP O
for IN B-PP O
adrenoleukodystrophy NN B-NP B-Disease
protein NN I-NP I-Disease
deficiency NN I-NP I-Disease
( ( O O
X NN B-NP B-Disease
- HYPH B-NP I-Disease
ALD NN I-NP I-Disease
) ) O O
: : O O
implications NNS B-NP O
for IN B-PP O
therapy NN B-NP O
. . O O

Inherited VBN B-NP B-Disease
defects NNS I-NP I-Disease
in IN B-PP O
the DT B-NP O
peroxisomal JJ I-NP O
ATP NN I-NP O
- HYPH O O
binding VBG B-VP O
cassette NN B-NP O
( ( O O
ABC NN B-NP O
) ) O O
transporter NN B-NP O
adrenoleukodystrophy NN I-NP B-Disease
protein NN I-NP O
( ( O O
ALDP NN B-NP O
) ) O O
lead VBP B-VP O
to TO B-PP O
the DT B-NP O
lethal JJ I-NP O
peroxisomal JJ I-NP B-Disease
disorder NN I-NP I-Disease
X NN I-NP B-Disease
- HYPH O I-Disease
linked VBN B-VP I-Disease
adrenoleukodystrophy NN B-NP I-Disease
( ( O O
X NN B-NP B-Disease
- HYPH B-NP I-Disease
ALD NN I-NP I-Disease
) ) O O
, , O O
for IN B-PP O
which WDT B-NP O
no DT B-NP O
efficient JJ I-NP O
treatment NN I-NP O
has VBZ B-VP O
been VBN I-VP O
established VBN I-VP O
so RB B-ADVP O
far RB I-ADVP O
. . O O

Three CD B-NP O
other JJ I-NP O
peroxisomal JJ I-NP O
ABC NNP I-NP O
transporters NNS I-NP O
currently RB B-ADVP O
are VBP B-VP O
known VBN I-VP O
adrenoleukodystrophy NN B-NP O
- HYPH O O
related VBN B-NP O
protein NN I-NP O
( ( O O
ALDRP NN B-NP O
) ) O O
, , O O
70 CD B-NP O
kDa NN I-NP O
peroxisomal JJ I-NP O
membrane NN I-NP O
protein NN I-NP O
( ( O O
PMP70 NN B-NP O
) ) O O
and CC O O
PMP70 NN B-NP O
- HYPH O O
related VBN B-NP O
protein NN I-NP O
. . O O

By IN B-PP O
using VBG B-VP O
transient JJ B-NP O
and CC I-NP O
stable JJ I-NP O
overexpression NN I-NP O
of IN B-PP O
human JJ B-NP O
cDNAs NNS I-NP O
encoding VBG B-VP O
ALDP NN B-NP O
and CC O O
its PRP$ B-NP O
closest JJS I-NP O
relative JJ I-NP O
ALDRP NN I-NP O
, , O O
we PRP B-NP O
could MD B-VP O
restore VB I-VP O
the DT B-NP O
impaired JJ I-NP O
peroxisomal JJ I-NP O
beta SYM I-NP O
- HYPH I-NP O
oxidation NN I-NP O
in IN B-PP O
fibroblasts NNS B-NP O
of IN B-PP O
X NN B-NP B-Disease
- HYPH O I-Disease
ALD NN B-NP I-Disease
patients NNS I-NP O
. . O O

The DT B-NP O
pathognomonic JJ I-NP O
accumulation NN I-NP O
of IN B-PP O
very RB B-NP O
long JJ I-NP O
chain NN I-NP O
fatty JJ I-NP O
acids NNS I-NP O
could MD B-VP O
also RB I-VP O
be VB I-VP O
prevented VBN I-VP O
by IN B-PP O
overexpression NN B-NP O
of IN B-PP O
ALDRP NN B-NP O
in IN B-PP O
immortalized VBN B-NP O
X NN I-NP O
- HYPH I-NP O
ALD NN I-NP O
cells NNS I-NP O
. . O O

Immunofluorescence NN B-NP O
analysis NN I-NP O
demonstrated VBD B-VP O
that IN B-SBAR O
the DT B-NP O
functional JJ I-NP O
replacement NN I-NP O
of IN B-PP O
ALDP NN B-NP O
by IN B-PP O
ALDRP NN B-NP O
was VBD B-VP O
not RB O O
due JJ B-ADJP O
to TO B-PP O
stabilization NN B-NP O
of IN B-PP O
the DT B-NP O
mutated VBN I-NP O
ALDP NN I-NP O
itself PRP B-NP O
. . O O

Moreover RB B-ADVP O
, , O O
we PRP B-NP O
were VBD B-VP O
able JJ B-ADJP O
to TO B-VP O
restore VB I-VP O
the DT B-NP O
peroxisomal JJ I-NP O
beta SYM I-NP O
- HYPH I-NP O
oxidation NN I-NP O
defect NN I-NP O
in IN B-PP O
the DT B-NP O
liver NN I-NP O
of IN B-PP O
ALDP NN B-NP O
- HYPH B-NP O
deficient JJ I-NP O
mice NNS I-NP O
by IN B-PP O
stimulation NN B-NP O
of IN B-PP O
ALDRP NN B-NP O
and CC I-NP O
PMP70 NN I-NP O
gene NN I-NP O
expression NN I-NP O
through IN B-PP O
a DT B-NP O
dietary JJ I-NP O
treatment NN I-NP O
with IN B-PP O
the DT B-NP O
peroxisome NN I-NP O
proliferator NN I-NP O
fenofibrate NN I-NP O
. . O O

These DT B-NP O
results NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
a DT B-NP O
correction NN I-NP O
of IN B-PP O
the DT B-NP O
biochemical JJ I-NP O
defect NN I-NP O
in IN B-PP O
X NN B-NP B-Disease
- HYPH O I-Disease
ALD NN B-NP I-Disease
could MD B-VP O
be VB I-VP O
possible JJ B-ADJP O
by IN B-PP O
drug NN B-NP O
- HYPH B-NP O
induced VBN I-NP O
overexpression NN I-NP O
or CC O O
ectopic JJ B-NP O
expression NN I-NP O
of IN B-PP O
ALDRP NN B-NP O
. . O O

. . O O

Centrosome NN B-NP O
amplification NN I-NP O
and CC O O
a DT B-NP O
defective JJ I-NP O
G2 NN I-NP O
- HYPH B-NP O
M NN I-NP O
cell NN I-NP O
cycle NN I-NP O
checkpoint NN I-NP O
induce VBP B-VP O
genetic JJ B-NP O
instability NN I-NP O
in IN B-PP O
BRCA1 NN B-NP O
exon NN I-NP O
11 CD B-NP O
isoform NN I-NP O
- HYPH B-NP O
deficient JJ I-NP O
cells NNS I-NP O
. . O O

Germline NN B-NP O
mutations NNS I-NP O
of IN B-PP O
the DT B-NP O
Brca1 NN I-NP O
tumor NN I-NP B-Disease
suppressor NN I-NP O
gene NN I-NP O
predispose NN I-NP O
women NNS I-NP O
to TO B-PP O
breast NN B-NP B-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancers NNS I-NP I-Disease
. . O O

To TO B-VP O
study VB I-VP O
mechanisms NNS B-NP O
underlying VBG B-VP O
BRCA1 NN B-NP O
- HYPH O O
related VBN B-NP O
tumorigenesis NN I-NP O
, , O O
we PRP B-NP O
derived VBD B-VP O
mouse NN B-NP O
embryonic JJ I-NP O
fibroblast NN I-NP O
cells NNS I-NP O
carrying VBG B-VP O
a DT B-NP O
targeted VBN I-NP O
deletion NN I-NP O
of IN B-PP O
exon NN B-NP O
11 CD I-NP O
of IN B-PP O
the DT B-NP O
Brca1 NN I-NP O
gene NN I-NP O
. . O O

We PRP B-NP O
show VBP B-VP O
that IN B-SBAR O
the DT B-NP O
mutant JJ I-NP O
cells NNS I-NP O
maintain VBP B-VP O
an DT B-NP O
intact JJ I-NP O
G1 NN I-NP O
- HYPH B-NP O
S NN I-NP O
cell NN I-NP O
cycle NN I-NP O
checkpoint NN I-NP O
and CC O O
proliferate VBP B-VP O
poorly RB B-ADVP O
. . O O

However RB B-ADVP O
, , O O
a DT B-NP O
defective JJ I-NP O
G2 NN I-NP O
- HYPH B-NP O
M NN I-NP O
checkpoint NN I-NP O
in IN B-PP O
these DT B-NP O
cells NNS I-NP O
is VBZ B-VP O
accompanied VBN I-VP O
by IN B-PP O
extensive JJ B-NP O
chromosomal JJ I-NP B-Disease
abnormalities NNS I-NP I-Disease
. . O O

Mutant JJ B-NP O
fibroblasts NNS I-NP O
contain VBP B-VP O
multiple JJ B-NP O
, , I-NP O
functional JJ I-NP O
centrosomes NNS I-NP O
, , O O
which WDT B-NP O
lead VBP B-VP O
to TO B-PP O
unequal JJ B-NP O
chromosome NN I-NP O
segregation NN I-NP O
, , O O
abnormal JJ B-NP O
nuclear JJ I-NP O
division NN I-NP O
, , O O
and CC O O
aneuploidy NN B-NP B-Disease
. . O O

These DT B-NP O
data NNS I-NP O
uncover VBP B-VP O
an DT B-NP O
essential JJ I-NP O
role NN I-NP O
of IN B-PP O
BRCA1 NN B-NP O
in IN B-PP O
maintaining VBG B-VP O
genetic JJ B-NP O
stability NN I-NP O
through IN B-PP O
the DT B-NP O
regulation NN I-NP O
of IN B-PP O
centrosome NN B-NP O
duplication NN I-NP O
and CC O O
the DT B-NP O
G2 NN I-NP O
- HYPH B-NP O
M NN I-NP O
checkpoint NN I-NP O
and CC O O
provide VBP B-VP O
a DT B-NP O
molecular JJ I-NP O
basis NN I-NP O
for IN B-PP O
the DT B-NP O
role NN I-NP O
of IN B-PP O
BRCA1 NN B-NP O
in IN B-PP O
tumorigenesis NN B-NP O
. . O O

. . O O

Defective JJ B-NP O
CD95 NN I-NP O
/ SYM B-NP O
APO NN I-NP O
- SYM B-NP O
1 CD I-NP O
/ SYM I-NP O
Fas NN I-NP O
signal NN I-NP O
complex NN I-NP O
formation NN I-NP O
in IN B-PP O
the DT B-NP O
human JJ I-NP O
autoimmune JJ I-NP B-Disease
lymphoproliferative JJ I-NP I-Disease
syndrome NN I-NP I-Disease
, , O I-Disease
type NN B-NP I-Disease
Ia NN I-NP I-Disease
. . O O

Heterozygous JJ B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
CD95 NN I-NP O
( ( O O
APO NN B-NP O
- HYPH B-NP O
1 CD I-NP O
/ SYM I-NP O
Fas NN I-NP O
) ) O O
receptor NN B-NP O
occur VBP B-VP O
in IN B-PP O
most JJS B-NP O
individuals NNS I-NP O
with IN B-PP O
autoimmune JJ B-NP B-Disease
lymphoproliferative JJ I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
ALPS NN B-NP B-Disease
) ) O O
and CC O O
dominantly RB B-VP O
interfere VBP I-VP O
with IN B-PP O
apoptosis NN B-NP O
by IN B-PP O
an DT B-NP O
unknown JJ I-NP O
mechanism NN I-NP O
. . O O

We PRP B-NP O
show VBP B-VP O
that IN B-SBAR O
local JJ B-NP O
or CC I-NP O
global JJ I-NP O
alterations NNS I-NP O
in IN B-PP O
the DT B-NP O
structure NN I-NP O
of IN B-PP O
the DT B-NP O
cytoplasmic JJ I-NP O
death NN I-NP O
domain NN I-NP O
from IN B-PP O
nine CD B-NP O
independent JJ I-NP O
ALPS NN I-NP B-Disease
CD95 NN I-NP O
death NN I-NP O
- HYPH B-NP O
domain NN I-NP O
mutations NNS I-NP O
result VBP B-VP O
in IN B-PP O
a DT B-NP O
failure NN I-NP O
to TO B-VP O
bind VB I-VP O
the DT B-NP O
FADD NN I-NP O
/ SYM B-NP O
MORT1 NN I-NP O
signaling NN I-NP O
protein NN I-NP O
. . O O

Despite IN B-PP O
heterozygosity NN B-NP O
for IN B-PP O
the DT B-NP O
abnormal JJ I-NP O
allele NN I-NP O
, , O O
lymphocytes NNS B-NP O
from IN B-PP O
ALPS NN B-NP B-Disease
patients NNS I-NP O
showed VBD B-VP O
markedly RB I-VP O
decreased VBN I-VP O
FADD NN B-NP O
association NN I-NP O
and CC O O
a DT B-NP O
loss NN I-NP O
of IN B-PP O
caspase NN B-NP O
recruitment NN I-NP O
and CC O O
activation NN B-NP O
after IN B-PP O
CD95 NN B-NP O
crosslinking NN I-NP O
. . O O

These DT B-NP O
data NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
intracytoplasmic JJ B-NP O
CD95 NN I-NP O
mutations NNS I-NP O
in IN B-PP O
ALPS NN B-NP B-Disease
impair NN I-NP O
apoptosis NN I-NP O
chiefly RB B-ADVP O
by IN B-PP O
disrupting VBG B-VP O
death NN B-NP O
- HYPH B-NP O
domain NN I-NP O
interactions NNS I-NP O
with IN B-PP O
the DT B-NP O
signaling NN I-NP O
protein NN I-NP O
FADD NN I-NP O
/ SYM B-NP O
MORT1 NN I-NP O
. . O O

. . O O

Analysis NN B-NP O
of IN B-PP O
alkaptonuria NN B-NP B-Disease
( ( O O
AKU NN B-NP B-Disease
) ) O O
mutations NNS B-NP O
and CC I-NP O
polymorphisms NNS I-NP O
reveals VBZ B-VP O
that IN B-SBAR O
the DT B-NP O
CCC NN I-NP O
sequence NN I-NP O
motif NN I-NP O
is VBZ B-VP O
a DT B-NP O
mutational JJ I-NP O
hot JJ I-NP O
spot NN I-NP O
in IN B-PP O
the DT B-NP O
homogentisate NN I-NP O
1 CD I-NP O
, , I-NP O
2 CD I-NP O
dioxygenase NN I-NP O
gene NN I-NP O
( ( O O
HGO NN B-NP O
) ) O O
. . O O

We PRP B-NP O
recently RB B-ADVP O
showed VBD B-VP O
that IN B-SBAR O
alkaptonuria NN B-NP B-Disease
( ( O O
AKU NN B-NP B-Disease
) ) O O
is VBZ B-VP O
caused VBN I-VP O
by IN B-PP O
loss NN B-NP O
- HYPH B-NP O
of IN B-PP O
- HYPH B-NP O
function NN I-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
homogentisate NN I-NP O
1 CD I-NP O
, , I-NP O
2 CD I-NP O
dioxygenase NN I-NP O
gene NN I-NP O
( ( O O
HGO NN B-NP O
) ) O O
. . O O

Herein RB B-ADVP O
we PRP B-NP O
describe VBP B-VP O
haplotype NN B-NP O
and CC O O
mutational JJ B-NP O
analyses NNS I-NP O
of IN B-PP O
HGO NN B-NP O
in IN B-PP O
seven CD B-NP O
new JJ I-NP O
AKU NN I-NP B-Disease
pedigrees NNS I-NP O
. . O O

These DT B-NP O
analyses NNS I-NP O
identified VBD B-VP O
two CD B-NP O
novel JJ I-NP O
single JJ I-NP O
- HYPH I-NP O
nucleotide NN I-NP O
polymorphisms NNS I-NP O
( ( O O
INV4 NN B-NP O
+ SYM B-NP O
31A NN I-NP O
- SYM B-NP O
- HYPH B-NP O
> SYM I-NP O
G NN I-NP O
and CC I-NP O
INV11 NN I-NP O
+ SYM B-NP O
18A NN I-NP O
- SYM B-NP O
- HYPH B-NP O
> SYM I-NP O
G NN I-NP O
) ) O O
and CC O O
six CD B-NP O
novel JJ I-NP O
AKU NN I-NP B-Disease
mutations NNS I-NP O
( ( O O
INV1 NN B-NP O
- HYPH B-NP O
1G NN I-NP O
- SYM B-NP O
- HYPH B-NP O
> SYM I-NP O
A NN I-NP O
, , O O
W60G NN B-NP O
, , O O
Y62C NN B-NP O
, , O O
A122D NN B-NP O
, , O O
P230T NN B-NP O
, , O O
and CC O O
D291E NN B-NP O
) ) O O
, , O O
which WDT B-NP O
further RB B-ADVP O
illustrates VBZ B-VP O
the DT B-NP O
remarkable JJ I-NP O
allelic JJ I-NP O
heterogeneity NN I-NP O
found VBN B-VP O
in IN B-PP O
AKU NN B-NP B-Disease
. . O O

Reexamination NN B-NP O
of IN B-PP O
all DT B-NP O
29 CD I-NP O
mutations NNS I-NP O
and CC I-NP O
polymorphisms NNS I-NP O
thus RB B-ADVP O
far RB B-VP O
described VBN I-VP O
in IN B-PP O
HGO NN B-NP O
shows VBZ B-VP O
that IN B-SBAR O
these DT B-NP O
nucleotide NN I-NP O
changes NNS I-NP O
are VBP B-VP O
not RB O O
randomly RB B-VP O
distributed VBN I-VP O
; : O O
the DT B-NP O
CCC NN I-NP O
sequence NN I-NP O
motif NN I-NP O
and CC O O
its PRP$ B-NP O
inverted VBN I-NP O
complement NN I-NP O
, , O O
GGG NN B-NP O
, , O O
are VBP B-VP O
preferentially RB I-VP O
mutated VBN I-VP O
. . O O

These DT B-NP O
analyses NNS I-NP O
also RB B-ADVP O
demonstrated VBD B-VP O
that IN B-SBAR O
the DT B-NP O
nucleotide NN I-NP O
substitutions NNS I-NP O
in IN B-PP O
HGO NN B-NP O
do VBP B-VP O
not RB I-VP O
involve VB I-VP O
CpG NN B-NP O
dinucleotides NNS I-NP O
, , O O
which WDT B-NP O
illustrates VBZ B-VP O
important JJ B-NP O
differences NNS I-NP O
between IN B-PP O
HGO NN B-NP O
and CC O O
other JJ B-NP O
genes NNS I-NP O
for IN B-PP O
the DT B-NP O
occurrence NN I-NP O
of IN B-PP O
mutation NN B-NP O
at IN B-PP O
specific JJ B-NP O
short JJ I-NP O
- HYPH I-NP O
sequence NN I-NP O
motifs NNS I-NP O
. . O O

Because IN B-SBAR O
the DT B-NP O
CCC NN I-NP O
sequence NN I-NP O
motifs NNS I-NP O
comprise VBP B-VP O
a DT B-NP O
significant JJ I-NP O
proportion NN I-NP O
( ( O O
34 CD B-NP O
. . O O

5 CD B-NP O
% NN I-NP O
) ) O O
of IN B-PP O
all DT B-NP O
mutated VBN I-NP O
bases NNS I-NP O
that WDT B-NP O
have VBP B-VP O
been VBN I-VP O
observed VBN I-VP O
in IN B-PP O
HGO NN B-NP O
, , O O
we PRP B-NP O
conclude VBP B-VP O
that IN B-SBAR O
the DT B-NP O
CCC NN I-NP O
triplet NN I-NP O
is VBZ B-VP O
a DT B-NP O
mutational JJ I-NP O
hot JJ I-NP O
spot NN I-NP O
in IN B-PP O
HGO NN B-NP O
. . O O

Fabry NN B-NP B-Disease
disease NN I-NP I-Disease
: : O O
identification NN B-NP O
of IN B-PP O
novel JJ B-NP O
alpha SYM I-NP O
- HYPH I-NP O
galactosidase NN I-NP O
A NN I-NP O
mutations NNS I-NP O
and CC O O
molecular JJ B-NP O
carrier NN I-NP O
detection NN I-NP O
by IN B-PP O
use NN B-NP O
of IN B-PP O
fluorescent JJ B-NP O
chemical JJ I-NP O
cleavage NN I-NP O
of IN B-PP O
mismatches NNS B-NP O
. . O O

Fabry NN B-NP B-Disease
disease NN I-NP I-Disease
( ( O O
FD NN B-NP B-Disease
) ) O O
( ( O O
angiokeratoma NN B-NP B-Disease
corporis NN I-NP I-Disease
diffusum NN I-NP I-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
X NN I-NP B-Disease
- HYPH O I-Disease
linked VBN B-VP I-Disease
inborn JJ B-NP I-Disease
error NN I-NP I-Disease
of IN B-PP I-Disease
glycosphingolipid NN B-NP I-Disease
metabolism NN I-NP I-Disease
caused VBN B-VP O
by IN B-PP O
defects NNS B-NP O
in IN B-PP O
the DT B-NP O
lysosomal JJ I-NP O
alpha SYM I-NP O
- HYPH I-NP O
galactosidase NN I-NP O
A NN I-NP O
gene NN I-NP O
( ( O O
GLA NN B-NP O
) ) O O
. . O O

The DT B-NP O
enzymatic JJ I-NP O
defect NN I-NP O
leads VBZ B-VP O
to TO B-PP O
the DT B-NP O
systemic JJ I-NP O
accumulation NN I-NP O
of IN B-PP O
neutral JJ B-NP O
glycosphingolipids NNS I-NP O
with IN B-PP O
terminal JJ B-NP O
alpha SYM I-NP O
- HYPH I-NP O
galactosyl NN I-NP O
moieties NNS I-NP O
. . O O

Clinically RB B-ADVP O
, , O O
affected VBD B-VP O
hemizygous JJ B-NP O
males NNS I-NP O
have VBP B-VP O
angiokeratoma NN B-NP B-Disease
, , O O
severe JJ B-NP B-Disease
acroparesthesia NN I-NP I-Disease
, , O O
renal JJ B-NP B-Disease
failure NN I-NP I-Disease
, , O O
and CC O O
vasculopathy NN B-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
heart NN I-NP I-Disease
and CC I-NP I-Disease
brain NN I-NP I-Disease
. . O O

While IN B-SBAR O
demonstration NN B-NP O
of IN B-PP O
alpha SYM B-NP B-Disease
- HYPH I-NP I-Disease
galactosidase NN I-NP I-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
leukocytes NNS B-NP O
is VBZ B-VP O
diagnostic JJ B-ADJP O
in IN B-PP O
affected VBN B-NP O
males NNS I-NP O
, , O O
enzymatic JJ B-NP O
detection NN I-NP O
of IN B-PP O
female JJ B-NP O
carriers NNS I-NP O
is VBZ B-VP O
often RB B-ADVP O
inconclusive JJ B-ADJP O
, , O O
due JJ B-ADJP O
to TO B-VP O
random VB I-VP O
X NN B-NP O
- HYPH B-NP O
chromosomal JJ I-NP O
inactivation NN I-NP O
, , O O
underlining VBG B-VP O
the DT B-NP O
need NN I-NP O
of IN B-PP O
molecular JJ B-NP O
investigations NNS I-NP O
for IN B-PP O
accurate JJ B-NP O
genetic JJ I-NP O
counseling NN I-NP O
. . O O

By IN B-PP O
use NN B-NP O
of IN B-PP O
chemical JJ B-NP O
cleavage NN I-NP O
of IN B-PP O
mismatches NNS B-NP O
adapted VBN B-VP O
to TO B-PP O
fluorescence NN B-NP O
- HYPH O O
based VBN B-NP O
detection NN I-NP O
systems NNS I-NP O
, , O O
we PRP B-NP O
have VBP B-VP O
characterized VBN I-VP O
the DT B-NP O
mutations NNS I-NP O
underlying VBG B-VP O
alpha SYM B-NP B-Disease
- HYPH I-NP I-Disease
Gal NN I-NP I-Disease
A NN I-NP I-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
16 CD B-NP O
individuals NNS I-NP O
from IN B-PP O
six CD B-NP O
unrelated JJ I-NP O
families NNS I-NP O
with IN B-PP O
FD NN B-NP B-Disease
. . O O

The DT B-NP O
mutational JJ I-NP O
spectrum NN I-NP O
included VBD B-VP O
five CD B-NP O
missense JJ I-NP O
mutations NNS I-NP O
( ( O O
C202W NN B-NP O
, , O O
C223G NN B-NP O
, , O O
N224D NN B-NP O
, , O O
R301Q NN B-NP O
, , O O
and CC O O
Q327K NN B-NP O
) ) O O
and CC O O
one CD B-NP O
splice NN I-NP O
- HYPH B-NP O
site NN I-NP O
mutation NN I-NP O
[ ( I-NP O
IVS3 NN I-NP O
G NN I-NP O
( ( O O
- SYM B-NP O
1 CD I-NP O
) ) O O
- SYM O O
- HYPH B-NP O
> SYM I-NP O
C NN I-NP O
] ) O O
. . O O

Studies NNS B-NP O
at IN B-PP O
the DT B-NP O
mRNA NN I-NP O
level NN I-NP O
showed VBD B-VP O
that IN B-SBAR O
the DT B-NP O
latter JJ I-NP O
led VBD B-VP O
to TO B-PP O
altered JJ B-NP O
pre AFX I-NP O
- HYPH O O
mRNA NN B-NP O
splicing NN I-NP O
with IN B-PP O
consequent JJ B-NP O
alteration NN I-NP O
of IN B-PP O
the DT B-NP O
mRNA NN I-NP O
translational JJ I-NP O
reading NN I-NP O
frame NN I-NP O
and CC I-NP O
generation NN I-NP O
of IN B-PP O
a DT B-NP O
premature JJ I-NP O
termination NN I-NP O
codon NN I-NP O
of IN B-PP O
translation NN B-NP O
. . O O

By IN B-PP O
use NN B-NP O
of IN B-PP O
this DT B-NP O
strategy NN I-NP O
, , O O
carrier NN B-NP O
status NN I-NP O
was VBD B-VP O
accurately RB I-VP O
assessed VBN I-VP O
in IN B-PP O
all DT B-NP O
seven CD I-NP O
at IN B-PP O
- HYPH B-NP O
risk NN I-NP O
females NNS I-NP O
tested VBN B-VP O
, , O O
whereas IN O O
enzymatic JJ B-NP O
dosages NNS I-NP O
failed VBD B-VP O
to TO B-PP O
diagnose NN B-NP O
or CC O O
exclude VB B-VP O
heterozygosity NN B-NP O
. . O O

. . O O

Prenatal JJ B-NP O
diagnosis NN I-NP O
by IN B-PP O
FISH NN B-NP O
in IN B-PP O
a DT B-NP O
family NN I-NP O
with IN B-PP O
Pelizaeus NNP B-NP B-Disease
- HYPH B-NP I-Disease
Merzbacher NNP I-NP I-Disease
disease NN I-NP I-Disease
caused VBN B-VP O
by IN B-PP O
duplication NN B-NP O
of IN B-PP O
PLP NN B-NP O
gene NN I-NP O
. . O O

A DT B-NP O
diagnosis NN I-NP O
of IN B-PP O
Pelizaeus NNP B-NP B-Disease
- HYPH I-NP I-Disease
Merzbacher NNP I-NP I-Disease
disease NN I-NP I-Disease
( ( O O
MIM NN B-NP O
312080 CD I-NP O
) ) O O
was VBD B-VP O
made VBN I-VP O
in IN B-PP O
a DT B-NP O
young JJ I-NP O
boy NN I-NP O
. . O O

No DT B-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
coding VBG I-NP O
region NN I-NP O
of IN B-PP O
the DT B-NP O
proteolipid NN I-NP O
protein NN I-NP O
( ( O O
PLP NN B-NP O
) ) O O
gene NN B-NP O
had VBD B-VP O
been VBN I-VP O
found VBN I-VP O
. . O O

The DT B-NP O
boys VBZ B-VP O
maternal JJ B-NP O
aunt NN I-NP O
came VBD B-VP O
for IN B-PP O
prenatal JJ B-NP O
diagnosis NN I-NP O
when WRB B-ADVP O
16 CD B-NP O
+ SYM I-NP O
weeks NNS I-NP O
pregnant JJ B-ADJP O
and CC O O
carrying VBG B-VP O
a DT B-NP O
male JJ I-NP O
fetus NN I-NP O
. . O O

Samples NNS B-NP O
were VBD B-VP O
tested VBN I-VP O
for IN B-PP O
duplication NN B-NP O
of IN B-PP O
the DT B-NP O
PLP NN I-NP O
gene NN I-NP O
, , O O
by IN B-PP O
interphase NN B-NP O
FISH NN I-NP O
, , O O
in IN B-PP O
lymphocyte NN B-NP O
preparations NNS I-NP O
from IN B-PP O
the DT B-NP O
proband NN I-NP O
, , O O
his PRP$ B-NP O
aunt NN I-NP O
and CC O O
an DT B-NP O
amniotic JJ I-NP O
fluid NN I-NP O
cell NN I-NP O
preparation NN I-NP O
from IN B-PP O
the DT B-NP O
fetus NN I-NP O
. . O O

The DT B-NP O
proband NN I-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
carry VB I-VP O
the DT B-NP O
duplication NN I-NP O
, , O O
thus RB B-ADVP O
confirming VBG B-VP O
the DT B-NP O
diagnosis NN I-NP O
of IN B-PP O
Pelizaeus NNP B-NP B-Disease
Merzbacher NNP I-NP I-Disease
disease NN I-NP I-Disease
, , O O
but CC O O
neither CC O O
the DT B-NP O
aunt NN I-NP O
nor CC O O
the DT B-NP O
fetus NN I-NP O
carried VBD B-VP O
a DT B-NP O
duplication NN I-NP O
. . O O

. . O O

Dominant JJ B-NP O
negative JJ I-NP O
effect NN I-NP O
of IN B-PP O
the DT B-NP O
APC1309 NN I-NP O
mutation NN I-NP O
: : O O
a DT B-NP O
possible JJ I-NP O
explanation NN I-NP O
for IN B-PP O
genotype NN B-NP O
- HYPH B-NP O
phenotype NN I-NP O
correlations NNS I-NP O
in IN B-PP O
familial JJ B-NP B-Disease
adenomatous JJ I-NP I-Disease
polyposis NN I-NP I-Disease
. . O O

Inactivation NN B-NP O
of IN B-PP O
the DT B-NP O
adenomatous JJ I-NP B-Disease
polyposis NN I-NP I-Disease
coli NN I-NP I-Disease
( ( O O
APC NN B-NP B-Disease
) ) O O
gene NN B-NP O
product NN I-NP O
initiates VBZ B-VP O
colorectal JJ B-NP O
tumorigenesis NN I-NP O
. . O O

Patients NNS B-NP O
with IN B-PP O
familial JJ B-NP B-Disease
APC NN I-NP I-Disease
( ( O O
FAP NN B-NP B-Disease
) ) O O
carry VBP B-VP O
germ NN B-NP O
- HYPH I-NP O
line NN I-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
and CC O O
develop VBP B-VP O
multiple JJ B-NP O
colorectal JJ I-NP B-Disease
adenomas NNS I-NP I-Disease
and CC O O
subsequent JJ B-NP O
carcinomas NNS I-NP B-Disease
early RB B-ADVP O
in IN B-PP O
life NN B-NP O
. . O O

The DT B-NP O
severity NN I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
correlates VBZ B-VP O
with IN B-PP O
the DT B-NP O
position NN I-NP O
of IN B-PP O
the DT B-NP O
inherited VBN I-NP O
APC NN I-NP B-Disease
mutation NN I-NP O
( ( O O
genotype NN B-NP O
- HYPH B-NP O
phenotype NN I-NP O
correlation NN I-NP O
) ) O O
. . O O

Together RB B-ADVP O
with IN B-PP O
the DT B-NP O
fact NN I-NP O
that IN B-SBAR O
both CC O O
germ NN B-NP O
- HYPH I-NP O
line NN I-NP O
and CC O O
sporadic JJ B-NP O
APC NN I-NP B-Disease
mutations NNS I-NP O
cluster VBP B-VP O
in IN B-PP O
the DT B-NP O
central JJ I-NP O
region NN I-NP O
of IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
, , O O
this DT B-NP O
points VBZ B-VP O
to TO B-PP O
a DT B-NP O
dominant JJ I-NP O
negative JJ I-NP O
effect NN I-NP O
of IN B-PP O
certain JJ B-NP O
APC NN I-NP B-Disease
mutants NNS I-NP O
. . O O

Loss NN B-NP O
of IN B-PP O
APC NN B-NP B-Disease
function NN I-NP O
was VBD B-VP O
recently RB I-VP O
shown VBN I-VP O
to TO I-VP O
result VB I-VP O
in IN B-PP O
enhanced VBN B-VP O
beta SYM B-NP O
- HYPH B-NP O
catenin NN I-NP O
- HYPH O O
/ SYM B-NP O
Tcf NN I-NP O
- HYPH O O
mediated VBN B-NP O
transcription NN I-NP O
in IN B-PP O
colon NN B-NP O
epithelial JJ I-NP O
cells NNS I-NP O
. . O O

Here RB B-ADVP O
, , O O
we PRP B-NP O
provide VBP B-VP O
experimental JJ B-NP O
evidence NN I-NP O
for IN B-PP O
a DT B-NP O
dominant JJ I-NP O
negative JJ I-NP O
effect NN I-NP O
of IN B-PP O
APC NN B-NP B-Disease
gene NN I-NP O
products NNS I-NP O
associated VBN B-VP O
with IN B-PP O
severe JJ B-NP O
polyposis NN I-NP B-Disease
. . O O

Wild JJ B-NP O
- HYPH I-NP O
type NN I-NP O
APC NN I-NP B-Disease
activity NN I-NP O
in IN B-PP O
beta SYM B-NP O
- HYPH B-NP O
catenin NN I-NP O
- HYPH O O
/ SYM B-NP O
Tcf NN I-NP O
- HYPH O O
mediated VBN B-NP O
transcription NN I-NP O
was VBD B-VP O
strongly RB I-VP O
inhibited VBN I-VP O
by IN B-PP O
a DT B-NP O
mutant JJ I-NP O
APC NN I-NP B-Disease
that WDT B-NP O
is VBZ B-VP O
truncated VBN I-VP O
at IN B-PP O
codon NN B-NP O
1309 CD I-NP O
. . O O

In IN B-PP O
contrast NN B-NP O
, , O O
mutant JJ B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
products NNS I-NP O
that WDT B-NP O
are VBP B-VP O
associated VBN I-VP O
with IN B-PP O
attenuated VBN B-NP B-Disease
polyposis NN I-NP I-Disease
( ( O O
codon NN B-NP O
386 CD I-NP O
or CC I-NP O
1465 CD I-NP O
) ) O O
interfered VBD B-VP O
only RB B-ADVP O
weakly RB I-ADVP O
with IN B-PP O
wild JJ B-NP O
- HYPH I-NP O
type NN I-NP O
APC NN I-NP B-Disease
activity NN I-NP O
. . O O

These DT B-NP O
results NNS I-NP O
suggest VBP B-VP O
a DT B-NP O
molecular JJ I-NP O
explanation NN I-NP O
for IN B-PP O
the DT B-NP O
genotype NN I-NP O
- HYPH B-NP O
phenotype NN I-NP O
correlation NN I-NP O
in IN B-PP O
FAP NN B-NP B-Disease
patients NNS I-NP O
and CC O O
support VBP B-VP O
the DT B-NP O
idea NN I-NP O
that IN B-SBAR O
colorectal JJ B-NP B-Disease
tumor NN I-NP I-Disease
growth NN I-NP O
might MD B-VP O
be VB I-VP O
, , O O
in IN B-PP O
part NN B-NP O
, , O O
driven VBN B-VP O
by IN B-PP O
selection NN B-NP O
for IN B-PP O
a DT B-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
mutation NN I-NP O
cluster NN I-NP O
region NN I-NP O
. . O O

. . O O

BRCA1 NN B-NP O
interacts VBZ B-VP O
with IN B-PP O
components NNS B-NP O
of IN B-PP O
the DT B-NP O
histone NN I-NP O
deacetylase NN I-NP O
complex NN I-NP O
. . O O

Germ NN B-NP O
- HYPH I-NP O
line NN I-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
BRCA1 NN I-NP O
tumor NN I-NP O
- HYPH B-NP O
suppressor NN I-NP O
gene NN I-NP O
are VBP B-VP O
associated VBN I-VP O
with IN B-PP O
an DT B-NP O
increased VBN I-NP O
susceptibility NN I-NP O
to TO B-PP O
breast NN B-NP B-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
. . O O

BRCA1 NN B-NP O
contains VBZ B-VP O
a DT B-NP O
carboxyl NN I-NP O
- HYPH B-NP O
terminal JJ I-NP O
domain NN I-NP O
( ( O O
BRCT NN B-NP O
) ) O O
that WDT B-NP O
is VBZ B-VP O
shared VBN I-VP O
with IN B-PP O
several JJ B-NP O
other JJ I-NP O
proteins NNS I-NP O
involved VBN B-VP O
in IN B-PP O
maintaining VBG B-VP O
genome NN B-NP O
integrity NN I-NP O
. . O O

In IN B-PP O
an DT B-NP O
effort NN I-NP O
to TO B-VP O
understand VB I-VP O
the DT B-NP O
function NN I-NP O
of IN B-PP O
BRCA1 NN B-NP O
, , O O
we PRP B-NP O
sought VBD B-VP O
to TO I-VP O
isolate VB I-VP O
proteins NNS B-NP O
that WDT B-NP O
interact VBP B-VP O
with IN B-PP O
the DT B-NP O
BRCT NN I-NP O
domain NN I-NP O
. . O O

Purified VBN B-NP O
BRCT NN I-NP O
polypeptide NN I-NP O
was VBD B-VP O
used VBN I-VP O
as IN B-PP O
a DT B-NP O
probe NN I-NP O
to TO B-VP O
screen VB I-VP O
a DT B-NP O
human JJ I-NP O
placenta NN I-NP O
cDNA NN I-NP O
expression NN I-NP O
library NN I-NP O
by IN B-PP O
Far NNP B-NP O
Western JJ I-NP O
analysis NN I-NP O
. . O O

Here RB B-ADVP O
we PRP B-NP O
report VBP B-VP O
that IN B-SBAR O
BRCA1 NN B-NP O
interacts VBZ B-VP O
in FW B-ADVP O
vivo FW I-ADVP O
and CC O O
in FW B-ADVP O
vitro FW I-ADVP O
with IN B-PP O
the DT B-NP O
Rb NN I-NP O
- HYPH B-NP O
binding VBG I-NP O
proteins NNS I-NP O
, , I-NP O
RbAp46 NN I-NP O
and CC I-NP O
RbAp48 NN I-NP O
, , O O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
with IN B-PP O
Rb NN B-NP O
. . O O

Moreover RB B-ADVP O
, , O O
the DT B-NP O
BRCT NN I-NP O
domain NN I-NP O
associates VBZ B-VP O
with IN B-PP O
the DT B-NP O
histone NN I-NP O
deacetylases NNS I-NP O
HDAC1 NN I-NP O
and CC I-NP O
HDAC2 NN I-NP O
. . O O

These DT B-NP O
results NNS I-NP O
demonstrate VBP B-VP O
that IN B-SBAR O
BRCA1 NN B-NP O
interacts VBZ B-VP O
with IN B-PP O
components NNS B-NP O
of IN B-PP O
the DT B-NP O
histone NN I-NP O
deacetylase NN I-NP O
complex NN I-NP O
, , O O
and CC O O
therefore RB B-VP O
may MD I-VP O
explain VB I-VP O
the DT B-NP O
involvement NN I-NP O
of IN B-PP O
BRCA1 NN B-NP O
in IN B-PP O
multiple JJ B-NP O
processes NNS I-NP O
such JJ B-PP O
as IN I-PP O
transcription NN B-NP O
, , O O
DNA NN B-NP O
repair NN I-NP O
, , O O
and CC O O
recombination NN B-NP O
. . O O

. . O O

Combined VBN B-NP B-Disease
genetic JJ I-NP I-Disease
deficiency NN I-NP I-Disease
of IN B-PP I-Disease
C6 NN B-NP I-Disease
and CC I-NP I-Disease
C7 NN I-NP I-Disease
in IN B-PP O
man NN B-NP O
. . O O

By IN B-PP O
routine JJ B-NP O
screening NN I-NP O
of IN B-PP O
sera NNS B-NP O
, , O O
a DT B-NP O
subject NN I-NP O
was VBD B-VP O
discovered VBN I-VP O
who WP B-NP O
showed VBD B-VP O
a DT B-NP O
sub AFX I-NP B-Disease
- HYPH I-NP I-Disease
total JJ I-NP I-Disease
deficiency NN I-NP I-Disease
of IN B-PP I-Disease
C6 NN B-NP I-Disease
and CC I-NP I-Disease
C7 NN I-NP I-Disease
. . O O

No DT B-NP O
clinical JJ I-NP O
disease NN I-NP O
was VBD B-VP O
associated VBN I-VP O
with IN B-PP O
this DT B-NP O
deficiency NN I-NP O
which WDT B-NP O
was VBD B-VP O
transmitted VBN I-VP O
through IN B-PP O
the DT B-NP O
subjects NNS I-NP O
family NN I-NP O
as IN B-PP O
a DT B-NP O
single JJ I-NP O
genetic JJ I-NP O
characteristic NN I-NP O
, , O O
the DT B-NP O
C6 NN I-NP B-Disease
deficiency NN I-NP I-Disease
being VBG B-VP O
associated VBN I-VP O
with IN B-PP O
a DT B-NP O
silent JJ I-NP O
allele NN I-NP O
at IN B-PP O
the DT B-NP O
structural JJ I-NP O
locus NN I-NP O
. . O O

The DT B-NP O
propositus NN I-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
have VB I-VP O
low JJ B-NP O
quantities NNS I-NP O
of IN B-PP O
an DT B-NP O
abnormal JJ I-NP O
C6 NN I-NP O
which WDT B-NP O
was VBD B-VP O
both CC O O
antigenically RB B-ADJP O
deficient JJ I-ADJP O
and CC O O
smaller JJR B-ADJP O
in IN B-PP O
size NN B-NP O
than IN B-PP O
normal JJ B-NP O
C6 NN I-NP O
( ( O O
110 CD B-NP O
, , O O
000 CD B-NP O
daltons NNS I-NP O
compared VBN B-PP O
with IN B-PP O
140 CD B-NP O
, , O O
000 CD B-NP O
daltons NNS I-NP O
) ) O O
and CC O O
small JJ B-NP O
quantities NNS I-NP O
of IN B-PP O
apparently RB B-NP O
normal JJ I-NP O
C7 NN I-NP O
. . O O

It PRP B-NP O
is VBZ B-VP O
concluded VBN I-VP O
that IN B-SBAR O
the DT B-NP O
most RBS I-NP O
likely JJ I-NP O
explanation NN I-NP O
for IN B-PP O
this DT B-NP O
defect NN I-NP O
is VBZ B-VP O
that IN B-SBAR O
the DT B-NP O
subject NN I-NP O
has VBZ B-VP O
a DT B-NP O
structural JJ I-NP O
mutation NN I-NP O
in IN B-PP O
his PRP$ B-NP O
C6 NN I-NP O
gene NN I-NP O
which WDT B-NP O
produces VBZ B-VP O
hyopsynthesis NN B-NP O
not RB B-CONJP O
only RB I-CONJP O
of IN B-PP O
C6 NN B-NP O
but CC B-CONJP O
also RB I-CONJP O
of IN B-PP O
the DT B-NP O
closely RB I-NP O
linked VBN I-NP O
gene NN I-NP O
for IN B-PP O
C7 NN B-NP O
. . O O

These DT B-NP O
findings NNS I-NP O
suggest VBP B-VP O
the DT B-NP O
possibility NN I-NP O
that IN B-SBAR O
C6 NN B-NP O
and CC I-NP O
C7 NN I-NP O
may MD B-VP O
function VB I-VP O
as IN B-PP O
a DT B-NP O
single JJ I-NP O
genetic JJ I-NP O
unit NN I-NP O
and CC O O
that IN B-SBAR O
the DT B-NP O
primary JJ I-NP O
transcript NN I-NP O
copied VBD B-VP O
from IN B-PP O
the DT B-NP O
genome NN I-NP O
includes VBZ B-VP O
information NN B-NP O
for IN B-PP O
both DT B-NP O
proteins NNS I-NP O
. . O O

. . O O

Changes NNS B-NP O
at IN B-PP O
P183 NN B-NP O
of IN B-PP O
emerin NN B-NP O
weaken VBN B-VP O
its PRP$ B-NP O
protein NN I-NP O
- HYPH O O
protein NN B-NP O
interactions NNS I-NP O
resulting VBG B-VP O
in IN B-PP O
X NN B-NP B-Disease
- HYPH O I-Disease
linked VBN B-VP I-Disease
Emery NNP B-NP I-Disease
- HYPH I-NP I-Disease
Dreifuss NNP I-NP I-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
. . O O

Emery NNP B-NP B-Disease
- HYPH I-NP I-Disease
Dreifuss NNP I-NP I-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
EDMD NN B-NP B-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
X NN I-NP B-Disease
- HYPH O I-Disease
linked VBN B-VP I-Disease
recessive JJ B-NP I-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
characterized VBN B-VP O
by IN B-PP O
early JJ B-NP O
contractures NNS I-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
elbows NNS I-NP I-Disease
, , O I-Disease
Achilles NNP B-NP I-Disease
tendons NNS I-NP I-Disease
and CC O I-Disease
spine NN B-NP I-Disease
, , O O
slowly RB B-NP O
progressive JJ I-NP O
muscle NN I-NP B-Disease
wasting NN I-NP I-Disease
and CC I-NP O
weakness NN I-NP B-Disease
, , O O
and CC O O
cardiomyopathy NN B-NP B-Disease
associated VBN B-VP O
with IN B-PP O
cardiac JJ B-NP B-Disease
conduction NN I-NP I-Disease
defects NNS I-NP I-Disease
. . O O

The DT B-NP O
emerin NN I-NP O
gene NN I-NP O
has VBZ B-VP O
been VBN I-VP O
mapped VBN I-VP O
to TO B-PP O
Xq28 NN B-NP O
and CC O O
encodes VBZ B-VP O
a DT B-NP O
34 CD I-NP O
- HYPH I-NP O
kDa NN I-NP O
serine NN I-NP O
- HYPH B-NP O
rich JJ I-NP O
protein NN I-NP O
, , O O
emerin NN B-NP O
, , O O
which WDT B-NP O
has VBZ B-VP O
been VBN I-VP O
localized JJ B-ADJP O
to TO B-PP O
the DT B-NP O
nuclear JJ I-NP O
envelope NN I-NP O
in IN B-PP O
a DT B-NP O
wide JJ I-NP O
variety NN I-NP O
of IN B-PP O
tissues NNS B-NP O
, , O O
including VBG B-PP O
skeletal JJ B-NP O
and CC I-NP O
cardiac JJ I-NP O
muscle NN I-NP O
. . O O

Mutations NNS B-NP O
spanning VBG B-VP O
the DT B-NP O
emerin NN I-NP O
gene NN I-NP O
have VBP B-VP O
been VBN I-VP O
identified VBN I-VP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
EDMD NN B-NP B-Disease
. . O O

We PRP B-NP O
present VBP B-VP O
here RB B-ADVP O
the DT B-NP O
effect NN I-NP O
, , O O
on IN B-PP O
emerin NN B-NP O
protein NN I-NP O
expression NN I-NP O
, , O O
of IN B-PP O
two CD B-NP O
missense JJ I-NP O
mutations NNS I-NP O
identified VBN B-VP O
in IN B-PP O
unrelated JJ B-NP O
EDMD NN I-NP B-Disease
patients NNS I-NP O
. . O O

These DT B-NP O
alterations NNS I-NP O
predict VBP B-VP O
the DT B-NP O
replacement NN I-NP O
of IN B-PP O
a DT B-NP O
proline NN I-NP O
residue NN I-NP O
at IN B-PP O
position NN B-NP O
183 CD I-NP O
with IN B-PP O
either CC O O
a DT B-NP O
histidine NN I-NP O
or CC O O
a DT B-NP O
threonine NN I-NP O
. . O O

Biochemical JJ B-NP O
analysis NN I-NP O
has VBZ B-VP O
demonstrated VBN I-VP O
that IN B-SBAR O
the DT B-NP O
mobility NN I-NP O
and CC I-NP O
expression NN I-NP O
levels NNS I-NP O
of IN B-PP O
the DT B-NP O
mutant JJ I-NP O
forms NNS I-NP O
of IN B-PP O
emerin NN B-NP O
are VBP B-VP O
indistinguishable JJ B-ADJP O
from IN B-PP O
that DT B-NP O
of IN B-PP O
wild JJ B-NP O
- HYPH I-NP O
type NN I-NP O
emerin NN I-NP O
, , O O
but CC O O
that IN B-SBAR O
they PRP B-NP O
have VBP B-VP O
weakened VBN I-VP O
interactions NNS B-NP O
with IN B-PP O
nuclear JJ B-NP O
lamina NN I-NP O
components NNS I-NP O
. . O O

In IN B-PP O
comparison NN B-NP O
with IN B-PP O
the DT B-NP O
usual JJ I-NP O
EDMD NN I-NP B-Disease
phenotype NN I-NP O
, , O O
patients NNS B-NP O
with IN B-PP O
P183 NN B-NP O
missense JJ I-NP O
mutations NNS I-NP O
have VBP B-VP O
a DT B-NP O
later JJ I-NP O
age NN I-NP O
at IN B-PP O
onset NN B-NP O
of IN B-PP O
first JJ B-NP O
symptoms NNS I-NP O
, , O O
elbow NN B-NP B-Disease
contractures NNS I-NP I-Disease
, , O O
ankle NN B-NP B-Disease
contractures NNS I-NP I-Disease
, , O O
upper JJ B-NP B-Disease
limb NN I-NP I-Disease
weakness NN I-NP I-Disease
and CC O O
lower JJR B-NP B-Disease
limb NN I-NP I-Disease
weakness NN I-NP I-Disease
, , O O
but CC O O
there EX B-NP O
is VBZ B-VP O
no DT B-NP O
difference NN I-NP O
for IN B-PP O
the DT B-NP O
age NN I-NP O
at IN B-PP O
onset NN B-NP O
of IN B-PP O
cardiac JJ B-NP B-Disease
involvement NN I-NP I-Disease
. . O O

This DT B-NP O
is VBZ B-VP O
the DT B-NP O
first JJ I-NP O
report NN I-NP O
of IN B-PP O
protein NN B-NP O
studies NNS I-NP O
on IN B-PP O
patients NNS B-NP O
with IN B-PP O
missense JJ B-NP O
mutations NNS I-NP O
resulting VBG B-VP O
in IN B-PP O
the DT B-NP O
clinical JJ I-NP O
features NNS I-NP O
of IN B-PP O
EDMD NN B-NP B-Disease
. . O O

These DT B-NP O
studies NNS I-NP O
demonstrate VBP B-VP O
the DT B-NP O
importance NN I-NP O
of IN B-PP O
proline NN B-NP O
183 CD I-NP O
for IN B-PP O
the DT B-NP O
proper JJ I-NP O
structure NN I-NP O
/ SYM B-NP O
function NN I-NP O
of IN B-PP O
emerin NN B-NP O
. . O O

. . O O

Microdeletions NNS B-NP O
at IN B-PP O
chromosome NN B-NP O
bands NNS I-NP O
1q32 CD B-NP O
- HYPH I-NP O
q41 NN I-NP O
as IN B-PP O
a DT B-NP O
cause NN I-NP O
of IN B-PP O
Van NNP B-NP B-Disease
der NNP I-NP I-Disease
Woude NNP I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

Van NNP B-NP B-Disease
der NNP I-NP I-Disease
Woude NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
VWS NN B-NP B-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
autosomal JJ I-NP B-Disease
dominant JJ I-NP I-Disease
disorder NN I-NP I-Disease
comprising VBG B-VP O
cleft NN B-NP B-Disease
lip NN I-NP I-Disease
and CC O O
/ SYM B-NP O
or CC O O
cleft JJ B-NP B-Disease
palate NN I-NP I-Disease
and CC I-NP O
lip NN I-NP B-Disease
pits NNS I-NP I-Disease
. . O O

We PRP B-NP O
reported VBD B-VP O
previously RB B-ADVP O
a DT B-NP O
family NN I-NP O
whose WP$ B-NP O
underlying VBG I-NP O
mutation NN I-NP O
is VBZ B-VP O
a DT B-NP O
500 CD I-NP O
- HYPH I-NP O
800 CD I-NP O
kb NN I-NP O
deletion NN I-NP O
localized VBD B-VP O
to TO B-PP O
chromosome NN B-NP O
bands NNS I-NP O
1q32 NN I-NP O
- HYPH B-NP O
q41 NN I-NP O
[ ( O O
Sander NNP B-NP O
et FW I-NP O
al FW I-NP O
. FW I-NP O

, , O O
1994 CD B-NP O
Hum NNP I-NP O
Mol NNP I-NP O
Genet NNP I-NP O
3 CD I-NP O
576 CD I-NP O
- HYPH I-NP O
578 CD I-NP O
] ) O O
. . O O

Along IN B-PP O
with IN B-PP O
cleft NN B-NP B-Disease
lip NN I-NP I-Disease
/ SYM B-NP I-Disease
palate NN I-NP I-Disease
and CC I-NP O
lip NN I-NP B-Disease
pits NNS I-NP I-Disease
, , O O
affected VBN B-NP O
relatives NNS I-NP O
exhibit VBP B-VP O
developmental JJ B-NP B-Disease
delays NNS I-NP I-Disease
, , O O
suggesting VBG B-VP O
that IN B-SBAR O
the DT B-NP O
function NN I-NP O
of IN B-PP O
a DT B-NP O
gene NN I-NP O
nearby RB B-ADVP O
may MD B-VP O
also RB I-VP O
be VB I-VP O
disrupted VBN I-VP O
. . O O

To TO B-VP O
further RB I-VP O
localize VB I-VP O
the DT B-NP O
VWS NN I-NP B-Disease
gene NN I-NP O
we PRP B-NP O
searched VBD B-VP O
for IN B-PP O
other JJ B-NP O
deletions NNS I-NP O
that WDT B-NP O
cause VBP B-VP O
VWS NNS B-NP B-Disease
. . O O

An DT B-NP O
allele NN I-NP O
loss NN I-NP O
assay NN I-NP O
was VBD B-VP O
performed VBN I-VP O
using VBG B-VP O
a DT B-NP O
novel JJ I-NP O
highly RB I-NP O
polymorphic JJ I-NP O
marker NN I-NP O
, , O O
D1S3753 NN B-NP O
. . O O

From IN B-PP O
a DT B-NP O
panel NN I-NP O
of IN B-PP O
37 CD B-NP O
unrelated JJ I-NP O
individuals NNS I-NP O
, , O O
we PRP B-NP O
detected VBD B-VP O
an DT B-NP O
allele NN I-NP O
loss NN I-NP O
in IN B-PP O
one CD B-NP O
family NN I-NP O
, , O O
indicating VBG B-VP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
a DT B-NP O
deletion NN I-NP O
. . O O

In IN B-PP O
this DT B-NP O
family NN I-NP O
, , O O
the DT B-NP O
phenotype NN I-NP O
in IN B-PP O
three CD B-NP O
generations NNS I-NP O
of IN B-PP O
affected VBN B-NP O
individuals NNS I-NP O
was VBD B-VP O
confined VBN I-VP O
to TO B-PP O
the DT B-NP O
cardinal JJ I-NP O
signs NNS I-NP O
of IN B-PP O
VWS NN B-NP B-Disease
. . O O

Surprisingly RB B-ADVP O
, , O O
mapping NN B-NP O
of IN B-PP O
the DT B-NP O
new JJ I-NP O
deletion NN I-NP O
showed VBD B-VP O
that IN B-SBAR O
it PRP B-NP O
extended VBD B-VP O
0 CD B-NP O
. . O O

2 CD B-NP O
- HYPH I-NP O
1 CD I-NP O
Mb NN I-NP O
beyond IN B-PP O
the DT B-NP O
proximal JJ I-NP O
breakpoint NN I-NP O
for IN B-PP O
the DT B-NP O
deletion NN I-NP O
described VBN B-VP O
previously RB B-ADVP O
. . O O

No DT B-NP O
deletions NNS I-NP O
were VBD B-VP O
detected VBN I-VP O
in IN B-PP O
seven CD B-NP O
cases NNS I-NP O
of IN B-PP O
popliteal JJ B-NP B-Disease
pterygia NN I-NP I-Disease
syndrome NN I-NP I-Disease
, , O O
76 CD B-NP O
cases NNS I-NP O
of IN B-PP O
mixed JJ B-NP O
syndromic JJ I-NP B-Disease
forms NNS I-NP I-Disease
of IN B-PP I-Disease
cleft NN B-NP I-Disease
lip NN I-NP I-Disease
and CC I-NP I-Disease
palate NN I-NP I-Disease
, , O O
and CC O O
178 CD B-NP O
cases NNS I-NP O
of IN B-PP O
nonsyndromic JJ B-NP B-Disease
cleft NN I-NP I-Disease
lip NN I-NP I-Disease
and CC I-NP I-Disease
palate NN I-NP I-Disease
. . O O

Splicing NN B-NP O
defects NNS I-NP O
in IN B-PP O
the DT B-NP O
ataxia NN I-NP B-Disease
- HYPH B-NP I-Disease
telangiectasia NN I-NP I-Disease
gene NN I-NP O
, , O O
ATM NN B-NP O
: : O O
underlying VBG B-NP O
mutations NNS I-NP O
and CC I-NP O
consequences NNS I-NP O
. . O O

Mutations NNS B-NP O
resulting VBG B-VP O
in IN B-PP O
defective JJ B-NP O
splicing NN I-NP O
constitute VBP B-VP O
a DT B-NP O
significant JJ I-NP O
proportion NN I-NP O
( ( O O
30 CD B-NP O
/ SYM I-NP O
62 CD I-NP O
[ ( O O
48 CD B-NP O
% NN I-NP O
] ) O O
) ) O O
of IN B-PP O
a DT B-NP O
new JJ I-NP O
series NN I-NP O
of IN B-PP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
ATM NN I-NP O
gene NN I-NP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
ataxia NN B-NP B-Disease
- HYPH O I-Disease
telangiectasia NN B-NP I-Disease
( ( O O
AT NN B-NP B-Disease
) ) O O
that WDT B-NP O
were VBD B-VP O
detected VBN I-VP O
by IN B-PP O
the DT B-NP O
protein NN I-NP O
- HYPH B-NP O
truncation NN I-NP O
assay NN I-NP O
followed VBN B-VP O
by IN B-PP O
sequence NN B-NP O
analysis NN I-NP O
of IN B-PP O
genomic JJ B-NP O
DNA NN I-NP O
. . O O

Fewer JJR B-NP O
than IN I-NP O
half NN I-NP O
of IN B-PP O
the DT B-NP O
splicing NN I-NP O
mutations NNS I-NP O
involved VBD B-VP O
the DT B-NP O
canonical JJ I-NP O
AG NN I-NP O
splice NN I-NP O
- HYPH B-NP O
acceptor NN I-NP O
site NN I-NP O
or CC O O
GT NN B-NP O
splice NN I-NP O
- HYPH B-NP O
donor NN I-NP O
site NN I-NP O
. . O O

A DT B-NP O
higher JJR I-NP O
percentage NN I-NP O
of IN B-PP O
mutations NNS B-NP O
occurred VBD B-VP O
at IN B-PP O
less RBR B-NP O
stringently RB I-NP O
conserved VBN I-NP O
sites NNS I-NP O
, , O O
including VBG B-PP O
silent JJ B-NP O
mutations NNS I-NP O
of IN B-PP O
the DT B-NP O
last JJ I-NP O
nucleotide NN I-NP O
of IN B-PP O
exons NNS B-NP O
, , O O
mutations NNS B-NP O
in IN B-PP O
nucleotides NNS B-NP O
other JJ B-ADJP O
than IN B-PP O
the DT B-NP O
conserved VBN I-NP O
AG NN I-NP O
and CC I-NP O
GT NN I-NP O
in IN B-PP O
the DT B-NP O
consensus NN I-NP O
splice NN I-NP O
sites NNS I-NP O
, , O O
and CC O O
creation NN B-NP O
of IN B-PP O
splice NN B-NP O
- HYPH B-NP O
acceptor NN I-NP O
or CC I-NP O
splice NN I-NP O
- HYPH B-NP O
donor NN I-NP O
sites NNS I-NP O
in IN B-PP O
either CC B-NP O
introns NNS I-NP O
or CC I-NP O
exons NNS I-NP O
. . O O

These DT B-NP O
splicing NN I-NP O
mutations NNS I-NP O
led VBD B-VP O
to TO B-PP O
a DT B-NP O
variety NN I-NP O
of IN B-PP O
consequences NNS B-NP O
, , O O
including VBG B-PP O
exon NN B-NP O
skipping NN I-NP O
and CC O O
, , O O
to TO B-PP O
a DT B-NP O
lesser JJR I-NP O
degree NN I-NP O
, , O O
intron NN B-NP O
retention NN I-NP O
, , O O
activation NN B-NP O
of IN B-PP O
cryptic JJ B-NP O
splice NN I-NP O
sites NNS I-NP O
, , O O
or CC O O
creation NN B-NP O
of IN B-PP O
new JJ B-NP O
splice NN I-NP O
sites NNS I-NP O
. . O O

In IN B-PP O
addition NN B-NP O
, , O O
5 CD B-NP O
of IN B-PP O
12 CD B-NP O
nonsense JJ I-NP O
mutations NNS I-NP O
and CC O O
1 CD B-NP O
missense JJ I-NP O
mutation NN I-NP O
were VBD B-VP O
associated VBN I-VP O
with IN B-PP O
deletion NN B-NP O
in IN B-PP O
the DT B-NP O
cDNA NN I-NP O
of IN B-PP O
the DT B-NP O
exons NNS I-NP O
in IN B-PP O
which WDT B-NP O
the DT B-NP O
mutations NNS I-NP O
occurred VBD B-VP O
. . O O

No DT B-NP O
ATM NN I-NP O
protein NN I-NP O
was VBD B-VP O
detected VBN I-VP O
by IN B-PP O
western JJ B-NP O
blotting NN I-NP O
in IN B-PP O
any DT B-NP O
AT NN I-NP B-Disease
cell NN I-NP O
line NN I-NP O
in IN B-PP O
which WDT B-NP O
splicing NN B-NP O
mutations NNS I-NP O
were VBD B-VP O
identified VBN I-VP O
. . O O

Several JJ B-NP O
cases NNS I-NP O
of IN B-PP O
exon NN B-NP O
skipping NN I-NP O
in IN B-PP O
both CC B-NP O
normal JJ I-NP O
controls NNS I-NP O
and CC O O
patients NNS B-NP O
for IN B-PP O
whom WP B-NP O
no DT B-NP O
underlying VBG I-NP O
defect NN I-NP O
could MD B-VP O
be VB I-VP O
found VBN I-VP O
in IN B-PP O
genomic JJ B-NP O
DNA NN I-NP O
were VBD B-VP O
also RB I-VP O
observed VBN I-VP O
, , O O
suggesting VBG B-VP O
caution NN B-NP O
in IN B-PP O
the DT B-NP O
interpretation NN I-NP O
of IN B-PP O
exon NN B-NP O
deletions NNS I-NP O
observed VBN B-VP O
in IN B-PP O
ATM NN B-NP O
cDNA NN I-NP O
when WRB B-ADVP O
there EX B-NP O
is VBZ B-VP O
no DT B-NP O
accompanying VBG I-NP O
identification NN I-NP O
of IN B-PP O
genomic JJ B-NP O
mutations NNS I-NP O
. . O O

. . O O

Alpha NN B-NP O
- HYPH I-NP O
cardiac JJ I-NP O
actin NN I-NP O
is VBZ B-VP O
a DT B-NP O
novel JJ I-NP O
disease NN I-NP O
gene NN I-NP O
in IN B-PP O
familial JJ B-NP B-Disease
hypertrophic JJ I-NP I-Disease
cardiomyopathy NN I-NP I-Disease
. . O O

We PRP B-NP O
identified VBD B-VP O
the DT B-NP O
alpha SYM I-NP O
- HYPH I-NP O
cardiac JJ I-NP O
actin NN I-NP O
gene NN I-NP O
( ( O O
ACTC NN B-NP O
) ) O O
as IN B-PP O
a DT B-NP O
novel JJ I-NP O
disease NN I-NP O
gene NN I-NP O
in IN B-PP O
a DT B-NP O
pedigree NN I-NP O
suffering VBG B-VP O
from IN B-PP O
familial JJ B-NP B-Disease
hypertrophic JJ I-NP I-Disease
cardiomyopathy NN I-NP I-Disease
( ( O O
FHC NN B-NP B-Disease
) ) O O
. . O O

Linkage NN B-NP O
analyses NNS I-NP O
excluded VBD B-VP O
all PDT B-NP O
the DT I-NP O
previously RB I-NP O
reported VBN I-NP O
FHC NN I-NP B-Disease
loci NNS I-NP O
as IN B-PP O
possible JJ B-NP O
disease NN I-NP O
loci NNS I-NP O
in IN B-PP O
the DT B-NP O
family NN I-NP O
studied VBN B-VP O
, , O O
with IN B-PP O
lod NN B-NP O
scores NNS I-NP O
varying VBG B-VP O
between IN B-PP O
- SYM B-NP O
2 CD I-NP O
. . O O

5 CD B-NP O
and CC O O
- SYM B-NP O
6 CD B-NP O
. . O O

0 CD B-NP O
0 CD I-NP O
. . O O

Further JJ B-NP O
linkage NN I-NP O
analyses NNS I-NP O
of IN B-PP O
plausible JJ B-NP O
candidate NN I-NP O
genes NNS I-NP O
highly RB B-VP O
expressed VBN I-VP O
in IN B-PP O
the DT B-NP O
adult JJ I-NP O
human JJ I-NP O
heart NN I-NP O
identified VBD B-VP O
ACTC NN B-NP O
as IN B-PP O
the DT B-NP O
most RBS I-NP O
likely JJ I-NP O
disease NN I-NP O
gene NN I-NP O
, , O O
showing VBG B-VP O
a DT B-NP O
maximal JJ I-NP O
lod NN I-NP O
score NN I-NP O
of IN B-PP O
3 CD B-NP O
. . O O

6 CD B-NP O
6 CD I-NP O
. . O O

Mutation NN B-NP O
analysis NN I-NP O
of IN B-PP O
ACTC NN B-NP O
revealed VBD B-VP O
an DT B-NP O
Ala295Ser NN I-NP O
mutation NN I-NP O
in IN B-PP O
exon NN B-NP O
5 CD I-NP O
close NN I-NP O
to TO B-PP O
2 CD B-NP O
missense JJ I-NP O
mutations NNS I-NP O
recently RB B-ADVP O
described VBD B-VP O
to TO I-VP O
cause VB I-VP O
the DT B-NP O
inherited VBN I-NP O
form NN I-NP O
of IN B-PP O
idiopathic JJ B-NP B-Disease
dilated JJ I-NP I-Disease
cardiomyopathy NN I-NP I-Disease
( ( O O
IDC NN B-NP B-Disease
) ) O O
. . O O

Overgrowth NN B-NP B-Disease
of IN B-PP I-Disease
oral JJ B-NP I-Disease
mucosa NN I-NP I-Disease
and CC O I-Disease
facial JJ B-NP I-Disease
skin NN I-NP I-Disease
, , O O
a DT B-NP O
novel JJ I-NP O
feature NN I-NP O
of IN B-PP O
aspartylglucosaminuria NN B-NP B-Disease
. . O O

Aspartylglucosaminuria NN B-NP B-Disease
( ( O O
AGU NN B-NP B-Disease
) ) O O
is VBZ B-VP O
a DT B-NP O
lysosomal JJ I-NP B-Disease
storage NN I-NP I-Disease
disorder NN I-NP I-Disease
caused VBN B-VP O
by IN B-PP O
deficiency NN B-NP B-Disease
of IN B-PP I-Disease
aspartylglucosaminidase NN B-NP I-Disease
( ( O O
AGA NN B-NP O
) ) O O
. . O O

The DT B-NP O
main JJ I-NP O
symptom NN I-NP O
is VBZ B-VP O
progressive JJ B-NP O
mental JJ I-NP B-Disease
retardation NN I-NP I-Disease
. . O O

A DT B-NP O
spectrum NN I-NP O
of IN B-PP O
different JJ B-NP O
mutations NNS I-NP O
has VBZ B-VP O
been VBN I-VP O
reported VBN I-VP O
in IN B-PP O
this DT B-NP O
disease NN I-NP O
, , O O
one CD B-NP O
missense JJ I-NP O
mutation NN I-NP O
( ( O O
Cys163Ser NN B-NP O
) ) O O
being VBG B-VP O
responsible JJ B-ADJP O
for IN B-PP O
the DT B-NP O
majority NN I-NP O
of IN B-PP O
Finnish JJ B-NP O
cases NNS I-NP O
. . O O

We PRP B-NP O
were VBD B-VP O
able JJ B-ADJP O
to TO B-VP O
examine VB I-VP O
66 CD B-NP O
Finnish JJ I-NP O
AGU NN I-NP B-Disease
patients NNS I-NP O
for IN B-PP O
changes NNS B-NP O
in IN B-PP O
the DT B-NP O
oral JJ I-NP O
mucosa NN I-NP O
and CC O O
44 CD B-NP O
of IN B-PP O
these DT B-NP O
for IN B-PP O
changes NNS B-NP O
in IN B-PP O
facial JJ B-NP O
skin NN I-NP O
. . O O

Biopsy NN B-NP O
specimens NNS I-NP O
of IN B-PP O
16 CD B-NP O
oral JJ I-NP O
lesions NNS I-NP O
, , O O
12 CD B-NP O
of IN B-PP O
them PRP B-NP O
associated VBN B-VP O
with IN B-PP O
the DT B-NP O
teeth NNS I-NP O
, , O O
plus CC O O
two CD B-NP O
facial JJ I-NP B-Disease
lesions NNS I-NP I-Disease
were VBD B-VP O
studied VBN I-VP O
histologically RB B-ADVP O
. . O O

Immunohistochemical JJ B-NP O
staining NN I-NP O
for IN B-PP O
AGA NN B-NP O
was VBD B-VP O
performed VBN I-VP O
on IN B-PP O
15 CD B-NP O
oral JJ I-NP O
specimens NNS I-NP O
. . O O

Skin NNP B-NP O
was VBD B-VP O
seborrhoeic JJ B-ADJP O
in IN B-PP O
adolescent JJ B-NP O
and CC I-NP O
adult JJ I-NP O
patients NNS I-NP O
, , O O
with IN B-PP O
erythema NN B-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
facial JJ I-NP I-Disease
skin NN I-NP I-Disease
already RB B-ADJP O
common JJ I-ADJP O
in IN B-PP O
childhood NN B-NP O
. . O O

Of IN B-PP O
44 CD B-NP O
patients NNS I-NP O
, , O O
nine CD B-NP O
( ( O O
20 CD B-NP O
% NN I-NP O
) ) O O
had VBD B-VP O
facial JJ B-NP B-Disease
angiofibromas NNS I-NP I-Disease
, , O O
tumours NNS B-NP B-Disease
primarily RB B-VP O
occurring VBG I-VP O
in IN B-PP O
association NN B-NP O
with IN B-PP O
tuberous JJ B-NP B-Disease
sclerosis NN I-NP I-Disease
. . O O

Oedemic JJ B-NP B-Disease
buccal JJ I-NP I-Disease
mucosa NN I-NP I-Disease
( ( O O
leucoedema NN B-NP B-Disease
) ) O O
and CC O O
gingival JJ B-NP B-Disease
overgrowths NNS I-NP I-Disease
were VBD B-VP O
more RBR B-ADJP O
frequent JJ I-ADJP O
in IN B-PP O
AGU NN B-NP B-Disease
patients NNS I-NP O
than IN B-PP O
in IN B-PP O
controls NNS B-NP O
( ( O O
p NN B-NP O
< SYM B-ADJP O
0 CD B-NP O
. . I-NP O

001 CD I-NP O
) ) O O
. . O O

Of IN B-PP O
16 CD B-NP O
oral JJ I-NP B-Disease
mucosal JJ I-NP I-Disease
lesions NNS I-NP I-Disease
studied VBN B-VP O
histologically RB B-ADVP O
, , O O
15 CD B-NP O
represented VBD B-VP O
fibroepithelial JJ B-NP B-Disease
or CC I-NP I-Disease
epithelial JJ I-NP I-Disease
hyperplasias NNS I-NP I-Disease
and CC O O
were VBD B-VP O
reactive JJ B-ADJP O
in IN B-PP O
nature NN B-NP O
. . O O

Cytoplasmic JJ B-NP O
vacuolisation NN I-NP O
was VBD B-VP O
evident JJ B-ADJP O
in IN B-PP O
four CD B-NP O
. . O O

Immunohistochemically RB B-ADVP O
, , O O
expression NN B-NP O
of IN B-PP O
AGA NN B-NP O
in IN B-PP O
AGU NN B-NP B-Disease
patients NNS I-NP O
mucosal JJ B-NP B-Disease
lesions NNS I-NP I-Disease
did VBD B-VP O
not RB I-VP O
differ VB I-VP O
from IN B-PP O
that DT B-NP O
seen VBN B-VP O
in IN B-PP O
corresponding VBG B-VP O
lesions NNS B-NP O
of IN B-PP O
normal JJ B-NP O
subjects NNS I-NP O
. . O O

Thus RB B-ADVP O
, , O O
the DT B-NP O
high JJ I-NP O
frequency NN I-NP O
of IN B-PP O
mucosal JJ B-NP B-Disease
overgrowth NN I-NP I-Disease
in IN B-PP O
AGU NN B-NP B-Disease
patients NNS I-NP O
does VBZ B-VP O
not RB I-VP O
appear VB I-VP O
to TO I-VP O
be VB I-VP O
directly RB I-VP O
associated VBN I-VP O
with IN B-PP O
lysosomal JJ B-NP O
storage NN I-NP O
or CC B-PP O
with IN B-PP O
alterations NNS B-NP O
in IN B-PP O
the DT B-NP O
level NN I-NP O
of IN B-PP O
AGA NN B-NP O
expression NN I-NP O
. . O O

Characterization NN B-NP O
of IN B-PP O
a DT B-NP O
germline NN I-NP O
mosaicism NN I-NP O
in IN B-PP O
families NNS B-NP O
with IN B-PP O
Lowe JJ B-NP B-Disease
syndrome NN I-NP I-Disease
, , O O
and CC O O
identification NN B-NP O
of IN B-PP O
seven CD B-NP O
novel JJ I-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
OCRL1 NN I-NP O
gene NN I-NP O
. . O O

The DT B-NP O
oculocerebrorenal JJ I-NP B-Disease
syndrome NN I-NP I-Disease
of IN B-PP I-Disease
Lowe NN B-NP I-Disease
( ( O O
OCRL NN B-NP B-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
X NN I-NP B-Disease
- HYPH B-VP I-Disease
linked VBN B-NP I-Disease
disorder NN I-NP I-Disease
characterized VBN B-VP O
by IN B-PP O
major JJ B-NP O
abnormalities NNS I-NP B-Disease
of IN B-PP I-Disease
eyes NNS B-NP I-Disease
, , O I-Disease
nervous JJ B-NP I-Disease
system NN I-NP I-Disease
, , O I-Disease
and CC O I-Disease
kidneys NNS B-NP I-Disease
. . O O

Mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
OCRL1 NN I-NP O
gene NN I-NP O
have VBP B-VP O
been VBN I-VP O
associated VBN I-VP O
with IN B-PP O
the DT B-NP O
disease NN I-NP O
. . O O

OCRL1 NN B-NP O
encodes VBZ B-VP O
a DT B-NP O
phosphatidylinositol NN I-NP O
4 CD I-NP O
, , I-NP O
5 CD I-NP O
- HYPH I-NP O
biphosphate NN I-NP O
( ( O O
PtdIns NN B-NP O
[ ( O O
4 CD B-NP O
, , I-NP O
5 CD I-NP O
] ) I-NP O
P2 NN I-NP O
) ) O O
5 CD B-NP O
- HYPH I-NP O
phosphatase NN I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
examined VBN I-VP O
the DT B-NP O
OCRL1 NN I-NP O
gene NN I-NP O
in IN B-PP O
eight CD B-NP O
unrelated JJ I-NP O
patients NNS I-NP O
with IN B-PP O
OCRL NN B-NP B-Disease
and CC O O
have VBP B-VP O
found VBN I-VP O
seven CD B-NP O
new JJ I-NP O
mutations NNS I-NP O
and CC O O
one CD B-NP O
recurrent JJ I-NP O
in IN B-PP O
- HYPH B-NP O
frame NN I-NP O
deletion NN I-NP O
. . O O

Among IN B-PP O
the DT B-NP O
new JJ I-NP O
mutations NNS I-NP O
, , O O
two CD B-NP O
nonsense JJ I-NP O
mutations NNS I-NP O
( ( O O
R317X NN B-NP O
and CC O O
E558X NN B-NP O
) ) O O
and CC O O
three CD B-NP O
other JJ I-NP O
frameshift NN I-NP O
mutations NNS I-NP O
caused VBD B-VP O
premature JJ B-NP O
termination NN I-NP O
of IN B-PP O
the DT B-NP O
protein NN I-NP O
. . O O

A DT B-NP O
missense JJ I-NP O
mutation NN I-NP O
, , O O
R483G NN B-NP O
, , O O
was VBD B-VP O
located VBN I-VP O
in IN B-PP O
the DT B-NP O
highly RB I-NP O
conserved VBN I-NP O
PtdIns NN I-NP O
( ( O O
4 CD B-NP O
, , I-NP O
5 CD I-NP O
) ) O O
P2 NN B-NP O
5 CD I-NP O
- HYPH I-NP O
phosphatase NN I-NP O
domain NN I-NP O
. . O O

Finally RB B-ADVP O
, , O O
one CD B-NP O
frameshift NN I-NP O
mutation NN I-NP O
, , O O
2799delC NN B-NP O
, , O O
modifies VBZ B-VP O
the DT B-NP O
C NN I-NP O
- HYPH B-NP O
terminal JJ I-NP O
part NN I-NP O
of IN B-PP O
OCRL1 NN B-NP O
, , O O
with IN B-PP O
an DT B-NP O
extension NN I-NP O
of IN B-PP O
six CD B-NP O
amino NN I-NP O
acids NNS I-NP O
. . O O

Altogether RB B-ADVP O
, , O O
70 CD B-NP O
% NN I-NP O
of IN B-PP O
missense JJ B-NP O
mutations NNS I-NP O
are VBP B-VP O
located JJ B-ADJP O
in IN B-PP O
exon NN B-NP O
15 CD I-NP O
, , O O
and CC O O
52 CD B-NP O
% NN I-NP O
of IN B-PP O
all DT B-NP O
mutations NNS I-NP O
cluster VBP B-VP O
in IN B-PP O
exons NNS B-NP O
11 CD B-NP O
- HYPH I-NP O
15 CD I-NP O
. . O O

We PRP B-NP O
also RB B-ADVP O
identified VBD B-VP O
two CD B-NP O
new JJ I-NP O
microsatellite NN I-NP O
markers NNS I-NP O
for IN B-PP O
the DT B-NP O
OCRL1 NN I-NP O
locus NN I-NP O
, , O O
and CC O O
we PRP B-NP O
detected VBD B-VP O
a DT B-NP O
germline NN I-NP O
mosaicism NN I-NP O
in IN B-PP O
one CD B-NP O
family NN I-NP O
. . O O

This DT B-NP O
observation NN I-NP O
has VBZ B-VP O
direct JJ B-NP O
implications NNS I-NP O
for IN B-PP O
genetic JJ B-NP O
counseling NN I-NP O
of IN B-PP O
Lowe JJ B-NP B-Disease
syndrome NN I-NP I-Disease
families NNS I-NP O
. . O O

. . O O

MEFV NN B-NP O
- HYPH I-NP O
Gene NN I-NP O
analysis NN I-NP O
in IN B-PP O
armenian JJ B-NP O
patients NNS I-NP O
with IN B-PP O
Familial JJ B-NP B-Disease
Mediterranean JJ I-NP I-Disease
fever NN I-NP I-Disease
: : O O
diagnostic JJ B-NP O
value NN I-NP O
and CC O O
unfavorable JJ B-NP O
renal JJ I-NP O
prognosis NN I-NP O
of IN B-PP O
the DT B-NP O
M694V NN I-NP O
homozygous JJ I-NP O
genotype NN I-NP O
- HYPH B-NP O
genetic JJ I-NP O
and CC I-NP O
therapeutic JJ I-NP O
implications NNS I-NP O
. . O O

Familial JJ B-NP B-Disease
Mediterranean JJ I-NP I-Disease
fever NN I-NP I-Disease
( ( O O
FMF NN B-NP B-Disease
) ) O O
is VBZ B-VP O
a DT B-NP O
recessively RB I-NP B-Disease
inherited VBN I-NP I-Disease
disorder NN I-NP I-Disease
that WDT B-NP O
is VBZ B-VP O
common JJ B-ADJP O
in IN B-PP O
patients NNS B-NP O
of IN B-PP O
Armenian JJ B-NP O
ancestry NN I-NP O
. . O O

To TO B-PP O
date NN B-NP O
, , O O
its PRP$ B-NP O
diagnosis NN I-NP O
, , O O
which WDT B-NP O
can MD B-VP O
be VB I-VP O
made VBN I-VP O
only RB B-ADVP O
retrospectively RB I-ADVP O
, , O O
is VBZ B-VP O
one CD B-NP O
of IN B-PP O
exclusion NN B-NP O
, , O O
based VBN B-VP O
entirely RB B-ADVP O
on IN B-PP O
nonspecific JJ B-NP O
clinical JJ I-NP O
signs NNS I-NP O
that WDT B-NP O
result VBP B-VP O
from IN B-PP O
serosal JJ B-NP B-Disease
inflammation NN I-NP I-Disease
and CC O O
that WDT B-NP O
may MD B-VP O
lead VB I-VP O
to TO B-PP O
unnecessary JJ B-NP O
surgery NN I-NP O
. . O O

Renal JJ B-NP B-Disease
amyloidosis NN I-NP I-Disease
, , O O
prevented VBN B-VP O
by IN B-PP O
colchicine NN B-NP O
, , O O
is VBZ B-VP O
the DT B-NP O
most RBS I-NP O
severe JJ I-NP O
complication NN I-NP O
of IN B-PP O
FMF NNP B-NP B-Disease
, , O O
a DT B-NP O
disorder NN I-NP O
associated VBN B-VP O
with IN B-PP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
MEFV NN I-NP O
gene NN I-NP O
. . O O

To TO B-VP O
evaluate VB I-VP O
the DT B-NP O
diagnostic JJ I-NP O
and CC I-NP O
prognostic JJ I-NP O
value NN I-NP O
of IN B-PP O
MEFV NN B-NP O
- HYPH I-NP O
gene NN I-NP O
analysis NN I-NP O
, , O O
we PRP B-NP O
investigated VBD B-VP O
90 CD B-NP O
Armenian JJ I-NP O
FMF NN I-NP B-Disease
patients NNS I-NP O
from IN B-PP O
77 CD B-NP O
unrelated JJ I-NP O
families NNS I-NP O
that WDT B-NP O
were VBD B-VP O
not RB I-VP O
selected VBN I-VP O
through IN B-PP O
genetic JJ B-NP O
- HYPH I-NP O
linkage NN I-NP O
analysis NN I-NP O
. . O O

Eight CD B-NP O
mutations NNS I-NP O
, , O O
one CD B-NP O
of IN B-PP O
which WDT B-NP O
( ( O O
R408Q NN B-NP O
) ) O O
is VBZ B-VP O
new JJ B-ADJP O
, , O O
were VBD B-VP O
found VBN I-VP O
to TO I-VP O
account VB I-VP O
for IN B-PP O
93 CD B-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
163 CD I-NP O
independent JJ I-NP O
FMF NN I-NP B-Disease
alleles NNS I-NP O
, , O O
with IN B-PP O
both DT B-NP O
FMF NN I-NP B-Disease
alleles NNS I-NP O
identified VBN B-VP O
in IN B-PP O
89 CD B-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
patients NNS I-NP O
. . O O

In IN B-PP O
several JJ B-NP O
instances NNS I-NP O
, , O O
family NN B-NP O
studies NNS I-NP O
provided VBD B-VP O
molecular JJ B-NP O
evidence NN I-NP O
for IN B-PP O
pseudodominant JJ B-NP O
transmission NN I-NP O
and CC O O
incomplete JJ B-NP O
penetrance NN I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
phenotype NN I-NP O
. . O O

The DT B-NP O
M694V NN I-NP O
homozygous JJ I-NP O
genotype NN I-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
be VB I-VP O
associated VBN I-VP O
with IN B-PP O
a DT B-NP O
higher JJR I-NP O
prevalence NN I-NP O
of IN B-PP O
renal JJ B-NP B-Disease
amyloidosis NN I-NP I-Disease
and CC I-NP O
arthritis NN I-NP B-Disease
, , O O
compared VBN B-PP O
with IN B-PP O
other JJ B-NP O
genotypes NNS I-NP O
( ( O O
P NN B-NP O
= SYM B-VP O
. . O O

0002 CD B-NP O
and CC O O
P NN B-NP O
= JJ I-NP O
. . I-NP O

006 CD I-NP O
, , O O
respectively RB B-ADVP O
) ) O O
. . O O

The DT B-NP O
demonstration NN I-NP O
of IN B-PP O
both CC O O
the DT B-NP O
diagnostic JJ I-NP O
and CC I-NP O
prognostic JJ I-NP O
value NN I-NP O
of IN B-PP O
MEFV NN B-NP O
analysis NN I-NP O
and CC O O
particular JJ B-NP O
modes NNS I-NP O
of IN B-PP O
inheritance NN B-NP O
should MD B-VP O
lead VB I-VP O
to TO B-PP O
new JJ B-NP O
ways NNS I-NP O
for IN B-PP O
management NN B-NP O
of IN B-PP O
FMF NN B-NP O
- HYPH B-PP O
including VBG B-PP O
genetic JJ B-NP O
counseling NN I-NP O
and CC O O
therapeutic JJ B-NP O
decisions NNS I-NP O
in IN B-PP O
affected VBN B-NP O
families NNS I-NP O
. . O O

Noninvasive JJ B-NP O
test NN I-NP O
for IN B-PP O
fragile JJ B-NP B-Disease
X NN I-NP I-Disease
syndrome NN I-NP I-Disease
, , O O
using VBG B-VP O
hair NN B-NP O
root NN I-NP O
analysis NN I-NP O
. . O O

Identification NN B-NP O
of IN B-PP O
the DT B-NP O
FMR1 NN I-NP O
gene NN I-NP O
and CC O O
the DT B-NP O
repeat NN I-NP O
- HYPH B-NP O
amplification NN I-NP O
mechanism NN I-NP O
causing VBG B-VP O
fragile JJ B-NP B-Disease
X NN I-NP I-Disease
syndrome NN I-NP I-Disease
led VBD B-VP O
to TO B-PP O
development NN B-NP O
of IN B-PP O
reliable JJ B-NP O
DNA NN I-NP O
- HYPH O O
based VBN B-NP O
diagnostic JJ I-NP O
methods NNS I-NP O
, , O O
including VBG B-PP O
Southern JJ B-NP O
blot NN I-NP O
hybridization NN I-NP O
and CC I-NP O
PCR NN I-NP O
. . O O

Both DT B-NP O
methods NNS I-NP O
are VBP B-VP O
performed VBN I-VP O
on IN B-PP O
DNA NN B-NP O
isolated VBN B-VP O
from IN B-PP O
peripheral JJ B-NP O
blood NN I-NP O
cells NNS I-NP O
and CC O O
measure VB B-VP O
the DT B-NP O
repeat NN I-NP O
size NN I-NP O
in IN B-PP O
FMR1 NN B-NP O
. . O O

Using VBG B-VP O
an DT B-NP O
immunocytochemical JJ I-NP O
technique NN I-NP O
on IN B-PP O
blood NN B-NP O
smears NNS I-NP O
, , O O
we PRP B-NP O
recently RB B-ADVP O
developed VBD B-VP O
a DT B-NP O
novel JJ I-NP O
test NN I-NP O
for IN B-PP O
identification NN B-NP O
of IN B-PP O
patients NNS B-NP O
with IN B-PP O
fragile JJ B-NP B-Disease
X NN I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

This DT B-NP O
method NN I-NP O
, , O O
also RB B-VP O
called VBN I-VP O
antibody NN B-NP O
test NN I-NP O
, , O O
uses VBZ B-VP O
monoclonal JJ B-NP O
antibodies NNS I-NP O
against IN B-PP O
the DT B-NP O
FMR1 NN I-NP O
gene NN I-NP O
product NN I-NP O
( ( O O
FMRP NN B-NP O
) ) O O
and CC O O
is VBZ B-VP O
based VBN I-VP O
on IN B-PP O
absence NN B-NP O
of IN B-PP O
FMRP NN B-NP O
in IN B-PP O
patients NNS B-NP O
cells NNS I-NP O
. . O O

Here RB B-ADVP O
we PRP B-NP O
describe VBP B-VP O
a DT B-NP O
new JJ I-NP O
diagnostic JJ I-NP O
test NN I-NP O
to TO B-VP O
identify VB I-VP O
male JJ B-NP O
patients NNS I-NP O
with IN B-PP O
fragile JJ B-NP B-Disease
X NN I-NP I-Disease
syndrome NN I-NP I-Disease
, , O O
on IN B-PP O
the DT B-NP O
basis NN I-NP O
of IN B-PP O
lack NN B-NP O
of IN B-PP O
FMRP NN B-NP O
in IN B-PP O
their PRP$ B-NP O
hair NN I-NP O
roots NNS I-NP O
. . O O

Expression NN B-NP O
of IN B-PP O
FMRP NN B-NP O
in IN B-PP O
hair NN B-NP O
roots NNS I-NP O
was VBD B-VP O
studied VBN I-VP O
by IN B-PP O
use NN B-NP O
of IN B-PP O
an DT B-NP O
FMRP NN I-NP O
- HYPH B-NP O
specific JJ I-NP O
antibody NN I-NP O
test NN I-NP O
, , O O
and CC O O
the DT B-NP O
percentage NN I-NP O
of IN B-PP O
FMRP NN B-NP O
- HYPH O O
expressing VBG B-VP O
hair NN B-NP O
roots NNS I-NP O
in IN B-PP O
controls NNS B-NP O
and CC B-PP O
in IN B-PP O
male JJ B-NP O
fragile JJ I-NP B-Disease
X NN I-NP I-Disease
patients NNS I-NP O
was VBD B-VP O
determined VBN I-VP O
. . O O

Control NN B-NP O
individuals NNS I-NP O
showed VBD B-VP O
clear JJ B-NP O
expression NN I-NP O
of IN B-PP O
FMRP NN B-NP O
in IN B-PP O
nearly RB B-NP O
every DT I-NP O
hair NN I-NP O
root NN I-NP O
, , O O
whereas IN O O
male JJ B-NP O
fragile JJ I-NP B-Disease
X NN I-NP I-Disease
patients NNS I-NP O
lacked VBD B-VP O
expression NN B-NP O
of IN B-PP O
FMRP NN B-NP O
in IN B-PP O
almost RB B-NP O
all DT I-NP O
their PRP$ I-NP O
hair NN I-NP O
roots NNS I-NP O
. . O O

Mentally RB B-NP B-Disease
retarded VBN I-NP I-Disease
female JJ I-NP O
patients NNS I-NP O
with IN B-PP O
a DT B-NP O
full JJ I-NP O
mutation NN I-NP O
showed VBD B-VP O
FMRP NN B-NP O
expression NN I-NP O
in IN B-PP O
only RB B-NP O
some DT I-NP O
of IN B-PP O
their PRP$ B-NP O
hair NN I-NP O
roots NNS I-NP O
( ( O O
< SYM B-NP O
55 CD B-NP O
% NN I-NP O
) ) O O
, , O O
and CC O O
no DT B-NP O
overlap NN I-NP O
with IN B-PP O
normal JJ B-NP O
female JJ I-NP O
controls NNS I-NP O
was VBD B-VP O
observed VBN I-VP O
. . O O

The DT B-NP O
advantages NNS I-NP O
of IN B-PP O
this DT B-NP O
test NN I-NP O
are VBP B-VP O
( ( B-LST O
1 LS I-LST O
) ) O O
plucking NN B-NP O
of IN B-PP O
hair NN B-NP O
follicles NNS I-NP O
does VBZ B-VP O
no DT B-NP O
appreciable JJ I-NP O
harm NN I-NP O
to TO B-PP O
the DT B-NP O
mentally RB I-NP B-Disease
retarded JJ I-NP I-Disease
patient NN I-NP O
, , O O
( ( O O
2 CD O O
) ) O O
hairs NNS B-NP O
can MD B-VP O
be VB I-VP O
sent VBN I-VP O
in IN B-PP O
a DT B-NP O
simple JJ I-NP O
envelope NN I-NP O
to TO B-PP O
a DT B-NP O
diagnostic JJ I-NP O
center NN I-NP O
, , O O
and CC O O
( ( B-LST O
3 LS I-LST O
) ) O O
the DT B-NP O
result NN I-NP O
of IN B-PP O
the DT B-NP O
test NN I-NP O
is VBZ B-VP O
available JJ B-ADJP O
within IN B-PP O
5 CD B-NP O
h NN I-NP O
of IN B-PP O
plucking NN B-NP O
. . O O

In IN B-PP O
addition NN B-NP O
, , O O
this DT B-NP O
test NN I-NP O
enabled VBD B-VP O
us PRP B-NP O
to TO B-VP O
identify VB I-VP O
two CD B-NP O
fragile JJ I-NP B-Disease
X NN I-NP I-Disease
patients NNS I-NP O
who WP B-NP O
did VBD B-VP O
not RB I-VP O
show VB I-VP O
the DT B-NP O
full JJ I-NP O
mutation NN I-NP O
by IN B-PP O
analysis NN B-NP O
of IN B-PP O
DNA NN B-NP O
isolated VBN B-VP O
from IN B-PP O
blood NN B-NP O
cells NNS I-NP O
. . O O

. . O O

In IN B-PP O
Swedish JJ B-NP O
families NNS I-NP O
with IN B-PP O
hereditary JJ B-NP B-Disease
prostate NN I-NP I-Disease
cancer NN I-NP I-Disease
, , O O
linkage NN B-NP O
to TO B-PP O
the DT B-NP O
HPC1 NN I-NP O
locus NN I-NP O
on IN B-PP O
chromosome NN B-NP O
1q24 CD I-NP O
- HYPH I-NP O
25 CD I-NP O
is VBZ B-VP O
restricted VBN I-VP O
to TO B-PP O
families NNS B-NP O
with IN B-PP O
early JJ B-NP O
- HYPH I-NP O
onset NN I-NP O
prostate NN I-NP B-Disease
cancer NN I-NP I-Disease
. . O O

Prostate NN B-NP B-Disease
cancer NN I-NP I-Disease
clusters NNS I-NP O
in IN B-PP O
some DT B-NP O
families NNS I-NP O
, , O O
and CC O O
an DT B-NP O
estimated VBN I-NP O
5 CD I-NP O
% NN I-NP O
- HYPH B-NP O
10 CD B-NP O
% NN I-NP O
of IN B-PP O
all DT B-NP O
cases NNS I-NP O
are VBP B-VP O
estimated VBN I-VP O
to TO I-VP O
result VB I-VP O
from IN B-PP O
inheritance NN B-NP O
of IN B-PP O
prostate NN B-NP O
cancer NN I-NP O
- HYPH B-NP O
susceptibility NN I-NP O
genes NNS I-NP O
. . O O

We PRP B-NP O
previously RB B-ADVP O
reported VBD B-VP O
evidence NN B-NP O
of IN B-PP O
linkage NN B-NP O
to TO B-PP O
the DT B-NP O
1q24 CD I-NP O
- HYPH I-NP O
25 CD I-NP O
region NN I-NP O
( ( O O
HPC1 NN B-NP O
) ) O O
in IN B-PP O
91 CD B-NP O
North JJ I-NP O
American JJ I-NP O
and CC I-NP O
Swedish JJ I-NP O
families NNS I-NP O
each DT B-NP O
with IN B-PP O
multiple JJ B-NP O
cases NNS I-NP O
of IN B-PP O
prostate NN B-NP B-Disease
cancer NN I-NP I-Disease
( ( O O
Smith NNP B-NP O
et FW I-NP O
al FW I-NP O
. . I-NP O

1996 CD I-NP O
) ) O O
. . O O

In IN B-PP O
the DT B-NP O
present JJ I-NP O
report NN I-NP O
we PRP B-NP O
analyze VBP B-VP O
40 CD B-NP O
( ( O O
12 CD B-NP O
original JJ I-NP O
and CC O O
28 CD B-NP O
newly RB B-VP O
identified VBN I-VP O
) ) O O
Swedish JJ B-NP O
families NNS I-NP O
with IN B-PP O
hereditary JJ B-NP B-Disease
prostate NN I-NP I-Disease
cancer NN I-NP I-Disease
( ( O O
HPC NN B-NP B-Disease
) ) O O
that WDT B-NP O
, , O O
on IN B-PP O
the DT B-NP O
basis NN I-NP O
of IN B-PP O
40 CD B-NP O
markers NNS I-NP O
spanning VBG B-VP O
a DT B-NP O
25 CD I-NP O
- HYPH I-NP O
cM NN I-NP O
interval NN I-NP O
within IN B-PP O
1q24 CD B-NP O
- HYPH I-NP O
25 CD I-NP O
, , O O
have VBP B-VP O
evidence NN B-NP O
of IN B-PP O
linkage NN B-NP O
. . O O

In IN B-PP O
the DT B-NP O
complete JJ I-NP O
set NN I-NP O
of IN B-PP O
families NNS B-NP O
, , O O
a DT B-NP O
maximum NN I-NP O
two CD I-NP O
- HYPH I-NP O
point NN I-NP O
LOD NN I-NP O
score NN I-NP O
of IN B-PP O
1 CD B-NP O
. . O O

10 CD B-NP O
was VBD B-VP O
observed VBN I-VP O
at IN B-PP O
D1S413 NN B-NP O
( ( O O
at IN B-PP O
a DT B-NP O
recombination NN I-NP O
fraction NN I-NP O
[ ( O O
theta NN B-NP O
] ) O O
of IN B-PP O
. . O O

1 CD B-NP O
) ) O O
, , O O
with IN B-PP O
a DT B-NP O
maximum NN I-NP O
NPL NN I-NP O
( ( O O
nonparametric JJ B-NP O
linkage NN I-NP O
) ) O O
Z NN B-NP O
score NN I-NP O
of IN B-PP O
1 CD B-NP O
. . O O

64 CD B-NP O
at IN B-PP O
D1S202 NN B-NP O
( ( O O
P NN B-NP O
= SYM B-VP O
. . B-NP O

05 CD I-NP O
) ) O O
. . O O

The DT B-NP O
evidence NN I-NP O
of IN B-PP O
linkage NN B-NP O
to TO B-PP O
this DT B-NP O
region NN I-NP O
originated VBD B-VP O
almost RB B-ADVP O
exclusively RB I-ADVP O
from IN B-PP O
the DT B-NP O
subset NN I-NP O
of IN B-PP O
12 CD B-NP O
early JJ I-NP O
- HYPH I-NP O
onset NN I-NP O
( ( O O
age NN B-NP O
< SYM O O
65 CD B-NP O
years NNS I-NP O
) ) O O
families NNS B-NP O
, , O O
which WDT B-NP O
yielded VBD B-VP O
a DT B-NP O
maximum NN I-NP O
LOD NN I-NP O
score NN I-NP O
of IN B-PP O
2 CD B-NP O
. . O O

38 CD B-NP O
at IN B-PP O
D1S413 NN B-NP O
( ( O O
straight JJ B-NP O
theta NN I-NP O
= SYM B-VP O
0 CD B-NP O
) ) O O
and CC O O
an DT B-NP O
NPL NN I-NP O
Z NN I-NP O
score NN I-NP O
of IN B-PP O
1 CD B-NP O
. . O O

95 CD B-NP O
at IN B-PP O
D1S422 NN B-NP O
( ( O O
P NN B-NP O
= SYM B-VP O
. . B-NP O

03 CD I-NP O
) ) O O
. . O O

Estimates NNS B-NP O
from IN B-PP O
heterogeneity NN B-NP O
tests NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
, , O O
within IN B-PP O
Sweden NNP B-NP O
, , O O
as RB B-NP O
many JJ I-NP O
as IN I-NP O
50 CD I-NP O
% NN I-NP O
of IN B-PP O
early JJ B-NP O
- HYPH I-NP O
onset NN I-NP O
families NNS I-NP O
had VBD B-VP O
evidence NN B-NP O
of IN B-PP O
linkage NN B-NP O
to TO B-PP O
the DT B-NP O
HPC1 NN I-NP O
region NN I-NP O
. . O O

These DT B-NP O
results NNS I-NP O
are VBP B-VP O
consistent JJ B-ADJP O
with IN B-PP O
the DT B-NP O
hypothesis NN I-NP O
of IN B-PP O
linkage NN B-NP O
to TO B-PP O
HPC1 NN B-NP O
in IN B-PP O
a DT B-NP O
subset NN I-NP O
of IN B-PP O
families NNS B-NP O
with IN B-PP O
prostate NN B-NP B-Disease
cancer NN I-NP I-Disease
, , O O
particularly RB B-ADVP O
those DT B-NP O
with IN B-PP O
an DT B-NP O
early JJ I-NP O
age NN I-NP O
at IN B-PP O
diagnosis NN B-NP O
. . O O

Molecular JJ B-NP O
basis NN I-NP O
of IN B-PP O
feline NN B-NP O
beta SYM B-NP B-Disease
- HYPH B-NP I-Disease
glucuronidase NN I-NP I-Disease
deficiency NN I-NP I-Disease
: : O O
an DT B-NP O
animal NN I-NP O
model NN I-NP O
of IN B-PP O
mucopolysaccharidosis NN B-NP B-Disease
VII CD I-NP I-Disease
. . O O

A DT B-NP O
family NN I-NP O
of IN B-PP O
domestic JJ B-NP O
cats NNS I-NP O
was VBD B-VP O
found VBN I-VP O
that WDT B-NP O
exhibited VBD B-VP O
clinical JJ B-NP O
and CC I-NP O
biochemical JJ I-NP O
abnormalities NNS I-NP O
consistent JJ B-ADJP O
with IN B-PP O
mucopolysaccharidosis NN B-NP B-Disease
VII CD I-NP I-Disease
, , O O
an DT B-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
lysosomal JJ I-NP I-Disease
storage NN I-NP I-Disease
disorder NN I-NP I-Disease
caused VBN B-VP O
by IN B-PP O
beta SYM B-NP B-Disease
- HYPH I-NP I-Disease
glucuronidase NN I-NP I-Disease
deficiency NN I-NP I-Disease
. . O O

beta SYM O O
- HYPH B-NP O
Glucuronidase NN I-NP O
activity NN I-NP O
was VBD B-VP O
undetectable JJ B-ADJP O
in IN B-PP O
affected VBN B-NP O
cat NN I-NP O
fibroblasts NNS I-NP O
and CC O O
restored VBN B-VP O
by IN B-PP O
retroviral JJ B-NP O
gene NN I-NP O
transfer NN I-NP O
of IN B-PP O
rat NN B-NP O
beta SYM O O
- HYPH O O
glucuronidase NN B-NP O
cDNA NN I-NP O
. . O O

beta SYM O O
- HYPH O O
Glucuronidase NN B-NP O
mRNA NN I-NP O
was VBD B-VP O
normal JJ B-ADJP O
in IN B-PP O
affected VBN B-NP O
cat NN I-NP O
testis NN I-NP O
by IN B-PP O
Northern NN B-NP O
blot NN I-NP O
analysis NN I-NP O
. . O O

Normal JJ B-NP O
feline NN I-NP O
beta SYM B-NP O
- HYPH B-NP O
glucuronidase NN I-NP O
cDNA NN I-NP O
was VBD B-VP O
cloned VBN I-VP O
and CC O O
characterized VBN B-VP O
, , O O
and CC O O
amplified VBN B-VP O
from IN B-PP O
affected VBN B-NP O
cat NN I-NP O
fibroblasts NNS I-NP O
by IN B-PP O
reverse JJ B-NP O
transcription NN I-NP O
coupled VBN B-VP O
polymerase NN B-NP O
chain NN I-NP O
reaction NN I-NP O
. . O O

There EX B-NP O
was VBD B-VP O
a DT B-NP O
G NN I-NP O
- HYPH B-ADJP O
to TO B-PP O
- HYPH B-NP O
A NN I-NP O
transition NN I-NP O
in IN B-PP O
the DT B-NP O
affected VBN I-NP O
cat NN I-NP O
cDNA NN I-NP O
that WDT B-NP O
predicted VBD B-VP O
an DT B-NP O
E351K NN I-NP O
substitution NN I-NP O
, , O O
destroyed VBD B-VP O
a DT B-NP O
BssSI NN I-NP O
site NN I-NP O
, , O O
and CC O O
eliminated VBD B-VP O
GUSB NN B-NP O
enzymatic JJ I-NP O
activity NN I-NP O
in IN B-PP O
expression NN B-NP O
studies NNS I-NP O
. . O O

Multiple JJ B-NP O
species NNS I-NP O
comparison NN I-NP O
and CC O O
the DT B-NP O
crystal JJ I-NP O
structure NN I-NP O
of IN B-PP O
human JJ B-NP O
beta SYM I-NP O
- HYPH I-NP O
glucuronidase NN I-NP O
indicated VBD B-VP O
that IN B-SBAR O
E351 NN B-NP O
is VBZ B-VP O
a DT B-NP O
highly RB I-NP O
conserved VBN I-NP O
residue NN I-NP O
most RBS B-ADVP O
likely RB I-ADVP O
essential JJ B-NP O
in IN B-PP O
maintenance NN B-NP O
of IN B-PP O
the DT B-NP O
enzymes NNS I-NP O
conformation NN I-NP O
. . O O

BssSI NN B-NP O
digestion NN I-NP O
of IN B-PP O
polymerase NN B-NP O
chain NN I-NP O
reaction NN I-NP O
products NNS I-NP O
amplified VBN B-VP O
from IN B-PP O
genomic JJ B-NP O
DNA NN I-NP O
indicated VBD B-VP O
that IN B-SBAR O
affected VBN B-NP O
cats NNS I-NP O
were VBD B-VP O
homozygous JJ B-ADJP O
and CC O O
cats NNS B-NP O
with IN B-PP O
half RB B-NP O
- HYPH I-NP O
normal JJ I-NP O
beta SYM I-NP O
- HYPH I-NP O
glucuronidase NN I-NP O
activity NN I-NP O
were VBD B-VP O
heterozygous JJ B-ADJP O
for IN B-PP O
the DT B-NP O
missense JJ I-NP O
mutation NN I-NP O
. . O O

Carriers NNS B-NP O
identified VBN B-VP O
in IN B-PP O
this DT B-NP O
manner NN I-NP O
produced VBD B-VP O
affected VBN I-VP O
kittens NNS B-NP O
in IN B-PP O
prospective JJ B-NP O
breedings NNS I-NP O
, , O O
and CC O O
a DT B-NP O
feline NN I-NP O
MPS NN I-NP B-Disease
VII CD I-NP I-Disease
breeding NN I-NP O
colony NN I-NP O
has VBZ B-VP O
been VBN I-VP O
established VBN I-VP O
. . O O

. . O O

A DT B-NP O
common JJ I-NP O
molecular JJ I-NP O
basis NN I-NP O
for IN B-PP O
rearrangement NN B-NP B-Disease
disorders NNS I-NP I-Disease
on IN B-PP O
chromosome NN B-NP O
22q11 CD I-NP O
. . O O

The DT B-NP O
chromosome NN I-NP O
22q11 CD I-NP O
region NN I-NP O
is VBZ B-VP O
susceptible JJ B-ADJP O
to TO B-PP O
rearrangements NNS B-NP O
that WDT B-NP O
are VBP B-VP O
associated VBN I-VP O
with IN B-PP O
congenital JJ B-NP B-Disease
anomaly JJ I-NP I-Disease
disorders NNS I-NP I-Disease
and CC O O
malignant JJ B-NP B-Disease
tumors NNS I-NP I-Disease
. . O O

Three CD B-NP O
congenital JJ I-NP B-Disease
anomaly JJ I-NP I-Disease
disorders NNS I-NP I-Disease
, , O O
cat NN B-NP B-Disease
- HYPH B-NP I-Disease
eye NN I-NP I-Disease
syndrome NN I-NP I-Disease
, , O O
der NN B-NP B-Disease
( ( O I-Disease
) ) O I-Disease
syndrome NN B-NP I-Disease
and CC O O
velo AFX B-VP B-Disease
- HYPH B-NP I-Disease
cardio AFX I-NP I-Disease
- HYPH I-NP I-Disease
facial JJ I-NP I-Disease
syndrome NN I-NP I-Disease
/ SYM B-VP O
DiGeorge NN B-NP B-Disease
syndrome NN I-NP I-Disease
( ( O O
VCFS NN B-NP B-Disease
/ SYM B-NP O
DGS NN I-NP B-Disease
) ) O O
are VBP B-VP O
associated VBN I-VP O
with IN B-PP O
tetrasomy NN B-NP O
, , I-NP O
trisomy NN I-NP O
or CC I-NP O
monosomy NN I-NP O
, , O O
respectively RB B-ADVP O
, , O O
for IN B-PP O
part NN B-NP O
of IN B-PP O
chromosome NN B-NP O
22q11 CD I-NP O
. . O O

VCFS NN B-NP B-Disease
/ SYM I-NP O
DGS NN I-NP B-Disease
is VBZ B-VP O
the DT B-NP O
most RBS I-NP O
common JJ I-NP O
syndrome NN I-NP O
associated VBN B-VP O
with IN B-PP O
22q11 CD B-NP O
rearrangements NNS I-NP O
. . O O

In IN B-SBAR O
order NN O O
to TO B-VP O
determine VB I-VP O
whether IN B-SBAR O
there EX B-NP O
are VBP B-VP O
particular JJ B-NP O
regions NNS I-NP O
on IN B-PP O
22q11 CD B-NP O
that WDT B-NP O
are VBP B-VP O
prone JJ B-ADJP O
to TO B-PP O
rearrangements NNS B-NP O
, , O O
the DT B-NP O
deletion NN I-NP O
end NN I-NP O
- HYPH B-NP O
points NNS I-NP O
in IN B-PP O
a DT B-NP O
large JJ I-NP O
number NN I-NP O
of IN B-PP O
VCFS NN B-NP B-Disease
/ SYM B-NP O
DGS NN B-NP B-Disease
patients NNS I-NP O
were VBD B-VP O
defined VBN I-VP O
by IN B-PP O
haplotype NN B-NP O
analysis NN I-NP O
. . O O

Most JJS B-NP O
VCFS NN I-NP B-Disease
/ SYM B-NP O
DGS NN B-NP B-Disease
patients NNS I-NP O
have VBP B-VP O
a DT B-NP O
similar JJ I-NP O
3 CD I-NP O
Mb NN I-NP O
deletion NN I-NP O
, , O O
some DT B-NP O
have VBP B-VP O
a DT B-NP O
nested JJ I-NP O
distal JJ I-NP O
deletion NN I-NP O
breakpoint NN I-NP O
resulting VBG B-VP O
in IN B-PP O
a DT B-NP O
1 CD I-NP O
. . O O

5 CD B-NP O
Mb NN I-NP O
deletion NN I-NP O
and CC O O
a DT B-NP O
few JJ I-NP O
rare JJ I-NP O
patients NNS I-NP O
have VBP B-VP O
unique JJ B-NP O
deletions NNS I-NP O
or CC I-NP O
translocations NNS I-NP O
. . O O

The DT B-NP O
high JJ I-NP O
prevalence NN I-NP O
of IN B-PP O
the DT B-NP O
disorder NN I-NP O
in IN B-PP O
the DT B-NP O
population NN I-NP O
and CC O O
the DT B-NP O
fact NN I-NP O
that IN B-SBAR O
most JJS B-NP O
cases NNS I-NP O
occur VBP B-VP O
sporadically RB B-ADVP O
suggest VBP B-VP O
that IN B-SBAR O
sequences NNS B-NP O
at IN B-PP O
or CC I-PP O
near IN I-PP O
the DT B-NP O
breakpoints NNS I-NP O
confer VBP B-VP O
susceptibility NN B-NP O
to TO B-PP O
chromosome NN B-NP O
rearrangements NNS I-NP O
. . O O

To TO B-VP O
investigate VB I-VP O
this DT B-NP O
hypothesis NN I-NP O
, , O O
we PRP B-NP O
developed VBD B-VP O
hamster NN B-NP O
- HYPH B-NP O
human JJ I-NP O
somatic JJ I-NP O
hybrid NN I-NP O
cell NN I-NP O
lines NNS I-NP O
from IN B-PP O
VCFS NN B-NP B-Disease
/ SYM B-VP O
DGS NN B-NP B-Disease
patients NNS I-NP O
with IN B-PP O
all DT B-NP O
three CD I-NP O
classes NNS I-NP O
of IN B-PP O
deletions NNS B-NP O
and CC O O
we PRP B-NP O
now RB B-ADVP O
show VBP B-VP O
that IN B-SBAR O
the DT B-NP O
breakpoints NNS I-NP O
occur VBP B-VP O
within IN B-PP O
similar JJ B-NP O
low JJ I-NP O
copy NN I-NP O
repeats NNS I-NP O
, , O O
termed VBN B-NP O
LCR22s NNS I-NP O
. . O O

To TO B-VP O
support VB I-VP O
this DT B-NP O
idea NN I-NP O
further RBR B-ADVP O
, , O O
we PRP B-NP O
identified VBD B-VP O
a DT B-NP O
family NN I-NP O
that WDT B-NP O
carries VBZ B-VP O
an DT B-NP O
interstitial JJ I-NP O
duplication NN I-NP O
of IN B-PP O
the DT B-NP O
same JJ I-NP O
3 CD I-NP O
Mb NN I-NP O
region NN I-NP O
that WDT B-NP O
is VBZ B-VP O
deleted VBN I-VP O
in IN B-PP O
VCFS NN B-NP B-Disease
/ SYM O O
DGS NN B-NP B-Disease
patients NNS I-NP O
. . O O

We PRP B-NP O
present VBP B-VP O
models NNS B-NP O
to TO B-VP O
explain VB I-VP O
how WRB B-ADVP O
the DT B-NP O
LCR22s NNS I-NP O
can MD B-VP O
mediate VB I-VP O
different JJ B-NP O
homologous JJ I-NP O
recombination NN I-NP O
events NNS I-NP O
, , O O
thereby RB B-VP O
generating VBG I-VP O
a DT B-NP O
number NN I-NP O
of IN B-PP O
rearrangements NNS B-NP O
that WDT B-NP O
are VBP B-VP O
associated VBN I-VP O
with IN B-PP O
congenital JJ B-NP B-Disease
anomaly JJ I-NP I-Disease
disorders NNS I-NP I-Disease
. . O O

We PRP B-NP O
identified VBD B-VP O
five CD B-NP O
additional JJ I-NP O
copies NNS I-NP O
of IN B-PP O
the DT B-NP O
LCR22 NN I-NP O
on IN B-PP O
22q11 CD B-NP O
that WDT B-NP O
may MD B-VP O
mediate VB I-VP O
other JJ B-NP O
rearrangements NNS I-NP O
leading VBG B-VP O
to TO B-PP O
disease NN B-NP O
. . O O

Functional JJ B-NP O
consequences NNS I-NP O
of IN B-PP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
early JJ I-NP O
growth NN I-NP O
response NN I-NP O
2 CD I-NP O
gene NN I-NP O
( ( O O
EGR2 NN B-NP O
) ) O O
correlate VBP B-VP O
with IN B-PP O
severity NN B-NP O
of IN B-PP O
human JJ B-NP O
myelinopathies NNS I-NP B-Disease
. . O O

The DT B-NP O
early JJ I-NP O
growth NN I-NP O
response NN I-NP O
2 CD I-NP O
gene NN I-NP O
( ( O O
EGR2 NN B-NP O
) ) O O
is VBZ B-VP O
a DT B-NP O
Cys2His2zinc NN I-NP O
finger NN I-NP O
transcription NN I-NP O
factor NN I-NP O
which WDT B-NP O
is VBZ B-VP O
thought VBN I-VP O
to TO I-VP O
play VB I-VP O
a DT B-NP O
role NN I-NP O
in IN B-PP O
the DT B-NP O
regulation NN I-NP O
of IN B-PP O
peripheral JJ B-NP O
nervous JJ I-NP O
system NN I-NP O
myelination NN I-NP O
. . O O

This DT B-NP O
idea NN I-NP O
is VBZ B-VP O
based VBN I-VP O
partly RB B-ADVP O
on IN B-PP O
the DT B-NP O
phenotype NN I-NP O
of IN B-PP O
homozygous JJ B-NP O
Krox20 NN I-NP O
( ( O O
Egr2 NN B-NP O
) ) O O
knockout NN B-NP O
mice NNS I-NP O
, , O O
which WDT B-NP O
display VBP B-VP O
hypomyelination NN B-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
PNS NN I-NP I-Disease
and CC O O
a DT B-NP O
block NN I-NP O
of IN B-PP O
Schwann NNP B-NP O
cells NNS I-NP O
at IN B-PP O
an DT B-NP O
early JJ I-NP O
stage NN I-NP O
of IN B-PP O
differentiation NN B-NP O
. . O O

Mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
human JJ I-NP O
EGR2 NN I-NP O
gene NN I-NP O
have VBP B-VP O
recently RB I-VP O
been VBN I-VP O
associated VBN I-VP O
with IN B-PP O
the DT B-NP O
inherited VBN I-NP B-Disease
peripheral JJ I-NP I-Disease
neuropathies NNS I-NP I-Disease
Charcot NNP I-NP B-Disease
- HYPH I-NP I-Disease
Marie NNP I-NP I-Disease
- HYPH I-NP I-Disease
Tooth NNP I-NP I-Disease
type NN I-NP I-Disease
1 CD I-NP I-Disease
, , O O
Dejerine NNP B-NP B-Disease
- HYPH I-NP I-Disease
Sottas NNP I-NP I-Disease
syndrome NN I-NP I-Disease
and CC I-NP O
congenital JJ I-NP B-Disease
hypomyelinating VBG I-NP I-Disease
neuropathy NN I-NP I-Disease
. . O O

Three CD B-NP O
of IN B-PP O
the DT B-NP O
four CD I-NP O
EGR2 NN I-NP O
mutations NNS I-NP O
are VBP B-VP O
dominant JJ B-ADJP O
and CC O O
occur VBP B-VP O
within IN B-PP O
the DT B-NP O
zinc NN I-NP O
finger NN I-NP O
DNA NN I-NP O
- HYPH O O
binding VBG B-NP O
domain NN I-NP O
. . O O

The DT B-NP O
fourth JJ I-NP O
mutation NN I-NP O
is VBZ B-VP O
recessive JJ B-ADJP O
and CC O O
affects VBZ B-VP O
the DT B-NP O
inhibitory JJ I-NP O
domain NN I-NP O
( ( O O
R1 NN B-NP O
) ) O O
that WDT B-NP O
binds VBZ B-VP O
the DT B-NP O
NAB NN I-NP O
transcriptional JJ B-ADJP O
co AFX O O
- HYPH O O
repressors NNS B-NP O
. . O O

A DT B-NP O
combination NN I-NP O
of IN B-PP O
DNA NN B-NP O
- HYPH O O
binding VBG B-NP O
assays NNS I-NP O
and CC O O
transcriptional JJ B-NP O
analysis NN I-NP O
was VBD B-VP O
used VBN I-VP O
to TO B-VP O
determine VB I-VP O
the DT B-NP O
functional JJ I-NP O
consequences NNS I-NP O
of IN B-PP O
these DT B-NP O
mutations NNS I-NP O
. . O O

The DT B-NP O
zinc NN I-NP O
finger NN I-NP O
mutations NNS I-NP O
affect VBP B-VP O
DNA NN B-NP O
binding NN I-NP O
and CC O O
the DT B-NP O
amount NN I-NP O
of IN B-PP O
residual JJ B-NP O
binding NN I-NP O
directly RB B-ADVP O
correlates VBZ B-VP O
with IN B-PP O
disease NN B-NP O
severity NN I-NP O
. . O O

The DT B-NP O
R1 NN I-NP O
domain NN I-NP O
mutation NN I-NP O
prevents VBZ B-VP O
interaction NN B-NP O
of IN B-PP O
EGR2 NN B-NP O
with IN B-PP O
the DT B-NP O
NAB NN I-NP O
co AFX O O
- HYPH O O
repressors NNS B-NP O
and CC O O
thereby RB B-VP O
increases VBZ I-VP O
transcriptional JJ B-NP O
activity NN I-NP O
. . O O

These DT B-NP O
data NNS I-NP O
provide VBP B-VP O
insight NN B-NP O
into IN B-PP O
the DT B-NP O
possible JJ I-NP O
disease NN I-NP O
mechanisms NNS I-NP O
underlying VBG B-VP O
EGR2 NN B-NP O
mutations NNS I-NP O
and CC O O
the DT B-NP O
reason NN I-NP O
for IN B-PP O
varying VBG B-VP O
severity NN B-NP O
and CC I-NP O
differences NNS I-NP O
in IN B-PP O
inheritance NN B-NP O
patterns NNS I-NP O
. . O O

. . O O

Autosomal JJ B-NP B-Disease
recessive JJ I-NP I-Disease
familial JJ I-NP I-Disease
neurohypophyseal JJ I-NP I-Disease
diabetes NN I-NP I-Disease
insipidus NN I-NP I-Disease
with IN B-PP O
continued VBN B-NP O
secretion NN I-NP O
of IN B-PP O
mutant JJ B-NP O
weakly RB I-NP O
active JJ I-NP O
vasopressin NN I-NP O
. . O O

Familial JJ B-NP B-Disease
neurohypophyseal JJ I-NP I-Disease
diabetes NN I-NP I-Disease
insipidus NN I-NP I-Disease
is VBZ B-VP O
an DT B-NP O
autosomal JJ I-NP B-Disease
dominant JJ I-NP I-Disease
disorder NN I-NP I-Disease
characterized VBN B-VP O
by IN B-PP O
post AFX B-NP O
- HYPH I-NP O
natal JJ I-NP O
development NN I-NP O
of IN B-PP O
arginine NN B-NP B-Disease
vasopressin NN I-NP I-Disease
( ( O I-Disease
AVP NN B-NP I-Disease
) ) O I-Disease
deficiency NN B-NP I-Disease
due JJ B-ADJP O
to TO B-PP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
AVP NN I-NP O
gene NN I-NP O
. . O O

All DT B-NP O
published VBN I-NP O
mutations NNS I-NP O
affect VBP B-VP O
the DT B-NP O
signal NN I-NP O
peptide NN I-NP O
or CC O O
the DT B-NP O
neurophysin NN I-NP O
- HYPH B-NP O
II CD I-NP O
carrier NN I-NP O
protein NN I-NP O
and CC O O
are VBP B-VP O
presumed VBN I-VP O
to TO I-VP O
interfere VB I-VP O
with IN B-PP O
processing NN B-NP O
of IN B-PP O
the DT B-NP O
preprohormone NN I-NP O
, , O O
leading VBG B-VP O
to TO B-PP O
neuronal JJ B-NP B-Disease
damage NN I-NP I-Disease
. . O O

We PRP B-NP O
studied VBD B-VP O
an DT B-NP O
unusual JJ I-NP O
Palestinian JJ I-NP O
family NN I-NP O
consisting VBG B-VP O
of IN B-PP O
asymptomatic JJ B-NP O
first JJ I-NP O
cousin NN I-NP O
parents NNS I-NP O
and CC O O
three CD B-NP O
children NNS I-NP O
affected VBN B-VP O
with IN B-PP O
neurohypophyseal JJ B-NP B-Disease
diabetes NN I-NP I-Disease
insipidus NN I-NP I-Disease
, , O O
suggesting VBG B-VP O
autosomal JJ B-NP O
recessive JJ I-NP O
inheritance NN I-NP O
. . O O

All DT B-NP O
three CD I-NP O
affected VBN I-NP O
children NNS I-NP O
were VBD B-VP O
homozygous JJ B-ADJP O
and CC O O
the DT B-NP O
parents NNS I-NP O
heterozygous JJ B-ADJP O
for IN B-PP O
a DT B-NP O
single JJ I-NP O
novel JJ I-NP O
mutation NN I-NP O
( ( O O
C301 NN B-NP O
- HYPH O O
> SYM O O
T NN B-NP O
) ) O O
in IN B-PP O
exon NN B-NP O
1 CD I-NP O
, , O O
replacing VBG B-VP O
Pro7 NN B-NP O
of IN B-PP O
mature JJ B-NP O
AVP NN I-NP O
with IN B-PP O
Leu NN B-NP O
( ( O O
Leu NN B-NP O
- HYPH B-NP O
AVP NN I-NP O
) ) O O
. . O O

Leu NN B-NP O
- HYPH I-NP O
AVP NN I-NP O
was VBD B-VP O
a DT B-NP O
weak JJ I-NP O
agonist NN I-NP O
with IN B-PP O
approximately RB B-NP O
30 CD I-NP O
- HYPH O O
fold RB B-VP O
reduced VBN I-VP O
binding VBG B-VP O
to TO B-PP O
the DT B-NP O
human JJ I-NP O
V2 NN I-NP O
receptor NN I-NP O
. . O O

Measured VBN B-VP O
by IN B-PP O
radioimmunoassay NN B-NP O
with IN B-PP O
a DT B-NP O
synthetic JJ I-NP O
Leu NN I-NP O
- HYPH B-NP O
AVP NN I-NP O
standard NN I-NP O
, , O O
serum NN B-NP O
Leu NN I-NP O
- HYPH B-NP O
AVP NN I-NP O
levels NNS I-NP O
were VBD B-VP O
elevated VBN I-VP O
in IN B-PP O
all DT B-NP O
three CD I-NP O
children NNS I-NP O
and CC O O
further RB B-VP O
increased VBD I-VP O
during IN B-PP O
water NN B-NP O
deprivation NN I-NP O
to TO B-PP O
as RB B-ADVP O
high JJ I-ADVP O
as IN B-PP O
30 CD B-NP O
times NNS I-NP O
normal JJ B-ADJP O
. . O O

The DT B-NP O
youngest JJS I-NP O
child NN I-NP O
( ( O O
2 CD B-NP O
years NNS I-NP O
old JJ B-ADJP O
) ) O O
was VBD B-VP O
only RB I-VP O
mildly RB I-VP O
affected VBD I-VP O
but CC I-VP O
had VBD I-VP O
Leu NN B-NP O
- HYPH B-NP O
AVP NN I-NP O
levels NNS I-NP O
similar JJ B-ADJP O
to TO B-PP O
her PRP B-NP O
severely RB B-VP O
affected VBD I-VP O
8 CD B-NP O
- HYPH I-NP O
year NN I-NP O
- HYPH O O
old JJ B-NP O
brother NN I-NP O
, , O O
suggesting VBG B-VP O
that IN B-SBAR O
unknown JJ B-NP O
mechanisms NNS I-NP O
may MD B-VP O
partially RB I-VP O
compensate VB I-VP O
for IN B-PP O
a DT B-NP O
deficiency NN I-NP B-Disease
of IN B-PP I-Disease
active JJ B-NP I-Disease
AVP NN I-NP I-Disease
in IN B-PP O
very RB B-NP O
young JJ I-NP O
children NNS I-NP O
. . O O

. . O O

X NN B-NP O
inactivation NN I-NP O
and CC O O
somatic JJ B-NP O
cell NN I-NP O
selection NN I-NP O
rescue NN I-NP O
female JJ I-NP O
mice NNS I-NP O
carrying VBG B-VP O
a DT B-NP O
Piga NNP I-NP O
- HYPH I-NP O
mutation NN I-NP O
. . O O

A DT B-NP O
somatic JJ I-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
X NN I-NP O
linked VBN I-NP O
PIGA NN I-NP O
gene NN I-NP O
is VBZ B-VP O
responsible JJ B-ADJP O
for IN B-PP O
the DT B-NP O
deficiency NN I-NP B-Disease
of IN B-PP I-Disease
glycosyl NN B-NP I-Disease
phosphatidylinositol NN I-NP I-Disease
( ( O I-Disease
GPI NN B-NP I-Disease
) ) O I-Disease
- HYPH B-NP I-Disease
anchored VBN I-NP I-Disease
proteins NNS I-NP I-Disease
on IN B-PP O
blood NN B-NP O
cells NNS I-NP O
from IN B-PP O
patients NNS B-NP O
with IN B-PP O
paroxysmal JJ B-NP B-Disease
nocturnal JJ I-NP I-Disease
hemoglobinuria NN I-NP I-Disease
. . O O

No DT B-NP O
inherited VBN I-NP O
form NN I-NP O
of IN B-PP O
GPI NN B-NP B-Disease
- HYPH B-NP I-Disease
anchor NN I-NP I-Disease
deficiency NN I-NP I-Disease
has VBZ B-VP O
been VBN I-VP O
described VBN I-VP O
. . O O

Because IN B-SBAR O
conventional JJ B-NP O
Piga NN I-NP O
gene NN I-NP O
knockout NN I-NP O
is VBZ B-VP O
associated VBN I-VP O
with IN B-PP O
high JJ B-NP O
embryonic JJ I-NP B-Disease
lethality NN I-NP I-Disease
in IN B-PP O
chimeric JJ B-NP O
mice NNS I-NP O
, , O O
we PRP B-NP O
used VBD B-VP O
the DT B-NP O
Cre NN I-NP O
/ SYM B-NP O
loxP NN I-NP O
system NN I-NP O
. . O O

We PRP B-NP O
generated VBD B-VP O
mice NNS B-NP O
in IN B-PP O
which WDT B-NP O
two CD B-NP O
loxP NN I-NP O
sites NNS I-NP O
flank VBP B-VP O
part NN B-NP O
of IN B-PP O
Piga NNP B-NP O
exon NN I-NP O
2 CD I-NP O
. . O O

After IN B-PP O
crossbreeding VBG B-VP O
with IN B-PP O
female JJ B-NP O
mice NNS I-NP O
of IN B-PP O
the DT B-NP O
EIIa NN I-NP O
- HYPH B-NP O
cre NN I-NP O
strain NN I-NP O
, , O O
the DT B-NP O
floxed JJ I-NP O
allele NN I-NP O
undergoes VBZ B-VP O
Cre NN B-NP O
- HYPH O O
mediated VBN B-NP O
recombination NN I-NP O
with IN B-PP O
high JJ B-NP O
efficiency NN I-NP O
during IN B-PP O
early JJ B-NP O
embryonic JJ I-NP O
development NN I-NP O
. . O O

Because IN B-PP O
of IN I-PP O
X NN B-NP O
chromosome NN I-NP O
inactivation NN I-NP O
, , O O
female JJ B-NP O
offspring NN I-NP O
are VBP B-VP O
mosaic JJ B-ADJP O
for IN B-PP O
cells NNS B-NP O
that WDT B-NP O
express VBP B-VP O
or CC I-VP O
lack VBP I-VP O
GPI NN B-NP O
- HYPH B-NP O
linked VBN I-NP O
proteins NNS I-NP O
. . O O

Analysis NN B-NP O
of IN B-PP O
mosaic JJ B-NP O
mice NNS I-NP O
showed VBD B-VP O
that IN B-SBAR O
in IN B-PP O
heart NN B-NP O
, , O O
lung NN B-NP O
, , O O
kidney NN B-NP O
, , O O
brain NN B-NP O
, , O O
and CC O O
liver NN B-NP O
, , O O
mainly RB B-NP O
wild JJ I-NP O
- HYPH I-NP O
type NN I-NP O
Piga NNP I-NP O
is VBZ B-VP O
active JJ B-ADJP O
, , O O
suggesting VBG B-VP O
that IN B-SBAR O
these DT B-NP O
tissues NNS I-NP O
require VBP B-VP O
GPI NN B-NP O
- HYPH B-NP O
linked VBN I-NP O
proteins NNS I-NP O
. . O O

The DT B-NP O
salient JJ I-NP O
exceptions NNS I-NP O
were VBD B-VP O
spleen NN B-NP O
, , O O
thymus NN B-NP O
, , O O
and CC O O
red JJ B-NP O
blood NN I-NP O
cells NNS I-NP O
, , O O
which WDT B-NP O
had VBD B-VP O
almost RB B-NP O
equal JJ I-NP O
numbers NNS I-NP O
of IN B-PP O
cells NNS B-NP O
expressing VBG B-VP O
the DT B-NP O
wild JJ I-NP O
- HYPH I-NP O
type NN I-NP O
or CC O O
the DT B-NP O
recombined JJ I-NP O
allele NN I-NP O
, , O O
implying VBG B-VP O
that IN B-SBAR O
GPI NN B-NP O
- HYPH B-NP O
linked VBN I-NP O
proteins NNS I-NP O
are VBP B-VP O
not RB O O
essential JJ B-ADJP O
for IN B-PP O
the DT B-NP O
derivation NN I-NP O
of IN B-PP O
these DT B-NP O
tissues NNS I-NP O
. . O O

PIGA NN B-NP O
( ( O O
- SYM O O
) ) O O
cells NNS B-NP O
had VBD B-VP O
no DT B-NP O
growth NN I-NP O
advantage NN I-NP O
, , O O
suggesting VBG B-VP O
that IN B-SBAR O
other JJ B-NP O
factors NNS I-NP O
are VBP B-VP O
needed VBN I-VP O
for IN B-PP O
their PRP$ B-NP O
clonal JJ I-NP O
dominance NN I-NP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
paroxysmal JJ B-NP B-Disease
nocturnal JJ I-NP I-Disease
hemoglobinuria NN I-NP I-Disease
. . O O

. . O O

The DT B-NP O
C282Y NN I-NP O
mutation NN I-NP O
causing VBG B-VP O
hereditary JJ B-NP B-Disease
hemochromatosis NN I-NP I-Disease
does VBZ B-VP O
not RB I-VP O
produce VB I-VP O
a DT B-NP O
allele NN I-NP O
. . O O

Targeted VBN B-NP O
mutagenesis NN I-NP O
was VBD B-VP O
used VBN I-VP O
to TO B-VP O
produce VB I-VP O
two CD B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
murine JJ I-NP O
hemochromatosis NN I-NP B-Disease
gene NN I-NP O
( ( O O
Hfe NN B-NP O
) ) O O
locus NN B-NP O
. . O O

The DT B-NP O
first JJ I-NP O
mutation NN I-NP O
deletes VBZ B-VP O
a DT B-NP O
large JJ I-NP O
portion NN I-NP O
of IN B-PP O
the DT B-NP O
coding VBG I-NP O
sequence NN I-NP O
, , O O
generating VBG B-VP O
a DT B-NP O
allele NN I-NP O
. . O O

The DT B-NP O
second JJ I-NP O
mutation NN I-NP O
introduces VBZ B-VP O
a DT B-NP O
missense JJ I-NP O
mutation NN I-NP O
( ( O O
C282Y NN B-NP O
) ) O O
into IN B-PP O
the DT B-NP O
Hfe NN I-NP O
locus NN I-NP O
, , O O
but CC O O
otherwise RB B-VP O
leaves VBZ I-VP O
the DT B-NP O
gene NN I-NP O
intact JJ B-ADJP O
. . O O

This DT B-NP O
mutation NN I-NP O
is VBZ B-VP O
identical JJ B-ADJP O
to TO B-PP O
the DT B-NP O
disease NN I-NP O
- HYPH O O
causing VBG B-VP O
mutation NN B-NP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
hereditary JJ B-NP B-Disease
hemochromatosis NN I-NP I-Disease
. . O O

Mice NNS B-NP O
carrying VBG B-VP O
each DT B-NP O
of IN B-PP O
the DT B-NP O
two CD I-NP O
mutations NNS I-NP O
were VBD B-VP O
bred VBN I-VP O
and CC O O
analyzed VBN B-VP O
. . O O

Homozygosity NN B-NP O
for IN B-PP O
either DT B-NP O
mutation NN I-NP O
results VBZ B-VP O
in IN B-PP O
postnatal JJ B-NP O
iron NN I-NP O
loading NN I-NP O
. . O O

The DT B-NP O
effects NNS I-NP O
of IN B-PP O
the DT B-NP O
mutation NN I-NP O
are VBP B-VP O
more RBR B-ADJP O
severe JJ I-ADJP O
than IN B-PP O
the DT B-NP O
effects NNS I-NP O
of IN B-PP O
the DT B-NP O
C282Y NN I-NP O
mutation NN I-NP O
. . O O

Mice NNS B-NP O
heterozygous JJ B-ADJP O
for IN B-PP O
either CC O O
mutation NN B-NP O
accumulate VBP B-VP O
more JJR B-NP O
iron NN I-NP O
than IN B-PP O
normal JJ B-NP O
controls NNS I-NP O
. . O O

Interestingly RB B-ADVP O
, , O O
although IN B-SBAR O
liver NN B-NP O
iron NN I-NP O
stores NNS I-NP O
are VBP B-VP O
greatly RB I-VP O
increased VBN I-VP O
, , O O
splenic JJ B-NP O
iron NN I-NP O
is VBZ B-VP O
decreased VBN I-VP O
. . O O

We PRP B-NP O
conclude VBP B-VP O
that IN B-SBAR O
the DT B-NP O
C282Y NN I-NP O
mutation NN I-NP O
does VBZ B-VP O
not RB I-VP O
result VB I-VP O
in IN B-PP O
a DT B-NP O
allele NN I-NP O
. . O O

. . O O

Genotype NN B-NP O
- HYPH I-NP O
phenotype NN I-NP O
analysis NN I-NP O
in IN B-PP O
X NN B-NP B-Disease
- HYPH O I-Disease
linked VBN B-VP I-Disease
Emery NNP B-NP I-Disease
- HYPH I-NP I-Disease
Dreifuss NNP I-NP I-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
and CC I-NP O
identification NN I-NP O
of IN B-PP O
a DT B-NP O
missense JJ I-NP O
mutation NN I-NP O
associated VBN B-VP O
with IN B-PP O
a DT B-NP O
milder JJR I-NP O
phenotype NN I-NP O
. . O O

Direct JJ B-NP O
sequencing NN I-NP O
of IN B-PP O
the DT B-NP O
emerin NN I-NP O
gene NN I-NP O
in IN B-PP O
22 CD B-NP O
families NNS I-NP O
with IN B-PP O
Emery NNP B-NP B-Disease
- HYPH I-NP I-Disease
Dreifuss NNP I-NP I-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
EMD NN B-NP B-Disease
) ) O O
revealed VBD B-VP O
mutations NNS B-NP O
in IN B-PP O
21 CD B-NP O
( ( O O
95 CD B-NP O
% NN I-NP O
) ) O O
, , O O
confirming VBG B-VP O
that IN B-SBAR O
emerin NN B-NP O
mutations NNS I-NP O
can MD B-VP O
be VB I-VP O
identified VBN I-VP O
in IN B-PP O
the DT B-NP O
majority NN I-NP O
of IN B-PP O
families NNS B-NP O
with IN B-PP O
X NN B-NP B-Disease
- HYPH O I-Disease
linked VBN B-NP I-Disease
EMD NN I-NP I-Disease
. . O O

Most JJS B-NP O
emerin NN I-NP O
mutations NNS I-NP O
result VBP B-VP O
in IN B-PP O
absence NN B-NP O
of IN B-PP O
the DT B-NP O
protein NN I-NP O
. . O O

In IN B-PP O
this DT B-NP O
study NN I-NP O
three CD B-NP O
mutations NNS I-NP O
( ( O O
a DT B-NP O
missense JJ I-NP O
mutation NN I-NP O
Pro183Thr NN I-NP O
and CC O O
two CD B-NP O
in IN B-PP O
- HYPH B-NP O
frame NN I-NP O
deletions NNS I-NP O
removing VBG B-VP O
residues NNS B-NP O
95 CD B-NP O
- HYPH I-NP O
99 CD I-NP O
and CC I-NP O
236 CD I-NP O
- HYPH I-NP O
241 CD I-NP O
, , O O
respectively RB B-ADVP O
) ) O O
were VBD B-VP O
unusual JJ B-ADJP O
in IN B-PP O
being VBG B-VP O
associated VBN I-VP O
with IN B-PP O
expression NN B-NP O
of IN B-PP O
mutant JJ B-NP O
protein NN I-NP O
. . O O

The DT B-NP O
phenotype NN I-NP O
in IN B-PP O
these DT B-NP O
families NNS I-NP O
was VBD B-VP O
compared VBN I-VP O
in IN B-PP O
detail NN B-NP O
with IN B-PP O
the DT B-NP O
clinical JJ I-NP O
features NNS I-NP O
in IN B-PP O
cases NNS B-NP O
with IN B-PP O
typical JJ B-NP O
mutations NNS I-NP O
. . O O

For IN B-PP O
the DT B-NP O
in IN B-PP O
- HYPH B-NP O
frame NN I-NP O
deletions NNS I-NP O
there EX B-NP O
were VBD B-VP O
no DT B-NP O
significant JJ I-NP O
differences NNS I-NP O
. . O O

In IN B-PP O
the DT B-NP O
family NN I-NP O
with IN B-PP O
the DT B-NP O
missense JJ I-NP O
mutation NN I-NP O
the DT B-NP O
phenotype NN I-NP O
was VBD B-VP O
milder JJR B-ADJP O
. . O O

Age NN B-NP O
at IN B-PP O
onset NN B-NP O
was VBD B-VP O
later JJ B-ADJP O
for IN B-PP O
first JJ B-NP O
symptoms NNS I-NP O
and CC B-PP O
for IN B-PP O
development NN B-NP O
of IN B-PP O
ankle NN B-NP B-Disease
contractures NNS I-NP I-Disease
and CC O O
muscle NN B-NP B-Disease
weakness NN I-NP I-Disease
. . O O

These DT B-NP O
findings NNS I-NP O
have VBP B-VP O
diagnostic JJ B-NP O
implications NNS I-NP O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
pointing VBG B-VP O
to TO B-PP O
functionally RB B-NP O
important JJ I-NP O
regions NNS I-NP O
of IN B-PP O
the DT B-NP O
emerin NN I-NP O
protein NN I-NP O
. . O O

. . O O

Severe JJ B-NP O
clinical JJ I-NP O
expression NN I-NP O
in IN B-PP O
X NN B-NP B-Disease
- HYPH O I-Disease
linked VBN B-VP I-Disease
Emery NNP B-NP I-Disease
- HYPH I-NP I-Disease
Dreifuss NNP I-NP I-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
. . O O

X NN B-NP B-Disease
- HYPH O I-Disease
linked VBN B-VP I-Disease
Emery NNP B-NP I-Disease
- HYPH I-NP I-Disease
Dreifuss NNP I-NP I-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
EDMD NN B-NP B-Disease
) ) O O
is VBZ B-VP O
a DT B-NP O
relatively RB I-NP O
rare JJ I-NP O
benign JJ I-NP B-Disease
neuromuscular JJ I-NP I-Disease
disorder NN I-NP I-Disease
which WDT B-NP O
can MD B-VP O
vary VB I-VP O
remarkably RB B-ADVP O
in IN B-PP O
onset NN B-NP O
, , I-NP O
course NN I-NP O
and CC I-NP O
severity NN I-NP O
. . O O

In IN B-PP O
the DT B-NP O
present JJ I-NP O
study NN I-NP O
, , O O
a DT B-NP O
TCTAC NN I-NP O
deletion NN I-NP O
spanning VBG B-VP O
the DT B-NP O
nucleotides NNS I-NP O
631 CD B-NP O
- HYPH I-NP O
635 CD I-NP O
of IN B-PP O
the DT B-NP O
emerin NN I-NP O
gene NN I-NP O
caused VBD B-VP O
an DT B-NP O
unusually RB I-NP O
severe JJ I-NP O
disease NN I-NP O
phenotype NN I-NP O
including VBG B-PP O
loss NN B-NP B-Disease
of IN B-PP I-Disease
ambulation NN B-NP I-Disease
and CC O O
severe JJ B-NP O
muscle NN I-NP B-Disease
wasting VBG B-VP I-Disease
in IN B-PP O
two CD B-NP O
affected VBN I-NP O
brothers NNS I-NP O
. . O O

The DT B-NP O
same JJ I-NP O
mutation NN I-NP O
has VBZ B-VP O
been VBN I-VP O
reported VBN I-VP O
previously RB B-ADVP O
in IN B-PP O
an DT B-NP O
unrelated JJ I-NP O
family NN I-NP O
showing VBG B-VP O
a DT B-NP O
significantly RB I-NP O
milder JJR I-NP O
phenotype NN I-NP O
. . O O

The DT B-NP O
interfamilial JJ I-NP O
heterogeneity NN I-NP O
in IN B-PP O
distribution NN B-NP O
and CC B-PP O
in IN B-PP O
severity NN B-NP O
of IN B-PP O
the DT B-NP O
features NNS I-NP O
in IN B-PP O
the DT B-NP O
two CD I-NP O
families NNS I-NP O
point VBP B-VP O
to TO B-PP O
environmental JJ B-NP O
or CC I-NP O
genetic JJ I-NP O
modification NN I-NP O
as IN B-PP O
the DT B-NP O
cause NN I-NP O
of IN B-PP O
clinical JJ B-NP O
variability NN I-NP O
in IN B-PP O
Emery NNP B-NP B-Disease
- HYPH B-NP I-Disease
Dreifuss NNP I-NP I-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
. . O O

. . O O

Common JJ B-NP O
mutations NNS I-NP O
in IN B-PP O
BRCA1 NN B-NP O
and CC I-NP O
BRCA2 NN I-NP O
do VBP B-VP O
not RB I-VP O
contribute VB I-VP O
to TO B-PP O
early JJ B-NP O
prostate NN I-NP B-Disease
cancer NN I-NP I-Disease
in IN B-PP O
Jewish JJ B-NP O
men NNS I-NP O
. . O O

BACKGROUND NN B-NP O
Families NNS I-NP O
with IN B-PP O
a DT B-NP O
high JJ I-NP O
incidence NN I-NP O
of IN B-PP O
hereditary JJ B-NP B-Disease
breast NN I-NP I-Disease
cancer NN I-NP I-Disease
, , O O
and CC O O
subsequently RB B-VP O
shown VBN I-VP O
to TO I-VP O
have VB I-VP O
terminating VBG I-VP O
mutations NNS B-NP O
in IN B-PP O
BRCA1 NN B-NP O
or CC I-NP O
BRCA2 NN I-NP O
, , O O
appear VBP B-VP O
to TO I-VP O
have VB I-VP O
a DT B-NP O
higher JJR I-NP O
incidence NN I-NP O
of IN B-PP O
prostate NN B-NP B-Disease
cancer NN I-NP I-Disease
among IN B-PP O
male JJ B-NP O
relatives NNS I-NP O
. . O O

We PRP B-NP O
aimed VBD B-VP O
to TO I-VP O
determine VB I-VP O
whether IN B-SBAR O
the DT B-NP O
common JJ I-NP O
germline NN I-NP O
mutations NNS I-NP O
of IN B-PP O
BRCA1 NN B-NP O
or CC I-NP O
BRCA2 NN I-NP O
in IN B-PP O
Ashkenazi NNP B-NP O
Jewish JJ I-NP O
men NNS I-NP O
predisposed VBD B-VP O
them PRP B-NP O
to TO B-PP O
prostate NN B-NP B-Disease
cancer NN I-NP I-Disease
. . O O

METHODS NNS B-NP O
We PRP B-NP O
examined VBD B-VP O
genomic JJ B-NP O
DNA NN I-NP O
from IN B-PP O
83 CD B-NP O
( ( O O
for IN B-PP O
BRCA1 NN B-NP O
185delAG NN I-NP O
) ) O O
or CC O O
82 CD B-NP O
( ( O O
for IN B-PP O
BRCA2 NN B-NP O
6174delT NN I-NP O
) ) O O
Ashkenazi NNP B-NP O
Jewish JJ I-NP O
prostate NN I-NP B-Disease
cancer NN I-NP I-Disease
patients NNS I-NP O
, , O O
most JJS B-NP O
of IN B-PP O
whom WP B-NP O
were VBD B-VP O
treated VBN I-VP O
at IN B-PP O
a DT B-NP O
relatively RB I-NP O
young JJ I-NP O
age NN I-NP O
, , O O
for IN B-PP O
the DT B-NP O
most RBS I-NP O
common JJ I-NP O
germline NN I-NP O
mutation NN I-NP O
in IN B-PP O
each DT B-NP O
gene NN I-NP O
seen VBN B-VP O
in IN B-PP O
the DT B-NP O
Ashkenazi NNP I-NP O
population NN I-NP O
. . O O

RESULTS NNS B-NP O
Our PRP$ B-NP O
study NN I-NP O
should MD B-VP O
have VB I-VP O
been VBN I-VP O
able JJ B-ADJP O
to TO B-VP O
detect VB I-VP O
a DT B-NP O
4 CD I-NP O
- HYPH I-NP O
5 CD I-NP O
- HYPH I-NP O
fold JJ I-NP O
increase NN I-NP O
in IN B-PP O
the DT B-NP O
risk NN I-NP O
of IN B-PP O
prostate NN B-NP B-Disease
cancer NN I-NP I-Disease
due IN B-PP O
to TO I-PP O
mutation NN B-NP O
of IN B-PP O
BRCA1 NN B-NP O
or CC I-NP O
BRCA2 NN I-NP O
. . O O

However RB B-ADVP O
, , O O
only RB B-NP O
one CD I-NP O
( ( O O
1 CD B-NP O
. . O O

15 CD B-NP O
% NN I-NP O
; : O O
95 CD B-NP O
% NN I-NP O
confidence NN I-NP O
interval NN I-NP O
, , O O
0 CD B-NP O
- HYPH I-NP O
3 CD I-NP O
. SYM I-NP O

6 CD I-NP O
% NN I-NP O
) ) O O
of IN B-PP O
the DT B-NP O
patients NNS I-NP O
was VBD B-VP O
heterozygous JJ B-ADJP O
for IN B-PP O
the DT B-NP O
BRCA1 NN I-NP O
mutant JJ I-NP O
allele NN I-NP O
, , O O
and CC O O
only RB B-NP O
two CD I-NP O
were VBD B-VP O
heterozygous JJ B-ADJP O
for IN B-PP O
the DT B-NP O
BRCA2 NN I-NP O
mutation NN I-NP O
( ( O O
2 CD B-NP O
. . O O

4 CD B-NP O
% NN I-NP O
; : O O
95 CD B-NP O
% NN I-NP O
confidence NN I-NP O
interval NN I-NP O
, , O O
0 CD B-NP O
- HYPH I-NP O
6 CD I-NP O
. . I-NP O

2 CD I-NP O
% NN I-NP O
) ) O O
. . O O

CONCLUSIONS NNS B-NP O
The DT B-NP O
incidence NN I-NP O
of IN B-PP O
each DT B-NP O
of IN B-PP O
the DT B-NP O
germline NN I-NP O
mutations NNS I-NP O
in IN B-PP O
these DT B-NP O
prostate NN I-NP B-Disease
cancer NN I-NP I-Disease
patients NNS I-NP O
closely RB B-ADVP O
matched VBD B-VP O
their PRP$ B-NP O
incidence NN I-NP O
( ( O O
about RB B-NP O
1 CD I-NP O
% NN I-NP O
) ) O O
in IN B-PP O
the DT B-NP O
general JJ I-NP O
Ashkenazi NNP I-NP O
Jewish JJ I-NP O
population NN I-NP O
. . O O

This DT B-NP O
suggests VBZ B-VP O
that IN B-SBAR O
unlike JJ B-NP O
cases NNS I-NP O
of IN B-PP O
breast NN B-NP B-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancers NNS I-NP I-Disease
, , O O
mutations NNS B-NP O
in IN B-PP O
BRCA1 NN B-NP O
or CC I-NP O
BRCA2 NN I-NP O
do VBP B-VP O
not RB I-VP O
significantly RB I-VP O
predispose VB I-VP O
men NNS B-NP O
to TO B-PP O
prostate NN B-NP B-Disease
cancer NN I-NP I-Disease
Beta SYM O O
- HYPH B-NP O
catenin NN I-NP O
accumulation NN I-NP O
and CC I-NP O
mutation NN I-NP O
of IN B-PP O
the DT B-NP O
CTNNB1 NN I-NP O
gene NN I-NP O
in IN B-PP O
hepatoblastoma NN B-NP B-Disease
. . O O

Hepatoblastoma NN B-NP B-Disease
is VBZ B-VP O
a DT B-NP O
rare JJ I-NP O
malignant JJ I-NP B-Disease
tumor NN I-NP I-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
liver NN I-NP I-Disease
that WDT B-NP O
occurs VBZ B-VP O
in IN B-PP O
children NNS B-NP O
at IN B-PP O
an DT B-NP O
average JJ I-NP O
age NN I-NP O
of IN B-PP O
2 CD B-NP O
to TO I-NP O
3 CD I-NP O
years NNS I-NP O
. . O O

Epidemiologic JJ B-NP O
studies NNS I-NP O
have VBP B-VP O
shown VBN I-VP O
an DT B-NP O
increased VBN I-NP O
frequency NN I-NP O
of IN B-PP O
this DT B-NP O
tumor NN I-NP B-Disease
type NN I-NP O
in IN B-PP O
families NNS B-NP O
affected VBN B-VP O
by IN B-PP O
adenomatous JJ B-NP B-Disease
polyposis NN I-NP I-Disease
coli NN I-NP I-Disease
. . O O

In IN B-PP O
addition NN B-NP O
to TO B-PP O
the DT B-NP O
epidemiologic JJ I-NP O
data NNS I-NP O
, , O O
molecular JJ B-NP O
genetic JJ I-NP O
studies NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
inactivation NN B-NP O
of IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
tumor NN I-NP I-Disease
suppressor NN I-NP O
may MD B-VP O
be VB I-VP O
involved VBN I-VP O
in IN B-PP O
hepatoblastoma NN B-NP B-Disease
tumorigenesis NN I-NP O
. . O O

A DT B-NP O
major JJ I-NP O
function NN I-NP O
of IN B-PP O
APC NN B-NP O
is VBZ B-VP O
the DT B-NP O
downregulation NN I-NP O
of IN B-PP O
beta SYM B-NP O
- HYPH O O
catenin NN B-NP O
, , O O
a DT B-NP O
transcription NN I-NP O
- HYPH O O
activating VBG B-VP O
protein NN B-NP O
with IN B-PP O
oncogenic JJ B-NP O
potential NN I-NP O
. . O O

In IN B-PP O
an DT B-NP O
ongoing JJ I-NP O
immunohistochemical JJ I-NP O
study NN I-NP O
of IN B-PP O
beta SYM B-NP O
- HYPH O O
catenin NN B-NP O
expression NN I-NP O
in IN B-PP O
sporadic JJ B-NP O
cases NNS I-NP O
of IN B-PP O
tumor NN B-NP B-Disease
types NNS I-NP O
that WDT B-NP O
are VBP B-VP O
associated VBN I-VP O
with IN B-PP O
adenomatous JJ B-NP B-Disease
polyposis NN I-NP I-Disease
coli NN I-NP I-Disease
, , O O
we PRP B-NP O
observed VBD B-VP O
increased VBN I-VP O
beta SYM B-NP O
- HYPH O O
catenin NN B-NP O
levels NNS I-NP O
in IN B-PP O
the DT B-NP O
cytoplasm NN I-NP O
and CC B-PP O
in IN B-PP O
the DT B-NP O
nuclei NNS I-NP O
of IN B-PP O
three CD B-NP O
investigated VBN I-NP O
hepatoblastomas NNS I-NP B-Disease
. . O O

Sequencing NN B-NP O
of IN B-PP O
exon NN B-NP O
3 CD I-NP O
of IN B-PP O
the DT B-NP O
beta SYM I-NP O
- HYPH I-NP O
catenin NN I-NP O
gene NN I-NP O
( ( O O
CTNNB1 NN B-NP O
) ) O O
revealed VBD B-VP O
an DT B-NP O
activating VBG I-NP O
mutation NN I-NP O
in IN B-PP O
one CD B-NP O
of IN B-PP O
the DT B-NP O
tumor NN I-NP B-Disease
samples NNS I-NP O
. . O O

Our PRP$ B-NP O
data NNS I-NP O
indicate VBP B-VP O
for IN B-PP O
the DT B-NP O
first JJ I-NP O
time NN I-NP O
that IN B-ADVP O
beta SYM B-NP O
- HYPH B-NP O
catenin NN I-NP O
accumulation NN I-NP O
may MD B-VP O
play VB I-VP O
a DT B-NP O
role NN I-NP O
in IN B-PP O
the DT B-NP O
development NN I-NP O
of IN B-PP O
hepatoblastoma NN B-NP B-Disease
and CC O O
that IN B-SBAR O
activating VBG B-VP O
mutations NNS B-NP O
of IN B-PP O
the DT B-NP O
beta SYM I-NP O
- HYPH I-NP O
catenin NN I-NP O
gene NN I-NP O
may MD B-VP O
substitute VB I-VP O
biallelic JJ B-NP O
APC NN I-NP O
inactivation NN I-NP O
in IN B-PP O
this DT B-NP O
tumor NN I-NP B-Disease
type NN I-NP O
. . O O

Genes NNP B-NP O
Chromosomes NNP I-NP O
Cancer NNP I-NP O
25 CD I-NP O
399 CD I-NP O
- HYPH B-NP O
402 CD I-NP O
, , I-NP O
1999 CD I-NP O
. . O O

. . O O

Decrease NN B-NP O
in IN B-PP O
GTP NN B-NP O
cyclohydrolase NN I-NP O
I CD I-NP O
gene NN I-NP O
expression NN I-NP O
caused VBN B-VP O
by IN B-PP O
inactivation NN B-NP O
of IN B-PP O
one CD B-NP O
allele NN I-NP O
in IN B-PP O
hereditary JJ B-NP B-Disease
progressive JJ I-NP I-Disease
dystonia NN I-NP I-Disease
with IN B-PP O
marked JJ B-NP O
diurnal JJ I-NP O
fluctuation NN I-NP O
. . O O

Hereditary JJ B-NP B-Disease
progressive JJ I-NP I-Disease
dystonia NN I-NP I-Disease
with IN B-PP O
marked JJ B-NP O
diurnal JJ I-NP O
fluctuation NN I-NP O
( ( O O
HPD NN B-NP B-Disease
; : O O
dopa NN B-NP B-Disease
- HYPH B-NP I-Disease
responsive JJ I-NP I-Disease
dystonia NN I-NP I-Disease
, , O O
DRD NN B-NP B-Disease
) ) O O
have VBP B-VP O
been VBN I-VP O
recently RB I-VP O
found VBN I-VP O
to TO I-VP O
be VB I-VP O
caused VBN I-VP O
by IN B-PP O
a DT B-NP O
genetic JJ I-NP B-Disease
defect NN I-NP I-Disease
in IN B-PP O
the DT B-NP O
GTP NN I-NP O
cyclohydrolase NN I-NP O
I CD I-NP O
( ( O O
GCH1 NN B-NP O
) ) O O
gene NN B-NP O
. . O O

In IN B-PP O
this DT B-NP O
study NN I-NP O
, , O O
we PRP B-NP O
quantified VBD B-VP O
the DT B-NP O
mRNA NN I-NP O
level NN I-NP O
of IN B-PP O
GCH1 NN B-NP O
in IN B-PP O
phytohemagglutinin NN B-NP O
( ( O O
PHA NN B-NP O
) ) O O
- HYPH O O
stimulated VBN B-NP O
mononuclear JJ I-NP O
blood NN I-NP O
cells NNS I-NP O
from IN B-PP O
one CD B-NP O
Japanese JJ I-NP O
family NN I-NP O
that WDT B-NP O
do VBP B-VP O
not RB I-VP O
have VB I-VP O
a DT B-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
coding VBG I-NP O
region NN I-NP O
or CC I-NP O
splice NN I-NP O
junctions NNS I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
. . O O

The DT B-NP O
results NNS I-NP O
showed VBD B-VP O
that IN B-SBAR O
the DT B-NP O
amounts NNS I-NP O
of IN B-PP O
the DT B-NP O
GCH1 NN I-NP O
mRNA NN I-NP O
were VBD B-VP O
decreased VBN I-VP O
to TO B-PP O
about RB B-NP O
40 CD I-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
normal JJ I-NP O
level NN I-NP O
in IN B-PP O
both DT B-NP O
patients NNS I-NP O
and CC I-NP O
carriers NNS I-NP O
. . O O

In IN B-PP O
addition NN B-NP O
, , O O
we PRP B-NP O
found VBD B-VP O
that IN B-SBAR O
the DT B-NP O
GCH1 NN I-NP O
mRNA NN I-NP O
was VBD B-VP O
transcribed VBN I-VP O
from IN B-PP O
only RB B-NP O
one CD I-NP O
allele NN I-NP O
, , O O
indicating VBG B-VP O
that IN B-SBAR O
the DT B-NP O
other JJ I-NP O
allele NN I-NP O
was VBD B-VP O
in IN B-PP O
an DT B-NP O
inactive JJ I-NP O
state NN I-NP O
. . O O

These DT B-NP O
results NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
some DT B-NP O
novel JJ I-NP O
mutations NNS I-NP O
should MD B-VP O
exist VB I-VP O
on IN B-PP O
one CD B-NP O
of IN B-PP O
the DT B-NP O
alleles NNS I-NP O
in IN B-PP O
some DT B-NP O
unknown JJ I-NP O
region NN I-NP O
of IN B-PP O
the DT B-NP O
GCH1 NN I-NP O
gene NN I-NP O
, , O O
and CC O O
may MD B-VP O
decrease VB I-VP O
the DT B-NP O
GCH1 NN I-NP O
mRNA NN I-NP O
causing VBG B-VP O
the DT B-NP O
HPD NN I-NP B-Disease
/ SYM B-NP O
DRD NN I-NP B-Disease
symptoms NNS I-NP O
. . O O

. . O O

Sulfate NN B-NP O
transport NN I-NP O
is VBZ B-VP O
not RB O O
impaired JJ B-ADJP O
in IN B-PP O
pendred JJ B-NP B-Disease
syndrome NN I-NP I-Disease
thyrocytes NNS I-NP O
. . O O

Pendred VBN B-NP B-Disease
syndrome NN I-NP I-Disease
is VBZ B-VP O
the DT B-NP O
most RBS I-NP O
common JJ I-NP O
form NN I-NP O
of IN B-PP O
syndromic JJ B-NP B-Disease
deafness NN I-NP I-Disease
, , O O
characterized VBN B-VP O
by IN B-PP O
dyshormonogenic JJ B-NP B-Disease
goiter NN I-NP I-Disease
associated VBN B-VP O
with IN B-PP O
sensory JJ B-NP B-Disease
- HYPH I-NP I-Disease
neural JJ I-NP I-Disease
deafness NN I-NP I-Disease
. . O O

The DT B-NP O
gene NN I-NP O
responsible JJ B-ADJP O
for IN B-PP O
the DT B-NP O
disease NN I-NP O
( ( O O
PDS NN B-NP B-Disease
) ) O O
has VBZ B-VP O
been VBN I-VP O
cloned VBN I-VP O
, , O O
but CC O O
its PRP$ B-NP O
function NN I-NP O
is VBZ B-VP O
as RB B-PP O
yet RB B-ADJP O
unknown JJ I-ADJP O
and CC O O
the DT B-NP O
connection NN I-NP O
between IN B-PP O
thyroid JJ B-NP B-Disease
goiter NN I-NP I-Disease
and CC I-NP O
sensory NN I-NP B-Disease
- HYPH B-NP I-Disease
neural JJ I-NP I-Disease
deafness NN I-NP I-Disease
remains VBZ B-VP O
an DT B-NP O
enigma NN I-NP O
. . O O

PDS NN B-NP O
codes VBZ B-VP O
for IN B-PP O
a DT B-NP O
novel JJ I-NP O
protein NN I-NP O
, , O O
pendrin NN B-NP O
, , O O
which WDT B-NP O
is VBZ B-VP O
closely RB B-ADJP O
related JJ I-ADJP O
to TO B-PP O
a DT B-NP O
number NN I-NP O
of IN B-PP O
sufate NN B-NP O
transporters NNS I-NP O
. . O O

Mechanisms NNS B-NP O
by IN B-PP O
which WDT B-NP O
abnormal JJ B-NP O
sulfate NN I-NP O
transport NN I-NP O
could MD B-VP O
deleteriously RB I-VP O
affect VB I-VP O
iodide NN B-NP O
organification NN I-NP O
have VBP B-VP O
been VBN I-VP O
proposed VBN I-VP O
. . O O

We PRP B-NP O
tested VBD B-VP O
sulfate NN B-NP O
transport NN I-NP O
in IN B-PP O
thyrocytes NNS B-NP O
obtained VBN B-VP O
from IN B-PP O
Pendred VBN B-NP B-Disease
syndrome NN I-NP I-Disease
patients NNS I-NP O
and CC O O
found VBD B-VP O
that IN B-SBAR O
it PRP B-NP O
was VBD B-VP O
not RB O O
defective JJ B-ADJP O
. . O O

This DT B-NP O
suggests VBZ B-VP O
that IN B-SBAR O
pendrin NN B-NP O
in IN B-PP O
fact NN B-NP O
may MD B-VP O
not RB I-VP O
be VB I-VP O
a DT B-NP O
sulfate NN I-NP O
transporter NN I-NP O
, , O O
and CC O O
emphasizes VBZ B-VP O
the DT B-NP O
importance NN I-NP O
of IN B-PP O
functional JJ B-NP O
studies NNS I-NP O
on IN B-PP O
this DT B-NP O
novel JJ I-NP O
protein NN I-NP O
. . O O

. . O O

Small JJ B-NP O
deletions NNS I-NP O
in IN B-PP O
the DT B-NP O
type NN I-NP O
II CD I-NP O
collagen NN I-NP O
triple JJ I-NP O
helix NN I-NP O
produce VBP B-VP O
kniest JJS B-NP B-Disease
dysplasia NN I-NP I-Disease
. . O O

Kniest JJS B-NP B-Disease
dysplasia NN I-NP I-Disease
is VBZ B-VP O
a DT B-NP O
moderately RB I-NP O
severe JJ I-NP O
type NN I-NP B-Disease
II CD I-NP I-Disease
collagenopathy NN I-NP I-Disease
, , O O
characterized VBN B-VP O
by IN B-PP O
short JJ B-NP O
trunk NN I-NP O
and CC I-NP O
limbs NNS I-NP O
, , O O
kyphoscoliosis NN B-NP B-Disease
, , O O
midface NN B-NP B-Disease
hypoplasia NN I-NP I-Disease
, , O O
severe JJ B-NP O
myopia NN I-NP B-Disease
, , O O
and CC O O
hearing NN B-NP B-Disease
loss NN I-NP I-Disease
. . O O

Mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
gene NN I-NP O
that WDT B-NP O
encodes VBZ B-VP O
type NN B-NP O
II CD I-NP O
collagen NN I-NP O
( ( O O
COL2A1 NN B-NP O
) ) O O
, , O O
the DT B-NP O
predominant JJ I-NP O
protein NN I-NP O
of IN B-PP O
cartilage NN B-NP O
, , O O
have VBP B-VP O
been VBN I-VP O
identified VBN I-VP O
in IN B-PP O
a DT B-NP O
number NN I-NP O
of IN B-PP O
individuals NNS B-NP O
with IN B-PP O
Kniest JJS B-NP B-Disease
dysplasia NN I-NP I-Disease
. . O O

All DT B-NP O
but CC I-NP O
two CD I-NP O
of IN B-PP O
these DT B-NP O
previously RB I-NP O
described VBN I-NP O
mutations NNS I-NP O
cause VBP B-VP O
in IN B-PP O
- HYPH B-NP O
frame NN I-NP O
deletions NNS I-NP O
in IN B-PP O
type NN B-NP O
II CD I-NP O
collagen NN I-NP O
, , O O
either CC O O
by IN B-PP O
small JJ B-NP O
deletions NNS I-NP O
in IN B-PP O
the DT B-NP O
gene NN I-NP O
or CC I-NP O
splice NN I-NP O
site NN I-NP O
alterations NNS I-NP O
. . O O

Furthermore RB B-ADVP O
, , O O
all DT B-NP O
but IN B-PP O
one CD B-NP O
of IN B-PP O
these DT B-NP O
mutations NNS I-NP O
is VBZ B-VP O
located JJ B-ADJP O
between IN B-PP O
exons NNS B-NP O
12 CD B-NP O
and CC I-NP O
24 CD I-NP O
in IN B-PP O
the DT B-NP O
COL2A1 NN I-NP O
gene NN I-NP O
. . O O

We PRP B-NP O
used VBD B-VP O
heteroduplex NN B-NP O
analysis NN I-NP O
to TO B-VP O
identify VB I-VP O
sequence NN B-NP O
anomalies NNS I-NP O
in IN B-PP O
five CD B-NP O
individuals NNS I-NP O
with IN B-PP O
Kniest JJS B-NP B-Disease
dysplasia NN I-NP I-Disease
. . O O

Sequencing NN B-NP O
of IN B-PP O
the DT B-NP O
index NN I-NP O
patients NNS I-NP O
genomic JJ B-NP O
DNA NN I-NP O
identified VBD B-VP O
four CD B-NP O
new JJ I-NP O
dominant JJ I-NP O
mutations NNS I-NP O
in IN B-PP O
COL2A1 NN B-NP O
that WDT B-NP O
result VBP B-VP O
in IN B-PP O
Kniest JJS B-NP B-Disease
dysplasia NN I-NP I-Disease
a DT B-NP O
21 CD I-NP O
- HYPH I-NP O
bp NN I-NP O
deletion NN I-NP O
in IN B-PP O
exon NN B-NP O
16 CD I-NP O
, , O O
an DT B-NP O
18 CD I-NP O
- HYPH I-NP O
bp NN I-NP O
deletion NN I-NP O
in IN B-PP O
exon NN B-NP O
19 CD I-NP O
, , O O
and CC O O
4 CD B-NP O
- HYPH I-NP O
bp NN I-NP O
deletions NNS I-NP O
in IN B-PP O
the DT B-NP O
splice NN I-NP O
donor NN I-NP O
sites NNS I-NP O
of IN B-PP O
introns NNS B-NP O
14 CD B-NP O
and CC I-NP O
20 CD I-NP O
. . O O

A DT B-NP O
previously RB I-NP O
described VBN I-NP O
28 CD I-NP O
- HYPH I-NP O
bp NN I-NP O
deletion NN I-NP O
at IN B-PP O
the DT B-NP O
COL2A1 NN I-NP O
exon NN I-NP O
12 CD I-NP O
- HYPH I-NP O
intron NN I-NP O
12 CD I-NP O
junction NN I-NP O
, , O O
deleting VBG B-VP O
the DT B-NP O
splice NN I-NP O
donor NN I-NP O
site NN I-NP O
, , O O
was VBD B-VP O
identified VBN I-VP O
in IN B-PP O
the DT B-NP O
fifth JJ I-NP O
case NN I-NP O
. . O O

The DT B-NP O
latter JJ I-NP O
three CD I-NP O
mutations NNS I-NP O
are VBP B-VP O
predicted VBN I-VP O
to TO I-VP O
result VB I-VP O
in IN B-PP O
exon NN B-NP O
skipping NN I-NP O
in IN B-PP O
the DT B-NP O
mRNA NN I-NP O
encoded VBN B-VP O
from IN B-PP O
the DT B-NP O
mutant JJ I-NP O
allele NN I-NP O
. . O O

These DT B-NP O
data NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
Kniest JJS B-NP B-Disease
dysplasia NN I-NP I-Disease
results VBZ B-VP O
from IN B-PP O
shorter JJR B-NP O
type NN I-NP O
II CD I-NP O
collagen NN I-NP O
monomers NNS I-NP O
, , O O
and CC O O
support VBP B-VP O
the DT B-NP O
hypothesis NN I-NP O
that IN B-SBAR O
alteration NN B-NP O
of IN B-PP O
a DT B-NP O
specific JJ I-NP O
COL2A1 NN I-NP O
domain NN I-NP O
, , O O
which WDT B-NP O
may MD B-VP O
span VB I-VP O
from IN B-PP O
exons NNS B-NP O
12 CD B-NP O
to TO B-PP O
24 CD B-NP O
, , O O
leads VBZ B-VP O
to TO B-PP O
the DT B-NP O
Kniest JJS I-NP B-Disease
dysplasia NN I-NP I-Disease
phenotype NN I-NP O
. . O O

. . O O

Classical JJ B-NP B-Disease
galactosemia NN I-NP I-Disease
and CC I-NP O
mutations NNS I-NP O
at IN B-PP O
the DT B-NP O
galactose NN I-NP O
- HYPH B-NP O
1 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
uridyl NN I-NP O
transferase NN I-NP O
( ( O O
GALT NN B-NP O
) ) O O
gene NN B-NP O
. . O O

Classical JJ B-NP B-Disease
galactosemia NN I-NP I-Disease
is VBZ B-VP O
caused VBN I-VP O
by IN B-PP O
a DT B-NP O
deficiency NN I-NP O
in IN B-PP O
activity NN B-NP O
of IN B-PP O
the DT B-NP O
enzyme NN I-NP O
galactose NN I-NP O
- HYPH B-NP O
1 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
uridyl NN I-NP O
transferase NN I-NP O
( ( O O
GALT NN B-NP O
) ) O O
, , O O
which WDT B-NP O
, , O O
in IN B-PP O
turn NN B-NP O
, , O O
is VBZ B-VP O
caused VBN I-VP O
by IN B-PP O
mutations NNS B-NP O
at IN B-PP O
the DT B-NP O
GALT NN I-NP O
gene NN I-NP O
. . O O

The DT B-NP O
disorder NN I-NP O
exhibits VBZ B-VP O
considerable JJ B-NP O
allelic JJ I-NP O
heterogeneity NN I-NP O
and CC O O
, , O O
at IN B-PP O
the DT B-NP O
end NN I-NP O
of IN B-PP O
1998 CD B-NP O
, , O O
more JJR B-NP O
than IN I-NP O
150 CD I-NP O
different JJ I-NP O
base NN I-NP O
changes NNS I-NP O
were VBD B-VP O
recorded VBN I-VP O
in IN B-PP O
24 CD B-NP O
different JJ I-NP O
populations NNS I-NP O
and CC I-NP O
ethnic JJ I-NP O
groups NNS I-NP O
in IN B-PP O
15 CD B-NP O
countries NNS I-NP O
worldwide RB B-ADVP O
. . O O

The DT B-NP O
mutations NNS I-NP O
most RBS B-VP O
frequently RB I-VP O
cited VBN I-VP O
are VBP B-VP O
Q188R NN B-NP O
, , O O
K285N NN B-NP O
, , O O
S135L NN B-NP O
, , O O
and CC O O
N314D NN B-NP O
. . O O

Q188R NN B-NP O
is VBZ B-VP O
the DT B-NP O
most RBS I-NP O
common JJ I-NP O
mutation NN I-NP O
in IN B-PP O
European JJ B-NP O
populations NNS I-NP O
or CC B-PP O
in IN B-PP O
those DT B-NP O
predominantly RB B-ADVP O
of IN B-PP O
European JJ B-NP O
descent NN I-NP O
. . O O

Overall RB B-ADVP O
, , O O
it PRP B-NP O
accounts VBZ B-VP O
for IN B-PP O
60 CD B-NP O
- HYPH I-NP O
70 CD I-NP O
% NN I-NP O
of IN B-PP O
mutant JJ B-NP O
chromosomes NNS I-NP O
, , O O
but CC O O
there EX B-NP O
are VBP B-VP O
significant JJ B-NP O
differences NNS I-NP O
in IN B-PP O
its PRP$ B-NP O
relative JJ I-NP O
frequency NN I-NP O
in IN B-PP O
individual JJ B-NP O
populations NNS I-NP O
. . O O

Individuals NNS B-NP O
homoallelic JJ B-ADJP O
for IN B-PP O
Q188R NN B-NP O
tend VBP B-VP O
to TO I-VP O
have VB I-VP O
a DT B-NP O
severe JJ I-NP O
phenotype NN I-NP O
and CC O O
this DT B-NP O
is VBZ B-VP O
in IN B-PP O
keeping VBG B-NP O
with IN B-PP O
the DT B-NP O
virtually RB I-NP O
complete JJ I-NP O
loss NN I-NP O
of IN B-PP O
enzyme NN B-NP O
activity NN I-NP O
observed VBN B-VP O
in IN B-PP O
in FW B-NP O
vitro FW I-NP O
expression NN I-NP O
systems NNS I-NP O
. . O O

Globally RB B-ADVP O
, , O O
K285N NN B-NP O
is VBZ B-VP O
rarer JJ B-ADJP O
, , O O
but CC O O
in IN B-PP O
many JJ B-NP O
European JJ I-NP O
populations NNS I-NP O
it PRP B-NP O
can MD B-VP O
be VB I-VP O
found VBN I-VP O
on IN B-PP O
25 CD B-NP O
- HYPH I-NP O
40 CD I-NP O
% NN I-NP O
of IN B-PP O
mutant JJ B-NP O
chromosomes NNS I-NP O
. . O O

It PRP B-NP O
is VBZ B-VP O
invariably RB I-VP O
associated VBN I-VP O
with IN B-PP O
a DT B-NP O
severe JJ I-NP O
phenotype NN I-NP O
. . O O

S135L NN B-NP O
is VBZ B-VP O
found VBN I-VP O
almost RB B-ADVP O
exclusively RB I-ADVP O
in IN B-PP O
African JJ B-NP O
Americans NNPS I-NP O
. . O O

In FW B-NP O
vitro FW I-NP O
expression NN I-NP O
results NNS I-NP O
are VBP B-VP O
discrepant JJ B-ADJP O
, , O O
but CC O O
some DT B-NP O
individuals NNS I-NP O
carrying VBG B-VP O
S135L NN B-NP O
appear VBP B-VP O
to TO I-VP O
exhibit VB I-VP O
GALT NN B-NP O
activity NN I-NP O
in IN B-PP O
some DT B-NP O
tissues NNS I-NP O
. . O O

Duarte NN B-NP O
1 CD I-NP O
( ( O O
or CC O O
Los NNP B-NP O
Angeles NNP I-NP O
) ) O O
and CC O O
Duarte NN B-NP O
2 CD I-NP O
( ( O O
or CC O O
Duarte JJ B-ADJP O
) ) O O
variants NNS B-NP O
carry VBP B-VP O
the DT B-NP O
same JJ I-NP O
amino JJ I-NP O
acid NN I-NP O
substitution NN I-NP O
, , O O
N314D NN B-NP O
, , O O
even RB B-SBAR O
though IN I-SBAR O
D1 NN B-NP O
is VBZ B-VP O
associated VBN I-VP O
with IN B-PP O
increased VBN B-NP O
erythrocyte NN I-NP O
GALT NN I-NP O
activity NN I-NP O
and CC O O
D2 NN B-NP O
with IN B-PP O
reduced VBN B-NP O
activity NN I-NP O
. . O O

N314D NN B-NP O
is VBZ B-VP O
in IN B-PP O
linkage NN B-NP O
disequilibrium NN I-NP O
with IN B-PP O
other JJ B-NP O
base NN I-NP O
changes NNS I-NP O
that WDT B-NP O
differ VBP B-VP O
on IN B-PP O
the DT B-NP O
D1 NN I-NP O
and CC I-NP O
D2 NN I-NP O
alleles NNS I-NP O
. . O O

N314D NN B-NP O
does VBZ B-VP O
not RB I-VP O
impair VB I-VP O
GALT NN B-NP O
activity NN I-NP O
in IN B-PP O
in FW B-NP O
vitro FW I-NP O
expression NN I-NP O
systems NNS I-NP O
. . O O

However RB B-ADVP O
, , O O
there EX B-NP O
are VBP B-VP O
differences NNS B-NP O
in IN B-PP O
the DT B-NP O
abundance NN I-NP O
of IN B-PP O
GALT NN B-NP O
protein NN I-NP O
in IN B-PP O
lymphoblastoid JJ B-NP O
cells NNS I-NP O
lines NNS B-NP O
from IN B-PP O
D2 NN B-NP O
and CC I-NP O
D1 NN I-NP O
individuals NNS I-NP O
. . O O

It PRP B-NP O
is VBZ B-VP O
unclear JJ B-ADJP O
whether IN B-SBAR O
the DT B-NP O
specific JJ I-NP O
molecular JJ I-NP O
changes NNS I-NP O
that WDT B-NP O
distinguish VBP B-VP O
the DT B-NP O
D1 NN I-NP O
and CC I-NP O
D2 NN I-NP O
alleles NNS I-NP O
account VBP B-VP O
for IN B-PP O
the DT B-NP O
different JJ I-NP O
activities NNS I-NP O
. . O O

The DT B-NP O
considerable JJ I-NP O
genetic JJ I-NP O
heterogeneity NN I-NP O
documented VBN B-VP O
to TO B-PP O
date NN B-NP O
undoubtedly RB B-ADVP O
contributes VBZ B-VP O
to TO B-PP O
the DT B-NP O
phenotypic JJ I-NP O
heterogeneity NN I-NP O
that WDT B-NP O
is VBZ B-VP O
observed VBN I-VP O
in IN B-PP O
galactosemia NN B-NP B-Disease
. . O O

The DT B-NP O
additional JJ I-NP O
effects NNS I-NP O
of IN B-PP O
nonallelic JJ B-NP O
variation NN I-NP O
and CC O O
other JJ B-NP O
constitutional JJ I-NP O
factors NNS I-NP O
on IN B-PP O
phenotypic JJ B-NP O
variability NN I-NP O
remain VBP B-VP O
to TO I-VP O
be VB I-VP O
elucidated VBN I-VP O
. . O O

. . O O

Mutations NNS B-NP O
of IN B-PP O
the DT B-NP O
VHL NN I-NP B-Disease
gene NN I-NP O
in IN B-PP O
sporadic JJ B-NP B-Disease
renal JJ I-NP I-Disease
cell NN I-NP I-Disease
carcinoma NN I-NP I-Disease
: : O O
definition NN B-NP O
of IN B-PP O
a DT B-NP O
risk NN I-NP O
factor NN I-NP O
for IN B-PP O
VHL NN B-NP B-Disease
patients NNS I-NP O
to TO B-VP O
develop VB I-VP O
an DT B-NP O
RCC NN I-NP B-Disease
. . O O

To TO B-VP O
investigate VB I-VP O
the DT B-NP O
nature NN I-NP O
of IN B-PP O
somatic JJ B-NP O
von NN I-NP B-Disease
Hippel NNP I-NP I-Disease
- HYPH I-NP I-Disease
Lindau NNP I-NP I-Disease
( ( O O
VHL NN B-NP B-Disease
) ) O O
mutations NNS B-NP O
, , O O
we PRP B-NP O
analyzed VBD B-VP O
173 CD B-NP O
primary JJ I-NP O
sporadic JJ I-NP O
human JJ I-NP O
renal JJ I-NP B-Disease
cell NN I-NP I-Disease
carcinomas NNS I-NP I-Disease
for IN B-PP O
mutations NNS B-NP O
of IN B-PP O
the DT B-NP O
VHL NN I-NP B-Disease
tumor NN I-NP I-Disease
suppressor NN I-NP O
gene NN I-NP O
, , O O
using VBG B-VP O
polymerase NN B-NP O
chain NN I-NP O
reaction NN I-NP O
( ( O O
PCR NN B-NP O
) ) O O
and CC O O
single JJ B-NP O
- HYPH I-NP O
strand NN I-NP O
conformational JJ I-NP O
polymorphism NN I-NP O
analysis NN I-NP O
( ( O O
SSCP NN B-NP O
) ) O O
of IN B-PP O
DNA NN B-NP O
. . O O

We PRP B-NP O
detected VBD B-VP O
abnormal JJ B-NP O
SSCP NN I-NP O
pattern NN I-NP O
in IN B-PP O
73 CD B-NP O
samples NNS I-NP O
. . O O

After IN B-PP O
sequencing NN B-NP O
, , O O
we PRP B-NP O
identified VBD B-VP O
microdeletions NNS B-NP O
in IN B-PP O
58 CD B-NP O
% NN I-NP O
of IN B-PP O
cases NNS B-NP O
, , O O
microinsertions NNS B-NP O
in IN B-PP O
17 CD B-NP O
% NN I-NP O
, , O O
nonsense JJ B-NP O
mutations NNS I-NP O
in IN B-PP O
8 CD B-NP O
% NN I-NP O
, , O O
and CC O O
missense JJ B-NP O
mutations NNS I-NP O
in IN B-PP O
17 CD B-NP O
% NN I-NP O
. . O O

Among IN B-PP O
these DT B-NP O
mutations NNS I-NP O
, , O O
50 CD B-NP O
% NN I-NP O
correspond VBP B-VP O
to TO B-PP O
new JJ B-NP O
mutations NNS I-NP O
. . O O

VHL NN B-NP B-Disease
mutations NNS I-NP O
were VBD B-VP O
found VBN I-VP O
only RB B-PP O
in IN I-PP O
the DT B-NP O
nonpapillary JJ I-NP B-Disease
renal JJ I-NP I-Disease
cell NN I-NP I-Disease
carcinoma NN I-NP I-Disease
( ( O O
RCC NN B-NP B-Disease
) ) O O
subtype NN B-NP O
, , O O
as IN B-SBAR O
previously RB B-ADVP O
reported VBN B-VP O
. . O O

To TO B-VP O
compare VB I-VP O
somatic JJ B-NP O
and CC I-NP O
germline NN I-NP O
mutations NNS I-NP O
, , O O
we PRP B-NP O
used VBD B-VP O
the DT B-NP O
VHL NN I-NP B-Disease
database NN I-NP O
, , O O
which WDT B-NP O
includes VBZ B-VP O
507 CD B-NP O
mutations NNS I-NP O
. . O O

The DT B-NP O
study NN I-NP O
of IN B-PP O
mutational JJ B-NP O
events NNS I-NP O
revealed VBD B-VP O
a DT B-NP O
significant JJ I-NP O
difference NN I-NP O
between IN B-PP O
somatic JJ B-NP O
and CC I-NP O
germline NN I-NP O
mutations NNS I-NP O
with IN B-PP O
mutations NNS B-NP O
leading VBG B-VP O
to TO B-PP O
truncated VBN B-NP O
proteins NNS I-NP O
observed VBN B-VP O
in IN B-PP O
78 CD B-NP O
% NN I-NP O
of IN B-PP O
somatic JJ B-NP O
mutations NNS I-NP O
vs CC O O
only RB B-NP O
37 CD I-NP O
% NN I-NP O
in IN B-PP O
germline NN B-NP O
mutations NNS I-NP O
( ( O O
P NN B-NP O
< SYM B-ADJP O
0 CD B-NP O
. . I-NP O

001 CD I-NP O
) ) O O
. . O O

We PRP B-NP O
postulated VBD B-VP O
that IN B-SBAR O
a DT B-NP O
specific JJ I-NP O
pattern NN I-NP O
of IN B-PP O
VHL NN B-NP B-Disease
mutations NNS I-NP O
is VBZ B-VP O
associated VBN I-VP O
with IN B-PP O
sporadic JJ B-NP B-Disease
RCC NN I-NP I-Disease
. . O O

This DT B-NP O
pattern NN I-NP O
corresponds VBZ B-VP O
to TO B-PP O
mutations NNS B-NP O
leading VBG B-VP O
mainly RB B-ADVP O
to TO B-PP O
truncated VBN B-NP O
proteins NNS I-NP O
with IN B-PP O
few JJ B-NP O
specific JJ I-NP O
missense JJ I-NP O
mutations NNS I-NP O
. . O O

We PRP B-NP O
then RB B-ADVP O
analyzed VBD B-VP O
the DT B-NP O
occurrence NN I-NP O
of IN B-PP O
RCC NN B-NP B-Disease
in IN B-PP O
VHL NN B-NP B-Disease
families NNS I-NP O
, , O O
based VBN B-PP O
on IN B-PP O
the DT B-NP O
nature NN I-NP O
of IN B-PP O
mutations NNS B-NP O
. . O O

We PRP B-NP O
observed VBD B-VP O
RCC NN B-NP B-Disease
in IN B-PP O
at IN B-NP O
least JJS I-NP O
one CD I-NP O
member NN I-NP O
of IN B-PP O
the DT B-NP O
VHL NN I-NP B-Disease
families NNS I-NP O
in IN B-PP O
77 CD B-NP O
% NN I-NP O
of IN B-PP O
cases NNS B-NP O
with IN B-PP O
mutations NNS B-NP O
leading VBG B-VP O
to TO B-PP O
truncated VBN B-NP O
proteins NNS I-NP O
versus IN B-PP O
55 CD B-NP O
% NN I-NP O
in IN B-PP O
cases NNS B-NP O
with IN B-PP O
missense JJ B-NP O
mutations NNS I-NP O
( ( O O
P NN B-NP O
< SYM B-ADJP O
0 CD B-NP O
. . I-NP O

05 CD I-NP O
) ) O O
. . O O

Thus RB B-ADVP O
, , O O
mutations NNS B-NP O
resulting VBG B-VP O
in IN B-PP O
truncated VBN B-NP O
proteins NNS I-NP O
may MD B-VP O
lead VB I-VP O
to TO B-PP O
a DT B-NP O
higher JJR I-NP O
risk NN I-NP O
of IN B-PP O
RCC NN B-NP B-Disease
in IN B-PP O
VHL NN B-NP B-Disease
patients NNS I-NP O
Defective JJ B-NP O
CTLA NN I-NP O
- HYPH B-NP O
4 CD I-NP O
cycling NN I-NP O
pathway NN I-NP O
in IN B-PP O
Chediak NNP B-NP B-Disease
- HYPH B-NP I-Disease
Higashi NNP I-NP I-Disease
syndrome NN I-NP I-Disease
: : O O
a DT B-NP O
possible JJ I-NP O
mechanism NN I-NP O
for IN B-PP O
deregulation NN B-NP O
of IN B-PP O
T NN B-NP O
lymphocyte NN I-NP O
activation NN I-NP O
. . O O

Cytotoxic JJ B-NP O
T NN I-NP O
lymphocyte NN I-NP O
- HYPH O O
associated VBN B-VP O
antigen NN B-NP O
4 CD I-NP O
( ( O O
CTLA NN B-NP O
- HYPH O O
4 CD B-NP O
, , O O
also RB B-VP O
known VBN I-VP O
as IN B-PP O
CD152 NN B-NP O
) ) O O
has VBZ B-VP O
been VBN I-VP O
shown VBN I-VP O
to TO I-VP O
play VB I-VP O
a DT B-NP O
major JJ I-NP O
role NN I-NP O
in IN B-PP O
the DT B-NP O
regulation NN I-NP O
of IN B-PP O
T NN B-NP O
cell NN I-NP O
activation NN I-NP O
. . O O

Its PRP$ B-NP O
membrane NN I-NP O
expression NN I-NP O
is VBZ B-VP O
highly RB I-VP O
regulated VBN I-VP O
by IN B-PP O
endocytosis NN B-NP O
and CC I-NP O
trafficking NN I-NP O
through IN B-PP O
the DT B-NP O
secretory JJ I-NP O
lysosome NN I-NP O
pathway NN I-NP O
. . O O

Chediak NNP B-NP B-Disease
- HYPH I-NP I-Disease
Higashi NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
CHS NN B-NP B-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
inherited VBN I-NP B-Disease
disorder NN I-NP I-Disease
caused VBN B-VP O
by IN B-PP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
lysosomal JJ I-NP O
trafficking NN I-NP O
regulator NN I-NP O
gene NN I-NP O
, , O O
LYST NN B-NP O
. . O O

It PRP B-NP O
results VBZ B-VP O
in IN B-PP O
defective JJ B-NP O
membrane NN I-NP O
targeting NN I-NP O
of IN B-PP O
the DT B-NP O
proteins NNS I-NP O
present JJ B-ADJP O
in IN B-PP O
secretory JJ B-NP O
lysosomes NNS I-NP O
, , O O
and CC O O
it PRP B-NP O
is VBZ B-VP O
associated VBN I-VP O
with IN B-PP O
a DT B-NP O
variety NN I-NP O
of IN B-PP O
features NNS B-NP O
, , O O
including VBG B-PP O
a DT B-NP O
lymphoproliferative JJ I-NP B-Disease
syndrome NN I-NP I-Disease
with IN B-PP O
hemophagocytosis NN B-NP B-Disease
. . O O

The DT B-NP O
murine JJ I-NP O
equivalent NN I-NP O
of IN B-PP O
CHS NNP B-NP B-Disease
, , O O
beige JJ B-NP O
mice NNS I-NP O
, , O O
present JJ B-NP O
similar JJ I-NP O
characteristics NNS I-NP O
but CC O O
do VBP B-VP O
not RB I-VP O
develop VB I-VP O
the DT B-NP O
lymphoproliferative JJ I-NP B-Disease
syndrome NN I-NP I-Disease
. . O O

We PRP B-NP O
show VBP B-VP O
herein RB B-ADVP O
that IN B-SBAR O
CTLA NN B-NP O
- HYPH O O
4 CD B-NP O
is VBZ B-VP O
present JJ B-ADJP O
in IN B-PP O
enlarged JJ B-NP O
, , I-NP O
abnormal JJ I-NP O
vesicles NNS I-NP O
in IN B-PP O
CHS NN B-NP B-Disease
T NN I-NP O
cells NNS I-NP O
and CC O O
is VBZ B-VP O
not RB I-VP O
properly RB I-VP O
expressed VBN I-VP O
at IN B-PP O
the DT B-NP O
cell NN I-NP O
surface NN I-NP O
after IN B-PP O
T NN B-NP O
cell NN I-NP O
activation NN I-NP O
, , O O
whereas IN O O
its PRP$ B-NP O
surface NN I-NP O
expression NN I-NP O
is VBZ B-VP O
not RB O O
impaired JJ B-ADJP O
. . O O

It PRP B-NP O
is VBZ B-VP O
therefore RB I-VP O
proposed VBN I-VP O
that IN B-SBAR O
the DT B-NP O
defective JJ I-NP O
surface NN I-NP O
expression NN I-NP O
of IN B-PP O
CTLA NN B-NP O
- HYPH O O
4 CD B-NP O
by IN B-PP O
CHS NN B-NP B-Disease
T NN I-NP O
cells NNS I-NP O
is VBZ B-VP O
involved VBN I-VP O
in IN B-PP O
the DT B-NP O
generation NN I-NP O
of IN B-PP O
lymphoproliferative JJ B-NP B-Disease
disease NN I-NP I-Disease
. . O O

This DT B-NP O
observation NN I-NP O
may MD B-VP O
provide VB I-VP O
insight NN B-NP O
into IN B-PP O
the DT B-NP O
role NN I-NP O
of IN B-PP O
CTLA NN B-NP O
- HYPH B-NP O
4 CD I-NP O
in IN B-PP O
humans NNS B-NP O
. . O O

. . O O

Proteolipoprotein NN B-NP O
gene NN I-NP O
analysis NN I-NP O
in IN B-PP O
82 CD B-NP O
patients NNS I-NP O
with IN B-PP O
sporadic JJ B-NP O
Pelizaeus NNP I-NP B-Disease
- HYPH I-NP I-Disease
Merzbacher NNP I-NP I-Disease
Disease NN I-NP I-Disease
: : O O
duplications NNS B-NP O
, , O O
the DT B-NP O
major JJ I-NP O
cause NN I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
, , O O
originate VBP B-VP O
more RBR B-ADVP O
frequently RB I-ADVP O
in IN B-PP O
male JJ B-NP O
germ NN I-NP O
cells NNS I-NP O
, , O O
but CC O O
point NN B-NP O
mutations NNS I-NP O
do VBP B-VP O
not RB O O
. . O O

The DT B-NP O
Clinical JJ I-NP O
European JJ I-NP O
Network NN I-NP O
on IN B-PP O
Brain NNP B-NP B-Disease
Dysmyelinating NNP I-NP I-Disease
Disease NN I-NP I-Disease
. . O O

Pelizaeus NNP B-NP B-Disease
- HYPH I-NP I-Disease
Merzbacher NNP I-NP I-Disease
Disease NN I-NP I-Disease
( ( O O
PMD NN B-NP B-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
X NN I-NP B-Disease
- HYPH O I-Disease
linked VBN B-VP I-Disease
developmental JJ B-NP I-Disease
defect NN I-NP I-Disease
of IN B-PP I-Disease
myelination NN B-NP I-Disease
affecting VBG B-VP O
the DT B-NP O
central JJ I-NP O
nervous JJ I-NP O
system NN I-NP O
and CC O O
segregating VBG B-VP O
with IN B-PP O
the DT B-NP O
proteolipoprotein NN I-NP O
( ( O O
PLP NN B-NP O
) ) O O
locus NN B-NP O
. . O O

Investigating VBG B-VP O
82 CD B-NP O
strictly RB I-NP O
selected VBN I-NP O
sporadic JJ I-NP O
cases NNS I-NP O
of IN B-PP O
PMD NN B-NP B-Disease
, , O O
we PRP B-NP O
found VBD B-VP O
PLP NN B-NP O
mutations NNS I-NP O
in IN B-PP O
77 CD B-NP O
% NN I-NP O
; : O O
complete JJ B-NP O
PLP NN I-NP O
- HYPH B-NP O
gene NN I-NP O
duplications NNS I-NP O
were VBD B-VP O
the DT B-NP O
most RBS I-NP O
frequent JJ I-NP O
abnormality NN I-NP O
( ( O O
62 CD B-NP O
% NN I-NP O
) ) O O
, , O O
whereas IN O O
point NN B-NP O
mutations NNS I-NP O
in IN B-PP O
coding NN B-NP O
or CC I-NP O
splice NN I-NP O
- HYPH B-NP O
site NN I-NP O
regions NNS I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
were VBD B-VP O
involved VBN I-VP O
less RBR B-ADVP O
frequently RB I-ADVP O
( ( O O
38 CD B-NP O
% NN I-NP O
) ) O O
. . O O

We PRP B-NP O
analyzed VBD B-VP O
the DT B-NP O
maternal JJ I-NP O
status NN I-NP O
of IN B-PP O
56 CD B-NP O
cases NNS I-NP O
to TO B-VP O
determine VB I-VP O
the DT B-NP O
origin NN I-NP O
of IN B-PP O
both DT B-NP O
types NNS I-NP O
of IN B-PP O
PLP NN B-NP O
mutation NN I-NP O
, , O O
since IN B-SBAR O
this DT B-NP O
is VBZ B-VP O
relevant JJ B-ADJP O
to TO B-PP O
genetic JJ B-NP O
counseling NN I-NP O
. . O O

In IN B-PP O
the DT B-NP O
22 CD I-NP O
point NN I-NP O
mutations NNS I-NP O
, , O O
68 CD B-NP O
% NN I-NP O
of IN B-PP O
mothers NNS B-NP O
were VBD B-VP O
heterozygous JJ B-ADJP O
for IN B-PP O
the DT B-NP O
mutation NN I-NP O
, , O O
a DT B-NP O
value NN I-NP O
identical JJ B-ADJP O
to TO B-PP O
the DT B-NP O
two CD I-NP O
- HYPH I-NP O
thirds NNS I-NP O
of IN B-PP O
carrier NN B-NP O
mothers NNS I-NP O
that WDT B-NP O
would MD B-VP O
be VB I-VP O
expected VBN I-VP O
if IN B-SBAR O
there EX B-NP O
were VBD B-VP O
an DT B-NP O
equal JJ I-NP O
mutation NN I-NP O
rate NN I-NP O
in IN B-PP O
male JJ B-NP O
and CC I-NP O
female JJ I-NP O
germ NN I-NP O
cells NNS I-NP O
. . O O

In IN B-PP O
sharp JJ B-NP O
contrast NN I-NP O
, , O O
among IN B-PP O
the DT B-NP O
34 CD I-NP O
duplicated VBN I-NP O
cases NNS I-NP O
, , O O
91 CD B-NP O
% NN I-NP O
of IN B-PP O
mothers NNS B-NP O
were VBD B-VP O
carriers NNS B-NP O
, , O O
a DT B-NP O
value NN I-NP O
significantly RB B-ADVP O
( ( O O
chi2 NN B-NP O
= JJ B-VP O
9 CD B-NP O
. . O O

20 CD B-NP O
, , O O
P NN B-NP O
< SYM B-NP O
. . I-NP O

01 CD I-NP O
) ) O O
in IN B-PP O
favor NN B-NP O
of IN B-PP O
a DT B-NP O
male JJ I-NP O
bias NN I-NP O
, , O O
with IN B-PP O
an DT B-NP O
estimation NN I-NP O
of IN B-PP O
the DT B-NP O
male JJ I-NP O
/ SYM I-NP O
female JJ I-NP O
mutation NN I-NP O
frequency NN I-NP O
( ( O O
k NN B-NP O
) ) O O
of IN B-PP O
9 CD B-NP O
. . O O

3 CD B-NP O
3 CD I-NP O
. . O O

Moreover RB B-ADVP O
, , O O
we PRP B-NP O
observed VBD B-VP O
the DT B-NP O
occurrence NN I-NP O
of IN B-PP O
de FW B-NP O
novo FW I-NP O
mutations NNS I-NP O
between IN B-PP O
parental JJ B-NP O
and CC I-NP O
grandparental JJ I-NP O
generations NNS I-NP O
in IN B-PP O
17 CD B-NP O
three CD I-NP O
- HYPH I-NP O
generation NN I-NP O
families NNS I-NP O
, , O O
which WDT B-NP O
allowed VBD B-VP O
a DT B-NP O
direct JJ I-NP O
estimation NN I-NP O
of IN B-PP O
the DT B-NP O
k NN I-NP O
value NN I-NP O
( ( O O
k NN B-NP O
= SYM B-VP O
11 CD B-NP O
) ) O O
. . O O

Again RB B-ADVP O
, , O O
a DT B-NP O
significant JJ I-NP O
male JJ I-NP O
mutation NN I-NP O
imbalance NN I-NP O
was VBD B-VP O
observed VBN I-VP O
only RB B-ADVP O
for IN B-PP O
the DT B-NP O
duplications NNS I-NP O
. . O O

Chromosome NN B-NP O
breakage NN I-NP O
in IN B-PP O
the DT B-NP O
Prader NNP I-NP B-Disease
- HYPH I-NP I-Disease
Willi NNP I-NP I-Disease
and CC I-NP I-Disease
Angelman NNP I-NP I-Disease
syndromes NNS I-NP I-Disease
involves VBZ B-VP O
recombination NN B-NP O
between IN B-PP O
large JJ B-NP O
, , I-NP O
transcribed VBN I-NP O
repeats NNS I-NP O
at IN B-PP O
proximal JJ B-NP O
and CC I-NP O
distal JJ I-NP O
breakpoints NNS I-NP O
. . O O

Prader NNP B-NP B-Disease
- HYPH I-NP I-Disease
Willi NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
PWS NN B-NP B-Disease
) ) O O
and CC O O
Angelman NN B-NP B-Disease
syndrome NN I-NP I-Disease
( ( O O
AS NN B-NP B-Disease
) ) O O
are VBP B-VP O
distinct JJ B-NP O
neurobehavioral JJ I-NP B-Disease
disorders NNS I-NP I-Disease
that WDT B-NP O
most RBS B-ADVP O
often RB I-ADVP O
arise VBP B-VP O
from IN B-PP O
a DT B-NP O
4 CD I-NP O
- HYPH I-NP O
Mb NN I-NP O
deletion NN I-NP O
of IN B-PP O
chromosome NN B-NP O
15q11 CD I-NP O
- HYPH I-NP O
q13 NN I-NP O
during IN B-PP O
paternal JJ B-NP O
or CC I-NP O
maternal JJ I-NP O
gametogenesis NN I-NP O
, , O O
respectively RB B-ADVP O
. . O O

At IN B-PP O
a DT B-NP O
de FW I-NP O
novo FW I-NP O
frequency NN I-NP O
of IN B-PP O
approximately RB B-ADVP O
. . O O

67 CD B-NP O
- HYPH I-NP O
1 CD I-NP O
/ SYM I-NP O
10 CD I-NP O
, , I-NP O
000 CD I-NP O
births NNS I-NP O
, , O O
these DT B-NP O
deletions NNS I-NP O
represent VBP B-VP O
a DT B-NP O
common JJ I-NP O
structural JJ I-NP O
chromosome NN I-NP O
change NN I-NP O
in IN B-PP O
the DT B-NP O
human JJ I-NP O
genome NN I-NP O
. . O O

To TO B-VP O
elucidate VB I-VP O
the DT B-NP O
mechanism NN I-NP O
underlying VBG B-VP O
these DT B-NP O
events NNS I-NP O
, , O O
we PRP B-NP O
characterized VBD B-VP O
the DT B-NP O
regions NNS I-NP O
that WDT B-NP O
contain VBP B-VP O
two CD B-NP O
proximal JJ I-NP O
breakpoint NN I-NP O
clusters NNS I-NP O
and CC O O
a DT B-NP O
distal JJ I-NP O
cluster NN I-NP O
. . O O

Novel JJ B-NP O
DNA NN I-NP O
sequences NNS I-NP O
potentially RB B-VP O
associated VBN I-VP O
with IN B-PP O
the DT B-NP O
breakpoints NNS I-NP O
were VBD B-VP O
positionally RB I-VP O
cloned VBN I-VP O
from IN B-PP O
YACs NNS B-NP O
within IN B-PP O
or CC I-PP O
near IN I-PP O
these DT B-NP O
regions NNS I-NP O
. . O O

Analyses NNS B-NP O
of IN B-PP O
rodent NN B-NP O
- HYPH B-NP O
human JJ I-NP O
somatic JJ I-NP O
- HYPH I-NP O
cell NN I-NP O
hybrids NNS I-NP O
, , O O
YAC NN B-NP O
contigs NNS I-NP O
, , O O
and CC O O
FISH NN B-NP O
of IN B-PP O
normal JJ B-NP O
or CC I-NP O
rearranged VBN I-NP O
chromosomes NNS I-NP O
15 CD B-NP O
identified VBD B-VP O
duplicated VBN B-NP O
sequences NNS I-NP O
( ( O O
the DT B-NP O
END NN I-NP O
repeats NNS I-NP O
) ) O O
at IN B-PP O
or CC I-PP O
near IN I-PP O
the DT B-NP O
breakpoints NNS I-NP O
. . O O

The DT B-NP O
END NN I-NP O
- HYPH I-NP O
repeat NN I-NP O
units NNS I-NP O
are VBP B-VP O
derived VBN I-VP O
from IN B-PP O
large JJ B-NP O
genomic JJ I-NP O
duplications NNS I-NP O
of IN B-PP O
a DT B-NP O
novel JJ I-NP O
gene NN I-NP O
( ( O O
HERC2 NN B-NP O
) ) O O
, , O O
many JJ B-NP O
copies NNS I-NP O
of IN B-PP O
which WDT B-NP O
are VBP B-VP O
transcriptionally RB B-ADJP O
active JJ I-ADJP O
in IN B-PP O
germline NN B-NP O
tissues NNS I-NP O
. . O O

One CD B-NP O
of IN B-PP O
five CD B-NP O
PWS NN I-NP B-Disease
/ SYM B-NP O
AS NN B-NP B-Disease
patients NNS I-NP O
analyzed VBN B-VP O
to TO B-PP O
date NN B-NP O
has VBZ B-VP O
an DT B-NP O
identifiable JJ I-NP O
, , I-NP O
rearranged JJ I-NP O
HERC2 NN I-NP O
transcript NN I-NP O
derived VBN B-VP O
from IN B-PP O
the DT B-NP O
deletion NN I-NP O
event NN I-NP O
. . O O

We PRP B-NP O
postulate VBP B-VP O
that IN B-SBAR O
the DT B-NP O
END NN I-NP O
repeats NNS I-NP O
flanking VBG B-VP O
15q11 CD B-NP O
- HYPH I-NP O
q13 NN I-NP O
mediate VBP B-VP O
homologous JJ B-NP O
recombination NN I-NP O
resulting VBG B-VP O
in IN B-PP O
deletion NN B-NP O
. . O O

Furthermore RB B-ADVP O
, , O O
we PRP B-NP O
propose VBP B-VP O
that IN B-SBAR O
active JJ B-NP O
transcription NN I-NP O
of IN B-PP O
these DT B-NP O
repeats NNS I-NP O
in IN B-PP O
male JJ B-NP O
and CC I-NP O
female JJ I-NP O
germ NN I-NP O
cells NNS I-NP O
may MD B-VP O
facilitate VB I-VP O
the DT B-NP O
homologous JJ I-NP O
recombination NN I-NP O
process NN I-NP O
. . O O

Linkage NN B-NP O
analysis NN I-NP O
in IN B-PP O
a DT B-NP O
large JJ I-NP O
Brazilian JJ I-NP O
family NN I-NP O
with IN B-PP O
van NNP B-NP B-Disease
der NNP I-NP I-Disease
Woude NNP I-NP I-Disease
syndrome NN I-NP I-Disease
suggests VBZ B-VP O
the DT B-NP O
existence NN I-NP O
of IN B-PP O
a DT B-NP O
susceptibility NN I-NP O
locus NN I-NP O
for IN B-PP O
cleft NN B-NP B-Disease
palate NN I-NP I-Disease
at IN B-PP O
17p11 CD B-NP O
. . O O

2 CD B-NP O
- : O O
11 CD B-NP O
. . I-NP O

1 CD I-NP O
. . O O

van NNP B-NP B-Disease
der NNP I-NP I-Disease
Woude NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
VWS NN B-NP B-Disease
) ) O O
, , O O
which WDT B-NP O
has VBZ B-VP O
been VBN I-VP O
mapped VBN I-VP O
to TO B-PP O
1q32 CD B-NP O
- HYPH O O
41 CD B-NP O
, , O O
is VBZ B-VP O
characterized VBN I-VP O
by IN B-PP O
pits NNS B-NP B-Disease
and CC O I-Disease
/ SYM B-NP I-Disease
or CC O I-Disease
sinuses NNS B-NP I-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
lower JJR I-NP I-Disease
lip NN I-NP I-Disease
, , O O
cleft NN B-NP B-Disease
lip NN I-NP I-Disease
/ SYM O I-Disease
palate NN B-NP I-Disease
( ( O O
CL NN B-NP B-Disease
/ SYM O I-Disease
P NN B-NP I-Disease
) ) O O
, , O O
cleft NN B-NP B-Disease
palate NN I-NP I-Disease
( ( O O
CP NN B-NP B-Disease
) ) O O
, , O O
bifid JJ B-NP B-Disease
uvula NN I-NP I-Disease
, , O O
and CC O O
hypodontia NN B-NP B-Disease
( ( O O
H NN B-NP B-Disease
) ) O O
. . O O

The DT B-NP O
expression NN I-NP O
of IN B-PP O
VWS NN B-NP B-Disease
, , O O
which WDT B-NP O
has VBZ B-VP O
incomplete JJ B-NP O
penetrance NN I-NP O
, , O O
is VBZ B-VP O
highly RB B-ADJP O
variable JJ I-ADJP O
. . O O

Both CC O O
the DT B-NP O
occurrence NN I-NP O
of IN B-PP O
CL NN B-NP B-Disease
/ SYM B-NP I-Disease
P NN I-NP I-Disease
and CC I-NP O
CP NN I-NP B-Disease
within IN B-PP O
the DT B-NP O
same JJ I-NP O
genealogy NN I-NP O
and CC O O
a DT B-NP O
recurrence NN I-NP O
risk NN I-NP O
< SYM O O
40 CD B-NP O
% NN I-NP O
for IN B-PP O
CP NN B-NP B-Disease
among IN B-PP O
descendants NNS B-NP O
with IN B-PP O
VWS NN B-NP B-Disease
have VBP B-VP O
suggested VBN I-VP O
that IN B-SBAR O
the DT B-NP O
development NN I-NP O
of IN B-PP O
clefts NNS B-NP B-Disease
in IN B-PP O
this DT B-NP O
syndrome NN I-NP O
is VBZ B-VP O
influenced VBN I-VP O
by IN B-PP O
modifying VBG B-VP O
genes NNS B-NP O
at IN B-PP O
other JJ B-NP O
loci NNS I-NP O
. . O O

To TO B-VP O
test VB I-VP O
this DT B-NP O
hypothesis NN I-NP O
, , O O
we PRP B-NP O
have VBP B-VP O
conducted VBN I-VP O
linkage NN B-NP O
analysis NN I-NP O
in IN B-PP O
a DT B-NP O
large JJ I-NP O
Brazilian JJ I-NP O
kindred NN I-NP O
with IN B-PP O
VWS NN B-NP B-Disease
, , O O
considering VBG B-VP O
as IN B-SBAR O
affected VBN B-VP O
the DT B-NP O
individuals NNS I-NP O
with IN B-PP O
CP NN B-NP B-Disease
, , O O
regardless RB B-ADVP O
of IN B-PP O
whether IN B-SBAR O
it PRP B-NP O
is VBZ B-VP O
associated VBN I-VP O
with IN B-PP O
other JJ B-NP O
clinical JJ I-NP O
signs NNS I-NP O
of IN B-PP O
VWS NN B-NP B-Disease
. . O O

Our PRP$ B-NP O
results NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
a DT B-NP O
gene NN I-NP O
at IN B-PP O
17p11 CD B-NP O
. . O O

2 CD B-NP O
- HYPH I-NP O
11 CD I-NP O
2 CD I-NP O
- : O O
11 CD B-NP O
. . O O

1 CD B-NP O
, , O O
together RB B-ADVP O
with IN B-PP O
the DT B-NP O
VWS NN I-NP B-Disease
gene NN I-NP O
at IN B-PP O
1p32 NN B-NP O
- HYPH O O
41 CD B-NP O
, , O O
enhances VBZ B-VP O
the DT B-NP O
probability NN I-NP O
of IN B-PP O
CP NN B-NP B-Disease
in IN B-PP O
an DT B-NP O
individual NN I-NP O
carrying VBG B-VP O
the DT B-NP O
two CD I-NP O
at IN B-PP O
- HYPH B-NP O
risk NN I-NP O
genes NNS I-NP O
. . O O

If IN B-SBAR O
this DT B-NP O
hypothesis NN I-NP O
is VBZ B-VP O
confirmed VBN I-VP O
in IN B-PP O
other JJ B-NP O
VWS NN I-NP B-Disease
pedigrees NNS I-NP O
, , O O
it PRP B-NP O
will MD B-VP O
represent VB I-VP O
one CD B-NP O
of IN B-PP O
the DT B-NP O
first JJ I-NP O
examples NNS I-NP O
of IN B-PP O
a DT B-NP O
gene NN I-NP O
, , O O
mapped VBN B-VP O
through IN B-PP O
linkage NN B-NP O
analysis NN I-NP O
, , O O
which WDT B-NP O
modifies VBZ B-VP O
the DT B-NP O
expression NN I-NP O
of IN B-PP O
a DT B-NP O
major JJ I-NP O
gene NN I-NP O
. . O O

New JJ B-NP O
mutations NNS I-NP O
, , O O
polymorphisms NNS B-NP O
, , O O
and CC O O
rare JJ B-NP O
variants NNS I-NP O
in IN B-PP O
the DT B-NP O
ATM NN I-NP O
gene NN I-NP O
detected VBN B-VP O
by IN B-PP O
a DT B-NP O
novel JJ I-NP O
SSCP NN I-NP O
strategy NN I-NP O
. . O O

The DT B-NP O
gene NN I-NP O
for IN B-PP O
ataxia NN B-NP B-Disease
- HYPH O I-Disease
telangiectasia NN B-NP I-Disease
, , O O
ATM NN B-NP O
, , O O
spans NNS B-NP O
about IN B-NP O
150 CD I-NP O
kb NN I-NP O
of IN B-PP O
genomic JJ B-NP O
DNA NN I-NP O
. . O O

ATM NN B-NP O
mutations NNS I-NP O
are VBP B-VP O
found VBN I-VP O
along IN B-PP O
the DT B-NP O
entire JJ I-NP O
gene NN I-NP O
, , O O
with IN B-PP O
no DT B-NP O
evidence NN I-NP O
of IN B-PP O
a DT B-NP O
mutational JJ I-NP O
hot JJ I-NP O
spot NN I-NP O
. . O O

Using VBG B-VP O
DNA NN B-NP O
as IN B-SBAR O
the DT B-NP O
starting VBG I-NP O
material NN I-NP O
, , O O
we PRP B-NP O
screened VBD B-VP O
the DT B-NP O
ATM NN I-NP O
gene NN I-NP O
in IN B-PP O
92 CD B-NP O
A NN I-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
patients NNS I-NP O
, , O O
using VBG B-VP O
an DT B-NP O
optimized VBN I-NP O
single JJ I-NP O
- HYPH I-NP O
strand NN I-NP O
conformation NN I-NP O
polymorphism NN I-NP O
( ( O O
SSCP NN B-NP O
) ) O O
technique NN B-NP O
that WDT B-NP O
detected VBD B-VP O
all DT B-NP O
previously RB I-NP O
known VBN I-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
polymerase NN I-NP O
chain NN I-NP O
reaction NN I-NP O
( ( O O
PCR NN B-NP O
) ) O O
segments NNS B-NP O
being VBG B-VP O
analyzed VBN I-VP O
. . O O

To TO B-VP O
expedite VB I-VP O
screening NN B-NP O
, , O O
we PRP B-NP O
sequentially RB B-ADVP O
loaded VBD B-VP O
the DT B-NP O
SSCP NN I-NP O
gels NNS I-NP O
with IN B-PP O
three CD B-NP O
different JJ I-NP O
sets NNS I-NP O
of IN B-PP O
PCR NN B-NP O
products NNS I-NP O
that WDT B-NP O
were VBD B-VP O
pretested VBN I-VP O
to TO I-VP O
avoid VB I-VP O
overlapping VBG I-VP O
patterns NNS B-NP O
. . O O

Many JJ B-NP O
of IN B-PP O
the DT B-NP O
DNA NN I-NP O
changes NNS I-NP O
we PRP B-NP O
detected VBD B-VP O
were VBD B-VP O
intragenic JJ B-NP O
polymorphisms NNS I-NP O
. . O O

Of IN B-PP O
an DT B-NP O
expected JJ I-NP O
177 CD I-NP O
unknown JJ I-NP O
mutations NNS I-NP O
, , O O
we PRP B-NP O
detected VBD B-VP O
approximately RB B-NP O
70 CD I-NP O
% NN I-NP O
, , O O
mostly RB B-NP O
protein NN I-NP O
truncating VBG B-VP O
mutations NNS B-NP O
( ( O O
that WDT B-NP O
would MD B-VP O
have VB I-VP O
been VBN I-VP O
detectable JJ B-ADJP O
by IN B-PP O
protein NN B-NP O
truncation NN I-NP O
testing NN I-NP O
if IN B-SBAR O
RNA NN B-NP O
starting NN I-NP O
material NN I-NP O
had VBD B-VP O
been VBN I-VP O
available JJ B-ADJP O
) ) O O
. . O O

Mutations NNS B-NP O
have VBP B-VP O
now RB I-VP O
been VBN I-VP O
defined VBN I-VP O
for IN B-PP O
every DT B-NP O
exon NN I-NP O
of IN B-PP O
the DT B-NP O
ATM NN I-NP O
gene NN I-NP O
. . O O

Herein RB B-ADVP O
, , O O
we PRP B-NP O
present VBP B-VP O
35 CD B-NP O
new JJ I-NP O
mutations NNS I-NP O
and CC O O
34 CD B-NP O
new JJ I-NP O
intragenic JJ I-NP O
polymorphisms NNS I-NP O
or CC O O
rare JJ B-NP O
variants NNS I-NP O
within IN B-PP O
the DT B-NP O
ATM NN I-NP O
gene NN I-NP O
. . O O

This DT B-NP O
is VBZ B-VP O
the DT B-NP O
most RBS I-NP O
comprehensive JJ I-NP O
compilation NN I-NP O
of IN B-PP O
ATM NN B-NP O
polymorphisms NNS I-NP O
assembled VBN B-VP O
to TO B-PP O
date NN B-NP O
. . O O

Defining VBG B-VP O
polymorphic JJ B-NP O
sites NNS I-NP O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
ATM NN I-NP O
gene NN I-NP O
will MD B-VP O
be VB I-VP O
of IN B-PP O
great JJ B-NP O
importance NN I-NP O
in IN B-PP O
designing VBG B-VP O
automated JJ B-NP O
methods NNS I-NP O
for IN B-PP O
detecting VBG B-VP O
mutations NNS B-NP O
. . O O

. . O O

A DT B-NP O
novel JJ I-NP O
frameshift NN I-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
McLeod NNP I-NP B-Disease
syndrome NN I-NP I-Disease
gene NN I-NP O
in IN B-PP O
a DT B-NP O
Japanese JJ I-NP O
family NN I-NP O
. . O O

We PRP B-NP O
report VBP B-VP O
a DT B-NP O
novel JJ I-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
XK NN I-NP O
gene NN I-NP O
( ( O O
XK NN B-NP O
) ) O O
in IN B-PP O
a DT B-NP O
Japanese JJ I-NP O
patient NN I-NP O
with IN B-PP O
McLeod NN B-NP B-Disease
syndrome NN I-NP I-Disease
. . O O

A DT B-NP O
50 CD I-NP O
- HYPH I-NP O
year NN I-NP O
- HYPH O O
old JJ B-NP O
man NN I-NP O
showed VBD B-VP O
progressive JJ B-NP O
muscular JJ I-NP B-Disease
atrophy NN I-NP I-Disease
, , O O
choreic JJ B-NP B-Disease
movement NN I-NP I-Disease
, , O O
elevated JJ B-NP O
level NN I-NP O
of IN B-PP O
serum NN B-NP O
creatinine NN I-NP O
kinase NN I-NP O
, , O O
and CC O O
acanthocytosis NN B-NP B-Disease
. . O O

The DT B-NP O
expression NN I-NP O
level NN I-NP O
of IN B-PP O
all PDT B-NP O
the DT I-NP O
Kell NNP I-NP O
antigens NNS I-NP O
in IN B-PP O
erythrocyte NN B-NP O
was VBD B-VP O
decreased VBN I-VP O
and CC B-NP O
molecular JJ I-NP O
analysis NN I-NP O
revealed VBD B-VP O
a DT B-NP O
single JJ I-NP O
- HYPH I-NP O
base NN I-NP O
( ( O O
T NN B-NP O
) ) O O
deletion NN B-NP O
at IN B-PP O
the DT B-NP O
nucleotide NN I-NP O
position NN I-NP O
1095 CD I-NP O
in IN B-PP O
XK NN B-NP O
. . O O

This DT B-NP O
deletion NN I-NP O
caused VBD B-VP O
a DT B-NP O
frameshift NN I-NP O
in IN B-PP O
translation NN B-NP O
, , O O
leading VBG B-VP O
to TO B-PP O
a DT B-NP O
premature JJ I-NP O
stop NN I-NP O
codon NN I-NP O
at IN B-PP O
the DT B-NP O
amino JJ I-NP O
acid NN I-NP O
position NN I-NP O
408 CD I-NP O
. . O O

We PRP B-NP O
conclude VBP B-VP O
this DT B-NP O
single JJ I-NP O
- HYPH I-NP O
base NN I-NP O
deletion NN I-NP O
causes VBZ B-VP O
defective JJ B-NP O
Kx NN I-NP O
protein NN I-NP O
, , O O
which WDT B-NP O
is VBZ B-VP O
responsible JJ B-ADJP O
for IN B-PP O
the DT B-NP O
McLeod NNP I-NP B-Disease
phenotype NN I-NP O
in IN B-PP O
this DT B-NP O
patient NN I-NP O
. . O O

. . O O

Association NN B-NP O
of IN B-PP O
BRCA1 NN B-NP O
with IN B-PP O
the DT B-NP O
hRad50 NN I-NP O
- HYPH B-NP O
hMre11 NN I-NP O
- HYPH I-NP O
p95 NN I-NP O
complex NN I-NP O
and CC O O
the DT B-NP O
DNA NN I-NP O
damage NN I-NP O
response NN I-NP O
. . O O

BRCA1 NN B-NP O
encodes VBZ B-VP O
a DT B-NP O
tumor NN I-NP B-Disease
suppressor NN I-NP O
that WDT B-NP O
is VBZ B-VP O
mutated VBN I-VP O
in IN B-PP O
familial JJ B-NP B-Disease
breast NN I-NP I-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancers NNS I-NP I-Disease
. . O O

Here RB B-ADVP O
, , O O
it PRP B-NP O
is VBZ B-VP O
shown VBN I-VP O
that IN B-SBAR O
BRCA1 NN B-NP O
interacts VBZ B-VP O
in FW B-ADVP O
vitro FW I-ADVP O
and CC O O
in FW B-ADVP O
vivo FW I-ADVP O
with IN B-PP O
hRad50 NN B-NP O
, , O O
which WDT B-NP O
forms VBZ B-VP O
a DT B-NP O
complex NN I-NP O
with IN B-PP O
hMre11 NN B-NP O
and CC I-NP O
p95 NN I-NP O
/ SYM B-NP O
nibrin NN I-NP O
. . O O

Upon IN B-PP O
irradiation NN B-NP O
, , O O
BRCA1 NN B-NP O
was VBD B-VP O
detected VBN I-VP O
in IN B-PP O
discrete JJ B-NP O
foci NNS I-NP O
in IN B-PP O
the DT B-NP O
nucleus NN I-NP O
, , O O
which WDT B-NP O
colocalize VBP B-VP O
with IN B-PP O
hRad50 NN B-NP O
. . O O

Formation NN B-NP O
of IN B-PP O
irradiation NN B-NP O
- HYPH B-NP O
induced VBN I-NP O
foci NNS I-NP O
positive JJ B-ADJP O
for IN B-PP O
BRCA1 NN B-NP O
, , O O
hRad50 NN B-NP O
, , O O
hMre11 NN B-NP O
, , O O
or CC O O
p95 NN B-NP O
was VBD B-VP O
dramatically RB I-VP O
reduced VBN I-VP O
in IN B-PP O
HCC NN B-NP O
/ SYM B-NP O
1937 CD I-NP O
breast NN I-NP B-Disease
cancer NN I-NP I-Disease
cells NNS I-NP O
carrying VBG B-VP O
a DT B-NP O
homozygous JJ I-NP O
mutation NN I-NP O
in IN B-PP O
BRCA1 NN B-NP O
but CC O O
was VBD B-VP O
restored VBN I-VP O
by IN B-PP O
transfection NN B-NP O
of IN B-PP O
wild JJ B-NP O
- HYPH I-NP O
type NN I-NP O
BRCA1 NN I-NP O
. . O O

Ectopic JJ B-NP O
expression NN I-NP O
of IN B-PP O
wild JJ B-NP O
- HYPH I-NP O
type NN I-NP O
, , O O
but CC O O
not RB B-VP O
mutated VBN I-VP O
, , O O
BRCA1 NN B-NP O
in IN B-PP O
these DT B-NP O
cells NNS I-NP O
rendered VBD B-VP O
them PRP B-NP O
less RBR B-ADJP O
sensitive JJ I-ADJP O
to TO B-PP O
the DT B-NP O
DNA NN I-NP O
damage NN I-NP O
agent NN I-NP O
, , O O
methyl NN B-NP O
methanesulfonate NN I-NP O
. . O O

These DT B-NP O
data NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
BRCA1 NN B-NP O
is VBZ B-VP O
important JJ B-ADJP O
for IN B-PP O
the DT B-NP O
cellular JJ I-NP O
responses NNS I-NP O
to TO B-PP O
DNA NN B-NP O
damage NN I-NP O
that WDT B-NP O
are VBP B-VP O
mediated VBN I-VP O
by IN B-PP O
the DT B-NP O
hRad50 NN I-NP O
- HYPH B-NP O
hMre11 NN I-NP O
- HYPH I-NP O
p95 NN I-NP O
complex NN I-NP O
. . O O

. . O O

Relationship NN B-NP O
among IN B-PP O
genotype NN B-NP O
, , O O
biochemical JJ B-NP O
phenotype NN I-NP O
, , O O
and CC O O
cognitive JJ B-NP O
performance NN I-NP O
in IN B-PP O
females NNS B-NP O
with IN B-PP O
phenylalanine NN B-NP B-Disease
hydroxylase NN I-NP I-Disease
deficiency NN I-NP I-Disease
: : O O
report NN B-NP O
from IN B-PP O
the DT B-NP O
Maternal NNP I-NP B-Disease
Phenylketonuria NNP I-NP I-Disease
Collaborative NNP I-NP O
Study NNP I-NP O
. . O O

OBJECTIVE NN B-NP O
To TO B-VP O
examine VB I-VP O
the DT B-NP O
relationship NN I-NP O
of IN B-PP O
phenylalanine NN B-NP O
hydroxylase NN I-NP O
( ( O O
PAH NN B-NP O
) ) O O
genotypes NNS B-NP O
to TO B-PP O
biochemical JJ B-NP O
phenotype NN I-NP O
and CC O O
cognitive JJ B-NP O
development NN I-NP O
in IN B-PP O
maternal JJ B-NP B-Disease
phenylketonuria NN I-NP I-Disease
( ( O O
PKU NN B-NP B-Disease
) ) O O
. . O O

METHODOLOGY NN B-NP O
PAH NN I-NP O
gene NN I-NP O
mutations NNS I-NP O
were VBD B-VP O
examined VBN I-VP O
in IN B-PP O
222 CD B-NP O
hyperphenylalaninemic JJ I-NP B-Disease
females NNS I-NP O
enrolled VBN B-VP O
in IN B-PP O
the DT B-NP O
Maternal JJ I-NP B-Disease
PKU NN I-NP I-Disease
Collaborative JJ I-NP O
Study NN I-NP O
( ( O O
MPKUCS NN B-NP O
) ) O O
. . O O

A DT B-NP O
total NN I-NP O
of IN B-PP O
84 CD B-NP O
different JJ I-NP O
mutations NNS I-NP O
were VBD B-VP O
detected VBN I-VP O
, , O O
and CC O O
complete JJ B-NP O
genotype NN I-NP O
was VBD B-VP O
obtained VBN I-VP O
in IN B-PP O
199 CD B-NP O
individuals NNS I-NP O
. . O O

Based VBN B-PP O
on IN B-PP O
previous JJ B-NP O
knowledge NN I-NP O
about IN B-PP O
mutation NN B-NP O
- HYPH B-NP O
phenotype NN I-NP O
associations NNS I-NP O
, , O O
78 CD B-NP O
of IN B-PP O
the DT B-NP O
mutations NNS I-NP O
could MD B-VP O
be VB I-VP O
assigned VBN I-VP O
to TO B-PP O
one CD B-NP O
of IN B-PP O
four CD B-NP O
classes NNS I-NP O
of IN B-PP O
severity NN B-NP O
( ( O O
severe JJ B-NP O
PKU NN I-NP B-Disease
, , O O
moderate JJ B-NP O
PKU NN I-NP B-Disease
, , O O
mild JJ B-NP O
PKU NN I-NP B-Disease
, , O O
and CC O O
mild JJ B-NP B-Disease
hyperphenylalaninemia NN I-NP I-Disease
[ ( O O
MHP NN B-NP B-Disease
] ) O O
) ) O O
. . O O

Then RB B-ADVP O
, , O O
189 CD B-NP O
MPKUCS NN I-NP O
subjects NNS I-NP O
were VBD B-VP O
grouped VBN I-VP O
according VBG B-PP O
to TO B-PP O
the DT B-NP O
various JJ I-NP O
combinations NNS I-NP O
of IN B-PP O
mutation NN B-NP O
classifications NNS I-NP O
. . O O

The DT B-NP O
sample NN I-NP O
sizes NNS I-NP O
were VBD B-VP O
large JJ B-ADJP O
enough RB I-ADJP O
for IN B-PP O
statistical JJ B-NP O
testing NN I-NP O
in IN B-PP O
four CD B-NP O
groups NNS I-NP O
with IN B-PP O
at IN B-NP O
least JJS I-NP O
one CD I-NP O
mutation NN I-NP O
that WDT B-NP O
completely RB B-VP O
abolishes VBZ I-VP O
enzyme NN B-NP O
activity NN I-NP O
. . O O

These DT B-NP O
patients NNS I-NP O
are VBP B-VP O
considered VBN I-VP O
functionally RB B-ADJP O
hemizygous JJ I-ADJP O
. . O O

RESULTS NNS B-NP O
The DT B-NP O
biochemical JJ I-NP O
phenotype NN I-NP O
predicted VBN B-VP O
from IN B-PP O
the DT B-NP O
genotype NN I-NP O
in IN B-PP O
functionally RB B-NP O
hemizygous JJ I-NP O
patients NNS I-NP O
was VBD B-VP O
related VBN I-VP O
significantly RB B-ADVP O
to TO B-PP O
the DT B-NP O
assigned VBN I-NP O
phenylalanine NN I-NP O
level NN I-NP O
. . O O

Cognitive JJ B-NP O
performance NN I-NP O
( ( O O
IQ NN B-NP O
) ) O O
was VBD B-VP O
also RB B-ADVP O
significantly RB B-ADJP O
related VBN I-ADJP O
to TO B-PP O
genotype NN B-NP O
. . O O

The DT B-NP O
IQ NN I-NP O
of IN B-PP O
PAH NN B-NP B-Disease
- HYPH B-NP I-Disease
deficient JJ I-NP I-Disease
mothers NNS I-NP O
with IN B-PP O
a DT B-NP O
severe JJ I-NP O
PKU NN I-NP B-Disease
mutation NN I-NP O
in IN B-PP O
combination NN B-NP O
with IN B-PP O
a DT B-NP O
MHP NN I-NP B-Disease
mutation NN I-NP O
or CC O O
a DT B-NP O
mild JJ I-NP O
PKU NN I-NP B-Disease
mutation NN I-NP O
was VBD B-VP O
99 CD B-NP O
and CC I-NP O
96 CD I-NP O
, , O O
respectively RB B-ADVP O
, , O O
whereas IN O O
the DT B-NP O
IQ NN I-NP O
of IN B-PP O
PKU NN B-NP B-Disease
mothers NNS I-NP O
with IN B-PP O
two CD B-NP O
severe JJ I-NP O
PKU NN I-NP B-Disease
mutations NNS I-NP O
or CC B-PP O
with IN B-PP O
one CD B-NP O
severe JJ I-NP O
and CC O O
one CD B-NP O
moderate JJ I-NP O
PKU NN I-NP B-Disease
mutation NN I-NP O
was VBD B-VP O
83 CD B-NP O
and CC I-NP O
84 CD I-NP O
, , O O
respectively RB B-ADVP O
. . O O

Of IN B-PP O
the DT B-NP O
patients NNS I-NP O
with IN B-PP O
PKU NN B-NP B-Disease
, , O O
92 CD B-NP O
% NN I-NP O
had VBD B-VP O
been VBN I-VP O
treated VBN I-VP O
during IN B-PP O
childhood NN B-NP O
. . O O

Those DT B-NP O
who WP B-NP O
were VBD B-VP O
untreated JJ B-ADJP O
or CC O O
treated VBN B-VP O
late RB B-ADVP O
had VBD B-VP O
lower JJR B-ADJP O
than IN B-PP O
average JJ B-NP O
IQ NN I-NP O
scores NNS I-NP O
for IN B-PP O
their PRP$ B-NP O
group NN I-NP O
of IN B-PP O
mutation NN B-NP O
combinations NNS I-NP O
. . O O

Females NNS B-NP O
with IN B-PP O
moderate JJ B-NP O
or CC I-NP O
mild JJ I-NP O
PKU NN I-NP B-Disease
who WP B-NP O
were VBD B-VP O
treated VBN I-VP O
early JJ B-ADVP O
and CC O O
treated VBN B-VP O
for IN B-PP O
> JJR B-NP O
6 CD I-NP O
years NNS I-NP O
showed VBD B-VP O
IQ NN B-NP O
scores NNS I-NP O
10 CD B-NP O
points NNS I-NP O
above IN B-PP O
average NN B-NP O
for IN B-PP O
their PRP$ B-NP O
group NN I-NP O
. . O O

CONCLUSIONS NNS B-NP O
The DT B-NP O
reproductive JJ I-NP O
outcome NN I-NP O
in IN B-PP O
maternal JJ B-NP B-Disease
phenylketonuria NN I-NP I-Disease
is VBZ B-VP O
dependent JJ B-ADJP O
on IN B-PP O
prenatal JJ B-NP O
metabolic JJ I-NP O
control NN I-NP O
and CC O O
postnatal JJ B-NP O
environmental JJ I-NP O
circumstances NNS I-NP O
. . O O

Both DT B-NP O
factors NNS I-NP O
depend VBP B-VP O
on IN B-PP O
the DT B-NP O
intellectual JJ I-NP O
resources NNS I-NP O
of IN B-PP O
the DT B-NP O
mother NN I-NP O
with IN B-PP O
PKU NN B-NP B-Disease
. . O O

The DT B-NP O
significant JJ I-NP O
relationship NN I-NP O
among IN B-PP O
genotype NN B-NP O
, , O O
biochemical JJ B-NP O
phenotype NN I-NP O
, , O O
and CC O O
cognitive JJ B-NP O
performance NN I-NP O
observed VBN B-VP O
in IN B-PP O
the DT B-NP O
present JJ I-NP O
study NN I-NP O
is VBZ B-VP O
of IN B-PP O
importance NN B-NP O
for IN B-PP O
the DT B-NP O
development NN I-NP O
of IN B-PP O
an DT B-NP O
optimal JJ I-NP O
strategy NN I-NP O
for IN B-PP O
future JJ B-NP O
treatment NN I-NP O
of IN B-PP O
females NNS B-NP O
with IN B-PP O
PKU NN B-NP B-Disease
who WP B-NP O
plan VBP B-VP O
pregnancy NN B-NP O
. . O O

. . O O

Spinal JJ B-NP B-Disease
xanthomatosis NN I-NP I-Disease
: : O O
a DT B-NP O
variant NN I-NP O
of IN B-PP O
cerebrotendinous JJ B-NP B-Disease
xanthomatosis NN I-NP I-Disease
. . O O

We PRP B-NP O
describe VBP B-VP O
seven CD B-NP O
Dutch JJ I-NP O
patients NNS I-NP O
from IN B-PP O
six CD B-NP O
families NNS I-NP O
with IN B-PP O
a DT B-NP O
slowly RB I-NP O
progressive JJ I-NP O
, , I-NP O
mainly RB I-NP O
spinal JJ I-NP B-Disease
cord NN I-NP I-Disease
syndrome NN I-NP I-Disease
that WDT B-NP O
remained VBD B-VP O
for IN B-PP O
many JJ B-NP O
years NNS I-NP O
the DT B-NP O
sole JJ I-NP O
expression NN I-NP O
of IN B-PP O
cerebrotendinous JJ B-NP B-Disease
xanthomatosis NN I-NP I-Disease
( ( O O
CTX NN B-NP B-Disease
) ) O O
. . O O

MRI NN B-NP O
demonstrated VBD B-VP O
white JJ B-NP B-Disease
matter NN I-NP I-Disease
abnormalities NNS I-NP I-Disease
in IN B-PP O
the DT B-NP O
lateral JJ I-NP O
and CC I-NP O
dorsal JJ I-NP O
columns NNS I-NP O
of IN B-PP O
the DT B-NP O
spinal JJ I-NP O
cord NN I-NP O
. . O O

Post AFX B-NP O
- HYPH I-NP O
mortem NN I-NP O
examination NN I-NP O
of IN B-PP O
one CD B-NP O
of IN B-PP O
the DT B-NP O
patients NNS I-NP O
showed VBD B-VP O
extensive JJ B-NP O
myelin NN I-NP O
loss NN I-NP O
in IN B-PP O
these DT B-NP O
columns NNS I-NP O
. . O O

An DT B-NP O
array NN I-NP O
of IN B-PP O
genotypes NNS B-NP O
was VBD B-VP O
found VBN I-VP O
in IN B-PP O
these DT B-NP O
patients NNS I-NP O
. . O O

We PRP B-NP O
conclude VBP B-VP O
that IN B-SBAR O
spinal JJ B-NP B-Disease
xanthomatosis NN I-NP I-Disease
is VBZ B-VP O
a DT B-NP O
clinical JJ I-NP O
and CC I-NP O
radiological JJ I-NP O
separate JJ I-NP O
entity NN I-NP O
of IN B-PP O
CTX NN B-NP B-Disease
that WDT B-NP O
should MD B-VP O
be VB I-VP O
included VBN I-VP O
in IN B-PP O
the DT B-NP O
differential JJ I-NP O
diagnosis NN I-NP O
of IN B-PP O
chronic JJ B-NP B-Disease
myelopathy NN I-NP I-Disease
. . O O

. . O O

A DT B-NP O
transgene NN I-NP O
insertion NN I-NP O
creating VBG B-VP O
a DT B-NP O
heritable JJ I-NP O
chromosome NN I-NP O
deletion NN I-NP O
mouse NN I-NP O
model NN I-NP O
of IN B-PP O
Prader NNP B-NP B-Disease
- HYPH I-NP I-Disease
Willi NNP I-NP I-Disease
and CC O I-Disease
angelman NN B-NP I-Disease
syndromes NNS I-NP I-Disease
. . O O

Prader NNP B-NP B-Disease
- HYPH I-NP I-Disease
Willi NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
PWS NN B-NP B-Disease
) ) O O
and CC O O
Angelman NN B-NP B-Disease
syndrome NN I-NP I-Disease
( ( O O
AS NN B-NP B-Disease
) ) O O
result VBP B-VP O
from IN B-PP O
the DT B-NP O
loss NN I-NP O
of IN B-PP O
function NN B-NP O
of IN B-PP O
imprinted JJ B-NP O
genes NNS I-NP O
in IN B-PP O
human JJ B-NP O
chromosome NN I-NP O
15q11 NN I-NP O
- HYPH B-NP O
q13 NN I-NP O
. . O O

The DT B-NP O
central JJ I-NP O
part NN I-NP O
of IN B-PP O
mouse NN B-NP O
chromosome NN I-NP O
7 CD I-NP O
is VBZ B-VP O
homologous JJ B-ADJP O
to TO B-PP O
human JJ B-NP O
15q11 CD I-NP O
- HYPH I-NP O
q13 NN I-NP O
, , O O
with IN B-PP O
conservation NN B-NP O
of IN B-PP O
both CC O O
gene NN B-NP O
order NN I-NP O
and CC O O
imprinted JJ B-NP O
features NNS I-NP O
. . O O

We PRP B-NP O
report VBP B-VP O
here RB B-ADVP O
the DT B-NP O
characterization NN I-NP O
of IN B-PP O
a DT B-NP O
transgene NN I-NP O
insertion NN I-NP O
( ( O O
Epstein NNP B-NP O
- HYPH B-NP O
Barr NNP I-NP O
virus NN I-NP O
Latent JJ I-NP O
Membrane NN I-NP O
Protein NN I-NP O
2A NN I-NP O
, , O O
LMP2A NN B-NP O
) ) O O
into IN B-PP O
mouse NN B-NP O
chromosome NN I-NP O
7C NN I-NP O
, , O O
which WDT B-NP O
has VBZ B-VP O
resulted VBN I-VP O
in IN B-PP O
mouse NN B-NP O
models NNS I-NP O
for IN B-PP O
PWS NN B-NP B-Disease
and CC I-NP O
AS NN I-NP B-Disease
dependent JJ B-ADJP O
on IN B-PP O
the DT B-NP O
sex NN I-NP O
of IN B-PP O
the DT B-NP O
transmitting JJ I-NP O
parent NN I-NP O
. . O O

Epigenotype NN B-NP O
( ( O O
allelic JJ B-NP O
expression NN B-NP O
and CC O O
DNA NN B-NP O
methylation NN I-NP O
) ) O O
and CC O O
fluorescence NN B-NP O
in FW B-NP O
situ FW I-NP O
hybridization NN I-NP O
analyses NNS I-NP O
indicate VBP B-VP O
that IN B-SBAR O
the DT B-NP O
transgene NN I-NP O
- HYPH B-NP O
induced VBN I-NP O
mutation NN I-NP O
has VBZ B-VP O
generated VBN I-VP O
a DT B-NP O
complete JJ I-NP O
deletion NN I-NP O
of IN B-PP O
the DT B-NP O
PWS NN I-NP B-Disease
/ SYM B-NP O
AS NN I-NP B-Disease
- HYPH B-NP O
homologous JJ I-NP O
region NN I-NP O
but CC O O
has VBZ B-VP O
not RB I-VP O
deleted VBN I-VP O
flanking NN B-NP O
loci NNS I-NP O
. . O O

Because IN B-SBAR O
the DT B-NP O
intact JJ I-NP O
chromosome NN I-NP O
7 CD I-NP O
, , O O
opposite IN B-PP O
the DT B-NP O
deleted VBN I-NP O
homolog NN I-NP O
, , O O
maintains VBZ B-VP O
the DT B-NP O
correct JJ I-NP O
imprint NN I-NP O
in IN B-PP O
somatic JJ B-NP O
cells NNS I-NP O
of IN B-PP O
PWS NN B-NP B-Disease
and CC O O
AS JJ B-NP B-Disease
mice NNS I-NP O
and CC O O
establishes VBZ B-VP O
the DT B-NP O
correct JJ I-NP O
imprint NN I-NP O
in IN B-PP O
male JJ B-NP O
and CC I-NP O
female JJ I-NP O
germ NN I-NP O
cells NNS I-NP O
of IN B-PP O
AS JJ B-NP B-Disease
mice NNS I-NP O
, , O O
homologous JJ B-NP O
association NN I-NP O
and CC O O
replication NN B-NP O
asynchrony NN I-NP O
are VBP B-VP O
not RB O O
part NN B-NP O
of IN B-PP O
the DT B-NP O
imprinting NN I-NP O
mechanism NN I-NP O
. . O O

This DT B-NP O
heritable JJ I-NP O
- HYPH I-NP O
deletion NN I-NP O
mouse NN I-NP O
model NN I-NP O
will MD B-VP O
be VB I-VP O
particularly RB B-ADJP O
useful JJ I-ADJP O
for IN B-PP O
the DT B-NP O
identification NN I-NP O
of IN B-PP O
the DT B-NP O
etiological JJ I-NP O
genes NNS I-NP O
and CC I-NP O
mechanisms NNS I-NP O
, , O O
phenotypic JJ B-NP O
basis NN I-NP O
, , O O
and CC O O
investigation NN B-NP O
of IN B-PP O
therapeutic JJ B-NP O
approaches NNS I-NP O
for IN B-PP O
PWS NN B-NP B-Disease
. . O O

. . O O

Linkage NN B-NP O
analysis NN I-NP O
of IN B-PP O
5 CD B-NP O
novel JJ I-NP O
van NNP I-NP B-Disease
der NNP I-NP I-Disease
Woude NNP I-NP I-Disease
syndrome NN I-NP I-Disease
kindreds NNS I-NP O
to TO B-PP O
1q32 CD B-NP O
- HYPH I-NP O
q41 NN I-NP O
markers NNS I-NP O
further RBR B-ADVP O
supports VBZ B-VP O
locus NN B-NP O
homogeneity NN I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
trait NN I-NP O
. . O O

van NNP B-NP B-Disease
der NNP I-NP I-Disease
Woude NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
vWS NN B-NP B-Disease
, , O O
MIM NN B-NP O
119300 CD I-NP O
) ) O O
is VBZ B-VP O
a DT B-NP O
rare JJ I-NP O
autosomal JJ I-NP B-Disease
dominant JJ I-NP I-Disease
clefting NN I-NP I-Disease
condition NN I-NP I-Disease
with IN B-PP O
cardinal JJ B-NP O
features NNS I-NP O
of IN B-PP O
mucous JJ B-NP B-Disease
cysts NNS I-NP I-Disease
( ( O O
lower JJR B-NP B-Disease
- HYPH I-NP I-Disease
lip NN I-NP I-Disease
pits NNS I-NP I-Disease
) ) O O
and CC O O
clefts NNS B-NP B-Disease
to TO B-PP I-Disease
the DT B-NP I-Disease
lip NN I-NP I-Disease
and CC O I-Disease
/ SYM B-NP I-Disease
or CC O I-Disease
palate NN B-NP I-Disease
. . O O

The DT B-NP O
vWS NN I-NP B-Disease
gene NN I-NP O
has VBZ B-VP O
been VBN I-VP O
assigned VBN I-VP O
to TO B-PP O
a DT B-NP O
locus NN I-NP O
in IN B-PP O
1q32 CD B-NP O
- HYPH I-NP O
q41 NN I-NP O
by IN B-PP O
linkage NN B-NP O
analysis NN I-NP O
and CC O O
physical JJ B-NP O
mapping NN I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
investigated VBN I-VP O
5 CD B-NP O
novel JJ I-NP O
vWS NN I-NP B-Disease
families NNS I-NP O
through IN B-PP O
probands NNS B-NP O
attended VBD B-VP O
for IN B-PP O
cleft NN B-NP B-Disease
lip NN I-NP I-Disease
and CC O I-Disease
/ SYM B-NP I-Disease
or CC O I-Disease
palate VB B-VP I-Disease
repair NN B-NP O
at IN B-PP O
the DT B-NP O
Department NNP I-NP O
of IN B-PP O
Maxillofacial NNP B-NP O
Surgery NNP I-NP O
of IN B-PP O
Hopital NNP B-NP O
Trousseau NNP I-NP O
, , O O
Paris NNP B-NP O
, , O O
in IN B-SBAR O
order NN O O
to TO B-VP O
tentatively RB I-VP O
refine VB I-VP O
the DT B-NP O
genetic JJ I-NP O
map NN I-NP O
of IN B-PP O
the DT B-NP O
vWS NN I-NP B-Disease
region NN I-NP O
in IN B-PP O
1q32 CD B-NP O
- HYPH I-NP O
q41 NN I-NP O
and CC O O
possibly RB B-VP O
identify VB I-VP O
unlinked JJ B-NP O
pedigrees NNS I-NP O
. . O O

Linkage NN B-NP O
analysis NN I-NP O
was VBD B-VP O
carried VBN I-VP O
out RB B-ADVP O
to TO B-PP O
6 CD B-NP O
microsatellite NN I-NP O
markers NNS I-NP O
( ( O O
D1S249 NN B-NP O
, , O O
D1S425 NN B-NP O
, , O O
D1S491 NN B-NP O
, , O O
D1S205 NN B-NP O
, , O O
D1S414 NN B-NP O
, , O O
D1S425 NN B-NP O
) ) O O
, , O O
yielding VBG B-VP O
a DT B-NP O
maximum NN I-NP O
cumulative JJ I-NP O
LOD NN I-NP O
score NN I-NP O
of IN B-PP O
Z NN B-NP O
= SYM B-VP O
3 CD B-NP O
. . O O

27 CD B-NP O
at IN B-PP O
theta NN B-NP O
= SYM B-VP O
0 CD B-NP O
. . O O

00 CD B-NP O
for IN B-PP O
D1S245 NN B-NP O
. . O O

The DT B-NP O
innermost JJ I-NP O
four CD I-NP O
markers NNS I-NP O
were VBD B-VP O
found VBN I-VP O
to TO I-VP O
be VB I-VP O
tightly RB I-VP O
linked VBN I-VP O
to TO B-PP O
one CD B-NP O
another DT I-NP O
, , O O
with IN B-PP O
no DT B-NP O
evidence NN I-NP O
for IN B-PP O
recombination NN B-NP O
. . O O

Our PRP$ B-NP O
results NNS I-NP O
support VBP B-VP O
linkage NN B-NP O
of IN B-PP O
vWS NN B-NP B-Disease
within IN B-PP O
a DT B-NP O
region NN I-NP O
of IN B-PP O
tightly RB B-NP O
linked VBN I-NP O
markers NNS I-NP O
and CC O O
do VBP B-VP O
not RB I-VP O
favour VB I-VP O
locus NN B-NP O
heterogeneity NN I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
trait NN I-NP O
. . O O

Null JJ B-NP O
mutation NN I-NP O
of IN B-PP O
the DT B-NP O
murine JJ I-NP O
ATP7B NN I-NP O
( ( O O
Wilson NN B-NP B-Disease
disease NN I-NP I-Disease
) ) O O
gene NN B-NP O
results VBZ B-VP O
in IN B-PP O
intracellular JJ B-NP B-Disease
copper NN I-NP I-Disease
accumulation NN I-NP I-Disease
and CC O O
late JJ B-NP B-Disease
- HYPH I-NP I-Disease
onset NN I-NP I-Disease
hepatic JJ I-NP I-Disease
nodular JJ I-NP I-Disease
transformation NN I-NP I-Disease
. . O O

The DT B-NP O
Atp7b NN I-NP O
protein NN I-NP O
is VBZ B-VP O
a DT B-NP O
copper NN I-NP O
- HYPH O O
transporting VBG B-VP O
ATPase NN B-NP O
expressed VBN B-VP O
predominantly RB B-ADVP O
in IN B-PP O
the DT B-NP O
liver NN I-NP O
and CC B-PP O
to TO B-PP O
a DT B-NP O
lesser JJR I-NP O
extent NN I-NP O
in IN B-PP O
most JJS B-NP O
other JJ I-NP O
tissues NNS I-NP O
. . O O

Mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
ATP7B NN I-NP O
gene NN I-NP O
lead VBP B-VP O
to TO B-PP O
Wilson NNP B-NP B-Disease
disease NN I-NP I-Disease
, , O O
a DT B-NP O
copper NN I-NP B-Disease
toxicity NN I-NP I-Disease
disorder NN I-NP I-Disease
characterized VBN B-VP O
by IN B-PP O
dramatic JJ B-NP O
build VB I-NP O
- HYPH B-VP O
up RP B-PRT O
of IN B-PP O
intracellular JJ B-NP O
hepatic JJ I-NP O
copper NN I-NP O
with IN B-PP O
subsequent JJ B-NP O
hepatic JJ I-NP B-Disease
and CC I-NP I-Disease
neuro AFX I-NP I-Disease
- HYPH I-NP I-Disease
logical JJ I-NP I-Disease
abnormalities NNS I-NP I-Disease
. . O O

Using VBG B-VP O
homologous JJ B-NP O
recombination NN I-NP O
to TO B-VP O
disrupt VB I-VP O
the DT B-NP O
normal JJ I-NP O
translation NN I-NP O
of IN B-PP O
ATP7B NN B-NP O
, , O O
we PRP B-NP O
have VBP B-VP O
generated VBN I-VP O
a DT B-NP O
strain NN I-NP O
of IN B-PP O
mice NNS B-NP O
that WDT B-NP O
are VBP B-VP O
homozygous JJ B-NP O
mutants NNS I-NP O
( ( O O
) ) O O
for IN B-PP O
the DT B-NP O
Wilson NNP I-NP B-Disease
disease NN I-NP I-Disease
gene NN I-NP O
. . O O

The DT B-NP O
ATP7B NN I-NP O
mice NNS I-NP O
display VBP B-VP O
a DT B-NP O
gradual JJ I-NP O
accumulation NN I-NP O
of IN B-PP O
hepatic JJ B-NP O
copper NN I-NP O
that WDT B-NP O
increases VBZ B-VP O
to TO B-PP O
a DT B-NP O
level NN I-NP O
60 CD I-NP O
- HYPH O O
fold RB B-ADJP O
greater JJR I-ADJP O
than IN B-PP O
normal JJ B-ADJP O
by IN B-PP O
5 CD B-NP O
months NNS I-NP O
of IN B-PP O
age NN B-NP O
. . O O

An DT B-NP O
increase NN I-NP O
in IN B-PP O
copper NN B-NP O
concentration NN I-NP O
was VBD B-VP O
also RB I-VP O
observed VBN I-VP O
in IN B-PP O
the DT B-NP O
kidney NN I-NP O
, , O O
brain NN B-NP O
, , O O
placenta NN B-NP O
and CC O O
lactating VBG B-VP O
mammary JJ B-NP O
glands NNS I-NP O
of IN B-PP O
homo AFX B-NP O
- HYPH I-NP O
zygous JJ I-NP O
mutants NNS I-NP O
, , O O
although IN B-SBAR O
milk NN B-NP O
from IN B-PP O
the DT B-NP O
mutant JJ I-NP O
glands NNS I-NP O
was VBD B-VP O
copper NN B-NP B-Disease
deficient JJ B-ADJP I-Disease
. . O O

Morphological JJ B-NP B-Disease
abnormalities NNS I-NP I-Disease
resembling VBG B-VP O
cirrhosis NN B-NP B-Disease
developed VBN B-VP O
in IN B-PP O
the DT B-NP O
majority NN I-NP O
of IN B-PP O
the DT B-NP O
livers NNS I-NP O
from IN B-PP O
homozygous JJ B-NP O
mutants NNS I-NP O
older JJR B-NP O
than IN I-NP O
7 CD I-NP O
months NNS I-NP O
of IN B-PP O
age NN B-NP O
. . O O

Progeny NN B-NP O
of IN B-PP O
the DT B-NP O
homozygous JJ I-NP O
mutant JJ I-NP O
females NNS I-NP O
demonstrated VBD B-VP O
neurological JJ B-NP B-Disease
abnormalities NNS I-NP I-Disease
and CC O O
growth NN B-NP B-Disease
retardation NN I-NP I-Disease
characteristic JJ B-ADJP O
of IN B-PP O
copper NN B-NP B-Disease
deficiency NN I-NP I-Disease
. . O O

Copper NN B-NP O
concentration NN I-NP O
in IN B-PP O
the DT B-NP O
livers NNS I-NP O
of IN B-PP O
the DT B-NP O
newborn JJ I-NP O
homozygous JJ I-NP O
mutants NNS I-NP O
was VBD B-VP O
decreased VBN I-VP O
dramatically RB B-ADVP O
. . O O

In IN B-PP O
summary NN B-NP O
, , O O
inactivation NN B-NP O
of IN B-PP O
the DT B-NP O
murine JJ I-NP O
ATP7B NN I-NP O
gene NN I-NP O
produces VBZ B-VP O
a DT B-NP O
form NN I-NP O
of IN B-PP O
cirrhotic JJ B-NP B-Disease
liver NN I-NP I-Disease
disease NN I-NP I-Disease
that WDT B-NP O
resembles VBZ B-VP O
Wilson NNP B-NP B-Disease
disease NN I-NP I-Disease
in IN B-PP O
humans NNS B-NP O
and CC O O
the DT B-NP O
toxic JJ I-NP O
milk NN I-NP O
phenotype NN I-NP O
in IN B-PP O
the DT B-NP O
mouse NN I-NP O
. . O O

. . O O

French JJ B-NP O
Machado NNP I-NP B-Disease
- HYPH I-NP I-Disease
Joseph NNP I-NP I-Disease
disease NN I-NP I-Disease
patients NNS I-NP O
do VBP B-VP O
not RB I-VP O
exhibit VB I-VP O
gametic JJ B-NP O
segregation NN I-NP O
distortion NN I-NP O
: : O O
a DT B-NP O
sperm NN I-NP O
typing NN I-NP O
analysis NN I-NP O
. . O O

Segregation NN B-NP O
distortion NN I-NP O
has VBZ B-VP O
been VBN I-VP O
reported VBN I-VP O
to TO I-VP O
occur VB I-VP O
in IN B-PP O
a DT B-NP O
number NN I-NP O
of IN B-PP O
the DT B-NP O
trinucleotide NN I-NP B-Disease
repeat NN I-NP I-Disease
disorders NNS I-NP I-Disease
. . O O

On IN B-PP O
the DT B-NP O
basis NN I-NP O
of IN B-PP O
a DT B-NP O
sperm NN I-NP O
typing NN I-NP O
study NN I-NP O
performed VBN B-VP O
in IN B-PP O
patients NNS B-NP O
of IN B-PP O
Japanese JJ B-NP O
descent NN I-NP O
with IN B-PP O
Machado NNP B-NP B-Disease
- HYPH I-NP I-Disease
Joseph NNP I-NP I-Disease
disease NN I-NP I-Disease
( ( O O
MJD NN B-NP B-Disease
) ) O O
, , O O
it PRP B-NP O
was VBD B-VP O
reported VBN I-VP O
that IN B-SBAR O
disease NN B-NP O
alleles NNS I-NP O
are VBP B-VP O
preferentially RB I-VP O
transmitted VBN I-VP O
during IN B-PP O
meiosis NN B-NP O
. . O O

We PRP B-NP O
performed VBD B-VP O
a DT B-NP O
sperm NN I-NP O
typing NN I-NP O
study NN I-NP O
of IN B-PP O
five CD B-NP O
MJD NN I-NP B-Disease
patients NNS I-NP O
of IN B-PP O
French JJ B-NP O
descent NN I-NP O
and CC I-NP O
analysis NN I-NP O
of IN B-PP O
the DT B-NP O
pooled VBN I-NP O
data NN I-NP O
shows VBZ B-VP O
a DT B-NP O
ratio NN I-NP O
of IN B-PP O
mutant NN B-NP O
to TO B-PP O
normal JJ B-NP O
alleles NNS I-NP O
of IN B-PP O
379 CD B-NP O
436 CD I-NP O
( ( O O
46 CD B-NP O
. . O O

5 CD B-NP O
53 CD I-NP O
. . O O

5 CD B-NP O
% NN I-NP O
) ) O O
, , O O
which WDT B-NP O
does VBZ B-VP O
not RB I-VP O
support VB I-VP O
meiotic JJ B-NP O
segregation NN I-NP O
distortion NN I-NP O
. . O O

To TO B-VP O
confirm VB I-VP O
these DT B-NP O
results NNS I-NP O
, , O O
sperm NN B-NP O
typing NN I-NP O
analysis NN I-NP O
was VBD B-VP O
also RB I-VP O
performed VBN I-VP O
using VBG B-VP O
a DT B-NP O
polymorphic JJ I-NP O
marker NN I-NP O
, , O O
D14S1050 NN B-NP O
, , O O
closely RB B-VP O
linked VBN I-VP O
to TO B-PP O
the DT B-NP O
MJD1 NN I-NP O
gene NN I-NP O
. . O O

Among IN B-PP O
910 CD B-NP O
sperm NN I-NP O
analyzed VBN B-VP O
, , O O
the DT B-NP O
allele NN I-NP O
linked VBN B-VP O
to TO B-PP O
the DT B-NP O
disease NN I-NP O
chromosome NN I-NP O
was VBD B-VP O
detected VBN I-VP O
in IN B-PP O
50 CD B-NP O
. . O O

3 CD B-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
samples NNS I-NP O
and CC O O
the DT B-NP O
allele NN I-NP O
linked VBN B-VP O
to TO B-PP O
the DT B-NP O
normal JJ I-NP O
chromosome NN I-NP O
was VBD B-VP O
found VBN I-VP O
in IN B-PP O
49 CD B-NP O
. . O O

6 CD B-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
sperm NN I-NP O
. . O O

The DT B-NP O
difference NN I-NP O
in IN B-PP O
frequency NN B-NP O
of IN B-PP O
these DT B-NP O
two CD I-NP O
alleles NNS I-NP O
is VBZ B-VP O
not RB O O
significant JJ B-ADJP O
( ( O O
P NN B-NP O
= SYM B-VP O
0 CD B-NP O
. . O O

8423 CD B-NP O
) ) O O
. . O O

Likelihood NN B-NP O
- HYPH O O
based VBN B-VP O
analysis NN B-NP O
of IN B-PP O
segregation NN B-NP O
distortion NN I-NP O
in IN B-PP O
the DT B-NP O
single JJ I-NP O
sperm NN I-NP O
data NNS I-NP O
using VBG B-VP O
the DT B-NP O
SPERMSEG NN I-NP O
program NN I-NP O
also RB B-ADVP O
showed VBD B-VP O
no DT B-NP O
support NN I-NP O
for IN B-PP O
segregation NN B-NP O
distortion NN I-NP O
at IN B-PP O
the DT B-NP O
gamete NN I-NP O
level NN I-NP O
in IN B-PP O
this DT B-NP O
patient NN I-NP O
population NN I-NP O
. . O O

The DT B-NP O
previous JJ I-NP O
report NN I-NP O
on IN B-PP O
the DT B-NP O
Japanese JJ I-NP O
patients NNS I-NP O
also RB B-ADVP O
suggested VBD B-VP O
that IN B-SBAR O
disease NN B-NP O
allele NN I-NP O
stability NN I-NP O
may MD B-VP O
be VB I-VP O
influenced VBN I-VP O
by IN B-PP O
a DT B-NP O
trans JJ I-NP O
effect NN I-NP O
of IN B-PP O
an DT B-NP O
intragenic JJ I-NP O
polymorphism NN I-NP O
( ( O O
987 CD B-NP O
G NN I-NP O
/ SYM B-NP O
C NN I-NP O
) ) O O
in IN B-PP O
the DT B-NP O
wild JJ I-NP O
- HYPH I-NP O
type NN I-NP O
allele NN I-NP O
. . O O

All DT B-NP O
of IN B-PP O
the DT B-NP O
French JJ I-NP O
patients NNS I-NP O
were VBD B-VP O
heterozygous JJ B-ADJP O
for IN B-PP O
this DT B-NP O
polymorphism NN I-NP O
. . O O

However RB B-ADVP O
, , O O
analysis NN B-NP O
of IN B-PP O
the DT B-NP O
variance NN I-NP O
in IN B-PP O
repeat NN B-NP O
number NN I-NP O
in IN B-PP O
sperm NN B-NP O
from IN B-PP O
the DT B-NP O
French JJ I-NP O
MJD NN I-NP B-Disease
patients NNS I-NP O
overlapped VBD B-VP O
significantly RB B-ADVP O
with IN B-PP O
the DT B-NP O
variance NN I-NP O
in IN B-PP O
repeat NN B-NP O
number NN I-NP O
observed VBN B-VP O
in IN B-PP O
the DT B-NP O
C NN I-NP O
/ SYM B-NP O
C NN I-NP O
homozygous JJ I-NP O
Japanese JJ I-NP O
patients NNS I-NP O
. . O O

Missense JJ B-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
alternative JJ I-NP O
splice NN I-NP O
region NN I-NP O
of IN B-PP O
the DT B-NP O
PAX6 NN I-NP O
gene NN I-NP O
in IN B-PP O
eye NN B-NP B-Disease
anomalies NNS I-NP I-Disease
. . O O

The DT B-NP O
PAX6 NN I-NP O
gene NN I-NP O
is VBZ B-VP O
involved VBN I-VP O
in IN B-PP O
ocular JJ B-NP O
morphogenesis NN I-NP O
, , O O
and CC O O
PAX6 NN B-NP O
mutations NNS I-NP O
have VBP B-VP O
been VBN I-VP O
detected VBN I-VP O
in IN B-PP O
various JJ B-NP O
types NNS I-NP O
of IN B-PP O
ocular JJ B-NP B-Disease
anomalies NNS I-NP I-Disease
, , O O
including VBG B-PP O
aniridia NN B-NP B-Disease
, , O O
Peters NNP B-NP B-Disease
anomaly RB B-ADVP I-Disease
, , O O
corneal JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
, , O O
congenital JJ B-NP B-Disease
cataract NN I-NP I-Disease
, , O O
and CC O O
foveal JJ B-NP B-Disease
hypoplasia NN I-NP I-Disease
. . O O

The DT B-NP O
gene NN I-NP O
encodes VBZ B-VP O
a DT B-NP O
transcriptional JJ I-NP O
regulator NN I-NP O
that WDT B-NP O
recognizes VBZ B-VP O
target NN B-NP O
genes NNS I-NP O
through IN B-PP O
its PRP$ B-NP O
paired JJ I-NP O
- HYPH I-NP O
type NN I-NP O
DNA NN I-NP O
- HYPH O O
binding VBG B-NP O
domain NN I-NP O
. . O O

The DT B-NP O
paired JJ I-NP O
domain NN I-NP O
is VBZ B-VP O
composed VBN I-VP O
of IN B-PP O
two CD B-NP O
distinct JJ I-NP O
DNA NN I-NP O
- HYPH B-VP O
binding VBG B-NP O
subdomains NNS I-NP O
, , O O
the DT B-NP O
N NN I-NP O
- HYPH B-NP O
terminal JJ I-NP O
subdomain NN I-NP O
( ( O O
NTS NNS B-NP O
) ) O O
and CC O O
the DT B-NP O
C NN I-NP O
- HYPH B-NP O
terminal JJ I-NP O
subdomain NN I-NP O
( ( O O
CTS NN B-NP O
) ) O O
, , O O
which WDT B-NP O
bind VBP B-VP O
respective JJ B-NP O
consensus NN I-NP O
DNA NN I-NP O
sequences NNS I-NP O
. . O O

The DT B-NP O
human JJ I-NP O
PAX6 NN I-NP O
gene NN I-NP O
produces VBZ B-VP O
two CD B-NP O
alternative JJ I-NP O
splice NN I-NP O
isoforms NNS I-NP O
that WDT B-NP O
have VBP B-VP O
the DT B-NP O
distinct JJ I-NP O
structure NN I-NP O
of IN B-PP O
the DT B-NP O
paired JJ I-NP O
domain NN I-NP O
. . O O

The DT B-NP O
insertion NN I-NP O
, , O O
into IN B-PP O
the DT B-NP O
NTS NNS I-NP O
, , O O
of IN B-PP O
14 CD B-NP O
additional JJ I-NP O
amino JJ I-NP O
acids NNS I-NP O
encoded VBN B-VP O
by IN B-PP O
exon NN B-NP O
5a CD I-NP O
abolishes VBZ B-VP O
the DT B-NP O
DNA NN I-NP O
- HYPH B-NP O
binding NN I-NP O
activity NN I-NP O
of IN B-PP O
the DT B-NP O
NTS NNS I-NP O
and CC O O
unmasks VBZ B-VP O
the DT B-NP O
DNA NN I-NP O
- HYPH B-PP O
binding VBG B-NP O
ability NN I-NP O
of IN B-PP O
the DT B-NP O
CTS NN I-NP O
. . O O

Thus RB B-ADVP O
, , O O
exon NN B-NP O
5a NN I-NP O
appears VBZ B-VP O
to TO I-VP O
function VB I-VP O
as IN B-PP O
a DT B-NP O
molecular JJ I-NP O
switch NN I-NP O
that WDT B-NP O
specifies VBZ B-VP O
target NN B-NP O
genes NNS I-NP O
. . O O

We PRP B-NP O
ascertained VBD B-VP O
a DT B-NP O
novel JJ I-NP O
missense JJ I-NP O
mutation NN I-NP O
in IN B-PP O
four CD B-NP O
pedigrees NNS I-NP O
with IN B-PP O
Peters NNP B-NP B-Disease
anomaly RB B-ADVP I-Disease
, , O O
congenital JJ B-NP B-Disease
cataract NN I-NP I-Disease
, , O O
Axenfeldt NNP B-NP B-Disease
anomaly RB B-ADVP I-Disease
, , O O
and CC O O
/ SYM B-NP O
or CC O O
foveal JJ B-NP B-Disease
hypoplasia NN I-NP I-Disease
, , O O
which WDT B-NP O
, , O O
to TO B-PP O
our PRP$ B-NP O
knowledge NN I-NP O
, , O O
is VBZ B-VP O
the DT B-NP O
first JJ I-NP O
mutation NN I-NP O
identified VBN B-VP O
in IN B-PP O
the DT B-NP O
splice NN I-NP O
- HYPH B-NP O
variant JJ I-NP O
region NN I-NP O
. . O O

A DT B-NP O
T NN I-NP O
- SYM O O
- HYPH O O
> SYM B-NP O
A DT B-NP O
transition NN I-NP O
at IN B-PP O
the DT B-NP O
20th JJ I-NP O
nucleotide NN I-NP O
position NN I-NP O
of IN B-PP O
exon NN B-NP O
5a CD I-NP O
results VBZ B-VP O
in IN B-PP O
a DT B-NP O
Val NN I-NP O
- SYM O O
- SYM O O
> SYM O O
Asp NN B-NP O
( ( O O
GTC NN B-NP O
- SYM O O
- HYPH B-NP O
> SYM I-NP O
GAC NN I-NP O
) ) O O
substitution NN B-NP O
at IN B-PP O
the DT B-NP O
7th JJ I-NP O
codon NN I-NP O
of IN B-PP O
the DT B-NP O
alternative JJ I-NP O
splice NN I-NP O
region NN I-NP O
. . O O

Functional JJ B-NP O
analyses NNS I-NP O
demonstrated VBD B-VP O
that IN B-SBAR O
the DT B-NP O
V54D NN I-NP O
mutation NN I-NP O
slightly RB B-ADVP O
increased VBD B-VP O
NTS NN B-NP O
binding NN I-NP O
and CC O O
decreased VBD B-VP O
CTS NN B-NP O
transactivation NN I-NP O
activity NN I-NP O
to TO B-PP O
almost RB B-NP O
half NN I-NP O
. . O O

. . O O

Penetrances NNS B-NP O
of IN B-PP O
BRCA1 NN B-NP O
1675delA NN I-NP O
and CC O O
1135insA NN B-NP O
with IN B-PP O
respect NN B-NP O
to TO B-PP O
breast NN B-NP B-Disease
cancer NN I-NP I-Disease
and CC O O
ovarian JJ B-NP B-Disease
cancer NN I-NP I-Disease
. . O O

For IN B-PP O
genetic JJ B-NP O
counseling NN I-NP O
and CC O O
predictive JJ B-NP O
testing NN I-NP O
in IN B-PP O
families NNS B-NP O
with IN B-PP O
inherited VBN B-NP B-Disease
breast NN I-NP I-Disease
- HYPH B-NP I-Disease
ovarian JJ I-NP I-Disease
cancer NN I-NP I-Disease
, , O O
penetrances NNS B-NP O
and CC I-NP O
expressions NNS I-NP O
of IN B-PP O
the DT B-NP O
underlying VBG I-NP O
mutations NNS I-NP O
should MD B-VP O
be VB I-VP O
known VBN I-VP O
. . O O

We PRP B-NP O
have VBP B-VP O
previously RB I-VP O
reported VBN I-VP O
two CD B-NP O
BRCA1 NN I-NP O
founder NN I-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
Norwegian JJ I-NP O
population NN I-NP O
. . O O

Index NN B-NP O
cases NNS I-NP O
for IN B-PP O
the DT B-NP O
present JJ I-NP O
study NN I-NP O
were VBD B-VP O
found VBN I-VP O
two CD B-NP O
different JJ I-NP O
ways NNS I-NP O
through IN B-PP O
a DT B-NP O
series NN I-NP O
of IN B-PP O
consecutive JJ B-NP O
ovarian JJ I-NP B-Disease
cancers NNS I-NP I-Disease
( ( O O
n NN B-NP O
= SYM B-VP O
16 CD B-NP O
) ) O O
and CC O O
through IN B-PP O
our PRP$ B-NP O
family NN I-NP O
cancer NN I-NP B-Disease
clinic NN I-NP O
( ( O O
n NN B-NP O
= SYM B-VP O
14 CD B-NP O
) ) O O
. . O O

Altogether RB B-ADVP O
, , O O
20 CD B-NP O
of IN B-PP O
the DT B-NP O
patients NNS I-NP O
had VBD B-VP O
BRCA1 NN B-NP O
1675delA NN I-NP O
, , O O
and CC O O
10 CD B-NP O
had VBD B-VP O
1135insA NN B-NP O
. . O O

Their PRP$ B-NP O
relatives NNS I-NP O
were VBD B-VP O
described VBN I-VP O
with IN B-PP O
respect NN B-NP O
to TO B-PP O
absence NN B-NP O
/ SYM I-NP O
presence NN I-NP O
of IN B-PP O
breast NN B-NP B-Disease
and CC O I-Disease
/ SYM B-NP I-Disease
or CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
. . O O

Of IN B-PP O
133 CD B-NP O
living VBG B-VP O
female JJ B-NP O
relatives NNS I-NP O
, , O O
83 CD B-NP O
( ( O O
62 CD B-NP O
% NN I-NP O
) ) O O
were VBD B-VP O
tested VBN I-VP O
for IN B-PP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
a DT B-NP O
mutation NN I-NP O
. . O O

No DT B-NP O
difference NN I-NP O
, , O O
in IN B-PP O
penetrance NN B-NP O
and CC I-NP O
expression NN I-NP O
, , O O
between IN B-PP O
the DT B-NP O
two CD I-NP O
mutations NNS I-NP O
were VBD B-VP O
found VBN I-VP O
, , O O
whereas IN O O
differences NNS B-NP O
according VBG B-PP O
to TO B-PP O
method NN B-NP O
of IN B-PP O
ascertainment NN B-NP O
were VBD B-VP O
seen VBN I-VP O
. . O O

The DT B-NP O
overall JJ I-NP O
findings NNS I-NP O
were VBD B-VP O
that IN B-SBAR O
disease NN B-NP O
started VBD B-VP O
to TO I-VP O
occur VB I-VP O
at IN B-PP O
age NN B-NP O
30 CD B-NP O
years NNS I-NP O
and CC O O
that DT B-NP O
by IN B-PP O
age NN B-NP O
50 CD B-NP O
years NNS I-NP O
48 CD B-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
mutation NN I-NP O
- HYPH B-VP O
carrying VBG B-NP O
women NNS I-NP O
had VBD B-VP O
experienced VBN I-VP O
breast NN B-NP B-Disease
and CC O I-Disease
/ SYM B-NP I-Disease
or CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
. . O O

More RBR B-NP O
ovarian JJ I-NP B-Disease
cancers NNS I-NP I-Disease
than IN B-PP O
breast NN B-NP B-Disease
cancers NNS I-NP I-Disease
were VBD B-VP O
recorded VBN I-VP O
. . O O

Both CC O O
penetrance NN B-NP O
and CC O O
expression NN B-NP O
( ( O O
breast NN B-NP B-Disease
cancer NN I-NP I-Disease
vs NNS I-NP O
. . O O

ovarian JJ B-NP B-Disease
cancer NN I-NP I-Disease
) ) O O
were VBD B-VP O
different JJ B-ADJP O
from IN B-PP O
those DT B-NP O
in IN B-PP O
reports NNS B-NP O
of IN B-PP O
the DT B-NP O
Ashkenazi NNP I-NP O
founder NN I-NP O
mutations NNS I-NP O
. . O O

Whether IN B-SBAR O
the DT B-NP O
reported VBN I-NP O
differences NNS I-NP O
reflect VBP B-VP O
true JJ B-NP O
differences NNS I-NP O
and CC O O
/ SYM B-NP O
or CC O O
methodological JJ B-NP O
problems NNS I-NP O
is VBZ B-VP O
discussed VBN I-VP O
. . O O

An DT B-NP O
observed VBN I-NP O
excess NN I-NP O
of IN B-PP O
mutation NN B-NP O
carriers NNS I-NP O
could MD B-VP O
not RB I-VP O
be VB I-VP O
accounted VBN I-VP O
for IN B-PP O
by IN B-PP O
methodological JJ B-NP O
problems NNS I-NP O
; : O O
possible JJ B-NP O
explanations NNS I-NP O
were VBD B-VP O
a DT B-NP O
true JJ I-NP O
low JJ I-NP O
penetrance NN I-NP O
or CC O O
preferential JJ B-NP O
segregation NN I-NP O
. . O O

. . O O

The DT B-NP O
dermatofibrosarcoma NN I-NP B-Disease
protuberans AFX O I-Disease
- HYPH O O
associated VBN B-NP O
collagen NN I-NP O
type NN I-NP O
Ialpha1 NN I-NP O
/ SYM B-NP O
platelet NN I-NP O
- HYPH O O
derived VBN B-NP O
growth NN I-NP O
factor NN I-NP O
( ( O O
PDGF NN B-NP O
) ) O O
B NN B-NP O
- HYPH B-NP O
chain NN I-NP O
fusion NN I-NP O
gene NN I-NP O
generates VBZ B-VP O
a DT B-NP O
transforming VBG I-NP O
protein NN I-NP O
that WDT B-NP O
is VBZ B-VP O
processed VBN I-VP O
to TO B-PP O
functional JJ B-NP O
PDGF NN I-NP O
- HYPH B-NP O
BB NN I-NP O
. . O O

Dermatofibrosarcoma NN B-NP B-Disease
protuberans NNS I-NP I-Disease
( ( O O
DFSP NN B-NP B-Disease
) ) O O
displays VBZ B-VP O
chromosomal JJ B-NP O
rearrangements NNS I-NP O
involving VBG B-VP O
chromosome NN B-NP O
17 CD I-NP O
and CC I-NP O
22 CD I-NP O
, , O O
which WDT B-NP O
fuse VBP B-VP O
the DT B-NP O
collagen NN I-NP O
type NN I-NP O
Ialpha1 NN I-NP O
( ( O O
COLIA1 NN B-NP O
) ) O O
gene NN B-NP O
to TO B-PP O
the DT B-NP O
platelet NN I-NP O
- HYPH B-VP O
derived VBN B-NP O
growth NN I-NP O
factor NN I-NP O
( ( O O
PDGF NN B-NP O
) ) O O
B NN B-NP O
- HYPH O O
chain NN B-NP O
( ( O O
PDGFB NN B-NP O
) ) O O
gene NN B-NP O
. . O O

To TO B-VP O
characterize VB I-VP O
the DT B-NP O
functional JJ I-NP O
and CC I-NP O
structural JJ I-NP O
properties NNS I-NP O
of IN B-PP O
the DT B-NP O
COLIA1 NN I-NP O
/ SYM B-NP O
PDGFB NN I-NP O
fusion NN I-NP O
protein NN I-NP O
, , O O
we PRP B-NP O
generated VBD B-VP O
a DT B-NP O
stable JJ I-NP O
NIH3T3 NN I-NP O
cell NN I-NP O
line NN I-NP O
that WDT B-NP O
contained VBD B-VP O
a DT B-NP O
tumor NN I-NP O
- HYPH B-VP O
derived VBN B-NP O
chimeric JJ I-NP O
gene NN I-NP O
resulting VBG B-VP O
from IN B-PP O
a DT B-NP O
COIA1 NN I-NP O
intron NN I-NP O
7 CD I-NP O
- HYPH I-NP O
PDGFB NN I-NP O
intron NN I-NP O
1 CD I-NP O
fusion NN I-NP O
. . O O

Expression NN B-NP O
of IN B-PP O
the DT B-NP O
fusion NN I-NP O
protein NN I-NP O
led VBD B-VP O
to TO B-PP O
morphological JJ B-NP O
transformation NN I-NP O
and CC O O
increased VBN B-NP O
growth NN I-NP O
rate NN I-NP O
of IN B-PP O
these DT B-NP O
cells NNS I-NP O
. . O O

The DT B-NP O
PDGF NN I-NP O
receptor NN I-NP O
kinase NN I-NP O
inhibitor NN I-NP O
CGP57148B NN I-NP O
reversed VBD B-VP O
the DT B-NP O
transformed VBN I-NP O
phenotype NN I-NP O
and CC O O
reduced VBD B-VP O
the DT B-NP O
growth NN I-NP O
rate NN I-NP O
of IN B-PP O
COLIA1 NN B-NP O
/ SYM B-NP O
PDGFB NN I-NP O
- HYPH O O
expressing VBG B-VP O
cells NNS B-NP O
but CC O O
had VBD B-VP O
no DT B-NP O
effects NNS I-NP O
on IN B-PP O
control NN B-NP O
cells NNS I-NP O
. . O O

The DT B-NP O
presence NN I-NP O
of IN B-PP O
dimeric JJ B-NP O
COLIA1 NN I-NP O
/ SYM B-VP O
PDGFB NN B-NP O
precursors NNS I-NP O
was VBD B-VP O
demonstrated VBN I-VP O
through IN B-PP O
PDGFB NN B-NP O
immunoprecipitations NNS I-NP O
of IN B-PP O
metabolically RB B-NP O
labeled VBN I-NP O
cells NNS I-NP O
and CC O O
also RB B-ADVP O
by IN B-PP O
PDGFB NN B-NP O
immunoprecipitations NNS I-NP O
followed VBN B-VP O
by IN B-PP O
immunoblotting VBG B-VP O
with IN B-PP O
COLIA1 NN B-NP O
antibodies NNS I-NP O
. . O O

Pulse NN B-NP O
- HYPH I-NP O
chase NN I-NP O
studies NNS I-NP O
demonstrated VBD B-VP O
that IN B-SBAR O
the DT B-NP O
COLIA1 NN I-NP O
/ SYM B-NP O
PDGFB NN I-NP O
precursor NN I-NP O
was VBD B-VP O
processed VBN I-VP O
to TO B-PP O
an DT B-NP O
end NN I-NP O
product NN I-NP O
that WDT B-NP O
was VBD B-VP O
indistinguishable JJ B-ADJP O
from IN B-PP O
wild JJ B-NP O
- HYPH I-NP O
type NN I-NP O
PDGF NN I-NP O
- HYPH B-NP O
BB NN I-NP O
. . O O

Finally RB B-ADVP O
, , O O
COLIA1 NN B-NP O
/ SYM B-NP O
PDGFB NN I-NP O
- HYPH O O
expressing VBG B-NP O
cells NNS I-NP O
generated VBD B-VP O
tumors NNS B-NP B-Disease
after IN B-PP O
s NNS B-NP O
. . O O

c NN B-NP O
c NN I-NP O
. . I-NP O

injection NN I-NP O
into IN B-PP O
nude JJ B-NP O
mice NNS I-NP O
, , O O
and CC O O
tumor NN B-NP B-Disease
growth NN I-NP O
was VBD B-VP O
reduced VBN I-VP O
by IN B-PP O
treatment NN B-NP O
with IN B-PP O
CGP57148B NN B-NP O
. . O O

We PRP B-NP O
conclude VBP B-VP O
that IN B-SBAR O
the DT B-NP O
COLIA1 NN I-NP O
/ SYM B-VP O
PDGFB NN B-NP O
fusion NN I-NP O
associated VBN B-VP O
with IN B-PP O
DFSP NN B-NP B-Disease
contributes VBZ B-VP O
to TO B-PP O
tumor NN B-NP B-Disease
development NN I-NP O
through IN B-PP O
ectopic JJ B-NP O
production NN I-NP O
of IN B-PP O
PDGF NN B-NP O
- HYPH I-NP O
BB NN I-NP O
and CC O O
the DT B-NP O
formation NN I-NP O
of IN B-PP O
an DT B-NP O
autocrine JJ I-NP O
loop NN I-NP O
. . O O

Our PRP$ B-NP O
findings NNS I-NP O
, , O O
thus RB B-ADVP O
, , O O
suggest VBP B-VP O
that IN B-SBAR O
PDGF NN B-NP O
receptors NNS I-NP O
could MD B-VP O
be VB I-VP O
a DT B-NP O
target NN I-NP O
for IN B-PP O
pharmacological JJ B-NP O
treatment NN I-NP O
of IN B-PP O
DFSP NN B-NP B-Disease
and CC I-NP O
giant JJ I-NP B-Disease
cell NN I-NP I-Disease
fibroblastoma NN I-NP I-Disease
, , O O
e NN B-NP O
. . I-NP O

g NN I-NP O
. . O O

, , O O
through IN B-PP O
the DT B-NP O
use NN I-NP O
of IN B-PP O
PDGF NN B-NP O
receptor NN I-NP O
kinase NN I-NP O
inhibitors NNS I-NP O
such JJ B-PP O
as IN I-PP O
CGP57148B NN B-NP O
. . O O

Identification NN B-NP O
of IN B-PP O
a DT B-NP O
common JJ I-NP O
PEX1 NN I-NP O
mutation NN I-NP O
in IN B-PP O
Zellweger NN B-NP B-Disease
syndrome NN I-NP I-Disease
. . O O

The DT B-NP O
Zellweger NNP I-NP B-Disease
spectrum NN I-NP I-Disease
of IN B-PP I-Disease
disease NN B-NP I-Disease
, , O O
encompassing VBG B-VP O
Zellweger NN B-NP B-Disease
syndrome NN I-NP I-Disease
and CC O O
the DT B-NP O
progressively RB I-NP O
milder JJR I-NP O
phenotypes NNS I-NP O
of IN B-PP O
neonatal JJ B-NP B-Disease
adrenoleukodystrophy NN I-NP I-Disease
and CC O O
infantile JJ B-NP B-Disease
Refsum NNP I-NP I-Disease
disease NN I-NP I-Disease
, , O O
is VBZ B-VP O
due JJ B-ADJP O
to TO B-PP O
a DT B-NP O
failure NN I-NP O
to TO B-VP O
form VB I-VP O
functional JJ B-NP O
peroxisomes NNS I-NP O
. . O O

Cell NN B-NP O
fusion NN I-NP O
complementation NN I-NP O
studies NNS I-NP O
demonstrated VBD B-VP O
that IN B-SBAR O
these DT B-NP O
diseases NNS I-NP O
are VBP B-VP O
genetically RB B-ADJP O
heterogeneous JJ I-ADJP O
, , O O
with IN B-PP O
two CD B-NP O
- HYPH I-NP O
thirds NNS I-NP O
of IN B-PP O
all DT B-NP O
patients NNS I-NP O
lying VBG B-VP O
within IN B-PP O
a DT B-NP O
single JJ I-NP O
complementation NN I-NP O
group NN I-NP O
, , O O
CG1 NN B-NP O
. . O O

Molecular JJ B-NP O
genetic JJ I-NP O
and CC I-NP O
cell NN I-NP O
biology NN I-NP O
studies NNS I-NP O
have VBP B-VP O
shown VBN I-VP O
that IN B-SBAR O
PEX1 NN B-NP O
is VBZ B-VP O
deficient JJ B-ADJP O
in IN B-PP O
many JJ B-NP O
CG1 NN I-NP O
patients NNS I-NP O
. . O O

However RB B-ADVP O
, , O O
previous JJ B-NP O
studies NNS I-NP O
have VBP B-VP O
focused VBN I-VP O
on IN B-PP O
mildly RB B-NP O
affected VBN I-NP O
patients NNS I-NP O
and CC O O
there EX B-NP O
is VBZ B-VP O
still RB B-ADVP O
no DT B-NP O
report NN I-NP O
of IN B-PP O
two CD B-NP O
mutant JJ I-NP O
PEX1 NN I-NP O
alleles NNS I-NP O
in IN B-PP O
any DT B-NP O
Zellweger NNP I-NP B-Disease
syndrome NN I-NP I-Disease
patient NN I-NP O
. . O O

Furthermore RB B-ADVP O
, , O O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
PMP70 NN I-NP O
gene NN I-NP O
have VBP B-VP O
also RB I-VP O
been VBN I-VP O
identified VBN I-VP O
in IN B-PP O
two CD B-NP O
Zellweger NN I-NP B-Disease
syndrome NN I-NP I-Disease
patients NNS I-NP O
from IN B-PP O
CG1 NN B-NP O
, , O O
raising VBG B-VP O
the DT B-NP O
possibility NN I-NP O
that IN B-SBAR O
CG1 NN B-NP O
patients NNS I-NP O
may MD B-VP O
represent VB I-VP O
a DT B-NP O
mixture NN I-NP O
of IN B-PP O
PEX1 NN B-NP O
- HYPH B-NP O
deficient JJ I-NP O
and CC I-NP O
PMP70 NN I-NP O
- HYPH B-NP O
deficient JJ I-NP O
individuals NNS I-NP O
. . O O

To TO B-VP O
address VB I-VP O
the DT B-NP O
molecular JJ I-NP O
basis NN I-NP O
of IN B-PP O
disease NN B-NP O
in IN B-PP O
Zellweger NNP B-NP B-Disease
syndrome NN I-NP I-Disease
patients NNS I-NP O
from IN B-PP O
CG1 NN B-NP O
, , O O
we PRP B-NP O
examined VBD B-VP O
all DT B-NP O
24 CD I-NP O
PEX1 NN I-NP O
exons NNS I-NP O
in IN B-PP O
four CD B-NP O
patients NNS I-NP O
, , O O
including VBG B-PP O
both DT B-NP O
patients NNS I-NP O
that WDT B-NP O
have VBP B-VP O
mutations NNS B-NP O
in IN B-PP O
PMP70 NN B-NP O
. . O O

PEX1 NN B-NP O
mutations NNS I-NP O
were VBD B-VP O
detected VBN I-VP O
in IN B-PP O
all DT B-NP O
four CD I-NP O
patients NNS I-NP O
, , O O
including VBG B-PP O
a DT B-NP O
1 CD I-NP O
- HYPH I-NP O
bp NN I-NP O
insertion NN I-NP O
( ( O O
c NN B-NP O
. . I-NP O

2097insT NN I-NP O
) ) O O
in IN B-PP O
exon NN B-NP O
13 CD I-NP O
that WDT B-NP O
was VBD B-VP O
present JJ B-ADJP O
in IN B-PP O
three CD B-NP O
of IN B-PP O
the DT B-NP O
four CD I-NP O
patients NNS I-NP O
. . O O

Subsequent JJ B-NP O
studies NNS I-NP O
demonstrated VBD B-VP O
that IN B-SBAR O
this DT B-NP O
mutation NN I-NP O
is VBZ B-VP O
present JJ B-ADJP O
in IN B-PP O
one CD B-NP O
- HYPH I-NP O
half NN I-NP O
of IN B-PP O
all DT B-NP O
CG1 NN I-NP O
patients NNS I-NP O
and CC O O
correlates VBZ B-VP O
with IN B-PP O
the DT B-NP O
Zellweger NNP I-NP B-Disease
syndrome NN I-NP I-Disease
phenotype NN I-NP O
. . O O

As IN B-SBAR O
this DT B-NP O
mutation NN I-NP O
leads VBZ B-VP O
to TO B-PP O
a DT B-NP O
loss NN I-NP O
of IN B-PP O
protein NN B-NP O
function NN I-NP O
its PRP$ B-NP O
frequency NN I-NP O
makes VBZ B-VP O
it PRP B-NP O
the DT B-NP O
most RBS I-NP O
common JJ I-NP O
cause NN I-NP O
of IN B-PP O
Zellweger NN B-NP B-Disease
syndrome NN I-NP I-Disease
, , O O
helping VBG B-VP O
to TO I-VP O
explain VB I-VP O
the DT B-NP O
high JJ I-NP O
percentage NN I-NP O
of IN B-PP O
patients NNS B-NP O
that WDT B-NP O
belong VBP B-VP O
to TO B-PP O
CG1 NN B-NP O
. . O O

Novel JJ B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
Wiskott NNP I-NP B-Disease
- HYPH I-NP I-Disease
Aldrich NNP I-NP I-Disease
syndrome NN I-NP I-Disease
protein NN I-NP O
gene NN I-NP O
and CC O O
their PRP$ B-NP O
effects NNS I-NP O
on IN B-PP O
transcriptional JJ B-NP O
, , I-NP O
translational JJ I-NP O
, , O O
and CC O O
clinical JJ B-NP O
phenotypes NNS I-NP O
. . O O

Wiskott NNP B-NP B-Disease
- HYPH I-NP I-Disease
Aldrich NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
WAS NN B-NP B-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
X NN I-NP B-Disease
- HYPH O I-Disease
linked VBN B-VP I-Disease
recessive JJ B-NP I-Disease
immunodeficiency NN I-NP I-Disease
characterized VBN B-VP O
by IN B-PP O
thrombocytopenia NN B-NP B-Disease
, , O O
eczema NN B-NP B-Disease
, , O O
and CC O O
recurrent JJ B-NP O
infections NNS I-NP O
, , O O
and CC O O
caused VBN B-VP O
by IN B-PP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
WAS NN I-NP B-Disease
protein NN I-NP O
( ( O O
WASP NN B-NP O
) ) O O
gene NN B-NP O
. . O O

WASP NN B-NP O
contains VBZ B-VP O
several JJ B-NP O
functional JJ I-NP O
domains NNS I-NP O
through IN B-PP O
which WDT B-NP O
it PRP B-NP O
interacts VBZ B-VP O
with IN B-PP O
proteins NNS B-NP O
involved VBN B-VP O
in IN B-PP O
intracellular JJ B-NP O
signaling NN I-NP O
and CC I-NP O
regulation NN I-NP O
of IN B-PP O
the DT B-NP O
actin NN I-NP O
cytoskeleton NN I-NP O
. . O O

In IN B-PP O
this DT B-NP O
report NN I-NP O
, , O O
17 CD B-NP O
WASP NN I-NP O
gene NN I-NP O
mutations NNS I-NP O
were VBD B-VP O
identified VBN I-VP O
, , O O
12 CD B-NP O
of IN B-PP O
which WDT B-NP O
are VBP B-VP O
novel JJ B-ADJP O
. . O O

DNA NN B-NP O
of IN B-PP O
affected VBN B-NP O
males NNS I-NP O
and CC O O
obligate JJ B-NP O
carriers NNS I-NP O
was VBD B-VP O
PCR NN I-VP O
amplified VBN I-VP O
and CC I-VP O
analyzed VBN I-VP O
by IN B-PP O
SSCA NN B-NP O
, , O O
heteroduplex NN B-NP O
analysis NN I-NP O
, , O O
and CC O O
direct JJ B-NP O
sequencing NN I-NP O
. . O O

The DT B-NP O
effects NNS I-NP O
of IN B-PP O
the DT B-NP O
mutations NNS I-NP O
at IN B-PP O
the DT B-NP O
mRNA NN I-NP O
and CC I-NP O
protein NN I-NP O
level NN I-NP O
were VBD B-VP O
ascertained VBN I-VP O
by IN B-PP O
RT NN B-NP O
- HYPH O O
PCR NN B-NP O
and CC O O
Western JJ B-NP O
blot NN I-NP O
analyses NNS I-NP O
. . O O

All DT B-NP O
missense JJ I-NP O
mutations NNS I-NP O
were VBD B-VP O
located JJ B-ADJP O
in IN B-PP O
exons NNS B-NP O
1 CD I-NP O
- HYPH I-NP O
4 CD I-NP O
. . O O

Most JJS B-NP O
of IN B-PP O
the DT B-NP O
nonsense NN I-NP O
, , I-NP O
frameshift NN I-NP O
and CC I-NP O
splice NN I-NP O
site NN I-NP O
mutations NNS I-NP O
were VBD B-VP O
found VBN I-VP O
in IN B-PP O
exons NNS B-NP O
6 CD B-NP O
- HYPH I-NP O
11 CD I-NP O
. . O O

Mutations NNS B-NP O
that WDT B-NP O
alter VBP B-VP O
splice NN B-NP O
sites NNS I-NP O
led VBD B-VP O
to TO B-PP O
the DT B-NP O
synthesis NN I-NP O
of IN B-PP O
several JJ B-NP O
types NNS I-NP O
of IN B-PP O
mRNAs NNS B-NP O
, , O O
a DT B-NP O
fraction NN I-NP O
of IN B-PP O
which WDT B-NP O
represented VBD B-VP O
the DT B-NP O
normally RB I-NP O
spliced VBN I-NP O
product NN I-NP O
. . O O

The DT B-NP O
presence NN I-NP O
of IN B-PP O
normally RB B-NP O
spliced VBN I-NP O
transcripts NNS I-NP O
was VBD B-VP O
correlated VBN I-VP O
with IN B-PP O
a DT B-NP O
milder JJR I-NP O
phenotype NN I-NP O
. . O O

When WRB B-ADVP O
one CD B-NP O
such JJ I-NP O
case NN I-NP O
was VBD B-VP O
studied VBN I-VP O
by IN B-PP O
Western JJ B-NP O
blotting NN I-NP O
, , O O
reduced VBN B-VP O
amounts NNS B-NP O
of IN B-PP O
normal JJ B-NP O
- HYPH I-NP O
size NN I-NP O
WASP NN I-NP O
were VBD B-VP O
present JJ B-ADJP O
. . O O

In IN B-PP O
other JJ B-NP O
cases NNS I-NP O
as RB B-ADVP O
well RB I-ADVP O
, , O O
a DT B-NP O
correlation NN I-NP O
was VBD B-VP O
found VBN I-VP O
between IN B-PP O
the DT B-NP O
amount NN I-NP O
of IN B-PP O
normal JJ B-NP O
or CC I-NP O
mutant JJ I-NP O
WASP NN I-NP O
present JJ B-ADJP O
and CC O O
the DT B-NP O
phenotypes NNS I-NP O
of IN B-PP O
the DT B-NP O
affected JJ I-NP O
individuals NNS I-NP O
. . O O

No DT B-NP O
protein NN I-NP O
was VBD B-VP O
detected VBN I-VP O
in IN B-PP O
two CD B-NP O
individuals NNS I-NP O
with IN B-PP O
severe JJ B-NP O
WAS NN I-NP B-Disease
. . O O

Reduced VBN B-NP O
levels NNS I-NP O
of IN B-PP O
a DT B-NP O
normal JJ I-NP O
- HYPH I-NP O
size NN I-NP O
WASP NN I-NP O
with IN B-PP O
a DT B-NP O
missense JJ I-NP O
mutation NN I-NP O
were VBD B-VP O
seen VBN I-VP O
in IN B-PP O
two CD B-NP O
individuals NNS I-NP O
with IN B-PP O
XLT NN B-NP B-Disease
. . O O

It PRP B-NP O
is VBZ B-VP O
concluded VBN I-VP O
that IN B-SBAR O
mutation NN B-NP O
analysis NN I-NP O
at IN B-PP O
the DT B-NP O
DNA NN I-NP O
level NN I-NP O
is VBZ B-VP O
not RB O O
sufficient JJ B-ADJP O
for IN B-PP O
predicting VBG B-VP O
clinical JJ B-NP O
course NN I-NP O
. . O O

Studies NNS B-NP O
at IN B-PP O
the DT B-NP O
transcript NN I-NP O
and CC I-NP O
protein NN I-NP O
level NN I-NP O
are VBP B-VP O
needed VBN I-VP O
for IN B-PP O
a DT B-NP O
better JJR I-NP O
assessment NN I-NP O
. . O O

. . O O

Aminoglycoside NN B-NP O
antibiotics NNS I-NP O
restore VBP B-VP O
dystrophin NN B-NP O
function NN I-NP O
to TO B-PP O
skeletal JJ B-NP O
muscles NNS I-NP O
of IN B-PP O
mdx NN B-NP O
mice NNS I-NP O
. . O O

Duchenne JJ B-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
DMD NN B-NP B-Disease
) ) O O
is VBZ B-VP O
caused VBN I-VP O
by IN B-PP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
dystrophin NN I-NP O
gene NN I-NP O
, , O O
leading VBG B-VP O
to TO B-PP O
the DT B-NP O
absence NN I-NP O
of IN B-PP O
the DT B-NP O
dystrophin NN I-NP O
protein NN I-NP O
in IN B-PP O
striated VBN B-NP O
muscle NN I-NP O
. . O O

A DT B-NP O
significant JJ I-NP O
number NN I-NP O
of IN B-PP O
these DT B-NP O
mutations NNS I-NP O
are VBP B-VP O
premature JJ B-NP O
stop NN I-NP O
codons NNS I-NP O
. . O O

On IN B-PP O
the DT B-NP O
basis NN I-NP O
of IN B-PP O
the DT B-NP O
observation NN I-NP O
that IN B-SBAR O
aminoglycoside NN B-NP O
treatment NN I-NP O
can MD B-VP O
suppress VB I-VP O
stop NN B-NP O
codons NNS I-NP O
in IN B-PP O
cultured VBN B-NP O
cells NNS I-NP O
, , O O
we PRP B-NP O
tested VBD B-VP O
the DT B-NP O
effect NN I-NP O
of IN B-PP O
gentamicin NN B-NP O
on IN B-PP O
cultured VBN B-NP O
muscle NN I-NP O
cells NNS I-NP O
from IN B-PP O
the DT B-NP O
mdx NN I-NP O
mouse NN I-NP O
- HYPH O O
an DT B-NP O
animal NN I-NP O
model NN I-NP O
for IN B-PP O
DMD NN B-NP B-Disease
that WDT B-NP O
possesses VBZ B-VP O
a DT B-NP O
premature JJ I-NP O
stop NN I-NP O
codon NN I-NP O
in IN B-PP O
the DT B-NP O
dystrophin NN I-NP O
gene NN I-NP O
. . O O

Exposure NN B-NP O
of IN B-PP O
mdx NN B-NP O
myotubes NNS I-NP O
to TO B-PP O
gentamicin NN B-NP O
led VBD B-VP O
to TO B-PP O
the DT B-NP O
expression NN I-NP O
and CC I-NP O
localization NN I-NP O
of IN B-PP O
dystrophin NN B-NP O
to TO B-PP O
the DT B-NP O
cell NN I-NP O
membrane NN I-NP O
. . O O

We PRP B-NP O
then RB B-ADVP O
evaluated VBD B-VP O
the DT B-NP O
effects NNS I-NP O
of IN B-PP O
differing VBG B-VP O
dosages NNS B-NP O
of IN B-PP O
gentamicin NN B-NP O
on IN B-PP O
expression NN B-NP O
and CC O O
functional JJ B-NP O
protection NN I-NP O
of IN B-PP O
the DT B-NP O
muscles NNS I-NP O
of IN B-PP O
mdx NN B-NP O
mice NNS I-NP O
. . O O

We PRP B-NP O
identified VBD B-VP O
a DT B-NP O
treatment NN I-NP O
regimen NN I-NP O
that WDT B-NP O
resulted VBD B-VP O
in IN B-PP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
dystrophin NN B-NP O
in IN B-PP O
the DT B-NP O
cell NN I-NP O
membrane NN I-NP O
in IN B-PP O
all DT B-NP O
striated VBN I-NP O
muscles NNS I-NP O
examined VBN B-VP O
and CC O O
that WDT B-NP O
provided VBD B-VP O
functional JJ B-NP O
protection NN I-NP O
against IN B-PP O
muscular JJ B-NP B-Disease
injury NN I-NP I-Disease
. . O O

To TO B-PP O
our PRP$ B-NP O
knowledge NN I-NP O
, , O O
our PRP$ B-NP O
results NNS I-NP O
are VBP B-VP O
the DT B-NP O
first JJ I-NP O
to TO B-VP O
demonstrate VB I-VP O
that IN B-SBAR O
aminoglycosides NNS B-NP O
can MD B-VP O
suppress VB I-VP O
stop NN B-NP O
codons NNS I-NP O
not RB B-CONJP O
only RB I-CONJP O
in FW B-ADVP O
vitro FW I-ADVP O
but CC B-CONJP O
also RB I-CONJP O
in FW B-ADVP O
vivo FW I-ADVP O
. . O O

Furthermore RB B-ADVP O
, , O O
these DT B-NP O
results NNS I-NP O
raise VBP B-VP O
the DT B-NP O
possibility NN I-NP O
of IN B-PP O
a DT B-NP O
novel JJ I-NP O
treatment NN I-NP O
regimen NN I-NP O
for IN B-PP O
muscular JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
and CC O O
other JJ B-NP O
diseases NNS I-NP O
caused VBN B-VP O
by IN B-PP O
premature JJ B-NP O
stop NN I-NP O
codon NN I-NP O
mutations NNS I-NP O
. . O O

This DT B-NP O
treatment NN I-NP O
could MD B-VP O
prove VB I-VP O
effective JJ B-ADJP O
in IN B-PP O
up IN B-NP O
to TO I-NP O
15 CD I-NP O
% NN I-NP O
of IN B-PP O
patients NNS B-NP O
with IN B-PP O
DMD NN B-NP B-Disease
. . O O

. . O O

Loss NN B-NP O
of IN B-PP O
the DT B-NP O
ataxia NN I-NP B-Disease
- HYPH B-NP I-Disease
telangiectasia NN I-NP I-Disease
gene NN I-NP O
product NN I-NP O
causes VBZ B-VP O
oxidative JJ B-NP O
damage NN I-NP O
in IN B-PP O
target NN B-NP O
organs NNS I-NP O
. . O O

Ataxia NN B-NP B-Disease
- HYPH O I-Disease
telangiectasia NN B-NP I-Disease
( ( O O
A NN B-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
) ) O O
is VBZ B-VP O
characterized VBN I-VP O
by IN B-PP O
a DT B-NP O
markedly RB I-NP O
increased VBN I-NP O
sensitivity NN I-NP O
to TO B-PP O
ionizing VBG B-VP O
radiation NN B-NP O
, , O O
increased VBD B-VP O
incidence NN B-NP O
of IN B-PP O
cancer NN B-NP B-Disease
, , O O
and CC O O
neurodegeneration NN B-NP B-Disease
, , O O
especially RB B-ADVP O
of IN B-PP O
the DT B-NP O
cerebellar JJ I-NP O
Purkinje NN I-NP O
cells NNS I-NP O
. . O O

Ionizing VBG B-VP O
radiation NN B-NP O
oxidizes VBZ B-VP O
macromolecules NNS B-NP O
and CC O O
causes VBZ B-VP O
tissue NN B-NP O
damage NN I-NP O
through IN B-PP O
the DT B-NP O
generation NN I-NP O
of IN B-PP O
reactive JJ B-NP O
oxygen NN I-NP O
species NNS I-NP O
( ( O O
ROS NNS B-NP O
) ) O O
. . O O

We PRP B-NP O
therefore RB B-ADVP O
hypothesized VBD B-VP O
that IN B-SBAR O
A NN B-NP B-Disease
- HYPH O I-Disease
T NN B-NP I-Disease
is VBZ B-VP O
due JJ B-ADJP O
to TO B-PP O
oxidative JJ B-NP O
damage NN I-NP O
resulting VBG B-VP O
from IN B-PP O
loss NN B-NP O
of IN B-PP O
function NN B-NP O
of IN B-PP O
the DT B-NP O
A NN I-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
gene NN I-NP O
product NN I-NP O
. . O O

To TO B-VP O
assess VB I-VP O
this DT B-NP O
hypothesis NN I-NP O
, , O O
we PRP B-NP O
employed VBD B-VP O
an DT B-NP O
animal NN I-NP O
model NN I-NP O
of IN B-PP O
A NN B-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
, , O O
the DT B-NP O
mouse NN I-NP O
with IN B-PP O
a DT B-NP O
disrupted VBN I-NP O
Atm NN I-NP O
gene NN I-NP O
. . O O

We PRP B-NP O
show VBP B-VP O
that IN B-SBAR O
organs NNS B-NP O
which WDT B-NP O
develop VBP B-VP O
pathologic JJ B-NP O
changes NNS I-NP O
in IN B-PP O
the DT B-NP O
Atm NN I-NP O
- HYPH B-NP O
deficient JJ I-NP O
mice NNS I-NP O
are VBP B-VP O
targets NNS B-NP O
of IN B-PP O
oxidative JJ B-NP O
damage NN I-NP O
, , O O
and CC O O
that IN B-SBAR O
cerebellar JJ B-NP O
Purkinje NN I-NP O
cells NNS I-NP O
are VBP B-VP O
particularly RB I-VP O
affected VBN I-VP O
. . O O

These DT B-NP O
observations NNS I-NP O
provide VBP B-VP O
a DT B-NP O
mechanistic JJ I-NP O
basis NN I-NP O
for IN B-PP O
the DT B-NP O
A NN I-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
phenotype NN I-NP O
and CC O O
lay VBD B-VP O
a DT B-NP O
rational JJ I-NP O
foundation NN I-NP O
for IN B-PP O
therapeutic JJ B-NP O
intervention NN I-NP O
. . O O

. . O O

Recessively RB B-NP O
inherited VBN I-NP O
multiple JJ I-NP B-Disease
epiphyseal JJ I-NP I-Disease
dysplasia NN I-NP I-Disease
with IN B-PP O
normal JJ B-NP O
stature NN I-NP O
, , O O
club NN B-NP B-Disease
foot NN I-NP I-Disease
, , O O
and CC O O
double JJ B-NP B-Disease
layered JJ I-NP I-Disease
patella NN I-NP I-Disease
caused VBN B-VP O
by IN B-PP O
a DT B-NP O
DTDST NN I-NP O
mutation NN I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
observed VBN I-VP O
over IN B-PP O
25 CD B-NP O
different JJ I-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
diastrophic JJ I-NP B-Disease
dysplasia NN I-NP I-Disease
sulphate NN I-NP O
transporter NN I-NP O
gene NN I-NP O
( ( O O
DTDST NN B-NP O
) ) O O
in IN B-PP O
association NN B-NP O
with IN B-PP O
the DT B-NP O
recessive JJ I-NP B-Disease
disorders NNS I-NP I-Disease
achondrogenesis NN I-NP B-Disease
1B NN I-NP I-Disease
, , O O
atelosteogenesis NN B-NP B-Disease
2 CD I-NP I-Disease
, , O O
and CC O O
diastrophic JJ B-NP B-Disease
dysplasia NN I-NP I-Disease
. . O O

The DT B-NP O
c862t NN I-NP O
( ( O O
R279W NN B-NP O
) ) O O
transition NN B-NP O
is VBZ B-VP O
the DT B-NP O
most RBS I-NP O
common JJ I-NP O
mutation NN I-NP O
in IN B-PP O
non AFX B-NP O
- HYPH I-NP O
Finnish JJ B-NP O
patients NNS I-NP O
, , O O
but CC O O
in IN B-PP O
these DT B-NP O
disorders NNS I-NP O
it PRP B-NP O
is VBZ B-VP O
usually RB I-VP O
combined VBN I-VP O
with IN B-PP O
other JJ B-NP O
DTDST NN I-NP O
mutations NNS I-NP O
. . O O

We PRP B-NP O
had VBD B-VP O
not RB I-VP O
seen VBN I-VP O
a DT B-NP O
case NN I-NP O
of IN B-PP O
homozygosity NN B-NP O
for IN B-PP O
c862t NN B-NP O
( ( O O
R279W NN B-NP O
) ) O O
until IN B-SBAR O
we PRP B-NP O
analysed VBD B-VP O
DNA NN B-NP O
from IN B-PP O
a DT B-NP O
36 CD I-NP O
year NN I-NP O
old JJ I-NP O
male NN I-NP O
with IN B-PP O
tall JJ B-NP O
- HYPH I-NP O
normal JJ I-NP O
stature NN I-NP O
( ( O O
180 CD B-NP O
cm NN I-NP O
) ) O O
who WP B-NP O
asked VBD B-VP O
for IN B-PP O
genetic JJ B-NP O
counselling NN I-NP O
for IN B-PP O
suspected VBN B-NP O
multiple JJ I-NP B-Disease
epiphyseal JJ I-NP I-Disease
dysplasia NN I-NP I-Disease
. . O O

He PRP B-NP O
was VBD B-VP O
treated VBN I-VP O
for IN B-PP O
club NN B-NP B-Disease
foot NN I-NP I-Disease
and CC I-NP O
hip NN I-NP B-Disease
dysplasia NN I-NP I-Disease
at IN B-PP O
birth NN B-NP O
. . O O

Skeletal JJ B-NP O
changes NNS I-NP O
consistent JJ B-ADJP O
with IN B-PP O
multiple JJ B-NP B-Disease
epiphyseal JJ I-NP I-Disease
dysplasia NN I-NP I-Disease
, , O O
with IN B-PP O
the DT B-NP O
peculiar JJ I-NP O
finding NN I-NP O
of IN B-PP O
a DT B-NP O
double JJ I-NP B-Disease
layered JJ I-NP I-Disease
patella NN I-NP I-Disease
, , O O
were VBD B-VP O
recognised VBN I-VP O
during IN B-PP O
childhood NN B-NP O
. . O O

Cleft NN B-NP B-Disease
palate NN I-NP I-Disease
, , O O
swelling VBG B-VP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
ear JJ I-NP I-Disease
pinna NN I-NP I-Disease
, , O O
and CC O O
hitch NN B-NP B-Disease
hiker NN I-NP I-Disease
thumb NN I-NP I-Disease
were VBD B-VP O
absent JJ B-ADJP O
. . O O

He PRP B-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
be VB I-VP O
homozygous JJ B-ADJP O
, , O O
and CC O O
both DT B-NP O
healthy JJ I-NP O
parents NNS I-NP O
heterozygous JJ B-ADJP O
, , O O
for IN B-PP O
the DT B-NP O
R279W NN I-NP O
mutation NN I-NP O
in IN B-PP O
DTDST NN B-NP O
, , O O
and CC O O
his PRP$ B-NP O
fibroblasts NNS I-NP O
showed VBD B-VP O
a DT B-NP O
sulphate NN I-NP O
incorporation NN I-NP O
defect NN I-NP O
typical JJ B-ADJP O
of IN B-PP O
DTDST NN B-NP B-Disease
disorders NNS I-NP I-Disease
. . O O

Counselling NN B-NP O
was VBD B-VP O
given VBN I-VP O
for IN B-PP O
a DT B-NP O
recessive JJ I-NP B-Disease
disorder NN I-NP I-Disease
, , O O
thereby RB B-VP O
considerably RB I-VP O
reducing VBG I-VP O
the DT B-NP O
probability NN I-NP O
of IN B-PP O
affected VBN B-NP O
offspring NN I-NP O
. . O O

Multiple JJ B-NP B-Disease
epiphyseal NN I-NP I-Disease
dysplasia NN I-NP I-Disease
is VBZ B-VP O
more RBR I-VP O
frequently RB I-VP O
caused VBN I-VP O
by IN B-PP O
dominant JJ B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
COMP NN I-NP O
( ( O O
EDM1 NN B-NP B-Disease
, , O O
McKusick NNP B-NP O
132400 CD I-NP O
) ) O O
and CC O O
COL9A2 NN B-NP O
genes NNS I-NP O
( ( O O
EDM2 NN B-NP B-Disease
, , O O
McKusick NNP B-NP O
600204 CD I-NP O
) ) O O
. . O O

A DT B-NP O
few JJ I-NP O
other JJ I-NP O
patients NNS I-NP O
and CC O O
families NNS B-NP O
with IN B-PP O
features NNS B-NP O
similar JJ B-ADJP O
to TO B-PP O
our PRP$ B-NP O
proband NN I-NP O
have VBP B-VP O
been VBN I-VP O
described VBN I-VP O
previously RB B-ADVP O
and CC O O
considered VBN B-VP O
to TO I-VP O
have VB I-VP O
autosomal JJ B-NP O
recessive JJ I-NP O
MED NN I-NP B-Disease
( ( O O
EDM4 NN B-NP B-Disease
, , O O
McKusick NNP B-NP O
226900 CD I-NP O
) ) O O
. . O O

This DT B-NP O
observation NN I-NP O
confirms VBZ B-VP O
the DT B-NP O
existence NN I-NP O
of IN B-PP O
this DT B-NP O
entity NN I-NP O
and CC O O
assigns VBZ B-VP O
it PRP B-NP O
to TO B-PP O
the DT B-NP O
phenotypic JJ I-NP O
spectrum NN I-NP O
associated VBN B-VP O
with IN B-PP O
mutations NNS B-NP O
at IN B-PP O
the DT B-NP O
DTDST NN I-NP O
locus NN I-NP O
. . O O

. . O O

Homozygosity NN B-NP O
for IN B-PP O
a DT B-NP O
novel JJ I-NP O
DTDST NN I-NP O
mutation NN I-NP O
in IN B-PP O
a DT B-NP O
child NN I-NP O
with IN B-PP O
a DT B-NP O
' `` I-NP O
broad JJ I-NP O
bone NN I-NP O
- HYPH I-NP O
platyspondylic JJ I-NP O
' '' I-NP O
variant NN I-NP O
of IN B-PP O
diastrophic JJ B-NP B-Disease
dysplasia NN I-NP I-Disease
. . O O

Atypical JJ B-NP O
or CC I-NP O
variant JJ I-NP O
forms NNS I-NP O
of IN B-PP O
well RB B-NP O
- HYPH I-NP O
known VBN I-NP O
chondrodysplasias NNS I-NP B-Disease
may MD B-VP O
pose VB I-VP O
diagnostic JJ B-NP O
problems NNS I-NP O
. . O O

We PRP B-NP O
report VBP B-VP O
on IN B-PP O
a DT B-NP O
girl NN I-NP O
with IN B-PP O
clinical JJ B-NP O
features NNS I-NP O
suggesting VBG B-VP O
diastrophic JJ B-NP B-Disease
dysplasia NN I-NP I-Disease
but CC B-PP O
with IN B-PP O
unusual JJ B-NP O
radiographic JJ I-NP O
features NNS I-NP O
including VBG B-PP O
severe JJ B-NP O
platyspondyly NN I-NP B-Disease
, , O O
wide JJ B-NP O
metaphyses NNS I-NP O
, , O O
and CC O O
fibular JJ B-NP O
overgrowth NN I-NP O
, , O O
which WDT B-NP O
are VBP B-VP O
partially RB B-ADJP O
reminiscent JJ I-ADJP O
of IN B-PP O
metatropic JJ B-NP B-Disease
dysplasia NN I-NP I-Disease
. . O O

The DT B-NP O
diagnosis NN I-NP O
was VBD B-VP O
clarified VBN I-VP O
by IN B-PP O
molecular JJ B-NP O
analysis NN I-NP O
of IN B-PP O
the DT B-NP O
DTDST NN I-NP O
gene NN I-NP O
, , O O
which WDT B-NP O
revealed VBD B-VP O
homozygosity NN B-NP O
for IN B-PP O
a DT B-NP O
previously RB I-NP O
undescribed JJ I-NP O
mutation NN I-NP O
leading VBG B-VP O
to TO B-PP O
a DT B-NP O
Q454P NN I-NP O
substitution NN I-NP O
in IN B-PP O
the DT B-NP O
10th JJ I-NP O
transmembrane JJ I-NP O
domain NN I-NP O
of IN B-PP O
the DT B-NP O
DTDST NN I-NP O
sulfate NN I-NP O
transporter NN I-NP O
. . O O

Molecular JJ B-NP O
analysis NN I-NP O
may MD B-VP O
be VB I-VP O
of IN B-PP O
particular JJ B-NP O
value NN I-NP O
in IN B-PP O
such JJ B-NP O
atypical JJ I-NP O
cases NNS I-NP O
. . O O

. . O O

The DT B-NP O
type NN I-NP O
of IN B-PP O
somatic JJ B-NP O
mutation NN I-NP O
at IN B-PP O
APC NN B-NP O
in IN B-PP O
familial JJ B-NP B-Disease
adenomatous JJ I-NP I-Disease
polyposis NN I-NP I-Disease
is VBZ B-VP O
determined VBN I-VP O
by IN B-PP O
the DT B-NP O
site NN I-NP O
of IN B-PP O
the DT B-NP O
germline NN I-NP O
mutation NN I-NP O
: : O O
a DT B-NP O
new JJ I-NP O
facet NN I-NP O
to TO B-PP O
Knudson NNP B-NP O
' POS B-NP O
s NNS I-NP O
' POS B-NP O
two CD I-NP O
- HYPH I-NP O
hit VBN I-NP O
' '' I-NP O
hypothesis NN I-NP O
. . O O

APC NN B-NP O
is VBZ B-VP O
often RB I-VP O
cited VBN I-VP O
as IN B-PP O
a DT B-NP O
prime JJ I-NP O
example NN I-NP O
of IN B-PP O
a DT B-NP O
tumor NN I-NP B-Disease
suppressor NN I-NP O
gene NN I-NP O
. . O O

Truncating VBG B-VP O
germline NN B-NP O
and CC O O
somatic JJ B-NP O
mutations NNS I-NP O
( ( O O
or CC O O
, , O O
infrequently RB B-ADVP O
, , O O
allelic JJ B-NP O
loss NN I-NP O
) ) O O
occur VBP B-VP O
in IN B-PP O
tumors NNS B-NP B-Disease
in IN B-PP O
FAP NN B-NP B-Disease
( ( O O
familial JJ B-NP B-Disease
adenomatous JJ I-NP I-Disease
polyposis NN I-NP I-Disease
) ) O O
. . O O

Most RBS B-NP O
sporadic JJ I-NP B-Disease
colorectal JJ I-NP I-Disease
cancers NNS I-NP I-Disease
also RB B-ADVP O
have VBP B-VP O
two CD B-NP O
APC NN I-NP B-Disease
mutations NNS I-NP O
. . O O

Clues NNS B-NP O
from IN B-PP O
attenuated VBN B-NP B-Disease
polyposis NN I-NP I-Disease
, , O O
missense JJ B-NP O
germline NN I-NP O
variants NNS I-NP O
with IN B-PP O
mild JJ B-NP O
disease NN I-NP O
and CC O O
the DT B-NP O
somatic JJ I-NP O
mutation NN I-NP O
cluster NN I-NP O
region NN I-NP O
( ( O O
codons NNS B-NP O
1 CD I-NP O
, , I-NP O
250 CD I-NP O
- HYPH B-NP O
1 CD I-NP O
, , I-NP O
450 CD I-NP O
) ) O O
indicate VBP B-VP O
, , O O
however RB B-ADVP O
, , O O
that IN B-SBAR O
APC NN B-NP B-Disease
mutations NNS I-NP O
might MD B-VP O
not RB I-VP O
result VB I-VP O
in IN B-PP O
simple JJ B-NP O
loss NN I-NP O
of IN B-PP O
protein NN B-NP O
function NN I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
found VBN I-VP O
that IN B-SBAR O
FAP NN B-NP B-Disease
patients NNS I-NP O
with IN B-PP O
germline NN B-NP O
APC NN I-NP B-Disease
mutations NNS I-NP O
within IN B-PP O
a DT B-NP O
small JJ I-NP O
region NN I-NP O
( ( O O
codons NNS B-NP O
1 CD I-NP O
, , I-NP O
194 CD I-NP O
- HYPH B-NP O
1 CD I-NP O
, , I-NP O
392 CD I-NP O
at IN B-ADVP O
most JJS I-ADVP O
) ) O O
mainly RB B-ADVP O
show VBP B-VP O
allelic JJ B-NP O
loss NN I-NP O
in IN B-PP O
their PRP$ B-NP O
colorectal JJ I-NP B-Disease
adenomas NNS I-NP I-Disease
, , O O
in IN B-PP O
contrast NN B-NP O
to TO B-PP O
other JJ B-NP O
FAP NN I-NP B-Disease
patients NNS I-NP O
, , O O
whose WP$ B-NP O
second JJ I-NP O
hits NNS I-NP O
tend VBP B-VP O
to TO I-VP O
occur VB I-VP O
by IN B-PP O
truncating VBG B-VP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
mutation NN I-NP O
cluster NN I-NP O
region NN I-NP O
. . O O

Our PRP$ B-NP O
results NNS I-NP O
indicate VBP B-VP O
that IN B-SBAR O
different JJ B-NP O
APC NN I-NP B-Disease
mutations NNS I-NP O
provide VBP B-VP O
cells NNS B-NP O
with IN B-PP O
different JJ B-NP O
selective JJ I-NP O
advantages NNS I-NP O
, , O O
with IN B-PP O
mutations NNS B-NP O
close RB B-ADJP O
to TO B-PP O
codon NN B-NP O
1 CD I-NP O
, , I-NP O
300 CD I-NP O
providing VBG B-VP O
the DT B-NP O
greatest JJS I-NP O
advantage NN I-NP O
. . O O

Allelic JJ B-NP O
loss NN I-NP O
is VBZ B-VP O
selected VBN I-VP O
strongly RB B-ADVP O
in IN B-PP O
cells NNS B-NP O
with IN B-PP O
one CD B-NP O
mutation NN I-NP O
near IN B-PP O
codon NN B-NP O
1 CD I-NP O
, , I-NP O
300 CD I-NP O
. . O O

A DT B-NP O
different JJ I-NP O
germline NN I-NP O
- HYPH B-NP O
somatic JJ I-NP O
APC NN I-NP B-Disease
mutation NN I-NP O
association NN I-NP O
exists VBZ B-VP O
in IN B-PP O
FAP NN B-NP B-Disease
desmoids NNS I-NP I-Disease
. . O O

APC NN B-NP O
is VBZ B-VP O
not RB O O
, , O O
therefore RB B-ADVP O
, , O O
a DT B-NP O
classical JJ I-NP O
tumor NN I-NP B-Disease
suppressor NN I-NP O
. . O O

Our PRP$ B-NP O
findings NNS I-NP O
also RB B-ADVP O
indicate VBP B-VP O
a DT B-NP O
new JJ I-NP O
mechanism NN I-NP O
for IN B-PP O
disease NN B-NP O
severity NN I-NP O
if IN B-SBAR O
a DT B-NP O
broader JJR I-NP O
spectrum NN I-NP O
of IN B-PP O
mutations NNS B-NP O
is VBZ B-VP O
selected VBN I-VP O
in IN B-PP O
tumors NNS B-NP B-Disease
, , O O
the DT B-NP O
somatic JJ I-NP O
mutation NN I-NP O
rate NN I-NP O
is VBZ B-VP O
effectively RB B-NP O
higher JJR I-NP O
and CC I-NP O
more JJR I-NP O
tumors NNS I-NP B-Disease
grow VBP B-VP O
. . O O

. . O O

Mxi1 NN B-NP O
mutations NNS I-NP O
in IN B-PP O
human JJ B-NP O
neurofibrosarcomas NNS I-NP B-Disease
. . O O

Mxi1 NN B-NP O
is VBZ B-VP O
thought VBN I-VP O
to TO I-VP O
negatively RB I-VP O
regulate VB I-VP O
Myc NN B-NP O
function NN I-NP O
and CC O O
may MD B-VP O
therefore RB I-VP O
be VB I-VP O
a DT B-NP O
potential JJ I-NP O
tumor NN I-NP B-Disease
suppressor NN I-NP O
gene NN I-NP O
. . O O

Little JJ B-NP O
effort NN I-NP O
has VBZ B-VP O
yet RB I-VP O
been VBN I-VP O
made VBN I-VP O
to TO B-VP O
find VB I-VP O
alterations NNS B-NP O
involving VBG B-VP O
this DT B-NP O
gene NN I-NP O
in IN B-PP O
human JJ B-NP O
solid JJ I-NP B-Disease
tumors NNS I-NP I-Disease
. . O O

We PRP B-NP O
screened VBD B-VP O
31 CD B-NP O
human JJ I-NP O
gastric JJ I-NP B-Disease
cancers NNS I-NP I-Disease
, , O O
7 CD B-NP O
esophageal JJ I-NP B-Disease
cancers NNS I-NP I-Disease
, , O O
85 CD B-NP O
bone NN I-NP B-Disease
and CC O I-Disease
soft JJ B-NP I-Disease
tissue NN I-NP I-Disease
tumors NNS I-NP I-Disease
of IN B-PP O
various JJ B-NP O
types NNS I-NP O
, , O O
including VBG B-PP O
4 CD B-NP O
neurofibrosarcomas NNS I-NP B-Disease
. . O O

We PRP B-NP O
also RB B-ADVP O
examined VBD B-VP O
29 CD B-NP O
human JJ I-NP O
tumor NN I-NP B-Disease
cell NN I-NP O
lines NNS I-NP O
consisting VBG B-VP O
of IN B-PP O
12 CD B-NP O
esophageal JJ I-NP B-Disease
cancers NNS I-NP I-Disease
, , O O
7 CD B-NP O
glioma NN I-NP B-Disease
/ SYM B-NP O
glioblastomas NNS I-NP B-Disease
and CC O O
10 CD B-NP O
others NNS I-NP O
for IN B-PP O
Mxi1 NN B-NP O
mutations NNS I-NP O
in IN B-PP O
exons NNS B-NP O
1 CD I-NP O
, , I-NP O
2 CD I-NP O
, , I-NP O
4 CD I-NP O
( ( O O
HLH NN B-NP O
domain NN I-NP O
) ) O O
, , O O
5 CD B-NP O
and CC I-NP O
6 CD I-NP O
. . O O

Polymerase NN B-NP O
chain NN I-NP O
reaction NN I-NP O
- HYPH B-NP O
single JJ I-NP O
- HYPH I-NP O
strand NN I-NP O
conformation NN I-NP O
polymorphism NN I-NP O
( ( O O
PCR NN B-NP O
- HYPH B-NP O
SSCP NN I-NP O
) ) O O
and CC O O
subsequent JJ B-NP O
sequencing NN I-NP O
revealed VBD B-VP O
three CD B-NP O
distinct JJ I-NP O
polymorphisms NNS I-NP O
in IN B-PP O
the DT B-NP O
intron NN I-NP O
- HYPH B-NP O
exon NN I-NP O
boundary JJ B-ADJP O
upstream RB B-ADVP O
from IN B-PP O
exon NN B-NP O
6 CD I-NP O
. . O O

We PRP B-NP O
discovered VBD B-VP O
a DT B-NP O
missense JJ I-NP O
mutation NN I-NP O
, , O O
GCA NN B-NP O
to TO B-PP O
GTA NN B-NP O
( ( O O
Ala NN B-NP O
54 CD I-NP O
Val NN I-NP O
) ) O O
, , O O
in IN B-PP O
exon NN B-NP O
2 CD I-NP O
in IN B-PP O
a DT B-NP O
neurofibrosarcoma NN I-NP B-Disease
patient NN I-NP O
( ( O O
case NN B-NP O
1 CD I-NP O
) ) O O
, , O O
two CD B-NP O
missense JJ I-NP O
mutations NNS I-NP O
, , O O
AAA NN B-NP O
to TO B-PP O
CAA NN B-NP O
( ( O O
Lys NNS B-NP O
118 CD B-NP O
Gln NN I-NP O
) ) O O
and CC O O
GAA NN B-NP O
to TO B-PP O
GGA NN B-NP O
( ( O O
Glu NN B-NP O
154 CD I-NP O
Gly NN I-NP O
) ) O O
in IN B-PP O
exon NN B-NP O
5 CD I-NP O
of IN B-PP O
another DT B-NP O
neurofibrosarcoma NN I-NP B-Disease
patient NN I-NP O
( ( O O
case NN B-NP O
2 CD I-NP O
) ) O O
, , O O
and CC O O
3 CD B-NP O
amino NN I-NP O
acid NN I-NP O
substitutions NNS I-NP O
, , O O
GTG NN B-NP O
to TO B-PP O
GCG NN B-NP O
( ( O O
Val NN B-NP O
179 CD I-NP O
Ala NN I-NP O
) ) O O
, , O O
GTT NN B-NP O
to TO B-PP O
GCT NN B-NP O
( ( O O
Val NN B-NP O
181 CD I-NP O
Ala NN I-NP O
) ) O O
and CC O O
TTC NN B-NP O
to TO B-PP O
CTC NN B-NP O
( ( O O
Phe NN B-NP O
186 CD I-NP O
Leu NN I-NP O
) ) O O
, , O O
in IN B-PP O
a DT B-NP O
third JJ I-NP O
neurofibrosarcoma NN I-NP B-Disease
patient NN I-NP O
( ( O O
case NN B-NP O
3 CD I-NP O
) ) O O
. . O O

In IN B-PP O
case NN B-NP O
3 CD I-NP O
, , O O
loss NN B-NP O
of IN B-PP O
heterozygosity NN B-NP O
was VBD B-VP O
also RB I-VP O
demonstrated VBN I-VP O
by IN B-PP O
informative JJ B-NP O
( ( O O
TTC NN B-NP O
) ) O O
3 CD B-NP O
/ SYM B-NP O
( ( O O
TTC NN B-NP O
) ) O O
2 CD B-NP O
polymorphism NN I-NP O
. . O O

Our PRP$ B-NP O
data NNS I-NP O
demonstrate VBP B-VP O
that IN B-SBAR O
mutations NNS B-NP O
occur VBP B-VP O
in IN B-PP O
the DT B-NP O
Mxi1 NN I-NP O
gene NN I-NP O
in IN B-PP O
neurofibrosarcoma NN B-NP B-Disease
. . O O

Missense JJ B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
functional JJ I-NP O
domain NN I-NP O
of IN B-PP O
Mxi1 NN B-NP O
in IN B-PP O
these DT B-NP O
cases NNS I-NP O
may MD B-VP O
be VB I-VP O
involved VBN I-VP O
in IN B-PP O
the DT B-NP O
pathogenesis NN I-NP O
of IN B-PP O
neurofibrosarcoma NN B-NP B-Disease
. . O O

. . O O

A DT B-NP O
population NN I-NP O
- HYPH B-VP O
based VBN I-VP O
study NN B-NP O
of IN B-PP O
the DT B-NP O
clinical JJ I-NP O
expression NN I-NP O
of IN B-PP O
the DT B-NP O
hemochromatosis NN I-NP B-Disease
gene NN I-NP O
. . O O

BACKGROUND NN B-NP O
AND CC I-NP O
METHODS NNS I-NP O
Hereditary JJ B-NP B-Disease
hemochromatosis NN I-NP I-Disease
is VBZ B-VP O
associated VBN I-VP O
with IN B-PP O
homozygosity NN B-NP O
for IN B-PP O
the DT B-NP O
C282Y NN I-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
hemochromatosis NN I-NP B-Disease
( ( O O
HFE NN B-NP O
) ) O O
gene NN B-NP O
on IN B-PP O
chromosome NN B-NP O
6 CD I-NP O
, , O O
elevated JJ B-NP O
serum NN I-NP O
transferrin NN I-NP O
saturation NN I-NP O
, , O O
and CC O O
excess JJ B-NP B-Disease
iron NN I-NP I-Disease
deposits NNS I-NP I-Disease
throughout IN B-PP O
the DT B-NP O
body NN I-NP O
. . O O

To TO B-VP O
assess VB I-VP O
the DT B-NP O
prevalence NN I-NP O
and CC O O
clinical JJ B-NP O
expression NN I-NP O
of IN B-PP O
the DT B-NP O
HFE NN I-NP O
gene NN I-NP O
, , O O
we PRP B-NP O
conducted VBD B-VP O
a DT B-NP O
population NN I-NP O
- HYPH O O
based VBN B-NP O
study NN I-NP O
in IN B-PP O
Busselton NNP B-NP O
, , O O
Australia NNP B-NP O
. . O O

In IN B-PP O
1994 CD B-NP O
, , O O
we PRP B-NP O
obtained VBD B-VP O
blood NN B-NP O
samples NNS I-NP O
for IN B-PP O
the DT B-NP O
determination NN I-NP O
of IN B-PP O
serum NN B-NP O
transferrin NN I-NP O
saturation NN I-NP O
and CC I-NP O
ferritin NN I-NP O
levels NNS I-NP O
and CC O O
the DT B-NP O
presence NN I-NP O
or CC I-NP O
absence NN I-NP O
of IN B-PP O
the DT B-NP O
C282Y NN I-NP O
mutation NN I-NP O
and CC O O
the DT B-NP O
H63D NN I-NP O
mutation NN I-NP O
( ( O O
which WDT B-NP O
may MD B-VP O
contribute VB I-VP O
to TO B-PP O
increased VBN B-NP O
hepatic JJ I-NP O
iron NN I-NP O
levels NNS I-NP O
) ) O O
in IN B-PP O
3011 CD B-NP O
unrelated JJ I-NP O
white JJ I-NP O
adults NNS I-NP O
. . O O

We PRP B-NP O
evaluated VBD B-VP O
all DT B-NP O
subjects NNS I-NP O
who WP B-NP O
had VBD B-VP O
persistently RB I-VP O
elevated VBN I-VP O
transferrin NN B-NP O
- HYPH B-NP O
saturation NN I-NP O
values NNS I-NP O
( ( O O
45 CD B-NP O
percent NN I-NP O
or CC O O
higher JJR B-ADJP O
) ) O O
or CC O O
were VBD B-VP O
homozygous JJ B-ADJP O
for IN B-PP O
the DT B-NP O
C282Y NN I-NP O
mutation NN I-NP O
. . O O

We PRP B-NP O
recommended VBD B-VP O
liver NN B-NP O
biopsy NN I-NP O
for IN B-PP O
subjects NNS B-NP O
with IN B-PP O
serum NN B-NP O
ferritin NN I-NP O
levels NNS I-NP O
of IN B-PP O
300 CD B-NP O
ng NN I-NP O
per IN B-PP O
milliliter JJR B-ADJP O
or CC I-ADJP O
higher JJR I-ADJP O
. . O O

The DT B-NP O
subjects NNS I-NP O
were VBD B-VP O
followed VBN I-VP O
for IN B-PP O
up RB B-NP O
to TO I-NP O
four CD I-NP O
years NNS I-NP O
. . O O

RESULTS NNS B-NP O
Sixteen CD B-NP O
of IN B-PP O
the DT B-NP O
subjects NNS I-NP O
( ( O O
0 CD B-NP O
. . O O

5 CD B-NP O
percent NN I-NP O
) ) O O
were VBD B-VP O
homozygous JJ B-ADJP O
for IN B-PP O
the DT B-NP O
C282Y NN I-NP O
mutation NN I-NP O
, , O O
and CC O O
424 CD B-NP O
( ( O O
14 CD B-NP O
. . O O

1 CD B-NP O
percent NN I-NP O
) ) O O
were VBD B-VP O
heterozygous JJ B-ADJP O
. . O O

The DT B-NP O
serum NN I-NP O
transferrin NN I-NP O
saturation NN I-NP O
was VBD B-VP O
45 CD B-NP O
percent NN I-NP O
or CC O O
higher JJR B-ADJP O
in IN B-PP O
15 CD B-NP O
of IN B-PP O
the DT B-NP O
16 CD I-NP O
who WP B-NP O
were VBD B-VP O
homozygous JJ B-ADJP O
; : O O
in IN B-PP O
1 CD B-NP O
subject NN I-NP O
it PRP B-NP O
was VBD B-VP O
43 CD B-NP O
percent NN I-NP O
. . O O

Four CD B-NP O
of IN B-PP O
the DT B-NP O
homozygous JJ I-NP O
subjects NNS I-NP O
had VBD B-VP O
previously RB I-VP O
been VBN I-VP O
given VBN I-VP O
a DT B-NP O
diagnosis NN I-NP O
of IN B-PP O
hemochromatosis NN B-NP B-Disease
, , O O
and CC O O
12 CD B-NP O
had VBD B-VP O
not RB O O
. . O O

Seven CD B-NP O
of IN B-PP O
these DT B-NP O
12 CD I-NP O
patients NNS I-NP O
had VBD B-VP O
elevated VBN I-VP O
serum NN B-NP O
ferritin NN I-NP O
levels NNS I-NP O
in IN B-PP O
1994 CD B-NP O
; : O O
6 CD B-NP O
of IN B-PP O
the DT B-NP O
7 CD I-NP O
had VBD B-VP O
further JJ B-NP O
increases NNS I-NP O
in IN B-PP O
1998 CD B-NP O
, , O O
and CC O O
1 CD B-NP O
had VBD B-VP O
a DT B-NP O
decrease NN I-NP O
, , O O
although IN B-SBAR O
the DT B-NP O
value NN I-NP O
remained VBD B-VP O
elevated JJ B-ADJP O
. . O O

The DT B-NP O
serum NN I-NP O
ferritin NN I-NP O
levels NNS I-NP O
in IN B-PP O
the DT B-NP O
four CD I-NP O
other JJ I-NP O
homozygous JJ I-NP O
patients NNS I-NP O
remained VBD B-VP O
in IN B-PP O
the DT B-NP O
normal JJ I-NP O
range NN I-NP O
. . O O

Eleven CD B-NP O
of IN B-PP O
the DT B-NP O
16 CD I-NP O
homozygous JJ I-NP O
subjects NNS I-NP O
underwent VBD B-VP O
liver NN B-NP O
biopsy NN I-NP O
; : O O
3 CD B-NP O
had VBD B-VP O
hepatic JJ B-NP B-Disease
fibrosis NN I-NP I-Disease
, , O O
and CC O O
1 CD B-NP O
, , O O
who WP B-NP O
had VBD B-VP O
a DT B-NP O
history NN I-NP O
of IN B-PP O
excessive JJ B-NP B-Disease
alcohol NN I-NP I-Disease
consumption NN I-NP I-Disease
, , O O
had VBD B-VP O
cirrhosis NN B-NP B-Disease
and CC O O
mild JJ B-NP O
microvesicular JJ I-NP B-Disease
steatosis NN I-NP I-Disease
. . O O

Eight CD B-NP O
of IN B-PP O
the DT B-NP O
16 CD I-NP O
homozygous JJ I-NP O
subjects NNS I-NP O
had VBD B-VP O
clinical JJ B-NP O
findings NNS I-NP O
that WDT B-NP O
were VBD B-VP O
consistent JJ B-ADJP O
with IN B-PP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
hereditary JJ B-NP B-Disease
hemochromatosis NN I-NP I-Disease
, , O O
such JJ B-PP O
as IN I-PP O
hepatomegaly NN B-NP B-Disease
, , O O
skin NN B-NP B-Disease
pigmentation NN I-NP I-Disease
, , O O
and CC O O
arthritis NN B-NP B-Disease
. . O O

CONCLUSIONS NNS B-NP O
In IN B-PP O
a DT B-NP O
population NN I-NP O
of IN B-PP O
white JJ B-NP O
adults NNS I-NP O
of IN B-PP O
northern JJ B-NP O
European JJ I-NP O
ancestry NN I-NP O
, , O O
0 CD B-NP O
. . O O

5 CD B-NP O
percent NN I-NP O
were VBD B-VP O
homozygous JJ B-ADJP O
for IN B-PP O
the DT B-NP O
C282Y NN I-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
HFE NN I-NP O
gene NN I-NP O
. . O O

However RB B-ADVP O
, , O O
only RB B-NP O
half NN I-NP O
of IN B-PP O
those DT B-NP O
who WP B-NP O
were VBD B-VP O
homozygous JJ B-ADJP O
had VBD B-VP O
clinical JJ B-NP O
features NNS I-NP O
of IN B-PP O
hemochromatosis NN B-NP B-Disease
, , O O
and CC O O
one CD B-NP O
quarter NN I-NP O
had VBD B-VP O
serum NN B-NP O
ferritin NN I-NP O
levels NNS I-NP O
that WDT B-NP O
remained VBD B-VP O
normal JJ B-ADJP O
over IN B-PP O
a DT B-NP O
four CD I-NP O
- HYPH I-NP O
year NN I-NP O
period NN I-NP O
. . O O

Large JJ B-NP O
heterozygous JJ I-NP O
deletion NN I-NP O
masquerading VBG B-VP O
as IN B-PP O
homozygous JJ B-NP O
missense JJ I-NP O
mutation NN I-NP O
: : O O
a DT B-NP O
pitfall NN I-NP O
in IN B-PP O
diagnostic JJ B-NP O
mutation NN I-NP O
analysis NN I-NP O
. . O O

The DT B-NP O
clinical JJ I-NP O
use NN I-NP O
of IN B-PP O
molecular JJ B-NP O
analyses NNS I-NP O
in IN B-PP O
recessive JJ B-NP B-Disease
disorders NNS I-NP I-Disease
relies VBZ B-VP O
on IN B-PP O
the DT B-NP O
exact JJ I-NP O
characterization NN I-NP O
of IN B-PP O
both DT B-NP O
mutant JJ I-NP O
alleles NNS I-NP O
in IN B-PP O
the DT B-NP O
affected VBN I-NP O
patient NN I-NP O
. . O O

This DT B-NP O
can MD B-VP O
be VB I-VP O
problematic JJ B-ADJP O
when WRB B-ADVP O
only RB B-NP O
part NN I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
is VBZ B-VP O
examined VBN I-VP O
or CC O O
when WRB B-ADVP O
relevant JJ B-NP O
DNA NN I-NP O
alterations NNS I-NP O
are VBP B-VP O
not RB I-VP O
recognized VBN I-VP O
by IN B-PP O
standard JJ B-NP O
methods NNS I-NP O
. . O O

We PRP B-NP O
present VBP B-VP O
a DT B-NP O
child NN I-NP O
in IN B-PP O
whom WP B-NP O
phenylketonuria NN B-NP B-Disease
was VBD B-VP O
apparently RB I-VP O
caused VBN I-VP O
by IN B-PP O
homozygosity NN B-NP O
for IN B-PP O
the DT B-NP O
mutation NN I-NP O
E390G NN I-NP O
in IN B-PP O
exon NN B-NP O
11 CD I-NP O
of IN B-PP O
the DT B-NP O
phenylalanine NN I-NP O
hydroxylase NN I-NP O
( ( O O
PAH NN B-NP O
) ) O O
gene NN B-NP O
. . O O

However RB B-ADVP O
, , O O
the DT B-NP O
clinical JJ I-NP O
severity NN I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
was VBD B-VP O
not RB O O
quite RB B-ADVP O
as IN B-PP O
mild JJ B-ADJP O
as IN B-SBAR O
expected VBN B-VP O
, , O O
the DT B-NP O
mutation NN I-NP O
was VBD B-VP O
not RB I-VP O
identified VBN I-VP O
in IN B-PP O
the DT B-NP O
father NN I-NP O
despite IN B-PP O
confirmed VBN B-NP O
paternity NN I-NP O
, , O O
and CC O O
the DT B-NP O
paternal JJ I-NP O
allele NN I-NP O
showed VBD B-VP O
a DT B-NP O
highly RB I-NP O
unusual JJ I-NP O
pattern NN I-NP O
of IN B-PP O
polymorphic JJ B-NP O
markers NNS I-NP O
in IN B-PP O
the DT B-NP O
PAH NN I-NP O
gene NN I-NP O
. . O O

Presence NN B-NP O
of IN B-PP O
a DT B-NP O
large JJ I-NP O
deletion NN I-NP O
involving VBG B-VP O
exons NNS B-NP O
9 CD I-NP O
, , I-NP O
10 CD I-NP O
and CC I-NP O
11 CD I-NP O
of IN B-PP O
the DT B-NP O
phenylalanine NN I-NP O
hydroxylase NN I-NP O
gene NN I-NP O
was VBD B-VP O
confirmed VBN I-VP O
by IN B-PP O
long JJ B-NP O
- HYPH I-NP O
range NN I-NP O
PCR NN I-NP O
. . O O

Diagnostic JJ B-NP O
DNA NN I-NP O
analyses NNS I-NP O
should MD B-VP O
include VB I-VP O
a DT B-NP O
comprehensive JJ I-NP O
examination NN I-NP O
of IN B-PP O
the DT B-NP O
whole JJ I-NP O
relevant JJ I-NP O
gene NN I-NP O
in IN B-PP O
the DT B-NP O
patient NN I-NP O
and CC I-NP O
confirmation NN I-NP O
of IN B-PP O
carrier NN B-NP O
status NN I-NP O
in IN B-PP O
both DT B-NP O
parents NNS I-NP O
. . O O

. . O O

Early RB B-NP O
onset NN I-NP O
of IN B-PP O
X NN B-NP B-Disease
- HYPH O I-Disease
linked VBN B-VP I-Disease
Emery NNP B-NP I-Disease
- HYPH I-NP I-Disease
Dreifuss NNP I-NP I-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
in IN B-PP O
a DT B-NP O
boy NN I-NP O
with IN B-PP O
emerin NN B-NP O
gene NN I-NP O
deletion NN I-NP O
. . O O

A DT B-NP O
boy NN I-NP O
developed VBD B-VP O
contractures NNS B-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
Achilles NNP I-NP I-Disease
tendons NNS I-NP I-Disease
at IN B-PP O
3 CD B-NP O
years NNS I-NP O
and CC B-PP O
of IN B-PP O
the DT B-NP O
postcervical JJ I-NP O
muscles NNS I-NP O
at IN B-PP O
7 CD B-NP O
years NNS I-NP O
, , O O
although IN B-SBAR O
neither DT B-NP O
contractures NNS I-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
elbows NNS I-NP I-Disease
nor CC O O
cardiac JJ B-NP B-Disease
abnormality NN I-NP I-Disease
were VBD B-VP O
recognized VBN I-VP O
by IN B-PP O
the DT B-NP O
age NN I-NP O
of IN B-PP O
9 CD B-NP O
years NNS I-NP O
. . O O

Muscle NN B-NP O
computed VBD B-VP O
tomography NN B-NP O
scanning NN I-NP O
revealed VBD B-VP O
changes NNS B-NP O
characteristic JJ B-ADJP O
of IN B-PP O
muscle NN B-NP O
involvement NN I-NP O
. . O O

Emerin NN B-NP O
was VBD B-VP O
not RB I-VP O
detected VBN I-VP O
in IN B-PP O
the DT B-NP O
biopsied VBN I-NP O
muscle NN I-NP O
, , O O
and CC O O
RT NN B-NP O
- HYPH B-NP O
PCR NN I-NP O
and CC I-NP O
PCR NN I-NP O
- HYPH O O
based VBN B-VP O
genomic JJ B-NP O
DNA NN I-NP O
analyses NNS I-NP O
of IN B-PP O
the DT B-NP O
emerin NN I-NP O
gene NN I-NP O
demonstrated VBD B-VP O
no DT B-NP O
amplification NN I-NP O
product NN I-NP O
in IN B-PP O
the DT B-NP O
patient NN I-NP O
. . O O

These DT B-NP O
results NNS I-NP O
confirmed VBD B-VP O
the DT B-NP O
diagnosis NN I-NP O
of IN B-PP O
X NN B-NP B-Disease
- HYPH O I-Disease
linked VBN B-VP I-Disease
Emery NNP B-NP I-Disease
- HYPH I-NP I-Disease
Dreifuss NNP I-NP I-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
EDMD NN B-NP B-Disease
) ) O O
, , O O
and CC O O
reinforce VB B-VP O
the DT B-NP O
necessity NN I-NP O
of IN B-PP O
molecular JJ B-NP O
genetic JJ I-NP O
diagnosis NN I-NP O
of IN B-PP O
the DT B-NP O
membrane NN I-NP O
protein NN I-NP O
emerin NN I-NP O
in IN B-PP O
younger JJR B-NP O
patients NNS I-NP O
with IN B-PP O
possible JJ B-NP O
EDMD NN I-NP B-Disease
before IN B-PP O
appearance NN B-NP O
of IN B-PP O
the DT B-NP O
typical JJ I-NP O
symptoms NNS I-NP O
, , O O
to TO B-VP O
avoid VB I-VP O
sudden JJ B-NP B-Disease
cardiac JJ I-NP I-Disease
death NN I-NP I-Disease
. . O O

. . O O

Duchenne NN B-NP B-Disease
/ SYM I-NP I-Disease
Becker NN I-NP I-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
: : O O
correlation NN B-NP O
of IN B-PP O
phenotype NN B-NP O
by IN B-PP O
electroretinography NN B-NP O
with IN B-PP O
sites NNS B-NP O
of IN B-PP O
dystrophin NN B-NP O
mutations NNS I-NP O
. . O O

The DT B-NP O
dark NN I-NP O
- HYPH O O
adapted VBN B-VP O
electroretinogram NN B-NP O
( ( O O
ERG NN B-NP O
) ) O O
of IN B-PP O
patients NNS B-NP O
with IN B-PP O
Duchenne NNP B-NP B-Disease
and CC I-NP I-Disease
Becker NNP I-NP I-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
DMD NN B-NP B-Disease
/ SYM B-NP O
BMD NN I-NP B-Disease
) ) O O
shows VBZ B-VP O
a DT B-NP O
marked JJ I-NP O
reduction NN I-NP O
in IN B-PP O
b NN B-NP O
- HYPH B-NP O
wave NN I-NP O
amplitude NN I-NP O
. . O O

Genotype NN B-NP O
- HYPH I-NP O
phenotype NN I-NP O
studies NNS I-NP O
of IN B-PP O
mouse NN B-NP O
models NNS I-NP O
for IN B-PP O
DMD NN B-NP B-Disease
show VBP B-VP O
position NN B-NP O
- HYPH B-NP O
specific JJ I-NP O
effects NNS I-NP O
of IN B-PP O
the DT B-NP O
mutations NNS I-NP O
upon IN B-PP O
the DT B-NP O
phenotype NN I-NP O
mice NNS I-NP O
with IN B-PP O
5 CD B-NP O
defects NNS I-NP O
of IN B-PP O
dystrophin NN B-NP O
have VBP B-VP O
normal JJ B-NP O
ERGs NNS I-NP O
, , O O
those DT B-NP O
with IN B-PP O
defects NNS B-NP O
in IN B-PP O
the DT B-NP O
central JJ I-NP O
region NN I-NP O
have VBP B-VP O
a DT B-NP O
normal JJ I-NP O
b NN I-NP O
- HYPH B-NP O
wave NN I-NP O
amplitude NN I-NP O
associated VBN B-VP O
with IN B-PP O
prolonged JJ B-NP O
implicit JJ I-NP O
times NNS I-NP O
for IN B-PP O
both CC O O
the DT B-NP O
b NN I-NP O
- HYPH B-NP O
wave NN I-NP O
and CC O O
oscillatory JJ B-NP O
potentials NNS I-NP O
, , O O
and CC O O
mice NNS B-NP O
with IN B-PP O
3 CD B-NP O
defects NNS I-NP O
have VBP B-VP O
a DT B-NP O
phenotype NN I-NP O
similar JJ B-ADJP O
to TO B-PP O
that DT B-NP O
seen VBN B-VP O
in IN B-PP O
DMD NN B-NP B-Disease
/ SYM B-NP O
BMD NN B-NP B-Disease
patients NNS I-NP O
. . O O

The DT B-NP O
mouse NN I-NP O
studies NNS I-NP O
suggest VBP B-VP O
a DT B-NP O
key JJ I-NP O
role NN I-NP O
for IN B-PP O
the DT B-NP O
carboxyl NN I-NP O
terminal JJ I-NP O
dystrophin NN I-NP O
isoform NN I-NP O
, , O O
Dp260 NN B-NP O
, , O O
in IN B-PP O
retinal JJ B-NP O
electrophysiology NN I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
undertaken VBN I-VP O
a DT B-NP O
systematic JJ I-NP O
evaluation NN I-NP O
of IN B-PP O
DMD NN B-NP B-Disease
/ SYM O O
BMD NN B-NP B-Disease
patients NNS I-NP O
through IN B-PP O
clinical JJ B-NP O
examination NN I-NP O
and CC I-NP O
review NN I-NP O
of IN B-PP O
the DT B-NP O
literature NN I-NP O
in IN B-SBAR O
order NN O O
to TO B-VP O
determine VB I-VP O
whether IN B-SBAR O
the DT B-NP O
position NN I-NP O
- HYPH B-NP O
specific JJ I-NP O
effects NNS I-NP O
of IN B-PP O
mutations NNS B-NP O
noted VBN B-VP O
in IN B-PP O
the DT B-NP O
mouse NN I-NP O
are VBP B-VP O
present JJ B-ADJP O
in IN B-PP O
man NN B-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
found VBN I-VP O
that IN B-SBAR O
, , O O
in IN B-PP O
man NN B-NP O
, , O O
a DT B-NP O
wider JJR I-NP O
variation NN I-NP O
of IN B-PP O
DMD NN B-NP B-Disease
defects NNS I-NP I-Disease
correlate VBP B-VP O
with IN B-PP O
reductions NNS B-NP O
in IN B-PP O
the DT B-NP O
b NN I-NP O
- HYPH B-NP O
wave NN I-NP O
amplitude NN I-NP O
. . O O

Individuals NNS B-NP O
with IN B-PP O
normal JJ B-NP O
ERGs NNS I-NP O
have VBP B-VP O
mutations NNS B-NP O
predominantly RB B-ADJP O
located JJ I-ADJP O
5 CD B-NP O
of IN B-PP O
the DT B-NP O
transcript NN I-NP O
initiation NN I-NP O
site NN I-NP O
of IN B-PP O
Dp260 NN B-NP O
. . O O

Our PRP$ B-NP O
results NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
the DT B-NP O
most RBS I-NP O
important JJ I-NP O
determinant NN I-NP O
in IN B-PP O
the DT B-NP O
ERG NN I-NP O
b NN I-NP O
- HYPH B-NP O
wave NN I-NP O
phenotype NN I-NP O
is VBZ B-VP O
the DT B-NP O
mutation NN I-NP O
position NN I-NP O
, , O O
rather RB B-PP O
than IN I-PP O
muscle NN B-NP B-Disease
disease NN I-NP I-Disease
severity NN I-NP O
. . O O

Forty CD B-NP O
- HYPH I-NP O
six CD I-NP O
per IN B-PP O
cent NN B-NP O
of IN B-PP O
patients NNS B-NP O
with IN B-PP O
mutations NNS B-NP O
5 CD B-NP O
of IN B-PP O
the DT B-NP O
Dp260 NN I-NP O
transcript NN I-NP O
start NN I-NP O
site NN I-NP O
have VBP B-VP O
abnormal JJ B-NP O
ERGs NNS I-NP O
, , O O
as IN B-SBAR O
opposed VBN B-VP O
to TO B-PP O
94 CD B-NP O
% NN I-NP O
with IN B-PP O
more RBR B-NP O
distal JJ I-NP O
mutations NNS I-NP O
. . O O

The DT B-NP O
human JJ I-NP O
genotype NN I-NP O
- HYPH I-NP O
phenotype NN I-NP O
correlations NNS I-NP O
are VBP B-VP O
consistent JJ B-ADJP O
with IN B-PP O
a DT B-NP O
role NN I-NP O
for IN B-PP O
Dp260 NN B-NP O
in IN B-PP O
normal JJ B-NP O
retinal JJ I-NP O
electrophysiology NN I-NP O
and CC O O
may MD B-VP O
also RB I-VP O
reflect VB I-VP O
the DT B-NP O
expression NN I-NP O
of IN B-PP O
other JJ B-NP O
C NN I-NP O
- HYPH B-NP O
terminal JJ I-NP O
dystrophin NN I-NP O
isoforms NNS I-NP O
and CC O O
their PRP$ B-NP O
contributions NNS I-NP O
to TO B-PP O
retinal JJ B-NP O
signal NN I-NP O
transmission NN I-NP O
. . O O

. . O O

Cis NN B-NP O
and CC I-NP O
trans JJ I-NP O
effects NNS I-NP O
of IN B-PP O
the DT B-NP O
myotonic JJ I-NP B-Disease
dystrophy NN I-NP I-Disease
( ( O O
DM NN B-NP B-Disease
) ) O O
mutation NN B-NP O
in IN B-PP O
a DT B-NP O
cell NN I-NP O
culture NN I-NP O
model NN I-NP O
. . O O

The DT B-NP O
mutation NN I-NP O
causing VBG B-VP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
( ( O O
DM NN B-NP B-Disease
) ) O O
has VBZ B-VP O
been VBN I-VP O
identified VBN I-VP O
as IN B-PP O
a DT B-NP O
CTG NN I-NP O
expansion NN I-NP O
in IN B-PP O
the DT B-NP O
3 CD I-NP O
- HYPH I-NP O
untranslated JJ I-NP O
region NN I-NP O
( ( O O
3 CD B-NP O
- HYPH I-NP O
UTR NN I-NP O
) ) O O
of IN B-PP O
the DT B-NP O
DM NN I-NP B-Disease
protein NN I-NP O
kinase NN I-NP O
gene NN I-NP O
( ( O O
DMPK NN B-NP O
) ) O O
, , O O
but CC O O
the DT B-NP O
mechanism NN I-NP O
( ( I-NP O
s NNS I-NP O
) ) O O
of IN B-PP O
pathogenesis NN B-NP O
remain VBP B-VP O
unknown JJ B-ADJP O
. . O O

Studies NNS B-NP O
using VBG B-VP O
DM NN B-NP B-Disease
patient NN I-NP O
materials NNS I-NP O
have VBP B-VP O
often RB I-VP O
produced VBN I-VP O
confusing JJ B-NP O
results NNS I-NP O
. . O O

Therefore RB B-ADVP O
, , O O
to TO B-VP O
study VB I-VP O
the DT B-NP O
effects NNS I-NP O
of IN B-PP O
the DT B-NP O
DM NN I-NP B-Disease
mutation NN I-NP O
in IN B-PP O
a DT B-NP O
controlled JJ I-NP O
environment NN I-NP O
, , O O
we PRP B-NP O
have VBP B-VP O
established VBN I-VP O
a DT B-NP O
cell NN I-NP O
culture NN I-NP O
model NN I-NP O
system NN I-NP O
using VBG B-VP O
C2C12 NN B-NP O
mouse NN I-NP O
myoblasts NNS I-NP O
. . O O

By IN B-PP O
expressing VBG B-VP O
chimeric JJ B-NP O
reporter NN I-NP O
constructs NNS I-NP O
containing VBG B-VP O
a DT B-NP O
reporter NN I-NP O
gene NN I-NP O
fused VBN B-VP O
to TO B-PP O
a DT B-NP O
human JJ I-NP O
DMPK NN I-NP O
3 CD I-NP O
- HYPH I-NP O
UTR NN I-NP O
, , O O
we PRP B-NP O
identified VBD B-VP O
both CC O O
cis NNS B-NP O
and CC O O
trans JJ B-NP O
effects NNS I-NP O
that WDT B-NP O
are VBP B-VP O
mediated VBN I-VP O
by IN B-PP O
the DT B-NP O
DM NN I-NP B-Disease
mutation NN I-NP O
. . O O

Our PRP$ B-NP O
data NNS I-NP O
show VBP B-VP O
that IN B-SBAR O
a DT B-NP O
mutant JJ I-NP O
DMPK NN I-NP O
3 CD I-NP O
- HYPH I-NP O
UTR NN I-NP O
, , O O
with IN B-PP O
as RB B-ADJP O
few JJ I-ADJP O
as IN B-PP O
57 CD B-NP O
CTGs NNS I-NP O
, , O O
had VBD B-VP O
a DT B-NP O
negative JJ I-NP O
cis NN I-NP O
effect NN I-NP O
on IN B-PP O
protein NN B-NP O
expression NN I-NP O
and CC O O
resulted VBD B-VP O
in IN B-PP O
the DT B-NP O
aggregation NN I-NP O
of IN B-PP O
reporter NN B-NP O
transcripts NNS I-NP O
into IN B-PP O
discrete JJ B-NP O
nuclear JJ I-NP O
foci NNS I-NP O
. . O O

We PRP B-NP O
determined VBD B-VP O
by IN B-PP O
deletion NN B-NP O
analysis NN I-NP O
that IN B-NP O
an DT B-NP O
expanded JJ I-NP O
( ( O O
CTG NN B-NP O
) ) O O
( ( O O
n NN B-NP O
) ) O O
tract NN B-NP O
alone RB B-ADVP O
was VBD B-VP O
sufficient JJ B-ADJP O
to TO B-VP O
mediate VB I-VP O
these DT B-NP O
cis JJ I-NP O
effects NNS I-NP O
. . O O

Furthermore RB B-ADVP O
, , O O
in IN B-PP O
contrast NN B-NP O
to TO B-PP O
the DT B-NP O
normal JJ I-NP O
DMPK NN I-NP O
3 CD I-NP O
- HYPH I-NP O
UTR NN I-NP O
mRNA NN I-NP O
, , O O
a DT B-NP O
mutant JJ I-NP O
DMPK NN I-NP O
3 CD I-NP O
- HYPH I-NP O
UTR NN I-NP O
mRNA NN I-NP O
with IN B-PP O
( ( O O
CUG NN B-NP O
) ) O O
( ( O O
200 CD B-NP O
) ) O O
selectively RB B-ADVP O
inhibited VBD B-VP O
myogenic JJ B-NP O
differentiation NN I-NP O
of IN B-PP O
C2C12 NN B-NP O
myoblasts NNS I-NP O
. . O O

Genetic JJ B-NP O
analysis NN I-NP O
and CC O O
the DT B-NP O
Cre NN I-NP O
- HYPH I-NP O
loxP NN I-NP O
system NN I-NP O
were VBD B-VP O
used VBN I-VP O
to TO B-VP O
clearly RB I-VP O
demonstrate VB I-VP O
that IN B-SBAR O
the DT B-NP O
myoblast NN I-NP O
fusion NN I-NP O
defect NN I-NP O
could MD B-VP O
be VB I-VP O
rescued VBN I-VP O
by IN B-PP O
eliminating VBG B-VP O
the DT B-NP O
expression NN I-NP O
of IN B-PP O
the DT B-NP O
mutant JJ I-NP O
DMPK NN I-NP O
3 CD I-NP O
- HYPH I-NP O
UTR NN I-NP O
transcript NN I-NP O
. . O O

Characterization NN B-NP O
of IN B-PP O
spontaneous JJ B-NP O
deletion NN I-NP O
events NNS I-NP O
mapped VBD B-VP O
the DT B-NP O
inhibitory JJ I-NP O
effect NN I-NP O
to TO B-PP O
the DT B-NP O
( ( O O
CTG NN O O
) ) O O
( ( O O
n NN B-NP O
) ) O O
expansion NN B-NP O
and CC O O
/ SYM B-NP O
or CC O O
the DT B-NP O
3 CD I-NP O
end NN I-NP O
of IN B-PP O
the DT B-NP O
DMPK NN I-NP O
3 CD I-NP O
- HYPH I-NP O
UTR NN I-NP O
. . O O

These DT B-NP O
results NNS I-NP O
provide VBP B-VP O
evidence NN B-NP O
that IN B-SBAR O
the DT B-NP O
DM NN I-NP B-Disease
mutation NN I-NP O
acts VBZ B-VP O
in IN B-PP O
cis NNS B-NP O
to TO B-VP O
reduce VB I-VP O
protein NN B-NP O
production NN I-NP O
( ( O O
consistent JJ B-ADJP O
with IN B-PP O
DMPK NN B-NP B-Disease
haploinsufficiency NN I-NP I-Disease
) ) O O
and CC O O
in IN B-PP O
trans NNS B-NP O
as IN B-PP O
a DT B-NP O
riboregulator NN I-NP O
to TO B-VP O
inhibit VB I-VP O
myogenesis NN B-NP O
. . O O

. . O O

Coats NNS B-NP B-Disease
' POS B-NP I-Disease
disease NN I-NP I-Disease
of IN B-PP O
the DT B-NP O
retina NN I-NP O
( ( O O
unilateral JJ B-NP B-Disease
retinal JJ I-NP I-Disease
telangiectasis NN I-NP I-Disease
) ) O O
caused VBN B-VP O
by IN B-PP O
somatic JJ B-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
NDP NN I-NP O
gene NN I-NP O
: : O O
a DT B-NP O
role NN I-NP O
for IN B-PP O
norrin NN B-NP O
in IN B-PP O
retinal JJ B-NP O
angiogenesis NN I-NP O
. . O O

Coats NNS B-NP B-Disease
disease NN I-NP I-Disease
is VBZ B-VP O
characterized VBN I-VP O
by IN B-PP O
abnormal JJ B-NP B-Disease
retinal JJ I-NP I-Disease
vascular JJ I-NP I-Disease
development NN I-NP I-Disease
( ( O O
so RB O O
- HYPH O O
called VBN B-VP O
retinal JJ B-NP B-Disease
telangiectasis NN I-NP I-Disease
) ) O O
which WDT B-NP O
results VBZ B-VP O
in IN B-PP O
massive JJ B-NP O
intraretinal JJ I-NP B-Disease
and CC I-NP I-Disease
subretinal JJ I-NP I-Disease
lipid NN I-NP I-Disease
accumulation NN I-NP I-Disease
( ( O O
exudative JJ B-NP B-Disease
retinal JJ I-NP I-Disease
detachment NN I-NP I-Disease
) ) O O
. . O O

The DT B-NP O
classical JJ I-NP O
form NN I-NP O
of IN B-PP O
Coats NNS B-NP B-Disease
disease NN I-NP I-Disease
is VBZ B-VP O
almost RB I-VP O
invariably RB I-VP O
isolated VBN I-VP O
, , O O
unilateral JJ B-ADJP O
and CC O O
seen VBN B-VP O
in IN B-PP O
males NNS B-NP O
. . O O

A DT B-NP O
female NN I-NP O
with IN B-PP O
a DT B-NP O
unilateral JJ I-NP O
variant NN I-NP O
of IN B-PP O
Coats NNS B-NP B-Disease
disease NN I-NP I-Disease
gave VBD B-VP O
birth NN B-NP O
to TO B-PP O
a DT B-NP O
son NN I-NP O
affected VBN B-VP O
by IN B-PP O
Norrie NNP B-NP B-Disease
disease NN I-NP I-Disease
. . O O

Both DT B-NP O
carried VBD B-VP O
a DT B-NP O
missense JJ I-NP O
mutation NN I-NP O
within IN B-PP O
the DT B-NP O
NDP NN I-NP O
gene NN I-NP O
on IN B-PP O
chromosome NN B-NP O
Xp11 NN I-NP O
. . O O

2 CD B-NP O
2 CD I-NP O
. . O O

Subsequently RB B-NP O
analysis NN I-NP O
of IN B-PP O
the DT B-NP O
retinas NNS I-NP O
of IN B-PP O
nine CD B-NP O
enucleated VBN I-NP O
eyes NNS I-NP O
from IN B-PP O
males NNS B-NP O
with IN B-PP O
Coats NNS B-NP B-Disease
disease NN I-NP I-Disease
demonstrated VBD B-VP O
in IN B-PP O
one CD B-NP O
a DT B-NP O
somatic JJ I-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
NDP NN I-NP O
gene NN I-NP O
which WDT B-NP O
was VBD B-VP O
not RB O O
present JJ B-ADJP O
within IN B-PP O
non AFX B-NP O
- HYPH I-NP O
retinal JJ I-NP O
tissue NN I-NP O
. . O O

We PRP B-NP O
suggest VBP B-VP O
that IN B-SBAR O
Coats NNS B-NP B-Disease
telangiectasis NN I-NP I-Disease
is VBZ B-VP O
secondary JJ B-ADJP O
to TO B-PP O
somatic JJ B-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
NDP NN I-NP O
gene NN I-NP O
which WDT B-NP O
results VBZ B-VP O
in IN B-PP O
a DT B-NP O
deficiency NN I-NP B-Disease
of IN B-PP I-Disease
norrin NN B-NP I-Disease
( ( O O
the DT B-NP O
protein NN I-NP O
product NN I-NP O
of IN B-PP O
the DT B-NP O
NDP NN I-NP O
gene NN I-NP O
) ) O O
within IN B-PP O
the DT B-NP O
developing VBG I-NP O
retina NN I-NP O
. . O O

This DT B-NP O
supports VBZ B-VP O
recent JJ B-NP O
observations NNS I-NP O
that IN B-SBAR O
the DT B-NP O
protein NN I-NP O
is VBZ B-VP O
critical JJ B-ADJP O
for IN B-PP O
normal JJ B-NP O
retinal JJ I-NP O
vasculogenesis NN I-NP O
. . O O

Hereditary JJ B-NP O
TP53 NN I-NP O
codon NN I-NP O
292 CD I-NP O
and CC O O
somatic JJ B-NP O
P16INK4A NN I-NP O
codon NN I-NP O
94 CD B-NP O
mutations NNS I-NP O
in IN B-PP O
a DT B-NP O
Li NNP I-NP B-Disease
- HYPH I-NP I-Disease
Fraumeni NNP I-NP I-Disease
syndrome NN I-NP I-Disease
family NN I-NP O
. . O O

Li NNP B-NP B-Disease
- HYPH I-NP I-Disease
Fraumeni NNP I-NP I-Disease
syndrome NN I-NP I-Disease
is VBZ B-VP O
an DT B-NP O
autosomal JJ I-NP B-Disease
dominant JJ I-NP I-Disease
disorder NN I-NP I-Disease
that WDT B-NP O
is VBZ B-VP O
characterized VBN I-VP O
by IN B-PP O
various JJ B-NP O
types NNS I-NP O
of IN B-PP O
cancer NN B-NP B-Disease
in IN B-PP O
childhood NN B-NP O
and CC O O
adult JJ B-NP O
cases NNS I-NP O
. . O O

Although IN B-SBAR O
hereditary JJ B-NP O
TP53 NN I-NP O
mutation NN I-NP O
is VBZ B-VP O
very RB B-ADJP O
rare JJ I-ADJP O
in IN B-PP O
different JJ B-NP O
human JJ I-NP O
cancers NNS I-NP B-Disease
, , O O
it PRP B-NP O
has VBZ B-VP O
been VBN I-VP O
frequently RB I-VP O
reported VBN I-VP O
in IN B-PP O
Li NNP B-NP B-Disease
- HYPH I-NP I-Disease
Fraumeni NNP I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

On IN B-PP O
the DT B-NP O
other JJ I-NP O
hand NN I-NP O
, , O O
hereditary JJ B-NP O
mutations NNS I-NP O
of IN B-PP O
TP57KIP2 NN B-NP O
, , O O
P15INK4B NN B-NP O
, , O O
and CC O O
P16INK4A NN B-NP O
, , O O
which WDT B-NP O
affect VBP B-VP O
the DT B-NP O
cell NN I-NP O
cycle NN I-NP O
similar JJ B-ADJP O
to TO B-PP O
TP53 NN B-NP O
, , O O
were VBD B-VP O
observed VBN I-VP O
in IN B-PP O
some DT B-NP O
types NNS I-NP O
of IN B-PP O
cancer NN B-NP B-Disease
. . O O

In IN B-PP O
a DT B-NP O
Turkish JJ I-NP O
family NN I-NP O
with IN B-PP O
the DT B-NP O
diagnosis NN I-NP O
of IN B-PP O
Li NNP B-NP B-Disease
- HYPH I-NP I-Disease
Fraumeni NNP I-NP I-Disease
syndrome NN I-NP I-Disease
, , O O
we PRP B-NP O
analyzed VBD B-VP O
the DT B-NP O
mutation NN I-NP O
pattern NN I-NP O
of IN B-PP O
TP53 NN B-NP O
, , O O
P57KIP2 NN B-NP O
, , O O
P15INK4B NN B-NP O
, , O O
and CC O O
P16INK4A NN B-NP O
in IN B-PP O
the DT B-NP O
peripheral JJ I-NP O
blood NN I-NP O
, , O O
and CC O O
loss NN B-NP O
of IN B-PP O
heterozygosity NN B-NP O
( ( O O
homo NN B-NP O
/ SYM O O
hemizygous JJ B-NP O
deletion NN I-NP O
) ) O O
pattern NN B-NP O
of IN B-PP O
TP53 NN B-NP O
and CC I-NP O
P15INK4B NN I-NP O
/ SYM B-NP O
P16INK4A NN I-NP O
in IN B-PP O
two CD B-NP O
tumor NN I-NP B-Disease
tissues NNS I-NP O
. . O O

The DT B-NP O
propositus NN I-NP O
had VBD B-VP O
a DT B-NP O
seminoma NN I-NP B-Disease
, , O O
his PRP$ B-NP O
daughter NN I-NP O
a DT B-NP O
medulloblastoma NN I-NP B-Disease
, , O O
and CC O O
one CD B-NP O
of IN B-PP O
his PRP$ B-NP O
healthy JJ I-NP O
cousins NNS I-NP O
, , O O
a DT B-NP O
TP53 NN I-NP O
codon NN I-NP O
292 CD I-NP O
missense JJ I-NP O
point NN I-NP O
mutation NN I-NP O
( ( O O
AAA NN B-NP O
- SYM O O
- HYPH B-NP O
> SYM I-NP O
ATA NN I-NP O
; : O O
Lys SYM B-NP O
- SYM B-NP O
- HYPH I-NP O
> SYM I-NP O
Ile NN I-NP O
) ) O O
in IN B-PP O
the DT B-NP O
peripheral JJ I-NP O
blood NN I-NP O
cells NNS I-NP O
. . O O

Tumor NN B-NP O
tissue NN I-NP O
obtained VBN B-VP O
from IN B-PP O
the DT B-NP O
propositus NN I-NP O
with IN B-PP O
the DT B-NP O
seminoma NN I-NP B-Disease
revealed VBD B-VP O
loss NN B-NP O
of IN B-PP O
heterozygosity NN B-NP O
in IN B-PP O
the DT B-NP O
TP53 NN I-NP O
gene NN I-NP O
. . O O

In IN B-PP O
the DT B-NP O
analyses NNS I-NP O
of IN B-PP O
tumor NN B-NP B-Disease
tissues NNS I-NP O
from IN B-PP O
the DT B-NP O
propositus NN I-NP O
and CC O O
his PRP$ B-NP O
daughter NN I-NP O
, , O O
a DT B-NP O
P16INK4A NN I-NP O
codon NN I-NP O
94 CD I-NP O
missense JJ I-NP O
point NN I-NP O
mutation NN I-NP O
( ( O O
GCG NN B-NP O
- SYM O O
- HYPH O O
> SYM O O
GAG NN B-NP O
; : O O
Ala NN B-NP O
- SYM B-NP O
- HYPH B-NP O
> SYM I-NP O
Glu NN I-NP O
) ) O O
was VBD B-VP O
observed VBN I-VP O
with IN B-PP O
the DT B-NP O
hereditary JJ I-NP O
TP53 NN I-NP O
mutation NN I-NP O
. . O O

P16INK4A NN B-NP O
codon NN I-NP O
94 CD I-NP O
mutation NN I-NP O
observed VBN B-VP O
in IN B-PP O
our PRP$ B-NP O
family NN I-NP O
is VBZ B-VP O
a DT B-NP O
novel JJ I-NP O
mutation NN I-NP O
in IN B-PP O
Li NNP B-NP B-Disease
- HYPH B-NP I-Disease
Fraumeni NNP I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

No DT B-NP O
other JJ I-NP O
gene NN I-NP O
alteration NN I-NP O
in IN B-PP O
TP53 NN B-NP O
, , O O
P57KIP2 NN B-NP O
, , O O
P15INK4B NN B-NP O
, , O O
and CC O O
P16INK4A NN B-NP O
was VBD B-VP O
observed VBN I-VP O
. . O O

Existence NN B-NP O
of IN B-PP O
the DT B-NP O
P16INK4A NN I-NP O
mutation NN I-NP O
and CC O O
the DT B-NP O
hereditary JJ I-NP O
TP53 NN I-NP O
mutation NN I-NP O
with IN B-PP O
or CC B-PP O
without IN B-PP O
loss NN B-NP O
of IN B-PP O
heterozygosity NN B-NP O
in IN B-PP O
the DT B-NP O
TP53 NN I-NP O
gene NN I-NP O
( ( O O
seminoma NN B-NP B-Disease
/ SYM B-NP O
medulloblastoma NN I-NP B-Disease
) ) O O
may MD B-VP O
be VB I-VP O
evidence NN B-NP O
for IN B-PP O
a DT B-NP O
common JJ I-NP O
mechanism NN I-NP O
involved VBN B-VP O
in IN B-PP O
tumorogenesis NN B-NP B-Disease
. . O O

The DT B-NP O
gene NN I-NP O
alterations NNS I-NP O
in IN B-PP O
TP53 NN B-NP O
and CC I-NP O
P16INK4A NN I-NP O
genes NNS I-NP O
may MD B-VP O
be VB I-VP O
used VBN I-VP O
as IN B-PP O
tumor NN B-NP B-Disease
markers NNS I-NP O
in IN B-PP O
our PRP$ B-NP O
family NN I-NP O
. . O O

. . O O

A DT B-NP O
novel JJ I-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
sodium NN I-NP O
/ SYM B-NP O
iodide NN I-NP O
symporter NN I-NP O
gene NN I-NP O
in IN B-PP O
the DT B-NP O
largest JJS I-NP O
family NN I-NP O
with IN B-PP O
iodide NN B-NP B-Disease
transport NN I-NP I-Disease
defect NN I-NP I-Disease
. . O O

We PRP B-NP O
previously RB B-ADVP O
reported VBD B-VP O
nine CD B-NP O
children NNS I-NP O
with IN B-PP O
an DT B-NP O
autosomally RB I-NP O
recessive JJ I-NP O
form NN I-NP O
of IN B-PP O
congenital JJ B-NP B-Disease
hypothyroidism NN I-NP I-Disease
due JJ B-PP O
to TO B-PP O
an DT B-NP O
iodide NN I-NP B-Disease
transport NN I-NP I-Disease
defect NN I-NP I-Disease
in IN B-PP O
a DT B-NP O
large JJ I-NP O
Hutterite NNP I-NP O
family NN I-NP O
with IN B-PP O
extensive JJ B-NP O
consanguinity NN I-NP O
living VBG B-VP O
in IN B-PP O
central JJ B-NP O
Canada NNP I-NP O
. . O O

Since IN B-SBAR O
the DT B-NP O
original JJ I-NP O
report NN I-NP O
, , O O
we PRP B-NP O
have VBP B-VP O
diagnosed VBN I-VP O
congenital JJ B-NP B-Disease
hypothyroidism NN I-NP I-Disease
by IN B-PP O
newborn JJ B-NP O
TSH NN I-NP O
screening NN I-NP O
in IN B-PP O
9 CD B-NP O
additional JJ I-NP O
children NNS I-NP O
from IN B-PP O
the DT B-NP O
family NN I-NP O
. . O O

We PRP B-NP O
performed VBD B-VP O
direct JJ B-NP O
sequencing NN I-NP O
of IN B-PP O
the DT B-NP O
PCR NN I-NP O
products NNS I-NP O
of IN B-PP O
each DT B-NP O
NIS NN I-NP O
( ( O O
sodium NN B-NP O
/ SYM O O
iodide NN B-NP O
symporter NN I-NP O
) ) O O
gene NN B-NP O
exon NN I-NP O
with IN B-PP O
flanking VBG B-VP O
introns NNS B-NP O
amplified VBN B-VP O
from IN B-PP O
genomic JJ B-NP O
DNA NN I-NP O
extracted VBN B-VP O
from IN B-PP O
peripheral JJ B-NP O
blood NN I-NP O
cells NNS I-NP O
of IN B-PP O
the DT B-NP O
patients NNS I-NP O
. . O O

We PRP B-NP O
identified VBD B-VP O
a DT B-NP O
novel JJ I-NP O
NIS NN I-NP O
gene NN I-NP O
mutation NN I-NP O
, , O O
G395R NN B-NP O
( ( O O
Gly395 NN B-NP O
- SYM O O
- HYPH O O
> SYM O O
Arg NN B-NP O
; : O O
GGA NN B-NP O
- SYM B-NP O
- HYPH B-NP O
> SYM I-NP O
AGA NN I-NP O
) ) O O
, , O O
in IN B-PP O
10 CD B-NP O
patients NNS I-NP O
examined VBN B-VP O
in IN B-PP O
the DT B-NP O
present JJ I-NP O
study NN I-NP O
. . O O

All DT B-NP O
of IN B-PP O
the DT B-NP O
parents NNS I-NP O
tested VBN B-VP O
were VBD B-VP O
heterozygous JJ B-ADJP O
for IN B-PP O
the DT B-NP O
mutation NN I-NP O
, , O O
suggesting VBG B-VP O
that IN B-SBAR O
the DT B-NP O
patients NNS I-NP O
were VBD B-VP O
homozygous JJ B-ADJP O
. . O O

The DT B-NP O
mutation NN I-NP O
was VBD B-VP O
located VBN I-VP O
in IN B-PP O
the DT B-NP O
10th JJ I-NP O
transmembrane JJ I-NP O
helix NN I-NP O
. . O O

Expression NN B-NP O
experiments NNS I-NP O
by IN B-PP O
transfection NN B-NP O
of IN B-PP O
the DT B-NP O
mutant JJ I-NP O
NIS NN I-NP O
complimentary JJ I-NP O
DNA NN I-NP O
into IN B-PP O
COS NN B-NP O
- HYPH B-NP O
7 CD I-NP O
cells NNS I-NP O
showed VBD B-VP O
no DT B-NP O
perchlorate NN I-NP O
- HYPH B-NP O
sensitive JJ I-NP O
iodide NN I-NP O
uptake NN I-NP O
, , O O
confirming VBG B-VP O
that IN B-SBAR O
the DT B-NP O
mutation NN I-NP O
is VBZ B-VP O
the DT B-NP O
direct JJ I-NP O
cause NN I-NP O
of IN B-PP O
the DT B-NP O
iodide NN I-NP B-Disease
transport NN I-NP I-Disease
defect NN I-NP I-Disease
in IN B-PP O
these DT B-NP O
patients NNS I-NP O
. . O O

A DT B-NP O
patient NN I-NP O
who WP B-NP O
showed VBD B-VP O
an DT B-NP O
intermediate JJ I-NP O
saliva NN I-NP O
/ SYM B-VP O
serum NN B-NP O
technetium NN I-NP O
ratio NN I-NP O
( ( O O
14 CD B-NP O
. . O O

0 CD B-NP O
; : O O
normal JJ B-ADJP O
, , O O
> SYM B-NP O
or CC O O
= SYM B-VP O
20 CD B-NP O
) ) O O
and CC O O
was VBD B-VP O
considered VBN I-VP O
to TO I-VP O
have VB I-VP O
a DT B-NP O
partial JJ I-NP O
or CC I-NP O
less RBR I-NP O
severe JJ I-NP O
defect NN I-NP O
in IN B-PP O
the DT B-NP O
previous JJ I-NP O
report NN I-NP O
( ( O O
IX CD B-NP O
- HYPH O O
24 CD B-NP O
) ) O O
did VBD B-VP O
not RB I-VP O
have VB I-VP O
a DT B-NP O
NIS NN I-NP O
gene NN I-NP O
mutation NN I-NP O
. . O O

It PRP B-NP O
is VBZ B-VP O
now RB B-ADVP O
possible JJ B-ADJP O
to TO B-VP O
use VB I-VP O
gene NN B-NP O
diagnostics NNS I-NP O
of IN B-PP O
this DT B-NP O
unique JJ I-NP O
NIS NN I-NP O
mutation NN I-NP O
to TO B-VP O
identify VB I-VP O
patients NNS B-NP O
with IN B-PP O
congenital JJ B-NP B-Disease
hypothyroidism NN I-NP I-Disease
due JJ B-PP O
to TO B-PP O
an DT B-NP O
iodide NN I-NP B-Disease
transport NN I-NP I-Disease
defect NN I-NP I-Disease
in IN B-PP O
this DT B-NP O
family NN I-NP O
and CC O O
to TO B-VP O
determine VB I-VP O
the DT B-NP O
carrier NN I-NP O
state NN I-NP O
of IN B-PP O
potential JJ B-NP O
parents NNS I-NP O
for IN B-PP O
genetic JJ B-NP O
counseling NN I-NP O
and CC O O
arranging VBG B-VP O
rapid JJ B-NP O
and CC I-NP O
early JJ I-NP O
diagnosis NN I-NP O
of IN B-PP O
their PRP$ B-NP O
infants NNS I-NP O
. . O O

Molecular JJ B-NP O
analysis NN I-NP O
in IN B-PP O
familial JJ B-NP B-Disease
neurohypophyseal JJ I-NP I-Disease
diabetes NN I-NP I-Disease
insipidus NN I-NP I-Disease
: : O O
early JJ B-NP O
diagnosis NN I-NP O
of IN B-PP O
an DT B-NP O
asymptomatic JJ I-NP O
carrier NN I-NP O
. . O O

Familial JJ B-NP B-Disease
neurohypophyseal JJ I-NP I-Disease
diabetes NN I-NP I-Disease
insipidus NN I-NP I-Disease
( ( O O
FNDI NN B-NP B-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
inherited VBN I-NP O
deficiency NN I-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
hormone NN I-NP I-Disease
arginine NN I-NP I-Disease
vasopressin NN I-NP I-Disease
( ( O O
AVP NN B-NP O
) ) O O
and CC O O
is VBZ B-VP O
transmitted VBN I-VP O
as IN B-PP O
an DT B-NP O
autosomal JJ I-NP O
dominant JJ I-NP O
trait NN I-NP O
. . O O

In IN B-PP O
the DT B-NP O
present JJ I-NP O
study NN I-NP O
we PRP B-NP O
have VBP B-VP O
analyzed VBN I-VP O
the DT B-NP O
AVP NN I-NP O
- HYPH O O
neurophysin NN B-NP O
II CD I-NP O
( ( O O
AVP NN B-NP O
- HYPH B-NP O
NPII NN I-NP O
) ) O O
gene NN B-NP O
in IN B-PP O
a DT B-NP O
Spanish JJ I-NP O
kindred NN I-NP O
. . O O

Studies NNS B-NP O
were VBD B-VP O
performed VBN I-VP O
on IN B-PP O
seven CD B-NP O
members NNS I-NP O
( ( O O
four CD B-NP O
clinically RB I-NP O
affected VBN I-VP O
) ) O O
of IN B-PP O
the DT B-NP O
family NN I-NP O
. . O O

Patients NNS B-NP O
were VBD B-VP O
diagnosed VBN I-VP O
at IN B-PP O
the DT B-NP O
Hospital NNP I-NP O
Universitario NNP I-NP O
Gregorio NNP I-NP O
Maranon NNP I-NP O
( ( O O
Madrid NNP B-NP O
, , O O
Spain NNP B-NP O
) ) O O
. . O O

The DT B-NP O
entire JJ I-NP O
coding VBG I-NP O
region NN I-NP O
of IN B-PP O
the DT B-NP O
AVP NN I-NP O
- HYPH B-NP O
NPII NN I-NP O
gene NN I-NP O
of IN B-PP O
all DT B-NP O
family NN I-NP O
members NNS I-NP O
was VBD B-VP O
amplified VBN I-VP O
by IN B-PP O
PCR NN B-NP O
and CC O O
sequenced VBN B-VP O
. . O O

All DT B-NP O
affected VBN I-NP O
individuals NNS I-NP O
presented VBD B-VP O
a DT B-NP O
missense JJ I-NP O
mutation NN I-NP O
( ( O O
G1757 NN B-NP O
- SYM O O
- HYPH B-NP O
> SYM I-NP O
A NN I-NP O
) ) O O
that WDT B-NP O
replaces VBZ B-VP O
glycine NN B-NP O
at IN B-PP O
position NN B-NP O
23 CD I-NP O
with IN B-PP O
arginine NN B-NP O
within IN B-PP O
the DT B-NP O
NPII NN I-NP O
domain NN I-NP O
. . O O

The DT B-NP O
substitution NN I-NP O
was VBD B-VP O
confirmed VBN I-VP O
by IN B-PP O
restriction NN B-NP O
endonuclease NN I-NP O
analysis NN I-NP O
and CC O O
was VBD B-VP O
present JJ B-ADJP O
in IN B-PP O
heterozygosis NN B-NP O
. . O O

Additionally RB B-ADVP O
, , O O
one CD B-NP O
of IN B-PP O
the DT B-NP O
asymptomatic JJ I-NP O
relatives NNS I-NP O
( ( O O
a DT B-NP O
girl NN I-NP O
8 CD B-NP O
months NNS I-NP O
old JJ B-ADJP O
at IN B-PP O
the DT B-NP O
time NN I-NP O
of IN B-PP O
study NN B-NP O
) ) O O
was VBD B-VP O
identified VBN I-VP O
as IN B-PP O
carrier NN B-NP O
of IN B-PP O
the DT B-NP O
same JJ I-NP O
mutation NN I-NP O
and CC O O
developed VBD B-VP O
the DT B-NP O
disease NN I-NP O
3 CD B-NP O
months NNS I-NP O
later RB B-ADVP O
. . O O

The DT B-NP O
alteration NN I-NP O
found VBN B-VP O
in IN B-PP O
the DT B-NP O
second JJ I-NP O
exon NN I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
in IN B-PP O
this DT B-NP O
family NN I-NP O
seems VBZ B-VP O
to TO I-VP O
be VB I-VP O
responsible JJ B-ADJP O
for IN B-PP O
the DT B-NP O
disease NN I-NP O
, , O O
as IN B-SBAR O
all DT B-NP O
individuals NNS I-NP O
harboring VBG B-VP O
the DT B-NP O
mutation NN I-NP O
had VBD B-VP O
been VBN I-VP O
previously RB I-VP O
diagnosed VBN I-VP O
or CC O O
have VB B-VP O
eventually RB I-VP O
developed VBN I-VP O
FNDI NNP B-NP B-Disease
. . O O

Identification NN B-NP O
of IN B-PP O
the DT B-NP O
molecular JJ I-NP O
defect NN I-NP O
underlying VBG B-VP O
FNDI NNP B-NP B-Disease
in IN B-PP O
affected VBN B-NP O
families NNS I-NP O
is VBZ B-VP O
a DT B-NP O
powerful JJ I-NP O
tool NN I-NP O
for IN B-PP O
early JJ B-NP O
asymptomatic JJ I-NP O
diagnosis NN I-NP O
in IN B-PP O
infants NNS B-NP O
. . O O

. . O O

Deficit NN B-NP O
of IN B-PP O
in FW B-NP O
vivo FW I-NP O
mitochondrial JJ I-NP O
ATP NN I-NP O
production NN I-NP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
Friedreich JJ B-NP B-Disease
ataxia NN I-NP I-Disease
. . O O

Friedreich NN B-NP B-Disease
ataxia NN I-NP I-Disease
( ( O O
FRDA NN B-NP B-Disease
) ) O O
, , O O
the DT B-NP O
most RBS I-NP O
common JJ I-NP O
of IN B-PP O
the DT B-NP O
inherited VBN I-NP B-Disease
ataxias NNS I-NP I-Disease
, , O O
is VBZ B-VP O
an DT B-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
degenerative JJ I-NP I-Disease
disorder NN I-NP I-Disease
, , O O
characterized VBN B-VP O
clinically RB B-ADVP O
by IN B-PP O
onset NN B-NP O
before IN B-PP O
the DT B-NP O
age NN I-NP O
of IN B-PP O
25 CD B-NP O
of IN B-PP O
progressive JJ B-NP B-Disease
gait NN I-NP I-Disease
and CC I-NP I-Disease
limb NN I-NP I-Disease
ataxia NN I-NP I-Disease
, , O O
absence NN B-NP B-Disease
of IN B-PP I-Disease
deep JJ B-NP I-Disease
tendon NN I-NP I-Disease
reflexes NNS I-NP I-Disease
, , O O
extensor NN B-NP B-Disease
plantar NN I-NP I-Disease
responses NNS I-NP I-Disease
, , O O
and CC O O
loss NN B-NP B-Disease
of IN B-PP I-Disease
position NN B-NP I-Disease
and CC I-NP I-Disease
vibration NN I-NP I-Disease
sense NN I-NP I-Disease
in IN B-PP O
the DT B-NP O
lower JJR I-NP O
limbs NNS I-NP O
. . O O

FRDA NN B-NP B-Disease
is VBZ B-VP O
caused VBN I-VP O
by IN B-PP O
a DT B-NP O
GAA NN I-NP O
triplet NN I-NP O
expansion NN I-NP O
in IN B-PP O
the DT B-NP O
first JJ I-NP O
intron NN I-NP O
of IN B-PP O
the DT B-NP O
FRDA NN I-NP B-Disease
gene NN I-NP O
on IN B-PP O
chromosome NN B-NP O
9q13 CD I-NP O
in IN B-PP O
97 CD B-NP O
% NN I-NP O
of IN B-PP O
patients NNS B-NP O
. . O O

The DT B-NP O
FRDA NN I-NP B-Disease
gene NN I-NP O
encodes VBZ B-VP O
a DT B-NP O
widely RB I-NP O
expressed VBN I-NP O
210 CD I-NP O
- HYPH I-NP O
aa NN I-NP O
protein NN I-NP O
, , O O
frataxin NN B-NP O
, , O O
which WDT B-NP O
is VBZ B-VP O
located VBN I-VP O
in IN B-PP O
mitochondria NNS B-NP O
and CC O O
is VBZ B-VP O
severely RB I-VP O
reduced VBN I-VP O
in IN B-PP O
FRDA NN B-NP B-Disease
patients NNS I-NP O
. . O O

Frataxin NN B-NP O
function NN I-NP O
is VBZ B-VP O
still RB B-ADVP O
unknown JJ B-ADJP O
but CC O O
the DT B-NP O
knockout NN I-NP O
of IN B-PP O
the DT B-NP O
yeast NN I-NP O
frataxin NN I-NP O
homologue NN I-NP O
gene NN I-NP O
( ( O O
YFH1 NN B-NP O
) ) O O
showed VBD B-VP O
a DT B-NP O
severe JJ I-NP O
defect NN I-NP O
of IN B-PP O
mitochondrial JJ B-NP O
respiration NN I-NP O
and CC I-NP O
loss NN I-NP O
of IN B-PP O
mtDNA NN B-NP O
associated VBN B-VP O
with IN B-PP O
elevated JJ B-NP O
intramitochondrial JJ I-NP O
iron NN I-NP O
. . O O

Here RB B-ADVP O
we PRP B-NP O
report VBP B-VP O
in FW B-NP O
vivo FW I-NP O
evidence NN I-NP O
of IN B-PP O
impaired JJ B-NP O
mitochondrial JJ I-NP O
respiration NN I-NP O
in IN B-PP O
skeletal JJ B-NP O
muscle NN I-NP O
of IN B-PP O
FRDA NN B-NP B-Disease
patients NNS I-NP O
. . O O

Using VBG B-VP O
phosphorus JJ B-NP O
magnetic JJ I-NP O
resonance NN I-NP O
spectroscopy NN I-NP O
we PRP B-NP O
demonstrated VBD B-VP O
a DT B-NP O
maximum NN I-NP O
rate NN I-NP O
of IN B-PP O
muscle NN B-NP O
mitochondrial JJ I-NP O
ATP NN I-NP O
production NN I-NP O
( ( O O
V NN B-NP O
( ( O O
max NN B-NP O
) ) O O
) ) O O
below IN B-PP O
the DT B-NP O
normal JJ I-NP O
range NN I-NP O
in IN B-PP O
all DT B-NP O
12 CD I-NP O
FRDA NN I-NP B-Disease
patients NNS I-NP O
and CC O O
a DT B-NP O
strong JJ I-NP O
negative JJ I-NP O
correlation NN I-NP O
between IN B-PP O
mitochondrial JJ B-NP O
V NN I-NP O
( ( O O
max NN B-NP O
) ) O O
and CC O O
the DT B-NP O
number NN I-NP O
of IN B-PP O
GAA NN B-NP O
repeats NNS I-NP O
in IN B-PP O
the DT B-NP O
smaller JJR I-NP O
allele NN I-NP O
. . O O

Our PRP$ B-NP O
results NNS I-NP O
show VBP B-VP O
that IN B-SBAR O
FRDA NN B-NP B-Disease
is VBZ B-VP O
a DT B-NP O
nuclear JJ I-NP O
- HYPH I-NP O
encoded VBN I-NP O
mitochondrial JJ I-NP B-Disease
disorder NN I-NP I-Disease
affecting VBG B-VP O
oxidative JJ B-NP O
phosphorylation NN I-NP O
and CC O O
give VB B-VP O
a DT B-NP O
rationale NN I-NP O
for IN B-PP O
treatments NNS B-NP O
aimed VBN B-VP O
to TO B-VP O
improve VB I-VP O
mitochondrial JJ B-NP O
function NN I-NP O
in IN B-PP O
this DT B-NP O
condition NN I-NP O
. . O O

. . O O

Identification NN B-NP O
of IN B-PP O
a DT B-NP O
novel JJ I-NP O
R21X NN I-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
liver NN I-NP O
- HYPH I-NP O
type NN I-NP O
arginase NN I-NP O
gene NN I-NP O
( ( O O
ARG1 NN B-NP O
) ) O O
in IN B-PP O
four CD B-NP O
Portuguese JJ I-NP O
patients NNS I-NP O
with IN B-PP O
argininemia NN B-NP B-Disease
. . O O

Argininemia NN B-NP B-Disease
is VBZ B-VP O
a DT B-NP O
rare JJ I-NP O
autossomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
disorder NN I-NP I-Disease
caused VBN B-VP O
by IN B-PP O
deficiency NN B-NP B-Disease
in IN B-PP I-Disease
the DT B-NP I-Disease
cytosolic JJ I-NP I-Disease
liver NN I-NP I-Disease
- HYPH I-NP I-Disease
type NN I-NP I-Disease
arginase NN I-NP I-Disease
enzyme NN I-NP I-Disease
( ( O O
L NN B-NP O
- HYPH O O
arginine NN B-NP O
urea NN I-NP O
- HYPH B-NP O
hydrolase NN I-NP O
; : O O
E NN B-NP O
. . O O

C NN B-NP O
. . O O

3 CD B-NP O
. . O O

5 CD B-NP O
. . O O

3 CD B-NP O
. . I-NP O

1 CD I-NP O
) ) O O
. . O O

In IN B-SBAR O
order NN O O
to TO B-VP O
investigate VB I-VP O
the DT B-NP O
molecular JJ I-NP O
basis NN I-NP O
for IN B-PP O
argininemia NN B-NP B-Disease
in IN B-PP O
four CD B-NP O
unrelated JJ I-NP O
Portuguese JJ I-NP O
patients NNS I-NP O
( ( O O
two CD B-NP O
from IN B-PP O
northern JJ B-NP O
Portugal NNP I-NP O
and CC O O
two CD B-NP O
from IN B-PP O
Madeira NNP B-NP O
Island NNP I-NP O
) ) O O
we PRP B-NP O
performed VBD B-VP O
a DT B-NP O
DNA NN I-NP O
sequence NN I-NP O
analysis NN I-NP O
of IN B-PP O
all PDT B-NP O
the DT I-NP O
exons NNS I-NP O
and CC I-NP O
exon NN I-NP O
/ SYM B-NP O
intron NN B-NP O
boundaries NNS I-NP O
of IN B-PP O
the DT B-NP O
liver NN I-NP O
- HYPH I-NP O
type NN I-NP O
arginase NN I-NP O
gene NN I-NP O
( ( O O
ARG1 NN B-NP O
) ) O O
. . O O

All DT B-NP O
patients NNS I-NP O
were VBD B-VP O
found VBN I-VP O
to TO I-VP O
be VB I-VP O
homozygous JJ B-ADJP O
for IN B-PP O
a DT B-NP O
newly RB I-NP O
identified VBN I-NP O
C NN I-NP O
- HYPH O O
> SYM B-NP O
T NN I-NP O
transition NN I-NP O
in IN B-PP O
codon NN B-NP O
21 CD I-NP O
( ( O O
exon NN B-NP O
2 CD I-NP O
) ) O O
substituting VBG B-VP O
arginine NN B-NP O
for IN B-PP O
a DT B-NP O
premature JJ I-NP O
stop NN I-NP O
codon NN I-NP O
( ( O O
R21X NN B-NP O
CGA NN I-NP O
to TO B-PP O
TGA NN B-NP O
) ) O O
and CC O O
generating VBG B-VP O
a DT B-NP O
NlaIII NN I-NP O
restriction NN I-NP O
site NN I-NP O
. . O O

Restriction NN B-NP O
digestion NN I-NP O
following VBG B-PP O
PCR NN B-NP O
amplification NN I-NP O
of IN B-PP O
ARG1 NN B-NP O
exon NN I-NP O
2 CD I-NP O
confirmed VBD B-VP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
the DT B-NP O
mutation NN I-NP O
. . O O

Mutation NN B-NP O
of IN B-PP O
the DT B-NP O
sterol NN I-NP O
27 CD I-NP O
- HYPH I-NP O
hydroxylase NN I-NP O
gene NN I-NP O
( ( O O
CYP27 NN B-NP O
) ) O O
results VBZ B-VP O
in IN B-PP O
truncation NN B-NP O
of IN B-PP O
mRNA NN B-NP O
expressed VBN B-VP O
in IN B-PP O
leucocytes NNS B-NP O
in IN B-PP O
a DT B-NP O
Japanese JJ I-NP O
family NN I-NP O
with IN B-PP O
cerebrotendinous JJ B-NP B-Disease
xanthomatosis NN I-NP I-Disease
. . O O

OBJECTIVES NNS B-NP O
A DT B-NP O
Japanese JJ I-NP O
family NN I-NP O
with IN B-PP O
cerebrotendinous JJ B-NP B-Disease
xanthomatosis NN I-NP I-Disease
( ( O O
CTX NN B-NP B-Disease
) ) O O
was VBD B-VP O
investigated VBN I-VP O
for IN B-PP O
a DT B-NP O
sequence NN I-NP O
alteration NN I-NP O
in IN B-PP O
the DT B-NP O
sterol NN I-NP O
27 CD I-NP O
- HYPH I-NP O
hydroxylase NN I-NP O
gene NN I-NP O
( ( O O
CYP27 NN B-NP O
) ) O O
. . O O

The DT B-NP O
expression NN I-NP O
of IN B-PP O
CYP27 NN B-NP O
has VBZ B-VP O
been VBN I-VP O
mostly RB I-VP O
explored VBN I-VP O
using VBG I-VP O
cultured VBN B-NP O
fibroblasts NNS I-NP O
, , O O
prompting VBG B-VP O
the DT B-NP O
examination NN I-NP O
of IN B-PP O
the DT B-NP O
transcripts NNS I-NP O
from IN B-PP O
blood NN B-NP O
leucocytes NNS I-NP O
as IN B-PP O
a DT B-NP O
simple JJ I-NP O
and CC I-NP O
rapid JJ I-NP O
technique NN I-NP O
. . O O

METHODS NNS B-NP O
An DT B-NP O
alteration NN I-NP O
in IN B-PP O
CYP27 NN B-NP O
of IN B-PP O
the DT B-NP O
proband NN I-NP O
was VBD B-VP O
searched VBN I-VP O
for IN B-PP O
by IN B-PP O
polymerase NN B-NP O
chain NN I-NP O
reaction NN I-NP O
- HYPH B-NP O
single JJ I-NP O
strand NN I-NP O
conformation NN I-NP O
polymorphism NN I-NP O
( ( O O
PCR NN B-NP O
- HYPH B-NP O
SSCP NN I-NP O
) ) O O
analysis NN B-NP O
and CC O O
subsequent JJ B-NP O
sequencing NN I-NP O
. . O O

Samples NNS B-NP O
of IN B-PP O
RNA NN B-NP O
were VBD B-VP O
subjected VBN I-VP O
to TO B-VP O
reverse VB I-VP O
transcription NN B-NP O
PCR NN I-NP O
( ( O O
RT NN B-NP O
- HYPH B-NP O
PCR NN I-NP O
) ) O O
and CC O O
the DT B-NP O
product NN I-NP O
of IN B-PP O
the DT B-NP O
proband NN I-NP O
was VBD B-VP O
amplified VBN I-VP O
with IN B-PP O
nested JJ B-NP O
primers NNS I-NP O
and CC O O
sequenced VBN B-VP O
. . O O

RESULTS NNS B-NP O
A DT B-NP O
homozygous JJ I-NP O
G NN I-NP O
to TO B-PP O
A NN B-NP O
transition NN I-NP O
at IN B-PP O
the DT B-NP O
5 CD I-NP O
end NN I-NP O
of IN B-PP O
intron NN B-NP O
7 CD I-NP O
was VBD B-VP O
detected VBN I-VP O
in IN B-PP O
the DT B-NP O
patient NN I-NP O
. . O O

In IN B-PP O
RT NN B-NP O
- HYPH B-NP O
PCR NN I-NP O
analysis NN I-NP O
, , O O
only RB B-NP O
a DT I-NP O
truncated VBN I-NP O
transcript NN I-NP O
was VBD B-VP O
detected VBN I-VP O
in IN B-PP O
the DT B-NP O
patient NN I-NP O
, , O O
whereas IN B-PP O
both CC B-NP O
normal JJ I-NP O
and CC I-NP O
truncated VBN I-NP O
transcripts NNS I-NP O
were VBD B-VP O
detected VBN I-VP O
in IN B-PP O
the DT B-NP O
siblings NNS I-NP O
. . O O

The DT B-NP O
sequencing NN I-NP O
of IN B-PP O
the DT B-NP O
patients NNS I-NP O
cDNA NN I-NP O
fragment NN I-NP O
disclosed VBD B-VP O
a DT B-NP O
direct JJ I-NP O
conjuction NN I-NP O
of IN B-PP O
exon NN B-NP O
6 CD I-NP O
and CC O O
exon NN B-NP O
8 CD I-NP O
. . O O

CONCLUSION NN B-NP O
The DT B-NP O
mutation NN I-NP O
at IN B-PP O
splice NN B-NP O
donor NN I-NP O
site NN I-NP O
and CC O O
the DT B-NP O
truncation NN I-NP O
of IN B-PP O
mRNA NN B-NP O
were VBD B-VP O
identical JJ B-ADJP O
with IN B-PP O
those DT B-NP O
of IN B-PP O
a DT B-NP O
recently RB I-NP O
reported VBN I-NP O
Italian JJ I-NP O
patient NN I-NP O
, , O O
although IN B-SBAR O
different JJ B-ADJP O
in IN B-PP O
symptomatology NN B-NP O
. . O O

The DT B-NP O
application NN I-NP O
of IN B-PP O
blood NN B-NP O
leucocytes NNS I-NP O
can MD B-VP O
be VB I-VP O
a DT B-NP O
simple JJ I-NP O
technique NN I-NP O
on IN B-PP O
analysing VBG B-VP O
a DT B-NP O
constructive JJ I-NP O
abnormality NN I-NP B-Disease
of IN B-PP I-Disease
CYP27 NN B-NP I-Disease
mRNA NN I-NP O
. . O O

. . O O

Clinical JJ B-NP O
and CC I-NP O
molecular JJ I-NP O
genetic JJ I-NP O
analysis NN I-NP O
of IN B-PP O
19 CD B-NP O
Wolfram NNP I-NP B-Disease
syndrome NN I-NP I-Disease
kindreds NNS I-NP O
demonstrating VBG B-VP O
a DT B-NP O
wide JJ I-NP O
spectrum NN I-NP O
of IN B-PP O
mutations NNS B-NP O
in IN B-PP O
WFS1 NN B-NP O
. . O O

Wolfram NN B-NP B-Disease
syndrome NN I-NP I-Disease
is VBZ B-VP O
an DT B-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
neurodegenerative JJ I-NP I-Disease
disorder NN I-NP I-Disease
characterized VBN B-VP O
by IN B-PP O
juvenile JJ B-NP B-Disease
- HYPH I-NP I-Disease
onset NN I-NP I-Disease
diabetes NN I-NP I-Disease
mellitus NN I-NP I-Disease
and CC O O
progressive JJ B-NP O
optic JJ I-NP B-Disease
atrophy NN I-NP I-Disease
. . O O

mtDNA NN B-NP O
deletions NNS I-NP O
have VBP B-VP O
been VBN I-VP O
described VBN I-VP O
, , O O
and CC O O
a DT B-NP O
gene NN I-NP O
( ( O O
WFS1 NN B-NP O
) ) O O
recently RB B-ADVP O
has VBZ B-VP O
been VBN I-VP O
identified VBN I-VP O
, , O O
on IN B-PP O
chromosome NN B-NP O
4p16 CD I-NP O
, , O O
encoding VBG B-VP O
a DT B-NP O
predicted VBN I-NP O
890 CD I-NP O
amino JJ I-NP O
acid NN I-NP O
transmembrane JJ I-NP O
protein NN I-NP O
. . O O

Direct JJ B-NP O
DNA NN I-NP O
sequencing NN I-NP O
was VBD B-VP O
done VBN I-VP O
to TO I-VP O
screen VB I-VP O
the DT B-NP O
entire JJ I-NP O
coding VBG I-NP O
region NN I-NP O
of IN B-PP O
the DT B-NP O
WFS1 NN I-NP O
gene NN I-NP O
in IN B-PP O
30 CD B-NP O
patients NNS I-NP O
from IN B-PP O
19 CD B-NP O
British JJ I-NP O
kindreds NNS I-NP O
with IN B-PP O
Wolfram NN B-NP B-Disease
syndrome NN I-NP I-Disease
. . O O

DNA NN B-NP O
was VBD B-VP O
also RB I-VP O
screened VBN I-VP O
for IN B-PP O
structural JJ B-NP O
rearrangements NNS I-NP O
( ( O O
deletions NNS B-NP O
and CC I-NP O
duplications NNS I-NP O
) ) O O
and CC O O
point NN B-NP O
mutations NNS I-NP O
in IN B-PP O
mtDNA NN B-NP O
. . O O

No DT B-NP O
pathogenic JJ I-NP O
mtDNA NN I-NP O
mutations NNS I-NP O
were VBD B-VP O
found VBN I-VP O
in IN B-PP O
our PRP$ B-NP O
cohort NN I-NP O
. . O O

We PRP B-NP O
identified VBD B-VP O
24 CD B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
WFS1 NN I-NP O
gene NN I-NP O
8 CD I-NP O
nonsense JJ I-NP O
mutations NNS I-NP O
, , O O
8 CD B-NP O
missense JJ I-NP O
mutations NNS I-NP O
, , O O
3 CD B-NP O
in IN B-PP O
- HYPH B-NP O
frame NN I-NP O
deletions NNS I-NP O
, , O O
1 CD B-NP O
in IN B-PP O
- HYPH B-NP O
frame NN I-NP O
insertion NN I-NP O
, , O O
and CC O O
4 CD B-NP O
frameshift NN I-NP O
mutations NNS I-NP O
. . O O

Of IN B-PP O
these DT B-NP O
, , O O
23 CD B-NP O
were VBD B-VP O
novel JJ B-NP O
mutations NNS I-NP O
, , O O
and CC O O
most JJS B-NP O
occurred VBD B-VP O
in IN B-PP O
exon NN B-NP O
8 CD I-NP O
. . O O

The DT B-NP O
majority NN I-NP O
of IN B-PP O
patients NNS B-NP O
were VBD B-VP O
compound NN B-NP O
heterozygotes NNS I-NP O
for IN B-PP O
two CD B-NP O
mutations NNS I-NP O
, , O O
and CC O O
there EX B-NP O
was VBD B-VP O
no DT B-NP O
common JJ I-NP O
founder NN I-NP O
mutation NN I-NP O
. . O O

The DT B-NP O
data NNS I-NP O
were VBD B-VP O
also RB I-VP O
analyzed VBN I-VP O
for IN B-PP O
genotype NN B-NP O
- HYPH I-NP O
phenotype NN I-NP O
relationships NNS I-NP O
. . O O

Although IN B-SBAR O
some DT B-NP O
interesting JJ I-NP O
cases NNS I-NP O
were VBD B-VP O
noted VBN I-VP O
, , O O
consideration NN B-NP O
of IN B-PP O
the DT B-NP O
small JJ I-NP O
sample NN I-NP O
size NN I-NP O
and CC I-NP O
frequency NN I-NP O
of IN B-PP O
each DT B-NP O
mutation NN I-NP O
indicated VBD B-VP O
no DT B-NP O
clear JJ I-NP O
- HYPH I-NP O
cut NN I-NP O
correlations NNS I-NP O
between IN B-PP O
any DT B-NP O
of IN B-PP O
the DT B-NP O
observed VBN I-NP O
mutations NNS I-NP O
and CC O O
disease NN B-NP O
severity NN I-NP O
. . O O

There EX B-NP O
were VBD B-VP O
no DT B-NP O
obvious JJ I-NP O
mutation NN I-NP O
hot JJ I-NP O
spots NNS I-NP O
or CC I-NP O
clusters NNS I-NP O
. . O O

Hence RB B-ADVP O
, , O O
molecular JJ B-NP O
screening NN I-NP O
for IN B-PP O
Wolfram NN B-NP B-Disease
syndrome NN I-NP I-Disease
in IN B-PP O
affected VBN B-NP O
families NNS I-NP O
and CC B-PP O
for IN B-PP O
Wolfram NN B-NP B-Disease
syndrome NN I-NP I-Disease
- HYPH I-NP O
carrier NN I-NP O
status NN I-NP O
in IN B-PP O
subjects NNS B-NP O
with IN B-PP O
psychiatric JJ B-NP B-Disease
disorders NNS I-NP I-Disease
or CC O O
diabetes NN B-NP B-Disease
mellitus NN I-NP I-Disease
will MD B-VP O
require VB I-VP O
complete JJ B-NP O
analysis NN I-NP O
of IN B-PP O
exon NN B-NP O
8 CD I-NP O
and CC O O
upstream JJ B-NP O
exons NNS I-NP O
. . O O

. . O O

Late JJ B-NP O
- HYPH I-NP O
onset NN I-NP O
familial JJ I-NP B-Disease
Mediterranean JJ I-NP I-Disease
fever NN I-NP I-Disease
( ( O O
FMF NN B-NP B-Disease
) ) O O
: : O O
a DT B-NP O
subset NN I-NP O
with IN B-PP O
distinct JJ B-NP O
clinical JJ I-NP O
, , I-NP O
demographic JJ I-NP O
, , O O
and CC O O
molecular JJ B-NP O
genetic JJ I-NP O
characteristics NNS I-NP O
. . O O

To TO B-VP O
determine VB I-VP O
the DT B-NP O
prevalence NN I-NP O
and CC O O
characterize VB B-VP O
demographic JJ B-ADJP O
, , O O
clinical JJ B-ADJP O
, , O O
and CC O O
genetic JJ B-NP O
features NNS I-NP O
of IN B-PP O
familial JJ B-NP B-Disease
Mediterranean JJ I-NP I-Disease
fever NN I-NP I-Disease
( ( O O
FMF NN B-NP B-Disease
) ) O O
of IN B-PP O
late JJ B-NP O
onset NN I-NP O
, , O O
all DT B-NP O
patients NNS I-NP O
experiencing VBG B-VP O
their PRP$ B-NP O
first JJ I-NP O
FMF NN I-NP B-Disease
attack NN I-NP O
at IN B-PP O
age NN B-NP O
40 CD B-NP O
years NNS I-NP O
or CC I-NP O
more JJR I-NP O
were VBD B-VP O
identified VBN I-VP O
using VBG B-VP O
the DT B-NP O
computerized JJ I-NP O
registry NN I-NP O
of IN B-PP O
our PRP$ B-NP O
FMF NN I-NP B-Disease
clinic NN I-NP O
, , O O
and CC O O
then RB B-VP O
thoroughly RB I-VP O
interviewed VBN I-VP O
and CC I-VP O
examined VBN I-VP O
. . O O

The DT B-NP O
control NN I-NP O
group NN I-NP O
consisted VBD B-VP O
of IN B-PP O
40 CD B-NP O
consecutive JJ I-NP O
FMF NN I-NP B-Disease
patients NNS I-NP O
, , O O
who WP B-NP O
arrived VBD B-VP O
at IN B-PP O
the DT B-NP O
FMF NN I-NP B-Disease
clinic NN I-NP O
for IN B-PP O
their PRP$ B-NP O
regular JJ I-NP O
follow VB I-NP O
- HYPH B-VP O
up RP B-PRT O
visit NN B-NP O
and CC O O
were VBD B-VP O
40 CD B-NP O
years NNS I-NP O
of IN B-PP O
age NN B-NP O
or CC O O
older JJR B-ADJP O
at IN B-PP O
the DT B-NP O
time NN I-NP O
of IN B-PP O
the DT B-NP O
examination NN I-NP O
. . O O

The DT B-NP O
severity NN I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
in IN B-PP O
patients NNS B-NP O
and CC I-NP O
controls NNS I-NP O
was VBD B-VP O
determined VBN I-VP O
using VBG I-VP O
a DT B-NP O
modified VBN I-NP O
score NN I-NP O
, , O O
developed VBN B-VP O
previously RB B-ADVP O
. . O O

Mutational JJ B-NP O
analysis NN I-NP O
in IN B-PP O
the DT B-NP O
FMF NN I-NP B-Disease
gene NN I-NP O
was VBD B-VP O
performed VBN I-VP O
using VBG B-VP O
a DT B-NP O
commercial JJ I-NP O
kit NN I-NP O
. . O O

Only RB B-NP O
20 CD I-NP O
of IN B-PP O
4000 CD B-NP O
( ( O O
0 CD B-NP O
. . O O

5 CD B-NP O
% NN I-NP O
) ) O O
patients NNS B-NP O
had VBD B-VP O
late JJ B-NP O
- HYPH I-NP O
onset NN I-NP O
FMF NN I-NP B-Disease
. . O O

These DT B-NP O
patients NNS I-NP O
were VBD B-VP O
mostly RB B-NP O
men NNS I-NP O
, , O O
of IN B-PP O
non AFX B-NP O
- HYPH I-NP O
North JJ I-NP O
African JJ I-NP O
origin NN I-NP O
, , O O
P NN B-NP O
< SYM B-VP O
0 CD B-NP O
. . O O

05 CD B-NP O
compared VBN B-PP O
to TO B-PP O
controls NNS B-NP O
. . O O

All DT B-NP O
had VBD B-VP O
abdominal JJ B-NP O
attacks NNS I-NP O
and CC B-PP O
in IN B-PP O
most JJS B-NP O
these DT I-NP O
were VBD B-VP O
the DT B-NP O
only JJ I-NP O
manifestation NN I-NP O
of IN B-PP O
their PRP$ B-NP O
disease NN I-NP O
, , O O
P NN B-NP O
< SYM B-VP O
0 CD B-NP O
. . O O

001 CD B-NP O
001 CD I-NP O
. . O O

None NN B-NP O
had VBD B-VP O
chronic JJ B-NP O
or CC I-NP O
prolonged JJ I-NP O
manifestations NNS I-NP O
of IN B-PP O
FMF NN B-NP B-Disease
, , O O
for IN B-PP O
example NN B-NP O
, , O O
amyloidosis NN B-NP B-Disease
, , O O
chronic JJ B-NP B-Disease
arthritis NN I-NP I-Disease
, , O O
or CC O O
protracted VBD B-VP O
myalgia NN B-NP B-Disease
, , O O
P NN B-NP O
< SYM B-VP O
0 CD B-NP O
. . O O

001 CD B-NP O
. . O O

The DT B-NP O
response NN I-NP O
to TO B-PP O
treatment NN B-NP O
was VBD B-VP O
good JJ B-ADJP O
despite IN B-PP O
using VBG B-VP O
low JJ B-NP O
colchicine NN I-NP O
dose NN I-NP O
, , O O
P NN B-NP O
< SYM B-VP O
0 CD B-NP O
. . O O

05 CD B-NP O
. . O O

The DT B-NP O
overall JJ I-NP O
severity NN I-NP O
score NN I-NP O
indicated VBD B-VP O
a DT B-NP O
mild JJ I-NP O
disease NN I-NP O
, , O O
P NN B-NP O
< SYM B-VP O
0 CD B-NP O
. . O O

001 CD B-NP O
. . O O

Mutational JJ B-NP O
analysis NN I-NP O
revealed VBD B-VP O
absence NN B-NP O
of IN B-PP O
M694V NN B-NP O
homozygosity NN I-NP O
, , O O
P NN B-NP O
< SYM B-VP O
0 CD B-NP O
. . O O

01 CD B-NP O
, , O O
compared VBN B-PP O
to TO B-PP O
our PRP$ B-NP O
regular JJ I-NP O
FMF NNP I-NP B-Disease
population NN I-NP O
. . O O

We PRP B-NP O
conclude VBP B-VP O
that IN B-SBAR O
the DT B-NP O
onset NN I-NP O
of IN B-PP O
FMF NN B-NP B-Disease
in IN B-PP O
a DT B-NP O
late JJ I-NP O
age NN I-NP O
defines VBZ B-VP O
a DT B-NP O
milder JJR I-NP O
form NN I-NP O
of IN B-PP O
disease NN B-NP O
with IN B-PP O
typical JJ B-NP O
clinical JJ I-NP O
, , I-NP O
demographic JJ I-NP O
, , O O
and CC O O
molecular JJ B-NP O
genetic JJ I-NP O
characteristics NNS I-NP O
A DT B-NP O
highly RB I-NP O
accurate JJ I-NP O
, , I-NP O
low JJ I-NP O
cost NN I-NP O
test NN I-NP O
for IN B-PP O
BRCA1 NN B-NP O
mutations NNS I-NP O
. . O O

The DT B-NP O
hereditary JJ I-NP B-Disease
breast NN I-NP I-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
syndrome NN I-NP I-Disease
is VBZ B-VP O
associated VBN I-VP O
with IN B-PP O
a DT B-NP O
high JJ I-NP O
frequency NN I-NP O
of IN B-PP O
BRCA1 NN B-NP O
mutations NNS I-NP O
. . O O

However RB B-ADVP O
, , O O
the DT B-NP O
widespread JJ I-NP O
use NN I-NP O
of IN B-PP O
BRCA1 NN B-NP O
testing NN I-NP O
has VBZ B-VP O
been VBN I-VP O
limited VBN I-VP O
to TO B-PP O
date NN B-NP O
by IN B-PP O
three CD B-NP O
principal JJ I-NP O
concerns NNS I-NP O
the DT B-NP O
fear NN I-NP O
of IN B-PP O
loss NN B-NP O
of IN B-PP O
health NN B-NP O
and CC I-NP O
life NN I-NP O
insurance NN I-NP O
, , O O
the DT B-NP O
uncertain JJ I-NP O
clinical JJ I-NP O
value NN I-NP O
of IN B-PP O
a DT B-NP O
positive JJ I-NP O
test NN I-NP O
result NN I-NP O
, , O O
and CC O O
the DT B-NP O
current JJ I-NP O
lack NN I-NP O
of IN B-PP O
an DT B-NP O
inexpensive JJ I-NP O
and CC I-NP O
sensitive JJ I-NP O
screening NN I-NP O
test NN I-NP O
for IN B-PP O
BRCA1 NN B-NP O
mutations NNS I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
developed VBN I-VP O
an DT B-NP O
inexpensive JJ I-NP O
system NN I-NP O
for IN B-PP O
gene NN B-NP O
mutational JJ I-NP O
scanning NN I-NP O
, , O O
based VBN B-PP O
on IN B-PP O
a DT B-NP O
combination NN I-NP O
of IN B-PP O
extensive JJ B-NP O
multiplex JJ I-NP O
PCR NN I-NP O
amplification NN I-NP O
and CC O O
two CD B-NP O
dimensional JJ I-NP O
electrophoresis NN I-NP O
. . O O

The DT B-NP O
efficiency NN I-NP O
of IN B-PP O
this DT B-NP O
system NN I-NP O
, , O O
as IN B-PP O
a DT B-NP O
screening NN I-NP O
test NN I-NP O
for IN B-PP O
BRCA1 NN B-NP O
mutations NNS I-NP O
, , O O
was VBD B-VP O
evaluated VBN I-VP O
in IN B-PP O
a DT B-NP O
panel NN I-NP O
of IN B-PP O
60 CD B-NP O
samples NNS I-NP O
from IN B-PP O
high JJ B-NP O
risk NN I-NP O
women NNS I-NP O
, , O O
14 CD B-NP O
of IN B-PP O
which WDT B-NP O
contained VBD B-VP O
a DT B-NP O
previously RB I-NP O
identified VBN I-NP O
mutation NN I-NP O
in IN B-PP O
BRCA1 NN B-NP O
. . O O

All DT B-NP O
14 CD I-NP O
mutations NNS I-NP O
were VBD B-VP O
identified VBN I-VP O
, , O O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
an DT B-NP O
additional JJ I-NP O
five CD I-NP O
that WDT B-NP O
had VBD B-VP O
previously RB I-VP O
escaped VBN I-VP O
detection NN B-NP O
. . O O

In IN B-PP O
addition NN B-NP O
to TO B-PP O
the DT B-NP O
19 CD I-NP O
mutations NNS I-NP O
, , O O
a DT B-NP O
total NN I-NP O
of IN B-PP O
15 CD B-NP O
different JJ I-NP O
polymorphic JJ I-NP O
variants NNS I-NP O
were VBD B-VP O
scored VBN I-VP O
, , O O
most JJS B-NP O
of IN B-PP O
which WDT B-NP O
were VBD B-VP O
recurring VBG I-VP O
. . O O

All DT B-NP O
were VBD B-VP O
confirmed VBN I-VP O
by IN B-PP O
nucleotide NN B-NP O
sequencing NN I-NP O
. . O O

The DT B-NP O
cost NN I-NP O
of IN B-PP O
screening NN B-NP O
per IN B-PP O
sample NN B-NP O
was VBD B-VP O
calculated VBN I-VP O
to TO I-VP O
be VB I-VP O
approximately RB B-ADVP O
US VBZ B-VP O
$ $ B-NP O
70 CD I-NP O
for IN B-PP O
the DT B-NP O
manual JJ I-NP O
technique NN I-NP O
used VBN B-VP O
in IN B-PP O
this DT B-NP O
study NN I-NP O
, , O O
and CC O O
may MD B-VP O
be VB I-VP O
reduced VBN I-VP O
to TO B-PP O
approximately RB B-VP O
US VBZ I-VP O
$ $ B-NP O
10 CD I-NP O
with IN B-PP O
the DT B-NP O
introduction NN I-NP O
of IN B-PP O
commercially RB B-NP O
available JJ I-NP O
PCR NN I-NP O
robotics NNS I-NP O
and CC O O
fluorescent JJ B-NP O
imaging NN I-NP O
. . O O

Implementation NN B-NP O
of IN B-PP O
this DT B-NP O
method NN I-NP O
of IN B-PP O
mutation NN B-NP O
screening NN I-NP O
in IN B-PP O
the DT B-NP O
research NN I-NP O
and CC I-NP O
clinical JJ I-NP O
setting NN I-NP O
should MD B-VP O
permit VB I-VP O
rapid JJ B-NP O
accrual NN I-NP O
of IN B-PP O
quantitative JJ B-NP O
data NNS I-NP O
on IN B-PP O
genotype NN B-NP O
- HYPH I-NP O
phenotype NN I-NP O
associations NNS I-NP O
for IN B-PP O
the DT B-NP O
evaluation NN I-NP O
of IN B-PP O
diagnostic JJ B-NP O
testing NN I-NP O
. . O O

. . O O

Maternal JJ B-NP B-Disease
uniparental JJ I-NP I-Disease
disomy NN I-NP I-Disease
for IN B-PP I-Disease
chromosome NN B-NP I-Disease
14 CD I-NP I-Disease
in IN B-PP O
a DT B-NP O
boy NN I-NP O
with IN B-PP O
a DT B-NP O
normal JJ I-NP O
karyotype NN I-NP O
. . O O

We PRP B-NP O
report VBP B-VP O
on IN B-PP O
a DT B-NP O
boy NN I-NP O
with IN B-PP O
a DT B-NP O
maternal JJ I-NP B-Disease
uniparental JJ I-NP I-Disease
disomy NN I-NP I-Disease
for IN B-PP I-Disease
chromosome NN B-NP I-Disease
14 CD I-NP I-Disease
( ( O O
UPD NN B-NP B-Disease
( ( O O
14 CD B-NP O
) ) O O
) ) O O
. . O O

At IN B-PP O
7 CD B-NP O
years NNS I-NP O
of IN B-PP O
age NN B-NP O
he PRP B-NP O
was VBD B-VP O
referred VBN I-VP O
to TO B-PP O
us PRP B-NP O
by IN B-PP O
the DT B-NP O
paediatrician NN I-NP O
because IN B-PP O
of IN I-PP O
symptoms NNS B-NP O
of IN B-PP O
Prader NNP B-NP B-Disease
- HYPH I-NP I-Disease
Willi NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
PWS NN B-NP B-Disease
) ) O O
. . O O

He PRP B-NP O
showed VBD B-VP O
short JJ B-NP B-Disease
stature NN I-NP I-Disease
, , O O
obesity NN B-NP B-Disease
, , O O
mild JJ B-NP O
developmental JJ I-NP B-Disease
delay NN I-NP I-Disease
, , O O
cryptorchidism NN B-NP B-Disease
, , O O
and CC O O
some DT B-NP O
mild JJ I-NP O
dysmorphic JJ I-NP B-Disease
features NNS I-NP I-Disease
. . O O

The DT B-NP O
history NN I-NP O
further RB B-ADVP O
indicated VBD B-VP O
intrauterine JJ B-NP B-Disease
growth NN I-NP I-Disease
retardation NN I-NP I-Disease
at IN B-PP O
the DT B-NP O
end NN I-NP O
of IN B-PP O
the DT B-NP O
pregnancy NN I-NP O
. . O O

His PRP$ B-NP O
mother NN I-NP O
was VBD B-VP O
44 CD B-NP O
years NNS I-NP O
of IN B-PP O
age NN B-NP O
at IN B-PP O
the DT B-NP O
time NN I-NP O
of IN B-PP O
his PRP$ B-NP O
birth NN I-NP O
. . O O

After IN B-PP O
birth NN B-NP O
he PRP B-NP O
showed VBD B-VP O
hypotonia NN B-NP B-Disease
with IN B-PP O
poor JJ B-NP O
sucking NN I-NP O
, , O O
for IN B-PP O
which WDT B-NP O
gavage NN B-NP O
feeding NN I-NP O
was VBD B-VP O
needed VBN I-VP O
. . O O

Motor NN B-NP O
development NN I-NP O
was VBD B-VP O
delayed VBN I-VP O
. . O O

After IN B-PP O
1 CD B-NP O
year NN I-NP O
he PRP B-NP O
became VBD B-VP O
obese JJ B-ADJP B-Disease
despite IN B-PP O
a DT B-NP O
normal JJ I-NP O
appetite NN I-NP O
. . O O

Recurrent JJ B-NP O
middle JJ I-NP B-Disease
ear NN I-NP I-Disease
infections NNS I-NP I-Disease
, , O O
a DT B-NP O
high JJ I-NP O
pain NN I-NP O
threshold NN I-NP O
, , O O
and CC O O
a DT B-NP O
great JJ I-NP O
skill NN I-NP O
with IN B-PP O
jigsaw NN B-NP O
puzzles NNS I-NP O
were VBD B-VP O
reported VBN I-VP O
. . O O

There EX B-NP O
were VBD B-VP O
no DT B-NP O
behavioural JJ I-NP O
problems NNS I-NP O
or CC O O
sleep VB B-VP O
disturbance NN B-NP O
. . O O

Chromosomal JJ B-NP O
analysis NN I-NP O
was VBD B-VP O
normal JJ B-ADJP O
( ( O O
46 CD B-NP O
, , O O
XY NN B-NP O
) ) O O
. . O O

DNA NN B-NP O
analysis NN I-NP O
for IN B-PP O
Prader NNP B-NP B-Disease
- HYPH I-NP I-Disease
Willi NNP I-NP I-Disease
syndrome NN I-NP I-Disease
showed VBD B-VP O
no DT B-NP O
abnormalities NNS I-NP O
. . O O

Two CD B-NP O
years NNS I-NP O
later RB B-ADVP O
he PRP B-NP O
was VBD B-VP O
re AFX B-ADJP O
- HYPH O O
examined VBN B-VP O
because IN B-SBAR O
we PRP B-NP O
thought VBD B-VP O
his PRP$ B-NP O
features NNS I-NP O
fitted VBD B-VP O
the DT B-NP O
PWS NN I-NP B-Disease
- HYPH B-VP O
like JJ B-NP O
phenotype NN I-NP O
associated VBN B-VP O
with IN B-PP O
maternal JJ B-NP O
UPD NN I-NP B-Disease
( ( O O
14 CD B-NP O
) ) O O
. . O O

At IN B-PP O
that DT B-NP O
time NN I-NP O
precocious JJ B-NP O
puberty NN I-NP O
was VBD B-VP O
evident JJ B-ADJP O
. . O O

DNA NN B-NP O
analysis NN I-NP O
showed VBD B-VP O
maternal JJ B-NP B-Disease
heterodisomy NN I-NP I-Disease
for IN B-PP O
chromosome NN B-NP O
14 CD I-NP O
. . O O

In IN B-PP O
all PDT B-NP O
the DT I-NP O
previously RB I-NP O
described VBN I-NP O
11 CD I-NP O
cases NNS I-NP O
with IN B-PP O
maternal JJ B-NP O
UPD NN I-NP B-Disease
( ( O O
14 CD B-NP O
) ) O O
, , O O
a DT B-NP O
Robertsonian JJ I-NP O
translocation NN I-NP O
involving VBG B-VP O
chromosome NN B-NP O
14 CD I-NP O
was VBD B-VP O
detected VBN I-VP O
cytogenetically RB B-ADVP O
before IN B-PP O
DNA NN B-NP O
analysis NN I-NP O
. . O O

This DT B-NP O
is VBZ B-VP O
the DT B-NP O
first JJ I-NP O
report NN I-NP O
of IN B-PP O
diagnosis NN B-NP O
of IN B-PP O
maternal JJ B-NP O
UPD NN I-NP B-Disease
( ( O O
14 CD B-NP O
) ) O O
based VBN B-PP O
on IN B-PP O
clinical JJ B-NP O
features NNS I-NP O
. . O O

This DT B-NP O
finding NN I-NP O
underlines VBZ B-VP O
the DT B-NP O
importance NN I-NP O
of IN B-PP O
DNA NN B-NP O
analysis NN I-NP O
for IN B-PP O
maternal JJ B-NP O
UPD NN I-NP O
( ( O O
14 CD B-NP O
) ) O O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
a DT B-NP O
similar JJ I-NP O
PWS NN I-NP B-Disease
- HYPH B-NP O
like JJ I-NP O
phenotype NN I-NP O
even RB B-ADVP O
without IN B-PP O
previous JJ B-NP O
identification NN I-NP O
of IN B-PP O
a DT B-NP O
Robertsonian JJ I-NP O
translocation NN I-NP O
involving VBG B-VP O
chromosome NN B-NP O
14 CD I-NP O
. . O O

. . O O

Clinical JJ B-NP O
and CC I-NP O
genetic JJ I-NP O
study NN I-NP O
of IN B-PP O
Friedreich NNP B-NP B-Disease
ataxia NN I-NP I-Disease
in IN B-PP O
an DT B-NP O
Australian JJ I-NP O
population NN I-NP O
. . O O

Friedreich JJ B-NP B-Disease
ataxia NN I-NP I-Disease
is VBZ B-VP O
an DT B-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
disorder NN I-NP I-Disease
caused VBN B-VP O
by IN B-PP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
FRDA NN I-NP B-Disease
gene NN I-NP O
that WDT B-NP O
encodes VBZ B-VP O
a DT B-NP O
210 CD I-NP O
- HYPH I-NP O
amino NN I-NP O
acid NN I-NP O
protein NN I-NP O
called VBN B-VP O
frataxin NN B-NP O
. . O O

An DT B-NP O
expansion NN I-NP O
of IN B-PP O
a DT B-NP O
GAA NN I-NP O
trinucleotide NN I-NP O
repeat NN I-NP O
in IN B-PP O
intron NN B-NP O
1 CD I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
is VBZ B-VP O
present JJ B-ADJP O
in IN B-PP O
more JJR B-NP O
than IN I-NP O
95 CD I-NP O
% NN I-NP O
of IN B-PP O
mutant JJ B-NP O
alleles NNS I-NP O
. . O O

Of IN B-PP O
the DT B-NP O
83 CD I-NP O
people NNS I-NP O
we PRP B-NP O
studied VBD B-VP O
who WP B-NP O
have VBP B-VP O
mutations NNS B-NP O
in IN B-PP O
FRDA NN B-NP O
, , O O
78 CD B-NP O
are VBP B-VP O
homozygous JJ B-ADJP O
for IN B-PP O
an DT B-NP O
expanded VBN I-NP O
GAA NN I-NP O
repeat NN I-NP O
; : O O
the DT B-NP O
other JJ I-NP O
five CD I-NP O
patients NNS I-NP O
have VBP B-VP O
an DT B-NP O
expansion NN I-NP O
in IN B-PP O
one CD B-NP O
allele NN I-NP O
and CC O O
a DT B-NP O
point NN I-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
other JJ I-NP O
. . O O

Here RB B-ADVP O
we PRP B-NP O
present VBP B-VP O
a DT B-NP O
detailed JJ I-NP O
clinical JJ I-NP O
and CC I-NP O
genetic JJ I-NP O
study NN I-NP O
of IN B-PP O
a DT B-NP O
subset NN I-NP O
of IN B-PP O
51 CD B-NP O
patients NNS I-NP O
homozygous JJ B-ADJP O
for IN B-PP O
an DT B-NP O
expansion NN I-NP O
of IN B-PP O
the DT B-NP O
GAA NN I-NP O
repeat NN I-NP O
. . O O

We PRP B-NP O
found VBD B-VP O
a DT B-NP O
correlation NN I-NP O
between IN B-PP O
the DT B-NP O
size NN I-NP O
of IN B-PP O
the DT B-NP O
smaller JJR I-NP O
of IN B-PP O
the DT B-NP O
two CD I-NP O
expanded VBN I-NP O
alleles NNS I-NP O
and CC O O
age NN B-NP O
at IN B-PP O
onset NN B-NP O
, , O O
age NN B-NP O
into IN B-PP O
wheelchair NN B-NP O
, , O O
scoliosis NN B-NP B-Disease
, , O O
impaired JJ B-NP O
vibration NN I-NP O
sense NN I-NP O
, , O O
and CC O O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
foot NN B-NP B-Disease
deformity NN I-NP I-Disease
. . O O

There EX B-NP O
was VBD B-VP O
no DT B-NP O
significant JJ I-NP O
correlation NN I-NP O
between IN B-PP O
the DT B-NP O
size NN I-NP O
of IN B-PP O
the DT B-NP O
smaller JJR I-NP O
allele NN I-NP O
and CC I-NP O
cardiomyopathy NN I-NP B-Disease
, , O O
diabetes NN B-NP B-Disease
mellitus NN I-NP I-Disease
, , O O
loss NN B-NP B-Disease
of IN B-PP I-Disease
proprioception NN B-NP I-Disease
, , O O
or CC O O
bladder NN B-NP B-Disease
symptoms NNS I-NP I-Disease
. . O O

The DT B-NP O
larger JJR I-NP O
allele NN I-NP O
size NN I-NP O
correlated VBD B-VP O
with IN B-PP O
bladder NN B-NP B-Disease
symptoms NNS I-NP I-Disease
and CC O O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
foot NN B-NP B-Disease
deformity NN I-NP I-Disease
. . O O

The DT B-NP O
duration NN I-NP O
of IN B-PP O
disease NN B-NP O
is VBZ B-VP O
correlated VBN I-VP O
with IN B-PP O
wheelchair NN B-NP O
use NN I-NP O
and CC O O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
diabetes NN B-NP B-Disease
, , O O
scoliosis NN B-NP B-Disease
, , O O
bladder NN B-NP B-Disease
symptoms NNS I-NP I-Disease
and CC O O
impaired JJ B-NP B-Disease
proprioception NN I-NP I-Disease
, , O O
and CC O O
vibration NN B-NP O
sense NN I-NP O
but CC O O
no DT B-NP O
other JJ I-NP O
complications NNS I-NP O
studied VBN B-VP O
. . O O

. . O O

Novel JJ B-NP O
mutations NNS I-NP O
in IN B-PP O
XLRS1 NN B-NP O
causing VBG B-VP O
retinoschisis NN B-NP B-Disease
, , O O
including VBG B-PP O
first JJ B-NP O
evidence NN I-NP O
of IN B-PP O
putative JJ B-NP O
leader NN I-NP O
sequence NN I-NP O
change NN I-NP O
. . O O

Juvenile JJ B-NP B-Disease
retinoschisis NN I-NP I-Disease
is VBZ B-VP O
an DT B-NP O
X NN I-NP B-Disease
- HYPH O I-Disease
linked VBN B-VP I-Disease
recessive JJ B-NP I-Disease
disease NN I-NP I-Disease
caused VBN B-VP O
by IN B-PP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
XLRS1 NN I-NP O
gene NN I-NP O
. . O O

We PRP B-NP O
screened VBD B-VP O
31 CD B-NP O
new JJ I-NP O
unrelated JJ I-NP O
patients NNS I-NP O
and CC I-NP O
families NNS I-NP O
for IN B-PP O
XLRS1 NN B-NP O
mutations NNS I-NP O
in IN B-PP O
addition NN B-NP O
to TO B-PP O
previously RB B-NP O
reported VBN I-NP O
mutations NNS I-NP O
for IN B-PP O
60 CD B-NP O
of IN B-PP O
our PRP$ B-NP O
families NNS I-NP O
( ( O O
Retinoschisis NNP B-NP B-Disease
Consortium NNP I-NP O
, , O O
Hum NNP B-NP O
Mol NNP I-NP O
Genet NNP I-NP O
1998 CD I-NP O
; : O O
7 CD B-NP O
1185 CD I-NP O
- HYPH B-NP O
1192 CD I-NP O
) ) O O
. . O O

Twenty CD B-NP O
- HYPH I-NP O
three CD I-NP O
different JJ I-NP O
mutations NNS I-NP O
including VBG B-PP O
12 CD B-NP O
novel JJ I-NP O
ones NNS I-NP O
were VBD B-VP O
identified VBN I-VP O
in IN B-PP O
28 CD B-NP O
patients NNS I-NP O
. . O O

Mutations NNS B-NP O
identified VBN B-VP O
in IN B-PP O
this DT B-NP O
study NN I-NP O
include VBP B-VP O
19 CD B-NP O
missense JJ I-NP O
mutations NNS I-NP O
, , O O
two CD B-NP O
nonsense JJ I-NP O
mutations NNS I-NP O
, , O O
one CD B-NP O
intragenic JJ I-NP O
deletion NN I-NP O
, , O O
four CD B-NP O
microdeletions NNS I-NP O
, , O O
one CD B-NP O
insertion NN I-NP O
, , O O
and CC O O
one CD B-NP O
intronic JJ I-NP O
sequence NN I-NP O
substitution NN I-NP O
that WDT B-NP O
is VBZ B-VP O
likely JJ B-ADJP O
to TO B-VP O
result VB I-VP O
in IN B-PP O
a DT B-NP O
splice NN I-NP O
site NN I-NP O
defect NN I-NP O
. . O O

Two CD B-NP O
novel JJ I-NP O
mutations NNS I-NP O
, , O O
c NN B-NP O
. . O O

38T NN B-NP O
- SYM O O
- SYM O O
> SYM O O
C NN B-NP O
( ( O O
L13P NN B-NP O
) ) O O
and CC O O
c NN B-NP O
. . O O

667T NN B-NP O
- SYM O O
- SYM O O
> SYM O O
C NN B-NP O
( ( O O
C223R NN B-NP O
) ) O O
, , O O
respectively RB B-ADVP O
, , O O
present VBP B-VP O
the DT B-NP O
first JJ I-NP O
genetic JJ I-NP O
evidence NN I-NP O
for IN B-PP O
the DT B-NP O
functional JJ I-NP O
significance NN I-NP O
of IN B-PP O
the DT B-NP O
putative JJ I-NP O
leader NN I-NP O
peptide NN I-NP O
sequence NN I-NP O
and CC B-PP O
for IN B-PP O
the DT B-NP O
functional JJ I-NP O
significance NN I-NP O
at IN B-PP O
the DT B-NP O
carboxyl NN I-NP O
terminal NN I-NP O
of IN B-PP O
the DT B-NP O
XLRS1 NN I-NP O
protein NN I-NP O
beyond IN B-PP O
the DT B-NP O
discoidin NN I-NP O
domain NN I-NP O
. . O O

Mutations NNS B-NP O
in IN B-PP O
25 CD B-NP O
of IN B-PP O
the DT B-NP O
families NNS I-NP O
were VBD B-VP O
localized JJ B-ADJP O
to TO B-PP O
exons NNS B-NP O
4 CD B-NP O
- HYPH I-NP O
6 CD I-NP O
, , O O
emphasizing VBG B-VP O
the DT B-NP O
critical JJ I-NP O
functional JJ I-NP O
significance NN I-NP O
of IN B-PP O
the DT B-NP O
discoidin NN I-NP O
domain NN I-NP O
of IN B-PP O
the DT B-NP O
XLRS1 NN I-NP O
protein NN I-NP O
Growth NN B-NP O
hormone NN I-NP O
treatment NN I-NP O
increases VBZ B-VP O
CO NN B-NP O
( ( O O
2 CD B-NP O
) ) O O
response NN B-NP O
, , O O
ventilation NN B-NP O
and CC O O
central JJ B-NP O
inspiratory JJ I-NP O
drive NN I-NP O
in IN B-PP O
children NNS B-NP O
with IN B-PP O
Prader NNP B-NP B-Disease
- HYPH I-NP I-Disease
Willi NNP I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

We PRP B-NP O
studied VBD B-VP O
whether IN B-SBAR O
the DT B-NP O
beneficial JJ I-NP O
effects NNS I-NP O
of IN B-PP O
growth NN B-NP O
hormone NN I-NP O
( ( O O
GH NN B-NP O
) ) O O
treatment NN B-NP O
on IN B-PP O
growth NN B-NP O
and CC I-NP O
body NN I-NP O
composition NN I-NP O
in IN B-PP O
PWS NN B-NP B-Disease
are VBP B-VP O
accompanied VBN I-VP O
by IN B-PP O
an DT B-NP O
improvement NN I-NP O
in IN B-PP O
respiratory JJ B-NP O
function NN I-NP O
. . O O

We PRP B-NP O
measured VBD B-VP O
resting VBG I-VP O
ventilation NN B-NP O
, , O O
airway NN B-NP O
occlusion NN I-NP O
pressure NN I-NP O
( ( O O
P NN B-NP O
( ( O O
0 CD B-NP O
. . O O

1 CD B-NP O
) ) O O
) ) O O
and CC O O
ventilatory JJ B-NP O
response NN I-NP O
to TO B-PP O
CO NN B-NP O
( ( O O
2 CD B-NP O
) ) O O
in IN B-PP O
nine CD B-NP O
children NNS I-NP O
, , O O
aged VBN B-VP O
7 CD B-NP O
- HYPH I-NP O
14 CD I-NP O
years NNS I-NP O
, , O O
before IN B-PP O
and CC B-NP O
6 CD I-NP O
- HYPH I-NP O
9 CD I-NP O
months NNS I-NP O
after IN B-PP O
the DT B-NP O
start NN I-NP O
of IN B-PP O
GH NN B-NP O
treatment NN I-NP O
. . O O

During IN B-PP O
GH NN B-NP O
treatment NN I-NP O
, , O O
resting VBG B-NP O
ventilation NN I-NP O
increased VBD B-VP O
by IN B-PP O
26 CD B-NP O
% NN I-NP O
, , O O
P NN B-NP O
( ( O O
0 CD B-NP O
. . I-NP O

1 CD I-NP O
) ) O O
by IN B-PP O
72 CD B-NP O
% NN I-NP O
and CC O O
the DT B-NP O
response NN I-NP O
to TO B-PP O
CO NN B-NP O
( ( O O
2 CD B-NP O
) ) O O
by IN B-PP O
65 CD B-NP O
% NN I-NP O
( ( O O
P NN B-NP O
< SYM B-ADJP O
0 CD B-NP O
. . I-NP O

002 CD I-NP O
, , O O
< SYM B-NP O
0 CD I-NP O
. . I-NP O

04 CD I-NP O
and CC O O
< SYM B-NP O
0 CD I-NP O
. . I-NP O

02 CD I-NP O
, , O O
respectively RB B-ADVP O
) ) O O
. . O O

This DT B-NP O
observed VBN I-NP O
increase NN I-NP O
in IN B-PP O
ventilatory JJ B-NP O
output NN I-NP O
was VBD B-VP O
not RB I-VP O
correlated VBN I-VP O
to TO B-PP O
changes NNS B-NP O
in IN B-PP O
body NN B-NP O
mass NN I-NP O
index NN I-NP O
. . O O

CONCLUSION NN B-NP O
Treatment NN I-NP O
of IN B-PP O
children NNS B-NP O
with IN B-PP O
Prader NNP B-NP B-Disease
- HYPH I-NP I-Disease
Willi NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
PWS NN B-NP B-Disease
) ) O O
seems VBZ B-VP O
to TO I-VP O
have VB I-VP O
a DT B-NP O
stimulatory JJ I-NP O
effect NN I-NP O
on IN B-PP O
central JJ B-NP O
respiratory JJ I-NP O
structures NNS I-NP O
. . O O

The DT B-NP O
observed VBN I-NP O
increase NN I-NP O
in IN B-PP O
ventilation NN B-NP O
and CC O O
inspiratory JJ B-NP O
drive NN I-NP O
may MD B-VP O
contribute VB I-VP O
to TO B-PP O
the DT B-NP O
improved JJ I-NP O
activity NN I-NP O
level NN I-NP O
reported VBN B-VP O
by IN B-PP O
parents NNS B-NP O
of IN B-PP O
PWS NN B-NP B-Disease
children NNS I-NP O
during IN B-PP O
growth NN B-NP O
hormone NN I-NP O
therapy NN I-NP O
G130V NN B-NP O
, , O O
a DT B-NP O
common JJ I-NP O
FRDA NN I-NP B-Disease
point NN I-NP O
mutation NN I-NP O
, , O O
appears VBZ B-VP O
to TO I-VP O
have VB I-VP O
arisen VBN I-VP O
from IN B-PP O
a DT B-NP O
common JJ I-NP O
founder NN I-NP O
. . O O

Friedreich NN B-NP B-Disease
ataxia NN I-NP I-Disease
( ( O O
FRDA NN B-NP B-Disease
) ) O O
is VBZ B-VP O
the DT B-NP O
most RBS I-NP O
common JJ I-NP O
inherited VBN I-NP B-Disease
ataxia NN I-NP I-Disease
. . O O

About RB B-NP O
98 CD I-NP O
% NN I-NP O
of IN B-PP O
mutant JJ B-NP O
alleles NNS I-NP O
have VBP B-VP O
an DT B-NP O
expansion NN I-NP O
of IN B-PP O
a DT B-NP O
GAA NN I-NP O
trinucleotide NN I-NP O
repeat NN I-NP O
in IN B-PP O
intron NN B-NP O
1 CD I-NP O
of IN B-PP O
the DT B-NP O
affected VBN I-NP O
gene NN I-NP O
, , O O
FRDA NN B-NP O
. . O O

The DT B-NP O
other JJ I-NP O
2 CD I-NP O
% NN I-NP O
are VBP B-VP O
point NN B-NP O
mutations NNS I-NP O
. . O O

Of IN B-PP O
the DT B-NP O
17 CD I-NP O
point NN I-NP O
mutations NNS I-NP O
so RB B-VP O
far RB I-VP O
described VBN I-VP O
, , O O
three CD B-NP O
appear VBP B-VP O
to TO I-VP O
be VB I-VP O
more RBR B-ADJP O
common JJ I-ADJP O
. . O O

One CD B-NP O
of IN B-PP O
these DT B-NP O
is VBZ B-VP O
the DT B-NP O
G130V NN I-NP O
mutation NN I-NP O
in IN B-PP O
exon NN B-NP O
4 CD I-NP O
of IN B-PP O
FRDA NN B-NP O
. . O O

G130V NN B-NP O
, , O O
when WRB B-ADVP O
present JJ B-ADJP O
with IN B-PP O
an DT B-NP O
expanded VBN I-NP O
GAA NN I-NP O
repeat NN I-NP O
on IN B-PP O
the DT B-NP O
other JJ I-NP O
allele NN I-NP O
, , O O
is VBZ B-VP O
associated VBN I-VP O
with IN B-PP O
an DT B-NP O
atypical JJ I-NP O
FRDA NN I-NP B-Disease
phenotype NN I-NP O
. . O O

Haplotype NN B-NP O
analysis NN I-NP O
was VBD B-VP O
undertaken VBN I-VP O
on IN B-PP O
the DT B-NP O
four CD I-NP O
families NNS I-NP O
who WP B-NP O
have VBP B-VP O
been VBN I-VP O
described VBN I-VP O
with IN B-PP O
this DT B-NP O
mutation NN I-NP O
. . O O

The DT B-NP O
results NNS I-NP O
suggest VBP B-VP O
a DT B-NP O
common JJ I-NP O
founder NN I-NP O
for IN B-PP O
this DT B-NP O
mutation NN I-NP O
. . O O

Although IN B-SBAR O
marked JJ B-NP O
differences NNS I-NP O
in IN B-PP O
extragenic JJ B-NP O
marker NN I-NP O
haplotypes NNS I-NP O
were VBD B-VP O
seen VBN I-VP O
in IN B-PP O
one CD B-NP O
family NN I-NP O
, , O O
similar JJ B-NP O
intragenic JJ I-NP O
haplotyping NN I-NP O
suggests VBZ B-VP O
the DT B-NP O
same JJ I-NP O
mutation NN I-NP O
founder NN I-NP O
for IN B-PP O
this DT B-NP O
family NN I-NP O
with IN B-PP O
the DT B-NP O
differences NNS I-NP O
explicable JJ B-ADJP O
by IN B-PP O
two CD B-NP O
recombination NN I-NP O
events NNS I-NP O
. . O O

. . O O

Synergistic JJ B-NP O
effect NN I-NP O
of IN B-PP O
histone NN B-NP O
hyperacetylation NN I-NP O
and CC O O
DNA NN B-NP O
demethylation NN I-NP O
in IN B-PP O
the DT B-NP O
reactivation NN I-NP O
of IN B-PP O
the DT B-NP O
FMR1 NN I-NP O
gene NN I-NP O
. . O O

Most JJS B-NP O
fragile JJ I-NP B-Disease
X NN I-NP I-Disease
syndrome NN I-NP I-Disease
patients NNS I-NP O
have VBP B-VP O
expansion NN B-NP O
of IN B-PP O
a DT B-NP O
( ( O O
CGG NN O O
) ) O O
( ( O O
n NN B-NP O
) ) O O
sequence NN B-NP O
with IN B-PP O
> SYM B-NP O
200 CD I-NP O
repeats NNS I-NP O
( ( O O
full JJ B-NP O
mutation NN I-NP O
) ) O O
in IN B-PP O
the DT B-NP O
FMR1 NN I-NP O
gene NN I-NP O
responsible JJ B-ADJP O
for IN B-PP O
this DT B-NP O
condition NN I-NP O
. . O O

Hypermethylation NN B-NP O
of IN B-PP O
the DT B-NP O
expanded VBN I-NP O
repeat NN I-NP O
and CC B-PP O
of IN B-PP O
the DT B-NP O
FMR1 NN I-NP O
promoter NN I-NP O
is VBZ B-VP O
almost RB B-ADJP O
always RB I-ADJP O
present JJ I-ADJP O
and CC O O
apparently RB B-VP O
suppresses VBZ I-VP O
transcription NN B-NP O
, , O O
resulting VBG B-VP O
in IN B-PP O
absence NN B-NP O
of IN B-PP O
the DT B-NP O
FMR1 NN I-NP O
protein NN I-NP O
. . O O

We PRP B-NP O
recently RB B-ADVP O
showed VBD B-VP O
that IN B-SBAR O
transcriptional JJ B-NP O
reactivation NN I-NP O
of IN B-PP O
FMR1 NN B-NP O
full JJ B-NP O
mutations NNS I-NP O
can MD B-VP O
be VB I-VP O
achieved VBN I-VP O
by IN B-PP O
inducing VBG B-VP O
DNA NN B-NP O
demethylation NN I-NP O
with IN B-PP O
5 CD B-NP O
- HYPH I-NP O
azadeoxycytidine NN I-NP O
( ( O O
5 CD B-NP O
- HYPH I-NP O
azadC NN I-NP O
) ) O O
. . O O

The DT B-NP O
level NN I-NP O
of IN B-PP O
histone NN B-NP O
acetylation NN I-NP O
is VBZ B-VP O
another DT B-NP O
important JJ I-NP O
factor NN I-NP O
in IN B-PP O
regulating VBG B-VP O
gene NN B-NP O
expression NN I-NP O
; : O O
therefore RB B-ADVP O
, , O O
we PRP B-NP O
treated VBD B-VP O
lymphoblastoid JJ B-NP O
cell NN I-NP O
lines NNS I-NP O
of IN B-PP O
non AFX B-NP O
- HYPH I-NP O
mosaic JJ I-NP O
full JJ I-NP O
mutation NN I-NP O
patients NNS I-NP O
with IN B-PP O
three CD B-NP O
drugs NNS I-NP O
capable JJ B-ADJP O
of IN B-PP O
inducing VBG B-VP O
histone NN B-NP O
hyperacetylation NN I-NP O
. . O O

We PRP B-NP O
observed VBD B-VP O
a DT B-NP O
consistent JJ I-NP O
, , O O
although IN B-SBAR O
modest JJ B-ADJP O
, , O O
reactivation NN B-NP O
of IN B-PP O
the DT B-NP O
FMR1 NN I-NP O
gene NN I-NP O
with IN B-PP O
4 CD B-NP O
- HYPH I-NP O
phenylbutyrate NN I-NP O
, , O O
sodium NN B-NP O
butyrate NN I-NP O
and CC O O
trichostatin NN B-NP O
A NN I-NP O
, , O O
as IN B-SBAR O
shown VBN B-VP O
by IN B-PP O
RT NN B-NP O
- HYPH B-NP O
PCR NN I-NP O
. . O O

However RB B-ADVP O
, , O O
we PRP B-NP O
report VBP B-VP O
that IN B-SBAR O
combining VBG B-VP O
these DT B-NP O
drugs NNS I-NP O
with IN B-PP O
5 CD B-NP O
- HYPH I-NP O
azadC NN I-NP O
results VBZ B-VP O
in IN B-PP O
a DT B-NP O
2 CD I-NP O
- HYPH I-NP O
to TO B-PP O
5 CD B-NP O
- HYPH I-NP O
fold JJ I-NP O
increase NN I-NP O
in IN B-PP O
FMR1 NN B-NP O
mRNA NN I-NP O
levels NNS I-NP O
obtained VBN B-VP O
with IN B-PP O
5 CD B-NP O
- HYPH I-NP O
azadC NN I-NP O
alone RB B-ADVP O
, , O O
thus RB B-ADVP O
showing VBG B-VP O
a DT B-NP O
marked JJ I-NP O
synergistic JJ I-NP O
effect NN I-NP O
of IN B-PP O
histone NN B-NP O
hyperacetylation NN I-NP O
and CC O O
DNA NN B-NP O
demethylation NN I-NP O
in IN B-PP O
the DT B-NP O
reactivation NN I-NP O
of IN B-PP O
FMR1 NN B-NP O
full JJ B-NP O
mutations NNS I-NP O
. . O O

. . O O

Constitutional NNP B-NP O
von NNP I-NP B-Disease
Hippel NNP I-NP I-Disease
- HYPH I-NP I-Disease
Lindau NNP I-NP I-Disease
( ( O O
VHL NNP O B-Disease
) ) O O
gene NN B-NP O
deletions NNS I-NP O
detected VBN B-VP O
in IN B-PP O
VHL NN B-NP B-Disease
families NNS I-NP O
by IN B-PP O
fluorescence NN B-NP O
in FW B-NP O
situ FW I-NP O
hybridization NN I-NP O
. . O O

von IN B-PP B-Disease
Hippel NNP B-NP I-Disease
- HYPH O I-Disease
Lindau NNP B-NP I-Disease
( ( O I-Disease
VHL NNP O I-Disease
) ) O I-Disease
disease NN B-NP I-Disease
is VBZ B-VP O
an DT B-NP O
autosomal JJ I-NP B-Disease
dominantly RB I-NP I-Disease
inherited VBN I-NP I-Disease
cancer NN I-NP I-Disease
syndrome NN I-NP I-Disease
predisposing VBG B-VP O
to TO B-PP O
a DT B-NP O
variety NN I-NP O
of IN B-PP O
tumor NN B-NP B-Disease
types NNS I-NP O
that WDT B-NP O
include VBP B-VP O
retinal JJ B-NP O
hemangioblastomas NNS I-NP B-Disease
, , O O
hemangioblastomas NNS B-NP B-Disease
of IN B-PP O
the DT B-NP O
central JJ I-NP O
nervous JJ I-NP O
system NN I-NP O
, , O O
renal JJ B-NP B-Disease
cell NN I-NP I-Disease
carcinomas NNS I-NP I-Disease
, , O O
pancreatic JJ B-NP B-Disease
cysts NNS I-NP I-Disease
and CC I-NP I-Disease
tumors NNS I-NP I-Disease
, , O O
pheochromocytomas NNS B-NP B-Disease
, , O O
endolymphatic JJ B-NP B-Disease
sac NN I-NP I-Disease
tumors NNS I-NP I-Disease
, , O O
and CC O O
epididymal JJ B-NP B-Disease
cystadenomas NNS I-NP I-Disease
[ ( O O
W NNP B-NP O
. . O O

M NN B-NP O
. . O O

Linehan NNP B-NP O
et FW I-NP O
al FW I-NP O
. FW I-NP O

, , O O
J NNP B-NP O
. . O O

Am NNP B-NP O
. . I-NP O

Med NNP I-NP O
. . I-NP O

Assoc NNP I-NP O
. . O O

, , O O
273 CD B-NP O
564 CD I-NP O
- HYPH B-NP O
570 CD I-NP O
, , I-NP O
1995 CD I-NP O
; : O O
E NNP B-NP O
. . I-NP O

A NNP I-NP O
. . I-NP O

Maher NNP I-NP O
and CC I-NP O
W NNP I-NP O
. . I-NP O

G NNP I-NP O
. NNP I-NP O

Kaelin NNP I-NP O
, , O O
Jr NNP B-NP O
. . O O

, , O O
Medicine NN B-NP O
( ( O O
Baltimore NNP B-NP O
) ) O O
, , O O
76 CD B-NP O
381 CD I-NP O
- HYPH B-NP O
391 CD I-NP O
, , I-NP O
1997 CD I-NP O
; : O O
W NNP B-NP O
. . I-NP O

M NNP I-NP O
. . I-NP O

Linehan NNP I-NP O
and CC I-NP O
R NNP I-NP O
. . I-NP O

D NNP I-NP O
. . I-NP O

Klausner NNP I-NP O
, , O O
In IN B-PP O
B NN B-NP O
. . O O

Vogelstein NN B-NP O
and CC I-NP O
K NN I-NP O
. . O O

Kinzler NNP B-NP O
( ( O O
eds NNS B-NP O
. . O O

) ) O O
, , O O
The DT B-NP O
Genetic JJ I-NP O
Basis NN I-NP O
of IN B-PP O
Human NNP B-NP O
Cancer NNP I-NP O
, , O O
pp NN B-NP O
. . O O

455 CD B-NP O
- HYPH I-NP O
473 CD I-NP O
, , O O
McGraw NNP B-NP O
- HYPH I-NP O
Hill NNP I-NP O
, , O O
1998 CD B-NP O
] ) O O
. . O O

The DT B-NP O
VHL NN I-NP B-Disease
gene NN I-NP O
was VBD B-VP O
localized JJ B-ADJP O
to TO B-PP O
chromosome NN B-NP O
3p25 CD I-NP O
- HYPH B-NP O
26 CD I-NP O
and CC O O
cloned VBN B-VP O
[ ( O O
F NNP B-NP O
. . I-NP O

Latif NNP I-NP O
et FW I-NP O
al FW I-NP O
. NN I-NP O

, , O O
Science NN B-NP O
( ( O O
Washington NNP B-NP O
DC NNP I-NP O
) ) O O
, , O O
260 CD B-NP O
1317 CD I-NP O
- HYPH B-NP O
1320 CD I-NP O
, , I-NP O
1993 CD I-NP O
] ) O O
. . O O

Germline NN B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
VHL NN I-NP B-Disease
gene NN I-NP O
have VBP B-VP O
been VBN I-VP O
detected VBN I-VP O
in IN B-PP O
the DT B-NP O
majority NN I-NP O
of IN B-PP O
VHL NN B-NP B-Disease
kindreds NNS I-NP O
. . O O

The DT B-NP O
reported VBN I-NP O
frequency NN I-NP O
of IN B-PP O
detection NN B-NP O
of IN B-PP O
VHL NN B-NP B-Disease
germline NN I-NP O
mutations NNS I-NP O
has VBZ B-VP O
varied VBN I-VP O
from IN B-PP O
39 CD B-NP O
to TO I-NP O
80 CD I-NP O
% NN I-NP O
( ( O O
J NNP B-NP O
. . I-NP O

M NNP I-NP O
. . I-NP O

Whaley NNP I-NP O
et FW I-NP O
al FW I-NP O
. FW I-NP O

, , O O
Am NNP B-NP O
. . I-NP O

J NNP I-NP O
. . I-NP O

Hum NNP I-NP O
. . I-NP O

Genet NNP I-NP O
. . O O

, , O O
55 CD B-NP O
1092 CD I-NP O
- HYPH B-NP O
1102 CD I-NP O
, , I-NP O
1994 CD I-NP O
; : O O
Clinical NNP B-NP O
Research NNP I-NP O
Group NNP I-NP O
for IN B-PP O
Japan NNP B-NP O
, , O O
Hum NNP B-NP O
. . I-NP O

Mol NNP I-NP O
. . I-NP O

Genet NNP I-NP O
. . O O

, , O O
4 CD B-NP O
2233 CD I-NP O
- HYPH B-NP O
2237 CD I-NP O
, , I-NP O
1995 CD I-NP O
; : O O
F NNP B-NP O
. . I-NP O

Chen NNP I-NP O
et FW I-NP O
al FW I-NP O
. FW I-NP O

, , O O
Hum NNP B-NP O
. . I-NP O

Mutat NNP I-NP O
. . O O

, , O O
5 CD B-NP O
66 CD I-NP O
- HYPH I-NP O
75 CD I-NP O
, , I-NP O
1995 CD I-NP O
; : O O
E NNP B-NP O
. . I-NP O

R NNP I-NP O
. . I-NP O

Maher NNP I-NP O
et FW I-NP O
al FW I-NP O
. FW I-NP O

, , O O
J NNP B-NP O
. . I-NP O

Med NNP I-NP O
. . I-NP O

Genet NNP I-NP O
. . O O

, , O O
33 CD B-NP O
328 CD I-NP O
- HYPH B-NP O
332 CD I-NP O
, , I-NP O
1996 CD I-NP O
; : O O
B NN B-NP O
. . O O

Zbar NNP B-NP O
, , O O
Cancer NNP B-NP O
Surv NNP I-NP O
. . O O

, , O O
25 CD B-NP O
219 CD I-NP O
- HYPH B-NP O
232 CD I-NP O
, , I-NP O
1995 CD I-NP O
) ) O O
. . O O

Recently RB B-ADVP O
a DT B-NP O
quantitative JJ I-NP O
Southern JJ I-NP O
blotting NN I-NP O
procedure NN I-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
improve VB I-VP O
this DT B-NP O
frequency NN I-NP O
( ( O O
C NN B-NP O
. . O O

Stolle NNP B-NP O
et FW I-NP O
al FW I-NP O
. FW I-NP O

, , O O
Hum NNP B-NP O
. . I-NP O

Mutat NNP I-NP O
. . O O

, , O O
12 CD B-NP O
417 CD I-NP O
- HYPH B-NP O
423 CD I-NP O
, , O O
1998 CD B-NP O
) ) O O
. . O O

In IN B-PP O
the DT B-NP O
present JJ I-NP O
study NN I-NP O
, , O O
we PRP B-NP O
report VBP B-VP O
the DT B-NP O
use NN I-NP O
of IN B-PP O
fluorescence NN B-NP O
in FW B-NP O
situ FW I-NP O
hybridization NN I-NP O
( ( O O
FISH NN B-NP O
) ) O O
as IN B-PP O
a DT B-NP O
method NN I-NP O
to TO B-VP O
detect VB I-VP O
and CC I-VP O
characterize VB I-VP O
VHL NN B-NP B-Disease
germline NN I-NP O
deletions NNS I-NP O
. . O O

We PRP B-NP O
reexamined VBD B-VP O
a DT B-NP O
group NN I-NP O
of IN B-PP O
VHL NN B-NP B-Disease
patients NNS I-NP O
shown VBN B-VP O
previously RB B-ADVP O
by IN B-PP O
single JJ B-NP O
- HYPH I-NP O
strand NN I-NP O
conformation NN I-NP O
and CC O O
sequencing NN B-NP O
analysis NN I-NP O
not RB O O
to TO B-VP O
harbor VB I-VP O
point NN B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
VHL NN I-NP B-Disease
locus NN I-NP O
. . O O

We PRP B-NP O
found VBD B-VP O
constitutional JJ B-NP O
deletions NNS I-NP O
in IN B-PP O
29 CD B-NP O
of IN B-PP O
30 CD B-NP O
VHL NN I-NP B-Disease
patients NNS I-NP O
in IN B-PP O
this DT B-NP O
group NN I-NP O
using VBG B-VP O
cosmid NN B-NP O
and CC I-NP O
P1 NN I-NP O
probes NNS I-NP O
that WDT B-NP O
cover VBP B-VP O
the DT B-NP O
VHL NN I-NP B-Disease
locus NN I-NP O
. . O O

We PRP B-NP O
then RB B-ADVP O
tested VBD B-VP O
six CD B-NP O
phenotypically RB I-NP O
normal JJ I-NP O
offspring NN I-NP O
from IN B-PP O
four CD B-NP O
of IN B-PP O
these DT B-NP O
VHL NN I-NP B-Disease
families NNS I-NP O
two CD B-NP O
were VBD B-VP O
found VBN I-VP O
to TO I-VP O
carry VB I-VP O
the DT B-NP O
deletion NN I-NP O
and CC O O
the DT B-NP O
other JJ I-NP O
four CD I-NP O
were VBD B-VP O
deletion NN B-NP O
- HYPH B-ADJP O
free JJ I-ADJP O
. . O O

In IN B-PP O
addition NN B-NP O
, , O O
germline NN B-NP O
mosaicism NN I-NP O
of IN B-PP O
the DT B-NP O
VHL NN I-NP B-Disease
gene NN I-NP O
was VBD B-VP O
identified VBN I-VP O
in IN B-PP O
one CD B-NP O
family NN I-NP O
. . O O

In IN B-PP O
sum NN B-NP O
, , O O
FISH NN B-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
be VB I-VP O
a DT B-NP O
simple JJ I-NP O
and CC I-NP O
reliable JJ I-NP O
method NN I-NP O
to TO B-VP O
detect VB I-VP O
VHL NN B-NP B-Disease
germline NN I-NP O
deletions NNS I-NP O
and CC O O
practically RB B-ADJP O
useful JJ I-ADJP O
in IN B-PP O
cases NNS B-NP O
where WRB B-ADVP O
other JJ B-NP O
methods NNS I-NP O
of IN B-PP O
screening NN B-NP O
have VBP B-VP O
failed VBN I-VP O
to TO I-VP O
detect VB I-VP O
a DT B-NP O
VHL NN I-NP B-Disease
gene NN I-NP I-Disease
abnormality NN I-NP I-Disease
Spectrum NN B-NP O
of IN B-PP O
hSNF5 NN B-NP O
/ SYM B-NP O
INI1 NN I-NP O
somatic JJ I-NP O
mutations NNS I-NP O
in IN B-PP O
human JJ B-NP O
cancer NN I-NP B-Disease
and CC I-NP O
genotype NN I-NP O
- HYPH B-NP O
phenotype NN I-NP O
correlations NNS I-NP O
. . O O

The DT B-NP O
hSNF5 NN I-NP O
/ SYM I-NP O
INI1 NN I-NP O
gene NN I-NP O
which WDT B-NP O
encodes VBZ B-VP O
a DT B-NP O
member NN I-NP O
of IN B-PP O
the DT B-NP O
SWI NN I-NP O
/ SYM B-NP O
SNF NN I-NP O
chromatin NN I-NP O
ATP NN I-NP O
- HYPH B-NP O
dependent JJ I-NP O
remodeling NN I-NP O
complex NN I-NP O
, , O O
is VBZ B-VP O
a DT B-NP O
new JJ I-NP O
tumor NN I-NP B-Disease
suppressor NN I-NP O
gene NN I-NP O
localized VBN B-VP O
on IN B-PP O
chromosome NN B-NP O
22q11 CD I-NP O
. . O O

2 CD B-NP O
and CC O O
recently RB B-VP O
shown VBN I-VP O
to TO I-VP O
be VB I-VP O
mutated VBN I-VP O
in IN B-PP O
malignant JJ B-NP B-Disease
rhabdoid JJ I-NP I-Disease
tumors NNS I-NP I-Disease
. . O O

We PRP B-NP O
have VBP B-VP O
searched VBN I-VP O
for IN B-PP O
hSNF5 NN B-NP O
/ SYM B-VP O
INI1 NN B-NP O
mutations NNS I-NP O
in IN B-PP O
229 CD B-NP O
tumors NNS I-NP B-Disease
of IN B-PP O
various JJ B-NP O
origins NNS I-NP O
using VBG B-VP O
a DT B-NP O
screening NN I-NP O
method NN I-NP O
based VBN B-VP O
on IN B-PP O
denaturing VBG B-VP O
high JJ B-NP O
- HYPH I-NP O
performance NN I-NP O
liquid NN I-NP O
chromatography NN I-NP O
. . O O

A DT B-NP O
total NN I-NP O
of IN B-PP O
31 CD B-NP O
homozygous JJ I-NP O
deletions NNS I-NP O
and CC O O
36 CD B-NP O
point NN I-NP O
alterations NNS I-NP O
were VBD B-VP O
identified VBN I-VP O
. . O O

Point NN B-NP O
mutations NNS I-NP O
were VBD B-VP O
scattered VBN I-VP O
along IN B-PP O
the DT B-NP O
coding VBG I-NP O
sequence NN I-NP O
and CC O O
included VBD B-VP O
15 CD B-NP O
nonsense NN I-NP O
, , O O
15 CD B-NP O
frameshift NN I-NP O
, , O O
three CD B-NP O
splice NN I-NP O
site NN I-NP O
, , O O
two CD B-NP O
missense JJ I-NP O
and CC O O
one CD B-NP O
editing NN I-NP O
mutations NNS I-NP O
. . O O

Mutations NNS B-NP O
were VBD B-VP O
retrieved VBN I-VP O
in IN B-PP O
most JJS B-NP O
rhabdoid JJ I-NP B-Disease
tumors NNS I-NP I-Disease
, , O O
whatever WDT B-NP O
their PRP$ B-NP O
sites NNS I-NP O
of IN B-PP O
occurrence NN B-NP O
, , O O
indicating VBG B-VP O
the DT B-NP O
common JJ I-NP O
pathogenetic JJ I-NP O
origin NN I-NP O
of IN B-PP O
these DT B-NP O
tumors NNS I-NP B-Disease
. . O O

Recurrent JJ B-NP O
hSNF5 NN I-NP O
/ SYM B-VP O
INI1 NN B-NP O
alterations NNS I-NP O
were VBD B-VP O
also RB I-VP O
observed VBN I-VP O
in IN B-PP O
choroid JJ B-NP B-Disease
plexus NN I-NP I-Disease
carcinomas NNS I-NP I-Disease
and CC B-PP O
in IN B-PP O
a DT B-NP O
subset NN I-NP O
of IN B-PP O
central JJ B-NP O
primitive JJ I-NP O
neuroectodermal JJ I-NP B-Disease
tumors NNS I-NP I-Disease
( ( O O
cPNETs NNS B-NP O
) ) O O
and CC O O
medulloblastomas NNS B-NP B-Disease
. . O O

In IN B-PP O
contrast NN B-NP O
, , O O
hSNF5 NN B-NP O
/ SYM I-NP O
INI1 NN I-NP O
point NN I-NP O
mutations NNS I-NP O
were VBD B-VP O
not RB I-VP O
detected VBN I-VP O
in IN B-PP O
breast NN B-NP B-Disease
cancers NNS I-NP I-Disease
, , O O
Wilms NNP B-NP B-Disease
tumors NNS I-NP I-Disease
, , O O
gliomas NNS B-NP B-Disease
, , O O
ependymomas NNS B-NP B-Disease
, , O O
sarcomas NNS B-NP B-Disease
and CC O O
other JJ B-NP O
tumor NN I-NP B-Disease
types NNS I-NP O
, , O O
even RB B-SBAR O
though IN I-SBAR O
most JJS B-NP O
analyzed VBN I-NP O
cases NNS I-NP O
harbored VBD B-VP O
loss NN B-NP O
of IN B-PP O
heterozygosity NN B-NP O
at IN B-PP O
22q11 CD B-NP O
. . O O

2 CD B-NP O
loci NNS I-NP O
. . O O

These DT B-NP O
results NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
rhabdoid JJ B-NP B-Disease
tumors NNS I-NP I-Disease
, , O O
choroid JJ B-NP B-Disease
plexus NN I-NP I-Disease
carcinomas NNS I-NP I-Disease
and CC O O
a DT B-NP O
subset NN I-NP O
of IN B-PP O
medulloblastomas NNS B-NP B-Disease
and CC I-NP O
cPNETs NNS I-NP O
share VBP B-VP O
common JJ B-NP O
pathways NNS I-NP O
of IN B-PP O
oncogenesis NN B-NP O
related VBN B-VP O
to TO B-PP O
hSNF5 NN B-NP O
/ SYM O O
INI1 NN B-NP O
alteration NN I-NP O
and CC O O
that IN B-SBAR O
hSNF5 NN B-NP O
/ SYM B-VP O
INI1 NN B-NP O
mutations NNS I-NP O
define VBP B-VP O
a DT B-NP O
genetically RB I-NP O
homogeneous JJ I-NP O
family NN I-NP O
of IN B-PP O
highly RB B-NP O
aggressive JJ I-NP O
cancers NNS I-NP B-Disease
mainly RB B-VP O
occurring VBG I-VP O
in IN B-PP O
young JJ B-NP O
children NNS I-NP O
and CC O O
frequently RB B-ADVP O
, , O O
but CC O O
not RB B-ADVP O
always RB I-ADVP O
, , O O
exhibiting VBG B-VP O
a DT B-NP O
rhabdoid JJ I-NP B-Disease
phenotype NN I-NP O
Ataxin NN B-NP O
- HYPH B-NP O
3 CD I-NP O
with IN B-PP O
an DT B-NP O
altered JJ I-NP O
conformation NN I-NP O
that WDT B-NP O
exposes VBZ B-VP O
the DT B-NP O
polyglutamine NN I-NP O
domain NN I-NP O
is VBZ B-VP O
associated VBN I-VP O
with IN B-PP O
the DT B-NP O
nuclear JJ I-NP O
matrix NN I-NP O
. . O O

Spinocerebellar JJ B-NP B-Disease
ataxia NN I-NP I-Disease
type NN I-NP I-Disease
- HYPH B-NP I-Disease
3 CD I-NP I-Disease
or CC O O
Machado NNP B-NP B-Disease
- HYPH O I-Disease
Joseph NNP B-NP I-Disease
disease NN I-NP I-Disease
( ( O O
SCA3 NN B-NP B-Disease
/ SYM B-NP O
MJD NN I-NP B-Disease
) ) O O
is VBZ B-VP O
a DT B-NP O
member NN I-NP O
of IN B-PP O
the DT B-NP O
CAG NN I-NP B-Disease
/ SYM B-NP I-Disease
polyglutamine NN I-NP I-Disease
repeat NN I-NP I-Disease
disease NN I-NP I-Disease
family NN I-NP O
. . O O

In IN B-PP O
this DT B-NP O
family NN I-NP O
of IN B-PP O
disorders NNS B-NP O
, , O O
a DT B-NP O
normally RB I-NP O
polymorphic JJ I-NP O
CAG NN I-NP O
repeat NN I-NP O
becomes VBZ B-VP O
expanded VBN I-VP O
, , O O
resulting VBG B-VP O
in IN B-PP O
expression NN B-NP O
of IN B-PP O
an DT B-NP O
expanded VBN I-NP O
polyglutamine NN I-NP O
domain NN I-NP O
in IN B-PP O
the DT B-NP O
disease NN I-NP O
gene NN I-NP O
product NN I-NP O
. . O O

Experimental JJ B-NP O
models NNS I-NP O
of IN B-PP O
polyglutamine NN B-NP B-Disease
disease NN I-NP I-Disease
implicate VBP B-VP O
the DT B-NP O
nucleus NN I-NP O
in IN B-PP O
pathogenesis NN B-NP O
; : O O
however RB B-ADVP O
, , O O
the DT B-NP O
link NN I-NP O
between IN B-PP O
intranuclear JJ B-NP O
expression NN I-NP O
of IN B-PP O
expanded VBN B-NP O
polyglutamine NN I-NP O
and CC O O
neuronal JJ B-NP B-Disease
dysfunction NN I-NP I-Disease
remains VBZ B-VP O
unclear JJ B-ADJP O
. . O O

Here RB B-ADVP O
we PRP B-NP O
demonstrate VBP B-VP O
that IN B-SBAR O
ataxin NN B-NP O
- HYPH B-NP O
3 CD I-NP O
, , O O
the DT B-NP O
disease NN I-NP O
protein NN I-NP O
in IN B-PP O
SCA3 NN B-NP B-Disease
/ SYM B-NP O
MJD NN I-NP B-Disease
, , O O
adopts VBZ B-VP O
a DT B-NP O
unique JJ I-NP O
conformation NN I-NP O
when WRB B-ADVP O
expressed VBN B-VP O
within IN B-PP O
the DT B-NP O
nucleus NN I-NP O
of IN B-PP O
transfected VBN B-NP O
cells NNS I-NP O
. . O O

The DT B-NP O
monoclonal JJ I-NP O
antibody NN I-NP O
1C2 NN I-NP O
is VBZ B-VP O
known VBN I-VP O
preferentially RB B-ADVP O
to TO B-VP O
bind VB I-VP O
expanded VBN B-NP O
polyglutamine NN I-NP O
, , O O
but CC O O
we PRP B-NP O
find VBP B-VP O
that IN B-SBAR O
it PRP B-NP O
also RB B-ADVP O
binds VBZ B-VP O
a DT B-NP O
fragment NN I-NP O
of IN B-PP O
ataxin NN B-NP O
- HYPH B-NP O
3 CD I-NP O
containing VBG B-VP O
a DT B-NP O
normal JJ I-NP O
glutamine NN I-NP O
repeat NN I-NP O
. . O O

In IN B-PP O
addition NN B-NP O
, , O O
expression NN B-NP O
of IN B-PP O
ataxin NN B-NP O
- HYPH B-NP O
3 CD I-NP O
within IN B-PP O
the DT B-NP O
nucleus NN I-NP O
exposes VBZ B-VP O
the DT B-NP O
glutamine NN I-NP O
domain NN I-NP O
of IN B-PP O
the DT B-NP O
full JJ I-NP O
- HYPH I-NP O
length NN I-NP O
non AFX O O
- HYPH O O
pathological JJ B-NP O
protein NN I-NP O
, , O O
allowing VBG B-VP O
it PRP B-NP O
to TO B-VP O
bind VB I-VP O
the DT B-NP O
monoclonal JJ I-NP O
antibody NN I-NP O
1C2 NN I-NP O
. . O O

Fractionation NN B-NP O
and CC O O
immunochemical JJ B-NP O
experiments NNS I-NP O
indicate VBP B-VP O
that IN B-SBAR O
this DT B-NP O
novel JJ I-NP O
conformation NN I-NP O
of IN B-PP O
intranuclear JJ B-NP O
ataxin NN I-NP O
- HYPH B-NP O
3 CD I-NP O
is VBZ B-VP O
not RB O O
due JJ B-ADJP O
to TO B-PP O
proteolysis NN B-NP O
, , O O
suggesting VBG B-VP O
instead RB B-ADVP O
that IN B-SBAR O
association NN B-NP O
with IN B-PP O
nuclear JJ B-NP O
protein NN I-NP O
( ( I-NP O
s NNS I-NP O
) ) O O
alters VBZ B-VP O
the DT B-NP O
structure NN I-NP O
of IN B-PP O
full JJ B-NP O
- HYPH I-NP O
length NN I-NP O
ataxin NN I-NP O
- HYPH B-NP O
3 CD I-NP O
which WDT B-NP O
exposes VBZ B-VP O
the DT B-NP O
polyglutamine NN I-NP O
domain NN I-NP O
. . O O

This DT B-NP O
conformationally RB I-NP O
altered VBN I-NP O
ataxin NN I-NP O
- HYPH B-NP O
3 CD I-NP O
is VBZ B-VP O
bound VBN I-VP O
to TO B-PP O
the DT B-NP O
nuclear JJ I-NP O
matrix NN I-NP O
. . O O

The DT B-NP O
pathological JJ I-NP O
form NN I-NP O
of IN B-PP O
ataxin NN B-NP O
- HYPH B-NP O
3 CD I-NP O
with IN B-PP O
an DT B-NP O
expanded VBN I-NP O
polyglutamine NN I-NP O
domain NN I-NP O
also RB B-ADVP O
associates VBZ B-VP O
with IN B-PP O
the DT B-NP O
nuclear JJ I-NP O
matrix NN I-NP O
. . O O

These DT B-NP O
data NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
an DT B-NP O
early JJ I-NP O
event NN I-NP O
in IN B-PP O
the DT B-NP O
pathogenesis NN I-NP O
of IN B-PP O
SCA3 NN B-NP B-Disease
/ SYM B-NP O
MJD NN I-NP B-Disease
may MD B-VP O
be VB I-VP O
an DT B-NP O
altered JJ I-NP O
conformation NN I-NP O
of IN B-PP O
ataxin NN B-NP O
- HYPH B-NP O
3 CD I-NP O
within IN B-PP O
the DT B-NP O
nucleus NN I-NP O
that WDT B-NP O
exposes VBZ B-VP O
the DT B-NP O
polyglutamine NN I-NP O
domain NN I-NP O
. . O O

. . O O

The DT B-NP O
human JJ I-NP O
MAGEL2 NN I-NP O
gene NN I-NP O
and CC O O
its PRP$ B-NP O
mouse NN I-NP O
homologue NN I-NP O
are VBP B-VP O
paternally RB I-VP O
expressed VBN I-VP O
and CC O O
mapped VBN B-VP O
to TO B-PP O
the DT B-NP O
Prader NNP I-NP B-Disease
- HYPH I-NP I-Disease
Willi NNP I-NP I-Disease
region NN I-NP O
. . O O

Prader NNP B-NP B-Disease
- HYPH I-NP I-Disease
Willi NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
PWS NN B-NP B-Disease
) ) O O
is VBZ B-VP O
a DT B-NP O
complex JJ I-NP O
neurogenetic JJ I-NP B-Disease
disorder NN I-NP I-Disease
. . O O

The DT B-NP O
phenotype NN I-NP O
is VBZ B-VP O
likely JJ B-ADJP O
to TO B-VP O
be VB I-VP O
a DT B-NP O
contiguous JJ I-NP B-Disease
gene NN I-NP I-Disease
syndrome NN I-NP I-Disease
involving VBG B-VP O
genes NNS B-NP O
which WDT B-NP O
are VBP B-VP O
paternally RB I-VP O
expressed VBN I-VP O
only RB B-ADVP O
, , O O
located JJ B-ADJP O
in IN B-PP O
the DT B-NP O
human JJ I-NP O
15q11 CD I-NP O
- HYPH I-NP O
q13 NN I-NP O
region NN I-NP O
. . O O

Four CD B-NP O
mouse NN I-NP O
models NNS I-NP O
of IN B-PP O
PWS NN B-NP B-Disease
have VBP B-VP O
been VBN I-VP O
reported VBN I-VP O
but CC O O
these DT B-NP O
do VBP B-VP O
not RB I-VP O
definitively RB I-VP O
allow VB I-VP O
the DT B-NP O
delineation NN I-NP O
of IN B-PP O
the DT B-NP O
critical JJ I-NP O
region NN I-NP O
and CC O O
the DT B-NP O
associated JJ I-NP O
genes NNS I-NP O
involved VBN B-VP O
in IN B-PP O
the DT B-NP O
aetiology NN I-NP O
of IN B-PP O
PWS NN B-NP B-Disease
. . O O

Moreover RB B-ADVP O
, , O O
targeted VBN B-NP O
mutagenesis NN I-NP O
of IN B-PP O
mouse NN B-NP O
homologues NNS I-NP O
of IN B-PP O
the DT B-NP O
human JJ I-NP O
candidate NN I-NP O
PWS NN I-NP B-Disease
genes NNS I-NP O
does VBZ B-VP O
not RB I-VP O
appear VB I-VP O
to TO I-VP O
result VB I-VP O
in IN B-PP O
any DT B-NP O
of IN B-PP O
the DT B-NP O
features NNS I-NP O
of IN B-PP O
PWS NN B-NP B-Disease
. . O O

Therefore RB B-ADVP O
, , O O
the DT B-NP O
isolation NN I-NP O
of IN B-PP O
new JJ B-NP O
genes NNS I-NP O
in IN B-PP O
this DT B-NP O
region NN I-NP O
remains VBZ B-VP O
crucial JJ B-ADJP O
for IN B-PP O
a DT B-NP O
better JJR I-NP O
understanding NN I-NP O
of IN B-PP O
the DT B-NP O
molecular JJ I-NP O
basis NN I-NP O
of IN B-PP O
PWS NN B-NP B-Disease
. . O O

In IN B-PP O
this DT B-NP O
manuscript NN I-NP O
, , O O
we PRP B-NP O
report VBP B-VP O
the DT B-NP O
characterization NN I-NP O
of IN B-PP O
MAGEL2 NN B-NP O
and CC O O
its PRP$ B-NP O
mouse NN I-NP O
homologue NN I-NP O
Magel2 NN I-NP O
. . O O

These DT B-NP O
are VBP B-VP O
located JJ B-ADJP O
in IN B-PP O
the DT B-NP O
human JJ I-NP O
15q11 CD I-NP O
- HYPH I-NP O
q13 NN I-NP O
and CC I-NP O
mouse NN I-NP O
7C NN I-NP O
regions NNS I-NP O
, , O O
in IN B-PP O
close JJ B-NP O
proximity NN I-NP O
to TO B-PP O
NDN NN B-NP O
/ SYM B-NP O
Ndn NN I-NP O
. . O O

By IN B-PP O
northern JJ B-NP O
blot NN I-NP O
analysis NN I-NP O
we PRP B-NP O
did VBD B-VP O
not RB I-VP O
detect VB I-VP O
any DT B-NP O
expression NN I-NP O
of IN B-PP O
MAGEL2 NN B-NP O
/ SYM B-NP O
Magel2 NN I-NP O
but CC B-PP O
by IN B-PP O
RT NN B-NP O
- HYPH B-NP O
PCR NN I-NP O
analysis NN I-NP O
, , O O
specific JJ B-NP O
expression NN I-NP O
was VBD B-VP O
detected VBN I-VP O
in IN B-PP O
fetal JJ B-NP O
and CC I-NP O
adult JJ I-NP O
brain NN I-NP O
and CC B-PP O
in IN B-PP O
placenta NN B-NP O
. . O O

Both DT B-NP O
genes NNS I-NP O
are VBP B-VP O
intronless JJ B-ADJP O
with IN B-PP O
tandem JJ B-NP O
direct JJ I-NP O
repeat NN I-NP O
sequences NNS I-NP O
contained VBD B-VP O
within IN B-PP O
a DT B-NP O
CpG NN I-NP O
island NN I-NP O
in IN B-PP O
the DT B-NP O
5 CD I-NP O
- HYPH I-NP O
untranscribed JJ I-NP O
region NN I-NP O
. . O O

The DT B-NP O
transcripts NNS I-NP O
encode VBP B-VP O
putative JJ B-NP O
proteins NNS I-NP O
that WDT B-NP O
are VBP B-VP O
homologous JJ B-ADJP O
to TO B-PP O
the DT B-NP O
MAGE NN I-NP O
proteins NNS I-NP O
and CC I-NP O
NDN NN I-NP O
. . O O

Moreover RB B-ADVP O
, , O O
MAGEL2 NN B-NP O
/ SYM I-NP O
Magel2 NN I-NP O
are VBP B-VP O
expressed VBN I-VP O
only RB B-ADVP O
from IN B-PP O
the DT B-NP O
paternal JJ I-NP O
allele NN I-NP O
in IN B-PP O
brain NN B-NP O
, , O O
suggesting VBG B-VP O
a DT B-NP O
potential JJ I-NP O
role NN I-NP O
in IN B-PP O
the DT B-NP O
aetiology NN I-NP O
of IN B-PP O
PWS NN B-NP B-Disease
and CC O O
its PRP$ B-NP O
mouse NN I-NP O
model NN I-NP O
, , O O
respectively RB B-ADVP O
. . O O

. . O O

cDNA NN B-NP O
microarrays NNS I-NP O
detect VBP B-VP O
activation NN B-NP O
of IN B-PP O
a DT B-NP O
myogenic JJ I-NP O
transcription NN I-NP O
program NN I-NP O
by IN B-PP O
the DT B-NP O
PAX3 NN I-NP O
- HYPH B-NP O
FKHR NN I-NP O
fusion NN I-NP O
oncogene NN I-NP O
. . O O

Alveolar JJ B-NP B-Disease
rhabdomyosarcoma NN I-NP I-Disease
is VBZ B-VP O
an DT B-NP O
aggressive JJ I-NP O
pediatric JJ I-NP B-Disease
cancer NN I-NP I-Disease
of IN B-PP I-Disease
striated VBN B-NP I-Disease
muscle NN I-NP I-Disease
characterized VBN B-VP O
in IN B-PP O
60 CD B-NP O
% NN I-NP O
of IN B-PP O
cases NNS B-NP O
by IN B-PP O
a DT B-NP O
t NN I-NP O
( ( O O
2 CD B-NP O
; : O O
13 CD B-NP O
) ) O O
( ( O O
q35 NN B-NP O
; : O O
q14 NN B-NP O
) ) O O
. . O O

This DT B-NP O
results VBZ B-VP O
in IN B-PP O
the DT B-NP O
fusion NN I-NP O
of IN B-PP O
PAX3 NN B-NP O
, , O O
a DT B-NP O
developmental JJ I-NP O
transcription NN I-NP O
factor NN I-NP O
required VBN B-VP O
for IN B-PP O
limb NN B-NP O
myogenesis NN I-NP O
, , O O
with IN B-PP O
FKHR NN B-NP O
, , O O
a DT B-NP O
member NN I-NP O
of IN B-PP O
the DT B-NP O
forkhead NN I-NP O
family NN I-NP O
of IN B-PP O
transcription NN B-NP O
factors NNS I-NP O
. . O O

The DT B-NP O
resultant JJ I-NP O
PAX3 NN I-NP O
- HYPH I-NP O
FKHR NN I-NP O
gene NN I-NP O
possesses VBZ B-VP O
transforming VBG B-VP O
properties NNS B-NP O
; : O O
however RB B-ADVP O
, , O O
the DT B-NP O
effects NNS I-NP O
of IN B-PP O
this DT B-NP O
chimeric JJ I-NP O
oncogene NN I-NP O
on IN B-PP O
gene NN B-NP O
expression NN I-NP O
are VBP B-VP O
largely RB B-ADJP O
unknown JJ I-ADJP O
. . O O

To TO B-VP O
investigate VB I-VP O
the DT B-NP O
actions NNS I-NP O
of IN B-PP O
these DT B-NP O
transcription NN I-NP O
factors NNS I-NP O
, , O O
both CC O O
Pax3 NN B-NP O
and CC I-NP O
PAX3 NN I-NP O
- HYPH B-NP O
FKHR NN I-NP O
were VBD B-VP O
introduced VBN I-VP O
into IN B-PP O
NIH NN B-NP O
3T3 NN I-NP O
cells NNS I-NP O
, , O O
and CC O O
the DT B-NP O
resultant JJ I-NP O
gene NN I-NP O
expression NN I-NP O
changes NNS I-NP O
were VBD B-VP O
analyzed VBN I-VP O
with IN B-PP O
a DT B-NP O
murine JJ I-NP O
cDNA NN I-NP O
microarray NN I-NP O
containing VBG B-VP O
2 CD B-NP O
, , O O
225 CD B-NP O
elements NNS I-NP O
. . O O

We PRP B-NP O
found VBD B-VP O
that IN B-SBAR O
PAX3 NN B-NP O
- HYPH B-NP O
FKHR NN I-NP O
but CC B-NP O
not RB I-NP O
PAX3 NN B-NP O
activated VBD B-VP O
a DT B-NP O
myogenic JJ I-NP O
transcription NN I-NP O
program NN I-NP O
including VBG B-PP O
the DT B-NP O
induction NN I-NP O
of IN B-PP O
transcription NN B-NP O
factors NNS I-NP O
MyoD NN B-NP O
, , O O
Myogenin NN B-NP O
, , O O
Six1 NN B-NP O
, , O O
and CC O O
Slug NN B-NP O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
a DT B-NP O
battery NN I-NP O
of IN B-PP O
genes NNS B-NP O
involved VBN B-VP O
in IN B-PP O
several JJ B-NP O
aspects NNS I-NP O
of IN B-PP O
muscle NN B-NP O
function NN I-NP O
. . O O

Notable JJ B-ADJP O
among IN B-PP O
this DT B-NP O
group NN I-NP O
were VBD B-VP O
the DT B-NP O
growth NN I-NP O
factor NN I-NP O
gene NN I-NP O
Igf2 NN I-NP O
and CC O O
its PRP$ B-NP O
binding VBG I-NP O
protein NN I-NP O
Igfbp5 NN I-NP O
. . O O

Relevance NN B-NP O
of IN B-PP O
this DT B-NP O
model NN I-NP O
was VBD B-VP O
suggested VBN I-VP O
by IN B-PP O
verification NN B-NP O
that IN B-SBAR O
three CD B-NP O
of IN B-PP O
these DT B-NP O
genes NNS I-NP O
( ( O O
IGFBP5 NN B-NP O
, , O O
HSIX1 NN B-NP O
, , O O
and CC O O
Slug NN B-NP O
) ) O O
were VBD B-VP O
also RB I-VP O
expressed VBN I-VP O
in IN B-PP O
alveolar JJ B-NP B-Disease
rhabdomyosarcoma NN I-NP I-Disease
cell NN I-NP O
lines NNS I-NP O
. . O O

This DT B-NP O
study NN I-NP O
utilizes VBZ B-VP O
cDNA NN B-NP O
microarrays NNS I-NP O
to TO B-VP O
elucidate VB I-VP O
the DT B-NP O
pattern NN I-NP O
of IN B-PP O
gene NN B-NP O
expression NN I-NP O
induced VBN B-VP O
by IN B-PP O
an DT B-NP O
oncogenic JJ I-NP O
transcription NN I-NP O
factor NN I-NP O
and CC O O
demonstrates VBZ B-VP O
the DT B-NP O
profound JJ I-NP O
myogenic JJ I-NP O
properties NNS I-NP O
of IN B-PP O
PAX3 NN B-NP O
- HYPH B-NP O
FKHR NN I-NP O
in IN B-PP O
NIH NN B-NP O
3T3 NN I-NP O
cells NNS I-NP O
. . O O

. . O O

Experimental JJ B-NP O
hemochromatosis NN I-NP B-Disease
due JJ B-ADJP O
to TO B-PP O
MHC NN B-NP O
class NN I-NP O
I CD I-NP O
HFE NN I-NP B-Disease
deficiency NN I-NP I-Disease
: : O O
immune JJ B-NP O
status NN I-NP O
and CC O O
iron NN B-NP O
metabolism NN I-NP O
. . O O

The DT B-NP O
puzzling JJ I-NP O
linkage NN I-NP O
between IN B-PP O
genetic JJ B-NP O
hemochromatosis NN I-NP B-Disease
and CC I-NP O
histocompatibility NN I-NP O
loci NNS I-NP O
became VBD B-VP O
even RB B-ADVP O
more RBR I-ADVP O
so RB I-ADVP O
when WRB B-ADVP O
the DT B-NP O
gene NN I-NP O
involved VBN B-VP O
, , O O
HFE NN B-NP O
, , O O
was VBD B-VP O
identified VBN I-VP O
. . O O

Indeed RB B-ADVP O
, , O O
within IN B-PP O
the DT B-NP O
well RB I-NP O
defined VBN I-NP O
, , O O
mainly RB B-NP O
peptide NN I-NP O
- HYPH O O
binding NN B-NP O
, , O O
MHC NN B-NP O
class NN I-NP O
I CD I-NP O
family NN I-NP O
of IN B-PP O
molecules NNS B-NP O
, , O O
HFE NN B-NP O
seems VBZ B-VP O
to TO I-VP O
perform VB I-VP O
an DT B-NP O
unusual JJ I-NP O
yet RB I-NP O
essential JJ I-NP O
function NN I-NP O
. . O O

As IN B-PP O
yet RB B-ADVP O
, , O O
our PRP$ B-NP O
understanding NN I-NP O
of IN B-PP O
HFE NN B-NP O
function NN I-NP O
in IN B-PP O
iron NN B-NP O
homeostasis NN I-NP O
is VBZ B-VP O
only RB B-ADJP O
partial JJ I-ADJP O
; : O O
an DT B-NP O
even RB I-NP O
more RBR I-NP O
open JJ I-NP O
question NN I-NP O
is VBZ B-VP O
its PRP$ B-NP O
possible JJ I-NP O
role NN I-NP O
in IN B-PP O
the DT B-NP O
immune JJ I-NP O
system NN I-NP O
. . O O

To TO B-VP O
advance VB I-VP O
on IN B-PP O
both DT B-NP O
of IN B-PP O
these DT B-NP O
avenues NNS I-NP O
, , O O
we PRP B-NP O
report VBP B-VP O
the DT B-NP O
deletion NN I-NP O
of IN B-PP O
HFE NN B-NP O
alpha1 NN I-NP O
and CC O O
alpha2 NN B-NP O
putative JJ I-NP O
ligand NN I-NP O
binding NN I-NP O
domains NNS I-NP O
in FW B-ADVP O
vivo FW I-ADVP O
. . O O

HFE NN B-NP B-Disease
- HYPH I-NP I-Disease
deficient JJ I-NP I-Disease
animals NNS I-NP O
were VBD B-VP O
analyzed VBN I-VP O
for IN B-PP O
a DT B-NP O
comprehensive JJ I-NP O
set NN I-NP O
of IN B-PP O
metabolic JJ B-NP O
and CC I-NP O
immune JJ I-NP O
parameters NNS I-NP O
. . O O

Faithfully RB B-ADVP O
mimicking VBG B-VP O
human JJ B-NP O
hemochromatosis NN I-NP B-Disease
, , O O
mice NNS B-NP O
homozygous JJ B-ADJP O
for IN B-PP O
this DT B-NP O
deletion NN I-NP O
develop NN I-NP O
iron NN I-NP O
overload NN I-NP O
, , O O
characterized VBN B-VP O
by IN B-PP O
a DT B-NP O
higher JJR I-NP O
plasma NN I-NP O
iron NN I-NP O
content NN I-NP O
and CC O O
a DT B-NP O
raised VBN I-NP O
transferrin NN I-NP O
saturation NN I-NP O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
an DT B-NP O
elevated JJ I-NP O
hepatic JJ I-NP O
iron NN I-NP O
load NN I-NP O
. . O O

The DT B-NP O
primary JJ I-NP O
defect NN I-NP O
could MD B-VP O
, , O O
indeed RB B-ADVP O
, , O O
be VB B-VP O
traced VBN I-VP O
to TO B-PP O
an DT B-NP O
augmented JJ I-NP O
duodenal JJ I-NP O
iron NN I-NP O
absorption NN I-NP O
. . O O

In IN B-PP O
parallel NN B-NP O
, , O O
measurement NN B-NP O
of IN B-PP O
the DT B-NP O
gut NN I-NP O
mucosal JJ I-NP O
iron NN I-NP O
content NN I-NP O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
iron NN B-NP O
regulatory JJ I-NP O
proteins NNS I-NP O
allows VBZ B-VP O
a DT B-NP O
more RBR I-NP O
informed JJ I-NP O
evaluation NN I-NP O
of IN B-PP O
various JJ B-NP O
hypotheses NNS I-NP O
regarding VBG B-VP O
the DT B-NP O
precise JJ I-NP O
role NN I-NP O
of IN B-PP O
HFE NN B-NP O
in IN B-PP O
iron NN B-NP O
homeostasis NN I-NP O
. . O O

Finally RB B-ADVP O
, , O O
an DT B-NP O
extensive JJ I-NP O
phenotyping NN I-NP O
of IN B-PP O
primary JJ B-NP O
and CC I-NP O
secondary JJ I-NP O
lymphoid JJ I-NP O
organs NNS I-NP O
including VBG B-PP O
the DT B-NP O
gut NN I-NP O
provides VBZ B-VP O
no DT B-NP O
compelling JJ I-NP O
evidence NN I-NP O
for IN B-PP O
an DT B-NP O
obvious JJ I-NP O
immune JJ I-NP O
- HYPH I-NP O
linked VBN I-NP O
function NN I-NP O
for IN B-PP O
HFE NN B-NP O
. . O O

. . O O

Somatic JJ B-NP O
rearrangement NN I-NP O
of IN B-PP O
chromosome NN B-NP O
14 CD I-NP O
in IN B-PP O
human JJ B-NP O
lymphocytes NNS I-NP O
. . O O

Ataxia NN B-NP B-Disease
- HYPH I-NP I-Disease
telangiectasia NN I-NP I-Disease
is VBZ B-VP O
a DT B-NP O
rare JJ I-NP O
genetic JJ I-NP B-Disease
disorder NN I-NP I-Disease
associated VBN B-VP O
with IN B-PP O
immune JJ B-NP B-Disease
deficiency NN I-NP I-Disease
, , O O
chromosome NN B-NP B-Disease
instability NN I-NP I-Disease
, , O O
and CC O O
a DT B-NP O
predisposition NN I-NP O
to TO B-PP O
lymphoid JJ B-NP B-Disease
malignancy NN I-NP I-Disease
. . O O

We PRP B-NP O
have VBP B-VP O
detected VBN I-VP O
chromosomally RB B-NP O
anomalous JJ I-NP O
clones NNS I-NP O
of IN B-PP O
lymphocytes NNS B-NP O
in IN B-PP O
eight CD B-NP O
patients NNS I-NP O
with IN B-PP O
this DT B-NP O
disorder NN I-NP O
. . O O

Chromosome NN B-NP O
banding NN I-NP O
disclosed VBD B-VP O
that IN B-SBAR O
the DT B-NP O
clones NNS I-NP O
are VBP B-VP O
consistently RB I-VP O
marked VBN I-VP O
by IN B-PP O
structural JJ B-NP O
rearrangement NN I-NP O
of IN B-PP O
the DT B-NP O
long JJ I-NP O
arm NN I-NP O
( ( O O
q NN B-NP O
) ) O O
of IN B-PP O
chromosome NN B-NP O
14 CD I-NP O
. . O O

A DT B-NP O
translocation NN I-NP O
involving VBG B-VP O
14q NN B-NP O
was VBD B-VP O
found VBN I-VP O
in IN B-PP O
clones NNS B-NP O
obtained VBN B-VP O
from IN B-PP O
seven CD B-NP O
of IN B-PP O
the DT B-NP O
eight CD I-NP O
patients NNS I-NP O
whereas IN B-PP O
a DT B-NP O
ring NN I-NP O
14 CD I-NP O
chromosome NN I-NP O
was VBD B-VP O
found VBN I-VP O
in IN B-PP O
a DT B-NP O
clone NN I-NP O
obtained VBN B-VP O
from IN B-PP O
the DT B-NP O
other JJ I-NP O
. . O O

These DT B-NP O
findings NNS I-NP O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
data NNS B-NP O
obtained VBN B-VP O
by IN B-PP O
others NNS B-NP O
for IN B-PP O
patients NNS B-NP O
with IN B-PP O
ataxia NN B-NP B-Disease
- HYPH O I-Disease
telangiectasia NN B-NP I-Disease
suggest VBP B-VP O
that IN B-SBAR O
structural JJ B-NP O
rearrangement NN I-NP O
of IN B-PP O
14q NN B-NP O
is VBZ B-VP O
the DT B-NP O
initial JJ I-NP O
chromosomal JJ I-NP O
change NN I-NP O
in IN B-PP O
lymphocyte NN B-NP O
clones NNS I-NP O
of IN B-PP O
patients NNS B-NP O
with IN B-PP O
this DT B-NP O
disorder NN I-NP O
. . O O

Chromosomes NNS B-NP O
of IN B-PP O
lymphocytes NNS B-NP O
from IN B-PP O
one CD B-NP O
of IN B-PP O
the DT B-NP O
patients NNS I-NP O
were VBD B-VP O
studied VBN I-VP O
before IN B-PP O
and CC I-PP O
after IN I-PP O
the DT B-NP O
onset NN I-NP O
of IN B-PP O
chronic JJ B-NP B-Disease
lymphocytic JJ I-NP I-Disease
leukemia NN I-NP I-Disease
. . O O

Before IN B-SBAR O
leukemia NN B-NP B-Disease
was VBD B-VP O
diagnosed VBN I-VP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
lymphocyte NN I-NP O
clone NN I-NP O
with IN B-PP O
a DT B-NP O
14q NN I-NP O
translocation NN I-NP O
. . O O

This DT B-NP O
clone NN I-NP O
appears VBZ B-VP O
to TO I-VP O
have VB I-VP O
given VBN I-VP O
rise NN B-NP O
to TO B-PP O
the DT B-NP O
leukemic JJ I-NP B-Disease
cells NNS I-NP O
. . O O

We PRP B-NP O
hypothesize VBP B-VP O
that IN B-SBAR O
structural JJ B-NP O
rearrangement NN I-NP O
of IN B-PP O
14q NN B-NP O
is VBZ B-VP O
directly RB B-ADJP O
related VBN I-ADJP O
to TO B-PP O
abnormal JJ B-NP O
growth NN I-NP O
of IN B-PP O
lymphocytes NNS B-NP O
and CC O O
that IN B-SBAR O
it PRP B-NP O
may MD B-VP O
be VB I-VP O
a DT B-NP O
step NN I-NP O
toward IN B-PP O
the DT B-NP O
development NN I-NP O
of IN B-PP O
lymphoid JJ B-NP B-Disease
malignancies NNS I-NP I-Disease
. . O O

Increasing VBG B-NP O
evidence NN I-NP O
, , O O
provided VBN B-PP O
by IN B-PP O
others NNS B-NP O
, , O O
for IN B-PP O
the DT B-NP O
nonrandom JJ I-NP O
involvement NN I-NP O
of IN B-PP O
14q NN B-NP O
in IN B-PP O
African JJ B-NP O
- HYPH I-NP O
type NN I-NP O
Burkitts NNS I-NP B-Disease
lymphoma NN I-NP I-Disease
and CC O O
other JJ B-NP O
lymphoid JJ I-NP B-Disease
neoplasms NNS I-NP I-Disease
further JJ B-NP O
strengthens NNS I-NP O
this DT B-NP O
hypothesis NN I-NP O
. . O O

. . O O

Exon NN B-NP O
9 CD B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
WT1 NN I-NP O
gene NN I-NP O
, , O O
without IN B-PP O
influencing VBG B-VP O
KTS NN B-NP O
splice NN I-NP O
isoforms NNS I-NP O
, , O O
are VBP B-VP O
also RB B-ADVP O
responsible JJ B-ADJP O
for IN B-PP O
Frasier JJR B-NP B-Disease
syndrome NN I-NP I-Disease
. . O O

We PRP B-NP O
report VBP B-VP O
new JJ B-NP O
mutations NNS I-NP O
in IN B-PP O
exon NN B-NP O
9 CD I-NP O
of IN B-PP O
the DT B-NP O
WT1 NN I-NP O
gene NN I-NP O
that WDT B-NP O
did VBD B-VP O
not RB I-VP O
alter VB I-VP O
the DT B-NP O
ratio NN I-NP O
of IN B-PP O
+ SYM B-NP O
/ SYM B-NP O
- HYPH B-NP O
KTS NN I-NP O
splice NN I-NP O
isoforms NNS I-NP O
in IN B-PP O
two CD B-NP O
unrelated JJ I-NP O
patients NNS I-NP O
with IN B-PP O
Frasier JJR B-NP B-Disease
syndrome NN I-NP I-Disease
( ( O O
FS NN B-NP B-Disease
) ) O O
. . O O

The DT B-NP O
mutation NN I-NP O
of IN B-PP O
intron NN B-NP O
9 CD I-NP O
inducing VBG B-VP O
defective JJ B-NP O
alternative JJ I-NP O
splicing NN I-NP O
was VBD B-VP O
reported VBN I-VP O
to TO I-VP O
be VB I-VP O
responsible JJ B-ADJP O
for IN B-PP O
this DT B-NP O
syndrome NN I-NP O
. . O O

The DT B-NP O
mutations NNS I-NP O
found VBN B-VP O
in IN B-PP O
our PRP$ B-NP O
cases NNS I-NP O
occurred VBD B-VP O
in IN B-PP O
the DT B-NP O
same JJ I-NP O
exon NN I-NP O
of IN B-PP O
the DT B-NP O
WT1 NN I-NP O
gene NN I-NP O
as IN B-SBAR O
detected VBN B-VP O
in IN B-PP O
Denys NNP B-NP B-Disease
- HYPH I-NP I-Disease
Drash NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
DDS NN B-NP B-Disease
) ) O O
and CC O O
could MD B-VP O
not RB I-VP O
be VB I-VP O
explained VBN I-VP O
by IN B-PP O
the DT B-NP O
previously RB I-NP O
proposed VBN I-NP O
mechanism NN I-NP O
. . O O

The DT B-NP O
results NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
the DT B-NP O
two CD I-NP O
syndromes NNS I-NP O
originate VBP B-VP O
from IN B-PP O
the DT B-NP O
same JJ I-NP O
WT1 NN I-NP B-Disease
gene NN I-NP I-Disease
abnormality NN I-NP I-Disease
. . O O

From IN B-PP O
a DT B-NP O
molecular JJ I-NP O
biological JJ I-NP O
point NN I-NP O
of IN B-PP O
view NN B-NP O
, , O O
we PRP B-NP O
concluded VBD B-VP O
that IN B-SBAR O
the DT B-NP O
two CD I-NP O
diseases NNS I-NP O
were VBD B-VP O
not RB O O
separable JJ B-ADJP O
, , O O
and CC O O
that IN B-SBAR O
FS NN B-NP B-Disease
should MD B-VP O
be VB I-VP O
included VBN I-VP O
as IN B-PP O
an DT B-NP O
atypical JJ I-NP O
form NN I-NP O
of IN B-PP O
DDS NN B-NP B-Disease
. . O O

. . O O

Splice NN B-NP O
- HYPH I-NP O
site NN I-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
PDS NN I-NP B-Disease
gene NN I-NP O
may MD B-VP O
result VB I-VP O
in IN B-PP O
intrafamilial JJ B-NP O
variability NN I-NP O
for IN B-PP O
deafness NN B-NP B-Disease
in IN B-PP O
Pendred NNP B-NP B-Disease
syndrome NN I-NP I-Disease
. . O O

Pendred VBN B-NP B-Disease
syndrome NN I-NP I-Disease
is VBZ B-VP O
a DT B-NP O
recessive JJ I-NP B-Disease
inherited VBN I-NP I-Disease
disorder NN I-NP I-Disease
that WDT B-NP O
consists VBZ B-VP O
of IN B-PP O
developmental JJ B-NP B-Disease
abnormalities NNS I-NP I-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
cochlea NN I-NP I-Disease
, , O O
sensorineural JJ B-NP B-Disease
hearing NN I-NP I-Disease
loss NN I-NP I-Disease
, , O O
and CC O O
diffuse JJ B-NP B-Disease
thyroid NN I-NP I-Disease
enlargement NN I-NP I-Disease
( ( O O
goiter NN B-NP B-Disease
) ) O O
. . O O

This DT B-NP O
disorder NN I-NP O
may MD B-VP O
account VB I-VP O
for IN B-PP O
up RB B-NP O
to TO I-NP O
10 CD I-NP O
% NN I-NP O
of IN B-PP O
cases NNS B-NP O
of IN B-PP O
hereditary JJ B-NP B-Disease
deafness NN I-NP I-Disease
. . O O

The DT B-NP O
disease NN I-NP O
gene NN I-NP O
( ( O O
PDS NN B-NP B-Disease
) ) O O
has VBZ B-VP O
been VBN I-VP O
mapped VBN I-VP O
to TO B-PP O
chromosome NN B-NP O
7q22 NN I-NP O
- HYPH B-NP O
q31 NN I-NP O
, , O O
and CC O O
encodes VBZ B-VP O
a DT B-NP O
chloride NN I-NP O
- HYPH I-NP O
iodide NN I-NP O
transport NN I-NP O
protein NN I-NP O
. . O O

We PRP B-NP O
performed VBD B-VP O
mutation NN B-NP O
analysis NN I-NP O
of IN B-PP O
individual JJ B-NP O
exons NNS I-NP O
of IN B-PP O
the DT B-NP O
PDS NN I-NP B-Disease
gene NN I-NP O
in IN B-PP O
one CD B-NP O
Spanish JJ I-NP O
family NN I-NP O
that WDT B-NP O
shows VBZ B-VP O
intrafamilial JJ B-NP O
variability NN I-NP O
of IN B-PP O
the DT B-NP O
deafness NN I-NP B-Disease
phenotype NN I-NP O
( ( O O
two CD B-NP O
patients NNS I-NP O
with IN B-PP O
profound JJ O O
and CC O O
one CD B-NP O
with IN B-PP O
moderate JJ B-NP O
- HYPH I-NP O
severe JJ I-NP O
deafness NN I-NP B-Disease
) ) O O
. . O O

We PRP B-NP O
identified VBD B-VP O
a DT B-NP O
new JJ I-NP O
splice NN I-NP O
- HYPH I-NP O
site NN I-NP O
mutation NN I-NP O
affecting VBG B-VP O
intron NN B-NP O
4 CD I-NP O
of IN B-PP O
the DT B-NP O
PDS NN I-NP B-Disease
gene NN I-NP O
, , O O
at IN B-PP O
nucleotide NN B-NP O
position NN I-NP O
639 CD I-NP O
+ SYM I-NP O
7 CD I-NP O
. . O O

RNA NN B-NP O
analysis NN I-NP O
from IN B-PP O
lymphocytes NNS B-NP O
of IN B-PP O
the DT B-NP O
affected VBN I-NP O
patients NNS I-NP O
showed VBD B-VP O
that IN B-SBAR O
mutation NN B-NP O
639 CD I-NP O
+ SYM I-NP O
7A NN I-NP O
- SYM O O
- HYPH O O
> SYM O O
G NN B-NP O
generates VBZ B-VP O
a DT B-NP O
new JJ I-NP O
donor NN I-NP O
splice NN I-NP O
site NN I-NP O
, , O O
leading VBG B-VP O
to TO B-PP O
an DT B-NP O
mRNA NN I-NP O
with IN B-PP O
an DT B-NP O
insertion NN I-NP O
of IN B-PP O
six CD B-NP O
nucleotides NNS I-NP O
from IN B-PP O
intron NN B-NP O
4 CD I-NP O
of IN B-PP O
PDS NN B-NP O
. . O O

Since IN B-SBAR O
the DT B-NP O
newly RB I-NP O
created VBN I-NP O
donor NN I-NP O
splice NN I-NP O
site NN I-NP O
is VBZ B-VP O
likely JJ B-ADJP O
to TO B-VP O
compete VB I-VP O
with IN B-PP O
the DT B-NP O
normal JJ I-NP O
one CD I-NP O
, , O O
variations NNS B-NP O
of IN B-PP O
the DT B-NP O
levels NNS I-NP O
of IN B-PP O
normal JJ B-NP O
and CC I-NP O
aberrant JJ I-NP O
transcripts NNS I-NP O
of IN B-PP O
the DT B-NP O
PDS NN I-NP B-Disease
gene NN I-NP O
in IN B-PP O
the DT B-NP O
cochlea NN I-NP O
may MD B-VP O
explain VB I-VP O
the DT B-NP O
variability NN I-NP O
in IN B-PP O
the DT B-NP O
deafness NN I-NP B-Disease
presentation NN I-NP O
. . O O

. . O O

The DT B-NP O
molecular JJ I-NP O
basis NN I-NP O
of IN B-PP O
Sjogren NN B-NP B-Disease
- HYPH B-NP I-Disease
Larsson NN I-NP I-Disease
syndrome NN I-NP I-Disease
: : O O
mutation NN B-NP O
analysis NN I-NP O
of IN B-PP O
the DT B-NP O
fatty JJ I-NP O
aldehyde NN I-NP O
dehydrogenase NN I-NP O
gene NN I-NP O
. . O O

Sjogren NN B-NP B-Disease
- HYPH I-NP I-Disease
Larsson NN I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
SLS NN B-NP B-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
disorder NN I-NP I-Disease
characterized VBN B-VP O
by IN B-PP O
ichthyosis NN B-NP B-Disease
, , O O
mental JJ B-NP B-Disease
retardation NN I-NP I-Disease
, , O O
spasticity NN B-NP B-Disease
, , O O
and CC O O
deficient JJ B-NP B-Disease
activity NN I-NP I-Disease
of IN B-PP I-Disease
fatty JJ B-NP I-Disease
aldehyde NN I-NP I-Disease
dehydrogenase NN I-NP I-Disease
( ( O O
FALDH NN B-NP O
) ) O O
. . O O

To TO B-VP O
define VB I-VP O
the DT B-NP O
molecular JJ I-NP O
defects NNS I-NP O
causing VBG B-VP O
SLS NN B-NP B-Disease
, , O O
we PRP B-NP O
performed VBD B-VP O
mutation NN B-NP O
analysis NN I-NP O
of IN B-PP O
the DT B-NP O
FALDH NN I-NP O
gene NN I-NP O
in IN B-PP O
probands NNS B-NP O
from IN B-PP O
63 CD B-NP O
kindreds NNS I-NP O
with IN B-PP O
SLS NN B-NP B-Disease
. . O O

Among IN B-PP O
these DT B-NP O
patients NNS I-NP O
, , O O
49 CD B-NP O
different JJ I-NP O
mutations NNS I-NP O
- HYPH B-PP O
including VBG B-PP O
10 CD B-NP O
deletions NNS I-NP O
, , O O
2 CD B-NP O
insertions NNS I-NP O
, , O O
22 CD B-NP O
amino NN I-NP O
acid NN I-NP O
substitutions NNS I-NP O
, , O O
3 CD B-NP O
nonsense JJ I-NP O
mutations NNS I-NP O
, , O O
9 CD B-NP O
splice NN I-NP O
- HYPH B-NP O
site NN I-NP O
defects NNS I-NP O
, , O O
and CC O O
3 CD B-NP O
complex JJ I-NP O
mutations NNS I-NP O
- : O O
were VBD B-VP O
found VBN I-VP O
. . O O

All DT B-NP O
of IN B-PP O
the DT B-NP O
patients NNS I-NP O
with IN B-PP O
SLS NN B-NP B-Disease
were VBD B-VP O
found VBN I-VP O
to TO I-VP O
carry VB I-VP O
mutations NNS B-NP O
. . O O

Nineteen CD B-NP O
of IN B-PP O
the DT B-NP O
missense JJ I-NP O
mutations NNS I-NP O
resulted VBD B-VP O
in IN B-PP O
a DT B-NP O
severe JJ I-NP O
reduction NN I-NP O
of IN B-PP O
FALDH NN B-NP O
enzyme NN I-NP O
catalytic JJ I-NP O
activity NN I-NP O
when WRB B-ADVP O
expressed VBN B-VP O
in IN B-PP O
mammalian JJ B-NP O
cells NNS I-NP O
, , O O
but CC O O
one CD B-NP O
mutation NN I-NP O
( ( O O
798G NN B-NP O
- SYM O O
- HYPH O O
> SYM O O
C NN B-NP O
[ ( O O
K266N NN B-NP O
] ) O O
) ) O O
seemed VBD B-VP O
to TO I-VP O
have VB I-VP O
a DT B-NP O
greater JJR I-NP O
effect NN I-NP O
on IN B-PP O
mRNA NN B-NP O
stability NN I-NP O
. . O O

The DT B-NP O
splice NN I-NP O
- HYPH I-NP O
site NN I-NP O
mutations NNS I-NP O
led VBD B-VP O
to TO I-VP O
exon VB I-VP O
skipping NN B-NP O
or CC I-NP O
utilization NN I-NP O
of IN B-PP O
cryptic JJ B-NP O
acceptor NN I-NP O
- HYPH B-NP O
splice NN I-NP O
sites NNS I-NP O
. . O O

Thirty CD B-NP O
- HYPH I-NP O
seven CD I-NP O
mutations NNS I-NP O
were VBD B-VP O
private JJ B-ADJP O
, , O O
and CC O O
12 CD B-NP O
mutations NNS I-NP O
were VBD B-VP O
seen VBN I-VP O
in IN B-PP O
two CD B-NP O
or CC I-NP O
more JJR I-NP O
probands NNS I-NP O
of IN B-PP O
European JJ B-NP O
or CC I-NP O
Middle NNP I-NP O
Eastern NNP I-NP O
descent NNP I-NP O
. . O O

Four CD B-NP O
single JJ I-NP O
- HYPH I-NP O
nucleotide NN I-NP O
polymorphisms NNS I-NP O
( ( O O
SNPs NNS B-NP O
) ) O O
were VBD B-VP O
found VBN I-VP O
in IN B-PP O
the DT B-NP O
FALDH NN I-NP O
gene NN I-NP O
. . O O

At IN B-NP O
least JJS I-NP O
four CD I-NP O
of IN B-PP O
the DT B-NP O
common JJ I-NP O
mutations NNS I-NP O
( ( O O
551C NN B-NP O
- SYM O O
- HYPH B-NP O
> SYM I-NP O
T NNP I-NP O
, , I-NP O
682C NN I-NP O
- HYPH O O
- HYPH B-NP O
> SYM I-NP O
T NNP I-NP O
, , I-NP O
733G NNP I-NP O
- HYPH I-NP O
- HYPH I-NP O
> SYM I-NP O
A NN I-NP O
, , O O
and CC O O
798 CD B-NP O
+ SYM I-NP O
1delG NN I-NP O
) ) O O
were VBD B-VP O
associated VBN I-VP O
with IN B-PP O
multiple JJ B-NP O
SNP NN I-NP O
haplotypes NNS I-NP O
, , O O
suggesting VBG B-VP O
that IN B-SBAR O
these DT B-NP O
mutations NNS I-NP O
originated VBD B-VP O
independently RB B-ADVP O
on IN B-PP O
more JJR B-NP O
than IN I-NP O
one CD I-NP O
occasion NN I-NP O
or CC O O
were VBD B-VP O
ancient JJ B-NP O
SLS NN I-NP B-Disease
genes NNS I-NP O
that WDT B-NP O
had VBD B-VP O
undergone VBN I-VP O
intragenic JJ B-NP O
recombination NN I-NP O
. . O O

Our PRP$ B-NP O
results NNS I-NP O
demonstrate VBP B-VP O
that IN B-SBAR O
SLS NN B-NP B-Disease
is VBZ B-VP O
caused VBN I-VP O
by IN B-PP O
a DT B-NP O
strikingly RB I-NP O
heterogeneous JJ I-NP O
group NN I-NP O
of IN B-PP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
FALDH NN I-NP O
gene NN I-NP O
and CC O O
provide VBP B-VP O
a DT B-NP O
framework NN I-NP O
for IN B-PP O
understanding VBG B-VP O
the DT B-NP O
genetic JJ I-NP O
basis NN I-NP O
of IN B-PP O
SLS NN B-NP B-Disease
and CC O O
the DT B-NP O
development NN I-NP O
of IN B-PP O
DNA NN B-NP O
- HYPH O O
based VBN B-NP O
diagnostic JJ I-NP O
tests NNS I-NP O
. . O O

. . O O

Loss NN B-NP O
- HYPH B-NP O
of IN B-PP O
- HYPH B-NP O
function NN I-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
cathepsin NN I-NP O
C NN I-NP O
gene NN I-NP O
result VBP B-VP O
in IN B-PP O
periodontal JJ B-NP B-Disease
disease NN I-NP I-Disease
and CC O O
palmoplantar JJ B-NP B-Disease
keratosis NN I-NP I-Disease
. . O O

Papillon NNP B-NP B-Disease
- HYPH I-NP I-Disease
Lefevre NNP I-NP I-Disease
syndrome NN I-NP I-Disease
, , O O
or CC O O
keratosis NN B-NP B-Disease
palmoplantaris NN I-NP I-Disease
with IN B-PP O
periodontopathia NN B-NP B-Disease
( ( O O
PLS NN B-NP B-Disease
, , O O
MIM NN B-NP O
245000 CD I-NP O
) ) O O
, , O O
is VBZ B-VP O
an DT B-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
disorder NN I-NP I-Disease
that WDT B-NP O
is VBZ B-VP O
mainly RB I-VP O
ascertained VBN I-VP O
by IN B-PP O
dentists NNS B-NP O
because IN B-PP O
of IN I-PP O
the DT B-NP O
severe JJ I-NP O
periodontitis NN I-NP B-Disease
that WDT B-NP O
afflicts VBZ B-VP O
patients NNS B-NP O
. . O O

Both CC O O
the DT B-NP O
deciduous JJ I-NP O
and CC I-NP O
permanent JJ I-NP O
dentitions NNS I-NP O
are VBP B-VP O
affected VBN I-VP O
, , O O
resulting VBG B-VP O
in IN B-PP O
premature JJ B-NP O
tooth JJ I-NP B-Disease
loss NN I-NP I-Disease
. . O O

Palmoplantar NNP B-NP B-Disease
keratosis NN I-NP I-Disease
, , O O
varying VBG B-VP O
from IN B-PP O
mild JJ B-NP O
psoriasiform NN I-NP O
scaly RB B-ADVP O
skin NN B-NP O
to TO B-PP O
overt JJ B-NP O
hyperkeratosis NN I-NP B-Disease
, , O O
typically RB B-ADVP O
develops VBZ B-VP O
within IN B-PP O
the DT B-NP O
first JJ I-NP O
three CD I-NP O
years NNS I-NP O
of IN B-PP O
life NN B-NP O
. . O O

Keratosis NNP B-NP B-Disease
also RB B-ADVP O
affects VBZ B-VP O
other JJ B-NP O
sites NNS I-NP O
such JJ B-PP O
as IN I-PP O
elbows NNS B-NP O
and CC I-NP O
knees NNS I-NP O
. . O O

Most JJS B-NP O
PLS NN I-NP B-Disease
patients NNS I-NP O
display VBP B-VP O
both CC O O
periodontitis NN B-NP B-Disease
and CC I-NP O
hyperkeratosis NN I-NP B-Disease
. . O O

Some DT B-NP O
patients NNS I-NP O
have VBP B-VP O
only RB B-NP O
palmoplantar JJ I-NP B-Disease
keratosis NN I-NP I-Disease
or CC I-NP O
periodontitis NN I-NP B-Disease
, , O O
and CC O O
in IN B-PP O
rare JJ B-NP O
individuals NNS I-NP O
the DT B-NP O
periodontitis NN I-NP B-Disease
is VBZ B-VP O
mild JJ B-ADJP O
and CC O O
of IN B-PP O
late JJ B-NP O
onset NN I-NP O
. . O O

The DT B-NP O
PLS NN I-NP O
locus NN I-NP O
has VBZ B-VP O
been VBN I-VP O
mapped VBN I-VP O
to TO B-PP O
chromosome NN B-NP O
11q14 NN I-NP O
- HYPH B-NP O
q21 NN I-NP O
( ( O O
refs NNS B-NP O
7 CD I-NP O
, , I-NP O
8 CD I-NP O
, , I-NP O
9 CD I-NP O
) ) O O
. . O O

Using VBG B-VP O
homozygosity NN B-NP O
mapping NN I-NP O
in IN B-PP O
eight CD B-NP O
small JJ I-NP O
consanguineous JJ I-NP O
families NNS I-NP O
, , O O
we PRP B-NP O
have VBP B-VP O
narrowed VBN I-VP O
the DT B-NP O
candidate NN I-NP O
region NN I-NP O
to TO B-PP O
a DT B-NP O
1 CD I-NP O
. . O O

2 CD B-NP O
- HYPH I-NP O
cM NN I-NP O
interval NN I-NP O
between IN B-PP O
D11S4082 NN B-NP O
and CC I-NP O
D11S931 NN I-NP O
. . O O

The DT B-NP O
gene NN I-NP O
( ( O O
CTSC NN B-NP O
) ) O O
encoding VBG B-VP O
the DT B-NP O
lysosomal JJ I-NP O
protease NN I-NP O
cathepsin NN I-NP O
C NN I-NP O
( ( O O
or CC O O
dipeptidyl NN B-NP O
aminopeptidase NN I-NP O
I CD I-NP O
) ) O O
lies VBZ B-VP O
within IN B-PP O
this DT B-NP O
interval NN I-NP O
. . O O

We PRP B-NP O
defined VBD B-VP O
the DT B-NP O
genomic JJ I-NP O
structure NN I-NP O
of IN B-PP O
CTSC NN B-NP O
and CC O O
found VBN B-NP O
mutations NNS I-NP O
in IN B-PP O
all DT B-NP O
eight CD I-NP O
families NNS I-NP O
. . O O

In IN B-PP O
two CD B-NP O
of IN B-PP O
these DT B-NP O
families NNS I-NP O
we PRP B-NP O
used VBD B-VP O
a DT B-NP O
functional JJ I-NP O
assay NN I-NP O
to TO B-VP O
demonstrate VB I-VP O
an DT B-NP O
almost RB I-NP O
total JJ I-NP O
loss NN I-NP O
of IN B-PP O
cathepsin NN B-NP O
C NN I-NP O
activity NN I-NP O
in IN B-PP O
PLS NN B-NP B-Disease
patients NNS I-NP O
and CC O O
reduced JJ B-NP O
activity NN I-NP O
in IN B-PP O
obligate JJ B-NP O
carriers NNS I-NP O
. . O O

Confirmation NN B-NP O
of IN B-PP O
linkage NN B-NP O
of IN B-PP O
Van NNP B-NP B-Disease
der NNP I-NP I-Disease
Woude NNP I-NP I-Disease
syndrome NN I-NP I-Disease
to TO B-PP O
chromosome NN B-NP O
1q32 NN I-NP O
: : O O
evidence NN B-NP O
of IN B-PP O
association NN B-NP O
with IN B-PP O
STR NN B-NP O
alleles NNS I-NP O
suggests VBZ B-VP O
possible JJ B-NP O
unique JJ I-NP O
origin NN I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
mutation NN I-NP O
. . O O

Van NNP B-NP B-Disease
der NNP I-NP I-Disease
Woude NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
VWS NN B-NP B-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
autosomal JJ I-NP B-Disease
dominant JJ I-NP I-Disease
craniofacial JJ I-NP I-Disease
disorder NN I-NP I-Disease
with IN B-PP O
high JJ B-NP O
penetrance NN I-NP O
and CC O O
variable JJ B-NP O
expression NN I-NP O
. . O O

Its PRP$ B-NP O
clinical JJ I-NP O
features NNS I-NP O
are VBP B-VP O
variably RB I-VP O
expressed VBN I-VP O
, , O O
but CC O O
include VBP B-VP O
cleft NN B-NP B-Disease
lip NN I-NP I-Disease
and CC O O
/ SYM B-NP O
or CC O O
cleft NN B-NP B-Disease
palate NN I-NP I-Disease
, , O O
lip NN B-NP B-Disease
pits NNS I-NP I-Disease
and CC O O
hypodontia NN B-NP B-Disease
. . O O

All DT B-NP O
VWS NN I-NP B-Disease
families NNS I-NP O
studied VBN B-VP O
to TO B-PP O
date NN B-NP O
map VBP B-VP O
the DT B-NP O
disease NN I-NP O
gene NN I-NP O
to TO B-PP O
a DT B-NP O
< JJR I-NP O
2 CD I-NP O
cM NN I-NP O
region NN I-NP O
of IN B-PP O
chromosome NN B-NP O
1q32 NN I-NP O
, , O O
with IN B-PP O
no DT B-NP O
evidence NN I-NP O
of IN B-PP O
locus NN B-NP O
heterogeneity NN I-NP O
. . O O

The DT B-NP O
aim NN I-NP O
of IN B-PP O
this DT B-NP O
study NN I-NP O
is VBZ B-VP O
to TO B-VP O
refine VB I-VP O
the DT B-NP O
localization NN I-NP O
of IN B-PP O
the DT B-NP O
VWS NN I-NP B-Disease
gene NN I-NP O
and CC O O
to TO B-VP O
further RB I-VP O
assess VB I-VP O
possible JJ B-NP O
heterogeneity NN I-NP O
. . O O

We PRP B-NP O
analyzed VBD B-VP O
four CD B-NP O
multiplex JJ I-NP O
VWS NN I-NP B-Disease
families NNS I-NP O
. . O O

All DT B-NP O
available JJ I-NP O
members NNS I-NP O
were VBD B-VP O
clinically RB I-VP O
assessed VBN I-VP O
and CC I-VP O
genotyped VBN I-VP O
for IN B-PP O
19 CD B-NP O
short JJ I-NP O
tandem JJ I-NP O
repeat NN I-NP O
markers NNS I-NP O
on IN B-PP O
chromosome NN B-NP O
1 CD I-NP O
in IN B-PP O
the DT B-NP O
VWS NN I-NP B-Disease
candidate NN I-NP O
gene NN I-NP O
region NN I-NP O
. . O O

We PRP B-NP O
performed VBD B-VP O
two CD B-NP O
- HYPH I-NP O
point NN I-NP O
and CC O O
multipoint JJ B-NP O
limit NN I-NP O
of IN B-PP O
detection NN B-NP O
( ( O O
LOD NN B-NP O
) ) O O
score NN B-NP O
analyses NNS I-NP O
using VBG B-VP O
a DT B-NP O
high JJ I-NP O
penetrance NN I-NP O
autosomal JJ I-NP O
dominant JJ I-NP O
model NN I-NP O
. . O O

All DT B-NP O
families NNS I-NP O
showed VBD B-VP O
positive JJ B-NP O
LOD NN I-NP O
scores NNS I-NP O
without IN B-PP O
any DT B-NP O
recombination NN I-NP O
in IN B-PP O
the DT B-NP O
candidate NN I-NP O
region NN I-NP O
. . O O

The DT B-NP O
largest JJS I-NP O
two CD I-NP O
- HYPH I-NP O
point NN I-NP O
LOD NN I-NP O
score NN I-NP O
was VBD B-VP O
5 CD B-NP O
. . O O

87 CD B-NP O
87 CD I-NP O
. . O O

Our PRP$ B-NP O
assay NN I-NP O
method NN I-NP O
for IN B-PP O
short JJ B-NP O
tandem JJ I-NP O
repeat NN I-NP O
( ( O O
STR NN B-NP O
) ) O O
markers NNS B-NP O
provided VBD B-VP O
highly RB B-NP O
accurate JJ I-NP O
size NN I-NP O
estimation NN I-NP O
of IN B-PP O
marker NN B-NP O
allele NN I-NP O
fragment NN I-NP O
sizes VBZ B-VP O
, , O O
and CC O O
therefore RB B-ADVP O
enabled VBD B-VP O
us PRP B-NP O
to TO B-VP O
determine VB I-VP O
the DT B-NP O
specific JJ I-NP O
alleles NNS I-NP O
segregating VBG B-VP O
with IN B-PP O
the DT B-NP O
VWS NN I-NP B-Disease
gene NN I-NP O
in IN B-PP O
each DT B-NP O
of IN B-PP O
our PRP$ B-NP O
four CD I-NP O
families NNS I-NP O
. . O O

We PRP B-NP O
observed VBD B-VP O
a DT B-NP O
striking JJ I-NP O
pattern NN I-NP O
of IN B-PP O
STR NN B-NP O
allele NN I-NP O
sharing VBG B-VP O
at IN B-PP O
several JJ B-NP O
closely RB I-NP O
linked VBN I-NP O
loci NNS I-NP O
among IN B-PP O
our PRP$ B-NP O
four CD I-NP O
Caucasian JJ I-NP O
VWS NN I-NP B-Disease
families NNS I-NP O
recruited VBN B-VP O
at IN B-PP O
three CD B-NP O
different JJ I-NP O
locations NNS I-NP O
in IN B-PP O
the DT B-NP O
US NNP I-NP O
. . O O

These DT B-NP O
results NNS I-NP O
suggest VBP B-VP O
the DT B-NP O
possibility NN I-NP O
of IN B-PP O
a DT B-NP O
unique JJ I-NP O
origin NN I-NP O
for IN B-PP O
a DT B-NP O
mutation NN I-NP O
responsible JJ B-ADJP O
for IN B-PP O
many JJ B-NP O
or CC I-NP O
most JJS I-NP O
cases NNS I-NP O
of IN B-PP O
VWS NN B-NP B-Disease
. . O O

A DT B-NP O
point NN I-NP O
mutation NN I-NP O
Thr NN I-NP O
( ( O O
799 CD B-NP O
) ) O O
Met NN B-NP O
on IN B-PP O
the DT B-NP O
alpha NN I-NP O
( ( O O
2 CD B-NP O
) ) O O
integrin NN B-NP O
leads VBZ B-VP O
to TO B-PP O
the DT B-NP O
formation NN I-NP O
of IN B-PP O
new JJ B-NP O
human JJ I-NP O
platelet NN I-NP O
alloantigen NN I-NP O
Sit NN I-NP O
( ( O O
a DT O O
) ) O O
and CC O O
affects VBZ B-VP O
collagen NN B-NP O
- HYPH B-NP O
induced VBN I-NP O
aggregation NN I-NP O
. . O O

A DT B-NP O
new JJ I-NP O
platelet NN I-NP O
- HYPH B-NP O
specific JJ I-NP O
alloantigen NN I-NP O
, , O O
termed VBN B-NP O
Sit NN I-NP O
( ( O O
a DT O O
) ) O O
, , O O
was VBD B-VP O
identified VBN I-VP O
in IN B-PP O
a DT B-NP O
severe JJ I-NP O
case NN I-NP O
of IN B-PP O
neonatal JJ B-NP B-Disease
alloimmune JJ I-NP I-Disease
thrombocytopenia NN I-NP I-Disease
. . O O

The DT B-NP O
Sit NN I-NP O
( ( B-LST O
a LS I-LST O
) ) O O
alloantigen NN B-NP O
is VBZ B-VP O
of IN B-PP O
low JJ B-NP O
frequency NN I-NP O
( ( O O
1 CD B-NP O
/ SYM B-NP O
400 CD I-NP O
) ) O O
in IN B-PP O
the DT B-NP O
German JJ I-NP O
population NN I-NP O
. . O O

Immunochemical JJ B-NP O
studies NNS I-NP O
demonstrated VBD B-VP O
that IN B-SBAR O
the DT B-NP O
Sit NN I-NP O
( ( O O
a NN B-NP O
) ) O O
epitopes VBZ B-VP O
reside NN B-NP O
on IN B-PP O
platelet NN B-NP O
glycoprotein NN I-NP O
( ( O O
GP NN B-NP O
) ) O O
Ia NN B-NP O
. . O O

Nucleotide NN B-NP O
sequence NN I-NP O
analysis NN I-NP O
of IN B-PP O
GPIa NN B-NP O
cDNA NN I-NP O
derived VBN B-VP O
from IN B-PP O
Sit NN B-NP O
( ( O O
a DT O O
) ) O O
- HYPH B-NP O
positive JJ I-NP O
platelets NNS I-NP O
showed VBD B-VP O
C NN B-NP O
( ( O O
2531 CD B-NP O
) ) O O
- SYM O O
- HYPH O O
> SYM O O
T NN B-NP O
( ( O O
2531 CD B-NP O
) ) O O
point NN B-NP O
mutation NN I-NP O
, , O O
resulting VBG B-VP O
in IN B-PP O
Thr NN B-NP O
( ( O O
799 CD B-NP O
) ) O O
Met NN B-NP O
dimorphism NN I-NP O
. . O O

Analysis NN B-NP O
of IN B-PP O
genomic JJ B-NP O
DNA NN I-NP O
from IN B-PP O
22 CD B-NP O
Sit NN I-NP O
( ( O O
a DT O O
) ) O O
- HYPH B-NP O
negative JJ I-NP O
normal JJ I-NP O
individuals NNS I-NP O
showed VBD B-VP O
that IN B-SBAR O
the DT B-NP O
Thr NN I-NP O
( ( O O
799 CD B-NP O
) ) O O
is VBZ B-VP O
encoded VBN I-VP O
by IN B-PP O
ACG NN B-NP O
( ( O O
2532 CD B-NP O
) ) O O
( ( O O
90 CD B-NP O
. . O O

9 CD B-NP O
% NN I-NP O
) ) O O
or CC O O
ACA NN B-NP O
( ( O O
2532 CD B-NP O
) ) O O
( ( O O
9 CD B-NP O
. SYM I-NP O

1 CD I-NP O
% NN I-NP O
) ) O O
. . O O

To TO B-VP O
establish VB I-VP O
a DT B-NP O
DNA NN I-NP O
typing NN I-NP O
technique NN I-NP O
, , O O
we PRP B-NP O
elucidated VBD B-VP O
the DT B-NP O
organization NN I-NP O
of IN B-PP O
the DT B-NP O
GPIa NN I-NP O
gene NN I-NP O
adjacent JJ B-ADJP O
to TO B-PP O
the DT B-NP O
polymorphic JJ I-NP O
bases NNS I-NP O
. . O O

The DT B-NP O
introns NNS I-NP O
( ( O O
421 CD B-NP O
bp NN I-NP O
and CC O O
1 CD B-NP O
. . O O

2 CD B-NP O
kb NN I-NP O
) ) O O
encompass VBZ B-VP O
a DT B-NP O
142 CD I-NP O
- HYPH I-NP O
bp NN I-NP O
exon NN I-NP O
with IN B-PP O
the DT B-NP O
2 CD I-NP O
polymorphic JJ I-NP O
bases NNS I-NP O
2531 CD B-NP O
and CC I-NP O
2532 CD I-NP O
. . O O

Polymerase NN B-NP O
chain NN I-NP O
reaction NN I-NP O
- HYPH B-NP O
restriction NN I-NP O
fragment NN I-NP O
length NN I-NP O
polymorphism NN I-NP O
analysis NN I-NP O
on IN B-PP O
DNA NN B-NP O
derived VBN B-VP O
from IN B-PP O
100 CD B-NP O
donors NNS I-NP O
using VBG B-VP O
the DT B-NP O
restriction NN I-NP O
enzyme NN I-NP O
Mae NN I-NP O
III CD I-NP O
showed VBD B-VP O
that IN B-SBAR O
the DT B-NP O
Met NN I-NP O
( ( O O
799 CD B-NP O
) ) O O
form NN B-NP O
of IN B-PP O
GPIa NN B-NP O
is VBZ B-VP O
restricted JJ B-ADJP O
to TO B-PP O
Sit NN B-NP O
( ( O O
a NN B-NP O
) ) O O
( ( O O
+ SYM O O
) ) O O
phenotype NN B-NP O
. . O O

Analysis NN B-NP O
of IN B-PP O
stable JJ B-NP O
Chinese JJ I-NP O
hamster NN I-NP O
ovary NN I-NP O
transfectants NNS I-NP O
expressing VBG B-VP O
allele NN B-NP O
- HYPH B-NP O
specific JJ I-NP O
recombinant JJ I-NP O
forms NNS I-NP O
of IN B-PP O
GPIa NN B-NP O
showed VBD B-VP O
that IN B-SBAR O
anti AFX B-NP O
- HYPH I-NP O
Sit NN I-NP O
( ( O O
a DT O O
) ) O O
exclusively RB B-ADVP O
reacted VBD B-VP O
with IN B-PP O
the DT B-NP O
Glu NN I-NP O
( ( O O
505 CD B-NP O
) ) O O
Met NN B-NP O
( ( O O
799 CD B-NP O
) ) O O
, , O O
but CC O O
not RB O O
with IN B-PP O
the DT B-NP O
Glu NN I-NP O
( ( O O
505 CD B-NP O
) ) O O
Thr NN B-NP O
( ( O O
799 CD B-NP O
) ) O O
and CC O O
the DT B-NP O
Lys NNPS I-NP O
( ( O O
505 CD B-NP O
) ) O O
Thr NN B-NP O
( ( O O
799 CD B-NP O
) ) O O
isoforms NNS B-NP O
. . O O

In IN B-PP O
contrast NN B-NP O
, , O O
anti AFX O O
- HYPH O O
Br NNP B-NP O
( ( O O
a DT O O
) ) O O
( ( O O
HPA NN B-NP O
- HYPH B-NP O
5b NN I-NP O
) ) O O
only RB B-ADVP O
recognized VBD B-VP O
the DT B-NP O
Lys NNPS I-NP O
( ( O O
505 CD B-NP O
) ) O O
Thr NN B-NP O
( ( O O
799 CD B-NP O
) ) O O
form NN B-NP O
, , O O
whereas IN O O
anti AFX O O
- HYPH O O
Br NN B-NP O
( ( O O
b NN B-NP O
) ) O O
( ( O O
HPA NN B-NP O
- HYPH B-NP O
5a NN I-NP O
) ) O O
reacted VBD B-VP O
with IN B-PP O
both CC O O
Glu NN B-NP O
( ( O O
505 CD B-NP O
) ) O O
Thr NN B-NP O
( ( O O
799 CD B-NP O
) ) O O
and CC O O
Glu NN B-NP O
( ( O O
505 CD B-NP O
) ) O O
Met NN B-NP O
( ( O O
799 CD B-NP O
) ) O O
isoforms NNS B-NP O
. . O O

These DT B-NP O
results NNS I-NP O
demonstrated VBD B-VP O
that IN B-SBAR O
the DT B-NP O
Met NN I-NP O
( ( O O
799 CD B-NP O
) ) O O
is VBZ B-VP O
responsible JJ B-ADJP O
for IN B-PP O
formation NN B-NP O
of IN B-PP O
the DT B-NP O
Sit NN I-NP O
( ( O O
a DT O O
) ) O O
alloantigenic JJ B-NP O
determinants NNS I-NP O
, , O O
whereas IN O O
amino NN B-NP O
acid NN I-NP O
505 CD I-NP O
( ( O O
Lys NN B-NP O
or CC O O
Glu NN B-NP O
) ) O O
specifically RB B-ADVP O
controls VBZ B-VP O
the DT B-NP O
expression NN I-NP O
of IN B-PP O
Br NNP B-NP O
( ( O O
a DT O O
) ) O O
and CC O O
Br NN B-NP O
( ( O O
b NN B-NP O
) ) O O
epitopes NNS B-NP O
, , O O
respectively RB B-ADVP O
. . O O

Platelet NN B-NP O
aggregation NN I-NP O
responses NNS I-NP O
of IN B-PP O
Sit NN B-NP O
( ( O O
a NN B-NP O
) ) O O
( ( O O
+ SYM O O
) ) O O
individuals NNS B-NP O
were VBD B-VP O
diminished VBN I-VP O
in IN B-PP O
response NN B-NP O
to TO B-PP O
collagen NN B-NP O
, , O O
indicating VBG B-VP O
that IN B-SBAR O
the DT B-NP O
Thr NN I-NP O
( ( O O
799 CD B-NP O
) ) O O
Met NN B-NP O
mutation NN I-NP O
affects VBZ B-VP O
the DT B-NP O
function NN I-NP O
of IN B-PP O
the DT B-NP O
GPIa NN I-NP O
/ SYM B-VP O
IIa NN B-NP O
complex NN I-NP O
Mutations NNS B-NP O
of IN B-PP O
the DT B-NP O
cathepsin NN I-NP O
C NN I-NP O
gene NN I-NP O
are VBP B-VP O
responsible JJ B-ADJP O
for IN B-PP O
Papillon NNP B-NP B-Disease
- HYPH I-NP I-Disease
Lefevre NNP I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

Papillon NNP B-NP B-Disease
- HYPH I-NP I-Disease
Lefevre NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
PLS NN B-NP B-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
disorder NN I-NP I-Disease
characterised VBN B-VP O
by IN B-PP O
palmoplantar JJ B-NP B-Disease
hyperkeratosis NN I-NP I-Disease
and CC O O
severe JJ B-NP O
early JJ I-NP O
onset NN I-NP O
periodontitis NN I-NP B-Disease
that WDT B-NP O
results VBZ B-VP O
in IN B-PP O
the DT B-NP O
premature JJ I-NP O
loss NN I-NP O
of IN B-PP O
the DT B-NP O
primary JJ I-NP O
and CC I-NP O
secondary JJ I-NP O
dentitions NNS I-NP O
. . O O

A DT B-NP O
major JJ I-NP O
gene NN I-NP O
locus NN I-NP O
for IN B-PP O
PLS NN B-NP B-Disease
has VBZ B-VP O
been VBN I-VP O
mapped VBN I-VP O
to TO B-PP O
a DT B-NP O
2 CD I-NP O
. . O O

8 CD B-NP O
cM NN I-NP O
interval NN I-NP O
on IN B-PP O
chromosome NN B-NP O
11q14 NN I-NP O
. . O O

Correlation NN B-NP O
of IN B-PP O
physical JJ B-NP O
and CC I-NP O
genetic JJ I-NP O
maps NNS I-NP O
of IN B-PP O
this DT B-NP O
interval NN I-NP O
indicate VBP B-VP O
it PRP B-NP O
includes VBZ B-VP O
at IN B-NP O
least JJS I-NP O
40 CD I-NP O
ESTs NNS I-NP O
and CC O O
six CD B-NP O
known VBN I-NP O
genes NNS I-NP O
including VBG B-PP O
the DT B-NP O
lysosomal JJ I-NP O
protease NN I-NP O
cathepsin NN I-NP O
C NN I-NP O
gene NN I-NP O
( ( O O
CTSC NN B-NP O
) ) O O
. . O O

The DT B-NP O
CTSC NNP I-NP O
message NN I-NP O
is VBZ B-VP O
expressed VBN I-VP O
at IN B-PP O
high JJ B-NP O
levels NNS I-NP O
in IN B-PP O
a DT B-NP O
variety NN I-NP O
of IN B-PP O
immune JJ B-NP O
cells NNS I-NP O
including VBG B-PP O
polymorphonuclear JJ B-NP O
leucocytes NNS I-NP O
, , O O
macrophages NNS B-NP O
, , O O
and CC O O
their PRP$ B-NP O
precursors NNS I-NP O
. . O O

By IN B-PP O
RT NN B-NP O
- HYPH B-NP O
PCR NN I-NP O
, , O O
we PRP B-NP O
found VBD B-VP O
CTSC NN B-NP O
is VBZ B-VP O
also RB I-VP O
expressed VBN I-VP O
in IN B-PP O
epithelial JJ B-NP O
regions NNS I-NP O
commonly RB B-VP O
affected VBN I-VP O
by IN B-PP O
PLS NN B-NP B-Disease
, , O O
including VBG B-PP O
the DT B-NP O
palms NNS I-NP O
, , O O
soles NNS B-NP O
, , O O
knees NNS B-NP O
, , O O
and CC O O
oral JJ B-NP O
keratinised VBN I-NP O
gingiva NN I-NP O
. . O O

The DT B-NP O
4 CD I-NP O
. . O O

7 CD B-NP O
kb NN I-NP O
CTSC NN I-NP O
gene NN I-NP O
consists VBZ B-VP O
of IN B-PP O
two CD B-NP O
exons NNS I-NP O
. . O O

Sequence NN B-NP O
analysis NN I-NP O
of IN B-PP O
CTSC NN B-NP O
from IN B-PP O
subjects NNS B-NP O
affected VBN B-VP O
with IN B-PP O
PLS NN B-NP B-Disease
from IN B-PP O
five CD B-NP O
consanguineous JJ I-NP O
Turkish JJ I-NP O
families NNS I-NP O
identified VBD B-VP O
four CD B-NP O
different JJ I-NP O
mutations NNS I-NP O
. . O O

An DT B-NP O
exon NN I-NP O
1 CD I-NP O
nonsense NN I-NP O
mutation NN I-NP O
( ( O O
856C NN B-NP O
- SYM O O
- HYPH O O
> SYM O O
T NN B-NP O
) ) O O
introduces VBZ B-VP O
a DT B-NP O
premature JJ I-NP O
stop NN I-NP O
codon NN I-NP O
at IN B-PP O
amino NN B-NP O
acid NN I-NP O
286 CD I-NP O
. . O O

Three CD B-NP O
exon NN I-NP O
2 CD B-NP O
mutations NNS I-NP O
were VBD B-VP O
identified VBN I-VP O
, , O O
including VBG B-PP O
a DT B-NP O
single JJ I-NP O
nucleotide NN I-NP O
deletion NN I-NP O
( ( O O
2692delA NN B-NP O
) ) O O
of IN B-PP O
codon NN B-NP O
349 CD I-NP O
introducing VBG B-VP O
a DT B-NP O
frameshift NN I-NP O
and CC I-NP O
premature JJ I-NP O
termination NN I-NP O
codon NN I-NP O
, , O O
a DT B-NP O
2 CD I-NP O
bp NN I-NP O
deletion NN I-NP O
( ( O O
2673 CD B-NP O
- HYPH I-NP O
2674delCT NN I-NP O
) ) O O
that WDT B-NP O
results VBZ B-VP O
in IN B-PP O
introduction NN B-NP O
of IN B-PP O
a DT B-NP O
stop NN I-NP O
codon NN I-NP O
at IN B-PP O
amino NN B-NP O
acid NN I-NP O
343 CD I-NP O
, , O O
and CC O O
a DT B-NP O
G NN I-NP O
- SYM B-NP O
- HYPH B-NP O
> SYM I-NP O
A NN I-NP O
substitution NN I-NP O
in IN B-PP O
codon NN B-NP O
429 CD I-NP O
( ( O O
2931G NN B-NP O
- SYM O O
- HYPH B-NP O
> SYM I-NP O
A NN I-NP O
) ) O O
introducing VBG B-VP O
a DT B-NP O
premature JJ I-NP O
termination NN I-NP O
codon NN I-NP O
. . O O

All DT B-NP O
PLS NN I-NP B-Disease
patients NNS I-NP O
were VBD B-VP O
homozygous JJ B-ADJP O
for IN B-PP O
cathepsin NN B-NP O
C NN I-NP O
mutations NNS I-NP O
inherited VBN B-VP O
from IN B-PP O
a DT B-NP O
common JJ I-NP O
ancestor NN I-NP O
. . O O

Parents NNS B-NP O
and CC I-NP O
sibs NNS I-NP O
heterozygous JJ B-ADJP O
for IN B-PP O
cathepsin NN B-NP O
C NN I-NP O
mutations NNS I-NP O
do VBP B-VP O
not RB I-VP O
show VB I-VP O
either CC O O
the DT B-NP O
palmoplantar NN I-NP B-Disease
hyperkeratosis NN I-NP I-Disease
or CC O O
severe JJ B-NP O
early JJ I-NP O
onset NN I-NP O
periodontitis NN I-NP B-Disease
characteristic JJ B-ADJP O
of IN B-PP O
PLS NN B-NP B-Disease
. . O O

A DT B-NP O
more RBR I-NP O
complete JJ I-NP O
understanding NN I-NP O
of IN B-PP O
the DT B-NP O
functional JJ I-NP O
physiology NN I-NP O
of IN B-PP O
cathepsin NN B-NP O
C NN I-NP O
carries VBZ B-VP O
significant JJ B-NP O
implications NNS I-NP O
for IN B-PP O
understanding VBG B-VP O
normal JJ B-NP O
and CC I-NP O
abnormal JJ I-NP O
skin NN I-NP O
development NN I-NP O
and CC O O
periodontal JJ B-NP B-Disease
disease NN I-NP I-Disease
susceptibility NN I-NP O
Mutational JJ B-NP O
analysis NN I-NP O
of IN B-PP O
the DT B-NP O
HGO NN I-NP O
gene NN I-NP O
in IN B-PP O
Finnish JJ B-NP O
alkaptonuria NN I-NP B-Disease
patients NNS I-NP O
. . O O

Alkaptonuria NN B-NP B-Disease
( ( O O
AKU NN B-NP B-Disease
) ) O O
, , O O
the DT B-NP O
prototypic JJ I-NP O
inborn JJ I-NP B-Disease
error NN I-NP I-Disease
of IN B-PP I-Disease
metabolism NN B-NP I-Disease
, , O O
has VBZ B-VP O
recently RB I-VP O
been VBN I-VP O
shown VBN I-VP O
to TO I-VP O
be VB I-VP O
caused VBN I-VP O
by IN B-PP O
loss NN B-NP O
of IN B-PP O
function NN B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
homogentisate NN I-NP O
- HYPH B-NP O
1 CD I-NP O
, , I-NP O
2 CD I-NP O
- HYPH I-NP O
dioxygenase NN I-NP O
gene NN I-NP O
( ( O O
HGO NN B-NP O
) ) O O
. . O O

So RB B-ADVP O
far RB I-ADVP O
17 CD B-NP O
mutations NNS I-NP O
have VBP B-VP O
been VBN I-VP O
characterised VBN I-VP O
in IN B-PP O
AKU NN B-NP B-Disease
patients NNS I-NP O
of IN B-PP O
different JJ B-NP O
ethnic JJ I-NP O
origin NN I-NP O
. . O O

We PRP B-NP O
describe VBP B-VP O
three CD B-NP O
novel JJ I-NP O
mutations NNS I-NP O
( ( O O
R58fs NNS B-NP O
, , O O
R330S NN B-NP O
, , O O
and CC O O
H371R NN B-NP O
) ) O O
and CC O O
one CD B-NP O
common JJ I-NP O
AKU NN I-NP B-Disease
mutation NN I-NP O
( ( O O
M368V NN B-NP O
) ) O O
, , O O
detected VBN B-VP O
by IN B-PP O
mutational JJ B-NP O
and CC I-NP O
polymorphism NN I-NP O
analysis NN I-NP O
of IN B-PP O
the DT B-NP O
HGO NN I-NP O
gene NN I-NP O
in IN B-PP O
five CD B-NP O
Finnish JJ I-NP O
AKU NN I-NP B-Disease
pedigrees NNS I-NP O
. . O O

The DT B-NP O
three CD I-NP O
novel JJ I-NP O
AKU NN I-NP B-Disease
mutations NNS I-NP O
are VBP B-VP O
most RBS B-ADVP O
likely RB I-ADVP O
specific JJ B-ADJP O
for IN B-PP O
the DT B-NP O
Finnish JJ I-NP O
population NN I-NP O
and CC O O
have VBP B-VP O
originated VBN I-VP O
recently RB B-ADVP O
. . O O

. . O O

The DT B-NP O
identical JJ I-NP O
5 CD I-NP O
' SYM I-NP O
splice NN I-NP O
- HYPH B-NP O
site NN I-NP O
acceptor NN I-NP O
mutation NN I-NP O
in IN B-PP O
five CD B-NP O
attenuated VBD B-VP B-Disease
APC NN B-NP I-Disease
families NNS I-NP O
from IN B-PP O
Newfoundland NNP B-NP O
demonstrates VBZ B-VP O
a DT B-NP O
founder NN I-NP O
effect NN I-NP O
. . O O

Inherited VBN B-NP O
mutations NNS I-NP O
of IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
predispose NN I-NP O
carriers NNS I-NP O
to TO B-PP O
multiple JJ B-NP O
adenomatous JJ I-NP B-Disease
polyps NNS I-NP I-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
colon NN I-NP I-Disease
and CC I-NP I-Disease
rectum NN I-NP I-Disease
and CC B-PP O
to TO B-PP O
colorectal JJ B-NP B-Disease
cancer NN I-NP I-Disease
. . O O

Mutations NNS B-NP O
located VBN B-VP O
at IN B-PP O
the DT B-NP O
extreme JJ I-NP O
5 CD I-NP O
end NN I-NP O
of IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
, , O O
however RB B-ADVP O
, , O O
are VBP B-VP O
associated VBN I-VP O
with IN B-PP O
a DT B-NP O
less RBR I-NP O
severe JJ I-NP O
disease NN I-NP O
known VBN B-VP O
as IN B-PP O
attenuated VBN B-NP B-Disease
adenomatous JJ I-NP I-Disease
polyposis NN I-NP I-Disease
coli NN I-NP I-Disease
( ( O O
AAPC NN B-NP B-Disease
) ) O O
. . O O

Many JJ B-NP O
individuals NNS I-NP O
with IN B-PP O
AAPC NN B-NP B-Disease
develop VBP B-VP O
relatively RB B-NP O
few JJ I-NP O
colorectal JJ I-NP B-Disease
polyps NNS I-NP I-Disease
but CC O O
are VBP B-VP O
still RB B-ADVP O
at IN B-PP O
high JJ B-NP O
risk NN I-NP O
for IN B-PP O
colorectal JJ B-NP B-Disease
cancer NN I-NP I-Disease
. . O O

We PRP B-NP O
report VBP B-VP O
here RB B-ADVP O
the DT B-NP O
identification NN I-NP O
of IN B-PP O
a DT B-NP O
5 CD I-NP O
APC NN I-NP B-Disease
germline NN I-NP O
mutation NN I-NP O
in IN B-PP O
five CD B-NP O
separately RB I-NP O
ascertained VBN I-NP O
AAPC NN I-NP B-Disease
families NNS I-NP O
from IN B-PP O
Newfoundland NNP B-NP O
, , O O
Canada NNP B-NP O
. . O O

This DT B-NP O
disease NN I-NP O
- HYPH O O
causing VBG B-VP O
mutation NN B-NP O
is VBZ B-VP O
a DT B-NP O
single JJ I-NP O
basepair NN I-NP O
change NN I-NP O
( ( O O
G NN B-NP O
to TO B-PP O
A NN B-NP O
) ) O O
in IN B-PP O
the DT B-NP O
splice NN I-NP O
- HYPH B-NP O
acceptor NN I-NP O
region NN I-NP O
of IN B-PP O
APC NN B-NP B-Disease
intron NN I-NP O
3 CD I-NP O
that WDT B-NP O
creates VBZ B-VP O
a DT B-NP O
mutant JJ I-NP O
RNA NN I-NP O
without IN B-PP O
exon NN B-NP O
4 CD I-NP O
of IN B-PP O
APC NN B-NP O
. . O O

The DT B-NP O
observation NN I-NP O
of IN B-PP O
the DT B-NP O
same JJ I-NP O
APC NN I-NP B-Disease
mutation NN I-NP O
in IN B-PP O
five CD B-NP O
families NNS I-NP O
from IN B-PP O
the DT B-NP O
same JJ I-NP O
geographic JJ I-NP O
area NN I-NP O
demonstrates VBZ B-VP O
a DT B-NP O
founder NN I-NP O
effect NN I-NP O
. . O O

Furthermore RB B-ADVP O
, , O O
the DT B-NP O
identification NN I-NP O
of IN B-PP O
this DT B-NP O
germline NN I-NP O
mutation NN I-NP O
strengthens VBZ B-VP O
the DT B-NP O
correlation NN I-NP O
between IN B-PP O
the DT B-NP O
5 CD I-NP O
location NN I-NP O
of IN B-PP O
an DT B-NP O
APC NN I-NP B-Disease
disease NN I-NP O
- HYPH O O
causing VBG B-VP O
mutation NN B-NP O
and CC O O
the DT B-NP O
attenuated VBN I-NP B-Disease
polyposis NN I-NP I-Disease
phenotype NN I-NP O
. . O O

. . O O

Alstrom IN B-PP B-Disease
syndrome NN B-NP I-Disease
: : O O
further JJ B-NP O
evidence NN I-NP O
for IN B-PP O
linkage NN B-NP O
to TO B-PP O
human JJ B-NP O
chromosome NN I-NP O
2p13 NN I-NP O
. . O O

Alstrom IN B-PP B-Disease
syndrome NN B-NP I-Disease
is VBZ B-VP O
a DT B-NP O
rare JJ I-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
disorder NN I-NP I-Disease
characterized VBN B-VP O
by IN B-PP O
retinal JJ B-NP B-Disease
degeneration NN I-NP I-Disease
, , O O
sensorineural JJ B-NP B-Disease
hearing NN I-NP I-Disease
loss NN I-NP I-Disease
, , O O
early JJ B-NP O
- HYPH I-NP O
onset NN I-NP O
obesity NN I-NP B-Disease
, , O O
and CC O O
non AFX O B-Disease
- HYPH B-NP I-Disease
insulin NN I-NP I-Disease
- HYPH I-NP I-Disease
dependent JJ I-NP I-Disease
diabetes NN I-NP I-Disease
mellitus NN I-NP I-Disease
. . O O

The DT B-NP O
gene NN I-NP O
for IN B-PP O
Alstrom IN B-PP B-Disease
syndrome NN B-NP I-Disease
( ( O O
ALMS1 NN B-NP O
) ) O O
has VBZ B-VP O
been VBN I-VP O
previously RB B-ADJP O
localized JJ I-ADJP O
to TO B-PP O
human JJ B-NP O
chromosome NN I-NP O
2p13 NN I-NP O
by IN B-PP O
homozygosity NN B-NP O
mapping NN I-NP O
in IN B-PP O
two CD B-NP O
distinct JJ I-NP O
isolated VBN I-NP O
populations NNS I-NP O
- HYPH B-NP O
French JJ I-NP O
Acadian NNP I-NP O
and CC I-NP O
North NNP I-NP O
African NNP I-NP O
. . O O

Pair NN B-NP O
- HYPH I-NP O
wise NN I-NP O
analyses NNS I-NP O
resulted VBD B-VP O
in IN B-PP O
maximum JJ B-NP O
lod NN I-NP O
( ( O O
logarithm NN B-NP O
of IN B-PP O
the DT B-NP O
odds NNS I-NP O
ratio NN I-NP O
) ) O O
scores NNS B-NP O
of IN B-PP O
3 CD B-NP O
. . O O

84 CD B-NP O
and CC I-NP O
2 CD I-NP O
. . O O

9 CD B-NP O
, , O O
respectively RB B-ADVP O
. . O O

To TO B-VP O
confirm VB I-VP O
these DT B-NP O
findings NNS I-NP O
, , O O
a DT B-NP O
large JJ I-NP O
linkage NN I-NP O
study NN I-NP O
was VBD B-VP O
performed VBN I-VP O
in IN B-PP O
twelve CD B-NP O
additional JJ I-NP O
families NNS I-NP O
segregating VBG B-VP O
for IN B-PP O
Alstrom IN B-PP B-Disease
syndrome NN B-NP I-Disease
. . O O

A DT B-NP O
maximum NN I-NP O
two CD I-NP O
- HYPH I-NP O
point NN I-NP O
lod NN I-NP O
score NN I-NP O
of IN B-PP O
7 CD B-NP O
. . O O

13 CD B-NP O
( ( O O
theta NN B-NP O
= SYM B-VP O
0 CD B-NP O
. SYM I-NP O

00 CD I-NP O
) ) O O
for IN B-PP O
marker NN B-NP O
D2S2110 NN I-NP O
and CC O O
a DT B-NP O
maximum NN I-NP O
cumulative JJ I-NP O
multipoint JJ I-NP O
lod NN I-NP O
score NN I-NP O
of IN B-PP O
9 CD B-NP O
. . O O

16 CD B-NP O
for IN B-PP O
marker NN B-NP O
D2S2110 NN I-NP O
were VBD B-VP O
observed VBN I-VP O
, , O O
further RBR B-VP O
supporting VBG I-VP O
linkage NN B-NP O
to TO B-PP O
chromosome NN B-NP O
2p13 NN I-NP O
. . O O

No DT B-NP O
evidence NN I-NP O
of IN B-PP O
genetic JJ B-NP O
heterogeneity NN I-NP O
was VBD B-VP O
observed VBN I-VP O
in IN B-PP O
these DT B-NP O
families NNS I-NP O
. . O O

Meiotic JJ B-NP O
recombination NN I-NP O
events NNS I-NP O
have VBP B-VP O
localized VBN I-VP O
the DT B-NP O
critical JJ I-NP O
region NN I-NP O
containing VBG B-VP O
ALMS1 NN B-NP O
to TO B-PP O
a DT B-NP O
6 CD I-NP O
. . O O

1 CD B-NP O
- HYPH I-NP O
cM NN I-NP O
interval NN I-NP O
flanked VBN B-VP O
by IN B-PP O
markers NNS B-NP O
D2S327 NN I-NP O
and CC I-NP O
D2S286 NN I-NP O
. . O O

A DT B-NP O
fine JJ I-NP O
resolution NN I-NP O
radiation NN I-NP O
hybrid NN I-NP O
map NN I-NP O
of IN B-PP O
31 CD B-NP O
genes NNS I-NP O
and CC I-NP O
markers NNS I-NP O
has VBZ B-VP O
been VBN I-VP O
constructed VBN I-VP O
. . O O

Pendred JJ B-NP B-Disease
syndrome NN I-NP I-Disease
: : O O
phenotypic JJ B-NP O
variability NN I-NP O
in IN B-PP O
two CD B-NP O
families NNS I-NP O
carrying VBG B-VP O
the DT B-NP O
same JJ I-NP O
PDS NN I-NP B-Disease
missense JJ I-NP O
mutation NN I-NP O
. . O O

Pendred VBN B-NP B-Disease
syndrome NN I-NP I-Disease
comprises VBZ B-VP O
congenital JJ B-NP B-Disease
sensorineural JJ I-NP I-Disease
hearing NN I-NP I-Disease
loss NN I-NP I-Disease
, , O O
thyroid JJ B-NP B-Disease
goiter NN I-NP I-Disease
, , O O
and CC O O
positive JJ B-NP O
perchlorate NN I-NP O
discharge NN I-NP O
test NN I-NP O
. . O O

Recently RB B-ADVP O
, , O O
this DT B-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
disorder NN I-NP I-Disease
was VBD B-VP O
shown VBN I-VP O
to TO I-VP O
be VB I-VP O
caused VBN I-VP O
by IN B-PP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
PDS NN I-NP B-Disease
gene NN I-NP O
, , O O
which WDT B-NP O
encodes VBZ B-VP O
an DT B-NP O
anion NN I-NP O
transporter NN I-NP O
called VBN B-VP O
pendrin NN B-NP O
. . O O

Molecular JJ B-NP O
analysis NN I-NP O
of IN B-PP O
the DT B-NP O
PDS NN I-NP B-Disease
gene NN I-NP O
was VBD B-VP O
performed VBN I-VP O
in IN B-PP O
two CD B-NP O
consanguineous JJ I-NP O
large JJ I-NP O
families NNS I-NP O
from IN B-PP O
Southern NNP B-NP O
Tunisia NNP I-NP O
comprising VBG B-VP O
a DT B-NP O
total NN I-NP O
of IN B-PP O
23 CD B-NP O
individuals NNS I-NP O
affected VBN B-VP O
with IN B-PP O
profound JJ B-NP O
congenital JJ I-NP B-Disease
deafness NN I-NP I-Disease
; : O O
the DT B-NP O
same JJ I-NP O
missense JJ I-NP O
mutation NN I-NP O
, , O O
L445W NN B-NP O
, , O O
was VBD B-VP O
identified VBN I-VP O
in IN B-PP O
all DT B-NP O
affected VBN I-NP O
individuals NNS I-NP O
. . O O

A DT B-NP O
widened VBN I-NP B-Disease
vestibular JJ I-NP I-Disease
aqueduct NN I-NP I-Disease
was VBD B-VP O
found VBN I-VP O
in IN B-PP O
all DT B-NP O
patients NNS I-NP O
who WP B-NP O
underwent VBD B-VP O
computed VBN I-VP O
tomography NN B-NP O
( ( O O
CT NN B-NP O
) ) O O
scan NN B-NP O
exploration NN I-NP O
of IN B-PP O
the DT B-NP O
inner JJ I-NP O
ear NN I-NP O
. . O O

In IN B-PP O
contrast NN B-NP O
, , O O
goiter NN B-NP B-Disease
was VBD B-VP O
present JJ B-ADJP O
in IN B-PP O
only RB B-NP O
11 CD I-NP O
affected VBN I-NP O
individuals NNS I-NP O
, , O O
who WP B-NP O
interestingly RB B-ADVP O
had VBD B-VP O
a DT B-NP O
normal JJ I-NP O
result NN I-NP O
of IN B-PP O
the DT B-NP O
perchlorate NN I-NP O
discharge NN I-NP O
test NN I-NP O
whenever WRB B-ADVP O
performed VBN B-VP O
. . O O

The DT B-NP O
present JJ I-NP O
results NNS I-NP O
question VBP B-VP O
the DT B-NP O
sensitivity NN I-NP O
of IN B-PP O
the DT B-NP O
perchlorate JJ I-NP O
test NN I-NP O
for IN B-PP O
the DT B-NP O
diagnosis NN I-NP O
of IN B-PP O
Pendred JJ B-NP B-Disease
syndrome NN I-NP I-Disease
and CC O O
support VBP B-VP O
the DT B-NP O
use NN I-NP O
of IN B-PP O
a DT B-NP O
molecular JJ I-NP O
analysis NN I-NP O
of IN B-PP O
the DT B-NP O
PDS NN I-NP B-Disease
gene NN I-NP O
in IN B-PP O
the DT B-NP O
assessment NN I-NP O
of IN B-PP O
individuals NNS B-NP O
with IN B-PP O
severe JJ B-ADJP O
to TO B-PP O
profound JJ B-NP O
congenital JJ I-NP B-Disease
hearing NN I-NP I-Disease
loss NN I-NP I-Disease
associated VBN B-VP O
with IN B-PP O
inner JJ B-NP B-Disease
ear NN I-NP I-Disease
morphological JJ B-ADJP I-Disease
anomaly RB B-ADVP I-Disease
even RB B-ADVP O
in IN B-PP O
the DT B-NP O
absence NN I-NP O
of IN B-PP O
a DT B-NP O
thyroid JJ I-NP B-Disease
goiter NN I-NP I-Disease
. . O O

. . O O

Knobloch NN B-NP B-Disease
syndrome NN I-NP I-Disease
involving VBG B-VP O
midline NN B-NP B-Disease
scalp NN I-NP I-Disease
defect NN I-NP I-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
frontal JJ I-NP I-Disease
region NN I-NP I-Disease
. . O O

We PRP B-NP O
report VBP B-VP O
on IN B-PP O
a DT B-NP O
4 CD I-NP O
- HYPH I-NP O
year NN I-NP O
- HYPH O O
old JJ B-NP O
boy NN I-NP O
with IN B-PP O
Knobloch NN B-NP B-Disease
syndrome NN I-NP I-Disease
. . O O

He PRP B-NP O
has VBZ B-VP O
vitreoretinal JJ B-NP B-Disease
degeneration NN I-NP I-Disease
, , O O
high JJ B-NP B-Disease
myopia NN I-NP I-Disease
, , O O
cataract NN B-NP B-Disease
, , O O
telecanthus NN B-NP B-Disease
, , O O
hypertelorism NN B-NP B-Disease
, , O O
and CC O O
a DT B-NP O
high JJ I-NP B-Disease
- HYPH I-NP I-Disease
arched JJ I-NP I-Disease
palate NN I-NP I-Disease
. . O O

He PRP B-NP O
also RB B-ADVP O
has VBZ B-VP O
a DT B-NP O
defect NN I-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
anterior JJ I-NP I-Disease
midline NN I-NP I-Disease
scalp NN I-NP I-Disease
with IN B-PP O
involvement NN B-NP O
of IN B-PP O
the DT B-NP O
frontal JJ I-NP O
bone NN I-NP O
as IN B-SBAR O
documented VBN B-VP O
by IN B-PP O
a DT B-NP O
computed VBN I-NP O
tomography NN I-NP O
( ( O O
CT NN B-NP O
) ) O O
scan NN B-NP O
. . O O

The DT B-NP O
brain NN I-NP O
was VBD B-VP O
normal JJ B-ADJP O
on IN B-PP O
CT NN B-NP O
scan NN I-NP O
and CC O O
magnetic JJ B-NP O
resonance NN I-NP O
imaging NN I-NP O
. . O O

We PRP B-NP O
present VBP B-VP O
a DT B-NP O
review NN I-NP O
of IN B-PP O
the DT B-NP O
23 CD I-NP O
published VBN I-NP O
cases NNS I-NP O
with IN B-PP O
this DT B-NP O
syndrome NN I-NP O
. . O O

Our PRP$ B-NP O
patient NN I-NP O
illustrates VBZ B-VP O
the DT B-NP O
importance NN I-NP O
of IN B-PP O
investigating VBG B-VP O
for IN B-PP O
underlying VBG B-VP O
ocular JJ B-NP O
and CC I-NP O
central JJ I-NP O
nervous JJ I-NP O
system NN I-NP O
pathology NN I-NP O
whenever WRB B-ADVP O
midline NN B-NP B-Disease
scalp NN I-NP I-Disease
defects NNS I-NP I-Disease
are VBP B-VP O
present JJ B-ADJP O
. . O O

. . O O

The DT B-NP O
DNA NN I-NP O
double JJ I-NP O
- HYPH I-NP O
strand NN I-NP O
break NN I-NP O
repair NN I-NP O
gene NN I-NP O
hMRE11 NN I-NP O
is VBZ B-VP O
mutated VBN I-VP O
in IN B-PP O
individuals NNS B-NP O
with IN B-PP O
an DT B-NP O
ataxia NN I-NP B-Disease
- HYPH B-NP I-Disease
telangiectasia NN I-NP I-Disease
- HYPH I-NP I-Disease
like JJ I-NP I-Disease
disorder NN I-NP I-Disease
. . O O

We PRP B-NP O
show VBP B-VP O
that IN B-SBAR O
hypomorphic JJ B-NP O
mutations NNS I-NP O
in IN B-PP O
hMRE11 NN B-NP O
, , B-PP O
but CC I-PP O
not RB B-PP O
in IN I-PP O
ATM NN B-NP O
, , O O
are VBP B-VP O
present JJ B-ADJP O
in IN B-PP O
certain JJ B-NP O
individuals NNS I-NP O
with IN B-PP O
an DT B-NP O
ataxia NN I-NP B-Disease
- HYPH B-NP I-Disease
telangiectasia NN I-NP I-Disease
- HYPH I-NP I-Disease
like JJ I-NP I-Disease
disorder NN I-NP I-Disease
( ( O O
ATLD NN B-NP B-Disease
) ) O O
. . O O

The DT B-NP O
cellular JJ I-NP O
features NNS I-NP O
resulting VBG B-VP O
from IN B-PP O
these DT B-NP O
hMRE11 NN I-NP O
mutations NNS I-NP O
are VBP B-VP O
similar JJ B-ADJP O
to TO B-PP O
those DT B-NP O
seen VBN B-VP O
in IN B-PP O
A NN B-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
NBS NNP B-NP B-Disease
and CC O O
include VBP B-VP O
hypersensitivity NN B-NP B-Disease
to TO B-PP I-Disease
ionizing VBG B-VP I-Disease
radiation NN B-NP I-Disease
, , O O
radioresistant JJ B-NP O
DNA NN I-NP O
synthesis NN I-NP O
, , O O
and CC O O
abrogation NN B-NP O
of IN B-PP O
ATM NN B-NP O
- HYPH B-NP O
dependent JJ I-NP O
events NNS I-NP O
, , O O
such JJ B-PP O
as IN I-PP O
the DT B-NP O
activation NN I-NP O
of IN B-PP O
Jun NN B-NP O
kinase NN I-NP O
following VBG B-PP O
exposure NN B-NP O
to TO B-PP O
gamma NN B-NP O
irradiation NN I-NP O
. . O O

Although IN B-SBAR O
the DT B-NP O
mutant JJ I-NP O
hMre11 NN I-NP O
proteins NNS I-NP O
retain VBP B-VP O
some DT B-NP O
ability NN I-NP O
to TO B-VP O
interact VB I-VP O
with IN B-PP O
hRad50 NN B-NP O
and CC I-NP O
Nbs1 NN I-NP O
, , O O
formation NN B-NP O
of IN B-PP O
ionizing VBG B-VP O
radiation NN B-NP O
- HYPH B-NP O
induced VBN I-NP O
hMre11 NN I-NP O
and CC I-NP O
Nbs1 NN I-NP O
foci NNS I-NP O
was VBD B-VP O
absent JJ B-ADJP O
in IN B-PP O
hMRE11 NN B-NP O
mutant JJ I-NP O
cells NNS I-NP O
. . O O

These DT B-NP O
data NNS I-NP O
demonstrate VBP B-VP O
that IN B-SBAR O
ATM NN B-NP O
and CC O O
the DT B-NP O
hMre11 NN I-NP O
/ SYM B-NP O
hRad50 NN I-NP O
/ SYM I-NP O
Nbs1 NN I-NP O
protein NN I-NP O
complex NN I-NP O
act VBP B-VP O
in IN B-PP O
the DT B-NP O
same JJ I-NP O
DNA NN I-NP O
damage NN I-NP O
response NN I-NP O
pathway NN I-NP O
and CC I-NP O
link NN I-NP O
hMre11 NN I-NP O
to TO B-PP O
the DT B-NP O
complex JJ I-NP O
pathology NN I-NP O
of IN B-PP O
A NN B-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
. . O O

. . O O

Mutations NNS B-NP O
in IN B-PP O
TNFRSF11A NN B-NP O
, , O O
affecting VBG B-VP O
the DT B-NP O
signal NN I-NP O
peptide NN I-NP O
of IN B-PP O
RANK NN B-NP O
, , O O
cause VBP B-VP O
familial JJ B-NP B-Disease
expansile NN I-NP I-Disease
osteolysis NN I-NP I-Disease
. . O O

Familial JJ B-NP B-Disease
expansile NN I-NP I-Disease
osteolysis NN I-NP I-Disease
( ( O O
FEO NN B-NP B-Disease
, , O O
MIM NN B-NP O
174810 CD I-NP O
) ) O O
is VBZ B-VP O
a DT B-NP O
rare JJ I-NP O
, , I-NP O
autosomal JJ I-NP B-Disease
dominant JJ I-NP I-Disease
bone NN I-NP I-Disease
disorder NN I-NP I-Disease
characterized VBN B-VP O
by IN B-PP O
focal JJ B-NP O
areas NNS I-NP O
of IN B-PP O
increased VBN B-NP B-Disease
bone NN I-NP I-Disease
remodelling NN I-NP I-Disease
. . O O

The DT B-NP O
osteolytic JJ I-NP B-Disease
lesions NNS I-NP I-Disease
, , O O
which WDT B-NP O
develop VBP B-VP O
usually RB B-ADVP O
in IN B-PP O
the DT B-NP O
long JJ I-NP O
bones NNS I-NP O
during IN B-PP O
early JJ B-NP O
adulthood NN I-NP O
, , O O
show VBP B-VP O
increased VBN I-VP O
osteoblast NN B-NP O
and CC I-NP O
osteoclast NN I-NP O
activity NN I-NP O
. . O O

Our PRP$ B-NP O
previous JJ I-NP O
linkage NN I-NP O
studies NNS I-NP O
mapped VBD B-VP O
the DT B-NP O
gene NN I-NP O
responsible JJ B-ADJP O
for IN B-PP O
FEO NNP B-NP B-Disease
to TO B-PP O
an DT B-NP O
interval NN I-NP O
of IN B-PP O
less JJR B-NP O
than IN I-NP O
5 CD I-NP O
cM NN I-NP O
between IN B-PP O
D18S64 NN B-NP O
and CC I-NP O
D18S51 NN I-NP O
on IN B-PP O
chromosome NN B-NP O
18q21 NN I-NP O
. . O O

2 CD O O
- HYPH O O
21 CD B-NP O
2 CD I-NP O
- : O O
21 CD B-NP O
. . O O

3 CD B-NP O
in IN B-PP O
a DT B-NP O
large JJ I-NP O
Northern JJ I-NP O
Irish JJ I-NP O
family NN I-NP O
. . O O

The DT B-NP O
gene NN I-NP O
encoding NN I-NP O
receptor NN I-NP O
activator NN I-NP O
of IN B-PP O
nuclear JJ B-NP O
factor NN I-NP O
- HYPH B-NP O
kappa NN I-NP O
B NN I-NP O
( ( O O
RANK NN B-NP O
; : O O
ref NN B-NP O
. . O O

5 CD B-NP O
) ) O O
, , O O
TNFRSF11A NN B-NP O
, , O O
maps VBZ B-VP O
to TO B-PP O
this DT B-NP O
region NN I-NP O
. . O O

RANK NN B-NP O
is VBZ B-VP O
essential JJ B-ADJP O
in IN B-PP O
osteoclast NN B-NP O
formation NN I-NP O
. . O O

We PRP B-NP O
identified VBD B-VP O
two CD B-NP O
heterozygous JJ I-NP O
insertion NN I-NP O
mutations NNS I-NP O
in IN B-PP O
exon NN B-NP O
1 CD I-NP O
of IN B-PP O
TNFRSF11A NN B-NP O
in IN B-PP O
affected VBN B-NP O
members NNS I-NP O
of IN B-PP O
four CD B-NP O
families NNS I-NP O
with IN B-PP O
FEO NN B-NP B-Disease
or CC O O
familial JJ B-NP B-Disease
Paget NN I-NP I-Disease
disease NN I-NP I-Disease
of IN B-PP I-Disease
bone NN B-NP I-Disease
( ( O O
PDB NN B-NP B-Disease
) ) O O
. . O O

One CD B-NP O
was VBD B-VP O
a DT B-NP O
duplication NN I-NP O
of IN B-PP O
18 CD B-NP O
bases NNS I-NP O
and CC O O
the DT B-NP O
other JJ I-NP O
a DT B-NP O
duplication NN I-NP O
of IN B-PP O
27 CD B-NP O
bases NNS I-NP O
, , O O
both DT B-NP O
of IN B-PP O
which WDT B-NP O
affected VBD B-VP O
the DT B-NP O
signal NN I-NP O
peptide NN I-NP O
region NN I-NP O
of IN B-PP O
the DT B-NP O
RANK NN I-NP O
molecule NN I-NP O
. . O O

Expression NN B-NP O
of IN B-PP O
recombinant JJ B-NP O
forms NNS I-NP O
of IN B-PP O
the DT B-NP O
mutant JJ I-NP O
RANK NN I-NP O
proteins NNS I-NP O
revealed VBD B-VP O
perturbations NNS B-NP O
in IN B-PP O
expression NN B-NP O
levels NNS I-NP O
and CC O O
lack NN B-NP O
of IN B-PP O
normal JJ B-NP O
cleavage NN I-NP O
of IN B-PP O
the DT B-NP O
signal NN I-NP O
peptide NN I-NP O
. . O O

Both DT B-NP O
mutations NNS I-NP O
caused VBD B-VP O
an DT B-NP O
increase NN I-NP O
in IN B-PP O
RANK NN B-NP O
- HYPH O O
mediated VBN B-VP O
nuclear JJ B-NP O
factor NN I-NP O
- HYPH O O
kappaB NN B-NP O
( ( O O
NF NN B-NP O
- HYPH B-NP O
kappaB NN I-NP O
) ) O O
signalling NN B-NP O
in FW B-ADVP O
vitro FW I-ADVP O
, , O O
consistent JJ B-ADJP O
with IN B-PP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
an DT B-NP O
activating VBG I-NP O
mutation NN I-NP O
. . O O

Cardiac JJ B-NP O
Na NN I-NP O
( ( O O
+ SYM O O
) ) O O
channel NN B-NP O
dysfunction NN I-NP O
in IN B-PP O
Brugada NNP B-NP B-Disease
syndrome NN I-NP I-Disease
is VBZ B-VP O
aggravated VBN I-VP O
by IN B-PP O
beta NN B-NP O
( ( O O
1 CD B-NP O
) ) O O
- HYPH B-NP O
subunit NN I-NP O
. . O O

BACKGROUND NN B-NP O
Mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
gene NN I-NP O
encoding VBG B-VP O
the DT B-NP O
human JJ I-NP O
cardiac JJ I-NP O
Na NN I-NP O
( ( O O
+ SYM O O
) ) O O
channel NN B-NP O
alpha SYM O O
- HYPH O O
subunit NN B-NP O
( ( O O
hH1 NN B-NP O
) ) O O
are VBP B-VP O
responsible JJ B-ADJP O
for IN B-PP O
chromosome NN B-NP O
3 CD I-NP O
- HYPH O O
linked VBN B-VP O
congenital JJ B-NP B-Disease
long JJ I-NP I-Disease
- HYPH I-NP I-Disease
QT NN I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
LQT3 NN B-NP B-Disease
) ) O O
and CC O O
idiopathic JJ B-NP B-Disease
ventricular JJ I-NP I-Disease
fibrillation NN I-NP I-Disease
( ( O O
IVF NN B-NP B-Disease
) ) O O
. . O O

An DT B-NP O
auxiliary JJ I-NP O
beta NN I-NP O
( ( O O
1 CD B-NP O
) ) O O
- HYPH B-NP O
subunit NN I-NP O
, , O O
widely RB B-VP O
expressed VBN I-VP O
in IN B-PP O
excitable JJ B-NP O
tissues NNS I-NP O
, , O O
shifts VBZ B-VP O
the DT B-NP O
voltage NN I-NP O
dependence NN I-NP O
of IN B-PP O
steady JJ B-NP O
- HYPH I-NP O
state NN I-NP O
inactivation NN I-NP O
toward IN B-PP O
more RBR B-NP O
negative JJ I-NP O
potentials NNS I-NP O
and CC O O
restores VBZ B-VP O
normal JJ B-NP O
gating VBG I-NP O
kinetics NNS I-NP O
of IN B-PP O
brain NN B-NP O
and CC O O
skeletal JJ B-NP O
muscle NN I-NP O
Na NN I-NP O
( ( O O
+ SYM O O
) ) O O
channels NNS B-NP O
expressed VBN B-VP O
in IN B-PP O
Xenopus NNP B-NP O
oocytes NNS I-NP O
but CC O O
has VBZ B-VP O
little JJ B-NP O
if IN B-SBAR O
any DT B-NP O
functional JJ I-NP O
effect NN I-NP O
on IN B-PP O
the DT B-NP O
cardiac JJ I-NP O
isoform NN I-NP O
. . O O

Here RB B-ADVP O
, , O O
we PRP B-NP O
characterize VBP B-VP O
the DT B-NP O
altered VBN I-NP O
effects NNS I-NP O
of IN B-PP O
a DT B-NP O
human JJ I-NP O
beta NN I-NP O
( ( O O
1 CD B-NP O
) ) O O
- HYPH O O
subunit NN B-NP O
( ( O O
hbeta NN B-NP O
( ( O O
1 CD B-NP O
) ) O O
) ) O O
on IN B-PP O
the DT B-NP O
heterologously RB I-NP O
expressed VBN I-NP O
hH1 NN I-NP O
mutation NN I-NP O
( ( O O
T1620M NN B-NP O
) ) O O
previously RB B-VP O
associated VBN I-VP O
with IN B-PP O
IVF NN B-NP B-Disease
. . O O

METHODS NNS B-NP O
AND CC I-NP O
RESULTS NNS I-NP O
When WRB B-ADVP O
expressed VBN B-VP O
alone RB B-ADVP O
in IN B-PP O
Xenopus NNP B-NP O
oocytes NNS I-NP O
, , O O
T1620M NN B-NP O
exhibited VBD B-VP O
no DT B-NP O
persistent JJ I-NP O
currents NNS I-NP O
, , O O
in IN B-PP O
contrast NN B-NP O
to TO B-PP O
the DT B-NP O
LQT3 NN I-NP B-Disease
mutant JJ I-NP O
channels NNS I-NP O
, , O O
but CC O O
the DT B-NP O
midpoint NN I-NP O
of IN B-PP O
steady JJ B-NP O
- HYPH I-NP O
state NN I-NP O
inactivation NN I-NP O
( ( O O
V NN B-NP O
( ( O O
1 CD B-NP O
/ SYM O O
2 CD O O
) ) O O
) ) O O
was VBD B-VP O
significantly RB I-VP O
shifted VBN I-VP O
toward IN B-PP O
more RBR B-NP O
positive JJ I-NP O
potentials NNS I-NP O
than IN B-PP O
for IN B-PP O
wild JJ B-NP O
- HYPH I-NP O
type NN I-NP O
hH1 NN I-NP O
. . O O

Coexpression NN B-NP O
of IN B-PP O
hbeta NN B-NP O
( ( O O
1 CD B-NP O
) ) O O
did VBD B-VP O
not RB I-VP O
significantly RB I-VP O
alter VB I-VP O
current JJ B-NP O
decay NN I-NP O
or CC I-NP O
recovery NN I-NP O
from IN B-PP O
inactivation NN B-NP O
of IN B-PP O
wild JJ B-NP O
- HYPH I-NP O
type NN I-NP O
hH1 NN I-NP O
; : O O
however RB B-ADVP O
, , O O
it PRP B-NP O
further RB B-ADVP O
shifted VBD B-VP O
the DT B-NP O
V NN I-NP O
( ( O O
1 CD B-NP O
/ SYM O O
2 CD O O
) ) O O
and CC O O
accelerated VBD B-VP O
the DT B-NP O
recovery NN I-NP O
from IN B-PP O
inactivation NN B-NP O
of IN B-PP O
T1620M NN B-NP O
. . O O

Oocyte NN B-NP O
macropatch NN I-NP O
analysis NN I-NP O
revealed VBD B-VP O
that IN B-SBAR O
the DT B-NP O
activation NN I-NP O
kinetics NNS I-NP O
of IN B-PP O
T1620M NN B-NP O
were VBD B-VP O
normal JJ B-ADJP O
. . O O

CONCLUSIONS NNS B-NP O
It PRP B-NP O
is VBZ B-VP O
suggested VBN I-VP O
that IN B-SBAR O
coexpression NN B-NP O
of IN B-PP O
hbeta NN B-NP O
( ( O O
1 CD B-NP O
) ) O O
exposes VBZ B-VP O
a DT B-NP O
more RBR I-NP O
severe JJ I-NP O
functional JJ I-NP O
defect NN I-NP O
that WDT B-NP O
results VBZ B-VP O
in IN B-PP O
a DT B-NP O
greater JJR I-NP O
overlap NN I-NP O
in IN B-PP O
the DT B-NP O
relationship NN I-NP O
between IN B-PP O
channel NN B-NP O
inactivation NN I-NP O
and CC O O
activation NN B-NP O
( ( O O
window NN B-NP O
current NN I-NP O
) ) O O
in IN B-PP O
T1620M NN B-NP O
, , O O
which WDT B-NP O
is VBZ B-VP O
proposed VBN I-VP O
to TO I-VP O
be VB I-VP O
a DT B-NP O
potential JJ I-NP O
pathophysiological JJ I-NP O
mechanism NN I-NP O
of IN B-PP O
IVF NN B-NP B-Disease
in FW B-ADVP O
vivo FW I-ADVP O
. . O O

One CD B-NP O
possible JJ I-NP O
explanation NN I-NP O
for IN B-PP O
our PRP$ B-NP O
finding NN I-NP O
is VBZ B-VP O
an DT B-NP O
altered JJ I-NP O
alpha SYM I-NP O
- HYPH I-NP O
/ SYM I-NP O
beta NN B-NP O
( ( O O
1 CD B-NP O
) ) O O
- HYPH B-NP O
subunit NN I-NP O
association NN I-NP O
in IN B-PP O
the DT B-NP O
mutant NN I-NP O
. . O O

. . O O

Meiotic JJ B-NP O
segregation NN I-NP O
analysis NN I-NP O
of IN B-PP O
RB1 NN B-NP O
alleles NNS I-NP O
in IN B-PP O
retinoblastoma NN B-NP B-Disease
pedigrees NNS I-NP O
by IN B-PP O
use NN B-NP O
of IN B-PP O
single JJ B-NP O
- HYPH I-NP O
sperm NN I-NP O
typing NN I-NP O
. . O O

In IN B-PP O
hereditary JJ B-NP B-Disease
retinoblastoma NN I-NP I-Disease
, , O O
different JJ B-NP O
epidemiological JJ I-NP O
studies NNS I-NP O
have VBP B-VP O
indicated VBN I-VP O
a DT B-NP O
preferential JJ I-NP O
paternal JJ I-NP O
transmission NN I-NP O
of IN B-PP O
mutant JJ B-NP O
retinoblastoma NN I-NP B-Disease
alleles NNS I-NP O
to TO B-PP O
offspring NN B-NP O
, , O O
suggesting VBG B-VP O
the DT B-NP O
occurrence NN I-NP O
of IN B-PP O
a DT B-NP O
meiotic JJ I-NP O
drive NN I-NP O
. . O O

To TO B-VP O
investigate VB I-VP O
this DT B-NP O
mechanism NN I-NP O
, , O O
we PRP B-NP O
analyzed VBD B-VP O
sperm NN B-NP O
samples NNS I-NP O
from IN B-PP O
six CD B-NP O
individuals NNS I-NP O
from IN B-PP O
five CD B-NP O
unrelated JJ I-NP O
families NNS I-NP O
affected VBN B-VP O
with IN B-PP O
hereditary JJ B-NP B-Disease
retinoblastoma NN I-NP I-Disease
. . O O

Single JJ B-NP O
- HYPH I-NP O
sperm NN I-NP O
typing NN I-NP O
techniques NNS I-NP O
were VBD B-VP O
performed VBN I-VP O
for IN B-PP O
each DT B-NP O
sample NN I-NP O
by IN B-PP O
study NN B-NP O
of IN B-PP O
two CD B-NP O
informative JJ I-NP O
short JJ I-NP O
tandem JJ I-NP O
repeats NNS I-NP O
located VBN B-VP O
either CC B-PP O
in IN I-PP O
or CC O O
close RB B-ADVP O
to TO B-PP O
the DT B-NP O
retinoblastoma NN I-NP B-Disease
gene NN I-NP O
( ( O O
RB1 NN B-NP O
) ) O O
. . O O

The DT B-NP O
segregation NN I-NP O
probability NN I-NP O
of IN B-PP O
mutant JJ B-NP O
RB1 NN I-NP O
alleles NNS I-NP O
in IN B-PP O
sperm NN B-NP O
samples NNS I-NP O
was VBD B-VP O
assessed VBN I-VP O
by IN B-PP O
use NN B-NP O
of IN B-PP O
the DT B-NP O
SPERMSEG NN I-NP O
program NN I-NP O
, , O O
which WDT B-NP O
includes VBZ B-VP O
experimental JJ B-NP O
parameters NNS I-NP O
, , O O
recombination NN B-NP O
fractions NNS I-NP O
between IN B-PP O
the DT B-NP O
markers NNS I-NP O
, , O O
and CC O O
segregation NN B-NP O
parameters NNS I-NP O
. . O O

A DT B-NP O
total NN I-NP O
of IN B-PP O
2 CD B-NP O
, , I-NP O
952 CD I-NP O
single JJ I-NP O
sperm NN I-NP O
from IN B-PP O
the DT B-NP O
six CD I-NP O
donors NNS I-NP O
were VBD B-VP O
analyzed VBN I-VP O
. . O O

We PRP B-NP O
detected VBD B-VP O
a DT B-NP O
significant JJ I-NP O
segregation NN I-NP O
distortion NN I-NP O
in IN B-PP O
the DT B-NP O
data NNS I-NP O
as IN B-PP O
a DT B-NP O
whole JJ I-NP O
( ( O O
P NN B-NP O
= SYM B-VP O
. . O O

0099 CD B-NP O
) ) O O
and CC O O
a DT B-NP O
significant JJ I-NP O
heterogeneity NN I-NP O
in IN B-PP O
the DT B-NP O
segregation NN I-NP O
rate NN I-NP O
across IN B-PP O
donors NNS B-NP O
( ( O O
. . O O

0092 CD O O
) ) O O
. . O O

Further JJ B-NP O
analysis NN I-NP O
shows VBZ B-VP O
that IN B-SBAR O
this DT B-NP O
result NN I-NP O
can MD B-VP O
be VB I-VP O
explained VBN I-VP O
by IN B-PP O
segregation NN B-NP O
distortion NN I-NP O
in IN B-PP O
favor NN B-NP O
of IN B-PP O
the DT B-NP O
normal JJ I-NP O
allele NN I-NP O
in IN B-PP O
one CD B-NP O
donor NN I-NP O
only RB B-ADVP O
and CC O O
that IN B-SBAR O
it PRP B-NP O
does VBZ B-VP O
not RB I-VP O
provide VB I-VP O
evidence NN B-NP O
of IN B-PP O
a DT B-NP O
significant JJ I-NP O
segregation NN I-NP O
distortion NN I-NP O
in IN B-PP O
the DT B-NP O
other JJ I-NP O
donors NNS I-NP O
. . O O

The DT B-NP O
segregation NN I-NP O
distortion NN I-NP O
favoring VBG B-VP O
the DT B-NP O
mutant JJ I-NP O
RB1 NN I-NP O
allele NN I-NP O
does VBZ B-VP O
not RB I-VP O
seem VB I-VP O
to TO I-VP O
occur VB I-VP O
during IN B-PP O
spermatogenesis NN B-NP O
, , O O
and CC O O
, , O O
thus RB B-ADVP O
, , O O
meiotic JJ B-NP O
drive NN I-NP O
may MD B-VP O
result VB I-VP O
either CC O O
from IN B-PP O
various JJ B-NP O
mechanisms NNS I-NP O
, , O O
including VBG B-PP O
a DT B-NP O
fertilization NN I-NP O
advantage NN I-NP O
or CC O O
a DT B-NP O
better JJR I-NP O
mobility NN I-NP O
in IN B-PP O
sperm NN B-NP O
bearing VBG B-VP O
a DT B-NP O
mutant JJ I-NP O
RB1 NN I-NP O
gene NN I-NP O
, , O O
or CC O O
from IN B-PP O
the DT B-NP O
existence NN I-NP O
of IN B-PP O
a DT B-NP O
defectively RB I-NP O
imprinted VBN I-NP O
gene NN I-NP O
located VBN B-VP O
on IN B-PP O
the DT B-NP O
human JJ I-NP O
X NN I-NP O
chromosome NN I-NP O
. . O O

Friedreich JJ B-NP B-Disease
ataxia NN I-NP I-Disease
: : O O
an DT B-NP O
overview NN I-NP O
. . O O

Friedreich NNP B-NP B-Disease
ataxia NN I-NP I-Disease
, , O O
an DT B-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
neurodegenerative JJ I-NP I-Disease
disease NN I-NP I-Disease
, , O O
is VBZ B-VP O
the DT B-NP O
most RBS I-NP O
common JJ I-NP O
of IN B-PP O
the DT B-NP O
inherited VBN I-NP B-Disease
ataxias NNS I-NP I-Disease
. . O O

The DT B-NP O
recent JJ I-NP O
discovery NN I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
that WDT B-NP O
is VBZ B-VP O
mutated VBN I-VP O
in IN B-PP O
this DT B-NP O
condition NN I-NP O
, , O O
FRDA NN B-NP O
, , O O
has VBZ B-VP O
led VBN I-VP O
to TO B-PP O
rapid JJ B-NP O
advances NNS I-NP O
in IN B-PP O
the DT B-NP O
understanding NN I-NP O
of IN B-PP O
the DT B-NP O
pathogenesis NN I-NP O
of IN B-PP O
Friedreich NNP B-NP B-Disease
ataxia NN I-NP I-Disease
. . O O

About RB B-NP O
98 CD I-NP O
% NN I-NP O
of IN B-PP O
mutant JJ B-NP O
alleles NNS I-NP O
have VBP B-VP O
an DT B-NP O
expansion NN I-NP O
of IN B-PP O
a DT B-NP O
GAA NN I-NP O
trinucleotide NN I-NP O
repeat NN I-NP O
in IN B-PP O
intron NN B-NP O
1 CD I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
. . O O

This DT B-NP O
leads VBZ B-VP O
to TO B-PP O
reduced VBN B-NP O
levels NNS I-NP O
of IN B-PP O
the DT B-NP O
protein NN I-NP O
, , O O
frataxin NN B-NP O
. . O O

There EX B-NP O
is VBZ B-VP O
mounting VBG B-NP O
evidence NN I-NP O
to TO B-VP O
suggest VB I-VP O
that IN B-SBAR O
Friedreich NNP B-NP B-Disease
ataxia NN I-NP I-Disease
is VBZ B-VP O
the DT B-NP O
result NN I-NP O
of IN B-PP O
accumulation NN B-NP O
of IN B-PP O
iron NN B-NP O
in IN B-PP O
mitochondria NNS B-NP O
leading VBG B-VP O
to TO B-PP O
excess JJ B-NP O
production NN I-NP O
of IN B-PP O
free JJ B-NP O
radicals NNS I-NP O
, , O O
which WDT B-NP O
then RB B-ADVP O
results VBZ B-VP O
in IN B-PP O
cellular JJ B-NP O
damage NN I-NP O
and CC I-NP O
death NN I-NP O
. . O O

Currently RB B-ADVP O
there EX B-NP O
is VBZ B-VP O
no DT B-NP O
known VBN I-NP O
treatment NN I-NP O
that WDT B-NP O
alters VBZ B-VP O
the DT B-NP O
natural JJ I-NP O
course NN I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
. . O O

The DT B-NP O
discovery NN I-NP O
of IN B-PP O
the DT B-NP O
FRDA NN I-NP B-Disease
gene NN I-NP O
and CC O O
its PRP$ B-NP O
possible JJ I-NP O
function NN I-NP O
has VBZ B-VP O
raised VBN I-VP O
hope NN B-NP O
that IN B-SBAR O
rational JJ B-NP O
therapeutic JJ I-NP O
strategies NNS I-NP O
will MD B-VP O
be VB I-VP O
developed VBN I-VP O
. . O O

. . O O

X NN B-NP B-Disease
- HYPH B-PP I-Disease
linked VBN B-NP I-Disease
retinoschisis NN I-NP I-Disease
with IN B-PP O
point NN B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
XLRS1 NN I-NP O
gene NN I-NP O
. . O O

BACKGROUND NN B-NP O
X NN I-NP B-Disease
- HYPH O I-Disease
linked VBN B-VP I-Disease
retinoschisis NN B-NP I-Disease
( ( O O
XLRS NN B-NP B-Disease
) ) O O
is VBZ B-VP O
a DT B-NP O
relatively RB I-NP O
rare JJ I-NP O
vitreoretinal JJ I-NP B-Disease
dystrophy NN I-NP I-Disease
that WDT B-NP O
causes VBZ B-VP O
visual JJ B-NP B-Disease
loss NN I-NP I-Disease
in IN B-PP O
young JJ B-NP O
men NNS I-NP O
. . O O

Recently RB B-ADVP O
, , O O
a DT B-NP O
gene NN I-NP O
responsible JJ B-ADJP O
for IN B-PP O
this DT B-NP O
disease NN I-NP O
, , O O
designated VBN B-VP O
XLRS1 NN B-NP O
, , O O
was VBD B-VP O
identified VBN I-VP O
, , O O
and CC O O
several JJ B-NP O
deleterious JJ I-NP O
gene NN I-NP O
mutations NNS I-NP O
were VBD B-VP O
reported VBN I-VP O
. . O O

OBJECTIVE NN B-NP O
To TO B-VP O
analyze VB I-VP O
Japanese JJ B-NP O
patients NNS I-NP O
clinically RB B-VP O
diagnosed VBN I-VP O
as IN B-PP O
having VBG B-VP O
XLRS NN B-NP B-Disease
formutational JJ I-NP O
changes NNS I-NP O
in IN B-PP O
the DT B-NP O
XLRS1 NN I-NP O
gene NN I-NP O
. . O O

METHODS NNS B-NP O
Ten CD B-NP O
patients NNS I-NP O
with IN B-PP O
XLRS NNS B-NP B-Disease
underwent VBD B-VP O
full JJ B-NP O
ophthalmologic JJ I-NP O
examination NN I-NP O
, , O O
including VBG B-PP O
slitlamp JJ B-NP O
biomicroscopy NN I-NP O
and CC O O
dilated JJ B-NP O
funduscopy NN I-NP O
. . O O

Genomic JJ B-NP O
DNA NN I-NP O
was VBD B-VP O
isolated VBN I-VP O
from IN B-PP O
leukocytes NNS B-NP O
, , O O
and CC O O
all DT B-NP O
exons NNS I-NP O
of IN B-PP O
the DT B-NP O
XLRS1 NN I-NP O
gene NN I-NP O
were VBD B-VP O
amplified VBN I-VP O
by IN B-PP O
polymerase NN B-NP O
chain NN I-NP O
reaction NN I-NP O
and CC O O
analyzed VBN B-VP O
using VBG B-VP O
a DT B-NP O
direct JJ I-NP O
sequencing NN I-NP O
method NN I-NP O
. . O O

RESULTS NNS B-NP O
Point NN I-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
XLRS1 NN I-NP O
gene NN I-NP O
were VBD B-VP O
identified VBN I-VP O
in IN B-PP O
all DT B-NP O
10 CD I-NP O
patients NNS I-NP O
. . O O

The DT B-NP O
mutations NNS I-NP O
were VBD B-VP O
identical JJ B-ADJP O
in IN B-PP O
each DT B-NP O
of IN B-PP O
2 CD B-NP O
pairs NNS I-NP O
of IN B-PP O
brothers NNS B-NP O
. . O O

Six CD B-NP O
of IN B-PP O
the DT B-NP O
point NN I-NP O
mutations NNS I-NP O
represented VBD B-VP O
missense JJ B-NP O
mutations NNS I-NP O
, , O O
1 CD B-NP O
was VBD B-VP O
a DT B-NP O
nonsense JJ I-NP O
mutation NN I-NP O
, , O O
and CC O O
1 CD B-NP O
was VBD B-VP O
a DT B-NP O
frameshift NN I-NP O
mutation NN I-NP O
. . O O

Five CD B-NP O
of IN B-PP O
the DT B-NP O
mutations NNS I-NP O
are VBP B-VP O
newly RB I-VP O
reported VBN I-VP O
herein RB B-ADVP O
. . O O

CONCLUSIONS NNS B-NP O
The DT B-NP O
discovery NN I-NP O
of IN B-PP O
new JJ B-NP O
point NN I-NP O
mutations NNS I-NP O
in IN B-PP O
this DT B-NP O
study NN I-NP O
increases VBZ B-VP O
the DT B-NP O
available JJ I-NP O
information NN I-NP O
regarding VBG B-VP O
the DT B-NP O
spectrum NN I-NP O
of IN B-PP O
genetic JJ B-NP B-Disease
abnormalities NNS I-NP I-Disease
and CC O O
clinical JJ B-NP O
manifestations NNS I-NP O
of IN B-PP O
XLRS NN B-NP B-Disease
. . O O

However RB B-ADVP O
, , O O
the DT B-NP O
limited JJ I-NP O
data NNS I-NP O
failed VBD B-VP O
to TO I-VP O
reveal VB I-VP O
a DT B-NP O
correlation NN I-NP O
between IN B-PP O
mutation NN B-NP O
and CC I-NP O
disease NN I-NP O
phenotype NN I-NP O
. . O O

CLINICAL JJ B-NP O
RELEVANCE NN I-NP O
Identification NN I-NP O
of IN B-PP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
XLRS1 NN I-NP O
gene NN I-NP O
and CC O O
expanded VBN B-NP O
information NN I-NP O
on IN B-PP O
clinical JJ B-NP O
manifestations NNS I-NP O
will MD B-VP O
facilitate VB I-VP O
early JJ B-NP O
diagnosis NN I-NP O
, , O O
appropriate JJ B-NP O
early JJ I-NP O
therapy NN I-NP O
, , O O
and CC O O
genetic JJ B-NP O
counseling NN I-NP O
regarding VBG B-VP O
the DT B-NP O
prognosis NN I-NP O
of IN B-PP O
XLRS NN B-NP B-Disease
. . O O

. . O O

Atm NN B-NP O
and CC I-NP O
Bax NN I-NP O
cooperate VBP B-VP O
in IN B-PP O
ionizing VBG B-VP O
radiation NN B-NP O
- HYPH O O
induced VBN B-NP O
apoptosis NN I-NP O
in IN B-PP O
the DT B-NP O
central JJ I-NP O
nervous JJ I-NP O
system NN I-NP O
. . O O

Ataxia NN B-NP B-Disease
- HYPH I-NP I-Disease
telangiectasia NN I-NP I-Disease
is VBZ B-VP O
a DT B-NP O
hereditary JJ I-NP B-Disease
multisystemic JJ I-NP I-Disease
disease NN I-NP I-Disease
resulting VBG B-VP O
from IN B-PP O
mutations NNS B-NP O
of IN B-PP O
ataxia NN B-NP B-Disease
telangiectasia NN I-NP I-Disease
, , O O
mutated VBN B-VP O
( ( O O
ATM NN B-NP O
) ) O O
and CC O O
is VBZ B-VP O
characterized VBN I-VP O
by IN B-PP O
neurodegeneration NN B-NP B-Disease
, , O O
cancer NN B-NP B-Disease
, , O O
immune JJ B-NP B-Disease
defects NNS I-NP I-Disease
, , O O
and CC O O
hypersensitivity NN B-NP B-Disease
to TO B-PP I-Disease
ionizing VBG B-VP I-Disease
radiation NN B-NP I-Disease
. . O O

The DT B-NP O
molecular JJ I-NP O
details NNS I-NP O
of IN B-PP O
ATM NN B-NP O
function NN I-NP O
in IN B-PP O
the DT B-NP O
nervous JJ I-NP O
system NN I-NP O
are VBP B-VP O
unclear JJ B-ADJP O
, , O O
although IN B-SBAR O
the DT B-NP O
neurological JJ I-NP B-Disease
lesion NN I-NP I-Disease
in IN B-PP O
ataxia NN B-NP B-Disease
- HYPH B-NP I-Disease
telangiectasia NN I-NP I-Disease
becomes VBZ B-VP O
apparent JJ B-ADJP O
early RB B-ADVP O
in IN B-PP O
life NN B-NP O
, , O O
suggesting VBG B-VP O
a DT B-NP O
developmental JJ I-NP O
origin NN I-NP O
. . O O

The DT B-NP O
central JJ I-NP O
nervous JJ I-NP O
system NN I-NP O
( ( O O
CNS NN B-NP O
) ) O O
of IN B-PP O
Atm NN B-NP O
- HYPH B-NP O
mice NNS I-NP O
shows VBZ B-VP O
a DT B-NP O
pronounced JJ I-NP O
defect NN I-NP O
in IN B-PP O
apoptosis NN B-NP O
induced VBN B-VP O
by IN B-PP O
genotoxic JJ B-NP O
stress NN I-NP O
, , O O
suggesting VBG B-VP O
ATM NN B-NP O
functions NNS I-NP O
to TO B-VP O
eliminate VB I-VP O
neurons NNS B-NP O
with IN B-PP O
excessive JJ B-NP O
genomic JJ I-NP O
damage NN I-NP O
. . O O

Here RB B-ADVP O
, , O O
we PRP B-NP O
report VBP B-VP O
that IN B-SBAR O
the DT B-NP O
death NN I-NP O
effector NN I-NP O
Bax NN I-NP O
is VBZ B-VP O
required VBN I-VP O
for IN B-PP O
a DT B-NP O
large JJ I-NP O
proportion NN I-NP O
of IN B-PP O
Atm NN B-NP O
- HYPH B-NP O
dependent JJ I-NP O
apoptosis NN I-NP O
in IN B-PP O
the DT B-NP O
developing VBG I-NP O
CNS NN I-NP O
after IN B-PP O
ionizing VBG B-VP O
radiation NN B-NP O
( ( O O
IR NN B-NP O
) ) O O
. . O O

Although IN B-SBAR O
many JJ B-NP O
of IN B-PP O
the DT B-NP O
same JJ I-NP O
regions NNS I-NP O
of IN B-PP O
the DT B-NP O
CNS NN I-NP O
in IN B-PP O
both CC O O
Bax NN B-NP O
- HYPH I-NP O
/ SYM I-NP O
- HYPH I-NP O
and CC I-NP O
Atm NN I-NP O
- HYPH O O
/ SYM O O
- HYPH O O
mice NNS B-NP O
were VBD B-VP O
radioresistant JJ B-ADJP O
, , O O
mice NNS B-NP O
nullizygous JJ B-ADJP O
for IN B-PP O
both CC O O
Bax NN B-NP O
and CC O O
Atm NN B-NP O
showed VBD B-VP O
additional JJ B-NP O
reduction NN I-NP O
in IN B-PP O
IR NN B-NP O
- HYPH B-NP O
induced VBN I-NP O
apoptosis NN I-NP O
in IN B-PP O
the DT B-NP O
CNS NN I-NP O
. . O O

Therefore RB B-ADVP O
, , O O
although IN B-SBAR O
the DT B-NP O
major JJ I-NP O
IR NN I-NP O
- HYPH O O
induced VBN B-NP O
apoptotic JJ I-NP O
pathway NN I-NP O
in IN B-PP O
the DT B-NP O
CNS NN I-NP O
requires VBZ B-VP O
Atm NN B-NP O
and CC I-NP O
Bax NN I-NP O
, , O O
a DT B-NP O
p53 NN I-NP O
- HYPH B-NP O
dependent JJ I-NP O
collateral NN I-NP O
pathway NN I-NP O
exists VBZ B-VP O
that DT B-NP O
has VBZ B-VP O
both CC I-VP O
Atm NN I-VP O
- HYPH B-NP O
and CC I-NP O
Bax NN I-NP O
- HYPH O O
independent JJ B-NP O
branches NNS I-NP O
. . O O

Further RB B-ADVP O
, , O O
Atm NN B-NP O
- HYPH B-NP O
and CC I-NP O
Bax NN I-NP O
- HYPH I-NP O
dependent JJ I-NP O
apoptosis NN I-NP O
in IN B-PP O
the DT B-NP O
CNS NN I-NP O
also RB B-ADVP O
required VBD B-VP O
caspase NN B-NP O
- HYPH O O
3 CD B-NP O
activation NN I-NP O
. . O O

These DT B-NP O
data NNS I-NP O
implicate VBP B-VP O
Bax NN B-NP O
and CC I-NP O
caspase NN I-NP O
- HYPH B-NP O
3 CD I-NP O
as IN B-SBAR O
death NN B-NP O
effectors NNS I-NP O
in IN B-PP O
neurodegenerative JJ B-NP O
pathways NNS I-NP O
. . O O

. . O O

Haim NNP B-NP B-Disease
- HYPH I-NP I-Disease
Munk NNP I-NP I-Disease
syndrome NN I-NP I-Disease
and CC O O
Papillon NNP B-NP B-Disease
- HYPH I-NP I-Disease
Lefevre NNP I-NP I-Disease
syndrome NN I-NP I-Disease
are VBP B-VP O
allelic JJ B-NP O
mutations NNS I-NP O
in IN B-PP O
cathepsin NN B-NP O
C NN I-NP O
. . O O

Of IN B-PP O
the DT B-NP O
many JJ I-NP O
palmoplantar JJ I-NP B-Disease
keratoderma NN I-NP I-Disease
( ( O I-Disease
PPK NN B-NP I-Disease
) ) O I-Disease
conditions NNS B-NP I-Disease
, , O O
only RB B-NP O
Papillon NNP I-NP B-Disease
- HYPH I-NP I-Disease
Lefevre NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
PLS NN B-NP B-Disease
) ) O O
and CC O O
Haim NN B-NP B-Disease
- HYPH O I-Disease
Munk NN B-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
HMS NN B-NP B-Disease
) ) O O
are VBP B-VP O
associated VBN I-VP O
with IN B-PP O
premature JJ B-NP O
periodontal JJ I-NP O
destruction NN I-NP O
. . O O

Although IN B-SBAR O
both CC O O
PLS NN B-NP B-Disease
and CC I-NP O
HMS NN I-NP B-Disease
share VBP B-VP O
the DT B-NP O
cardinal JJ I-NP O
features NNS I-NP O
of IN B-PP O
PPK NN B-NP B-Disease
and CC O O
severe JJ B-NP O
periodontitis NN I-NP B-Disease
, , O O
a DT B-NP O
number NN I-NP O
of IN B-PP O
additional JJ B-NP O
findings NNS I-NP O
are VBP B-VP O
reported VBN I-VP O
in IN B-PP O
HMS NN B-NP B-Disease
including VBG B-PP O
arachnodactyly RB B-ADVP B-Disease
, , O O
acro AFX B-NP B-Disease
- HYPH I-NP I-Disease
osteolysis NN I-NP I-Disease
, , O O
atrophic JJ B-NP B-Disease
changes NNS I-NP I-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
nails NNS I-NP I-Disease
, , O O
and CC O O
a DT B-NP O
radiographic JJ I-NP B-Disease
deformity NN I-NP I-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
fingers NNS I-NP I-Disease
. . O O

While IN B-SBAR O
PLS NN B-NP B-Disease
cases NNS I-NP O
have VBP B-VP O
been VBN I-VP O
identified VBN I-VP O
throughout IN B-PP O
the DT B-NP O
world NN I-NP O
, , O O
HMS NN B-NP B-Disease
has VBZ B-VP O
only RB I-VP O
been VBN I-VP O
described VBN I-VP O
among IN B-PP O
descendants NNS B-NP O
of IN B-PP O
a DT B-NP O
religious JJ I-NP O
isolate NN I-NP O
originally RB B-ADVP O
from IN B-PP O
Cochin NNP B-NP O
, , O O
India NNP B-NP O
. . O O

Parental JJ B-NP O
consanguinity NN I-NP O
is VBZ B-VP O
a DT B-NP O
characteristic NN I-NP O
of IN B-PP O
many JJ B-NP O
cases NNS I-NP O
of IN B-PP O
both DT B-NP O
conditions NNS I-NP O
. . O O

Although IN B-SBAR O
autosomal JJ B-NP O
recessive JJ I-NP O
transmission NN I-NP O
of IN B-PP O
PLS NN B-NP B-Disease
is VBZ B-VP O
evident JJ B-ADJP O
, , O O
a DT O O
more RBR B-NP O
complex JJ I-NP O
autosomal JJ I-NP O
recessive JJ I-NP O
pattern NN I-NP O
of IN B-PP O
inheritance NN B-NP O
with IN B-PP O
phenotypic JJ B-NP O
influences NNS I-NP O
from IN B-PP O
a DT B-NP O
closely RB I-NP O
linked VBN I-NP O
modifying VBG I-NP O
locus NN I-NP O
has VBZ B-VP O
been VBN I-VP O
hypothesised VBN I-VP O
for IN B-PP O
HMS NN B-NP B-Disease
. . O O

Recently RB B-ADVP O
, , O O
mutations NNS B-NP O
of IN B-PP O
the DT B-NP O
cathepsin NN I-NP O
C NN I-NP O
gene NN I-NP O
have VBP B-VP O
been VBN I-VP O
identified VBN I-VP O
as IN B-PP O
the DT B-NP O
underlying VBG I-NP O
genetic JJ I-NP B-Disease
defect NN I-NP I-Disease
in IN B-PP O
PLS NN B-NP B-Disease
. . O O

To TO B-VP O
determine VB I-VP O
if IN B-SBAR O
a DT B-NP O
cathepsin NN I-NP O
C NN I-NP O
mutation NN I-NP O
is VBZ B-VP O
also RB B-ADVP O
responsible JJ B-ADJP O
for IN B-PP O
HMS NN B-NP B-Disease
, , O O
we PRP B-NP O
sequenced VBD B-VP O
the DT B-NP O
gene NN I-NP O
in IN B-PP O
affected VBN B-NP O
and CC I-NP O
unaffected JJ I-NP O
subjects NNS I-NP O
from IN B-PP O
the DT B-NP O
Cochin NN I-NP O
isolate NN I-NP O
in IN B-PP O
which WDT B-NP O
both CC O O
the DT B-NP O
PLS NN I-NP B-Disease
and CC I-NP O
HMS NN I-NP B-Disease
phenotypes NNS I-NP O
appear VBP B-VP O
. . O O

Here RB B-ADVP O
we PRP B-NP O
report VBP B-VP O
identification NN B-NP O
of IN B-PP O
a DT B-NP O
mutation NN I-NP O
of IN B-PP O
cathepsin NN B-NP O
C NN I-NP O
( ( O O
exon NN B-NP O
6 CD I-NP O
, , O O
2127A NN B-NP O
- SYM B-VP O
- SYM B-NP O
> SYM I-NP O
G NN I-NP O
) ) O O
that WDT B-NP O
changes VBZ B-VP O
a DT B-NP O
highly RB I-NP O
conserved VBN I-NP O
amino JJ I-NP O
acid NN I-NP O
in IN B-PP O
the DT B-NP O
cathepsin NN I-NP O
C NN I-NP O
peptide NN I-NP O
. . O O

This DT B-NP O
mutation NN I-NP O
segregates VBZ B-VP O
with IN B-PP O
HMS NN B-NP B-Disease
in IN B-PP O
four CD B-NP O
nuclear JJ I-NP O
families NNS I-NP O
. . O O

Additionally RB B-ADVP O
, , O O
the DT B-NP O
existence NN I-NP O
of IN B-PP O
a DT B-NP O
shared JJ I-NP O
common JJ I-NP O
haplotype NN I-NP O
for IN B-PP O
genetic JJ B-NP O
loci NNS I-NP O
flanking VBG B-VP O
the DT B-NP O
cathepsin NN I-NP O
C NN I-NP O
gene NN I-NP O
suggests VBZ B-VP O
that IN B-SBAR O
affected JJ B-NP O
subjects NNS I-NP O
descended VBN B-VP O
from IN B-PP O
the DT B-NP O
Cochin NN I-NP O
isolate NN I-NP O
are VBP B-VP O
homozygous JJ B-ADJP O
for IN B-PP O
a DT B-NP O
mutation NN I-NP O
inherited VBN B-VP O
identical JJ B-ADJP O
by IN B-PP O
descent JJ B-ADJP O
from IN B-PP O
a DT B-NP O
common JJ I-NP O
ancestor NN I-NP O
. . O O

This DT B-NP O
finding NN I-NP O
supports VBZ B-VP O
simple JJ B-NP O
autosomal JJ I-NP O
recessive JJ I-NP O
inheritance NN I-NP O
for IN B-PP O
HMS NN B-NP B-Disease
in IN B-PP O
these DT B-NP O
families NNS I-NP O
. . O O

We PRP B-NP O
also RB B-ADVP O
report VBP B-VP O
a DT B-NP O
mutation NN I-NP O
of IN B-PP O
the DT B-NP O
same JJ I-NP O
exon NN I-NP O
6 CD I-NP O
CTSC NN I-NP O
codon NN I-NP O
( ( O O
2126C NN B-NP O
- SYM O O
- HYPH O O
> SYM O O
T NN B-NP O
) ) O O
in IN B-PP O
a DT B-NP O
Turkish JJ I-NP O
family NN I-NP O
with IN B-PP O
classical JJ B-NP O
PLS NN I-NP B-Disease
. . O O

These DT B-NP O
findings NNS I-NP O
provide VBP B-VP O
evidence NN B-NP O
that IN B-SBAR O
PLS NN B-NP B-Disease
and CC I-NP O
HMS NN I-NP B-Disease
are VBP B-VP O
allelic JJ B-NP O
variants NNS I-NP O
of IN B-PP O
cathepsin NN B-NP O
C NN I-NP O
gene NN I-NP O
mutations NNS I-NP O
. . O O

. . O O

ATM NN B-NP O
- HYPH I-NP O
heterozygous JJ I-NP O
germline NN I-NP O
mutations NNS I-NP O
contribute VBP B-VP O
to TO B-PP O
breast NN B-NP B-Disease
cancer NN I-NP I-Disease
- HYPH B-NP O
susceptibility NN I-NP O
. . O O

Approximately RB B-NP O
0 CD I-NP O
. . O O

5 CD B-NP O
% NN I-NP O
- HYPH B-NP O
1 CD I-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
general JJ I-NP O
population NN I-NP O
has VBZ B-VP O
been VBN I-VP O
estimated VBN I-VP O
to TO I-VP O
be VB I-VP O
heterozygous JJ B-ADJP O
for IN B-PP O
a DT B-NP O
germline NN I-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
ATM NN I-NP O
gene NN I-NP O
. . O O

Mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
ATM NN I-NP O
gene NN I-NP O
are VBP B-VP O
responsible JJ B-ADJP O
for IN B-PP O
the DT B-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
disorder NN I-NP I-Disease
ataxia NN I-NP B-Disease
- HYPH B-NP I-Disease
telangiectasia NN I-NP I-Disease
( ( O O
A NN B-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
) ) O O
( ( O O
MIM NN B-NP O
208900 CD I-NP O
) ) O O
. . O O

The DT B-NP O
finding NN I-NP O
that IN B-SBAR O
ATM NN B-NP O
- HYPH O O
heterozygotes NNS B-NP O
have VBP B-VP O
an DT B-NP O
increased VBN I-NP O
relative JJ I-NP O
risk NN I-NP O
for IN B-PP O
breast NN B-NP B-Disease
cancer NN I-NP I-Disease
was VBD B-VP O
supported VBN I-VP O
by IN B-PP O
some DT B-NP O
studies NNS I-NP O
but CC O O
not RB B-VP O
confirmed VBN I-VP O
by IN B-PP O
others NNS B-NP O
. . O O

In IN B-PP O
view NN B-NP O
of IN B-PP O
this DT B-NP O
discrepancy NN I-NP O
, , O O
we PRP B-NP O
examined VBD B-VP O
the DT B-NP O
frequency NN I-NP O
of IN B-PP O
ATM NN B-NP O
germline NN I-NP O
mutations NNS I-NP O
in IN B-PP O
a DT B-NP O
selected VBN I-NP O
group NN I-NP O
of IN B-PP O
Dutch JJ B-NP O
patients NNS I-NP O
with IN B-PP O
breast NN B-NP B-Disease
cancer NN I-NP I-Disease
. . O O

We PRP B-NP O
have VBP B-VP O
analyzed VBN I-VP O
ATM NN B-NP O
germline NN I-NP O
mutations NNS I-NP O
in IN B-PP O
normal JJ B-NP O
blood NN I-NP O
lymphocytes NNS I-NP O
, , O O
using VBG B-VP O
the DT B-NP O
protein NN I-NP O
- HYPH I-NP O
truncation NN I-NP O
test NN I-NP O
followed VBN B-VP O
by IN B-PP O
genomic JJ B-NP O
- HYPH I-NP O
sequence NN I-NP O
analysis NN I-NP O
. . O O

A DT B-NP O
high JJ I-NP O
percentage NN I-NP O
of IN B-PP O
ATM NN B-NP O
germline NN I-NP O
mutations NNS I-NP O
was VBD B-VP O
demonstrated VBN I-VP O
among IN B-PP O
patients NNS B-NP O
with IN B-PP O
sporadic JJ B-NP B-Disease
breast NN I-NP I-Disease
cancer NN I-NP I-Disease
. . O O

The DT B-NP O
82 CD I-NP O
patients NNS I-NP O
included VBN B-VP O
in IN B-PP O
this DT B-NP O
study NN I-NP O
had VBD B-VP O
developed VBN I-VP O
breast NN B-NP B-Disease
cancer NN I-NP I-Disease
at IN B-PP O
age NN B-NP O
< SYM B-NP O
45 CD I-NP O
and CC O O
had VBD B-VP O
survived VBN I-VP O
> SYM B-NP O
/ SYM B-NP O
= SYM B-VP O
5 CD B-NP O
years NNS I-NP O
( ( O O
mean NN B-NP O
15 CD B-NP O
years NNS I-NP O
) ) O O
, , O O
and CC O O
in IN B-PP O
33 CD B-NP O
( ( O O
40 CD B-NP O
% NN I-NP O
) ) O O
of IN B-PP O
the DT B-NP O
patients NNS I-NP O
a DT B-NP O
contralateral JJ I-NP O
breast NN I-NP O
tumor NN I-NP O
had VBD B-VP O
been VBN I-VP O
diagnosed VBN I-VP O
. . O O

Among IN B-PP O
these DT B-NP O
patients NNS I-NP O
we PRP B-NP O
identified VBD B-VP O
seven CD B-NP O
( ( O O
8 CD B-NP O
. . O O

5 CD B-NP O
% NN I-NP O
) ) O O
ATM NN B-NP O
germline NN I-NP O
mutations NNS I-NP O
, , O O
of IN B-PP O
which WDT B-NP O
five CD B-NP O
are VBP B-VP O
distinct JJ B-ADJP O
. . O O

One CD B-NP O
splice NN I-NP O
- HYPH O O
site NN B-NP O
mutation NN I-NP O
( ( O O
IVS10 NN B-NP O
- HYPH B-NP O
6T NN I-NP O
- SYM B-NP O
- HYPH B-NP O
> SYM I-NP O
G NN I-NP O
) ) O O
was VBD B-VP O
detected VBN I-VP O
three CD B-NP O
times NNS I-NP O
in IN B-PP O
our PRP$ B-NP O
series NN I-NP O
. . O O

Four CD B-NP O
heterozygous JJ I-NP O
carriers NNS I-NP O
were VBD B-VP O
patients NNS B-NP O
with IN B-PP O
bilateral JJ B-NP O
breast NN I-NP O
cancer NN I-NP O
. . O O

Our PRP$ B-NP O
results NNS I-NP O
indicate VBP B-VP O
that IN B-SBAR O
the DT B-NP O
mutations NNS I-NP O
identified VBN B-VP O
in IN B-PP O
this DT B-NP O
study NN I-NP O
are VBP B-VP O
A NN B-NP O
- HYPH I-NP O
T NN I-NP O
disease NN I-NP O
- HYPH O O
causing VBG B-VP O
mutations NNS B-NP O
that WDT B-NP O
might MD B-VP O
be VB I-VP O
associated VBN I-VP O
with IN B-PP O
an DT B-NP O
increased VBN I-NP O
risk NN I-NP O
of IN B-PP O
breast NN B-NP O
cancer NN I-NP O
in IN B-PP O
heterozygotes NNS B-NP O
. . O O

We PRP B-NP O
conclude VBP B-VP O
that IN B-SBAR O
ATM NN B-NP O
heterozygotes NNS I-NP O
have VBP B-VP O
an DT B-NP O
approximately RB I-NP O
ninefold RB I-NP O
- HYPH I-NP O
increased VBN B-NP O
risk NN I-NP O
of IN B-PP O
developing VBG B-VP O
a DT B-NP O
type NN I-NP O
of IN B-PP O
breast NN B-NP O
cancer NN I-NP O
characterized VBN B-VP O
by IN B-PP O
frequent JJ B-NP O
bilateral JJ I-NP O
occurrence NN I-NP O
, , O O
early JJ B-NP O
age NN I-NP O
at IN B-PP O
onset NN B-NP O
, , O O
and CC O O
long JJ B-NP O
- HYPH I-NP O
term NN I-NP O
survival NN I-NP O
. . O O

The DT B-NP O
specific JJ I-NP O
characteristics NNS I-NP O
of IN B-PP O
our PRP$ B-NP O
population NN I-NP O
of IN B-PP O
patients NNS B-NP O
may MD B-VP O
explain VB I-VP O
why WRB B-ADVP O
such JJ B-NP O
a DT I-NP O
high JJ I-NP O
frequency NN I-NP O
was VBD B-VP O
not RB I-VP O
found VBN I-VP O
in IN B-PP O
other JJ B-NP O
series NN I-NP O
. . O O

Human JJ B-NP O
mutations NNS I-NP O
in IN B-PP O
glucose NN B-NP O
6 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
dehydrogenase NN I-NP O
reflect VBP B-VP O
evolutionary JJ B-NP O
history NN I-NP O
. . O O

Glucose NN B-NP O
6 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
dehydrogenase NN I-NP O
( ( O O
G6PD NN B-NP O
) ) O O
is VBZ B-VP O
a DT B-NP O
cytosolic JJ I-NP O
enzyme NN I-NP O
encoded VBN B-VP O
by IN B-PP O
a DT B-NP O
housekeeping NN I-NP O
X NN I-NP O
- HYPH B-VP O
linked VBN B-NP O
gene NN I-NP O
whose WP$ B-NP O
main JJ I-NP O
function NN I-NP O
is VBZ B-VP O
to TO B-VP O
produce VB I-VP O
NADPH NN B-NP O
, , O O
a DT B-NP O
key JJ I-NP O
electron NN I-NP O
donor NN I-NP O
in IN B-PP O
the DT B-NP O
defense NN I-NP O
against IN B-PP O
oxidizing VBG B-NP O
agents NNS I-NP O
and CC B-PP O
in IN B-PP O
reductive JJ B-NP O
biosynthetic JJ I-NP O
reactions NNS I-NP O
. . O O

Inherited VBN B-NP O
G6PD NN I-NP B-Disease
deficiency NN I-NP I-Disease
is VBZ B-VP O
associated VBN I-VP O
with IN B-PP O
either CC B-NP O
episodic JJ I-NP B-Disease
hemolytic JJ I-NP I-Disease
anemia NN I-NP I-Disease
( ( O O
triggered VBN B-VP O
by IN B-PP O
fava NN B-NP O
beans NNS I-NP O
or CC O O
other JJ B-NP O
agents NNS I-NP O
) ) O O
or CC O O
life NN B-NP B-Disease
- HYPH B-NP I-Disease
long JJ I-NP I-Disease
hemolytic JJ I-NP I-Disease
anemia NN I-NP I-Disease
. . O O

We PRP B-NP O
show VBP B-VP O
here RB B-ADVP O
that IN B-SBAR O
an DT B-NP O
evolutionary JJ I-NP O
analysis NN I-NP O
is VBZ B-VP O
a DT B-NP O
key NN I-NP O
to TO B-PP O
understanding VBG B-VP O
the DT B-NP O
biology NN I-NP O
of IN B-PP O
a DT B-NP O
housekeeping NN I-NP O
gene NN I-NP O
. . O O

From IN B-PP O
the DT B-NP O
alignment NN I-NP O
of IN B-PP O
the DT B-NP O
amino NN I-NP O
acid NN I-NP O
( ( O O
aa NN B-NP O
) ) O O
sequence NN B-NP O
of IN B-PP O
52 CD B-NP O
glucose NN I-NP O
6 CD B-NP O
- HYPH I-NP O
phosphate NN I-NP O
dehydrogenase NN I-NP O
( ( O O
G6PD NN B-NP O
) ) O O
species NNS B-NP O
from IN B-PP O
42 CD B-NP O
different JJ I-NP O
organisms NNS I-NP O
, , O O
we PRP B-NP O
found VBD B-VP O
a DT B-NP O
striking JJ I-NP O
correlation NN I-NP O
between IN B-PP O
the DT B-NP O
aa NN I-NP O
replacements NNS I-NP O
that WDT B-NP O
cause VBP B-VP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
humans NNS B-NP O
and CC O O
the DT B-NP O
sequence NN I-NP O
conservation NN I-NP O
of IN B-PP O
G6PD NN B-NP O
two CD I-NP O
- HYPH I-NP O
thirds NNS I-NP O
of IN B-PP O
such JJ B-NP O
replacements NNS I-NP O
are VBP B-VP O
in IN B-PP O
highly RB B-ADVP O
and CC I-ADVP O
moderately RB B-VP O
conserved VBN I-VP O
( ( O O
50 CD B-NP O
- HYPH I-NP O
99 CD I-NP O
% NN I-NP O
) ) O O
aa NN B-NP O
; : O O
relatively RB B-NP O
few JJ I-NP O
are VBP B-VP O
in IN B-PP O
fully RB B-NP O
conserved VBN I-NP O
aa NN I-NP O
( ( O O
where WRB B-ADVP O
they PRP B-NP O
might MD B-VP O
be VB I-VP O
lethal JJ B-ADJP O
) ) O O
or CC O O
in IN B-PP O
poorly RB B-NP O
conserved VBN I-NP O
aa NN I-NP O
, , O O
where WRB B-ADVP O
presumably RB O O
they PRP B-NP O
simply RB B-ADVP O
would MD B-VP O
not RB I-VP O
cause VB I-VP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
. . O O

This DT B-NP O
is VBZ B-VP O
consistent JJ B-ADJP O
with IN B-PP O
the DT B-NP O
notion NN I-NP O
that IN B-SBAR O
all DT B-NP O
human JJ I-NP O
mutants NNS I-NP O
have VBP B-VP O
residual JJ B-NP O
enzyme NN I-NP O
activity NN I-NP O
and CC O O
that IN B-SBAR O
mutations NNS I-NP O
are VBP B-VP O
lethal JJ B-ADJP O
at IN B-PP O
some DT B-NP O
stage NN I-NP O
of IN B-PP O
development NN B-NP O
. . O O

Comparing VBG B-VP O
the DT B-NP O
distribution NN I-NP O
of IN B-PP O
mutations NNS B-NP O
in IN B-PP O
a DT B-NP O
human JJ I-NP O
housekeeping NN I-NP O
gene NN I-NP O
with IN B-PP O
evolutionary JJ B-NP O
conservation NN I-NP O
is VBZ B-VP O
a DT B-NP O
useful JJ I-NP O
tool NN I-NP O
for IN B-PP O
pinpointing VBG B-VP O
amino JJ B-NP O
acid NN I-NP O
residues NNS I-NP O
important JJ B-ADJP O
for IN B-PP O
the DT B-NP O
stability NN I-NP O
or CC O O
the DT B-NP O
function NN I-NP O
of IN B-PP O
the DT B-NP O
corresponding JJ I-NP O
protein NN I-NP O
. . O O

In IN B-PP O
view NN B-NP O
of IN B-PP O
the DT B-NP O
current JJ I-NP O
explosive JJ I-NP O
increase NN I-NP O
in IN B-PP O
full JJ B-NP O
genome NN I-NP O
sequencing NN I-NP O
projects NNS I-NP O
, , O O
this DT B-NP O
tool NN I-NP O
will MD B-VP O
become VB I-VP O
rapidly RB B-ADJP O
available JJ I-ADJP O
for IN B-PP O
numerous JJ B-NP O
other JJ I-NP O
genes NNS I-NP O
. . O O

. . O O

Constitutive JJ B-NP O
and CC I-NP O
regulated VBN I-NP O
modes NNS I-NP O
of IN B-PP O
splicing NN B-NP O
produce VBP B-VP O
six CD B-NP O
major JJ I-NP O
myotonic JJ I-NP B-Disease
dystrophy NN I-NP I-Disease
protein NN I-NP O
kinase NN I-NP O
( ( O O
DMPK NN B-NP O
) ) O O
isoforms NNS B-NP O
with IN B-PP O
distinct JJ B-NP O
properties NNS I-NP O
. . O O

Myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
( ( O O
DM NN B-NP B-Disease
) ) O O
is VBZ B-VP O
the DT B-NP O
most RBS I-NP O
prevalent JJ I-NP O
inherited VBN I-NP B-Disease
neuromuscular JJ I-NP I-Disease
disease NN I-NP I-Disease
in IN B-PP O
adults NNS B-NP O
. . O O

The DT B-NP O
genetic JJ I-NP B-Disease
defect NN I-NP I-Disease
is VBZ B-VP O
a DT B-NP O
CTG NN I-NP O
triplet NN I-NP O
repeat NN I-NP O
expansion NN I-NP O
in IN B-PP O
the DT B-NP O
3 CD I-NP O
- HYPH I-NP O
untranslated JJ I-NP O
region NN I-NP O
of IN B-PP O
the DT B-NP O
myotonic JJ I-NP B-Disease
dystrophy NN I-NP I-Disease
protein NN I-NP O
kinase NN I-NP O
( ( O O
DMPK NN B-NP O
) ) O O
gene NN B-NP O
, , O O
consisting VBG B-VP O
of IN B-PP O
15 CD B-NP O
exons NNS I-NP O
. . O O

Using VBG B-VP O
a DT B-NP O
transgenic JJ I-NP O
DMPK NN I-NP O
- HYPH B-NP O
overexpressor NN I-NP O
mouse NN I-NP O
model NN I-NP O
, , O O
we PRP B-NP O
demonstrate VBP B-VP O
here RB B-ADVP O
that IN B-SBAR O
the DT B-NP O
endogenous JJ I-NP O
mouse NN I-NP O
DMPK NN I-NP O
gene NN I-NP O
and CC O O
the DT B-NP O
human JJ I-NP O
DMPK NN I-NP O
transgene NN I-NP O
produce VBP B-VP O
six CD B-NP O
major JJ I-NP O
alternatively RB I-NP O
spliced VBN I-NP O
mRNAs NNS I-NP O
which WDT B-NP O
have VBP B-VP O
almost RB B-NP O
identical JJ I-NP O
cell NN I-NP O
type NN I-NP O
- HYPH B-NP O
dependent JJ I-NP O
distribution NN I-NP O
frequencies NNS I-NP O
and CC O O
expression NN B-NP O
patterns NNS I-NP O
. . O O

Use NN B-NP O
of IN B-PP O
a DT B-NP O
cryptic JJ I-NP O
5 CD I-NP O
splice NN I-NP O
site NN I-NP O
in IN B-PP O
exon NN B-NP O
8 CD I-NP O
, , O O
which WDT B-NP O
results VBZ B-VP O
in IN B-PP O
absence NN B-NP O
or CC I-NP O
presence NN I-NP O
of IN B-PP O
15 CD B-NP O
nucleotides NNS I-NP O
specifying VBG B-VP O
a DT B-NP O
VSGGG NN I-NP O
peptide NN I-NP O
motif NN I-NP O
, , O O
and CC O O
/ SYM B-NP O
or CC O O
use NN B-NP O
of IN B-PP O
a DT B-NP O
cryptic JJ I-NP O
3 CD I-NP O
splice NN I-NP O
site NN I-NP O
in IN B-PP O
exon NN B-NP O
14 CD I-NP O
, , O O
which WDT B-NP O
leads VBZ B-VP O
to TO B-PP O
a DT B-NP O
frameshift NN I-NP O
in IN B-PP O
the DT B-NP O
mRNA NN I-NP O
reading NN I-NP O
frame NN I-NP O
, , O O
occur VBP B-VP O
as IN B-PP O
independent JJ B-NP O
stochastic JJ I-NP O
events NNS I-NP O
in IN B-PP O
all DT B-NP O
tissues NNS I-NP O
examined VBN B-VP O
. . O O

In IN B-PP O
contrast NN B-NP O
, , O O
the DT B-NP O
excision NN I-NP O
of IN B-PP O
exons NNS B-NP O
13 CD B-NP O
/ SYM I-NP O
14 CD I-NP O
that WDT B-NP O
causes VBZ B-VP O
a DT B-NP O
frameshift NN I-NP O
and CC O O
creates VBZ B-VP O
a DT B-NP O
C NN I-NP O
- HYPH B-VP O
terminally RB B-NP O
truncated VBN I-NP O
protein NN I-NP O
is VBZ B-VP O
clearly RB B-ADVP O
cell NN B-NP O
type NN I-NP O
dependent JJ B-ADJP O
and CC O O
occurs VBZ B-VP O
predominantly RB B-ADVP O
in IN B-PP O
smooth JJ B-NP O
muscle NN I-NP O
. . O O

We PRP B-NP O
generated VBD B-VP O
all DT B-NP O
six CD I-NP O
full JJ I-NP O
- HYPH I-NP O
length NN I-NP O
mouse NN I-NP O
cDNAs NNS I-NP O
that WDT B-NP O
result VBP B-VP O
from IN B-PP O
combinations NNS B-NP O
of IN B-PP O
these DT B-NP O
three CD I-NP O
major JJ I-NP O
splicing NN I-NP O
events NNS I-NP O
and CC O O
show VBP B-VP O
that IN B-SBAR O
their PRP$ B-NP O
transfection NN I-NP O
into IN B-PP O
cells NNS B-NP O
in IN B-PP O
culture NN B-NP O
leads VBZ B-VP O
to TO B-PP O
production NN B-NP O
of IN B-PP O
four CD B-NP O
different JJ I-NP O
approximately RB I-NP O
74 CD I-NP O
kDa NN I-NP O
full JJ B-ADJP O
- HYPH O O
length NN B-NP O
( ( O O
heart NN B-NP O
- HYPH B-ADJP O
, , O O
skeletal JJ B-NP O
muscle NN I-NP O
- HYPH B-NP O
or CC I-NP O
brain NN I-NP O
- HYPH O O
specific JJ B-ADJP O
) ) O O
and CC O O
two CD B-NP O
C JJ I-NP O
- HYPH I-NP O
terminally RB B-VP O
truncated VBN I-VP O
approximately RB B-NP O
68 CD I-NP O
kDa NN I-NP O
( ( O O
smooth JJ B-NP O
muscle NN I-NP O
- HYPH B-NP O
specific JJ I-NP O
) ) O O
isoforms NNS B-NP O
. . O O

Information NN B-NP O
on IN B-PP O
DMPK NN B-NP O
mRNA NN I-NP O
and CC O O
protein NN B-NP O
isoform NN I-NP O
expression NN I-NP O
patterns NNS I-NP O
will MD B-VP O
be VB I-VP O
useful JJ B-ADJP O
for IN B-PP O
recognizing VBG B-VP O
differential JJ B-NP O
effects NNS I-NP O
of IN B-PP O
( ( O O
CTG NN B-NP O
) ) O O
( ( O O
n NN B-NP O
) ) O O
expansion NN B-NP O
in IN B-PP O
DM NN B-NP B-Disease
manifestation NN I-NP O
. . O O

. . O O

Genetic JJ B-NP O
analysis NN I-NP O
, , O O
phenotypic JJ B-NP O
diagnosis NN I-NP O
, , O O
and CC O O
risk NN B-NP O
of IN B-PP O
venous JJ B-NP B-Disease
thrombosis NN I-NP I-Disease
in IN B-PP O
families NNS B-NP O
with IN B-PP O
inherited VBN B-NP O
deficiencies NNS I-NP B-Disease
of IN B-PP I-Disease
protein NN B-NP I-Disease
S NN I-NP I-Disease
. . O O

Protein NN B-NP B-Disease
S NN I-NP I-Disease
deficiency NN I-NP I-Disease
is VBZ B-VP O
a DT B-NP O
recognized VBN I-NP O
risk NN I-NP O
factor NN I-NP O
for IN B-PP O
venous JJ B-NP B-Disease
thrombosis NN I-NP I-Disease
. . O O

Of IN B-PP O
all PDT B-NP O
the DT I-NP O
inherited VBN I-NP O
thrombophilic JJ I-NP B-Disease
conditions NNS I-NP I-Disease
, , O O
it PRP B-NP O
remains VBZ B-VP O
the DT B-NP O
most RBS I-NP O
difficult JJ I-NP O
to TO B-VP O
diagnose VB I-VP O
because IN B-PP O
of IN I-PP O
phenotypic JJ B-NP O
variability NN I-NP O
, , O O
which WDT B-NP O
can MD B-VP O
lead VB I-VP O
to TO B-PP O
inconclusive JJ B-NP O
results NNS I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
overcome VBN I-VP O
this DT B-NP O
problem NN I-NP O
by IN B-PP O
studying VBG B-VP O
a DT B-NP O
cohort NN I-NP O
of IN B-PP O
patients NNS B-NP O
from IN B-PP O
a DT B-NP O
single JJ I-NP O
center NN I-NP O
where WRB B-ADVP O
the DT B-NP O
diagnosis NN I-NP O
was VBD B-VP O
confirmed VBN I-VP O
at IN B-PP O
the DT B-NP O
genetic JJ I-NP O
level NN I-NP O
. . O O

Twenty CD B-NP O
- HYPH I-NP O
eight CD I-NP O
index NN I-NP O
patients NNS I-NP O
with IN B-PP O
protein NN B-NP B-Disease
S NN I-NP I-Disease
deficiency NN I-NP I-Disease
and CC O O
a DT B-NP O
PROS1 NN I-NP B-Disease
gene NN I-NP I-Disease
defect NN I-NP I-Disease
were VBD B-VP O
studied VBN I-VP O
, , O O
together RB B-ADVP O
with IN B-PP O
109 CD B-NP O
first JJ I-NP O
- HYPH I-NP O
degree NN I-NP O
relatives NNS I-NP O
. . O O

To TO B-VP O
avoid VB I-VP O
selection NN B-NP O
bias NN I-NP O
, , O O
we PRP B-NP O
confined VBD B-VP O
analysis NN B-NP O
of IN B-PP O
total JJ B-NP O
and CC I-NP O
free JJ I-NP O
protein NN I-NP O
S NN I-NP O
levels NNS I-NP O
and CC O O
thrombotic JJ B-NP O
risk NN I-NP O
to TO B-PP O
the DT B-NP O
patients NNS I-NP O
relatives NNS I-NP O
. . O O

In IN B-PP O
this DT B-NP O
group NN I-NP O
of IN B-PP O
relatives NNS B-NP O
, , O O
a DT B-NP O
low JJ I-NP O
free JJ I-NP O
protein NN I-NP O
S NN I-NP O
level NN I-NP O
was VBD B-VP O
the DT B-NP O
most RBS I-NP O
reliable JJ I-NP O
predictor NN I-NP O
of IN B-PP O
a DT B-NP O
PROS1 NN I-NP B-Disease
gene NN I-NP I-Disease
defect NN I-NP I-Disease
( ( O O
sensitivity NN B-NP O
97 CD I-NP O
. . O O

7 CD B-NP O
% NN I-NP O
, , O O
specificity NN B-NP O
100 CD B-NP O
% NN I-NP O
) ) O O
. . O O

First JJ B-NP O
- HYPH I-NP O
degree NN I-NP O
relatives NNS I-NP O
with IN B-PP O
a DT B-NP O
PROS1 NN I-NP B-Disease
gene NN I-NP I-Disease
defect NN I-NP I-Disease
had VBD B-VP O
a DT B-NP O
5 CD I-NP O
. . O O

0 CD B-NP O
- HYPH B-ADJP O
fold RB B-NP O
higher JJR I-NP O
risk NN I-NP O
of IN B-PP O
thrombosis NN B-NP B-Disease
( ( O O
95 CD B-NP O
% NN I-NP O
confidence NN I-NP O
interval NN I-NP O
, , O O
1 CD B-NP O
. . O O

5 CD B-NP O
- HYPH I-NP O
16 CD I-NP O
. . I-NP O

8 CD I-NP O
) ) O O
than IN B-PP O
those DT B-NP O
with IN B-PP O
a DT B-NP O
normal JJ I-NP O
PROS1 NN I-NP O
gene NN I-NP O
and CC O O
no DT B-NP O
other JJ I-NP O
recognized VBN I-NP O
thrombophilic JJ I-NP B-Disease
defect NN I-NP I-Disease
. . O O

Although IN B-SBAR O
pregnancy NN B-NP O
/ SYM B-NP O
puerperium NN I-NP O
and CC I-NP O
immobility NN I-NP O
/ SYM B-NP O
trauma NN I-NP B-Disease
were VBD B-VP O
important JJ B-NP O
precipitating VBG I-NP O
factors NNS I-NP O
for IN B-PP O
thrombosis NN B-NP B-Disease
, , O O
almost RB B-NP O
half NN I-NP O
of IN B-PP O
the DT B-NP O
events NNS I-NP O
were VBD B-VP O
spontaneous JJ B-ADJP O
. . O O

Relatives NNS B-NP O
with IN B-PP O
splice NN B-NP O
- HYPH O O
site NN B-NP O
or CC O O
major JJ B-NP O
structural JJ I-NP O
defects NNS I-NP B-Disease
in IN B-PP I-Disease
the DT B-NP I-Disease
PROS1 NN I-NP I-Disease
gene NN I-NP I-Disease
were VBD B-VP O
more RBR B-ADJP O
likely JJ I-ADJP O
to TO B-VP O
have VB I-VP O
had VBN I-VP O
a DT B-NP O
thrombotic JJ I-NP O
event NN I-NP O
and CC O O
had VBD B-VP O
significantly RB B-NP O
lower JJR I-NP O
total JJ I-NP O
and CC I-NP O
free JJ I-NP O
protein NN I-NP O
S NN I-NP O
levels NNS I-NP O
than IN B-PP O
those DT B-NP O
relatives NNS I-NP O
having VBG B-VP O
missense JJ B-NP O
mutations NNS I-NP O
. . O O

We PRP B-NP O
conclude VBP B-VP O
that IN B-SBAR O
persons NNS B-NP O
with IN B-PP O
PROS1 NN B-NP B-Disease
gene NN I-NP I-Disease
defects NNS I-NP I-Disease
and CC O O
protein NN B-NP B-Disease
S NN I-NP I-Disease
deficiency NN I-NP I-Disease
are VBP B-VP O
at IN B-PP O
increased VBN B-NP O
risk NN I-NP O
of IN B-PP O
thrombosis NN B-NP B-Disease
and CC O O
that IN B-SBAR O
free JJ B-NP O
protein NN I-NP O
S NN I-NP O
estimation NN I-NP O
offers VBZ B-VP O
the DT B-NP O
most RBS I-NP O
reliable JJ I-NP O
way NN I-NP O
of IN B-PP O
diagnosing VBG B-VP O
the DT B-NP O
deficiency NN I-NP O
. . O O

( ( O O
Blood NNP B-NP O
. . I-NP O

2000 CD I-NP O
; : O O
95 CD B-NP O
1935 CD I-NP O
- HYPH B-NP O
1941 CD I-NP O
) ) O O
. . O O

Autoimmune JJ B-NP B-Disease
lymphoproliferative JJ I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
ALPS NN B-NP B-Disease
) ) O O
in IN B-PP O
a DT B-NP O
child NN I-NP O
from IN B-PP O
consanguineous JJ B-NP O
parents NNS I-NP O
: : O O
a DT B-NP O
dominant JJ I-NP O
or CC I-NP O
recessive JJ I-NP O
disease NN I-NP O
? . O O

Autoimmune JJ B-NP B-Disease
lymphoproliferative JJ I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
ALPS NN B-NP B-Disease
) ) O O
is VBZ B-VP O
characterized VBN I-VP O
by IN B-PP O
autoimmune JJ B-NP O
features NNS I-NP O
and CC I-NP O
lymphoproliferations NNS I-NP O
and CC O O
is VBZ B-VP O
generally RB I-VP O
caused VBN I-VP O
by IN B-PP O
defective JJ B-NP O
Fas NN I-NP O
- HYPH B-VP O
mediated VBN B-NP O
apoptosis NN I-NP O
. . O O

This DT B-NP O
report NN I-NP O
describes VBZ B-VP O
a DT B-NP O
child NN I-NP O
with IN B-PP O
clinical JJ B-NP O
features NNS I-NP O
of IN B-PP O
ALPS NN B-NP B-Disease
without IN B-PP O
detectable JJ B-NP O
Fas NN I-NP O
expression NN I-NP O
on IN B-PP O
freshly RB B-NP O
isolated VBN I-NP O
blood NN I-NP O
leukocytes NNS I-NP O
. . O O

Detection NN B-NP O
of IN B-PP O
FAS NN B-NP O
transcripts NNS I-NP O
via IN B-PP O
real JJ B-NP O
- HYPH I-NP O
time NN I-NP O
quantitative JJ I-NP O
PCR NN I-NP O
made VBD B-VP O
a DT B-NP O
severe JJ I-NP O
transcriptional JJ I-NP O
defect NN I-NP O
unlikely JJ B-ADJP O
. . O O

Sequencing NN B-NP O
of IN B-PP O
the DT B-NP O
FAS NN I-NP O
gene NN I-NP O
revealed VBD B-VP O
a DT B-NP O
20 CD I-NP O
- HYPH I-NP O
nucleotide NN I-NP O
duplication NN I-NP O
in IN B-PP O
the DT B-NP O
last JJ I-NP O
exon NN I-NP O
affecting VBG B-VP O
the DT B-NP O
cytoplasmic JJ I-NP O
signaling NN I-NP O
domain NN I-NP O
. . O O

The DT B-NP O
patient NN I-NP O
was VBD B-VP O
homozygous JJ B-ADJP O
for IN B-PP O
this DT B-NP O
mutation NN I-NP O
, , O O
whereas IN O O
the DT B-NP O
consanguineous JJ I-NP O
parents NNS I-NP O
and CC O O
the DT B-NP O
siblings NNS I-NP O
were VBD B-VP O
heterozygous JJ B-ADJP O
. . O O

The DT B-NP O
patient NN I-NP O
reported VBN B-VP O
here RB B-ADVP O
is VBZ B-VP O
a DT B-NP O
human JJ I-NP O
homologue NN I-NP O
of IN B-PP O
the DT B-NP O
Fas NN I-NP O
- HYPH B-NP O
mouse NN I-NP O
, , O O
inasmuch RB B-ADVP O
as IN B-SBAR O
she PRP B-NP O
carries VBZ B-VP O
an DT B-NP O
autosomal JJ I-NP O
homozygous JJ I-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
FAS NN I-NP O
gene NN I-NP O
and CC O O
she PRP B-NP O
shows VBZ B-VP O
the DT B-NP O
severe JJ I-NP O
and CC I-NP O
accelerated VBN I-NP O
ALPS NN I-NP B-Disease
phenotype NN I-NP O
. . O O

The DT B-NP O
heterozygous JJ I-NP O
family NN I-NP O
members NNS I-NP O
did VBD B-VP O
not RB I-VP O
have VB I-VP O
the DT B-NP O
ALPS NN I-NP B-Disease
phenotype NN I-NP O
, , O O
indicating VBG B-VP O
that IN B-SBAR O
the DT B-NP O
disease NN I-NP O
- HYPH O O
causing VBG B-VP O
FAS NN B-NP O
mutation NN I-NP O
in IN B-PP O
this DT B-NP O
family NN I-NP O
is VBZ B-VP O
autosomal JJ B-ADJP O
recessive JJ I-ADJP O
. . O O

. . O O

Identification NN B-NP O
of IN B-PP O
novel JJ B-NP O
imprinted JJ I-NP O
transcripts NNS I-NP O
in IN B-PP O
the DT B-NP O
Prader NNP I-NP B-Disease
- HYPH I-NP I-Disease
Willi NNP I-NP I-Disease
syndrome NN I-NP I-Disease
and CC O O
Angelman NNP B-NP B-Disease
syndrome NN I-NP I-Disease
deletion NN I-NP O
region NN I-NP O
: : O O
further JJ B-NP O
evidence NN I-NP O
for IN B-PP O
regional JJ B-NP O
imprinting NN I-NP O
control NN I-NP O
. . O O

Deletions NNS B-NP O
and CC O O
other JJ B-NP O
abnormalities NNS I-NP O
of IN B-PP O
human JJ B-NP O
chromosome NN I-NP O
15q11 NN I-NP O
- HYPH B-NP O
q13 NN I-NP O
are VBP B-VP O
associated VBN I-VP O
with IN B-PP O
two CD B-NP O
developmental JJ I-NP O
disorders NNS I-NP O
, , O O
Prader NNP B-NP B-Disease
- HYPH I-NP I-Disease
Willi NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
PWS NN B-NP B-Disease
) ) O O
and CC O O
Angelman NN B-NP B-Disease
syndrome NN I-NP I-Disease
( ( O O
AS NN B-NP B-Disease
) ) O O
. . O O

Loss NN B-NP O
of IN B-PP O
expression NN B-NP O
of IN B-PP O
imprinted VBN O O
, , O O
paternally RB B-NP O
expressed VBN I-NP O
genes NNS I-NP O
has VBZ B-VP O
been VBN I-VP O
implicated VBN I-VP O
in IN B-PP O
PWS NN B-NP B-Disease
. . O O

However RB B-ADVP O
, , O O
the DT B-NP O
number NN I-NP O
of IN B-PP O
imprinted JJ B-NP O
genes NNS I-NP O
that WDT B-NP O
contribute VBP B-VP O
to TO B-PP O
PWS NN B-NP B-Disease
, , O O
and CC O O
the DT B-NP O
range NN I-NP O
over IN B-PP O
which WDT B-NP O
the DT B-NP O
imprinting NN I-NP O
signal NN I-NP O
acts VBZ B-VP O
to TO I-VP O
silence VB I-VP O
one CD B-NP O
copy NN I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
in IN B-PP O
a DT B-NP O
parent NN I-NP O
- HYPH B-NP O
of IN B-PP O
- HYPH B-NP O
origin NN I-NP O
- HYPH B-NP O
specific JJ I-NP O
manner NN I-NP O
, , O O
are VBP B-VP O
unknown JJ B-ADJP O
. . O O

To TO B-VP O
identify VB I-VP O
additional JJ B-NP O
imprinted JJ I-NP O
genes NNS I-NP O
that WDT B-NP O
could MD B-VP O
contribute VB I-VP O
to TO B-PP O
the DT B-NP O
PWS NN I-NP B-Disease
phenotype NN I-NP O
and CC O O
to TO B-VP O
understand VB I-VP O
the DT B-NP O
regional JJ I-NP O
control NN I-NP O
of IN B-PP O
imprinting NN B-NP O
in IN B-PP O
15q11 CD B-NP O
- HYPH I-NP O
q13 NN I-NP O
, , O O
we PRP B-NP O
have VBP B-VP O
constructed VBN I-VP O
an DT B-NP O
imprinted JJ I-NP O
transcript NN I-NP O
map NN I-NP O
of IN B-PP O
the DT B-NP O
PWS NN I-NP O
- HYPH B-NP O
AS JJ I-NP O
deletion NN I-NP O
interval NN I-NP O
. . O O

The DT B-NP O
imprinting NN I-NP O
status NN I-NP O
of IN B-PP O
22 CD B-NP O
expressed VBD B-VP O
sequence NN B-NP O
tags NNS I-NP O
derived VBN B-VP O
from IN B-PP O
the DT B-NP O
radiation NN I-NP O
- HYPH B-NP O
hybrid NN I-NP O
human JJ I-NP O
transcript NN I-NP O
maps NNS I-NP O
or CC O O
physical JJ B-NP O
maps NNS I-NP O
was VBD B-VP O
determined VBN I-VP O
in IN B-PP O
a DT B-NP O
reverse JJ I-NP O
transcriptase NN I-NP O
- HYPH B-NP O
PCR NN I-NP O
assay NN I-NP O
and CC O O
correlated VBD B-VP O
with IN B-PP O
the DT B-NP O
position NN I-NP O
of IN B-PP O
the DT B-NP O
transcripts NNS I-NP O
on IN B-PP O
the DT B-NP O
physical JJ I-NP O
map NN I-NP O
. . O O

Seven CD B-NP O
new JJ I-NP O
paternally RB I-NP O
expressed VBN I-NP O
transcripts NNS I-NP O
localize VBP B-VP O
to TO B-PP O
an DT B-NP O
approximately RB I-NP O
1 CD I-NP O
. . O O

5 CD B-NP O
- HYPH I-NP O
Mb NN I-NP O
domain NN I-NP O
surrounding VBG B-VP O
the DT B-NP O
SNRPN NN I-NP O
- HYPH B-VP O
associated VBN B-NP O
imprinting NN I-NP O
center NN I-NP O
, , O O
which WDT B-NP O
already RB B-ADVP O
includes VBZ B-VP O
four CD B-NP O
imprinted VBN B-VP O
, , O O
paternally RB B-NP O
expressed VBN I-NP O
genes NNS I-NP O
. . O O

All DT B-NP O
other JJ I-NP O
tested VBD B-VP O
new JJ B-NP O
transcripts NNS I-NP O
in IN B-PP O
the DT B-NP O
deletion NN I-NP O
region NN I-NP O
were VBD B-VP O
expressed VBN I-VP O
from IN B-PP O
both DT B-NP O
alleles NNS I-NP O
. . O O

A DT B-NP O
domain NN I-NP O
of IN B-PP O
exclusive JJ B-NP O
paternal JJ I-NP O
expression NN I-NP O
surrounding VBG B-VP O
the DT B-NP O
imprinting NN I-NP O
center NN I-NP O
suggests VBZ B-VP O
strong JJ B-NP O
regional JJ I-NP O
control NN I-NP O
of IN B-PP O
the DT B-NP O
imprinting NN I-NP O
process NN I-NP O
. . O O

This DT B-NP O
study NN I-NP O
provides VBZ B-VP O
the DT B-NP O
means NNS I-NP O
for IN B-PP O
further JJ B-NP O
investigation NN I-NP O
of IN B-PP O
additional JJ B-NP O
genes NNS I-NP O
that WDT B-NP O
cause VBP B-VP O
or CC O O
modify VB B-VP O
the DT B-NP O
phenotypes NNS I-NP O
associated VBN B-VP O
with IN B-PP O
rearrangements NNS B-NP O
of IN B-PP O
15q11 CD B-NP O
- HYPH I-NP O
q13 NN I-NP O
. . O O

Combined VBN B-NP O
analysis NN I-NP O
of IN B-PP O
hereditary JJ B-NP B-Disease
prostate NN I-NP I-Disease
cancer NN I-NP I-Disease
linkage NN I-NP O
to TO B-PP O
1q24 CD B-NP O
- HYPH I-NP O
25 CD I-NP O
: : O O
results NNS B-NP O
from IN B-PP O
772 CD B-NP O
hereditary JJ I-NP B-Disease
prostate NN I-NP I-Disease
cancer NN I-NP I-Disease
families NNS I-NP O
from IN B-PP O
the DT B-NP O
International NNP I-NP O
Consortium NNP I-NP O
for IN B-PP O
Prostate NNP B-NP B-Disease
Cancer NNP I-NP I-Disease
Genetics NNP I-NP O
. . O O

A DT B-NP O
previous JJ I-NP O
linkage NN I-NP O
study NN I-NP O
provided VBD B-VP O
evidence NN B-NP O
for IN B-PP O
a DT B-NP O
prostate NN I-NP B-Disease
cancer NN I-NP I-Disease
- HYPH B-NP O
susceptibility NN I-NP O
locus NN I-NP O
at IN B-PP O
1q24 CD B-NP O
- HYPH I-NP O
25 CD I-NP O
. . O O

Subsequent JJ B-NP O
reports NNS I-NP O
in IN B-PP O
additional JJ B-NP O
collections NNS I-NP O
of IN B-PP O
families NNS B-NP O
have VBP B-VP O
yielded VBN I-VP O
conflicting VBG I-VP O
results NNS B-NP O
. . O O

In IN B-PP O
addition NN B-NP O
, , O O
evidence NN B-NP O
for IN B-PP O
locus NN B-NP O
heterogeneity NN I-NP O
has VBZ B-VP O
been VBN I-VP O
provided VBN I-VP O
by IN B-PP O
the DT B-NP O
identification NN I-NP O
of IN B-PP O
other JJ B-NP O
putative JJ I-NP O
hereditary JJ I-NP B-Disease
prostate NN I-NP I-Disease
cancer NN I-NP I-Disease
loci NNS I-NP O
on IN B-PP O
Xq27 NN B-NP O
- HYPH B-NP O
28 CD I-NP O
, , I-NP O
1q42 CD I-NP O
- HYPH B-NP O
43 CD I-NP O
, , O O
and CC O O
1p36 NN B-NP O
. . O O

The DT B-NP O
present JJ I-NP O
study NN I-NP O
describes VBZ B-VP O
a DT B-NP O
combined JJ I-NP O
analysis NN I-NP O
for IN B-PP O
six CD B-NP O
markers NNS I-NP O
in IN B-PP O
the DT B-NP O
1q24 CD I-NP O
- HYPH I-NP O
25 CD I-NP O
region NN I-NP O
in IN B-PP O
772 CD B-NP O
families NNS I-NP O
affected VBN B-VP O
by IN B-PP O
hereditary JJ B-NP B-Disease
prostate NN I-NP I-Disease
cancer NN I-NP I-Disease
and CC O O
ascertained VBN B-VP O
by IN B-PP O
the DT B-NP O
members NNS I-NP O
of IN B-PP O
the DT B-NP O
International NNP I-NP O
Consortium NNP I-NP O
for IN B-PP O
Prostate NNP B-NP B-Disease
Cancer NNP I-NP I-Disease
Genetics NNP I-NP O
( ( O O
ICPCG NN B-NP O
) ) O O
from IN B-PP O
North NNP B-NP O
America NNP I-NP O
, , O O
Australia NNP B-NP O
, , O O
Finland NNP B-NP O
, , O O
Norway NNP B-NP O
, , O O
Sweden NNP B-NP O
, , O O
and CC O O
the DT B-NP O
United NNP I-NP O
Kingdom NNP I-NP O
. . O O

Overall RB B-ADVP O
, , O O
there EX B-NP O
was VBD B-VP O
some DT B-NP O
evidence NN I-NP O
for IN B-PP O
linkage NN B-NP O
, , O O
with IN B-PP O
a DT B-NP O
peak NN I-NP O
parametric JJ I-NP O
multipoint JJ I-NP O
LOD NN I-NP O
score NN I-NP O
assuming VBG B-VP O
heterogeneity NN B-NP O
( ( O O
HLOD NN B-NP O
) ) O O
of IN B-PP O
1 CD B-NP O
. . O O

40 CD B-NP O
( ( O O
P NN B-NP O
= SYM B-VP O
. . B-NP O

01 CD I-NP O
) ) O O
at IN B-PP O
D1S212 NN B-NP O
. . O O

The DT B-NP O
estimated VBN I-NP O
proportion NN I-NP O
of IN B-PP O
families NNS B-NP O
( ( O O
alpha NN B-NP O
) ) O O
linked VBN B-VP O
to TO B-PP O
the DT B-NP O
locus NN I-NP O
was VBD B-VP O
. . O O

06 CD B-NP O
( ( O O
1 CD B-NP O
- HYPH I-NP O
LOD NN I-NP O
support NN I-NP O
interval NN I-NP O
. . O O

01 CD B-NP O
- HYPH I-NP O
. . I-NP O

12 CD I-NP O
) ) O O
. . O O

This DT B-NP O
evidence NN I-NP O
was VBD B-VP O
not RB I-VP O
observed VBN I-VP O
by IN B-PP O
a DT B-NP O
nonparametric JJ I-NP O
approach NN I-NP O
, , O O
presumably RB B-ADVP O
because IN B-PP O
of IN I-PP O
the DT B-NP O
extensive JJ I-NP O
heterogeneity NN I-NP O
. . O O

Further JJ B-NP O
parametric JJ I-NP O
analysis NN I-NP O
revealed VBD B-VP O
a DT B-NP O
significant JJ I-NP O
effect NN I-NP O
of IN B-PP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
male NN B-NP O
- HYPH B-ADVP O
to TO B-PP O
- HYPH B-NP O
male JJ I-NP O
disease NN I-NP O
transmission NN I-NP O
within IN B-PP O
the DT B-NP O
families NNS I-NP O
. . O O

In IN B-PP O
the DT B-NP O
subset NN I-NP O
of IN B-PP O
491 CD B-NP O
such JJ I-NP O
families NNS I-NP O
, , O O
the DT B-NP O
peak JJ I-NP O
HLOD NN I-NP O
was VBD B-VP O
2 CD B-NP O
. . O O

In IN B-PP O
the DT B-NP O
subset NN I-NP O
of IN B-PP O
491 CD B-NP O
such JJ I-NP O
families NNS I-NP O
, , O O
the DT B-NP O
peak JJ I-NP O
HLOD NN I-NP O
was VBD B-VP O
2 CD B-NP O
. . O O

56 CD B-NP O
( ( O O
P NN B-NP O
= SYM B-VP O
. . O O

0006 CD B-NP O
) ) O O
and CC O O
alpha NN B-NP O
= SYM B-NP O
. . O O

11 CD B-NP O
( ( O O
1 CD B-NP O
- HYPH I-NP O
LOD NN I-NP O
support NN I-NP O
interval NN I-NP O
. . O O

04 CD B-NP O
- HYPH I-NP O
. SYM I-NP O

19 CD I-NP O
) ) O O
, , O O
compared VBN B-PP O
with IN B-PP O
HLODs NNS B-NP O
of IN B-PP O
0 CD B-NP O
in IN B-PP O
the DT B-NP O
remaining VBG I-NP O
281 CD I-NP O
families NNS I-NP O
. . O O

Within IN B-PP O
the DT B-NP O
families NNS I-NP O
with IN B-PP O
male JJ B-ADJP O
- HYPH I-ADJP O
to TO B-PP O
- HYPH B-NP O
male JJ I-NP O
disease NN I-NP O
transmission NN I-NP O
, , O O
alpha NN B-NP O
increased VBD B-VP O
with IN B-PP O
the DT B-NP O
early JJ I-NP O
mean JJ I-NP O
age NN I-NP O
at IN B-PP O
diagnosis NN B-NP O
( ( O O
< SYM B-NP O
65 CD B-NP O
years NNS I-NP O
, , O O
alpha NN B-NP O
= SYM B-VP O
. . O O

19 CD B-NP O
, , O O
with IN B-PP O
1 CD B-NP O
- HYPH I-NP O
LOD NN I-NP O
support NN I-NP O
interval NN I-NP O
. . O O

06 CD B-NP O
- HYPH I-NP O
. . I-NP O

34 CD I-NP O
) ) O O
and CC O O
the DT B-NP O
number NN I-NP O
of IN B-PP O
affected VBN B-NP O
family NN I-NP O
members NNS I-NP O
( ( O O
five CD B-NP O
or CC I-NP O
more JJR I-NP O
family NN I-NP O
members NNS I-NP O
, , O O
alpha NN B-NP O
= SYM B-VP O
. . O O

15 CD B-NP O
, , O O
with IN B-PP O
1 CD B-NP O
- HYPH I-NP O
LOD NN I-NP O
support NN I-NP O
interval NN I-NP O
. . O O

04 CD B-NP O
- HYPH I-NP O
. . I-NP O

28 CD I-NP O
) ) O O
. . O O

The DT B-NP O
highest JJS I-NP O
value NN I-NP O
of IN B-PP O
alpha NN B-NP O
was VBD B-VP O
observed VBN I-VP O
for IN B-PP O
the DT B-NP O
48 CD I-NP O
families NNS I-NP O
that WDT B-NP O
met VBD B-VP O
all DT B-NP O
three CD I-NP O
criteria NNS I-NP O
( ( O O
peak JJ B-NP O
HLOD NN I-NP O
= SYM B-VP O
2 CD B-NP O
. SYM I-NP O

25 CD I-NP O
, , O O
P NN B-NP O
= SYM B-VP O
. . O O

001 CD B-NP O
, , O O
alpha NN B-NP O
= SYM B-VP O
. . B-NP O

29 CD I-NP O
, , O O
with IN B-PP O
1 CD B-NP O
- HYPH I-NP O
LOD NN I-NP O
support NN I-NP O
interval NN I-NP O
. . O O

08 CD B-NP O
- HYPH I-NP O
. . I-NP O

53 CD I-NP O
) ) O O
. . O O

These DT B-NP O
results NNS I-NP O
support VBP B-VP O
the DT B-NP O
finding NN I-NP O
of IN B-PP O
a DT B-NP O
prostate NN I-NP B-Disease
cancer NN I-NP I-Disease
- HYPH B-NP O
susceptibility NN I-NP O
gene NN I-NP O
linked VBN B-VP O
to TO B-PP O
1q24 CD B-NP O
- HYPH I-NP O
25 CD I-NP O
, , O O
albeit IN B-ADVP O
in IN B-PP O
a DT B-NP O
defined VBN I-NP O
subset NN I-NP O
of IN B-PP O
prostate NN B-NP B-Disease
cancer NN I-NP I-Disease
families NNS I-NP O
. . O O

Although IN B-SBAR O
HPC1 NN B-NP O
accounts VBZ B-VP O
for IN B-PP O
only RB B-NP O
a DT I-NP O
small JJ I-NP O
proportion NN I-NP O
of IN B-PP O
all DT B-NP O
families NNS I-NP O
affected VBN B-VP O
by IN B-PP O
hereditary JJ B-NP B-Disease
prostate NN I-NP I-Disease
cancer NN I-NP I-Disease
, , O O
it PRP B-NP O
appears VBZ B-VP O
to TO I-VP O
play VB I-VP O
a DT B-NP O
more RBR I-NP O
prominent JJ I-NP O
role NN I-NP O
in IN B-PP O
the DT B-NP O
subset NN I-NP O
of IN B-PP O
families NNS B-NP O
with IN B-PP O
several JJ B-NP O
members NNS I-NP O
affected VBN B-VP O
at IN B-PP O
an DT B-NP O
early JJ I-NP O
age NN I-NP O
and CC B-PP O
with IN B-PP O
male JJ B-ADJP O
- HYPH I-ADJP O
to TO B-PP O
- HYPH B-NP O
male JJ I-NP O
disease NN I-NP O
transmission NN I-NP O
. . O O

A DT B-NP O
recurrent JJ I-NP O
expansion NN I-NP O
of IN B-PP O
a DT B-NP O
maternal JJ I-NP O
allele NN I-NP O
with IN B-PP O
36 CD B-NP O
CAG NN I-NP O
repeats NNS I-NP O
causes VBZ B-VP O
Huntington NNP B-NP B-Disease
disease NN I-NP I-Disease
in IN B-PP O
two CD B-NP O
sisters NNS I-NP O
. . O O

Large JJ B-NP O
intergenerational JJ I-NP O
repeat NN I-NP O
expansions NNS I-NP O
of IN B-PP O
the DT B-NP O
CAG NN I-NP O
trinucleotide NN I-NP O
repeat NN I-NP O
in IN B-PP O
the DT B-NP O
HD NN I-NP B-Disease
gene NN I-NP O
have VBP B-VP O
been VBN I-VP O
well RB I-VP O
documented VBN I-VP O
for IN B-PP O
the DT B-NP O
male JJ I-NP O
germline NN I-NP O
. . O O

We PRP B-NP O
describe VBP B-VP O
a DT B-NP O
recurrent JJ I-NP O
large JJ I-NP O
expansion NN I-NP O
of IN B-PP O
a DT B-NP O
maternal JJ I-NP O
allele NN I-NP O
with IN B-PP O
36 CD B-NP O
CAG NN I-NP O
repeats NNS I-NP O
( ( O O
to TO B-PP O
66 CD B-NP O
and CC I-NP O
57 CD I-NP O
repeats NNS I-NP O
, , O O
respectively RB B-ADVP O
, , O O
in IN B-PP O
two CD B-NP O
daughters NNS I-NP O
) ) O O
associated VBN B-VP O
with IN B-PP O
onset NN B-NP O
of IN B-PP O
Huntington NNP B-NP B-Disease
disease NN I-NP I-Disease
( ( O O
HD NN B-NP B-Disease
) ) O O
in IN B-PP O
the DT B-NP O
second JJ I-NP O
and CC I-NP O
third JJ I-NP O
decade NN I-NP O
in IN B-PP O
a DT B-NP O
family NN I-NP O
without IN B-PP O
history NN B-NP O
of IN B-PP O
HD NN B-NP B-Disease
. . O O

Our PRP$ B-NP O
findings NNS I-NP O
give VBP B-VP O
evidence NN B-NP O
of IN B-PP O
a DT B-NP O
gonadal JJ I-NP O
mosaicism NN I-NP O
in IN B-PP O
the DT B-NP O
unaffected JJ I-NP O
mother NN I-NP O
. . O O

We PRP B-NP O
hypothesize VBP B-VP O
that IN B-SBAR O
large JJ B-NP O
expansions NNS I-NP O
also RB B-ADVP O
occur VBP B-VP O
in IN B-PP O
the DT B-NP O
female JJ I-NP O
germline NN I-NP O
and CC O O
that IN B-SBAR O
a DT B-NP O
negative JJ I-NP O
selection NN I-NP O
of IN B-PP O
oocytes NNS B-NP O
with IN B-PP O
long JJ B-NP O
repeats NNS I-NP O
might MD B-VP O
explain VB I-VP O
the DT B-NP O
different JJ I-NP O
instability NN I-NP O
behavior NN I-NP O
of IN B-PP O
the DT B-NP O
male JJ I-NP O
and CC O O
the DT B-NP O
female JJ I-NP O
germlines NNS I-NP O
. . O O

. . O O

Abnormal JJ B-NP O
development NN I-NP O
of IN B-PP O
Purkinje NN B-NP O
cells NNS I-NP O
and CC O O
lymphocytes NNS B-NP O
in IN B-PP O
Atm NN B-NP O
mutant JJ I-NP O
mice NNS I-NP O
. . O O

Motor NNP B-NP B-Disease
incoordination NN I-NP I-Disease
, , O O
immune JJ B-NP B-Disease
deficiencies NNS I-NP I-Disease
, , O O
and CC O O
an DT B-NP O
increased VBN I-NP O
risk NN I-NP O
of IN B-PP O
cancer NN B-NP B-Disease
are VBP B-VP O
the DT B-NP O
characteristic JJ I-NP O
features NNS I-NP O
of IN B-PP O
the DT B-NP O
hereditary JJ I-NP B-Disease
disease NN I-NP I-Disease
ataxia NN I-NP B-Disease
- HYPH B-NP I-Disease
telangiectasia NN I-NP I-Disease
( ( O O
A NN B-NP B-Disease
- HYPH O I-Disease
T NN B-NP I-Disease
) ) O O
, , O O
which WDT B-NP O
is VBZ B-VP O
caused VBN I-VP O
by IN B-PP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
ATM NN I-NP O
gene NN I-NP O
. . O O

Through IN B-PP O
gene NN B-NP O
targeting NN I-NP O
, , O O
we PRP B-NP O
have VBP B-VP O
generated VBN I-VP O
a DT B-NP O
line NN I-NP O
of IN B-PP O
Atm NN B-NP O
mutant JJ I-NP O
mice NNS I-NP O
, , O O
Atm NN B-NP O
( ( O O
y NN B-NP O
/ SYM O O
y NN O O
) ) O O
mice NNS B-NP O
. . O O

In IN B-PP O
contrast NN B-NP O
to TO B-PP O
other JJ B-NP O
Atm NN I-NP O
mutant JJ I-NP O
mice NNS I-NP O
, , O O
Atm NN B-NP O
( ( O O
y NN B-NP O
/ SYM O O
y NN O O
) ) O O
mice NNS B-NP O
show VBP B-VP O
a DT B-NP O
lower JJR I-NP O
incidence NN I-NP O
of IN B-PP O
thymic JJ B-NP B-Disease
lymphoma NN I-NP I-Disease
and CC O O
survive VB B-VP O
beyond IN B-PP O
a DT B-NP O
few JJ I-NP O
months NNS I-NP O
of IN B-PP O
age NN B-NP O
. . O O

Atm NN B-NP O
( ( O O
y NN B-NP O
/ SYM O O
y NN O O
) ) O O
mice NNS B-NP O
exhibit VBP B-VP O
deficits NNS B-NP O
in IN B-PP O
motor NN B-NP O
learning NN I-NP O
indicative JJ B-ADJP O
of IN B-PP O
cerebellar JJ B-NP B-Disease
dysfunction NN I-NP I-Disease
. . O O

Even RB B-SBAR O
though IN I-SBAR O
we PRP B-NP O
found VBD B-VP O
no DT B-NP O
gross JJ I-NP O
cerebellar JJ I-NP B-Disease
degeneration NN I-NP I-Disease
in IN B-PP O
older JJR B-NP O
Atm NN I-NP O
( ( O O
y NN B-NP O
/ SYM O O
y NN O O
) ) O O
animals NNS B-NP O
, , O O
ectopic JJ B-NP O
and CC I-NP O
abnormally RB I-NP O
differentiated VBN I-NP O
Purkinje NN I-NP O
cells NNS I-NP O
were VBD B-VP O
apparent JJ B-ADJP O
in IN B-PP O
mutant JJ B-NP O
mice NNS I-NP O
of IN B-PP O
all DT B-NP O
ages NNS I-NP O
. . O O

These DT B-NP O
findings NNS I-NP O
establish VBP B-VP O
that IN B-SBAR O
some DT B-NP O
neuropathological JJ I-NP B-Disease
abnormalities NNS I-NP I-Disease
seen VBN B-VP O
in IN B-PP O
A NN B-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
patients NNS I-NP O
also RB B-ADVP O
are VBP B-VP O
present JJ B-ADJP O
in IN B-PP O
Atm NN B-NP O
mutant JJ I-NP O
mice NNS I-NP O
. . O O

In IN B-PP O
addition NN B-NP O
, , O O
we PRP B-NP O
report VBP B-VP O
a DT B-NP O
previously RB I-NP O
unrecognized JJ I-NP O
effect NN I-NP O
of IN B-PP O
Atm NN B-NP B-Disease
deficiency NN I-NP I-Disease
on IN B-PP O
development NN B-NP O
or CC I-NP O
maintenance NN I-NP O
of IN B-PP O
CD4 NN B-NP O
( ( O O
+ SYM B-NP O
) ) O O
8 CD B-NP O
( ( O O
+ SYM O O
) ) O O
thymocytes NNS B-NP O
. . O O

We PRP B-NP O
discuss VBP B-VP O
these DT B-NP O
findings NNS I-NP O
in IN B-PP O
the DT B-NP O
context NN I-NP O
of IN B-PP O
the DT B-NP O
hypothesis NN I-NP O
that IN B-SBAR O
abnormal JJ B-NP O
development NN I-NP O
of IN B-PP O
Purkinje NN B-NP O
cells NNS I-NP O
and CC O O
lymphocytes NNS B-NP O
contributes VBZ B-VP O
to TO B-PP O
the DT B-NP O
pathogenesis NN I-NP O
of IN B-PP O
A NN B-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
. . O O

. . O O

Novel JJ B-NP O
mutations NNS I-NP O
of IN B-PP O
the DT B-NP O
ATP7B NN I-NP O
gene NN I-NP O
in IN B-PP O
Japanese JJ B-NP O
patients NNS I-NP O
with IN B-PP O
Wilson NNP B-NP B-Disease
disease NN I-NP I-Disease
. . O O

Wilson NN B-NP B-Disease
disease NN I-NP I-Disease
( ( O O
WD NN B-NP B-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
disorder NN I-NP I-Disease
characterized VBN B-VP O
by IN B-PP O
copper NN B-NP O
accumulation NN I-NP O
in IN B-PP O
the DT B-NP O
liver NN I-NP O
, , O O
brain NN B-NP O
, , O O
kidneys NNS B-NP O
, , O O
and CC O O
corneas NN B-NP O
, , O O
and CC O O
culminating VBG B-VP O
in IN B-PP O
copper NN B-NP O
toxication NN I-NP O
in IN B-PP O
these DT B-NP O
organs NNS I-NP O
. . O O

In IN B-PP O
this DT B-NP O
study NN I-NP O
, , O O
we PRP B-NP O
analyzed VBD B-VP O
mutations NNS B-NP O
of IN B-PP O
the DT B-NP O
responsible JJ I-NP O
gene NN I-NP O
, , O O
ATP7B NN B-NP O
, , O O
in IN B-PP O
four CD B-NP O
Japanese JJ I-NP O
patients NNS I-NP O
with IN B-PP O
WD NN B-NP B-Disease
. . O O

By IN B-PP O
direct JJ B-NP O
sequencing NN I-NP O
, , O O
we PRP B-NP O
identified VBD B-VP O
five CD B-NP O
mutations NNS I-NP O
, , O O
of IN B-PP O
which WDT B-NP O
two CD B-NP O
were VBD B-VP O
novel JJ B-ADJP O
, , O O
and CC O O
16 CD B-NP O
polymorphisms NNS I-NP O
, , O O
of IN B-PP O
which WDT B-NP O
6 CD B-NP O
were VBD B-VP O
novel JJ B-ADJP O
. . O O

The DT B-NP O
mutations NNS I-NP O
2871delC NN I-NP O
and CC I-NP O
2513delA NN I-NP O
shift NN I-NP O
the DT B-NP O
reading NN I-NP O
frame NN I-NP O
so IN B-SBAR O
that IN I-SBAR O
truncated VBN B-NP O
abnormal JJ I-NP O
protein NN I-NP O
is VBZ B-VP O
expected VBN I-VP O
. . O O

In IN B-PP O
contrast NN B-NP O
to TO B-PP O
these DT B-NP O
mutations NNS I-NP O
found VBN B-VP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
hepatic JJ B-NP O
- HYPH I-NP O
type NN I-NP O
of IN B-PP O
early JJ B-NP O
onset NN I-NP O
, , O O
the DT B-NP O
mutations NNS I-NP O
A874V NN I-NP O
, , O O
R778L NN B-NP O
, , O O
and CC O O
3892delGTC NN B-NP O
were VBD B-VP O
either CC O O
missense JJ B-NP O
mutations NNS I-NP O
or CC B-PP O
in IN B-PP O
frame NN B-NP O
1 CD I-NP O
- HYPH I-NP O
amino NN I-NP O
acid NN I-NP O
deletion NN I-NP O
, , O O
and CC O O
occurred VBD B-VP O
in IN B-PP O
the DT B-NP O
patients NNS I-NP O
with IN B-PP O
hepato NN B-NP O
- HYPH B-NP O
neurologic JJ I-NP O
type NN I-NP O
of IN B-PP O
late JJ B-NP O
onset NN I-NP O
. . O O

The DT B-NP O
mutations NNS I-NP O
2871delC NN I-NP O
and CC I-NP O
R778L NN I-NP O
have VBP B-VP O
been VBN I-VP O
previously RB I-VP O
reported VBN I-VP O
in IN B-PP O
a DT B-NP O
relatively RB I-NP O
large JJ I-NP O
number NN I-NP O
of IN B-PP O
Japanese JJ B-NP O
patients NNS I-NP O
. . O O

In IN B-PP O
particular JJ B-NP O
, , O O
R778L NN B-NP O
is VBZ B-VP O
known VBN I-VP O
to TO I-VP O
be VB I-VP O
more RBR B-ADJP O
prevalent JJ I-ADJP O
in IN B-PP O
Asian JJ B-NP O
countries NNS I-NP O
than IN B-PP O
in IN B-PP O
other JJ B-NP O
countries NNS I-NP O
of IN B-PP O
the DT B-NP O
world NN I-NP O
. . O O

Our PRP$ B-NP O
data NNS I-NP O
are VBP B-VP O
compatible JJ B-ADJP O
with IN B-PP O
the DT B-NP O
hypothesis NN I-NP O
that IN B-SBAR O
the DT B-NP O
mutations NNS I-NP O
tend VBP B-VP O
to TO I-VP O
occur VB I-VP O
in IN B-PP O
a DT B-NP O
population NN I-NP O
- HYPH B-NP O
specific JJ I-NP O
manner NN I-NP O
. . O O

Therefore RB B-ADVP O
, , O O
the DT B-NP O
accumulation NN I-NP O
of IN B-PP O
the DT B-NP O
types NNS I-NP O
of IN B-PP O
mutations NNS B-NP O
in IN B-PP O
Japanese JJ B-NP O
patients NNS I-NP O
with IN B-PP O
WD NN B-NP B-Disease
will MD B-VP O
facilitate VB I-VP O
the DT B-NP O
fast JJ I-NP O
and CC I-NP O
effective JJ I-NP O
genetic JJ I-NP O
diagnosis NN I-NP O
of IN B-PP O
WD NN B-NP B-Disease
in IN B-PP O
Japanese JJ B-NP O
patients NNS I-NP O
. . O O

. . O O

Autoinhibition NN B-NP O
and CC I-NP O
activation NN I-NP O
mechanisms NNS I-NP O
of IN B-PP O
the DT B-NP O
Wiskott NNP I-NP B-Disease
- HYPH I-NP I-Disease
Aldrich NNP I-NP I-Disease
syndrome NN I-NP I-Disease
protein NN I-NP O
. . O O

The DT B-NP O
Rho NN I-NP O
- HYPH I-NP O
family NN I-NP O
GTPase NN I-NP O
, , O O
Cdc42 NN B-NP O
, , O O
can MD B-VP O
regulate VB I-VP O
the DT B-NP O
actin NN I-NP O
cytoskeleton NN I-NP O
through IN B-PP O
activation NN B-NP O
of IN B-PP O
Wiskott NNP B-NP B-Disease
- HYPH B-NP I-Disease
Aldrich NNP I-NP I-Disease
syndrome NN I-NP I-Disease
protein NN I-NP O
( ( O O
WASP NN B-NP O
) ) O O
family NN B-NP O
members NNS I-NP O
. . O O

Activation NN B-NP O
relieves VBZ B-VP O
an DT B-NP O
autoinhibitory JJ I-NP O
contact NN I-NP O
between IN B-PP O
the DT B-NP O
GTPase NN I-NP O
- HYPH B-PP O
binding VBG B-NP O
domain NN I-NP O
and CC O O
the DT B-NP O
carboxy NN I-NP O
- HYPH B-NP O
terminal JJ I-NP O
region NN I-NP O
of IN B-PP O
WASP NN B-NP O
proteins NNS I-NP O
. . O O

Here RB B-ADVP O
we PRP B-NP O
report VBP B-VP O
the DT B-NP O
autoinhibited VBN I-NP O
structure NN I-NP O
of IN B-PP O
the DT B-NP O
GTPase NN I-NP O
- HYPH B-PP O
binding VBG B-NP O
domain NN I-NP O
of IN B-PP O
WASP NN B-NP O
, , O O
which WDT B-NP O
can MD B-VP O
be VB I-VP O
induced VBN I-VP O
by IN B-PP O
the DT B-NP O
C NN I-NP O
- HYPH B-NP O
terminal JJ I-NP O
region NN I-NP O
or CC B-PP O
by IN B-PP O
organic JJ B-NP O
co AFX I-NP O
- HYPH I-NP O
solvents NNS I-NP O
. . O O

In IN B-PP O
the DT B-NP O
autoinhibited JJ I-NP O
complex NN I-NP O
, , O O
intramolecular JJ B-NP O
interactions NNS I-NP O
with IN B-PP O
the DT B-NP O
GTPase NN I-NP O
- HYPH B-PP O
binding VBG B-NP O
domain NN I-NP O
occlude VBP B-VP O
residues NNS B-NP O
of IN B-PP O
the DT B-NP O
C NN I-NP O
terminus NN I-NP O
that WDT B-NP O
regulate VBP B-VP O
the DT B-NP O
Arp2 NN I-NP O
/ SYM O O
3 CD B-NP O
actin NN I-NP O
- HYPH O O
nucleating VBG B-VP O
complex NN B-NP O
. . O O

Binding NN B-NP O
of IN B-PP O
Cdc42 NN B-NP O
to TO B-PP O
the DT B-NP O
GTPase NN I-NP O
- HYPH B-PP O
binding VBG B-NP O
domain NN I-NP O
causes VBZ B-VP O
a DT B-NP O
dramatic JJ I-NP O
conformational JJ I-NP O
change NN I-NP O
, , O O
resulting VBG B-VP O
in IN B-PP O
disruption NN B-NP O
of IN B-PP O
the DT B-NP O
hydrophobic JJ I-NP O
core NN I-NP O
and CC I-NP O
release NN I-NP O
of IN B-PP O
the DT B-NP O
C NN I-NP O
terminus NN I-NP O
, , O O
enabling VBG B-VP O
its PRP$ B-NP O
interaction NN I-NP O
with IN B-PP O
the DT B-NP O
actin NN I-NP O
regulatory JJ I-NP O
machinery NN I-NP O
. . O O

These DT B-NP O
data NNS I-NP O
show VBP B-VP O
that IN B-SBAR O
intrinsically RB B-NP O
unstructured JJ I-NP O
peptides NNS I-NP O
such JJ B-PP O
as IN I-PP O
the DT B-NP O
GTPase NN I-NP O
- HYPH B-PP O
binding VBG B-NP O
domain NN I-NP O
of IN B-PP O
WASP NN B-NP O
can MD B-VP O
be VB I-VP O
induced VBN I-VP O
into IN B-PP O
distinct JJ B-NP O
structural JJ I-NP O
and CC I-NP O
functional JJ I-NP O
states NNS I-NP O
depending VBG B-PP O
on IN B-PP O
context NN B-NP O
. . O O

. . O O

hCds1 NN B-NP O
- HYPH B-PP O
mediated VBN B-NP O
phosphorylation NN I-NP O
of IN B-PP O
BRCA1 NN B-NP O
regulates VBZ B-VP O
the DT B-NP O
DNA NN I-NP O
damage NN I-NP O
response NN I-NP O
. . O O

Mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
BRCA1 NN I-NP O
( ( O O
ref NN B-NP O
. . O O

1 CD O O
) ) O O
tumour NN B-NP B-Disease
suppressor NN I-NP O
gene NN I-NP O
are VBP B-VP O
found VBN I-VP O
in IN B-PP O
almost RB B-NP O
all DT I-NP O
of IN B-PP O
the DT B-NP O
families NNS I-NP O
with IN B-PP O
inherited VBN B-NP B-Disease
breast NN I-NP I-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancers NNS I-NP I-Disease
and CC O O
about IN B-NP O
half NN I-NP O
of IN B-PP O
the DT B-NP O
families NNS I-NP O
with IN B-PP O
only RB B-NP O
breast NN I-NP B-Disease
cancer NN I-NP I-Disease
. . O O

Although IN B-SBAR O
the DT B-NP O
biochemical JJ I-NP O
function NN I-NP O
of IN B-PP O
BRCA1 NN B-NP O
is VBZ B-VP O
not RB O O
well RB B-VP O
understood VBN I-VP O
, , O O
it PRP B-NP O
is VBZ B-VP O
important JJ B-ADJP O
for IN B-PP O
DNA NN B-NP O
damage NN I-NP O
repair NN I-NP O
and CC I-NP O
cell NN I-NP O
- HYPH B-NP O
cycle NN I-NP O
checkpoint NN I-NP O
. . O O

BRCA1 NN B-NP O
exists VBZ B-VP O
in IN B-PP O
nuclear JJ B-NP O
foci NNS I-NP O
but CC O O
is VBZ B-VP O
hyperphosphorylated VBN I-VP O
and CC O O
disperses NNS B-NP O
after IN B-PP O
DNA NN B-NP O
damage NN I-NP O
. . O O

It PRP B-NP O
is VBZ B-VP O
not RB I-VP O
known VBN I-VP O
whether IN B-SBAR O
BRCA1 NN B-NP O
phosphorylation NN I-NP O
and CC I-NP O
dispersion NN I-NP O
and CC O O
its PRP$ B-NP O
function NN I-NP O
in IN B-PP O
DNA NN B-NP O
damage NN I-NP O
response NN I-NP O
are VBP B-VP O
related VBN I-VP O
. . O O

In IN B-PP O
yeast NN B-NP O
the DT B-NP O
DNA NN I-NP O
damage NN I-NP O
response NN I-NP O
and CC O O
the DT B-NP O
replication NN I-NP O
- HYPH B-NP O
block NN I-NP O
checkpoint NN I-NP O
are VBP B-VP O
mediated VBN I-VP O
partly RB B-ADVP O
through IN B-PP O
the DT B-NP O
Cds1 NN I-NP O
kinase NN I-NP O
family NN I-NP O
. . O O

Here RB B-ADVP O
we PRP B-NP O
report VBP B-VP O
that IN B-SBAR O
the DT B-NP O
human JJ I-NP O
Cds1 NN I-NP O
kinase NN I-NP O
( ( O O
hCds1 NN B-NP O
/ SYM B-NP O
Chk2 NN I-NP O
) ) O O
regulates VBZ B-VP O
BRCA1 NN B-NP O
function NN I-NP O
after IN B-PP O
DNA NN B-NP O
damage NN I-NP O
by IN B-PP O
phosphorylating VBG B-VP O
serine NN B-NP O
988 CD I-NP O
of IN B-PP O
BRCA1 NN B-NP O
. . O O

We PRP B-NP O
show VBP B-VP O
that IN B-SBAR O
hCds1 NN B-NP O
and CC I-NP O
BRCA1 NN I-NP O
interact VBP B-VP O
and CC O O
co AFX O O
- HYPH O O
localize VB B-VP O
within IN B-PP O
discrete JJ B-NP O
nuclear JJ I-NP O
foci NNS I-NP O
but CC O O
separate JJ B-ADJP O
after IN B-PP O
gamma NN B-NP O
irradiation NN I-NP O
. . O O

Phosphorylation NN B-NP O
of IN B-PP O
BRCA1 NN B-NP O
at IN B-PP O
serine NN B-NP O
988 CD I-NP O
is VBZ B-VP O
required VBN I-VP O
for IN B-PP O
the DT B-NP O
release NN I-NP O
of IN B-PP O
BRCA1 NN B-NP O
from IN B-PP O
hCds1 NN B-NP O
. . O O

This DT B-NP O
phosphorylation NN I-NP O
is VBZ B-VP O
also RB B-ADVP O
important JJ B-ADJP O
for IN B-PP O
the DT B-NP O
ability NN I-NP O
of IN B-PP O
BRCA1 NN B-NP O
to TO B-VP O
restore VB I-VP O
survival NN B-NP O
after IN B-PP O
DNA NN B-NP O
damage NN I-NP O
in IN B-PP O
the DT B-NP O
BRCA1 NN I-NP O
- HYPH B-NP O
mutated VBN I-NP O
cell NN I-NP O
line NN I-NP O
HCC1937 NN I-NP O
. . O O

. . O O

Characterization NN B-NP O
of IN B-PP O
the DT B-NP O
rat NN I-NP O
spinocerebellar JJ I-NP O
ataxia NN I-NP O
type NN I-NP O
3 CD I-NP O
gene NN I-NP O
. . O O

Machado NNP B-NP B-Disease
- HYPH I-NP I-Disease
Joseph NNP I-NP I-Disease
disease NN I-NP I-Disease
( ( O O
MJD NN B-NP B-Disease
) ) O O
belongs VBZ B-VP O
to TO B-PP O
a DT B-NP O
group NN I-NP O
of IN B-PP O
clinically RB B-NP O
and CC I-NP O
genetically RB I-NP O
heterogeneous JJ I-NP O
neurodegenerative JJ I-NP B-Disease
disorders NNS I-NP I-Disease
characterized VBN B-VP O
by IN B-PP O
progressive JJ B-NP B-Disease
cerebellar JJ I-NP I-Disease
ataxia NN I-NP I-Disease
. . O O

The DT B-NP O
disease NN I-NP O
- HYPH O O
causing VBG B-VP O
mutation NN B-NP O
has VBZ B-VP O
recently RB I-VP O
been VBN I-VP O
identified VBN I-VP O
as IN B-PP O
an DT B-NP O
unstable JJ I-NP O
and CC I-NP O
expanded VBN I-NP O
( ( O O
CAG NN B-NP O
) ) O O
n NN B-NP O
trinucleotide NN I-NP O
repeat NN I-NP O
in IN B-PP O
a DT B-NP O
novel JJ I-NP O
gene NN I-NP O
of IN B-PP O
unknown JJ B-NP O
function NN I-NP O
. . O O

In IN B-PP O
Caucasians NNPS B-NP O
, , O O
repeat NN B-NP O
expansions NNS I-NP O
in IN B-PP O
the DT B-NP O
MJD1 NN I-NP O
gene NN I-NP O
have VBP B-VP O
also RB I-VP O
been VBN I-VP O
found VBN I-VP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
the DT B-NP O
clinically RB I-NP O
distinct JJ I-NP O
autosomal JJ I-NP O
dominant JJ I-NP O
spinocerebellar JJ I-NP B-Disease
ataxia NN I-NP I-Disease
type NN I-NP I-Disease
3 CD I-NP I-Disease
( ( O O
SCA3 NN B-NP B-Disease
) ) O O
. . O O

In IN B-SBAR O
order NN O O
to TO B-VP O
gain VB I-VP O
insight NN B-NP O
into IN B-PP O
the DT B-NP O
biology NN I-NP O
of IN B-PP O
the DT B-NP O
MJD1 NN I-NP O
/ SYM B-NP O
SCA3 NN I-NP O
gene NN I-NP O
we PRP B-NP O
cloned VBD B-VP O
the DT B-NP O
rat NN I-NP O
homologue NN I-NP O
and CC O O
studied VBN B-VP O
its PRP$ B-NP O
expression NN I-NP O
. . O O

The DT B-NP O
rat NN I-NP O
and CC O O
human JJ B-NP O
ataxin NN I-NP O
- HYPH B-NP O
3 CD I-NP O
genes NNS I-NP O
are VBP B-VP O
highly RB B-ADJP O
homologous JJ I-ADJP O
with IN B-PP O
an DT B-NP O
overall JJ I-NP O
sequence NN I-NP O
identity NN I-NP O
of IN B-PP O
approximately RB B-NP O
88 CD I-NP O
% NN I-NP O
. . O O

However RB B-ADVP O
, , O O
the DT B-NP O
C NN I-NP O
- HYPH B-NP O
terminal JJ I-NP O
end NN I-NP O
of IN B-PP O
the DT B-NP O
putative JJ I-NP O
protein NN I-NP O
differs VBZ B-VP O
strongly RB B-ADVP O
from IN B-PP O
the DT B-NP O
published VBN I-NP O
human JJ I-NP O
sequence NN I-NP O
. . O O

The DT B-NP O
( ( O O
CAG NN O O
) ) O O
n NN B-NP O
block NN I-NP O
in IN B-PP O
the DT B-NP O
rat NN I-NP O
cDNA NN I-NP O
consists VBZ B-VP O
of IN B-PP O
just RB B-NP O
three CD I-NP O
interrupted VBD B-VP O
units NNS B-NP O
suggesting VBG B-VP O
that IN B-SBAR O
a DT B-NP O
long JJ I-NP O
polyglutamine NN I-NP O
stretch NN I-NP O
is VBZ B-VP O
not RB O O
essential JJ B-ADJP O
for IN B-PP O
the DT B-NP O
normal JJ I-NP O
function NN I-NP O
of IN B-PP O
the DT B-NP O
ataxin NN I-NP O
- HYPH B-NP O
3 CD I-NP O
protein NN I-NP O
in IN B-PP O
rodents NNS B-NP O
. . O O

The DT B-NP O
expression NN I-NP O
pattern NN I-NP O
of IN B-PP O
the DT B-NP O
SCA3 NN I-NP O
gene NN I-NP O
in IN B-PP O
various JJ B-NP O
rat NN I-NP O
and CC O O
human JJ B-NP O
tissues NNS I-NP O
was VBD B-VP O
investigated VBN I-VP O
by IN B-PP O
Northern JJ B-NP O
blot NN I-NP O
analyses NNS I-NP O
. . O O

The DT B-NP O
mature JJ I-NP O
transcript NN I-NP O
is VBZ B-VP O
approximately RB B-NP O
6 CD I-NP O
kb NN I-NP O
in IN B-PP O
length NN B-NP O
. . O O

In IN B-PP O
rat NN B-NP O
testis NN I-NP O
, , O O
a DT B-NP O
smaller JJR I-NP O
transcript NN I-NP O
of IN B-PP O
1 CD B-NP O
. . O O

3 CD B-NP O
kb NN I-NP O
was VBD B-VP O
identified VBN I-VP O
. . O O

Transcription NN B-NP O
of IN B-PP O
rsca3 NN B-NP O
was VBD B-VP O
detected VBN I-VP O
in IN B-PP O
most JJS B-NP O
rat NN I-NP O
tissues NNS I-NP O
including VBG B-PP O
brain NN B-NP O
. . O O

Analyzing VBG B-VP O
the DT B-NP O
expression NN I-NP O
level NN I-NP O
of IN B-PP O
the DT B-NP O
SCA3 NN I-NP O
gene NN I-NP O
in IN B-PP O
several JJ B-NP O
human JJ I-NP O
brain NN I-NP O
sections NNS I-NP O
revealed VBD B-VP O
no DT B-NP O
significant JJ I-NP O
higher JJR I-NP O
mRNA NN I-NP O
level NN I-NP O
in IN B-PP O
regions NNS B-NP O
predominantly RB B-VP O
affected VBN I-VP O
in IN B-PP O
MJD NN B-NP B-Disease
. . O O

Thus RB B-NP O
additional JJ I-NP O
molecules NNS I-NP O
and CC O O
/ SYM B-NP O
or CC O O
regulatory JJ B-NP O
events NNS I-NP O
are VBP B-VP O
necessary JJ B-ADJP O
to TO B-VP O
explain VB I-VP O
the DT B-NP O
exclusive JJ I-NP O
degeneration NN I-NP B-Disease
of IN B-PP I-Disease
certain JJ B-NP I-Disease
brain NN I-NP I-Disease
areas NNS I-NP I-Disease
. . O O

Emerin NN B-NP B-Disease
, , O I-Disease
deficiency NN B-NP I-Disease
of IN B-PP O
which WDT B-NP O
causes VBZ B-VP O
Emery NNP B-NP B-Disease
- HYPH I-NP I-Disease
Dreifuss NNP I-NP I-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
, , O O
is VBZ B-VP O
localized VBN I-VP O
at IN B-PP O
the DT B-NP O
inner JJ I-NP O
nuclear JJ I-NP O
membrane NN I-NP O
. . O O

X NN B-NP B-Disease
- HYPH O I-Disease
linked VBN B-VP I-Disease
recessive JJ B-NP I-Disease
Emery NNP I-NP I-Disease
- HYPH I-NP I-Disease
Dreifuss NNP I-NP I-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
EDMD NN B-NP B-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
inherited VBN I-NP B-Disease
muscle NN I-NP I-Disease
disorder NN I-NP I-Disease
characterized VBN B-VP O
by IN B-PP O
the DT B-NP O
clinical JJ I-NP O
triad NN I-NP O
of IN B-PP O
progressive JJ B-NP O
wasting NN I-NP B-Disease
of IN B-PP I-Disease
humero AFX B-NP I-Disease
- HYPH I-NP I-Disease
peroneal JJ I-NP I-Disease
muscles NNS I-NP I-Disease
, , O O
early JJ B-NP O
contractures NNS I-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
elbows NNS I-NP I-Disease
, , O I-Disease
Achilles NNP B-NP I-Disease
tendons NNS I-NP I-Disease
and CC O I-Disease
postcervical JJ B-NP I-Disease
muscles NNS I-NP I-Disease
, , O O
and CC O O
cardiac JJ B-NP B-Disease
conduction NN I-NP I-Disease
block NN I-NP I-Disease
with IN B-PP O
a DT B-NP O
high JJ I-NP O
risk NN I-NP O
of IN B-PP O
sudden JJ B-NP B-Disease
death NN I-NP I-Disease
. . O O

The DT B-NP O
gene NN I-NP O
for IN B-PP O
EDMD NN B-NP B-Disease
on IN B-PP O
Xq28 NN B-NP O
encodes VBZ B-VP O
a DT B-NP O
novel JJ I-NP O
protein NN I-NP O
named VBN B-VP O
emerin NN B-NP O
that WDT B-NP O
localizes VBZ B-VP O
at IN B-PP O
the DT B-NP O
nuclear JJ I-NP O
membrane NN I-NP O
of IN B-PP O
skeletal JJ B-NP O
, , I-NP O
cardiac JJ I-NP O
and CC I-NP O
smooth JJ I-NP O
muscles NNS I-NP O
and CC O O
some DT B-NP O
other JJ I-NP O
non AFX I-NP O
- HYPH I-NP O
muscle NN I-NP O
tissues NNS I-NP O
. . O O

To TO B-VP O
investigate VB I-VP O
a DT B-NP O
possible JJ I-NP O
physiological JJ I-NP O
role NN I-NP O
for IN B-PP O
emerin NN B-NP O
, , O O
we PRP B-NP O
examined VBD B-VP O
the DT B-NP O
ultrastructural JJ I-NP O
localization NN I-NP O
of IN B-PP O
the DT B-NP O
protein NN I-NP O
in IN B-PP O
human JJ B-NP O
skeletal JJ I-NP O
muscle NN I-NP O
and CC I-NP O
HeLa NN I-NP O
cells NNS I-NP O
, , O O
using VBG B-VP O
ultrathin JJ B-NP O
cryosections NNS I-NP O
. . O O

We PRP B-NP O
found VBD B-VP O
that IN B-SBAR O
the DT B-NP O
immune JJ I-NP O
- HYPH I-NP O
labeled VBN B-VP O
colloidal JJ B-NP O
gold NN I-NP O
particles NNS I-NP O
were VBD B-VP O
localized VBN I-VP O
on IN B-PP O
the DT B-NP O
nucleoplasmic JJ I-NP O
surface NN I-NP O
of IN B-PP O
the DT B-NP O
inner JJ I-NP O
nuclear JJ I-NP O
membrane NN I-NP O
, , O O
but CC B-PP O
not RB I-PP O
on IN B-PP O
the DT B-NP O
nuclear JJ I-NP O
pore NN I-NP O
. . O O

Emerin NN B-NP O
stayed VBD B-VP O
on IN B-PP O
the DT B-NP O
cytoplasmic JJ I-NP O
surface NN I-NP O
of IN B-PP O
the DT B-NP O
nuclear JJ I-NP O
lamina NN I-NP O
, , O O
even RB B-ADVP O
after IN B-PP O
detergent NN B-NP O
treatment NN I-NP O
that WDT B-NP O
solubilizes VBZ B-VP O
membrane NN B-NP O
lipids NNS I-NP O
and CC O O
washes VBZ B-VP O
out RP B-PRT O
membrane NN B-NP O
proteins NNS I-NP O
. . O O

These DT B-NP O
results NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
emerin NN B-NP O
anchors NNS I-NP O
at IN B-PP O
the DT B-NP O
inner JJ I-NP O
nuclear JJ I-NP O
membrane NN I-NP O
through IN B-PP O
the DT B-NP O
hydrophobic JJ I-NP O
stretch NN I-NP O
, , O O
and CC O O
protrudes NNS B-NP O
from IN B-PP O
the DT B-NP O
hydrophilic JJ I-NP O
region NN I-NP O
to TO B-PP O
the DT B-NP O
nucleoplasm NN I-NP O
where WRB B-ADVP O
it PRP B-NP O
interacts VBZ B-VP O
with IN B-PP O
the DT B-NP O
nuclear JJ I-NP O
lamina NN I-NP O
. . O O

We PRP B-NP O
speculate VBP B-VP O
that IN B-SBAR O
emerin NN B-NP O
contributes VBZ B-VP O
to TO I-VP O
maintain VB I-VP O
the DT B-NP O
nuclear JJ I-NP O
structure NN I-NP O
and CC I-NP O
stability NN I-NP O
, , O O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
nuclear JJ B-NP O
functions NNS I-NP O
, , O O
particularly RB B-ADVP O
in IN B-PP O
muscle NN B-NP O
tissues NNS I-NP O
that WDT B-NP O
have VBP B-VP O
severe JJ B-NP O
stress NN I-NP O
with IN B-PP O
rigorous JJ B-NP O
contraction NN I-NP O
- HYPH B-NP O
relaxation NN I-NP O
movements NNS I-NP O
and CC O O
calcium NN B-NP O
flux NN I-NP O
. . O O

. . O O

Locus NN B-NP O
heterogeneity NN I-NP O
in IN B-PP O
Friedreich NNP B-NP B-Disease
ataxia NN I-NP I-Disease
. . O O

Friedreich NN B-NP B-Disease
ataxia NN I-NP I-Disease
( ( O O
FRDA NN B-NP B-Disease
) ) O O
is VBZ B-VP O
the DT B-NP O
most RBS I-NP O
common JJ I-NP O
form NN I-NP O
of IN B-PP O
autosomal JJ B-NP B-Disease
recessive JJ I-NP I-Disease
ataxia NN I-NP I-Disease
. . O O

The DT B-NP O
disease NN I-NP O
locus NN I-NP O
was VBD B-VP O
assigned VBN I-VP O
to TO B-PP O
chromosome NN B-NP O
9 CD I-NP O
and CC O O
the DT B-NP O
disease NN I-NP O
gene NN I-NP O
, , O O
STM7 NN B-NP O
/ SYM B-NP O
X25 NN I-NP O
, , O O
has VBZ B-VP O
been VBN I-VP O
isolated VBN I-VP O
. . O O

To TO B-VP O
date VB I-VP O
most JJS B-NP O
data NNS I-NP O
suggest VBP B-VP O
locus NN B-NP O
homogeneity NN I-NP O
in IN B-PP O
FRDA NN B-NP B-Disease
. . O O

We PRP B-NP O
now RB B-ADVP O
provide VBP B-VP O
strong JJ B-NP O
evidence NN I-NP O
of IN B-PP O
a DT B-NP O
second JJ I-NP O
FRDA NN I-NP B-Disease
locus NN I-NP O
. . O O

Studying VBG B-VP O
two CD B-NP O
siblings NNS I-NP O
with IN B-PP O
FRDA NN B-NP B-Disease
from IN B-PP O
two CD B-NP O
families NNS I-NP O
we PRP B-NP O
did VBD B-VP O
not RB I-VP O
detect VB I-VP O
a DT B-NP O
mutation NN I-NP O
in IN B-PP O
STM7 NN B-NP O
/ SYM B-NP O
X25 NN I-NP O
. . O O

Haplotype NN B-NP O
analysis NN I-NP O
of IN B-PP O
the DT B-NP O
STM7 NN I-NP O
/ SYM B-NP O
X25 NN I-NP O
region NN I-NP O
of IN B-PP O
chromosome NN B-NP O
9 CD I-NP O
demonstrated VBD B-VP O
that IN B-SBAR O
the DT B-NP O
relevant JJ I-NP O
portion NN I-NP O
of IN B-PP O
chromosome NN B-NP O
9 CD I-NP O
differs VBZ B-VP O
in IN B-PP O
the DT B-NP O
patients NNS I-NP O
. . O O

Although IN B-SBAR O
the DT B-NP O
patients NNS I-NP O
studied VBN B-VP O
had VBD B-VP O
typical JJ B-NP O
FRDA NN I-NP B-Disease
, , O O
one CD B-NP O
sibpair NN I-NP O
had VBD B-VP O
the DT B-NP O
uncommon JJ I-NP O
symptom NN I-NP O
of IN B-PP O
retained VBN B-NP O
tendon NN I-NP O
reflexes NNS I-NP O
. . O O

In IN B-SBAR O
order NN O O
to TO B-VP O
investigate VB I-VP O
whether IN B-SBAR O
retained VBN B-NP O
tendon NN I-NP O
reflexes NNS I-NP O
are VBP B-VP O
characteristic JJ B-ADJP O
of IN B-PP O
FRDA NN B-NP B-Disease
caused VBN B-VP O
by IN B-PP O
the DT B-NP O
second JJ I-NP O
locus NN I-NP O
, , O O
FRDA2 NN B-NP O
, , O O
we PRP B-NP O
studied VBD B-VP O
an DT B-NP O
unrelated JJ I-NP O
FRDA NN I-NP B-Disease
patient NN I-NP O
with IN B-PP O
retained VBN B-NP O
tendon NN I-NP O
reflexes NNS I-NP O
. . O O

The DT B-NP O
observation NN I-NP O
of IN B-PP O
typical JJ B-NP O
mutations NNS I-NP O
in IN B-PP O
STM7 NN B-NP O
/ SYM O O
X25 NN B-NP O
( ( O O
GAA NN B-NP O
expansions NNS I-NP O
) ) O O
in IN B-PP O
this DT B-NP O
patient NN I-NP O
demonstrates VBZ B-VP O
that IN B-SBAR O
the DT B-NP O
two CD I-NP O
genetically RB I-NP O
different JJ I-NP O
forms NNS I-NP O
of IN B-PP O
FRDA NN B-NP B-Disease
cannot MD B-VP O
be VB I-VP O
distinguished VBN I-VP O
clinically RB B-ADVP O
. . O O

. . O O

Glycerol NN B-NP O
as IN B-PP O
a DT B-NP O
correlate NN I-NP O
of IN B-PP O
impaired JJ B-NP B-Disease
glucose NN I-NP I-Disease
tolerance NN I-NP I-Disease
: : O O
dissection NN B-NP O
of IN B-PP O
a DT B-NP O
complex JJ I-NP O
system NN I-NP O
by IN B-PP O
use NN B-NP O
of IN B-PP O
a DT B-NP O
simple JJ I-NP O
genetic JJ I-NP O
trait NN I-NP O
. . O O

Glycerol NN B-NP O
kinase NN I-NP O
( ( O O
GK NN B-NP O
) ) O O
represents VBZ B-VP O
the DT B-NP O
primary JJ I-NP O
entry NN I-NP O
of IN B-PP O
glycerol NN B-NP O
into IN B-PP O
glucose NN B-NP O
and CC I-NP O
triglyceride NN I-NP O
metabolism NN I-NP O
. . O O

Impaired JJ B-NP B-Disease
glucose NN I-NP I-Disease
tolerance NN I-NP I-Disease
( ( O O
IGT NN B-NP B-Disease
) ) O O
and CC O O
hypertriglyceridemia NN B-NP B-Disease
are VBP B-VP O
associated VBN I-VP O
with IN B-PP O
an DT B-NP O
increased VBN I-NP O
risk NN I-NP O
of IN B-PP O
diabetes NN B-NP B-Disease
mellitus NN I-NP I-Disease
and CC O O
cardiovascular JJ B-NP B-Disease
disease NN I-NP I-Disease
. . O O

The DT B-NP O
relationship NN I-NP O
between IN B-PP O
glycerol NN B-NP O
and CC O O
the DT B-NP O
risk NN I-NP O
of IN B-PP O
IGT NN B-NP B-Disease
, , O O
however RB B-ADVP O
, , O O
is VBZ B-VP O
poorly RB B-ADJP O
understood VBN I-ADJP O
. . O O

We PRP B-NP O
therefore RB B-ADVP O
undertook VBD B-VP O
the DT B-NP O
study NN I-NP O
of IN B-PP O
fasting VBG B-VP O
plasma NN B-NP O
glycerol NN I-NP O
levels NNS I-NP O
in IN B-PP O
a DT B-NP O
cohort NN I-NP O
of IN B-PP O
1 CD B-NP O
, , O O
056 CD B-NP O
unrelated JJ I-NP O
men NNS I-NP O
and CC I-NP O
women NNS I-NP O
of IN B-PP O
French JJ B-NP O
- HYPH I-NP O
Canadian JJ I-NP O
descent NN I-NP O
. . O O

Family RB B-NP O
screening NN I-NP O
in IN B-PP O
the DT B-NP O
initial JJ I-NP O
cohort JJ I-NP O
identified VBN B-VP O
18 CD B-NP O
men NNS I-NP O
from IN B-PP O
five CD B-NP O
families NNS I-NP O
with IN B-PP O
severe JJ B-NP O
hyperglycerolemia NN I-NP B-Disease
( ( O O
values NNS B-NP O
above IN B-PP O
2 CD B-NP O
. . O O

0 CD B-NP O
mmol NN I-NP O
/ SYM B-NP O
liter NN I-NP O
) ) O O
and CC O O
demonstrated VBD B-VP O
an DT B-NP O
X NN I-NP O
- HYPH B-VP O
linked VBN B-NP O
pattern NN I-NP O
of IN B-PP O
inheritance NN B-NP O
. . O O

Linkage NN B-NP O
analysis NN I-NP O
of IN B-PP O
the DT B-NP O
data NNS I-NP O
from IN B-PP O
12 CD B-NP O
microsatellite NN I-NP O
markers NNS I-NP O
surrounding VBG B-VP O
the DT B-NP O
Xp21 NN I-NP O
. . O O

3 CD B-NP O
GK NN I-NP O
gene NN I-NP O
resulted VBD B-VP O
in IN B-PP O
a DT B-NP O
peak JJ I-NP O
LOD NN I-NP O
score NN I-NP O
of IN B-PP O
3 CD B-NP O
. . O O

46 CD B-NP O
, , O O
centered VBN B-ADJP O
around IN B-PP O
marker NN B-NP O
DXS8039 NN I-NP O
. . O O

In IN B-PP O
addition NN B-NP O
, , O O
since IN B-SBAR O
all DT B-NP O
of IN B-PP O
the DT B-NP O
families NNS I-NP O
originated VBN B-VP O
in IN B-PP O
a DT B-NP O
population NN I-NP O
with IN B-PP O
a DT B-NP O
proven JJ I-NP O
founder NN I-NP O
effect NN I-NP O
- HYPH O O
the DT B-NP O
Saguenay NNP I-NP O
Lac NNP I-NP O
- HYPH I-NP O
St NNP I-NP O
. . O O

- HYPH B-NP O
Jean JJ I-NP O
region NN I-NP O
of IN B-PP O
Quebec NNP B-NP O
- : O O
a DT B-NP O
common JJ I-NP O
disease NN I-NP O
haplotype NN I-NP O
was VBD B-VP O
sought VBN I-VP O
. . O O

Indeed RB B-ADVP O
, , O O
a DT B-NP O
six CD I-NP O
- HYPH I-NP O
marker NN I-NP O
haplotype NN I-NP O
extending VBG B-VP O
over IN B-PP O
a DT B-NP O
region NN I-NP O
of IN B-PP O
5 CD B-NP O
. . O O

5 CD B-NP O
cM NN I-NP O
was VBD B-VP O
observed VBN I-VP O
in IN B-PP O
all DT B-NP O
families NNS I-NP O
. . O O

Resequencing NN B-NP O
of IN B-PP O
the DT B-NP O
GK NN I-NP O
gene NN I-NP O
in IN B-PP O
family NN B-NP O
members NNS I-NP O
led VBD B-VP O
to TO B-PP O
the DT B-NP O
discovery NN I-NP O
of IN B-PP O
a DT B-NP O
N288D NN I-NP O
missense JJ I-NP O
mutation NN I-NP O
in IN B-PP O
exon NN B-NP O
10 CD I-NP O
, , O O
which WDT B-NP O
resulted VBD B-VP O
in IN B-PP O
the DT B-NP O
substitution NN I-NP O
of IN B-PP O
a DT B-NP O
highly RB I-NP O
conserved VBN I-NP O
asparagine NN I-NP O
residue NN I-NP O
by IN B-PP O
a DT B-NP O
negatively RB I-NP O
charged VBN I-NP O
aspartic JJ I-NP O
acid NN I-NP O
. . O O

Clinical JJ B-NP O
and CC I-NP O
molecular JJ I-NP O
genetics NNS I-NP O
of IN B-PP O
primary JJ B-NP B-Disease
dystonias NNS I-NP I-Disease
. . O O

Primary JJ B-NP B-Disease
dystonias NNS I-NP I-Disease
are VBP B-VP O
movement NN B-NP B-Disease
disorders NNS I-NP I-Disease
with IN B-PP O
dystonia NN B-NP B-Disease
as IN B-PP O
a DT B-NP O
major JJ I-NP O
symptom NN I-NP O
. . O O

They PRP B-NP O
are VBP B-VP O
frequently RB I-VP O
inherited VBN I-VP O
as IN B-PP O
Mendelian JJ B-NP O
traits NNS I-NP O
. . O O

There EX B-NP O
are VBP B-VP O
at IN B-NP O
least JJS I-NP O
eight CD I-NP O
clinically RB I-NP O
distinct JJ I-NP O
autosomal JJ I-NP O
dominant JJ I-NP O
and CC I-NP O
two CD I-NP O
X SYM B-NP O
- HYPH B-VP O
linked VBN B-NP O
recessive JJ I-NP O
forms NNS I-NP O
. . O O

In IN B-PP O
addition NN B-NP O
, , O O
pedigree NN B-NP O
analyses NNS I-NP O
suggest VBP B-VP O
the DT B-NP O
occurrence NN I-NP O
of IN B-PP O
an DT B-NP O
autosomal JJ I-NP O
recessive JJ I-NP O
variant NN I-NP O
. . O O

The DT B-NP O
clinical JJ I-NP O
classification NN I-NP O
is VBZ B-VP O
increasingly RB I-VP O
being VBG I-VP O
replaced VBN I-VP O
by IN B-PP O
a DT B-NP O
genetic JJ I-NP O
one CD I-NP O
. . O O

To TO B-PP O
date NN B-NP O
gene NN I-NP O
loci NNS I-NP O
have VBP B-VP O
been VBN I-VP O
identified VBN I-VP O
in IN B-PP O
at IN B-NP O
least JJS I-NP O
six CD I-NP O
autosomal JJ I-NP O
dominant JJ I-NP O
forms NNS I-NP O
, , O O
i NN B-NP O
. . I-NP O

e NN I-NP O
. . O O

, , O O
in IN B-PP O
idiopathic JJ B-NP B-Disease
torsion NN I-NP I-Disease
dystonia NN I-NP I-Disease
( ( O O
9q34 CD B-NP O
) ) O O
, , O O
focal JJ B-NP B-Disease
dystonia NN I-NP I-Disease
( ( O O
18p NN B-NP O
) ) O O
, , O O
adult JJ B-NP O
- HYPH I-NP O
onset NN I-NP O
idiopathic JJ I-NP B-Disease
torsion NN I-NP I-Disease
dystonia NN I-NP I-Disease
of IN B-PP O
mixed VBN B-NP O
type NN I-NP O
( ( O O
8p21 NN B-NP O
- HYPH B-NP O
q22 NN I-NP O
) ) O O
, , O O
dopa NN B-NP B-Disease
- HYPH B-NP I-Disease
responsive JJ I-NP I-Disease
dystonia NN I-NP I-Disease
( ( O O
14q22 CD B-NP O
. . O O

1 CD B-NP O
- HYPH I-NP O
q22 NN I-NP O
. . I-NP O

2 CD I-NP O
) ) O O
, , O O
and CC O O
paroxysmal JJ B-NP B-Disease
dystonic JJ I-NP I-Disease
choreoathetosis NN I-NP I-Disease
( ( O O
2q25 CD B-NP O
- HYPH I-NP O
q33 NN I-NP O
; : O O
1p21 NN B-NP O
- HYPH I-NP O
p13 NN I-NP O
. . I-NP O

3 CD I-NP O
) ) O O
. . O O

Gene NN B-NP O
loci NNS I-NP O
in IN B-PP O
the DT B-NP O
X NN I-NP O
- HYPH B-VP O
linked VBN I-VP O
recessive JJ B-NP O
forms NNS I-NP O
have VBP B-VP O
been VBN I-VP O
assigned VBN I-VP O
to TO B-PP O
Xq13 NN B-NP O
. . O O

1 CD B-NP O
in IN B-PP O
the DT B-NP O
X NN I-NP B-Disease
- HYPH B-VP I-Disease
linked VBN B-NP I-Disease
dystonia NN I-NP I-Disease
parkinsonism NN I-NP I-Disease
syndrome NN I-NP I-Disease
and CC B-PP O
to TO B-PP O
Xq22 NN B-NP O
in IN B-PP O
X NN B-NP B-Disease
- HYPH O I-Disease
linked VBN B-VP I-Disease
sensorineural JJ B-NP I-Disease
deafness NN I-NP I-Disease
, , O O
dystonia NN B-NP B-Disease
, , O O
and CC O O
mental JJ B-NP B-Disease
retardation NN I-NP I-Disease
. . O O

The DT B-NP O
disease NN I-NP O
genes NNS I-NP O
have VBP B-VP O
been VBN I-VP O
identified VBN I-VP O
in IN B-PP O
two CD B-NP O
autosomal JJ I-NP O
dominant JJ I-NP O
forms NNS I-NP O
and CC O O
in IN B-PP O
one CD B-NP O
X SYM B-NP O
- HYPH B-VP O
linked VBN B-NP O
recessive JJ I-NP O
form NN I-NP O
. . O O

Mutations NNS B-NP O
in IN B-PP O
a DT B-NP O
gene NN I-NP O
coding VBG B-VP O
for IN B-PP O
an DT B-NP O
ATP NN I-NP O
- HYPH B-PP O
binding VBG B-NP O
protein NN I-NP O
were VBD B-VP O
detected VBN I-VP O
in IN B-PP O
idiopathic JJ B-NP B-Disease
torsion NN I-NP I-Disease
dystonia NN I-NP I-Disease
( ( O O
DYT1 NN B-NP O
) ) O O
, , O O
and CC O O
the DT B-NP O
GTP NN I-NP O
cyclohydrolase NN I-NP O
1 CD I-NP O
gene NN I-NP O
is VBZ B-VP O
mutated VBN I-VP O
in IN B-PP O
dopa NN B-NP B-Disease
- HYPH B-NP I-Disease
responsive JJ I-NP I-Disease
dystonia NN I-NP I-Disease
( ( O O
DYT5 NN B-NP O
) ) O O
. . O O

In IN B-PP O
sensorineural JJ B-NP B-Disease
deafness NN I-NP I-Disease
, , O O
dystonia NN B-NP B-Disease
, , O O
and CC O O
mental JJ B-NP B-Disease
retardation NN I-NP I-Disease
, , O O
mutations NNS B-NP O
were VBD B-VP O
found VBN I-VP O
in IN B-PP O
the DT B-NP O
gene NN I-NP O
DDP NN I-NP O
coding VBG B-VP O
for IN B-PP O
a DT B-NP O
polypeptide NN I-NP O
of IN B-PP O
unknown JJ B-NP O
function NN I-NP O
. . O O

This DT B-NP O
article NN I-NP O
reviews VBZ B-VP O
the DT B-NP O
clinical JJ I-NP O
and CC I-NP O
molecular JJ I-NP O
genetics NNS I-NP O
of IN B-PP O
primary JJ B-NP B-Disease
dystonias NNS I-NP I-Disease
, , O O
critically RB B-VP O
discusses VBZ I-VP O
present JJ B-NP O
findings NNS I-NP O
, , O O
and CC O O
proposes VBZ B-VP O
referring VBG I-VP O
to TO B-PP O
the DT B-NP O
known JJ I-NP O
forms NNS I-NP O
, , O O
most JJS B-NP O
of IN B-PP O
which WDT B-NP O
can MD B-VP O
be VB I-VP O
distinguished VBN I-VP O
by IN B-PP O
genetic JJ B-NP O
criteria NNS I-NP O
, , O O
as IN B-SBAR O
dystonias NNS B-NP B-Disease
1 CD I-NP I-Disease
- HYPH I-NP I-Disease
12 CD I-NP I-Disease
. . O O

Determination NN B-NP O
of IN B-PP O
30 CD B-NP O
X SYM I-NP B-Disease
- HYPH I-NP I-Disease
linked VBN I-NP I-Disease
adrenoleukodystrophy NN I-NP I-Disease
mutations NNS I-NP O
, , O O
including VBG B-PP O
15 CD B-NP O
not RB B-VP O
previously RB I-VP O
described VBN I-VP O
. . O O

X NN B-NP B-Disease
- HYPH O I-Disease
linked VBN B-VP I-Disease
Adrenoleukodystrophy NN B-NP I-Disease
( ( O O
X NN B-NP B-Disease
- HYPH B-NP I-Disease
ALD NN I-NP I-Disease
) ) O O
is VBZ B-VP O
the DT B-NP O
most RBS I-NP O
frequent JJ I-NP O
peroxisomal JJ I-NP B-Disease
disease NN I-NP I-Disease
. . O O

It PRP B-NP O
mainly RB B-ADVP O
involves VBZ B-VP O
the DT B-NP O
nervous JJ I-NP O
system NN I-NP O
white JJ I-NP O
matter NN I-NP O
, , O O
adrenal JJ B-NP O
cortex NN I-NP O
and CC I-NP O
testes NNS I-NP O
. . O O

Several JJ B-NP O
distinct JJ I-NP O
clinical JJ I-NP O
phenotypes NNS I-NP O
are VBP B-VP O
known VBN I-VP O
. . O O

The DT B-NP O
principal JJ I-NP O
biochemical JJ I-NP O
abnormality NN I-NP O
is VBZ B-VP O
the DT B-NP O
accumulation NN I-NP O
of IN B-PP O
saturated VBN B-NP O
very RB I-NP O
- HYPH I-NP O
long JJ I-NP O
- HYPH I-NP O
chain NN I-NP O
fatty JJ I-NP O
acids NNS I-NP O
( ( O O
VLCFAs NNS B-NP O
> SYM O O
C22 NN B-NP O
0 CD I-NP O
, , O O
mainly RB B-ADVP O
C26 NN B-NP O
0 CD I-NP O
) ) O O
, , O O
which WDT B-NP O
is VBZ B-VP O
due JJ B-ADJP O
to TO B-PP O
impaired VBN B-NP O
capacity NN I-NP O
for IN B-PP O
beta SYM B-NP O
- HYPH B-VP O
oxidation NN B-NP O
in IN B-PP O
peroxisomes NNS B-NP O
. . O O

Diagnosis NN B-NP O
is VBZ B-VP O
usually RB I-VP O
based VBN I-VP O
on IN B-PP O
the DT B-NP O
VLCFA NN I-NP O
levels NNS I-NP O
in IN B-PP O
plasma NN B-NP O
or CC O O
cultured VBN B-NP O
skin NN I-NP O
fibroblasts NNS I-NP O
in IN B-PP O
both CC B-NP O
patients NNS I-NP O
and CC I-NP O
carriers NNS I-NP O
. . O O

In IN B-PP O
0 CD B-NP O
. . O O

1 CD B-NP O
% NN I-NP O
of IN B-PP O
affected VBN B-NP O
males NNS I-NP O
, , O O
however RB B-ADVP O
, , O O
the DT B-NP O
plasma NN I-NP O
C26 NN I-NP O
0 CD I-NP O
level NN I-NP O
is VBZ B-VP O
borderline JJ B-ADJP O
normal JJ B-ADJP O
, , O O
and CC O O
15 CD B-NP O
% NN I-NP O
of IN B-PP O
obligate JJ B-NP O
female JJ I-NP O
carriers NNS I-NP O
have VBP B-VP O
normal JJ B-NP O
results NNS I-NP O
. . O O

Effective JJ B-NP O
mutation NN I-NP O
detection NN I-NP O
in IN B-PP O
these DT B-NP O
families NNS I-NP O
is VBZ B-VP O
therefore RB B-ADVP O
fundamental JJ B-ADJP O
to TO B-VP O
unambiguously RB I-VP O
determine VB I-VP O
the DT B-NP O
genetic JJ I-NP O
status NN I-NP O
of IN B-PP O
each DT B-NP O
individual NN I-NP O
at IN B-PP O
risk NN B-NP O
. . O O

Of IN B-PP O
particular JJ B-NP O
concern NN I-NP O
are VBP B-VP O
female JJ B-NP O
members NNS I-NP O
of IN B-PP O
kindreds NNS B-NP O
segregating VBG B-VP O
X NN B-NP B-Disease
- HYPH B-NP I-Disease
ALD NN I-NP I-Disease
mutations NNS I-NP O
, , O O
because IN B-SBAR O
normal JJ B-NP O
VLCFA NN I-NP O
levels NNS I-NP O
do VBP B-VP O
not RB I-VP O
guarantee VB I-VP O
lack NN B-NP O
of IN B-PP O
carrier NN B-NP O
status NN I-NP O
. . O O

We PRP B-NP O
describe VBP B-VP O
a DT B-NP O
fast JJ I-NP O
method NN I-NP O
for IN B-PP O
detection NN B-NP O
of IN B-PP O
X NN B-NP B-Disease
- HYPH B-NP I-Disease
ALD NN I-NP I-Disease
mutations NNS I-NP O
. . O O

The DT B-NP O
method NN I-NP O
is VBZ B-VP O
based VBN I-VP O
on IN B-PP O
SSCP NN B-NP O
analysis NN I-NP O
of IN B-PP O
nested JJ B-NP O
PCR NN I-NP O
fragments NNS I-NP O
followed VBN B-VP O
by IN B-PP O
sequence NN B-NP O
- HYPH B-NP O
determination NN I-NP O
reactions NNS I-NP O
. . O O

Using VBG B-VP O
this DT B-NP O
methodology NN I-NP O
we PRP B-NP O
have VBP B-VP O
found VBN I-VP O
X NN B-NP B-Disease
- HYPH B-NP I-Disease
ALD NN I-NP I-Disease
mutations NNS I-NP O
in IN B-PP O
30 CD B-NP O
kindreds NNS I-NP O
, , O O
including VBG B-PP O
15 CD B-NP O
not RB O O
previously RB B-VP O
reported VBN I-VP O
. . O O

beta SYM O O
- HYPH B-NP O
galactosidase NN I-NP O
gene NN I-NP O
mutations NNS I-NP O
affecting VBG B-VP O
the DT B-NP O
lysosomal JJ I-NP O
enzyme NN I-NP O
and CC O O
the DT B-NP O
elastin NN I-NP O
- HYPH B-PP O
binding VBG B-NP O
protein NN I-NP O
in IN B-PP O
GM1 NN B-NP B-Disease
- HYPH O I-Disease
gangliosidosis NN B-NP I-Disease
patients NNS I-NP O
with IN B-PP O
cardiac JJ B-NP B-Disease
involvement NN I-NP I-Disease
. . O O

GM1 NN B-NP B-Disease
- HYPH I-NP I-Disease
gangliosidosis NN I-NP I-Disease
is VBZ B-VP O
a DT B-NP O
lysosomal JJ I-NP B-Disease
storage NN I-NP I-Disease
disorder NN I-NP I-Disease
caused VBN B-VP O
by IN B-PP O
deficiency NN B-NP B-Disease
of IN B-PP I-Disease
acid NN B-NP I-Disease
beta SYM O I-Disease
- HYPH O I-Disease
galactosidase NN B-NP I-Disease
( ( O O
GLB1 NN B-NP O
) ) O O
. . O O

We PRP B-NP O
report VBP B-VP O
five CD B-NP O
new JJ I-NP O
beta SYM I-NP O
- HYPH I-NP O
galactosidase NN I-NP O
gene NN I-NP O
mutations NNS I-NP O
in IN B-PP O
nine CD B-NP O
Italian JJ I-NP O
patients NNS I-NP O
and CC O O
one CD B-NP O
fetus NN I-NP O
, , O O
segregating VBG B-VP O
in IN B-PP O
seven CD B-NP O
unrelated JJ I-NP O
families NNS I-NP O
. . O O

Six CD B-NP O
of IN B-PP O
the DT B-NP O
eight CD I-NP O
patients NNS I-NP O
with IN B-PP O
the DT B-NP O
infantile JJ I-NP O
, , I-NP O
severe JJ I-NP O
form NN I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
presented VBD B-VP O
cardiac JJ B-NP B-Disease
involvement NN I-NP I-Disease
, , O O
a DT B-NP O
feature NN I-NP O
rarely RB B-VP O
associated VBN I-VP O
with IN B-PP O
GM1 NN B-NP B-Disease
- HYPH I-NP I-Disease
gangliosidosis NN I-NP I-Disease
. . O O

Molecular JJ B-NP O
analysis NN I-NP O
of IN B-PP O
the DT B-NP O
patients NNS I-NP O
RNA NN I-NP O
and CC I-NP O
DNA NN I-NP O
identified VBD B-VP O
two CD B-NP O
new JJ I-NP O
RNA NN I-NP O
splicing NN I-NP O
defects NNS I-NP O
, , O O
three CD B-NP O
new JJ I-NP O
and CC I-NP O
three CD I-NP O
previously RB I-NP O
described VBN I-NP O
amino JJ I-NP O
acid NN I-NP O
substitutions NNS I-NP O
. . O O

Interestingly RB B-ADVP O
, , O O
all DT B-NP O
patients NNS I-NP O
with IN B-PP O
cardiac JJ B-NP B-Disease
involvement NN I-NP I-Disease
were VBD B-VP O
homozygous JJ B-ADJP O
for IN B-PP O
one CD B-NP O
of IN B-PP O
these DT B-NP O
mutations NNS I-NP O
R59H NN I-NP O
, , O O
Y591C NN B-NP O
, , O O
Y591N NN B-NP O
, , O O
or CC O O
IVS14 NN B-NP O
- HYPH B-NP O
2A NN I-NP O
> SYM I-NP O
G NN I-NP O
. . O O

In IN B-PP O
contrast NN B-NP O
, , O O
all DT B-NP O
other JJ I-NP O
patients NNS I-NP O
were VBD B-VP O
compound NN B-ADJP O
heterozygous JJ I-ADJP O
for IN B-PP O
one CD B-NP O
of IN B-PP O
the DT B-NP O
following VBG I-NP O
mutations NNS I-NP O
R201H NN I-NP O
, , O O
R482H NN B-NP O
, , O O
G579D NN B-NP O
, , O O
IVS8 NN B-NP O
+ SYM B-NP O
2T NN I-NP O
> SYM I-NP O
C NN I-NP O
. . O O

Although IN B-SBAR O
we PRP B-NP O
could MD B-VP O
not RB I-VP O
directly RB I-VP O
correlate VB I-VP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
cardiac JJ B-NP B-Disease
abnormalities NNS I-NP I-Disease
with IN B-PP O
specific JJ B-NP O
genetic JJ I-NP B-Disease
lesions NNS I-NP I-Disease
, , O O
the DT B-NP O
mutations NNS I-NP O
identified VBN B-VP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
cardiomyopathy NN B-NP B-Disease
fell VBD B-VP O
in IN B-PP O
the DT B-NP O
GLB1 NN I-NP O
cDNA NN I-NP O
region NN I-NP O
common JJ B-ADJP O
to TO B-PP O
the DT B-NP O
lysosomal JJ I-NP O
enzyme NN I-NP O
and CC O O
the DT B-NP O
Hbeta NN I-NP O
- HYPH B-NP O
Gal NN I-NP O
- HYPH B-NP O
related VBN I-NP O
protein NN I-NP O
, , O O
also RB B-VP O
known VBN I-VP O
as IN B-PP O
the DT B-NP O
elastin NN I-NP O
binding NN I-NP O
protein NN I-NP O
( ( O O
EBP NN B-NP O
) ) O O
. . O O

Consequently RB B-ADVP O
, , O O
both DT B-NP O
molecules NNS I-NP O
are VBP B-VP O
affected VBN I-VP O
by IN B-PP O
the DT B-NP O
mutations NNS I-NP O
, , O O
and CC O O
they PRP B-NP O
may MD B-VP O
contribute VB I-VP O
differently RB B-ADVP O
to TO B-PP O
the DT B-NP O
occurrence NN I-NP O
of IN B-PP O
specific JJ B-NP O
clinical JJ I-NP O
manifestations NNS I-NP O
. . O O

. . O O

In FW B-NP O
vivo FW I-NP O
modulation NN I-NP O
of IN B-PP O
Hmgic NN B-NP O
reduces VBZ B-VP O
obesity NN B-NP B-Disease
. . O O

The DT B-NP O
HMGI NN I-NP O
family NN I-NP O
of IN B-PP O
proteins NNS B-NP O
consists VBZ B-VP O
of IN B-PP O
three CD B-NP O
members NNS I-NP O
, , O O
HMGIC NN B-NP O
, , O O
HMGI NN B-NP O
and CC O O
HMGI NN B-NP O
( ( O O
Y NN B-NP O
) ) O O
, , O O
that WDT B-NP O
function VBP B-VP O
as IN B-PP O
architectural JJ B-NP O
factors NNS I-NP O
and CC O O
are VBP B-VP O
essential JJ B-NP O
components NNS I-NP O
of IN B-PP O
the DT B-NP O
enhancesome NN I-NP O
. . O O

HMGIC NN B-NP O
is VBZ B-VP O
predominantly RB I-VP O
expressed VBN I-VP O
in IN B-PP O
proliferating VBG B-VP O
, , O O
undifferentiated JJ B-NP O
mesenchymal JJ I-NP O
cells NNS I-NP O
and CC O O
is VBZ B-VP O
not RB I-VP O
detected VBN I-VP O
in IN B-PP O
adult JJ B-NP O
tissues NNS I-NP O
. . O O

It PRP B-NP O
is VBZ B-VP O
disrupted VBN I-VP O
and CC I-VP O
misexpressed VBN I-VP O
in IN B-PP O
a DT B-NP O
number NN I-NP O
of IN B-PP O
mesenchymal JJ B-NP B-Disease
tumour NN I-NP I-Disease
cell NN I-NP O
types NNS I-NP O
, , O O
including VBG B-PP O
fat JJ B-NP B-Disease
- HYPH I-NP I-Disease
cell NN I-NP I-Disease
tumours NNS I-NP I-Disease
( ( O O
lipomas NNS B-NP B-Disease
) ) O O
. . O O

In IN B-PP O
addition NN B-NP O
Hmgic JJ B-ADJP O
- HYPH O O
/ SYM O O
- HYPH O O
mice NNS B-NP O
have VBP B-VP O
a DT B-NP O
deficiency NN I-NP O
in IN B-PP O
fat JJ B-NP O
tissue NN I-NP O
. . O O

To TO B-VP O
study VB I-VP O
its PRP$ B-NP O
role NN I-NP O
in IN B-PP O
adipogenesis NN B-NP O
and CC I-NP O
obesity NN I-NP B-Disease
, , O O
we PRP B-NP O
examined VBD B-VP O
Hmgic JJ B-NP O
expression NN I-NP O
in IN B-PP O
the DT B-NP O
adipose NN I-NP O
tissue NN I-NP O
of IN B-PP O
adult JJ B-NP O
, , I-NP O
obese JJ I-NP B-Disease
mice NNS I-NP O
. . O O

Mice NNS B-NP O
with IN B-PP O
a DT B-NP O
partial JJ I-NP B-Disease
or CC I-NP I-Disease
complete JJ I-NP I-Disease
deficiency NN I-NP I-Disease
of IN B-PP I-Disease
Hmgic JJ B-NP I-Disease
resisted VBD B-VP O
diet NN B-NP O
- HYPH B-NP O
induced VBN I-NP O
obesity NN I-NP B-Disease
. . O O

Disruption NN B-NP O
of IN B-PP O
Hmgic NNP B-NP O
caused VBD B-VP O
a DT B-NP O
reduction NN I-NP O
in IN B-PP O
the DT B-NP O
obesity NN I-NP B-Disease
induced VBN B-VP O
by IN B-PP O
leptin NN B-NP B-Disease
deficiency NN I-NP I-Disease
( ( O O
Lepob NN B-NP O
/ SYM B-NP O
Lepob NN I-NP O
) ) O O
in IN B-PP O
a DT B-NP O
gene NN I-NP O
- HYPH B-NP O
dose NN I-NP O
- HYPH B-NP O
dependent JJ I-NP O
manner NN I-NP O
. . O O

Our PRP$ B-NP O
studies NNS I-NP O
implicate VBP B-VP O
a DT B-NP O
role NN I-NP O
for IN B-PP O
HMGIC NN B-NP O
in IN B-PP O
fat NN B-NP O
- HYPH B-NP O
cell NN I-NP O
proliferation NN I-NP O
, , O O
indicating VBG B-VP O
that IN B-SBAR O
it PRP B-NP O
may MD B-VP O
be VB I-VP O
an DT B-NP O
adipose NN I-NP O
- HYPH B-NP O
specific JJ I-NP O
target NN I-NP O
for IN B-PP O
the DT B-NP O
treatment NN I-NP O
of IN B-PP O
obesity NN B-NP B-Disease
. . O O

. . O O

Molecular JJ B-NP O
analysis NN I-NP O
of IN B-PP O
the DT B-NP O
genotype NN I-NP O
- HYPH B-NP O
phenotype NN I-NP O
relationship NN I-NP O
in IN B-PP O
factor NN B-NP B-Disease
X NN I-NP I-Disease
deficiency NN I-NP I-Disease
. . O O

Factor NN B-NP B-Disease
X SYM I-NP I-Disease
deficiency NN I-NP I-Disease
is VBZ B-VP O
a DT B-NP O
rare JJ I-NP O
haemorrhagic JJ I-NP B-Disease
condition NN I-NP I-Disease
, , O O
normally RB B-VP O
inherited VBN I-VP O
as IN B-PP O
an DT B-NP O
autosomal JJ I-NP O
recessive JJ I-NP O
trait NN I-NP O
, , O O
in IN B-PP O
which WDT B-NP O
a DT B-NP O
variable JJ I-NP O
clinical JJ I-NP O
presentation NN I-NP O
correlates VBZ B-VP O
poorly RB B-ADVP O
with IN B-PP O
laboratory NN B-NP O
phenotype NN I-NP O
. . O O

The DT B-NP O
factor NN I-NP O
X NN I-NP O
( ( O O
F10 NN B-NP O
) ) O O
genes NNS B-NP O
of IN B-PP O
14 CD B-NP O
unrelated JJ I-NP O
individuals NNS I-NP O
with IN B-PP O
factor NN B-NP B-Disease
X SYM O I-Disease
deficiency NN B-NP I-Disease
( ( O O
12 CD B-NP O
familial JJ I-NP O
and CC O O
two CD B-NP O
sporadic JJ I-NP O
cases NNS I-NP O
) ) O O
were VBD B-VP O
sequenced VBN I-VP O
yielding VBG B-VP O
a DT B-NP O
total NN I-NP O
of IN B-PP O
13 CD B-NP O
novel JJ I-NP O
mutations NNS I-NP O
. . O O

Family NN B-NP O
studies NNS I-NP O
were VBD B-VP O
performed VBN I-VP O
in IN B-SBAR O
order NN O O
to TO B-VP O
distinguish VB I-VP O
the DT B-NP O
contributions NNS I-NP O
of IN B-PP O
individual JJ B-NP O
mutant JJ I-NP O
F10 NN I-NP O
alleles NNS I-NP O
to TO B-PP O
the DT B-NP O
clinical JJ I-NP O
and CC I-NP O
laboratory NN I-NP O
phenotypes NNS I-NP O
. . O O

Missense JJ B-NP O
mutations NNS I-NP O
were VBD B-VP O
studied VBN I-VP O
by IN B-PP O
means NNS B-NP O
of IN B-PP O
molecular JJ B-NP O
modelling NN I-NP O
, , O O
whereas IN O O
single JJ B-NP O
basepair NN I-NP O
substitutions NNS I-NP O
in IN B-PP O
splice NN B-NP O
sites NNS I-NP O
and CC O O
the DT B-NP O
5 CD I-NP O
flanking NN I-NP O
region NN I-NP O
were VBD B-VP O
examined VBN I-VP O
by IN B-PP O
in FW B-NP O
vitro FW I-NP O
splicing NN I-NP O
assay NN I-NP O
and CC O O
luciferase NN B-NP O
reporter NN I-NP O
gene NN I-NP O
assay NN I-NP O
respectively RB B-ADVP O
. . O O

The DT B-NP O
deletion NN I-NP O
allele NN I-NP O
of IN B-PP O
a DT B-NP O
novel JJ I-NP O
hexanucleotide NN I-NP O
insertion NN I-NP O
/ SYM B-NP O
deletion NN I-NP O
polymorphism NN I-NP O
in IN B-PP O
the DT B-NP O
F10 NN I-NP O
gene NN I-NP O
promoter NN I-NP O
region NN I-NP O
was VBD B-VP O
shown VBN I-VP O
by IN B-PP O
reporter NN B-NP O
gene NN I-NP O
assay NN I-NP O
, , O O
to TO B-VP O
reduce VB I-VP O
promoter NN B-NP O
activity NN I-NP O
by IN B-PP O
approximately RB B-NP O
20 CD I-NP O
% NN I-NP O
. . O O

One CD B-NP O
family NN I-NP O
manifesting VBG B-VP O
an DT B-NP O
autosomal JJ I-NP O
dominant JJ I-NP O
pattern NN I-NP O
of IN B-PP O
inheritance NN B-NP O
possessed VBD B-VP O
three CD B-NP O
clinically RB I-NP O
affected VBN I-NP O
members NNS I-NP O
who WP B-NP O
were VBD B-VP O
heterozygous JJ B-ADJP O
for IN B-PP O
a DT B-NP O
splice NN I-NP O
- HYPH I-NP O
site NN I-NP O
mutation NN I-NP O
that WDT B-NP O
was VBD B-VP O
predicted VBN I-VP O
to TO I-VP O
lead VB I-VP O
to TO B-PP O
the DT B-NP O
production NN I-NP O
of IN B-PP O
a DT B-NP O
truncated VBN I-NP O
protein NN I-NP O
product NN I-NP O
. . O O

A DT B-NP O
model NN I-NP O
which WDT B-NP O
accounts VBZ B-VP O
for IN B-PP O
the DT B-NP O
dominant JJ I-NP O
negative JJ I-NP O
effect NN I-NP O
of IN B-PP O
this DT B-NP O
lesion NN I-NP O
is VBZ B-VP O
presented VBN I-VP O
. . O O

Variation NN B-NP O
in IN B-PP O
the DT B-NP O
antigen NN I-NP O
level NN I-NP O
of IN B-PP O
heterozygous JJ B-NP O
relatives NNS I-NP O
of IN B-PP O
probands NNS B-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
be VB I-VP O
significantly RB B-ADJP O
higher JJR I-ADJP O
between IN B-PP O
families NNS B-NP O
than IN B-PP O
within IN B-PP O
families NNS B-NP O
, , O O
consistent JJ B-ADJP O
with IN B-PP O
the DT B-NP O
view NN I-NP O
that IN B-SBAR O
the DT B-NP O
nature NN I-NP O
of IN B-PP O
the DT B-NP O
F10 NN I-NP O
lesion NN I-NP O
( ( I-NP O
s NNS I-NP O
) ) O O
segregating VBG B-VP O
in IN B-PP O
a DT B-NP O
given VBN I-NP O
family NN I-NP O
is VBZ B-VP O
a DT B-NP O
prime JJ I-NP O
determinant NN I-NP O
of IN B-PP O
the DT B-NP O
laboratory NN I-NP O
phenotype NN I-NP O
. . O O

By IN B-PP O
contrast NN B-NP O
, , O O
no DT B-NP O
such JJ I-NP O
relationship NN I-NP O
could MD B-VP O
be VB I-VP O
discerned VBN I-VP O
between IN B-PP O
laboratory NN B-NP O
phenotype NN I-NP O
and CC O O
polymorphism NN B-NP O
genotype NN I-NP O
. . O O

. . O O

Transgenic JJ B-NP O
mice NNS I-NP O
expressing VBG B-VP O
a DT B-NP O
truncated VBN I-NP O
form NN I-NP O
of IN B-PP O
the DT B-NP O
high JJ I-NP O
mobility NN I-NP O
group NN I-NP O
I CD I-NP O
- HYPH I-NP O
C NN I-NP O
protein NN I-NP O
develop VBP B-VP O
adiposity NN B-NP O
and CC O O
an DT B-NP O
abnormally RB I-NP O
high JJ I-NP O
prevalence NN I-NP O
of IN B-PP O
lipomas NNS B-NP B-Disease
. . O O

Chromosomal JJ B-NP O
translocations NNS I-NP O
in IN B-PP O
human JJ B-NP O
lipomas NNS I-NP B-Disease
frequently RB B-ADVP O
create VBP B-VP O
fusion NN B-NP O
transcripts NNS I-NP O
encoding VBG B-VP O
high JJ B-NP O
mobility NN I-NP O
group NN I-NP O
( ( O O
HMG NN B-NP O
) ) O O
I CD B-NP O
- HYPH I-NP O
C NN I-NP O
DNA NN I-NP O
- HYPH O O
binding VBG B-VP O
domains NNS B-NP O
and CC I-NP O
C NN I-NP O
- HYPH B-NP O
terminal JJ I-NP O
sequences NNS I-NP O
from IN B-PP O
different JJ B-NP O
presumed VBN I-NP O
transcription NN I-NP O
factors NNS I-NP O
, , O O
suggesting VBG B-VP O
a DT B-NP O
potential JJ I-NP O
role NN I-NP O
for IN B-PP O
HMG NN B-NP O
I CD I-NP O
- HYPH I-NP O
C NN I-NP O
in IN B-PP O
the DT B-NP O
development NN I-NP O
of IN B-PP O
lipomas NNS B-NP B-Disease
. . O O

To TO B-VP O
evaluate VB I-VP O
the DT B-NP O
role NN I-NP O
of IN B-PP O
the DT B-NP O
HMG NN I-NP O
I CD I-NP O
- HYPH I-NP O
C NN I-NP O
component NN I-NP O
, , O O
the DT B-NP O
three CD I-NP O
DNA NN I-NP O
- HYPH O O
binding VBG B-VP O
domains NNS B-NP O
of IN B-PP O
HMG NN B-NP O
I CD I-NP O
- HYPH I-NP O
C NN I-NP O
have VBP B-VP O
now RB I-VP O
been VBN I-VP O
expressed VBN I-VP O
in IN B-PP O
transgenic JJ B-NP O
mice NNS I-NP O
. . O O

Despite IN B-PP O
the DT B-NP O
ubiquitous JJ I-NP O
expression NN I-NP O
of IN B-PP O
the DT B-NP O
truncated VBN I-NP O
HMG NN I-NP O
I CD I-NP O
- HYPH I-NP O
C NN I-NP O
protein NN I-NP O
, , O O
the DT B-NP O
transgenic JJ I-NP O
mice NNS I-NP O
develop VBP B-VP O
a DT B-NP O
selective JJ I-NP O
abundance NN I-NP O
of IN B-PP O
fat JJ B-NP O
tissue NN I-NP O
early RB B-ADVP O
in IN B-PP O
life NN B-NP O
, , O O
show VBP B-VP O
marked JJ B-NP O
adipose NN I-NP B-Disease
tissue NN I-NP I-Disease
inflammation NN I-NP I-Disease
, , O O
and CC O O
have VBP B-VP O
an DT B-NP O
abnormally RB I-NP O
high JJ I-NP O
incidence NN I-NP O
of IN B-PP O
lipomas NNS B-NP B-Disease
. . O O

These DT B-NP O
findings NNS I-NP O
demonstrate VBP B-VP O
that IN B-SBAR O
the DT B-NP O
DNA NN I-NP O
- HYPH O O
binding VBG B-VP O
domains NNS B-NP O
of IN B-PP O
HMG NN B-NP O
I CD I-NP O
- HYPH I-NP O
C NN I-NP O
, , O O
in IN B-PP O
the DT B-NP O
absence NN I-NP O
of IN B-PP O
a DT B-NP O
C NN I-NP O
- HYPH B-NP O
terminal JJ I-NP O
fusion NN I-NP O
partner NN I-NP O
, , O O
are VBP B-VP O
sufficient JJ B-ADJP O
to TO B-VP O
perturb VB I-VP O
adipogenesis NN B-NP O
and CC O O
predispose VB B-VP O
to TO B-PP O
lipomas NNS B-NP B-Disease
. . O O

We PRP B-NP O
provide VBP B-VP O
data NNS B-NP O
supporting VBG B-VP O
the DT B-NP O
central JJ I-NP O
utility NN I-NP O
of IN B-PP O
this DT B-NP O
animal NN I-NP O
model NN I-NP O
as IN B-PP O
a DT B-NP O
tool NN I-NP O
to TO B-VP O
understand VB I-VP O
the DT B-NP O
molecular JJ I-NP O
mechanisms NNS I-NP O
underlying VBG B-VP O
the DT B-NP O
development NN I-NP O
of IN B-PP O
one CD B-NP O
of IN B-PP O
the DT B-NP O
most RBS I-NP O
common JJ I-NP O
kind NN I-NP O
of IN B-PP O
human JJ B-NP O
benign JJ I-NP B-Disease
tumors NNS I-NP I-Disease
. . O O

. . O O

ATM NN B-NP O
phosphorylates VBZ B-VP O
p95 NN B-NP O
/ SYM I-NP O
nbs1 NN I-NP O
in IN B-PP O
an DT B-NP O
S NN I-NP O
- HYPH I-NP O
phase NN I-NP O
checkpoint NN I-NP O
pathway NN I-NP O
. . O O

The DT B-NP O
rare JJ I-NP B-Disease
diseases NNS I-NP I-Disease
ataxia NN I-NP B-Disease
- HYPH O I-Disease
telangiectasia NN B-NP I-Disease
( ( O O
AT NN B-NP B-Disease
) ) O O
, , O O
caused VBN B-VP O
by IN B-PP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
ATM NN I-NP O
gene NN I-NP O
, , O O
and CC O O
Nijmegen NN B-NP B-Disease
breakage NN I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
NBS NN B-NP B-Disease
) ) O O
, , O O
with IN B-PP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
p95 NN I-NP O
/ SYM B-NP O
nbs1 NN I-NP O
gene NN I-NP O
, , O O
share VBP B-VP O
a DT B-NP O
variety NN I-NP O
of IN B-PP O
phenotypic JJ B-NP B-Disease
abnormalities NNS I-NP I-Disease
such JJ B-PP O
as IN I-PP O
chromosomal JJ B-NP B-Disease
instability NN I-NP I-Disease
, , O O
radiation NN B-NP O
sensitivity NN I-NP O
and CC O O
defects NNS B-NP O
in IN B-PP O
cell NN B-NP O
- HYPH B-NP O
cycle NN I-NP O
checkpoints NNS I-NP O
in IN B-PP O
response NN B-NP O
to TO B-PP O
ionizing VBG B-VP O
radiation NN B-NP O
. . O O

The DT B-NP O
ATM NN I-NP O
gene NN I-NP O
encodes VBZ B-VP O
a DT B-NP O
protein NN I-NP O
kinase NN I-NP O
that WDT B-NP O
is VBZ B-VP O
activated VBN I-VP O
by IN B-PP O
ionizing VBG B-VP O
radiation NN B-NP O
or CC O O
radiomimetic JJ B-NP O
drugs NNS I-NP O
, , O O
whereas IN O O
p95 NN B-NP O
/ SYM B-NP O
nbs1 NN I-NP O
is VBZ B-VP O
part NN B-NP O
of IN B-PP O
a DT B-NP O
protein NN I-NP O
complex NN I-NP O
that WDT B-NP O
is VBZ B-VP O
involved VBN I-VP O
in IN B-PP O
responses NNS B-NP O
to TO B-PP O
DNA NN B-NP O
double JJ I-NP O
- HYPH I-NP O
strand NN I-NP O
breaks NNS I-NP O
. . O O

Here RB B-ADVP O
, , O O
because IN B-PP O
of IN I-PP O
the DT B-NP O
similarities NNS I-NP O
between IN B-PP O
AT NN B-NP B-Disease
and CC I-NP O
NBS NN I-NP B-Disease
, , O O
we PRP B-NP O
evaluated VBD B-VP O
the DT B-NP O
functional JJ I-NP O
interactions NNS I-NP O
between IN B-PP O
ATM NN B-NP O
and CC I-NP O
p95 NN I-NP O
/ SYM B-NP O
nbs1 NN I-NP O
. . O O

Activation NN B-NP O
of IN B-PP O
the DT B-NP O
ATM NN I-NP O
kinase NN I-NP O
by IN B-PP O
ionizing VBG B-VP O
radiation NN B-NP O
and CC I-NP O
induction NN I-NP O
of IN B-PP O
ATM NN B-NP O
- HYPH B-NP O
dependent JJ I-NP O
responses NNS I-NP O
in IN B-PP O
NBS NN B-NP B-Disease
cells NNS I-NP O
indicated VBD B-VP O
that IN B-SBAR O
p95 NN B-NP O
/ SYM B-NP O
nbs1 NN I-NP O
may MD B-VP O
not RB I-VP O
be VB I-VP O
required VBN I-VP O
for IN B-PP O
signalling NN B-NP O
to TO B-PP O
ATM NN B-NP O
after IN B-PP O
ionizing VBG B-VP O
radiation NN B-NP O
. . O O

However RB B-ADVP O
, , O O
p95 NN B-NP O
/ SYM I-NP O
nbs1 NN I-NP O
was VBD B-VP O
phosphorylated VBN I-VP O
on IN B-PP O
serine NN B-NP O
343 CD I-NP O
in IN B-PP O
an DT B-NP O
ATM NN I-NP O
- HYPH B-NP O
dependent JJ I-NP O
manner NN I-NP O
in FW B-ADVP O
vitro FW I-ADVP O
and CC O O
in FW B-ADVP O
vivo FW I-ADVP O
after IN B-PP O
ionizing VBG B-VP O
radiation NN B-NP O
. . O O

A DT B-NP O
p95 NN I-NP O
/ SYM B-NP O
nbs1 NN I-NP O
construct NN I-NP O
mutated VBN B-VP O
at IN B-PP O
the DT B-NP O
ATM NN I-NP O
phosphorylation NN I-NP O
site NN I-NP O
abrogated VBD B-VP O
an DT B-NP O
S NN I-NP O
- HYPH B-NP O
phase NN I-NP O
checkpoint NN I-NP O
induced VBN B-VP O
by IN B-PP O
ionizing VBG B-VP O
radiation NN B-NP O
in IN B-PP O
normal JJ B-NP O
cells NNS I-NP O
and CC O O
failed VBD B-VP O
to TO I-VP O
compensate VB I-VP O
for IN B-PP O
this DT B-NP O
functional JJ I-NP O
deficiency NN I-NP O
in IN B-PP O
NBS NN B-NP B-Disease
cells NNS I-NP O
. . O O

These DT B-NP O
observations NNS I-NP O
link VBP B-VP O
ATM NN B-NP O
and CC I-NP O
p95 NN I-NP O
/ SYM B-NP O
nbs1 NN I-NP O
in IN B-PP O
a DT B-NP O
common JJ I-NP O
signalling NN I-NP O
pathway NN I-NP O
and CC O O
provide VBP B-VP O
an DT B-NP O
explanation NN I-NP O
for IN B-PP O
phenotypic JJ B-NP O
similarities NNS I-NP O
in IN B-PP O
these DT B-NP O
two CD I-NP O
diseases NNS I-NP O
. . O O

. . O O

Understanding VBG B-VP O
the DT B-NP O
molecular JJ I-NP O
basis NN I-NP O
of IN B-PP O
fragile JJ B-NP B-Disease
X NN I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

Fragile JJ B-NP B-Disease
X NN I-NP I-Disease
syndrome NN I-NP I-Disease
, , O O
a DT B-NP O
common JJ I-NP O
form NN I-NP O
of IN B-PP O
inherited VBN B-NP B-Disease
mental JJ I-NP I-Disease
retardation NN I-NP I-Disease
, , O O
is VBZ B-VP O
mainly RB I-VP O
caused VBN I-VP O
by IN B-PP O
massive JJ B-NP O
expansion NN I-NP O
of IN B-PP O
CGG NN B-NP O
triplet NN I-NP O
repeats NNS I-NP O
located VBN B-VP O
in IN B-PP O
the DT B-NP O
5 CD I-NP O
- HYPH I-NP O
untranslated JJ I-NP O
region NN I-NP O
of IN B-PP O
the DT B-NP O
fragile JJ I-NP B-Disease
X NN I-NP I-Disease
mental JJ I-NP I-Disease
retardation NN I-NP I-Disease
- HYPH B-NP O
1 CD I-NP O
( ( O O
FMR1 NN B-NP O
) ) O O
gene NN B-NP O
. . O O

In IN B-PP O
patients NNS B-NP O
with IN B-PP O
fragile JJ B-NP B-Disease
X NN I-NP I-Disease
syndrome NN I-NP I-Disease
, , O O
the DT B-NP O
expanded VBN I-NP O
CGG NN I-NP O
triplet JJ I-NP O
repeats NNS I-NP O
are VBP B-VP O
hypermethylated VBN I-VP O
and CC O O
the DT B-NP O
expression NN I-NP O
of IN B-PP O
the DT B-NP O
FMR1 NN I-NP O
gene NN I-NP O
is VBZ B-VP O
repressed VBN I-VP O
, , O O
which WDT B-NP O
leads VBZ B-VP O
to TO B-PP O
the DT B-NP O
absence NN I-NP O
of IN B-PP O
FMR1 NN B-NP O
protein NN I-NP O
( ( O O
FMRP NN B-NP O
) ) O O
and CC O O
subsequent JJ B-NP O
mental JJ I-NP B-Disease
retardation NN I-NP I-Disease
. . O O

FMRP NN B-NP O
is VBZ B-VP O
an DT B-NP O
RNA NN I-NP O
- HYPH B-PP O
binding VBG B-NP O
protein NN I-NP O
that WDT B-NP O
shuttles VBZ B-VP O
between IN B-PP O
the DT B-NP O
nucleus NN I-NP O
and CC I-NP O
cytoplasm NN I-NP O
. . O O

This DT B-NP O
protein NN I-NP O
has VBZ B-VP O
been VBN I-VP O
implicated VBN I-VP O
in IN B-PP O
protein NN B-NP O
translation NN I-NP O
as IN B-SBAR O
it PRP B-NP O
is VBZ B-VP O
found VBN I-VP O
associated VBN I-VP O
with IN B-PP O
polyribosomes NNS B-NP O
and CC O O
the DT B-NP O
rough JJ I-NP O
endoplasmic JJ I-NP O
reticulum NN I-NP O
. . O O

We PRP B-NP O
discuss VBP B-VP O
here RB B-ADVP O
the DT B-NP O
recent JJ I-NP O
progress NN I-NP O
made VBN B-VP O
towards IN B-PP O
understanding VBG B-VP O
the DT B-NP O
molecular JJ I-NP O
mechanism NN I-NP O
of IN B-PP O
CGG NN B-NP O
repeat NN I-NP O
expansion NN I-NP O
and CC O O
physiological JJ B-NP O
function NN I-NP O
( ( I-NP O
s NNS I-NP O
) ) O O
of IN B-PP O
FMRP NN B-NP O
. . O O

These DT B-NP O
studies NNS I-NP O
will MD B-VP O
not RB I-VP O
only RB I-VP O
help VB I-VP O
to TO I-VP O
illuminate VB I-VP O
the DT B-NP O
molecular JJ I-NP O
basis NN I-NP O
of IN B-PP O
the DT B-NP O
general JJ I-NP O
class NN I-NP O
of IN B-PP O
human JJ B-NP O
diseases NNS I-NP O
with IN B-PP O
trinucleotide NN B-NP O
repeat NN I-NP O
expansion NN I-NP O
but CC B-CONJP O
also RB I-CONJP O
provide VBP B-VP O
an DT B-NP O
avenue NN I-NP O
to TO B-VP O
understand VB I-VP O
aspects NNS B-NP O
of IN B-PP O
human JJ B-NP O
cognition NN I-NP O
and CC I-NP O
intelligence NN I-NP O
. . O O

. . O O

Haploinsufficiency NN B-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
transcription NN I-NP I-Disease
factors NNS I-NP I-Disease
FOXC1 NN B-NP I-Disease
and CC I-NP I-Disease
FOXC2 NN I-NP I-Disease
results VBZ B-VP O
in IN B-PP O
aberrant JJ B-NP O
ocular JJ I-NP O
development NN I-NP O
. . O O

Anterior JJ B-NP B-Disease
segment NN I-NP I-Disease
developmental JJ I-NP I-Disease
disorders NNS I-NP I-Disease
, , O O
including VBG B-PP O
Axenfeld NNP B-NP B-Disease
- HYPH O I-Disease
Rieger NNP B-NP I-Disease
anomaly RB B-ADVP I-Disease
( ( O O
ARA NN B-NP B-Disease
) ) O O
, , O O
variably RB B-ADVP O
associate VBP B-VP O
with IN B-PP O
harmfully RB B-NP O
elevated JJ I-NP O
intraocular JJ I-NP O
pressure NN I-NP O
( ( O O
IOP NN B-NP O
) ) O O
, , O O
which WDT B-NP O
causes VBZ B-VP O
glaucoma NN B-NP B-Disease
. . O O

Clinically RB B-NP O
observed VBN I-NP O
dysgenesis NN I-NP O
does VBZ B-VP O
not RB I-VP O
correlate VB I-VP O
with IN B-PP O
IOP NN B-NP O
, , O O
however RB B-ADVP O
, , O O
and CC O O
the DT B-NP O
etiology NN I-NP O
of IN B-PP O
glaucoma NN B-NP B-Disease
development NN I-NP O
is VBZ B-VP O
not RB I-VP O
understood VBN I-VP O
. . O O

The DT B-NP O
forkhead NN I-NP O
transcription NN I-NP O
factor NN I-NP O
genes NNS I-NP O
Foxc1 NN I-NP O
( ( O O
formerly RB B-ADVP O
Mf1 NN B-NP O
) ) O O
and CC O O
Foxc2 NN B-NP O
( ( O O
formerly RB B-NP O
Mfh1 NN I-NP O
) ) O O
are VBP B-VP O
expressed VBN I-VP O
in IN B-PP O
the DT B-NP O
mesenchyme NN I-NP O
from IN B-PP O
which WDT B-NP O
the DT B-NP O
ocular JJ I-NP O
drainage NN I-NP O
structures NNS I-NP O
derive VBP B-VP O
. . O O

Mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
human JJ I-NP O
homolog NN I-NP O
of IN B-PP O
Foxc1 NN B-NP O
, , O O
FKHL7 NN B-NP O
, , O O
cause VBP B-VP O
dominant JJ B-NP O
anterior JJ I-NP B-Disease
segment NN I-NP I-Disease
defects NNS I-NP I-Disease
and CC O O
glaucoma NN B-NP B-Disease
in IN B-PP O
various JJ B-NP O
families NNS I-NP O
. . O O

We PRP B-NP O
show VBP B-VP O
that IN B-SBAR O
Foxc1 CD B-NP O
( ( O O
+ SYM O O
/ SYM O O
- SYM O O
) ) O O
mice NNS B-NP O
have VBP B-VP O
anterior JJ B-NP B-Disease
segment NN I-NP I-Disease
abnormalities NNS I-NP I-Disease
similar JJ B-ADJP O
to TO B-PP O
those DT B-NP O
reported VBN B-VP O
in IN B-PP O
human JJ B-NP O
patients NNS I-NP O
. . O O

These DT B-NP O
abnormalities NNS I-NP O
include VBP B-VP O
small JJ B-NP O
or CC I-NP O
absent JJ I-NP O
Schlemms NNP I-NP O
canal NN I-NP O
, , O O
aberrantly RB B-ADVP O
developed VBD B-VP O
trabecular JJ B-NP O
meshwork NN I-NP O
, , O O
iris NN B-NP B-Disease
hypoplasia NN I-NP I-Disease
, , O O
severely RB B-NP O
eccentric JJ I-NP O
pupils NNS I-NP O
and CC O O
displaced VBD B-VP O
Schwalbes NNP B-NP O
line NN I-NP O
. . O O

The DT B-NP O
penetrance NN I-NP O
of IN B-PP O
clinically RB B-NP O
obvious JJ I-NP O
abnormalities NNS I-NP O
varies VBZ B-VP O
with IN B-PP O
genetic JJ B-NP O
background NN I-NP O
. . O O

In IN B-PP O
some DT B-NP O
affected VBN I-NP O
eyes NNS I-NP O
, , O O
collagen NN B-NP O
bundles NNS I-NP O
were VBD B-VP O
half DT B-NP O
normal JJ I-NP O
diameter NN I-NP O
, , O O
or CC O O
collagen NN B-NP O
and CC O O
elastic JJ B-NP O
tissue NN I-NP O
were VBD B-VP O
very RB B-ADJP O
sparse JJ I-ADJP O
. . O O

Thus RB B-ADVP O
, , O O
abnormalities NNS B-NP O
in IN B-PP O
extracellular JJ B-NP O
matrix NN I-NP O
synthesis NN I-NP O
or CC I-NP O
organization NN I-NP O
may MD B-VP O
contribute VB I-VP O
to TO B-PP O
development NN B-NP O
of IN B-PP O
the DT B-NP O
ocular JJ I-NP O
phenotypes NNS I-NP O
. . O O

Despite IN B-PP O
the DT B-NP O
abnormalities NNS I-NP O
in IN B-PP O
ocular JJ B-NP O
drainage NN I-NP O
structures NNS I-NP O
in IN B-PP O
Foxc1 CD B-NP O
( ( O O
+ SYM O O
/ SYM O O
- SYM O O
) ) O O
mice NNS B-NP O
, , O O
IOP NN B-NP O
was VBD B-VP O
normal JJ B-ADJP O
in IN B-PP O
almost RB B-NP O
all DT I-NP O
mice NNS I-NP O
analyzed VBN B-VP O
, , O O
on IN B-PP O
all DT B-NP O
genetic JJ I-NP O
backgrounds NNS I-NP O
and CC B-PP O
at IN B-PP O
all DT B-NP O
ages NNS I-NP O
. . O O

Similar JJ B-NP O
abnormalities NNS I-NP O
were VBD B-VP O
found VBN I-VP O
in IN B-PP O
Foxc2 CD B-NP O
( ( O O
+ SYM O O
/ SYM O O
- SYM O O
) ) O O
mice NNS B-NP O
, , O O
but CC O O
no DT B-NP O
disease NN I-NP O
- HYPH B-NP O
associated VBN I-NP O
mutations NNS I-NP O
were VBD B-VP O
identified VBN I-VP O
in IN B-PP O
the DT B-NP O
human JJ I-NP O
homolog NN I-NP O
FKHL14 NN I-NP O
in IN B-PP O
32 CD B-NP O
ARA NN I-NP B-Disease
patients NNS I-NP O
. . O O

Foxc1 CD B-NP O
( ( O O
+ SYM B-NP O
/ SYM O O
- SYM B-NP O
) ) O O
and CC O O
Foxc2 CD B-NP O
( ( O O
+ SYM O O
/ SYM O O
- SYM O O
) ) O O
mice NNS B-NP O
are VBP B-VP O
useful JJ B-NP O
models NNS I-NP O
for IN B-PP O
studying VBG B-VP O
anterior JJ B-NP O
segment NN I-NP O
development NN I-NP O
and CC O O
its PRP$ B-NP O
anomalies NNS I-NP O
, , O O
and CC O O
may MD B-VP O
allow VB I-VP O
identification NN B-NP O
of IN B-PP O
genes NNS B-NP O
that WDT B-NP O
interact VBP B-VP O
with IN B-PP O
Foxc1 NN B-NP O
and CC I-NP O
Foxc2 NN I-NP O
( ( O O
or CC O O
FKHL7 NN B-NP O
and CC O O
FKHL14 NN B-NP O
) ) O O
to TO B-VP O
produce VB I-VP O
a DT B-NP O
phenotype NN I-NP O
with IN B-PP O
elevated JJ B-NP O
IOP NN I-NP O
and CC I-NP O
glaucoma NN I-NP B-Disease
. . O O

. . O O

( ( O O
Over IN B-PP O
) ) O O
correction NN B-NP O
of IN B-PP O
FMR1 NN B-NP B-Disease
deficiency NN I-NP I-Disease
with IN B-PP O
YAC NN B-NP O
transgenics NNS I-NP O
: : O O
behavioral JJ B-NP O
and CC I-NP O
physical JJ I-NP O
features NNS I-NP O
. . O O

Fragile JJ B-NP B-Disease
X NN I-NP I-Disease
syndrome NN I-NP I-Disease
is VBZ B-VP O
a DT B-NP O
common JJ I-NP O
cause NN I-NP O
of IN B-PP O
mental JJ B-NP B-Disease
retardation NN I-NP I-Disease
involving VBG B-VP O
loss NN B-NP O
of IN B-PP O
expression NN B-NP O
of IN B-PP O
the DT B-NP O
FMR1 NN I-NP O
gene NN I-NP O
. . O O

The DT B-NP O
role NN I-NP O
of IN B-PP O
FMR1 NN B-NP O
remains VBZ B-VP O
undetermined JJ B-ADJP O
but CC O O
the DT B-NP O
protein NN I-NP O
appears VBZ B-VP O
to TO I-VP O
be VB I-VP O
involved VBN I-VP O
in IN B-PP O
RNA NN B-NP O
metabolism NN I-NP O
. . O O

Fmr1 NN B-NP O
knockout NN I-NP O
mice NNS I-NP O
exhibit VBP B-VP O
a DT B-NP O
phenotype NN I-NP O
with IN B-PP O
some DT B-NP O
similarities NNS I-NP O
to TO B-PP O
humans NNS B-NP O
, , O O
such JJ B-PP O
as IN I-PP O
macroorchidism NN B-NP B-Disease
and CC O O
behavioral JJ B-NP O
abnormalities NNS I-NP O
. . O O

As IN B-PP O
a DT B-NP O
step NN I-NP O
toward IN B-PP O
understanding VBG B-VP O
the DT B-NP O
function NN I-NP O
of IN B-PP O
FMR1 NN B-NP O
and CC O O
the DT B-NP O
determination NN I-NP O
of IN B-PP O
the DT B-NP O
potential NN I-NP O
for IN B-PP O
therapeutic JJ B-NP O
approaches NNS I-NP O
to TO B-PP O
fragile JJ B-NP B-Disease
X NN I-NP I-Disease
syndrome NN I-NP I-Disease
, , O O
yeast NN B-NP O
artificial JJ I-NP O
chromosome NN I-NP O
( ( O O
YAC NN B-NP O
) ) O O
transgenic JJ B-NP O
mice NNS I-NP O
were VBD B-VP O
generated VBN I-VP O
in IN B-SBAR O
order NN O O
to TO B-VP O
determine VB I-VP O
whether IN B-SBAR O
the DT B-NP O
Fmr1 NN I-NP O
knockout NN I-NP O
mouse NN I-NP O
phenotype NN I-NP O
could MD B-VP O
be VB I-VP O
rescued VBN I-VP O
. . O O

Several JJ B-NP O
transgenic JJ I-NP O
lines NNS I-NP O
were VBD B-VP O
generated VBN I-VP O
that WDT B-NP O
carried VBD B-VP O
the DT B-NP O
entire JJ I-NP O
FMR1 NN I-NP O
locus NN I-NP O
with IN B-PP O
extensive JJ B-NP O
amounts NNS I-NP O
of IN B-PP O
flanking NN B-NP O
sequence NN I-NP O
. . O O

We PRP B-NP O
observed VBD B-VP O
that IN B-SBAR O
the DT B-NP O
YAC NN I-NP O
transgene NN I-NP O
supported VBD B-VP O
production NN B-NP O
of IN B-PP O
the DT B-NP O
human JJ I-NP O
protein NN I-NP O
( ( O O
FMRP NN B-NP O
) ) O O
which WDT B-NP O
was VBD B-VP O
present JJ B-ADJP O
at IN B-PP O
levels NNS B-NP O
10 CD B-NP O
to TO I-NP O
15 CD I-NP O
times NNS I-NP O
that IN I-NP O
of IN B-PP O
endogenous JJ B-NP O
protein NN I-NP O
and CC O O
was VBD B-VP O
expressed VBN I-VP O
in IN B-PP O
a DT B-NP O
cell NN I-NP O
- HYPH B-NP O
and CC I-NP O
tissue NN I-NP O
- HYPH I-NP O
specific JJ I-NP O
manner NN I-NP O
. . O O

Macro AFX B-NP O
- HYPH I-NP O
orchidism NN B-NP O
was VBD B-VP O
absent JJ B-ADJP O
in IN B-PP O
knockout JJ B-NP O
mice NNS I-NP O
carrying VBG B-VP O
the DT B-NP O
YAC NN I-NP O
transgene NN I-NP O
indicating VBG B-VP O
functional JJ B-NP O
rescue NN I-NP O
by IN B-PP O
the DT B-NP O
human JJ I-NP O
protein NN I-NP O
. . O O

Given VBN B-PP O
the DT B-NP O
complex JJ I-NP O
behavioral JJ I-NP O
phenotype NN I-NP O
in IN B-PP O
fragile JJ B-NP B-Disease
X NN I-NP I-Disease
patients NNS I-NP O
and CC O O
the DT B-NP O
mild JJ I-NP O
phenotype NN I-NP O
previously RB B-VP O
reported VBN I-VP O
for IN B-PP O
the DT B-NP O
Fmr1 NN I-NP O
knockout NN I-NP O
mouse NN I-NP O
, , O O
we PRP B-NP O
performed VBD B-VP O
a DT B-NP O
more RBR I-NP O
thorough JJ I-NP O
evaluation NN I-NP O
of IN B-PP O
the DT B-NP O
Fmr1 NN I-NP O
knockout NN I-NP O
phenotype NN I-NP O
using VBG B-VP O
additional JJ B-NP O
behavioral JJ I-NP O
assays NNS I-NP O
that WDT B-NP O
had VBD B-VP O
not RB I-VP O
previously RB I-VP O
been VBN I-VP O
reported VBN I-VP O
for IN B-PP O
this DT B-NP O
animal NN I-NP O
model NN I-NP O
. . O O

The DT B-NP O
mouse NN I-NP O
displayed VBD B-VP O
reduced VBN B-NP O
anxiety NN I-NP B-Disease
- HYPH B-NP O
related VBN I-NP O
responses NNS I-NP O
with IN B-PP O
increased VBN B-NP O
exploratory JJ I-NP O
behavior NN I-NP O
. . O O

FMR1 NN B-NP O
YAC NN I-NP O
transgenic JJ I-NP O
mice NNS I-NP O
overexpressing VBG B-VP O
the DT B-NP O
human JJ I-NP O
protein NN I-NP O
did VBD B-VP O
produce VB I-VP O
opposing VBG I-VP O
behavioral JJ B-NP O
responses NNS I-NP O
and CC O O
additional JJ B-NP O
abnormal JJ I-NP O
behaviors NNS I-NP O
were VBD B-VP O
also RB I-VP O
observed VBN I-VP O
. . O O

These DT B-NP O
findings NNS I-NP O
have VBP B-VP O
significant JJ B-NP O
implications NNS I-NP O
for IN B-PP O
gene NN B-NP O
therapy NN I-NP O
for IN B-PP O
fragile JJ B-NP B-Disease
X NN I-NP I-Disease
syndrome NN I-NP I-Disease
since IN B-PP O
overexpression NN B-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
may MD B-VP O
harbor VB I-VP O
its PRP$ B-NP O
own JJ I-NP O
phenotype NN I-NP O
. . O O

. . O O

Transgenic JJ B-NP O
mice NNS I-NP O
carrying VBG B-VP O
large JJ B-NP O
human JJ I-NP O
genomic JJ I-NP O
sequences NNS I-NP O
with IN B-PP O
expanded VBN B-NP O
CTG NN I-NP O
repeat NN I-NP O
mimic VBP B-VP O
closely RB B-ADVP O
the DT B-NP O
DM NN I-NP B-Disease
CTG NN I-NP O
repeat NN I-NP O
intergenerational JJ I-NP O
and CC I-NP O
somatic JJ I-NP O
instability NN I-NP O
. . O O

Myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
( ( O O
DM NN B-NP B-Disease
) ) O O
is VBZ B-VP O
caused VBN I-VP O
by IN B-PP O
a DT B-NP O
CTG NN I-NP O
repeat NN I-NP O
expansion NN I-NP O
in IN B-PP O
the DT B-NP O
3UTR NN I-NP O
of IN B-PP O
the DT B-NP O
DM NN I-NP B-Disease
protein NN I-NP O
kinase NN I-NP O
( ( O O
DMPK NN B-NP O
) ) O O
gene NN B-NP O
. . O O

A DT B-NP O
very RB I-NP O
high JJ I-NP O
level NN I-NP O
of IN B-PP O
instability NN B-NP O
is VBZ B-VP O
observed VBN I-VP O
through IN B-PP O
successive JJ B-NP O
generations NNS I-NP O
and CC O O
the DT B-NP O
size NN I-NP O
of IN B-PP O
the DT B-NP O
repeat NN I-NP O
is VBZ B-VP O
generally RB I-VP O
correlated VBN I-VP O
with IN B-PP O
the DT B-NP O
severity NN I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
and CC B-PP O
with IN B-PP O
age NN B-NP O
at IN B-PP O
onset NN B-NP O
. . O O

Furthermore RB B-ADVP O
, , O O
tissues NNS B-NP O
from IN B-PP O
DM NN B-NP B-Disease
patients NNS I-NP O
exhibit VBP B-VP O
somatic JJ B-NP O
mosaicism NN I-NP O
that WDT B-NP O
increases VBZ B-VP O
with IN B-PP O
age NN B-NP O
. . O O

We PRP B-NP O
generated VBD B-VP O
transgenic JJ B-NP O
mice NNS I-NP O
carrying VBG B-VP O
large JJ B-NP O
human JJ I-NP O
genomic JJ I-NP O
sequences NNS I-NP O
with IN B-PP O
20 CD B-NP O
, , I-NP O
55 CD I-NP O
or CC I-NP O
> JJR I-NP O
300 CD I-NP O
CTG NN I-NP O
, , O O
cloned VBN B-VP O
from IN B-PP O
patients NNS B-NP O
from IN B-PP O
the DT B-NP O
same JJ I-NP O
affected VBN I-NP O
DM NN I-NP B-Disease
family NN I-NP O
. . O O

Using VBG B-VP O
large JJ B-NP O
human JJ I-NP O
flanking NN I-NP O
sequences NNS I-NP O
and CC O O
a DT B-NP O
large JJ I-NP O
amplification NN I-NP O
, , O O
we PRP B-NP O
demonstrate VBP B-VP O
that IN B-SBAR O
the DT B-NP O
intergenerational JJ I-NP O
CTG NN I-NP O
repeat NN I-NP O
instability NN I-NP O
is VBZ B-VP O
reproduced VBN I-VP O
in IN B-PP O
mice NNS B-NP O
, , O O
with IN B-PP O
a DT B-NP O
strong JJ I-NP O
bias NN I-NP O
towards IN B-PP O
expansions NNS B-NP O
and CC B-PP O
with IN B-PP O
the DT B-NP O
same JJ I-NP O
sex NN I-NP O
- HYPH B-NP O
and CC I-NP O
size NN I-NP O
- HYPH I-NP O
dependent JJ I-NP O
characteristics NNS I-NP O
as IN B-PP O
in IN B-PP O
humans NNS B-NP O
. . O O

Moreover RB B-ADVP O
, , O O
a DT B-NP O
high JJ I-NP O
level NN I-NP O
of IN B-PP O
instability NN B-NP O
, , O O
increasing VBG B-VP O
with IN B-PP O
age NN B-NP O
, , O O
can MD B-VP O
be VB I-VP O
observed VBN I-VP O
in IN B-PP O
tissues NNS B-NP O
and CC B-PP O
in IN B-PP O
sperm NN B-NP O
. . O O

Although IN B-SBAR O
we PRP B-NP O
did VBD B-VP O
not RB I-VP O
observe VB I-VP O
dramatic JJ B-NP O
expansions NNS I-NP O
( ( O O
or CC O O
big JJ B-NP O
jumps NNS I-NP O
over IN B-PP O
several JJ B-NP O
hundred CD I-NP O
CTG NN I-NP O
repeats NNS I-NP O
) ) O O
as IN B-PP O
in IN B-PP O
congenital JJ B-NP O
forms NNS I-NP O
of IN B-PP O
DM NN B-NP B-Disease
, , O O
our PRP$ B-NP O
model NN I-NP O
carrying VBG B-VP O
> SYM B-ADVP O
300 CD B-NP O
CTG NN I-NP O
is VBZ B-VP O
the DT B-NP O
first JJ I-NP O
to TO B-VP O
show VB I-VP O
instability NN B-NP O
so RB B-VP O
close RB I-VP O
to TO B-PP O
the DT B-NP O
human JJ I-NP O
DM NN I-NP B-Disease
situation NN I-NP O
. . O O

Our PRP$ B-NP O
three CD I-NP O
models NNS I-NP O
carrying VBG B-VP O
different JJ B-NP O
sizes NNS I-NP O
of IN B-PP O
CTG NN B-NP O
repeat NN I-NP O
provide VBP B-VP O
insight NN B-NP O
on IN B-PP O
the DT B-NP O
different JJ I-NP O
factors NNS I-NP O
modulating VBG B-VP O
the DT B-NP O
CTG NN I-NP O
repeat NN I-NP O
instability NN I-NP O
. . O O

. . O O

Inactivation NN B-NP O
of IN B-PP O
the DT B-NP O
Friedreich NNP I-NP B-Disease
ataxia NN I-NP I-Disease
mouse NN I-NP O
gene NN I-NP O
leads VBZ B-VP O
to TO B-PP O
early JJ B-NP O
embryonic JJ I-NP B-Disease
lethality NN I-NP I-Disease
without IN B-PP O
iron NN B-NP O
accumulation NN I-NP O
. . O O

Friedreich NN B-NP B-Disease
ataxia NN I-NP I-Disease
( ( O O
FRDA NN B-NP B-Disease
) ) O O
, , O O
the DT B-NP O
most RBS I-NP O
common JJ I-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
ataxia NN I-NP I-Disease
, , O O
is VBZ B-VP O
caused VBN I-VP O
in IN B-PP O
almost RB B-NP O
all DT I-NP O
cases NNS I-NP O
by IN B-PP O
homozygous JJ B-NP O
intronic JJ I-NP O
expansions NNS I-NP O
resulting VBG B-VP O
in IN B-PP O
the DT B-NP O
loss NN I-NP O
of IN B-PP O
frataxin NN B-NP O
, , O O
a DT B-NP O
mitochondrial JJ I-NP O
protein NN I-NP O
conserved VBN B-VP O
through IN B-PP O
evolution NN B-NP O
, , O O
and CC O O
involved VBN B-VP O
in IN B-PP O
mitochondrial JJ B-NP O
iron NN I-NP O
homeostasis NN I-NP O
. . O O

Yeast NN B-NP O
knockout NN I-NP O
models NNS I-NP O
, , O O
and CC O O
histological JJ B-NP O
and CC I-NP O
biochemical JJ I-NP O
data NNS I-NP O
from IN B-PP O
patient NN B-NP O
heart NN I-NP O
biopsies NNS I-NP O
or CC I-NP O
autopsies NNS I-NP O
indicate VBP B-VP O
that IN B-SBAR O
the DT B-NP O
frataxin NN I-NP O
defect NN I-NP O
causes VBZ B-VP O
a DT B-NP O
specific JJ I-NP O
iron NN I-NP B-Disease
- HYPH I-NP I-Disease
sulfur NN I-NP I-Disease
protein NN I-NP I-Disease
deficiency NN I-NP I-Disease
and CC O O
mitochondrial JJ B-NP O
iron NN I-NP O
accumulation NN I-NP O
leading VBG B-VP O
to TO B-PP O
the DT B-NP O
pathological JJ I-NP O
changes NNS I-NP O
. . O O

Affected VBN B-NP O
human JJ I-NP O
tissues NNS I-NP O
are VBP B-VP O
rarely RB B-ADVP O
available JJ B-ADJP O
to TO B-VP O
further RB I-VP O
examine VB I-VP O
this DT B-NP O
hypothesis NN I-NP O
. . O O

To TO B-VP O
study VB I-VP O
the DT B-NP O
mechanism NN I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
, , O O
we PRP B-NP O
generated VBD B-VP O
a DT B-NP O
mouse NN I-NP O
model NN I-NP O
by IN B-PP O
deletion NN B-NP O
of IN B-PP O
exon NN B-NP O
4 CD I-NP O
leading VBG B-VP O
to TO B-PP O
inactivation NN B-NP O
of IN B-PP O
the DT B-NP O
Frda NNP I-NP B-Disease
gene NN I-NP O
product NN I-NP O
. . O O

We PRP B-NP O
show VBP B-VP O
that IN B-SBAR O
homozygous JJ B-NP O
deletions NNS I-NP O
cause VBP B-VP O
embryonic JJ B-NP B-Disease
lethality NN I-NP I-Disease
a DT B-NP O
few JJ I-NP O
days NNS I-NP O
after IN B-PP O
implantation NN B-NP O
, , O O
demonstrating VBG B-VP O
an DT B-NP O
important JJ I-NP O
role NN I-NP O
for IN B-PP O
frataxin NN B-NP O
during IN B-PP O
early JJ B-NP O
development NN I-NP O
. . O O

These DT B-NP O
results NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
the DT B-NP O
milder JJR I-NP O
phenotype NN I-NP O
in IN B-PP O
humans NNS B-NP O
is VBZ B-VP O
due JJ B-ADJP O
to TO B-PP O
residual JJ B-NP O
frataxin NN I-NP O
expression NN I-NP O
associated VBN B-VP O
with IN B-PP O
the DT B-NP O
expansion NN I-NP O
mutations NNS I-NP O
. . O O

Surprisingly RB B-ADVP O
, , O O
in IN B-PP O
the DT B-NP O
frataxin NN I-NP O
knockout NN I-NP O
mouse NN I-NP O
, , O O
no DT B-NP O
iron NN I-NP O
accumulation NN I-NP O
was VBD B-VP O
observed VBN I-VP O
during IN B-PP O
embryonic JJ B-NP O
resorption NN I-NP O
, , O O
suggesting VBG B-VP O
that IN B-SBAR O
cell NN B-NP O
death NN I-NP O
could MD B-VP O
be VB I-VP O
due JJ B-ADVP O
to TO B-PP O
a DT B-NP O
mechanism NN I-NP O
independent JJ B-ADJP O
of IN B-PP O
iron NN B-NP O
accumulation NN I-NP O
. . O O

. . O O

Gaucher NNP B-NP B-Disease
disease NN I-NP I-Disease
: : O O
the DT B-NP O
origins NNS I-NP O
of IN B-PP O
the DT B-NP O
Ashkenazi NNP I-NP O
Jewish NNP I-NP O
N370S NN I-NP O
and CC I-NP O
84GG NN I-NP O
acid NN I-NP O
beta SYM B-NP O
- HYPH B-NP O
glucosidase NN I-NP O
mutations NNS I-NP O
. . O O

Type NN B-NP O
1 CD I-NP O
Gaucher NNP I-NP B-Disease
disease NN I-NP I-Disease
( ( O O
GD NN B-NP B-Disease
) ) O O
, , O O
a DT B-NP O
non AFX I-NP O
- HYPH I-NP O
neuronopathic JJ I-NP O
lysosomal JJ I-NP B-Disease
storage NN I-NP I-Disease
disorder NN I-NP I-Disease
, , O O
results VBZ B-VP O
from IN B-PP O
the DT B-NP O
deficient JJ I-NP O
activity NN I-NP O
of IN B-PP O
acid NN B-NP O
beta SYM O O
- HYPH O O
glucosidase NN B-NP O
( ( O O
GBA NN B-NP O
) ) O O
. . O O

Type NN B-NP O
1 CD I-NP O
disease NN I-NP O
is VBZ B-VP O
panethnic JJ B-ADJP O
but CC O O
is VBZ B-VP O
more RBR B-ADJP O
prevalent JJ I-ADJP O
in IN B-PP O
individuals NNS B-NP O
of IN B-PP O
Ashkenazi NNP B-NP O
Jewish NNP I-NP O
( ( O O
AJ NN B-NP O
) ) O O
descent NN B-NP O
. . O O

Of IN B-PP O
the DT B-NP O
causative JJ I-NP O
GBA NN I-NP O
mutations NNS I-NP O
, , O O
N370S NN B-NP O
is VBZ B-VP O
particularly RB B-ADJP O
frequent JJ I-ADJP O
in IN B-PP O
the DT B-NP O
AJ NNP I-NP O
population NN I-NP O
, , O O
( ( O O
q NN B-NP O
approximately RB B-NP O
. . I-NP O

03 CD I-NP O
) ) O O
, , O O
whereas IN O O
the DT B-NP O
84GG NN I-NP O
insertion NN I-NP O
( ( O O
q NN B-NP O
approximately RB B-NP O
. . I-NP O

003 CD I-NP O
) ) O O
occurs VBZ B-VP O
exclusively RB B-ADVP O
in IN B-PP O
the DT B-NP O
Ashkenazim NNP I-NP O
. . O O

To TO B-VP O
investigate VB I-VP O
the DT B-NP O
genetic JJ I-NP O
history NN I-NP O
of IN B-PP O
these DT B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
AJ NNP I-NP O
population NN I-NP O
, , O O
short JJ B-NP O
tandem JJ I-NP O
repeat NN I-NP O
( ( O O
STR NN B-NP O
) ) O O
markers NNS B-NP O
were VBD B-VP O
used VBN I-VP O
to TO B-VP O
map VB I-VP O
a DT B-NP O
9 CD I-NP O
. . O O

3 CD B-NP O
- HYPH I-NP O
cM NN I-NP O
region NN I-NP O
containing VBG B-VP O
the DT B-NP O
GBA NN I-NP O
locus NN I-NP O
and CC B-PP O
to TO B-PP O
genotype NN B-NP O
261 CD I-NP O
AJ NN I-NP O
N370S NN I-NP O
chromosomes NNS I-NP O
, , O O
60 CD B-NP O
European JJ I-NP O
non AFX I-NP O
- HYPH I-NP O
Jewish JJ I-NP O
N370S NN I-NP O
chromosomes NNS I-NP O
, , O O
and CC O O
62 CD B-NP O
AJ NN I-NP O
84GG NN I-NP O
chromosomes NNS I-NP O
. . O O

A DT B-NP O
highly RB I-NP O
conserved VBN I-NP O
haplotype NN I-NP O
at IN B-PP O
four CD B-NP O
markers NNS I-NP O
flanking VBG B-VP O
GBA NN B-NP O
( ( O O
PKLR NN B-NP O
, , O O
D1S1595 NN B-NP O
, , O O
D1S2721 NN B-NP O
, , O O
and CC O O
D1S2777 NN B-NP O
) ) O O
was VBD B-VP O
observed VBN I-VP O
on IN B-PP O
both CC O O
the DT B-NP O
AJ NN I-NP O
chromosomes NNS I-NP O
and CC O O
the DT B-NP O
non AFX I-NP O
- HYPH I-NP O
Jewish JJ I-NP O
N370S NN I-NP O
chromosomes NNS I-NP O
, , O O
suggesting VBG B-VP O
the DT B-NP O
occurrence NN I-NP O
of IN B-PP O
a DT B-NP O
founder NN I-NP O
common JJ B-ADJP O
to TO B-PP O
both DT B-NP O
populations NNS I-NP O
. . O O

Of IN B-PP O
note NN B-NP O
, , O O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
different JJ B-NP O
divergent JJ I-NP O
haplotypes NNS I-NP O
suggested VBD B-VP O
the DT B-NP O
occurrence NN I-NP O
of IN B-PP O
de FW B-NP O
novo FW I-NP O
, , O O
recurrent JJ B-NP O
N370S NN I-NP O
mutations NNS I-NP O
. . O O

In IN B-PP O
contrast NN B-NP O
, , O O
a DT B-NP O
different JJ I-NP O
conserved VBN I-NP O
haplotype NN I-NP O
at IN B-PP O
these DT B-NP O
markers NNS I-NP O
was VBD B-VP O
identified VBN I-VP O
on IN B-PP O
the DT B-NP O
84GG NN I-NP O
chromosomes NNS I-NP O
, , O O
which WDT B-NP O
was VBD B-VP O
unique JJ B-ADJP O
to TO B-PP O
the DT B-NP O
AJ NNP I-NP O
population NN I-NP O
. . O O

On IN B-PP O
the DT B-NP O
basis NN I-NP O
of IN B-PP O
the DT B-NP O
linkage NN I-NP O
disequilibrium NN I-NP O
( ( O O
LD NN B-NP O
) ) O O
delta NN B-NP O
values NNS I-NP O
, , O O
the DT B-NP O
non AFX I-NP O
- HYPH I-NP O
Jewish JJ I-NP O
European JJ I-NP O
N370S NN I-NP O
chromosomes NNS I-NP O
had VBD B-VP O
greater JJR B-NP O
haplotype NN I-NP O
diversity NN I-NP O
and CC O O
less JJR B-NP O
LD NN I-NP O
at IN B-PP O
the DT B-NP O
markers NNS I-NP O
flanking VBG B-VP O
the DT B-NP O
conserved VBN I-NP O
haplotype NN I-NP O
than IN B-SBAR O
did VBD O O
the DT B-NP O
AJ NN I-NP O
N370S NN I-NP O
chromosomes NNS I-NP O
. . O O

This DT B-NP O
finding NN I-NP O
is VBZ B-VP O
consistent JJ B-ADJP O
with IN B-PP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
the DT B-NP O
N370S NN I-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
non AFX I-NP O
- HYPH I-NP O
Jewish JJ I-NP O
European JJ I-NP O
population NN I-NP O
prior JJ B-ADJP O
to TO B-PP O
the DT B-NP O
founding NN I-NP O
of IN B-PP O
the DT B-NP O
AJ NNP I-NP O
population NN I-NP O
. . O O

Coalescence NN B-NP O
analyses NNS I-NP O
for IN B-PP O
the DT B-NP O
N370S NN I-NP O
and CC I-NP O
84GG NN I-NP O
mutations NNS I-NP O
estimated VBD B-VP O
similar JJ B-NP O
coalescence NN I-NP O
times NNS I-NP O
, , O O
of IN B-PP O
48 CD B-NP O
and CC I-NP O
55 CD I-NP O
. . O O

5 CD B-NP O
generations NNS I-NP O
ago RB B-ADVP O
, , O O
respectively RB B-ADVP O
. . O O

The DT B-NP O
results NNS I-NP O
of IN B-PP O
these DT B-NP O
studies NNS I-NP O
are VBP B-VP O
consistent JJ B-ADJP O
with IN B-PP O
a DT B-NP O
significant JJ I-NP O
bottleneck NN I-NP O
occurring VBG B-VP O
in IN B-PP O
the DT B-NP O
AJ NN I-NP O
population NN I-NP O
during IN B-PP O
the DT B-NP O
first JJ I-NP O
millennium NN I-NP O
, , O O
when WRB B-ADVP O
the DT B-NP O
population NN I-NP O
became VBD B-VP O
established VBN I-VP O
in IN B-PP O
Europe NNP B-NP O
. . O O

HLA NN B-NP O
B27 NN I-NP O
and CC O O
the DT B-NP O
genetics NNS I-NP O
of IN B-PP O
ankylosing VBG B-VP B-Disease
spondylitis NN B-NP I-Disease
. . O O

One CD B-NP O
hundred CD I-NP O
and CC I-NP O
twenty CD I-NP O
- HYPH I-NP O
eight CD I-NP O
of IN B-PP O
145 CD B-NP O
patients NNS I-NP O
with IN B-PP O
ankylosing VBG B-VP B-Disease
spondylitis NN B-NP I-Disease
( ( O O
AS NN B-NP B-Disease
) ) O O
were VBD B-VP O
found VBN I-VP O
to TO I-VP O
be VB I-VP O
HLA NN B-NP O
B27 NN I-NP O
positive JJ B-ADJP O
. . O O

Five CD B-NP O
patients NNS I-NP O
had VBD B-VP O
evidence NN B-NP O
of IN B-PP O
a DT B-NP O
sero AFX I-NP O
- HYPH I-NP O
negative JJ I-NP O
peripheral JJ I-NP B-Disease
arthritis NN I-NP I-Disease
resembling VBG B-VP O
peripheral JJ B-NP B-Disease
psoriatic JJ I-NP I-Disease
arthritis NN I-NP I-Disease
and CC O O
3 CD B-NP O
of IN B-PP O
these DT B-NP O
were VBD B-VP O
B27 NN B-ADJP O
negative JJ I-ADJP O
. . O O

One CD B-NP O
further JJ I-NP O
B27 NN I-NP O
negative JJ I-NP O
patients NNS I-NP O
had VBD B-VP O
a DT B-NP O
sister NN I-NP O
with IN B-PP O
ankylosing VBG B-VP B-Disease
spondylitis NN B-NP I-Disease
and CC O O
ulcerative JJ B-NP B-Disease
colitis NN I-NP I-Disease
and CC O O
a DT B-NP O
mother NN I-NP O
with IN B-PP O
ulcerative JJ B-NP B-Disease
colitis NN I-NP I-Disease
. . O O

There EX B-NP O
was VBD B-VP O
evidence NN B-NP O
of IN B-PP O
a DT B-NP O
somewhat RB I-NP O
later JJ I-NP O
age NN I-NP O
of IN B-PP O
onset NN B-NP O
of IN B-PP O
symptoms NNS B-NP O
in IN B-PP O
B27 NN B-NP O
negative JJ I-NP O
patients NNS I-NP O
. . O O

These DT B-NP O
findings NNS I-NP O
are VBP B-VP O
interpreted VBN I-VP O
as IN B-PP O
suggesting VBG B-VP O
some DT B-NP O
degree NN I-NP O
of IN B-PP O
clinical JJ B-NP O
and CC I-NP O
genetic JJ I-NP O
heterogeneity NN I-NP O
in IN B-PP O
ankylosing VBG B-VP B-Disease
spondylitis NN B-NP I-Disease
with IN B-PP O
genes NNS B-NP O
for IN B-PP O
psoriasis NN B-NP B-Disease
and CC O O
inflammatory JJ B-NP B-Disease
bowel NN I-NP I-Disease
disease NN I-NP I-Disease
being VBG B-VP O
important JJ B-ADJP O
in IN B-PP O
some DT B-NP O
individuals NNS I-NP O
, , O O
particularly RB B-ADVP O
those DT B-NP O
who WP B-NP O
are VBP B-VP O
B27 NN B-NP O
negative JJ B-ADJP O
. . O O

Twenty CD B-NP O
- HYPH I-NP O
five CD I-NP O
first JJ I-NP O
- HYPH I-NP O
degree NN I-NP O
relatives NNS I-NP O
with IN B-PP O
ankylosing VBG B-NP B-Disease
spondylitis NN I-NP I-Disease
were VBD B-VP O
all DT B-NP O
B27 NN I-NP O
positive JJ B-ADJP O
. . O O

The DT B-NP O
only JJ I-NP O
instance NN I-NP O
of IN B-PP O
disassociation NN B-NP O
of IN B-PP O
B27 NN B-NP O
and CC I-NP O
spondylitis NN I-NP B-Disease
in IN B-PP O
a DT B-NP O
family NN I-NP O
was VBD B-VP O
where WRB B-ADVP O
the DT B-NP O
proband NN I-NP O
had VBD B-VP O
ulcerative JJ B-NP B-Disease
colitis NN I-NP I-Disease
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
spondylitis NN B-NP B-Disease
. . O O

Of IN B-PP O
13 CD B-NP O
B27 NN I-NP O
positive JJ I-NP O
fathers NNS I-NP O
3 CD B-NP O
could MD B-VP O
be VB I-VP O
diagnosed VBN I-VP O
as IN B-PP O
having VBG B-VP O
definite JJ B-NP O
ankylosing VBG I-NP B-Disease
spondylitis NN I-NP I-Disease
( ( O O
23 CD B-NP O
% NN I-NP O
) ) O O
. . O O

These DT B-NP O
findings NNS I-NP O
are VBP B-VP O
thought VBN I-VP O
to TO I-VP O
provide VB I-VP O
evidence NN B-NP O
against IN B-PP O
the DT B-NP O
concept NN I-NP O
that IN B-SBAR O
the DT B-NP O
gene NN I-NP O
for IN B-PP O
ankylosing VBG B-VP B-Disease
spondylitis NN B-NP I-Disease
is VBZ B-VP O
not RB O O
B27 NN B-NP O
but CC O O
a DT B-NP O
closely RB I-NP O
linked VBN I-NP O
gene NN I-NP O
and CC O O
favour VBP B-VP O
the DT B-NP O
occurrence NN I-NP O
of IN B-PP O
an DT B-NP O
environmental JJ I-NP O
event NN I-NP O
affecting VBG B-VP O
approximately RB B-NP O
one CD I-NP O
- HYPH I-NP O
fifth NN I-NP O
of IN B-PP O
B27 NN B-NP O
positive JJ I-NP O
males NNS I-NP O
to TO B-VP O
result VB I-VP O
in IN B-PP O
disease NN B-NP O
. . O O

. . O O

Founder NN B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
BRCA1 NN I-NP O
gene NN I-NP O
in IN B-PP O
Polish JJ B-NP O
families NNS I-NP O
with IN B-PP O
breast NN B-NP B-Disease
- HYPH B-NP I-Disease
ovarian JJ I-NP I-Disease
cancer NN I-NP I-Disease
. . O O

We PRP B-NP O
have VBP B-VP O
undertaken VBN I-VP O
a DT B-NP O
hospital NN I-NP O
- HYPH O O
based VBN B-NP O
study NN I-NP O
, , O O
to TO B-VP O
identify VB I-VP O
possible JJ B-NP O
BRCA1 NN I-NP O
and CC I-NP O
BRCA2 NN I-NP O
founder NN I-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
Polish JJ I-NP O
population NN I-NP O
. . O O

The DT B-NP O
study NN I-NP O
group NN I-NP O
consisted VBD B-VP O
of IN B-PP O
66 CD B-NP O
Polish JJ I-NP O
families NNS I-NP O
with IN B-PP O
cancer NN B-NP B-Disease
who WP B-NP O
have VBP B-VP O
at IN B-NP O
least JJS I-NP O
three CD I-NP O
related JJ I-NP O
females NNS I-NP O
affected VBN B-VP O
with IN B-PP O
breast NN B-NP B-Disease
or CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
and CC O O
who WP B-NP O
had VBD B-VP O
cancer NN I-VP B-Disease
diagnosed VBN I-VP O
, , O O
in IN B-PP O
at IN B-NP O
least JJS I-NP O
one CD I-NP O
of IN B-PP O
the DT B-NP O
three CD I-NP O
affected VBN I-NP O
females NNS I-NP O
, , O O
at IN B-PP O
age NN B-NP O
< SYM B-VP O
50 CD B-NP O
years NNS I-NP O
. . O O

A DT B-NP O
total NN I-NP O
of IN B-PP O
26 CD B-NP O
families NNS I-NP O
had VBD B-VP O
both CC O O
breast NN B-NP B-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancers NNS I-NP I-Disease
, , O O
4 CD B-NP O
families NNS I-NP O
had VBD B-VP O
ovarian JJ B-NP B-Disease
cancers NNS I-NP I-Disease
only RB B-ADVP O
, , O O
and CC O O
36 CD B-NP O
families NNS I-NP O
had VBD B-VP O
breast NN B-NP B-Disease
cancers NNS I-NP I-Disease
only RB B-ADVP O
. . O O

Genomic JJ B-NP O
DNA NN I-NP O
was VBD B-VP O
prepared VBN I-VP O
from IN B-PP O
the DT B-NP O
peripheral JJ I-NP O
blood NN I-NP O
leukocytes NNS I-NP O
of IN B-PP O
at IN B-NP O
least JJS I-NP O
one CD I-NP O
affected VBD B-VP O
woman NN B-NP O
from IN B-PP O
each DT B-NP O
family NN I-NP O
. . O O

The DT B-NP O
entire JJ I-NP O
coding VBG I-NP O
region NN I-NP O
of IN B-PP O
BRCA1 NN B-NP O
and CC I-NP O
BRCA2 NN I-NP O
was VBD B-VP O
screened VBN I-VP O
for IN B-PP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
germline NN B-NP O
mutations NNS I-NP O
, , O O
by IN B-PP O
use NN B-NP O
of IN B-PP O
SSCP NN B-NP O
followed VBN B-VP O
by IN B-PP O
direct JJ B-NP O
sequencing NN I-NP O
of IN B-PP O
observed VBN B-NP O
variants NNS I-NP O
. . O O

Mutations NNS B-NP O
were VBD B-VP O
found VBN I-VP O
in IN B-PP O
35 CD B-NP O
( ( O O
53 CD B-NP O
% NN I-NP O
) ) O O
of IN B-PP O
the DT B-NP O
66 CD I-NP O
families NNS I-NP O
studied VBN B-VP O
. . O O

All DT B-NP O
but IN B-PP O
one CD B-NP O
of IN B-PP O
the DT B-NP O
mutations NNS I-NP O
were VBD B-VP O
detected VBN I-VP O
within IN B-PP O
the DT B-NP O
BRCA1 NN I-NP O
gene NN I-NP O
. . O O

BRCA1 NN B-NP B-Disease
abnormalities NNS I-NP I-Disease
were VBD B-VP O
identified VBN I-VP O
in IN B-PP O
all DT B-NP O
four CD I-NP O
families NNS I-NP O
with IN B-PP O
ovarian JJ B-NP B-Disease
cancer NN I-NP I-Disease
only RB B-ADVP O
, , O O
in IN B-PP O
67 CD B-NP O
% NN I-NP O
of IN B-PP O
27 CD B-NP O
families NNS I-NP O
with IN B-PP O
both CC O O
breast NN B-NP B-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
, , O O
and CC O O
in IN B-PP O
34 CD B-NP O
% NN I-NP O
of IN B-PP O
35 CD B-NP O
families NNS I-NP O
with IN B-PP O
breast NN B-NP B-Disease
cancer NN I-NP I-Disease
only RB B-ADVP O
. . O O

The DT B-NP O
single JJ I-NP O
family NN I-NP O
with IN B-PP O
a DT B-NP O
BRCA2 NN I-NP O
mutation NN I-NP O
had VBD B-VP O
the DT B-NP O
breast NN I-NP B-Disease
- HYPH B-NP I-Disease
ovarian JJ I-NP I-Disease
cancer NN I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

Seven CD B-NP O
distinct JJ I-NP O
mutations NNS I-NP O
were VBD B-VP O
identified VBN I-VP O
; : O O
five CD B-NP O
of IN B-PP O
these DT B-NP O
occurred VBD B-VP O
in IN B-PP O
two CD B-NP O
or CC I-NP O
more JJR I-NP O
families NNS I-NP O
. . O O

In IN B-PP O
total JJ B-NP O
, , I-NP O
recurrent JJ I-NP O
mutations NNS I-NP O
were VBD B-VP O
found VBN I-VP O
in IN B-PP O
33 CD B-NP O
( ( O O
94 CD B-NP O
% NN I-NP O
) ) O O
of IN B-PP O
the DT B-NP O
35 CD I-NP O
families NNS I-NP O
with IN B-PP O
detected VBN B-NP O
mutations NNS I-NP O
. . O O

Three CD B-NP O
BRCA1 NN I-NP B-Disease
abnormalities NNS I-NP I-Disease
- HYPH O O
5382insC NN B-NP O
, , O O
C61G NN B-NP O
, , O O
and CC O O
4153delA NN B-NP O
- HYPH O O
accounted VBN B-VP O
for IN B-PP O
51 CD B-NP O
% NN I-NP O
, , O O
20 CD B-NP O
% NN I-NP O
, , O O
and CC O O
11 CD B-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
identified VBN I-NP O
mutations NNS I-NP O
, , O O
respectively RB B-ADVP O
. . O O

. . O O

Molecular JJ B-NP O
basis NN I-NP O
of IN B-PP O
very RB B-NP B-Disease
long JJ I-NP I-Disease
chain NN I-NP I-Disease
acyl NN I-NP I-Disease
- HYPH B-NP I-Disease
CoA NN I-NP I-Disease
dehydrogenase NN I-NP I-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
three CD B-NP O
Israeli JJ I-NP O
patients NNS I-NP O
: : O O
identification NN B-NP O
of IN B-PP O
a DT B-NP O
complex JJ I-NP O
mutant JJ I-NP O
allele NN I-NP O
with IN B-PP O
P65L NN B-NP O
and CC I-NP O
K247Q NN I-NP O
mutations NNS I-NP O
, , O O
the DT B-NP O
former JJ I-NP O
being VBG B-VP O
an DT B-NP O
exonic JJ I-NP O
mutation NN I-NP O
causing VBG B-VP O
exon NN B-NP O
3 CD I-NP O
skipping NN I-NP O
. . O O

Very JJ B-NP B-Disease
long JJ I-NP I-Disease
chain NN I-NP I-Disease
acyl NN I-NP I-Disease
- HYPH B-NP I-Disease
CoA NN I-NP I-Disease
dehydrogenase NN I-NP I-Disease
( ( O I-Disease
VLCAD NN B-NP I-Disease
) ) O I-Disease
deficiency NN B-NP I-Disease
is VBZ B-VP O
a DT B-NP O
life NN I-NP O
- HYPH O O
threatening VBG B-VP O
disorder NN B-NP O
of IN B-PP O
mitochondrial JJ B-NP O
fatty JJ I-NP O
acid NN I-NP O
beta SYM B-VP O
- HYPH O O
oxidation NN B-NP O
. . O O

We PRP B-NP O
identified VBD B-VP O
four CD B-NP O
novel JJ I-NP O
mutations NNS I-NP O
in IN B-PP O
three CD B-NP O
unrelated JJ I-NP O
patients NNS I-NP O
. . O O

All DT B-NP O
patients NNS I-NP O
had VBD B-VP O
the DT B-NP O
severe JJ I-NP O
childhood NN I-NP O
form NN I-NP O
of IN B-PP O
VLCAD NN B-NP B-Disease
deficiency NN I-NP I-Disease
with IN B-PP O
early JJ B-NP O
onset NN I-NP O
and CC O O
high JJ B-NP O
mortality NN I-NP O
. . O O

Immunoblot NN B-NP O
analysis NN I-NP O
revealed VBD B-VP O
that IN B-SBAR O
VLCAD NN B-NP O
protein NN I-NP O
was VBD B-VP O
undetectable JJ B-ADJP O
in IN B-PP O
patients NNS B-NP O
2 CD B-NP O
and CC I-NP O
3 CD I-NP O
, , O O
whereas IN B-PP O
normal JJ B-NP O
- HYPH I-NP O
size NN I-NP O
VLCAD NN I-NP O
protein NN I-NP O
and CC O O
an DT B-NP O
aberrant JJ I-NP O
form NN I-NP O
of IN B-PP O
VLCAD NN B-NP O
( ( O O
4kDa NN B-NP O
smaller JJR B-ADJP O
) ) O O
were VBD B-VP O
detected VBN I-VP O
in IN B-PP O
patient NN B-NP O
1 CD I-NP O
. . O O

As IN B-SBAR O
expected VBN B-VP O
, , O O
mutations NNS I-NP O
were VBD B-VP O
found VBN I-VP O
in IN B-PP O
patients NNS B-NP O
2 CD B-NP O
and CC I-NP O
3 CD I-NP O
patient NN I-NP O
2 CD B-NP O
is VBZ B-VP O
homozygous JJ B-ADJP O
for IN B-PP O
a DT B-NP O
frameshift NN I-NP O
mutation NN I-NP O
, , O O
del NN B-NP O
4 CD I-NP O
bp NN I-NP O
at IN B-PP O
798 CD B-NP O
- HYPH I-NP O
801 CD I-NP O
, , O O
and CC O O
patient NN B-NP O
3 CD I-NP O
is VBZ B-VP O
homozygous JJ B-ADJP O
for IN B-PP O
a DT B-NP O
nonsense JJ I-NP O
mutation NN I-NP O
65C NN I-NP O
> SYM O O
A NN B-NP O
( ( O O
S22X NN B-NP O
) ) O O
. . O O

Patient NN B-NP O
1 CD I-NP O
was VBD B-VP O
homozygous JJ B-ADJP O
for IN B-PP O
a DT B-NP O
complex JJ I-NP O
mutant JJ I-NP O
allele NN I-NP O
containing VBG B-VP O
two CD B-NP O
alterations NNS I-NP O
, , O O
including VBG B-PP O
a DT B-NP O
194C NN I-NP O
> JJ I-NP O
T NN I-NP O
transition NN I-NP O
( ( O O
P65L NN B-NP O
) ) O O
and CC O O
739A NN B-NP O
> SYM O O
C NN B-NP O
transversion NN I-NP O
( ( O O
K247Q NN B-NP O
) ) O O
; : O O
in IN B-PP O
the DT B-NP O
case NN I-NP O
of IN B-PP O
P65L NN B-NP O
, , O O
the DT B-NP O
amino JJ I-NP O
acid NN I-NP O
change NN I-NP O
does VBZ B-VP O
not RB I-VP O
reduce VB I-VP O
enzyme NN B-NP O
activity NN I-NP O
. . O O

However RB B-ADVP O
, , O O
the DT B-NP O
nucleotide NN I-NP O
change NN I-NP O
resulted VBD B-VP O
in IN B-PP O
exon NN B-NP O
3 CD I-NP O
skipping NN I-NP O
, , O O
whereas IN O O
the DT B-NP O
latter JJ I-NP O
K247Q NN I-NP O
mutation NN I-NP O
had VBD B-VP O
a DT B-NP O
drastic JJ I-NP O
effect NN I-NP O
on IN B-PP O
enzyme NN B-NP O
activity NN I-NP O
. . O O

We PRP B-NP O
verified VBD B-VP O
these DT B-NP O
events NNS I-NP O
by IN B-PP O
in FW B-NP O
vivo FW I-NP O
splicing NN I-NP O
experiments NNS I-NP O
and CC O O
transient JJ B-NP O
expression NN I-NP O
analysis NN I-NP O
of IN B-PP O
mutant JJ B-NP O
cDNAs NNS I-NP O
. . O O

The DT B-NP O
P65L NN I-NP O
mutation NN I-NP O
locates VBZ B-VP O
11 CD B-NP O
bases NNS I-NP O
upstream RB B-ADVP O
of IN B-PP O
a DT B-NP O
splice NN I-NP O
donor NN I-NP O
site NN I-NP O
of IN B-PP O
intron NN B-NP O
3 CD I-NP O
. . O O

This DT B-NP O
is VBZ B-VP O
an DT B-NP O
example NN I-NP O
of IN B-PP O
an DT B-NP O
exonic JJ I-NP O
mutation NN I-NP O
which WDT B-NP O
affects VBZ B-VP O
exon NN B-NP O
- HYPH I-NP O
splicing NN I-NP O
. . O O

. . O O

Submicroscopic JJ B-NP O
deletion NN I-NP O
in IN B-PP O
cousins NNS B-NP O
with IN B-PP O
Prader NNP B-NP B-Disease
- HYPH I-NP I-Disease
Willi NNP I-NP I-Disease
syndrome NN I-NP I-Disease
causes VBZ B-VP O
a DT B-NP O
grandmatrilineal JJ I-NP O
inheritance NN I-NP O
pattern NN I-NP O
: : O O
effects NNS B-NP O
of IN B-PP O
imprinting NN B-NP O
. . O O

The DT B-NP O
Prader NNP I-NP B-Disease
- HYPH I-NP I-Disease
Willi NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
PWS NN B-NP B-Disease
) ) O O
critical JJ B-NP O
region NN I-NP O
on IN B-PP O
15q11 NN B-NP O
- HYPH O O
q13 NN B-NP O
is VBZ B-VP O
subject JJ B-ADJP O
to TO B-PP O
imprinting NN B-NP O
. . O O

PWS NN B-NP B-Disease
becomes VBZ B-VP O
apparent JJ B-ADJP O
when WRB B-ADVP O
genes NNS B-NP O
on IN B-PP O
the DT B-NP O
paternally RB I-NP O
inherited VBN I-NP O
chromosome NN I-NP O
are VBP B-VP O
not RB I-VP O
expressed VBN I-VP O
. . O O

Familial JJ B-NP B-Disease
PWS NN I-NP I-Disease
is VBZ B-VP O
rare JJ B-ADJP O
. . O O

We PRP B-NP O
report VBP B-VP O
on IN B-PP O
a DT B-NP O
family NN I-NP O
in IN B-PP O
which WDT B-NP O
a DT B-NP O
male JJ I-NP O
and CC O O
a DT B-NP O
female JJ I-NP O
paternal JJ I-NP O
first JJ I-NP O
cousin NN I-NP O
both DT B-NP O
have VBP B-VP O
PWS NN B-NP B-Disease
with IN B-PP O
cytogenetically RB B-NP O
normal JJ I-NP O
karyotypes NNS I-NP O
. . O O

Fluorescence NN B-NP O
in FW B-NP O
situ FW I-NP O
hybridization NN I-NP O
( ( O O
FISH NN B-NP O
) ) O O
analysis NN B-NP O
shows VBZ B-VP O
a DT B-NP O
submicroscopic JJ I-NP O
deletion NN I-NP O
of IN B-PP O
SNRPN NN B-NP O
, , B-NP O
but CC I-NP O
not RB I-NP O
the DT B-NP O
closely RB I-NP O
associated VBN I-NP O
loci NNS I-NP O
D15S10 NN I-NP O
, , O O
D15S11 NN B-NP O
, , O O
D15S63 NN B-NP O
, , O O
and CC O O
GABRB3 NN B-NP O
. . O O

The DT B-NP O
cousins NNS I-NP O
fathers NNS I-NP O
and CC O O
two CD B-NP O
paternal JJ I-NP O
aunts NNS I-NP O
have VBP B-VP O
the DT B-NP O
same JJ I-NP O
deletion NN I-NP O
and CC O O
are VBP B-VP O
clinically RB B-ADJP O
normal JJ I-ADJP O
. . O O

The DT B-NP O
grandmother NN I-NP O
of IN B-PP O
the DT B-NP O
cousins NNS I-NP O
is VBZ B-VP O
deceased VBN I-VP O
and CC O O
not RB B-ADJP O
available JJ I-ADJP O
for IN B-PP O
study NN B-NP O
, , O O
and CC O O
their PRP$ B-NP O
grandfather NN I-NP O
is VBZ B-VP O
not RB I-VP O
deleted VBN I-VP O
for IN B-PP O
SNRPN NN B-NP O
. . O O

DNA NN B-NP O
methylation NN I-NP O
analysis NN I-NP O
of IN B-PP O
D15S63 NN B-NP O
is VBZ B-VP O
consistent JJ B-ADJP O
with IN B-PP O
an DT B-NP O
abnormality NN I-NP O
of IN B-PP O
the DT B-NP O
imprinting NN I-NP O
center NN I-NP O
associated VBN B-VP O
with IN B-PP O
PWS NN B-NP B-Disease
. . O O

Grandmatrilineal JJ I-NP O
inheritance NN I-NP O
occurs VBZ B-VP O
when WRB B-ADVP O
a DT B-NP O
woman NN I-NP O
with IN B-PP O
deletion NN B-NP O
of IN B-PP O
an DT B-NP O
imprinted VBN I-NP O
, , I-NP O
paternally RB I-NP O
expressed VBN I-NP O
gene NN I-NP O
is VBZ B-VP O
at IN B-PP O
risk NN B-NP O
of IN B-PP O
having VBG B-VP O
affected VBN I-VP O
grandchildren NNS B-NP O
through IN B-PP O
her PRP$ B-NP O
sons NNS I-NP O
. . O O

In IN B-PP O
this DT B-NP O
case NN I-NP O
, , O O
PWS NN B-NP B-Disease
does VBZ B-VP O
not RB I-VP O
become VB I-VP O
evident JJ B-ADJP O
as RB B-ADVP O
long RB I-ADVP O
as IN B-SBAR O
the DT B-NP O
deletion NN I-NP O
is VBZ B-VP O
passed VBN I-VP O
through IN B-PP O
the DT B-NP O
matrilineal JJ I-NP O
line NN I-NP O
. . O O

This DT B-NP O
represents VBZ B-VP O
a DT B-NP O
unique JJ I-NP O
inheritance NN I-NP O
pattern NN I-NP O
due IN B-PP O
to TO I-PP O
imprinting NN B-NP O
. . O O

. . O O

Human JJ B-NP O
glycine NN I-NP O
decarboxylase NN I-NP O
gene NN I-NP O
( ( O O
GLDC NN B-NP O
) ) O O
and CC O O
its PRP$ B-NP O
highly RB I-NP O
conserved VBN I-NP O
processed VBN I-NP O
pseudogene NN I-NP O
( ( O O
psiGLDC NN B-NP O
) ) O O
: : O O
their PRP$ B-NP O
structure NN I-NP O
and CC I-NP O
expression NN I-NP O
, , O O
and CC O O
the DT B-NP O
identification NN I-NP O
of IN B-PP O
a DT B-NP O
large JJ I-NP O
deletion NN I-NP O
in IN B-PP O
a DT B-NP O
family NN I-NP O
with IN B-PP O
nonketotic JJ B-NP B-Disease
hyperglycinemia NN I-NP I-Disease
. . O O

Mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
glycine NN I-NP O
decarboxylase NN I-NP O
gene NN I-NP O
( ( O O
GLDC NN B-NP O
) ) O O
cause VBP B-VP O
nonketotic JJ B-NP B-Disease
hyperglycinemia NN I-NP I-Disease
( ( O O
NKH NN B-NP B-Disease
) ) O O
, , O O
an DT B-NP O
in IN B-PP B-Disease
- HYPH B-NP I-Disease
born VBN I-NP I-Disease
error NN I-NP I-Disease
of IN B-PP I-Disease
metabolism NN B-NP I-Disease
characterized VBN B-VP O
by IN B-PP O
severe JJ B-NP O
neurological JJ I-NP B-Disease
disturbance NN I-NP I-Disease
. . O O

We PRP B-NP O
have VBP B-VP O
determined VBN I-VP O
the DT B-NP O
structure NN I-NP O
of IN B-PP O
GLDC NN B-NP O
and CC B-PP O
of IN B-PP O
its PRP$ B-NP O
pseudogene NN I-NP O
( ( O O
psiGLDC NN B-NP O
) ) O O
and CC O O
studied VBD B-VP O
their PRP$ B-NP O
expression NN I-NP O
for IN B-PP O
a DT B-NP O
molecular JJ I-NP O
analysis NN I-NP O
of IN B-PP O
NKH NN B-NP B-Disease
. . O O

The DT B-NP O
GLDC NN I-NP O
gene NN I-NP O
spans NNS I-NP O
at IN B-NP O
least JJS I-NP O
135 CD I-NP O
kb NN I-NP O
and CC O O
consists VBZ B-VP O
of IN B-PP O
25 CD B-NP O
exons NNS I-NP O
. . O O

All DT B-NP O
donor NN I-NP O
and CC I-NP O
acceptor NN I-NP O
sites NNS I-NP O
adhere JJ B-ADJP O
to TO B-PP O
the DT B-NP O
canonical JJ I-NP O
GT NN I-NP O
- HYPH B-NP O
AG NN I-NP O
rule NN I-NP O
, , O O
except IN B-PP O
for IN B-PP O
the DT B-NP O
donor NN I-NP O
site NN I-NP O
of IN B-PP O
intron NN B-NP O
21 CD I-NP O
, , O O
where WRB B-ADVP O
a DT B-NP O
variant JJ I-NP O
form NN I-NP O
GC NN I-NP O
is VBZ B-VP O
used VBN I-VP O
instead RB B-PP O
of IN I-PP O
GT NN B-NP O
. . O O

The DT B-NP O
transcription NN I-NP O
initiation NN I-NP O
site NN I-NP O
has VBZ B-VP O
been VBN I-VP O
assigned VBN I-VP O
to TO B-PP O
a DT B-NP O
residue NN I-NP O
163 CD I-NP O
bp NN I-NP O
upstream RB B-ADVP O
from IN B-PP O
the DT B-NP O
translation NN I-NP O
initiation NN I-NP O
triplet VBN B-VP O
by IN B-PP O
primer NN B-NP O
extension NN I-NP O
analysis NN I-NP O
. . O O

The DT B-NP O
psiGLDC NN I-NP O
gene NN I-NP O
has VBZ B-VP O
no DT B-NP O
intron NN I-NP O
and CC I-NP O
shares NNS I-NP O
97 CD B-NP O
. . O O

5 CD B-NP O
% NN I-NP O
homology NN I-NP O
with IN B-PP O
the DT B-NP O
coding VBG I-NP O
region NN I-NP O
of IN B-PP O
functional JJ B-NP O
GLDC NN I-NP O
, , O O
suggesting VBG B-VP O
that IN B-SBAR O
psiGLDC NN B-NP O
is VBZ B-VP O
a DT B-NP O
processed VBN I-NP O
pseudogene NN I-NP O
that WDT B-NP O
arose VBD B-VP O
from IN B-PP O
the DT B-NP O
GLDC NN I-NP O
transcript NN I-NP O
about RB B-NP O
4 CD I-NP O
- HYPH I-NP O
8 CD I-NP O
million CD I-NP O
years NNS I-NP O
ago RB B-ADVP O
. . O O

RNA NN B-NP O
blotting NN I-NP O
analysis NN I-NP O
has VBZ B-VP O
revealed VBN I-VP O
that IN B-SBAR O
GLDC NN B-NP O
is VBZ B-VP O
expressed VBN I-VP O
in IN B-PP O
human JJ B-NP O
liver NN I-NP O
, , O O
kidney NN B-NP O
, , O O
brain NN B-NP O
, , O O
and CC O O
placenta NN B-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
also RB I-VP O
examined VBN I-VP O
a DT B-NP O
patient NN I-NP O
with IN B-PP O
NKH NN B-NP B-Disease
with IN B-PP O
no DT B-NP O
detectable JJ I-NP O
GLDC NN I-NP O
mRNA NN I-NP O
in IN B-PP O
his PRP$ B-NP O
lymphoblasts NNS I-NP O
. . O O

Exons NNS B-NP O
1 CD I-NP O
- HYPH I-NP O
3 CD I-NP O
of IN B-PP O
the DT B-NP O
functional JJ I-NP O
GLDC NN I-NP O
gene NN I-NP O
from IN B-PP O
this DT B-NP O
patient NN I-NP O
are VBP B-VP O
not RB I-VP O
amplified VBN I-VP O
by IN B-PP O
polymerase NN B-NP O
chain NN I-NP O
reaction NN I-NP O
( ( O O
PCR NN B-NP O
) ) O O
, , O O
whereas IN O O
those DT B-NP O
from IN B-PP O
control NN B-NP O
subjects NNS I-NP O
are VBP B-VP O
. . O O

These DT B-NP O
results NNS I-NP O
suggest VBP B-VP O
a DT B-NP O
large JJ I-NP O
homozygous JJ I-NP O
deletion NN I-NP O
( ( O O
at IN B-NP O
least JJS I-NP O
30 CD I-NP O
kb NN I-NP O
) ) O O
in IN B-PP O
the DT B-NP O
patient NN I-NP O
. . O O

Furthermore RB B-ADVP O
, , O O
we PRP B-NP O
have VBP B-VP O
devised VBN I-VP O
a DT B-NP O
semi AFX I-NP O
- HYPH I-NP O
quantitative JJ I-NP O
PCR NN I-NP O
to TO B-VP O
estimate VB I-VP O
the DT B-NP O
number NN I-NP O
of IN B-PP O
GLDC NN B-NP O
alleles NNS I-NP O
by IN B-PP O
using VBG B-VP O
psiGLDC NN B-NP O
as IN B-PP O
an DT B-NP O
internal JJ I-NP O
control NN I-NP O
and CC O O
have VBP B-VP O
confirmed VBN I-VP O
the DT B-NP O
homozygosity NN I-NP O
and CC I-NP O
heterozygosity NN I-NP O
of IN B-PP O
the DT B-NP O
deletion NN I-NP O
in IN B-PP O
the DT B-NP O
patient NN I-NP O
and CC O O
his PRP$ B-NP O
parents NNS I-NP O
, , O O
respectively RB B-ADVP O
. . O O

Structural JJ B-NP O
information NN I-NP O
of IN B-PP O
GLDC NN B-NP O
and CC I-NP O
psiGLDC NN I-NP O
should MD B-VP O
facilitate VB I-VP O
the DT B-NP O
molecular JJ I-NP O
analysis NN I-NP O
of IN B-PP O
NKH NN B-NP B-Disease
. . O O

De FW B-NP O
novo FW I-NP O
deletions NNS I-NP O
of IN B-PP O
SNRPN NN B-NP O
exon NN I-NP O
1 CD I-NP O
in IN B-PP O
early JJ B-NP O
human JJ I-NP O
and CC I-NP O
mouse NN I-NP O
embryos NNS I-NP O
result VBP B-VP O
in IN B-PP O
a DT B-NP O
paternal JJ I-NP O
to TO B-PP O
maternal JJ B-NP O
imprint NN I-NP O
switch NN I-NP O
. . O O

Prader NNP B-NP B-Disease
- HYPH I-NP I-Disease
Willi NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
PWS NN B-NP B-Disease
) ) O O
is VBZ B-VP O
a DT B-NP O
neurogenetic JJ I-NP B-Disease
disease NN I-NP I-Disease
characterized VBN B-VP O
by IN B-PP O
infantile JJ B-NP B-Disease
hypotonia NN I-NP I-Disease
, , O O
gonadal JJ B-NP B-Disease
hypoplasia NN I-NP I-Disease
, , O O
obsessive JJ B-NP O
behaviour NN I-NP O
and CC O O
neonatal JJ B-NP O
feeding NN I-NP O
difficulties NNS I-NP O
followed VBN B-VP O
by IN B-PP O
hyperphagia NN B-NP B-Disease
, , O O
leading VBG B-VP O
to TO B-PP O
profound JJ B-NP O
obesity NN I-NP B-Disease
. . O O

PWS NN B-NP B-Disease
is VBZ B-VP O
due IN B-PP O
to TO B-PP O
a DT B-NP O
lack NN I-NP O
of IN B-PP O
paternal JJ B-NP O
genetic JJ I-NP O
information NN I-NP O
at IN B-PP O
15q11 CD B-NP O
- HYPH I-NP O
q13 NN I-NP O
( ( O O
ref NN B-NP O
. . O O

2 CD B-NP O
) ) O O
. . O O

Five CD B-NP O
imprinted VBN B-VP O
, , O O
paternally RB B-NP O
expressed VBN I-NP O
genes NNS I-NP O
map VBP B-VP O
to TO B-PP O
the DT B-NP O
PWS NN I-NP B-Disease
region NN I-NP O
, , O O
MKRN3 NN B-NP O
( ( O O
ref NN B-NP O
. . B-NP O

3 CD I-NP O
) ) O O
, , O O
NDN NN B-NP O
( ( O O
ref NN B-NP O
. . O O

4 CD B-NP O
) ) O O
, , O O
NDNL1 NN B-NP O
( ( O O
ref NN B-NP O
. . O O

5 CD B-NP O
) ) O O
, , O O
SNRPN NN B-NP O
( ( O O
refs NNS B-NP O
6 CD B-NP O
- HYPH I-NP O
8 CD I-NP O
) ) O O
and CC O O
IPW NN B-NP O
( ( O O
ref NN B-NP O
. . O O

9 CD B-NP O
) ) O O
, , O O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
two CD B-NP O
poorly RB I-NP O
characterized VBN I-NP O
framents NNS I-NP O
designated VBN B-VP O
PAR NN B-NP O
- HYPH B-NP O
1 CD I-NP O
and CC I-NP O
PAR NN I-NP O
- HYPH O O
5 CD B-NP O
( ( O O
ref NN B-NP O
. . I-NP O

10 CD I-NP O
) ) O O
. . O O

Imprinting NN B-NP O
of IN B-PP O
this DT B-NP O
region NN I-NP O
involves VBZ B-VP O
a DT B-NP O
bipartite JJ I-NP O
imprinting NN I-NP O
centre NN I-NP O
( ( O O
IC NN B-NP O
) ) O O
, , O O
which WDT B-NP O
overlaps VBZ B-VP O
SNRPN NN B-NP O
( ( O O
refs NNS B-NP O
10 CD I-NP O
, , I-NP O
11 CD I-NP O
) ) O O
. . O O

Deletion NN B-NP O
of IN B-PP O
the DT B-NP O
SNRPN NN I-NP O
promoter NN I-NP O
/ SYM B-VP O
exon NN B-NP O
1 CD I-NP O
region NN I-NP O
( ( O O
the DT B-NP O
PWS NN I-NP B-Disease
IC NN I-NP O
element NN I-NP O
) ) O O
appears VBZ B-VP O
to TO I-VP O
impair VB I-VP O
the DT B-NP O
establishment NN I-NP O
of IN B-PP O
the DT B-NP O
paternal JJ I-NP O
imprint NN I-NP O
in IN B-PP O
the DT B-NP O
male JJ I-NP O
germ NN I-NP O
line NN I-NP O
and CC O O
leads VBZ B-VP O
to TO B-PP O
PWS NN B-NP B-Disease
. . O O

Here RB B-ADVP O
we PRP B-NP O
report VBP B-VP O
a DT B-NP O
PWS NN I-NP B-Disease
family NN I-NP O
in IN B-PP O
which WDT B-NP O
the DT B-NP O
father NN I-NP O
is VBZ B-VP O
mosaic JJ B-ADJP O
for IN B-PP O
an DT B-NP O
IC NN I-NP O
deletion NN I-NP O
on IN B-PP O
his PRP$ B-NP O
paternal JJ I-NP O
chromosome NN I-NP O
. . O O

The DT B-NP O
deletion NN I-NP O
chromosome NN I-NP O
has VBZ B-VP O
acquired VBN I-VP O
a DT B-NP O
maternal JJ I-NP O
methylation NN I-NP O
imprint NN I-NP O
in IN B-PP O
his PRP$ B-NP O
somatic JJ I-NP O
cells NNS I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
made VBN I-VP O
identical JJ B-NP O
findings NNS I-NP O
in IN B-PP O
chimaeric JJ B-NP O
mice NNS I-NP O
generated VBN B-VP O
from IN B-PP O
two CD B-NP O
independent JJ I-NP O
embryonic JJ I-NP O
stem NN I-NP O
( ( O O
ES NN B-NP O
) ) O O
cell NN B-NP O
lines NNS I-NP O
harbouring VBG B-VP O
a DT B-NP O
similar JJ I-NP O
deletion NN I-NP O
. . O O

Our PRP$ B-NP O
studies NNS I-NP O
demonstrate VBP B-VP O
that IN B-SBAR O
the DT B-NP O
PWS NN I-NP B-Disease
IC NN I-NP O
element NN I-NP O
is VBZ B-VP O
not RB O O
only RB O O
required VBN B-VP O
for IN B-PP O
the DT B-NP O
establishment NN I-NP O
of IN B-PP O
the DT B-NP O
paternal JJ I-NP O
imprint NN I-NP O
, , O O
but CC B-CONJP O
also RB I-CONJP O
for IN B-PP O
its PRP$ B-NP O
postzygotic JJ I-NP O
maintenance NN I-NP O
. . O O

. . O O

Mice NNS B-NP O
deficient JJ B-ADJP B-Disease
in IN B-PP I-Disease
Six5 CD B-NP I-Disease
develop JJ I-NP O
cataracts NNS I-NP B-Disease
: : O O
implications NNS B-NP O
for IN B-PP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
. . O O

Expansion NN B-NP O
of IN B-PP O
a DT B-NP O
CTG NN I-NP O
trinucleotide NN I-NP O
repeat NN I-NP O
in IN B-PP O
the DT B-NP O
3 CD I-NP O
UTR NN I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
DMPK NN I-NP O
at IN B-PP O
the DT B-NP O
DM1 NN I-NP O
locus NN I-NP O
on IN B-PP O
chromosome NN B-NP O
19 CD I-NP O
causes VBZ B-VP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
, , O O
a DT B-NP O
dominantly RB I-NP B-Disease
inherited VBN I-NP I-Disease
disease NN I-NP I-Disease
characterized VBN B-VP O
by IN B-PP O
skeletal JJ B-NP O
muscle NN I-NP B-Disease
dystrophy NN I-NP I-Disease
and CC I-NP O
myotonia NN I-NP B-Disease
, , O O
cataracts NNS B-NP B-Disease
and CC O O
cardiac JJ B-NP B-Disease
conduction NN I-NP I-Disease
defects NNS I-NP I-Disease
. . O O

Targeted VBN B-NP O
deletion NN I-NP O
of IN B-PP O
Dm15 NN B-NP O
, , O O
the DT B-NP O
mouse NN I-NP O
orthologue NN I-NP O
of IN B-PP O
human JJ B-NP O
DMPK NN I-NP O
, , O O
produced VBD B-VP O
mice NNS B-NP O
with IN B-PP O
a DT B-NP O
mild JJ I-NP O
myopathy NN I-NP B-Disease
and CC O O
cardiac JJ B-NP B-Disease
conduction NN I-NP I-Disease
abnormalities NNS I-NP I-Disease
, , O O
but CC O O
without IN B-PP O
other JJ B-NP O
features NNS I-NP O
of IN B-PP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
, , O O
such JJ B-PP O
as IN I-PP O
myotonia NNS B-NP B-Disease
and CC I-NP O
cataracts NNS I-NP B-Disease
. . O O

We PRP B-NP O
, , O O
and CC O O
others NNS B-NP O
, , O O
have VBP B-VP O
demonstrated VBN I-VP O
that IN B-SBAR O
repeat NN B-NP O
expansion NN I-NP O
decreases VBZ B-VP O
expression NN B-NP O
of IN B-PP O
the DT B-NP O
adjacent JJ I-NP O
gene NN I-NP O
SIX5 NN I-NP O
( ( O O
refs NNS B-NP O
7 CD B-NP O
, , I-NP O
8 CD I-NP O
) ) O O
, , O O
which WDT B-NP O
encodes VBZ B-VP O
a DT B-NP O
homeodomain NN I-NP O
transcription NN I-NP O
factor NN I-NP O
. . O O

To TO B-VP O
determine VB I-VP O
whether IN B-SBAR O
SIX5 NN B-NP B-Disease
deficiency NN I-NP I-Disease
contributes VBZ B-VP O
to TO B-PP O
the DT B-NP O
myotonic JJ I-NP B-Disease
dystrophy NN I-NP I-Disease
phenotype NN I-NP O
, , O O
we PRP B-NP O
disrupted VBD B-VP O
mouse NN B-NP O
Six5 CD I-NP O
by IN B-PP O
replacing VBG B-VP O
the DT B-NP O
first JJ I-NP O
exon NN I-NP O
with IN B-PP O
a DT B-NP O
beta SYM I-NP O
- HYPH I-NP O
galactosidase NN I-NP O
reporter NN I-NP O
. . O O

Six5 CD B-NP O
- HYPH I-NP O
mutant JJ I-NP O
mice NNS I-NP O
showed VBD B-VP O
reporter NN B-NP O
expression NN I-NP O
in IN B-PP O
multiple JJ B-NP O
tissues NNS I-NP O
, , O O
including VBG B-PP O
the DT B-NP O
developing VBG I-NP O
lens NN I-NP O
. . O O

Homozygous JJ B-NP O
mutant JJ I-NP O
mice NNS I-NP O
had VBD B-VP O
no DT B-NP O
apparent JJ I-NP O
abnormalities NNS I-NP B-Disease
of IN B-PP I-Disease
skeletal JJ B-NP I-Disease
muscle NN I-NP I-Disease
function NN I-NP I-Disease
, , O O
but CC O O
developed VBD B-VP O
lenticular JJ B-NP B-Disease
opacities NNS I-NP I-Disease
at IN B-PP O
a DT B-NP O
higher JJR I-NP O
rate NN I-NP O
than IN B-PP O
controls NNS B-NP O
. . O O

Our PRP$ B-NP O
results NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
SIX5 NN B-NP B-Disease
deficiency NN I-NP I-Disease
contributes VBZ B-VP O
to TO B-PP O
the DT B-NP O
cataract NN I-NP B-Disease
phenotype NN I-NP O
in IN B-PP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
, , O O
and CC O O
that IN B-SBAR O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
represents VBZ B-VP O
a DT B-NP O
multigenic JJ I-NP B-Disease
disorder NN I-NP I-Disease
. . O O

. . O O

Heterozygous JJ B-NP O
loss NN I-NP O
of IN B-PP O
Six5 CD B-NP O
in IN B-PP O
mice NNS B-NP O
is VBZ B-VP O
sufficient JJ B-ADJP O
to TO B-VP O
cause VB I-VP O
ocular JJ B-NP O
cataracts NNS I-NP B-Disease
. . O O

Myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
( ( O O
DM NN B-NP B-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
autosomal JJ I-NP B-Disease
dominant JJ I-NP I-Disease
disorder NN I-NP I-Disease
characterized VBN B-VP O
by IN B-PP O
skeletal JJ B-NP O
muscle NN I-NP B-Disease
wasting NN I-NP I-Disease
, , O O
myotonia NN B-NP B-Disease
, , O O
cardiac JJ B-NP B-Disease
arrhythmia NN I-NP I-Disease
, , O O
hyperinsulinaemia NN B-NP B-Disease
, , O O
mental JJ B-NP B-Disease
retardation NN I-NP I-Disease
and CC O O
ocular JJ B-NP O
cataracts NNS I-NP B-Disease
. . O O

The DT B-NP O
genetic JJ I-NP B-Disease
defect NN I-NP I-Disease
in IN B-PP O
DM NN B-NP B-Disease
is VBZ B-VP O
a DT B-NP O
CTG NN I-NP O
repeat NN I-NP O
expansion NN I-NP O
located JJ B-ADJP O
in IN B-PP O
the DT B-NP O
3 CD I-NP O
untranslated JJ I-NP O
region NN I-NP O
of IN B-PP O
DMPK NN B-NP O
and CC O O
5 CD B-NP O
of IN B-PP O
a DT B-NP O
homeodomain NN I-NP O
- HYPH O O
encoding VBG B-VP O
gene NN B-NP O
, , O O
SIX5 NN B-NP O
( ( O O
formerly RB B-NP O
DMAHP NN I-NP O
; : O O
refs NNS B-NP O
2 CD B-NP O
- HYPH I-NP O
5 CD I-NP O
) ) O O
. . O O

There EX B-NP O
are VBP B-VP O
three CD B-NP O
mechanisms NNS I-NP O
by IN B-PP O
which WDT B-NP O
CTG NN B-NP O
expansion NN I-NP O
can MD B-VP O
result VB I-VP O
in IN B-PP O
DM NN B-NP B-Disease
. . O O

First RB B-ADVP O
, , O O
repeat NN B-NP O
expansion NN I-NP O
may MD B-VP O
alter VB I-VP O
the DT B-NP O
processing NN I-NP O
or CC I-NP O
transport NN I-NP O
of IN B-PP O
the DT B-NP O
mutant JJ I-NP O
DMPK NN I-NP O
mRNA NN I-NP O
and CC O O
consequently RB B-VP O
reduce VB I-VP O
DMPK NN B-NP O
levels NNS I-NP O
. . O O

Second RB B-ADVP O
, , O O
CTG NN B-NP O
expansion NN I-NP O
may MD B-VP O
establish VB I-VP O
a DT B-NP O
region NN I-NP O
of IN B-PP O
heterochromatin NN B-NP O
3 CD I-NP O
of IN B-PP O
the DT B-NP O
repeat NN I-NP O
sequence NN I-NP O
and CC O O
decrease VB B-VP O
SIX5 NN B-NP O
transcription NN I-NP O
. . O O

Third JJ B-NP O
, , I-NP O
toxic JJ I-NP O
effects NNS I-NP O
of IN B-PP O
the DT B-NP O
repeat NN I-NP O
expansion NN I-NP O
may MD B-VP O
be VB I-VP O
intrinsic JJ B-ADJP O
to TO B-PP O
the DT B-NP O
repeated VBN I-NP O
elements NNS I-NP O
at IN B-PP O
the DT B-NP O
level NN I-NP O
of IN B-PP O
DNA NN B-NP O
or CC I-NP O
RNA NN I-NP O
( ( O O
refs NNS B-NP O
10 CD I-NP O
, , I-NP O
11 CD I-NP O
) ) O O
. . O O

Previous JJ B-NP O
studies NNS I-NP O
have VBP B-VP O
demonstrated VBN I-VP O
that IN B-SBAR O
a DT B-NP O
dose NN I-NP O
- HYPH B-NP O
dependent JJ I-NP O
loss NN I-NP O
of IN B-PP O
Dm15 NN B-NP O
( ( O O
the DT B-NP O
mouse NN I-NP O
DMPK NN I-NP O
homologue NN I-NP O
) ) O O
in IN B-PP O
mice NNS B-NP O
produces VBZ B-VP O
a DT B-NP O
partial JJ I-NP O
DM NN I-NP B-Disease
phenotype NN I-NP O
characterized VBN B-VP O
by IN B-PP O
decreased VBN B-NP O
development NN I-NP O
of IN B-PP O
skeletal JJ B-NP O
muscle NN I-NP O
force NN I-NP O
and CC O O
cardiac JJ B-NP B-Disease
conduction NN I-NP I-Disease
disorders NNS I-NP I-Disease
. . O O

To TO B-VP O
test VB I-VP O
the DT B-NP O
role NN I-NP O
of IN B-PP O
Six5 CD B-NP O
loss NN I-NP O
in IN B-PP O
DM NN B-NP B-Disease
, , O O
we PRP B-NP O
have VBP B-VP O
analysed VBN I-VP O
a DT B-NP O
strain NN I-NP O
of IN B-PP O
mice NNS B-NP O
in IN B-PP O
which WDT B-NP O
Six5 CD B-NP O
was VBD B-VP O
deleted VBN I-VP O
. . O O

Our PRP$ B-NP O
results NNS I-NP O
demonstrate VBP B-VP O
that IN B-SBAR O
the DT B-NP O
rate NN I-NP O
and CC I-NP O
severity NN I-NP O
of IN B-PP O
cataract NN B-NP B-Disease
formation NN I-NP O
is VBZ B-VP O
inversely RB I-VP O
related VBN I-VP O
to TO B-PP O
Six5 CD B-NP O
dosage NN I-NP O
and CC O O
is VBZ B-VP O
temporally RB B-ADJP O
progressive JJ I-ADJP O
. . O O

Six5 CD B-NP O
+ SYM O O
/ SYM O O
- HYPH O O
and CC O O
Six5 CD B-NP O
- HYPH O O
/ SYM O O
- HYPH O O
mice NNS B-NP O
show VBP B-VP O
increased VBN I-VP O
steady JJ B-NP O
- HYPH I-NP O
state NN I-NP O
levels NNS I-NP O
of IN B-PP O
the DT B-NP O
Na NN I-NP O
+ SYM B-VP O
/ SYM B-NP O
K NN I-NP O
+ SYM B-NP O
- HYPH B-NP O
ATPase NN I-NP O
alpha SYM O O
- HYPH O O
1 CD B-NP O
subunit NN I-NP O
and CC O O
decreased VBD B-VP O
Dm15 NN B-NP O
mRNA NN I-NP O
levels NNS I-NP O
. . O O

Thus RB B-ADVP O
, , O O
altered VBN B-NP O
ion NN I-NP O
homeostasis NN I-NP O
within IN B-PP O
the DT B-NP O
lens NN I-NP O
may MD B-VP O
contribute VB I-VP O
to TO I-VP O
cataract VB I-VP B-Disease
formation NN B-NP O
. . O O

As IN B-SBAR O
ocular JJ B-NP O
cataracts NNS I-NP B-Disease
are VBP B-VP O
a DT B-NP O
characteristic JJ I-NP O
feature NN I-NP O
of IN B-PP O
DM NN B-NP B-Disease
, , O O
these DT B-NP O
results NNS I-NP O
demonstrate VBP B-VP O
that IN B-SBAR O
decreased VBN B-NP O
SIX5 NN I-NP O
transcription NN I-NP O
is VBZ B-VP O
important JJ B-ADJP O
in IN B-PP O
the DT B-NP O
aetiology NN I-NP O
of IN B-PP O
DM NN B-NP B-Disease
. . O O

Our PRP$ B-NP O
data NNS I-NP O
support VBP B-VP O
the DT B-NP O
hypothesis NN I-NP O
that IN B-SBAR O
DM NN B-NP B-Disease
is VBZ B-VP O
a DT B-NP O
contiguous JJ I-NP O
gene NN I-NP O
syndrome NN I-NP O
associated VBN B-VP O
with IN B-PP O
the DT B-NP O
partial JJ I-NP O
loss NN I-NP O
of IN B-PP O
both CC O O
DMPK NN B-NP O
and CC I-NP O
SIX5 NN I-NP O
. . O O

. . O O

ATM NN B-NP O
- HYPH I-NP O
dependent JJ I-NP O
phosphorylation NN I-NP O
of IN B-PP O
nibrin NN B-NP O
in IN B-PP O
response NN I-PP O
to TO I-PP O
radiation NN B-NP O
exposure NN I-NP O
. . O O

Mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
gene NN I-NP O
ATM NN I-NP O
are VBP B-VP O
responsible JJ B-ADJP O
for IN B-PP O
the DT B-NP O
genetic JJ I-NP B-Disease
disorder NN I-NP I-Disease
ataxia NN I-NP B-Disease
- HYPH B-NP I-Disease
telangiectasia NN I-NP I-Disease
( ( O O
A NN B-NP B-Disease
- HYPH O I-Disease
T NN B-NP I-Disease
) ) O O
, , O O
which WDT B-NP O
is VBZ B-VP O
characterized VBN I-VP O
by IN B-PP O
cerebellar JJ B-NP B-Disease
dysfunction NN I-NP I-Disease
, , O O
radiosensitivity NN B-NP O
, , O O
chromosomal JJ B-NP O
instability NN I-NP O
and CC I-NP O
cancer NN I-NP B-Disease
predisposition NN I-NP O
. . O O

Both CC O O
the DT B-NP O
A NN I-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
phenotype NN I-NP O
and CC O O
the DT B-NP O
similarity NN I-NP O
of IN B-PP O
the DT B-NP O
ATM NN I-NP O
protein NN I-NP O
to TO B-PP O
other JJ B-NP O
DNA NN I-NP O
- HYPH I-NP O
damage NN I-NP O
sensors NNS I-NP O
suggests VBZ B-VP O
a DT B-NP O
role NN I-NP O
for IN B-PP O
ATM NN B-NP O
in IN B-PP O
biochemical JJ B-NP O
pathways NNS I-NP O
involved VBN B-VP O
in IN B-PP O
the DT B-NP O
recognition NN I-NP O
, , I-NP O
signalling NN I-NP O
and CC I-NP O
repair NN I-NP O
of IN B-PP O
DNA NN B-NP O
double JJ I-NP O
- HYPH I-NP O
strand NN I-NP O
breaks NNS I-NP O
( ( O O
DSBs NNS B-NP O
) ) O O
. . O O

There EX B-NP O
are VBP B-VP O
strong JJ B-NP O
parallels NNS I-NP O
between IN B-PP O
the DT B-NP O
pattern NN I-NP O
of IN B-PP O
radiosensitivity NN B-NP O
, , O O
chromosomal JJ B-NP O
instability NN I-NP O
and CC I-NP O
cancer NN I-NP B-Disease
predisposition NN I-NP O
in IN B-PP O
A NN B-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
patients NNS I-NP O
and CC O O
that IN B-SBAR O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
Nijmegen NN B-NP B-Disease
breakage NN I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
NBS NN B-NP B-Disease
) ) O O
. . O O

The DT B-NP O
protein NN I-NP O
defective JJ B-ADJP O
in IN B-PP O
NBS NN B-NP B-Disease
, , O O
nibrin NN B-NP O
( ( O O
encoded VBN B-VP O
by IN B-PP O
NBS1 NN B-NP O
) ) O O
, , O O
forms VBZ B-VP O
a DT B-NP O
complex NN I-NP O
with IN B-PP O
MRE11 NN B-NP O
and CC O O
RAD50 NN B-NP O
( ( O O
refs NNS B-NP O
1 CD I-NP O
, , I-NP O
2 CD I-NP O
) ) O O
. . O O

This DT B-NP O
complex NN I-NP O
localizes VBZ B-VP O
to TO B-PP O
DSBs NNS B-NP O
within IN B-PP O
30 CD B-NP O
minutes NNS I-NP O
after IN B-PP O
cellular JJ B-NP O
exposure NN I-NP O
to TO B-PP O
ionizing VBG B-VP O
radiation NN B-NP O
( ( O O
IR NN B-NP O
) ) O O
and CC O O
is VBZ B-VP O
observed VBN I-VP O
in IN B-PP O
brightly RB B-ADVP O
staining VBG B-VP O
nuclear JJ B-NP O
foci NNS I-NP O
after IN B-PP O
a DT B-NP O
longer JJR I-NP O
period NN I-NP O
of IN B-PP O
time NN B-NP O
. . O O

The DT B-NP O
overlap NN I-NP O
between IN B-PP O
clinical JJ B-NP O
and CC I-NP O
cellular JJ I-NP O
phenotypes NNS I-NP O
in IN B-PP O
A NN B-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
and CC O O
NBS NNP B-NP B-Disease
suggests VBZ B-VP O
that IN B-SBAR O
ATM NN B-NP O
and CC I-NP O
nibrin NN I-NP O
may MD B-VP O
function VB I-VP O
in IN B-PP O
the DT B-NP O
same JJ I-NP O
biochemical JJ I-NP O
pathway NN I-NP O
. . O O

Here RB B-ADVP O
we PRP B-NP O
demonstrate VBP B-VP O
that IN B-SBAR O
nibrin NN B-NP O
is VBZ B-VP O
phosphorylated VBN I-VP O
within IN B-PP O
one CD B-NP O
hour NN I-NP O
of IN B-PP O
treatment NN B-NP O
of IN B-PP O
cells NNS B-NP O
with IN B-PP O
IR NN B-NP O
. . O O

This DT B-NP O
response NN I-NP O
is VBZ B-VP O
abrogated VBN I-VP O
in IN B-PP O
A NN B-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
cells NNS I-NP O
that WDT B-NP O
either CC O O
do VBP B-VP O
not RB I-VP O
express VB I-VP O
ATM NN B-NP O
protein NN I-NP O
or CC I-NP O
express NN I-NP O
near IN B-PP O
full JJ B-NP O
- HYPH I-NP O
length NN I-NP O
mutant JJ I-NP O
protein NN I-NP O
. . O O

We PRP B-NP O
also RB B-ADVP O
show VBP B-VP O
that IN B-SBAR O
ATM NN B-NP O
physically RB B-ADVP O
interacts VBZ B-VP O
with IN B-PP O
and CC O O
phosphorylates VBZ B-VP O
nibrin NN B-NP O
on IN B-PP O
serine NN B-NP O
343 CD I-NP O
both CC O O
in FW B-ADVP O
vivo FW I-ADVP O
and CC O O
in FW B-ADVP O
vitro FW I-ADVP O
. . O O

Phosphorylation NN B-NP O
of IN B-PP O
this DT B-NP O
site NN I-NP O
appears VBZ B-VP O
to TO I-VP O
be VB I-VP O
functionally RB B-ADJP O
important JJ I-ADJP O
because IN B-SBAR O
mutated VBN B-NP O
nibrin NN I-NP O
( ( O O
S343A NN B-NP O
) ) O O
does VBZ B-VP O
not RB I-VP O
completely RB I-VP O
complement NN B-NP O
radiosensitivity NN I-NP O
in IN B-PP O
NBS NN B-NP B-Disease
cells NNS I-NP O
. . O O

ATM NN B-NP O
phosphorylation NN I-NP O
of IN B-PP O
nibrin NN B-NP O
does VBZ B-VP O
not RB I-VP O
affect VB I-VP O
nibrin NN B-NP O
- HYPH B-NP O
MRE11 NN I-NP O
- HYPH B-NP O
RAD50 NN I-NP O
association NN I-NP O
as IN B-SBAR O
revealed VBN B-VP O
by IN B-PP O
radiation NN B-NP O
- HYPH B-NP O
induced VBN I-NP O
foci NNS I-NP O
formation NN I-NP O
. . O O

Our PRP$ B-NP O
data NNS I-NP O
provide VBP B-VP O
a DT B-NP O
biochemical JJ I-NP O
explanation NN I-NP O
for IN B-PP O
the DT B-NP O
similarity NN I-NP O
in IN B-PP O
phenotype NN B-NP O
between IN B-PP O
A NN B-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
and CC I-NP O
NBS NN I-NP B-Disease
. . O O

. . O O

Clinicopathologic JJ B-NP O
features NNS I-NP O
of IN B-PP O
BRCA NN B-NP B-Disease
- HYPH B-VP I-Disease
linked VBN B-NP I-Disease
and CC I-NP I-Disease
sporadic JJ I-NP I-Disease
ovarian JJ I-NP I-Disease
cancer NN I-NP I-Disease
. . O O

CONTEXT NN B-NP O
Most JJS I-NP O
hereditary JJ I-NP B-Disease
ovarian JJ I-NP I-Disease
cancers NNS I-NP I-Disease
are VBP B-VP O
associated VBN I-VP O
with IN B-PP O
germline NN B-NP O
mutations NNS I-NP O
in IN B-PP O
BRCA1 NN B-NP O
or CC I-NP O
BRCA2 NN I-NP O
. . O O

Attempts NNS B-NP O
to TO B-VP O
define VB I-VP O
the DT B-NP O
clinical JJ I-NP O
significance NN I-NP O
of IN B-PP O
BRCA NN B-NP O
mutation NN I-NP O
status NN I-NP O
in IN B-PP O
ovarian JJ B-NP B-Disease
cancer NN I-NP I-Disease
have VBP B-VP O
produced VBN I-VP O
conflicting VBG I-VP O
results NNS B-NP O
, , O O
especially RB B-ADVP O
regarding VBG B-VP O
survival NN B-NP O
. . O O

OBJECTIVE NN B-NP O
To TO B-VP O
determine VB I-VP O
whether IN B-SBAR O
hereditary JJ B-NP B-Disease
ovarian JJ I-NP I-Disease
cancers NNS I-NP I-Disease
have VBP B-VP O
distinct JJ B-NP O
clinical JJ I-NP O
and CC I-NP O
pathological JJ I-NP O
features NNS I-NP O
compared VBN B-PP O
with IN B-PP O
sporadic JJ O B-Disease
( ( O I-Disease
nonhereditary JJ B-ADJP I-Disease
) ) O I-Disease
ovarian JJ B-NP I-Disease
cancers NNS I-NP I-Disease
. . O O

DESIGN NN B-NP O
AND CC O O
SETTING VBG B-VP O
Retrospective JJ B-NP O
cohort JJ I-NP O
study NN I-NP O
of IN B-PP O
a DT B-NP O
consecutive JJ I-NP O
series NN I-NP O
of IN B-PP O
933 CD B-NP O
ovarian JJ I-NP B-Disease
cancers NNS I-NP I-Disease
diagnosed VBN B-VP O
and CC I-VP O
treated VBN I-VP O
at IN B-PP O
our PRP$ B-NP O
institution NN I-NP O
, , O O
which WDT B-NP O
is VBZ B-VP O
a DT B-NP O
comprehensive JJ I-NP O
cancer NN I-NP B-Disease
center NN I-NP O
as IN B-SBAR O
designated VBN B-VP O
by IN B-PP O
the DT B-NP O
National NNP I-NP O
Cancer NNP I-NP B-Disease
Institute NNP I-NP O
, , O O
over IN B-PP O
a DT B-NP O
12 CD I-NP O
- HYPH I-NP O
year NN I-NP O
period NN I-NP O
( ( O O
December NNP B-NP O
1986 CD I-NP O
to TO B-PP O
August NNP B-NP O
1998 CD I-NP O
) ) O O
. . O O

PATIENTS NNS B-NP O
The DT B-NP O
study NN I-NP O
was VBD B-VP O
restricted JJ B-ADJP O
to TO B-PP O
patients NNS B-NP O
of IN B-PP O
Jewish JJ B-NP O
origin NN I-NP O
because IN B-PP O
of IN I-PP O
the DT B-NP O
ease NN I-NP O
of IN B-PP O
BRCA1 NN B-NP O
and CC I-NP O
BRCA2 NN I-NP O
genotyping NN I-NP O
in IN B-PP O
this DT B-NP O
ethnic JJ I-NP O
group NN I-NP O
. . O O

From IN B-PP O
the DT B-NP O
189 CD I-NP O
patients NNS I-NP O
who WP B-NP O
identified VBD B-VP O
themselves PRP B-NP O
as IN B-PP O
Jewish NN B-NP O
, , O O
88 CD B-NP O
hereditary JJ I-NP O
cases NNS I-NP O
were VBD B-VP O
identified VBN I-VP O
with IN B-PP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
a DT B-NP O
germline NN I-NP O
founder NN I-NP O
mutation NN I-NP O
in IN B-PP O
BRCA1 NN B-NP O
or CC I-NP O
BRCA2 NN I-NP O
. . O O

The DT B-NP O
remaining VBG I-NP O
101 CD I-NP O
cases NNS I-NP O
from IN B-PP O
the DT B-NP O
same JJ I-NP O
series NN I-NP O
not RB B-VP O
associated VBN I-VP O
with IN B-PP O
a DT B-NP O
BRCA NN I-NP O
mutation NN I-NP O
and CC O O
2 CD B-NP O
additional JJ I-NP O
groups NNS I-NP O
( ( O O
Gynecologic NNP B-NP O
Oncology NNP I-NP O
Group NNP I-NP O
protocols NNS I-NP O
52 CD B-NP O
and CC I-NP O
111 CD I-NP O
) ) O O
with IN B-PP O
ovarian JJ B-NP B-Disease
cancer NN I-NP I-Disease
from IN B-PP O
clinical JJ B-NP O
trials NNS I-NP O
( ( O O
for IN B-PP O
the DT B-NP O
survival NN I-NP O
analysis NN I-NP O
) ) O O
were VBD B-VP O
included VBN I-VP O
for IN B-PP O
comparison NN B-NP O
. . O O

MAIN NNP B-NP O
OUTCOME NNP I-NP O
MEASURES NNP I-NP O
Age NNP I-NP O
at IN B-PP O
diagnosis NN B-NP O
, , O O
surgical JJ B-NP O
stage NN I-NP O
, , O O
histologic JJ B-NP O
cell NN I-NP O
type NN I-NP O
and CC I-NP O
grade NN I-NP O
, , O O
and CC O O
surgical JJ B-NP O
outcome NN I-NP O
; : O O
and CC O O
response NN B-NP O
to TO B-PP O
chemotherapy NN B-NP O
and CC I-NP O
survival NN I-NP O
for IN B-PP O
advanced VBN B-NP O
- HYPH I-NP O
stage NN B-NP O
( ( O O
II CD B-NP O
and CC I-NP O
IV CD I-NP O
) ) O O
cases NNS B-NP O
. . O O

RESULTS NNS B-NP O
Hereditary JJ I-NP B-Disease
cancers NNS I-NP I-Disease
were VBD B-VP O
rarely RB I-VP O
diagnosed VBN I-VP O
before IN B-PP O
age NN B-NP O
40 CD B-NP O
years NNS I-NP O
and CC O O
were VBD B-VP O
common JJ B-ADJP O
after IN B-PP O
age NN B-NP O
60 CD B-NP O
years NNS I-NP O
, , O O
with IN B-PP O
mean JJ B-NP O
age NN I-NP O
at IN B-PP O
diagnosis NN B-NP O
being VBG B-VP O
significantly RB B-ADJP O
younger JJR I-ADJP O
for IN B-PP O
BRCA1 NN B-NP O
- HYPH B-VP O
vs IN B-PP O
BRCA2 NN B-NP O
- HYPH B-NP O
linked VBN I-NP O
patients NNS I-NP O
( ( O O
54 CD B-NP O
vs IN I-NP O
62 CD I-NP O
years NNS I-NP O
; : O O
P NN B-NP O
= JJ I-NP O
. . I-NP O

04 CD I-NP O
) ) O O
. . O O

Histology NN B-NP O
, , O O
grade NN B-NP O
, , O O
stage NN B-NP O
, , O O
and CC O O
success NN B-NP O
of IN B-PP O
cytoreductive JJ B-NP O
surgery NN I-NP O
were VBD B-VP O
similar JJ B-ADJP O
for IN B-PP O
hereditary JJ B-NP O
and CC I-NP O
sporadic JJ I-NP O
cases NNS I-NP O
. . O O

The DT B-NP O
hereditary JJ I-NP O
group NN I-NP O
had VBD B-VP O
a DT B-NP O
longer JJR I-NP O
disease NN I-NP O
- HYPH O O
free JJ B-NP O
interval NN I-NP O
following VBG B-PP O
primary JJ B-NP O
chemotherapy NN I-NP O
in IN B-PP O
comparison NN B-NP O
with IN B-PP O
the DT B-NP O
nonhereditary JJ I-NP O
group NN I-NP O
, , O O
with IN B-PP O
a DT B-NP O
median JJ I-NP O
time NN I-NP O
to TO B-PP O
recurrence NN B-NP O
of IN B-PP O
14 CD B-NP O
months NNS I-NP O
and CC O O
7 CD B-NP O
months NNS I-NP O
, , O O
respectively RB B-ADVP O
( ( O O
P NN B-NP O
< SYM B-NP O
. . I-NP O

001 CD I-NP O
) ) O O
. . O O

Those DT B-NP O
with IN B-PP O
hereditary JJ B-NP B-Disease
cancers NNS I-NP I-Disease
had VBD B-VP O
improved VBN I-VP O
survival NN B-NP O
compared VBN B-PP O
with IN B-PP O
the DT B-NP O
nonhereditary JJ I-NP O
group NN I-NP O
( ( O O
P NN B-NP O
= SYM B-VP O
. . B-NP O

004 CD I-NP O
) ) O O
. . O O

For IN B-PP O
stage NN B-NP B-Disease
III CD B-NP I-Disease
cancers NNS I-NP I-Disease
, , O O
BRCA NN B-NP O
mutation NN I-NP O
status NN I-NP O
was VBD B-VP O
an DT B-NP O
independent JJ I-NP O
prognostic JJ I-NP O
variable NN I-NP O
( ( O O
P NN B-NP O
= SYM B-VP O
. . B-NP O

03 CD I-NP O
) ) O O
. . O O

CONCLUSIONS NNS B-NP O
Although IN B-PP O
BRCA NN B-NP B-Disease
- HYPH O I-Disease
associated VBN B-VP I-Disease
hereditary JJ B-NP I-Disease
ovarian JJ I-NP I-Disease
cancers NNS I-NP I-Disease
in IN B-PP O
this DT B-NP O
population NN I-NP O
have VBP B-VP O
surgical JJ B-NP O
and CC I-NP O
pathological JJ I-NP O
characteristics NNS I-NP O
similar JJ B-ADJP O
to TO B-PP O
those DT B-NP O
of IN B-PP O
sporadic JJ B-NP B-Disease
cancers NNS I-NP I-Disease
, , O O
advanced VBN B-VP B-Disease
- HYPH B-NP I-Disease
stage NN I-NP I-Disease
hereditary JJ I-NP I-Disease
cancer NN I-NP I-Disease
patients NNS I-NP O
survive VBP B-VP O
longer RBR B-ADVP O
than IN B-PP O
nonhereditary JJ B-NP B-Disease
cancer NN I-NP I-Disease
patients NNS I-NP O
. . O O

Age NN B-NP O
penetrance NN I-NP O
is VBZ B-VP O
greater JJR B-ADJP O
for IN B-PP O
BRCA1 NN B-NP B-Disease
- HYPH B-VP I-Disease
linked VBN I-VP I-Disease
than IN B-PP I-Disease
for IN B-PP I-Disease
BRCA2 NN B-NP I-Disease
- HYPH B-NP I-Disease
linked VBN I-NP I-Disease
cancers NNS I-NP I-Disease
in IN B-PP O
this DT B-NP O
population NN I-NP O
. . O O

The DT B-NP O
gene NN I-NP O
for IN B-PP O
familial JJ B-NP B-Disease
Mediterranean JJ I-NP I-Disease
fever NN I-NP I-Disease
, , O O
MEFV NN B-NP O
, , O O
is VBZ B-VP O
expressed VBN I-VP O
in IN B-PP O
early JJ B-NP O
leukocyte NN I-NP O
development NN I-NP O
and CC O O
is VBZ B-VP O
regulated VBN I-VP O
in IN B-PP O
response NN B-NP O
to TO B-PP O
inflammatory JJ B-NP O
mediators NNS I-NP O
. . O O

Familial JJ B-NP B-Disease
Mediterranean JJ I-NP I-Disease
fever NN I-NP I-Disease
( ( O O
FMF NN B-NP B-Disease
) ) O O
is VBZ B-VP O
a DT B-NP O
recessive JJ I-NP B-Disease
disorder NN I-NP I-Disease
characterized VBN B-VP O
by IN B-PP O
episodes NNS B-NP O
of IN B-PP O
fever NN B-NP B-Disease
and CC I-NP O
neutrophil NN I-NP B-Disease
- HYPH O I-Disease
mediated VBN B-NP I-Disease
serosal JJ I-NP I-Disease
inflammation NN I-NP I-Disease
. . O O

We PRP B-NP O
recently RB B-ADVP O
identified VBD B-VP O
the DT B-NP O
gene NN I-NP O
causing VBG B-VP O
FMF NNP B-NP B-Disease
, , O O
designated VBN B-VP O
MEFV NN B-NP O
, , O O
and CC O O
found VBD B-VP O
it PRP B-NP O
to TO B-VP O
be VB I-VP O
expressed VBN I-VP O
in IN B-PP O
mature JJ B-NP O
neutrophils NNS I-NP O
, , O O
suggesting VBG B-VP O
that IN B-SBAR O
it PRP B-NP O
functions VBZ B-VP O
as IN B-PP O
an DT B-NP O
inflammatory JJ I-NP O
regulator NN I-NP O
. . O O

To TO B-VP O
facilitate VB I-VP O
our PRP$ B-NP O
understanding NN I-NP O
of IN B-PP O
the DT B-NP O
normal JJ I-NP O
function NN I-NP O
of IN B-PP O
MEFV NN B-NP O
, , O O
we PRP B-NP O
extended VBD B-VP O
our PRP$ B-NP O
previous JJ I-NP O
studies NNS I-NP O
. . O O

MEFV NN B-NP O
messenger NN I-NP O
RNA NN I-NP O
was VBD B-VP O
detected VBN I-VP O
by IN B-PP O
reverse JJ B-NP O
transcriptase NN I-NP O
- HYPH I-NP O
polymerase NN I-NP O
chain NN I-NP O
reaction NN I-NP O
in IN B-PP O
bone NN B-NP O
marrow NN I-NP O
leukocytes NNS I-NP O
, , O O
with IN B-PP O
differential JJ B-NP O
expression NN I-NP O
observed VBN B-VP O
among IN B-PP O
cells NNS B-NP O
by IN B-PP O
in FW B-NP O
situ FW I-NP O
hybridization NN I-NP O
. . O O

CD34 NN B-NP O
hematopoietic JJ I-NP O
stem NN I-NP O
- HYPH B-NP O
cell NN I-NP O
cultures NNS I-NP O
induced VBN B-VP O
toward IN B-PP O
the DT B-NP O
granulocytic JJ I-NP O
lineage NN I-NP O
expressed VBD B-VP O
MEFV NN B-NP O
at IN B-PP O
the DT B-NP O
myelocyte JJ I-NP O
stage NN I-NP O
, , O O
concurrently RB B-ADVP O
with IN B-PP O
lineage NN B-NP O
commitment NN I-NP O
. . O O

The DT B-NP O
prepromyelocytic JJ I-NP O
cell NN I-NP O
line NN I-NP O
HL60 NN I-NP O
expressed VBD B-VP O
MEFV NN B-NP O
only RB B-ADVP O
at IN B-PP O
granulocytic JJ B-NP O
and CC I-NP O
monocytic JJ I-NP O
differentiation NN I-NP O
. . O O

MEFV NN B-NP O
was VBD B-VP O
also RB I-VP O
expressed VBN I-VP O
in IN B-PP O
the DT B-NP O
monocytic JJ I-NP O
cell NN I-NP O
lines NNS I-NP O
U937 NN I-NP O
and CC I-NP O
THP NN I-NP O
- HYPH B-NP O
1 CD I-NP O
. . O O

Among IN B-PP O
peripheral JJ B-NP O
blood NN I-NP O
leukocytes NNS I-NP O
, , O O
MEFV NN B-NP O
expression NN I-NP O
was VBD B-VP O
detected VBN I-VP O
in IN B-PP O
neutrophils NNS B-NP O
, , O O
eosinophils NNS B-NP O
, , O O
and CC O O
to TO B-PP O
varying VBG B-NP O
degrees NNS I-NP O
, , O O
monocytes NNS B-NP O
. . O O

Consistent JJ B-ADJP O
with IN B-PP O
the DT B-NP O
tissue NN I-NP O
specificity NN I-NP O
of IN B-PP O
expression NN B-NP O
, , O O
complete JJ B-NP O
sequencing NN I-NP O
and CC O O
analysis NN B-NP O
of IN B-PP O
upstream JJ B-NP O
regulatory JJ I-NP O
regions NNS I-NP O
of IN B-PP O
MEFV NN B-NP O
revealed VBD B-VP O
homology NN B-NP O
to TO B-PP O
myeloid JJ B-NP O
- HYPH I-NP O
specific JJ I-NP O
promoters NNS I-NP O
and CC O O
to TO B-VP O
more RBR I-VP O
broadly RB I-VP O
expressed VBN I-VP O
inflammatory JJ B-NP O
promoter NN I-NP O
elements NNS I-NP O
. . O O

In FW B-NP O
vitro FW I-NP O
stimulation NN I-NP O
of IN B-PP O
monocytes NNS B-NP O
with IN B-PP O
the DT B-NP O
proinflammatory JJ I-NP O
agents NNS I-NP O
interferon NN I-NP O
( ( O O
IFN NN B-NP O
) ) O O
gamma NN B-NP O
, , O O
tumor NN B-NP B-Disease
necrosis NN I-NP O
factor NN I-NP O
, , O O
and CC O O
lipopolysaccharide NN B-NP O
induced VBD B-VP O
MEFV NN B-NP O
expression NN I-NP O
, , O O
whereas IN O O
the DT B-NP O
antiinflammatory JJ I-NP O
cytokines NNS I-NP O
interleukin NN I-NP O
( ( O O
IL NN B-NP O
) ) O O
4 CD B-NP O
, , O O
IL NN B-NP O
- HYPH B-NP O
10 CD I-NP O
, , O O
and CC O O
transforming VBG B-VP O
growth NN B-NP O
factor NN I-NP O
beta SYM B-NP O
inhibited VBD B-VP O
such JJ B-NP O
expression NN I-NP O
. . O O

Induction NN B-NP O
by IN B-PP O
IFN NN B-NP O
- HYPH O O
gamma SYM B-NP O
occurred VBD B-VP O
rapidly RB B-ADVP O
and CC O O
was VBD B-VP O
resistant JJ B-ADJP O
to TO B-PP O
cycloheximide NN B-NP O
. . O O

IFN NN B-NP O
- HYPH I-NP O
alpha NN I-NP O
also RB B-ADVP O
induced VBD B-VP O
MEFV NN B-NP O
expression NN I-NP O
. . O O

In IN B-PP O
granulocytes NNS B-NP O
, , O O
MEFV NN B-NP O
was VBD B-VP O
up RB B-ADVP O
- HYPH B-NP O
regulated VBN B-VP O
by IN B-PP O
IFN NN B-NP O
- HYPH B-NP O
gamma NN I-NP O
and CC O O
the DT B-NP O
combination NN I-NP O
of IN B-PP O
IFN NN B-NP O
- HYPH O O
alpha SYM B-NP O
and CC O O
colchicine NN B-NP O
. . O O

These DT B-NP O
results NNS I-NP O
refine VBP B-VP O
understanding NN B-NP O
of IN B-PP O
MEFV NN B-NP O
by IN B-PP O
placing VBG B-VP O
the DT B-NP O
gene NN I-NP O
in IN B-PP O
the DT B-NP O
myelomonocytic JJ I-NP O
- HYPH I-NP O
specific JJ I-NP O
proinflammatory JJ I-NP O
pathway NN I-NP O
and CC O O
identifying VBG B-VP O
it PRP B-NP O
as IN B-PP O
an DT B-NP O
IFN NN I-NP O
- HYPH O O
gamma SYM B-NP O
immediate JJ I-NP O
early JJ I-NP O
gene NN I-NP O
. . O O

. . O O

Biochemical JJ B-NP O
and CC I-NP O
structural JJ I-NP O
analysis NN I-NP O
of IN B-PP O
missense JJ B-NP O
mutations NNS I-NP O
in IN B-PP O
N NN B-NP O
- HYPH B-NP O
acetylgalactosamine NN I-NP O
- HYPH B-NP O
6 CD I-NP O
- HYPH I-NP O
sulfate NN I-NP O
sulfatase NN I-NP O
causing VBG B-VP O
mucopolysaccharidosis NN B-NP B-Disease
IVA NN I-NP I-Disease
phenotypes NNS I-NP O
. . O O

Mucopolysaccharidosis NN B-NP B-Disease
IVA NN I-NP I-Disease
( ( O O
MPS NN B-NP B-Disease
IVA NN I-NP I-Disease
; : O O
OMIM NN B-NP O
# # B-NP O
253000 CD I-NP O
) ) O O
, , O O
a DT B-NP O
lysosomal JJ I-NP B-Disease
storage NN I-NP I-Disease
disorder NN I-NP I-Disease
caused VBN B-VP O
by IN B-PP O
a DT B-NP O
deficiency NN I-NP B-Disease
of IN B-PP I-Disease
N NN B-NP I-Disease
- HYPH B-NP I-Disease
acetylgalactosamine NN I-NP I-Disease
- HYPH B-NP I-Disease
6 CD I-NP I-Disease
- HYPH I-NP I-Disease
sulfate NN I-NP I-Disease
sulfatase NN I-NP I-Disease
( ( O O
GALNS NN B-NP O
) ) O O
, , O O
has VBZ B-VP O
variable JJ B-NP O
clinical JJ I-NP O
phenotypes NNS I-NP O
. . O O

To TO B-PP O
date NN B-NP O
we PRP B-NP O
have VBP B-VP O
identified VBN I-VP O
65 CD B-NP O
missense JJ I-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
GALNS NN I-NP O
gene NN I-NP O
from IN B-PP O
MPS NN B-NP B-Disease
IVA NN I-NP I-Disease
patients NNS I-NP O
, , O O
but CC O O
the DT B-NP O
correlation NN I-NP O
between IN B-PP O
genotype NN B-NP O
and CC I-NP O
phenotype NN I-NP O
has VBZ B-VP O
remained VBN I-VP O
unclear JJ B-ADJP O
. . O O

We PRP B-NP O
studied VBD B-VP O
17 CD B-NP O
missense JJ I-NP O
mutations NNS I-NP O
using VBG B-VP O
biochemical JJ B-NP O
approaches NNS I-NP O
and CC O O
32 CD B-NP O
missense JJ I-NP O
mutations NNS I-NP O
, , O O
using VBG B-VP O
structural JJ B-NP O
analyses NNS I-NP O
. . O O

Fifteen CD B-NP O
missense JJ I-NP O
mutations NNS I-NP O
and CC O O
two CD B-NP O
newly RB I-NP O
engineered VBN I-NP O
active JJ I-NP O
site NN I-NP O
mutations NNS I-NP O
( ( O O
C79S NN B-NP O
, , I-NP O
C79T NN I-NP O
) ) O O
were VBD B-VP O
characterized VBN I-VP O
by IN B-PP O
transient JJ B-NP O
expression NN I-NP O
analysis NN I-NP O
. . O O

Mutant JJ B-NP O
proteins NNS I-NP O
, , O O
except IN B-PP O
for IN B-PP O
C79S NN B-NP O
and CC I-NP O
C79T NN I-NP O
, , O O
were VBD B-VP O
destabilized VBN I-VP O
and CC O O
detected VBN B-VP O
as IN B-PP O
insoluble JJ B-NP O
precursor NN I-NP O
forms NNS I-NP O
while IN B-SBAR O
the DT B-NP O
C79S NN I-NP O
and CC I-NP O
C79T NN I-NP O
mutants NNS I-NP O
were VBD B-VP O
of IN B-PP O
a DT B-NP O
soluble JJ I-NP O
mature JJ I-NP O
size NN I-NP O
. . O O

Mutants NNS B-NP O
found VBN B-VP O
in IN B-PP O
the DT B-NP O
severe JJ I-NP O
phenotype NN I-NP O
had VBD B-VP O
no DT B-NP O
activity NN I-NP O
. . O O

Mutants NNS B-NP O
found VBN B-VP O
in IN B-PP O
the DT B-NP O
mild JJ I-NP O
phenotype NN I-NP O
had VBD B-VP O
a DT B-NP O
considerable JJ I-NP O
residual JJ I-NP O
activity NN I-NP O
( ( O O
1 CD B-NP O
. . O O

3 CD B-NP O
- HYPH I-NP O
13 CD I-NP O
. . O O

3 CD B-NP O
% NN I-NP O
of IN B-PP O
wild JJ B-NP O
- HYPH I-NP O
type NN I-NP O
GALNS NN I-NP O
activity NN I-NP O
) ) O O
. . O O

Sulfatases NNS B-NP O
, , O O
including VBG B-PP O
GALNS NN B-NP O
, , O O
are VBP B-VP O
members NNS B-NP O
of IN B-PP O
a DT B-NP O
highly RB I-NP O
conserved VBN I-NP O
gene NN I-NP O
family NN I-NP O
sharing VBG B-VP O
an DT B-NP O
extensive JJ I-NP O
sequence NN I-NP O
homology NN I-NP O
. . O O

Thus RB B-ADVP O
, , O O
a DT B-NP O
tertiary JJ I-NP O
structural JJ I-NP O
model NN I-NP O
of IN B-PP O
human JJ B-NP O
GALNS NN I-NP O
was VBD B-VP O
constructed VBN I-VP O
from IN B-PP O
the DT B-NP O
X NN I-NP O
- HYPH B-NP O
ray NN I-NP O
crystal NN I-NP O
structure NN I-NP O
of IN B-PP O
N NN B-NP O
- HYPH O O
acetylgalacto AFX O O
- HYPH B-NP O
samine NN I-NP O
- HYPH B-NP O
4 CD I-NP O
- HYPH I-NP O
sulfatase NN I-NP O
and CC I-NP O
arylsulfatase NN I-NP O
A NN I-NP O
, , O O
using VBG B-VP O
homology NN B-NP O
modeling NN I-NP O
, , O O
and CC O O
32 CD B-NP O
missense JJ I-NP O
mutations NNS I-NP O
were VBD B-VP O
investigated VBN I-VP O
. . O O

Consequently RB B-ADVP O
, , O O
we PRP B-NP O
propose VBP B-VP O
that IN B-SBAR O
there EX B-NP O
are VBP B-VP O
at IN B-NP O
least JJS I-NP O
three CD I-NP O
different JJ I-NP O
reasons NNS I-NP O
for IN B-PP O
the DT B-NP O
severe JJ I-NP O
phenotype NN I-NP O
( ( O O
i NN B-NP O
) ) O O
destruction NN B-NP O
of IN B-PP O
the DT B-NP O
hydrophobic JJ I-NP O
core NN I-NP O
or CC I-NP O
modification NN I-NP O
of IN B-PP O
the DT B-NP O
packing NN I-NP O
; : O O
( ( B-LST O
ii LS I-LST O
) ) O O
removal NN B-NP O
of IN B-PP O
a DT B-NP O
salt NN I-NP O
bridge NN I-NP O
to TO B-VP O
destabilize VB I-VP O
the DT B-NP O
entire JJ I-NP O
conformation NN I-NP O
; : O O
( ( B-LST O
iii LS I-LST O
) ) O O
modification NN B-NP O
of IN B-PP O
the DT B-NP O
active JJ I-NP O
site NN I-NP O
. . O O

In IN B-PP O
contrast NN B-NP O
, , O O
mild JJ B-NP O
mutations NNS I-NP O
were VBD B-VP O
mostly RB B-ADJP O
located JJ I-ADJP O
on IN B-PP O
the DT B-NP O
surface NN I-NP O
of IN B-PP O
the DT B-NP O
GALNS NN I-NP O
protein NN I-NP O
. . O O

These DT B-NP O
studies NNS I-NP O
shed VBD B-VP O
further JJ B-NP O
light NN I-NP O
on IN B-PP O
the DT B-NP O
genotype NN I-NP O
- HYPH B-NP O
phenotype NN I-NP O
correlation NN I-NP O
of IN B-PP O
MPS NN B-NP B-Disease
IVA NN I-NP I-Disease
and CC I-NP O
structure NN I-NP O
- HYPH B-NP O
function NN I-NP O
relationship NN I-NP O
in IN B-PP O
the DT B-NP O
sulfatase NN I-NP O
family NN I-NP O
. . O O

Mutations NNS B-NP O
at IN B-PP O
the DT B-NP O
ataxia NN I-NP B-Disease
- HYPH B-NP I-Disease
telangiectasia NN I-NP I-Disease
locus NN I-NP O
and CC O O
clinical JJ B-NP O
phenotypes NNS I-NP O
of IN B-PP O
A NN B-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
patients NNS I-NP O
. . O O

Mutations NNS B-NP O
at IN B-PP O
the DT B-NP O
ataxia NN I-NP B-Disease
- HYPH B-NP I-Disease
telangiectasia NN I-NP I-Disease
( ( O O
A NN B-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
) ) O O
locus NN B-NP O
on IN B-PP O
chromosome NN B-NP O
band NN I-NP O
11q22 NN I-NP O
cause VBP B-VP O
a DT B-NP O
distinctive JJ I-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
syndrome NN I-NP I-Disease
in IN B-PP O
homozygotes NNS B-NP O
and CC O O
predispose VB B-VP O
heterozygotes NNS B-NP O
to TO B-PP O
cancer NN B-NP B-Disease
, , O O
ischemic JJ B-NP B-Disease
heart NN I-NP I-Disease
disease NN I-NP I-Disease
, , O O
and CC O O
early JJ B-NP O
mortality NN I-NP O
. . O O

PCR NN B-NP O
amplification NN I-NP O
from IN B-PP O
genomic JJ B-NP O
DNA NN I-NP O
and CC O O
automated VBN B-NP O
sequencing NN I-NP O
of IN B-PP O
the DT B-NP O
entire JJ I-NP O
coding VBG I-NP O
region NN I-NP O
( ( O O
66 CD B-NP O
exons NNS I-NP O
) ) O O
and CC O O
splice NN B-NP O
junctions NNS I-NP O
detected VBD B-VP O
77 CD B-NP O
mutations NNS I-NP O
( ( O O
85 CD B-NP O
% NN I-NP O
) ) O O
in IN B-PP O
90 CD B-NP O
A NN I-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
chromosomes NNS I-NP O
. . O O

Heteroduplex NN B-NP O
analysis NN I-NP O
detected VBD B-VP O
another DT B-NP O
42 CD I-NP O
mutations NNS I-NP O
at IN B-PP O
the DT B-NP O
A NN I-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
locus NN I-NP O
. . O O

Out IN B-PP O
of IN B-PP O
a DT B-NP O
total NN I-NP O
of IN B-PP O
71 CD B-NP O
unique JJ I-NP O
mutations NNS I-NP O
, , O O
50 CD B-NP O
were VBD B-VP O
found VBN I-VP O
only RB B-PP O
in IN I-PP O
a DT B-NP O
single JJ I-NP O
family NN I-NP O
, , O O
and CC O O
51 CD B-NP O
had VBD B-VP O
not RB I-VP O
been VBN I-VP O
reported VBN I-VP O
previously RB B-ADVP O
. . O O

Most JJS B-NP O
( ( O O
58 CD B-NP O
/ SYM I-NP O
71 CD I-NP O
, , O O
82 CD B-NP O
% NN I-NP O
) ) O O
mutations NNS B-NP O
were VBD B-VP O
frameshift NN B-NP O
and CC O O
nonsense JJ B-NP O
mutations NNS I-NP O
that WDT B-NP O
are VBP B-VP O
predicted VBN I-VP O
to TO I-VP O
cause VB I-VP O
truncation NN B-NP O
of IN B-PP O
the DT B-NP O
A NN I-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
protein NN I-NP O
; : O O
the DT B-NP O
less RBR I-NP O
common JJ I-NP O
mutation NN I-NP O
types NNS I-NP O
were VBD B-VP O
missense JJ B-ADJP O
( ( O O
9 CD B-NP O
/ SYM O O
71 CD B-NP O
, , O O
13 CD B-NP O
% NN I-NP O
) ) O O
, , O O
splicing NN B-NP O
( ( O O
3 CD B-NP O
/ SYM O O
71 CD B-NP O
, , O O
4 CD B-NP O
% NN I-NP O
) ) O O
and CC O O
one CD B-NP O
in IN B-PP O
- HYPH B-NP O
frame NN I-NP O
deletion NN I-NP O
, , O O
2546 CD B-NP O
3 CD I-NP O
( NN I-NP O
1 CD B-NP O
/ SYM I-NP O
71 CD I-NP O
, , I-NP O
1 CD I-NP O
% NN I-NP O
) ) O O
. . O O

The DT B-NP O
mean JJ I-NP O
survival NN I-NP O
and CC I-NP O
height NN I-NP O
distribution NN I-NP O
of IN B-PP O
134 CD B-NP O
A NN I-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
patients NNS I-NP O
correlated VBD B-VP O
significantly RB B-ADVP O
with IN B-PP O
the DT B-NP O
specific JJ I-NP O
mutations NNS I-NP O
present JJ B-ADJP O
in IN B-PP O
the DT B-NP O
patients NNS I-NP O
. . O O

Patients NNS B-NP O
homozygous JJ B-ADJP O
for IN B-PP O
a DT B-NP O
single JJ I-NP O
truncating VBG I-NP O
mutation NN I-NP O
, , O O
typically RB B-ADVP O
near IN B-PP O
the DT B-NP O
N NN I-NP O
- HYPH B-NP O
terminal JJ I-NP O
end NN I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
, , O O
or CC O O
heterozygous JJ B-ADJP O
for IN B-PP O
the DT B-NP O
in IN B-PP O
- HYPH B-NP O
frame NN I-NP O
deletion NN I-NP O
2546 CD I-NP O
3 CD I-NP O
, , O O
were VBD B-VP O
shorter JJR B-ADJP O
and CC O O
had VBD B-VP O
significantly RB B-NP O
shorter JJR I-NP O
survival NN I-NP O
than IN B-PP O
those DT B-NP O
heterozygous JJ B-ADJP O
for IN B-PP O
a DT B-NP O
splice NN I-NP O
site NN I-NP O
or CC O O
missense JJ B-NP O
mutation NN I-NP O
, , O O
or CC O O
heterozygous JJ B-ADJP O
for IN B-PP O
two CD B-NP O
truncating VBG I-NP O
mutations NNS I-NP O
. . O O

Alterations NNS B-NP O
of IN B-PP O
the DT B-NP O
length NN I-NP O
or CC I-NP O
amino NN I-NP O
acid NN I-NP O
composition NN I-NP O
of IN B-PP O
the DT B-NP O
A NN I-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
gene NN I-NP O
product NN I-NP O
affect VBP B-VP O
the DT B-NP O
A NN I-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
clinical JJ I-NP O
phenotype NN I-NP O
in IN B-PP O
different JJ B-NP O
ways NNS I-NP O
. . O O

Mutation NN B-NP O
analysis NN I-NP O
at IN B-PP O
the DT B-NP O
A NN I-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
locus NN I-NP O
may MD B-VP O
help VB I-VP O
estimate VB I-VP O
the DT B-NP O
prognosis NN I-NP O
of IN B-PP O
A NN B-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
patients NNS I-NP O
. . O O

. . O O

Isolation NN B-NP O
, , O O
genomic JJ B-NP O
organization NN I-NP O
, , O O
and CC O O
expression NN B-NP O
analysis NN I-NP O
of IN B-PP O
the DT B-NP O
mouse NN I-NP O
and CC I-NP O
rat NN I-NP O
homologs NNS I-NP O
of IN B-PP O
MEFV NN B-NP O
, , O O
the DT B-NP O
gene NN I-NP O
for IN B-PP O
familial JJ B-NP B-Disease
mediterranean JJ I-NP I-Disease
fever NN I-NP I-Disease
. . O O

Familial JJ B-NP B-Disease
Mediterranean JJ I-NP I-Disease
fever NN I-NP I-Disease
( ( O O
FMF NN B-NP B-Disease
) ) O O
is VBZ B-VP O
a DT B-NP O
recessive JJ I-NP B-Disease
disorder NN I-NP I-Disease
characterized VBN B-VP O
by IN B-PP O
episodes NNS B-NP O
of IN B-PP O
fever NN B-NP B-Disease
with IN B-PP O
serositis NN B-NP B-Disease
or CC I-NP O
synovitis NN I-NP B-Disease
. . O O

Recently RB B-ADVP O
the DT B-NP O
FMF NN I-NP B-Disease
gene NN I-NP O
( ( O O
MEFV NN B-NP O
) ) O O
was VBD B-VP O
cloned VBN I-VP O
; : O O
the DT B-NP O
protein NN I-NP O
product NN I-NP O
, , O O
pyrin NN B-NP O
/ SYM B-NP O
marenostrin NN I-NP O
, , O O
is VBZ B-VP O
thought VBN I-VP O
to TO I-VP O
regulate VB I-VP O
inflammation NN B-NP O
in IN B-PP O
myeloid JJ B-NP O
cells NNS I-NP O
. . O O

In IN B-PP O
this DT B-NP O
manuscript NN I-NP O
we PRP B-NP O
report VBP B-VP O
the DT B-NP O
mouse NN I-NP O
and CC I-NP O
rat NN I-NP O
homologs NNS I-NP O
of IN B-PP O
MEFV NN B-NP O
. . O O

The DT B-NP O
murine JJ I-NP O
gene NN I-NP O
contains VBZ B-VP O
ten CD B-NP O
exons NNS I-NP O
with IN B-PP O
a DT B-NP O
coding VBG I-NP O
sequence NN I-NP O
of IN B-PP O
2304 CD B-NP O
bp NN I-NP O
, , O O
while IN B-SBAR O
the DT B-NP O
rat NN I-NP O
homolog NN I-NP O
has VBZ B-VP O
nine CD B-NP O
exons NNS I-NP O
with IN B-PP O
a DT B-NP O
coding VBG I-NP O
sequence NN I-NP O
of IN B-PP O
2253 CD B-NP O
bp NN I-NP O
. . O O

A DT B-NP O
considerable JJ I-NP O
amino NN I-NP O
acid NN I-NP O
sequence NN I-NP O
homology NN I-NP O
was VBD B-VP O
observed VBN I-VP O
between IN B-PP O
the DT B-NP O
mouse NN I-NP O
and CC O O
human JJ B-ADJP O
( ( O O
47 CD B-NP O
. . O O

6 CD B-NP O
% NN I-NP O
identity NN I-NP O
and CC O O
65 CD B-NP O
. . O O

5 CD B-NP O
% NN I-NP O
similarity NN I-NP O
) ) O O
and CC O O
between IN B-PP O
the DT B-NP O
mouse NN I-NP O
and CC I-NP O
rat NN I-NP O
genes NNS I-NP O
( ( O O
73 CD B-NP O
. . O O

5 CD B-NP O
% NN I-NP O
identity NN I-NP O
and CC O O
82 CD B-NP O
. . O O

1 CD B-NP O
% NN I-NP O
similarity NN I-NP O
) ) O O
. . O O

The DT B-NP O
predicted VBN I-NP O
rodent NN I-NP O
proteins NNS I-NP O
have VBP B-VP O
several JJ B-NP O
important JJ I-NP O
domains NNS I-NP O
and CC I-NP O
signals NNS I-NP O
found VBN B-VP O
in IN B-PP O
human JJ B-NP O
pyrin NN I-NP O
, , O O
including VBG B-PP O
a DT B-NP O
B NN I-NP O
- HYPH I-NP O
box NN I-NP O
zinc NN I-NP O
finger NN I-NP O
domain NN I-NP O
, , O O
Robbins NNP B-NP O
- HYPH I-NP O
Dingwall NNP I-NP O
nuclear JJ I-NP O
localization NN I-NP O
signal NN I-NP O
, , O O
and CC O O
coiled VBN B-VP O
- HYPH B-NP O
coil NN I-NP O
domain NN I-NP O
. . O O

However RB B-ADVP O
, , O O
perhaps RB B-ADVP O
because IN B-PP O
of IN I-PP O
an DT B-NP O
ancient JJ I-NP O
frame NN I-NP O
- HYPH B-NP O
shift NN I-NP O
mutation NN I-NP O
, , O O
neither CC O O
the DT B-NP O
mouse NN I-NP O
nor CC O O
the DT B-NP O
rat NN I-NP O
protein NN I-NP O
has VBZ B-VP O
an DT B-NP O
intact JJ I-NP O
C NN I-NP O
- HYPH B-NP O
terminal JJ I-NP O
B30 NN I-NP O
. . O O

2 CD B-NP O
domain NN I-NP O
, , O O
in IN B-PP O
which WDT B-NP O
most JJS B-NP O
FMF NN I-NP B-Disease
- HYPH B-NP O
associated VBN I-NP O
mutations NNS I-NP O
have VBP B-VP O
been VBN I-VP O
found VBN I-VP O
in IN B-PP O
human JJ B-NP O
MEFV NN I-NP O
. . O O

Nevertheless RB B-ADVP O
, , O O
like IN B-PP O
the DT B-NP O
human JJ I-NP O
gene NN I-NP O
, , O O
mouse NN B-NP O
Mefv NN I-NP O
is VBZ B-VP O
expressed VBN I-VP O
in IN B-PP O
peripheral JJ B-NP O
blood NN I-NP O
granulocytes NNS I-NP O
but CC B-NP O
not RB I-NP O
lymphocytes NNS B-NP O
. . O O

Consistent JJ B-ADJP O
with IN B-PP O
its PRP$ B-NP O
expression NN I-NP O
in IN B-PP O
granulocytes NNS B-NP O
, , O O
Mefv NN B-NP O
was VBD B-VP O
detected VBN I-VP O
at IN B-PP O
high JJ B-NP O
levels NNS I-NP O
in IN B-PP O
the DT B-NP O
primary JJ I-NP O
follicles NNS I-NP O
and CC O O
marginal JJ B-NP O
zones NNS I-NP O
of IN B-PP O
the DT B-NP O
splenic JJ I-NP O
white JJ I-NP O
pulp NN I-NP O
. . O O

Mefv NN B-NP O
is VBZ B-VP O
localized VBN I-VP O
on IN B-PP O
mouse NN B-NP O
Chromosome NN I-NP O
( ( O O
Chr NN B-NP O
) ) O O
16 CD B-NP O
, , O O
region NN B-NP O
A3 NN I-NP O
- HYPH B-NP O
B1 NN I-NP O
, , O O
extending VBG B-VP O
a DT B-NP O
region NN I-NP O
of IN B-PP O
synteny NN B-NP O
with IN B-PP O
human JJ B-NP O
Chr NN I-NP O
16p13 CD I-NP O
. . O O

3 LS B-LST O
. . O O

Development NN B-NP O
of IN B-PP O
knockout NN B-NP O
and CC I-NP O
knockin NN I-NP O
mouse NN I-NP O
models NNS I-NP O
may MD B-VP O
provide VB I-VP O
further JJ B-NP O
insights NNS I-NP O
into IN B-PP O
the DT B-NP O
functional JJ I-NP O
evolution NN I-NP O
of IN B-PP O
this DT B-NP O
gene NN I-NP O
. . O O

Additional JJ B-NP O
copies NNS I-NP O
of IN B-PP O
the DT B-NP O
proteolipid NN I-NP O
protein NN I-NP O
gene NN I-NP O
causing VBG B-VP O
Pelizaeus NNP B-NP B-Disease
- HYPH I-NP I-Disease
Merzbacher NNP I-NP I-Disease
disease NN I-NP I-Disease
arise NN I-NP O
by IN B-PP O
separate JJ B-NP O
integration NN I-NP O
into IN B-PP O
the DT B-NP O
X NN I-NP O
chromosome NN I-NP O
. . O O

The DT B-NP O
proteolipid NN I-NP O
protein NN I-NP O
gene NN I-NP O
( ( O O
PLP NN B-NP O
) ) O O
is VBZ B-VP O
normally RB B-ADVP O
present JJ B-ADJP O
at IN B-PP O
chromosome NN B-NP O
Xq22 NN I-NP O
. . O O

Mutations NNS B-NP O
and CC I-NP O
duplications NNS I-NP O
of IN B-PP O
this DT B-NP O
gene NN I-NP O
are VBP B-VP O
associated VBN I-VP O
with IN B-PP O
Pelizaeus NNP B-NP B-Disease
- HYPH I-NP I-Disease
Merzbacher NNP I-NP I-Disease
disease NN I-NP I-Disease
( ( O O
PMD NN B-NP B-Disease
) ) O O
. . O O

Here RB B-ADVP O
we PRP B-NP O
describe VBP B-VP O
two CD B-NP O
new JJ I-NP O
families NNS I-NP O
in IN B-PP O
which WDT B-NP O
males NNS B-NP O
affected VBN B-VP O
with IN B-PP O
PMD NN B-NP B-Disease
were VBD B-VP O
found VBN I-VP O
to TO I-VP O
have VB I-VP O
a DT B-NP O
copy NN I-NP O
of IN B-PP O
PLP NN B-NP O
on IN B-PP O
the DT B-NP O
short JJ I-NP O
arm NN I-NP O
of IN B-PP O
the DT B-NP O
X NN I-NP O
chromosome NN I-NP O
, , O O
in IN B-PP O
addition NN B-NP O
to TO B-PP O
a DT B-NP O
normal JJ I-NP O
copy NN I-NP O
on IN B-PP O
Xq22 NN B-NP O
. . O O

In IN B-PP O
the DT B-NP O
first JJ I-NP O
family NN I-NP O
, , O O
the DT B-NP O
extra JJ I-NP O
copy NN I-NP O
was VBD B-VP O
first RB I-VP O
detected VBN I-VP O
by IN B-PP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
heterozygosity NN B-NP O
of IN B-PP O
the DT B-NP O
AhaII NN I-NP O
dimorphism NN I-NP O
within IN B-PP O
the DT B-NP O
PLP NN I-NP O
gene NN I-NP O
. . O O

The DT B-NP O
results NNS I-NP O
of IN B-PP O
FISH NN B-NP O
analysis NN I-NP O
showed VBD B-VP O
an DT B-NP O
additional JJ I-NP O
copy NN I-NP O
of IN B-PP O
PLP NN B-NP O
in IN B-PP O
Xp22 NN B-NP O
. . O O

1 CD B-NP O
, , O O
although IN B-SBAR O
no DT B-NP O
chromosomal JJ I-NP O
rearrangements NNS I-NP O
could MD B-VP O
be VB I-VP O
detected VBN I-VP O
by IN B-PP O
standard JJ B-NP O
karyotype NN I-NP O
analysis NN I-NP O
. . O O

Another DT B-NP O
three CD I-NP O
affected VBN I-NP O
males NNS I-NP O
from IN B-PP O
the DT B-NP O
family NN I-NP O
had VBD B-VP O
similar JJ B-NP O
findings NNS I-NP O
. . O O

In IN B-PP O
a DT B-NP O
second JJ I-NP O
unrelated JJ I-NP O
family NN I-NP O
with IN B-PP O
signs NNS B-NP O
of IN B-PP O
PMD NN B-NP B-Disease
, , O O
cytogenetic JJ B-NP O
analysis NN I-NP O
showed VBD B-VP O
a DT B-NP O
pericentric JJ I-NP O
inversion NN I-NP O
of IN B-PP O
the DT B-NP O
X NN I-NP O
chromosome NN I-NP O
. . O O

In IN B-PP O
the DT B-NP O
inv NN I-NP O
( ( O O
X NN B-NP O
) ) O O
carried VBN B-VP O
by IN B-PP O
several JJ B-NP O
affected VBN I-NP O
family NN I-NP O
members NNS I-NP O
, , O O
FISH NN B-NP O
showed VBD B-VP O
PLP NN B-NP O
signals NNS I-NP O
at IN B-PP O
Xp11 NN B-NP O
. . O O

4 CD B-NP O
and CC I-NP O
Xq22 NN I-NP O
. . O O

A DT B-NP O
third JJ I-NP O
family NN I-NP O
has VBZ B-VP O
previously RB I-VP O
been VBN I-VP O
reported VBN I-VP O
, , O O
in IN B-PP O
which WDT B-NP O
affected VBD B-VP O
members NNS B-NP O
had VBD B-VP O
an DT B-NP O
extra JJ I-NP O
copy NN I-NP O
of IN B-PP O
the DT B-NP O
PLP NN I-NP O
gene NN I-NP O
detected VBN B-VP O
at IN B-PP O
Xq26 NN B-NP O
in IN B-PP O
a DT B-NP O
chromosome NN I-NP O
with IN B-PP O
an DT B-NP O
otherwise RB I-NP O
normal JJ I-NP O
banding NN I-NP O
pattern NN I-NP O
. . O O

The DT B-NP O
identification NN I-NP O
of IN B-PP O
three CD B-NP O
separate JJ I-NP O
families NNS I-NP O
in IN B-PP O
which WDT B-NP O
PLP NN B-NP O
is VBZ B-VP O
duplicated VBN I-VP O
at IN B-PP O
a DT B-NP O
noncontiguous JJ I-NP O
site NN I-NP O
suggests VBZ B-VP O
that IN B-SBAR O
such JJ B-NP O
duplications NNS I-NP O
could MD B-VP O
be VB I-VP O
a DT B-NP O
relatively RB I-NP O
common JJ I-NP O
but CC O O
previously RB B-NP O
undetected JJ I-NP O
cause NN I-NP O
of IN B-PP O
genetic JJ B-NP B-Disease
disorders NNS I-NP I-Disease
. . O O

The DT B-NP O
exon NN I-NP O
13 CD I-NP O
duplication NN I-NP O
in IN B-PP O
the DT B-NP O
BRCA1 NN I-NP O
gene NN I-NP O
is VBZ B-VP O
a DT B-NP O
founder NN I-NP O
mutation NN I-NP O
present JJ B-ADJP O
in IN B-PP O
geographically RB B-NP O
diverse JJ I-NP O
populations NNS I-NP O
. . O O

The DT B-NP O
BRCA1 NN I-NP O
Exon NNP B-NP O
13 CD I-NP O
Duplication NNP I-NP O
Screening NNP I-NP O
Group NNP I-NP O
. . O O

Recently RB B-ADVP O
, , O O
a DT B-NP O
6 CD I-NP O
- HYPH I-NP O
kb NN I-NP O
duplication NN I-NP O
of IN B-PP O
exon NN B-NP O
13 CD I-NP O
, , O O
which WDT B-NP O
creates VBZ B-VP O
a DT B-NP O
frameshift NN I-NP O
in IN B-PP O
the DT B-NP O
coding VBG I-NP O
sequence NN I-NP O
of IN B-PP O
the DT B-NP O
BRCA1 NN I-NP O
gene NN I-NP O
, , O O
has VBZ B-VP O
been VBN I-VP O
described VBN I-VP O
in IN B-PP O
three CD B-NP O
unrelated JJ I-NP O
U NN I-NP O
. . O O

S NNP B-NP O
S NNP I-NP O
. . I-NP O

families NNS I-NP O
of IN B-PP O
European JJ B-NP O
ancestry NN I-NP O
and CC O O
in IN B-PP O
one CD B-NP O
Portuguese NN I-NP O
family NN I-NP O
. . O O

Here RB B-ADVP O
, , O O
our PRP$ B-NP O
goal NN I-NP O
was VBD B-VP O
to TO B-VP O
estimate VB I-VP O
the DT B-NP O
frequency NN I-NP O
and CC I-NP O
geographic JJ I-NP O
diversity NN I-NP O
of IN B-PP O
carriers NNS B-NP O
of IN B-PP O
this DT B-NP O
duplication NN I-NP O
. . O O

To TO B-VP O
do VB I-VP O
this DT B-NP O
, , O O
a DT B-NP O
collaborative JJ I-NP O
screening NN I-NP O
study NN I-NP O
was VBD B-VP O
set VBN I-VP O
up RP B-PRT O
that WDT B-NP O
involved VBD B-VP O
39 CD B-NP O
institutions NNS I-NP O
from IN B-PP O
19 CD B-NP O
countries NNS I-NP O
and CC O O
included VBD B-VP O
3 CD B-NP O
, , O O
580 CD B-NP O
unrelated JJ I-NP O
individuals NNS I-NP O
with IN B-PP O
a DT B-NP O
family NN I-NP O
history NN I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
and CC O O
934 CD B-NP O
early JJ I-NP O
- HYPH I-NP O
onset NN I-NP O
breast NN I-NP B-Disease
and CC O I-Disease
/ SYM B-NP I-Disease
or CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
cases NNS I-NP O
. . O O

A DT B-NP O
total NN I-NP O
of IN B-PP O
11 CD B-NP O
additional JJ I-NP O
families NNS I-NP O
carrying VBG B-VP O
this DT B-NP O
mutation NN I-NP O
were VBD B-VP O
identified VBN I-VP O
in IN B-PP O
Australia NNP B-NP O
( ( O O
1 CD B-NP O
) ) O O
, , O O
Belgium NN B-NP O
( ( O O
1 CD B-NP O
) ) O O
, , O O
Canada NNP B-NP O
( ( O O
1 CD B-NP O
) ) O O
, , O O
Great JJ B-NP O
Britain NNP I-NP O
( ( O O
6 CD B-NP O
) ) O O
, , O O
and CC O O
the DT B-NP O
United NNP I-NP O
States NNPS I-NP O
( ( O O
2 CD B-NP O
) ) O O
. . O O

Haplotyping NN B-NP O
showed VBD B-VP O
that IN B-SBAR O
they PRP B-NP O
are VBP B-VP O
likely JJ B-ADJP O
to TO B-VP O
derive VB I-VP O
from IN B-PP O
a DT B-NP O
common JJ I-NP O
ancestor NN I-NP O
, , O O
possibly RB B-ADVP O
of IN B-PP O
northern JJ B-NP O
British JJ I-NP O
origin NN I-NP O
. . O O

Our PRP$ B-NP O
results NNS I-NP O
demonstrate VBP B-VP O
that IN B-SBAR O
it PRP B-NP O
is VBZ B-VP O
strongly RB B-ADJP O
advisable JJ I-ADJP O
, , O O
for IN B-PP O
laboratories NNS B-NP O
carrying VBG B-VP O
out RP B-PRT O
screening VBG B-VP O
either CC O O
in IN B-PP O
English NNP B-NP O
- HYPH B-VP O
speaking VBG B-NP O
countries NNS I-NP O
or CC B-PP O
in IN B-PP O
countries NNS B-NP O
with IN B-PP O
historical JJ B-NP O
links NNS I-NP O
with IN B-PP O
Britain NNP B-NP O
, , O O
to TO B-VP O
include VB I-VP O
within IN B-PP O
their PRP$ B-NP O
BRCA1 NN I-NP O
screening NN I-NP O
protocols VBZ B-VP O
the DT B-NP O
polymerase NN I-NP O
chain NN I-NP O
reaction NN I-NP O
- HYPH B-NP O
based VBN I-NP O
assay NN I-NP O
described VBN B-VP O
in IN B-PP O
this DT B-NP O
report NN I-NP O
. . O O

Genotype NN B-NP O
- HYPH I-NP O
phenotype NN I-NP O
correlations NNS I-NP O
in IN B-PP O
families NNS B-NP O
with IN B-PP O
deletions NNS B-NP O
in IN B-PP O
the DT B-NP O
von NNP I-NP B-Disease
Hippel NNP I-NP I-Disease
- HYPH I-NP I-Disease
Lindau NNP I-NP I-Disease
( ( O O
VHL NNP O B-Disease
) ) O O
gene NN B-NP O
. . O O

Von NNP B-NP B-Disease
Hippel NNP I-NP I-Disease
- HYPH I-NP I-Disease
Lindau NNP I-NP I-Disease
( ( O I-Disease
VHL NNP O I-Disease
) ) O I-Disease
disease NN B-NP I-Disease
is VBZ B-VP O
a DT B-NP O
hereditary JJ I-NP B-Disease
tumor NN I-NP I-Disease
syndrome NN I-NP I-Disease
characterized VBN B-VP O
by IN B-PP O
predisposition NN B-NP O
for IN B-PP O
bilateral JJ B-ADJP B-Disease
and CC O I-Disease
multi AFX B-NP I-Disease
- HYPH I-NP I-Disease
centric JJ I-NP I-Disease
hemangioblastoma NN I-NP I-Disease
in IN B-PP O
the DT B-NP O
retina NN I-NP O
and CC I-NP O
central JJ I-NP O
nervous JJ I-NP O
system NN I-NP O
, , O O
pheochromocytoma NN B-NP B-Disease
, , O O
renal JJ B-NP B-Disease
cell NN I-NP I-Disease
carcinoma NN I-NP I-Disease
, , O O
and CC O O
cysts NNS B-NP B-Disease
in IN B-PP I-Disease
the DT B-NP I-Disease
kidney NN I-NP I-Disease
, , O I-Disease
pancreas NN B-NP I-Disease
, , O I-Disease
and CC O I-Disease
epididymis NN B-NP I-Disease
. . O O

We PRP B-NP O
describe VBP B-VP O
five CD B-NP O
families NNS I-NP O
for IN B-PP O
which WDT B-NP O
direct JJ B-NP O
sequencing NN I-NP O
of IN B-PP O
the DT B-NP O
coding VBG I-NP O
region NN I-NP O
of IN B-PP O
the DT B-NP O
VHL NN I-NP B-Disease
gene NN I-NP O
had VBD B-VP O
failed VBN I-VP O
to TO I-VP O
identify VB I-VP O
the DT B-NP O
family NN I-NP O
- HYPH B-NP O
specific JJ I-NP O
mutation NN I-NP O
. . O O

Further JJ B-NP O
molecular JJ I-NP O
analysis NN I-NP O
revealed VBD B-VP O
deletions NNS B-NP O
involving VBG B-VP O
the DT B-NP O
VHL NN I-NP B-Disease
gene NN I-NP O
in IN B-PP O
each DT B-NP O
of IN B-PP O
these DT B-NP O
families NNS I-NP O
. . O O

In IN B-PP O
four CD B-NP O
families NNS I-NP O
, , O O
partial JJ B-NP O
deletions NNS I-NP O
of IN B-PP O
one CD B-NP O
or CC I-NP O
more JJR I-NP O
exons NNS I-NP O
were VBD B-VP O
detected VBN I-VP O
by IN B-PP O
Southern JJ B-NP O
blot NN I-NP O
analysis NN I-NP O
. . O O

In IN B-PP O
the DT B-NP O
fifth JJ I-NP O
family NN I-NP O
, , O O
FISH NN B-NP O
analysis NN I-NP O
demonstrated VBD B-VP O
the DT B-NP O
deletion NN I-NP O
of IN B-PP O
the DT B-NP O
entire JJ I-NP O
VHL NN I-NP B-Disease
gene NN I-NP O
. . O O

Our PRP$ B-NP O
results NNS I-NP O
show VBP B-VP O
that IN B-SBAR O
( ( O O
quantitative JJ B-ADJP O
) ) O O
Southern JJ B-NP O
blot NN I-NP O
analysis NN I-NP O
is VBZ B-VP O
a DT B-NP O
sensitive JJ I-NP O
method NN I-NP O
for IN B-PP O
detecting VBG B-VP O
germline NN B-NP O
deletions NNS I-NP O
of IN B-PP O
the DT B-NP O
VHL NN I-NP B-Disease
gene NN I-NP O
and CC O O
should MD B-VP O
be VB I-VP O
implemented VBN I-VP O
in IN B-PP O
routine JJ B-NP O
DNA NN I-NP O
diagnosis NN I-NP O
for IN B-PP O
VHL NN B-NP B-Disease
disease NN I-NP I-Disease
. . O O

Our PRP$ B-NP O
data NNS I-NP O
support VBP B-VP O
the DT B-NP O
previously RB I-NP O
established VBN I-NP O
observation NN I-NP O
that IN B-SBAR O
families NNS B-NP O
with IN B-PP O
a DT B-NP O
germline NN I-NP O
deletion NN I-NP O
have VBP B-VP O
a DT B-NP O
low JJ I-NP O
risk NN I-NP O
for IN B-PP O
pheochromocytoma NN B-NP B-Disease
. . O O

Further JJ B-NP O
unraveling NN I-NP O
of IN B-PP O
genotype NN B-NP O
- HYPH B-NP O
phenotype NN I-NP O
correlations NNS I-NP O
in IN B-PP O
VHL NN B-NP B-Disease
disease NN I-NP I-Disease
has VBZ B-VP O
revealed VBN I-VP O
that IN B-SBAR O
families NNS B-NP O
with IN B-PP O
a DT B-NP O
full JJ I-NP O
or CC I-NP O
partial JJ I-NP O
deletion NN I-NP O
of IN B-PP O
the DT B-NP O
VHL NN I-NP B-Disease
gene NN I-NP O
exhibit VBP B-VP O
a DT B-NP O
phenotype NN I-NP O
with IN B-PP O
a DT B-NP O
preponderance NN I-NP O
of IN B-PP O
central JJ B-NP B-Disease
nervous JJ I-NP I-Disease
system NN I-NP I-Disease
hemangioblastoma NN I-NP I-Disease
. . O O

. . O O

Age NN B-NP O
of IN B-PP O
the DT B-NP O
intronic JJ I-NP O
GAA NN I-NP O
triplet NN I-NP O
repeat NN I-NP O
expansion NN I-NP O
mutation NN I-NP O
in IN B-PP O
Friedreich NNP B-NP B-Disease
ataxia NN I-NP I-Disease
. . O O

Friedreich NN B-NP B-Disease
ataxia NN I-NP I-Disease
( ( O O
FRDA NN B-NP B-Disease
) ) O O
, , O O
the DT B-NP O
most RBS I-NP O
frequently RB I-NP O
inherited VBN I-NP B-Disease
ataxia NN I-NP I-Disease
, , O O
is VBZ B-VP O
due JJ B-ADJP O
in IN B-PP O
the DT B-NP O
vast JJ I-NP O
majority NN I-NP O
of IN B-PP O
cases NNS B-NP O
to TO B-PP O
a DT B-NP O
large JJ I-NP O
expansion NN I-NP O
of IN B-PP O
an DT B-NP O
intronic JJ I-NP O
GAA NN I-NP O
repeat NN I-NP O
. . O O

Using VBG B-VP O
linkage NN B-NP O
disequilibrium NN I-NP O
analysis NN I-NP O
based VBN B-VP O
on IN B-PP O
haplotype NN B-NP O
data NNS I-NP O
of IN B-PP O
seven CD B-NP O
polymorphic JJ I-NP O
markers NNS I-NP O
close RB B-ADJP O
to TO B-PP O
the DT B-NP O
frataxin NN I-NP O
gene NN I-NP O
, , O O
the DT B-NP O
age NN I-NP O
of IN B-PP O
FRDA NN B-NP B-Disease
founding VBG B-VP O
mutational JJ B-NP O
event NN I-NP O
( ( I-NP O
s NNS I-NP O
) ) O O
is VBZ B-VP O
estimated VBN I-VP O
to TO I-VP O
be VB I-VP O
at IN B-NP O
least JJS I-NP O
682 CD I-NP O
+ SYM O O
/ SYM O O
- SYM B-NP O
203 CD B-NP O
generations NNS I-NP O
( ( O O
95 CD B-NP O
% NN I-NP O
confidence NN I-NP O
interval NN I-NP O
564 CD I-NP O
- HYPH I-NP O
801 CD I-NP O
g NN I-NP O
) ) O O
, , O O
a DT B-NP O
dating NN I-NP O
which WDT B-NP O
is VBZ B-VP O
consistent JJ B-ADJP O
with IN B-PP O
little JJ B-NP O
or CC I-NP O
no DT I-NP O
negative JJ I-NP O
selection NN I-NP O
and CC O O
provides VBZ B-VP O
further JJ B-NP O
evidence NN I-NP O
for IN B-PP O
an DT B-NP O
ancient JJ I-NP O
spread NN I-NP O
of IN B-PP O
a DT B-NP O
pre AFX I-NP O
- HYPH I-NP O
mutation NN I-NP O
( ( O O
at IN B-PP O
- HYPH B-NP O
risk NN I-NP O
alleles NNS I-NP O
) ) O O
in IN B-PP O
western JJ B-NP O
Europe NNP I-NP O
. . O O

. . O O

Functional JJ B-NP O
link NN I-NP O
between IN B-PP O
ataxia NN B-NP B-Disease
- HYPH I-NP I-Disease
telangiectasia NN I-NP I-Disease
and CC I-NP O
Nijmegen NN I-NP B-Disease
breakage NN I-NP I-Disease
syndrome NN I-NP I-Disease
gene NN I-NP O
products NNS I-NP O
. . O O

Ataxia NN B-NP B-Disease
- HYPH O I-Disease
telangiectasia NN B-NP I-Disease
( ( O O
A NN B-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
) ) O O
and CC O O
Nijmegen NN B-NP B-Disease
breakage NN I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
NBS NN B-NP B-Disease
) ) O O
are VBP B-VP O
recessive JJ B-NP B-Disease
genetic JJ I-NP I-Disease
disorders NNS I-NP I-Disease
with IN B-PP O
susceptibility NN B-NP O
to TO B-PP O
cancer NN B-NP B-Disease
and CC O O
similar JJ B-NP O
cellular JJ I-NP O
phenotypes NNS I-NP O
. . O O

The DT B-NP O
protein NN I-NP O
product NN I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
responsible JJ B-ADJP O
for IN B-PP O
A NN B-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
, , O O
designated VBN B-VP O
ATM NN B-NP O
, , O O
is VBZ B-VP O
a DT B-NP O
member NN I-NP O
of IN B-PP O
a DT B-NP O
family NN I-NP O
of IN B-PP O
kinases NNS B-NP O
characterized VBN B-VP O
by IN B-PP O
a DT B-NP O
carboxy NN I-NP O
- HYPH B-NP O
terminal JJ I-NP O
phosphatidylinositol NN I-NP O
3 CD I-NP O
- HYPH I-NP O
kinase NN I-NP O
- HYPH B-NP O
like JJ I-NP O
domain NN I-NP O
. . O O

The DT B-NP O
NBS1 NN I-NP O
protein NN I-NP O
is VBZ B-VP O
specifically RB I-VP O
mutated VBN I-VP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
Nijmegen NN B-NP B-Disease
breakage NN I-NP I-Disease
syndrome NN I-NP I-Disease
and CC O O
forms VBZ B-VP O
a DT B-NP O
complex NN I-NP O
with IN B-PP O
the DT B-NP O
DNA NN I-NP O
repair NN I-NP O
proteins NNS I-NP O
Rad50 NN I-NP O
and CC I-NP O
Mrel1 NN I-NP O
. . O O

Here RB B-ADVP O
we PRP B-NP O
show VBP B-VP O
that IN B-SBAR O
phosphorylation NN B-NP O
of IN B-PP O
NBS1 NN B-NP O
, , O O
induced VBN B-VP O
by IN B-PP O
ionizing VBG B-VP O
radiation NN B-NP O
, , O O
requires VBZ B-VP O
catalytically RB B-NP O
active JJ I-NP O
ATM NN I-NP O
. . O O

Complexes NNS B-NP O
containing VBG B-VP O
ATM NN B-NP O
and CC I-NP O
NBS1 NN I-NP O
exist VBP B-VP O
in FW B-ADVP O
vivo FW I-ADVP O
in IN B-PP O
both CC B-NP O
untreated JJ I-NP O
cells NNS I-NP O
and CC O O
cells NNS B-NP O
treated VBN B-VP O
with IN B-PP O
ionizing VBG B-VP O
radiation NN B-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
identified VBN I-VP O
two CD B-NP O
residues NNS I-NP O
of IN B-PP O
NBS1 NN B-NP O
, , O O
Ser NN B-NP O
278 CD I-NP O
and CC O O
Ser NN B-NP O
343 NN I-NP O
that WDT B-NP O
are VBP B-VP O
phosphorylated VBN I-VP O
in FW B-ADVP O
vitro FW I-ADVP O
by IN B-PP O
ATM NN B-NP O
and CC O O
whose WP$ B-NP O
modification NN I-NP O
in FW B-ADVP O
vivo FW I-ADVP O
is VBZ B-VP O
essential JJ B-ADJP O
for IN B-PP O
the DT B-NP O
cellular JJ I-NP O
response NN I-NP O
to TO B-PP O
DNA NN B-NP O
damage NN I-NP O
. . O O

This DT B-NP O
response NN I-NP O
includes VBZ B-VP O
S NN B-NP O
- HYPH I-NP O
phase NN I-NP O
checkpoint NN I-NP O
activation NN I-NP O
, , O O
formation NN B-NP O
of IN B-PP O
the DT B-NP O
NBS1 NN I-NP O
/ SYM B-NP O
Mrel1 NN I-NP O
/ SYM B-NP O
Rad50 NN I-NP O
nuclear JJ I-NP O
foci NNS I-NP O
and CC O O
rescue NN B-NP O
of IN B-PP O
hypersensitivity NN B-NP B-Disease
to TO B-PP I-Disease
ionizing VBG B-VP I-Disease
radiation NN B-NP I-Disease
. . O O

Together RB B-ADVP O
, , O O
these DT B-NP O
results NNS I-NP O
demonstrate VBP B-VP O
a DT B-NP O
biochemical JJ I-NP O
link NN I-NP O
between IN B-PP O
cell NN B-NP O
- HYPH I-NP O
cycle NN I-NP O
checkpoints NNS I-NP O
activated VBN B-VP O
by IN B-PP O
DNA NN B-NP O
damage NN I-NP O
and CC I-NP O
DNA NN I-NP O
repair NN I-NP O
in IN B-PP O
two CD B-NP O
genetic JJ I-NP B-Disease
diseases NNS I-NP I-Disease
with IN B-PP O
overlapping VBG B-NP O
phenotypes NNS I-NP O
. . O O

. . O O

Homozygosity NN B-NP O
mapping NN I-NP O
in IN B-PP O
a DT B-NP O
family NN I-NP O
with IN B-PP O
microcephaly JJ B-NP B-Disease
, , I-NP O
mental JJ I-NP B-Disease
retardation NN I-NP I-Disease
, , O O
and CC O O
short JJ B-NP B-Disease
stature NN I-NP I-Disease
to TO B-PP O
a DT B-NP O
Cohen NNP I-NP B-Disease
syndrome NN I-NP I-Disease
region NN I-NP O
on IN B-PP O
8q21 CD B-NP O
. . O O

3 CD B-NP O
- HYPH I-NP O
8q22 CD I-NP O
. . I-NP O

1 CD I-NP O
: : O O
redefining VBG B-VP O
a DT B-NP O
clinical JJ I-NP O
entity NN I-NP O
. . O O

A DT B-NP O
syndrome NN I-NP O
of IN B-PP O
microcephaly JJ B-NP B-Disease
, , I-NP O
progressive JJ I-NP O
postnatal JJ I-NP B-Disease
growth NN I-NP I-Disease
deficiency NN I-NP I-Disease
, , O O
and CC O O
mental JJ B-NP B-Disease
retardation NN I-NP I-Disease
was VBD B-VP O
observed VBN I-VP O
in IN B-PP O
two CD B-NP O
brothers NNS I-NP O
and CC O O
their PRP$ B-NP O
cousin NN I-NP O
from IN B-PP O
a DT B-NP O
multiply JJ I-NP O
consanguineous JJ I-NP O
kindred NN I-NP O
of IN B-PP O
Lebanese JJ B-NP O
descent NN I-NP O
. . O O

Hypotonia NNP B-NP B-Disease
, , O O
chorioretinal JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
, , O O
and CC O O
myopia NN B-NP B-Disease
were VBD B-VP O
also RB I-VP O
identified VBN I-VP O
. . O O

The DT B-NP O
severity NN I-NP O
of IN B-PP O
the DT B-NP O
condition NN I-NP O
varied VBD B-VP O
among IN B-PP O
the DT B-NP O
closely RB I-NP O
related JJ I-NP O
patients NNS I-NP O
. . O O

Because IN B-PP O
of IN I-PP O
absence NN B-NP O
of IN B-PP O
a DT B-NP O
distinctive JJ I-NP O
facial JJ I-NP O
appearance NN I-NP O
, , O O
the DT B-NP O
degree NN I-NP O
of IN B-PP O
mental JJ B-NP B-Disease
retardation NN I-NP I-Disease
, , O O
and CC O O
short JJ B-NP B-Disease
stature NN I-NP I-Disease
, , O O
the DT B-NP O
initially RB I-NP O
considered VBN I-NP O
clinical JJ I-NP O
diagnosis NN I-NP O
of IN B-PP O
Cohen NN B-NP B-Disease
syndrome NN I-NP I-Disease
was VBD B-VP O
withdrawn VBN I-VP O
and CC O O
a DT B-NP O
novel JJ I-NP O
genetic JJ I-NP O
entity NN I-NP O
was VBD B-VP O
assumed VBN I-VP O
. . O O

Homozygosity NN B-NP O
mapping NN I-NP O
in IN B-PP O
this DT B-NP O
family NN I-NP O
assigned VBD B-VP O
the DT B-NP O
gene NN I-NP O
to TO B-PP O
a DT B-NP O
26 CD I-NP O
. . O O

8 CD B-NP O
- HYPH I-NP O
cM NN I-NP O
region NN I-NP O
on IN B-PP O
the DT B-NP O
chromosome NN I-NP O
band NN I-NP O
8q21 NN I-NP O
. . O O

3 CD B-NP O
- HYPH I-NP O
22 CD I-NP O
. . O O

1 CD B-NP O
, , O O
between IN B-PP O
the DT B-NP O
microsatellites NNS I-NP O
at IN B-PP O
D8S270 NN B-NP O
and CC I-NP O
D8S514 NN I-NP O
. . O O

The DT B-NP O
maximum NN I-NP O
two CD I-NP O
- HYPH I-NP O
point NN I-NP O
LOD NN I-NP O
score NN I-NP O
was VBD B-VP O
found VBN I-VP O
for IN B-PP O
marker NN B-NP O
at IN B-PP O
D8S267 NN B-NP O
( ( O O
Zmax NN B-NP O
= SYM B-VP O
3 CD B-NP O
. . O O

. . O O

237 CD B-NP O
at IN B-PP O
Omax NN B-NP O
= SYM B-VP O
0 CD B-NP O
. SYM I-NP O

00 CD I-NP O
) ) O O
. . O O

Intriguingly RB B-ADVP O
enough RB I-ADVP O
, , O O
the DT B-NP O
identified VBN I-NP O
gene NN I-NP O
region NN I-NP O
overlaps VBZ B-VP O
the DT B-NP O
refined VBN I-NP O
gene NN I-NP O
region NN I-NP O
for IN B-PP O
Cohen NNP B-NP B-Disease
syndrome NN I-NP I-Disease
( ( O O
COH1 NN B-NP O
) ) O O
[ ( O O
Kolehmainen NNP B-NP O
et FW I-NP O
al FW I-NP O
. FW I-NP O

, , O O
1997 CD B-NP O
Euro NNP I-NP O
J NNP I-NP O
Hum NNP I-NP O
Genet NNP I-NP O
5 CD I-NP O
206 CD I-NP O
- HYPH I-NP O
213 CD I-NP O
] ) O O
. . O O

This DT B-NP O
fact NN I-NP O
encourages VBZ B-VP O
the DT B-NP O
hypothesis NN I-NP O
that IN B-SBAR O
the DT B-NP O
described VBN I-NP O
kindred NN I-NP O
segregates NNS I-NP O
for IN B-PP O
a DT B-NP O
variant NN I-NP O
of IN B-PP O
Cohen NN B-NP B-Disease
syndrome NN I-NP I-Disease
and CC O O
suggests VBZ B-VP O
a DT B-NP O
redefinition NN I-NP O
of IN B-PP O
its PRP$ B-NP O
phenotype NN I-NP O
Polymorphisms NNS B-NP O
of IN B-PP O
the DT B-NP O
CYP2D6 NN I-NP O
gene NN I-NP O
increase VBP B-VP O
susceptibility NN B-NP O
to TO B-PP O
ankylosing VBG B-VP B-Disease
spondylitis NN B-NP I-Disease
. . O O

Ankylosing VBG B-VP B-Disease
spondylitis NN B-NP I-Disease
( ( O O
AS NN B-NP B-Disease
) ) O O
is VBZ B-VP O
a DT B-NP O
common JJ I-NP O
and CC I-NP O
highly RB I-NP O
familial JJ I-NP O
rheumatic JJ I-NP B-Disease
disorder NN I-NP I-Disease
. . O O

The DT B-NP O
sibling NN I-NP O
recurrence NN I-NP O
risk NN I-NP O
ratio NN I-NP O
for IN B-PP O
the DT B-NP O
disease NN I-NP O
is VBZ B-VP O
63 CD B-NP O
and CC O O
heritability NN B-NP O
assessed VBN B-VP O
in IN B-PP O
twins NNS B-NP O
> SYM O O
90 CD B-NP O
% NN I-NP O
. . O O

Although IN B-SBAR O
MHC NN B-NP O
genes NNS I-NP O
, , O O
including VBG B-PP O
HLA NN B-NP O
- HYPH O O
B27 NN B-NP O
, , O O
contribute VBP B-VP O
only RB B-NP O
20 CD I-NP O
- HYPH I-NP O
50 CD I-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
genetic JJ I-NP O
risk NN I-NP O
for IN B-PP O
the DT B-NP O
disease NN I-NP O
, , O O
no DT B-NP O
non AFX I-NP O
- HYPH I-NP O
MHC NN I-NP O
gene NN I-NP O
has VBZ B-VP O
yet RB I-VP O
been VBN I-VP O
convincingly RB I-VP O
demonstrated VBN I-VP O
to TO I-VP O
influence VB I-VP O
either CC O O
susceptibility NN B-NP O
to TO B-PP O
the DT B-NP O
disease NN I-NP O
or CC O O
its PRP$ B-NP O
phenotypic JJ I-NP O
expression NN I-NP O
. . O O

Previous JJ B-NP O
linkage NN I-NP O
and CC I-NP O
association NN I-NP O
studies NNS I-NP O
have VBP B-VP O
suggested VBN I-VP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
a DT B-NP O
susceptibility NN I-NP O
gene NN I-NP O
for IN B-PP O
AS NN B-NP B-Disease
close JJ B-ADJP O
to TO B-PP O
, , O O
or CC O O
within IN B-ADVP O
, , O O
the DT B-NP O
cytochrome NN I-NP O
P450 NN I-NP O
2D6 NN I-NP O
gene NN I-NP O
( ( O O
CYP2D6 NN B-NP O
, , O O
debrisoquine NN B-NP O
hydroxylase NN I-NP O
) ) O O
located JJ B-ADJP O
at IN B-PP O
chromosome NN B-NP O
22q13 CD I-NP O
. . I-NP O

1 CD I-NP O
. . O O

We PRP B-NP O
performed VBD B-VP O
a DT B-NP O
linkage NN I-NP O
study NN I-NP O
of IN B-PP O
chromosome NN B-NP O
22 CD I-NP O
in IN B-PP O
200 CD B-NP O
families NNS I-NP O
with IN B-PP O
AS NN B-NP B-Disease
affected VBD B-VP O
sibling NN B-NP O
- HYPH B-NP O
pairs NNS I-NP O
. . O O

Association NN B-NP O
of IN B-PP O
alleles NNS B-NP O
of IN B-PP O
the DT B-NP O
CYP2D6 NN I-NP O
gene NN I-NP O
was VBD B-VP O
examined VBN I-VP O
by IN B-PP O
both CC O O
case NN O O
- HYPH O O
control NN B-NP O
and CC O O
within IN B-PP O
- HYPH B-NP O
family NN I-NP O
means NNS I-NP O
. . O O

For IN B-SBAR O
case NN O O
- HYPH O O
control NN B-NP O
studies NNS I-NP O
, , O O
617 CD B-NP O
unrelated JJ I-NP O
individuals NNS I-NP O
with IN B-PP O
AS NN B-NP B-Disease
( ( O O
361 CD B-NP O
probands NNS I-NP O
from IN B-PP O
sibling NN B-NP O
- HYPH B-NP O
pair NN I-NP O
and CC I-NP O
parent NN I-NP O
- HYPH B-NP O
case NN I-NP O
trio NN I-NP O
families NNS I-NP O
and CC O O
256 CD B-NP O
unrelated JJ I-NP O
non AFX I-NP O
- HYPH I-NP O
familial JJ I-NP O
sporadic JJ I-NP O
cases NNS I-NP O
) ) O O
and CC O O
402 CD B-NP O
healthy JJ I-NP O
ethnically RB I-NP O
matched VBN I-NP O
controls NNS I-NP O
were VBD B-VP O
employed VBN I-VP O
. . O O

For IN B-PP O
within IN B-PP O
- HYPH B-NP O
family NN I-NP O
association NN I-NP O
studies NNS I-NP O
, , O O
361 CD B-NP O
families NNS I-NP O
including VBG B-PP O
161 CD B-NP O
parent NN I-NP O
- HYPH B-NP O
case NN I-NP O
trios NNS I-NP O
and CC O O
200 CD B-NP O
affected VBD B-VP O
sibling NN B-NP O
- HYPH B-NP O
pair NN I-NP O
families NNS I-NP O
were VBD B-VP O
employed VBN I-VP O
. . O O

Homozygosity NN B-NP O
for IN B-PP O
poor JJ B-NP O
metabolizer NN I-NP O
alleles NNS I-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
be VB I-VP O
associated VBN I-VP O
with IN B-PP O
AS NN B-NP B-Disease
. . O O

Heterozygosity NN B-NP O
for IN B-PP O
the DT B-NP O
most RBS I-NP O
frequent JJ I-NP O
poor JJ I-NP O
metabolizer NN I-NP O
allele NN I-NP O
( ( O O
CYP2D6 NN B-NP O
* SYM B-NP O
4 CD I-NP O
) ) O O
was VBD B-VP O
not RB I-VP O
associated VBN I-VP O
with IN B-PP O
increased VBN B-NP O
susceptibility NN I-NP O
to TO B-PP O
AS NN B-NP B-Disease
. . O O

Significant JJ B-ADJP O
within IN B-PP O
- HYPH B-NP O
family NN I-NP O
association NN I-NP O
of IN B-PP O
CYP2D6 NN B-NP O
* SYM O O
4 CD B-NP O
alleles NNS I-NP O
and CC I-NP O
AS NN I-NP B-Disease
was VBD B-VP O
demonstrated VBN I-VP O
. . O O

Weak JJ B-NP O
linkage NN I-NP O
was VBD B-VP O
also RB I-VP O
demonstrated VBN I-VP O
between IN B-PP O
CYP2D6 NN B-NP O
and CC I-NP O
AS NN I-NP B-Disease
. . O O

We PRP B-NP O
postulate VBP B-VP O
that IN B-SBAR O
altered VBN B-NP O
metabolism NN I-NP O
of IN B-PP O
a DT B-NP O
natural JJ I-NP O
toxin NN I-NP O
or CC O O
antigen NN B-NP O
by IN B-PP O
the DT B-NP O
CYP2D6 NN I-NP O
gene NN I-NP O
may MD B-VP O
increase VB I-VP O
susceptibility NN B-NP O
to TO B-PP O
AS NN B-NP B-Disease
. . O O

Functional JJ B-NP O
differences NNS I-NP O
of IN B-PP O
the DT B-NP O
PDS NN I-NP B-Disease
gene NN I-NP O
product NN I-NP O
are VBP B-VP O
associated VBN I-VP O
with IN B-PP O
phenotypic JJ B-NP O
variation NN I-NP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
Pendred VBN B-NP B-Disease
syndrome NN I-NP I-Disease
and CC O O
non AFX B-NP B-Disease
- HYPH I-NP I-Disease
syndromic JJ I-NP I-Disease
hearing NN I-NP I-Disease
loss NN I-NP I-Disease
( ( O O
DFNB4 NN B-NP B-Disease
) ) O O
. . O O

The DT B-NP O
PDS NN I-NP B-Disease
gene NN I-NP O
encodes VBZ B-VP O
a DT B-NP O
transmembrane JJ I-NP O
protein NN I-NP O
, , O O
known VBN B-VP O
as IN B-PP O
pendrin NN B-NP O
, , O O
which WDT B-NP O
functions VBZ B-VP O
as IN B-PP O
a DT B-NP O
transporter NN I-NP O
of IN B-PP O
iodide NN B-NP O
and CC I-NP O
chloride NN I-NP O
. . O O

Mutations NNS B-NP O
in IN B-PP O
this DT B-NP O
gene NN I-NP O
are VBP B-VP O
responsible JJ B-ADJP O
for IN B-PP O
Pendred JJ B-NP B-Disease
syndrome NN I-NP I-Disease
and CC O O
autosomal JJ B-NP B-Disease
recessive JJ I-NP I-Disease
non AFX B-NP I-Disease
- HYPH I-NP I-Disease
syndromic JJ I-NP I-Disease
hearing NN I-NP I-Disease
loss NN I-NP I-Disease
at IN B-PP O
the DT B-NP O
DFNB4 NN I-NP B-Disease
locus NN I-NP O
on IN B-PP O
chromosome NN B-NP O
7q31 NN I-NP O
. . O O

A DT B-NP O
screen NN I-NP O
of IN B-PP O
20 CD B-NP O
individuals NNS I-NP O
from IN B-PP O
the DT B-NP O
midwestern JJ I-NP O
USA NN I-NP O
with IN B-PP O
non AFX B-NP B-Disease
- HYPH I-NP I-Disease
syndromic JJ I-NP I-Disease
hearing NN I-NP I-Disease
loss NN I-NP I-Disease
and CC O O
dilated JJ B-NP O
vestibular JJ I-NP O
aqueducts NNS I-NP O
identified VBD B-VP O
three CD B-NP O
people NNS I-NP O
( ( O O
15 CD B-NP O
% NN I-NP O
) ) O O
with IN B-PP O
PDS NN B-NP B-Disease
mutations NNS I-NP O
. . O O

To TO B-VP O
determine VB I-VP O
whether IN B-SBAR O
PDS NN B-NP B-Disease
mutations NNS I-NP O
in IN B-PP O
individuals NNS B-NP O
with IN B-PP O
Pendred JJ B-NP B-Disease
syndrome NN I-NP I-Disease
differ VBP B-VP O
functionally RB B-ADVP O
from IN B-PP O
PDS NN B-NP B-Disease
mutations NNS I-NP O
in IN B-PP O
individuals NNS B-NP O
with IN B-PP O
non AFX B-NP B-Disease
- HYPH I-NP I-Disease
syndromic JJ I-NP I-Disease
hearing NN I-NP I-Disease
loss NN I-NP I-Disease
, , O O
we PRP B-NP O
compared VBD B-VP O
three CD B-NP O
common JJ I-NP O
Pendred NNP I-NP B-Disease
syndrome NN I-NP I-Disease
allele NN I-NP O
variants NNS I-NP O
( ( O O
L236P NN B-NP O
, , O O
T416P NN B-NP O
and CC O O
E384G NN B-NP O
) ) O O
, , O O
with IN B-PP O
three CD B-NP O
PDS NN I-NP B-Disease
mutations NNS I-NP O
reported VBN B-VP O
only RB B-PP O
in IN I-PP O
individuals NNS B-NP O
with IN B-PP O
non AFX B-NP B-Disease
- HYPH I-NP I-Disease
syndromic JJ I-NP I-Disease
hearing NN I-NP I-Disease
loss NN I-NP I-Disease
( ( O O
V480D NN B-NP O
, , I-NP O
V653A NN I-NP O
and CC I-NP O
I490L NN I-NP O
/ SYM B-NP O
G497S NN I-NP O
) ) O O
. . O O

The DT B-NP O
mutations NNS I-NP O
associated VBN B-VP O
with IN B-PP O
Pendred JJ B-NP B-Disease
syndrome NN I-NP I-Disease
have VBP B-VP O
complete JJ B-NP O
loss NN I-NP O
of IN B-PP O
pendrin NN B-NP O
- HYPH B-NP O
induced VBN I-NP O
chloride NN I-NP O
and CC I-NP O
iodide NN I-NP O
transport NN I-NP O
, , O O
while IN B-SBAR O
alleles NNS B-NP O
unique JJ B-ADJP O
to TO B-PP O
people NNS B-NP O
with IN B-PP O
DFNB4 NN B-NP B-Disease
are VBP B-VP O
able JJ B-ADJP O
to TO B-VP O
transport VB I-VP O
both CC O O
iodide NN B-NP O
and CC I-NP O
chloride NN I-NP O
, , O O
albeit IN B-ADVP O
at IN B-PP O
a DT B-NP O
much RB I-NP O
lower JJR I-NP O
level NN I-NP O
than IN B-PP O
wild JJ B-NP O
- HYPH I-NP O
type NN I-NP O
pendrin NN I-NP O
. . O O

We PRP B-NP O
hypothesize VBP B-VP O
that IN B-SBAR O
this DT B-NP O
residual JJ I-NP O
level NN I-NP O
of IN B-PP O
anion NN B-NP O
transport NN I-NP O
is VBZ B-VP O
sufficient JJ B-ADJP O
to TO B-VP O
eliminate VB I-VP O
or CC I-VP O
postpone VB I-VP O
the DT B-NP O
onset NN I-NP O
of IN B-PP O
goiter NN B-NP B-Disease
in IN B-PP O
individuals NNS B-NP O
with IN B-PP O
DFNB4 NN B-NP B-Disease
. . O O

We PRP B-NP O
propose VBP B-VP O
a DT B-NP O
model NN I-NP O
for IN B-PP O
pendrin NN B-NP O
function NN I-NP O
in IN B-PP O
the DT B-NP O
thyroid NN I-NP O
in IN B-PP O
which WDT B-NP O
pendrin NN B-NP O
transports VBZ B-VP O
iodide NN B-NP O
across IN B-PP O
the DT B-NP O
apical JJ I-NP O
membrane NN I-NP O
of IN B-PP O
the DT B-NP O
thyrocyte NN I-NP O
into IN B-PP O
the DT B-NP O
colloid JJ I-NP O
space NN I-NP O
. . O O

. . O O

The DT B-NP O
human JJ I-NP O
factor NN I-NP O
IX CD I-NP O
gene NN I-NP O
as IN B-PP O
germline NN B-NP O
mutagen NN I-NP O
test NN I-NP O
: : O O
samples NNS B-NP O
from IN B-PP O
Mainland NNP B-NP O
China NNP I-NP O
have VBP B-VP O
the DT B-NP O
putatively RB I-NP O
endogenous JJ I-NP O
pattern NN I-NP O
of IN B-PP O
mutation NN B-NP O
. . O O

Germline NN B-NP O
mutations NNS I-NP O
are VBP B-VP O
the DT B-NP O
major JJ I-NP O
source NN I-NP O
of IN B-PP O
genetic JJ B-NP O
variation NN I-NP O
that WDT B-NP O
allows VBZ B-VP O
a DT B-NP O
species NN I-NP O
to TO B-VP O
evolve VB I-VP O
over IN B-PP O
time NN B-NP O
but CC O O
at IN B-PP O
the DT B-NP O
cost NN I-NP O
of IN B-PP O
Mendelian JJ B-NP B-Disease
disease NN I-NP I-Disease
and CC O O
genetic JJ B-NP O
predisposition NN I-NP O
to TO B-PP O
multifactorial JJ B-NP B-Disease
diseases NNS I-NP I-Disease
. . O O

Previous JJ B-NP O
analyses NNS I-NP O
have VBP B-VP O
revealed VBN I-VP O
that IN B-SBAR O
the DT B-NP O
pattern NN I-NP O
of IN B-PP O
germline NN B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
factor NN I-NP O
IX CD I-NP O
gene NN I-NP O
( ( O O
F9 NN B-NP O
) ) O O
is VBZ B-VP O
similar JJ B-ADJP O
among IN B-PP O
a DT B-NP O
variety NN I-NP O
of IN B-PP O
ethnically RB B-NP O
and CC I-NP O
geographically RB I-NP O
diverse JJ I-NP O
populations NNS I-NP O
and CC O O
compatible JJ B-ADJP O
with IN B-PP O
the DT B-NP O
ancient JJ I-NP O
pattern NN I-NP O
that WDT B-NP O
has VBZ B-VP O
shaped VBN I-VP O
the DT B-NP O
mammalian JJ I-NP O
genome NN I-NP O
. . O O

Here RB B-ADVP O
, , O O
we PRP B-NP O
compare VBP B-VP O
the DT B-NP O
pattern NN I-NP O
of IN B-PP O
germline NN B-NP O
mutation NN I-NP O
in IN B-PP O
a DT B-NP O
population NN I-NP O
of IN B-PP O
hemophilia NN B-NP B-Disease
B NN I-NP I-Disease
patients NNS I-NP O
from IN B-PP O
Mainland NNP B-NP O
China NNP I-NP O
( ( O O
n NN B-NP O
= SYM B-VP O
66 CD B-NP O
) ) O O
to TO B-PP O
that DT B-NP O
in IN B-PP O
U NN B-NP O
. . O O

S NN B-NP O
. . O O

Caucasians NNS B-NP O
, , O O
Blacks NNS B-NP O
, , O O
and CC O O
Mexican NNP B-NP O
Hispanics NNPS I-NP O
and CC O O
stratify VB B-VP O
by IN B-PP O
disease NN B-NP O
severity NN I-NP O
and CC I-NP O
ethnicity NN I-NP O
. . O O

The DT B-NP O
similar JJ I-NP O
pattern NN I-NP O
of IN B-PP O
germline NN B-NP O
mutation NN I-NP O
in IN B-PP O
all DT B-NP O
ethnic JJ I-NP O
groups NNS I-NP O
studied VBN B-VP O
to TO B-PP O
date NN B-NP O
provides VBZ B-VP O
additional JJ B-NP O
data NNS I-NP O
compatible JJ B-ADJP O
with IN B-PP O
the DT B-NP O
inference NN I-NP O
that IN B-SBAR O
endogenous JJ B-NP O
processes NNS I-NP O
predominate VBP B-VP O
in IN B-PP O
germline NN B-NP O
mutations NNS I-NP O
. . O O

Fas NN B-NP O
preassociation NN I-NP O
required VBN B-VP O
for IN B-PP O
apoptosis NN B-NP O
signaling NN I-NP O
and CC O O
dominant JJ B-NP O
inhibition NN I-NP O
by IN B-PP O
pathogenic JJ B-NP O
mutations NNS I-NP O
. . O O

Heterozygous JJ B-NP O
mutations NNS I-NP O
encoding VBG B-VP O
abnormal JJ B-NP O
forms NNS I-NP O
of IN B-PP O
the DT B-NP O
death NN I-NP O
receptor NN I-NP O
Fas NN I-NP O
dominantly RB B-ADVP O
interfere VBP B-VP O
with IN B-PP O
Fas NN B-NP O
- HYPH B-NP O
induced VBN I-NP O
lymphocyte NN I-NP O
apoptosis NN I-NP O
in IN B-PP O
human JJ B-NP O
autoimmune JJ I-NP B-Disease
lymphoproliferative JJ I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

This DT B-NP O
effect NN I-NP O
, , O O
rather RB B-PP O
than IN I-PP O
depending VBG B-VP O
on IN B-PP O
ligand NN B-NP O
- HYPH B-NP O
induced VBN I-NP O
receptor NN I-NP O
oligomerization NN I-NP O
, , O O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
stem VB I-VP O
from IN B-PP O
ligand NN B-NP O
- HYPH B-NP O
independent JJ I-NP O
interaction NN I-NP O
of IN B-PP O
wild JJ B-NP O
- HYPH I-NP O
type NN I-NP O
and CC I-NP O
mutant JJ I-NP O
Fas NN I-NP O
receptors NNS I-NP O
through IN B-PP O
a DT B-NP O
specific JJ I-NP O
region NN I-NP O
in IN B-PP O
the DT B-NP O
extracellular JJ I-NP O
domain NN I-NP O
. . O O

Preassociated VBN B-NP O
Fas NN I-NP O
complexes NNS I-NP O
were VBD B-VP O
found VBN I-VP O
in IN B-PP O
living VBG B-VP O
cells NNS B-NP O
by IN B-PP O
means NNS B-NP O
of IN B-PP O
fluorescence NN B-NP O
resonance NN I-NP O
energy NN I-NP O
transfer NN I-NP O
between IN B-PP O
variants NNS B-NP O
of IN B-PP O
green JJ B-NP O
fluorescent JJ I-NP O
protein NN I-NP O
. . O O

These DT B-NP O
results NNS I-NP O
show VBP B-VP O
that IN B-SBAR O
formation NN B-NP O
of IN B-PP O
preassociated JJ B-NP O
receptor NN I-NP O
complexes NNS I-NP O
is VBZ B-VP O
necessary JJ B-ADJP O
for IN B-PP O
Fas NN B-NP O
signaling NN I-NP O
and CC O O
dominant JJ B-NP O
interference NN I-NP O
in IN B-PP O
human JJ B-NP O
disease NN I-NP O
. . O O

. . O O

Determination NN B-NP O
of IN B-PP O
carrier NN B-NP O
status NN I-NP O
for IN B-PP O
the DT B-NP O
Wiskott NNP I-NP B-Disease
- HYPH I-NP I-Disease
Aldrich NNP I-NP I-Disease
syndrome NN I-NP I-Disease
by IN B-PP O
flow NN B-NP O
cytometric JJ I-NP O
analysis NN I-NP O
of IN B-PP O
Wiskott NNP B-NP B-Disease
- HYPH I-NP I-Disease
Aldrich NNP I-NP I-Disease
syndrome NN I-NP I-Disease
protein NN I-NP O
expression NN I-NP O
in IN B-PP O
peripheral JJ B-NP O
blood NN I-NP O
mononuclear JJ I-NP O
cells NNS I-NP O
. . O O

The DT B-NP O
Wiskott NNP I-NP B-Disease
- HYPH I-NP I-Disease
Aldrich NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
WAS NN B-NP B-Disease
) ) O O
is VBZ B-VP O
caused VBN I-VP O
by IN B-PP O
defects NNS B-NP O
in IN B-PP O
the DT B-NP O
WAS NN I-NP B-Disease
protein NN I-NP O
( ( O O
WASP NN B-NP O
) ) O O
gene NN B-NP O
on IN B-PP O
the DT B-NP O
X NN I-NP O
chromosome NN I-NP O
. . O O

Previous JJ B-NP O
study NN I-NP O
disclosed VBD B-VP O
that IN B-SBAR O
flow NN B-NP O
cytometric JJ I-NP O
analysis NN I-NP O
of IN B-PP O
intracellular JJ B-NP O
WASP NN I-NP O
expression NN I-NP O
( ( O O
FCM NN B-NP O
- HYPH B-NP O
WASP NN I-NP O
analysis NN I-NP O
) ) O O
in IN B-PP O
lymphocytes NNS B-NP O
was VBD B-VP O
useful JJ B-ADJP O
for IN B-PP O
the DT B-NP O
diagnosis NN I-NP O
of IN B-PP O
WAS NN B-NP B-Disease
patients NNS I-NP O
. . O O

Lymphocytes NNS B-NP O
from IN B-PP O
all DT B-NP O
WAS NNP I-NP B-Disease
patients NNS I-NP O
showed VBD B-VP O
WASPdim NNP B-NP O
instead RB B-PP O
of IN I-PP O
WASPbright NNP B-NP O
. . O O

Here RB B-ADVP O
we PRP B-NP O
report VBP B-VP O
that IN B-SBAR O
FCM NN B-NP O
- HYPH B-NP O
WASP NN I-NP O
analysis NN I-NP O
in IN B-PP O
monocytes NNS B-NP O
could MD B-VP O
be VB I-VP O
a DT B-NP O
useful JJ I-NP O
tool NN I-NP O
for IN B-PP O
the DT B-NP O
WAS NN I-NP B-Disease
carrier NN I-NP O
diagnosis NN I-NP O
. . O O

Monocytes NNS B-NP O
from IN B-PP O
all DT B-NP O
nine CD I-NP O
WAS NNP I-NP B-Disease
carriers NNS I-NP O
showed VBD B-VP O
varied JJ B-NP O
population NN I-NP O
of IN B-PP O
WASPdim NNP B-NP O
together RB B-ADVP O
with IN B-PP O
WASPbright NNP B-NP O
. . O O

None NN B-NP O
of IN B-PP O
control NN B-NP O
individuals NNS I-NP O
possessed VBD B-VP O
the DT B-NP O
WASPdim NNP I-NP O
population NN I-NP O
. . O O

In IN B-PP O
contrast NN B-NP O
, , O O
lymphocytes NNS B-NP O
from IN B-PP O
all PDT B-NP O
the DT I-NP O
carriers NNS I-NP O
except IN B-PP O
two CD B-NP O
lacked VBD B-VP O
the DT B-NP O
WASPdim NNP I-NP O
population NN I-NP O
. . O O

The DT B-NP O
difference NN I-NP O
of IN B-PP O
the DT B-NP O
WASPdim NNP I-NP O
population NN I-NP O
in IN B-PP O
monocytes NNS B-NP O
and CC I-NP O
lymphocytes NNS I-NP O
observed VBN B-VP O
in IN B-PP O
WAS NN B-NP B-Disease
carriers NNS I-NP O
suggests VBZ B-VP O
that IN B-SBAR O
WASP NN B-NP O
plays VBZ B-VP O
a DT B-NP O
more RBR I-NP O
critical JJ I-NP O
role NN I-NP O
in IN B-PP O
the DT B-NP O
development NN I-NP O
of IN B-PP O
lymphocytes NNS B-NP O
than IN B-PP O
in IN B-PP O
that DT B-NP O
of IN B-PP O
monocytes NNS B-NP O
. . O O

The DT B-NP O
present JJ I-NP O
studies NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
a DT B-NP O
skewed JJ I-NP O
X NN I-NP O
- HYPH B-NP O
chromosomal JJ I-NP O
inactivation NN I-NP O
pattern NN I-NP O
observed VBN B-VP O
in IN B-PP O
WAS NN B-NP B-Disease
carrier NN I-NP O
peripheral JJ I-NP O
blood NN I-NP O
cells NNS I-NP O
is VBZ B-VP O
not RB I-VP O
fixed VBN I-VP O
at IN B-PP O
the DT B-NP O
hemopoietic JJ I-NP O
stem NN I-NP O
cell NN I-NP O
level NN I-NP O
but CC O O
progresses VBZ B-VP O
after IN B-PP O
the DT B-NP O
lineage NN I-NP O
commitment NN I-NP O
. . O O

. . O O

Restoration NN B-NP O
of IN B-PP O
photoreceptor NN B-NP O
ultrastructure NN I-NP O
and CC I-NP O
function NN I-NP O
in IN B-PP O
retinal JJ B-NP B-Disease
degeneration NN I-NP I-Disease
slow JJ I-NP O
mice NNS I-NP O
by IN B-PP O
gene NN B-NP O
therapy NN I-NP O
. . O O

The DT B-NP O
gene NN I-NP O
Prph2 NN I-NP O
encodes VBZ B-VP O
a DT B-NP O
photoreceptor NN I-NP O
- HYPH B-NP O
specific JJ I-NP O
membrane NN I-NP O
glycoprotein NN I-NP O
, , O O
peripherin NN B-NP O
- HYPH B-NP O
2 CD I-NP O
( ( O O
also RB B-VP O
known VBN I-VP O
as IN B-PP O
peripherin NN B-NP O
/ SYM B-NP O
rds NNS I-NP O
) ) O O
, , O O
which WDT B-NP O
is VBZ B-VP O
inserted VBN I-VP O
into IN B-PP O
the DT B-NP O
rims NNS I-NP O
of IN B-PP O
photoreceptor NN B-NP O
outer JJ I-NP O
segment NN I-NP O
discs NNS I-NP O
in IN B-PP O
a DT B-NP O
complex NN I-NP O
with IN B-PP O
rom NN B-NP O
- HYPH B-NP O
1 CD I-NP O
( ( O O
ref NN B-NP O
. . O O

2 CD B-NP O
) ) O O
. . O O

The DT B-NP O
complex NN I-NP O
is VBZ B-VP O
necessary JJ B-ADJP O
for IN B-PP O
the DT B-NP O
stabilization NN I-NP O
of IN B-PP O
the DT B-NP O
discs NNS I-NP O
, , O O
which WDT B-NP O
are VBP B-VP O
renewed VBN I-VP O
constantly RB B-ADVP O
throughout IN B-PP O
life NN B-NP O
, , O O
and CC O O
which WDT B-NP O
contain VBP B-VP O
the DT B-NP O
visual JJ I-NP O
pigments NNS I-NP O
necessary JJ B-ADJP O
for IN B-PP O
photon NN B-NP O
capture NN I-NP O
. . O O

Mutations NNS B-NP O
in IN B-PP O
Prph2 NN B-NP O
have VBP B-VP O
been VBN I-VP O
shown VBN I-VP O
to TO I-VP O
result VB I-VP O
in IN B-PP O
a DT B-NP O
variety NN I-NP O
of IN B-PP O
photoreceptor NN B-NP B-Disease
dystrophies NNS I-NP I-Disease
, , O O
including VBG B-PP O
autosomal JJ B-NP B-Disease
dominant JJ I-NP I-Disease
retinitis NN I-NP I-Disease
pigmentosa NN I-NP I-Disease
and CC O O
macular JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
. . O O

A DT B-NP O
common JJ I-NP O
feature NN I-NP O
of IN B-PP O
these DT B-NP O
diseases NNS I-NP O
is VBZ B-VP O
the DT B-NP O
loss NN I-NP O
of IN B-PP O
photoreceptor NN B-NP O
function NN I-NP O
, , O O
also RB B-VP O
seen VBN I-VP O
in IN B-PP O
the DT B-NP O
retinal JJ I-NP B-Disease
degeneration NN I-NP I-Disease
slow JJ B-ADJP O
( ( O O
rds NNS B-NP O
or CC O O
Prph2 NN B-NP O
Rd2 NN I-NP O
/ SYM B-NP O
Rd2 NN I-NP O
) ) O O
mouse NN B-NP O
, , O O
which WDT B-NP O
is VBZ B-VP O
homozygous JJ B-ADJP O
for IN B-PP O
a DT B-NP O
mutation NN I-NP O
in IN B-PP O
Prph2 NN B-NP O
. . O O

It PRP B-NP O
is VBZ B-VP O
characterized VBN I-VP O
by IN B-PP O
a DT B-NP O
complete JJ I-NP O
failure NN I-NP O
to TO B-VP O
develop VB I-VP O
photoreceptor NN B-NP O
discs NNS I-NP O
and CC O O
outer JJ B-NP O
segments NNS I-NP O
, , O O
downregulation NN B-NP O
of IN B-PP O
rhodopsin NN B-NP O
and CC O O
apoptotic JJ B-NP O
loss NN I-NP O
of IN B-PP O
photoreceptor NN B-NP O
cells NNS I-NP O
. . O O

The DT B-NP O
electroretinograms NNS I-NP O
( ( O O
ERGs NNS B-NP O
) ) O O
of IN B-PP O
Prph2Rd2 NN B-NP O
/ SYM B-NP O
Rd2 NN I-NP O
mice NNS I-NP O
have VBP B-VP O
greatly RB I-VP O
diminished VBN I-VP O
a DT B-NP O
- HYPH I-NP O
wave NN I-NP O
and CC I-NP O
b NN I-NP O
- HYPH B-NP O
wave NN I-NP O
amplitudes NNS I-NP O
, , O O
which WDT B-NP O
decline VBP B-VP O
to TO B-PP O
virtually RB B-NP O
undetectable JJ I-NP O
concentrations NNS I-NP O
by IN B-PP O
two CD B-NP O
months NNS I-NP O
. . O O

Subretinal JJ B-NP O
injection NN I-NP O
of IN B-PP O
recombinant JJ B-NP O
adeno AFX I-NP O
- HYPH I-NP O
associated VBN B-NP O
virus NN I-NP O
( ( O O
AAV NN B-NP O
) ) O O
encoding VBG B-VP O
a DT B-NP O
Prph2 NN I-NP O
transgene NN I-NP O
results VBZ B-VP O
in IN B-PP O
stable JJ B-NP O
generation NN I-NP O
of IN B-PP O
outer JJ B-NP O
segment NN I-NP O
structures NNS I-NP O
and CC O O
formation NN B-NP O
of IN B-PP O
new JJ B-NP O
stacks NNS I-NP O
of IN B-PP O
discs NNS B-NP O
containing VBG B-VP O
both CC O O
perpherin NN B-NP O
- HYPH O O
2 CD B-NP O
and CC O O
rhodopsin NN B-NP O
, , O O
which WDT B-NP O
in IN B-PP O
many JJ B-NP O
cases NNS I-NP O
are VBP B-VP O
morphologically RB B-ADJP O
similar JJ I-ADJP O
to TO B-PP O
normal JJ B-NP O
outer JJ I-NP O
segments NNS I-NP O
. . O O

Moreover RB B-ADVP O
, , O O
the DT B-NP O
re AFX I-NP O
- HYPH I-NP O
establishment NN I-NP O
of IN B-PP O
the DT B-NP O
structural JJ I-NP O
integrity NN I-NP O
of IN B-PP O
the DT B-NP O
photoreceptor NN I-NP O
layer NN I-NP O
also RB B-ADVP O
results VBZ B-VP O
in IN B-PP O
electrophysiological JJ B-NP O
correction NN I-NP O
. . O O

These DT B-NP O
studies NNS I-NP O
demonstrate VBP B-VP O
for IN B-PP O
the DT B-NP O
first JJ I-NP O
time NN I-NP O
that IN B-ADVP O
a DT B-NP O
complex JJ I-NP O
ultrastructural JJ I-NP O
cell NN I-NP O
defect NN I-NP O
can MD B-VP O
be VB I-VP O
corrected VBN I-VP O
both CC O O
morphologically RB B-ADVP O
and CC I-ADVP O
functionally RB I-ADVP O
by IN B-PP O
in FW B-NP O
vivo FW I-NP O
gene NN I-NP O
transfer NN I-NP O
. . O O

. . O O

Mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
fibrinogen NN I-NP O
aalpha NN I-NP O
gene NN I-NP O
account NN I-NP O
for IN B-PP O
the DT B-NP O
majority NN I-NP O
of IN B-PP O
cases NNS B-NP O
of IN B-PP O
congenital JJ B-NP B-Disease
afibrinogenemia NN I-NP I-Disease
. . O O

Congenital JJ B-NP B-Disease
afibrinogenemia NN I-NP I-Disease
is VBZ B-VP O
a DT B-NP O
rare JJ I-NP O
, , I-NP O
autosomal JJ I-NP B-Disease
, , I-NP I-Disease
recessive JJ I-NP I-Disease
disorder NN I-NP I-Disease
characterized VBN B-VP O
by IN B-PP O
the DT B-NP O
complete JJ I-NP O
absence NN I-NP O
of IN B-PP O
detectable JJ B-NP O
fibrinogen NN I-NP O
. . O O

We PRP B-NP O
previously RB B-ADVP O
identified VBD B-VP O
the DT B-NP O
first JJ I-NP O
causative JJ I-NP O
mutations NNS I-NP O
in IN B-PP O
a DT B-NP O
nonconsanguineous JJ I-NP O
Swiss JJ I-NP O
family NN I-NP O
; : O O
the DT B-NP O
4 CD I-NP O
affected VBN I-NP O
persons NNS I-NP O
have VBP B-VP O
homozygous JJ B-NP O
deletions NNS I-NP O
of IN B-PP O
approximately RB B-NP O
11 CD I-NP O
kb NN I-NP O
of IN B-PP O
the DT B-NP O
fibrinogen NN I-NP O
alpha NN I-NP O
( ( O O
FGA NN B-NP O
) ) O O
gene NN B-NP O
. . O O

Haplotype NN B-NP O
data NNS I-NP O
implied VBD B-VP O
that IN B-SBAR O
these DT B-NP O
deletions NNS I-NP O
occurred VBD B-VP O
on IN B-PP O
distinct JJ B-NP O
ancestral JJ I-NP O
chromosomes NNS I-NP O
, , O O
suggesting VBG B-VP O
that IN B-SBAR O
this DT B-NP O
region NN I-NP O
may MD B-VP O
be VB I-VP O
susceptible JJ B-ADJP O
to TO B-PP O
deletion NN B-NP O
by IN B-PP O
a DT B-NP O
common JJ I-NP O
mechanism NN I-NP O
. . O O

We PRP B-NP O
subsequently RB B-ADVP O
showed VBD B-VP O
that IN B-SBAR O
all PDT B-NP O
the DT I-NP O
deletions NNS I-NP O
were VBD B-VP O
identical JJ B-ADJP O
to TO B-PP O
the DT B-NP O
base NN I-NP O
pair NN I-NP O
and CC O O
probably RB B-VP O
resulted VBD I-VP O
from IN B-PP O
a DT B-NP O
nonhomologous JJ I-NP O
recombination NN I-NP O
mediated VBN B-VP O
by IN B-PP O
7 CD B-NP O
- HYPH I-NP O
bp NN I-NP O
direct JJ I-NP O
repeats NNS I-NP O
. . O O

In IN B-PP O
this DT B-NP O
study NN I-NP O
, , O O
we PRP B-NP O
have VBP B-VP O
collected VBN I-VP O
data NNS B-NP O
on IN B-PP O
13 CD B-NP O
additional JJ I-NP O
unrelated JJ I-NP O
patients NNS I-NP O
to TO B-VP O
identify VB I-VP O
the DT B-NP O
causative JJ I-NP O
mutations NNS I-NP O
and CC O O
to TO B-VP O
determine VB I-VP O
the DT B-NP O
prevalence NN I-NP O
of IN B-PP O
the DT B-NP O
11 CD I-NP O
- HYPH I-NP O
kb NN I-NP O
deletion NN I-NP O
. . O O

A DT B-NP O
common JJ I-NP O
recurrent JJ I-NP O
mutation NN I-NP O
, , O O
at IN B-PP O
the DT B-NP O
donor NN I-NP O
splice NN I-NP O
site NN I-NP O
of IN B-PP O
FGA NN B-NP O
intron NN I-NP O
4 CD I-NP O
( ( O O
IVS4 NN B-NP O
+ SYM O O
1 CD B-NP O
G NN I-NP O
> SYM O O
T NN B-NP O
) ) O O
, , O O
accounted VBD B-VP O
for IN B-PP O
14 CD B-NP O
of IN B-PP O
the DT B-NP O
26 CD I-NP O
( ( O O
54 CD B-NP O
% NN I-NP O
) ) O O
alleles NNS B-NP O
. . O O

One CD B-NP O
patient NN I-NP O
was VBD B-VP O
heterozygous JJ B-ADJP O
for IN B-PP O
the DT B-NP O
previously RB I-NP O
identified VBN I-NP O
deletion NN I-NP O
. . O O

Three CD B-NP O
more JJR I-NP O
frameshift NN I-NP O
mutations NNS I-NP O
, , O O
2 CD B-NP O
nonsense JJ I-NP O
mutations NNS I-NP O
, , O O
and CC O O
a DT B-NP O
second JJ I-NP O
splice NN I-NP O
site NN I-NP O
mutation NN I-NP O
were VBD B-VP O
also RB I-VP O
identified VBN I-VP O
. . O O

Consequently RB B-ADVP O
, , O O
86 CD B-NP O
% NN I-NP O
of IN B-PP O
afibrinogenemia NN B-NP B-Disease
alleles NNS I-NP O
analyzed VBN B-VP O
to TO B-PP O
date NN B-NP O
have VBP B-VP O
truncating VBG I-VP O
mutations NNS B-NP O
of IN B-PP O
FGA NN B-NP O
, , O O
though IN B-SBAR O
mutations NNS B-NP O
in IN B-PP O
all DT B-NP O
3 CD I-NP O
fibrinogen NN I-NP O
genes NNS I-NP O
, , O O
FGG NN B-NP O
, , O O
FGA NN B-NP O
, , O O
and CC O O
FGB NN B-NP O
, , O O
might MD B-VP O
be VB I-VP O
predicted VBN I-VP O
to TO B-VP O
cause VB I-VP O
congenital JJ B-NP B-Disease
afibrinogenemia NN I-NP I-Disease
. . O O

. . O O

Myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
: : O O
the DT B-NP O
role NN I-NP O
of IN B-PP O
the DT B-NP O
CUG NN I-NP O
triplet NN I-NP O
repeats NNS I-NP O
in IN B-PP O
splicing NN B-NP O
of IN B-PP O
a DT B-NP O
novel JJ I-NP O
DMPK NN I-NP O
exon NN I-NP O
and CC O O
altered VBD B-VP O
cytoplasmic JJ B-NP O
DMPK NN I-NP O
mRNA NN I-NP O
isoform NN I-NP O
ratios NNS I-NP O
. . O O

The DT B-NP O
mechanism NN I-NP O
by IN B-PP O
which WDT B-NP O
( ( O O
CTG NN B-NP O
) ) O O
n NN B-NP O
expansion NN I-NP O
in IN B-PP O
the DT B-NP O
3 CD I-NP O
UTR NN I-NP O
of IN B-PP O
the DT B-NP O
DMPK NN I-NP O
gene NN I-NP O
causes VBZ B-VP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
( ( O O
DM NN B-NP B-Disease
) ) O O
is VBZ B-VP O
unknown JJ B-ADJP O
. . O O

We PRP B-NP O
identified VBD B-VP O
four CD B-NP O
RNA NN I-NP O
splicing NN I-NP O
factors NNS I-NP O
- SYM B-NP O
- HYPH B-NP O
hnRNP NN I-NP O
C NN I-NP O
, , O O
U2AF NN B-NP O
( ( O O
U2 NN B-NP O
auxiliary JJ I-NP O
factor NN I-NP O
) ) O O
, , O O
PTB NN B-NP O
( ( O O
polypyrimidine NN B-NP O
tract NN I-NP O
binding NN I-NP O
protein NN I-NP O
) ) O O
, , O O
and CC O O
PSF NN B-NP O
( ( O O
PTB NN B-NP O
associated VBN I-NP O
splicing NN I-NP O
factor NN I-NP O
) ) O O
- SYM O O
- HYPH O O
that WDT B-NP O
bind VBP B-VP O
to TO B-PP O
two CD B-NP O
short JJ I-NP O
regions NNS I-NP O
3 CD B-NP O
of IN B-PP O
the DT B-NP O
( ( O O
CUG NN O O
) ) O O
n NN B-NP O
, , O O
and CC O O
found VBD B-VP O
a DT B-NP O
novel JJ I-NP O
3 CD I-NP O
DMPK NN I-NP O
exon NN I-NP O
resulting VBG B-VP O
in IN B-PP O
an DT B-NP O
mRNA NN I-NP O
lacking VBG B-VP O
the DT B-NP O
repeats NNS I-NP O
. . O O

We PRP B-NP O
propose VBP B-VP O
that IN B-SBAR O
the DT B-NP O
( ( O O
CUG NN O O
) ) O O
n NN B-NP O
is VBZ B-VP O
an DT B-NP O
essential JJ I-NP O
cis NN I-NP O
acting VBG B-VP O
element NN B-NP O
for IN B-PP O
this DT B-NP O
splicing NN I-NP O
event NN I-NP O
. . O O

In IN B-PP O
contrast NN B-NP O
to TO B-PP O
( ( B-NP O
CUG NN I-NP O
) ) O O
n NN B-NP O
containing VBG B-VP O
mRNAs NNS B-NP O
, , O O
the DT B-NP O
novel JJ I-NP O
isoform NN I-NP O
is VBZ B-VP O
not RB I-VP O
retained VBN I-VP O
in IN B-PP O
the DT B-NP O
nucleus NN I-NP O
in IN B-PP O
DM NN B-NP B-Disease
cells NNS I-NP O
, , O O
resulting VBG B-VP O
in IN B-PP O
imbalances NNS B-NP O
in IN B-PP O
relative JJ B-NP O
levels NNS I-NP O
of IN B-PP O
cytoplasmic JJ B-NP O
DMPK NN I-NP O
mRNA NN I-NP O
isoforms NNS I-NP O
and CC O O
a DT B-NP O
new JJ I-NP O
dominant JJ I-NP O
effect NN I-NP O
of IN B-PP O
the DT B-NP O
mutation NN I-NP O
on IN B-PP O
DMPK NN B-NP O
. . O O

. . O O

Expression NN B-NP O
and CC I-NP O
imprinting NN I-NP O
of IN B-PP O
MAGEL2 NN B-NP O
suggest VBP B-VP O
a DT B-NP O
role NN I-NP O
in IN B-PP O
Prader NN B-NP B-Disease
- HYPH B-NP I-Disease
willi JJ I-NP I-Disease
syndrome NN I-NP I-Disease
and CC O O
the DT B-NP O
homologous JJ I-NP O
murine JJ I-NP O
imprinting NN I-NP O
phenotype NN I-NP O
. . O O

Prader NNP B-NP B-Disease
- HYPH I-NP I-Disease
Willi NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
PWS NN B-NP B-Disease
) ) O O
is VBZ B-VP O
caused VBN I-VP O
by IN B-PP O
the DT B-NP O
loss NN I-NP O
of IN B-PP O
expression NN B-NP O
of IN B-PP O
imprinted JJ B-NP O
genes NNS I-NP O
in IN B-PP O
chromosome NN B-NP O
15q11 CD I-NP O
- HYPH I-NP O
q13 NN I-NP O
. . O O

Affected JJ B-NP O
individuals NNS I-NP O
exhibit VBP B-VP O
neonatal JJ B-NP B-Disease
hypotonia NN I-NP I-Disease
, , O O
developmental JJ B-NP B-Disease
delay NN I-NP I-Disease
and CC I-NP O
childhood NN I-NP B-Disease
- HYPH B-NP I-Disease
onset NN I-NP I-Disease
obesity NN I-NP I-Disease
. . O O

Necdin NN B-NP O
, , O O
a DT B-NP O
protein NN I-NP O
implicated VBN B-VP O
in IN B-PP O
the DT B-NP O
terminal JJ I-NP O
differentiation NN I-NP O
of IN B-PP O
neurons NNS B-NP O
, , O O
is VBZ B-VP O
the DT B-NP O
only JJ I-NP O
PWS NN I-NP B-Disease
candidate NN I-NP O
gene NN I-NP O
to TO B-VP O
reduce VB I-VP O
viability NN B-NP O
when WRB B-ADVP O
disrupted VBN B-VP O
in IN B-PP O
a DT B-NP O
mouse NN I-NP O
model NN I-NP O
. . O O

In IN B-PP O
this DT B-NP O
study NN I-NP O
, , O O
we PRP B-NP O
have VBP B-VP O
characterized VBN I-VP O
MAGEL2 NN B-NP O
( ( O O
also RB B-VP O
known VBN I-VP O
as IN B-PP O
NDNL1 NN B-NP O
) ) O O
, , O O
a DT B-NP O
gene NN I-NP O
with IN B-PP O
51 CD B-NP O
% NN I-NP O
amino JJ I-NP O
acid NN I-NP O
sequence NN I-NP O
similarity NN I-NP O
to TO B-PP O
necdin NN B-NP O
and CC O O
located JJ B-NP O
41 CD I-NP O
kb NN I-NP O
distal JJ B-ADJP O
to TO B-PP O
NDN NN B-NP O
in IN B-PP O
the DT B-NP O
PWS NN I-NP B-Disease
deletion NN I-NP O
region NN I-NP O
. . O O

MAGEL2 NN B-NP O
is VBZ B-VP O
expressed VBN I-VP O
predominantly RB B-ADVP O
in IN B-PP O
brain NN B-NP O
, , O O
the DT B-NP O
primary JJ I-NP O
tissue NN I-NP O
affected VBN B-VP O
in IN B-PP O
PWS NN B-NP B-Disease
and CC B-PP O
in IN B-PP O
several JJ B-NP O
fetal JJ I-NP O
tissues NNS I-NP O
as IN B-SBAR O
shown VBN B-VP O
by IN B-PP O
northern JJ B-NP O
blot NN I-NP O
analysis NN I-NP O
. . O O

MAGEL2 NN B-NP O
is VBZ B-VP O
imprinted VBN I-VP O
with IN B-PP O
monoallelic JJ B-NP O
expression NN I-NP O
in IN B-PP O
control NN B-NP O
brain NN I-NP O
, , O O
and CC O O
paternal JJ B-ADJP O
- HYPH O O
only RB B-NP O
expression NN I-NP O
in IN B-PP O
the DT B-NP O
central JJ I-NP O
nervous JJ I-NP O
system NN I-NP O
as IN B-SBAR O
demonstrated VBN B-VP O
by IN B-PP O
its PRP$ B-NP O
lack NN I-NP O
of IN B-PP O
expression NN B-NP O
in IN B-PP O
brain NN B-NP O
from IN B-PP O
a DT B-NP O
PWS NN I-NP B-Disease
- HYPH B-VP O
affected VBN I-VP O
individual NN B-NP O
. . O O

The DT B-NP O
orthologous JJ I-NP O
mouse NN I-NP O
gene NN I-NP O
( ( O O
Magel2 NN B-NP O
) ) O O
is VBZ B-VP O
located JJ B-ADJP O
within IN B-PP O
150 CD B-NP O
kb NN I-NP O
of IN B-PP O
NDN NN B-NP O
, , O O
is VBZ B-VP O
imprinted VBN I-VP O
with IN B-PP O
paternal JJ B-NP O
- HYPH I-NP O
only RB I-NP O
expression NN I-NP O
and CC O O
is VBZ B-VP O
expressed VBN I-VP O
predominantly RB B-ADVP O
in IN B-PP O
late JJ B-NP O
developmental JJ I-NP O
stages NNS I-NP O
and CC O O
adult JJ B-NP O
brain NN I-NP O
as IN B-SBAR O
shown VBN B-VP O
by IN B-PP O
northern JJ B-NP O
blotting NN I-NP O
, , O O
RT NN B-NP O
- HYPH B-NP O
PCR NN I-NP O
and CC O O
whole JJ B-NP O
- HYPH I-NP O
mount NN I-NP O
RNA NN I-NP O
in FW B-NP O
situ FW I-NP O
hybridization NN I-NP O
. . O O

Magel2 NN B-NP O
distribution NN I-NP O
partially RB B-ADVP O
overlaps VBZ B-VP O
that DT B-NP O
of IN B-PP O
NDN NN B-NP O
, , O O
with IN B-PP O
strong JJ B-NP O
expression NN I-NP O
being VBG B-VP O
detected VBN I-VP O
in IN B-PP O
the DT B-NP O
central JJ I-NP O
nervous JJ I-NP O
system NN I-NP O
in IN B-PP O
mid JJ B-NP O
- HYPH I-NP O
gestation NN I-NP O
mouse NN I-NP O
embryos NNS I-NP O
by IN B-PP O
in FW B-NP O
situ FW I-NP O
hybridization NN I-NP O
. . O O

We PRP B-NP O
hypothesize VBP B-VP O
that IN B-SBAR O
, , O O
although IN B-SBAR O
loss NN B-NP O
of IN B-PP O
necdin NN B-NP O
expression NN I-NP O
may MD B-VP O
be VB I-VP O
important JJ B-ADJP O
in IN B-PP O
the DT B-NP O
neonatal JJ I-NP O
presentation NN I-NP O
of IN B-PP O
PWS NN B-NP B-Disease
, , O O
loss NN B-NP O
of IN B-PP O
MAGEL2 NN B-NP O
may MD B-VP O
be VB I-VP O
critical JJ B-ADJP O
to TO B-PP O
abnormalities NNS B-NP B-Disease
in IN B-PP I-Disease
brain NN B-NP I-Disease
development NN I-NP I-Disease
and CC O O
dysmorphic JJ B-NP B-Disease
features NNS I-NP I-Disease
in IN B-PP O
individuals NNS B-NP O
with IN B-PP O
PWS NN B-NP B-Disease
. . O O

. . O O

Retinoschisin NNP B-NP O
, , O O
the DT B-NP O
X NN I-NP B-Disease
- HYPH B-VP I-Disease
linked VBN B-NP I-Disease
retinoschisis NN I-NP I-Disease
protein NN I-NP O
, , O O
is VBZ B-VP O
a DT B-NP O
secreted VBN I-NP O
photoreceptor NN I-NP O
protein NN I-NP O
, , O O
and CC O O
is VBZ B-VP O
expressed VBN I-VP O
and CC I-VP O
released VBN I-VP O
by IN B-PP O
Weri NNP B-NP O
- HYPH I-NP O
Rb1 NN I-NP O
cells NNS I-NP O
. . O O

X NN B-NP B-Disease
- HYPH B-PP I-Disease
linked VBN B-NP I-Disease
retinoschisis NN I-NP I-Disease
is VBZ B-VP O
characterized VBN I-VP O
by IN B-PP O
microcystic JJ B-NP O
- HYPH I-NP O
like JJ I-NP O
changes NNS I-NP O
of IN B-PP O
the DT B-NP O
macular JJ I-NP O
region NN I-NP O
and CC I-NP O
schisis NN I-NP O
within IN B-PP O
the DT B-NP O
inner JJ I-NP O
retinal JJ I-NP O
layers NNS I-NP O
, , O O
leading VBG B-VP O
to TO B-PP O
visual JJ B-NP B-Disease
deterioration NN I-NP I-Disease
in IN B-PP O
males NNS B-NP O
. . O O

Many JJ B-NP O
missense NN I-NP O
and CC I-NP O
protein NN I-NP O
- HYPH O O
truncating VBG B-VP O
mutations NNS B-NP O
of IN B-PP O
the DT B-NP O
causative JJ I-NP O
gene NN I-NP O
RS1 NN I-NP O
have VBP B-VP O
now RB I-VP O
been VBN I-VP O
identified VBN I-VP O
and CC O O
are VBP B-VP O
thought VBN I-VP O
to TO I-VP O
be VB I-VP O
inactivating VBG I-VP O
. . O O

RS1 NN B-NP O
encodes VBZ B-VP O
a DT B-NP O
224 CD I-NP O
amino NN I-NP O
acid NN I-NP O
protein NN I-NP O
, , O O
retinoschisin NN B-NP O
, , O O
which WDT B-NP O
contains VBZ B-VP O
a DT B-NP O
discoidin NN I-NP O
domain NN I-NP O
but CC O O
is VBZ B-VP O
of IN B-PP O
unknown JJ B-NP O
function NN I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
generated VBN I-VP O
a DT B-NP O
polyclonal JJ I-NP O
antibody NN I-NP O
against IN B-PP O
a DT B-NP O
peptide NN I-NP O
from IN B-PP O
a DT B-NP O
unique JJ I-NP O
region NN I-NP O
within IN B-PP O
retinoschisin NN B-NP O
, , O O
which WDT B-NP O
detects VBZ B-VP O
a DT B-NP O
protein NN I-NP O
of IN B-PP O
approximately RB B-NP O
28 CD I-NP O
kDa NN I-NP O
in IN B-PP O
retinal JJ B-NP O
samples NNS I-NP O
reduced VBN B-VP O
with IN B-PP O
dithiothreitol NN B-NP O
, , O O
but CC O O
multimers NNS B-NP O
sized VBD B-VP O
> SYM B-NP O
40 CD I-NP O
kDa NN I-NP O
under IN B-PP O
non AFX B-NP O
- HYPH I-NP O
reducing VBG B-VP O
conditions NNS B-NP O
. . O O

A DT B-NP O
screen NN I-NP O
of IN B-PP O
human JJ B-NP O
tissues NNS I-NP O
with IN B-PP O
this DT B-NP O
antibody NN I-NP O
reveals VBZ B-VP O
retinoschisin NN B-NP O
to TO B-VP O
be VB I-VP O
retina NN B-NP O
specific JJ I-NP O
and CC O O
the DT B-NP O
antibody NN I-NP O
detects VBZ B-VP O
a DT B-NP O
protein NN I-NP O
of IN B-PP O
similar JJ B-NP O
size NN I-NP O
in IN B-PP O
bovine JJ B-NP O
and CC I-NP O
murine JJ I-NP O
retinae NNS I-NP O
. . O O

We PRP B-NP O
investigated VBD B-VP O
the DT B-NP O
expression NN I-NP O
pattern NN I-NP O
in IN B-PP O
the DT B-NP O
retina NN I-NP O
of IN B-PP O
both CC O O
RS1 NN B-NP O
mRNA NN I-NP O
( ( O O
using VBG B-VP O
in FW B-NP O
situ FW I-NP O
hybridization NN I-NP O
with IN B-PP O
riboprobes NNS B-NP O
) ) O O
and CC O O
retinoschisin NN B-NP O
( ( O O
using VBG B-VP O
immunohistochemistry NN B-NP O
) ) O O
. . O O

The DT B-NP O
antisense JJ I-NP O
riboprobe NN I-NP O
detected VBD B-VP O
RS1 NN B-NP O
mRNA NN I-NP O
only RB B-ADVP O
in IN B-PP O
the DT B-NP O
photoreceptor NN I-NP O
layer NN I-NP O
but CC O O
the DT B-NP O
protein NN I-NP O
product NN I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
was VBD B-VP O
present JJ B-ADJP O
both CC O O
in IN B-PP O
the DT B-NP O
photoreceptors NNS I-NP O
and CC B-PP O
within IN B-PP O
the DT B-NP O
inner JJ I-NP O
portions NNS I-NP O
of IN B-PP O
the DT B-NP O
retina NN I-NP O
. . O O

Furthermore RB B-ADVP O
, , O O
differentiated VBN B-NP O
retinoblastoma NN I-NP B-Disease
cells NNS I-NP O
( ( O O
Weri NNP B-NP O
- HYPH I-NP O
Rb1 NN I-NP O
cells NNS I-NP O
) ) O O
were VBD B-VP O
found VBN I-VP O
to TO I-VP O
express VB I-VP O
RS1 NN B-NP O
mRNA NN I-NP O
and CC O O
to TO B-VP O
release VB I-VP O
retinoschisin NN B-NP O
. . O O

These DT B-NP O
results NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
retinoschisin NN B-NP O
is VBZ B-VP O
released VBN I-VP O
by IN B-PP O
photo AFX B-NP O
- HYPH I-NP O
receptors NNS I-NP O
and CC O O
has VBZ B-VP O
functions NNS B-NP O
within IN B-PP O
the DT B-NP O
inner JJ I-NP O
retinal JJ I-NP O
layers NNS I-NP O
. . O O

Thus RB B-ADVP O
, , O O
X NN B-NP B-Disease
- HYPH B-VP I-Disease
linked VBN B-NP I-Disease
retinoschisis NN I-NP I-Disease
is VBZ B-VP O
caused VBN I-VP O
by IN B-PP O
abnormalities NNS B-NP O
in IN B-PP O
a DT B-NP O
putative JJ I-NP O
secreted VBN I-NP O
photoreceptor NN I-NP O
protein NN I-NP O
and CC O O
is VBZ B-VP O
the DT B-NP O
first JJ I-NP O
example NN I-NP O
of IN B-PP O
a DT B-NP O
secreted VBN I-NP O
photo AFX I-NP O
- HYPH I-NP O
receptor NN I-NP O
protein NN I-NP O
associated VBN B-VP O
with IN B-PP O
a DT B-NP O
retinal JJ I-NP B-Disease
dystrophy NN I-NP I-Disease
. . O O

. . O O

Study NN B-NP O
of IN B-PP O
the DT B-NP O
voltage NN I-NP O
- HYPH B-VP O
gated VBN B-NP O
sodium NN I-NP O
channel NN I-NP O
beta SYM B-NP O
1 CD I-NP O
subunit NN I-NP O
gene NN I-NP O
( ( O O
SCN1B NN B-NP O
) ) O O
in IN B-PP O
the DT B-NP O
benign JJ I-NP B-Disease
familial JJ I-NP I-Disease
infantile JJ I-NP I-Disease
convulsions NNS I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
BFIC NN B-NP B-Disease
) ) O O
. . O O

Benign JJ B-NP B-Disease
familial JJ I-NP I-Disease
infantile JJ I-NP I-Disease
convulsions NNS I-NP I-Disease
( ( O O
BFIC NN B-NP B-Disease
) ) O O
is VBZ B-VP O
a DT B-NP O
rare JJ I-NP O
autosomal JJ I-NP B-Disease
dominant JJ I-NP I-Disease
epilepsy NN I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

This DT B-NP O
syndrome NN I-NP O
has VBZ B-VP O
been VBN I-VP O
recently RB I-VP O
described VBN I-VP O
in IN B-PP O
Italian JJ B-NP O
and CC I-NP O
French JJ I-NP O
pedigrees NNS I-NP O
. . O O

Patients NNS B-NP O
present JJ B-ADJP O
with IN B-PP O
partial JJ B-NP O
, , I-NP O
then RB I-NP O
generalized VBN I-NP O
seizures NNS I-NP O
, , O O
with IN B-PP O
onset NN B-NP O
at IN B-PP O
age NN B-NP O
three CD B-NP O
months NNS I-NP O
. . O O

The DT B-NP O
seizures NNS I-NP O
usually RB B-ADVP O
spontaneously RB B-NP O
cease NN I-NP O
after IN B-PP O
one CD B-NP O
year NN I-NP O
without IN B-PP O
treatment NN B-NP O
, , O O
leaving VBG B-VP O
no DT B-NP O
neurological JJ I-NP B-Disease
abnormalities NNS I-NP I-Disease
. . O O

We PRP B-NP O
have VBP B-VP O
mapped VBN I-VP O
BFIC NN B-NP B-Disease
to TO B-PP O
chromosome NN B-NP O
19q NN I-NP O
in IN B-PP O
five CD B-NP O
Italian JJ I-NP O
pedigrees NNS I-NP O
. . O O

The DT B-NP O
sodium NN I-NP O
channel NN I-NP O
beta1 NN I-NP O
subunit NN I-NP O
gene NN I-NP O
( ( O O
SCN1B NN B-NP O
) ) O O
maps VBZ B-VP O
to TO B-PP O
this DT B-NP O
candidate NN I-NP O
region NN I-NP O
and CC O O
has VBZ B-VP O
been VBN I-VP O
shown VBN I-VP O
to TO I-VP O
be VB I-VP O
involved VBN I-VP O
in IN B-PP O
one CD B-NP O
Australian JJ I-NP O
pedigree NN I-NP O
with IN B-PP O
generalized VBN B-NP B-Disease
epilepsy NN I-NP I-Disease
and CC I-NP I-Disease
febrile NN I-NP I-Disease
seizures NNS I-NP I-Disease
plus CC O I-Disease
( ( O O
GEFS NN B-NP O
+ SYM B-ADJP O
) ) O O
. . O O

In IN B-PP O
this DT B-NP O
family NN I-NP O
, , O O
a DT B-NP O
missense JJ I-NP O
mutation NN I-NP O
in IN B-PP O
SCN1B NN B-NP O
cosegregates NNS I-NP O
with IN B-PP O
the DT B-NP O
GEFS NN I-NP O
+ SYM B-NP O
phenotype NN I-NP O
. . O O

BFIC NN B-NP B-Disease
and CC I-NP O
GEFS NN I-NP O
+ SYM B-NP O
have VBP B-VP O
clinical JJ B-NP O
features NNS I-NP O
in IN B-PP O
common JJ B-NP O
, , O O
therefore RB B-ADVP O
SCN1B NN B-NP O
is VBZ B-VP O
a DT B-NP O
candidate NN I-NP O
gene NN I-NP O
for IN B-PP O
BFIC NN B-NP B-Disease
. . O O

We PRP B-NP O
studied VBD B-VP O
SCN1B NN B-NP O
exons NNS I-NP O
1 CD I-NP O
, , I-NP O
2 CD I-NP O
, , I-NP O
3 CD I-NP O
, , I-NP O
4 CD I-NP O
, , O O
and CC O O
5 CD B-NP O
, , O O
using VBG B-VP O
four CD B-NP O
SSCP NN I-NP O
methods NNS I-NP O
in IN B-PP O
10 CD B-NP O
Caucasian JJ I-NP O
BFIC NN I-NP B-Disease
probands NNS I-NP O
of IN B-PP O
Western NNP B-NP O
Europe NNP I-NP O
. . O O

We PRP B-NP O
found VBD B-VP O
no DT B-NP O
exon NN I-NP O
variants NNS I-NP O
. . O O

One CD B-NP O
variant NN I-NP O
was VBD B-VP O
identified VBN I-VP O
in IN B-PP O
intron NN B-NP O
5 CD I-NP O
( ( O O
IVS5 NN B-NP O
- HYPH B-NP O
10C NN I-NP O
> SYM I-NP O
G NN I-NP O
) ) O O
, , O O
which WDT B-NP O
did VBD B-VP O
not RB I-VP O
segregate VB I-VP O
with IN B-PP O
BFIC NN B-NP B-Disease
and CC O O
was VBD B-VP O
observed VBN I-VP O
in IN B-PP O
9 CD B-NP O
. . O O

2 CD B-NP O
% NN I-NP O
controls NNS I-NP O
. . O O

A DT B-NP O
second JJ I-NP O
variant NN I-NP O
in IN B-PP O
intron NN B-NP O
5 CD I-NP O
was VBD B-VP O
identified VBN I-VP O
( ( O O
IVS5 NN B-NP O
+ SYM B-NP O
30G NN I-NP O
> SYM I-NP O
A NN I-NP O
) ) O O
. . O O

It PRP B-NP O
was VBD B-VP O
rare JJ B-ADJP O
, , O O
as IN B-SBAR O
not RB O O
observed VBN B-VP O
in IN B-PP O
controls NNS B-NP O
, , O O
but CC O O
not RB O O
segregating VBG B-VP O
with IN B-PP O
the DT B-NP O
BFIC NN I-NP B-Disease
phenotype NN I-NP O
. . O O

Inactivation NN B-NP O
of IN B-PP O
germline NN B-NP O
mutant JJ I-NP O
APC NN I-NP B-Disease
alleles NNS I-NP O
by IN B-PP O
attenuated VBN B-NP O
somatic JJ I-NP O
mutations NNS I-NP O
: : O O
a DT B-NP O
molecular JJ I-NP O
genetic JJ I-NP O
mechanism NN I-NP O
for IN B-PP O
attenuated VBN B-NP B-Disease
familial JJ I-NP I-Disease
adenomatous JJ I-NP I-Disease
polyposis NN I-NP I-Disease
. . O O

Germline NN B-NP O
mutations NNS I-NP O
of IN B-PP O
the DT B-NP O
adenomatous JJ I-NP B-Disease
polyposis NN I-NP I-Disease
coli NN I-NP I-Disease
( ( O I-Disease
APC NN B-NP I-Disease
) ) O I-Disease
tumor NN B-NP I-Disease
- HYPH B-NP O
suppressor NN I-NP O
gene NN I-NP O
result VBP B-VP O
in IN B-PP O
familial JJ B-NP B-Disease
adenomatous JJ I-NP I-Disease
polyposis NN I-NP I-Disease
( ( O O
FAP NN B-NP B-Disease
) ) O O
. . O O

Patients NNS B-NP O
with IN B-PP O
FAP NN B-NP B-Disease
typically RB B-ADVP O
develop VBP B-VP O
hundreds NNS B-NP O
to TO B-PP O
thousands NNS B-NP O
of IN B-PP O
benign JJ B-NP B-Disease
colorectal JJ I-NP I-Disease
tumors NNS I-NP I-Disease
and CC O O
early JJ B-NP O
- HYPH I-NP O
onset NN I-NP O
colorectal JJ I-NP B-Disease
cancer NN I-NP I-Disease
. . O O

A DT B-NP O
subset NN I-NP O
of IN B-PP O
germline NN B-NP O
APC NN I-NP B-Disease
mutations NNS I-NP O
results VBZ B-VP O
in IN B-PP O
an DT B-NP O
attenuated VBN I-NP B-Disease
FAP NN I-NP I-Disease
( ( O O
AFAP NN B-NP B-Disease
) ) O O
phenotype NN B-NP O
, , O O
in IN B-PP O
which WDT B-NP O
patients NNS B-NP O
develop VBP B-VP O
fewer JJR B-NP O
tumors NNS I-NP B-Disease
and CC O O
develop VB B-VP O
them PRP B-NP O
at IN B-PP O
an DT B-NP O
older JJR I-NP O
age NN I-NP O
. . O O

Although IN B-SBAR O
a DT B-NP O
genotype NN I-NP O
- HYPH B-NP O
phenotype NN I-NP O
correlation NN I-NP O
between IN B-PP O
the DT B-NP O
locations NNS I-NP O
of IN B-PP O
APC NN B-NP B-Disease
germline NN I-NP O
mutations NNS I-NP O
and CC O O
the DT B-NP O
development NN I-NP O
of IN B-PP O
AFAP NN B-NP B-Disease
has VBZ B-VP O
been VBN I-VP O
well RB I-VP O
documented VBN I-VP O
, , O O
the DT B-NP O
mechanism NN I-NP O
for IN B-PP O
AFAP NN B-NP B-Disease
has VBZ B-VP O
not RB I-VP O
been VBN I-VP O
well RB B-ADJP O
defined VBN I-ADJP O
. . O O

We PRP B-NP O
investigated VBD B-VP O
the DT B-NP O
mechanism NN I-NP O
for IN B-PP O
AFAP NN B-NP B-Disease
in IN B-PP O
patients NNS B-NP O
carrying VBG B-VP O
a DT B-NP O
mutant JJ I-NP O
APC NN I-NP B-Disease
allele NN I-NP O
( ( O O
APC NN B-NP O
( ( O O
AS9 NN B-NP O
) ) O O
) ) O O
that WDT B-NP O
has VBZ B-VP O
a DT B-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
alternatively RB I-NP O
spliced VBN I-NP O
region NN I-NP O
of IN B-PP O
exon NN B-NP O
9 CD I-NP O
. . O O

APC NN B-NP O
( ( O O
AS9 NN B-NP O
) ) O O
was VBD B-VP O
found VBN I-VP O
to TO B-PP O
down RB B-VP O
- HYPH I-VP O
regulate VB I-VP O
beta SYM B-NP O
- HYPH B-NP O
catenin NN I-NP O
- HYPH O O
regulated VBN B-NP O
transcription NN I-NP O
, , O O
the DT B-NP O
major JJ I-NP O
tumor NN I-NP B-Disease
- HYPH I-NP O
suppressor NN I-NP O
function NN I-NP O
of IN B-PP O
APC NN B-NP O
, , O O
as IN B-SBAR O
did VBD B-VP O
the DT B-NP O
wild JJ I-NP O
- HYPH I-NP O
type NN I-NP O
APC NN I-NP O
. . O O

Mutation NN B-NP O
analysis NN I-NP O
showed VBD B-VP O
that IN B-SBAR O
both CC O O
APC NN B-NP O
( ( O O
AS9 NN B-NP O
) ) O O
and CC O O
the DT B-NP O
wild JJ I-NP O
- HYPH I-NP O
type NN I-NP O
APC NN I-NP B-Disease
alleles NNS I-NP O
were VBD B-VP O
somatically RB B-ADJP O
mutated JJ I-ADJP O
in IN B-PP O
most JJS B-NP O
colorectal JJ I-NP B-Disease
tumors NNS I-NP I-Disease
from IN B-PP O
these DT B-NP O
patients NNS I-NP O
. . O O

Functional JJ B-NP O
analysis NN I-NP O
showed VBD B-VP O
that IN B-SBAR O
4666insA NN B-NP O
, , O O
a DT B-NP O
common JJ I-NP O
somatic JJ I-NP O
mutation NN I-NP O
in IN B-PP O
APC NN B-NP O
( ( O O
AS9 NN B-NP O
) ) O O
in IN B-PP O
these DT B-NP O
tumors NNS I-NP B-Disease
, , O O
did VBD B-VP O
not RB I-VP O
inactivate VB I-VP O
the DT B-NP O
wild JJ I-NP O
- HYPH I-NP O
type NN I-NP O
APC NN I-NP O
. . O O

Our PRP$ B-NP O
results NNS I-NP O
indicate VBP B-VP O
that IN B-SBAR O
carriers NNS B-NP O
of IN B-PP O
APC NN B-NP O
( ( O O
AS9 NN B-NP O
) ) O O
develop VBP B-VP O
fewer JJR B-NP O
colorectal JJ I-NP B-Disease
tumors NNS I-NP I-Disease
than IN B-SBAR O
do VBP B-VP O
typical JJ B-NP O
patients NNS I-NP O
with IN B-PP O
FAP NN B-NP B-Disease
because IN B-SBAR O
somatic JJ B-NP O
inactivation NN I-NP O
of IN B-PP O
both DT B-NP O
APC NN I-NP B-Disease
alleles NNS I-NP O
is VBZ B-VP O
necessary JJ B-ADJP O
for IN B-PP O
colorectal JJ B-NP O
tumorigenesis NN I-NP O
. . O O

However RB B-ADVP O
, , O O
these DT B-NP O
patients NNS I-NP O
develop VBP B-VP O
colorectal JJ B-NP B-Disease
tumors NNS I-NP I-Disease
more RBR B-ADVP O
frequently RB I-ADVP O
than IN B-SBAR O
does VBZ O O
the DT B-NP O
general JJ I-NP O
population NN I-NP O
because IN B-SBAR O
APC NN B-NP O
( ( O O
AS9 NN B-NP O
) ) O O
is VBZ B-VP O
inactivated VBN I-VP O
by IN B-PP O
mutations NNS B-NP O
that WDT B-NP O
do VBP B-VP O
not RB I-VP O
inactivate VB I-VP O
the DT B-NP O
wild JJ I-NP O
- HYPH I-NP O
type NN I-NP O
APC NN I-NP O
. . O O

. . O O

Iron NN B-NP O
- HYPH B-NP O
dependent JJ I-NP O
self AFX I-NP O
- HYPH I-NP O
assembly NN I-NP O
of IN B-PP O
recombinant JJ B-NP O
yeast NN I-NP O
frataxin NN I-NP O
: : O O
implications NNS B-NP O
for IN B-PP O
Friedreich NNP B-NP B-Disease
ataxia NN I-NP I-Disease
. . O O

Frataxin NN B-NP B-Disease
deficiency NN I-NP I-Disease
is VBZ B-VP O
the DT B-NP O
primary JJ I-NP O
cause NN I-NP O
of IN B-PP O
Friedreich NNP B-NP B-Disease
ataxia NN I-NP I-Disease
( ( O O
FRDA NN B-NP B-Disease
) ) O O
, , O O
an DT B-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
cardiodegenerative JJ I-NP I-Disease
and CC I-NP I-Disease
neurodegenerative JJ I-NP I-Disease
disease NN I-NP I-Disease
. . O O

Frataxin NN B-NP O
is VBZ B-VP O
a DT B-NP O
nuclear JJ I-NP O
- HYPH I-NP O
encoded VBN I-NP O
mitochondrial JJ I-NP O
protein NN I-NP O
that WDT B-NP O
is VBZ B-VP O
widely RB I-VP O
conserved VBN I-VP O
among IN B-PP O
eukaryotes NNS B-NP O
. . O O

Genetic JJ B-NP O
inactivation NN I-NP O
of IN B-PP O
the DT B-NP O
yeast NN I-NP O
frataxin NN I-NP O
homologue NN I-NP O
( ( O O
Yfh1p NN B-NP O
) ) O O
results VBZ B-VP O
in IN B-PP O
mitochondrial JJ B-NP B-Disease
iron NN I-NP I-Disease
accumulation NN I-NP I-Disease
and CC O O
hypersensitivity NN B-NP B-Disease
to TO B-PP I-Disease
oxidative JJ B-NP I-Disease
stress NN I-NP I-Disease
. . O O

Increased VBN B-NP O
iron NN I-NP O
deposition NN I-NP O
and CC I-NP O
evidence NN I-NP O
of IN B-PP O
oxidative JJ B-NP O
damage NN I-NP O
have VBP B-VP O
also RB I-VP O
been VBN I-VP O
observed VBN I-VP O
in IN B-PP O
cardiac JJ B-NP O
tissue NN I-NP O
and CC O O
cultured VBN B-VP O
fibroblasts NNS B-NP O
from IN B-PP O
patients NNS B-NP O
with IN B-PP O
FRDA NN B-NP B-Disease
. . O O

These DT B-NP O
findings NNS I-NP O
indicate VBP B-VP O
that IN B-SBAR O
frataxin NN B-NP O
is VBZ B-VP O
essential JJ B-ADJP O
for IN B-PP O
mitochondrial JJ B-NP O
iron NN I-NP O
homeostasis NN I-NP O
and CC I-NP O
protection NN I-NP O
from IN B-PP O
iron NN B-NP O
- HYPH B-NP O
induced VBN I-NP O
formation NN I-NP O
of IN B-PP O
free JJ B-NP O
radicals NNS I-NP O
. . O O

The DT B-NP O
functional JJ I-NP O
mechanism NN I-NP O
of IN B-PP O
frataxin NN B-NP O
, , O O
however RB B-ADVP O
, , O O
is VBZ B-VP O
still RB B-ADVP O
unknown JJ B-ADJP O
. . O O

We PRP B-NP O
have VBP B-VP O
expressed VBN I-VP O
the DT B-NP O
mature JJ I-NP O
form NN I-NP O
of IN B-PP O
Yfh1p NN B-NP O
( ( O O
mYfh1p NN B-NP O
) ) O O
in IN B-PP O
Escherichia FW B-NP O
coli FW I-NP O
and CC O O
have VBP B-VP O
analyzed VBN I-VP O
its PRP$ B-NP O
function NN I-NP O
in FW B-ADVP O
vitro FW I-ADVP O
. . O O

Isolated VBN B-NP O
mYfh1p NN I-NP O
is VBZ B-VP O
a DT B-NP O
soluble JJ I-NP O
monomer NN I-NP O
( ( O O
13 CD B-NP O
, , O O
783 CD B-NP O
Da NN I-NP O
) ) O O
that WDT B-NP O
contains VBZ B-VP O
no DT B-NP O
iron NN I-NP O
and CC O O
shows VBZ B-VP O
no DT B-NP O
significant JJ I-NP O
tendency NN I-NP O
to TO B-PP O
self AFX B-NP O
- HYPH I-NP O
associate NN I-NP O
. . O O

Aerobic JJ B-NP O
addition NN I-NP O
of IN B-PP O
ferrous JJ B-NP O
iron NN I-NP O
to TO B-PP O
mYfh1p NN B-NP O
results VBZ B-VP O
in IN B-PP O
assembly NN B-NP O
of IN B-PP O
regular JJ B-NP O
spherical JJ I-NP O
multimers NNS I-NP O
with IN B-PP O
a DT B-NP O
molecular JJ I-NP O
mass NN I-NP O
of IN B-PP O
approximately RB B-NP O
1 CD I-NP O
. . O O

1 CD B-NP O
MDa NN I-NP O
( ( O O
megadaltons NNS B-NP O
) ) O O
and CC O O
a DT B-NP O
diameter NN I-NP O
of IN B-PP O
13 CD B-NP O
+ SYM O O
/ SYM O O
- SYM O O
2 CD B-NP O
nm NN I-NP O
. . O O

Each DT B-NP O
multimer NN I-NP O
consists VBZ B-VP O
of IN B-PP O
approximately RB B-NP O
60 CD I-NP O
subunits NNS I-NP O
and CC O O
can MD B-VP O
sequester VB I-VP O
> JJR B-NP O
3 CD I-NP O
, , I-NP O
000 CD I-NP O
atoms NNS I-NP O
of IN B-PP O
iron NN B-NP O
. . O O

Titration NN B-NP O
of IN B-PP O
mYfh1p NN B-NP O
with IN B-PP O
increasing VBG B-NP O
iron NN I-NP O
concentrations NNS I-NP O
supports VBZ B-VP O
a DT B-NP O
stepwise JJ I-NP O
mechanism NN I-NP O
of IN B-PP O
multimer NN B-NP O
assembly NN I-NP O
. . O O

Sequential JJ B-NP O
addition NN I-NP O
of IN B-PP O
an DT B-NP O
iron NN I-NP O
chelator NN I-NP O
and CC O O
a DT B-NP O
reducing VBG I-NP O
agent NN I-NP O
results VBZ B-VP O
in IN B-PP O
quantitative JJ B-NP O
iron NN I-NP O
release NN I-NP O
with IN B-PP O
concomitant JJ B-NP O
disassembly NN I-NP O
of IN B-PP O
the DT B-NP O
multimer NN I-NP O
, , O O
indicating VBG B-VP O
that IN B-SBAR O
mYfh1p NN B-NP O
sequesters NNS I-NP O
iron NN I-NP O
in IN B-PP O
an DT B-NP O
available JJ I-NP O
form NN I-NP O
. . O O

In IN B-PP O
yeast NN B-NP O
mitochondria NNS I-NP O
, , O O
native JJ B-NP O
mYfh1p NN I-NP O
exists VBZ B-VP O
as IN B-PP O
monomer NN B-NP O
and CC O O
a DT B-NP O
higher JJR I-NP O
- HYPH I-NP O
order NN I-NP O
species NNS I-NP O
with IN B-PP O
a DT B-NP O
molecular JJ I-NP O
weight NN I-NP O
> JJR I-NP O
600 CD I-NP O
, , I-NP O
000 CD I-NP O
. . O O

After IN B-PP O
addition NN B-NP O
of IN B-PP O
( ( O O
55 CD B-NP O
) ) O O
Fe NNP B-NP O
to TO B-PP O
the DT B-NP O
medium NN I-NP O
, , O O
immunoprecipitates NNS B-NP O
of IN B-PP O
this DT B-NP O
species NNS I-NP O
contain VBP B-VP O
> JJR B-NP O
16 CD I-NP O
atoms NNS I-NP O
of IN B-PP O
( ( O O
55 CD B-NP O
) ) O O
Fe NN B-NP O
per IN B-PP O
molecule NN B-NP O
of IN B-PP O
mYfh1p NN B-NP O
. . O O

We PRP B-NP O
propose VBP B-VP O
that IN B-SBAR O
iron NN B-NP O
- HYPH O O
dependent JJ B-NP O
self AFX I-NP O
- HYPH I-NP O
assembly NN I-NP O
of IN B-PP O
recombinant JJ B-NP O
mYfh1p NN I-NP O
reflects VBZ B-VP O
a DT B-NP O
physiological JJ I-NP O
role NN I-NP O
for IN B-PP O
frataxin NN B-NP O
in IN B-PP O
mitochondrial JJ B-NP O
iron NN I-NP O
sequestration NN I-NP O
and CC I-NP O
bioavailability NN I-NP O
. . O O

. . O O

A DT B-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
pleckstrin NN I-NP O
homology NN I-NP O
( ( O O
PH NN B-NP O
) ) O O
domain NN B-NP O
of IN B-PP O
the DT B-NP O
FGD1 NN I-NP O
gene NN I-NP O
in IN B-PP O
an DT B-NP O
Italian JJ I-NP O
family NN I-NP O
with IN B-PP O
faciogenital JJ B-NP B-Disease
dysplasia NN I-NP I-Disease
( ( O O
Aarskog NN B-NP B-Disease
- HYPH B-NP I-Disease
Scott NN I-NP I-Disease
syndrome NN I-NP I-Disease
) ) O O
. . O O

Aarskog NN B-NP B-Disease
- HYPH I-NP I-Disease
Scott NN I-NP I-Disease
Syndrome NN I-NP I-Disease
( ( O O
AAS NN B-NP B-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
X NN I-NP B-Disease
- HYPH B-VP I-Disease
linked VBN B-NP I-Disease
disorder NN I-NP I-Disease
characterised VBN B-VP O
by IN B-PP O
short JJ B-NP B-Disease
stature NN I-NP I-Disease
and CC O O
multiple JJ B-NP O
facial JJ I-NP B-Disease
, , I-NP I-Disease
limb NN I-NP I-Disease
and CC I-NP I-Disease
genital JJ I-NP I-Disease
abnormalities NNS I-NP I-Disease
. . O O

A DT B-NP O
gene NN I-NP O
, , O O
FGD1 NN B-NP O
, , O O
altered VBN B-VP O
in IN B-PP O
a DT B-NP O
patient NN I-NP O
with IN B-PP O
AAS NN B-NP B-Disease
phenotype NN I-NP O
, , O O
has VBZ B-VP O
been VBN I-VP O
identified VBN I-VP O
and CC O O
found VBN B-VP O
to TO I-VP O
encode VB I-VP O
a DT B-NP O
protein NN I-NP O
with IN B-PP O
homology NN B-NP O
to TO B-PP O
Rho NN B-NP O
/ SYM B-NP O
Rac NN I-NP O
guanine NN I-NP O
nucleotide NN I-NP O
exchange NN I-NP O
factors NNS I-NP O
( ( O O
Rho NN B-NP O
/ SYM O O
Rac NN B-NP O
GEF NN I-NP O
) ) O O
. . O O

However RB B-ADVP O
, , O O
since IN B-SBAR O
this DT B-NP O
original JJ I-NP O
report NN I-NP O
on IN B-PP O
identification NN B-NP O
of IN B-PP O
a DT B-NP O
mutated VBN I-NP O
FGD1 NN I-NP O
gene NN I-NP O
in IN B-PP O
an DT B-NP O
AAS NN I-NP B-Disease
patient NN I-NP O
, , O O
no DT B-NP O
additional JJ I-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
FGD1 NN I-NP O
gene NN I-NP O
have VBP B-VP O
been VBN I-VP O
described VBN I-VP O
. . O O

We PRP B-NP O
analysed VBD B-VP O
13 CD B-NP O
independent JJ I-NP O
patients NNS I-NP O
with IN B-PP O
clinical JJ B-NP O
diagnosis NN I-NP O
of IN B-PP O
AAS NN B-NP B-Disease
. . O O

One CD B-NP O
patient NN I-NP O
presented VBD B-VP O
a DT B-NP O
mutation NN I-NP O
that WDT B-NP O
results VBZ B-VP O
in IN B-PP O
a DT B-NP O
nucleotide NN I-NP O
change NN I-NP O
in IN B-PP O
exon NN B-NP O
10 CD I-NP O
of IN B-PP O
the DT B-NP O
FGD1 NN I-NP O
gene NN I-NP O
( ( O O
G2559 NN B-NP O
> SYM B-NP O
A NN I-NP O
) ) O O
substituting VBG B-VP O
a DT B-NP O
Gln NN I-NP O
for IN B-PP O
Arg NN B-NP O
in IN B-PP O
position NN B-NP O
610 CD I-NP O
. . O O

The DT B-NP O
mutation NN I-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
segregate VB I-VP O
with IN B-PP O
the DT B-NP O
AAS NN I-NP B-Disease
phenotype NN I-NP O
in IN B-PP O
affected VBN B-NP O
males NNS I-NP O
and CC O O
carrier NN B-NP O
females NNS I-NP O
in IN B-PP O
the DT B-NP O
family NN I-NP O
of IN B-PP O
this DT B-NP O
patient NN I-NP O
. . O O

Interestingly RB B-ADVP O
, , O O
Arg NN B-NP O
- HYPH O O
610 CD B-NP O
is VBZ B-VP O
located JJ B-ADJP O
within IN B-PP O
one CD B-NP O
of IN B-PP O
the DT B-NP O
two CD I-NP O
pleckstrin NN I-NP O
homology NN I-NP O
( ( O O
PH NN B-NP O
) ) O O
domains NNS B-NP O
of IN B-PP O
the DT B-NP O
FGD1 NN I-NP O
gene NN I-NP O
and CC O O
it PRP B-NP O
corresponds VBZ B-VP O
to TO B-PP O
a DT B-NP O
highly RB I-NP O
conserved VBN I-NP O
residue NN I-NP O
which WDT B-NP O
has VBZ B-VP O
been VBN I-VP O
involved VBN I-VP O
in IN B-PP O
InsP NN B-NP O
binding NN I-NP O
in IN B-PP O
PH NN B-NP O
domains NNS I-NP O
of IN B-PP O
other JJ B-NP O
proteins NNS I-NP O
. . O O

The DT B-NP O
same JJ I-NP O
residue NN I-NP O
is VBZ B-VP O
often RB B-ADVP O
mutated JJ B-ADJP O
in IN B-PP O
the DT B-NP O
Brutons NNP I-NP O
tyrosine NN I-NP O
kinase NN I-NP O
( ( O O
Btk NN B-NP O
) ) O O
gene NN B-NP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
an DT B-NP O
X NN I-NP B-Disease
- HYPH B-VP I-Disease
linked VBN B-NP I-Disease
agammaglobulinemia NN I-NP I-Disease
. . O O

The DT B-NP O
Arg610Gln NN I-NP O
mutation NN I-NP O
represents VBZ B-VP O
the DT B-NP O
first JJ I-NP O
case NN I-NP O
of IN B-PP O
a DT B-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
PH NN I-NP O
domain NN I-NP O
of IN B-PP O
the DT B-NP O
FGD1 NN I-NP O
gene NN I-NP O
and CC O O
additional JJ B-NP O
evidence NN I-NP O
that IN B-SBAR O
mutations NNS B-NP O
in IN B-PP O
PH NN B-NP O
domains NNS I-NP O
can MD B-VP O
be VB I-VP O
associated VBN I-VP O
to TO B-PP O
human JJ B-NP O
diseases NNS I-NP O
. . O O

. . O O

Amino AFX B-NP O
- HYPH I-NP O
terminal JJ I-NP O
fragments NNS I-NP O
of IN B-PP O
mutant JJ B-NP O
huntingtin NN I-NP O
show VBP B-VP O
selective JJ B-NP O
accumulation NN I-NP O
in IN B-PP O
striatal JJ B-NP O
neurons NNS I-NP O
and CC O O
synaptic JJ B-NP O
toxicity NN I-NP O
. . O O

Huntington NNP B-NP B-Disease
disease NN I-NP I-Disease
( ( O O
HD NN B-NP B-Disease
) ) O O
is VBZ B-VP O
caused VBN I-VP O
by IN B-PP O
expansion NN B-NP O
of IN B-PP O
a DT B-NP O
glutamine NN I-NP O
repeat NN I-NP O
in IN B-PP O
the DT B-NP O
amino JJ I-NP O
- HYPH I-NP O
terminal JJ I-NP O
region NN I-NP O
of IN B-PP O
huntingtin NN B-NP O
. . O O

Despite IN B-PP O
its PRP$ B-NP O
widespread JJ I-NP O
expression NN I-NP O
, , O O
mutant JJ B-NP O
huntingtin NN I-NP O
induces VBZ B-VP O
selective JJ B-NP O
neuronal JJ I-NP O
loss NN I-NP O
in IN B-PP O
striatal JJ B-NP O
neurons NNS I-NP O
. . O O

Here RB B-ADVP O
we PRP B-NP O
report VBP B-VP O
that IN B-SBAR O
, , O O
in IN B-PP O
mutant JJ B-NP O
mice NNS I-NP O
expressing VBG B-VP O
HD NN B-NP B-Disease
repeats NNS I-NP O
, , O O
the DT B-NP O
production NN I-NP O
and CC I-NP O
aggregation NN I-NP O
of IN B-PP O
N NN B-NP O
- HYPH B-NP O
terminal JJ I-NP O
huntingtin NN I-NP O
fragments NNS I-NP O
preferentially RB B-ADVP O
occur VBP B-VP O
in IN B-PP O
HD NN B-NP B-Disease
- HYPH O O
affected VBN B-NP O
neurons NNS I-NP O
and CC O O
their PRP$ B-NP O
processes NNS I-NP O
and CC O O
axonal JJ B-NP O
terminals NNS I-NP O
. . O O

N NN B-NP O
- HYPH I-NP O
terminal JJ I-NP O
fragments NNS I-NP O
of IN B-PP O
mutant JJ B-NP O
huntingtin NN I-NP O
form NN I-NP O
aggregates NNS I-NP O
and CC O O
induce VB B-VP O
neuritic JJ B-NP B-Disease
degeneration NN I-NP I-Disease
in IN B-PP O
cultured VBN B-NP O
striatal JJ I-NP O
neurons NNS I-NP O
. . O O

N NN B-NP O
- HYPH I-NP O
terminal JJ I-NP O
mutant JJ I-NP O
huntingtin NN I-NP O
also RB B-ADVP O
binds VBZ B-VP O
to TO B-PP O
synaptic JJ B-NP O
vesicles NNS I-NP O
and CC O O
inhibits VBZ B-VP O
their PRP$ B-NP O
glutamate NN I-NP O
uptake NN I-NP O
in FW B-ADVP O
vitro FW I-ADVP O
. . O O

The DT B-NP O
specific JJ I-NP O
processing NN I-NP O
and CC I-NP O
accumulation NN I-NP O
of IN B-PP O
toxic JJ B-NP O
fragments NNS I-NP O
of IN B-PP O
N NN B-NP O
- HYPH B-NP O
terminal JJ I-NP O
huntingtin NN I-NP O
in IN B-PP O
HD NN B-NP B-Disease
- HYPH B-VP O
affected VBN I-VP O
striatal JJ B-NP O
neurons NNS I-NP O
, , O O
especially RB B-ADVP O
in IN B-PP O
their PRP$ B-NP O
neuronal JJ I-NP O
processes NNS I-NP O
and CC O O
axonal JJ B-NP O
terminals NNS I-NP O
, , O O
may MD B-VP O
contribute VB I-VP O
to TO B-PP O
the DT B-NP O
selective JJ I-NP O
neuropathology NN I-NP O
of IN B-PP O
HD NN B-NP B-Disease
. . O O

. . O O

BRCA1 NN B-NP O
is VBZ B-VP O
associated VBN I-VP O
with IN B-PP O
a DT B-NP O
human JJ I-NP O
SWI NN I-NP O
/ SYM B-NP O
SNF NN I-NP O
- HYPH B-NP O
related VBN I-NP O
complex NN I-NP O
: : O O
linking VBG B-VP O
chromatin NN B-NP O
remodeling NN I-NP O
to TO B-PP O
breast NN B-NP B-Disease
cancer NN I-NP I-Disease
. . O O

Germline NN B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
tumor NN I-NP B-Disease
suppressor NN I-NP O
gene NN I-NP O
, , O O
BRCA1 NN B-NP O
, , O O
predispose VB B-VP O
individuals NNS B-NP O
to TO B-PP O
breast NN B-NP B-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancers NNS I-NP I-Disease
. . O O

Using VBG B-VP O
a DT B-NP O
combination NN I-NP O
of IN B-PP O
affinity NN B-NP O
- HYPH B-NP O
and CC I-NP O
conventional JJ I-NP O
chromatographic JJ I-NP O
techniques NNS I-NP O
, , O O
we PRP B-NP O
have VBP B-VP O
isolated VBN I-VP O
a DT B-NP O
predominant JJ I-NP O
form NN I-NP O
of IN B-PP O
a DT B-NP O
multiprotein NN I-NP O
BRCA1 NN I-NP O
- HYPH O O
containing VBG B-VP O
complex NN B-NP O
from IN B-PP O
human JJ B-NP O
cells NNS I-NP O
displaying VBG B-VP O
chromatin NN B-NP O
- HYPH O O
remodeling VBG B-VP O
activity NN B-NP O
. . O O

Mass NNP B-NP O
spectrometric JJ I-NP O
sequencing NN I-NP O
of IN B-PP O
components NNS B-NP O
of IN B-PP O
this DT B-NP O
complex NN I-NP O
indicated VBD B-VP O
that IN B-SBAR O
BRCA1 NN B-NP O
is VBZ B-VP O
associated VBN I-VP O
with IN B-PP O
a DT B-NP O
SWI NN I-NP O
/ SYM B-NP O
SNF NN I-NP O
- HYPH B-NP O
related VBN I-NP O
complex NN I-NP O
. . O O

We PRP B-NP O
show VBP B-VP O
that IN B-SBAR O
BRCA1 NN B-NP O
can MD B-VP O
directly RB I-VP O
interact VB I-VP O
with IN B-PP O
the DT B-NP O
BRG1 NN I-NP O
subunit NN I-NP O
of IN B-PP O
the DT B-NP O
SWI NN I-NP O
/ SYM B-NP O
SNF NN I-NP O
complex NN I-NP O
. . O O

Moreover RB B-ADVP O
, , O O
p53 NN B-NP O
- HYPH B-VP O
mediated VBN B-NP O
stimulation NN I-NP O
of IN B-PP O
transcription NN B-NP O
by IN B-PP O
BRCA1 NN B-NP O
was VBD B-VP O
completely RB I-VP O
abrogated VBN I-VP O
by IN B-PP O
either CC O O
a DT B-NP O
dominant JJ I-NP O
- HYPH I-NP O
negative JJ I-NP O
mutant NN I-NP O
of IN B-PP O
BRG1 NN B-NP O
or CC O O
the DT B-NP O
cancer NN I-NP B-Disease
- HYPH O O
causing VBG B-VP O
deletion NN B-NP O
in IN B-PP O
exon NN B-NP O
11 CD I-NP O
of IN B-PP O
BRCA1 NN B-NP O
. . O O

These DT B-NP O
findings NNS I-NP O
reveal VBP B-VP O
a DT B-NP O
direct JJ I-NP O
function NN I-NP O
for IN B-PP O
BRCA1 NN B-NP O
in IN B-PP O
transcriptional JJ B-NP O
control NN I-NP O
through IN B-PP O
modulation NN B-NP O
of IN B-PP O
chromatin NN B-NP O
structure NN I-NP O
. . O O

. . O O

Asef NN B-NP O
, , O O
a DT B-NP O
link NN I-NP O
between IN B-PP O
the DT B-NP O
tumor NN I-NP B-Disease
suppressor NN I-NP O
APC NN I-NP O
and CC I-NP O
G NN I-NP O
- HYPH B-NP O
protein NN I-NP O
signaling NN I-NP O
. . O O

The DT B-NP O
adenomatous JJ I-NP B-Disease
polyposis NN I-NP I-Disease
coli NN I-NP I-Disease
gene NN I-NP O
( ( O O
APC NN B-NP O
) ) O O
is VBZ B-VP O
mutated VBN I-VP O
in IN B-PP O
familial JJ B-NP B-Disease
adenomatous JJ I-NP I-Disease
polyposis NN I-NP I-Disease
and CC B-PP O
in IN B-PP O
sporadic JJ B-NP O
colorectal JJ I-NP B-Disease
tumors NNS I-NP I-Disease
. . O O

Here RB B-ADVP O
the DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
product NN I-NP O
is VBZ B-VP O
shown VBN I-VP O
to TO I-VP O
bind VB I-VP O
through IN B-PP O
its PRP$ B-NP O
armadillo NN I-NP O
repeat NN I-NP O
domain NN I-NP O
to TO B-PP O
a DT B-NP O
Rac NN I-NP O
- HYPH B-NP O
specific JJ I-NP O
guanine NN I-NP O
nucleotide NN I-NP O
exchange NN I-NP O
factor NN I-NP O
( ( O O
GEF NN B-NP O
) ) O O
, , O O
termed VBN B-NP O
Asef NN I-NP O
. . O O

Endogenous JJ B-NP O
APC NN I-NP O
colocalized VBD B-VP O
with IN B-PP O
Asef NN B-NP O
in IN B-PP O
mouse NN B-NP O
colon NN I-NP O
epithelial JJ I-NP O
cells NNS I-NP O
and CC O O
neuronal JJ B-NP O
cells NNS I-NP O
. . O O

Furthermore RB B-ADVP O
, , O O
APC NN B-NP O
enhanced VBD B-VP O
the DT B-NP O
GEF NN I-NP O
activity NN I-NP O
of IN B-PP O
Asef NN B-NP O
and CC O O
stimulated VBD B-VP O
Asef NN B-NP O
- HYPH O O
mediated VBN B-NP O
cell NN I-NP O
flattening NN I-NP O
, , O O
membrane NN B-NP O
ruffling NN I-NP O
, , O O
and CC O O
lamellipodia NN B-NP O
formation NN I-NP O
in IN B-PP O
MDCK NN B-NP O
cells NNS I-NP O
. . O O

These DT B-NP O
results NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
the DT B-NP O
APC NN I-NP O
- HYPH B-NP O
Asef NN I-NP O
complex NN I-NP O
may MD B-VP O
regulate VB I-VP O
the DT B-NP O
actin NN I-NP O
cytoskeletal JJ I-NP O
network NN I-NP O
, , O O
cell NN B-NP O
morphology NN I-NP O
and CC I-NP O
migration NN I-NP O
, , O O
and CC O O
neuronal JJ B-NP O
function NN I-NP O
. . O O

. . O O

Function NN B-NP O
of IN B-PP O
an DT B-NP O
axonal JJ I-NP O
chemoattractant NN I-NP O
modulated VBN B-VP O
by IN B-PP O
metalloprotease NN B-NP O
activity NN I-NP O
. . O O

The DT B-NP O
axonal JJ I-NP O
chemoattractant NN I-NP O
netrin NN I-NP O
- HYPH B-NP O
1 CD I-NP O
guides NNS I-NP O
spinal JJ B-NP O
commissural JJ I-NP O
axons NNS I-NP O
by IN B-PP O
activating VBG B-VP O
its PRP$ B-NP O
receptor NN I-NP O
DCC NN I-NP O
( ( O O
Deleted VBN B-VP O
in IN B-PP O
Colorectal JJ B-NP B-Disease
Cancer NN I-NP I-Disease
) ) O O
. . O O

We PRP B-NP O
have VBP B-VP O
found VBN I-VP O
that IN B-SBAR O
chemical JJ B-NP O
inhibitors NNS I-NP O
of IN B-PP O
metalloproteases NNS B-NP O
potentiate VBP B-VP O
netrin NN B-NP O
- HYPH B-VP O
mediated VBN B-NP O
axon NN I-NP O
outgrowth NN I-NP O
in FW B-ADVP O
vitro FW I-ADVP O
. . O O

We PRP B-NP O
have VBP B-VP O
also RB I-VP O
found VBN I-VP O
that IN B-SBAR O
DCC NN B-NP O
is VBZ B-VP O
a DT B-NP O
substrate NN I-NP O
for IN B-PP O
metalloprotease NN B-NP O
- HYPH B-NP O
dependent JJ I-NP O
ectodomain NN I-NP O
shedding NN I-NP O
, , O O
and CC O O
that IN B-SBAR O
the DT B-NP O
inhibitors NNS I-NP O
block VBP B-VP O
proteolytic JJ B-NP O
processing NN I-NP O
of IN B-PP O
DCC NN B-NP O
and CC O O
cause VB B-VP O
an DT B-NP O
increase NN I-NP O
in IN B-PP O
DCC NN B-NP O
protein NN I-NP O
levels NNS I-NP O
on IN B-PP O
axons NNS B-NP O
within IN B-PP O
spinal JJ B-NP O
cord NN I-NP O
explants NNS I-NP O
. . O O

Thus RB B-ADVP O
, , O O
potentiation NN B-NP O
of IN B-PP O
netrin NN B-NP O
activity NN I-NP O
by IN B-PP O
inhibitors NNS B-NP O
may MD B-VP O
result VB I-VP O
from IN B-PP O
stabilization NN B-NP O
of IN B-PP O
DCC NN B-NP O
on IN B-PP O
the DT B-NP O
axons NNS I-NP O
, , O O
and CC O O
proteolytic JJ B-NP O
activity NN I-NP O
may MD B-VP O
regulate VB I-VP O
axon NN B-NP O
migration NN I-NP O
by IN B-PP O
controlling VBG B-VP O
the DT B-NP O
number NN I-NP O
of IN B-PP O
functional JJ B-NP O
extracellular JJ I-NP O
axon NN I-NP O
guidance NN I-NP O
receptors NNS I-NP O
. . O O

. . O O

Myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
in IN B-PP O
transgenic JJ B-NP O
mice NNS I-NP O
expressing VBG B-VP O
an DT B-NP O
expanded VBN I-NP O
CUG NN I-NP O
repeat NN I-NP O
. . O O

Myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
( ( O O
DM NN B-NP B-Disease
) ) O O
, , O O
the DT B-NP O
most RBS I-NP O
common JJ I-NP O
form NN I-NP O
of IN B-PP O
muscular JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
in IN B-PP O
adult JJ B-NP O
humans NNS I-NP O
, , O O
results VBZ B-VP O
from IN B-PP O
expansion NN B-NP O
of IN B-PP O
a DT B-NP O
CTG NN I-NP O
repeat NN I-NP O
in IN B-PP O
the DT B-NP O
3 CD I-NP O
untranslated JJ I-NP O
region NN I-NP O
of IN B-PP O
the DT B-NP O
DMPK NN I-NP O
gene NN I-NP O
. . O O

The DT B-NP O
mutant JJ I-NP O
DMPK NN I-NP O
messenger NN I-NP O
RNA NN I-NP O
( ( O O
mRNA NN B-NP O
) ) O O
contains VBZ B-VP O
an DT B-NP O
expanded VBN I-NP O
CUG NN I-NP O
repeat NN I-NP O
and CC O O
is VBZ B-VP O
retained VBN I-VP O
in IN B-PP O
the DT B-NP O
nucleus NN I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
expressed VBN I-VP O
an DT B-NP O
untranslated JJ I-NP O
CUG NN I-NP O
repeat NN I-NP O
in IN B-PP O
an DT B-NP O
unrelated JJ I-NP O
mRNA NN I-NP O
in IN B-PP O
transgenic JJ B-NP O
mice NNS I-NP O
. . O O

Mice NNS B-NP O
that WDT B-NP O
expressed VBD B-VP O
expanded VBN I-VP O
CUG NN B-NP O
repeats NNS I-NP O
developed VBD B-VP O
myotonia NN B-NP B-Disease
and CC I-NP O
myopathy NN I-NP B-Disease
, , O O
whereas IN B-PP O
mice NNS B-NP O
expressing VBG B-VP O
a DT B-NP O
nonexpanded JJ I-NP O
repeat NN I-NP O
did VBD B-VP O
not RB O O
. . O O

Thus RB B-ADVP O
, , O O
transcripts NNS B-NP O
with IN B-PP O
expanded VBN B-NP O
CUG NN I-NP O
repeats NNS I-NP O
are VBP B-VP O
sufficient JJ B-ADJP O
to TO B-VP O
generate VB I-VP O
a DT B-NP O
DM NN I-NP B-Disease
phenotype NN I-NP O
. . O O

This DT B-NP O
result NN I-NP O
supports VBZ B-VP O
a DT B-NP O
role NN I-NP O
for IN B-PP O
RNA NN B-NP O
gain NN I-NP O
of IN B-PP O
function NN B-NP O
in IN B-PP O
disease NN B-NP O
pathogenesis NN I-NP O
. . O O

. . O O

Genomic JJ B-NP O
rearrangements NNS I-NP O
of IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
tumor NN I-NP I-Disease
- HYPH B-NP O
suppressor NN I-NP O
gene NN I-NP O
in IN B-PP O
familial JJ B-NP B-Disease
adenomatous JJ I-NP I-Disease
polyposis NN I-NP I-Disease
. . O O

Germline NN B-NP O
mutations NNS I-NP O
of IN B-PP O
the DT B-NP O
adenomatous JJ I-NP B-Disease
polyposis NN I-NP I-Disease
coli NN I-NP I-Disease
( ( O I-Disease
APC NN B-NP I-Disease
) ) O I-Disease
tumor NN B-NP I-Disease
- HYPH B-NP O
suppressor NN I-NP O
gene NN I-NP O
result VBP B-VP O
in IN B-PP O
the DT B-NP O
hereditary JJ I-NP B-Disease
colorectal JJ I-NP I-Disease
cancer NN I-NP I-Disease
syndrome NN I-NP I-Disease
familial JJ I-NP B-Disease
adenomatous JJ I-NP I-Disease
polyposis NN I-NP I-Disease
( ( O O
FAP NN B-NP B-Disease
) ) O O
. . O O

Almost RB B-NP O
all DT I-NP O
APC NN I-NP B-Disease
mutations NNS I-NP O
that WDT B-NP O
have VBP B-VP O
been VBN I-VP O
identified VBN I-VP O
are VBP B-VP O
single JJ B-NP O
- HYPH I-NP O
nucleotide NN I-NP O
alterations NNS I-NP O
, , O O
small JJ B-NP O
insertions NNS I-NP O
, , O O
or CC O O
small JJ B-NP O
deletions NNS I-NP O
that WDT B-NP O
would MD B-VP O
truncate VB I-VP O
the DT B-NP O
protein NN I-NP O
product NN I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
. . O O

No DT B-NP O
well RB I-NP O
- HYPH I-NP O
characterized VBN I-NP O
intragenic JJ I-NP O
rearrangement NN I-NP O
of IN B-PP O
APC NN B-NP O
has VBZ B-VP O
been VBN I-VP O
described VBN I-VP O
, , O O
and CC O O
the DT B-NP O
prevalence NN I-NP O
of IN B-PP O
this DT B-NP O
type NN I-NP O
of IN B-PP O
mutation NN B-NP O
in IN B-PP O
FAP NN B-NP B-Disease
patients NNS I-NP O
is VBZ B-VP O
not RB O O
clear JJ B-ADJP O
. . O O

We PRP B-NP O
screened VBD B-VP O
49 CD B-NP O
potential JJ I-NP O
FAP NN I-NP B-Disease
families NNS I-NP O
and CC O O
identified VBD B-VP O
26 CD B-NP O
different JJ I-NP O
germline NN I-NP O
APC NN I-NP B-Disease
mutations NNS I-NP O
in IN B-PP O
30 CD B-NP O
families NNS I-NP O
. . O O

Four CD B-NP O
of IN B-PP O
these DT B-NP O
mutations NNS I-NP O
were VBD B-VP O
genomic JJ B-NP O
rearrangements NNS I-NP O
resulting VBG B-VP O
from IN B-PP O
homologous JJ B-NP O
and CC I-NP O
nonhomologous JJ I-NP O
recombinations NNS I-NP O
mediated VBN B-VP O
by IN B-PP O
Alu NN B-NP O
elements NNS I-NP O
. . O O

Two CD B-NP O
of IN B-PP O
these DT B-NP O
four CD I-NP O
rearrangements NNS I-NP O
were VBD B-VP O
complex JJ B-ADJP O
, , O O
involving VBG B-VP O
deletion NN B-NP O
and CC I-NP O
insertion NN I-NP O
of IN B-PP O
nucleotides NNS B-NP O
. . O O

Of IN B-PP O
these DT B-NP O
four CD I-NP O
rearrangements NNS I-NP O
, , O O
one CD B-NP O
resulted VBD B-VP O
in IN B-PP O
the DT B-NP O
deletion NN I-NP O
of IN B-PP O
exons NNS B-NP O
11 CD B-NP O
and CC I-NP O
12 CD I-NP O
and CC I-NP O
two CD I-NP O
others NNS I-NP O
resulted VBD B-VP O
in IN B-PP O
either CC B-NP O
complete JJ I-NP O
or CC I-NP O
partial JJ I-NP O
deletion NN I-NP O
of IN B-PP O
exon NN B-NP O
14 CD I-NP O
. . O O

The DT B-NP O
fourth JJ I-NP O
rearrangement NN I-NP O
grossly RB B-ADVP O
altered VBD B-VP O
the DT B-NP O
sequence NN I-NP O
within IN B-PP O
intron NN B-NP O
14 CD I-NP O
. . O O

Although IN B-SBAR O
this DT B-NP O
rearrangement NN I-NP O
did VBD B-VP O
not RB I-VP O
affect VB I-VP O
any DT B-NP O
coding VBG I-NP O
sequence NN I-NP O
of IN B-PP O
APC NN B-NP O
at IN B-PP O
the DT B-NP O
genomic JJ I-NP O
DNA NN I-NP O
level NN I-NP O
, , O O
it PRP B-NP O
caused VBD B-VP O
inappropriate JJ B-NP O
splicing NN I-NP O
of IN B-PP O
exon NN B-NP O
14 CD I-NP O
. . O O

These DT B-NP O
rearrangements NNS I-NP O
were VBD B-VP O
initially RB I-VP O
revealed VBN I-VP O
by IN B-PP O
analyzing VBG B-VP O
cDNAs NNS B-NP O
and CC O O
could MD B-VP O
not RB I-VP O
have VB I-VP O
been VBN I-VP O
identified VBN I-VP O
by IN B-PP O
using VBG B-VP O
mutation NN B-NP O
detection NN I-NP O
methods NNS I-NP O
that WDT B-NP O
screened VBD B-VP O
each DT B-NP O
exon NN I-NP O
individually RB B-ADVP O
. . O O

The DT B-NP O
identification NN I-NP O
of IN B-PP O
a DT B-NP O
rearrangement NN I-NP O
that WDT B-NP O
did VBD B-VP O
not RB I-VP O
alter VB I-VP O
any DT B-NP O
coding VBG I-NP O
exons NNS I-NP O
yet RB B-VP O
affected VBD I-VP O
the DT B-NP O
splicing NN I-NP O
further RBR B-ADVP O
underscores VBZ B-VP O
the DT B-NP O
importance NN I-NP O
of IN B-PP O
using VBG B-VP O
cDNA NN B-NP O
for IN B-PP O
mutation NN B-NP O
analysis NN I-NP O
. . O O

The DT B-NP O
identification NN I-NP O
of IN B-PP O
four CD B-NP O
genomic JJ I-NP O
rearrangements NNS I-NP O
among IN B-PP O
30 CD B-NP O
mutations NNS I-NP O
suggests VBZ B-VP O
that IN B-SBAR O
genomic JJ B-NP O
rearrangements NNS I-NP O
are VBP B-VP O
frequent JJ B-NP O
germline NN I-NP O
APC NN I-NP B-Disease
mutations NNS I-NP O
. . O O

. . O O

Detection NN B-NP O
of IN B-PP O
a DT B-NP O
novel JJ I-NP O
missense JJ I-NP O
mutation NN I-NP O
and CC O O
second JJ B-NP O
recurrent JJ I-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
CACNA1A NN I-NP O
gene NN I-NP O
in IN B-PP O
individuals NNS B-NP O
with IN B-PP O
EA NN B-NP B-Disease
- HYPH B-NP I-Disease
2 CD I-NP I-Disease
and CC O O
FHM NN B-NP B-Disease
. . O O

Mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
brain NN I-NP O
specific JJ I-NP O
P NN I-NP O
/ SYM I-NP O
Q NN I-NP O
type NN I-NP O
Ca2 NN I-NP O
+ SYM B-NP O
channel NN I-NP O
alpha1 NN I-NP O
subunit NN I-NP O
gene NN I-NP O
, , O O
CACNA1A NN B-NP O
, , O O
have VBP B-VP O
been VBN I-VP O
identified VBN I-VP O
in IN B-PP O
three CD B-NP O
clinically RB I-NP O
distinct JJ I-NP O
disorders NNS I-NP O
, , O O
viz NN B-NP O
. . O O

episodic JJ B-NP B-Disease
ataxia NN I-NP I-Disease
type NN I-NP I-Disease
2 CD I-NP I-Disease
( ( O O
EA NN B-NP B-Disease
- HYPH O I-Disease
2 CD B-NP I-Disease
) ) O O
, , O O
familial JJ B-NP B-Disease
hemiplegic JJ I-NP I-Disease
migraine NN I-NP I-Disease
( ( O O
FHM NN B-NP B-Disease
) ) O O
and CC O O
spinocerebellar JJ B-NP B-Disease
ataxia NN I-NP I-Disease
6 CD I-NP I-Disease
( ( O O
SCA6 NN B-NP B-Disease
) ) O O
. . O O

For IN B-PP O
individuals NNS B-NP O
with IN B-PP O
EA NN B-NP B-Disease
- HYPH O I-Disease
2 CD B-NP I-Disease
, , O O
the DT B-NP O
mutations NNS I-NP O
described VBN B-VP O
thus RB B-ADVP O
far RB I-ADVP O
are VBP B-VP O
presumed VBN I-VP O
to TO I-VP O
result VB I-VP O
in IN B-PP O
a DT B-NP O
truncated VBN I-NP O
protein NN I-NP O
product NN I-NP O
. . O O

Several JJ B-NP O
different JJ I-NP O
missense JJ I-NP O
mutations NNS I-NP O
have VBP B-VP O
been VBN I-VP O
identified VBN I-VP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
FHM NN B-NP B-Disease
. . O O

At IN B-NP O
least JJS I-NP O
two CD I-NP O
of IN B-PP O
these DT B-NP O
mutations NNS I-NP O
have VBP B-VP O
been VBN I-VP O
identified VBN I-VP O
on IN B-PP O
two CD B-NP O
different JJ I-NP O
chromosome NN I-NP O
19p13 CD B-NP O
haplotypes NNS I-NP O
and CC O O
thus RB B-VP O
represent VBP I-VP O
recurrent JJ B-NP O
mutations NNS I-NP O
. . O O

In IN B-PP O
the DT B-NP O
present JJ I-NP O
study NN I-NP O
, , O O
we PRP B-NP O
have VBP B-VP O
screened VBN I-VP O
several JJ B-NP O
individuals NNS I-NP O
for IN B-PP O
mutations NNS B-NP O
in IN B-PP O
all DT B-NP O
47 CD I-NP O
exons NNS I-NP O
in IN B-PP O
the DT B-NP O
CACNA1A NN I-NP O
gene NN I-NP O
by IN B-PP O
single JJ B-NP O
- HYPH I-NP O
strand NN I-NP O
conformation NN I-NP O
analysis NN I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
characterised VBN I-VP O
a DT B-NP O
novel JJ I-NP O
missense JJ I-NP O
mutation NN I-NP O
, , O O
G5260A NN B-NP O
, , O O
in IN B-PP O
exon NN B-NP O
32 CD I-NP O
in IN B-PP O
a DT B-NP O
family NN I-NP O
segregating VBG B-VP O
for IN B-PP O
EA NN B-NP B-Disease
- HYPH B-NP I-Disease
2 CD I-NP I-Disease
. . O O

The DT B-NP O
consequence NN I-NP O
of IN B-PP O
this DT B-NP O
mutation NN I-NP O
is VBZ B-VP O
an DT B-NP O
amino JJ I-NP O
acid NN I-NP O
substitution NN I-NP O
at IN B-PP O
a DT B-NP O
highly RB I-NP O
conserved VBN I-NP O
position NN I-NP O
within IN B-PP O
the DT B-NP O
CACNA1A NN I-NP O
gene NN I-NP O
. . O O

This DT B-NP O
represents VBZ B-VP O
the DT B-NP O
first JJ I-NP O
point NN I-NP O
mutation NN I-NP O
not RB B-VP O
resulting VBG I-VP O
in IN B-PP O
a DT B-NP O
proposed VBN I-NP O
truncated VBN I-NP O
protein NN I-NP O
. . O O

Furthermore RB B-ADVP O
, , O O
this DT B-NP O
mutation NN I-NP O
has VBZ B-VP O
been VBN I-VP O
detected VBN I-VP O
in IN B-PP O
a DT B-NP O
family NN I-NP O
member NN I-NP O
with IN B-PP O
mild JJ B-NP O
clinical JJ I-NP O
signs NNS I-NP O
including VBG B-PP O
only JJ B-NP O
migraine NN I-NP B-Disease
. . O O

Additionally RB B-ADVP O
, , O O
a DT B-NP O
second JJ I-NP O
previously RB I-NP O
identified VBN I-NP O
recurrent JJ I-NP O
muta NN I-NP O
tion NN I-NP O
, , O O
C2272T NN B-NP O
, , O O
in IN B-PP O
exon NN B-NP O
16 CD I-NP O
has VBZ B-VP O
been VBN I-VP O
discovered VBN I-VP O
in IN B-PP O
a DT B-NP O
patient NN I-NP O
with IN B-PP O
FHM NN B-NP B-Disease
. . O O

. . O O

Analbuminemia NN B-NP B-Disease
in IN B-PP O
a DT B-NP O
neonate NN I-NP O
. . O O

A DT B-NP O
small JJ I-NP O
- HYPH I-NP O
for IN B-PP O
- HYPH B-NP O
gestational JJ I-NP O
- HYPH I-NP O
age NN I-NP O
infant NN I-NP O
, , O O
found VBN B-VP O
to TO I-VP O
have VB I-VP O
analbuminemia NN B-NP B-Disease
in IN B-PP O
the DT B-NP O
neonatal JJ I-NP O
period NN I-NP O
, , O O
is VBZ B-VP O
reported VBN I-VP O
and CC O O
the DT B-NP O
twelve CD I-NP O
cases NNS I-NP O
recorded VBN B-VP O
in IN B-PP O
the DT B-NP O
world NN I-NP O
literature NN I-NP O
are VBP B-VP O
reviewed VBN I-VP O
. . O O

Patients NNS B-NP O
lacking VBG B-VP O
this DT B-NP O
serum NN I-NP O
protein NN I-NP O
are VBP B-VP O
essentially RB B-ADJP O
asymptomatic JJ I-ADJP O
, , O O
apart RB B-ADVP O
from IN B-PP O
minimal JJ B-NP O
ankle NN I-NP B-Disease
edema NN I-NP I-Disease
and CC O O
ease NN B-NP B-Disease
of IN B-PP I-Disease
fatigue NN B-NP I-Disease
. . O O

Apparent JJ B-NP O
compensatory JJ I-NP O
mechanisms NNS I-NP O
which WDT B-NP O
come VBP B-VP O
into IN B-PP O
play NN B-NP O
when WRB B-ADVP O
serum NN B-NP O
albumin NN I-NP O
is VBZ B-VP O
low JJ B-NP O
include NN I-NP O
prolonged VBN I-NP O
half NN I-NP O
- HYPH I-NP O
life NN I-NP O
of IN B-PP O
albumin NN B-NP O
and CC I-NP O
transferrin NN I-NP O
, , O O
an DT B-NP O
increase NN I-NP O
in IN B-PP O
serum NN B-NP O
globulins NNS I-NP O
, , O O
beta NN B-NP O
lipoprotein NN I-NP O
, , O O
and CC O O
glycoproteins NNS B-NP O
, , O O
arterial JJ B-NP B-Disease
hypotension NN I-NP I-Disease
with IN B-PP O
reduced VBN B-NP O
capillary JJ I-NP O
hydrostatic JJ I-NP O
pressure NN I-NP O
, , O O
and CC O O
the DT B-NP O
ability NN I-NP O
to TO B-VP O
respond VB I-VP O
with IN B-PP O
rapid JJ B-NP O
sodium NN I-NP O
and CC I-NP O
chloride NN I-NP O
diuresis NN I-NP O
in IN B-PP O
response NN B-NP O
to TO B-PP O
small JJ B-NP O
volume NN I-NP O
changes NNS I-NP O
. . O O

Examination NN B-NP O
of IN B-PP O
plasma NN B-NP O
amino JJ I-NP O
acids NNS I-NP O
, , O O
an DT B-NP O
investigation NN I-NP O
not RB B-VP O
previously RB I-VP O
reported VBN I-VP O
, , O O
revealed VBD B-VP O
an DT B-NP O
extremely RB I-NP O
low JJ I-NP O
plasma NN I-NP O
tryptophan NN I-NP O
level NN I-NP O
, , O O
a DT B-NP O
finding NN I-NP O
which WDT B-NP O
may MD B-VP O
be VB I-VP O
important JJ B-ADJP O
in IN B-PP O
view NN B-NP O
of IN B-PP O
the DT B-NP O
role NN I-NP O
of IN B-PP O
tryptophan NN B-NP O
in IN B-PP O
albumin NN B-NP O
synthesis NN I-NP O
. . O O

. . O O

Histidinemia NNP B-NP B-Disease
. . O O

Classical JJ B-NP O
and CC I-NP O
atypical JJ I-NP O
form NN I-NP O
in IN B-PP O
siblings NNS B-NP O
. . O O

Two CD B-NP O
brothers NNS I-NP O
, , O O
6 CD B-NP O
and CC I-NP O
13 CD I-NP O
years NNS I-NP O
old JJ B-ADJP O
, , O O
had VBD B-VP O
histidinemia NN B-NP B-Disease
. . O O

On IN B-PP O
the DT B-NP O
basis NN I-NP O
of IN B-PP O
clinical JJ B-NP O
and CC I-NP O
biochemical JJ I-NP O
observations NNS I-NP O
, , O O
the DT B-NP O
younger JJR I-NP O
boy NN I-NP O
was VBD B-VP O
considered VBN I-VP O
to TO I-VP O
have VB I-VP O
a DT B-NP O
classical JJ I-NP O
type NN I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
, , O O
while IN B-SBAR O
the DT B-NP O
older JJR I-NP O
boy NN I-NP O
had VBD B-VP O
an DT B-NP O
atypical JJ I-NP O
form NN I-NP O
characterized VBN B-VP O
by IN B-PP O
partial JJ B-NP O
impairment NN I-NP O
of IN B-PP O
the DT B-NP O
skin NN I-NP O
histidase NN I-NP O
activity NN I-NP O
and CC O O
a DT B-NP O
moderately RB I-NP O
prolonged JJ I-NP O
half NN I-NP O
- HYPH I-NP O
life NN I-NP O
of IN B-PP O
blood NN B-NP O
histidine NN I-NP O
. . O O

The DT B-NP O
mother NN I-NP O
is VBZ B-VP O
a DT B-NP O
heterozygous JJ I-NP O
carrier NN I-NP O
, , O O
while IN B-SBAR O
the DT B-NP O
father NN I-NP O
and CC I-NP O
sister NN I-NP O
seem VBP B-VP O
to TO I-VP O
be VB I-VP O
normal JJ B-ADJP O
. . O O

. . O O

Carrier JJR B-NP O
detection NN I-NP O
of IN B-PP O
pyruvate NN B-NP B-Disease
carboxylase NN I-NP I-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
fibroblasts NNS B-NP O
and CC I-NP O
lymphocytes NNS I-NP O
. . O O

Pyruvate NN B-NP O
carboxylase NN I-NP O
( ( O O
E NN B-NP O
. . O O

C NN B-NP O
. . O O

6 CD B-NP O
. . O O

4 CD B-NP O
. . I-NP O

1 CD I-NP O
. . O O

1 CD O O
) ) O O
activity NN B-NP O
was VBD B-VP O
determined VBN I-VP O
in IN B-PP O
the DT B-NP O
circulating VBG I-NP O
peripheral JJ I-NP O
lymphocytes NNS I-NP O
and CC O O
cultured VBN B-NP O
skin NN I-NP O
fibroblasts NNS I-NP O
from IN B-PP O
the DT B-NP O
family NN I-NP O
of IN B-PP O
a DT B-NP O
patient NN I-NP O
with IN B-PP O
hepatic JJ B-NP O
, , I-NP O
cerebral JJ I-NP O
, , I-NP O
renal JJ I-NP O
cortical JJ I-NP O
, , I-NP O
leukocyte NN I-NP O
, , O O
and CC O O
fibroblast NN B-NP O
pyruvate VBP B-VP B-Disease
carboxylase NN B-NP I-Disease
deficiency NN I-NP I-Disease
( ( O O
PC NN B-NP B-Disease
Portland NN I-NP I-Disease
deficiency NN I-NP I-Disease
) ) O O
. . O O

Lymphocyte NN B-NP O
activities NNS I-NP O
were VBD B-VP O
mother NN B-NP O
, , O O
33 CD B-NP O
- HYPH O O
- SYM O O
39 CD B-NP O
% NN I-NP O
; : O O
father NN B-NP O
, , O O
11 CD B-NP O
- HYPH O O
- SYM O O
29 CD B-NP O
% NN I-NP O
; : O O
brother NN B-NP O
, , O O
82 CD B-NP O
- HYPH I-NP O
- SYM I-NP O
103 CD I-NP O
% NN I-NP O
; : O O
and CC O O
sister NN B-NP O
, , O O
38 CD B-NP O
- HYPH O O
- SYM O O
48 CD B-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
lowest JJS I-NP O
normal JJ I-NP O
. . O O

Fibroblasts NNS B-NP O
from IN B-PP O
the DT B-NP O
patients NNS I-NP O
mother NN I-NP O
and CC O O
father NN B-NP O
had VBD B-VP O
42 CD B-NP O
and CC I-NP O
34 CD I-NP O
% NN I-NP O
, , O O
respectively RB B-ADVP O
, , O O
of IN B-PP O
the DT B-NP O
activity NN I-NP O
of IN B-PP O
the DT B-NP O
lowest JJS I-NP O
normal JJ I-NP O
. . O O

These DT B-NP O
data NNS I-NP O
demonstrate VBP B-VP O
that IN B-SBAR O
the DT B-NP O
disease NN I-NP O
is VBZ B-VP O
inherited VBN I-VP O
in IN B-PP O
an DT B-NP O
autosomal JJ I-NP O
recessive JJ I-NP O
manner NN I-NP O
and CC O O
that IN B-SBAR O
lymphocytes NNS B-NP O
and CC I-NP O
fibroblasts NNS I-NP O
can MD B-VP O
be VB I-VP O
used VBN I-VP O
to TO B-VP O
detect VB I-VP O
carriers NNS B-NP O
. . O O

Neither CC O O
pyruvate NN B-NP O
carboxylase NN I-NP O
nor CC O O
mitochondrial JJ B-NP O
PEPCK NN I-NP O
activity NN I-NP O
in IN B-PP O
lymphocytes NNS B-NP O
was VBD B-VP O
increased VBN I-VP O
by IN B-PP O
a DT B-NP O
21 CD I-NP O
- HYPH I-NP O
hr NN I-NP O
fast RB B-ADVP O
. . O O

Glucose NN B-NP O
- HYPH B-NP O
6 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
dehydrogenase NN I-NP O
variants NNS I-NP O
from IN B-PP O
Italian JJ B-NP O
subjects NNS I-NP O
associated VBN B-VP O
with IN B-PP O
severe JJ B-NP B-Disease
neonatal JJ I-NP I-Disease
jaundice NN I-NP I-Disease
. . O O

Screening NN B-NP O
for IN B-PP O
the DT B-NP O
G6PD NN I-NP B-Disease
deficiency NN I-NP I-Disease
was VBD B-VP O
carried VBN I-VP O
out RP B-PRT O
at IN B-PP O
the DT B-NP O
Maternity NNP I-NP O
Division NNP I-NP O
of IN B-PP O
the DT B-NP O
Galliera NNP I-NP O
Hospital NNP I-NP O
in IN B-PP O
Genoa NNP B-NP O
, , O O
Italy NNP B-NP O
. . O O

Two CD B-NP O
groups NNS I-NP O
of IN B-PP O
subjects NNS B-NP O
with IN B-PP O
hyperbilirubinaemia NN B-NP B-Disease
of IN B-PP O
non AFX B-NP O
- HYPH I-NP O
immunological JJ I-NP O
origin NN I-NP O
were VBD B-VP O
examined VBN I-VP O
( ( O O
a DT O O
) ) O O
302 CD B-NP O
newborn JJ I-NP O
babies NNS I-NP O
of IN B-PP O
Sardinian JJ B-NP O
extraction NN I-NP O
( ( O O
on IN B-PP O
cord NN B-NP O
blood NN I-NP O
) ) O O
and CC O O
( ( O O
b NN B-NP O
) ) O O
201 CD B-NP O
newborn JJ I-NP O
babies NNS I-NP O
of IN B-PP O
south JJ B-NP O
Italian JJ I-NP O
ancestry NN I-NP O
( ( O O
on IN B-PP O
peripheral JJ B-NP O
blood NN I-NP O
) ) O O
. . O O

Among IN B-PP O
503 CD B-NP O
subjects NNS I-NP O
, , O O
43 CD B-NP O
showed VBD B-VP O
an DT B-NP O
enzyme NN I-NP O
deficiency NN I-NP O
; : O O
in IN B-PP O
39 CD B-NP O
the DT B-NP O
defect NN I-NP O
was VBD B-VP O
of IN B-PP O
the DT B-NP O
Mediterranean JJ I-NP O
type NN I-NP O
. . O O

In IN B-PP O
one CD B-NP O
case NN I-NP O
, , O O
previously RB B-VP O
described VBN I-VP O
, , O O
the DT B-NP O
enzyme NN I-NP O
was VBD B-VP O
of IN B-PP O
the DT B-NP O
A NN I-NP O
- HYPH I-NP O
type NN I-NP O
. . O O

In IN B-PP O
the DT B-NP O
remaining VBG I-NP O
cases NNS I-NP O
three CD B-NP O
different JJ I-NP O
variants NNS I-NP O
were VBD B-VP O
identified VBN I-VP O
. . O O

In IN B-PP O
the DT B-NP O
present JJ I-NP O
work NN I-NP O
these DT B-NP O
three CD I-NP O
cases NNS I-NP O
, , O O
each DT B-NP O
with IN B-PP O
severe JJ B-NP B-Disease
neonatal JJ I-NP I-Disease
jaundice NN I-NP I-Disease
, , O O
are VBP B-VP O
reported VBN I-VP O
. . O O

Their PRP$ B-NP O
parents NNS I-NP O
originated VBN B-VP O
from IN B-PP O
Calabria NNP B-NP O
, , O O
from IN B-PP O
Sardinia NNP B-NP O
and CC B-PP O
from IN B-PP O
Sicily NNP B-NP O
. . O O

The DT B-NP O
abnormal JJ I-NP O
enzymes NNS I-NP O
are VBP B-VP O
respectively RB I-VP O
designated VBN I-VP O
as IN B-PP O
GdDcbrousse NN B-NP O
- HYPH B-NP O
like JJ I-NP O
, , I-NP O
GdGallura NNP I-NP O
and CC I-NP O
GdAgrigento NNP I-NP O
. . O O

. . O O

Cytogenetic JJ B-NP O
investigations NNS I-NP O
in IN B-PP O
families NNS B-NP O
with IN B-PP O
ataxia NN B-NP B-Disease
- HYPH I-NP I-Disease
telangiectasia NN I-NP I-Disease
. . O O

Chromosomal JJ B-NP O
studies NNS I-NP O
were VBD B-VP O
performed VBN I-VP O
on IN B-PP O
peripheral JJ B-NP O
blood NN I-NP O
lymphocytes NNS I-NP O
and CC O O
cultured VBN B-NP O
skin NN I-NP O
fibroblasts NNS I-NP O
from IN B-PP O
five CD B-NP O
Israeli NNP I-NP O
- HYPH I-NP O
Moroccan NNP I-NP O
families NNS I-NP O
with IN B-PP O
ataxia NN B-NP B-Disease
- HYPH I-NP I-Disease
telangiectasia NN I-NP I-Disease
. . O O

A DT B-NP O
total NN I-NP O
of IN B-PP O
24 CD B-NP O
individuals NNS I-NP O
, , O O
including VBG B-PP O
seven CD B-NP O
propositi NNS I-NP O
, , O O
was VBD B-VP O
investigated VBN I-VP O
. . O O

Among IN B-PP O
the DT B-NP O
probands NNS I-NP O
, , O O
significantly RB B-NP O
elevated JJ I-NP O
rates NNS I-NP O
of IN B-PP O
chromosome NN B-NP O
damage NN I-NP O
were VBD B-VP O
observed VBN I-VP O
in IN B-PP O
both CC O O
blood NN B-NP O
and CC I-NP O
skin NN I-NP O
. . O O

Skin NN B-NP O
fibroblasts NNS I-NP O
of IN B-PP O
affected VBN B-NP O
individuals NNS I-NP O
showed VBD B-VP O
several JJ B-NP O
orders NNS I-NP O
of IN B-PP O
magnitude NN B-NP O
more JJR I-NP O
chromosome NN I-NP O
breakage NN I-NP O
than IN B-PP O
lymphocytes NNS B-NP O
. . O O

Increased VBN B-NP O
rates NNS I-NP O
of IN B-PP O
chromosome NN B-NP O
damage NN I-NP O
were VBD B-VP O
also RB I-VP O
observed VBN I-VP O
in IN B-PP O
the DT B-NP O
fibroblasts NNS I-NP O
of IN B-PP O
some DT B-NP O
phenotypically RB I-NP O
normal JJ I-NP O
family NN I-NP O
members NNS I-NP O
( ( O O
obligate JJ B-NP O
heterozygotes NNS I-NP O
and CC I-NP O
sibs NNS I-NP O
) ) O O
when WRB B-ADVP O
compared VBN B-VP O
to TO B-PP O
normal JJ B-NP O
controls NNS I-NP O
. . O O

An DT B-NP O
apparent JJ I-NP O
abnormal JJ I-NP O
clone NN I-NP O
of IN B-PP O
cells NNS B-NP O
, , O O
possessing VBG B-VP O
a DT B-NP O
large JJ I-NP O
acrocentric JJ I-NP O
marker NN I-NP O
chromosome NN I-NP O
( ( O O
14q NN B-NP O
+ SYM B-ADJP O
) ) O O
, , O O
was VBD B-VP O
observed VBN I-VP O
in IN B-PP O
varying VBG B-NP O
proportions NNS I-NP O
among IN B-PP O
cells NNS B-NP O
of IN B-PP O
all PDT B-NP O
the DT I-NP O
propositi NN I-NP O
( ( O O
2 CD B-NP O
- HYPH I-NP O
5 CD I-NP O
% NN I-NP O
of IN B-PP O
lymphocytes NNS B-NP O
; : O O
1 CD B-NP O
- HYPH I-NP O
9 CD I-NP O
% NN I-NP O
of IN B-PP O
fibroblasts NNS B-NP O
) ) O O
. . O O

. . O O

Prenatal JJ B-NP O
diagnosis NN I-NP O
of IN B-PP O
Wolman NNP B-NP B-Disease
disease NN I-NP I-Disease
. . O O

Two CD B-NP O
pregnancies NNS I-NP O
at IN B-PP O
risk NN B-NP O
for IN B-PP O
Wolman NNP B-NP B-Disease
disease NN I-NP I-Disease
were VBD B-VP O
monitored VBN I-VP O
by IN B-PP O
assay NN B-NP O
and CC I-NP O
electrophoresis NN I-NP O
of IN B-PP O
acid NN B-NP O
lipase NN I-NP O
in IN B-PP O
cultured VBN B-NP O
amniotic JJ I-NP O
- HYPH I-NP O
fluid NN I-NP O
cells NNS I-NP O
. . O O

Cells NNS B-NP O
from IN B-PP O
patient NN B-NP O
1 CD I-NP O
had VBD B-VP O
5 CD B-NP O
% NN I-NP O
of IN B-PP O
control NN B-NP O
levels NNS I-NP O
of IN B-PP O
acid NN B-NP O
lipase NN I-NP O
, , O O
using VBG B-VP O
14C NN B-NP O
- HYPH B-NP O
triolein NN I-NP O
as IN B-PP O
substrate NN B-NP O
; : O O
however RB B-ADVP O
, , O O
when WRB B-ADVP O
artificial JJ B-NP O
substrates NNS I-NP O
( ( O O
esters NNS B-NP O
of IN B-PP O
4 CD B-NP O
- HYPH I-NP O
methylumbelliferone NN I-NP O
and CC I-NP O
p NN I-NP O
- HYPH B-NP O
nitrophenol NN I-NP O
) ) O O
were VBD B-VP O
used VBN I-VP O
to TO B-VP O
measure VB I-VP O
acid NN B-NP O
lipase NN I-NP O
, , O O
these DT B-NP O
cells NNS I-NP O
had VBD B-VP O
30 CD B-NP O
% NN I-NP O
of IN B-PP O
control NN B-NP O
levels NNS I-NP O
. . O O

Electrophoresis NN B-NP O
of IN B-PP O
cell NN B-NP O
extracts NNS I-NP O
revealed VBD B-VP O
the DT B-NP O
absence NN I-NP O
of IN B-PP O
the DT B-NP O
A NN I-NP O
form NN I-NP O
of IN B-PP O
acid NN B-NP O
lipase NN I-NP O
, , O O
consistent JJ B-ADJP O
with IN B-PP O
the DT B-NP O
diagnosis NN I-NP O
of IN B-PP O
Wolman NNP B-NP B-Disease
disease NN I-NP I-Disease
. . O O

Analysis NN B-NP O
of IN B-PP O
fetal JJ B-NP O
tissues NNS I-NP O
following VBG B-PP O
prostaglandin NN B-NP O
termination NN I-NP O
of IN B-PP O
this DT B-NP O
pregnancy NN I-NP O
confirmed VBD B-VP O
the DT B-NP O
diagnosis NN I-NP O
. . O O

Assay NN B-NP O
of IN B-PP O
fetal JJ B-NP O
- HYPH I-NP O
skin NN I-NP O
fibroblasts NNS I-NP O
with IN B-PP O
14C NN B-NP O
- HYPH O O
triolein NN B-NP O
, , O O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
with IN B-PP O
artificial JJ B-NP O
substrates NNS I-NP O
, , O O
showed VBD B-VP O
marked JJ B-NP O
deficiency NN I-NP O
of IN B-PP O
acid NN B-NP O
lipase NN I-NP O
activity NN I-NP O
. . O O

Electrophoresis NN B-NP O
of IN B-PP O
fetal JJ B-NP O
- HYPH I-NP O
tissue NN I-NP O
extracts NNS I-NP O
also RB B-ADVP O
demonstrated VBD B-VP O
the DT B-NP O
absence NN I-NP O
of IN B-PP O
the DT B-NP O
A NN I-NP O
form NN I-NP O
of IN B-PP O
acid NN B-NP O
lipase NN I-NP O
. . O O

Amniotic JJ B-NP O
- HYPH I-NP O
fluid NN I-NP O
cells NNS I-NP O
from IN B-PP O
patient NN B-NP O
2 CD I-NP O
showed VBD B-VP O
normal JJ B-NP O
levels NNS I-NP O
of IN B-PP O
acid NN B-NP O
lipase NN I-NP O
with IN B-PP O
all DT B-NP O
substrates NNS I-NP O
tested VBN B-VP O
; : O O
the DT B-NP O
electrophoretic JJ I-NP O
pattern NN I-NP O
of IN B-PP O
acid NN B-NP O
lipase NN I-NP O
was VBD B-VP O
normal JJ B-ADJP O
. . O O

The DT B-NP O
results NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
the DT B-NP O
prenatal JJ I-NP O
diagnosis NN I-NP O
of IN B-PP O
Wolman NNP B-NP B-Disease
disease NN I-NP I-Disease
be VB B-VP O
made VBN I-VP O
using VBG B-VP O
the DT B-NP O
radioassay NN I-NP O
of IN B-PP O
acid NN B-NP O
lipase NN I-NP O
and CC O O
/ SYM B-NP O
or CC O O
electrophoresis NN B-NP O
. . O O

. . O O

Malignant JJ B-NP B-Disease
neoplasms NNS I-NP I-Disease
in IN B-PP O
the DT B-NP O
families NNS I-NP O
of IN B-PP O
patients NNS B-NP O
with IN B-PP O
ataxia NN B-NP B-Disease
- HYPH B-NP I-Disease
telangiectasia NN I-NP I-Disease
. . O O

Ataxia NN B-NP B-Disease
- HYPH O I-Disease
telangiectasia NN B-NP I-Disease
( ( O O
A NN B-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
syndrome NN I-NP I-Disease
associated VBN B-VP O
with IN B-PP O
a DT B-NP O
greatly RB I-NP O
increased VBN I-NP O
incidence NN I-NP O
of IN B-PP O
malignant JJ B-NP B-Disease
neoplasms NNS I-NP I-Disease
in IN B-PP O
homozygous JJ B-NP O
affected JJ I-NP O
individuals NNS I-NP O
. . O O

Heterozygotes NNS B-NP O
for IN B-PP O
the DT B-NP O
gene NN I-NP O
for IN B-PP O
A NN B-NP B-Disease
- HYPH O I-Disease
T NN B-NP I-Disease
are VBP B-VP O
thought VBN I-VP O
to TO I-VP O
comprise VB I-VP O
about IN B-NP O
1 CD I-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
general JJ I-NP O
population NN I-NP O
and CC O O
, , O O
therefore RB B-ADVP O
, , O O
it PRP B-NP O
is VBZ B-VP O
important JJ B-ADJP O
to TO B-VP O
know VB I-VP O
whether IN B-SBAR O
this DT B-NP O
gene NN I-NP O
also RB B-ADVP O
predisposes VBZ B-VP O
the DT B-NP O
heterozygous JJ I-NP O
carrier NN I-NP O
to TO B-PP O
cancers NNS B-NP B-Disease
. . O O

Heterozygous JJ B-NP O
carriers NNS I-NP O
of IN B-PP O
this DT B-NP O
gene NN I-NP O
are VBP B-VP O
common JJ B-ADJP O
among IN B-PP O
the DT B-NP O
close JJ I-NP O
relatives NNS I-NP O
of IN B-PP O
patients NNS B-NP O
with IN B-PP O
A NN B-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
, , O O
although IN B-SBAR O
individual JJ B-NP O
carriers NNS I-NP O
cannot MD B-VP O
be VB I-VP O
identified VBN I-VP O
by IN B-PP O
any DT B-NP O
clinical JJ I-NP O
criterion NN I-NP O
or CC I-NP O
laboratory NN I-NP O
test NN I-NP O
. . O O

For IN B-PP O
this DT B-NP O
reason NN I-NP O
, , O O
we PRP B-NP O
compared VBD B-VP O
the DT B-NP O
incidence NN I-NP O
of IN B-PP O
death NN B-NP O
from IN B-PP O
malignant JJ B-NP B-Disease
neoplasms NNS I-NP I-Disease
in IN B-PP O
2 CD B-NP O
families NNS I-NP O
of IN B-PP O
patients NNS B-NP O
with IN B-PP O
A NN B-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
to TO B-PP O
that DT B-NP O
expected VBN B-VP O
in IN B-PP O
a DT B-NP O
random JJ I-NP O
sample NN I-NP O
of IN B-PP O
the DT B-NP O
general JJ I-NP O
population NN I-NP O
. . O O

There EX B-NP O
were VBD B-VP O
59 CD B-NP O
deaths NNS I-NP O
from IN B-PP O
malignant JJ B-NP B-Disease
neoplasms NNS I-NP I-Disease
in IN B-PP O
relatives NNS B-NP O
dying VBG B-VP O
before IN B-PP O
age NN B-NP O
75 CD I-NP O
, , O O
compared VBN B-VP O
to TO B-PP O
42 CD B-NP O
. . O O

6 CD B-NP O
expected VBN B-VP O
( ( O O
p NN B-NP O
less JJR B-NP O
than IN I-NP O
0 CD I-NP O
. . I-NP O

02 CD I-NP O
) ) O O
. . O O

For IN B-PP O
A NN B-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
heterozygotes NNS I-NP O
younger JJR B-ADJP O
than IN B-PP O
age NN B-NP O
45 CD I-NP O
, , O O
the DT B-NP O
risk NN I-NP O
of IN B-PP O
dying VBG B-VP O
from IN B-PP O
a DT B-NP O
malignant JJ I-NP B-Disease
neoplasm NN I-NP I-Disease
was VBD B-VP O
estimated VBN I-VP O
to TO I-VP O
be VB I-VP O
greater JJR B-ADJP O
than IN B-PP O
5 CD B-NP O
times NNS I-NP O
the DT I-NP O
risk NN I-NP O
for IN B-PP O
the DT B-NP O
general JJ I-NP O
population NN I-NP O
. . O O

A DT B-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
heterozygotes NNS I-NP O
may MD B-VP O
comprise VB I-VP O
more JJR B-NP O
than IN I-NP O
5 CD I-NP O
% NN I-NP O
of IN B-PP O
all DT B-NP O
persons NNS I-NP O
dying VBG B-VP O
from IN B-PP O
a DT B-NP O
cancer NN I-NP B-Disease
before IN B-PP O
age NN B-NP O
45 CD I-NP O
. . O O

The DT B-NP O
incidence NN I-NP O
of IN B-PP O
ovarian JJ B-NP B-Disease
, , I-NP I-Disease
gastric JJ I-NP I-Disease
, , I-NP I-Disease
and CC I-NP I-Disease
biliary JJ I-NP I-Disease
system NN I-NP I-Disease
carcinomas NNS I-NP I-Disease
and CC B-PP O
of IN B-PP O
leukemia NN B-NP B-Disease
and CC I-NP O
lymphoma NN I-NP B-Disease
was VBD B-VP O
increased VBN I-VP O
in IN B-PP O
these DT B-NP O
A NN I-NP B-Disease
- HYPH I-NP I-Disease
T NN I-NP I-Disease
families NNS I-NP O
. . O O

Other JJ B-NP O
neoplasms NNS I-NP B-Disease
that WDT B-NP O
may MD B-VP O
be VB I-VP O
associated VBN I-VP O
with IN B-PP O
this DT B-NP O
gene NN I-NP O
in IN B-PP O
heterozygotes NNS B-NP O
include VBP B-VP O
pancreatic JJ B-NP B-Disease
, , I-NP I-Disease
basal JJ I-NP I-Disease
cell NN I-NP I-Disease
, , O I-Disease
colonic JJ B-NP I-Disease
, , I-NP I-Disease
breast NN I-NP I-Disease
, , O I-Disease
and CC O I-Disease
cervical JJ B-NP I-Disease
carcinomas NNS I-NP I-Disease
. . O O

Striking VBG B-VP O
prevalence NN B-NP O
of IN B-PP O
ankylosing VBG B-VP B-Disease
spondylitis NN B-NP I-Disease
in IN B-PP O
healthy JJ I-NP O
w27 NN I-NP O
positive JJ I-NP O
males NNS I-NP O
and CC I-NP O
females NNS I-NP O
. . O O

Ankylosing VBG B-VP B-Disease
spondylitis NN B-NP I-Disease
is VBZ B-VP O
diagnosed VBN I-VP O
once RB B-ADVP O
or CC I-ADVP O
twice RB I-ADVP O
in IN B-PP O
each DT B-NP O
1000 CD I-NP O
males NNS I-NP O
and CC O O
one CD B-NP O
tenth NN I-NP O
as RB B-ADVP O
frequently RB I-ADVP O
in IN B-PP O
females NNS B-NP O
, , O O
but CC O O
the DT B-NP O
true JJ I-NP O
prevalence NN I-NP O
is VBZ B-VP O
unknown JJ B-ADJP O
. . O O

Indentification NN B-NP O
of IN B-PP O
genetic JJ B-NP O
marker NN I-NP O
, , O O
HL NN B-NP O
- HYPH B-NP O
A NN I-NP O
W27 NN I-NP O
, , O O
for IN B-PP O
susceptible JJ B-NP O
persons NNS I-NP O
has VBZ B-VP O
provided VBN I-VP O
a DT B-NP O
tool NN I-NP O
facilitating VBG B-VP O
epidemiologic JJ B-NP O
studies NNS I-NP O
and CC O O
allowing VBG B-VP O
identification NN B-NP O
of IN B-PP O
control NN I-NP O
populations NNS I-NP O
without IN B-PP O
the DT B-NP O
marker NN I-NP O
. . O O

Evaluation NN B-NP O
by IN B-PP O
postal JJ B-NP O
questionnaires NNS I-NP O
, , O O
and CC O O
pelvic JJ B-NP O
radiography NN I-NP O
of IN B-PP O
78 CD B-NP O
HL NN I-NP O
- HYPH O O
A DT B-NP O
27W NN I-NP O
- HYPH B-NP O
positive JJ I-NP O
blood NN I-NP O
donors NNS I-NP O
selected VBN B-VP O
from IN B-PP O
a DT B-NP O
group NN I-NP O
of IN B-PP O
apparently RB B-NP O
healthy JJ I-NP O
subjects NNS I-NP O
revealed VBD B-VP O
14 CD B-NP O
who WP B-NP O
satisfied VBD B-VP O
the DT B-NP O
criteria NNS I-NP O
for IN B-PP O
definite JJ B-NP O
ankylosing NN I-NP B-Disease
spondylitis NN I-NP I-Disease
. . O O

The DT B-NP O
prevalence NN I-NP O
was VBD B-VP O
similar JJ B-ADJP O
in IN B-PP O
both DT B-NP O
sexes NNS I-NP O
. . O O

One CD B-NP O
hundred CD I-NP O
and CC I-NP O
twenty CD I-NP O
- HYPH I-NP O
six CD I-NP O
W27 NN I-NP O
- HYPH I-NP O
negative JJ I-NP O
controls NNS I-NP O
matched VBN B-VP O
for IN B-PP O
race NN B-NP O
, , O O
sex NN B-NP O
, , O O
and CC O O
age NN B-NP O
failed VBD B-VP O
to TO I-VP O
yield VB I-VP O
a DT B-NP O
single JJ I-NP O
case NN I-NP O
. . O O

For IN B-PP O
a DT B-NP O
person NN I-NP O
of IN B-PP O
either CC O O
sex NN B-NP O
with IN B-PP O
HL NN B-NP O
- HYPH I-NP O
A NN I-NP O
W27 NN I-NP O
, , O O
there EX B-NP O
appears VBZ B-VP O
to TO I-VP O
be VB I-VP O
about IN B-PP O
a DT B-NP O
20 CD I-NP O
per IN B-PP O
cent NN B-NP O
chance NN I-NP O
that IN B-SBAR O
ankylosing VBG B-VP B-Disease
spondylitis NN B-NP I-Disease
will MD B-VP O
develop VB I-VP O
, , O O
suggesting VBG B-VP O
a DT B-NP O
prevalence NN I-NP O
of IN B-PP O
10 CD B-NP O
to TO B-PP O
15 CD B-NP O
per IN B-PP O
thousand CD B-NP O
. . O O

Hitherto NNP B-NP O
accepted VBD B-VP O
figures NNS B-NP O
may MD B-VP O
underestimate VB I-VP O
the DT B-NP O
frequency NN I-NP O
by IN B-PP O
a DT B-NP O
factor NN I-NP O
of IN B-PP O
10 CD B-NP O
to TO I-NP O
20 CD I-NP O
. . O O

. . O O

Analbuminemia NN B-NP B-Disease
in IN B-PP O
an DT B-NP O
American JJ I-NP O
Indian JJ I-NP O
girl NN I-NP O
. . O O

Analbuminemia NN B-NP B-Disease
was VBD B-VP O
fortuitously RB I-VP O
detected VBN I-VP O
in IN B-PP O
a DT B-NP O
nonedematous JJ I-NP O
12 CD I-NP O
- HYPH I-NP O
year NN I-NP O
- HYPH O O
old JJ B-NP O
American JJ I-NP O
Indian JJ I-NP O
girl NN I-NP O
with IN B-PP O
atopic JJ B-NP B-Disease
dermatitis NN I-NP I-Disease
, , O O
mild JJ B-NP O
bronchial JJ I-NP B-Disease
asthma NN I-NP I-Disease
, , O O
a DT B-NP O
mild JJ I-NP O
seizure NN I-NP B-Disease
disorder NN I-NP I-Disease
, , O O
and CC O O
hyperlipoproteinemia NN B-NP B-Disease
with IN B-PP O
a DT B-NP O
corneal JJ I-NP B-Disease
arcus NN I-NP I-Disease
. . O O

Immunologic JJ B-NP O
methods NNS I-NP O
revealed VBD B-VP O
trace NN B-NP O
amounts NNS I-NP O
( ( O O
17 CD B-NP O
mg NN I-NP O
/ SYM B-NP O
100 CD B-NP O
ml NN I-NP O
) ) O O
of IN B-PP O
apparently RB B-NP O
normal JJ I-NP O
serum NN I-NP O
albumin NN I-NP O
. . O O

The DT B-NP O
patients NNS I-NP O
parents NNS I-NP O
were VBD B-VP O
remotely RB B-ADJP O
related VBN I-ADJP O
. . O O

The DT B-NP O
pedigree NN I-NP O
and CC O O
clinical JJ B-NP O
findings NNS I-NP O
were VBD B-VP O
compatible JJ B-ADJP O
with IN B-PP O
autosomal JJ B-NP O
recessive JJ I-NP O
transmission NN I-NP O
of IN B-PP O
analbuminemia NN B-NP B-Disease
. . O O

Heterozygotes NNS B-NP O
had VBD B-VP O
subnormal JJ B-NP O
levels NNS I-NP O
of IN B-PP O
serum NN B-NP O
albumin NN I-NP O
. . O O

The DT B-NP O
Gc NN I-NP O
- HYPH I-NP O
locus NN I-NP O
is VBZ B-VP O
closely RB I-VP O
linked VBN I-VP O
to TO B-PP O
the DT B-NP O
structural JJ I-NP O
albumin NN I-NP O
locus NN I-NP O
. . O O

Gc NN B-NP O
- HYPH I-NP O
protein NN I-NP O
levels NNS I-NP O
were VBD B-VP O
normal JJ B-ADJP O
in IN B-PP O
the DT B-NP O
patient NN I-NP O
and CC O O
together RB B-ADVP O
with IN B-PP O
normal JJ B-NP O
chromosomal JJ I-NP O
banding NN I-NP O
studies NNS I-NP O
make VBP B-VP O
it PRP B-NP O
unlikely JJ B-ADJP O
that IN B-SBAR O
a DT B-NP O
chromosomal JJ I-NP O
deletion NN I-NP O
caused VBD B-VP O
analbuminemia NN B-NP B-Disease
. . O O

Gc NN B-NP O
- HYPH I-NP O
types NNS I-NP O
in IN B-PP O
the DT B-NP O
family NN I-NP O
were VBD B-VP O
compatible JJ B-ADJP O
with IN B-PP O
, , O O
but CC O O
did VBD B-VP O
not RB I-VP O
prove VB I-VP O
, , O O
linkage NN B-NP O
of IN B-PP O
analbuminemia NN B-NP B-Disease
to TO B-PP O
the DT B-NP O
Gc NN I-NP O
- HYPH B-NP O
locus NN I-NP O
. . O O

These DT B-NP O
findings NNS I-NP O
suggest VBP B-VP O
a DT B-NP O
thalassemia NN I-NP B-Disease
- HYPH B-NP O
like JJ I-NP O
mutation NN I-NP O
for IN B-PP O
this DT B-NP O
disorder NN I-NP O
. . O O

. . O O

Deletion NN B-NP O
of IN B-PP O
the DT B-NP O
KIT NN I-NP O
and CC I-NP O
PDGFRA NN I-NP O
genes NNS I-NP O
in IN B-PP O
a DT B-NP O
patient NN I-NP O
with IN B-PP O
piebaldism NN B-NP B-Disease
. . O O

We PRP B-NP O
have VBP B-VP O
previously RB I-VP O
shown VBN I-VP O
that IN B-SBAR O
human JJ B-NP O
piebaldism NN I-NP B-Disease
results VBZ B-VP O
from IN B-PP O
mutations NNS B-NP O
of IN B-PP O
the DT B-NP O
KIT NN I-NP O
gene NN I-NP O
, , O O
which WDT B-NP O
encodes VBZ B-VP O
the DT B-NP O
receptor NN I-NP O
for IN B-PP O
the DT B-NP O
mast NN I-NP O
/ SYM B-NP O
stem NN I-NP O
cell NN I-NP O
growth NN I-NP O
factor NN I-NP O
and CC O O
is VBZ B-VP O
located VBN I-VP O
in IN B-PP O
chromosome NN B-NP O
segment NN I-NP O
4q12 CD I-NP O
. . O O

Using VBG B-VP O
DNA NN B-NP O
of IN B-PP O
a DT B-NP O
patient NN I-NP O
with IN B-PP O
piebaldism NN B-NP B-Disease
, , O O
mental JJ B-NP B-Disease
retardation NN I-NP I-Disease
, , O O
and CC O O
multiple JJ B-NP B-Disease
congenital JJ I-NP I-Disease
anomalies NNS I-NP I-Disease
associated VBN B-VP O
with IN B-PP O
a DT B-NP O
46 CD I-NP O
, , O O
XY NN B-NP O
, , O O
del NN B-NP O
( ( O O
4 CD B-NP O
) ) O O
( ( O O
q12q21 NN B-NP O
. . O O

1 CD O O
) ) O O
karyotype NN B-NP O
, , O O
we PRP B-NP O
carried VBD B-VP O
out RP B-PRT O
quantitative JJ B-NP O
Southern JJ I-NP O
blot NN I-NP O
hybridization NN I-NP O
analyses NNS I-NP O
of IN B-PP O
the DT B-NP O
KIT NN I-NP O
gene NN I-NP O
and CC O O
the DT B-NP O
adjacent JJ I-NP O
PDGFRA NN I-NP O
( ( O O
platelet NN B-NP O
- HYPH O O
derived VBN B-NP O
growth NN I-NP O
factor NN I-NP O
receptor NN I-NP O
alpha NN I-NP O
subunit NN I-NP O
) ) O O
genes NNS B-NP O
. . O O

The DT B-NP O
patient NN I-NP O
was VBD B-VP O
hemizygous JJ B-ADJP O
for IN B-PP O
both CC O O
the DT B-NP O
KIT NN I-NP O
and CC I-NP O
PDGFRA NN I-NP O
genes NNS I-NP O
, , O O
indicating VBG B-VP O
that IN B-SBAR O
both DT B-NP O
of IN B-PP O
these DT B-NP O
genes NNS I-NP O
are VBP B-VP O
included VBN I-VP O
within IN B-PP O
the DT B-NP O
deleted VBN I-NP O
region NN I-NP O
. . O O

Therefore RB B-ADVP O
, , O O
deletion NN B-NP O
of IN B-PP O
the DT B-NP O
KIT NN I-NP O
and CC I-NP O
PDGFRA NN I-NP O
genes NNS I-NP O
may MD B-VP O
account VB I-VP O
for IN B-PP O
the DT B-NP O
piebald JJ I-NP B-Disease
phenotype NN I-NP O
in IN B-PP O
this DT B-NP O
patient NN I-NP O
. . O O

A DT B-NP O
germ NN I-NP O
line NN I-NP O
mutation NN I-NP O
within IN B-PP O
the DT B-NP O
coding VBG I-NP O
sequence NN I-NP O
for IN B-PP O
the DT B-NP O
putative JJ I-NP O
5 CD I-NP O
- HYPH I-NP O
phosphoribosyl NN I-NP O
- HYPH B-NP O
1 CD I-NP O
- HYPH I-NP O
pyrophosphate NN I-NP O
binding NN I-NP O
site NN I-NP O
of IN B-PP O
hypoxanthine NN B-NP O
- HYPH O O
guanine NN B-NP O
phosphoribosyltransferase NN I-NP O
( ( O O
HPRT NN B-NP O
) ) O O
in IN B-PP O
a DT B-NP O
Lesch NNP I-NP B-Disease
- HYPH I-NP I-Disease
Nyhan NNP I-NP I-Disease
patient NN I-NP O
: : O O
missense JJ B-NP O
mutations NNS I-NP O
within IN B-PP O
a DT B-NP O
functionally RB I-NP O
important JJ I-NP O
region NN I-NP O
probably RB B-ADVP O
cause VBP B-VP O
disease NN B-NP O
. . O O

Lesch NNP B-NP B-Disease
- HYPH I-NP I-Disease
Nyhan NNP I-NP I-Disease
syndrome NN I-NP I-Disease
caused VBN B-VP O
by IN B-PP O
a DT B-NP O
complete JJ I-NP B-Disease
deficiency NN I-NP I-Disease
of IN B-PP I-Disease
hypoxanthine NN B-NP I-Disease
guanine NN I-NP I-Disease
phosphoribosyltransferase NN I-NP I-Disease
( ( O O
HPRT NN B-NP O
) ) O O
is VBZ B-VP O
the DT B-NP O
result NN I-NP O
of IN B-PP O
a DT B-NP O
heterogeneous JJ I-NP O
group NN I-NP O
of IN B-PP O
germ NN B-NP O
line NN I-NP O
mutations NNS I-NP O
. . O O

Identification NN B-NP O
of IN B-PP O
each DT B-NP O
mutant JJ I-NP O
gene NN I-NP O
provides VBZ B-VP O
valuable JJ B-NP O
information NN I-NP O
as IN B-PP O
to TO B-PP O
the DT B-NP O
type NN I-NP O
of IN B-PP O
mutation NN B-NP O
that WDT B-NP O
occurs VBZ B-VP O
spontaneously RB B-ADVP O
. . O O

We PRP B-NP O
report VBP B-VP O
here RB B-ADVP O
a DT B-NP O
newly RB I-NP O
identified VBN I-NP O
HPRT NN I-NP O
mutation NN I-NP O
in IN B-PP O
a DT B-NP O
Japanese JJ I-NP O
patient NN I-NP O
with IN B-PP O
Lesch NNP B-NP B-Disease
- HYPH I-NP I-Disease
Nyhan NNP I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

This DT B-NP O
gene NN I-NP O
, , O O
designated VBN B-VP O
HPRT NNP B-NP O
Tokyo NNP I-NP O
, , O O
had VBD B-VP O
a DT B-NP O
single JJ I-NP O
nucleotide NN I-NP O
change NN I-NP O
from IN B-PP O
G NN B-NP O
to TO B-PP O
A NN B-NP O
, , O O
as IN B-SBAR O
identified VBN B-VP O
by IN B-PP O
sequencing NN B-NP O
cDNA NN I-NP O
amplified VBN B-VP O
by IN B-PP O
the DT B-NP O
polymerase NN I-NP O
chain NN I-NP O
reaction NN I-NP O
. . O O

Allele NN B-NP O
specific JJ I-NP O
oligonucleotide NN I-NP O
hybridization NN I-NP O
analysis NN I-NP O
using VBG B-VP O
amplified VBN B-NP O
genomic JJ I-NP O
DNA NN I-NP O
showed VBD B-VP O
that IN B-SBAR O
the DT B-NP O
mutant JJ I-NP O
gene NN I-NP O
was VBD B-VP O
transmitted VBN I-VP O
from IN B-PP O
the DT B-NP O
maternal JJ I-NP O
germ NN I-NP O
line NN I-NP O
. . O O

This DT B-NP O
mutation NN I-NP O
would MD B-VP O
lead VB I-VP O
to TO B-PP O
an DT B-NP O
amino JJ I-NP O
acid NN I-NP O
substitution NN I-NP O
of IN B-PP O
Asp NN B-NP O
for IN B-PP O
Gly NN B-NP O
at IN B-PP O
the DT B-NP O
amino JJ I-NP O
acid NN I-NP O
position NN I-NP O
140 CD I-NP O
located JJ I-NP O
within IN B-PP O
the DT B-NP O
putative JJ I-NP O
5 CD I-NP O
- HYPH I-NP O
phosphoribosyl NN I-NP O
- HYPH B-NP O
1 CD I-NP O
- HYPH I-NP O
pyrophosphate NN I-NP O
( ( O O
PRPP NN B-NP O
) ) O O
binding NN B-NP O
region NN I-NP O
. . O O

Missense JJ B-NP O
mutations NNS I-NP O
in IN B-PP O
human JJ B-NP O
HPRT NN I-NP B-Disease
deficient JJ B-NP I-Disease
patients NNS I-NP O
thus RB B-ADVP O
far RB B-VP O
reported VBN I-VP O
tend NN B-NP O
to TO B-VP O
accumulate VB I-VP O
in IN B-PP O
this DT B-NP O
functionally RB I-NP O
active JJ I-NP O
region NN I-NP O
. . O O

However RB B-ADVP O
, , O O
a DT B-NP O
comparison NN I-NP O
of IN B-PP O
the DT B-NP O
data NNS I-NP O
suggested VBD B-VP O
that IN B-SBAR O
both CC B-NP O
missense JJ I-NP O
and CC I-NP O
synonymous JJ I-NP O
mutations NNS I-NP O
can MD B-VP O
occur VB I-VP O
at IN B-PP O
any DT B-NP O
coding VBG I-NP O
sequence NN I-NP O
of IN B-PP O
the DT B-NP O
human JJ I-NP O
germ NN I-NP O
line NN I-NP O
HPRT NN I-NP O
gene NN I-NP O
, , O O
but CC O O
that IN B-SBAR O
a DT B-NP O
limited JJ I-NP O
percentage NN I-NP O
of IN B-PP O
all PDT B-NP O
the DT I-NP O
missense JJ I-NP O
mutations NNS I-NP O
cause VBP B-VP O
disease NN B-NP O
. . O O

The DT B-NP O
probability NN I-NP O
that IN B-SBAR O
a DT B-NP O
mutation NN I-NP O
will MD B-VP O
cause VB I-VP O
disease NN B-NP O
tends VBZ B-VP O
to TO I-VP O
be VB I-VP O
higher JJR B-ADJP O
when WRB B-ADVP O
the DT B-NP O
missense JJ I-NP O
mutation NN I-NP O
is VBZ B-VP O
within IN B-PP O
a DT B-NP O
functionally RB I-NP O
important JJ I-NP O
sequence NN I-NP O
. . O O

. . O O

Characterisation NN B-NP O
of IN B-PP O
a DT B-NP O
new JJ I-NP O
rare JJ I-NP O
fragile JJ I-NP O
site NN I-NP O
easily RB B-VP O
confused VBN I-VP O
with IN B-PP O
the DT B-NP O
fragile JJ I-NP B-Disease
X NN I-NP I-Disease
. . O O

A DT B-NP O
new JJ I-NP O
fragile JJ I-NP O
site NN I-NP O
( ( O O
FRAXE NN B-NP O
) ) O O
in IN B-PP O
Xq28 NN B-NP O
is VBZ B-VP O
described VBN I-VP O
. . O O

It PRP B-NP O
appears VBZ B-VP O
to TO I-VP O
be VB I-VP O
a DT B-NP O
typical JJ I-NP O
folate NN I-NP O
sensitive JJ I-NP O
fragile JJ I-NP O
site NN I-NP O
. . O O

The DT B-NP O
fragile JJ I-NP O
site NN I-NP O
is VBZ B-VP O
not RB I-VP O
associated VBN I-VP O
with IN B-PP O
mental JJ B-NP B-Disease
retardation NN I-NP I-Disease
, , O O
it PRP B-NP O
does VBZ B-VP O
not RB I-VP O
give VB I-VP O
abnormal JJ B-NP O
results NNS I-NP O
when WRB B-ADVP O
subjected VBN B-VP O
to TO B-PP O
Southern JJ B-NP O
analysis NN I-NP O
with IN B-PP O
probe NN B-NP O
pfxa3 NN I-NP O
which WDT B-NP O
detects VBZ B-VP O
the DT B-NP O
unstable JJ I-NP O
DNA NN I-NP O
sequence NN I-NP O
characteristic JJ B-ADJP O
of IN B-PP O
fragile JJ B-NP B-Disease
X NN I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

In FW B-NP O
situ FW I-NP O
hybridization NN I-NP O
mapping NN I-NP O
locates VBZ B-VP O
the DT B-NP O
fragile JJ I-NP O
site NN I-NP O
between IN B-PP O
150 CD B-NP O
kb NN I-NP O
and CC O O
600 CD B-NP O
kb NN I-NP O
distal JJ B-ADJP O
to TO B-PP O
FRAXA NN B-NP O
. . O O

The DT B-NP O
distinction NN I-NP O
between IN B-PP O
the DT B-NP O
two CD I-NP O
fragile JJ I-NP O
sites NNS I-NP O
is VBZ B-VP O
important JJ B-ADJP O
clinically RB B-ADVP O
since IN B-PP O
cytogenetic JJ B-NP O
detection NN I-NP O
of IN B-PP O
FRAXE NN B-NP O
, , O O
without IN B-PP O
molecular JJ B-NP O
analysis NN I-NP O
, , O O
could MD B-VP O
result VB I-VP O
in IN B-PP O
misdiagnosis NN B-NP O
of IN B-PP O
fragile JJ B-NP B-Disease
X NN I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

. . O O

The DT B-NP O
Norrie NNP I-NP B-Disease
disease NN I-NP I-Disease
gene NN I-NP O
maps VBZ B-VP O
to TO B-PP O
a DT B-NP O
150 CD I-NP O
kb NN I-NP O
region NN I-NP O
on IN B-PP O
chromosome NN B-NP O
Xp11 NN I-NP O
. . B-NP O

3 CD I-NP O
. . O O

Norrie NN B-NP B-Disease
disease NN I-NP I-Disease
is VBZ B-VP O
a DT B-NP O
human JJ I-NP O
X NN I-NP B-Disease
- HYPH O I-Disease
linked VBN B-VP I-Disease
recessive JJ B-NP I-Disease
disorder NN I-NP I-Disease
of IN B-PP O
unknown JJ B-NP O
etiology NN I-NP O
characterized VBN B-VP O
by IN B-PP O
congenital JJ B-NP B-Disease
blindness NN I-NP I-Disease
, , O O
sensory JJ B-NP B-Disease
neural JJ I-NP I-Disease
deafness NN I-NP I-Disease
and CC O O
mental JJ B-NP B-Disease
retardation NN I-NP I-Disease
. . O O

This DT B-NP O
disease NN I-NP O
gene NN I-NP O
was VBD B-VP O
previously RB I-VP O
linked VBN I-VP O
to TO B-PP O
the DT B-NP O
DXS7 NN I-NP O
( ( O O
L1 NN B-NP O
. . O O

28 CD O O
) ) O O
locus NN B-NP O
and CC O O
the DT B-NP O
MAO NN I-NP O
genes NNS I-NP O
in IN B-PP O
band NN B-NP O
Xp11 NN I-NP O
. . O O

3 CD B-NP O
3 CD I-NP O
. . O O

We PRP B-NP O
report VBP B-VP O
here RB B-ADVP O
fine JJ B-NP O
physical JJ I-NP O
mapping NN I-NP O
of IN B-PP O
the DT B-NP O
obligate JJ I-NP O
region NN I-NP O
containing VBG B-VP O
the DT B-NP O
Norrie NNP I-NP B-Disease
disease NN I-NP I-Disease
gene NN I-NP O
( ( O O
NDP NN B-NP O
) ) O O
defined VBN B-VP O
by IN B-PP O
a DT B-NP O
recombination NN I-NP O
and CC B-PP O
by IN B-PP O
the DT B-NP O
smallest JJS I-NP O
submicroscopic JJ I-NP O
chromosomal JJ I-NP O
deletion NN I-NP O
associated VBN B-VP O
with IN B-PP O
Norrie NNP B-NP B-Disease
disease NN I-NP I-Disease
identified VBD B-VP O
to TO B-PP O
date NN B-NP O
. . O O

Analysis NN B-NP O
, , O O
using VBG B-VP O
in IN B-PP O
addition NN B-NP O
two CD I-NP O
overlapping VBG I-NP O
YAC NN I-NP O
clones NNS I-NP O
from IN B-PP O
this DT B-NP O
region NN I-NP O
, , O O
allowed VBD B-VP O
orientation NN B-NP O
of IN B-PP O
the DT B-NP O
MAOA NN I-NP O
and CC I-NP O
MAOB NN I-NP O
genes NNS I-NP O
in IN B-PP O
a DT B-NP O
5 CD I-NP O
- HYPH I-NP O
3 CD I-NP O
- HYPH I-NP O
3 CD I-NP O
- HYPH I-NP O
5 CD I-NP O
configuration NN I-NP O
. . O O

A DT B-NP O
recombination NN I-NP O
event NN I-NP O
between IN B-PP O
a DT B-NP O
( ( I-NP O
GT NN I-NP O
) ) I-NP O
n NN I-NP O
polymorphism NN I-NP O
in IN B-PP O
intron NN B-NP O
2 CD I-NP O
of IN B-PP O
the DT B-NP O
MAOB NN I-NP O
gene NN I-NP O
and CC O O
the DT B-NP O
NDP NN I-NP O
locus NN I-NP O
, , O O
in IN B-PP O
a DT B-NP O
family NN I-NP O
previously RB B-VP O
reported VBN I-VP O
to TO I-VP O
have VB I-VP O
a DT B-NP O
recombination NN I-NP O
between IN B-PP O
DXS7 NN B-NP O
and CC I-NP O
NDP NN I-NP O
, , O O
delineates VBZ B-VP O
a DT B-NP O
flanking JJ I-NP O
marker NN I-NP O
telomeric JJ B-ADJP O
to TO B-PP O
this DT B-NP O
disease NN I-NP O
gene NN I-NP O
. . O O

An DT B-NP O
anonymous JJ I-NP O
DNA NN I-NP O
probe NN I-NP O
, , O O
dc12 NN B-NP O
, , O O
present JJ B-ADJP O
in IN B-PP O
one CD B-NP O
of IN B-PP O
the DT B-NP O
YACs NNS I-NP O
and CC B-PP O
in IN B-PP O
a DT B-NP O
patient NN I-NP O
with IN B-PP O
a DT B-NP O
submicroscopic JJ I-NP O
deletion NN I-NP O
which WDT B-NP O
includes VBZ B-VP O
MAOA NN B-NP O
and CC I-NP O
MAOB NN I-NP O
but CC B-NP O
not RB I-NP O
L1 NN B-NP O
. . O O

28 CD B-NP O
, , O O
serves VBZ B-VP O
as IN B-PP O
a DT B-NP O
flanking NN I-NP O
marker NN I-NP O
centromeric JJ B-ADJP O
to TO B-PP O
the DT B-NP O
disease NN I-NP O
gene NN I-NP O
. . O O

An DT B-NP O
Alu NN I-NP O
- HYPH B-NP O
PCR NN I-NP O
fragment NN I-NP O
from IN B-PP O
the DT B-NP O
right JJ I-NP O
arm NN I-NP O
of IN B-PP O
the DT B-NP O
MAO NN I-NP O
YAC NN I-NP O
( ( O O
YMAO NN B-NP O
. . I-NP O

AluR NN I-NP O
) ) O O
is VBZ B-VP O
not RB I-VP O
deleted VBN I-VP O
in IN B-PP O
this DT B-NP O
patient NN I-NP O
and CC O O
also RB B-VP O
delineates VBZ I-VP O
the DT B-NP O
centromeric JJ I-NP O
extent NN I-NP O
of IN B-PP O
the DT B-NP O
obligate JJ I-NP O
disease NN I-NP O
region NN I-NP O
. . O O

The DT B-NP O
apparent JJ I-NP O
order NN I-NP O
of IN B-PP O
these DT B-NP O
loci NNS I-NP O
is VBZ B-VP O
telomere JJ B-ADJP O
. . O O

DXS7 NN B-NP O
- HYPH I-NP O
MAOA NN I-NP O
- HYPH B-NP O
MAOB NN I-NP O
- HYPH B-NP O
NDP NN I-NP O
- HYPH B-NP O
dc12 NN I-NP O
- HYPH O O
YMAO NN B-NP O
DXS7 NN I-NP O
- HYPH B-NP O
MAOA NN I-NP O
- HYPH B-NP O
MAOB NN I-NP O
- HYPH B-NP O
NDP NN I-NP O
- HYPH B-NP O
dc12 NN I-NP O
- HYPH B-NP O
YMAO NN I-NP O
. . O O

AluR NN B-NP O
. . I-NP O

centromere NNP I-NP O
. . O O

Together RB B-ADVP O
these DT B-NP O
data NNS I-NP O
define VBP B-VP O
the DT B-NP O
obligate JJ I-NP O
region NN I-NP O
containing VBG B-VP O
the DT B-NP O
NDP NN I-NP O
gene NN I-NP O
to TO B-PP O
a DT B-NP O
chromosomal JJ I-NP O
segment NN I-NP O
less JJR B-NP O
than IN I-NP O
150 CD I-NP O
kb NN I-NP O
. . O O

Molecular JJ B-NP O
basis NN I-NP O
of IN B-PP O
phenylketonuria NN B-NP B-Disease
and CC O O
related JJ B-NP O
hyperphenylalaninemias NNS I-NP B-Disease
: : O O
mutations NNS B-NP O
and CC I-NP O
polymorphisms NNS I-NP O
in IN B-PP O
the DT B-NP O
human JJ I-NP O
phenylalanine NN I-NP O
hydroxylase NN I-NP O
gene NN I-NP O
. . O O

Mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
human JJ I-NP O
phenylalanine NN I-NP O
hydroxylase NN I-NP O
gene NN I-NP O
producing VBG B-VP O
phenylketonuria NN B-NP B-Disease
or CC I-NP O
hyperphenylalaninemia NN I-NP B-Disease
have VBP B-VP O
now RB I-VP O
been VBN I-VP O
identified VBN I-VP O
in IN B-PP O
many JJ B-NP O
patients NNS I-NP O
from IN B-PP O
various JJ B-NP O
ethnic JJ I-NP O
groups NNS I-NP O
. . O O

These DT B-NP O
mutations NNS I-NP O
all DT B-ADVP O
exhibit VBP B-VP O
a DT B-NP O
high JJ I-NP O
degree NN I-NP O
of IN B-PP O
association NN B-NP O
with IN B-PP O
specific JJ B-NP O
restriction NN I-NP O
fragment NN I-NP O
- HYPH B-NP O
length NN I-NP O
polymorphism NN I-NP O
haplotypes NNS I-NP O
at IN B-PP O
the DT B-NP O
PAH NN I-NP O
locus NN I-NP O
. . O O

About IN B-NP O
50 CD I-NP O
of IN B-PP O
these DT B-NP O
mutations NNS I-NP O
are VBP B-VP O
single JJ B-ADJP O
- HYPH B-NP O
base NN I-NP O
substitutions NNS I-NP O
, , O O
including VBG B-PP O
six CD B-NP O
nonsense JJ I-NP O
mutations NNS I-NP O
and CC O O
eight CD B-NP O
splicing NN I-NP O
mutations NNS I-NP O
, , O O
with IN B-PP O
the DT B-NP O
remainder NN I-NP O
being VBG B-VP O
missense JJ B-NP O
mutations NNS I-NP O
. . O O

One CD B-NP O
splicing NN I-NP O
mutation NN I-NP O
results VBZ B-VP O
in IN B-PP O
a DT B-NP O
3 CD I-NP O
amino NN I-NP O
acid NN I-NP O
in IN B-PP O
- HYPH B-NP O
frame NN I-NP O
insertion NN I-NP O
. . O O

Two CD B-NP O
or CC I-NP O
3 CD I-NP O
large JJ I-NP O
deletions NNS I-NP O
, , O O
2 CD B-NP O
single JJ I-NP O
codon NN I-NP O
deletions NNS I-NP O
, , O O
and CC O O
2 CD B-NP O
single JJ I-NP O
base NN I-NP O
deletions NNS I-NP O
have VBP B-VP O
been VBN I-VP O
found VBN I-VP O
. . O O

Twelve CD B-NP O
of IN B-PP O
the DT B-NP O
missense JJ I-NP O
mutations NNS I-NP O
apparently RB B-ADVP O
result VBP B-VP O
from IN B-PP O
the DT B-NP O
methylation NN I-NP O
and CC I-NP O
subsequent JJ I-NP O
deamination NN I-NP O
of IN B-PP O
highly RB B-NP O
mutagenic JJ I-NP O
CpG NN I-NP O
dinucleotides NNS I-NP O
. . O O

Recurrent JJ B-NP O
mutation NN I-NP O
has VBZ B-VP O
been VBN I-VP O
observed VBN I-VP O
at IN B-PP O
several JJ B-NP O
of IN B-PP O
these DT B-NP O
sites NNS I-NP O
, , O O
producing VBG B-VP O
associations NNS B-NP O
with IN B-PP O
different JJ B-NP O
haplotypes NNS I-NP O
in IN B-PP O
different JJ B-NP O
populations NNS I-NP O
. . O O

About IN B-NP O
half NN I-NP O
of IN B-PP O
all DT B-NP O
missense JJ I-NP O
mutations NNS I-NP O
have VBP B-VP O
been VBN I-VP O
examined VBN I-VP O
by IN B-PP O
in FW B-NP O
vitro FW I-NP O
expression NN I-NP O
analysis NN I-NP O
, , O O
and CC O O
a DT B-NP O
significant JJ I-NP O
correlation NN I-NP O
has VBZ B-VP O
been VBN I-VP O
observed VBN I-VP O
between IN B-PP O
residual JJ B-NP O
PAH NN I-NP O
activity NN I-NP O
and CC O O
disease NN B-NP O
phenotype NN I-NP O
. . O O

Since IN B-PP O
continuing VBG B-NP O
advances NNS I-NP O
in IN B-PP O
molecular JJ B-NP O
methodologies NNS I-NP O
have VBP B-VP O
dramatically RB I-VP O
accelerated VBN I-VP O
the DT B-NP O
rate NN I-NP O
in IN B-PP O
which WDT B-NP O
new JJ B-NP O
mutations NNS I-NP O
are VBP B-VP O
being VBG I-VP O
identified VBN I-VP O
and CC I-VP O
characterized VBN I-VP O
, , O O
this DT B-NP O
register NN I-NP O
of IN B-PP O
mutations NNS B-NP O
will MD B-VP O
be VB I-VP O
updated VBN I-VP O
periodically RB B-ADVP O
. . O O

. . O O

A DT B-NP O
glycine250 NN I-NP O
- SYM B-VP O
- SYM B-NP O
> SYM I-NP O
aspartate NN I-NP O
substitution NN I-NP O
in IN B-PP O
the DT B-NP O
alpha SYM I-NP O
- HYPH I-NP O
subunit NN I-NP O
of IN B-PP O
hexosaminidase NN B-NP O
A NN I-NP O
causes VBZ B-VP O
juvenile JJ B-NP O
- HYPH I-NP O
onset JJ I-NP O
Tay NNP I-NP B-Disease
- HYPH I-NP I-Disease
Sachs NNP I-NP I-Disease
disease NN I-NP I-Disease
in IN B-PP O
a DT B-NP O
Lebanese JJ I-NP O
- HYPH I-NP O
Canadian JJ I-NP O
family NN I-NP O
. . O O

The DT B-NP O
mutation NN I-NP O
causing VBG B-VP O
juvenile JJ B-NP O
Tay NNP I-NP B-Disease
- HYPH I-NP I-Disease
Sachs NNP I-NP I-Disease
disease NN I-NP I-Disease
( ( O O
TSD NN B-NP B-Disease
) ) O O
in IN B-PP O
two CD B-NP O
sibs NNS I-NP O
of IN B-PP O
Lebanese JJ B-NP O
- HYPH I-NP O
Maronite NN I-NP O
origin NN I-NP O
is VBZ B-VP O
described VBN I-VP O
. . O O

An DT B-NP O
mRNA NN I-NP O
- HYPH O O
containing VBG B-VP O
extract NN B-NP O
of IN B-PP O
cultured VBN B-NP O
fibroblasts NNS I-NP O
obtained VBN B-VP O
from IN B-PP O
one CD B-NP O
of IN B-PP O
the DT B-NP O
probands NNS I-NP O
was VBD B-VP O
used VBN I-VP O
as IN B-PP O
a DT B-NP O
template NN I-NP O
to TO B-VP O
amplify VB I-VP O
the DT B-NP O
coding VBG I-NP O
sequence NN I-NP O
of IN B-PP O
the DT B-NP O
hexosaminidase NN I-NP O
A NN I-NP O
( ( O O
Hex NN B-NP O
A NN I-NP O
) ) O O
alpha SYM O O
- HYPH O O
subunit NN B-NP O
. . O O

Sequencing NN B-NP O
of IN B-PP O
amplified VBN B-NP O
cDNA NN I-NP O
fragments NNS I-NP O
revealed VBD B-VP O
a DT B-NP O
single JJ I-NP O
alteration NN I-NP O
, , O O
guanine NN B-NP O
to TO B-PP O
adenine NN B-NP O
at IN B-PP O
nt NN B-NP O
749 CD I-NP O
creating VBG B-VP O
a DT B-NP O
G250D NN I-NP O
mutation NN I-NP O
. . O O

The DT B-NP O
mutation NN I-NP O
introduces VBZ B-VP O
a DT B-NP O
new JJ I-NP O
recognition NN I-NP O
site NN I-NP O
for IN B-PP O
the DT B-NP O
restriction NN I-NP O
enzyme NN I-NP O
Eco NNP I-NP O
RV NNP I-NP O
, , O O
permitting VBG B-VP O
identification NN B-NP O
of IN B-PP O
heterozygotes NNS B-NP O
for IN B-PP O
this DT B-NP O
allele NN I-NP O
following VBG B-PP O
PCR NN B-NP O
amplification NN I-NP O
and CC O O
Eco NNP B-NP O
RV NN I-NP O
digestion NN I-NP O
of IN B-PP O
exon NN B-NP O
7 CD B-NP O
sequences NNS I-NP O
from IN B-PP O
genomic JJ B-NP O
DNA NN I-NP O
templates NNS I-NP O
. . O O

In IN B-SBAR O
order NN O O
to TO B-VP O
test VB I-VP O
the DT B-NP O
effect NN I-NP O
of IN B-PP O
this DT B-NP O
substitution NN I-NP O
, , O O
an DT B-NP O
in FW I-NP O
vitro FW I-NP O
mutagenized VBN I-NP O
cDNA NN I-NP O
construct NN I-NP O
was VBD B-VP O
introduced VBN I-VP O
into IN B-PP O
a DT B-NP O
mammalian JJ I-NP O
expression NN I-NP O
vector NN I-NP O
and CC O O
transfected VBN B-VP O
into IN B-PP O
monkey NN B-NP O
Cos NN I-NP O
- HYPH B-NP O
1 CD I-NP O
cells NNS I-NP O
separately RB B-ADVP O
or CC I-ADVP O
along RB I-ADVP O
with IN B-PP O
a DT B-NP O
beta SYM I-NP O
- HYPH I-NP O
cDNA NN I-NP O
expression NN I-NP O
vector NN I-NP O
. . O O

When WRB B-ADVP O
the DT B-NP O
mutant NN I-NP O
alpha SYM O O
- HYPH O O
cDNA NN B-NP O
was VBD B-VP O
the DT B-NP O
only JJ I-NP O
gene NN I-NP O
introduced VBN B-VP O
into IN B-PP O
COS NN B-NP O
cells NNS I-NP O
no DT B-NP O
enzymatic JJ I-NP O
activity NN I-NP O
above IN B-PP O
endogenous JJ B-NP O
COS NN I-NP O
cell NN I-NP O
activity NN I-NP O
was VBD B-VP O
detected VBN I-VP O
. . O O

Cotransfection NN B-NP O
of IN B-PP O
normal JJ B-NP O
alpha SYM I-NP O
- HYPH I-NP O
cDNA NN I-NP O
and CC O O
beta SYM O O
- HYPH O O
cDNA NN B-NP O
followed VBN B-VP O
by IN B-PP O
immunoprecipitation NN B-NP O
of IN B-PP O
human JJ B-NP O
Hex NN I-NP O
A NN I-NP O
resulted VBD B-VP O
in IN B-PP O
20 CD B-NP O
- HYPH I-NP O
fold JJ I-NP O
increase NN I-NP O
in IN B-PP O
the DT B-NP O
ratio NN I-NP O
between IN B-PP O
positive JJ B-NP O
and CC I-NP O
negative JJ I-NP O
( ( O O
mock JJ B-NP O
transfection NN I-NP O
) ) O O
control NN B-NP O
values NNS I-NP O
. . O O

This DT B-NP O
allowed VBD B-VP O
the DT B-NP O
detection NN I-NP O
of IN B-PP O
some DT B-NP O
residual JJ I-NP O
activity NN I-NP O
( ( O O
12 CD B-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
positive JJ I-NP O
control NN I-NP O
) ) O O
when WRB B-ADVP O
the DT B-NP O
mutant NN I-NP O
alpha SYM O O
- HYPH O O
cDNA NN B-NP O
replaced VBD B-VP O
its PRP$ B-NP O
wild JJ I-NP O
- HYPH I-NP O
type NN I-NP O
counterpart NN I-NP O
. . O O

The DT B-NP O
predicted VBN I-NP O
protein NN I-NP O
environment NN I-NP O
in IN B-PP O
which WDT B-NP O
the DT B-NP O
mutation NN I-NP O
occurs VBZ B-VP O
is VBZ B-VP O
compared VBN I-VP O
to TO B-PP O
that DT B-NP O
of IN B-PP O
the DT B-NP O
adult NN I-NP O
- HYPH B-NP O
onset JJ I-NP O
Tay NNP I-NP B-Disease
- HYPH I-NP I-Disease
Sachs NNP I-NP I-Disease
disease NN I-NP I-Disease
mutation NN I-NP O
caused VBN B-VP O
by IN B-PP O
a DT B-NP O
Gly269 NN I-NP O
- SYM B-NP O
- SYM B-NP O
> SYM I-NP O
Ser NN I-NP O
substitution NN I-NP O
in IN B-PP O
exon NN B-NP O
7 CD I-NP O
. . O O

( ( O O
ABSTRACT NN B-NP O
TRUNCATED VBN B-VP O
AT IN B-PP O
250 CD B-NP O
WORDS NNS I-NP O
) ) O O
. . O O

Novel NNP B-NP O
Tay NNP I-NP B-Disease
- HYPH B-NP I-Disease
Sachs NNP I-NP I-Disease
disease NN I-NP I-Disease
mutations NNS I-NP O
from IN B-PP O
China NNP B-NP O
. . O O

We PRP B-NP O
describe VBP B-VP O
three CD B-NP O
HEXA NN I-NP O
mutations NNS I-NP O
associated VBN B-VP O
with IN B-PP O
infantile JJ B-NP O
Tay NNP I-NP B-Disease
- HYPH I-NP I-Disease
Sachs NNP I-NP I-Disease
disease NN I-NP I-Disease
( ( O O
TSD NN B-NP B-Disease
) ) O O
in IN B-PP O
three CD B-NP O
unrelated JJ I-NP O
nonconsanguineous JJ I-NP O
Chinese JJ I-NP O
families NNS I-NP O
. . O O

Novel JJ B-NP O
mutations NNS I-NP O
were VBD B-VP O
found VBN I-VP O
in IN B-PP O
two CD B-NP O
of IN B-PP O
these DT B-NP O
families NNS I-NP O
. . O O

The DT B-NP O
third JJ I-NP O
is VBZ B-VP O
a DT B-NP O
previously RB I-NP O
reported VBN I-NP O
mutation NN I-NP O
( ( O O
G NN B-NP O
- SYM O O
- HYPH B-NP O
> SYM I-NP O
A NN I-NP O
transition NN I-NP O
at IN B-PP O
nt NN B-NP O
1444 CD I-NP O
) ) O O
( ( O O
Nakano NNP B-NP O
et FW I-NP O
al FW I-NP O
. FW I-NP O

, , O O
1988 CD B-NP O
) ) O O
. . O O

Direct JJ B-NP O
sequencing NN I-NP O
of IN B-PP O
PCR NN B-NP O
products NNS I-NP O
identified VBD B-VP O
a DT B-NP O
novel JJ I-NP O
insertion NN I-NP O
of IN B-PP O
an DT B-NP O
A NN I-NP O
after IN B-PP O
nt NN B-NP O
547 CD I-NP O
in IN B-PP O
family NN B-NP O
1 CD I-NP O
. . O O

This DT B-NP O
change NN I-NP O
generates VBZ B-VP O
an DT B-NP O
early JJ I-NP O
termination NN I-NP O
codon NN I-NP O
6 CD I-NP O
bp NN I-NP O
downstream RB B-ADVP O
from IN B-PP O
the DT B-NP O
insertion NN I-NP O
site NN I-NP O
. . O O

Allele NN B-NP O
- HYPH I-NP O
specific JJ I-NP O
oligonucleotide NN I-NP O
hybridization NN I-NP O
confirmed VBD B-VP O
homozygosity NN B-NP O
in IN B-PP O
the DT B-NP O
proband NN I-NP O
. . O O

Single JJ B-NP O
strand NN I-NP O
conformational JJ I-NP O
polymorphism NN I-NP O
analysis NN I-NP O
and CC O O
direct JJ B-NP O
sequencing NN I-NP O
of IN B-PP O
amplified VBN B-NP O
exon NN I-NP O
13 CD I-NP O
revealed VBD B-VP O
a DT B-NP O
T NN I-NP O
- SYM B-NP O
- SYM I-NP O
> SYM I-NP O
C NN I-NP O
transition NN I-NP O
at IN B-PP O
nt NN B-NP O
1453 CD I-NP O
with IN B-PP O
the DT B-NP O
corresponding VBG I-NP O
amino JJ I-NP O
acid NN I-NP O
substitution NN I-NP O
W485R NN I-NP O
in IN B-PP O
the DT B-NP O
second JJ I-NP O
family NN I-NP O
. . O O

This DT B-NP O
mutation NN I-NP O
creates VBZ B-VP O
an DT B-NP O
Fnu4HI NN I-NP O
restriction NN I-NP O
site NN I-NP O
. . O O

The DT B-NP O
proband NN I-NP O
is VBZ B-VP O
homozygous JJ B-ADJP O
for IN B-PP O
this DT B-NP O
allele NN I-NP O
. . O O

When WRB B-ADVP O
the DT B-NP O
site NN I-NP O
- HYPH I-NP O
specific JJ I-NP O
mutagenized VBN I-NP O
alpha NN I-NP O
cDNA NN I-NP O
carrying VBG B-VP O
the DT B-NP O
T NN I-NP O
- SYM B-NP O
- SYM I-NP O
> SYM I-NP O
C NN I-NP O
transition NN I-NP O
at IN B-PP O
nt NN B-NP O
1453 CD I-NP O
was VBD B-VP O
expressed VBN I-VP O
in IN B-PP O
COS NN B-NP O
1 CD I-NP O
cells NNS I-NP O
hexosaminidase NN I-NP O
S NN I-NP O
activity NN I-NP O
was VBD B-VP O
not RB O O
detectable JJ B-ADJP O
above IN B-PP O
background NN B-NP O
. . O O

A DT B-NP O
G NN I-NP O
- SYM B-VP O
- HYPH B-NP O
> SYM I-NP O
A NN I-NP O
transition NN I-NP O
at IN B-PP O
nt NN B-NP O
1444 CD I-NP O
( ( O O
exon NN B-NP O
13 CD I-NP O
) ) O O
corresponding VBG B-VP O
to TO B-PP O
the DT B-NP O
E482K NN I-NP O
substitution NN I-NP O
was VBD B-VP O
found VBN I-VP O
in IN B-PP O
the DT B-NP O
third JJ I-NP O
family NN I-NP O
. . O O

This DT B-NP O
mutation NN I-NP O
occurs VBZ B-VP O
at IN B-PP O
a DT B-NP O
CpG NN I-NP O
dinucleotide NN I-NP O
. . O O

It PRP B-NP O
has VBZ B-VP O
been VBN I-VP O
reported VBN I-VP O
in IN B-PP O
an DT B-NP O
Italian JJ I-NP O
TSD NN I-NP B-Disease
proband NN I-NP O
and CC O O
causes VBZ B-VP O
defective JJ B-NP O
intracellular JJ I-NP O
transport NN I-NP O
of IN B-PP O
the DT B-NP O
alpha SYM I-NP O
- HYPH I-NP O
subunit NN I-NP O
from IN B-PP O
the DT B-NP O
rough JJ I-NP O
endoplasmic JJ I-NP O
reticulum NN I-NP O
to TO B-PP O
the DT B-NP O
Golgi NNP I-NP O
apparatus NN I-NP O
. . O O

Two CD B-NP O
missense JJ I-NP O
mutations NNS I-NP O
causing VBG B-VP O
mild JJ B-NP O
hyperphenylalaninemia NN I-NP B-Disease
associated VBN B-VP O
with IN B-PP O
DNA NN B-NP O
haplotype NN I-NP O
12 CD I-NP O
. . O O

The DT B-NP O
genetic JJ I-NP B-Disease
defects NNS I-NP I-Disease
responsible JJ B-ADJP O
for IN B-PP O
most JJS B-NP O
phenylketonuria NN I-NP B-Disease
( ( O O
PKU NN B-NP B-Disease
) ) O O
and CC O O
hyperphenylalaninemia NN B-NP B-Disease
( ( O O
HPA NN B-NP B-Disease
) ) O O
cases NNS B-NP O
are VBP B-VP O
located JJ B-ADJP O
in IN B-PP O
the DT B-NP O
phenylalanine NN I-NP O
hydroxylase NN I-NP O
( ( O O
PAH NN B-NP O
) ) O O
gene NN B-NP O
. . O O

Approximately RB B-NP O
50 CD I-NP O
- HYPH I-NP O
60 CD I-NP O
mutations NNS I-NP O
have VBP B-VP O
been VBN I-VP O
reported VBN I-VP O
in IN B-PP O
Caucasians NNS B-NP O
and CC O O
are VBP B-VP O
reflected VBN I-VP O
in IN B-PP O
a DT B-NP O
wide JJ I-NP O
range NN I-NP O
of IN B-PP O
clinical JJ B-NP O
severities NNS I-NP O
. . O O

Most JJS B-NP O
mutations NNS I-NP O
are VBP B-VP O
linked VBN I-VP O
to TO B-PP O
specific JJ B-NP O
haplotypes NNS I-NP O
, , O O
as IN B-SBAR O
defined VBN B-VP O
by IN B-PP O
eight CD B-NP O
polymorphic JJ I-NP O
restriction NN I-NP O
sites NNS I-NP O
in IN B-PP O
the DT B-NP O
PAH NN I-NP O
gene NN I-NP O
. . O O

We PRP B-NP O
hypothesized VBD B-VP O
that IN B-SBAR O
there EX B-NP O
is VBZ B-VP O
at IN B-NP O
least JJS I-NP O
one CD I-NP O
mild JJ I-NP O
mutation NN I-NP O
linked VBN B-VP O
to TO B-PP O
haplotype NN B-NP O
12 CD I-NP O
in IN B-PP O
the DT B-NP O
Swedish JJ I-NP O
PKU NN I-NP B-Disease
/ SYM B-NP O
HPA NN I-NP B-Disease
population NN I-NP O
, , O O
since IN B-SBAR O
7 CD B-NP O
of IN B-PP O
8 CD B-NP O
patients NNS I-NP O
carrying VBG B-VP O
haplotype NN B-NP O
12 CD I-NP O
had VBD B-VP O
mild JJ B-NP O
HPA NN I-NP B-Disease
. . O O

Sequence NN B-NP O
analysis NN I-NP O
revealed VBD B-VP O
a DT B-NP O
C NN I-NP O
- HYPH B-ADJP O
to TO B-PP O
- HYPH B-NP O
G NN I-NP O
transversion NN I-NP O
at IN B-PP O
the DT B-NP O
second JJ I-NP O
base NN I-NP O
of IN B-PP O
codon NN B-NP O
322 CD I-NP O
, , O O
resulting VBG B-VP O
in IN B-PP O
a DT B-NP O
substitution NN I-NP O
of IN B-PP O
glycine NN B-NP O
for IN B-PP O
alanine NN B-NP O
, , O O
in IN B-PP O
four CD B-NP O
mutant JJ I-NP O
haplotype NN I-NP O
12 CD B-NP O
genes NNS I-NP O
, , O O
and CC O O
a DT B-NP O
G NN I-NP O
- HYPH B-ADJP O
to TO B-PP O
- HYPH B-NP O
A NN I-NP O
transition NN I-NP O
at IN B-PP O
the DT B-NP O
second JJ I-NP O
base NN I-NP O
of IN B-PP O
codon NN B-NP O
408 CD I-NP O
, , O O
resulting VBG B-VP O
in IN B-PP O
a DT B-NP O
substitution NN I-NP O
of IN B-PP O
glutamine NN B-NP O
for IN B-PP O
arginine NN B-NP O
, , O O
in IN B-PP O
another DT B-NP O
three CD I-NP O
mutant JJ I-NP O
haplotype NN I-NP O
12 CD B-NP O
genes NNS I-NP O
. . O O

These DT B-NP O
mutations NNS I-NP O
segregated VBD B-VP O
with IN B-PP O
mutant JJ B-NP O
haplotype NN I-NP O
12 CD B-NP O
alleles NNS I-NP O
in IN B-PP O
nuclear JJ B-NP O
families NNS I-NP O
but CC O O
were VBD B-VP O
not RB O O
present JJ B-ADJP O
on IN B-PP O
normal JJ B-NP O
or CC I-NP O
other JJ I-NP O
mutant JJ I-NP O
alleles NNS I-NP O
. . O O

Both DT B-NP O
mutations NNS I-NP O
were VBD B-VP O
tested VBN I-VP O
in IN B-PP O
a DT B-NP O
eukaryotic JJ I-NP O
expression NN I-NP O
system NN I-NP O
in IN B-PP O
which WDT B-NP O
enzyme NN B-NP O
activities NNS I-NP O
of IN B-PP O
different JJ B-NP O
mutant JJ I-NP O
PAH NN I-NP O
enzymes NNS I-NP O
reflect VBP B-VP O
the DT B-NP O
relative JJ I-NP O
severities NNS I-NP O
of IN B-PP O
the DT B-NP O
mutations NNS I-NP O
, , O O
although IN B-SBAR O
these DT B-NP O
in FW I-NP O
vitro FW I-NP O
activities NNS I-NP O
cannot MD B-VP O
be VB I-VP O
translated VBN I-VP O
directly RB B-ADVP O
into IN B-PP O
in FW B-NP O
vivo FW I-NP O
hepatic JJ I-NP O
activities NNS I-NP O
. . O O

The DT B-NP O
A322G NN I-NP O
mutant JJ I-NP O
PAH NN I-NP O
had VBD B-VP O
about RB B-NP O
75 CD I-NP O
% NN I-NP O
and CC O O
the DT B-NP O
R408Q NN I-NP O
mutant JJ I-NP O
PAH NN I-NP O
about RB B-NP O
55 CD I-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
wild JJ I-NP O
- HYPH I-NP O
type NN I-NP O
PAH NN I-NP O
enzyme NN I-NP O
activity NN I-NP O
. . O O

These DT B-NP O
in FW I-NP O
vitro FW I-NP O
activities NNS I-NP O
are VBP B-VP O
the DT B-NP O
highest JJS I-NP O
reported VBN B-VP O
for IN B-PP O
mutant JJ B-NP O
PAH NN I-NP O
enzymes NNS I-NP O
produced VBN B-VP O
in IN B-PP O
the DT B-NP O
same JJ I-NP O
expression NN I-NP O
system NN I-NP O
. . O O

( ( O O
ABSTRACT NN B-NP O
TRUNCATED VBN B-VP O
AT IN B-PP O
250 CD B-NP O
WORDS NNS I-NP O
) ) O O
. . O O

In FW B-ADVP O
vitro FW I-ADVP O
and CC O O
in FW B-NP O
vivo FW I-NP O
correlations NNS I-NP O
for IN B-PP O
I65T NN B-NP O
and CC I-NP O
M1V NN I-NP O
mutations NNS I-NP O
at IN B-PP O
the DT B-NP O
phenylalanine NN I-NP O
hydroxylase NN I-NP O
locus NN I-NP O
. . O O

Mutations NNS B-NP O
at IN B-PP O
the DT B-NP O
phenylalanine NN I-NP O
hydroxylase NN I-NP O
( ( O O
PAH NN B-NP O
) ) O O
locus NN B-NP O
are VBP B-VP O
the DT B-NP O
major JJ I-NP O
cause NN I-NP O
of IN B-PP O
hyperphenylalaninemia NN B-NP B-Disease
. . O O

We PRP B-NP O
have VBP B-VP O
previously RB I-VP O
described VBN I-VP O
four CD B-NP O
mutations NNS I-NP O
( ( O O
M1V NN B-NP O
, , O O
IVS12nt1 NN B-NP O
, , O O
R408W NN B-NP O
, , O O
and CC O O
S349P NN B-NP O
) ) O O
at IN B-PP O
the DT B-NP O
PAH NN I-NP O
locus NN I-NP O
in IN B-PP O
French JJ B-NP O
Canadians NNS I-NP O
with IN B-PP O
ancestry NN B-NP O
in IN B-PP O
eastern JJ B-NP O
Quebec NNP I-NP O
. . O O

Here RB B-ADVP O
we PRP B-NP O
report VBP B-VP O
( ( B-LST O
1 LS I-LST O
) ) O O
identification NN B-NP O
of IN B-PP O
another DT B-NP O
mutation NN I-NP O
, , O O
on IN B-PP O
a DT B-NP O
haplotype NN I-NP O
9 CD I-NP O
chromosome NN I-NP O
, , O O
which WDT B-NP O
converts VBZ B-VP O
codon NN B-NP O
65 CD I-NP O
from IN B-PP O
isoleucine NN B-NP O
( ( O O
ATT NN B-NP O
) ) O O
to TO B-PP O
threonine NN B-NP O
( ( O O
ACT NN B-NP O
) ) O O
, , O O
( ( B-LST O
2 LS I-LST O
) ) O O
expression NN B-NP O
analysis NN I-NP O
of IN B-PP O
the DT B-NP O
I65T NN I-NP O
mutation NN I-NP O
in IN B-PP O
COS NN B-NP O
cells NNS I-NP O
demonstrating VBG B-VP O
75 CD B-NP O
% NN I-NP O
loss NN I-NP O
of IN B-PP O
both CC B-NP O
immunoreactive JJ I-NP O
protein NN I-NP O
and CC I-NP O
enzyme NN I-NP O
activity NN I-NP O
, , O O
and CC O O
( ( B-LST O
3 LS I-LST O
) ) O O
expression NN B-NP O
analysis NN I-NP O
of IN B-PP O
the DT B-NP O
most RBS I-NP O
prevalent JJ I-NP O
PKU NN I-NP B-Disease
allele NN I-NP O
( ( O O
M1V NN B-NP O
) ) O O
in IN B-PP O
eastern JJ B-NP O
Quebec NNP I-NP O
, , O O
showing VBG B-VP O
nondetectable JJ B-NP O
levels NNS I-NP O
of IN B-PP O
PAH NN B-NP O
protein NN I-NP O
and CC I-NP O
activity NN I-NP O
, , O O
a DT B-NP O
finding NN I-NP O
compatible JJ B-ADJP O
with IN B-PP O
a DT B-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
translation NN I-NP O
initiation NN I-NP O
codon NN I-NP O
. . O O

Homozygosity NN B-NP O
for IN B-PP O
M1V NN B-NP O
and CC O O
codominant JJ B-NP O
inheritance NN I-NP O
of IN B-PP O
I65T NN B-NP O
/ SYM B-NP O
R408W NN I-NP O
were VBD B-VP O
both DT O O
associated VBN B-VP O
with IN B-PP O
classical JJ B-NP B-Disease
phenylketonuria NN I-NP I-Disease
. . O O

. . O O

Molecular JJ B-NP O
basis NN I-NP O
of IN B-PP O
hexosaminidase NN B-NP B-Disease
A NN I-NP I-Disease
deficiency NN I-NP I-Disease
and CC I-NP O
pseudodeficiency NN I-NP O
in IN B-PP O
the DT B-NP O
Berks NNP I-NP O
County NNP I-NP O
Pennsylvania NNP I-NP O
Dutch NNP I-NP O
. . O O

Following VBG B-PP O
the DT B-NP O
birth NN I-NP O
of IN B-PP O
two CD B-NP O
infants NNS I-NP O
with IN B-PP O
Tay NNP B-NP B-Disease
- HYPH I-NP I-Disease
Sachs NNP I-NP I-Disease
disease NN I-NP I-Disease
( ( O O
TSD NN B-NP B-Disease
) ) O O
, , O O
a DT B-NP O
non AFX I-NP O
- HYPH I-NP O
Jewish NNP I-NP O
, , O O
Pennsylvania NNP B-NP O
Dutch NNP I-NP O
kindred NN I-NP O
was VBD B-VP O
screened VBN I-VP O
for IN B-PP O
TSD NN B-NP B-Disease
carriers NNS I-NP O
using VBG B-VP O
the DT B-NP O
biochemical JJ I-NP O
assay NN I-NP O
. . O O

A DT B-NP O
high JJ I-NP O
frequency NN I-NP O
of IN B-PP O
individuals NNS B-NP O
who WP B-NP O
appeared VBD B-VP O
to TO I-VP O
be VB I-VP O
TSD NN B-NP B-Disease
heterozygotes NNS I-NP O
was VBD B-VP O
detected VBN I-VP O
( ( O O
Kelly NNP B-NP O
et FW I-NP O
al FW I-NP O
. FW I-NP O

, , O O
1975 CD B-NP O
) ) O O
. . O O

Clinical JJ B-NP O
and CC I-NP O
biochemical JJ I-NP O
evidence NN I-NP O
suggested VBD B-VP O
that IN B-SBAR O
the DT B-NP O
increased VBN I-NP O
carrier NN I-NP O
frequency NN I-NP O
was VBD B-VP O
due JJ B-ADJP O
to TO B-PP O
at IN B-NP O
least JJS I-NP O
two CD I-NP O
altered VBN I-NP O
alleles NNS I-NP O
for IN B-PP O
the DT B-NP O
hexosaminidase NN I-NP O
A NN I-NP O
alpha SYM O O
- HYPH O O
subunit NN B-NP O
. . O O

We PRP B-NP O
now RB B-ADVP O
report VBP B-VP O
two CD B-NP O
mutant JJ I-NP O
alleles NNS I-NP O
in IN B-PP O
this DT B-NP O
Pennsylvania NNP I-NP O
Dutch NNP I-NP O
kindred NN I-NP O
, , O O
and CC O O
one CD B-NP O
polymorphism NN I-NP O
. . O O

One CD B-NP O
allele NN I-NP O
, , O O
reported VBN B-VP O
originally RB B-ADVP O
in IN B-PP O
a DT B-NP O
French JJ I-NP O
TSD NN I-NP B-Disease
patient NN I-NP O
( ( O O
Akli NNP B-NP O
et FW I-NP O
al FW I-NP O
. FW I-NP O

, , O O
1991 CD B-NP O
) ) O O
, , O O
is VBZ B-VP O
a DT B-NP O
GT NN I-NP O
- SYM B-NP O
- SYM B-NP O
> SYM I-NP O
AT NN I-NP O
transition NN I-NP O
at IN B-PP O
the DT B-NP O
donor NN I-NP O
splice NN I-NP O
- HYPH B-NP O
site NN I-NP O
of IN B-PP O
intron NN B-NP O
9 CD I-NP O
. . O O

The DT B-NP O
second JJ I-NP O
, , O O
a DT B-NP O
C NN I-NP O
- SYM B-NP O
- SYM B-NP O
> SYM I-NP O
T NN I-NP O
transition NN I-NP O
at IN B-PP O
nucleotide NN B-NP O
739 CD I-NP O
( ( O O
Arg247Trp NN B-NP O
) ) O O
, , O O
has VBZ B-VP O
been VBN I-VP O
shown VBN I-VP O
by IN B-PP O
Triggs NNP B-NP O
- HYPH I-NP O
Raine NNP I-NP O
et FW I-NP O
al FW I-NP O
. . O O

( ( O O
1992 CD B-NP O
) ) O O
to TO B-VP O
be VB I-VP O
a DT B-NP O
clinically RB I-NP O
benign JJ I-NP O
pseudodeficient JJ I-NP O
allele NN I-NP O
associated VBN B-VP O
with IN B-PP O
reduced VBN B-NP O
enzyme NN I-NP O
activity NN I-NP O
against IN B-PP O
artificial JJ B-NP O
substrate NN I-NP O
. . O O

Finally RB B-ADVP O
, , O O
a DT B-NP O
polymorphism NN I-NP O
[ ( O O
G NN B-NP O
- SYM B-VP O
- HYPH B-NP O
> SYM I-NP O
A NN I-NP O
( ( O O
759 CD B-NP O
) ) O O
] ) O O
, , O O
which WDT B-NP O
leaves VBZ B-VP O
valine NN B-NP O
at IN B-PP O
codon NN B-NP O
253 CD I-NP O
unchanged JJ I-NP O
, , O O
is VBZ B-VP O
described VBN I-VP O
. . O O

A DT B-NP O
mutation NN I-NP O
common JJ B-ADJP O
in IN B-PP O
non AFX B-NP O
- HYPH I-NP O
Jewish JJ I-NP O
Tay NNP I-NP B-Disease
- HYPH I-NP I-Disease
Sachs NNP I-NP I-Disease
disease NN I-NP I-Disease
: : O O
frequency NN B-NP O
and CC I-NP O
RNA NN I-NP O
studies NNS I-NP O
. . O O

Tay NNP B-NP B-Disease
- HYPH I-NP I-Disease
Sachs NNP I-NP I-Disease
disease NN I-NP I-Disease
( ( O O
TSD NN B-NP B-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
genetic JJ I-NP I-Disease
disorder NN I-NP I-Disease
resulting VBG B-VP O
from IN B-PP O
mutation NN B-NP O
of IN B-PP O
the DT B-NP O
HEXA NN I-NP O
gene NN I-NP O
encoding VBG B-VP O
the DT B-NP O
alpha SYM I-NP O
- HYPH I-NP O
subunit NN I-NP O
of IN B-PP O
the DT B-NP O
lysosomal JJ I-NP O
enzyme NN I-NP O
, , O O
beta SYM B-NP O
- HYPH B-NP O
N NN I-NP O
- HYPH O O
acetylhexosaminidase NN B-NP O
A NN I-NP O
( ( O O
Hex NN B-NP O
A NN I-NP O
) ) O O
. . O O

We PRP B-NP O
have VBP B-VP O
discovered VBN I-VP O
that IN B-SBAR O
a DT B-NP O
Tay NNP I-NP B-Disease
- HYPH I-NP I-Disease
Sachs NNP I-NP I-Disease
mutation NN I-NP O
, , O O
IVS NN B-NP O
- HYPH B-NP O
9 CD I-NP O
+ SYM I-NP O
1 CD I-NP O
G NN I-NP O
- SYM B-VP O
- HYPH B-NP O
> SYM I-NP O
A NN I-NP O
, , O O
first RB B-VP O
detected VBN I-VP O
by IN B-PP O
Akli NNP B-NP O
et FW I-NP O
al FW I-NP O
. . O O

( ( O O
Genomics NNS B-NP O
11 CD B-NP O
124 CD I-NP O
- HYPH B-NP O
134 CD I-NP O
, , I-NP O
1991 CD I-NP O
) ) O O
, , O O
is VBZ B-VP O
a DT B-NP O
common JJ I-NP O
disease NN I-NP O
allele NN I-NP O
in IN B-PP O
non AFX B-NP O
- HYPH I-NP O
Jewish JJ I-NP O
Caucasians NNPS I-NP O
( ( O O
10 CD B-NP O
/ SYM O O
58 CD B-NP O
alleles NNS I-NP O
examined VBN B-VP O
) ) O O
. . O O

A DT B-NP O
PCR NN I-NP O
- HYPH B-VP O
based VBN I-VP O
diagnostic JJ B-NP O
test NN I-NP O
, , O O
which WDT B-NP O
detects VBZ B-VP O
an DT B-NP O
NlaIII NN I-NP O
site NN I-NP O
generated VBN B-VP O
by IN B-PP O
the DT B-NP O
mutation NN I-NP O
, , O O
revealed VBD B-VP O
a DT B-NP O
frequency NN I-NP O
among IN B-PP O
enzyme NN B-NP O
- HYPH B-NP O
defined VBN I-NP O
carriers NNS I-NP O
of IN B-PP O
9 CD B-NP O
/ SYM I-NP O
64 CD I-NP O
( ( O O
14 CD B-NP O
% NN I-NP O
) ) O O
. . O O

Most JJS B-NP O
of IN B-PP O
those DT B-NP O
carrying VBG B-VP O
the DT B-NP O
allele NN I-NP O
trace VBP B-VP O
their PRP$ B-NP O
origins NNS I-NP O
to TO B-PP O
the DT B-NP O
United NNP I-NP O
Kingdom NNP I-NP O
, , O O
Ireland NNP B-NP O
, , O O
or CC O O
Western NNP B-NP O
Europe NNP I-NP O
. . O O

It PRP B-NP O
was VBD B-VP O
not RB I-VP O
identified VBN I-VP O
among IN B-PP O
12 CD B-NP O
Black JJ I-NP O
American JJ I-NP O
TSD NN I-NP B-Disease
alleles NNS I-NP O
or CC B-PP O
in IN B-PP O
any DT B-NP O
of IN B-PP O
18 CD B-NP O
Ashkenazi NNP I-NP O
Jewish NNP I-NP O
, , O O
enzyme NN B-NP O
- HYPH B-NP O
defined VBN I-NP O
carriers NNS I-NP O
who WP B-NP O
did VBD B-VP O
not RB I-VP O
carry VB I-VP O
any DT B-NP O
of IN B-PP O
the DT B-NP O
mutations NNS I-NP O
common JJ B-ADJP O
to TO B-PP O
this DT B-NP O
population NN I-NP O
. . O O

No DT B-NP O
normally RB I-NP O
spliced VBN I-NP O
RNA NN I-NP O
was VBD B-VP O
detected VBN I-VP O
in IN B-PP O
PCR NN B-NP O
products NNS I-NP O
generated VBN B-VP O
from IN B-PP O
reverse JJ B-NP O
transcription NN I-NP O
of IN B-PP O
RNA NN B-NP O
carrying VBG B-VP O
the DT B-NP O
IVS NN I-NP O
- HYPH B-NP O
9 CD I-NP O
mutation NN I-NP O
. . O O

Instead RB B-ADVP O
, , O O
the DT B-NP O
low JJ I-NP O
levels NNS I-NP O
of IN B-PP O
mRNA NN B-NP O
from IN B-PP O
this DT B-NP O
allele NN I-NP O
were VBD B-VP O
comprised VBN I-VP O
of IN B-PP O
aberrant JJ B-NP O
species NNS I-NP O
resulting VBG B-VP O
from IN B-PP O
the DT B-NP O
use NN I-NP O
of IN B-PP O
either DT B-NP O
of IN B-PP O
two CD B-NP O
cryptic JJ I-NP O
donor NN I-NP O
sites NNS I-NP O
, , O O
one CD B-NP O
truncating VBG B-VP O
exon NN B-NP O
9 CD I-NP O
and CC O O
the DT B-NP O
other JJ I-NP O
within IN B-PP O
IVS NN B-NP O
- HYPH B-NP O
9 CD I-NP O
, , O O
spliced VBN B-VP O
to TO B-PP O
exon NN B-NP O
10 CD I-NP O
. . O O

Numerous JJ B-NP O
additional JJ I-NP O
splice NN I-NP O
products NNS I-NP O
were VBD B-VP O
detected VBN I-VP O
, , O O
most JJS B-NP O
involving VBG I-NP O
skipping NN B-NP O
of IN B-PP O
one CD B-NP O
or CC I-NP O
more JJR I-NP O
surrounding JJ I-NP O
exons NNS I-NP O
. . O O

Together RB B-ADVP O
with IN B-PP O
a DT B-NP O
recently RB I-NP O
identified VBN I-NP O
allele NN I-NP O
responsible JJ B-ADJP O
for IN B-PP O
Hex NN B-NP O
A NN I-NP O
pseudodeficiency NN I-NP O
( ( O O
Triggs NNP B-NP O
- HYPH O O
Raine NNP B-NP O
et FW I-NP O
al FW I-NP O
. . O O

Am NNP B-NP O
J NNP I-NP O
Hum NNP I-NP O
Genet NNP I-NP O
, , O O
1992 CD B-NP O
) ) O O
, , O O
these DT B-NP O
two CD I-NP O
alleles NNS I-NP O
accounted VBD B-VP O
for IN B-PP O
almost RB B-NP O
50 CD I-NP O
% NN I-NP O
( ( O O
29 CD B-NP O
/ SYM O O
64 CD B-NP O
) ) O O
of IN B-PP O
TSD NN B-NP B-Disease
or CC I-NP O
carrier NN I-NP O
alleles NNS I-NP O
ascertained VBN B-VP O
by IN B-PP O
enzyme NN B-NP O
screening NN I-NP O
tests NNS I-NP O
in IN B-PP O
non AFX B-NP O
- HYPH I-NP O
Jewish NNPS I-NP O
Caucasians NNPS I-NP O
. . O O

. . O O

Aberrant JJ B-NP O
splicing NN I-NP O
of IN B-PP O
the DT B-NP O
CHM NN I-NP B-Disease
gene NN I-NP O
is VBZ B-VP O
a DT B-NP O
significant JJ I-NP O
cause NN I-NP O
of IN B-PP O
choroideremia NN B-NP B-Disease
. . O O

Choroideremia NN B-NP B-Disease
( ( O O
CHM NN B-NP B-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
X NN I-NP B-Disease
- HYPH O I-Disease
linked VBN B-VP I-Disease
progressive JJ B-NP I-Disease
degeneration NN I-NP I-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
choroid NN I-NP I-Disease
and CC I-NP I-Disease
retina NN I-NP I-Disease
. . O O

12 CD B-NP O
% NN I-NP O
of IN B-PP O
unrelated JJ B-NP O
male JJ I-NP O
patients NNS I-NP O
carry VBP B-VP O
deletions NNS B-NP O
of IN B-PP O
the DT B-NP O
partially RB I-NP O
cloned VBN I-NP O
CHM NN I-NP B-Disease
gene NN I-NP O
. . O O

In IN B-PP O
Finland NNP B-NP O
, , O O
there EX B-NP O
are VBP B-VP O
more JJR B-NP O
than IN I-NP O
120 CD I-NP O
living NN I-NP O
CHM NN I-NP B-Disease
patients NNS I-NP O
belonging VBG B-VP O
to TO B-PP O
eight CD B-NP O
apparently RB I-NP O
unrelated JJ I-NP O
pedigrees NNS I-NP O
. . O O

Molecular JJ B-NP O
deletions NNS I-NP O
involving VBG B-VP O
the DT B-NP O
CHM NN I-NP B-Disease
gene NN I-NP O
have VBP B-VP O
been VBN I-VP O
detected VBN I-VP O
in IN B-PP O
three CD B-NP O
families NNS I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
screened VBN I-VP O
the DT B-NP O
remaining VBG I-NP O
five CD I-NP O
families NNS I-NP O
for IN B-PP O
point NN B-NP O
mutations NNS I-NP O
. . O O

In IN B-PP O
one CD B-NP O
large JJ I-NP O
family NN I-NP O
a DT B-NP O
single JJ I-NP O
nucleotide NN I-NP O
( ( O O
T NN B-NP O
) ) O O
insertion NN B-NP O
into IN B-PP O
the DT B-NP O
donor NN I-NP O
splice NN I-NP O
site NN I-NP O
of IN B-PP O
exon NN B-NP O
C NN I-NP O
leads VBZ B-VP O
to TO B-PP O
two CD B-NP O
aberrantly RB I-NP O
spliced VBN I-NP O
mRNAs NNS I-NP O
both CC O O
producing VBG B-VP O
a DT B-NP O
premature JJ I-NP O
stop NN I-NP O
codon NN I-NP O
. . O O

The DT B-NP O
mutation NN I-NP O
can MD B-VP O
be VB I-VP O
assayed VBN I-VP O
easily RB B-ADVP O
by IN B-PP O
amplification NN B-NP O
and CC I-NP O
digestion NN I-NP O
with IN B-PP O
Msel NNP B-NP O
. . O O

Our PRP$ B-NP O
findings NNS I-NP O
provide VBP B-VP O
additional JJ B-NP O
evidence NN I-NP O
for IN B-PP O
the DT B-NP O
pathogenetic JJ I-NP O
role NN I-NP O
of IN B-PP O
CHM NN B-NP B-Disease
mutations NNS I-NP O
and CC O O
provide VB B-VP O
a DT B-NP O
diagnostic JJ I-NP O
tool NN I-NP O
for IN B-PP O
one CD B-NP O
fifth NN I-NP O
of IN B-PP O
the DT B-NP O
worlds NNS I-NP O
known VBN B-VP O
CHM NN B-NP B-Disease
patients NNS I-NP O
. . O O

. . O O

Germline NN B-NP O
intronic JJ I-NP O
and CC I-NP O
exonic JJ I-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
Wilms NNP I-NP B-Disease
' POS B-NP I-Disease
tumour NN I-NP I-Disease
gene NN I-NP O
( ( O O
WT1 NN B-NP O
) ) O O
affecting VBG B-VP O
urogenital JJ B-NP O
development NN I-NP O
. . O O

Denys AFX B-NP B-Disease
- HYPH I-NP I-Disease
Drash NN I-NP I-Disease
syndrome NN I-NP I-Disease
is VBZ B-VP O
a DT B-NP O
rare JJ I-NP O
human JJ I-NP O
developmental JJ I-NP B-Disease
disorder NN I-NP I-Disease
affecting VBG B-VP O
the DT B-NP O
urogenital JJ I-NP O
system NN I-NP O
and CC O O
leading VBG B-VP O
to TO B-PP O
renal JJ B-NP B-Disease
failure NN I-NP I-Disease
, , O O
intersex NN B-NP B-Disease
disorders NNS I-NP I-Disease
and CC O O
Wilms NNP B-NP B-Disease
tumour NN I-NP I-Disease
. . O O

In IN B-PP O
this DT B-NP O
report NN I-NP O
, , O O
four CD B-NP O
individuals NNS I-NP O
with IN B-PP O
this DT B-NP O
syndrome NN I-NP O
are VBP B-VP O
described VBN I-VP O
carrying VBG I-VP O
germline NN B-NP O
point NN I-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
Wilms NNP I-NP B-Disease
tumour NN I-NP I-Disease
suppressor NN I-NP O
gene NN I-NP O
, , O O
WT1 NN B-NP O
. . O O

Three CD B-NP O
of IN B-PP O
these DT B-NP O
mutations NNS I-NP O
were VBD B-VP O
in IN B-PP O
the DT B-NP O
zinc NN I-NP O
finger NN I-NP O
domains NNS I-NP O
of IN B-PP O
WT1 NN B-NP O
. . O O

The DT B-NP O
fourth JJ I-NP O
occurred VBD B-VP O
within IN B-PP O
intron NN B-NP O
9 CD I-NP O
, , O O
preventing VBG B-VP O
splicing NN B-NP O
at IN B-PP O
one CD B-NP O
of IN B-PP O
the DT B-NP O
alternatively RB I-NP O
chosen VBN I-NP O
splice NN I-NP O
donor NN I-NP O
sites NNS I-NP O
of IN B-PP O
exon NN B-NP O
9 CD I-NP O
when WRB B-ADVP O
assayed VBN B-VP O
in FW B-ADVP O
vitro FW I-ADVP O
. . O O

These DT B-NP O
results NNS I-NP O
provide VBP B-VP O
genetic JJ B-NP O
evidence NN I-NP O
for IN B-PP O
distinct JJ B-NP O
functional JJ I-NP O
roles NNS I-NP O
of IN B-PP O
the DT B-NP O
WT1 NN I-NP O
isoforms NNS I-NP O
in IN B-PP O
urogenital JJ B-NP O
development NN I-NP O
. . O O

. . O O

Characterization NN B-NP O
of IN B-PP O
the DT B-NP O
myotonic JJ I-NP B-Disease
dystrophy NN I-NP I-Disease
region NN I-NP O
predicts VBZ B-VP O
multiple JJ B-NP O
protein NN I-NP O
isoform NN I-NP O
- HYPH O O
encoding VBG B-VP O
mRNAs NNS B-NP O
. . O O

The DT B-NP O
mutation NN I-NP O
underlying VBG B-VP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
( ( O O
DM NN B-NP B-Disease
) ) O O
has VBZ B-VP O
been VBN I-VP O
identified VBN I-VP O
as IN B-PP O
an DT B-NP O
expansion NN I-NP O
of IN B-PP O
a DT B-NP O
polymorphic JJ I-NP O
CTG NN I-NP O
- HYPH B-NP O
repeat NN I-NP O
in IN B-PP O
a DT B-NP O
gene NN I-NP O
encoding VBG B-VP O
protein NN B-NP O
kinase NN I-NP O
activity NN I-NP O
. . O O

Brain NN B-NP O
and CC I-NP O
heart NN I-NP O
transcripts NNS I-NP O
of IN B-PP O
the DT B-NP O
DM NN I-NP O
- HYPH O O
kinase NN B-NP O
( ( O O
DMR NN B-NP O
- HYPH B-NP O
B15 NN I-NP O
) ) I-NP O
gene NN I-NP O
are VBP B-VP O
subject JJ B-ADJP O
to TO B-PP O
alternative JJ B-NP O
RNA NN I-NP O
splicing NN I-NP O
in IN B-PP O
both CC B-NP O
human JJ I-NP O
and CC I-NP O
mouse NN I-NP O
. . O O

The DT B-NP O
unstable JJ I-NP O
[ ( I-NP O
CTG NN I-NP O
] ) O O
5 CD B-NP O
- HYPH I-NP O
30 CD I-NP O
motif NN I-NP O
is VBZ B-VP O
found VBN I-VP O
uniquely RB B-ADVP O
in IN B-PP O
humans NNS B-NP O
, , O O
although IN B-SBAR O
the DT B-NP O
flanking NN I-NP O
nucleotides NNS I-NP O
are VBP B-VP O
also RB B-ADVP O
present JJ B-ADJP O
in IN B-PP O
mouse NN B-NP O
. . O O

Characterization NN B-NP O
of IN B-PP O
the DT B-NP O
DM NN I-NP B-Disease
region NN I-NP O
of IN B-PP O
both DT B-NP O
species NNS I-NP O
reveals VBZ B-VP O
another DT B-NP O
active JJ I-NP O
gene NN I-NP O
( ( O O
DMR NN B-NP O
- HYPH B-NP O
N9 NN I-NP O
) ) O O
in IN B-PP O
close JJ B-NP O
proximity NN I-NP O
to TO B-PP O
the DT B-NP O
kinase NN I-NP O
gene NN I-NP O
. . O O

DMR NN B-NP O
- HYPH I-NP O
N9 NN I-NP O
transcripts NNS I-NP O
, , O O
mainly RB B-VP O
expressed VBN I-VP O
in IN B-PP O
brain NN B-NP O
and CC I-NP O
testis NN I-NP O
, , O O
possess VBP B-VP O
a DT B-NP O
single JJ I-NP O
, , I-NP O
large JJ I-NP O
open JJ I-NP O
reading NN I-NP O
frame NN I-NP O
, , O O
but CC O O
the DT B-NP O
function NN I-NP O
of IN B-PP O
its PRP$ B-NP O
protein NN I-NP O
product NN I-NP O
is VBZ B-VP O
unknown JJ B-ADJP O
. . O O

Clinical JJ B-NP O
manifestation NN I-NP O
of IN B-PP O
DM NN B-NP B-Disease
may MD B-VP O
be VB I-VP O
caused VBN I-VP O
by IN B-PP O
the DT B-NP O
expanded VBN I-NP O
CTG NN I-NP O
- HYPH I-NP O
repeat NN I-NP O
compromising VBG B-VP O
the DT O O
( ( O O
alternative JJ O O
) ) O O
expression NN B-NP O
of IN B-PP O
DM NN B-NP O
- HYPH B-NP O
kinase NN I-NP O
or CC I-NP O
DMR NN I-NP O
- HYPH B-NP O
N9 NN I-NP O
proteins NNS I-NP O
. . O O

. . O O

Fragile JJ B-NP B-Disease
X NN I-NP I-Disease
syndrome NN I-NP I-Disease
without IN B-PP O
CCG NN B-NP O
amplification NN I-NP O
has VBZ B-VP O
an DT B-NP O
FMR1 NN I-NP O
deletion NN I-NP O
. . O O

We PRP B-NP O
describe VBP B-VP O
a DT B-NP O
patient NN I-NP O
with IN B-PP O
typical JJ B-NP O
clinical JJ I-NP O
features NNS I-NP O
of IN B-PP O
the DT B-NP O
fragile JJ I-NP B-Disease
X NN I-NP I-Disease
syndrome NN I-NP I-Disease
, , O O
but CC O O
without IN B-PP O
cytogenetic JJ B-NP O
expression NN I-NP O
of IN B-PP O
the DT B-NP O
fragile JJ I-NP B-Disease
X NN I-NP I-Disease
or CC O O
an DT B-NP O
amplified VBN I-NP O
CCG NN I-NP O
trinucleotide NN I-NP O
repeat NN I-NP O
fragment NN I-NP O
. . O O

The DT B-NP O
patient NN I-NP O
has VBZ B-VP O
a DT B-NP O
previously RB I-NP O
uncharacterized JJ I-NP O
submicroscopic JJ I-NP O
deletion NN I-NP O
encompassing VBG B-VP O
the DT B-NP O
CCG NN I-NP O
repeat NN I-NP O
, , O O
the DT B-NP O
entire JJ I-NP O
FMR1 NN I-NP O
gene NN I-NP O
and CC O O
about IN B-NP O
2 CD I-NP O
. . O O

5 CD B-NP O
megabases NNS I-NP O
of IN B-PP O
flanking VBG B-VP O
sequences NNS B-NP O
. . O O

This DT B-NP O
finding NN I-NP O
confirms VBZ B-VP O
that IN B-SBAR O
the DT B-NP O
fragile JJ I-NP B-Disease
X NN I-NP I-Disease
phenotype NN I-NP O
can MD B-VP O
exist VB I-VP O
, , O O
without IN B-PP O
amplification NN B-NP O
of IN B-PP O
the DT B-NP O
CCG NN I-NP O
repeat NN I-NP O
or CC O O
cytogenetic JJ B-NP O
expression NN I-NP O
of IN B-PP O
the DT B-NP O
fragile JJ I-NP B-Disease
X NN I-NP I-Disease
, , O O
and CC O O
that IN B-SBAR O
fragile JJ B-NP B-Disease
X NN I-NP I-Disease
syndrome NN I-NP I-Disease
is VBZ B-VP O
a DT B-NP O
genetically RB I-NP O
homogeneous JJ I-NP O
disorder NN I-NP O
involving VBG B-VP O
FMR1 NN B-NP O
. . O O

We PRP B-NP O
also RB B-ADVP O
found VBD B-VP O
random JJ B-NP O
X NN I-NP O
- HYPH B-NP O
inactivation NN I-NP O
in IN B-PP O
the DT B-NP O
mother NN I-NP O
of IN B-PP O
the DT B-NP O
patient NN I-NP O
who WP B-NP O
was VBD B-VP O
shown VBN I-VP O
to TO I-VP O
be VB I-VP O
a DT B-NP O
carrier NN I-NP O
of IN B-PP O
this DT B-NP O
deletion NN I-NP O
. . O O

Cloning NN B-NP O
of IN B-PP O
the DT B-NP O
Huntington NNP I-NP B-Disease
disease NN I-NP I-Disease
region NN I-NP O
in IN B-PP O
yeast NN B-NP O
artificial JJ I-NP O
chromosomes NNS I-NP O
. . O O

The DT B-NP O
gene NN I-NP O
responsible JJ B-ADJP O
for IN B-PP O
Huntington NNP B-NP B-Disease
disease NN I-NP I-Disease
has VBZ B-VP O
been VBN I-VP O
localized JJ B-ADJP O
to TO B-PP O
a DT B-NP O
2 CD I-NP O
. . O O

5 CD B-NP O
million CD I-NP O
base NN I-NP O
pair NN I-NP O
( ( O O
Mb NN B-NP O
) ) O O
region NN B-NP O
between IN B-PP O
the DT B-NP O
loci NNS I-NP O
D4S10 NN I-NP O
and CC I-NP O
D4S168 NN I-NP O
on IN B-PP O
the DT B-NP O
short JJ I-NP O
arm NN I-NP O
of IN B-PP O
chromosome NN B-NP O
4 CD I-NP O
. . O O

As IN B-PP O
part NN B-NP O
of IN B-PP O
a DT B-NP O
strategy NN I-NP O
to TO B-VP O
clone VB I-VP O
the DT B-NP O
HD NN I-NP B-Disease
gene NN I-NP O
on IN B-PP O
the DT B-NP O
basis NN I-NP O
of IN B-PP O
its PRP$ B-NP O
chromosomal JJ I-NP O
location NN I-NP O
, , O O
we PRP B-NP O
isolated VBD B-VP O
genomic JJ B-NP O
DNA NN I-NP O
from IN B-PP O
the DT B-NP O
HD NN I-NP B-Disease
region NN I-NP O
as IN B-PP O
a DT B-NP O
set NN I-NP O
of IN B-PP O
overlapping VBG B-VP O
yeast NN B-NP O
artificial JJ I-NP O
chromosome NN I-NP O
( ( O O
YAC NN B-NP O
) ) O O
clones NNS B-NP O
. . O O

Twenty CD B-NP O
- HYPH I-NP O
eight CD I-NP O
YAC NN I-NP O
clones NNS I-NP O
were VBD B-VP O
identified VBN I-VP O
by IN B-PP O
screening VBG B-VP O
human JJ B-NP O
YAC NN I-NP O
libraries NNS I-NP O
with IN B-PP O
twelve CD B-NP O
PCR NN I-NP O
- HYPH O O
based VBN B-NP O
sequence NN I-NP O
- HYPH O O
tagged VBN B-NP O
sites NNS I-NP O
( ( O O
STSs NNS B-NP O
) ) O O
from IN B-PP O
the DT B-NP O
region NN I-NP O
. . O O

We PRP B-NP O
assembled VBD B-VP O
the DT B-NP O
YAC NN I-NP O
clones NNS I-NP O
into IN B-PP O
overlapping VBG B-VP O
sets NNS B-NP O
by IN B-PP O
hybridizing VBG B-VP O
them PRP B-NP O
to TO B-PP O
a DT B-NP O
large JJ I-NP O
number NN I-NP O
of IN B-PP O
DNA NN B-NP O
probes NNS I-NP O
from IN B-PP O
the DT B-NP O
HD NN I-NP B-Disease
region NN I-NP O
, , O O
including VBG B-PP O
the DT B-NP O
STSs NNS I-NP O
. . O O

In IN B-PP O
addition NN B-NP O
, , O O
we PRP B-NP O
isolated VBD B-VP O
the DT B-NP O
ends NNS I-NP O
of IN B-PP O
the DT B-NP O
human JJ I-NP O
DNA NN I-NP O
inserts NNS I-NP O
of IN B-PP O
most JJS B-NP O
of IN B-PP O
the DT B-NP O
YAC NN I-NP O
clones NNS I-NP O
to TO B-VP O
assist VB I-VP O
in IN B-PP O
the DT B-NP O
construction NN I-NP O
of IN B-PP O
the DT B-NP O
contig NN I-NP O
. . O O

Although IN B-SBAR O
almost RB B-NP O
half NN I-NP O
of IN B-PP O
the DT B-NP O
YACs NNS I-NP O
appear VBP B-VP O
to TO I-VP O
contain VB I-VP O
chimeric JJ B-NP O
inserts NNS I-NP O
and CC O O
several JJ B-NP O
contain VBP B-VP O
internal JJ B-NP O
deletions NNS I-NP O
or CC O O
other JJ B-NP O
rearrangements NNS I-NP O
, , O O
we PRP B-NP O
were VBD B-VP O
able JJ B-ADJP O
to TO B-VP O
obtain VB I-VP O
over IN B-PP O
2 CD B-NP O
. . O O

2 CD B-NP O
Mb NN I-NP O
of IN B-PP O
the DT B-NP O
HD NN I-NP B-Disease
region NN I-NP O
in IN B-PP O
YACs NNS B-NP O
, , O O
including VBG B-PP O
one CD B-NP O
continuous JJ I-NP O
segment NN I-NP O
of IN B-PP O
2 CD B-NP O
. . O O

0 CD B-NP O
Mb NN I-NP O
covering VBG B-VP O
the DT B-NP O
region NN I-NP O
that IN B-NP O
most RBS B-ADVP O
likely RB I-ADVP O
contains VBZ B-VP O
the DT B-NP O
HD NN I-NP B-Disease
gene NN I-NP O
. . O O

Ten CD B-NP O
of IN B-PP O
the DT B-NP O
twenty CD I-NP O
eight CD I-NP O
YAC NN I-NP O
clones NNS I-NP O
comprise VBP B-VP O
a DT B-NP O
minimal JJ I-NP O
set NN I-NP O
spanning VBG B-VP O
the DT B-NP O
2 CD I-NP O
. . O O

2 CD B-NP O
Mb NN I-NP O
. . O O

These DT B-NP O
clones NNS I-NP O
provide VBP B-VP O
reagents NNS B-NP O
for IN B-PP O
the DT B-NP O
complete JJ I-NP O
characterization NN I-NP O
of IN B-PP O
this DT B-NP O
region NN I-NP O
of IN B-PP O
the DT B-NP O
genome NN I-NP O
and CC B-PP O
for IN B-PP O
the DT B-NP O
eventual JJ I-NP O
isolation NN I-NP O
of IN B-PP O
the DT B-NP O
HD NN I-NP B-Disease
gene NN I-NP O
. . O O

Characterization NN B-NP O
of IN B-PP O
a DT B-NP O
YAC NN I-NP O
containing VBG B-VP O
part NN B-NP O
or CC I-NP O
all DT I-NP O
of IN B-PP O
the DT B-NP O
Norrie NNP I-NP B-Disease
disease NN I-NP I-Disease
locus NN I-NP O
. . O O

It PRP B-NP O
has VBZ B-VP O
been VBN I-VP O
shown VBN I-VP O
from IN B-PP O
pulsed VBN B-NP O
- HYPH I-NP O
field NN I-NP O
gel NN I-NP O
electrophoresis NN I-NP O
( ( O O
PFGE NN B-NP O
) ) O O
that IN B-SBAR O
the DT B-NP O
monoamine NN I-NP O
oxidase NN I-NP O
genes NNS I-NP O
A NN I-NP O
and CC O O
B NN B-NP O
( ( O O
MAOA NN B-NP O
& CC I-NP O
MAOB NN I-NP O
) ) O O
and CC O O
DXS7 NN B-NP O
loci NNS I-NP O
are VBP B-VP O
physically RB B-ADVP O
very RB B-ADJP O
close JJ I-ADJP O
. . O O

We PRP B-NP O
have VBP B-VP O
therefore RB I-VP O
extended VBN I-VP O
studies NNS B-NP O
on IN B-PP O
their PRP$ B-NP O
relationship NN I-NP O
through IN B-PP O
the DT B-NP O
characterisation NN I-NP O
of IN B-PP O
a DT B-NP O
650 CD I-NP O
kb NN I-NP O
YAC NN I-NP O
isolated VBN B-VP O
using VBG B-VP O
L1 NN B-NP O
. . O O

28 CD B-NP O
( ( O O
recognising VBG B-VP O
the DT B-NP O
DXS7 NN I-NP O
locus NN I-NP O
) ) O O
as IN B-PP O
a DT B-NP O
probe NN I-NP O
. . O O

Restriction NN B-NP O
mapping NN I-NP O
of IN B-PP O
the DT B-NP O
YAC NN I-NP O
indicates VBZ B-VP O
that IN B-SBAR O
it PRP B-NP O
contains VBZ B-VP O
both CC O O
MAOA NN B-NP O
and CC I-NP O
MAOB NN I-NP O
genes NNS I-NP O
in IN B-PP O
addition NN B-NP O
to TO B-PP O
the DT B-NP O
DXS7 NN I-NP O
locus NN I-NP O
. . O O

The DT B-NP O
map NN I-NP O
derived VBN B-VP O
from IN B-PP O
the DT B-NP O
YL1 NN I-NP O
. . O O

28 CD B-NP O
- HYPH I-NP O
YAC NN I-NP O
is VBZ B-VP O
compatible JJ B-ADJP O
both DT O O
with IN B-PP O
the DT B-NP O
map NN I-NP O
from IN B-PP O
an DT B-NP O
independently RB I-NP O
derived VBN I-NP O
YAC NN I-NP O
carrying VBG B-VP O
MAOA NN B-NP O
and CC I-NP O
B NN I-NP O
genes NNS I-NP O
and CC B-PP O
with IN B-PP O
the DT B-NP O
long JJ I-NP O
range NN I-NP O
genomic JJ I-NP O
map NN I-NP O
for IN B-PP O
the DT B-NP O
region NN I-NP O
. . O O

A DT B-NP O
series NN I-NP O
of IN B-PP O
subclones NNS B-NP O
prepared VBN B-VP O
from IN B-PP O
a DT B-NP O
phage NN I-NP O
library NN I-NP O
( ( O O
lambda SYM B-NP O
DASH NN B-NP O
II CD I-NP O
) ) O O
of IN B-PP O
the DT B-NP O
YAC NN I-NP O
have VBP B-VP O
been VBN I-VP O
characterised VBN I-VP O
and CC O O
have VBP B-VP O
been VBN I-VP O
employed VBN I-VP O
to TO B-VP O
determine VB I-VP O
the DT B-NP O
end NN I-NP O
point NN I-NP O
of IN B-PP O
the DT B-NP O
deletion NN I-NP O
of IN B-PP O
a DT B-NP O
Norrie NNP I-NP B-Disease
disease NN I-NP I-Disease
( ( O O
NDP NN B-NP B-Disease
) ) O O
patient NN B-NP O
who WP B-NP O
has VBZ B-VP O
been VBN I-VP O
shown VBN I-VP O
to TO I-VP O
lack VB I-VP O
both CC O O
DXS7 NN B-NP O
and CC O O
MAO NN B-NP O
coding NN I-NP O
sequences NNS I-NP O
. . O O

The DT B-NP O
pattern NN I-NP O
of IN B-PP O
retention NN B-NP O
of IN B-PP O
subclones NNS B-NP O
in IN B-PP O
the DT B-NP O
deletion NN I-NP O
patient NN I-NP O
place VBP B-VP O
the DT B-NP O
end NN I-NP O
point NN I-NP O
of IN B-PP O
the DT B-NP O
deletion NN I-NP O
within IN B-PP O
30 CD B-NP O
- HYPH I-NP O
130 CD I-NP O
kb NN I-NP O
of IN B-PP O
the DT B-NP O
proximal JJ I-NP O
end NN I-NP O
of IN B-PP O
the DT B-NP O
YAC NN I-NP O
. . O O

By IN B-PP O
combining VBG B-VP O
the DT B-NP O
data NNS I-NP O
with IN B-PP O
established VBN B-NP O
recombination NN I-NP O
analysis NN I-NP O
, , O O
we PRP B-NP O
provide VBP B-VP O
evidence NN B-NP O
that IN B-SBAR O
all DT B-NP O
or CC I-NP O
part NN I-NP O
of IN B-PP O
the DT B-NP O
NDP NN I-NP O
lies VBZ B-VP O
in IN B-PP O
the DT B-NP O
interval NN I-NP O
of IN B-PP O
approximately RB B-NP O
250kb JJ I-NP O
within IN B-PP O
the DT B-NP O
YAC NN I-NP O
. . O O

Both DT B-NP O
mutations NNS I-NP O
in IN B-PP O
G6PD NN B-NP O
A NN I-NP O
- HYPH B-NP O
are VBP B-VP O
necessary JJ B-ADJP O
to TO B-VP O
produce VB I-VP O
the DT B-NP O
G6PD NN I-NP B-Disease
deficient JJ I-NP I-Disease
phenotype NN I-NP O
. . O O

The DT B-NP O
high JJ I-NP O
prevalence NN I-NP O
of IN B-PP O
glucose NN B-NP B-Disease
6 CD I-NP I-Disease
- HYPH I-NP I-Disease
phosphate NN I-NP I-Disease
dehydrogenase NN I-NP I-Disease
( ( O I-Disease
G6PD NN B-NP I-Disease
) ) O I-Disease
deficiency NN B-NP I-Disease
in IN B-PP O
African JJ B-NP O
populations NNS I-NP O
is VBZ B-VP O
due JJ B-ADJP O
almost RB B-ADVP O
entirely RB I-ADVP O
to TO B-PP O
the DT B-NP O
enzyme NN I-NP O
variant NN I-NP O
A NN I-NP O
- HYPH B-ADJP O
, , O O
which WDT B-NP O
differs VBZ B-VP O
from IN B-PP O
the DT B-NP O
wild JJ I-NP O
- HYPH I-NP O
type NN I-NP O
G6PD NN I-NP O
B NN I-NP O
by IN B-PP O
two CD B-NP O
amino NN I-NP O
acid NN I-NP O
replacements NNS I-NP O
, , O O
68 CD B-NP O
Val NN I-NP O
- SYM B-NP O
- HYPH B-NP O
> SYM I-NP O
Met NN I-NP O
and CC O O
126 CD B-NP O
Asn NN I-NP O
- SYM B-NP O
- HYPH B-NP O
> SYM I-NP O
Asp NN I-NP O
. . O O

The DT B-NP O
non AFX I-NP O
- HYPH I-NP O
deficient JJ I-NP O
polymorphic JJ I-NP O
variant JJ I-NP O
G6PD NN I-NP O
A NN I-NP O
contains VBZ B-VP O
only RB B-NP O
the DT I-NP O
mutation NN I-NP O
126 CD I-NP O
Asn NN I-NP O
- SYM B-NP O
- HYPH B-NP O
> SYM I-NP O
Asp NN I-NP O
. . O O

The DT B-NP O
frequencies NNS I-NP O
of IN B-PP O
the DT B-NP O
G6PD NN I-NP O
A NN I-NP O
and CC B-PP O
of IN B-PP O
the DT B-NP O
G6PD NN I-NP O
A NN I-NP O
- HYPH B-VP O
genes NNS B-NP O
in IN B-PP O
parts NNS B-NP O
of IN B-PP O
Africa NNP B-NP O
are VBP B-VP O
both DT O O
about IN B-PP O
0 CD B-NP O
. . O O

2 LS B-LST O
. . O O

The DT B-NP O
68 CD I-NP O
Val NN I-NP O
- SYM B-NP O
- HYPH B-NP O
> SYM I-NP O
Met NN I-NP O
mutation NN I-NP O
has VBZ B-VP O
not RB I-VP O
been VBN I-VP O
found VBN I-VP O
in IN B-PP O
a DT B-NP O
B NN I-NP O
background NN I-NP O
. . O O

This DT B-NP O
could MD B-VP O
be VB I-VP O
because IN B-SBAR O
the DT B-NP O
68 CD I-NP O
Val NN I-NP O
- SYM B-NP O
- HYPH B-NP O
> SYM I-NP O
Met NN I-NP O
mutation NN I-NP O
happened VBD B-VP O
to TO I-VP O
arise VB I-VP O
in IN B-PP O
an DT B-NP O
A NN I-NP O
gene NN I-NP O
in IN B-PP O
the DT B-NP O
first JJ I-NP O
instance NN I-NP O
, , O O
or CC O O
because IN B-SBAR O
the DT B-NP O
68 CD I-NP O
Val NN I-NP O
- SYM B-NP O
- HYPH B-NP O
> SYM I-NP O
Met NN I-NP O
mutation NN I-NP O
alone RB B-ADVP O
is VBZ B-VP O
not RB O O
sufficient JJ B-ADJP O
to TO B-VP O
cause VB I-VP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
. . O O

We PRP B-NP O
have VBP B-VP O
approached VBN I-VP O
this DT B-NP O
question NN I-NP O
by IN B-PP O
producing VBG B-VP O
G6PD NN B-NP O
B NN I-NP O
, , O O
A NN B-NP O
, , O O
A NN B-NP O
- HYPH B-ADJP O
, , O O
and CC O O
G6PD NN B-NP O
68 CD I-NP O
Val NN I-NP O
- SYM B-NP O
- HYPH B-NP O
> SYM I-NP O
Met NN I-NP O
in IN B-PP O
a DT B-NP O
bacterial JJ I-NP O
expression NN I-NP O
system NN I-NP O
and CC O O
analysing VBG B-VP O
their PRP$ B-NP O
biochemical JJ I-NP O
properties NNS I-NP O
. . O O

With IN B-PP O
each DT B-NP O
single JJ I-NP O
mutation NN I-NP O
we PRP B-NP O
found VBD B-VP O
a DT B-NP O
slight JJ I-NP O
decrease NN I-NP O
in IN B-PP O
both CC B-NP O
the DT I-NP O
specific JJ I-NP O
activity NN I-NP O
and CC O O
the DT B-NP O
yield NN I-NP O
of IN B-PP O
enzyme NN B-NP O
when WRB B-ADVP O
compared VBN B-VP O
to TO B-PP O
G6PD NN B-NP O
B NN I-NP O
. . O O

When WRB B-ADVP O
both DT B-NP O
mutations NNS I-NP O
were VBD B-VP O
introduced VBN I-VP O
together RB B-ADVP O
, , O O
there EX B-NP O
was VBD B-VP O
a DT B-NP O
roughly RB I-NP O
additive JJ I-NP O
effect NN I-NP O
on IN B-PP O
specific JJ B-NP O
activity NN I-NP O
, , O O
but CC O O
a DT O O
much RB B-ADVP O
more RBR I-ADVP O
drastic JJ B-NP O
effect NN I-NP O
on IN B-PP O
enzyme NN B-NP O
yield NN I-NP O
( ( O O
4 CD B-NP O
% NN I-NP O
of IN B-PP O
normal JJ B-NP O
) ) O O
. . O O

This DT B-NP O
synergistic JJ I-NP O
effect NN I-NP O
was VBD B-VP O
also RB I-VP O
demonstrated VBN I-VP O
on IN B-PP O
thermal JJ B-NP O
stability NN I-NP O
, , O O
especially RB B-ADVP O
at IN B-PP O
low JJ B-NP O
NADP NN I-NP O
concentrations NNS I-NP O
. . O O

Comparable JJ B-NP O
results NNS I-NP O
were VBD B-VP O
produced VBN I-VP O
when WRB B-ADVP O
the DT B-NP O
replacement NN I-NP O
119 CD I-NP O
Gln NN I-NP O
- SYM B-NP O
- HYPH B-NP O
> SYM I-NP O
Glu NN I-NP O
was VBD B-VP O
studied VBN I-VP O
instead RB B-PP O
of IN I-PP O
126 CD B-NP O
Asn NN I-NP O
- SYM B-NP O
- HYPH B-NP O
> SYM I-NP O
Asp NN I-NP O
. . O O

We PRP B-NP O
infer VBP B-VP O
that IN B-SBAR O
the DT B-NP O
coexistence NN I-NP O
of IN B-PP O
the DT B-NP O
two CD I-NP O
mutations NNS I-NP O
is VBZ B-VP O
responsible JJ B-ADJP O
for IN B-PP O
enzyme NN B-NP B-Disease
deficiency NN I-NP I-Disease
in IN B-PP I-Disease
G6PD NN B-NP I-Disease
A NN I-NP O
- : O O
because IN B-SBAR O
they PRP B-NP O
act VBP B-VP O
synergistically RB B-ADVP O
in IN B-PP O
causing VBG B-VP O
instability NN B-NP O
of IN B-PP O
the DT B-NP O
enzyme NN I-NP O
. . O O

Small JJ B-NP O
nuclear JJ I-NP O
ribonucleoprotein NN I-NP O
polypeptide NN I-NP O
N NN I-NP O
( ( O O
SNRPN NN B-NP O
) ) O O
, , O O
an DT B-NP O
expressed VBN I-NP O
gene NN I-NP O
in IN B-PP O
the DT B-NP O
Prader NNP I-NP B-Disease
- HYPH I-NP I-Disease
Willi NNP I-NP I-Disease
syndrome NN I-NP I-Disease
critical JJ I-NP O
region NN I-NP O
. . O O

Prader NNP B-NP B-Disease
- HYPH I-NP I-Disease
Willi NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
PWS NN B-NP B-Disease
) ) O O
is VBZ B-VP O
associated VBN I-VP O
with IN B-PP O
paternally RB B-NP O
derived VBN I-NP O
chromosomal JJ I-NP O
deletions NNS I-NP O
in IN B-PP O
region NN B-NP O
15q11 CD I-NP O
- HYPH I-NP O
13 CD I-NP O
or CC B-PP O
with IN B-PP O
maternal JJ B-NP B-Disease
disomy NN I-NP I-Disease
for IN B-PP I-Disease
chromosome NN B-NP I-Disease
15 CD I-NP I-Disease
. . O O

Therefore RB B-ADVP O
, , O O
loss NN B-NP O
of IN B-PP O
the DT B-NP O
expressed VBN I-NP O
paternal JJ I-NP O
alleles NNS I-NP O
of IN B-PP O
maternally RB B-NP O
imprinted JJ I-NP O
genes NNS I-NP O
must MD B-VP O
be VB I-VP O
responsible JJ B-ADJP O
for IN B-PP O
the DT B-NP O
PWS NN I-NP B-Disease
phenotype NN I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
mapped VBN I-VP O
the DT B-NP O
gene NN I-NP O
encoding VBG B-VP O
the DT B-NP O
small JJ I-NP O
nuclear JJ I-NP O
RNA NN I-NP O
associated VBN I-NP O
polypeptide NN I-NP O
SmN NN I-NP O
( ( O O
SNRPN NN B-NP O
) ) O O
to TO B-PP O
human JJ B-NP O
chromosome NN I-NP O
15q12 NN I-NP O
and CC O O
a DT B-NP O
processed VBN I-NP O
pseudogene NN I-NP O
SNRPNP1 NN I-NP O
to TO B-PP O
chromosome NN B-NP O
region NN I-NP O
6pter NN I-NP O
- HYPH B-NP O
p21 NN I-NP O
. . O O

Furthermore RB B-ADVP O
, , O O
SNRPN NN B-NP O
was VBD B-VP O
mapped VBN I-VP O
to TO B-PP O
the DT B-NP O
minimal JJ I-NP O
deletion NN I-NP O
interval NN I-NP O
that WDT B-NP O
is VBZ B-VP O
critical JJ B-ADJP O
for IN B-PP O
PWS NN B-NP B-Disease
. . O O

The DT B-NP O
fact NN I-NP O
that IN B-SBAR O
the DT B-NP O
mouse NN I-NP O
Snrpn NN I-NP O
gene NN I-NP O
is VBZ B-VP O
maternally RB I-VP O
imprinted VBN I-VP O
in IN B-PP O
brain NN B-NP O
suggests VBZ B-VP O
that IN B-SBAR O
loss NN B-NP O
of IN B-PP O
the DT B-NP O
paternally RB I-NP O
derived VBN I-NP O
SNRPN NN I-NP O
allele NN I-NP O
may MD B-VP O
be VB I-VP O
involved VBN I-VP O
in IN B-PP O
the DT B-NP O
PWS NN I-NP B-Disease
phenotype NN I-NP O
. . O O

. . O O

The DT B-NP O
presence NN I-NP O
of IN B-PP O
two CD B-NP O
different JJ I-NP O
infantile JJ I-NP O
Tay NNP I-NP B-Disease
- HYPH I-NP I-Disease
Sachs NNP I-NP I-Disease
disease NN I-NP I-Disease
mutations NNS I-NP O
in IN B-PP O
a DT B-NP O
Cajun NNP I-NP O
population NN I-NP O
. . O O

A DT B-NP O
study NN I-NP O
was VBD B-VP O
undertaken VBN I-VP O
to TO I-VP O
characterize VB I-VP O
the DT B-NP O
mutation NN I-NP O
( ( I-NP O
s NNS I-NP O
) ) O O
responsible JJ B-ADJP O
for IN B-PP O
Tay NNP B-NP B-Disease
- HYPH I-NP I-Disease
Sachs NNP I-NP I-Disease
disease NN I-NP I-Disease
( ( O O
TSD NN B-NP B-Disease
) ) O O
in IN B-PP O
a DT B-NP O
Cajun NNP I-NP O
population NN I-NP O
in IN B-PP O
southwest JJ B-NP O
Louisiana NNP I-NP O
and CC O O
to TO B-VP O
identify VB I-VP O
the DT B-NP O
origins NNS I-NP O
of IN B-PP O
these DT B-NP O
mutations NNS I-NP O
. . O O

Eleven CD B-NP O
of IN B-PP O
12 CD B-NP O
infantile JJ I-NP O
TSD NN I-NP B-Disease
alleles NNS I-NP O
examined VBN B-VP O
in IN B-PP O
six CD B-NP O
families NNS I-NP O
had VBD B-VP O
the DT B-NP O
beta SYM I-NP O
- HYPH I-NP O
hexosaminidase NN I-NP O
A NN I-NP O
( ( O O
Hex NN B-NP O
A NN I-NP O
) ) O O
alpha SYM B-NP O
- HYPH B-NP O
subunit NN I-NP O
exon NN I-NP O
11 CD I-NP O
insertion NN I-NP O
mutation NN I-NP O
that WDT B-NP O
is VBZ B-VP O
present JJ B-ADJP O
in IN B-PP O
approximately RB B-NP O
70 CD I-NP O
% NN I-NP O
of IN B-PP O
Ashkenazi NNP B-NP O
Jewish JJ I-NP O
TSD NN I-NP B-Disease
heterozygotes NNS I-NP O
. . O O

The DT B-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
remaining VBG I-NP O
allele NN I-NP O
was VBD B-VP O
a DT B-NP O
single JJ I-NP O
- HYPH I-NP O
base NN I-NP O
transition NN I-NP O
in IN B-PP O
the DT B-NP O
donor NN I-NP O
splice NN I-NP O
site NN I-NP O
of IN B-PP O
the DT B-NP O
alpha SYM I-NP O
- HYPH I-NP O
subunit NN I-NP O
intron NN I-NP O
9 CD I-NP O
. . O O

To TO B-VP O
determine VB I-VP O
the DT B-NP O
origins NNS I-NP O
of IN B-PP O
these DT B-NP O
two CD I-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
Cajun NNP I-NP O
population NN I-NP O
, , O O
the DT B-NP O
TSD NN I-NP B-Disease
carrier NN I-NP O
status NN I-NP O
was VBD B-VP O
enzymatically RB I-VP O
determined VBN I-VP O
for IN B-PP O
90 CD B-NP O
members NNS I-NP O
of IN B-PP O
four CD B-NP O
of IN B-PP O
the DT B-NP O
six CD I-NP O
families NNS I-NP O
, , O O
and CC O O
extensive JJ B-NP O
pedigrees NNS I-NP O
were VBD B-VP O
constructed VBN I-VP O
for IN B-PP O
all DT B-NP O
carriers NNS I-NP O
. . O O

A DT B-NP O
single JJ I-NP O
ancestral JJ I-NP O
couple NN I-NP O
from IN B-PP O
France NNP B-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
be VB I-VP O
common JJ B-ADJP O
to TO B-PP O
most JJS B-NP O
of IN B-PP O
the DT B-NP O
carriers NNS I-NP O
of IN B-PP O
the DT B-NP O
exon NN I-NP O
11 CD I-NP O
insertion NN I-NP O
. . O O

Pedigree NNP B-NP O
data NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
this DT B-NP O
mutation NN I-NP O
has VBZ B-VP O
been VBN I-VP O
in IN B-PP O
the DT B-NP O
Cajun NNP I-NP O
population NN I-NP O
since IN B-PP O
its PRP$ B-NP O
founding NN I-NP O
over IN B-PP O
2 CD B-NP O
centuries NNS I-NP O
ago IN B-ADVP O
and CC O O
that IN B-SBAR O
it PRP B-NP O
may MD B-VP O
be VB I-VP O
widely RB I-VP O
distributed VBN I-VP O
within IN B-PP O
the DT B-NP O
population NN I-NP O
. . O O

In IN B-PP O
contrast NN B-NP O
, , O O
the DT B-NP O
intron NN I-NP O
9 CD I-NP O
mutation NN I-NP O
apparently RB B-ADVP O
was VBD B-VP O
introduced VBN I-VP O
within IN B-PP O
the DT B-NP O
last JJ I-NP O
century NN I-NP O
and CC O O
probably RB B-ADVP O
is VBZ B-VP O
limited VBN I-VP O
to TO B-PP O
a DT B-NP O
few JJ I-NP O
Louisiana NNP I-NP O
families NNS I-NP O
. . O O

. . O O

Mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
candidate NN I-NP O
gene NN I-NP O
for IN B-PP O
Norrie NNP B-NP B-Disease
disease NN I-NP I-Disease
. . O O

Recently RB B-ADVP O
, , O O
we PRP B-NP O
and CC I-NP O
others NNS I-NP O
have VBP B-VP O
isolated VBN I-VP O
a DT B-NP O
candidate NN I-NP O
gene NN I-NP O
for IN B-PP O
X NN B-NP B-Disease
linked VBN B-VP I-Disease
Norrie NNP B-NP I-Disease
disease NN I-NP I-Disease
( ( O O
ND NN B-NP B-Disease
) ) O O
which WDT B-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
be VB I-VP O
deleted VBN I-VP O
or CC I-VP O
disrupted VBN I-VP O
in IN B-PP O
several JJ B-NP O
patients NNS I-NP O
. . O O

As IN B-PP O
a DT B-NP O
prerequisite NN I-NP O
for IN B-PP O
the DT B-NP O
identification NN I-NP O
of IN B-PP O
point NN B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
ND NN I-NP B-Disease
gene NN I-NP O
we PRP B-NP O
have VBP B-VP O
established VBN I-VP O
the DT B-NP O
exon NN I-NP O
- HYPH B-NP O
intron NN I-NP O
structure NN I-NP O
of IN B-PP O
this DT B-NP O
gene NN I-NP O
. . O O

In IN B-PP O
17 CD B-NP O
unrelated JJ I-NP O
patients NNS I-NP O
and CC O O
15 CD B-NP O
controls NNS I-NP O
, , O O
PCR NN B-NP O
products NNS I-NP O
derived VBN B-VP O
from IN B-PP O
the DT B-NP O
promoter NN I-NP O
region NN I-NP O
, , O O
exons NNS B-NP O
1 CD I-NP O
and CC O O
2 CD O O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
the DT B-NP O
coding VBG I-NP O
part NN I-NP O
of IN B-PP O
exon NN B-NP O
3 CD I-NP O
were VBD B-VP O
analysed VBN I-VP O
with IN B-PP O
the DT B-NP O
single JJ I-NP O
strand NN I-NP O
conformation NN I-NP O
polymorphism NN I-NP O
( ( O O
SSCP NN B-NP O
) ) O O
technique NN B-NP O
. . O O

In IN B-PP O
12 CD B-NP O
patients NNS I-NP O
altered VBD B-VP O
PCR NN B-NP O
fragments NNS I-NP O
were VBD B-VP O
detected VBN I-VP O
which WDT B-NP O
were VBD B-VP O
studied VBN I-VP O
in IN B-PP O
detail NN B-NP O
by IN B-PP O
direct JJ B-NP O
sequencing NN I-NP O
. . O O

Eleven CD B-NP O
different JJ I-NP O
mutations NNS I-NP O
were VBD B-VP O
found VBN I-VP O
, , O O
and CC O O
all DT O O
but IN B-PP O
one CD B-NP O
are VBP B-VP O
likely JJ B-ADJP O
to TO B-VP O
give VB I-VP O
rise NN B-NP O
to TO B-PP O
significant JJ B-NP O
structural JJ I-NP O
changes NNS I-NP O
in IN B-PP O
the DT B-NP O
predicted VBN I-NP O
protein NN I-NP O
. . O O

These DT B-NP O
findings NNS I-NP O
, , O O
and CC O O
the DT B-NP O
absence NN I-NP O
of IN B-PP O
functionally RB B-NP O
relevant JJ I-NP O
base NN I-NP O
changes NNS I-NP O
in IN B-PP O
healthy JJ B-NP O
controls NNS I-NP O
, , O O
emphasize VBP B-VP O
the DT B-NP O
causal JJ I-NP O
role NN I-NP O
of IN B-PP O
this DT B-NP O
candidate NN I-NP O
gene NN I-NP O
in IN B-PP O
Norrie NNP B-NP B-Disease
disease NN I-NP I-Disease
and CC O O
pave VBP B-VP O
the DT B-NP O
way NN I-NP O
for IN B-PP O
reliable JJ B-NP O
diagnosis NN I-NP O
and CC I-NP O
carrier NN I-NP O
detection NN I-NP O
. . O O

. . O O

Detection NN B-NP O
of IN B-PP O
a DT B-NP O
nonsense JJ I-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
dystrophin NN I-NP O
gene NN I-NP O
by IN B-PP O
multiple JJ B-NP O
SSCP NN I-NP O
. . O O

A DT B-NP O
combination NN I-NP O
of IN B-PP O
multiplex JJ B-NP O
PCR NN I-NP O
with IN B-PP O
the DT B-NP O
single JJ I-NP O
strand NN I-NP O
conformation NN I-NP O
polymorphism NN I-NP O
( ( O O
SSCP NN B-NP O
) ) O O
technique NN B-NP O
was VBD B-VP O
employed VBN I-VP O
to TO I-VP O
screen VB I-VP O
for IN B-PP O
point NN B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
human JJ I-NP O
dystrophin NN I-NP O
gene NN I-NP O
. . O O

Co AFX B-NP O
- HYPH I-NP O
amplification NN B-NP O
of IN B-PP O
11 CD B-NP O
exons NNS I-NP O
from IN B-PP O
genomic JJ B-NP O
DNA NN I-NP O
of IN B-PP O
Duchenne NNP B-NP B-Disease
and CC I-NP I-Disease
Becker NNP I-NP I-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
DMD NN B-NP B-Disease
/ SYM O O
BMD NN B-NP B-Disease
) ) O O
patients NNS B-NP O
with IN B-PP O
no DT B-NP O
deletion NN I-NP O
or CC I-NP O
duplication NN I-NP O
was VBD B-VP O
performed VBN I-VP O
and CC O O
the DT B-NP O
samples NNS I-NP O
subjected VBN B-VP O
to TO B-PP O
multiple JJ B-NP O
SSCP NN I-NP O
analysis NN I-NP O
. . O O

We PRP B-NP O
report VBP B-VP O
the DT B-NP O
case NN I-NP O
of IN B-PP O
a DT B-NP O
nonsense JJ I-NP O
mutation NN I-NP O
in IN B-PP O
a DT B-NP O
Duchenne JJ I-NP B-Disease
patient NN I-NP O
identified VBN B-VP O
by IN B-PP O
this DT B-NP O
approach NN I-NP O
. . O O

The DT B-NP O
mutation NN I-NP O
introduces VBZ B-VP O
a DT B-NP O
termination NN I-NP O
codon NN I-NP O
within IN B-PP O
exon NN B-NP O
8 CD I-NP O
of IN B-PP O
the DT B-NP O
dystrophin NN I-NP O
gene NN I-NP O
. . O O

It PRP B-NP O
is VBZ B-VP O
predicted VBN I-VP O
to TO I-VP O
cause VB I-VP O
a DT B-NP O
very RB I-NP O
premature JJ I-NP O
translational JJ I-NP O
termination NN I-NP O
accounting VBG B-VP O
for IN B-PP O
the DT B-NP O
severe JJ I-NP O
phenotype NN I-NP O
observed VBN B-VP O
. . O O

The DT B-NP O
patient NN I-NP O
inherited VBD B-VP O
this DT B-NP O
mutation NN I-NP O
from IN B-PP O
his PRP$ B-NP O
mother NN I-NP O
. . O O

In IN B-PP O
addition NN B-NP O
the DT B-NP O
analysis NN I-NP O
revealed VBD B-VP O
5 CD B-NP O
polymorphisms NNS I-NP O
useful JJ B-ADJP O
for IN B-PP O
internal JJ B-NP O
control NN I-NP O
. . O O

. . O O

Proliferation NN B-NP O
- HYPH O O
related VBN B-VP O
expression NN B-NP O
of IN B-PP O
p19 NN B-NP O
/ SYM B-NP O
nm23 NN I-NP O
nucleoside NN I-NP O
diphosphate NN I-NP O
kinase NN I-NP O
. . O O

High JJ B-NP O
level NN I-NP O
expression NN I-NP O
of IN B-PP O
the DT B-NP O
nm23 NN I-NP O
- HYPH B-NP O
H1 NN I-NP O
gene NN I-NP O
, , O O
which WDT B-NP O
encodes VBZ B-VP O
for IN B-PP O
a DT B-NP O
nucleoside NN I-NP O
diphosphate NN I-NP O
kinase NN I-NP O
, , O O
has VBZ B-VP O
been VBN I-VP O
found VBN I-VP O
to TO I-VP O
correlate VB I-VP O
with IN B-PP O
diminished VBN B-NP O
metastasis NN I-NP O
in IN B-PP O
some DT B-NP O
tumors NNS I-NP B-Disease
but CC B-PP O
not RB B-PP O
in IN I-PP O
others NNS B-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
previously RB I-VP O
identified VBN I-VP O
the DT B-NP O
protein NN I-NP O
product NN I-NP O
of IN B-PP O
the DT B-NP O
nm23 NN I-NP O
- HYPH B-NP O
H1 NN I-NP O
gene NN I-NP O
in IN B-PP O
two CD B-NP O
- HYPH I-NP O
dimensional JJ I-NP O
electrophoretic JJ I-NP O
gels NNS I-NP O
and CC O O
have VBP B-VP O
designated VBN I-VP O
it PRP B-NP O
p19 NN B-NP O
/ SYM B-NP O
nm23 NN I-NP O
. . O O

In IN B-PP O
neuroblastoma NN B-NP B-Disease
, , O O
higher JJR B-NP O
levels NNS I-NP O
of IN B-PP O
p19 NN B-NP O
/ SYM B-NP O
nm23 NN I-NP O
, , O O
which WDT B-NP O
are VBP B-VP O
associated VBN I-VP O
with IN B-PP O
amplification NN B-NP O
of IN B-PP O
the DT B-NP O
N NN I-NP O
- HYPH B-NP O
myc NN I-NP O
oncogene NN I-NP O
, , O O
large JJ B-NP O
tumor NN I-NP B-Disease
mass NN I-NP O
, , O O
and CC O O
metastasis NN B-NP O
, , O O
were VBD B-VP O
observed VBN I-VP O
in IN B-PP O
advanced VBN B-NP O
stage NN I-NP O
tumors NNS I-NP B-Disease
compared VBN B-PP O
with IN B-PP O
limited JJ B-NP O
stage NN I-NP O
disease NN I-NP O
. . O O

Because IN B-PP O
of IN I-PP O
the DT B-NP O
variable JJ I-NP O
expression NN I-NP O
of IN B-PP O
nm23 NN B-NP O
- HYPH B-NP O
H1 NN I-NP O
in IN B-PP O
different JJ B-NP O
tumors NNS I-NP B-Disease
, , O O
we PRP B-NP O
have VBP B-VP O
investigated VBN I-VP O
the DT B-NP O
relationship NN I-NP O
between IN B-PP O
amounts NNS B-NP O
of IN B-PP O
the DT B-NP O
protein NN I-NP O
and CC I-NP O
cell NN I-NP O
proliferation NN I-NP O
. . O O

The DT B-NP O
levels NNS I-NP O
of IN B-PP O
p19 NN B-NP O
/ SYM B-NP O
nm23 NN I-NP O
were VBD B-VP O
compared VBN I-VP O
between IN B-PP O
resting VBG B-NP O
and CC I-NP O
mitotically RB I-NP O
stimulated VBN I-NP O
normal JJ I-NP O
human JJ I-NP O
PBLs NNS I-NP O
and CC B-PP O
in IN B-PP O
leukemia NN B-NP B-Disease
cells NNS I-NP O
. . O O

The DT B-NP O
amount NN I-NP O
of IN B-PP O
p19 NN B-NP O
/ SYM B-NP O
nm23 NN I-NP O
increased VBD B-VP O
in IN B-PP O
normal JJ B-NP O
lymphocytes NNS I-NP O
in IN B-PP O
response NN B-NP O
to TO B-PP O
mitotic JJ B-NP O
stimulation NN I-NP O
and CC O O
paralleled VBD B-VP O
the DT B-NP O
increase NN I-NP O
in IN B-PP O
DNA NN B-NP O
synthesis NN I-NP O
. . O O

In IN B-PP O
leukemia NN B-NP B-Disease
cells NNS I-NP O
obtained VBN B-VP O
from IN B-PP O
patients NNS B-NP O
with IN B-PP O
different JJ B-NP O
subtypes NNS I-NP O
of IN B-PP O
acute JJ B-NP B-Disease
leukemia NN I-NP I-Disease
, , O O
p19 NN B-NP O
/ SYM I-NP O
nm23 NN I-NP O
levels NNS I-NP O
were VBD B-VP O
also RB I-VP O
increased VBN I-VP O
relative JJ B-ADJP O
to TO B-PP O
resting VBG B-NP O
normal JJ I-NP O
lymphocytes NNS I-NP O
. . O O

Treatment NN B-NP O
of IN B-PP O
mitotically RB B-NP O
stimulated VBN I-NP O
lymphocytes NNS I-NP O
with IN B-PP O
cyclosporin NN B-NP O
, , O O
which WDT B-NP O
inhibits VBZ B-VP O
proliferation NN B-NP O
, , O O
blocked VBD B-VP O
the DT B-NP O
increase NN I-NP O
in IN B-PP O
p19 NN B-NP O
/ SYM O O
nm23 NN B-NP O
; : O O
treatment NN B-NP O
of IN B-PP O
the DT B-NP O
leukemia NN I-NP B-Disease
cell NN I-NP O
line NN I-NP O
HL NN I-NP O
- HYPH B-ADJP O
60 CD B-NP O
with IN B-PP O
dimethylsulfoxide NN B-NP O
, , O O
which WDT B-NP O
induces VBZ B-VP O
terminal JJ B-NP O
differentiation NN I-NP O
, , O O
resulted VBD B-VP O
in IN B-PP O
diminished VBN B-NP O
levels NNS I-NP O
of IN B-PP O
p19 NN B-NP O
/ SYM B-NP O
nm23 NN I-NP O
. . O O

Our PRP$ B-NP O
data NNS I-NP O
therefore RB B-ADVP O
provide VBP B-VP O
evidence NN B-NP O
that IN B-SBAR O
nm23 NN B-NP O
- HYPH O O
H1 NN B-NP O
expression NN I-NP O
is VBZ B-VP O
related VBN I-VP O
to TO B-PP O
cell NN B-NP O
proliferative JJ I-NP O
activity NN I-NP O
. . O O

. . O O

An DT B-NP O
intrachromosomal JJ I-NP O
insertion NN I-NP O
causing VBG B-VP O
5q22 NN B-NP O
deletion NN I-NP O
and CC O O
familial JJ B-NP B-Disease
adenomatous JJ I-NP I-Disease
polyposis NN I-NP I-Disease
coli NN I-NP I-Disease
in IN B-PP O
two CD B-NP O
generations NNS I-NP O
. . O O

We PRP B-NP O
report VBP B-VP O
familial JJ B-NP B-Disease
adenomatous JJ I-NP I-Disease
polyposis NN I-NP I-Disease
coli NN I-NP I-Disease
( ( O O
FAPC NN B-NP B-Disease
) ) O O
with IN B-PP O
epidermoid JJ B-NP B-Disease
cysts NNS I-NP I-Disease
, , O O
osteomata NNS B-NP B-Disease
, , O O
and CC O O
areas NNS B-NP O
of IN B-PP O
congenital JJ B-NP B-Disease
hypertrophy NN I-NP I-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
retinal JJ I-NP I-Disease
pigment NN I-NP I-Disease
epithelium NN I-NP I-Disease
( ( O O
CHRPEs NNS B-NP B-Disease
) ) O O
in IN B-PP O
a DT B-NP O
male JJ I-NP O
patient NN I-NP O
and CC O O
his PRP$ B-NP O
maternal JJ I-NP O
aunt NN I-NP O
, , O O
both DT B-NP O
of IN B-PP O
whom WP B-NP O
suffered VBD B-VP O
a DT B-NP O
mild JJ I-NP O
to TO I-NP O
moderate JJ I-NP O
degree NN I-NP O
of IN B-PP O
mental JJ B-NP B-Disease
handicap NN I-NP I-Disease
. . O O

Both DT B-NP O
had VBD B-VP O
an DT B-NP O
interstitial JJ I-NP O
deletion NN I-NP O
of IN B-PP O
the DT B-NP O
long JJ I-NP O
arm NN I-NP O
of IN B-PP O
chromosome NN B-NP O
5 CD I-NP O
( ( O O
del NN B-NP O
( ( O O
5 CD B-NP O
) ) O O
( ( O O
q22q23 CD B-NP O
. . O O

2 CD O O
) ) O O
) ) O O
. . O O

Two CD B-NP O
other JJ I-NP O
normal JJ I-NP O
family NN I-NP O
members NNS I-NP O
had VBD B-VP O
the DT B-NP O
underlying VBG I-NP O
direct JJ I-NP O
insertion NN I-NP O
of IN B-PP O
chromosome NN B-NP O
5 CD I-NP O
( ( O O
dir NN B-NP O
ins NNS I-NP O
( ( O O
5 CD B-NP O
) ) O O
( ( O O
q31 NN B-NP O
. . O O

3q22q23 CD B-NP O
3q22q23 NN I-NP O
. . O O

2 CD O O
) ) O O
) ) O O
. . O O

Molecular JJ B-NP O
genetic JJ I-NP O
and CC I-NP O
fluorescent JJ I-NP O
hybridisation NN I-NP O
studies NNS I-NP O
have VBP B-VP O
shown VBN I-VP O
that IN B-SBAR O
loci NNS B-NP O
D5S37 NN I-NP O
and CC I-NP O
D5S98 NN I-NP O
are VBP B-VP O
outside IN B-PP O
the DT B-NP O
deletion NN I-NP O
whereas IN B-PP O
loci NNS B-NP O
detected VBN B-VP O
by IN B-PP O
probes NNS B-NP O
EF5 NN I-NP O
. . O O

44 CD B-NP O
and CC O O
YN5 NN B-NP O
. . O O

48 CD B-NP O
are VBP B-VP O
lost VBN I-VP O
. . O O

As IN B-SBAR O
expected VBN B-VP O
, , O O
the DT B-NP O
molecular JJ I-NP O
analyses NNS I-NP O
indicate VBP B-VP O
loss NN B-NP O
of IN B-PP O
one CD B-NP O
allele NN I-NP O
at IN B-PP O
the DT B-NP O
MCC NN I-NP O
and CC I-NP O
APC NN I-NP B-Disease
loci NNS I-NP O
. . O O

The DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
is VBZ B-VP O
located JJ B-ADJP O
within IN B-PP O
band NN B-NP O
5q22 NN I-NP O
. . O O

Familial JJ B-NP O
direct JJ I-NP O
insertions NNS I-NP O
should MD B-VP O
be VB I-VP O
considered VBN I-VP O
as IN B-PP O
a DT B-NP O
cause NN I-NP O
of IN B-PP O
recurrent JJ B-NP O
microdeletion NN I-NP O
syndromes NNS I-NP O
. . O O

Chromosome NN B-NP O
mapping NN I-NP O
of IN B-PP O
the DT B-NP O
rod NN I-NP O
photoreceptor NN I-NP O
cGMP NN I-NP O
phosphodiesterase NN I-NP O
beta SYM B-NP O
- HYPH B-NP O
subunit NN I-NP O
gene NN I-NP O
in IN B-PP O
mouse NN B-NP O
and CC O O
human JJ B-ADJP O
: : O O
tight JJ B-NP O
linkage NN I-NP O
to TO B-PP O
the DT B-NP O
Huntington NNP I-NP B-Disease
disease NN I-NP I-Disease
region NN I-NP O
( ( O O
4p16 CD B-NP O
. . I-NP O

3 CD I-NP O
) ) O O
. . O O

The DT B-NP O
retinal JJ I-NP B-Disease
degeneration NN I-NP I-Disease
mouse NN I-NP O
( ( O O
gene NN B-NP O
symbol NN I-NP O
, , O O
rd NN B-NP O
) ) O O
is VBZ B-VP O
an DT B-NP O
animal NN I-NP O
model NN I-NP O
for IN B-PP O
certain JJ B-NP O
forms NNS I-NP O
of IN B-PP O
human JJ B-NP O
hereditary JJ I-NP B-Disease
retinopathies NNS I-NP I-Disease
. . O O

Recent JJ B-NP O
findings NNS I-NP O
of IN B-PP O
a DT B-NP O
nonsense JJ I-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
rd NN I-NP O
mouse NN I-NP O
PDE NN I-NP O
beta SYM O O
- HYPH O O
subunit NN B-NP O
gene NN I-NP O
( ( O O
Pdeb NN B-NP O
) ) O O
prompted VBD B-VP O
us PRP B-NP O
to TO B-VP O
investigate VB I-VP O
the DT B-NP O
chromosome NN I-NP O
locations NNS I-NP O
of IN B-PP O
the DT B-NP O
mouse NN I-NP O
and CC O O
human JJ B-NP O
genes NNS I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
utilized VBN I-VP O
backcross JJ B-NP O
analysis NN I-NP O
in IN B-PP O
mice NNS B-NP O
to TO B-VP O
verify VB I-VP O
and CC I-VP O
define VB I-VP O
more RBR B-ADVP O
precisely RB I-ADVP O
the DT B-NP O
location NN I-NP O
of IN B-PP O
the DT B-NP O
Pdeb NN I-NP O
locus NN I-NP O
6 CD I-NP O
. . O O

1 CD B-NP O
+ SYM O O
/ SYM O O
- SYM B-NP O
2 CD B-NP O
. . O O

3 CD B-NP O
cM NN I-NP O
distal JJ B-ADJP O
of IN B-PP O
Mgsa NN B-NP O
on IN B-PP O
mouse NN B-NP O
chromosome NN I-NP O
5 CD I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
determined VBN I-VP O
that IN B-SBAR O
the DT B-NP O
human JJ I-NP O
gene NN I-NP O
( ( O O
PDEB NN B-NP O
) ) O O
maps VBZ B-VP O
to TO B-PP O
4p16 CD B-NP O
. . O O

3 CD B-NP O
, , O O
very RB B-ADVP O
close RB I-ADVP O
to TO B-PP O
the DT B-NP O
Huntington NNP I-NP B-Disease
disease NN I-NP I-Disease
( ( O O
HD NN B-NP B-Disease
) ) O O
region NN B-NP O
. . O O

Analysis NN B-NP O
of IN B-PP O
the DT B-NP O
comparative JJ I-NP O
map NN I-NP O
for IN B-PP O
mice NNS B-NP O
and CC I-NP O
humans NNS I-NP O
shows VBZ B-VP O
that IN B-SBAR O
the DT B-NP O
mouse NN I-NP O
homologue NN I-NP O
of IN B-PP O
the DT B-NP O
HD NN I-NP B-Disease
gene NN I-NP O
will MD B-VP O
reside VB I-VP O
on IN B-PP O
chromosome NN B-NP O
5 CD I-NP O
. . O O

Linkage NN B-NP O
of IN B-PP O
the DT B-NP O
mouse NN I-NP O
Pdeb NN I-NP O
locus NN I-NP O
with IN B-PP O
other JJ B-NP O
homologues NNS I-NP O
in IN B-PP O
the DT B-NP O
human JJ I-NP O
4p16 CD I-NP O
. . O O

3 CD B-NP O
region NN I-NP O
is VBZ B-VP O
maintained VBN I-VP O
but CC O O
gene NN B-NP O
order NN I-NP O
is VBZ B-VP O
not RB O O
, , O O
suggesting VBG B-VP O
at IN B-NP O
least JJS I-NP O
three CD I-NP O
possible JJ I-NP O
sites NNS I-NP O
for IN B-PP O
the DT B-NP O
corresponding VBG I-NP O
mouse NN I-NP O
HD NN I-NP B-Disease
gene NN I-NP O
. . O O

Coincident JJ B-NP O
Kaposi NNP I-NP B-Disease
sarcoma NN I-NP I-Disease
and CC I-NP O
T NN I-NP B-Disease
- HYPH B-NP I-Disease
cell NN I-NP I-Disease
lymphoma NN I-NP I-Disease
in IN B-PP O
a DT B-NP O
patient NN I-NP O
with IN B-PP O
the DT B-NP O
Wiskott NNP I-NP B-Disease
- HYPH I-NP I-Disease
Aldrich NNP I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

A DT B-NP O
24 CD I-NP O
year NN I-NP O
old JJ I-NP O
male NN I-NP O
with IN B-PP O
a DT B-NP O
history NN I-NP O
of IN B-PP O
eczema NN B-NP B-Disease
, , O O
recurrent JJ B-NP O
mild JJ I-NP O
infections NNS I-NP O
, , O O
and CC O O
thrombocytopenia NN B-NP B-Disease
consistent JJ B-ADJP O
with IN B-PP O
the DT B-NP O
Wiskott NNP I-NP B-Disease
- HYPH I-NP I-Disease
Aldrich NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
WAS NN B-NP B-Disease
) ) O O
presented VBD B-VP O
with IN B-PP O
a DT B-NP O
mediastinal JJ I-NP O
mass NN I-NP O
, , O O
generalized VBN B-VP O
lymphadenopathy NN B-NP B-Disease
, , O O
splenomegaly NN B-NP B-Disease
, , O O
and CC O O
severe JJ B-NP O
thrombocytopenia NN I-NP B-Disease
. . O O

Studies NNS B-NP O
of IN B-PP O
immune JJ B-NP O
function NN I-NP O
including VBG B-PP O
immunoglobulin NN B-NP O
levels NNS I-NP O
and CC O O
T NN B-NP O
- HYPH B-NP O
cell NN I-NP O
subsets NNS I-NP O
were VBD B-VP O
normal JJ B-ADJP O
. . O O

Furthermore RB B-ADVP O
, , O O
his PRP$ B-NP O
T NN I-NP O
lymphocytes NNS I-NP O
proliferated VBD B-VP O
normally RB B-ADVP O
in IN B-PP O
response NN B-NP O
to TO B-PP O
phytohemagglutinin NN B-NP O
, , O O
concanavalin NN B-NP O
A NN I-NP O
, , O O
and CC O O
the DT B-NP O
combination NN I-NP O
of IN B-PP O
neuraminidase NN B-NP O
/ SYM I-NP O
galactose NN I-NP O
oxidase NN I-NP O
. . O O

However RB B-ADVP O
, , O O
their PRP$ B-NP O
proliferative JJ I-NP O
responses NNS I-NP O
to TO B-PP O
anti AFX B-NP O
- HYPH I-NP O
CD43 NN I-NP O
antibody NN I-NP O
and CC I-NP O
periodate NN I-NP O
were VBD B-VP O
diminished VBN I-VP O
, , O O
consistent JJ B-ADJP O
with IN B-PP O
the DT B-NP O
clinical JJ I-NP O
diagnosis NN I-NP O
of IN B-PP O
WAS NNP B-NP B-Disease
. . O O

An DT B-NP O
initial JJ I-NP O
inguinal JJ I-NP O
lymph NN I-NP O
node NN I-NP O
biopsy NN I-NP O
surprisingly RB B-ADVP O
revealed VBD B-VP O
Kaposi NNP B-NP B-Disease
sarcoma NN I-NP I-Disease
. . O O

However RB B-ADVP O
, , O O
following VBG B-PP O
splenectomy NN B-NP O
to TO B-VP O
increase VB I-VP O
the DT B-NP O
platelet NN I-NP O
count NN I-NP O
, , O O
biopsy NN B-NP O
of IN B-PP O
the DT B-NP O
mediastinal JJ I-NP O
mass NN I-NP O
revealed VBD B-VP O
T NN B-NP B-Disease
- HYPH I-NP I-Disease
cell NN I-NP I-Disease
large JJ I-NP I-Disease
cell NN I-NP I-Disease
lymphoma NN I-NP I-Disease
. . O O

Studies NNS B-NP O
of IN B-PP O
biopsied JJ B-NP O
tissue NN I-NP O
for IN B-PP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
Epstein NNP B-NP B-Disease
- HYPH I-NP I-Disease
Barr NNP I-NP I-Disease
virus NN I-NP I-Disease
and CC I-NP O
cytomegalovirus NN I-NP B-Disease
were VBD B-VP O
negative JJ B-ADJP O
, , O O
as IN B-SBAR O
were VBD B-VP O
studies NNS B-NP O
of IN B-PP O
blood NN B-NP O
, , O O
including VBG B-PP O
the DT B-NP O
polymerase NN I-NP O
chain NN I-NP O
reaction NN I-NP O
, , O O
for IN B-PP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
the DT B-NP O
human JJ I-NP B-Disease
immunodeficiency NN I-NP I-Disease
virus NN I-NP I-Disease
( ( O O
HIV NN B-NP B-Disease
) ) O O
. . O O

This DT B-NP O
is VBZ B-VP O
the DT B-NP O
first JJ I-NP O
report NN I-NP O
of IN B-PP O
Kaposi NNP B-NP B-Disease
sarcoma NN I-NP I-Disease
arising VBG B-VP O
in IN B-PP O
a DT B-NP O
patient NN I-NP O
with IN B-PP O
a DT B-NP O
congenital JJ I-NP B-Disease
immunodeficiency NN I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

Although IN B-SBAR O
Kaposi NNP B-NP B-Disease
sarcoma NN I-NP I-Disease
can MD B-VP O
arise VB I-VP O
in IN B-PP O
the DT B-NP O
face NN I-NP O
of IN B-PP O
the DT B-NP O
severe JJ I-NP O
immunosuppression NN I-NP O
that WDT B-NP O
follows VBZ B-VP O
allograft NN B-NP O
transplantation NN I-NP O
and CC B-PP O
in IN B-PP O
patients NNS B-NP O
infected VBN B-VP O
with IN B-PP O
HIV NN B-NP B-Disease
, , O O
we PRP B-NP O
postulate VBP B-VP O
that IN B-SBAR O
longevity NN B-NP O
in IN B-PP O
the DT B-NP O
face NN I-NP O
of IN B-PP O
mild JJ B-NP O
immunosuppression NN I-NP O
was VBD B-VP O
the DT B-NP O
major JJ I-NP O
factor NN I-NP O
in IN B-PP O
the DT B-NP O
development NN I-NP O
of IN B-PP O
Kaposi NNP B-NP B-Disease
sarcoma NN I-NP I-Disease
in IN B-PP O
this DT B-NP O
patient NN I-NP O
. . O O

. . O O

The DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
, , O O
responsible JJ B-ADJP O
for IN B-PP O
familial JJ B-NP B-Disease
adenomatous JJ I-NP I-Disease
polyposis NN I-NP I-Disease
, , O O
is VBZ B-VP O
mutated VBN I-VP O
in IN B-PP O
human JJ B-NP O
gastric JJ I-NP B-Disease
cancer NN I-NP I-Disease
. . O O

Although IN B-SBAR O
gastric JJ B-NP B-Disease
cancer NN I-NP I-Disease
is VBZ B-VP O
the DT B-NP O
most RBS I-NP O
common JJ I-NP O
cancer NN I-NP B-Disease
in IN B-PP O
the DT B-NP O
world NN I-NP O
, , O O
genetic JJ B-NP O
changes NNS I-NP O
during IN B-PP O
its PRP$ B-NP O
carcinogenesis NN I-NP O
are VBP B-VP O
not RB O O
well RB B-ADJP O
understood VBN I-ADJP O
. . O O

Since IN B-SBAR O
some DT B-NP O
gastric JJ I-NP B-Disease
cancers NNS I-NP I-Disease
are VBP B-VP O
considered VBN I-VP O
to TO I-VP O
originate VB I-VP O
from IN B-PP O
the DT B-NP O
intestinal JJ I-NP O
metaplasia NN I-NP O
, , O O
it PRP B-NP O
is VBZ B-VP O
likely JJ B-ADJP O
that IN B-SBAR O
the DT B-NP O
adenomatous JJ I-NP B-Disease
polyposis NN I-NP I-Disease
coli NN I-NP I-Disease
( ( O O
APC NN B-NP B-Disease
) ) O O
gene NN B-NP O
, , O O
the DT B-NP O
mutation NN I-NP O
of IN B-PP O
which WDT B-NP O
causes VBZ B-VP O
adenomatous JJ B-NP B-Disease
polyps NNS I-NP I-Disease
in IN B-PP I-Disease
the DT B-NP I-Disease
colon NN I-NP I-Disease
, , O O
is VBZ B-VP O
associated VBN I-VP O
with IN B-PP O
carcinogenesis NN B-NP O
of IN B-PP O
gastric JJ B-NP B-Disease
cancer NN I-NP I-Disease
. . O O

Based VBN B-PP O
on IN B-PP O
this DT B-NP O
idea NN I-NP O
, , O O
DNAs NNS B-NP O
isolated VBN B-VP O
from IN B-PP O
gastric JJ B-NP B-Disease
cancers NNS I-NP I-Disease
were VBD B-VP O
examined VBN I-VP O
by IN B-PP O
means NNS B-NP O
of IN B-PP O
a DT B-NP O
RNase NN I-NP O
protection NN I-NP O
analysis NN I-NP O
coupled VBN B-VP O
with IN B-PP O
polymerase NN B-NP O
chain NN I-NP O
reaction NN I-NP O
followed VBN B-VP O
by IN B-PP O
sequencing NN B-NP O
of IN B-PP O
the DT B-NP O
polymerase NN I-NP O
chain NN I-NP O
reaction NN I-NP O
products NNS I-NP O
. . O O

By IN B-PP O
screening VBG B-VP O
nearly RB B-NP O
one CD I-NP O
- HYPH I-NP O
half NN I-NP O
of IN B-PP O
the DT B-NP O
coding VBG I-NP O
region NN I-NP O
of IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
in IN B-PP O
44 CD B-NP O
tumors NNS I-NP B-Disease
, , O O
somatic JJ B-NP O
mutations NNS I-NP O
were VBD B-VP O
detected VBN I-VP O
in IN B-PP O
three CD B-NP O
tumors NNS I-NP B-Disease
a DT B-NP O
missense JJ I-NP O
mutation NN I-NP O
, , O O
a DT B-NP O
nonsense JJ I-NP O
mutation NN I-NP O
, , O O
and CC O O
a DT B-NP O
5 CD I-NP O
- HYPH I-NP O
base NN I-NP O
pair NN I-NP O
deletion NN I-NP O
resulting VBG B-VP O
in IN B-PP O
a DT B-NP O
frame NN I-NP O
shift NN I-NP O
which WDT B-NP O
causes VBZ B-VP O
truncation NN B-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
product NN I-NP O
. . O O

These DT B-NP O
results NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
the DT B-NP O
mutation NN I-NP O
of IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
also RB B-ADVP O
plays VBZ B-VP O
an DT B-NP O
important JJ I-NP O
role NN I-NP O
during IN B-PP O
the DT B-NP O
carcinogenesis NN I-NP O
of IN B-PP O
at IN B-ADVP O
least JJS I-ADVP O
some DT B-NP O
gastric JJ I-NP B-Disease
cancers NNS I-NP I-Disease
. . O O

. . O O

A DT B-NP O
71 CD I-NP O
- HYPH I-NP O
kilodalton NN I-NP O
protein NN I-NP O
is VBZ B-VP O
a DT B-NP O
major JJ I-NP O
product NN I-NP O
of IN B-PP O
the DT B-NP O
Duchenne NNP I-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
gene NN I-NP O
in IN B-PP O
brain NN B-NP O
and CC O O
other JJ B-NP O
nonmuscle JJ I-NP O
tissues NNS I-NP O
. . O O

The DT B-NP O
known JJ I-NP O
Duchenne NNP I-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
DMD NN B-NP B-Disease
) ) O O
gene NN B-NP O
products NNS I-NP O
, , O O
the DT B-NP O
muscle NN I-NP O
- HYPH B-NP O
and CC I-NP O
brain NN I-NP O
- HYPH I-NP O
type NN I-NP O
dystrophin NN I-NP O
isoforms NNS I-NP O
, , O O
are VBP B-VP O
427 CD B-NP O
- HYPH I-NP O
kDa NN I-NP O
proteins NNS I-NP O
translated VBN B-VP O
from IN B-PP O
14 CD B-NP O
- HYPH I-NP O
kilobase NN I-NP O
( ( O O
kb NN B-NP O
) ) O O
mRNAs NNS B-NP O
. . O O

Recently RB B-ADVP O
we PRP B-NP O
described VBD B-VP O
a DT B-NP O
6 CD I-NP O
. . O O

5 CD B-NP O
- HYPH I-NP O
kb NN I-NP O
mRNA NN I-NP O
that WDT B-NP O
also RB B-ADVP O
is VBZ B-VP O
transcribed VBN I-VP O
from IN B-PP O
the DT B-NP O
DMD NN I-NP B-Disease
gene NN I-NP O
. . O O

Cloning NN B-NP O
and CC O O
in FW B-NP O
vitro FW I-NP O
transcription NN I-NP O
and CC I-NP O
translation NN I-NP O
of IN B-PP O
the DT B-NP O
entire JJ I-NP O
coding VBG I-NP O
region NN I-NP O
show VBP B-VP O
that IN B-SBAR O
the DT B-NP O
6 CD I-NP O
. . O O

5 CD B-NP O
- HYPH I-NP O
kb NN I-NP O
mRNA NN I-NP O
encodes VBZ B-VP O
a DT B-NP O
70 CD I-NP O
. . O O

8 CD B-NP O
- HYPH I-NP O
kDa NN I-NP O
protein NN I-NP O
that WDT B-NP O
is VBZ B-VP O
a DT B-NP O
major JJ I-NP O
product NN I-NP O
of IN B-PP O
the DT B-NP O
DMD NN I-NP B-Disease
gene NN I-NP O
. . O O

It PRP B-NP O
contains VBZ B-VP O
the DT B-NP O
C NN I-NP O
- HYPH B-VP O
terminal JJ B-ADJP O
and CC O O
the DT B-NP O
cysteine NN I-NP O
- HYPH B-NP O
rich JJ I-NP O
domains NNS I-NP O
of IN B-PP O
dystrophin NN B-NP O
, , O O
seven CD B-NP O
additional JJ I-NP O
amino NN I-NP O
acids NNS I-NP O
at IN B-PP O
the DT B-NP O
N NN I-NP O
terminus NN I-NP O
, , O O
and CC O O
some DT B-NP O
modifications NNS I-NP O
formed VBN B-VP O
by IN B-PP O
alternative JJ B-NP O
splicing NN I-NP O
in IN B-PP O
the DT B-NP O
C NN I-NP O
- HYPH B-NP O
terminal JJ I-NP O
domain NN I-NP O
. . O O

It PRP B-NP O
lacks VBZ B-VP O
the DT B-NP O
entire JJ I-NP O
large JJ I-NP O
domain NN I-NP O
of IN B-PP O
spectrin NN B-NP O
- HYPH B-ADVP O
like JJ B-PP O
repeats NNS B-NP O
and CC O O
the DT B-NP O
actin NN I-NP O
- HYPH B-PP O
binding VBG B-NP O
N NN I-NP O
- HYPH B-NP O
terminal JJ I-NP O
domain NN I-NP O
of IN B-PP O
dystrophin NN B-NP O
. . O O

This DT B-NP O
protein NN I-NP O
is VBZ B-VP O
the DT B-NP O
major JJ I-NP O
DMD NN I-NP B-Disease
gene NN I-NP O
product NN I-NP O
in IN B-PP O
brain NN B-NP O
and CC O O
other JJ B-NP O
nonmuscle JJ I-NP O
tissues NNS I-NP O
but CC O O
is VBZ B-VP O
undetectable JJ B-ADJP O
in IN B-PP O
skeletal JJ B-NP O
muscle NN I-NP O
extracts NNS I-NP O
. . O O

Correlation NN B-NP O
between IN B-PP O
the DT B-NP O
location NN I-NP O
of IN B-PP O
germ NN B-NP O
- HYPH I-NP O
line NN I-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
and CC O O
the DT B-NP O
number NN I-NP O
of IN B-PP O
colorectal JJ B-NP B-Disease
polyps NNS I-NP I-Disease
in IN B-PP O
familial JJ B-NP B-Disease
adenomatous JJ I-NP I-Disease
polyposis NN I-NP I-Disease
patients NNS I-NP O
. . O O

Recently RB B-ADVP O
we PRP B-NP O
have VBP B-VP O
isolated VBN I-VP O
the DT B-NP O
adenomatous JJ I-NP B-Disease
polyposis NN I-NP I-Disease
coli NN I-NP I-Disease
( ( O O
APC NN B-NP B-Disease
) ) O O
gene NN B-NP O
which WDT B-NP O
causes VBZ B-VP O
familial JJ B-NP B-Disease
adenomatous JJ I-NP I-Disease
polyposis NN I-NP I-Disease
( ( O O
FAP NN B-NP B-Disease
) ) O O
, , O O
and CC O O
its PRP$ B-NP O
germ NN I-NP O
- HYPH I-NP O
line NN I-NP O
mutations NNS I-NP O
in IN B-PP O
a DT B-NP O
substantial JJ I-NP O
number NN I-NP O
of IN B-PP O
FAP NN B-NP B-Disease
patients NNS I-NP O
have VBP B-VP O
been VBN I-VP O
identified VBN I-VP O
. . O O

On IN B-PP O
the DT B-NP O
basis NN I-NP O
of IN B-PP O
this DT B-NP O
information NN I-NP O
, , O O
we PRP B-NP O
compared VBD B-VP O
the DT B-NP O
location NN I-NP O
of IN B-PP O
germ NN B-NP O
- HYPH I-NP O
line NN I-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
in IN B-PP O
22 CD B-NP O
unrelated JJ I-NP O
patients NNS I-NP O
( ( O O
12 CD B-NP O
of IN B-PP O
whom WP B-NP O
have VBP B-VP O
been VBN I-VP O
reported VBN I-VP O
previously RB B-ADVP O
) ) O O
with IN B-PP O
the DT B-NP O
number NN I-NP O
of IN B-PP O
colorectal JJ B-NP B-Disease
polyps NNS I-NP I-Disease
developed VBN B-VP O
in IN B-PP O
FAP NN B-NP B-Disease
patients NNS I-NP O
; : O O
17 CD B-NP O
were VBD B-VP O
sparse JJ B-NP O
types NNS I-NP O
and CC O O
five CD B-NP O
were VBD B-VP O
profuse NN B-NP O
types NNS I-NP O
. . O O

All DT B-NP O
but IN B-PP O
one CD B-NP O
of IN B-PP O
the DT B-NP O
mutations NNS I-NP O
were VBD B-VP O
considered VBN I-VP O
to TO I-VP O
cause VB I-VP O
truncation NN B-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
product NN I-NP O
by IN B-PP O
frame NN B-NP O
- HYPH I-NP O
shift NN I-NP O
due JJ B-ADJP O
to TO B-PP O
deletion NN B-NP O
( ( O O
14 CD B-NP O
cases NNS I-NP O
) ) O O
or CC O O
nonsense JJ B-NP O
mutation NN I-NP O
( ( O O
seven CD B-NP O
cases NNS I-NP O
) ) O O
. . O O

The DT B-NP O
location NN I-NP O
of IN B-PP O
the DT B-NP O
germ NN I-NP O
- HYPH I-NP O
line NN I-NP O
mutations NNS I-NP O
seems VBZ B-VP O
to TO I-VP O
correlate VB I-VP O
with IN B-PP O
the DT B-NP O
two CD I-NP O
clinical JJ I-NP O
types NNS I-NP O
; : O O
germ NN B-NP O
- HYPH I-NP O
line NN I-NP O
mutations NNS I-NP O
in IN B-PP O
five CD B-NP O
FAP NN I-NP B-Disease
patients NNS I-NP O
with IN B-PP O
profuse NN B-NP O
polyps NNS I-NP B-Disease
were VBD B-VP O
observed VBN I-VP O
between IN B-PP O
codon NN B-NP O
1250 CD I-NP O
and CC O O
codon NN B-NP O
1464 CD I-NP O
, , O O
whereas IN O O
mutations NNS B-NP O
in IN B-PP O
17 CD B-NP O
FAP NN I-NP B-Disease
patients NNS I-NP O
with IN B-PP O
fewer JJR B-NP O
polyps NNS I-NP B-Disease
were VBD B-VP O
observed VBN I-VP O
in IN B-PP O
the DT B-NP O
other JJ I-NP O
regions NNS I-NP O
of IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
. . O O

The DT B-NP O
result NN I-NP O
suggests VBZ B-VP O
that IN B-SBAR O
the DT B-NP O
number NN I-NP O
of IN B-PP O
colorectal JJ B-NP B-Disease
polyps NNS I-NP I-Disease
in IN B-PP O
FAP NN B-NP B-Disease
patients NNS I-NP O
may MD B-VP O
be VB I-VP O
associated VBN I-VP O
with IN B-PP O
a DT B-NP O
difference NN I-NP O
in IN B-PP O
the DT B-NP O
stability NN I-NP O
or CC I-NP O
biological JJ I-NP O
function NN I-NP O
of IN B-PP O
the DT B-NP O
truncated VBN I-NP O
APC NN I-NP B-Disease
protein NN I-NP O
. . O O

. . O O

Identification NN B-NP O
and CC O O
rapid JJ B-NP O
detection NN I-NP O
of IN B-PP O
three CD B-NP O
Tay NNP I-NP B-Disease
- HYPH I-NP I-Disease
Sachs NNP I-NP I-Disease
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
Moroccan NNP I-NP O
Jewish NNP I-NP O
population NN I-NP O
. . O O

Infantile JJ B-NP O
Tay NNP I-NP B-Disease
- HYPH I-NP I-Disease
Sachs NNP I-NP I-Disease
disease NN I-NP I-Disease
( ( O O
TSD NN B-NP B-Disease
) ) O O
is VBZ B-VP O
caused VBN I-VP O
by IN B-PP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
HEXA NN I-NP O
gene NN I-NP O
that WDT B-NP O
result VBP B-VP O
in IN B-PP O
the DT B-NP O
complete JJ I-NP O
absence NN I-NP O
of IN B-PP O
beta SYM B-NP O
- HYPH I-NP O
hexosaminidase NN I-NP O
A NN I-NP O
activity NN I-NP O
. . O O

It PRP B-NP O
is VBZ B-VP O
well RB I-VP O
known VBN I-VP O
that IN B-SBAR O
an DT B-NP O
elevated JJ I-NP O
frequency NN I-NP O
of IN B-PP O
TSD NN B-NP B-Disease
mutations NNS I-NP O
exists VBZ B-VP O
among IN B-PP O
Ashkenazi NNP B-NP O
Jews NNP I-NP O
. . O O

More RBR B-ADVP O
recently RB I-ADVP O
it PRP B-NP O
has VBZ B-VP O
become VBN I-VP O
apparent JJ B-ADJP O
that IN B-SBAR O
elevated JJ B-NP O
carrier NN I-NP O
frequencies NNS I-NP O
for IN B-PP O
TSD NN B-NP B-Disease
also RB B-ADVP O
occur VBP B-VP O
in IN B-PP O
several JJ B-NP O
other JJ I-NP O
ethnic JJ I-NP O
groups NNS I-NP O
, , O O
including VBG B-PP O
Moroccan NNP B-NP O
Jews NNP I-NP O
, , O O
a DT B-NP O
subgroup NN I-NP O
of IN B-PP O
Sephardic JJ B-NP O
Jews NNS I-NP O
. . O O

Elsewhere RB B-ADVP O
we PRP B-NP O
reported VBD B-VP O
an DT B-NP O
in IN B-PP O
- HYPH B-NP O
frame NN I-NP O
deletion NN I-NP O
of IN B-PP O
one CD B-NP O
of IN B-PP O
the DT B-NP O
two CD I-NP O
adjacent JJ I-NP O
phenylalanine NN I-NP O
codons NNS I-NP O
at IN B-PP O
position NN B-NP O
304 CD I-NP O
or CC I-NP O
305 CD I-NP O
( ( O O
delta SYM O O
F304 NN B-NP O
/ SYM B-NP O
305 CD I-NP O
) ) O O
in IN B-PP O
one CD B-NP O
HEXA NN I-NP O
allele NN I-NP O
of IN B-PP O
a DT B-NP O
Moroccan NNP I-NP O
Jewish NNP I-NP O
TSD NN I-NP B-Disease
patient NN I-NP O
and CC O O
in IN B-PP O
three CD B-NP O
obligate JJ I-NP O
carriers NNS I-NP O
from IN B-PP O
six CD B-NP O
unrelated JJ I-NP O
Moroccan NNP I-NP O
Jewish JJ I-NP O
families NNS I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
now RB I-VP O
identified VBN I-VP O
two CD B-NP O
additional JJ I-NP O
mutations NNS I-NP O
within IN B-PP O
exon NN B-NP O
5 CD I-NP O
of IN B-PP O
the DT B-NP O
HEXA NN I-NP O
gene NN I-NP O
that WDT B-NP O
account VBP B-VP O
for IN B-PP O
the DT B-NP O
remaining VBG I-NP O
TSD NN I-NP B-Disease
alleles NNS I-NP O
in IN B-PP O
the DT B-NP O
patient NN I-NP O
and CC I-NP O
carriers NNS I-NP O
. . O O

One CD B-NP O
of IN B-PP O
the DT B-NP O
mutations NNS I-NP O
is VBZ B-VP O
a DT B-NP O
novel JJ I-NP O
C NN I-NP O
- HYPH B-ADJP O
to TO B-PP O
- HYPH B-NP O
G NN I-NP O
transversion NN I-NP O
, , O O
resulting VBG B-VP O
in IN B-PP O
a DT B-NP O
replacement NN I-NP O
of IN B-PP O
Tyr180 NN B-NP O
by IN B-PP O
a DT B-NP O
stop NN I-NP O
codon NN I-NP O
. . O O

The DT B-NP O
other JJ I-NP O
mutation NN I-NP O
is VBZ B-VP O
a DT B-NP O
G NN I-NP O
- HYPH B-ADJP O
to TO B-PP O
- HYPH B-NP O
A NN I-NP O
transition NN I-NP O
resulting VBG B-VP O
in IN B-PP O
an DT B-NP O
Arg170 NN I-NP O
- HYPH B-ADJP O
to TO B-PP O
- HYPH B-NP O
Gln NN I-NP O
substitution NN I-NP O
. . O O

This DT B-NP O
mutation NN I-NP O
is VBZ B-VP O
at IN B-PP O
a DT B-NP O
CpG NN I-NP O
site NN I-NP O
in IN B-PP O
a DT B-NP O
Japanese JJ I-NP O
infant NN I-NP O
with IN B-PP O
Tay NNP B-NP B-Disease
- HYPH I-NP I-Disease
Sachs NNP I-NP I-Disease
disease NN I-NP I-Disease
and CC O O
was VBD B-VP O
described VBN I-VP O
elsewhere RB B-ADVP O
. . O O

Analysis NN B-NP O
of IN B-PP O
nine CD B-NP O
obligate JJ I-NP O
carriers NNS I-NP O
from IN B-PP O
seven CD B-NP O
unrelated JJ I-NP O
families NNS I-NP O
showed VBD B-VP O
that IN B-SBAR O
four CD B-NP O
harbor VBP B-VP O
the DT B-NP O
delta SYM I-NP O
F304 NN I-NP O
/ SYM O O
305 CD B-NP O
mutation NN I-NP O
, , O O
two CD B-NP O
the DT B-NP O
Arg170 NN I-NP O
- SYM B-VP O
- SYM B-NP O
- SYM I-NP O
- HYPH I-NP O
Gln NN I-NP O
mutation NN I-NP O
, , O O
and CC O O
one CD B-NP O
the DT B-NP O
Tyr180 NN I-NP O
- SYM B-VP O
- SYM B-NP O
- SYM I-NP O
- HYPH I-NP O
Stop NN I-NP O
mutation NN I-NP O
. . O O

We PRP B-NP O
also RB B-ADVP O
have VBP B-VP O
developed VBN I-VP O
rapid JJ B-NP O
, , I-NP O
nonradioactive JJ I-NP O
assays NNS I-NP O
for IN B-PP O
the DT B-NP O
detection NN I-NP O
of IN B-PP O
each DT B-NP O
mutation NN I-NP O
, , O O
which WDT B-NP O
should MD B-VP O
be VB I-VP O
helpful JJ B-ADJP O
for IN B-PP O
carrier NN B-NP O
screening NN I-NP O
. . O O

. . O O

Molecular JJ B-NP O
characterization NN I-NP O
of IN B-PP O
glucose NN B-NP B-Disease
- HYPH B-NP I-Disease
6 CD I-NP I-Disease
- HYPH I-NP I-Disease
phosphate NN I-NP I-Disease
dehydrogenase NN I-NP I-Disease
( ( O I-Disease
G6PD NN B-NP I-Disease
) ) O I-Disease
deficiency NN B-NP I-Disease
by IN B-PP O
natural JJ B-NP O
and CC I-NP O
amplification NN I-NP O
created VBD B-VP O
restriction NN B-NP O
sites NNS I-NP O
: : O O
five CD B-NP O
mutations NNS I-NP O
account VBP B-VP O
for IN B-PP O
most JJS B-NP O
G6PD NN I-NP B-Disease
deficiency NN I-NP I-Disease
cases NNS I-NP O
in IN B-PP O
Taiwan NNP B-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
developed VBN I-VP O
a DT B-NP O
rapid JJ I-NP O
and CC I-NP O
simple JJ I-NP O
method NN I-NP O
to TO B-VP O
diagnose VB I-VP O
the DT B-NP O
molecular JJ I-NP O
defects NNS I-NP O
of IN B-PP O
glucose NN B-NP B-Disease
- HYPH B-NP I-Disease
6 CD I-NP I-Disease
- HYPH I-NP I-Disease
phosphate NN I-NP I-Disease
dehydrogenase NN I-NP I-Disease
( ( O I-Disease
G6PD NN B-NP I-Disease
) ) O I-Disease
deficiency NN B-NP I-Disease
in IN B-PP O
Chinese NNP B-NP O
in IN B-PP O
Taiwan NNP B-NP O
. . O O

This DT B-NP O
method NN I-NP O
involves VBZ B-VP O
the DT B-NP O
selective JJ I-NP O
amplification NN I-NP O
of IN B-PP O
a DT B-NP O
DNA NN I-NP O
fragment NN I-NP O
from IN B-PP O
human JJ B-NP O
G6PD NN I-NP O
gene NN I-NP O
with IN B-PP O
specific JJ B-NP O
oligonucleotide NN I-NP O
primers NNS I-NP O
followed VBN B-VP O
by IN B-PP O
digestion NN B-NP O
with IN B-PP O
restriction NN B-NP O
enzymes NNS I-NP O
that WDT B-NP O
recognize VBP B-VP O
artificially RB I-VP O
created VBN I-VP O
or CC O O
naturally RB B-VP O
occurring VBG I-VP O
restriction NN B-NP O
sites NNS I-NP O
. . O O

Ninety CD B-NP O
- HYPH I-NP O
four CD I-NP O
Chinese JJ I-NP O
males NNS I-NP O
with IN B-PP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
were VBD B-VP O
studied VBN I-VP O
. . O O

The DT B-NP O
results NNS I-NP O
show VBP B-VP O
that IN B-SBAR O
50 CD B-NP O
% NN I-NP O
( ( O O
47 CD B-NP O
of IN B-PP O
94 CD B-NP O
) ) O O
were VBD B-VP O
G NN B-NP O
to TO B-PP O
T NN B-NP O
mutation NN I-NP O
at IN B-PP O
nucleotide NN B-NP O
( ( O O
nt NN B-NP O
) ) O O
1376 CD B-NP O
, , I-NP O
21 CD I-NP O
. . O O

3 CD B-NP O
% NN I-NP O
( ( O O
20 CD B-NP O
of IN B-PP O
94 CD B-NP O
) ) O O
were VBD B-VP O
G NN B-NP O
to TO B-PP O
A NN B-NP O
mutation NN I-NP O
at IN B-PP O
nt NN B-NP O
1388 CD I-NP O
, , I-NP O
7 CD I-NP O
. . O O

4 CD B-NP O
% NN I-NP O
( ( O O
7 CD B-NP O
of IN B-PP O
94 CD B-NP O
) ) O O
were VBD B-VP O
A NN B-NP O
to TO B-PP O
G NN B-NP O
mutation NN I-NP O
at IN B-PP O
nt NN B-NP O
493 CD I-NP O
, , I-NP O
7 CD I-NP O
. . O O

4 CD B-NP O
% NN I-NP O
( ( O O
7 CD B-NP O
of IN B-PP O
94 CD B-NP O
) ) O O
were VBD B-VP O
A NN B-NP O
to TO B-PP O
G NN B-NP O
mutation NN I-NP O
at IN B-PP O
nt NN B-NP O
95 CD I-NP O
, , I-NP O
4 CD I-NP O
. . O O

2 CD B-NP O
% NN I-NP O
( ( O O
4 CD B-NP O
of IN B-PP O
94 CD B-NP O
) ) O O
were VBD B-VP O
C NN B-NP O
to TO B-PP O
T NN B-NP O
mutation NN I-NP O
at IN B-PP O
nt NN B-NP O
1024 CD I-NP O
, , I-NP O
1 CD I-NP O
. . O O

1 CD B-NP O
% NN I-NP O
( ( O O
1 CD B-NP O
of IN B-PP O
94 CD B-NP O
) ) O O
was VBD B-VP O
G NN B-NP O
to TO B-PP O
T NN B-NP O
mutation NN I-NP O
at IN B-PP O
nt NN B-NP O
392 CD I-NP O
, , O O
and CC O O
1 CD B-NP O
. . O O

1 CD B-NP O
% NN I-NP O
( ( O O
1 CD B-NP O
of IN B-PP O
94 CD B-NP O
) ) O O
was VBD B-VP O
G NN B-NP O
to TO B-PP O
A NN B-NP O
mutation NN I-NP O
at IN B-PP O
nt NN B-NP O
487 CD I-NP O
. . O O

These DT B-NP O
results NNS I-NP O
show VBP B-VP O
that IN B-SBAR O
the DT B-NP O
former JJ I-NP O
five CD I-NP O
mutations NNS I-NP O
account VBP B-VP O
for IN B-PP O
more JJR B-NP O
than IN I-NP O
90 CD I-NP O
% NN I-NP O
of IN B-PP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
cases NNS I-NP O
in IN B-PP O
Taiwan NNP B-NP O
. . O O

Aside RB B-ADVP O
from IN B-PP O
showing VBG B-VP O
that DT B-NP O
G NN I-NP O
to TO B-PP O
T NN B-NP O
change NN I-NP O
at IN B-PP O
nt NN B-NP O
1376 CD I-NP O
is VBZ B-VP O
the DT B-NP O
most RBS I-NP O
common JJ I-NP O
mutation NN I-NP O
, , O O
our PRP$ B-NP O
research NN I-NP O
indicates VBZ B-VP O
that IN B-SBAR O
nt NN B-NP O
493 CD I-NP O
mutation NN I-NP O
is VBZ B-VP O
a DT B-NP O
frequent JJ I-NP O
mutation NN I-NP O
among IN B-PP O
Chinese NNP B-NP O
in IN B-PP O
Taiwan NNP B-NP O
. . O O

We PRP B-NP O
compared VBD B-VP O
G6PD NN B-NP O
activity NN I-NP O
among IN B-PP O
different JJ B-NP O
mutations NNS I-NP O
, , O O
without IN B-PP O
discovering VBG B-VP O
significant JJ B-NP O
differences NNS I-NP O
between IN B-PP O
them PRP B-NP O
. . O O

Eight CD B-NP O
novel JJ I-NP O
inactivating VBG I-NP O
germ NN I-NP O
line NN I-NP O
mutations NNS I-NP O
at IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
identified VBN B-VP O
by IN B-PP O
denaturing VBG B-VP O
gradient NN B-NP O
gel NN I-NP O
electrophoresis NN I-NP O
. . O O

Familial JJ B-NP B-Disease
adenomatous JJ I-NP I-Disease
polyposis NN I-NP I-Disease
( ( O O
FAP NN B-NP B-Disease
) ) O O
is VBZ B-VP O
a DT B-NP O
dominantly RB I-NP O
inherited VBN I-NP O
condition NN I-NP O
predisposing VBG B-VP O
to TO B-PP O
colorectal JJ B-NP B-Disease
cancer NN I-NP I-Disease
. . O O

The DT B-NP O
recent JJ I-NP O
isolation NN I-NP O
of IN B-PP O
the DT B-NP O
responsible JJ I-NP O
gene NN I-NP O
( ( O O
adenomatous JJ B-NP B-Disease
polyposis NN I-NP I-Disease
coli NN I-NP I-Disease
or CC O O
APC NN B-NP B-Disease
) ) O O
has VBZ B-VP O
facilitated VBN I-VP O
the DT B-NP O
search NN I-NP O
for IN B-PP O
germ NN B-NP O
line NN I-NP O
mutations NNS I-NP O
in IN B-PP O
affected VBN B-NP O
individuals NNS I-NP O
. . O O

Previous JJ B-NP O
authors NNS I-NP O
have VBP B-VP O
used VBN I-VP O
the DT B-NP O
RNase NN I-NP O
protection NN I-NP O
assay NN I-NP O
and CC O O
the DT B-NP O
single JJ I-NP O
- HYPH I-NP O
strand NN I-NP O
conformation NN I-NP O
polymorphisms NNS I-NP O
procedure VBP B-VP O
to TO I-VP O
screen VB I-VP O
for IN B-PP O
mutations NNS B-NP O
. . O O

In IN B-PP O
this DT B-NP O
study NN I-NP O
we PRP B-NP O
used VBD B-VP O
denaturing VBG I-VP O
gradient NN B-NP O
gel NN I-NP O
electrophoresis NN I-NP O
( ( O O
DGGE NN B-NP O
) ) O O
. . O O

DGGE NN B-NP O
analysis NN I-NP O
of IN B-PP O
10 CD B-NP O
APC NN I-NP B-Disease
exons NNS I-NP O
( ( O O
4 CD B-NP O
, , I-NP O
5 CD I-NP O
, , I-NP O
7 CD I-NP O
, , I-NP O
8 CD I-NP O
, , I-NP O
9 CD I-NP O
, , I-NP O
10 CD I-NP O
, , I-NP O
12 CD I-NP O
, , I-NP O
13 CD I-NP O
, , I-NP O
14 CD I-NP O
, , O O
and CC O O
part NN B-NP O
of IN B-PP O
15 CD B-NP O
) ) O O
in IN B-PP O
33 CD B-NP O
unrelated JJ I-NP O
Dutch JJ I-NP O
FAP NN I-NP B-Disease
patients NNS I-NP O
has VBZ B-VP O
led VBN I-VP O
to TO B-PP O
the DT B-NP O
identification NN I-NP O
of IN B-PP O
eight CD B-NP O
novel JJ I-NP O
germ NN I-NP O
line NN I-NP O
mutations NNS I-NP O
resulting VBG B-VP O
in IN B-PP O
stop NN B-NP O
codons NNS I-NP O
or CC I-NP O
frameshifts NNS I-NP O
. . O O

The DT B-NP O
results NNS I-NP O
reported VBN B-VP O
here RB B-ADVP O
indicate VBP B-VP O
that IN B-SBAR O
( ( B-LST O
1 LS I-LST O
) ) O O
familial JJ B-NP B-Disease
adenomatous JJ I-NP I-Disease
polyposis NN I-NP I-Disease
is VBZ B-VP O
caused VBN I-VP O
by IN B-PP O
an DT B-NP O
extremely RB I-NP O
heterogeneous JJ I-NP O
spectrum NN I-NP O
of IN B-PP O
point NN B-NP O
mutations NNS I-NP O
; : O O
( ( B-LST O
2 LS I-LST O
) ) O O
all PDT B-NP O
the DT I-NP O
mutations NNS I-NP O
found VBN B-VP O
in IN B-PP O
this DT B-NP O
study NN I-NP O
are VBP B-VP O
chain NN B-NP O
terminating NN I-NP O
; : O O
and CC O O
( ( B-LST O
3 LS I-LST O
) ) O O
DGGE NN B-NP O
represents VBZ B-VP O
a DT B-NP O
rapid JJ I-NP O
and CC I-NP O
sensitive JJ I-NP O
technique NN I-NP O
for IN B-PP O
the DT B-NP O
detection NN I-NP O
of IN B-PP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
unusually RB I-NP O
large JJ I-NP O
APC NN I-NP B-Disease
gene NN I-NP O
. . O O

An DT B-NP O
extension NN I-NP O
of IN B-PP O
the DT B-NP O
DGGE NN I-NP O
analysis NN I-NP O
to TO B-PP O
the DT B-NP O
entire JJ I-NP O
coding VBG I-NP O
region NN I-NP O
in IN B-PP O
a DT B-NP O
sufficient JJ I-NP O
number NN I-NP O
of IN B-PP O
clinically RB B-NP O
well RB I-NP O
- HYPH I-NP O
characterized VBN B-VP O
, , O O
unrelated JJ B-NP O
patients NNS I-NP O
will MD B-VP O
facilitate VB I-VP O
the DT B-NP O
establishment NN I-NP O
of IN B-PP O
genotype NN B-NP O
- HYPH B-NP O
phenotype NN I-NP O
correlations NNS I-NP O
. . O O

On IN B-PP O
the DT B-NP O
other JJ I-NP O
hand NN I-NP O
, , O O
the DT B-NP O
occurrence NN I-NP O
of IN B-PP O
an DT B-NP O
extremely RB I-NP O
heterogeneous JJ I-NP O
spectrum NN I-NP O
of IN B-PP O
mutations NNS B-NP O
spread VBN B-VP O
throughout IN B-PP O
the DT B-NP O
entire JJ I-NP O
length NN I-NP O
of IN B-PP O
the DT B-NP O
large JJ I-NP O
APC NN I-NP B-Disease
gene NN I-NP O
among IN B-PP O
the DT B-NP O
FAP NN I-NP B-Disease
patients NNS I-NP O
indicates VBZ B-VP O
that IN B-SBAR O
this DT B-NP O
approach NN I-NP O
may MD B-VP O
not RB I-VP O
be VB I-VP O
useful JJ B-ADJP O
as IN B-PP O
a DT B-NP O
rapid JJ I-NP O
presymptomatic JJ I-NP O
diagnostic JJ I-NP O
procedure NN I-NP O
in IN B-PP O
a DT B-NP O
routine JJ I-NP O
laboratory NN I-NP O
. . O O

Nevertheless RB B-ADVP O
, , O O
the DT B-NP O
above JJ I-NP O
DGGE NN I-NP O
approach NN I-NP O
has VBZ B-VP O
incidentally RB I-VP O
led VBN I-VP O
to TO B-PP O
the DT B-NP O
identification NN I-NP O
of IN B-PP O
a DT B-NP O
common JJ I-NP O
polymorphism NN I-NP O
in IN B-PP O
exon NN B-NP O
13 CD I-NP O
. . O O

Such JJ B-NP O
intragenic JJ I-NP O
polymorphisms NNS I-NP O
offer VBP B-VP O
a DT B-NP O
practical JJ I-NP O
approach NN I-NP O
to TO B-PP O
a DT B-NP O
more RBR I-NP O
rapid JJ I-NP O
procedure NN I-NP O
for IN B-PP O
presymptomatic JJ B-NP O
diagnosis NN I-NP O
of IN B-PP O
FAP NN B-NP B-Disease
by IN B-PP O
linkage NN B-NP O
analysis NN I-NP O
in IN B-PP O
informative JJ B-NP O
families NNS I-NP O
. . O O

. . O O

Yeast JJ B-NP O
artificial JJ I-NP O
chromosomes NNS I-NP O
for IN B-PP O
the DT B-NP O
molecular JJ I-NP O
analysis NN I-NP O
of IN B-PP O
the DT B-NP O
familial JJ I-NP B-Disease
polyposis NN I-NP I-Disease
APC NN I-NP I-Disease
gene NN I-NP O
region NN I-NP O
. . O O

Two CD B-NP O
yeast NN I-NP O
artificial JJ I-NP O
chromosomes NNS I-NP O
( ( O O
YACs NNS B-NP O
) ) O O
spanning VBG B-VP O
a DT B-NP O
total JJ I-NP O
distance NN I-NP O
of IN B-PP O
1 CD B-NP O
. . O O

1 CD B-NP O
megabase NN I-NP O
pairs NNS I-NP O
of IN B-PP O
DNA NN B-NP O
around IN B-PP O
the DT B-NP O
MCC NN I-NP O
( ( O O
for IN B-PP O
mutated VBN B-VP O
in IN B-PP O
colorectal JJ B-NP B-Disease
carcinoma NN I-NP I-Disease
) ) O O
and CC O O
APC NN B-NP B-Disease
( ( O O
for IN B-PP O
adenomatous JJ B-NP B-Disease
polyposis NN I-NP I-Disease
coli NN I-NP I-Disease
) ) O O
genes NNS B-NP O
at IN B-PP O
5q21 NN B-NP O
have VBP B-VP O
been VBN I-VP O
isolated VBN I-VP O
and CC I-VP O
characterized VBN I-VP O
. . O O

Starting VBG B-VP O
from IN B-PP O
the DT B-NP O
MCC NN I-NP O
gene NN I-NP O
, , O O
a DT B-NP O
strategy NN I-NP O
was VBD B-VP O
undertaken VBN I-VP O
to TO I-VP O
identify VB I-VP O
constitutional JJ B-NP O
submicroscopic JJ I-NP O
deletions NNS I-NP O
in IN B-PP O
familial JJ B-NP B-Disease
adenomatous JJ I-NP I-Disease
polyposis NN I-NP I-Disease
patients NNS I-NP O
that WDT B-NP O
might MD B-VP O
considerably RB I-VP O
narrow VB I-VP O
down RP B-PRT O
the DT B-NP O
position NN I-NP O
of IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
. . O O

To TO B-PP O
this DT B-NP O
end NN I-NP O
, , O O
YACs NNS B-NP O
identified VBN B-VP O
by IN B-PP O
the DT B-NP O
MCC NN I-NP O
gene NN I-NP O
were VBD B-VP O
screened VBN I-VP O
across IN B-PP O
a DT B-NP O
chromosome NN I-NP O
5 CD I-NP O
- HYPH I-NP O
specific JJ I-NP O
cosmid NN I-NP O
library NN I-NP O
to TO B-VP O
provide VB I-VP O
a DT B-NP O
source NN I-NP O
of IN B-PP O
DNA NN B-NP O
probes NNS I-NP O
for IN B-PP O
genomic JJ B-NP O
scanning NN I-NP O
. . O O

The DT B-NP O
cosmids NNS I-NP O
isolated VBN B-VP O
from IN B-PP O
these DT B-NP O
experiments NNS I-NP O
were VBD B-VP O
used VBN I-VP O
to TO B-VP O
screen VB I-VP O
a DT B-NP O
panel NN I-NP O
of IN B-PP O
somatic JJ B-NP O
cell NN I-NP O
hybrids NNS I-NP O
containing VBG B-VP O
chromosome NN B-NP O
5 CD I-NP O
segregated VBD B-VP O
from IN B-PP O
patients NNS B-NP O
suspected VBN B-VP O
to TO B-VP O
carry VB I-VP O
putative JJ B-NP O
interstitial JJ I-NP O
deletions NNS I-NP O
. . O O

This DT B-NP O
screening NN I-NP O
approach NN I-NP O
led VBD B-VP O
to TO B-PP O
the DT B-NP O
confirmation NN I-NP O
of IN B-PP O
a DT B-NP O
small JJ I-NP O
heterozygous JJ I-NP O
deletion NN I-NP O
in IN B-PP O
a DT B-NP O
polyposis NN I-NP B-Disease
patient NN I-NP O
that WDT B-NP O
overlaps VBZ B-VP O
one CD B-NP O
of IN B-PP O
the DT B-NP O
two CD I-NP O
isolated VBN I-NP O
YACs NNS I-NP O
. . O O

This DT B-NP O
YAC NNP I-NP O
has VBZ B-VP O
been VBN I-VP O
shown VBN I-VP O
to TO I-VP O
contain VB I-VP O
the DT B-NP O
entire JJ I-NP O
APC NN I-NP B-Disease
gene NN I-NP O
, , O O
in IN B-PP O
addition NN B-NP O
to TO B-PP O
a DT B-NP O
significant JJ I-NP O
portion NN I-NP O
of IN B-PP O
DNA NN B-NP O
flanking VBG B-VP O
the DT B-NP O
5 CD I-NP O
end NN I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
, , O O
and CC O O
should MD B-VP O
therefore RB I-VP O
prove VB I-VP O
a DT B-NP O
valuable JJ I-NP O
resource NN I-NP O
for IN B-PP O
functional JJ B-NP O
studies NNS I-NP O
by IN B-PP O
transfer NN B-NP O
to TO B-PP O
colorectal JJ B-NP B-Disease
tumor NN I-NP I-Disease
- HYPH B-VP O
derived VBN B-NP O
cell NN I-NP O
lines NNS I-NP O
. . O O

Inherited VBN B-NP O
WT1 NN I-NP O
mutation NN I-NP O
in IN B-PP O
Denys NNP B-NP B-Disease
- HYPH B-NP I-Disease
Drash NNP I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

Patients NNS B-NP O
with IN B-PP O
the DT B-NP O
Denys NNPS I-NP B-Disease
- HYPH I-NP I-Disease
Drash NN I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
Wilms NNP B-NP B-Disease
tumor NN I-NP I-Disease
, , O O
genital JJ B-NP B-Disease
anomalies NNS I-NP I-Disease
, , O O
and CC O O
nephropathy NN B-NP B-Disease
) ) O O
have VBP B-VP O
been VBN I-VP O
demonstrated VBN I-VP O
to TO I-VP O
carry VB I-VP O
de FW B-NP O
novo FW I-NP O
constitutional JJ I-NP O
mutations NNS I-NP O
in IN B-PP O
WT1 NN B-NP O
, , O O
the DT B-NP O
Wilms NNP I-NP B-Disease
tumor NN I-NP I-Disease
gene NN I-NP O
at IN B-PP O
chromosome NN B-NP O
11p13 NN I-NP O
. . O O

We PRP B-NP O
report VBP B-VP O
three CD B-NP O
new JJ I-NP O
cases NNS I-NP O
, , O O
two CD B-NP O
carrying VBG B-VP O
a DT B-NP O
previously RB I-NP O
described VBN I-NP O
WT1 NN I-NP O
exon NN I-NP O
9 CD I-NP O
mutation NN I-NP O
and CC O O
one CD B-NP O
with IN B-PP O
a DT B-NP O
novel JJ I-NP O
WT1 NN I-NP O
exon NN I-NP O
8 CD I-NP O
mutation NN I-NP O
. . O O

However RB B-ADVP O
, , O O
unlike JJ B-NP O
patients NNS I-NP O
in IN B-PP O
previous JJ B-NP O
reports NNS I-NP O
, , O O
one CD B-NP O
of IN B-PP O
our PRP$ B-NP O
three CD I-NP O
patients NNS I-NP O
inherited VBD B-VP O
the DT B-NP O
affected VBN I-NP O
allele NN I-NP O
from IN B-PP O
his PRP$ B-NP O
phenotypically RB I-NP O
unaffected JJ I-NP O
father NN I-NP O
. . O O

This DT B-NP O
observation NN I-NP O
indicates VBZ B-VP O
that IN B-SBAR O
the DT B-NP O
WT1 NN I-NP O
exon NN I-NP O
9 CD I-NP O
mutation NN I-NP O
affecting VBG I-NP O
394Arg NN I-NP O
demonstrated VBD B-VP O
in IN B-PP O
over IN B-NP O
one CD I-NP O
- HYPH I-NP O
half NN I-NP O
of IN B-PP O
the DT B-NP O
patients NNS I-NP O
with IN B-PP O
the DT B-NP O
Denys NNPS I-NP B-Disease
- HYPH I-NP I-Disease
Drash NN I-NP I-Disease
syndrome NN I-NP I-Disease
may MD B-VP O
exhibit VB I-VP O
incomplete JJ B-NP O
penetrance NN I-NP O
. . O O

Consequently RB B-ADVP O
, , O O
familial JJ B-NP O
studies NNS I-NP O
in IN B-PP O
patients NNS B-NP O
affected VBN B-VP O
by IN B-PP O
this DT B-NP O
syndrome NN I-NP O
are VBP B-VP O
recommended VBN I-VP O
. . O O

. . O O

Submicroscopic JJ B-NP O
deletions NNS I-NP O
at IN B-PP O
the DT B-NP O
WAGR NN I-NP B-Disease
locus NN I-NP O
, , O O
revealed VBN B-VP O
by IN B-PP O
nonradioactive JJ B-NP O
in FW I-NP O
situ FW I-NP O
hybridization NN I-NP O
. . O O

Fluorescence NN B-NP O
in FW B-NP O
situ FW I-NP O
hybridization NN I-NP O
( ( O O
FISH NN B-NP O
) ) O O
with IN B-PP O
biotin NN B-NP O
- HYPH B-NP O
labeled VBN I-NP O
probes NNS I-NP O
mapping VBG B-VP O
to TO B-PP O
11p13 NN B-NP O
has VBZ B-VP O
been VBN I-VP O
used VBN I-VP O
for IN B-PP O
the DT B-NP O
molecular JJ I-NP O
analysis NN I-NP O
of IN B-PP O
deletions NNS B-NP O
of IN B-PP O
the DT B-NP O
WAGR NN I-NP B-Disease
( ( O O
Wilms NNP B-NP B-Disease
tumor NN I-NP I-Disease
, , O O
aniridia NN B-NP B-Disease
, , O O
genitourinary JJ B-NP B-Disease
abnormalities NNS I-NP I-Disease
, , O O
and CC O O
mental JJ B-NP B-Disease
retardation NN I-NP I-Disease
) ) O O
locus NN B-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
detected VBN I-VP O
a DT B-NP O
submicroscopic JJ I-NP O
11p13 NN I-NP O
deletion NN I-NP O
in IN B-PP O
a DT B-NP O
child NN I-NP O
with IN B-PP O
inherited VBN B-NP O
aniridia NN I-NP B-Disease
who WP B-NP O
subsequently RB B-VP O
presented VBD I-VP O
with IN B-PP O
Wilms NNP B-NP B-Disease
tumor NN I-NP I-Disease
in IN B-PP O
a DT B-NP O
horseshoe NN I-NP O
kidney NN I-NP O
, , O O
only RB B-ADVP O
revealed VBD B-VP O
at IN B-PP O
surgery NN B-NP O
. . O O

The DT B-NP O
mother NN I-NP O
, , O O
who WP B-NP O
has VBZ B-VP O
aniridia NN B-NP B-Disease
, , O O
was VBD B-VP O
also RB I-VP O
found VBN I-VP O
to TO I-VP O
carry VB I-VP O
a DT B-NP O
deletion NN I-NP O
including VBG B-PP O
both CC O O
the DT B-NP O
aniridia NN I-NP B-Disease
candidate NN I-NP O
gene NN I-NP O
( ( O O
AN2 NN B-NP O
) ) O O
and CC O O
the DT B-NP O
Wilms NNP I-NP B-Disease
tumor NN I-NP I-Disease
predisposition NN I-NP O
gene NN I-NP O
( ( O O
WT1 NN B-NP O
) ) O O
. . O O

This DT B-NP O
is VBZ B-VP O
therefore RB B-ADVP O
a DT B-NP O
rare JJ I-NP O
case NN I-NP O
of IN B-PP O
an DT B-NP O
inherited VBN I-NP O
WAGR NN I-NP B-Disease
deletion NN I-NP O
. . O O

Wilms NNP B-NP B-Disease
tumor NN I-NP I-Disease
has VBZ B-VP O
so RB B-ADVP O
far RB I-ADVP O
only RB B-VP O
been VBN I-VP O
associated VBN I-VP O
with IN B-PP O
sporadic JJ B-NP O
de FW I-NP O
novo FW I-NP O
aniridia NN I-NP B-Disease
cases NNS I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
shown VBN I-VP O
that IN B-SBAR O
a DT B-NP O
cosmid NN I-NP O
probe NN I-NP O
for IN B-PP O
a DT B-NP O
candidate NN I-NP O
aniridia NN I-NP B-Disease
gene NN I-NP O
, , O O
homologous JJ B-ADJP O
to TO B-PP O
the DT B-NP O
mouse NN I-NP O
Pax NN I-NP O
- HYPH B-NP O
6 CD I-NP O
gene NN I-NP O
, , O O
is VBZ B-VP O
deleted VBN I-VP O
in IN B-PP O
cell NN B-NP O
lines NNS I-NP O
from IN B-PP O
aniridia NN B-NP B-Disease
patients NNS I-NP O
with IN B-PP O
previously RB B-NP O
characterized VBN I-NP O
deletions NNS I-NP O
at IN B-PP O
11p13 NN B-NP O
, , O O
while IN B-SBAR O
another DT B-NP O
cosmid NN I-NP O
marker NN I-NP O
mapping VBG B-VP O
between IN B-PP O
two CD B-NP O
aniridia NN I-NP B-Disease
- HYPH O O
associated VBN B-NP O
translocation NN I-NP O
breakpoints NNS I-NP O
( ( O O
and CC O O
hence RB B-ADVP O
a DT B-NP O
second JJ I-NP O
candidate NN I-NP O
marker NN I-NP O
) ) O O
is VBZ B-VP O
present JJ B-ADJP O
on IN B-PP O
both DT B-NP O
chromosomes NNS I-NP O
. . O O

These DT B-NP O
results NNS I-NP O
support VBP B-VP O
the DT B-NP O
Pax NN I-NP O
- HYPH I-NP O
6 CD I-NP O
homologue NN I-NP O
as IN B-PP O
a DT B-NP O
strong JJ I-NP O
candidate NN I-NP O
for IN B-PP O
the DT B-NP O
AN2 NN I-NP O
gene NN I-NP O
. . O O

FISH NN B-NP O
with IN B-PP O
cosmid NN B-NP O
probes NNS I-NP O
has VBZ B-VP O
proved VBN I-VP O
to TO I-VP O
be VB I-VP O
a DT B-NP O
fast JJ I-NP O
and CC I-NP O
reliable JJ I-NP O
technique NN I-NP O
for IN B-PP O
the DT B-NP O
molecular JJ I-NP O
analysis NN I-NP O
of IN B-PP O
deletions NNS B-NP O
. . O O

It PRP B-NP O
can MD B-VP O
be VB I-VP O
used VBN I-VP O
with IN B-PP O
limited VBN B-NP O
amounts NNS I-NP O
of IN B-PP O
material NN B-NP O
and CC O O
has VBZ B-VP O
strong JJ B-NP O
potential NN I-NP O
for IN B-PP O
clinical JJ B-NP O
applications NNS I-NP O
. . O O

. . O O

Linkage NN B-NP O
of IN B-PP O
gene NN B-NP O
for IN B-PP O
C2 NN B-NP B-Disease
deficiency NN I-NP I-Disease
and CC O O
the DT B-NP O
major JJ I-NP O
histocompatibility NN I-NP O
complex NN I-NP O
MHC NN I-NP O
in IN B-PP O
man NN B-NP O
. . O O

Family RB B-NP O
study NN I-NP O
of IN B-PP O
a DT B-NP O
further JJ I-NP O
case NN I-NP O
. . O O

Close JJ B-NP O
linkage NN I-NP O
between IN B-PP O
HL NN B-NP O
- HYPH I-NP O
A NN I-NP O
and CC I-NP O
C2 NN I-NP B-Disease
deficiency NN I-NP I-Disease
was VBD B-VP O
first RB I-VP O
reported VBN I-VP O
by IN B-PP O
FU NN B-NP O
and CC O O
co AFX B-NP O
- HYPH I-NP O
workers NNS I-NP O
in IN B-PP O
1974 CD B-NP O
. . O O

We PRP B-NP O
present VBP B-VP O
here RB B-ADVP O
a DT B-NP O
pedigree NN I-NP O
of IN B-PP O
a DT B-NP O
31 CD I-NP O
- HYPH I-NP O
year NN I-NP O
- HYPH O O
old JJ B-NP O
C2 NN I-NP B-Disease
- HYPH B-NP I-Disease
deficient JJ I-NP I-Disease
individual NN I-NP O
with IN B-PP O
clinical JJ B-NP O
manifestations NNS I-NP O
of IN B-PP O
Hodgkins NNP B-NP B-Disease
disease NN I-NP I-Disease
. . O O

The DT B-NP O
following VBG I-NP O
markers NNS I-NP O
were VBD B-VP O
tested VBN I-VP O
C2 NN B-NP O
levels NNS I-NP O
, , O O
factor NN B-NP O
B NN I-NP O
polymorphism NN I-NP O
, , O O
blood NN B-NP O
groups NNS I-NP O
, , O O
and CC O O
enzyme NN B-NP O
typing NN I-NP O
. . O O

In IN B-PP O
addition NN B-NP O
to TO B-VP O
close VB I-VP O
linkage NN B-NP O
between IN B-PP O
HL NN B-NP O
- HYPH I-NP O
A NN I-NP O
and CC I-NP O
C2 NN I-NP B-Disease
deficiency NN I-NP I-Disease
, , O O
both DT B-NP O
parents NNS I-NP O
were VBD B-VP O
heterozygous JJ B-ADJP O
for IN B-PP O
Bf NN B-NP O
( ( O O
HL NN B-NP O
- HYPH B-NP O
A NN I-NP O
linked VBN B-VP O
, , O O
electrophoretic JJ B-NP O
variation NN I-NP O
of IN B-PP O
B NN B-NP O
) ) O O
. . O O

The DT B-NP O
two CD I-NP O
HL NN I-NP O
- HYPH O O
A DT B-NP O
haplotypes NNS I-NP O
closely RB B-VP O
linked VBN I-VP O
to TO B-PP O
C2 NN B-NP B-Disease
deficiency NN I-NP I-Disease
are VBP B-VP O
different JJ B-NP O
2 CD I-NP O
, , I-NP O
W18 NN I-NP O
and CC I-NP O
W24 NN I-NP O
, , O O
W18 NN B-NP O
. . O O

They PRP B-NP O
share VBP B-VP O
, , O O
however RB B-ADVP O
, , O O
the DT B-NP O
SD2 NN I-NP O
antigen NN I-NP O
W18 NN I-NP O
and CC O O
the DT B-NP O
LD NN I-NP O
type NN I-NP O
7a NN I-NP O
. . O O

. . O O

Screening NN B-NP O
for IN B-PP O
germ NN B-NP O
- HYPH I-NP O
line NN I-NP O
mutations NNS I-NP O
in IN B-PP O
familial JJ B-NP B-Disease
adenomatous JJ I-NP I-Disease
polyposis NN I-NP I-Disease
patients NNS I-NP O
: : O O
61 CD B-NP O
new JJ I-NP O
patients NNS I-NP O
and CC O O
a DT B-NP O
summary NN I-NP O
of IN B-PP O
150 CD B-NP O
unrelated JJ I-NP O
patients NNS I-NP O
. . O O

We PRP B-NP O
report VBP B-VP O
here RB B-ADVP O
the DT B-NP O
result NN I-NP O
of IN B-PP O
a DT B-NP O
screening NN I-NP O
for IN B-PP O
germ NN B-NP O
- HYPH I-NP O
line NN I-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
adenomatous JJ I-NP B-Disease
polyposis NN I-NP I-Disease
coli NN I-NP I-Disease
( ( O O
APC NN B-NP B-Disease
) ) O O
gene NN B-NP O
in IN B-PP O
61 CD B-NP O
new JJ I-NP O
familial JJ I-NP B-Disease
adenomatous JJ I-NP I-Disease
polyposis NN I-NP I-Disease
( ( O O
FAP NN B-NP B-Disease
) ) O O
patients NNS B-NP O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
a DT B-NP O
summary NN I-NP O
of IN B-PP O
the DT B-NP O
results NNS I-NP O
of IN B-PP O
150 CD B-NP O
patients NNS I-NP O
. . O O

Examination NN B-NP O
of IN B-PP O
the DT B-NP O
entire JJ I-NP O
coding VBG I-NP O
region NN I-NP O
of IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
, , O O
based VBN B-PP O
on IN B-PP O
a DT B-NP O
ribonuclease NN I-NP O
protection NN I-NP O
assay NN I-NP O
coupled VBN B-VP O
with IN B-PP O
the DT B-NP O
polymerase NN I-NP O
chain NN I-NP O
reaction NN I-NP O
( ( O O
PCR NN B-NP O
) ) O O
, , O O
disclosed VBN B-NP O
mutations NNS I-NP O
that WDT B-NP O
were VBD B-VP O
considered VBN I-VP O
to TO I-VP O
cause VB I-VP O
significant JJ B-NP O
defects NNS I-NP O
in IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
product NN I-NP O
in IN B-PP O
97 CD B-NP O
of IN B-PP O
150 CD B-NP O
unrelated JJ I-NP O
FAP NN I-NP B-Disease
patients NNS I-NP O
. . O O

Our PRP$ B-NP O
findings NNS I-NP O
revealed VBD B-VP O
the DT B-NP O
following VBG I-NP O
characteristics NNS I-NP O
of IN B-PP O
the DT B-NP O
germ NN I-NP O
- HYPH I-NP O
line NN I-NP O
mutations NNS I-NP O
of IN B-PP O
APC NN B-NP O
1 CD I-NP O
) ) O O
the DT B-NP O
great JJ I-NP O
majority NN I-NP O
of IN B-PP O
the DT B-NP O
mutations NNS I-NP O
were VBD B-VP O
found VBN I-VP O
to TO I-VP O
truncate VB I-VP O
the DT B-NP O
APC NN I-NP B-Disease
product NN I-NP O
; : O O
2 LS B-LST O
) ) O O
almost RB B-NP O
all DT I-NP O
of IN B-PP O
the DT B-NP O
mutations NNS I-NP O
were VBD B-VP O
located JJ B-ADJP O
within IN B-PP O
the DT B-NP O
first JJ I-NP O
half NN I-NP O
of IN B-PP O
the DT B-NP O
coding VBG I-NP O
region NN I-NP O
; : O O
3 LS B-LST O
) ) O O
no DT B-NP O
correlation NN I-NP O
was VBD B-VP O
observed VBN I-VP O
between IN B-PP O
the DT B-NP O
locations NNS I-NP O
of IN B-PP O
germ NN B-NP O
- HYPH I-NP O
line NN I-NP O
mutations NNS I-NP O
and CC O O
extracolonic JJ B-NP O
manifestations NNS I-NP O
in IN B-PP O
FAP NN B-NP B-Disease
patients NNS I-NP O
; : O O
4 CD B-NP O
) ) O O
more RBR B-NP O
than IN I-NP O
80 CD I-NP O
% NN I-NP O
of IN B-PP O
base NN B-NP O
substitutions NNS I-NP O
in IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
were VBD B-VP O
from IN B-PP O
cytosine NN B-NP O
to TO B-PP O
other JJ B-NP O
nucleotides NNS I-NP O
, , O O
nearly RB B-NP O
one CD I-NP O
- HYPH I-NP O
third NN I-NP O
of IN B-PP O
which WDT B-NP O
occurred VBD B-VP O
at IN B-PP O
the DT B-NP O
GpG NN I-NP O
site NN I-NP O
. . O O

Our PRP$ B-NP O
results NNS I-NP O
provide VBP B-VP O
information NN B-NP O
helpful JJ B-ADJP O
to TO B-PP O
an DT B-NP O
understanding NN I-NP O
of IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
and CC O O
will MD B-VP O
also RB I-VP O
contribute VB I-VP O
to TO B-PP O
presymptomatic JJ B-NP O
diagnosis NN I-NP O
of IN B-PP O
members NNS B-NP O
in IN B-PP O
FAP NN B-NP B-Disease
families NNS I-NP O
. . O O

. . O O

Somatic JJ B-NP O
mutations NNS I-NP O
of IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
in IN B-PP O
colorectal JJ B-NP B-Disease
tumors NNS I-NP I-Disease
: : O O
mutation NN B-NP O
cluster NN I-NP O
region NN I-NP O
in IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
. . O O

We PRP B-NP O
examined VBD B-VP O
somatic JJ B-NP O
mutations NNS I-NP O
of IN B-PP O
the DT B-NP O
adenomatous JJ I-NP B-Disease
polyposis NN I-NP I-Disease
coli NN I-NP I-Disease
( ( O O
APC NN B-NP B-Disease
) ) O O
gene NN B-NP O
in IN B-PP O
63 CD B-NP O
colorectal JJ I-NP B-Disease
tumors NNS I-NP I-Disease
( ( O O
16 CD B-NP O
adenomas NNS I-NP B-Disease
and CC O O
47 CD B-NP O
carcinomas NNS I-NP B-Disease
) ) O O
developed VBN B-VP O
in IN B-PP O
familial JJ B-NP B-Disease
adenomatous JJ I-NP I-Disease
polyposis NN I-NP I-Disease
( ( O O
FAP NN B-NP B-Disease
) ) O O
and CC O O
non AFX B-NP O
- HYPH I-NP O
FAP NN B-NP O
patients NNS I-NP O
. . O O

In IN B-PP O
addition NN B-NP O
to TO B-PP O
loss NN B-NP O
of IN B-PP O
heterozygosity NN B-NP O
( ( O O
LOH NN B-NP O
) ) O O
at IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
locus NN I-NP O
in IN B-PP O
30 CD B-NP O
tumors NNS I-NP B-Disease
, , O O
43 CD B-NP O
other JJ I-NP O
somatic JJ I-NP O
mutations NNS I-NP O
were VBD B-VP O
detected VBN I-VP O
. . O O

Twenty CD B-NP O
- HYPH I-NP O
one CD I-NP O
of IN B-PP O
them PRP B-NP O
were VBD B-VP O
point NN B-NP O
mutations NNS I-NP O
; : O O
16 CD B-NP O
nonsense JJ I-NP O
and CC O O
two CD B-NP O
missense JJ I-NP O
mutations NNS I-NP O
, , O O
and CC O O
three CD B-NP O
occurred VBD B-VP O
in IN B-PP O
introns NNS B-NP O
at IN B-PP O
the DT B-NP O
splicing NN I-NP O
site NN I-NP O
. . O O

Twenty CD B-NP O
- HYPH I-NP O
two CD I-NP O
tumors NNS I-NP B-Disease
had VBD B-VP O
frameshift NN B-NP O
mutations NNS I-NP O
due IN B-PP O
to TO B-PP O
deletion NN B-NP O
or CC I-NP O
insertion NN I-NP O
; : O O
nineteen CD B-NP O
of IN B-PP O
them PRP B-NP O
were VBD B-VP O
deletions NNS B-NP O
of IN B-PP O
one CD B-NP O
to TO I-NP O
31 CD I-NP O
bp NN I-NP O
and CC O O
three CD B-NP O
were VBD B-VP O
a DT B-NP O
1 CD I-NP O
- HYPH I-NP O
bp NN I-NP O
insertion NN I-NP O
. . O O

One CD B-NP O
tumor NN I-NP B-Disease
had VBD B-VP O
a DT B-NP O
1 CD I-NP O
- HYPH I-NP O
bp NN I-NP O
deletion NN I-NP O
in IN B-PP O
an DT B-NP O
intron NN I-NP O
near IN B-PP O
the DT B-NP O
splicing NN I-NP O
site NN I-NP O
. . O O

Hence RB B-ADVP O
, , O O
41 CD B-NP O
( ( O O
95 CD B-NP O
% NN I-NP O
) ) O O
of IN B-PP O
43 CD B-NP O
mutations NNS I-NP O
resulted VBD B-VP O
in IN B-PP O
truncation NN B-NP O
of IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
protein NN I-NP O
. . O O

Over IN B-PP O
60 CD B-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
somatic JJ I-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
were VBD B-VP O
clustered VBN I-VP O
within IN B-PP O
a DT B-NP O
small JJ I-NP O
region NN I-NP O
of IN B-PP O
exon NN B-NP O
15 CD I-NP O
, , O O
designated VBN B-VP O
as IN B-PP O
MCR NN B-NP O
( ( O O
mutation NN B-NP O
cluster NN I-NP O
region NN I-NP O
) ) O O
, , O O
which WDT B-NP O
accounted VBD B-VP O
for IN B-PP O
less JJR B-NP O
than IN I-NP O
10 CD I-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
coding VBG I-NP O
region NN I-NP O
. . O O

Combining VBG B-VP O
these DT B-NP O
data NNS I-NP O
and CC O O
the DT B-NP O
results NNS I-NP O
of IN B-PP O
LOH NN B-NP O
, , O O
more JJR B-NP O
than IN I-NP O
80 CD I-NP O
% NN I-NP O
of IN B-PP O
tumors NNS B-NP B-Disease
( ( O O
14 CD B-NP O
adenomas NNS I-NP B-Disease
and CC O O
39 CD B-NP O
carcinomas NNS I-NP B-Disease
) ) O O
had VBD B-VP O
at IN B-NP O
least JJS I-NP O
one CD I-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
, , O O
of IN B-PP O
which WDT B-NP O
more JJR B-NP O
than IN I-NP O
60 CD I-NP O
% NN I-NP O
( ( O O
9 CD B-NP O
adenomas NNS I-NP B-Disease
and CC O O
23 CD B-NP O
carcinomas NNS I-NP B-Disease
) ) O O
had VBD B-VP O
two CD B-NP O
mutations NNS I-NP O
. . O O

These DT B-NP O
results NNS I-NP O
strongly RB B-VP O
suggest VBP I-VP O
that IN B-SBAR O
somatic JJ B-NP O
mutations NNS I-NP O
of IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
are VBP B-VP O
associated VBN I-VP O
with IN B-PP O
development NN B-NP O
of IN B-PP O
a DT B-NP O
great JJ I-NP O
majority NN I-NP O
of IN B-PP O
colorectal JJ B-NP B-Disease
tumors NNS I-NP I-Disease
. . O O

. . O O

Constitutional JJ B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
WT1 NN I-NP O
gene NN I-NP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
Denys NNP B-NP B-Disease
- HYPH B-NP I-Disease
Drash NNP I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

The DT B-NP O
Denys NNPS I-NP B-Disease
- HYPH I-NP I-Disease
Drash NN I-NP I-Disease
syndrome NN I-NP I-Disease
is VBZ B-VP O
characterised VBN I-VP O
by IN B-PP O
a DT B-NP O
typical JJ I-NP O
nephropathy NN I-NP B-Disease
, , O O
genital JJ B-NP B-Disease
abnormalities NNS I-NP I-Disease
and CC O O
also RB B-VP O
predisposes VBZ I-VP O
to TO B-PP O
the DT B-NP O
development NN I-NP O
of IN B-PP O
Wilms NNP B-NP B-Disease
tumor NN I-NP I-Disease
. . O O

These DT B-NP O
patients NNS I-NP O
eventually RB B-ADVP O
go VBP B-VP O
into IN B-PP O
end NN B-NP O
stage NN I-NP O
renal JJ I-NP B-Disease
failure NN I-NP I-Disease
. . O O

A DT B-NP O
candidate NN I-NP O
Wilms NNP I-NP B-Disease
tumor NN I-NP I-Disease
gene NN I-NP O
, , O O
WT1 NN B-NP O
, , O O
from IN B-PP O
the DT B-NP O
11p13 NN I-NP O
chromosome NN I-NP O
region NN I-NP O
has VBZ B-VP O
recently RB I-VP O
been VBN I-VP O
cloned VBN I-VP O
. . O O

We PRP B-NP O
have VBP B-VP O
analysed VBN I-VP O
the DT B-NP O
DNA NN I-NP O
sequence NN I-NP O
in IN B-PP O
constitutional JJ B-NP O
cells NNS I-NP O
from IN B-PP O
eight CD B-NP O
patients NNS I-NP O
and CC O O
have VBP B-VP O
shown VBN I-VP O
heterozygous JJ B-NP O
mutations NNS I-NP O
in IN B-PP O
six CD B-NP O
of IN B-PP O
them PRP B-NP O
. . O O

Four CD B-NP O
of IN B-PP O
the DT B-NP O
mutations NNS I-NP O
were VBD B-VP O
in IN B-PP O
exon NN B-NP O
9 CD I-NP O
, , O O
all DT B-NP O
resulting VBG B-VP O
in IN B-PP O
missense JJ B-NP O
mutations NNS I-NP O
. . O O

Three CD B-NP O
were VBD B-VP O
at IN B-PP O
nucleotide NN B-NP O
position NN I-NP O
1180 CD I-NP O
resulting VBG B-VP O
in IN B-PP O
an DT B-NP O
arg NN I-NP O
> SYM B-NP O
trp NN I-NP O
amino JJ I-NP O
acid NN I-NP O
change NN I-NP O
. . O O

The DT B-NP O
other JJ I-NP O
was VBD B-VP O
at IN B-PP O
position NN B-NP O
1186 CD I-NP O
converting VBG B-VP O
an DT B-NP O
asp NN I-NP O
> SYM B-NP O
asn NN I-NP O
in IN B-PP O
the DT B-NP O
predicted VBN I-NP O
resultant JJ I-NP O
protein NN I-NP O
. . O O

One CD B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
missense JJ I-NP O
mutation NN I-NP O
in IN B-PP O
exon NN B-NP O
8 CD I-NP O
, , O O
converting VBG B-VP O
an DT B-NP O
arg NN I-NP O
> SYM B-VP O
his PRP$ B-NP O
. . O O

A DT B-NP O
single JJ I-NP O
base NN I-NP O
pair NN I-NP O
insertion NN I-NP O
at IN B-PP O
nucleotide NN B-NP O
position NN I-NP O
821 CD I-NP O
in IN B-PP O
exon NN B-NP O
6 CD I-NP O
resulted VBD B-VP O
in IN B-PP O
the DT B-NP O
generation NN I-NP O
of IN B-PP O
a DT B-NP O
premature JJ I-NP O
stop NN I-NP O
codon NN I-NP O
in IN B-PP O
the DT B-NP O
last JJ I-NP O
patient NN I-NP O
. . O O

We PRP B-NP O
were VBD B-VP O
unable JJ B-ADJP O
to TO B-VP O
find VB I-VP O
a DT B-NP O
mutation NN I-NP O
in IN B-PP O
one CD B-NP O
patient NN I-NP O
despite IN B-PP O
complete JJ B-NP O
sequencing NN I-NP O
of IN B-PP O
the DT B-NP O
genomic JJ I-NP O
sequence NN I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
. . O O

The DT B-NP O
last JJ I-NP O
patient NN I-NP O
carried VBD B-VP O
a DT B-NP O
constitutional JJ I-NP O
deletion NN I-NP O
of IN B-PP O
the DT B-NP O
11p13 NN I-NP O
region NN I-NP O
and CC O O
no DT B-NP O
additional JJ I-NP O
mutation NN I-NP O
was VBD B-VP O
found VBN I-VP O
. . O O

There EX B-NP O
was VBD B-VP O
no DT B-NP O
obvious JJ I-NP O
correlation NN I-NP O
between IN B-PP O
the DT B-NP O
type NN I-NP O
of IN B-PP O
mutation NN B-NP O
and CC O O
phenotypic JJ B-NP O
expression NN I-NP O
. . O O

These DT B-NP O
results NNS I-NP O
further RB B-ADVP O
demonstrate VBP B-VP O
that IN B-SBAR O
the DT B-NP O
WT1 NN I-NP O
gene NN I-NP O
is VBZ B-VP O
important JJ B-ADJP O
in IN B-PP O
both CC O O
the DT B-NP O
development NN I-NP O
of IN B-PP O
the DT B-NP O
kidney NN I-NP O
and CC O O
the DT B-NP O
genito AFX I-NP O
- HYPH I-NP O
urinary JJ I-NP O
system NN I-NP O
. . O O

. . O O

Linkage NN B-NP O
disequilibrium NN I-NP O
mapping NN I-NP O
in IN B-PP O
isolated VBN B-NP O
founder NN I-NP O
populations NNS I-NP O
: : O O
diastrophic JJ B-NP B-Disease
dysplasia NN I-NP I-Disease
in IN B-PP O
Finland NNP B-NP O
. . O O

Linkage NN B-NP O
disequilibrium NN I-NP O
mapping NN I-NP O
in IN B-PP O
isolated VBN B-NP O
populations NNS I-NP O
provides VBZ B-VP O
a DT B-NP O
powerful JJ I-NP O
tool NN I-NP O
for IN B-PP O
fine JJ B-NP O
structure NN I-NP O
localization NN I-NP O
of IN B-PP O
disease NN B-NP O
genes NNS I-NP O
. . O O

Here RB B-ADVP O
, , O O
Luria NNP B-NP O
and CC I-NP O
Delbrucks NNP I-NP O
classical JJ I-NP O
methods NNS I-NP O
for IN B-PP O
analysing VBG B-VP O
bacterial JJ B-NP O
cultures NNS I-NP O
are VBP B-VP O
adapted VBN I-VP O
to TO B-PP O
the DT B-NP O
study NN I-NP O
of IN B-PP O
human JJ B-NP O
isolated VBN I-NP O
founder NN I-NP O
populations NNS I-NP O
in IN B-SBAR O
order NN O O
to TO B-VP O
estimate VB I-VP O
( ( B-LST O
i LS I-LST O
) ) O O
the DT B-NP O
recombination NN I-NP O
fraction NN I-NP O
between IN B-PP O
a DT B-NP O
disease NN I-NP O
locus NN I-NP O
and CC O O
a DT B-NP O
marker NN I-NP O
; : O O
( ( B-LST O
ii LS I-LST O
) ) O O
the DT B-NP O
expected VBN I-NP O
degree NN I-NP O
of IN B-PP O
allelic JJ B-NP O
homogeneity NN I-NP O
in IN B-PP O
a DT B-NP O
population NN I-NP O
; : O O
and CC O O
( ( B-LST O
iii LS I-LST O
) ) O O
the DT B-NP O
mutation NN I-NP O
rate NN I-NP O
of IN B-PP O
marker NN B-NP O
loci NNS I-NP O
. . O O

Using VBG B-VP O
these DT B-NP O
methods NNS I-NP O
, , O O
we PRP B-NP O
report VBP B-VP O
striking JJ B-NP O
linkage NN I-NP O
disequilibrium NN I-NP O
for IN B-PP O
diastrophic JJ B-NP B-Disease
dysplasia NN I-NP I-Disease
( ( O O
DTD NN B-NP B-Disease
) ) O O
in IN B-PP O
Finland NNP B-NP O
indicating VBG B-VP O
that IN B-SBAR O
the DT B-NP O
DTD NN I-NP B-Disease
gene NN I-NP O
should MD B-VP O
lie VB I-VP O
within IN B-PP O
0 CD B-NP O
. . O O

06 CD B-NP O
centimorgans NNS I-NP O
( ( O O
or CC O O
about IN B-NP O
60 CD I-NP O
kilobases NNS I-NP O
) ) O O
of IN B-PP O
the DT B-NP O
CSF1R NN I-NP O
gene NN I-NP O
. . O O

Predictions NNS B-NP O
about IN B-PP O
allelic JJ B-NP O
homogeneity NN I-NP O
in IN B-PP O
Finland NNP B-NP O
and CC O O
mutation NN B-NP O
rates NNS I-NP O
in IN B-PP O
simple JJ B-NP O
sequence NN I-NP O
repeats NNS I-NP O
are VBP B-VP O
confirmed VBN I-VP O
by IN B-PP O
independent JJ B-NP O
observations NNS I-NP O
. . O O

The DT B-NP O
Wiskott NNP I-NP B-Disease
- HYPH I-NP I-Disease
Aldrich NNP I-NP I-Disease
syndrome NN I-NP I-Disease
: : O O
refinement NN B-NP O
of IN B-PP O
the DT B-NP O
localization NN I-NP O
on IN B-PP O
Xp NN B-NP O
and CC I-NP O
identification NN I-NP O
of IN B-PP O
another DT B-NP O
closely RB I-NP O
linked VBN I-NP O
marker NN I-NP O
locus NN I-NP O
, , O O
OATL1 NN B-NP O
. . O O

The DT B-NP O
Wiskott NNP I-NP B-Disease
- HYPH I-NP I-Disease
Aldrich NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
WAS NN B-NP B-Disease
) ) O O
has VBZ B-VP O
previously RB I-VP O
been VBN I-VP O
mapped VBN I-VP O
to TO B-PP O
the DT B-NP O
proximal JJ I-NP O
short JJ I-NP O
arm NN I-NP O
of IN B-PP O
the DT B-NP O
X NN I-NP O
chromosome NN I-NP O
between IN B-PP O
the DT B-NP O
DXS14 NN I-NP O
and CC I-NP O
DXS7 NN I-NP O
loci NNS I-NP O
. . O O

In IN B-PP O
this DT B-NP O
study NN I-NP O
, , O O
further JJ B-NP O
segregation NN I-NP O
analysis NN I-NP O
has VBZ B-VP O
been VBN I-VP O
performed VBN I-VP O
using VBG B-VP O
a DT B-NP O
newly RB I-NP O
identified VBN I-NP O
WAS NN I-NP B-Disease
family NN I-NP O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
an DT B-NP O
additional JJ I-NP O
marker NN I-NP O
probe NN I-NP O
, , O O
HOATL1 NN B-NP O
. . O O

The DT B-NP O
results NNS I-NP O
indicate VBP B-VP O
close JJ B-NP O
linkage NN I-NP O
between IN B-PP O
the DT B-NP O
WAS NN I-NP B-Disease
and CC I-NP O
OATL1 NN I-NP O
loci NNS I-NP O
( ( O O
Z NN B-NP O
= SYM B-VP O
6 CD B-NP O
. SYM I-NP O

08 CD I-NP O
at IN B-PP O
theta NN B-NP O
= SYM B-VP O
0 CD B-NP O
. SYM I-NP O

00 CD I-NP O
) ) O O
and CC O O
localize VBP B-VP O
the DT B-NP O
TIMP NN I-NP O
, , O O
OATL1 NN B-NP O
, , O O
DXS255 NN B-NP O
, , O O
and CC O O
WAS NN B-NP B-Disease
loci NNS I-NP O
distal JJ B-ADJP O
to TO B-PP O
DXS146 NN B-NP O
and CC O O
the DT B-NP O
OATL1 NN I-NP O
and CC I-NP O
WAS NN I-NP B-Disease
loci NNS I-NP O
proximal JJ B-ADJP O
to TO B-PP O
TIMP NN B-NP O
. . O O

These DT B-NP O
linkage NN I-NP O
data NNS I-NP O
narrow VBP B-VP O
the DT B-NP O
boundaries NNS I-NP O
within IN B-PP O
which WDT B-NP O
the DT B-NP O
WAS NN I-NP B-Disease
locus NN I-NP O
maps VBZ B-VP O
to TO B-PP O
the DT B-NP O
chromosomal JJ I-NP O
region NN I-NP O
bracketed VBN B-VP O
by IN B-PP O
TIMP NN B-NP O
and CC I-NP O
DXS146 NN I-NP O
and CC O O
support VBP B-VP O
the DT B-NP O
loci NNS I-NP O
order NN I-NP O
Xpter NN I-NP O
- HYPH B-NP O
DXS7 NN I-NP O
- HYPH B-NP O
TIMP NN I-NP O
- HYPH O O
( ( O O
OATL1 NN B-NP O
, , O O
WAS NN B-NP O
, , O O
DXS255 NN B-NP O
) ) O O
- HYPH B-NP O
DXS146 NN I-NP O
. . O O

Detection NN B-NP O
of IN B-PP O
an DT B-NP O
unstable JJ I-NP O
fragment NN I-NP O
of IN B-PP O
DNA NN B-NP O
specific JJ B-ADJP O
to TO B-PP O
individuals NNS B-NP O
with IN B-PP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
. . O O

Myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
( ( O O
DM NN B-NP B-Disease
) ) O O
is VBZ B-VP O
the DT B-NP O
most RBS I-NP O
common JJ I-NP O
form NN I-NP O
of IN B-PP O
adult JJ B-NP O
muscular JJ I-NP B-Disease
dystrophy NN I-NP I-Disease
, , O O
with IN B-PP O
a DT B-NP O
prevalence NN I-NP O
of IN B-PP O
2 CD B-NP O
- HYPH I-NP O
14 CD I-NP O
per IN B-PP O
100 CD B-NP O
, , O O
000 CD B-NP O
individuals NNS I-NP O
. . O O

The DT B-NP O
disease NN I-NP O
is VBZ B-VP O
characterized VBN I-VP O
by IN B-PP O
progressive JJ B-NP O
muscle NN I-NP B-Disease
weakness NN I-NP I-Disease
and CC O O
sustained VBN B-NP B-Disease
muscle NN I-NP I-Disease
contraction NN I-NP I-Disease
, , O O
often RB B-ADVP O
with IN B-PP O
a DT B-NP O
wide JJ I-NP O
range NN I-NP O
of IN B-PP O
accompanying VBG B-VP O
symptoms NNS B-NP O
. . O O

The DT B-NP O
age NN I-NP O
at IN B-PP O
onset NN B-NP O
and CC I-NP O
severity NN I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
show VBP B-VP O
extreme JJ B-NP O
variation NN I-NP O
, , O O
both CC B-PP O
within IN I-PP O
and CC I-PP O
between IN I-PP O
families NNS B-NP O
. . O O

Despite IN B-PP O
its PRP$ B-NP O
clinical JJ I-NP O
variability NN I-NP O
, , O O
this DT B-NP O
dominant JJ I-NP O
condition NN I-NP O
segregates NNS I-NP O
as IN B-PP O
a DT B-NP O
single JJ I-NP O
locus NN I-NP O
at IN B-PP O
chromosome NN B-NP O
19q13 CD I-NP O
. . O O

3 CD B-NP O
in IN B-PP O
every DT B-NP O
population NN I-NP O
studied VBN B-VP O
. . O O

It PRP B-NP O
is VBZ B-VP O
flanked VBN I-VP O
by IN B-PP O
the DT B-NP O
tightly RB I-NP O
linked VBN I-NP O
genetic JJ I-NP O
markers NNS I-NP O
ERCC1 NN I-NP O
proximally RB B-ADVP O
and CC O O
D19S51 NN B-NP O
distally RB B-ADVP O
; : O O
these DT B-NP O
define NN I-NP O
the DT B-NP O
DM NN I-NP B-Disease
critical JJ I-NP O
region NN I-NP O
. . O O

We PRP B-NP O
report VBP B-VP O
the DT B-NP O
isolation NN I-NP O
of IN B-PP O
an DT B-NP O
expressed VBN I-NP O
sequence NN I-NP O
from IN B-PP O
this DT B-NP O
region NN I-NP O
which WDT B-NP O
detects VBZ B-VP O
a DT B-NP O
DNA NN I-NP O
fragment NN I-NP O
that WDT B-NP O
is VBZ B-VP O
larger JJR B-ADJP O
in IN B-PP O
affected VBN B-NP O
individuals NNS I-NP O
than IN B-PP O
in IN B-PP O
normal JJ B-NP O
siblings NNS I-NP O
or CC O O
unaffected JJ B-NP O
controls NNS I-NP O
. . O O

The DT B-NP O
size NN I-NP O
of IN B-PP O
this DT B-NP O
fragment NN I-NP O
varies VBZ B-VP O
between IN B-PP O
affected VBN B-NP O
siblings NNS I-NP O
, , O O
and CC O O
increases NNS B-NP O
in IN B-PP O
size NN B-NP O
through IN B-PP O
generations NNS B-NP O
in IN B-PP O
parallel NN B-NP O
with IN B-PP O
increasing VBG B-NP O
severity NN I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
. . O O

We PRP B-NP O
postulate VBP B-VP O
that IN B-SBAR O
this DT B-NP O
unstable JJ I-NP O
DNA NN I-NP O
sequence NN I-NP O
is VBZ B-VP O
the DT B-NP O
molecular JJ I-NP O
feature NN I-NP O
that WDT B-NP O
underlies VBZ B-VP O
DM NN B-NP B-Disease
. . O O

Common JJ B-NP O
sequence NN I-NP O
motifs NNS I-NP O
at IN B-PP O
the DT B-NP O
rearrangement NN I-NP O
sites NNS I-NP O
of IN B-PP O
a DT B-NP O
constitutional JJ I-NP O
X NN I-NP O
/ SYM B-VP O
autosome NN B-NP O
translocation NN I-NP O
and CC O O
associated VBN B-VP O
deletion NN B-NP O
. . O O

Reciprocal JJ B-NP O
chromosome NN I-NP O
translocations NNS I-NP O
are VBP B-VP O
common JJ B-NP O
de FW I-NP O
novo FW I-NP O
rearrangements NNS I-NP O
that WDT B-NP O
occur VBP B-VP O
randomly RB B-ADVP O
throughout IN B-PP O
the DT B-NP O
human JJ I-NP O
genome NN I-NP O
. . O O

To TO B-VP O
learn VB I-VP O
about IN B-PP O
causative JJ B-NP O
mechanisms NNS I-NP O
, , O O
we PRP B-NP O
have VBP B-VP O
cloned VBN I-VP O
and CC I-VP O
sequenced VBN I-VP O
the DT B-NP O
breakpoints NNS I-NP O
of IN B-PP O
a DT B-NP O
cytologically RB I-NP O
balanced JJ I-NP O
constitutional JJ I-NP O
reciprocal JJ I-NP O
translocation NN I-NP O
, , O O
t NN B-NP O
( ( O O
X NN B-NP O
; : O O
4 CD B-NP O
) ) O O
( ( O O
p21 NN B-NP O
. . I-NP O

2 CD I-NP O
; : O O
q31 CD B-NP O
. . O O

22 CD B-NP O
) ) O O
, , O O
present JJ B-ADJP O
in IN B-PP O
a DT B-NP O
girl NN I-NP O
with IN B-PP O
Duchenne JJ B-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
DMD NN B-NP B-Disease
) ) O O
. . O O

Physical JJ B-NP O
mapping NN I-NP O
of IN B-PP O
the DT B-NP O
derivative JJ I-NP O
chromosomes NNS I-NP O
, , O O
after IN B-PP O
their PRP$ B-NP O
separation NN I-NP O
in IN B-PP O
somatic JJ B-NP O
cell NN I-NP O
hybrids NNS I-NP O
, , O O
reveals VBZ B-VP O
that IN B-SBAR O
the DT B-NP O
translocation NN I-NP O
disrupts VBZ B-VP O
the DT B-NP O
DMD NN I-NP B-Disease
gene NN I-NP O
in IN B-PP O
Xp21 NN B-NP O
within IN B-PP O
the DT B-NP O
18 CD I-NP O
- HYPH I-NP O
kb NN I-NP O
intron NN I-NP O
16 CD I-NP O
. . O O

Restriction NN B-NP O
mapping NN I-NP O
and CC I-NP O
sequencing NN I-NP O
of IN B-PP O
clones NNS B-NP O
that WDT B-NP O
span VBP B-VP O
both DT B-NP O
translocation NN I-NP O
breakpoints NNS I-NP O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
the DT B-NP O
corresponding VBG I-NP O
normal JJ I-NP O
regions NNS I-NP O
indicate VBP B-VP O
the DT B-NP O
loss NN I-NP O
of IN B-PP O
approximately RB B-NP O
5 CD I-NP O
kb NN I-NP O
in IN B-PP O
the DT B-NP O
formation NN I-NP O
of IN B-PP O
the DT B-NP O
derivative JJ I-NP O
X NN I-NP O
chromosome NN I-NP O
, , O O
with IN B-PP O
4 CD B-NP O
- HYPH I-NP O
6 CD I-NP O
bp NN I-NP O
deleted VBN B-VP O
from IN B-PP O
chromosome NN B-NP O
4 CD I-NP O
. . O O

RFLP NN B-NP O
and CC O O
Southern JJ B-NP O
analyses NNS I-NP O
indicate VBP B-VP O
that IN B-SBAR O
the DT B-NP O
de FW I-NP O
novo FW I-NP O
translocation NN I-NP O
is VBZ B-VP O
a DT B-NP O
paternal JJ I-NP O
origin NN I-NP O
and CC O O
that IN B-SBAR O
the DT B-NP O
fathers NNS I-NP O
X NN I-NP O
chromosome NN I-NP O
contains VBZ B-VP O
the DT B-NP O
DNA NN I-NP O
that WDT B-NP O
is VBZ B-VP O
deleted VBN I-VP O
in IN B-PP O
the DT B-NP O
derivative JJ I-NP O
X NN I-NP O
. . O O

Most RBS B-ADVP O
likely RB I-ADVP O
, , O O
deletion NN B-NP O
and CC I-NP O
translation NN I-NP O
arose VBD B-VP O
simultaneously RB B-ADVP O
from IN B-PP O
a DT B-NP O
complex JJ I-NP O
rearrangement NN I-NP O
event NN I-NP O
that WDT B-NP O
involves VBZ B-VP O
three CD B-NP O
chromosomal JJ I-NP O
breakpoints NNS I-NP O
. . O O

Short JJ B-NP O
regions NNS I-NP O
of IN B-PP O
sequence NN B-NP O
homology NN I-NP O
were VBD B-VP O
present JJ B-ADJP O
at IN B-PP O
the DT B-NP O
three CD I-NP O
sites NNS I-NP O
. . O O

A DT B-NP O
5 CD I-NP O
- HYPH I-NP O
bp NN I-NP O
sequence NN I-NP O
, , O O
GGAAT NN B-NP O
, , O O
found VBN B-VP O
exactly RB B-ADVP O
at IN B-PP O
the DT B-NP O
translocation NN I-NP O
breakpoints NNS I-NP O
on IN B-PP O
both DT B-NP O
normal JJ I-NP O
chromosomes NNS I-NP O
X NN I-NP O
and CC O O
4 CD B-NP O
, , O O
has VBZ B-VP O
been VBN I-VP O
preserved VBN I-VP O
only RB B-ADVP O
on IN B-PP O
the DT B-NP O
der NN I-NP O
( ( O O
4 CD B-NP O
) ) O O
chromosome NN B-NP O
. . O O

It PRP B-NP O
is VBZ B-VP O
likely JJ B-ADJP O
that IN B-SBAR O
the DT B-NP O
X NN I-NP O
- HYPH B-VP O
derived VBN B-NP O
sequence NN I-NP O
GGAATCA NN I-NP O
has VBZ B-VP O
been VBN I-VP O
lost VBN I-VP O
in IN B-PP O
the DT B-NP O
formation NN I-NP O
of IN B-PP O
the DT B-NP O
der NN I-NP O
( ( O O
X NN B-NP O
) ) O O
chromosome NN B-NP O
, , O O
as IN B-SBAR O
it PRP B-NP O
matches VBZ B-VP O
an DT B-NP O
inverted VBN I-NP O
GAATCA NN I-NP O
sequence NN I-NP O
present JJ B-ADJP O
on IN B-PP O
the DT B-NP O
opposite JJ I-NP O
strand NN I-NP O
exactly RB B-ADVP O
at IN B-PP O
the DT B-NP O
other JJ I-NP O
end NN I-NP O
of IN B-PP O
the DT B-NP O
deleted VBN I-NP O
5 CD I-NP O
- HYPH I-NP O
kb NN I-NP O
fragment NN I-NP O
. . O O

A DT B-NP O
genetic JJ I-NP O
etiology NN I-NP O
for IN B-PP O
DiGeorge NNP B-NP B-Disease
syndrome NN I-NP I-Disease
: : O O
consistent JJ B-NP O
deletions NNS I-NP O
and CC I-NP O
microdeletions NNS I-NP O
of IN B-PP O
22q11 CD B-NP O
. . O O

DiGeorge NN B-NP B-Disease
syndrome NN I-NP I-Disease
( ( O O
DGS NN B-NP B-Disease
) ) O O
, , O O
a DT B-NP O
developmental JJ I-NP O
field NN I-NP O
defect NN I-NP O
of IN B-PP O
the DT B-NP O
third JJ I-NP O
and CC I-NP O
fourth JJ I-NP O
pharyngeal JJ I-NP O
pouches NNS I-NP O
, , O O
is VBZ B-VP O
characterized VBN I-VP O
by IN B-PP O
aplasia NN B-NP B-Disease
or CC I-NP I-Disease
hypoplasia NN I-NP I-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
thymus NN I-NP I-Disease
and CC O I-Disease
parathyroid JJ B-NP I-Disease
glands NNS I-NP I-Disease
and CC B-PP O
by IN B-PP O
conotruncal JJ B-NP B-Disease
cardiac JJ I-NP I-Disease
malformations NNS I-NP I-Disease
. . O O

Cytogenetic JJ B-NP O
studies NNS I-NP O
support VBP B-VP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
a DT B-NP O
DGS NN I-NP B-Disease
critical JJ I-NP O
region NN I-NP O
in IN B-PP O
band NN B-NP O
22q11 CD I-NP O
. . O O

In IN B-PP O
the DT B-NP O
present JJ I-NP O
study NN I-NP O
, , O O
we PRP B-NP O
report VBP B-VP O
the DT B-NP O
results NNS I-NP O
of IN B-PP O
clinical JJ B-NP O
, , I-NP O
cytogenetic JJ I-NP O
, , O O
and CC O O
molecular JJ B-NP O
studies NNS I-NP O
of IN B-PP O
14 CD B-NP O
patients NNS I-NP O
with IN B-PP O
DGS NN B-NP B-Disease
. . O O

Chromosome NN B-NP O
analysis NN I-NP O
, , O O
utilizing VBG B-VP O
high JJ B-NP O
- HYPH I-NP O
resolution NN I-NP O
banding NN I-NP O
techniques NNS I-NP O
, , O O
detected VBD B-VP O
interstitial JJ B-NP O
deletions NNS I-NP O
in IN B-PP O
five CD B-NP O
probands NNS I-NP O
and CC O O
was VBD B-VP O
inconclusive JJ B-ADJP O
for IN B-PP O
a DT B-NP O
deletion NN I-NP O
in IN B-PP O
three CD B-NP O
probands NNS I-NP O
. . O O

The DT B-NP O
remaining VBG I-NP O
six CD I-NP O
patients NNS I-NP O
had VBD B-VP O
normal JJ B-NP O
karyotypes NNS I-NP O
. . O O

In IN B-PP O
contrast NN B-NP O
, , O O
molecular JJ B-NP O
analysis NN I-NP O
detected VBD B-VP O
DNA NN B-NP O
deletions NNS I-NP O
in IN B-PP O
all DT B-NP O
14 CD I-NP O
probands NNS I-NP O
. . O O

Two CD B-NP O
of IN I-NP O
10 CD I-NP O
loci NNS I-NP O
tested VBN B-VP O
, , O O
D22S75 NN B-NP O
and CC I-NP O
D22S259 NN I-NP O
, , O O
are VBP B-VP O
deleted VBN I-VP O
in IN B-PP O
all DT B-NP O
14 CD I-NP O
patients NNS I-NP O
. . O O

A DT B-NP O
third JJ I-NP O
locus NN I-NP O
, , O O
D22S66 NN B-NP O
, , O O
is VBZ B-VP O
deleted VBN I-VP O
in IN B-PP O
the DT B-NP O
eight CD I-NP O
DGS NN I-NP B-Disease
probands NNS I-NP O
tested VBN B-VP O
. . O O

Physical JJ B-NP O
mapping NN I-NP O
using VBG B-VP O
somatic JJ B-NP O
cell NN I-NP O
hybrids NNS I-NP O
places VBZ B-VP O
D22S66 NN B-NP O
between IN B-PP O
D22S75 NN B-NP O
and CC I-NP O
D22S259 NN I-NP O
, , O O
suggesting VBG B-VP O
that IN B-SBAR O
it PRP B-NP O
should MD B-VP O
be VB I-VP O
deleted VBN I-VP O
in IN B-PP O
the DT B-NP O
remaining VBG I-NP O
six CD I-NP O
cases NNS I-NP O
. . O O

Parent NN B-NP O
- HYPH B-NP O
of IN B-PP O
- HYPH B-NP O
origin NN I-NP O
studies NNS I-NP O
were VBD B-VP O
performed VBN I-VP O
in IN B-PP O
five CD B-NP O
families NNS I-NP O
. . O O

Four CD B-NP O
probands NNS I-NP O
failed VBD B-VP O
to TO I-VP O
inherit VB I-VP O
a DT B-NP O
maternal JJ I-NP O
allele NN I-NP O
, , O O
and CC O O
one CD B-NP O
failed VBD B-VP O
to TO I-VP O
inherit VB I-VP O
a DT B-NP O
paternal JJ I-NP O
allele NN I-NP O
. . O O

On IN B-PP O
the DT B-NP O
basis NN I-NP O
of IN B-PP O
these DT B-NP O
families NNS I-NP O
, , O O
and CC O O
of IN B-PP O
six CD B-NP O
maternally RB I-NP O
and CC I-NP O
five CD I-NP O
paternally RB I-NP O
derived VBN I-NP O
unbalanced JJ I-NP O
- HYPH I-NP O
translocation NN I-NP O
DGS NN I-NP B-Disease
probands NNS I-NP O
in IN B-PP O
the DT B-NP O
literature NN I-NP O
, , O O
parent NN B-NP O
of IN B-PP O
origin NN B-NP O
or CC I-NP O
imprinting NN I-NP O
does VBZ B-VP O
not RB I-VP O
appear VB I-VP O
to TO I-VP O
play VB I-VP O
an DT B-NP O
important JJ I-NP O
role NN I-NP O
in IN B-PP O
the DT B-NP O
pathogenesis NN I-NP O
of IN B-PP O
DGS NN B-NP B-Disease
. . O O

Deletion NN B-NP O
of IN B-PP O
the DT B-NP O
same JJ I-NP O
three CD I-NP O
loci NNS I-NP O
in IN B-PP O
all DT B-NP O
14 CD I-NP O
DGS NN I-NP B-Disease
probands NNS I-NP O
begins VBZ B-VP O
to TO I-VP O
delineate VB I-VP O
the DT B-NP O
region NN I-NP O
of IN B-PP O
chromosome NN B-NP O
22 CD I-NP O
critical JJ B-ADJP O
for IN B-PP O
DGS NN B-NP B-Disease
and CC O O
confirms VBZ B-VP O
the DT B-NP O
hypothesis NN I-NP O
that IN B-SBAR O
submicroscopic JJ B-NP O
deletions NNS I-NP O
of IN B-PP O
22q11 CD B-NP O
are VBP B-VP O
etiologic JJ B-ADJP O
in IN B-PP O
the DT B-NP O
vast JJ I-NP O
majority NN I-NP O
of IN B-PP O
cases NNS B-NP O
. . O O

. . O O

Loss NN B-NP O
of IN B-PP O
normal JJ B-NP O
allele NN I-NP O
of IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
in IN B-PP O
an DT B-NP O
adrenocortical JJ I-NP B-Disease
carcinoma NN I-NP I-Disease
from IN B-PP O
a DT B-NP O
patient NN I-NP O
with IN B-PP O
familial JJ B-NP B-Disease
adenomatous JJ I-NP I-Disease
polyposis NN I-NP I-Disease
. . O O

Endocrine JJ B-NP B-Disease
neoplasms NNS I-NP I-Disease
have VBP B-VP O
been VBN I-VP O
reported VBN I-VP O
occasionally RB B-ADVP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
familial JJ B-NP B-Disease
adenomatous JJ I-NP I-Disease
polyposis NN I-NP I-Disease
( ( O O
FAP NN B-NP B-Disease
) ) O O
. . O O

An DT B-NP O
adrenocorotical JJ I-NP B-Disease
carcinoma NN I-NP I-Disease
was VBD B-VP O
studied VBN I-VP O
in IN B-PP O
a DT B-NP O
patient NN I-NP O
with IN B-PP O
a DT B-NP O
family NN I-NP O
history NN I-NP O
of IN B-PP O
FAP NN B-NP B-Disease
. . O O

Loss NN B-NP O
of IN B-PP O
heterozygosity NN B-NP O
( ( O O
LOH NN B-NP O
) ) O O
in IN B-PP O
the DT B-NP O
region NN I-NP O
close JJ B-ADJP O
to TO B-PP O
the DT B-NP O
adenomatous JJ I-NP B-Disease
polyposis NN I-NP I-Disease
coli NN I-NP I-Disease
( ( O O
APC NN B-NP B-Disease
) ) O O
gene NN B-NP O
was VBD B-VP O
detected VBN I-VP O
in IN B-PP O
this DT B-NP O
carcinoma NN I-NP B-Disease
, , O O
and CC O O
evidence NN B-NP O
was VBD B-VP O
obtained VBN I-VP O
that IN B-SBAR O
there EX B-NP O
was VBD B-VP O
a DT B-NP O
loss NN I-NP O
of IN B-PP O
the DT B-NP O
normal JJ I-NP O
allele NN I-NP O
of IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
. . O O

This DT B-NP O
is VBZ B-VP O
the DT B-NP O
first JJ I-NP O
demonstration NN I-NP O
of IN B-PP O
LOH NN B-NP O
at IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
locus NN I-NP O
in IN B-PP O
adrenocortical JJ B-NP B-Disease
tumors NNS I-NP I-Disease
. . O O

The DT B-NP O
present JJ I-NP O
results NNS I-NP O
and CC O O
our PRP$ B-NP O
previous JJ I-NP O
data NNS I-NP O
on IN B-PP O
LOH NN B-NP O
in IN B-PP O
a DT B-NP O
recurring VBG I-NP O
desmoid JJ I-NP B-Disease
tumor NN I-NP I-Disease
suggest VBP B-VP O
that IN B-SBAR O
the DT B-NP O
heterozygous JJ I-NP O
mutant NN I-NP O
/ SYM B-NP O
wild JJ I-NP O
- HYPH I-NP O
type NN I-NP O
condition NN I-NP O
of IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
may MD B-VP O
give VB I-VP O
rise NN B-NP O
to TO B-PP O
benign JJ B-NP B-Disease
tumors NNS I-NP I-Disease
, , O O
and CC O O
that IN B-SBAR O
functional JJ B-NP O
loss NN I-NP O
of IN B-PP O
this DT B-NP O
gene NN I-NP O
leads VBZ B-VP O
to TO B-PP O
development NN B-NP O
of IN B-PP O
tumors NNS B-NP B-Disease
not RB B-CONJP O
only RB I-CONJP O
in IN B-PP O
the DT B-NP O
colon NN I-NP O
but CC B-CONJP O
also RB I-CONJP O
in IN B-PP O
other JJ B-NP O
various JJ I-NP O
parts NNS I-NP O
of IN B-PP O
the DT B-NP O
body NN I-NP O
in IN B-PP O
FAP NN B-NP B-Disease
patients NNS I-NP O
. . O O

. . O O

Oncogenic JJ B-NP O
point NN I-NP O
mutations NNS I-NP O
in IN B-PP O
exon NN B-NP O
20 CD I-NP O
of IN B-PP O
the DT B-NP O
RB1 NN I-NP O
gene NN I-NP O
in IN B-PP O
families NNS B-NP O
showing VBG B-VP O
incomplete JJ B-NP O
penetrance NN I-NP O
and CC O O
mild JJ B-NP O
expression NN I-NP O
of IN B-PP O
the DT B-NP O
retinoblastoma NN I-NP B-Disease
phenotype NN I-NP O
. . O O

The DT B-NP O
retinoblastoma NN I-NP B-Disease
- HYPH I-NP O
predisposition NN I-NP O
gene NN I-NP O
, , O O
RB1 NN B-NP O
, , O O
segregates VBZ B-VP O
as IN B-PP O
an DT B-NP O
autosomal JJ I-NP O
dominant JJ I-NP O
trait NN I-NP O
with IN B-PP O
high JJ B-NP O
( ( O O
90 CD B-NP O
% NN I-NP O
) ) O O
penetrance NN B-NP O
. . O O

Certain JJ B-NP O
families NNS I-NP O
, , O O
however RB B-ADVP O
, , O O
show VBP B-VP O
an DT B-NP O
unusual JJ I-NP O
low JJ I-NP O
- HYPH I-NP O
penetrance NN I-NP O
phenotype NN I-NP O
with IN B-PP O
many JJ B-NP O
individuals NNS I-NP O
being VBG B-VP O
unaffected JJ B-ADJP O
, , O O
unilaterally RB B-VP O
affected VBN I-VP O
, , O O
or CC O O
with IN B-PP O
evidence NN B-NP O
of IN B-PP O
spontaneously RB B-NP O
regressed VBN I-NP O
tumors NNS I-NP B-Disease
. . O O

We PRP B-NP O
have VBP B-VP O
used VBN I-VP O
single JJ B-NP O
- HYPH I-NP O
strand NN I-NP O
conformation NN I-NP O
polymorphism NN I-NP O
analysis NN I-NP O
and CC O O
PCR NN B-NP O
sequencing NN I-NP O
to TO B-VP O
study VB I-VP O
two CD B-NP O
such JJ I-NP O
families NNS I-NP O
. . O O

Mutations NNS B-NP O
were VBD B-VP O
found VBN I-VP O
in IN B-PP O
exon NN B-NP O
20 CD I-NP O
of IN B-PP O
RB1 NN B-NP O
in IN B-PP O
both DT B-NP O
cases NNS I-NP O
. . O O

In IN B-PP O
one CD B-NP O
family NN I-NP O
a DT B-NP O
C NN I-NP O
- SYM B-NP O
- SYM B-NP O
- SYM I-NP O
- HYPH I-NP O
T NN I-NP O
transition NN I-NP O
in IN B-PP O
codon NN B-NP O
661 CD I-NP O
converts VBZ B-VP O
an DT B-NP O
arginine NN I-NP O
( ( O O
CGG NN B-NP O
) ) O O
to TO B-PP O
a DT B-NP O
tryptophan NN I-NP O
( ( O O
TGG NN B-NP O
) ) O O
codon NN B-NP O
. . O O

In IN B-PP O
this DT B-NP O
family NN I-NP O
, , O O
incomplete JJ B-NP O
penetrance NN I-NP O
and CC O O
mild JJ B-NP O
phenotypic JJ I-NP O
expression NN I-NP O
were VBD B-VP O
observed VBN I-VP O
in IN B-PP O
virtually RB B-NP O
all DT I-NP O
patients NNS I-NP O
, , O O
possibly RB B-VP O
indicating VBG I-VP O
that IN B-SBAR O
single JJ B-NP O
amino JJ I-NP O
acid NN I-NP O
changes NNS I-NP O
may MD B-VP O
modify VB I-VP O
protein NN B-NP O
structure NN I-NP O
/ SYM B-NP O
function NN I-NP O
such JJ B-NP O
that IN I-NP O
tumorigenesis NN B-NP O
is VBZ B-VP O
not RB O O
inevitable JJ B-ADJP O
. . O O

In IN B-PP O
the DT B-NP O
second JJ I-NP O
family NN I-NP O
the DT B-NP O
mutation NN I-NP O
in IN B-PP O
codon NN B-NP O
675 CD I-NP O
is VBZ B-VP O
a DT B-NP O
G NN I-NP O
- SYM B-NP O
- SYM B-NP O
- SYM I-NP O
- HYPH I-NP O
T NN I-NP O
transversion NN I-NP O
that WDT B-NP O
converts VBZ B-VP O
a DT B-NP O
glutamine NN I-NP O
( ( O O
GAA NN B-NP O
) ) O O
to TO B-PP O
a DT B-NP O
stop NN I-NP O
( ( O O
TAA NN B-NP O
) ) O O
codon NN B-NP O
. . O O

However RB B-ADVP O
, , O O
this DT B-NP O
mutation NN I-NP O
also RB B-ADVP O
occurs VBZ B-VP O
near IN B-PP O
a DT B-NP O
potential JJ I-NP O
cryptic JJ I-NP O
splice NN I-NP O
acceptor NN I-NP O
site NN I-NP O
, , O O
raising VBG B-VP O
the DT B-NP O
possibility NN I-NP O
of IN B-PP O
alternative JJ B-NP O
splicing NN I-NP O
resulting VBG B-VP O
in IN B-PP O
a DT O O
less RBR B-ADVP O
severely RB I-ADVP O
disrupted VBN B-NP O
protein NN I-NP O
. . O O

. . O O

Late JJ B-NP O
- HYPH I-NP O
onset NN I-NP O
metachromatic JJ I-NP B-Disease
leukodystrophy NN I-NP I-Disease
: : O O
molecular JJ B-NP O
pathology NN I-NP O
in IN B-PP O
two CD B-NP O
siblings NNS I-NP O
. . O O

We PRP B-NP O
report VBP B-VP O
on IN B-PP O
a DT B-NP O
new JJ I-NP O
allele NN I-NP O
at IN B-PP O
the DT B-NP O
arylsulfatase NN I-NP O
A NN I-NP O
( ( O O
ARSA NN B-NP O
) ) O O
locus NN B-NP O
causing VBG B-VP O
late JJ B-NP O
- HYPH I-NP O
onset NN I-NP O
metachromatic JJ I-NP B-Disease
leukodystrophy NN I-NP I-Disease
( ( O O
MLD NN B-NP B-Disease
) ) O O
. . O O

In IN B-PP O
that DT B-NP O
allele NN I-NP O
arginine84 NN I-NP O
, , O O
a DT B-NP O
residue NN I-NP O
that WDT B-NP O
is VBZ B-VP O
highly RB I-VP O
conserved VBN I-VP O
in IN B-PP O
the DT B-NP O
arylsulfatase NN I-NP O
gene NN I-NP O
family NN I-NP O
, , O O
is VBZ B-VP O
replaced VBN I-VP O
by IN B-PP O
glutamine NN B-NP O
. . O O

In IN B-PP O
contrast NN B-NP O
to TO B-PP O
alleles NNS B-NP O
that WDT B-NP O
cause VBP B-VP O
early JJ B-NP O
- HYPH I-NP O
onset NN I-NP O
MLD NN I-NP B-Disease
, , O O
the DT B-NP O
arginine84 NN I-NP O
to TO B-PP O
glutamine NN B-NP O
substitution NN I-NP O
is VBZ B-VP O
associated VBN I-VP O
with IN B-PP O
some DT B-NP O
residual JJ I-NP O
ARSA NN I-NP O
activity NN I-NP O
. . O O

A DT B-NP O
comparison NN I-NP O
of IN B-PP O
genotypes NNS B-NP O
, , O O
ARSA NN B-NP O
activities NNS I-NP O
, , O O
and CC O O
clinical JJ B-NP O
data NNS I-NP O
on IN B-PP O
4 CD B-NP O
individuals NNS I-NP O
carrying VBG B-VP O
the DT B-NP O
allele NN I-NP O
of IN B-PP O
81 CD B-NP O
patients NNS I-NP O
with IN B-PP O
MLD NN B-NP B-Disease
examined VBN B-VP O
, , O O
further RBR B-ADVP O
validates VBZ B-VP O
the DT B-NP O
concept NN I-NP O
that IN B-SBAR O
different JJ B-NP O
degrees NNS I-NP O
of IN B-PP O
residual JJ B-NP O
ARSA NN I-NP O
activity NN I-NP O
are VBP B-VP O
the DT B-NP O
basis NN I-NP O
of IN B-PP O
phenotypical JJ B-NP O
variation NN I-NP O
in IN B-PP O
MLD NN B-NP B-Disease
. . O O

. . O O

Trisomy NN B-NP B-Disease
15 CD I-NP I-Disease
with IN B-PP O
loss NN B-NP O
of IN B-PP O
the DT B-NP O
paternal JJ I-NP O
15 CD I-NP O
as IN B-PP O
a DT B-NP O
cause NN I-NP O
of IN B-PP O
Prader NNP B-NP B-Disease
- HYPH I-NP I-Disease
Willi NNP I-NP I-Disease
syndrome NN I-NP I-Disease
due IN B-PP O
to TO B-PP O
maternal JJ B-NP B-Disease
disomy NN I-NP I-Disease
. . O O

Uniparental JJ B-NP B-Disease
disomy NN I-NP I-Disease
has VBZ B-VP O
recently RB I-VP O
been VBN I-VP O
recognized VBN I-VP O
to TO B-VP O
cause VB I-VP O
human JJ B-NP O
disorders NNS I-NP O
, , O O
including VBG B-PP O
Prader NNP B-NP B-Disease
- HYPH I-NP I-Disease
Willi NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
PWS NN B-NP B-Disease
) ) O O
. . O O

We PRP B-NP O
describe VBP B-VP O
a DT B-NP O
particularly RB I-NP O
instructive JJ I-NP O
case NN I-NP O
which WDT B-NP O
raises VBZ B-VP O
important JJ B-NP O
issues NNS I-NP O
concerning VBG B-VP O
the DT B-NP O
mechanisms NNS I-NP O
producing VBG B-VP O
uniparental JJ B-NP B-Disease
disomy NN I-NP I-Disease
and CC O O
whose WP$ B-NP O
evaluation NN I-NP O
provides VBZ B-VP O
evidence NN B-NP O
that IN B-SBAR O
trisomy NN B-NP O
may MD B-VP O
precede VB I-VP O
uniparental JJ B-NP B-Disease
disomy NN I-NP I-Disease
in IN B-PP O
a DT B-NP O
fetus NN I-NP O
. . O O

Chorionic JJ B-NP O
villus NN I-NP O
sampling NN I-NP O
performed VBN B-VP O
for IN B-PP O
advanced VBN B-NP O
maternal JJ I-NP O
age NN I-NP O
revealed VBD B-VP O
trisomy NN B-NP B-Disease
15 CD I-NP I-Disease
in IN B-PP O
all DT B-NP O
direct JJ I-NP O
and CC I-NP O
cultured VBN I-NP O
cells NNS I-NP O
, , O O
though IN B-SBAR O
the DT B-NP O
fetus NN I-NP O
appeared VBD B-VP O
normal JJ B-ADJP O
. . O O

Chromosome NN B-NP O
analysis NN I-NP O
of IN B-PP O
amniocytes NNS B-NP O
obtained VBN B-VP O
at IN B-PP O
15 CD B-NP O
wk NN I-NP O
was VBD B-VP O
normal JJ B-ADJP O
in IN B-PP O
over IN B-NP O
100 CD I-NP O
cells NNS I-NP O
studied VBN B-VP O
. . O O

The DT B-NP O
child NN I-NP O
was VBD B-VP O
hypotonic JJ B-ADJP B-Disease
at IN B-PP O
birth NN B-NP O
, , O O
and CC O O
high JJ B-NP O
- HYPH I-NP O
resolution NN I-NP O
banding NN I-NP O
failed VBD B-VP O
to TO I-VP O
reveal VB I-VP O
the DT B-NP O
deletion NN I-NP O
of IN B-PP O
15q11 CD B-NP O
- HYPH I-NP O
13 CD I-NP O
, , O O
a DT B-NP O
deletion NN I-NP O
which WDT B-NP O
is VBZ B-VP O
found VBN I-VP O
in IN B-PP O
50 CD B-NP O
% NN I-NP O
- HYPH O O
70 CD B-NP O
% NN I-NP O
of IN B-PP O
patients NNS B-NP O
with IN B-PP O
PWS NN B-NP B-Disease
. . O O

Over IN B-PP O
time NN B-NP O
, , O O
typical JJ B-NP O
features NNS I-NP O
of IN B-PP O
PWS NN B-NP B-Disease
developed VBD B-VP O
. . O O

Molecular JJ B-NP O
genetic JJ I-NP O
analysis NN I-NP O
using VBG B-VP O
probes NNS B-NP O
for IN B-PP O
chromosome NN B-NP O
15 CD I-NP O
revealed VBD B-VP O
maternal JJ B-NP O
disomy NN I-NP O
. . O O

Maternal JJ B-NP O
nondisjunction NN I-NP O
with IN B-PP O
fertilization NN B-NP O
of IN B-PP O
a DT B-NP O
disomic JJ I-NP O
egg NN I-NP O
by IN B-PP O
a DT B-NP O
normal JJ I-NP O
sperm NN I-NP O
, , O O
followed VBN B-VP O
by IN B-PP O
loss NN B-NP O
of IN B-PP O
the DT B-NP O
paternal JJ I-NP O
15 CD I-NP O
, , O O
is VBZ B-VP O
a DT B-NP O
likely JJ I-NP O
cause NN I-NP O
of IN B-PP O
confined VBN B-NP O
placental JJ I-NP O
mosaicism NN I-NP O
and CC O O
uniparental JJ B-NP B-Disease
disomy NN I-NP I-Disease
in IN B-PP O
this DT B-NP O
case NN I-NP O
of IN B-PP O
PWS NN B-NP B-Disease
, , O O
and CC O O
advanced VBN B-VP O
maternal JJ B-NP O
age NN I-NP O
may MD B-VP O
be VB I-VP O
a DT B-NP O
predisposing VBG I-NP O
factor NN I-NP O
. . O O

. . O O

Genetic JJ B-NP O
heterogeneity NN I-NP O
in IN B-PP O
X NN B-NP B-Disease
- HYPH B-NP I-Disease
linked VBN I-NP I-Disease
amelogenesis NN I-NP I-Disease
imperfecta NN I-NP I-Disease
. . O O

The DT B-NP O
AMELX NN I-NP O
gene NN I-NP O
located VBN B-VP O
at IN B-PP O
Xp22 NN B-NP O
. . O O

1 CD B-NP O
- HYPH I-NP O
p22 NN I-NP O
. . O O

3 CD B-NP O
encodes VBZ B-VP O
for IN B-PP O
the DT B-NP O
enamel NN I-NP O
protein NN I-NP O
amelogenin NN I-NP O
and CC O O
has VBZ B-VP O
been VBN I-VP O
implicated VBN I-VP O
as IN B-PP O
the DT B-NP O
gene NN I-NP O
responsible JJ B-ADJP O
for IN B-PP O
the DT B-NP O
inherited VBN I-NP B-Disease
dental JJ I-NP I-Disease
abnormality NN I-NP I-Disease
X NN I-NP B-Disease
- HYPH B-VP I-Disease
linked VBN B-NP I-Disease
amelogenesis NN I-NP I-Disease
imperfecta NN I-NP I-Disease
( ( O O
XAI NN B-NP B-Disease
) ) O O
. . O O

Three CD B-NP O
families NNS I-NP O
with IN B-PP O
XAI NN B-NP B-Disease
have VBP B-VP O
been VBN I-VP O
investigated VBN I-VP O
using VBG B-VP O
polymorphic JJ B-NP O
DNA NN I-NP O
markers NNS I-NP O
flanking VBG B-VP O
the DT B-NP O
position NN I-NP O
of IN B-PP O
AMELX NN B-NP O
. . O O

Using VBG B-VP O
two CD B-NP O
- HYPH I-NP O
point NN I-NP O
linkage NN I-NP O
analysis NN I-NP O
, , O O
linkage NN B-NP O
was VBD B-VP O
established VBN I-VP O
between IN B-PP O
XAI NN B-NP B-Disease
and CC O O
several JJ B-NP O
of IN B-PP O
these DT B-NP O
markers NNS I-NP O
in IN B-PP O
two CD B-NP O
families NNS I-NP O
, , O O
with IN B-PP O
a DT B-NP O
combined JJ I-NP O
lod NN I-NP O
score NN I-NP O
of IN B-PP O
6 CD B-NP O
. . O O

05 CD B-NP O
for IN B-PP O
DXS16 NN B-NP O
at IN B-PP O
theta NN B-NP O
= SYM B-VP O
0 CD B-NP O
. . O O

04 CD B-NP O
04 CD I-NP O
. . O O

This DT B-NP O
supports VBZ B-VP O
the DT B-NP O
involvement NN I-NP O
of IN B-PP O
AMELX NN B-NP O
, , O O
located JJ B-ADJP O
close RB I-ADJP O
to TO B-PP O
DXS16 NN B-NP O
, , O O
in IN B-PP O
the DT B-NP O
XAI NN I-NP B-Disease
disease NN I-NP I-Disease
process NN I-NP O
( ( O O
AIH1 NN B-NP O
) ) O O
in IN B-PP O
those DT B-NP O
families NNS I-NP O
. . O O

Using VBG B-VP O
multipoint JJ B-NP O
linkage NN I-NP O
analysis NN I-NP O
, , O O
the DT B-NP O
combined JJ I-NP O
maximum JJ I-NP O
lod NN I-NP O
score NN I-NP O
for IN B-PP O
these DT B-NP O
two CD I-NP O
families NNS I-NP O
was VBD B-VP O
7 CD B-NP O
. . O O

30 CD B-NP O
for IN B-PP O
a DT B-NP O
location NN I-NP O
of IN B-PP O
AIH1 NN B-NP O
at IN B-PP O
2 CD B-NP O
cM NN I-NP O
distal JJ B-ADJP O
to TO B-PP O
DXS16 NN B-NP O
. . O O

The DT B-NP O
support NN I-NP O
interval NN I-NP O
around IN B-PP O
this DT B-NP O
location NN I-NP O
extended VBD B-VP O
about IN B-NP O
8 CD I-NP O
cM NN I-NP O
proximal JJ B-ADJP O
to TO B-PP O
DXS92 NN B-NP O
, , O O
and CC O O
the DT B-NP O
AIH1 NN I-NP O
location NN I-NP O
could MD B-VP O
not RB I-VP O
be VB I-VP O
precisely RB I-VP O
defined VBN I-VP O
by IN B-PP O
multipoint JJ B-NP O
mapping NN I-NP O
. . O O

Study NN B-NP O
of IN B-PP O
recombination NN B-NP O
events NNS I-NP O
indicated VBD B-VP O
that IN B-SBAR O
AIH1 NN B-NP O
lies VBZ B-VP O
in IN B-PP O
the DT B-NP O
interval NN I-NP O
between IN B-PP O
DXS143 NN B-NP O
and CC I-NP O
DXS85 NN I-NP O
. . O O

There EX B-NP O
was VBD B-VP O
significant JJ B-NP O
evidence NN I-NP O
against IN B-PP O
linkage NN B-NP O
to TO B-PP O
this DT B-NP O
region NN I-NP O
in IN B-PP O
the DT B-NP O
third JJ I-NP O
family NN I-NP O
, , O O
indicating VBG B-VP O
locus NN B-NP O
heterogeneity NN I-NP O
in IN B-PP O
XAI NN B-NP B-Disease
. . O O

Further JJ B-NP O
analysis NN I-NP O
with IN B-PP O
markers NNS B-NP O
on IN B-PP O
the DT B-NP O
long JJ I-NP O
arm NN I-NP O
of IN B-PP O
the DT B-NP O
X NN I-NP O
chromosome NN I-NP O
showed VBD B-VP O
evidence NN B-NP O
of IN B-PP O
linkage NN B-NP O
to TO B-PP O
DXS144E NN B-NP O
and CC I-NP O
F9 NN I-NP O
with IN B-PP O
no DT B-NP O
recombination NN I-NP O
with IN B-PP O
either DT B-NP O
of IN B-PP O
these DT B-NP O
markers NNS I-NP O
. . O O

Two CD B-NP O
- HYPH I-NP O
point NN I-NP O
analysis NN I-NP O
gave VBD B-VP O
a DT B-NP O
peak JJ I-NP O
lod NN I-NP O
score NN I-NP O
at IN B-PP O
DXS144E NN B-NP O
with IN B-PP O
a DT B-NP O
maximum NN I-NP O
lod NN I-NP O
score NN I-NP O
of IN B-PP O
2 CD B-NP O
. . O O

83 CD B-NP O
at IN B-PP O
theta NN B-NP O
= SYM B-VP O
0 CD B-NP O
, , O O
with IN B-PP O
a DT B-NP O
peak JJ I-NP O
lod NN I-NP O
score NN I-NP O
in IN B-PP O
multipoint JJ B-NP O
linkage NN I-NP O
analysis NN I-NP O
of IN B-PP O
2 CD B-NP O
. . O O

84 CD B-NP O
at IN B-PP O
theta NN B-NP O
= SYM B-VP O
0 CD B-NP O
. . O O

The DT B-NP O
support NN I-NP O
interval NN I-NP O
extended VBD B-VP O
9 CD B-NP O
cM NN I-NP O
proximal JJ B-ADJP O
to TO B-PP O
DXS144E NN B-NP O
and CC O O
14 CD B-NP O
cM NN I-NP O
distal JJ B-ADJP O
to TO B-PP O
F9 NN B-NP O
. . O O

( ( O O
ABSTRACT NN B-NP O
TRUNCATED VBN B-VP O
AT IN B-PP O
250 CD B-NP O
WORDS NNS I-NP O
) ) O O
. . O O

Multiple JJ B-NP O
origins NNS I-NP O
for IN B-PP O
phenylketonuria NN B-NP B-Disease
in IN B-PP O
Europe NNP B-NP O
. . O O

Phenylketonuria NN B-NP B-Disease
( ( O O
PKU NN B-NP B-Disease
) ) O O
, , O O
a DT B-NP O
disorder NN I-NP B-Disease
of IN B-PP I-Disease
amino JJ B-NP I-Disease
acid NN I-NP I-Disease
metabolism NN I-NP I-Disease
prevalent JJ B-ADJP O
among IN B-PP O
Caucasians NNPS B-NP O
and CC O O
other JJ B-NP O
ethnic JJ I-NP O
groups NNS I-NP O
, , O O
is VBZ B-VP O
caused VBN I-VP O
primarily RB B-ADVP O
by IN B-PP O
a DT B-NP O
deficiency NN I-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
hepatic JJ I-NP I-Disease
enzyme NN I-NP I-Disease
phenylalanine NN I-NP I-Disease
hydroxylase NN I-NP I-Disease
( ( O O
PAH NN B-NP O
) ) O O
. . O O

PKU NN B-NP B-Disease
is VBZ B-VP O
a DT B-NP O
highly RB I-NP O
heterogeneous JJ I-NP O
disorder NN I-NP O
, , O O
with IN B-PP O
more JJR B-NP O
than IN I-NP O
60 CD I-NP O
molecular JJ I-NP O
lesions NNS I-NP O
identified VBN B-VP O
in IN B-PP O
the DT B-NP O
PAH NN I-NP O
gene NN I-NP O
. . O O

The DT B-NP O
haplotype NN I-NP O
associations NNS I-NP O
, , O O
relative JJ B-NP O
frequencies NNS I-NP O
, , O O
and CC O O
distributions NNS B-NP O
of IN B-PP O
five CD B-NP O
prevalent JJ I-NP O
PAH NN I-NP O
mutations NNS I-NP O
( ( O O
R158Q NN B-NP O
, , O O
R261Q NN B-NP O
, , O O
IVS10nt546 NN B-NP O
, , O O
R408W NN B-NP O
, , O O
and CC O O
IVS12n1 NN B-NP O
) ) O O
were VBD B-VP O
established VBN I-VP O
in IN B-PP O
a DT B-NP O
comprehensive JJ I-NP O
European JJ I-NP O
sample NN I-NP O
population NN I-NP O
and CC O O
subsequently RB B-ADVP O
were VBD B-VP O
examined VBN I-VP O
to TO B-VP O
determine VB I-VP O
the DT B-NP O
potential JJ I-NP O
roles NNS I-NP O
of IN B-PP O
several JJ B-NP O
genetic JJ I-NP O
mechanisms NNS I-NP O
in IN B-PP O
explaining VBG B-VP O
the DT B-NP O
present JJ I-NP O
distribution NN I-NP O
of IN B-PP O
the DT B-NP O
major JJ I-NP O
PKU NN I-NP B-Disease
alleles NNS I-NP O
. . O O

Each DT B-NP O
of IN B-PP O
these DT B-NP O
five CD I-NP O
mutations NNS I-NP O
was VBD B-VP O
strongly RB I-VP O
associated VBN I-VP O
with IN B-PP O
only RB B-NP O
one CD I-NP O
of IN B-PP O
the DT B-NP O
more JJR I-NP O
than IN I-NP O
70 CD I-NP O
chromosomal JJ I-NP O
haplotypes NNS I-NP O
defined VBN B-VP O
by IN B-PP O
eight CD B-NP O
RFLPs NNS I-NP O
in IN B-PP O
or CC I-PP O
near IN I-PP O
the DT B-NP O
PAH NN I-NP O
gene NN I-NP O
. . O O

These DT B-NP O
findings NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
each DT B-NP O
of IN B-PP O
these DT B-NP O
mutations NNS I-NP O
arose VBD B-VP O
through IN B-PP O
a DT B-NP O
single JJ I-NP O
founding JJ I-NP O
event NN I-NP O
that WDT B-NP O
occurred VBD B-VP O
within IN B-PP O
time NN B-NP O
periods NNS I-NP O
ranging VBG B-VP O
from IN B-PP O
several JJ B-NP O
hundred CD I-NP O
to TO B-PP O
several JJ B-NP O
thousand CD I-NP O
years NNS I-NP O
ago RB B-ADVP O
. . O O

From IN B-PP O
the DT B-NP O
significant JJ I-NP O
differences NNS I-NP O
observed VBN B-VP O
in IN B-PP O
the DT B-NP O
relative JJ I-NP O
frequencies NNS I-NP O
and CC I-NP O
distributions NNS I-NP O
of IN B-PP O
these DT B-NP O
five CD I-NP O
alleles NNS I-NP O
throughout IN B-PP O
Europe NNP B-NP O
, , O O
four CD B-NP O
of IN B-PP O
these DT B-NP O
putative JJ I-NP O
founding JJ I-NP O
events NNS I-NP O
could MD B-VP O
be VB I-VP O
localized JJ B-ADJP O
to TO B-PP O
specific JJ B-NP O
ethnic JJ I-NP O
subgroups NNS I-NP O
. . O O

Together RB B-ADVP O
, , O O
these DT B-NP O
data NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
there EX B-NP O
were VBD B-VP O
multiple JJ B-ADJP O
, , O O
geographically RB B-ADVP O
and CC I-ADVP O
ethnically RB I-ADVP O
distinct JJ B-NP O
origins NNS I-NP O
for IN B-PP O
PKU NN B-NP B-Disease
within IN B-PP O
the DT B-NP O
European JJ I-NP O
population NN I-NP O
. . O O

. . O O

Complement NN B-NP B-Disease
factor NN I-NP I-Disease
2 CD I-NP I-Disease
deficiency NN I-NP I-Disease
: : O O
a DT B-NP O
clinical JJ I-NP O
and CC I-NP O
serological JJ I-NP O
family NN I-NP O
study NN I-NP O
. . O O

Inherited VBN B-NP B-Disease
complement NN I-NP I-Disease
deficiencies NNS I-NP I-Disease
are VBP B-VP O
associated VBN I-VP O
with IN B-PP O
a DT B-NP O
variety NN I-NP O
of IN B-PP O
connective JJ B-NP O
tissue NN I-NP O
diseases NNS I-NP O
. . O O

A DT B-NP O
family NN I-NP O
with IN B-PP O
inherited VBN B-NP B-Disease
deficiency NN I-NP I-Disease
of IN B-PP I-Disease
complement NN B-NP I-Disease
factor NN I-NP I-Disease
2 CD I-NP I-Disease
( ( O O
C2 NN B-NP O
) ) O O
is VBZ B-VP O
described VBN I-VP O
in IN B-PP O
which WDT B-NP O
two CD B-NP O
family NN I-NP O
members NNS I-NP O
with IN B-PP O
homozygous JJ B-NP O
C2 NN I-NP B-Disease
deficiency NN I-NP I-Disease
developed VBD B-VP O
cutaneous JJ B-NP B-Disease
vasculitis NN I-NP I-Disease
and CC I-NP O
sicca NN I-NP B-Disease
syndrome NN I-NP I-Disease
. . O O

The DT B-NP O
other JJ I-NP O
family NN I-NP O
members NNS I-NP O
had VBD B-VP O
heterozygous JJ B-NP O
C2 NN I-NP B-Disease
deficiency NN I-NP I-Disease
and CC O O
each DT B-NP O
member NN I-NP O
had VBD B-VP O
the DT B-NP O
HLA NN I-NP O
- HYPH O O
A25 NN B-NP O
, , O O
B18 NN B-NP O
, , O O
DR2 NN B-NP O
( ( O O
w15 NN B-NP O
) ) O O
haplotype NN B-NP O
. . O O

The DT B-NP O
mother NN I-NP O
had VBD B-VP O
seropositive JJ B-NP B-Disease
rheumatoid JJ I-NP I-Disease
arthritis NN I-NP I-Disease
. . O O

Further JJ B-NP O
studies NNS I-NP O
showed VBD B-VP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
cryoglobulins NNS B-NP O
, , O O
antibodies NNS B-NP O
against IN B-PP O
endothelial JJ B-NP O
cells NNS I-NP O
, , O O
and CC O O
anticardiolipin NN B-NP O
antibodies NNS I-NP O
. . O O

. . O O

New JJ B-NP O
variant NN I-NP O
in IN B-PP O
exon NN B-NP O
3 CD I-NP O
of IN B-PP O
the DT B-NP O
proteolipid NN I-NP O
protein NN I-NP O
( ( O O
PLP NN B-NP O
) ) O O
gene NN B-NP O
in IN B-PP O
a DT B-NP O
family NN I-NP O
with IN B-PP O
Pelizaeus NNP B-NP B-Disease
- HYPH B-NP I-Disease
Merzbacher NNP I-NP I-Disease
disease NN I-NP I-Disease
. . O O

A DT B-NP O
C NN I-NP O
- HYPH B-VP O
- HYPH I-VP O
greater JJR B-ADJP O
than IN B-PP O
G NN B-NP O
transversion NN I-NP O
has VBZ B-VP O
been VBN I-VP O
found VBN I-VP O
in IN B-PP O
exon NN B-NP O
3 CD I-NP O
of IN B-PP O
the DT B-NP O
PLP NN I-NP O
gene NN I-NP O
of IN B-PP O
affected VBN B-NP O
males NNS I-NP O
and CC O O
their PRP$ B-NP O
mother NN I-NP O
in IN B-PP O
a DT B-NP O
single JJ I-NP O
sibship NN I-NP O
with IN B-PP O
Pelizaeus NN B-NP B-Disease
- HYPH O I-Disease
merzbacher NN B-NP I-Disease
disease NN I-NP I-Disease
( ( O O
PMD NN B-NP B-Disease
) ) O O
. . O O

The DT B-NP O
transversion NN I-NP O
should MD B-VP O
not RB I-VP O
result VB I-VP O
in IN B-PP O
an DT B-NP O
amino JJ I-NP O
acid NN I-NP O
change NN I-NP O
in IN B-PP O
the DT B-NP O
protein NN I-NP O
but CC O O
it PRP B-NP O
does VBZ B-VP O
result VB I-VP O
in IN B-PP O
the DT B-NP O
loss NN I-NP O
of IN B-PP O
a DT B-NP O
HaeIII NN I-NP O
restriction NN I-NP O
endonuclease NN I-NP O
cleavage NN I-NP O
site NN I-NP O
. . O O

It PRP B-NP O
is VBZ B-VP O
concordant JJ B-ADJP O
with IN B-PP O
the DT B-NP O
disease NN I-NP O
in IN B-PP O
this DT B-NP O
family NN I-NP O
. . O O

One CD B-NP O
- HYPH I-NP O
hundred CD I-NP O
- HYPH I-NP O
ten CD I-NP O
unrelated JJ I-NP O
X NN I-NP O
chromosomes NNS I-NP O
are VBP B-VP O
negative JJ B-ADJP O
for IN B-PP O
this DT B-NP O
mutation NN I-NP O
. . O O

No DT B-NP O
other JJ I-NP O
sequence NN I-NP O
defect NN I-NP O
was VBD B-VP O
found VBN I-VP O
in IN B-PP O
the DT B-NP O
PLP NN I-NP O
exons NNS I-NP O
of IN B-PP O
the DT B-NP O
affected VBN I-NP O
males NNS I-NP O
. . O O

The DT B-NP O
cause NN I-NP O
of IN B-PP O
disease NN B-NP O
in IN B-PP O
this DT B-NP O
family NN I-NP O
remains VBZ B-VP O
unknown JJ B-ADJP O
, , O O
but CC O O
the DT B-NP O
association NN I-NP O
between IN B-PP O
this DT B-NP O
rare JJ I-NP O
mutation NN I-NP O
and CC I-NP O
PMD NN I-NP B-Disease
is VBZ B-VP O
intriguing VBG I-VP O
. . O O

The DT B-NP O
mutation NN I-NP O
can MD B-VP O
serve VB I-VP O
as IN B-PP O
a DT B-NP O
marker NN I-NP O
for IN B-PP O
following VBG B-VP O
segregation NN B-NP O
of IN B-PP O
the DT B-NP O
PLP NN I-NP O
gene NN I-NP O
. . O O

. . O O

Uncoupling NN B-NP O
of IN B-PP O
hypomyelination NN B-NP B-Disease
and CC O O
glial JJ B-NP B-Disease
cell NN I-NP I-Disease
death NN I-NP I-Disease
by IN B-PP O
a DT B-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
proteolipid NN I-NP O
protein NN I-NP O
gene NN I-NP O
. . O O

Proteolipid NN B-NP O
protein NN I-NP O
( ( O O
PLP NN B-NP O
; : O O
M NN B-NP O
( ( O O
r NN B-NP O
) ) O O
30 CD B-NP O
, , I-NP O
000 CD I-NP O
) ) O O
is VBZ B-VP O
a DT B-NP O
highly RB I-NP O
conserved VBN I-NP O
major JJ I-NP O
polytopic JJ I-NP O
membrane NN I-NP O
protein NN I-NP O
in IN B-PP O
myelin NN B-NP O
but CC O O
its PRP$ B-NP O
cellular JJ I-NP O
function NN I-NP O
remains VBZ B-VP O
obscure JJ B-ADJP O
. . O O

Neurological JJ B-NP O
mutant JJ I-NP O
mice NNS I-NP O
can MD B-VP O
often RB I-VP O
provide VB I-VP O
model NN B-NP O
systems NNS I-NP O
for IN B-PP O
human JJ B-NP O
genetic JJ I-NP B-Disease
disorders NNS I-NP I-Disease
. . O O

Mutations NNS B-NP O
of IN B-PP O
the DT B-NP O
X NN I-NP O
- HYPH B-NP O
chromosome NN I-NP O
- HYPH O O
linked VBN B-NP O
PLP NN I-NP O
gene NN I-NP O
are VBP B-VP O
lethal JJ B-ADJP O
, , O O
identified VBN B-VP O
first RB B-ADVP O
in IN B-PP O
the DT B-NP O
jimpy JJ I-NP O
mouse NN I-NP O
and CC O O
subsequently RB B-ADVP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
Pelizaeus NNP B-NP B-Disease
- HYPH B-NP I-Disease
Merzbacher NNP I-NP I-Disease
disease NN I-NP I-Disease
. . O O

The DT B-NP O
unexplained JJ I-NP O
phenotype NN I-NP O
of IN B-PP O
these DT B-NP O
mutations NNS I-NP O
includes VBZ B-VP O
degeneration NN B-NP B-Disease
and CC I-NP I-Disease
premature JJ I-NP I-Disease
cell NN I-NP I-Disease
death NN I-NP I-Disease
of IN B-PP I-Disease
oligodendrocytes NNS B-NP I-Disease
with IN B-PP O
associated VBN B-NP O
hypomyelination NN I-NP B-Disease
. . O O

Here RB B-ADVP O
we PRP B-NP O
show VBP B-VP O
that IN B-SBAR O
a DT B-NP O
new JJ I-NP O
mouse NN I-NP O
mutant JJ I-NP O
rumpshaker NN I-NP O
is VBZ B-VP O
defined VBN I-VP O
by IN B-PP O
the DT B-NP O
amino JJ I-NP O
- HYPH I-NP O
acid NN I-NP O
substitution NN I-NP O
Ile NN I-NP O
- HYPH B-ADJP O
to TO B-PP O
- HYPH B-NP O
Thr NN I-NP O
at IN B-PP O
residue NN B-NP O
186 CD I-NP O
in IN B-PP O
a DT B-NP O
membrane NN I-NP O
- HYPH O O
embedded VBN B-NP O
domain NN I-NP O
of IN B-PP O
PLP NN B-NP O
. . O O

Surprisingly RB B-ADVP O
, , O O
rumpshaker NN B-NP O
mice NNS I-NP O
, , O O
although IN B-SBAR O
myelin NN B-NP B-Disease
- HYPH B-VP I-Disease
deficient JJ B-ADJP I-Disease
, , O O
have VBP B-VP O
normal JJ B-NP O
longevity NN I-NP O
and CC O O
a DT B-NP O
full JJ I-NP O
complement NN I-NP O
of IN B-PP O
morphologically RB B-NP O
normal JJ I-NP O
oligodendrocytes NNS I-NP O
. . O O

Hypomyelination NN B-NP B-Disease
can MD B-VP O
thus RB I-VP O
be VB I-VP O
genetically RB I-VP O
separated VBN I-VP O
from IN B-PP O
the DT B-NP O
PLP NN I-NP O
- HYPH B-NP O
dependent JJ I-NP O
oligodendrocyte NN I-NP B-Disease
degeneration NN I-NP I-Disease
. . O O

We PRP B-NP O
suggest VBP B-VP O
that IN B-SBAR O
PLP NN B-NP O
has VBZ B-VP O
a DT B-NP O
vital JJ I-NP O
function NN I-NP O
in IN B-PP O
glial JJ B-NP O
cell NN I-NP O
development NN I-NP O
, , O O
distinct JJ B-ADJP O
from IN B-PP O
its PRP$ B-NP O
later JJ I-NP O
role NN I-NP O
in IN B-PP O
myelin NN B-NP O
assembly NN I-NP O
, , O O
and CC O O
that IN B-SBAR O
this DT B-NP O
dichotomy NN I-NP O
of IN B-PP O
action NN B-NP O
may MD B-VP O
explain VB I-VP O
the DT B-NP O
clinical JJ I-NP O
spectrum NN I-NP O
of IN B-PP O
Pelizaeus NNP B-NP B-Disease
- HYPH I-NP I-Disease
Merzbacher NNP I-NP I-Disease
disease NN I-NP I-Disease
. . O O

. . O O

A DT B-NP O
pseudodeficiency NN I-NP O
allele NN I-NP O
common JJ B-ADJP O
in IN B-PP O
non AFX B-NP O
- HYPH I-NP O
Jewish JJ I-NP O
Tay NNP I-NP B-Disease
- HYPH I-NP I-Disease
Sachs NNP I-NP I-Disease
carriers NNS I-NP O
: : O O
implications NNS B-NP O
for IN B-PP O
carrier NN B-NP O
screening NN I-NP O
. . O O

Deficiency NN B-NP B-Disease
of IN B-PP I-Disease
beta SYM B-NP I-Disease
- HYPH O I-Disease
hexosaminidase NN B-NP I-Disease
A NN I-NP I-Disease
( ( O O
Hex NN B-NP O
A NN I-NP O
) ) O O
activity NN B-NP O
typically RB B-ADVP O
results VBZ B-VP O
in IN B-PP O
Tay NNP B-NP B-Disease
- HYPH I-NP I-Disease
Sachs NNP I-NP I-Disease
disease NN I-NP I-Disease
. . O O

However RB B-ADVP O
, , O O
healthy JJ B-NP O
subjects NNS I-NP O
found VBN B-VP O
to TO I-VP O
be VB I-VP O
deficient JJ B-ADJP B-Disease
in IN B-PP I-Disease
Hex NN B-NP I-Disease
A NN I-NP I-Disease
activity NN I-NP O
( ( O O
i NN B-NP O
. . I-NP O

e NN I-NP O
. . O O

, , O O
pseudodeficient JJ B-ADJP O
) ) O O
by IN B-PP O
means NNS B-NP O
of IN B-PP O
in FW B-NP O
vitro FW I-NP O
biochemical JJ I-NP O
tests NNS I-NP O
have VBP B-VP O
been VBN I-VP O
described VBN I-VP O
. . O O

We PRP B-NP O
analyzed VBD B-VP O
the DT B-NP O
HEXA NN I-NP O
gene NN I-NP O
of IN B-PP O
one CD B-NP O
pseudodeficient JJ I-NP O
subject NN I-NP O
and CC O O
identified VBD B-VP O
both CC O O
a DT B-NP O
C739 NN I-NP O
- HYPH B-ADJP O
to TO B-PP O
- HYPH B-NP O
T NN I-NP O
substitution NN I-NP O
that WDT B-NP O
changes VBZ B-VP O
Arg247 NN B-NP O
- SYM O O
- SYM O O
- SYM O O
- HYPH O O
Trp NN B-NP O
on IN B-PP O
one CD B-NP O
allele NN I-NP O
and CC O O
a DT B-NP O
previously RB I-NP O
identified VBN I-NP O
Tay NNP I-NP B-Disease
- HYPH I-NP I-Disease
Sachs NNP I-NP I-Disease
disease NN I-NP I-Disease
mutation NN I-NP O
on IN B-PP O
the DT B-NP O
second JJ I-NP O
allele NN I-NP O
. . O O

Six CD B-NP O
additional JJ I-NP O
pseudodeficient JJ I-NP O
subjects NNS I-NP O
were VBD B-VP O
found VBN I-VP O
to TO I-VP O
have VB I-VP O
the DT B-NP O
C739 NN I-NP O
- HYPH B-ADJP O
to TO B-PP O
- HYPH B-NP O
T NN I-NP O
mutation NN I-NP O
. . O O

This DT B-NP O
allele NN I-NP O
accounted VBD B-VP O
for IN B-PP O
32 CD B-NP O
% NN I-NP O
( ( O O
20 CD B-NP O
/ SYM I-NP O
62 CD I-NP O
) ) O O
of IN B-PP O
non AFX B-NP O
- HYPH I-NP O
Jewish JJ B-NP O
enzyme NN I-NP O
- HYPH O O
defined VBN B-VP O
Tay NNP B-NP B-Disease
- HYPH I-NP I-Disease
Sachs NNP I-NP I-Disease
disease NN I-NP I-Disease
carriers NNS I-NP O
but CC B-PP O
for IN B-PP O
none NN B-NP O
of IN B-PP O
36 CD B-NP O
Jewish JJ I-NP O
enzyme NN I-NP O
- HYPH B-NP O
defined VBN I-NP O
carriers NNS I-NP O
who WP B-NP O
did VBD B-VP O
not RB I-VP O
have VB I-VP O
one CD B-NP O
of IN B-PP O
three CD B-NP O
known VBN I-NP O
mutations NNS I-NP O
common JJ B-ADJP O
to TO B-PP O
this DT B-NP O
group NN I-NP O
. . O O

The DT B-NP O
C739 NN I-NP O
- HYPH B-ADVP O
to TO B-PP O
- HYPH B-NP O
T NN I-NP O
allele NN I-NP O
, , O O
together RB B-ADVP O
with IN B-PP O
a DT B-NP O
true JJ I-NP O
Tay NNP I-NP B-Disease
- HYPH I-NP I-Disease
Sachs NNP I-NP I-Disease
disease NN I-NP I-Disease
allele NN I-NP O
, , O O
causes VBZ B-VP O
Hex NNP B-NP O
A NNP I-NP O
pseudodeficiency NN I-NP O
. . O O

Given VBN B-VP O
both CC O O
the DT B-NP O
large JJ I-NP O
proportion NN I-NP O
of IN B-PP O
non AFX B-NP O
- HYPH I-NP O
Jewish JJ I-NP O
carriers NNS I-NP O
with IN B-PP O
this DT B-NP O
allele NN I-NP O
and CC O O
that IN B-SBAR O
standard JJ B-NP O
biochemical JJ I-NP O
screening NN I-NP O
cannot MD B-VP O
differentiate VB I-VP O
between IN B-PP O
heterozygotes NNS B-NP O
for IN B-PP O
the DT B-NP O
C739 NN I-NP O
- HYPH B-ADJP O
to TO B-PP O
- HYPH B-NP O
T NN I-NP O
mutations NNS I-NP O
and CC O O
Tay NNP B-NP B-Disease
- HYPH I-NP I-Disease
Sachs NNP I-NP I-Disease
disease NN I-NP I-Disease
carriers NNS I-NP O
, , O O
DNA NN B-NP O
testing NN I-NP O
for IN B-PP O
this DT B-NP O
mutation NN I-NP O
in IN B-PP O
at IN B-PP O
- HYPH B-NP O
risk NN I-NP O
couples NNS I-NP O
is VBZ B-VP O
essential JJ B-ADJP O
. . O O

Pelizaeus NNP B-NP B-Disease
- HYPH I-NP I-Disease
Merzbacher NNP I-NP I-Disease
disease NN I-NP I-Disease
: : O O
detection NN B-NP O
of IN B-PP O
mutations NNS B-NP O
Thr181 CD B-NP O
- HYPH B-NP O
- SYM I-NP O
- SYM I-NP O
- HYPH I-NP O
Pro NN I-NP O
and CC I-NP O
Leu223 NN I-NP O
- SYM B-NP O
- SYM B-NP O
- SYM O O
- HYPH O O
Pro NN B-NP O
in IN B-PP O
the DT B-NP O
proteolipid NN I-NP O
protein NN I-NP O
gene NN I-NP O
, , O O
and CC O O
prenatal JJ B-NP O
diagnosis NN I-NP O
. . O O

A DT B-NP O
family NN I-NP O
with IN B-PP O
an DT B-NP O
apparent JJ I-NP O
history NN I-NP O
of IN B-PP O
X NN B-NP O
- HYPH O O
linked VBN B-VP O
Pelizaeus NNP B-NP B-Disease
- HYPH I-NP I-Disease
Merzbacher NNP I-NP I-Disease
disease NN I-NP I-Disease
presented VBN B-VP O
for IN B-PP O
genetic JJ B-NP O
counseling NN I-NP O
, , O O
requesting VBG B-VP O
carrier NN B-NP O
detection NN I-NP O
and CC O O
prenatal JJ B-NP O
diagnosis NN I-NP O
. . O O

RFLP NN B-NP O
analysis NN I-NP O
using VBG B-VP O
the DT B-NP O
proteolipid NN I-NP O
protein NN I-NP O
( ( O O
PLP NN B-NP O
) ) O O
gene NN B-NP O
probe NN I-NP O
was VBD B-VP O
uninformative JJ B-ADJP O
in IN B-PP O
this DT B-NP O
family NN I-NP O
. . O O

A DT B-NP O
prenatal JJ I-NP O
diagnosis NN I-NP O
on IN B-PP O
a DT B-NP O
chorionic JJ I-NP O
villus NN I-NP O
sample NN I-NP O
( ( O O
CVS NN B-NP O
) ) O O
was VBD B-VP O
carried VBN I-VP O
out RP B-PRT O
using VBG B-VP O
single JJ B-NP O
- HYPH I-NP O
strand NN I-NP O
conformation NN I-NP O
polymorphism NN I-NP O
( ( O O
SSCP NN B-NP O
) ) O O
analysis NN B-NP O
of IN B-PP O
a DT B-NP O
variant NN I-NP O
in IN B-PP O
exon NN B-NP O
4 CD I-NP O
of IN B-PP O
the DT B-NP O
PLP NN I-NP O
gene NN I-NP O
. . O O

The DT B-NP O
fetus NN I-NP O
was VBD B-VP O
predicted VBN I-VP O
to TO I-VP O
be VB I-VP O
unaffected JJ B-ADJP O
. . O O

Sequencing NN B-NP O
of IN B-PP O
the DT B-NP O
exon NN I-NP O
from IN B-PP O
the DT B-NP O
CVS NN I-NP O
, , O O
the DT B-NP O
predicted VBN I-NP O
- HYPH I-NP O
carrier NN I-NP O
mother NN I-NP O
, , O O
and CC O O
the DT B-NP O
obligate JJ I-NP O
- HYPH I-NP O
carrier NN I-NP O
grandmother NN I-NP O
revealed VBD B-VP O
an DT B-NP O
A NN I-NP O
- HYPH B-ADJP O
to TO B-PP O
- HYPH B-NP O
C NN I-NP O
change NN I-NP O
at IN B-PP O
nucleotide NN B-NP O
541 CD I-NP O
in IN B-PP O
the DT B-NP O
two CD I-NP O
women NNS I-NP O
but CC B-PP O
not RB B-PP O
in IN I-PP O
the DT B-NP O
fetus NN I-NP O
. . O O

As IN B-SBAR O
this DT B-NP O
change NN I-NP O
results VBZ B-VP O
in IN B-PP O
a DT B-NP O
Thr NN I-NP O
- HYPH B-ADJP O
to TO B-PP O
- HYPH B-NP O
Pro NN I-NP O
change NN I-NP O
at IN B-PP O
amino NN B-NP O
acid NN I-NP O
181 CD I-NP O
in IN B-PP O
a DT B-NP O
region NN I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
predicted VBN B-VP O
to TO I-VP O
be VB I-VP O
part NN B-NP O
of IN B-PP O
a DT B-NP O
transmembrane JJ I-NP O
segment NN I-NP O
, , O O
it PRP B-NP O
was VBD B-VP O
concluded VBN I-VP O
that IN B-SBAR O
this DT B-NP O
was VBD B-VP O
the DT B-NP O
mutation NN I-NP O
causing VBG B-VP O
the DT B-NP O
disease NN I-NP O
in IN B-PP O
this DT B-NP O
family NN I-NP O
. . O O

In IN B-PP O
addition NN B-NP O
, , O O
in IN B-PP O
a DT B-NP O
second JJ I-NP O
family NN I-NP O
, , O O
an DT B-NP O
exon NN I-NP O
5 CD I-NP O
variant JJ I-NP O
band NN I-NP O
pattern NN I-NP O
on IN B-PP O
SSCP NN B-NP O
analysis NN I-NP O
was VBD B-VP O
shown VBN I-VP O
by IN B-PP O
sequencing VBG B-VP O
to TO I-VP O
be VB I-VP O
due IN B-PP O
to TO B-PP O
a DT B-NP O
T NN I-NP O
- HYPH B-ADJP O
to TO B-PP O
- HYPH B-NP O
C NN I-NP O
change NN I-NP O
at IN B-PP O
nucleotide NN B-NP O
668 CD I-NP O
. . O O

This DT B-NP O
results VBZ B-VP O
in IN B-PP O
a DT B-NP O
Leu NN I-NP O
- HYPH B-ADJP O
to TO B-PP O
- HYPH B-NP O
Pro NN I-NP O
change NN I-NP O
in IN B-PP O
a DT B-NP O
carrier NN I-NP O
mother NN I-NP O
and CC B-PP O
in IN B-PP O
her PRP$ B-NP O
two CD I-NP O
affected VBN I-NP O
sons NNS I-NP O
. . O O

These DT B-NP O
results NNS I-NP O
provide VBP B-VP O
further JJ B-NP O
examples NNS I-NP O
of IN B-PP O
mutations NNS B-NP O
in IN B-PP O
PLP NN B-NP O
that WDT B-NP O
cause VBP B-VP O
Pelizaeus NNP B-NP B-Disease
- HYPH I-NP I-Disease
Merzbacher NNP I-NP I-Disease
disease NN I-NP I-Disease
and CC O O
illustrate VB B-VP O
the DT B-NP O
value NN I-NP O
of IN B-PP O
SSCP NN B-NP O
in IN B-PP O
genetic JJ B-NP O
analysis NN I-NP O
. . O O

. . O O

von NN B-NP B-Disease
Willebrand NN I-NP I-Disease
disease NN I-NP I-Disease
type NN I-NP I-Disease
B NN I-NP I-Disease
: : O O
a DT B-NP O
missense JJ I-NP O
mutation NN I-NP O
selectively RB B-ADVP O
abolishes VBZ B-VP O
ristocetin NN B-NP O
- HYPH B-NP O
induced VBN I-NP O
von NN I-NP B-Disease
Willebrand NN I-NP I-Disease
factor NN I-NP O
binding VBG B-VP O
to TO I-VP O
platelet VB I-VP O
glycoprotein NN B-NP O
Ib NN I-NP O
. . O O

von NN B-NP B-Disease
Willebrand NN I-NP I-Disease
factor NN I-NP O
( ( O O
vWF NN B-NP O
) ) O O
is VBZ B-VP O
a DT B-NP O
multimeric JJ I-NP O
glycoprotein NN I-NP O
that WDT B-NP O
mediates VBZ B-VP O
the DT B-NP O
adhesion NN I-NP O
of IN B-PP O
platelets NNS B-NP O
to TO B-PP O
the DT B-NP O
subendothelium NN I-NP O
by IN B-PP O
binding VBG B-VP O
to TO I-VP O
platelet VB I-VP O
glycoprotein NN B-NP O
Ib NN I-NP O
. . O O

For IN B-PP O
human JJ B-NP O
vWF NN I-NP O
, , O O
this DT B-NP O
interaction NN I-NP O
can MD B-VP O
be VB I-VP O
induced VBN I-VP O
in FW B-ADVP O
vitro FW I-ADVP O
by IN B-PP O
the DT B-NP O
antibiotic JJ I-NP O
ristocetin NN I-NP O
or CC O O
the DT B-NP O
snake NN I-NP O
venom NN I-NP O
protein NN I-NP O
botrocetin NN I-NP O
. . O O

A DT B-NP O
missense JJ I-NP O
mutation NN I-NP O
, , O O
Gly NN B-NP O
- HYPH B-NP O
561 CD I-NP O
- HYPH B-NP O
- HYPH I-NP O
> SYM I-NP O
Ser NN I-NP O
, , O O
was VBD B-VP O
identified VBN I-VP O
within IN B-PP O
the DT B-NP O
proposed VBN I-NP O
glycoprotein NN I-NP O
Ib NN I-NP O
binding NN I-NP O
domain NN I-NP O
of IN B-PP O
vWF NN B-NP O
in IN B-PP O
the DT B-NP O
proband NN I-NP O
with IN B-PP O
von NN B-NP B-Disease
Willebrand NN I-NP I-Disease
disease NN I-NP I-Disease
type NN I-NP I-Disease
B NN I-NP I-Disease
, , O O
a DT B-NP O
unique JJ I-NP O
variant NN I-NP O
characterized VBN B-VP O
by IN B-PP O
no DT B-NP O
ristocetin NN I-NP O
- HYPH O O
induced VBN B-VP O
, , O O
but CC O O
normal JJ B-NP O
botrocetin NN I-NP O
- HYPH O O
induced VBN B-VP O
, , O O
binding VBG B-VP O
to TO B-PP O
glycoprotein NN B-NP O
Ib NN I-NP O
. . O O

The DT B-NP O
corresponding VBG I-NP O
mutant JJ I-NP O
recombinant JJ I-NP O
protein NN I-NP O
, , O O
rvWF NN B-NP O
( ( O O
G561S NN B-NP O
) ) O O
, , O O
formed VBD B-VP O
normal JJ B-NP O
multimers NNS I-NP O
and CC O O
exhibited VBD B-VP O
the DT B-NP O
same JJ I-NP O
functional JJ I-NP O
defect NN I-NP O
as IN B-PP O
the DT B-NP O
patients NNS I-NP O
plasma NN I-NP O
vWF NN I-NP O
, , O O
confirming VBG B-VP O
that IN B-SBAR O
this DT B-NP O
mutation NN I-NP O
causes VBZ B-VP O
von NN B-NP B-Disease
Willebrand NN I-NP I-Disease
disease NN I-NP I-Disease
type NN I-NP I-Disease
B NN I-NP I-Disease
. . O O

These DT B-NP O
data NNS I-NP O
show VBP B-VP O
that IN B-SBAR O
botrocetin NN B-NP O
and CC I-NP O
ristocetin NN I-NP O
cofactor NN I-NP O
activities NNS I-NP O
of IN B-PP O
vWF NN B-NP O
can MD B-VP O
be VB I-VP O
dissociated VBN I-VP O
by IN B-PP O
a DT B-NP O
point NN I-NP O
mutation NN I-NP O
and CC O O
confirm VBP B-VP O
that IN B-SBAR O
these DT B-NP O
mediators NNS I-NP O
promote VBP B-VP O
vWF NN B-NP O
binding VBG B-VP O
to TO B-PP O
platelets NNS B-NP O
by IN B-PP O
different JJ B-NP O
mechanisms NNS I-NP O
. . O O

The DT B-NP O
normal JJ I-NP O
botrocetin NN I-NP O
- HYPH B-VP O
induced VBN B-NP O
binding NN I-NP O
and CC O O
the DT B-NP O
defective JJ I-NP O
ristocetin NN I-NP O
- HYPH B-NP O
induced VBN I-NP O
binding NN I-NP O
of IN B-PP O
rvWF NN B-NP O
( ( O O
G561S NN B-NP O
) ) O O
suggest VBP B-VP O
that IN B-SBAR O
the DT B-NP O
primary JJ I-NP O
defect NN I-NP O
in IN B-PP O
von NN B-NP B-Disease
Willebrand NN I-NP I-Disease
disease NN I-NP I-Disease
type NN I-NP I-Disease
B NN I-NP I-Disease
may MD B-VP O
be VB I-VP O
a DT B-NP O
failure NN I-NP O
of IN B-PP O
normal JJ B-NP O
allosteric JJ I-NP O
regulation NN I-NP O
of IN B-PP O
the DT B-NP O
glycoprotein NN I-NP O
Ib NN I-NP O
binding NN I-NP O
function NN I-NP O
of IN B-PP O
vWF NN B-NP O
. . O O

. . O O

Typical JJ B-NP O
and CC I-NP O
partial JJ I-NP O
cat NN I-NP B-Disease
eye NN I-NP I-Disease
syndrome NN I-NP I-Disease
: : O O
identification NN B-NP O
of IN B-PP O
the DT B-NP O
marker NN I-NP O
chromosome NN I-NP O
by IN B-PP O
FISH NN B-NP O
. . O O

Three CD B-NP O
children NNS I-NP O
are VBP B-VP O
reported VBN I-VP O
with IN B-PP O
typical JJ B-NP O
cat NN I-NP B-Disease
eye NN I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
CES NN B-NP B-Disease
) ) O O
and CC O O
three CD B-NP O
more JJR I-NP O
children NNS I-NP O
with IN B-PP O
partial JJ B-NP O
CES NNS I-NP B-Disease
because IN B-PP O
of IN I-PP O
absence NN B-NP O
of IN B-PP O
coloboma NN B-NP O
, , O O
in IN B-PP O
which WDT B-NP O
the DT B-NP O
supernumerary JJ I-NP O
marker NN I-NP O
chromosome NN I-NP O
was VBD B-VP O
studied VBN I-VP O
by IN B-PP O
FISH NN B-NP O
. . O O

Using VBG B-VP O
a DT B-NP O
genomic JJ I-NP O
library NN I-NP O
, , O O
and CC O O
also RB B-ADVP O
a DT B-NP O
centromeric JJ I-NP O
and CC I-NP O
particularly RB I-NP O
a DT B-NP O
cosmid NN I-NP O
probe NN I-NP O
of IN B-PP O
22q11 CD B-NP O
, , O O
partial JJ B-NP O
tetrasomy NN I-NP B-Disease
was VBD B-VP O
shown VBN I-VP O
in IN B-PP O
all DT B-NP O
cases NNS I-NP O
. . O O

. . O O

[ ( O O
Genetic JJ B-NP O
heterogeneity NN I-NP O
of IN B-PP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
: : O O
mutant JJ B-NP O
alleles NNS I-NP O
of IN B-PP O
G6PD NN B-NP O
in IN B-PP O
the DT B-NP O
Shekii NNP I-NP O
district NN I-NP O
of IN B-PP O
Azerbaijan NNP B-NP O
] ) O O
Examination NN B-NP O
on IN B-PP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
349 CD B-NP O
patients NNS I-NP O
of IN B-PP O
Shekii NNP B-NP O
district NN I-NP O
hospital NN I-NP O
( ( O O
Azerbaijan NN B-NP O
) ) O O
revealed VBD B-VP O
16 CD B-NP O
hemi NN I-NP O
- HYPH B-ADVP O
, , O O
4 CD B-NP O
homo NN I-NP O
- HYPH B-ADJP O
and CC O O
9 CD B-NP O
heterozygotic JJ I-NP O
carriers NNS I-NP O
of IN B-PP O
the DT B-NP O
defect NN I-NP O
. . O O

Gd NN B-NP O
- HYPH I-NP O
frequency NN I-NP O
, , O O
calculated VBN B-VP O
from IN B-PP O
the DT B-NP O
data NNS I-NP O
obtained VBN B-VP O
( ( O O
7 CD B-NP O
. . O O

7 CD B-NP O
% NN I-NP O
) ) O O
, , O O
may MD B-VP O
be VB I-VP O
compared VBN I-VP O
to TO B-PP O
neighbouring VBG B-VP O
regions NNS B-NP O
frequencies NNS I-NP O
( ( O O
6 CD B-NP O
- HYPH I-NP O
30 CD I-NP O
% NN I-NP O
) ) O O
. . O O

Carriers NNS B-NP O
of IN B-PP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
are VBP B-VP O
residents NNS B-NP O
of IN B-PP O
11 CD B-NP O
villages NNS I-NP O
located VBN B-VP O
in IN B-PP O
Alasani NNP B-NP O
- HYPH B-NP O
Aphtalan NNP I-NP O
valley NN I-NP O
, , O O
highly RB B-ADJP O
endemic JJ I-ADJP O
with IN B-PP O
malaria NN B-NP B-Disease
in IN B-PP O
the DT B-NP O
past NN I-NP O
; : O O
nearly RB B-NP O
all DT I-NP O
marriages NNS I-NP O
are VBP B-VP O
endogamic JJ B-ADJP O
. . O O

Physico NNP B-NP O
- HYPH B-NP O
chemical JJ I-NP O
and CC I-NP O
kinetic JJ I-NP O
study NN I-NP O
of IN B-PP O
10 CD B-NP O
mutant JJ I-NP O
forms NNS I-NP O
of IN B-PP O
G6PD NN B-NP O
, , O O
according VBG B-PP O
to TO B-PP O
WHO WP B-NP O
program NN I-NP O
, , O O
led VBD B-VP O
to TO B-PP O
identification NN B-NP O
of IN B-PP O
5 CD B-NP O
variants NNS I-NP O
of IN B-PP O
the DT B-NP O
II CD I-NP O
class NN I-NP O
( ( O O
Shekii NNP B-NP O
, , O O
Bideiz NNP B-NP O
, , O O
Shirin NNP B-NP O
- HYPH I-NP O
Bulakh NNP I-NP O
, , O O
Okhut NNP B-NP O
I NNP I-NP O
and CC O O
Zakataly NNP B-NP O
) ) O O
and CC O O
2 CD B-NP O
variants NNS I-NP O
of IN B-PP O
the DT B-NP O
III CD I-NP O
class NN I-NP O
( ( O O
Okhut NN B-NP O
II CD I-NP O
and CC O O
Martinique JJ B-NP O
- HYPH I-NP O
like JJ I-NP O
) ) O O
. . O O

Resemblance NN B-NP O
of IN B-PP O
the DT B-NP O
majority NN I-NP O
of IN B-PP O
variants NNS B-NP O
in IN B-PP O
electrophoretic JJ B-NP O
mobility NN I-NP O
and CC O O
the DT B-NP O
level NN I-NP O
of IN B-PP O
erythrocyte NN B-NP O
enzyme NN I-NP O
activity NN I-NP O
permit NN I-NP O
to TO B-VP O
suggest VB I-VP O
the DT B-NP O
existence NN I-NP O
of IN B-PP O
a DT B-NP O
common JJ I-NP O
parental JJ I-NP O
mutant JJ I-NP O
G6PD NN I-NP O
allele NN I-NP O
distributed VBN B-VP O
in IN B-PP O
this DT B-NP O
area NN I-NP O
. . O O

Craniofrontonasal JJ B-NP B-Disease
dysplasia NN I-NP I-Disease
. . O O

We PRP B-NP O
report VBP B-VP O
on IN B-PP O
nine CD B-NP O
patients NNS I-NP O
with IN B-PP O
craniofrontonasal JJ B-NP B-Disease
dysplasia NN I-NP I-Disease
( ( O O
CFND NN B-NP B-Disease
) ) O O
. . O O

Seven CD B-NP O
classical JJ I-NP O
cases NNS I-NP O
had VBD B-VP O
facial JJ B-NP O
features NNS I-NP O
suggestive JJ B-ADJP O
of IN B-PP O
frontonasal JJ B-NP B-Disease
dysplasia NN I-NP I-Disease
and CC O O
coronal JJ B-NP B-Disease
craniosynostosis NN I-NP I-Disease
. . O O

Extracranial JJ B-NP B-Disease
abnormalities NNS I-NP I-Disease
such JJ B-PP O
as IN I-PP O
brittle JJ B-NP B-Disease
nails NNS I-NP I-Disease
with IN B-PP I-Disease
prominent JJ B-NP I-Disease
longitudinal JJ I-NP I-Disease
grooves NNS I-NP I-Disease
or CC O O
syndactyly RB B-ADVP B-Disease
of IN B-PP I-Disease
fingers NNS B-NP I-Disease
and CC I-NP I-Disease
toes NNS I-NP I-Disease
were VBD B-VP O
observed VBN I-VP O
in IN B-PP O
individual JJ B-NP O
patients NNS I-NP O
. . O O

In IN B-PP O
two CD B-NP O
families NNS I-NP O
the DT B-NP O
father NN I-NP O
of IN B-PP O
classical JJ B-NP O
cases NNS I-NP O
showed VBD B-VP O
a DT B-NP O
milder JJR I-NP O
pattern NN I-NP O
of IN B-PP O
abnormalities NNS B-NP O
, , O O
consistent JJ B-ADJP O
with IN B-PP O
the DT B-NP O
diagnosis NN I-NP O
. . O O

We PRP B-NP O
present VBP B-VP O
a DT B-NP O
2 CD I-NP O
- HYPH O O
to TO B-PP O
13 CD B-NP O
- HYPH B-NP O
year NN I-NP O
follow VB B-VP O
- HYPH O O
up RP B-PRT O
on IN B-PP O
our PRP$ B-NP O
patients NNS I-NP O
. . O O

Hypotonia NN B-NP B-Disease
and CC I-NP O
laxity NN I-NP B-Disease
of IN B-PP I-Disease
joints NNS B-NP I-Disease
are VBP B-VP O
common JJ B-ADJP O
and CC O O
may MD B-VP O
necessitate VB I-VP O
supportive JJ B-NP O
measures NNS I-NP O
. . O O

Mild JJ B-NP O
developmental JJ I-NP B-Disease
delay NN I-NP I-Disease
was VBD B-VP O
noted VBN I-VP O
in IN B-PP O
three CD B-NP O
out IN I-NP O
of IN I-NP O
six CD I-NP O
classical JJ I-NP O
cases NNS I-NP O
studied VBN B-VP O
in IN B-PP O
detail NN B-NP O
. . O O

Unlike IN B-PP O
almost RB B-NP O
all DT I-NP O
other JJ I-NP O
X NN I-NP B-Disease
- HYPH B-NP I-Disease
linked VBN I-NP I-Disease
disorders NNS I-NP I-Disease
, , O O
clinical JJ B-NP O
expression NN I-NP O
in IN B-PP O
CFND NN B-NP B-Disease
is VBZ B-VP O
generally RB B-ADVP O
much RB B-ADJP O
more RBR I-ADJP O
severe JJ I-ADJP O
in IN B-PP O
females NNS B-NP O
than IN B-PP O
in IN B-PP O
males NNS B-NP O
. . O O

In IN B-PP O
contrast NN B-NP O
to TO B-PP O
previous JJ B-NP O
reports NNS I-NP O
of IN B-PP O
this DT B-NP O
condition NN I-NP O
, , O O
one CD B-NP O
of IN B-PP O
our PRP$ B-NP O
severely RB I-NP O
affected VBN I-NP O
cases NNS I-NP O
is VBZ B-VP O
a DT B-NP O
male NN I-NP O
. . O O

. . O O

The DT B-NP O
intron NN I-NP O
7 CD I-NP O
donor NN I-NP O
splice NN I-NP O
site NN I-NP O
transition NN I-NP O
: : O O
a DT B-NP O
second JJ I-NP O
Tay NNP I-NP B-Disease
- HYPH I-NP I-Disease
Sachs NNP I-NP I-Disease
disease NN I-NP I-Disease
mutation NN I-NP O
in IN B-PP O
French NNP B-NP O
Canada NNP I-NP O
. . O O

Mutations NNS B-NP O
at IN B-PP O
the DT B-NP O
hexosaminidase NN I-NP O
A NN I-NP O
( ( O O
HEXA NN B-NP O
) ) O O
gene NN B-NP O
which WDT B-NP O
cause VBP B-VP O
Tay NNP B-NP B-Disease
- HYPH I-NP I-Disease
Sachs NNP I-NP I-Disease
disease NN I-NP I-Disease
( ( O O
TSD NN B-NP B-Disease
) ) O O
have VBP B-VP O
elevated VBN I-VP O
frequency NN B-NP O
in IN B-PP O
the DT B-NP O
Ashkenazi NNP I-NP O
Jewish NNP I-NP O
and CC O O
French JJ B-NP O
- HYPH I-NP O
Canadian JJ I-NP O
populations NNS I-NP O
. . O O

We PRP B-NP O
report VBP B-VP O
a DT B-NP O
novel JJ I-NP O
TSD NN I-NP B-Disease
allele NN I-NP O
in IN B-PP O
the DT B-NP O
French JJ I-NP O
- HYPH I-NP O
Canadian JJ I-NP O
population NN I-NP O
associated VBN B-VP O
with IN B-PP O
the DT B-NP O
infantile JJ I-NP O
form NN I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
. . O O

The DT B-NP O
mutation NN I-NP O
, , O O
a DT B-NP O
G NN I-NP O
- SYM B-NP O
- HYPH B-NP O
> SYM I-NP O
A NN I-NP O
transition NN I-NP O
at IN B-PP O
the DT B-NP O
+ SYM I-NP O
1 CD I-NP O
position NN I-NP O
of IN B-PP O
intron NN B-NP O
7 CD I-NP O
, , O O
abolishes VBZ B-VP O
the DT B-NP O
donor NN I-NP O
splice NN I-NP O
site NN I-NP O
. . O O

Cultured VBN B-NP O
human JJ I-NP O
fibroblasts NNS I-NP O
from IN B-PP O
a DT B-NP O
compound NN I-NP O
heterozygote NN I-NP O
for IN B-PP O
this DT B-NP O
transition NN I-NP O
( ( O O
and CC O O
for IN B-PP O
a DT B-NP O
deletion NN I-NP O
mutation NN I-NP O
) ) O O
produce VBP B-VP O
no DT B-NP O
detectable JJ I-NP O
HEXA NN I-NP O
mRNA NN I-NP O
. . O O

The DT B-NP O
intron NN I-NP O
7 CD I-NP O
+ SYM I-NP O
1 CD I-NP O
mutation NN I-NP O
occurs VBZ B-VP O
in IN B-PP O
the DT B-NP O
base NN I-NP O
adjacent JJ B-ADJP O
to TO B-PP O
the DT B-NP O
site NN I-NP O
of IN B-PP O
the DT B-NP O
adult JJ I-NP O
- HYPH I-NP O
onset NN I-NP O
TSD NN I-NP B-Disease
mutation NN I-NP O
( ( O O
G805A NN B-NP O
) ) O O
. . O O

In IN B-PP O
both DT B-NP O
mutations NNS I-NP O
a DT B-NP O
restriction NN I-NP O
site NN I-NP O
for IN B-PP O
the DT B-NP O
endonuclease NN I-NP O
EcoRII NN I-NP O
is VBZ B-VP O
abolished VBN I-VP O
. . O O

Unambiguous JJ B-NP O
diagnosis NN I-NP O
, , O O
therefore RB B-ADVP O
, , O O
requires VBZ B-VP O
allele NN B-NP O
- HYPH B-NP O
specific JJ I-NP O
oligonucleotide NN I-NP O
hybridization NN I-NP O
to TO B-VP O
distinguish VB I-VP O
between IN B-PP O
these DT B-NP O
two CD I-NP O
mutant JJ I-NP O
alleles NNS I-NP O
. . O O

The DT B-NP O
intron NN I-NP O
7 CD I-NP O
+ SYM I-NP O
1 CD I-NP O
mutation NN I-NP O
has VBZ B-VP O
been VBN I-VP O
detected VBN I-VP O
in IN B-PP O
three CD B-NP O
unrelated JJ I-NP O
families NNS I-NP O
. . O O

Obligate JJ B-NP O
heterozygotes NNS I-NP O
for IN B-PP O
the DT B-NP O
intron NN I-NP O
7 CD I-NP O
+ SYM B-NP O
1 CD I-NP O
mutation NN I-NP O
were VBD B-VP O
born VBN I-VP O
in IN B-PP O
the DT B-NP O
Saguenay NNP I-NP O
- HYPH I-NP O
Lac NN I-NP O
- HYPH B-NP O
St NN I-NP O
- HYPH I-NP O
Jean JJ I-NP O
region NN I-NP O
of IN B-PP O
Quebec NNP B-NP O
. . O O

The DT B-NP O
most RBS I-NP O
recent JJ I-NP O
ancestors NNS I-NP O
common JJ B-ADJP O
to TO B-VP O
obligate VB I-VP O
carriers NNS B-NP O
of IN B-PP O
this DT B-NP O
mutation NN I-NP O
were VBD B-VP O
from IN B-PP O
the DT B-NP O
Charlevoix NNP I-NP O
region NN I-NP O
of IN B-PP O
the DT B-NP O
province NN I-NP O
of IN B-PP O
Quebec NNP B-NP O
. . O O

This DT B-NP O
mutation NN I-NP O
thus RB B-ADVP O
has VBZ B-VP O
a DT B-NP O
different JJ I-NP O
geographic JJ I-NP O
centre NN I-NP O
of IN B-PP O
diffusion NN B-NP O
and CC O O
is VBZ B-VP O
probably RB B-ADJP O
less RBR I-ADJP O
common JJ I-ADJP O
than IN B-PP O
the DT B-NP O
exon NN I-NP O
1 CD I-NP O
deletion NN I-NP O
TSD NN I-NP B-Disease
mutation NN I-NP O
in IN B-PP O
French JJ B-NP O
Canadians NNS I-NP O
. . O O

Neither DT B-NP O
mutation NN I-NP O
has VBZ B-VP O
been VBN I-VP O
detected VBN I-VP O
in IN B-PP O
France NNP B-NP O
, , O O
the DT B-NP O
ancestral JJ I-NP O
homeland NN I-NP O
of IN B-PP O
French NNP B-NP O
Canada NNP I-NP O
. . O O

. . O O

Assignment NN B-NP O
of IN B-PP O
the DT B-NP O
aspartylglucosaminidase NN I-NP O
gene NN I-NP O
( ( O O
AGA NN B-NP O
) ) O O
to TO B-PP O
4q33 CD B-NP O
- HYPH O O
- SYM O O
- SYM O O
- HYPH O O
q35 NN B-NP O
based VBN B-PP O
on IN B-PP O
decreased VBN B-NP O
activity NN I-NP O
in IN B-PP O
a DT B-NP O
girl NN I-NP O
with IN B-PP O
a DT B-NP O
46 CD I-NP O
, , O O
XX NN B-NP O
, , O O
del NN B-NP O
( ( O O
4 CD B-NP O
) ) O O
( ( O O
q33 NN B-NP O
) ) O O
karyotype NN B-NP O
. . O O

Aspartylglucosaminuria NN B-NP B-Disease
( ( O O
AGU NN B-NP B-Disease
) ) O O
is VBZ B-VP O
a DT B-NP O
recessive JJ I-NP O
autosomally RB I-NP O
inherited VBN I-NP O
lysosomal JJ I-NP B-Disease
storage NN I-NP I-Disease
disorder NN I-NP I-Disease
due IN B-PP O
to TO I-PP O
deficiency NN B-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
enzyme NN I-NP I-Disease
aspartylglucosaminidase NN I-NP I-Disease
( ( O O
AGA NN B-NP O
) ) O O
. . O O

The DT B-NP O
structural JJ I-NP O
gene NN I-NP O
for IN B-PP O
this DT B-NP O
human JJ I-NP O
enzyme NN I-NP O
( ( O O
AGA NN B-NP O
) ) O O
has VBZ B-VP O
been VBN I-VP O
assigned VBN I-VP O
to TO B-PP O
the DT B-NP O
region NN I-NP O
4q21 CD I-NP O
- HYPH O O
- SYM O O
- SYM O O
- HYPH O O
qter NN B-NP O
. . O O

We PRP B-NP O
determined VBD B-VP O
the DT B-NP O
AGA NN I-NP O
activity NN I-NP O
in IN B-PP O
cultured VBN B-NP O
fibroblasts NNS I-NP O
of IN B-PP O
a DT B-NP O
girl NN I-NP O
with IN B-PP O
a DT B-NP O
46 CD I-NP O
, , O O
XX NN B-NP O
, , O O
del NN B-NP O
( ( O O
4 CD B-NP O
) ) O O
( ( O O
q33 NN B-NP O
) ) O O
karyotype NN B-NP O
. . O O

The DT B-NP O
results NNS I-NP O
indicate VBP B-VP O
that IN B-SBAR O
the DT B-NP O
girl NN I-NP O
is VBZ B-VP O
a DT B-NP O
hemizygote NN I-NP O
for IN B-PP O
AGA NN B-NP O
, , O O
permitting VBG B-VP O
the DT B-NP O
assignment NN I-NP O
of IN B-PP O
human JJ B-NP O
AGA NN I-NP O
to TO B-PP O
the DT B-NP O
region NN I-NP O
4q33 CD I-NP O
- HYPH O O
- SYM O O
- SYM O O
- HYPH O O
qter NN B-NP O
. . O O

. . O O

Resolution NN B-NP O
of IN B-PP O
the DT B-NP O
two CD I-NP O
loci NNS I-NP O
for IN B-PP O
autosomal JJ B-NP O
dominant JJ I-NP O
aniridia NN I-NP B-Disease
, , I-NP O
AN1 NN I-NP O
and CC I-NP O
AN2 NN I-NP O
, , O O
to TO B-PP O
a DT B-NP O
single JJ I-NP O
locus NN I-NP O
on IN B-PP O
chromosome NN B-NP O
11p13 NN I-NP O
. . O O

Two CD B-NP O
distinct JJ I-NP O
loci NNS I-NP O
have VBP B-VP O
been VBN I-VP O
proposed VBN I-VP O
for IN B-PP O
aniridia NN B-NP B-Disease
; : O O
AN1 NN B-NP O
for IN B-PP O
autosomal JJ B-NP O
dominant JJ I-NP O
aniridia NN I-NP B-Disease
on IN B-PP O
chromosome NN B-NP O
2p NN I-NP O
and CC I-NP O
AN2 NN I-NP O
for IN B-PP O
the DT B-NP O
aniridia NN I-NP B-Disease
in IN B-PP O
the DT B-NP O
WAGR NN I-NP B-Disease
contiguous JJ I-NP I-Disease
gene NN I-NP I-Disease
syndrome NN I-NP I-Disease
on IN B-PP O
chromosome NN B-NP O
11p13 NN I-NP O
. . O O

In IN B-PP O
this DT B-NP O
report NN I-NP O
, , O O
the DT B-NP O
kindred NN I-NP O
segregating VBG B-VP O
for IN B-PP O
autosomal JJ B-NP O
dominant JJ I-NP O
aniridia NN I-NP B-Disease
, , O O
which WDT B-NP O
suggested VBD B-VP O
linkage NN B-NP O
to TO B-PP O
acid NN B-NP O
phosphatase NN I-NP O
- HYPH B-NP O
1 CD I-NP O
( ( O O
ACP1 NN B-NP O
) ) O O
and CC O O
led VBD B-VP O
to TO B-PP O
the DT B-NP O
assignment NN I-NP O
of IN B-PP O
the DT B-NP O
AN1 NN I-NP O
locus NN I-NP O
on IN B-PP O
chromosome NN B-NP O
2p NN I-NP O
, , O O
has VBZ B-VP O
been VBN I-VP O
updated VBN I-VP O
and CC I-VP O
expanded VBN I-VP O
. . O O

Linkage NN B-NP O
analysis NN I-NP O
between IN B-PP O
the DT B-NP O
aniridia NN I-NP B-Disease
phenotype NN I-NP O
and CC O O
ACP1 NN B-NP O
does VBZ B-VP O
not RB I-VP O
support VB I-VP O
the DT B-NP O
original JJ I-NP O
linkage NN I-NP O
results NNS I-NP O
, , O O
excluding VBG B-PP O
linkage NN B-NP O
up IN B-PP O
to TO B-PP O
theta NN B-NP O
= SYM B-VP O
0 CD B-NP O
. . O O

17 CD B-NP O
with IN B-PP O
Z NN B-NP O
= SYM B-VP O
- SYM B-NP O
2 CD I-NP O
. . O O

Tests NNS B-NP O
for IN B-PP O
linkage NN B-NP O
to TO B-PP O
other JJ B-NP O
chromosome NN I-NP O
2p NN I-NP O
markers NNS I-NP O
. . O O

APOB NN B-NP O
, , O O
D2S71 NN B-NP O
, , O O
D2S5 NN B-NP O
, , O O
and CC O O
D2S1 NN B-NP O
, , O O
also RB B-ADVP O
excluded VBD B-VP O
linkage NN B-NP O
to TO B-PP O
aniridia NN B-NP B-Disease
. . O O

Markers NNS B-NP O
that WDT B-NP O
have VBP B-VP O
been VBN I-VP O
isolated VBN I-VP O
from IN B-PP O
the DT B-NP O
chromosome NN I-NP O
11p13 NN I-NP O
region NN I-NP O
were VBD B-VP O
then RB I-VP O
analyzed VBN I-VP O
in IN B-PP O
this DT B-NP O
aniridia NN I-NP B-Disease
family NN I-NP O
. . O O

Two CD B-NP O
RFLPs NNS I-NP O
at IN B-PP O
the DT B-NP O
D11S323 NN I-NP O
locus NN I-NP O
give VBP B-VP O
significant JJ B-NP O
evidence NN I-NP O
for IN B-PP O
linkage NN B-NP O
. . O O

The DT B-NP O
PvuII NN I-NP O
polymorphism NN I-NP O
detected VBN B-VP O
by IN B-PP O
probe NN B-NP O
p5S1 NN I-NP O
. . O O

6 CD B-NP O
detects NNS I-NP O
no DT B-NP O
recombinants NNS I-NP O
, , O O
with IN B-PP O
a DT B-NP O
maximum NN I-NP O
lod NN I-NP O
score NN I-NP O
of IN B-PP O
Z NN B-NP O
= SYM B-VP O
6 CD B-NP O
. . O O

97 CD B-NP O
at IN B-PP O
theta NN B-NP O
= SYM B-VP O
0 CD B-NP O
. . O O

00 CD B-NP O
00 CD I-NP O
. . O O

The DT B-NP O
HaeIII NNP I-NP O
polymorphism NN I-NP O
detected VBN B-VP O
by IN B-PP O
the DT B-NP O
probe NN I-NP O
p5BE1 NN I-NP O
. . O O

2 CD B-NP O
gives VBZ B-VP O
a DT B-NP O
maximum NN I-NP O
lod NN I-NP O
score NN I-NP O
of IN B-PP O
Z NN B-NP O
= SYM B-VP O
2 CD B-NP O
. . O O

57 CD B-NP O
at IN B-PP O
theta NN B-NP O
= SYM B-VP O
0 CD B-NP O
. . O O

00 CD B-NP O
00 CD I-NP O
. . O O

Locus NN B-NP O
D11S325 NN I-NP O
gives VBZ B-VP O
a DT B-NP O
lod NN I-NP O
score NN I-NP O
of IN B-PP O
Z NN B-NP O
= SYM B-VP O
1 CD B-NP O
. . O O

53 CD B-NP O
at IN B-PP O
theta NN B-NP O
= SYM B-VP O
0 CD B-NP O
. . O O

00 CD B-NP O
00 CD I-NP O
. . O O

These DT B-NP O
data NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
a DT B-NP O
locus NN I-NP O
for IN B-PP O
aniridia NN B-NP B-Disease
( ( O O
AN1 NN B-NP O
) ) O O
on IN B-PP O
chromosome NN B-NP O
2p NN I-NP O
has VBZ B-VP O
been VBN I-VP O
misassigned VBN I-VP O
and CC O O
that IN B-SBAR O
this DT B-NP O
autosomal JJ I-NP O
dominant JJ I-NP O
aniridia NN I-NP B-Disease
family NN I-NP O
is VBZ B-VP O
segregating VBG I-VP O
for IN B-PP O
an DT B-NP O
aniridia NN I-NP B-Disease
mutation NN I-NP O
linked VBN B-VP O
to TO B-PP O
markers NNS B-NP O
in IN B-PP O
the DT B-NP O
11p13 NN I-NP O
region NN I-NP O
. . O O

Fatal JJ B-NP O
pyoderma NN I-NP B-Disease
gangrenosum NN I-NP I-Disease
in IN B-PP O
association NN B-NP O
with IN B-PP O
C7 NN B-NP B-Disease
deficiency NN I-NP I-Disease
. . O O

Although IN B-SBAR O
pyoderma NN B-NP B-Disease
gangrenosum NN I-NP I-Disease
( ( O O
PG NN B-NP B-Disease
) ) O O
is VBZ B-VP O
often RB I-VP O
associated VBN I-VP O
with IN B-PP O
systemic JJ B-NP B-Disease
diseases NNS I-NP I-Disease
, , O O
it PRP B-NP O
has VBZ B-VP O
not RB I-VP O
been VBN I-VP O
reported VBN I-VP O
in IN B-PP O
association NN B-NP O
with IN B-PP O
congenital JJ B-NP B-Disease
complement NN I-NP I-Disease
deficiencies NNS I-NP I-Disease
. . O O

We PRP B-NP O
describe VBP B-VP O
an DT B-NP O
aggressive JJ I-NP O
and CC I-NP O
ultimately RB I-NP O
fatal JJ I-NP O
case NN I-NP O
of IN B-PP O
PG NN B-NP B-Disease
in IN B-PP O
a DT B-NP O
patient NN I-NP O
with IN B-PP O
a DT B-NP O
congenital JJ I-NP O
C7 NN I-NP B-Disease
deficiency NN I-NP I-Disease
. . O O

Deficiencies NNS B-NP B-Disease
of IN B-PP I-Disease
C7 NN B-NP I-Disease
can MD B-VP O
be VB I-VP O
associated VBN I-VP O
with IN B-PP O
decreased VBN B-NP O
neutrophil NN I-NP O
chemotaxis NN I-NP O
, , O O
phagocytosis NN B-NP O
, , O O
and CC O O
opsonization NN B-NP O
, , O O
similar JJ B-ADJP O
to TO B-PP O
the DT B-NP O
immunologic JJ I-NP B-Disease
abnormalities NNS I-NP I-Disease
described VBN B-VP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
PG NN B-NP B-Disease
. . O O

Our PRP$ B-NP O
patients NNS I-NP O
decreased VBD B-VP O
complement NN B-NP O
level NN I-NP O
, , O O
if IN B-SBAR O
not RB O O
directly RB B-VP O
related VBN I-VP O
to TO B-PP O
the DT B-NP O
development NN I-NP O
of IN B-PP O
PG NN B-NP B-Disease
, , O O
may MD B-VP O
have VB I-VP O
contributed VBN I-VP O
to TO B-PP O
the DT B-NP O
aggressive JJ I-NP O
nature NN I-NP O
of IN B-PP O
her PRP$ B-NP O
disease NN I-NP O
. . O O

. . O O

Diverse JJ B-NP O
point NN I-NP O
mutations NNS I-NP O
result VBP B-VP O
in IN B-PP O
glucose NN B-NP O
- HYPH B-NP O
6 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
dehydrogenase NN I-NP O
( ( O O
G6PD NN B-NP O
) ) O O
polymorphism NN B-NP O
in IN B-PP O
Taiwan NNP B-NP O
. . O O

Glucose NN B-NP B-Disease
- HYPH B-NP I-Disease
6 CD I-NP I-Disease
- HYPH I-NP I-Disease
PHOSPHATE NN I-NP I-Disease
dehydrogenase NN I-NP I-Disease
( ( O I-Disease
G6PD NN B-NP I-Disease
; : O I-Disease
EC NNP B-NP I-Disease
1 CD I-NP I-Disease
. . O I-Disease

1 CD B-NP I-Disease
. . I-NP I-Disease

1 CD I-NP I-Disease
. . O I-Disease

49 CD O I-Disease
) ) O I-Disease
deficiency NN B-NP I-Disease
is VBZ B-VP O
the DT B-NP O
most RBS I-NP O
common JJ I-NP O
human JJ I-NP O
enzymopathy NN I-NP B-Disease
, , O O
affecting VBG B-VP O
more JJR B-NP O
than IN I-NP O
200 CD I-NP O
million CD I-NP O
people NNS I-NP O
worldwide RB B-ADVP O
. . O O

Although IN B-SBAR O
greater JJR B-NP O
than IN I-NP O
400 CD I-NP O
variants NNS I-NP O
have VBP B-VP O
been VBN I-VP O
described VBN I-VP O
based VBN B-PP O
on IN B-PP O
clinical JJ B-NP O
and CC I-NP O
biochemical JJ I-NP O
criteria NNS I-NP O
, , O O
little JJ B-NP O
is VBZ B-VP O
known VBN I-VP O
about IN B-PP O
the DT B-NP O
molecular JJ I-NP O
basis NN I-NP O
of IN B-PP O
these DT B-NP O
G6PD NN I-NP B-Disease
deficiencies NNS I-NP I-Disease
. . O O

Recently RB B-ADVP O
, , O O
the DT B-NP O
gene NN I-NP O
that WDT B-NP O
encodes VBZ B-VP O
human JJ B-NP O
G6PD NN I-NP O
has VBZ B-VP O
been VBN I-VP O
cloned VBN I-VP O
and CC I-VP O
sequenced VBN I-VP O
, , O O
which WDT B-NP O
enables VBZ B-VP O
us PRP B-NP O
to TO B-VP O
examine VB I-VP O
directly RB B-ADVP O
the DT B-NP O
heterogeneity NN I-NP O
of IN B-PP O
G6PD NN B-NP O
at IN B-PP O
the DT B-NP O
DNA NN I-NP O
level NN I-NP O
. . O O

During IN B-PP O
the DT B-NP O
past JJ I-NP O
10 CD I-NP O
years NNS I-NP O
, , O O
we PRP B-NP O
examined VBD B-VP O
the DT B-NP O
G6PD NN I-NP O
activity NN I-NP O
in IN B-PP O
21 CD B-NP O
, , O O
271 CD B-NP O
newborn JJ I-NP O
Chinese JJ I-NP O
infants NNS I-NP O
( ( O O
11 CD B-NP O
, , O O
400 CD B-NP O
males NNS I-NP O
and CC O O
9 CD B-NP O
, , O O
871 CD B-NP O
females NNS I-NP O
) ) O O
and CC O O
identified VBD B-VP O
314 CD B-NP O
( ( O O
2 CD B-NP O
. . O O

8 CD B-NP O
% NN I-NP O
) ) O O
males NNS B-NP O
and CC O O
246 CD B-NP O
( ( O O
2 CD B-NP O
. . O O

5 CD B-NP O
% NN I-NP O
) ) O O
females NNS B-NP O
having VBG B-VP O
low JJ B-NP O
G6PD NN I-NP O
activity NN I-NP O
. . O O

The DT B-NP O
G6PD NN I-NP O
gene NN I-NP O
from IN B-PP O
10 CD B-NP O
randomly RB I-NP O
selected VBN I-NP O
affected VBN I-NP O
individuals NNS I-NP O
and CC O O
their PRP$ B-NP O
relatives NNS I-NP O
was VBD B-VP O
polymerase NN B-NP O
chain NN I-NP O
reaction NN I-NP O
( ( O O
PCR NN B-NP O
) ) O O
amplified VBN B-VP O
, , O O
subcloned VBN B-VP O
, , O O
and CC O O
sequenced VBN B-VP O
. . O O

Our PRP$ B-NP O
results NNS I-NP O
indicate VBP B-VP O
that IN B-SBAR O
at IN B-NP O
least JJS I-NP O
four CD I-NP O
types NNS I-NP O
of IN B-PP O
mutation NN B-NP O
are VBP B-VP O
responsible JJ B-ADJP O
for IN B-PP O
the DT B-NP O
G6PD NN I-NP O
polymorphism NN I-NP O
in IN B-PP O
Taiwan NNP B-NP O
. . O O

The DT B-NP O
first JJ I-NP O
type NN I-NP O
of IN B-PP O
mutation NN B-NP O
( ( O O
487 CD B-NP O
G NN I-NP O
- SYM B-NP O
- SYM B-NP O
- SYM I-NP O
- HYPH I-NP O
A NN I-NP O
) ) O O
was VBD B-VP O
found VBN I-VP O
in IN B-PP O
an DT B-NP O
affected VBN I-NP O
Chinese JJ I-NP O
with IN B-PP O
a DT B-NP O
G NN I-NP O
to TO B-PP O
A NN B-NP O
change NN I-NP O
at IN B-PP O
nucleotide NN B-NP O
487 CD I-NP O
, , O O
which WDT B-NP O
results VBZ B-VP O
in IN B-PP O
a DT B-NP O
( ( O O
163 CD O O
) ) O O
Gly NN B-NP O
to TO B-PP O
Ser NN B-NP O
substitution NN I-NP O
. . O O

The DT B-NP O
second JJ I-NP O
type NN I-NP O
of IN B-PP O
mutation NN B-NP O
( ( O O
493 CD B-NP O
A NN I-NP O
- SYM B-NP O
- SYM B-NP O
- SYM I-NP O
- HYPH I-NP O
G NN I-NP O
) ) O O
is VBZ B-VP O
a DT B-NP O
novel JJ I-NP O
mutation NN I-NP O
that WDT B-NP O
has VBZ B-VP O
not RB I-VP O
been VBN I-VP O
reported VBN I-VP O
in IN B-PP O
any DT B-NP O
other JJ I-NP O
ethnic JJ I-NP O
group NN I-NP O
and CC O O
was VBD B-VP O
identified VBN I-VP O
in IN B-PP O
two CD B-NP O
affected VBD B-VP O
Chinese NNP B-NP O
. . O O

This DT B-NP O
mutation NN I-NP O
causes VBZ B-VP O
an DT B-NP O
A NN I-NP O
to TO B-PP O
G NN B-NP O
change NN I-NP O
at IN B-PP O
nucleotide NN B-NP O
position NN I-NP O
493 CD I-NP O
, , O O
producing VBG B-VP O
an DT B-NP O
( ( I-NP O
165 CD I-NP O
) ) I-NP O
Asn NN I-NP O
to TO B-PP O
Asp NN B-NP O
substitution NN I-NP O
. . O O

Interestingly RB B-ADVP O
, , O O
the DT B-NP O
487 CD I-NP O
G NN I-NP O
- SYM B-NP O
- SYM B-NP O
- SYM I-NP O
- HYPH I-NP O
A NN I-NP O
and CC O O
493 CD B-NP O
A NN I-NP O
- SYM O O
- SYM O O
- SYM O O
- HYPH O O
G NN B-NP O
mutations NNS I-NP O
create VBP B-VP O
Alu NN B-NP O
I CD I-NP O
and CC O O
Ava NNP B-NP O
II CD I-NP O
recognition NN I-NP O
sites NNS I-NP O
, , O O
respectively RB B-ADVP O
, , O O
which WDT B-NP O
enabled VBD B-VP O
us PRP B-NP O
to TO B-VP O
rapidly RB I-VP O
detect VB I-VP O
these DT B-NP O
two CD I-NP O
mutations NNS I-NP O
by IN B-PP O
PCR NN B-NP O
/ SYM O O
restriction NN B-NP O
enzyme NN I-NP O
( ( O O
RE NN B-NP O
) ) O O
digestion NN B-NP O
method NN I-NP O
. . O O

The DT B-NP O
third JJ I-NP O
mutation NN I-NP O
( ( O O
1376 CD B-NP O
G NN I-NP O
- SYM O O
- SYM O O
- SYM O O
- HYPH O O
T NN B-NP O
) ) O O
was VBD B-VP O
found VBN I-VP O
in IN B-PP O
four CD B-NP O
affected VBD B-VP O
Chinese NNP B-NP O
. . O O

This DT B-NP O
mutation NN I-NP O
causes VBZ B-VP O
a DT B-NP O
G NN I-NP O
to TO B-PP O
T NN B-NP O
change NN I-NP O
at IN B-PP O
nucleotide NN B-NP O
position NN I-NP O
1376 CD I-NP O
that WDT B-NP O
results VBZ B-VP O
in IN B-PP O
an DT B-NP O
( ( O O
459 CD O O
) ) O O
Arg NN B-NP O
to TO B-PP O
Leu NN B-NP O
substitution NN I-NP O
. . O O

The DT B-NP O
1376 CD I-NP O
G NN I-NP O
- SYM B-NP O
- SYM B-NP O
- SYM I-NP O
- HYPH I-NP O
T NN I-NP O
mutation NN I-NP O
seems VBZ B-VP O
to TO I-VP O
be VB I-VP O
the DT B-NP O
dominant JJ I-NP O
allele NN I-NP O
that WDT B-NP O
causes VBZ B-VP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
Taiwan NNP B-NP O
. . O O

Finally RB B-ADVP O
, , O O
two CD B-NP O
affected VBD B-VP O
Chinese NNP B-NP O
were VBD B-VP O
identified VBN I-VP O
as IN B-PP O
having VBG B-VP O
the DT B-NP O
fourth JJ I-NP O
mutation NN I-NP O
( ( O O
1388 CD B-NP O
G NN I-NP O
- SYM B-NP O
- SYM B-NP O
- SYM I-NP O
- HYPH I-NP O
A NN I-NP O
) ) O O
. . O O

This DT B-NP O
mutation NN I-NP O
causes VBZ B-VP O
a DT B-NP O
G NN I-NP O
to TO B-PP O
A NN B-NP O
change NN I-NP O
at IN B-PP O
nucleotide NN B-NP O
1388 CD I-NP O
that WDT B-NP O
produces VBZ B-VP O
an DT B-NP O
( ( O O
463 CD O O
) ) O O
Arg NN B-NP O
to TO B-PP O
His PRP$ B-NP O
substitution NN I-NP O
. . O O

Our PRP$ B-NP O
studies NNS I-NP O
provide VBP B-VP O
the DT B-NP O
direct JJ I-NP O
proof NN I-NP O
of IN B-PP O
the DT B-NP O
genetic JJ I-NP O
heterogeneity NN I-NP O
of IN B-PP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
the DT B-NP O
Chinese JJ I-NP O
populations NNS I-NP O
of IN B-PP O
Taiwan NNP B-NP O
and CC O O
the DT B-NP O
PCR NN I-NP O
/ SYM B-NP O
RE NN I-NP O
digestion NN I-NP O
method NN I-NP O
is VBZ B-VP O
suitable JJ B-ADJP O
for IN B-PP O
simultaneous JJ B-NP O
detection NN I-NP O
of IN B-PP O
the DT B-NP O
487 CD I-NP O
G NN I-NP O
- SYM B-NP O
- SYM B-NP O
- SYM I-NP O
- HYPH I-NP O
A NN I-NP O
and CC O O
493 CD B-NP O
A NN I-NP O
- SYM B-NP O
- SYM B-NP O
- SYM I-NP O
- HYPH I-NP O
G NN I-NP O
mutations NNS I-NP O
. . O O

An DT B-NP O
error NN I-NP O
in IN B-PP O
dystrophin NN B-NP O
mRNA NN I-NP O
processing NN I-NP O
in IN B-PP O
golden JJ B-NP B-Disease
retriever NN I-NP I-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
, , O O
an DT B-NP O
animal NN I-NP O
homologue NN I-NP O
of IN B-PP O
Duchenne NNP B-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
. . O O

Golden JJ B-NP B-Disease
retriever NN I-NP I-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
GRMD NN B-NP B-Disease
) ) O O
is VBZ B-VP O
a DT B-NP O
spontaneous JJ I-NP O
, , I-NP O
X NN I-NP O
- HYPH I-NP O
linked VBN B-VP O
, , O O
progressively RB B-NP O
fatal JJ I-NP O
disease NN I-NP O
of IN B-PP O
dogs NNS B-NP O
and CC O O
is VBZ B-VP O
also RB B-ADVP O
a DT B-NP O
homologue NN I-NP O
of IN B-PP O
Duchenne NNP B-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
DMD NN B-NP B-Disease
) ) O O
. . O O

Two CD B-NP O
- HYPH I-NP O
thirds NNS I-NP O
of IN B-PP O
DMD NN B-NP B-Disease
patients NNS I-NP O
carry VBP B-VP O
detectable JJ B-NP O
deletions NNS I-NP O
in IN B-PP O
their PRP$ B-NP O
dystrophin NN I-NP O
gene NN I-NP O
. . O O

The DT B-NP O
defect NN I-NP O
underlying VBG B-VP O
the DT B-NP O
remaining VBG I-NP O
one CD I-NP O
- HYPH I-NP O
third JJ I-NP O
of IN B-PP O
DMD NN B-NP B-Disease
patients NNS I-NP O
is VBZ B-VP O
undetermined JJ B-ADJP O
. . O O

Analysis NN B-NP O
of IN B-PP O
the DT B-NP O
canine JJ I-NP O
dystrophin NN I-NP O
gene NN I-NP O
in IN B-PP O
normal JJ B-NP O
and CC I-NP O
GRMD NN I-NP B-Disease
dogs NNS I-NP O
has VBZ B-VP O
failed VBN I-VP O
to TO I-VP O
demonstrate VB I-VP O
any DT B-NP O
detectable JJ I-NP O
loss NN I-NP O
of IN B-PP O
exons NNS B-NP O
. . O O

Here RB B-ADVP O
, , O O
we PRP B-NP O
have VBP B-VP O
demonstrated VBN I-VP O
a DT B-NP O
RNA NN I-NP O
processing NN I-NP O
error NN I-NP O
in IN B-PP O
GRMD NN B-NP B-Disease
that WDT B-NP O
results VBZ B-VP O
from IN B-PP O
a DT B-NP O
single JJ I-NP O
base NN I-NP O
change NN I-NP O
in IN B-PP O
the DT B-NP O
3 CD I-NP O
consensus NN I-NP O
splice NN I-NP O
site NN I-NP O
of IN B-PP O
intron NN B-NP O
6 CD I-NP O
. . O O

The DT B-NP O
seventh JJ I-NP O
exon NN I-NP O
is VBZ B-VP O
then RB I-VP O
skipped VBN I-VP O
, , O O
which WDT B-NP O
predicts VBZ B-VP O
a DT B-NP O
termination NN I-NP O
of IN B-PP O
the DT B-NP O
dystrophin NN I-NP O
reading NN I-NP O
frame NN I-NP O
within IN B-PP O
its PRP$ B-NP O
N NN I-NP O
- HYPH I-NP O
terminal JJ I-NP O
domain NN I-NP O
in IN B-PP O
exon NN B-NP O
8 CD I-NP O
. . O O

This DT B-NP O
is VBZ B-VP O
the DT B-NP O
first JJ I-NP O
example NN I-NP O
of IN B-PP O
dystrophin NN B-NP B-Disease
deficiency NN I-NP I-Disease
caused VBN B-VP O
by IN B-PP O
a DT B-NP O
splice NN I-NP O
- HYPH I-NP O
site NN I-NP O
mutation NN I-NP O
. . O O

. . O O

Type NN B-NP B-Disease
I CD I-NP I-Disease
human JJ I-NP I-Disease
complement NN I-NP I-Disease
C2 NN I-NP I-Disease
deficiency NN I-NP I-Disease
. . O O

A DT B-NP O
28 CD I-NP O
- HYPH I-NP O
base NN I-NP O
pair NN I-NP O
gene NN I-NP O
deletion NN I-NP O
causes VBZ B-VP O
skipping NN B-NP O
of IN B-PP O
exon NN B-NP O
6 CD I-NP O
during IN B-PP O
RNA NN B-NP O
splicing NN I-NP O
. . O O

Two CD B-NP O
variants NNS I-NP O
of IN B-PP O
a DT B-NP O
genetic JJ I-NP O
deficiency NN I-NP B-Disease
of IN B-PP I-Disease
complement NN B-NP I-Disease
protein NN I-NP I-Disease
C2 NN I-NP I-Disease
( ( O O
C2D NN B-NP O
) ) O O
have VBP B-VP O
been VBN I-VP O
previously RB I-VP O
identified VBN I-VP O
. . O O

No DT B-NP O
C2 NN I-NP O
protein NN I-NP O
translation NN I-NP O
is VBZ B-VP O
detected VBN I-VP O
in IN B-PP O
type NN B-NP O
I CD I-NP O
deficiency NN I-NP O
, , O O
while IN B-SBAR O
type NN B-NP O
II CD I-NP O
deficiency NN I-NP O
is VBZ B-VP O
characterized VBN I-VP O
by IN B-PP O
a DT B-NP O
selective JJ I-NP O
block NN I-NP O
in IN B-PP O
C2 NN B-NP O
secretion NN I-NP O
. . O O

Type NN B-NP B-Disease
I CD I-NP I-Disease
C2 NN I-NP I-Disease
deficiency NN I-NP I-Disease
was VBD B-VP O
described VBN I-VP O
in IN B-PP O
a DT B-NP O
family NN I-NP O
in IN B-PP O
which WDT B-NP O
the DT B-NP O
C2 NN I-NP O
allele NN I-NP O
( ( O O
C2Q0 NN B-NP O
) ) O O
is VBZ B-VP O
associated VBN I-VP O
with IN B-PP O
the DT B-NP O
major JJ I-NP O
histocompatibility NN I-NP O
haplotype NN I-NP O
/ SYM B-VP O
complotype NN B-NP O
HLA NN I-NP O
- HYPH B-NP O
A25 NN I-NP O
, , O O
B18 NN B-NP O
, , O O
C2Q0 NN B-NP O
, , O O
BfS NN B-NP O
, , O O
C4A4 NN B-NP O
, , O O
C4B2 NN B-NP O
, , O O
Drw2 NN B-NP O
; : O O
this DT B-NP O
extended VBN I-NP O
haplotype NN I-NP O
occurs VBZ B-VP O
in IN B-PP O
over IN B-NP O
90 CD I-NP O
% NN I-NP O
of IN B-PP O
C2 NN B-NP B-Disease
- HYPH B-NP I-Disease
deficient JJ I-NP I-Disease
individuals NNS I-NP O
( ( O O
common JJ B-NP O
complotype NN I-NP O
/ SYM B-NP O
haplotype NN I-NP O
) ) O O
. . O O

To TO B-VP O
determine VB I-VP O
the DT B-NP O
molecular JJ I-NP O
basis NN I-NP O
of IN B-PP O
type NN B-NP B-Disease
I CD I-NP I-Disease
C2 NN I-NP I-Disease
deficiency NN I-NP I-Disease
, , O O
the DT B-NP O
C2 NN I-NP O
gene NN I-NP O
and CC I-NP O
cDNA NN I-NP O
were VBD B-VP O
characterized VBN I-VP O
from IN B-PP O
a DT B-NP O
homozygous JJ I-NP O
type NN I-NP B-Disease
I CD I-NP I-Disease
C2 NN I-NP I-Disease
- HYPH B-NP I-Disease
deficient JJ I-NP I-Disease
individual NN I-NP O
with IN B-PP O
the DT B-NP O
common JJ I-NP O
associated VBN I-NP O
haplotype NN I-NP O
/ SYM B-NP O
complotype NN I-NP O
. . O O

We PRP B-NP O
found VBD B-VP O
a DT B-NP O
28 CD I-NP O
- HYPH I-NP O
base NN I-NP O
pair NN I-NP O
deletion NN I-NP O
in IN B-PP O
the DT B-NP O
type NN I-NP O
I CD I-NP O
C2Q0 NN I-NP O
gene NN I-NP O
, , O O
beginning VBG B-VP O
9 CD B-NP O
base NN I-NP O
pairs NNS I-NP O
upstream RB B-ADVP O
of IN B-PP O
the DT B-NP O
3 CD I-NP O
- HYPH I-NP O
end NN I-NP O
of IN B-PP O
exon NN B-NP O
6 CD I-NP O
, , O O
that WDT B-NP O
generates VBZ B-VP O
a DT B-NP O
C2 NN I-NP O
transcript NN I-NP O
with IN B-PP O
a DT B-NP O
complete JJ I-NP O
deletion NN I-NP O
of IN B-PP O
exon NN B-NP O
6 CD I-NP O
( ( O O
134 CD B-NP O
base NN I-NP O
pair NN I-NP O
) ) O O
and CC O O
a DT B-NP O
premature JJ I-NP O
termination NN I-NP O
codon NN I-NP O
. . O O

In IN B-PP O
studies NNS B-NP O
of IN B-PP O
eight CD B-NP O
kindred NN I-NP O
, , O O
the DT B-NP O
28 CD I-NP O
- HYPH I-NP O
base NN I-NP O
pair NN I-NP O
deletion NN I-NP O
was VBD B-VP O
observed VBN I-VP O
in IN B-PP O
all DT B-NP O
C2Q0 NN I-NP O
alleles NNS I-NP O
associated VBN B-VP O
with IN B-PP O
the DT B-NP O
common JJ I-NP O
type NN I-NP O
I CD I-NP O
deficient JJ I-NP O
complotype NN I-NP O
/ SYM B-NP O
haplotype NN I-NP O
; : O O
this DT B-NP O
deletion NN I-NP O
was VBD B-VP O
not RB O O
present JJ B-ADJP O
in IN B-PP O
normal JJ B-NP O
C2 NN I-NP O
nor CC B-PP O
in IN B-PP O
type NN B-NP B-Disease
II CD I-NP I-Disease
C2 NN I-NP I-Disease
- HYPH B-NP I-Disease
deficient JJ I-NP I-Disease
genes NNS I-NP O
. . O O

These DT B-NP O
data NNS I-NP O
demonstrate VBP B-VP O
that IN B-SBAR O
1 LS B-LST O
) ) O O
type NN B-NP B-Disease
I CD I-NP I-Disease
human JJ I-NP I-Disease
complement NN I-NP I-Disease
C2 NN I-NP I-Disease
deficiency NN I-NP I-Disease
is VBZ B-VP O
caused VBN I-VP O
by IN B-PP O
a DT B-NP O
28 CD I-NP O
- HYPH I-NP O
base NN I-NP O
pair NN I-NP O
genomic JJ I-NP O
deletion NN I-NP O
that WDT B-NP O
causes VBZ B-VP O
skipping NN B-NP O
of IN B-PP O
exon NN B-NP O
6 CD I-NP O
during IN B-PP O
RNA NN B-NP O
splicing NN I-NP O
, , O O
resulting VBG B-VP O
in IN B-PP O
generation NN B-NP O
of IN B-PP O
a DT B-NP O
premature JJ I-NP O
termination NN I-NP O
codon NN I-NP O
, , O O
2 LS B-LST O
) ) O O
the DT B-NP O
28 CD I-NP O
- HYPH I-NP O
base NN I-NP O
pair NN I-NP O
deletion NN I-NP O
in IN B-PP O
the DT B-NP O
type NN I-NP O
I CD I-NP O
C2Q0 NN I-NP O
gene NN I-NP O
is VBZ B-VP O
strongly RB I-VP O
associated VBN I-VP O
with IN B-PP O
the DT B-NP O
HLA NN I-NP O
haplotype NN I-NP O
/ SYM B-NP O
complotype NN I-NP O
A25 NN I-NP O
, , O O
B18 NN B-NP O
, , O O
C2Q0 NN B-NP O
, , O O
BfS NN B-NP O
, , O O
C4A4 NN B-NP O
, , O O
C4B2 NN B-NP O
, , O O
Drw2 NN B-NP O
, , O O
suggesting VBG B-VP O
that IN B-SBAR O
all DT B-NP O
C2 NN I-NP B-Disease
- HYPH O I-Disease
deficient JJ B-NP I-Disease
individuals NNS I-NP O
with IN B-PP O
this DT B-NP O
haplotype NN I-NP O
/ SYM B-NP O
complotype NN I-NP O
will MD B-VP O
harbor VB I-VP O
the DT B-NP O
28 CD I-NP O
- HYPH I-NP O
base NN I-NP O
pair NN I-NP O
C2 NN I-NP O
gene NN I-NP O
deletion NN I-NP O
, , O O
and CC O O
3 LS B-LST O
) ) O O
type NN B-NP B-Disease
II CD I-NP I-Disease
C2 NN I-NP I-Disease
deficiency NN I-NP I-Disease
is VBZ B-VP O
caused VBN I-VP O
by IN B-PP O
a DT B-NP O
different JJ I-NP O
, , O O
as IN B-SBAR O
yet RB B-NP O
uncharacterized JJ I-NP O
, , I-NP O
molecular JJ I-NP O
genetic JJ I-NP B-Disease
defect NN I-NP I-Disease
. . O O

. . O O

Molecular JJ B-NP O
characterization NN I-NP O
of IN B-PP O
two CD B-NP O
galactosemia NN I-NP B-Disease
mutations NNS I-NP O
and CC O O
one CD B-NP O
polymorphism NN I-NP O
: : O O
implications NNS B-NP O
for IN B-PP O
structure NN B-NP O
- HYPH B-NP O
function NN I-NP O
analysis NN I-NP O
of IN B-PP O
human JJ B-NP O
galactose NN I-NP O
- HYPH B-NP O
1 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
uridyltransferase NN I-NP O
. . O O

We PRP B-NP O
report VBP B-VP O
here RB B-ADVP O
the DT B-NP O
molecular JJ I-NP O
characterization NN I-NP O
of IN B-PP O
two CD B-NP O
galactosemia NN I-NP B-Disease
mutations NNS I-NP O
, , O O
L74P NN B-NP O
and CC I-NP O
F171S NN I-NP O
, , O O
and CC O O
one CD B-NP O
polymorphism NN I-NP O
, , O O
S135L NN B-NP O
, , O O
in IN B-PP O
human JJ B-NP O
galactose NN I-NP O
- HYPH B-NP O
1 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
uridyltransferase NN I-NP O
( ( O O
GALT NN B-NP O
) ) O O
. . O O

Both DT B-NP O
galactosemia NN I-NP B-Disease
mutations NNS I-NP O
result VBP B-VP O
in IN B-PP O
reduced VBN B-NP O
enzymatic JJ I-NP O
activity NN I-NP O
when WRB B-ADVP O
reconstructed VBN B-VP O
in IN B-PP O
the DT B-NP O
cDNA NN I-NP O
and CC O O
overexpressed VBN B-VP O
. . O O

The DT B-NP O
polymorphism NN I-NP O
, , O O
in IN B-PP O
contrast NN B-NP O
, , O O
has VBZ B-VP O
near IN B-PP O
normal JJ B-NP O
activity NN I-NP O
. . O O

Both DT B-NP O
mutations NNS I-NP O
affect VBP B-VP O
evolutionarily RB B-NP O
conserved VBN I-NP O
residues NNS I-NP O
, , O O
suggesting VBG B-VP O
that IN B-SBAR O
they PRP B-NP O
are VBP B-VP O
functionally RB B-ADJP O
important JJ I-ADJP O
, , O O
while IN B-SBAR O
the DT B-NP O
polymorphism NN I-NP O
occurs VBZ B-VP O
in IN B-PP O
a DT B-NP O
nonconserved JJ I-NP O
domain NN I-NP O
which WDT B-NP O
is VBZ B-VP O
presumably RB B-ADVP O
not RB O O
critical JJ B-ADJP O
for IN B-PP O
enzymatic JJ B-NP O
function NN I-NP O
. . O O

The DT B-NP O
F171S NN I-NP O
mutation NN I-NP O
is VBZ B-VP O
close JJ B-ADJP O
to TO B-PP O
the DT B-NP O
putative JJ I-NP O
active JJ I-NP O
- HYPH I-NP O
site NN I-NP O
nucleophile NN I-NP O
. . O O

Our PRP$ B-NP O
data NNS I-NP O
further RB B-ADVP O
support VBP B-VP O
the DT B-NP O
notion NN I-NP O
of IN B-PP O
molecular JJ B-NP O
heterogeneity NN I-NP O
of IN B-PP O
galactosemia NN B-NP B-Disease
and CC O O
suggest VBP B-VP O
that IN B-SBAR O
galactosemia NN B-NP B-Disease
mutations NNS I-NP O
and CC O O
GALT NN B-NP O
polymorphisms NNS I-NP O
may MD B-VP O
be VB I-VP O
useful JJ B-NP O
tools NNS I-NP O
in IN B-PP O
highlighting VBG B-VP O
different JJ B-NP O
functional JJ I-NP O
domains NNS I-NP O
in IN B-PP O
human JJ B-NP O
GALT NN I-NP O
. . O O

. . O O

Linkage NN B-NP O
relationship NN I-NP O
of IN B-PP O
C2 NN B-NP B-Disease
deficiency NN I-NP I-Disease
, , O O
HLA NN B-NP O
and CC I-NP O
glyoxalase NN I-NP O
I CD B-NP O
loci NNS I-NP O
. . O O

Immunogenetic JJ B-NP O
analysis NN I-NP O
of IN B-PP O
a DT B-NP O
homozygous JJ I-NP O
C2 NN I-NP B-Disease
- HYPH B-NP I-Disease
deficient JJ I-NP I-Disease
individual NN I-NP O
and CC I-NP O
family NN I-NP O
members NNS I-NP O
demonstrated VBD B-VP O
linkage NN B-NP O
of IN B-PP O
HLA NN B-NP O
- HYPH B-NP O
A25 NN I-NP O
, , I-NP O
B18 NN I-NP O
and CC I-NP O
C2o NN I-NP O
. . O O

HLA NN B-NP O
- HYPH I-NP O
D NN I-NP O
typing NN I-NP O
showed VBD B-VP O
that IN B-SBAR O
5 CD B-NP O
members NNS I-NP O
typed VBN B-VP O
with IN B-PP O
homozygous JJ B-NP O
Dw2 NN I-NP O
typing NN I-NP O
cells NNS I-NP O
from IN B-PP O
an DT B-NP O
individual NN I-NP O
with IN B-PP O
C2 NN B-NP B-Disease
deficiency NN I-NP I-Disease
but CC B-PP O
not RB B-PP O
with IN I-PP O
Dw2 NN B-NP O
typing NN I-NP O
cells NNS I-NP O
from IN B-PP O
2 CD B-NP O
individuals NNS I-NP O
with IN B-PP O
normal JJ B-NP O
C2 NN I-NP O
. . O O

The DT B-NP O
homozygous JJ I-NP O
C2 NN I-NP B-Disease
- HYPH B-NP I-Disease
deficient JJ I-NP I-Disease
propositus NN I-NP O
and CC I-NP O
brother NN I-NP O
were VBD B-VP O
HLA NN B-NP O
- HYPH B-NP O
A NN I-NP O
and CC I-NP O
B NN I-NP O
homozygous JJ B-ADJP O
but CC I-ADJP O
heterozygous JJ I-ADJP O
at IN B-PP O
the DT B-NP O
HLA NN I-NP O
- HYPH B-NP O
D NN I-NP O
and CC I-NP O
glyoxalase NN I-NP O
I CD B-NP O
loci NNS I-NP O
. . O O

Therefore RB B-ADVP O
, , O O
in IN B-PP O
this DT B-NP O
family NN I-NP O
, , O O
the DT B-NP O
C2o NN I-NP O
gene NN I-NP O
is VBZ B-VP O
linked VBN I-VP O
with IN B-PP O
two CD B-NP O
distinct JJ I-NP O
haplotypes NNS I-NP O
HLA NN I-NP O
- HYPH B-NP O
A25 NN I-NP O
, , O O
B18 NN B-NP O
, , O O
Dw2 NN B-NP O
, , O O
GLO1 NN B-NP O
and CC I-NP O
HLA NN I-NP O
- HYPH B-NP O
A25 NN I-NP O
, , O O
B18 NN B-NP O
, , O O
D NN B-NP O
unknown JJ I-NP O
, , I-NP O
GL02 NN I-NP O
. . O O

These DT B-NP O
results NNS I-NP O
could MD B-VP O
be VB I-VP O
explained VBN I-VP O
by IN B-PP O
an DT B-NP O
ancestral JJ I-NP O
recombinant JJ I-NP O
event NN I-NP O
, , O O
which WDT B-NP O
occurred VBD B-VP O
between IN B-PP O
the DT B-NP O
C2o NN I-NP O
locus NN I-NP O
and CC I-NP O
HLA NN I-NP O
- HYPH B-NP O
D NN I-NP O
locus NN I-NP O
in IN B-PP O
which WDT B-NP O
C2o NN B-NP O
segregated VBD B-VP O
with IN B-PP O
HLA NN B-NP O
- HYPH B-NP O
B NN I-NP O
. . O O

This DT B-NP O
would MD B-VP O
suggest VB I-VP O
that IN B-SBAR O
the DT B-NP O
locus NN I-NP O
for IN B-PP O
the DT B-NP O
C2o NN I-NP O
gene NN I-NP O
maps VBZ B-VP O
between IN B-PP O
HLA NN B-NP O
- HYPH B-NP O
B NN I-NP O
and CC I-NP O
HLA NN I-NP O
- HYPH B-NP O
D NN I-NP O
on IN B-PP O
the DT B-NP O
sixth JJ I-NP O
chromosome NN I-NP O
. . O O

. . O O

Germline NN B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
Wilms NNP I-NP B-Disease
' POS B-NP I-Disease
tumor NN I-NP I-Disease
suppressor NN I-NP O
gene NN I-NP O
are VBP B-VP O
associated VBN I-VP O
with IN B-PP O
abnormal JJ B-NP O
urogenital JJ I-NP O
development NN I-NP O
in IN B-PP O
Denys NNP B-NP B-Disease
- HYPH B-NP I-Disease
Drash NNP I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

Denys AFX B-NP B-Disease
- HYPH I-NP I-Disease
Drash NN I-NP I-Disease
syndrome NN I-NP I-Disease
is VBZ B-VP O
a DT B-NP O
rare JJ I-NP O
human JJ I-NP O
condition NN I-NP O
in IN B-PP O
which WDT B-NP O
severe JJ B-NP O
urogenital JJ I-NP B-Disease
aberrations NNS I-NP I-Disease
result VBP B-VP O
in IN B-PP O
renal JJ B-NP B-Disease
failure NN I-NP I-Disease
, , O O
pseudohermaphroditism NN B-NP B-Disease
, , O O
and CC O O
Wilms NNP B-NP B-Disease
tumor NN I-NP I-Disease
( ( O O
nephroblastoma NN B-NP B-Disease
) ) O O
. . O O

To TO B-VP O
investigate VB I-VP O
its PRP$ B-NP O
possible JJ I-NP O
role NN I-NP O
, , O O
we PRP B-NP O
have VBP B-VP O
analyzed VBN I-VP O
the DT B-NP O
coding VBG I-NP O
exons NNS I-NP O
of IN B-PP O
the DT B-NP O
Wilms NNP I-NP B-Disease
tumor NN I-NP I-Disease
suppressor NN I-NP O
gene NN I-NP O
( ( O O
WT1 NN B-NP O
) ) O O
for IN B-PP O
germline NN B-NP O
mutations NNS I-NP O
. . O O

In IN B-PP O
ten CD B-NP O
independent JJ I-NP O
cases NNS I-NP O
of IN B-PP O
Denys NNP B-NP B-Disease
- HYPH I-NP I-Disease
Drash NNP I-NP I-Disease
syndrome NN I-NP I-Disease
, , O O
point NN B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
zinc NN I-NP O
finger NN I-NP O
domains NNS I-NP O
of IN B-PP O
one CD B-NP O
WT1 NN I-NP O
gene NN I-NP O
copy NN I-NP O
were VBD B-VP O
found VBN I-VP O
. . O O

Nine CD B-NP O
of IN B-PP O
these DT B-NP O
mutations NNS I-NP O
are VBP B-VP O
found VBN I-VP O
within IN B-PP O
exon NN B-NP O
9 CD I-NP O
( ( O O
zinc NN B-NP O
finger NN I-NP O
III CD I-NP O
) ) O O
; : O O
the DT B-NP O
remaining VBG I-NP O
mutation NN I-NP O
is VBZ B-VP O
in IN B-PP O
exon NN B-NP O
8 CD I-NP O
( ( O O
zinc NN B-NP O
finger NN I-NP O
II CD I-NP O
) ) O O
. . O O

These DT B-NP O
mutations NNS I-NP O
directly RB B-VP O
affect VBP I-VP O
DNA NN B-NP O
sequence NN I-NP O
recognition NN I-NP O
. . O O

In IN B-PP O
two CD B-NP O
families NNS I-NP O
analyzed VBN B-VP O
, , O O
the DT B-NP O
mutations NNS I-NP O
were VBD B-VP O
shown VBN I-VP O
to TO I-VP O
arise VB I-VP O
de FW B-NP O
novo FW I-NP O
. . O O

Wilms NNS B-NP B-Disease
tumors NNS I-NP I-Disease
from IN B-PP O
three CD B-NP O
individuals NNS I-NP O
and CC O O
one CD B-NP O
juvenile JJ I-NP O
granulosa NN I-NP O
cell NN I-NP O
tumor NN I-NP B-Disease
demonstrate VBP B-VP O
reduction NN B-NP O
to TO B-PP O
homozygosity NN B-NP O
for IN B-PP O
the DT B-NP O
mutated VBN I-NP O
WT1 NN I-NP O
allele NN I-NP O
. . O O

Our PRP$ B-NP O
results NNS I-NP O
provide VBP B-VP O
evidence NN B-NP O
of IN B-PP O
a DT B-NP O
direct JJ I-NP O
role NN I-NP O
for IN B-PP O
WT1 NN B-NP O
in IN B-PP O
Denys NNP B-NP B-Disease
- HYPH I-NP I-Disease
Drash NN I-NP I-Disease
syndrome NN I-NP I-Disease
and CC O O
thus RB B-NP O
urogenital JJ I-NP O
system NN I-NP O
development NN I-NP O
. . O O

. . O O

Linkage NN B-NP O
analysis NN I-NP O
in IN B-PP O
X NN B-NP B-Disease
- HYPH B-NP I-Disease
linked VBN I-NP I-Disease
adrenoleukodystrophy NN I-NP I-Disease
and CC I-NP O
application NN I-NP O
in IN B-PP O
post AFX B-NP O
- HYPH I-NP O
and CC I-NP O
prenatal JJ I-NP O
diagnosis NN I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
performed VBN I-VP O
linkage NN B-NP O
analysis NN I-NP O
with IN B-PP O
the DT B-NP O
DNA NN I-NP O
markers NNS I-NP O
DXS52 NN I-NP O
and CC O O
the DT B-NP O
clotting NN I-NP O
factor NN I-NP O
VIII CD I-NP O
gene NN I-NP O
( ( O O
F8C NN B-NP O
) ) O O
, , O O
in IN B-PP O
several JJ B-NP O
large JJ I-NP O
families NNS I-NP O
with IN B-PP O
X NN B-NP B-Disease
- HYPH O I-Disease
linked VBN B-VP I-Disease
adrenoleukodystrophy NN B-NP I-Disease
( ( O O
ALD NN B-NP B-Disease
) ) O O
. . O O

The DT B-NP O
tight JJ I-NP O
linkage NN I-NP O
to TO B-PP O
DXS52 NN B-NP O
could MD B-VP O
be VB I-VP O
extended VBN I-VP O
giving VBG B-VP O
a DT B-NP O
maximal JJ I-NP O
LOD NN I-NP O
score NN I-NP O
of IN B-PP O
22 CD B-NP O
. . O O

5 CD B-NP O
at IN B-PP O
1 CD B-NP O
cM NN I-NP O
. . O O

F8C NN B-NP O
was VBD B-VP O
also RB B-ADVP O
tightly RB B-VP O
linked VBN I-VP O
to TO B-PP O
ALD NN B-NP B-Disease
with IN B-PP O
a DT B-NP O
maximal JJ I-NP O
LOD NN I-NP O
score NN I-NP O
of IN B-PP O
7 CD B-NP O
. . O O

8 CD B-NP O
without IN B-PP O
recombination NN B-NP O
. . O O

Multipoint JJ B-NP O
linkage NN I-NP O
analysis NN I-NP O
with IN B-PP O
the DT B-NP O
markers NNS I-NP O
DXS304 NN I-NP O
, , O O
DXS52 NN B-NP O
, , O O
and CC O O
F8C NN B-NP O
indicated VBD B-VP O
that IN B-SBAR O
both CC O O
the DT B-NP O
gene NN I-NP O
for IN B-PP O
ALD NN B-NP B-Disease
and CC B-PP O
for IN B-PP O
F8C NN B-NP O
are VBP B-VP O
distal JJ B-ADJP O
to TO B-PP O
DXS52 NN B-NP O
. . O O

In IN B-PP O
four CD B-NP O
patients NNS I-NP O
with IN B-PP O
ALD NN B-NP B-Disease
, , O O
no DT B-NP O
major JJ I-NP O
structural JJ I-NP O
rearrangement NN I-NP O
in IN B-PP O
the DT B-NP O
Xqter NN I-NP O
region NN I-NP O
was VBD B-VP O
observed VBN I-VP O
; : O O
in IN B-PP O
particular JJ B-ADJP O
, , O O
there EX B-NP O
were VBD B-VP O
no DT B-NP O
abnormalities NNS I-NP B-Disease
in IN B-PP I-Disease
the DT B-NP I-Disease
vision NN I-NP I-Disease
blindness NN I-NP I-Disease
genes NNS I-NP I-Disease
. . O O

DNA NN B-NP O
analysis NN I-NP O
appeared VBD B-VP O
to TO I-VP O
be VB I-VP O
of IN B-PP O
use NN B-NP O
in IN B-PP O
determination NN B-NP O
of IN B-PP O
the DT B-NP O
carrier NN I-NP O
status NN I-NP O
of IN B-PP O
females NNS B-NP O
at IN B-PP O
risk NN B-NP O
, , O O
for IN B-PP O
the DT B-NP O
determination NN I-NP O
of IN B-PP O
the DT B-NP O
origin NN I-NP O
of IN B-PP O
the DT B-NP O
mutation NN I-NP O
in IN B-PP O
a DT B-NP O
particular JJ I-NP O
family NN I-NP O
, , O O
and CC O O
for IN B-PP O
prenatal JJ B-NP O
diagnosis NN I-NP O
. . O O

Two CD B-NP O
distinct JJ I-NP O
mutations NNS I-NP O
at IN B-PP O
a DT B-NP O
single JJ I-NP O
BamHI NN I-NP O
site NN I-NP O
in IN B-PP O
phenylketonuria NN B-NP B-Disease
. . O O

Classical JJ B-NP B-Disease
phenylketonuria NN I-NP I-Disease
is VBZ B-VP O
an DT B-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
disease NN I-NP I-Disease
caused VBN B-VP O
by IN B-PP O
a DT B-NP O
deficiency NN I-NP B-Disease
of IN B-PP I-Disease
hepatic JJ B-NP I-Disease
phenylalanine NN I-NP I-Disease
hydroxylase NN I-NP I-Disease
( ( O O
PAH NN B-NP O
) ) O O
. . O O

The DT B-NP O
abolition NN I-NP O
of IN B-PP O
an DT B-NP O
invariant JJ I-NP O
BamHI NN I-NP O
site NN I-NP O
located JJ B-ADJP O
in IN B-PP O
the DT B-NP O
coding VBG I-NP O
sequence NN I-NP O
of IN B-PP O
the DT B-NP O
PAH NN I-NP O
gene NN I-NP O
( ( O O
exon NN B-NP O
7 CD I-NP O
) ) O O
led VBD B-VP O
to TO B-PP O
the DT B-NP O
recognition NN I-NP O
of IN B-PP O
two CD B-NP O
new JJ I-NP O
point NN I-NP O
mutations NNS I-NP O
at IN B-PP O
codon NN B-NP O
272 CD I-NP O
and CC I-NP O
273 CD I-NP O
( ( O O
272gly RB O O
- HYPH O O
- SYM O O
- SYM O O
- HYPH O O
stop NN B-NP O
and CC O O
273ser SYM B-NP O
- SYM O O
- SYM O O
- SYM O O
- HYPH O O
phe NN B-NP O
, , O O
respectively RB B-ADVP O
) ) O O
. . O O

Both DT B-NP O
mutations NNS I-NP O
were VBD B-VP O
detected VBN I-VP O
in IN B-PP O
north JJ B-NP O
eastern JJ I-NP O
France NNP I-NP O
or CC I-NP O
Belgium NNP I-NP O
and CC O O
occurred VBD B-VP O
on IN B-PP O
the DT B-NP O
background NN I-NP O
of IN B-PP O
RFLP NN B-NP O
haplotype NN I-NP O
7 CD B-NP O
alleles NNS I-NP O
. . O O

The DT B-NP O
present JJ I-NP O
study NN I-NP O
supports VBZ B-VP O
the DT B-NP O
view NN I-NP O
that IN B-SBAR O
the DT B-NP O
clinical JJ I-NP O
heterogeneity NN I-NP O
in IN B-PP O
PKU NN B-NP B-Disease
is VBZ B-VP O
accounted VBN I-VP O
for IN B-PP O
by IN B-PP O
the DT B-NP O
large JJ I-NP O
variety NN I-NP O
of IN B-PP O
mutant JJ B-NP O
genotypes NNS I-NP O
associated VBN B-VP O
with IN B-PP O
PAH NN B-NP B-Disease
deficiencies NNS I-NP I-Disease
. . O O

. . O O

A DT B-NP O
detailed JJ I-NP O
multipoint JJ I-NP O
map NN I-NP O
of IN B-PP O
human JJ B-NP O
chromosome NN I-NP O
4 CD I-NP O
provides VBZ B-VP O
evidence NN B-NP O
for IN B-PP O
linkage NN B-NP O
heterogeneity NN I-NP O
and CC I-NP O
position NN I-NP O
- HYPH B-NP O
specific JJ I-NP O
recombination NN I-NP O
rates NNS I-NP O
. . O O

Utilizing VBG B-VP O
the DT B-NP O
CEPH NN I-NP O
reference NN I-NP O
panel NN I-NP O
and CC O O
genotypic JJ B-NP O
data NNS I-NP O
for IN B-PP O
53 CD B-NP O
markers NNS I-NP O
, , O O
we PRP B-NP O
have VBP B-VP O
constructed VBN I-VP O
a DT B-NP O
20 CD I-NP O
- HYPH I-NP O
locus NN I-NP O
multipoint JJ I-NP O
genetic JJ I-NP O
map NN I-NP O
of IN B-PP O
human JJ B-NP O
chromosome NN I-NP O
4 CD I-NP O
. . O O

New JJ B-NP O
RFLPs NNS I-NP O
are VBP B-VP O
reported VBN I-VP O
for IN B-PP O
four CD B-NP O
loci NNS I-NP O
. . O O

The DT B-NP O
map NN I-NP O
integrates VBZ B-VP O
a DT B-NP O
high JJ I-NP O
- HYPH I-NP O
resolution NN I-NP O
genetic JJ I-NP O
map NN I-NP O
of IN B-PP O
4p16 CD B-NP O
into IN B-PP O
a DT B-NP O
continuous JJ I-NP O
map NN I-NP O
extending VBG B-VP O
to TO B-PP O
4q31 CD B-NP O
and CC O O
an DT B-NP O
unlinked JJ I-NP O
cluster NN I-NP O
of IN B-PP O
three CD B-NP O
loci NNS I-NP O
at IN B-PP O
4q35 CD B-NP O
. . O O

The DT B-NP O
20 CD I-NP O
linked VBN I-NP O
markers NNS I-NP O
form VBP B-VP O
a DT B-NP O
continuous JJ I-NP O
linkage NN I-NP O
group NN I-NP O
of IN B-PP O
152 CD B-NP O
cM NN I-NP O
in IN B-PP O
males NNS B-NP O
and CC O O
202 CD B-NP O
cM NN I-NP O
in IN B-PP O
females NNS B-NP O
. . O O

Likely RB B-NP O
genetic JJ I-NP O
locations NNS I-NP O
are VBP B-VP O
provided VBN I-VP O
for IN B-PP O
25 CD B-NP O
polymorphic JJ I-NP O
anonymous JJ I-NP O
sequences NNS I-NP O
and CC O O
28 CD B-NP O
gene NN I-NP O
- HYPH B-NP O
specific JJ I-NP O
RFLPs NNS I-NP O
. . O O

The DT B-NP O
map NN I-NP O
was VBD B-VP O
constructed VBN I-VP O
employing VBG I-VP O
the DT B-NP O
LINKAGE NN I-NP O
and CC I-NP O
CRIMAP NN I-NP O
computational JJ I-NP O
methodologies NNS I-NP O
to TO B-VP O
build VB I-VP O
the DT B-NP O
multipoint JJ I-NP O
map NN I-NP O
via IN B-PP O
a DT B-NP O
stepwise JJ I-NP O
algorithm NN I-NP O
. . O O

A DT B-NP O
detailed JJ I-NP O
10 CD I-NP O
- HYPH I-NP O
point NN I-NP O
map NN I-NP O
of IN B-PP O
the DT B-NP O
4p16 CD I-NP O
region NN I-NP O
constructed VBN B-VP O
from IN B-PP O
the DT B-NP O
CEPH NN I-NP O
panel NN I-NP O
provides VBZ B-VP O
evidence NN B-NP O
for IN B-PP O
heterogeneity NN B-NP O
in IN B-PP O
the DT B-NP O
linkage NN I-NP O
maps NNS I-NP O
constructed VBN B-VP O
from IN B-PP O
families NNS B-NP O
segregating VBG B-VP O
for IN B-PP O
Huntington NNP B-NP B-Disease
disease NN I-NP I-Disease
( ( O O
HD NN B-NP B-Disease
) ) O O
. . O O

It PRP B-NP O
additionally RB B-ADVP O
provides VBZ B-VP O
evidence NN B-NP O
for IN B-PP O
position NN B-NP O
- HYPH B-NP O
specific JJ I-NP O
recombination NN I-NP O
frequencies NNS I-NP O
in IN B-PP O
the DT B-NP O
telomeric JJ I-NP O
region NN I-NP O
of IN B-PP O
4p NN B-NP O
. . O O

. . O O

Carrier NN B-NP O
detection NN I-NP O
and CC O O
prenatal JJ B-NP O
diagnosis NN I-NP O
of IN B-PP O
Pelizaeus NNP B-NP B-Disease
- HYPH I-NP I-Disease
Merzbacher NNP I-NP I-Disease
disease NN I-NP I-Disease
using VBG B-VP O
a DT B-NP O
combination NN I-NP O
of IN B-PP O
anonymous JJ B-NP O
DNA NN I-NP O
polymorphisms NNS I-NP O
and CC O O
the DT B-NP O
proteolipid NN I-NP O
protein NN I-NP O
( ( O O
PLP NN B-NP O
) ) O O
gene NN B-NP O
cDNA NN I-NP O
. . O O

We PRP B-NP O
report VBP B-VP O
carrier NN B-NP O
identification NN I-NP O
and CC O O
a DT B-NP O
prenatal JJ I-NP O
diagnosis NN I-NP O
using VBG B-VP O
DNA NN B-NP O
polymorphisms NNS I-NP O
in IN B-PP O
2 CD B-NP O
families NNS I-NP O
with IN B-PP O
X NN B-NP B-Disease
- HYPH O I-Disease
linked VBN B-VP I-Disease
Pelizaeus NNP B-NP I-Disease
- HYPH I-NP I-Disease
Merzbacher NNP I-NP I-Disease
disease NN I-NP I-Disease
( ( O O
PMD NN B-NP B-Disease
) ) O O
. . O O

In IN B-PP O
both DT B-NP O
families NNS I-NP O
, , O O
the DT B-NP O
proteolipid NN I-NP O
protein NN I-NP O
( ( O O
PLP NN B-NP O
) ) O O
gene NN B-NP O
in IN B-PP O
the DT B-NP O
single JJ I-NP O
affected VBN I-NP O
male NN I-NP O
could MD B-VP O
be VB I-VP O
traced VBN I-VP O
back RB B-ADVP O
to TO B-PP O
his PRP$ B-NP O
unaffected JJ I-NP O
maternal JJ I-NP O
grandfather NN I-NP O
. . O O

Therefore RB B-ADVP O
, , O O
each DT B-NP O
family NN I-NP O
contains VBZ B-VP O
a DT B-NP O
new JJ I-NP O
mutation NN I-NP O
. . O O

In IN B-PP O
the DT B-NP O
case NN I-NP O
of IN B-PP O
the DT B-NP O
prenatal JJ I-NP O
diagnosis NN I-NP O
, , O O
the DT B-NP O
fetus NN I-NP O
was VBD B-VP O
shown VBN I-VP O
by IN B-PP O
cytogenetic JJ B-NP O
analysis NN I-NP O
to TO B-VP O
be VB I-VP O
a DT B-NP O
female NN I-NP O
, , O O
who WP B-NP O
we PRP B-NP O
predict VBP B-VP O
will MD B-VP O
be VB I-VP O
a DT B-NP O
noncarrier NN I-NP O
of IN B-PP O
PMD NN B-NP B-Disease
based VBN B-VP O
on IN B-PP O
her PRP$ B-NP O
genotype NN I-NP O
with IN B-PP O
the DT B-NP O
PLP NN I-NP O
intragenic JJ I-NP O
polymorphism NN I-NP O
. . O O

. . O O

Identification NN B-NP O
of IN B-PP O
deletion NN B-NP O
mutations NNS I-NP O
and CC O O
three CD B-NP O
new JJ I-NP O
genes NNS I-NP O
at IN B-PP O
the DT B-NP O
familial JJ I-NP B-Disease
polyposis NN I-NP I-Disease
locus NN I-NP O
. . O O

Small JJ B-ADJP O
( ( O O
100 CD B-NP O
- HYPH I-NP O
260 CD I-NP O
kb NN I-NP O
) ) O O
, , O O
nested VBN B-NP O
deletions NNS I-NP O
were VBD B-VP O
characterized VBN I-VP O
in IN B-PP O
DNA NN B-NP O
from IN B-PP O
two CD B-NP O
unrelated JJ I-NP O
patients NNS I-NP O
with IN B-PP O
familial JJ B-NP B-Disease
adenomatous JJ I-NP I-Disease
polyposis NN I-NP I-Disease
coli NN I-NP I-Disease
( ( O O
APC NN B-NP B-Disease
) ) O O
. . O O

Three CD B-NP O
candidate NN I-NP O
genes NNS I-NP O
located JJ B-ADJP O
within IN B-PP O
the DT B-NP O
deleted VBN I-NP O
region NN I-NP O
were VBD B-VP O
ascertained VBN I-VP O
and CC O O
a DT B-NP O
previous JJ I-NP O
candidate NN I-NP O
gene NN I-NP O
, , O O
MCC NN B-NP O
, , O O
was VBD B-VP O
shown VBN I-VP O
to TO I-VP O
be VB I-VP O
located VBN I-VP O
outside IN B-PP O
the DT B-NP O
deleted VBN I-NP O
region NN I-NP O
. . O O

One CD B-NP O
of IN B-PP O
the DT B-NP O
new JJ I-NP O
genes NNS I-NP O
contained VBD B-VP O
sequence NN B-NP O
identical JJ B-ADJP O
to TO B-PP O
SRP19 NN B-NP O
, , O O
the DT B-NP O
gene NN I-NP O
coding VBG B-VP O
for IN B-PP O
the DT B-NP O
19 CD I-NP O
kd NN I-NP O
component NN I-NP O
of IN B-PP O
the DT B-NP O
ribosomal JJ I-NP O
signal NN I-NP O
recognition NN I-NP O
particle NN I-NP O
. . O O

The DT B-NP O
second JJ I-NP O
, , O O
provisionally RB B-NP O
designated VBN I-NP O
DP1 NN I-NP O
( ( O O
deleted VBN B-VP O
in IN B-PP O
polyposis NN B-NP O
1 CD I-NP O
) ) O O
, , O O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
be VB I-VP O
transcribed VBN I-VP O
in IN B-PP O
the DT B-NP O
same JJ I-NP O
orientation NN I-NP O
as IN B-PP O
MCC NN B-NP O
. . O O

Two CD B-NP O
other JJ I-NP O
cDNAs NNS I-NP O
, , O O
DP2 NN B-NP O
and CC I-NP O
DP3 NN I-NP O
, , O O
were VBD B-VP O
found VBN I-VP O
to TO I-VP O
overlap VB I-VP O
, , O O
forming VBG B-VP O
a DT B-NP O
single JJ I-NP O
gene NN I-NP O
, , O O
DP2 NN B-NP O
. . O O

5 CD B-NP O
, , O O
that WDT B-NP O
is VBZ B-VP O
transcribed VBN I-VP O
in IN B-PP O
the DT B-NP O
same JJ I-NP O
orientation NN I-NP O
as IN B-PP O
SRP19 NN B-NP O
. . O O

Exclusion NN B-NP O
of IN B-PP O
linkage NN B-NP O
between IN B-PP O
familial JJ B-NP B-Disease
Mediterranean JJ I-NP I-Disease
fever NN I-NP I-Disease
and CC O O
the DT B-NP O
human JJ I-NP O
serum NN I-NP O
amyloid NN I-NP O
A NN I-NP O
( ( O O
SAA NN B-NP O
) ) O O
gene NN B-NP O
cluster NN I-NP O
. . O O

We PRP B-NP O
studied VBD B-VP O
the DT B-NP O
relationship NN I-NP O
between IN B-PP O
the DT B-NP O
autosomal JJ I-NP O
recessive JJ I-NP O
trait NN I-NP O
familial JJ I-NP B-Disease
Mediterranean JJ I-NP I-Disease
fever NN I-NP I-Disease
( ( O O
FMF NN B-NP B-Disease
) ) O O
and CC O O
the DT B-NP O
serum NN I-NP O
amyloid NN I-NP O
A NN I-NP O
( ( O O
SAA NN B-NP O
) ) O O
genes NNS B-NP O
by IN B-PP O
comparing VBG B-VP O
alleles NNS B-NP O
of IN B-PP O
a DT B-NP O
highly RB I-NP O
polymorphic JJ I-NP O
dinucleotide NN I-NP O
repeat NN I-NP O
and CC O O
a DT B-NP O
conventional JJ I-NP O
restriction NN I-NP O
fragment NN I-NP O
length NN I-NP O
polymorphism NN I-NP O
( ( O O
RFLP NN B-NP O
) ) O O
in IN B-PP O
the DT B-NP O
SAA NN I-NP O
gene NN I-NP O
cluster NN I-NP O
in IN B-PP O
Israeli JJ B-NP O
FMF NN I-NP B-Disease
kindreds NNS I-NP O
. . O O

By IN B-PP O
haplotype NN B-NP O
analysis NN I-NP O
, , O O
our PRP$ B-NP O
data NNS I-NP O
indicate VBP B-VP O
a DT B-NP O
minimum JJ I-NP O
crossover NN I-NP O
frequency NN I-NP O
of IN B-PP O
22 CD B-NP O
% NN I-NP O
between IN B-PP O
the DT B-NP O
SAA NN I-NP O
gene NN I-NP O
marker NN I-NP O
and CC O O
FMF NN B-NP B-Disease
. . O O

By IN B-PP O
conventional JJ B-NP O
linkage NN I-NP O
analysis NN I-NP O
this DT B-NP O
eliminates VBZ B-VP O
a DT B-NP O
minimum NN I-NP O
of IN B-PP O
10 CD B-NP O
. . O O

4 CD B-NP O
cM NN I-NP O
including VBG B-PP O
and CC O O
surrounding VBG B-VP O
the DT B-NP O
SAA NN I-NP O
gene NN I-NP O
cluster NN I-NP O
as IN B-PP O
the DT B-NP O
site NN I-NP O
of IN B-PP O
the DT B-NP O
FMF NN I-NP B-Disease
mutation NN I-NP O
although IN B-SBAR O
SAA NN B-NP O
proteins NNS I-NP O
are VBP B-VP O
prominent JJ B-NP O
physiologic JJ I-NP O
markers NNS I-NP O
of IN B-PP O
the DT B-NP O
acute JJ I-NP O
attacks NNS I-NP O
. . O O

PRAD1 NN B-NP O
, , O O
a DT B-NP O
candidate NN I-NP O
BCL1 NN I-NP O
oncogene NN I-NP O
: : O O
mapping NN B-NP O
and CC I-NP O
expression NN I-NP O
in IN B-PP O
centrocytic JJ B-NP B-Disease
lymphoma NN I-NP I-Disease
. . O O

Rearrangement NN B-NP O
of IN B-PP O
the DT B-NP O
BCL1 NN I-NP O
( ( O O
B NN B-NP O
- HYPH O O
cell NN B-NP O
lymphoma NN I-NP O
1 CD O O
) ) O O
region NN B-NP O
on IN B-PP O
chromosome NN B-NP O
11q13 NN I-NP O
appears VBZ B-VP O
to TO I-VP O
be VB I-VP O
highly RB B-ADJP O
characteristic JJ I-ADJP O
of IN B-PP O
centrocytic JJ B-NP B-Disease
lymphoma NN I-NP I-Disease
and CC O O
also RB B-ADVP O
is VBZ B-VP O
found VBN I-VP O
infrequently RB B-ADVP O
in IN B-PP O
other JJ B-NP O
B NN I-NP B-Disease
- HYPH B-NP I-Disease
cell NN I-NP I-Disease
neoplasms NNS I-NP I-Disease
. . O O

Rearrangement NN B-NP O
is VBZ B-VP O
thought VBN I-VP O
to TO I-VP O
deregulate VB I-VP O
a DT B-NP O
nearby JJ I-NP O
protooncogene NN I-NP O
, , O O
but CC O O
transcribed VBN B-VP O
sequences NNS B-NP O
in IN B-PP O
the DT B-NP O
immediate JJ I-NP O
vicinity NN I-NP O
of IN B-PP O
BCL1 NN B-NP O
breakpoints NNS I-NP O
had VBD B-VP O
not RB I-VP O
been VBN I-VP O
identified VBN I-VP O
. . O O

PRAD1 NN B-NP O
, , O O
previously RB B-NP O
designated VBN I-NP O
D11S287E NN I-NP O
, , O O
was VBD B-VP O
identified VBN I-VP O
on IN B-PP O
11q13 NN B-NP O
as IN B-PP O
a DT B-NP O
chromosomal JJ I-NP O
breakpoint NN I-NP O
region NN I-NP O
rearranged VBN B-VP O
with IN B-PP O
the DT B-NP O
parathyroid JJ I-NP O
hormone NN I-NP O
gene NN I-NP O
in IN B-PP O
a DT B-NP O
subset NN I-NP O
of IN B-PP O
parathyroid JJ B-NP B-Disease
adenomas NNS I-NP I-Disease
; : O O
this DT B-NP O
highly RB I-NP O
conserved VBN I-NP O
putative JJ I-NP O
oncogene NN I-NP O
, , O O
which WDT B-NP O
encodes VBZ B-VP O
a DT B-NP O
novel JJ I-NP O
cyclin NN I-NP O
, , O O
has VBZ B-VP O
been VBN I-VP O
linked VBN I-VP O
to TO B-PP O
BCL1 NN B-NP O
and CC O O
implicated VBN B-VP O
also RB B-ADVP O
in IN B-PP O
subsets NNS B-NP O
of IN B-PP O
breast NN B-NP B-Disease
and CC O I-Disease
squamous JJ B-NP I-Disease
cell NN I-NP I-Disease
neoplasms NNS I-NP I-Disease
with IN B-PP O
11q13 NN B-NP O
amplification NN I-NP O
. . O O

We PRP B-NP O
report VBP B-VP O
pulsed VBN I-VP O
- HYPH B-NP O
field NN I-NP O
gel NN I-NP O
electrophoresis NN I-NP O
data NNS I-NP O
showing VBG B-VP O
BCL1 NN B-NP O
and CC I-NP O
PRAD1 NN I-NP O
to TO B-VP O
be VB I-VP O
no RB B-NP O
more JJR I-NP O
than IN I-NP O
130 CD I-NP O
kilobases NNS I-NP O
apart RB B-ADVP O
. . O O

PRAD1 NN B-NP O
mRNA NN I-NP O
is VBZ B-VP O
abundantly RB I-VP O
expressed VBN I-VP O
in IN B-PP O
seven CD B-NP O
of IN B-PP O
seven CD B-NP O
centrocytic JJ I-NP B-Disease
lymphomas NNS I-NP I-Disease
( ( O O
Kiel NN B-NP O
classification NN I-NP O
) ) O O
, , O O
in IN B-PP O
contrast NN B-NP O
to TO B-PP O
13 CD B-NP O
closely RB I-NP O
related JJ I-NP O
but CC I-NP O
noncentrocytic JJ I-NP B-Disease
lymphomas NNS I-NP I-Disease
. . O O

Three CD B-NP O
of IN B-PP O
the DT B-NP O
seven CD I-NP O
centrocytic JJ I-NP B-Disease
lymphomas NNS I-NP I-Disease
had VBD B-VP O
detectable JJ B-NP O
BCL1 NN I-NP O
DNA NN I-NP O
rearrangement NN I-NP O
. . O O

Also RB B-ADVP O
, , O O
two CD B-NP O
unusual JJ I-NP O
cases NNS I-NP O
of IN B-PP O
CLL NN B-NP O
with IN B-PP O
BCL1 NN B-NP O
rearrangement NN I-NP O
overexpressed VBD B-VP O
PRAD1 NN B-NP O
, , O O
in IN B-PP O
contrast NN B-NP O
to TO B-PP O
five CD B-NP O
CLL NN I-NP O
controls NNS I-NP O
. . O O

Thus RB B-ADVP O
, , O O
PRAD1 NN B-NP O
is VBZ B-VP O
an DT B-NP O
excellent JJ I-NP O
candidate NN I-NP O
BCL1 NN B-NP O
oncogene NN I-NP O
. . O O

Its PRP$ B-NP O
overexpression NN I-NP O
may MD B-VP O
be VB I-VP O
a DT B-NP O
key JJ I-NP O
consequence NN I-NP O
of IN B-PP O
rearrangement NN B-NP O
of IN B-PP O
the DT B-NP O
BCL1 NN I-NP O
vicinity NN I-NP O
in IN B-PP O
B NN B-NP B-Disease
- HYPH B-NP I-Disease
cell NN I-NP I-Disease
neoplasms NNS I-NP I-Disease
and CC O O
a DT B-NP O
unifying JJ I-NP O
pathogenetic JJ I-NP O
feature NN I-NP O
in IN B-PP O
centrocytic JJ B-NP B-Disease
lymphoma NN I-NP I-Disease
. . O O

Two CD B-NP O
new JJ I-NP O
arylsulfatase NN I-NP O
A NN I-NP O
( ( O O
ARSA NN B-NP O
) ) O O
mutations NNS B-NP O
in IN B-PP O
a DT B-NP O
juvenile JJ I-NP O
metachromatic JJ I-NP B-Disease
leukodystrophy NN I-NP I-Disease
( ( O O
MLD NN B-NP B-Disease
) ) O O
patient NN B-NP O
. . O O

Fragments NNS B-NP O
of IN B-PP O
the DT B-NP O
arylsulfatase NN I-NP O
A NN I-NP O
( ( O O
ARSA NN B-NP O
) ) O O
gene NN B-NP O
from IN B-PP O
a DT B-NP O
patient NN I-NP O
with IN B-PP O
juvenile JJ B-NP O
- HYPH I-NP O
onset NN I-NP O
metachromatic JJ I-NP B-Disease
leukodystrophy NN I-NP I-Disease
( ( O O
MLD NN B-NP B-Disease
) ) O O
were VBD B-VP O
amplified VBN I-VP O
by IN B-PP O
PCR NN B-NP O
and CC O O
ligated VBN B-VP O
into IN B-PP O
MP13 NN B-NP O
cloning NN I-NP O
vectors NNS I-NP O
. . O O

Clones NNS B-NP O
hybridizing VBG B-VP O
with IN B-PP O
cDNA NN B-NP O
for IN B-PP O
human JJ B-NP O
ARSA NN I-NP O
were VBD B-VP O
selected VBN I-VP O
, , O O
examined VBN B-VP O
for IN B-PP O
appropriate JJ B-NP O
size NN I-NP O
inserts NNS I-NP O
, , O O
and CC O O
used VBN B-VP O
to TO B-VP O
prepare VB I-VP O
single JJ B-NP O
- HYPH I-NP O
stranded JJ I-NP O
phage NN I-NP O
DNA NN I-NP O
. . O O

Examination NN B-NP O
of IN B-PP O
the DT B-NP O
entire JJ I-NP O
coding NN I-NP O
and CC O O
most JJS B-NP O
of IN B-PP O
the DT B-NP O
intronic JJ I-NP O
sequence NN I-NP O
revealed VBD B-VP O
two CD B-NP O
putative JJ I-NP O
disease NN I-NP O
- HYPH B-NP O
related VBN I-NP O
mutations NNS I-NP O
. . O O

One CD B-NP O
, , O O
a DT B-NP O
point NN I-NP O
mutation NN I-NP O
in IN B-PP O
exon NN B-NP O
3 CD I-NP O
, , O O
resulted VBD B-VP O
in IN B-PP O
the DT B-NP O
substitution NN I-NP O
of IN B-PP O
isoleucine NN B-NP O
by IN B-PP O
serine NN B-NP O
. . O O

Introduction NN B-NP O
of IN B-PP O
this DT B-NP O
alteration NN I-NP O
into IN B-PP O
the DT B-NP O
normal JJ I-NP O
ARSA NN I-NP O
cDNA NN I-NP O
sequence NN I-NP O
resulted VBD B-VP O
in IN B-PP O
a DT B-NP O
substantial JJ I-NP O
decrease NN I-NP O
in IN B-PP O
ARSA NN B-NP O
activity NN I-NP O
on IN B-PP O
transient JJ B-NP O
expression NN I-NP O
in IN B-PP O
cultured VBN B-NP O
baby NN I-NP O
hamster NN I-NP O
kidney NN I-NP O
cells NNS I-NP O
. . O O

About RB B-NP O
5 CD I-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
control NN I-NP O
expression NN I-NP O
was VBD B-VP O
observed VBN I-VP O
, , O O
suggesting VBG B-VP O
a DT B-NP O
small JJ I-NP O
residual JJ I-NP O
activity NN I-NP O
in IN B-PP O
the DT B-NP O
mutated VBN I-NP O
ARSA NN I-NP O
. . O O

The DT B-NP O
second JJ I-NP O
mutation NN I-NP O
, , O O
a DT B-NP O
G NN I-NP O
- HYPH B-ADJP O
to TO B-PP O
- HYPH B-NP O
A NN I-NP O
transition NN I-NP O
, , O O
occurred VBD B-VP O
in IN B-PP O
the DT B-NP O
other JJ I-NP O
allele NN I-NP O
and CC O O
resulted VBD B-VP O
in IN B-PP O
an DT B-NP O
altered JJ I-NP O
splice NN I-NP O
- HYPH B-NP O
recognition NN I-NP O
sequence NN I-NP O
between IN B-PP O
exon NN B-NP O
7 CD I-NP O
and CC O O
the DT B-NP O
following JJ I-NP O
intron NN I-NP O
. . O O

The DT B-NP O
mutation NN I-NP O
also RB B-ADVP O
resulted VBD B-VP O
in IN B-PP O
the DT B-NP O
loss NN I-NP O
of IN B-PP O
a DT B-NP O
restriction NN I-NP O
site NN I-NP O
. . O O

Apparently RB B-NP O
normal JJ I-NP O
levels NNS I-NP O
of IN B-PP O
mRNA NN B-NP O
were VBD B-VP O
generated VBN I-VP O
from IN B-PP O
this DT B-NP O
allele NN I-NP O
, , O O
but CC O O
no DT B-NP O
ARSA NN I-NP O
activity NN I-NP O
or CC O O
immuno AFX O O
- HYPH B-NP O
cross AFX I-NP O
- HYPH I-NP O
reactive JJ I-NP O
material NN I-NP O
could MD B-VP O
be VB I-VP O
detected VBN I-VP O
. . O O

A DT B-NP O
collection NN I-NP O
of IN B-PP O
DNA NN B-NP O
samples NNS I-NP O
from IN B-PP O
known VBN B-NP O
or CC I-NP O
suspected VBN I-NP O
MLD NN I-NP B-Disease
patients NNS I-NP O
, , O O
members NNS B-NP O
of IN B-PP O
their PRP$ B-NP O
families NNS I-NP O
, , O O
and CC O O
normal JJ B-NP O
controls NNS I-NP O
was VBD B-VP O
screened VBN I-VP O
for IN B-PP O
these DT B-NP O
mutations NNS I-NP O
. . O O

Four CD B-NP O
additional JJ I-NP O
individuals NNS I-NP O
carrying VBG B-VP O
each DT B-NP O
of IN B-PP O
the DT B-NP O
mutations NNS I-NP O
were VBD B-VP O
found VBN I-VP O
among IN B-PP O
the DT B-NP O
nearly RB I-NP O
100 CD I-NP O
MLD NN I-NP B-Disease
patients NNS I-NP O
in IN B-PP O
the DT B-NP O
sample NN I-NP O
. . O O

Gene NN B-NP O
segregation NN I-NP O
in IN B-PP O
the DT B-NP O
original JJ I-NP O
patients NNS I-NP O
family NN I-NP O
was VBD B-VP O
consistent JJ B-ADJP O
with IN B-PP O
available JJ B-NP O
clinical JJ I-NP O
and CC I-NP O
biochemical JJ I-NP O
data NNS I-NP O
. . O O

No DT B-NP O
individuals NNS I-NP O
homozygous JJ B-ADJP O
for IN B-PP O
either DT B-NP O
of IN B-PP O
these DT B-NP O
two CD I-NP O
mutations NNS I-NP O
were VBD B-VP O
identified VBN I-VP O
. . O O

However RB B-ADVP O
, , O O
combinations NNS B-NP O
with IN B-PP O
other JJ B-NP O
MLD NN I-NP B-Disease
mutations NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
the DT B-NP O
point NN I-NP O
mutation NN I-NP O
in IN B-PP O
exon NN B-NP O
3 CD I-NP O
does VBZ B-VP O
result VB I-VP O
in IN B-PP O
some DT B-NP O
residual JJ I-NP O
enzyme NN I-NP O
activity NN I-NP O
and CC O O
is VBZ B-VP O
associated VBN I-VP O
with IN B-PP O
late JJ B-NP O
- HYPH I-NP O
onset NN I-NP O
forms NNS I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
. . O O

The DT B-NP O
splice NN I-NP O
- HYPH I-NP O
site NN I-NP O
mutation NN I-NP O
following VBG B-PP O
exon NN B-NP O
7 CD I-NP O
produces VBZ B-VP O
late JJ B-NP O
- HYPH I-NP O
infantile JJ I-NP O
MLD NN I-NP B-Disease
when WRB B-ADVP O
combined VBN B-VP O
with IN B-PP O
other JJ B-NP O
enzyme NN I-NP O
- HYPH B-NP O
mutations NNS I-NP O
, , O O
implying VBG B-VP O
that IN B-SBAR O
it PRP B-NP O
is VBZ B-VP O
completely RB B-ADJP O
silent JJ I-ADJP O
enzymatically RB B-ADVP O
. . O O

. . O O

Analysis NN B-NP O
of IN B-PP O
X NN B-NP O
- HYPH B-NP O
chromosome NN I-NP O
inactivation NN I-NP O
and CC O O
presumptive JJ B-NP O
expression NN I-NP O
of IN B-PP O
the DT B-NP O
Wiskott NNP I-NP B-Disease
- HYPH I-NP I-Disease
Aldrich NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
WAS NN B-NP B-Disease
) ) O O
gene NN B-NP O
in IN B-PP O
hematopoietic JJ B-NP O
cell NN I-NP O
lineages NNS I-NP O
of IN B-PP O
a DT B-NP O
thrombocytopenic JJ I-NP O
carrier NN I-NP O
female NN I-NP O
of IN B-PP O
WAS NNP B-NP B-Disease
. . O O

We PRP B-NP O
report VBP B-VP O
on IN B-PP O
a DT B-NP O
thrombocytopenic JJ I-NP B-Disease
female NN I-NP O
belonging VBG B-VP O
to TO B-PP O
a DT B-NP O
pedigree NN I-NP O
with IN B-PP O
the DT B-NP O
Wiskott NNP I-NP B-Disease
- HYPH I-NP I-Disease
Aldrich NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
WAS NN B-NP B-Disease
) ) O O
. . O O

Restriction NN B-NP O
fragment NN I-NP O
length NN I-NP O
polymorphism NN I-NP O
( ( O O
RFLP NN B-NP O
) ) O O
analysis NN B-NP O
with IN B-PP O
probe NN B-NP O
M27 NN I-NP O
beta NN I-NP O
, , O O
closely RB B-VP O
linked VBN I-VP O
to TO B-PP O
the DT B-NP O
WAS NN I-NP B-Disease
gene NN I-NP O
, , O O
demonstrated VBD B-VP O
that IN B-SBAR O
she PRP B-NP O
is VBZ B-VP O
a DT B-NP O
carrier NN I-NP O
of IN B-PP O
WAS NNP B-NP B-Disease
. . O O

Both CC O O
small JJ B-NP O
- HYPH I-NP O
sized JJ I-NP O
and CC I-NP O
normal JJ I-NP O
- HYPH I-NP O
sized VBN I-NP O
platelets NNS I-NP O
were VBD B-VP O
present JJ B-ADJP O
, , O O
suggesting VBG B-VP O
that IN B-SBAR O
, , O O
unlike IN B-PP O
the DT B-NP O
vast JJ I-NP O
majority NN I-NP O
of IN B-PP O
WAS NN B-NP B-Disease
carriers NNS I-NP O
, , O O
she PRP B-NP O
does VBZ B-VP O
not RB I-VP O
manifest VB I-VP O
nonrandom JJ B-NP O
X NN I-NP O
- HYPH B-NP O
chromosome NN I-NP O
inactivation NN I-NP O
in IN B-PP O
the DT B-NP O
thrombopoietic JJ I-NP O
cell NN I-NP O
lineage NN I-NP O
. . O O

Study NN B-NP O
of IN B-PP O
X NN B-NP O
- HYPH B-NP O
chromosome NN I-NP O
inactivation NN I-NP O
by IN B-PP O
means NNS B-NP O
of IN B-PP O
RFLP NN B-NP O
and CC I-NP O
methylation NN I-NP O
analysis NN I-NP O
demonstrated VBD B-VP O
that IN B-SBAR O
the DT B-NP O
pattern NN I-NP O
of IN B-PP O
X NN B-NP O
- HYPH B-NP O
chromosome NN I-NP O
inactivation NN I-NP O
was VBD B-VP O
nonrandom JJ B-ADJP O
in IN B-PP O
T NN B-NP O
lymphocytes NNS I-NP O
, , O O
but CC O O
random VBP B-VP O
in IN B-PP O
granulocytes NNS B-NP O
. . O O

While IN B-SBAR O
this DT B-NP O
is VBZ B-VP O
the DT B-NP O
first JJ I-NP O
complete JJ I-NP O
report NN I-NP O
on IN B-PP O
the DT B-NP O
occurrence NN I-NP O
of IN B-PP O
thrombocytopenia NN B-NP B-Disease
in IN B-PP O
a DT B-NP O
carrier NN I-NP O
female NN I-NP O
of IN B-PP O
WAS NN B-NP B-Disease
as IN B-PP O
the DT B-NP O
result NN I-NP O
of IN B-PP O
atypical JJ B-NP O
lyonization NN I-NP O
, , O O
it PRP B-NP O
also RB B-ADVP O
suggests VBZ B-VP O
that IN B-SBAR O
expression NN B-NP O
of IN B-PP O
the DT B-NP O
WAS NN I-NP B-Disease
gene NN I-NP O
occurs VBZ B-VP O
at IN B-PP O
( ( O O
or CC O O
extends VBZ B-VP O
up RP B-PRT O
to TO B-PP O
) ) O O
a DT B-NP O
later JJ I-NP O
stage NN I-NP O
than IN B-PP O
the DT B-NP O
multipotent JJ I-NP O
stem NN I-NP O
cell NN I-NP O
along IN B-PP O
the DT B-NP O
hematopoietic JJ I-NP O
differentiation NN I-NP O
pathway NN I-NP O
. . O O

. . O O

A DT B-NP O
new JJ I-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
proteolipid NN I-NP O
protein NN I-NP O
( ( O O
PLP NN B-NP O
) ) O O
gene NN B-NP O
in IN B-PP O
a DT B-NP O
German JJ I-NP O
family NN I-NP O
with IN B-PP O
Pelizaeus NNP B-NP B-Disease
- HYPH B-NP I-Disease
Merzbacher NNP I-NP I-Disease
disease NN I-NP I-Disease
. . O O

A DT B-NP O
C NN I-NP O
- HYPH B-ADJP O
to TO B-PP O
- HYPH B-NP O
T NN I-NP O
transition NN I-NP O
in IN B-PP O
exon NN B-NP O
4 CD I-NP O
of IN B-PP O
the DT B-NP O
PLP NN I-NP O
gene NN I-NP O
was VBD B-VP O
found VBN I-VP O
in IN B-PP O
2 CD B-NP O
affected VBN I-NP O
males NNS I-NP O
and CC O O
two CD B-NP O
obligate JJ I-NP O
carriers NNS I-NP O
in IN B-PP O
a DT B-NP O
German JJ I-NP O
family NN I-NP O
with IN B-PP O
Pelizaeus NNP B-NP B-Disease
- HYPH B-NP I-Disease
Merzbacher NNP I-NP I-Disease
disease NN I-NP I-Disease
. . O O

The DT B-NP O
mutation NN I-NP O
, , O O
which WDT B-NP O
causes VBZ B-VP O
loss NN B-NP O
of IN B-PP O
an DT B-NP O
HphI NN I-NP O
site NN I-NP O
and CC I-NP O
changes NNS I-NP O
amino NN I-NP O
acid NN I-NP O
155 CD I-NP O
from IN B-PP O
threonine NN B-NP O
to TO B-PP O
isoleucine NN B-NP O
, , O O
was VBD B-VP O
absent JJ B-ADJP O
from IN B-PP O
108 CD B-NP O
normal JJ I-NP O
chromosomes NNS I-NP O
. . O O

There EX B-NP O
are VBP B-VP O
5 CD B-NP O
concordances NNS I-NP O
and CC O O
1 CD B-NP O
discrepancy NN I-NP O
between IN B-PP O
these DT B-NP O
results NNS I-NP O
and CC O O
those DT B-NP O
obtained VBN B-VP O
by IN B-PP O
magnetic JJ B-NP O
resonance NN I-NP O
imaging NN I-NP O
in IN B-PP O
this DT B-NP O
family NN I-NP O
. . O O

. . O O

A DT B-NP O
3 CD I-NP O
- HYPH I-NP O
base NN I-NP O
pair NN I-NP O
in IN B-PP O
- HYPH B-NP O
frame NN I-NP O
deletion NN I-NP O
of IN B-PP O
the DT B-NP O
phenylalanine NN I-NP O
hydroxylase NN I-NP O
gene NN I-NP O
results VBZ B-VP O
in IN B-PP O
a DT B-NP O
kinetic JJ I-NP O
variant NN I-NP O
of IN B-PP O
phenylketonuria NN B-NP B-Disease
. . O O

Phenylketonuria NN B-NP B-Disease
( ( O O
PKU NN B-NP B-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
disease NN I-NP I-Disease
due JJ B-ADJP O
to TO B-PP O
deficiency NN B-NP B-Disease
of IN B-PP I-Disease
a DT B-NP I-Disease
hepatic JJ I-NP I-Disease
enzyme NN I-NP I-Disease
, , O I-Disease
phenylalanine NN B-NP I-Disease
hydroxylase NN I-NP I-Disease
( ( O O
PAH NN B-NP O
) ) O O
. . O O

The DT B-NP O
absence NN I-NP O
of IN B-PP O
PAH NN B-NP O
activity NN I-NP O
results VBZ B-VP O
in IN B-PP O
typical JJ B-NP O
PKU NN I-NP B-Disease
while IN B-SBAR O
persistence NN B-NP O
of IN B-PP O
a DT B-NP O
residual JJ I-NP O
enzyme NN I-NP O
activity NN I-NP O
gives VBZ B-VP O
rise NN B-NP O
to TO B-PP O
variant JJ B-NP O
forms NNS I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
. . O O

We PRP B-NP O
report VBP B-VP O
here RB B-ADVP O
a DT B-NP O
3 CD I-NP O
- HYPH I-NP O
base NN I-NP O
pair NN I-NP O
in IN B-PP O
- HYPH B-NP O
frame NN I-NP O
deletion NN I-NP O
of IN B-PP O
the DT B-NP O
PAH NN I-NP O
gene NN I-NP O
( ( O O
delta SYM B-NP O
194 CD I-NP O
) ) O O
in IN B-PP O
a DT B-NP O
mild JJ I-NP O
variant NN I-NP O
, , O O
with IN B-PP O
markedly RB B-NP O
reduced VBN I-NP O
affinity NN I-NP O
of IN B-PP O
the DT B-NP O
enzyme NN I-NP O
for IN B-PP O
phenylalanine NN B-NP O
( ( O O
Km NN B-NP O
= SYM B-VP O
160 CD B-NP O
nM NN I-NP O
) ) O O
, , O O
and CC O O
we PRP B-NP O
provide VBP B-VP O
functional JJ B-NP O
evidence NN I-NP O
for IN B-PP O
responsibility NN B-NP O
of IN B-PP O
the DT B-NP O
deletion NN I-NP O
in IN B-PP O
the DT B-NP O
mutant JJ I-NP O
phenotype NN I-NP O
. . O O

Since IN B-SBAR O
the DT B-NP O
deletion NN I-NP O
was VBD B-VP O
located VBN I-VP O
in IN B-PP O
the DT B-NP O
third JJ I-NP O
exon NN I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
, , O O
which WDT B-NP O
presents VBZ B-VP O
no DT B-NP O
homology NN I-NP O
with IN B-PP O
other JJ B-NP O
hydroxylases NNS I-NP O
, , O O
we PRP B-NP O
suggest VBP B-VP O
that IN B-SBAR O
exon NN B-NP O
3 CD I-NP O
is VBZ B-VP O
involved VBN I-VP O
in IN B-PP O
the DT B-NP O
specificity NN I-NP O
of IN B-PP O
the DT B-NP O
enzyme NN I-NP O
for IN B-PP O
phenylalanine NN B-NP O
. . O O

Finally RB B-ADVP O
, , O O
since IN B-SBAR O
none NN B-NP O
of IN B-PP O
the DT B-NP O
98 CD I-NP O
PKU NN I-NP B-Disease
patients NNS I-NP O
tested VBN B-VP O
were VBD B-VP O
found VBN I-VP O
to TO I-VP O
carry VB I-VP O
this DT B-NP O
particular JJ I-NP O
deletion NN I-NP O
, , O O
our PRP$ B-NP O
study NN I-NP O
suggests VBZ B-VP O
that IN B-SBAR O
this DT B-NP O
molecular JJ I-NP O
event NN I-NP O
probably RB B-ADVP O
occurred VBD B-VP O
recently RB B-ADVP O
on IN B-PP O
the DT B-NP O
background NN I-NP O
of IN B-PP O
a DT B-NP O
haplotype NN I-NP O
2 CD I-NP O
gene NN I-NP O
in IN B-PP O
Portugal NNP B-NP O
. . O O

. . O O

Mutation NN B-NP O
of IN B-PP O
the DT B-NP O
KIT NN I-NP O
( ( O O
mast NN B-NP O
/ SYM O O
stem NN B-NP O
cell NN I-NP O
growth NN I-NP O
factor NN I-NP O
receptor NN I-NP O
) ) O O
protooncogene NN B-NP O
in IN B-PP O
human JJ B-NP O
piebaldism NN I-NP B-Disease
. . O O

Piebaldism NNP B-NP B-Disease
is VBZ B-VP O
an DT B-NP O
autosomal JJ I-NP B-Disease
dominant JJ I-NP I-Disease
genetic JJ I-NP I-Disease
disorder NN I-NP I-Disease
characterized VBN B-VP O
by IN B-PP O
cogenital JJ B-NP O
patches NNS I-NP O
of IN B-PP O
skin NN B-NP O
and CC I-NP O
hair NN I-NP O
from IN B-PP O
which WDT B-NP O
melanocytes NNS B-NP O
are VBP B-VP O
completely RB B-ADJP O
absent JJ I-ADJP O
. . O O

A DT B-NP O
similar JJ I-NP O
disorder NN I-NP O
of IN B-PP O
mouse NN B-NP O
, , O O
dominant JJ B-NP O
white JJ I-NP O
spotting NN I-NP O
( ( O O
W NN B-NP O
) ) O O
, , O O
results VBZ B-VP O
from IN B-PP O
mutations NNS B-NP O
of IN B-PP O
the DT B-NP O
c NN I-NP O
- HYPH B-NP O
Kit NN I-NP O
protooncogene NN I-NP O
, , O O
which WDT B-NP O
encodes VBZ B-VP O
and CC O O
receptor NN B-NP O
for IN B-PP O
mast NN B-NP O
/ SYM I-NP O
stem NN I-NP O
cell NN I-NP O
growth NN I-NP O
factor NN I-NP O
. . O O

We PRP B-NP O
identified VBD B-VP O
a DT B-NP O
KIT NN I-NP O
gene NN I-NP O
mutation NN I-NP O
in IN B-PP O
a DT B-NP O
proband NN I-NP O
with IN B-PP O
classic JJ B-NP O
autosomal JJ I-NP O
dominant JJ I-NP O
piebaldism NN I-NP B-Disease
. . O O

This DT B-NP O
mutation NN I-NP O
results VBZ B-VP O
in IN B-PP O
a DT B-NP O
Gly NN I-NP O
- SYM B-NP O
- SYM B-NP O
- SYM I-NP O
- HYPH I-NP O
Arg NN I-NP O
substitution NN I-NP O
at IN B-PP O
codon NN B-NP O
664 CD I-NP O
, , O O
within IN B-PP O
the DT B-NP O
tyrosine NN I-NP O
kinase NN I-NP O
domain NN I-NP O
. . O O

This DT B-NP O
substitution NN I-NP O
was VBD B-VP O
not RB I-VP O
seen VBN I-VP O
in IN B-PP O
any DT B-NP O
normal JJ I-NP O
individuals NNS I-NP O
and CC O O
was VBD B-VP O
completely RB I-VP O
linked VBN I-VP O
to TO B-PP O
the DT B-NP O
piebald JJ I-NP B-Disease
phenotype NN I-NP O
in IN B-PP O
the DT B-NP O
probands NNS I-NP O
family NN I-NP O
. . O O

Piebaldism NN B-NP B-Disease
in IN B-PP O
this DT B-NP O
family NN I-NP O
thus RB B-ADVP O
appears VBZ B-VP O
to TO I-VP O
be VB I-VP O
the DT B-NP O
human JJ I-NP O
homologue NN I-NP O
to TO B-PP O
dominant JJ B-NP O
white JJ I-NP O
spotting NN I-NP O
( ( O O
W NN B-NP O
) ) O O
of IN B-PP O
the DT B-NP O
mouse NN I-NP O
. . O O

. . O O

Genetic JJ B-NP O
analysis NN I-NP O
of IN B-PP O
a DT B-NP O
Japanese JJ I-NP O
family NN I-NP O
with IN B-PP O
normotriglyceridemic JJ B-NP B-Disease
abetalipoproteinemia NN I-NP I-Disease
indicates VBZ B-VP O
a DT B-NP O
lack NN I-NP O
of IN B-PP O
linkage NN B-NP O
to TO B-PP O
the DT B-NP O
apolipoprotein NN I-NP O
B NN I-NP O
gene NN I-NP O
. . O O

Normotriglyceridemic JJ B-NP B-Disease
abetalipoproteinemia NN I-NP I-Disease
is VBZ B-VP O
a DT B-NP O
rare JJ I-NP O
familial JJ I-NP B-Disease
disorder NN I-NP I-Disease
characterized VBN B-VP O
by IN B-PP O
an DT B-NP O
isolated VBN I-NP O
deficiency NN I-NP B-Disease
of IN B-PP I-Disease
apoB NN B-NP I-Disease
- HYPH B-NP I-Disease
100 CD I-NP I-Disease
. . O O

We PRP B-NP O
have VBP B-VP O
previously RB I-VP O
reported VBN I-VP O
a DT B-NP O
patient NN I-NP O
with IN B-PP O
this DT B-NP O
disease NN I-NP O
, , O O
who WP B-NP O
had VBD B-VP O
normal JJ B-NP O
apoB NN I-NP O
- HYPH O O
48 CD B-NP O
but CC O O
no DT B-NP O
apoB NN I-NP O
- HYPH B-ADJP O
100 CD B-NP O
. . O O

To TO B-VP O
elucidate VB I-VP O
the DT B-NP O
genetic JJ I-NP B-Disease
abnormalities NNS I-NP I-Disease
in IN B-PP O
this DT B-NP O
family NN I-NP O
, , O O
we PRP B-NP O
studied VBD B-VP O
the DT B-NP O
linkage NN I-NP O
of IN B-PP O
apoB NN B-NP O
gene NN I-NP O
using VBG B-VP O
three CD B-NP O
genetic JJ I-NP O
markers NNS I-NP O
. . O O

The DT B-NP O
proband NN I-NP O
and CC O O
her PRP$ B-NP O
affected VBN I-NP O
brother NN I-NP O
showed VBD B-VP O
completely RB B-NP O
different JJ I-NP O
apoB NN I-NP O
gene NN I-NP O
alleles NNS I-NP O
, , O O
suggesting VBG B-VP O
that IN B-SBAR O
the DT B-NP O
apoB NN I-NP O
gene NN I-NP O
itself PRP B-NP O
is VBZ B-VP O
not RB O O
related JJ B-ADJP O
to TO B-PP O
this DT B-NP O
disorder NN I-NP O
in IN B-PP O
this DT B-NP O
family NN I-NP O
. . O O

By IN B-PP O
contrast NN B-NP O
, , O O
an DT B-NP O
American JJ I-NP O
case NN I-NP O
had VBD B-VP O
a DT B-NP O
point NN I-NP O
substitution NN I-NP O
in IN B-PP O
the DT B-NP O
apoB NN I-NP O
gene NN I-NP O
generating VBG B-VP O
an DT B-ADVP O
in IN B-PP O
- HYPH B-NP O
frame NN I-NP O
stop NN I-NP O
codon NN I-NP O
. . O O

These DT B-NP O
results NNS I-NP O
indicate VBP B-VP O
that IN B-SBAR O
this DT B-NP O
disorder NN I-NP O
can MD B-VP O
be VB I-VP O
caused VBN I-VP O
by IN B-PP O
defect NN B-NP O
( ( O O
s NNS B-NP O
) ) O O
of IN B-PP O
either CC O O
an DT B-NP O
apoB NN I-NP O
gene NN I-NP O
or CC O O
other JJ B-NP O
genes NNS I-NP O
. . O O

. . O O

Localisation NN B-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
for IN B-PP O
Norrie NNP B-NP B-Disease
disease NN I-NP I-Disease
to TO B-PP O
between IN B-PP O
DXS7 NN B-NP O
and CC I-NP O
DXS426 NN I-NP O
on IN B-PP O
Xp NN B-NP O
. . O O

A DT B-NP O
highly RB I-NP O
informative JJ I-NP O
microsatellite NN I-NP O
marker NN I-NP O
, , O O
DXS426 NN B-NP O
, , O O
which WDT B-NP O
maps VBZ B-VP O
proximal JJ B-ADJP O
to TO B-PP O
DXS7 NN B-NP O
in IN B-PP O
the DT B-NP O
interval JJ I-NP O
Xp11 NN I-NP O
. . O O

4 CD B-NP O
- HYPH I-NP O
Xp11 NN I-NP O
4 CD I-NP O
- HYPH I-NP O
Xp11 NN I-NP O
. . O O

23 CD B-NP O
, , O O
has VBZ B-VP O
been VBN I-VP O
used VBN I-VP O
to TO I-VP O
refine VB I-VP O
further RBR B-ADVP O
the DT B-NP O
localisation NN I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
for IN B-PP O
Norrie NNP B-NP B-Disease
disease NN I-NP I-Disease
( ( O O
NDP NN B-NP B-Disease
) ) O O
. . O O

The DT B-NP O
results NNS I-NP O
from IN B-PP O
a DT B-NP O
multiply JJ I-NP O
informative JJ I-NP O
crossover NN I-NP O
localize VBP B-VP O
the DT B-NP O
NDP NN I-NP B-Disease
gene NN I-NP O
proximal JJ B-ADJP O
to TO B-PP O
DXS7 NN B-NP O
. . O O

In IN B-PP O
conjunction NN B-NP O
with IN B-PP O
information NN B-NP O
from IN B-PP O
2 CD B-NP O
NDP NN I-NP B-Disease
patients NNS I-NP O
who WP B-NP O
have VBP B-VP O
a DT B-NP O
deletion NN I-NP O
for IN B-PP O
DXS7 NN B-NP O
but CC B-PP O
not RB B-PP O
for IN I-PP O
DSX426 NN B-NP O
, , O O
our PRP$ B-NP O
data NNS I-NP O
indicate VBP B-VP O
that IN B-SBAR O
the DT B-NP O
NDP NN I-NP B-Disease
gene NN I-NP O
lies VBZ B-VP O
between IN B-PP O
DXS7 NN B-NP O
and CC I-NP O
DXS426 NN I-NP O
on IN B-PP O
proximal JJ B-NP O
Xp NN I-NP O
. . O O

Aberrant JJ B-NP O
splicing NN I-NP O
of IN B-PP O
phenylalanine NN B-NP O
hydroxylase NN I-NP O
mRNA NN I-NP O
: : O O
the DT B-NP O
major JJ I-NP O
cause NN I-NP O
for IN B-PP O
phenylketonuria NN B-NP B-Disease
in IN B-PP O
parts NNS B-NP O
of IN B-PP O
southern JJ B-NP O
Europe NNP I-NP O
. . O O

We PRP B-NP O
report VBP B-VP O
a DT B-NP O
mutation NN I-NP O
within IN B-PP O
the DT B-NP O
phenylalanine NN I-NP O
hydroxylase NN I-NP O
( ( O O
PAH NN B-NP O
) ) O O
gene NN B-NP O
that WDT B-NP O
causes VBZ B-VP O
aberrant JJ B-NP O
splicing NN I-NP O
of IN B-PP O
the DT B-NP O
mRNA NN I-NP O
and CC O O
that DT B-NP O
is VBZ B-VP O
in IN B-PP O
tight JJ B-NP O
association NN I-NP O
with IN B-PP O
chromosomal JJ B-NP O
haplotypes NNS I-NP O
6 CD B-NP O
, , I-NP O
10 CD I-NP O
, , O O
and CC O O
36 CD B-NP O
. . O O

Because IN B-PP O
of IN I-PP O
the DT B-NP O
high JJ I-NP O
frequency NN I-NP O
of IN B-PP O
these DT B-NP O
particular JJ I-NP O
haplotypes NNS I-NP O
in IN B-PP O
Bulgaria NNP B-NP O
, , O O
Italy NNP B-NP O
, , O O
and CC O O
Turkey NNP B-NP O
, , O O
it PRP B-NP O
appears VBZ B-VP O
to TO I-VP O
be VB I-VP O
one CD B-NP O
of IN B-PP O
the DT B-NP O
more RBR I-NP O
frequent JJ I-NP O
defects NNS I-NP O
in IN B-PP O
the DT B-NP O
PAH NN I-NP O
gene NN I-NP O
causing VBG B-VP O
classical JJ B-NP O
phenylketonuria NN I-NP B-Disease
in IN B-PP O
this DT B-NP O
part NN I-NP O
of IN B-PP O
Europe NNP B-NP O
. . O O

The DT B-NP O
mutation NN I-NP O
is VBZ B-VP O
a DT B-NP O
G NN I-NP O
to TO B-PP O
A NN B-NP O
transition NN I-NP O
at IN B-PP O
position NN B-NP O
546 CD I-NP O
in IN B-PP O
intron NN B-NP O
10 CD I-NP O
of IN B-PP O
the DT B-NP O
PAH NN I-NP O
gene NN I-NP O
, , O O
11 CD B-NP O
bp NN I-NP O
upstream RB B-ADVP O
from IN B-PP O
the DT B-NP O
intron NN I-NP O
10 CD I-NP O
/ SYM I-NP O
exon NN I-NP O
11 CD I-NP O
boundary NN I-NP O
. . O O

It PRP B-NP O
activates VBZ B-VP O
a DT B-NP O
cryptic JJ I-NP O
splice NN I-NP O
site NN I-NP O
and CC O O
results VBZ B-VP O
in IN B-PP O
an DT B-NP O
in IN B-PP O
- HYPH B-NP O
frame NN I-NP O
insertion NN I-NP O
of IN B-PP O
9 CD B-NP O
nucleotides NNS I-NP O
between IN B-PP O
exon NN B-NP O
10 CD I-NP O
and CC I-NP O
exon NN I-NP O
11 CD I-NP O
of IN B-PP O
the DT B-NP O
processed VBN I-NP O
mRNA NN I-NP O
. . O O

Normal JJ B-NP O
amounts NNS I-NP O
of IN B-PP O
liver NN B-NP O
PAH NN I-NP O
protein NN I-NP O
are VBP B-VP O
present JJ B-ADJP O
in IN B-PP O
homozygous JJ B-NP O
patients NNS I-NP O
, , O O
but CC O O
no DT B-NP O
catalytic JJ I-NP O
activity NN I-NP O
can MD B-VP O
be VB I-VP O
detected VBN I-VP O
. . O O

This DT B-NP O
loss NN I-NP O
of IN B-PP O
enzyme NN B-NP O
activity NN I-NP O
is VBZ B-VP O
probably RB I-VP O
caused VBN I-VP O
by IN B-PP O
conformational JJ B-NP O
changes NNS I-NP O
resulting VBG B-VP O
from IN B-PP O
the DT B-NP O
insertion NN I-NP O
of IN B-PP O
three CD B-NP O
additional JJ I-NP O
amino JJ I-NP O
acids NNS I-NP O
( ( O O
Gly NN B-NP O
- HYPH B-NP O
Leu NN I-NP O
- HYPH I-NP O
Gln NN I-NP O
) ) O O
between IN B-PP O
the DT B-NP O
normal JJ I-NP O
sequences NNS I-NP O
encoded VBN B-VP O
by IN B-PP O
exon NN B-NP O
10 CD I-NP O
and CC O O
exon NN B-NP O
11 CD I-NP O
. . O O

. . O O

Gardner NN B-NP B-Disease
syndrome NN I-NP I-Disease
in IN B-PP O
a DT B-NP O
boy NN I-NP O
with IN B-PP O
interstitial JJ B-NP O
deletion NN I-NP O
of IN B-PP O
the DT B-NP O
long JJ I-NP O
arm NN I-NP O
of IN B-PP O
chromosome NN B-NP O
5 CD I-NP O
. . O O

We PRP B-NP O
described VBD B-VP O
a DT B-NP O
15 CD I-NP O
- HYPH I-NP O
year NN I-NP O
- HYPH O O
old JJ B-NP O
boy NN I-NP O
with IN B-PP O
Gardner NN B-NP B-Disease
syndrome NN I-NP I-Disease
( ( O O
GS NN B-NP B-Disease
) ) O O
, , O O
mental JJ B-NP B-Disease
retardation NN I-NP I-Disease
, , O O
and CC O O
craniofacial JJ B-NP B-Disease
abnormalities NNS I-NP I-Disease
. . O O

High JJ B-NP O
- HYPH I-NP O
resolution NN I-NP O
banding NN I-NP O
analysis NN I-NP O
showed VBD B-VP O
an DT B-NP O
interstitial JJ I-NP O
deletion NN I-NP O
of IN B-PP O
the DT B-NP O
long JJ I-NP O
arm NN I-NP O
of IN B-PP O
chromosome NN B-NP O
5 CD I-NP O
( ( O O
q22 NN B-NP O
. . O O

1 CD B-NP O
- HYPH O O
- SYM O O
- SYM O O
- SYM O O
q31 NN B-NP O
1 CD I-NP O
- HYPH B-NP O
- SYM I-NP O
- SYM I-NP O
- HYPH I-NP O
q31 NN I-NP O
. . I-NP O

1 CD I-NP O
) ) O O
. . O O

The DT B-NP O
breakpoints NNS I-NP O
in IN B-PP O
the DT B-NP O
present JJ I-NP O
case NN I-NP O
and CC O O
in IN B-PP O
3 CD B-NP O
previously RB I-NP O
reported VBN I-NP O
5q NN I-NP O
- SYM O O
patients NNS B-NP O
with IN B-PP O
adenomatous JJ B-NP B-Disease
polyposis NN I-NP I-Disease
coli NN I-NP I-Disease
suggest VBP B-VP O
that IN B-SBAR O
the DT B-NP O
gene NN I-NP O
responsible JJ B-ADJP O
for IN B-PP O
GS NN B-NP B-Disease
/ SYM B-NP O
or CC O O
familial JJ B-NP B-Disease
polyposis NN I-NP I-Disease
coli NN I-NP I-Disease
( ( O O
FPC NN B-NP B-Disease
) ) O O
is VBZ B-VP O
in IN B-PP O
the DT B-NP O
5q22 NN I-NP O
region NN I-NP O
, , O O
a DT B-NP O
result NN I-NP O
consistent JJ B-ADJP O
with IN B-PP O
the DT B-NP O
findings NNS I-NP O
of IN B-PP O
linkage NN B-NP O
studies NNS I-NP O
Huntington NNP B-NP B-Disease
disease NN I-NP I-Disease
and CC O O
childhood NN B-NP O
- HYPH B-NP O
onset JJ I-NP O
Tourette NNP I-NP B-Disease
syndrome NN I-NP I-Disease
. . O O

A DT B-NP O
40 CD I-NP O
- HYPH I-NP O
year NN I-NP O
- HYPH O O
old JJ B-NP O
man NN I-NP O
with IN B-PP O
childhood NN B-NP O
- HYPH I-NP O
onset NN I-NP O
Tourette NN I-NP B-Disease
syndrome NN I-NP I-Disease
( ( O O
TS NN B-NP B-Disease
) ) O O
developed VBD B-VP O
Huntington NNP B-NP B-Disease
disease NN I-NP I-Disease
( ( O O
HD NN B-NP B-Disease
) ) O O
. . O O

We PRP B-NP O
believe VBP B-VP O
this DT B-NP O
to TO B-VP O
be VB I-VP O
the DT B-NP O
first JJ I-NP O
reported VBN I-NP O
case NN I-NP O
of IN B-PP O
childhood NN B-NP O
- HYPH B-NP O
onset NN I-NP O
TS NN I-NP B-Disease
with IN B-PP O
adult JJ B-NP O
onset NN I-NP O
HD NN I-NP B-Disease
. . O O

Discovery NNP B-NP O
of IN B-PP O
other JJ B-NP O
cases NNS I-NP O
with IN B-PP O
both DT B-NP O
disorders NNS I-NP O
may MD B-VP O
provide VB I-VP O
clues NNS B-NP O
to TO B-PP O
the DT B-NP O
pathophysiology NN I-NP O
of IN B-PP O
both DT B-NP O
conditions NNS I-NP O
. . O O

. . O O

Sequence NN B-NP O
of IN B-PP O
DNA NN B-NP O
flanking VBG B-VP O
the DT B-NP O
exons NNS I-NP O
of IN B-PP O
the DT B-NP O
HEXA NN I-NP O
gene NN I-NP O
, , O O
and CC O O
identification NN B-NP O
of IN B-PP O
mutations NNS B-NP O
in IN B-PP O
Tay NNP B-NP B-Disease
- HYPH I-NP I-Disease
Sachs NNP I-NP I-Disease
disease NN I-NP I-Disease
. . O O

The DT B-NP O
rapid JJ I-NP O
identification NN I-NP O
of IN B-PP O
mutations NNS B-NP O
causing VBG B-VP O
Tay NNP B-NP B-Disease
- HYPH I-NP I-Disease
Sachs NNP I-NP I-Disease
disease NN I-NP I-Disease
requires VBZ B-VP O
the DT B-NP O
capacity NN I-NP O
to TO B-VP O
readily RB I-VP O
screen VB I-VP O
the DT B-NP O
regions NNS I-NP O
of IN B-PP O
the DT B-NP O
HEXA NN I-NP O
gene NN I-NP O
most RBS B-ADJP O
likely JJ I-ADJP O
to TO B-VP O
be VB I-VP O
affected VBN I-VP O
by IN B-PP O
mutation NN B-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
sequenced VBN I-VP O
the DT B-NP O
portions NNS I-NP O
of IN B-PP O
the DT B-NP O
introns NNS I-NP O
flanking VBG B-VP O
each DT B-NP O
of IN B-PP O
the DT B-NP O
14 CD I-NP O
HEXA NN I-NP O
exons NNS I-NP O
in IN B-SBAR O
order NN O O
to TO B-VP O
specify VB I-VP O
oligonucleotide NN B-NP O
primers NNS I-NP O
for IN B-PP O
the DT B-NP O
PCR NN I-NP O
- HYPH B-NP O
dependent JJ I-NP O
amplification NN I-NP O
of IN B-PP O
each DT B-NP O
exon NN I-NP O
and CC I-NP O
splice NN I-NP O
- HYPH B-NP O
junction NN I-NP O
sequence NN I-NP O
. . O O

The DT B-NP O
amplified VBN I-NP O
products NNS I-NP O
were VBD B-VP O
analyzed VBN I-VP O
, , O O
by IN B-PP O
electrophoresis NN B-NP O
in IN B-PP O
nondenaturing JJ B-NP O
polyacrylamide NN I-NP O
gels NNS I-NP O
, , O O
for IN B-PP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
either DT B-NP O
heteroduplexes NNS I-NP O
, , O O
derived VBN B-VP O
from IN B-PP O
the DT B-NP O
annealing NN I-NP O
of IN B-PP O
normal JJ B-NP O
and CC I-NP O
mutant JJ I-NP O
DNA NN I-NP O
strands NNS I-NP O
, , O O
or CC O O
single JJ B-NP O
- HYPH I-NP O
strand NN I-NP O
conformational JJ I-NP O
polymorphisms NNS I-NP O
( ( O O
SSCP NN B-NP O
) ) O O
, , O O
derived VBN B-VP O
from IN B-PP O
the DT B-NP O
renaturation NN I-NP O
of IN B-PP O
single JJ B-NP O
- HYPH I-NP O
stranded JJ I-NP O
DNA NN I-NP O
. . O O

Five CD B-NP O
novel JJ I-NP O
mutations NNS I-NP O
from IN B-PP O
Tay NNP B-NP B-Disease
- HYPH I-NP I-Disease
Sachs NNP I-NP I-Disease
disease NN I-NP I-Disease
patients NNS I-NP O
were VBD B-VP O
detected VBN I-VP O
a DT B-NP O
5 CD I-NP O
- HYPH I-NP O
bp NN I-NP O
deletion NN I-NP O
of IN B-PP O
TCTCC NN B-NP O
in IN B-PP O
IVS NN B-NP O
- HYPH B-NP O
9 CD I-NP O
; : O O
a DT B-NP O
2 CD I-NP O
- HYPH I-NP O
bp NN I-NP O
deletion NN I-NP O
of IN B-PP O
TG NN B-NP O
in IN B-PP O
exon NN B-NP O
5 CD I-NP O
; : O O
G78 NN B-NP O
to TO B-PP O
A NN B-NP O
, , O O
giving VBG B-VP O
a DT B-NP O
stop NN I-NP O
codon NN I-NP O
in IN B-PP O
exon NN B-NP O
1 CD I-NP O
; : O O
G533 NN B-NP O
to TO B-PP O
T NN B-NP O
in IN B-PP O
exon NN B-NP O
5 CD I-NP O
, , O O
producing VBG B-VP O
the DT B-NP O
third JJ I-NP O
amino NN I-NP O
acid NN I-NP O
substitution NN I-NP O
detected VBN B-VP O
at IN B-PP O
this DT B-NP O
site NN I-NP O
; : O O
and CC O O
G NN B-NP O
to TO B-PP O
C NN B-NP O
at IN B-PP O
position NN B-NP O
1 CD I-NP O
of IN B-PP O
IVS NN B-NP O
- HYPH B-NP O
2 CD I-NP O
, , O O
expected VBN B-VP O
to TO I-VP O
produce VB I-VP O
abnormal JJ B-NP O
splicing NN I-NP O
. . O O

In IN B-PP O
addition NN B-NP O
, , O O
two CD B-NP O
mutations NNS I-NP O
, , O O
( ( O O
G1496 NN B-NP O
to TO B-PP O
A NN B-NP O
in IN B-PP O
exon NN B-NP O
13 CD I-NP O
and CC O O
a DT B-NP O
4 CD I-NP O
- HYPH I-NP O
bp NN I-NP O
insertion NN I-NP O
in IN B-PP O
exon NN B-NP O
11 CD I-NP O
) ) O O
that WDT B-NP O
have VBP B-VP O
previously RB I-VP O
been VBN I-VP O
reported VBN I-VP O
were VBD B-VP O
identified VBN I-VP O
. . O O

. . O O

Molecular JJ B-NP O
characterization NN I-NP O
of IN B-PP O
two CD B-NP O
galactosemia NN I-NP B-Disease
mutations NNS I-NP O
: : O O
correlation NN B-NP O
of IN B-PP O
mutations NNS B-NP O
with IN B-PP O
highly RB B-NP O
conserved JJ I-NP O
domains NNS I-NP O
in IN B-PP O
galactose NN B-NP O
- HYPH B-NP O
1 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
uridyl NN I-NP O
transferase NN I-NP O
. . O O

Galactosemia NN B-NP B-Disease
is VBZ B-VP O
an DT B-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
disorder NN I-NP I-Disease
of IN B-PP I-Disease
human JJ B-NP I-Disease
galactose NN I-NP I-Disease
metabolism NN I-NP I-Disease
caused VBN B-VP O
by IN B-PP O
deficiency NN B-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
enzyme NN I-NP I-Disease
galactose NN I-NP I-Disease
- HYPH B-NP I-Disease
1 CD I-NP I-Disease
- HYPH I-NP I-Disease
phosphate NN I-NP I-Disease
uridyl NN I-NP I-Disease
transferase NN I-NP I-Disease
( ( O O
GALT NN B-NP O
) ) O O
. . O O

The DT B-NP O
molecular JJ I-NP O
basis NN I-NP O
of IN B-PP O
this DT B-NP O
disorder NN I-NP O
is VBZ B-VP O
at IN B-PP O
present JJ B-ADJP O
not RB O O
well RB B-VP O
understood VBN I-VP O
. . O O

We PRP B-NP O
report VBP B-VP O
here RB B-ADVP O
two CD B-NP O
missense JJ I-NP O
mutations NNS I-NP O
which WDT B-NP O
result VBP B-VP O
in IN B-PP O
low JJ B-NP O
or CC I-NP O
undetectable JJ I-NP O
enzymatic JJ I-NP O
activity NN I-NP O
. . O O

First RB B-ADVP O
, , O O
we PRP B-NP O
identified VBD B-VP O
at IN B-PP O
nucleotide NN B-NP O
591 CD I-NP O
a DT B-NP O
transition NN I-NP O
which WDT B-NP O
substitutes VBZ B-VP O
glutamine NN B-NP O
188 CD I-NP O
by IN B-PP O
arginine NN B-NP O
. . O O

The DT B-NP O
mutated VBN I-NP O
glutamine NN I-NP O
is VBZ B-VP O
not RB B-VP O
only RB I-VP O
highly RB I-VP O
conserved VBN I-VP O
in IN B-PP O
evolution NN B-NP O
( ( O O
conserved VBN B-VP O
also RB B-ADVP O
in IN B-PP O
Escherichia NNP B-NP O
coli NNP I-NP O
and CC O O
Saccharomyces NNP B-NP O
cerevisiae NNP I-NP O
) ) O O
, , O O
but CC O O
is VBZ B-VP O
also RB B-ADVP O
two CD B-NP O
amino NN I-NP O
acid NN I-NP O
residues NNS I-NP O
downstream RB B-ADVP O
from IN B-PP O
the DT B-NP O
active JJ I-NP O
site NN I-NP O
histidine NN I-NP O
- HYPH B-NP O
proline NN I-NP O
- HYPH B-NP O
histidine NN I-NP O
triad NN I-NP O
and CC O O
results VBZ B-VP O
in IN B-PP O
about RB B-NP O
10 CD I-NP O
% NN I-NP O
of IN B-PP O
normal JJ B-NP O
enzymatic JJ I-NP O
activity NN I-NP O
. . O O

The DT B-NP O
arginine NN I-NP O
188 CD I-NP O
mutation NN I-NP O
is VBZ B-VP O
the DT B-NP O
most RBS I-NP O
common JJ I-NP O
galactosemia NN I-NP B-Disease
mutation NN I-NP O
characterized VBN B-VP O
to TO B-PP O
date NN B-NP O
. . O O

It PRP B-NP O
accounts VBZ B-VP O
for IN B-PP O
one CD B-NP O
- HYPH I-NP O
fourth JJ I-NP O
of IN B-PP O
the DT B-NP O
galactosemia NN I-NP B-Disease
alleles NNS I-NP O
studied VBN B-VP O
. . O O

Second RB B-ADVP O
, , O O
we PRP B-NP O
report VBP B-VP O
the DT B-NP O
substitution NN I-NP O
of IN B-PP O
arginine NN B-NP O
333 CD I-NP O
by IN B-PP O
tryptophan NN B-NP O
, , O O
caused VBN B-VP O
by IN B-PP O
a DT B-NP O
transition NN I-NP O
at IN B-PP O
nucleotide NN B-NP O
1025 CD I-NP O
. . O O

The DT B-NP O
area NN I-NP O
surrounding VBG B-VP O
this DT B-NP O
missense JJ I-NP O
mutation NN I-NP O
is VBZ B-VP O
the DT B-NP O
most RBS I-NP O
highly RB I-NP O
conserved VBN I-NP O
domain NN I-NP O
in IN B-PP O
the DT B-NP O
homologous JJ I-NP O
enzymes NNS I-NP O
from IN B-PP O
E NN B-NP O
. . O O

coli NN B-NP O
, , O O
yeast NN B-NP O
, , O O
and CC O O
humans NNS B-NP O
, , O O
and CC O O
this DT B-NP O
mutation NN I-NP O
results VBZ B-VP O
in IN B-PP O
undetectable JJ B-NP O
enzymatic JJ I-NP O
activity NN I-NP O
, , O O
suggesting VBG B-VP O
that IN B-SBAR O
this DT B-NP O
is VBZ B-VP O
a DT B-NP O
severe JJ I-NP O
mutation NN I-NP O
. . O O

This DT B-NP O
second JJ I-NP O
mutation NN I-NP O
appears VBZ B-VP O
to TO I-VP O
be VB I-VP O
rare JJ B-ADJP O
, , O O
since IN B-SBAR O
it PRP B-NP O
was VBD B-VP O
found VBN I-VP O
only RB B-PP O
in IN I-PP O
the DT B-NP O
patient NN I-NP O
we PRP B-NP O
sequenced VBD B-VP O
. . O O

Our PRP$ B-NP O
data NNS I-NP O
provide VBP B-VP O
further JJ B-NP O
evidence NN I-NP O
for IN B-PP O
the DT B-NP O
heterogeneity NN I-NP O
of IN B-PP O
galactosemia NN B-NP B-Disease
at IN B-PP O
the DT B-NP O
molecular JJ I-NP O
level NN I-NP O
, , O O
heterogeneity NN B-NP O
which WDT B-NP O
might MD B-VP O
be VB I-VP O
related JJ B-ADJP O
to TO B-PP O
the DT B-NP O
variable JJ I-NP O
clinical JJ I-NP O
outcome NN I-NP O
observed VBN B-VP O
in IN B-PP O
this DT B-NP O
disorder NN I-NP O
. . O O

. . O O

Hypoxanthine NN B-NP B-Disease
- HYPH I-NP I-Disease
guanine NN I-NP I-Disease
phosphoribosyltransferase NN I-NP I-Disease
deficiency NN I-NP I-Disease
: : O O
analysis NN B-NP O
of IN B-PP O
HPRT NN B-NP O
mutations NNS I-NP O
by IN B-PP O
direct JJ B-NP O
sequencing NN I-NP O
and CC I-NP O
allele NN I-NP O
- HYPH B-NP O
specific JJ I-NP O
amplification NN I-NP O
. . O O

The DT B-NP O
Lesch NNP I-NP B-Disease
- HYPH I-NP I-Disease
Nyhan NNP I-NP I-Disease
syndrome NN I-NP I-Disease
is VBZ B-VP O
a DT B-NP O
severe JJ I-NP O
X NN I-NP B-Disease
chromosome NN I-NP I-Disease
- HYPH B-VP I-Disease
linked VBN B-NP I-Disease
human JJ I-NP I-Disease
disease NN I-NP I-Disease
caused VBN B-VP O
by IN B-PP O
a DT B-NP O
virtual JJ I-NP O
absence NN I-NP B-Disease
of IN B-PP I-Disease
hypoxanthine NN B-NP I-Disease
- HYPH O I-Disease
guanine NN B-NP I-Disease
phosphoribosyltransferase NN I-NP I-Disease
( ( O I-Disease
HPRT NN B-NP I-Disease
) ) O I-Disease
activity NN B-NP I-Disease
. . O O

A DT B-NP O
partial JJ I-NP O
deficiency NN I-NP O
in IN B-PP O
the DT B-NP O
activity NN I-NP O
of IN B-PP O
this DT B-NP O
enzyme NN I-NP O
can MD B-VP O
result VB I-VP O
in IN B-PP O
gouty NN B-NP B-Disease
arthritis NN I-NP I-Disease
. . O O

To TO B-VP O
determine VB I-VP O
the DT B-NP O
genetic JJ I-NP O
basis NN I-NP O
for IN B-PP O
reduction NN B-NP O
or CC I-NP O
loss NN I-NP O
of IN B-PP O
enzyme NN B-NP O
activity NN I-NP O
, , O O
we PRP B-NP O
have VBP B-VP O
amplified VBN I-VP O
and CC I-VP O
sequenced VBN I-VP O
the DT B-NP O
coding VBG I-NP O
region NN I-NP O
of IN B-PP O
HPRT NN B-NP O
cDNA NN I-NP O
from IN B-PP O
four CD B-NP O
patients NNS I-NP O
one CD B-NP O
with IN B-PP O
Lesch NNP B-NP B-Disease
- HYPH I-NP I-Disease
Nyhan NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
HPRTPerth NN B-NP O
) ) O O
and CC O O
three CD B-NP O
with IN B-PP O
partial JJ B-NP B-Disease
deficiencies NNS I-NP I-Disease
of IN B-PP I-Disease
HPRT NN B-NP I-Disease
activity NN I-NP I-Disease
, , O O
which WDT B-NP O
have VBP B-VP O
been VBN I-VP O
designated VBN I-VP O
HPRTUrangan NNP B-NP O
, , O O
HPRTSwan NNP B-NP O
and CC O O
HPRTToowong NNP B-NP O
. . O O

In IN B-PP O
all DT B-NP O
four CD I-NP O
patients NNS I-NP O
, , O O
the DT B-NP O
only JJ I-NP O
mutation NN I-NP O
identified VBN B-VP O
was VBD B-VP O
a DT B-NP O
single JJ I-NP O
base NN I-NP O
substitution NN I-NP O
in IN B-PP O
exons NNS B-NP O
2 CD B-NP O
or CC I-NP O
3 CD I-NP O
of IN B-PP O
the DT B-NP O
coding VBG I-NP O
region NN I-NP O
, , O O
which WDT B-NP O
in IN B-PP O
each DT B-NP O
case NN I-NP O
predicts VBZ B-VP O
a DT B-NP O
single JJ I-NP O
amino NN I-NP O
acid NN I-NP O
substitution NN I-NP O
in IN B-PP O
the DT B-NP O
translated VBN I-NP O
protein NN I-NP O
. . O O

Each DT B-NP O
base NN I-NP O
change NN I-NP O
was VBD B-VP O
confirmed VBN I-VP O
by IN B-PP O
allele NN B-NP O
- HYPH B-NP O
specific JJ I-NP O
amplification NN I-NP O
of IN B-PP O
the DT B-NP O
patients NNS I-NP O
genomic JJ B-NP O
DNA NN I-NP O
. . O O

It PRP B-NP O
is VBZ B-VP O
interesting JJ B-ADJP O
to TO B-VP O
note VB I-VP O
that IN B-SBAR O
the DT B-NP O
mutation NN I-NP O
found VBN B-VP O
for IN B-PP O
HPRTPerth NN B-NP O
is VBZ B-VP O
identical JJ B-ADJP O
to TO B-PP O
that DT B-NP O
reported VBN B-VP O
for IN B-PP O
HPRTFlint NN B-NP O
. . O O

It PRP B-NP O
appears VBZ B-VP O
that IN B-SBAR O
the DT B-NP O
two CD I-NP O
mutations NNS I-NP O
are VBP B-VP O
de FW B-NP O
novo FW I-NP O
events NNS I-NP O
. . O O

. . O O

Molecular JJ B-NP O
and CC I-NP O
metabolic JJ I-NP O
basis NN I-NP O
for IN B-PP O
the DT B-NP O
metabolic JJ I-NP B-Disease
disorder NN I-NP I-Disease
normotriglyceridemic JJ I-NP B-Disease
abetalipoproteinemia NN I-NP I-Disease
. . O O

We PRP B-NP O
have VBP B-VP O
previously RB I-VP O
described VBN I-VP O
a DT B-NP O
disorder NN I-NP O
, , O O
normotriglyceridemic JJ B-NP B-Disease
abetalipoproteinemia NN I-NP I-Disease
, , O O
that WDT B-NP O
is VBZ B-VP O
characterized VBN I-VP O
by IN B-PP O
the DT B-NP O
virtual JJ I-NP O
absence NN I-NP O
of IN B-PP O
plasma NN B-NP O
low JJ I-NP O
density NN I-NP O
lipoproteins NNS I-NP O
and CC O O
complete JJ B-NP O
absence NN I-NP O
of IN B-PP O
apoB NN B-NP O
- HYPH B-NP O
100 CD I-NP O
, , O O
but CC O O
with IN B-PP O
apparently RB B-NP O
normal JJ I-NP O
secretion NN I-NP O
of IN B-PP O
triglyceride NN B-NP O
- HYPH B-NP O
rich JJ I-NP O
lipoproteins NNS I-NP O
containing VBG B-VP O
apoB NN B-NP O
- HYPH B-NP O
48 CD I-NP O
. . O O

The DT B-NP O
patients NNS I-NP O
plasma NN I-NP O
lipoproteins NNS I-NP O
were VBD B-VP O
shown VBN I-VP O
on IN B-PP O
polyacrylamide NN B-NP O
gels NNS I-NP O
and CC B-PP O
by IN B-PP O
antibody NN B-NP O
mapping NN I-NP O
to TO B-VP O
have VB I-VP O
a DT B-NP O
new JJ I-NP O
truncated VBN I-NP O
apoB NN I-NP O
variant NN I-NP O
, , O O
apoB NN B-NP O
- HYPH B-NP O
50 CD I-NP O
, , O O
circulating VBG B-VP O
along IN B-ADVP O
with IN B-PP O
her PRP$ B-NP O
apoB NN I-NP O
- HYPH B-NP O
48 CD I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
found VBN I-VP O
this DT B-NP O
individual NN I-NP O
to TO B-VP O
be VB I-VP O
homozygous JJ B-ADJP O
for IN B-PP O
a DT B-NP O
single JJ I-NP O
C NN I-NP O
- HYPH B-ADJP O
to TO B-PP O
- HYPH B-NP O
T NN I-NP O
nucleotide NN I-NP O
substitution NN I-NP O
at IN B-PP O
apoB NN B-NP O
codon NN I-NP O
2252 CD I-NP O
, , O O
which WDT B-NP O
produces VBZ B-VP O
a DT B-NP O
premature JJ I-NP O
in IN B-PP O
- HYPH B-NP O
frame NN I-NP O
stop NN I-NP O
codon NN I-NP O
. . O O

Thus RB B-ADVP O
, , O O
this DT B-NP O
is VBZ B-VP O
a DT B-NP O
rare JJ I-NP O
example NN I-NP O
of IN B-PP O
homozygous JJ B-NP B-Disease
hypobetalipoproteinemia NN I-NP I-Disease
. . O O

Electron NN B-NP O
photomicrographs NNS I-NP O
revealed VBD B-VP O
that IN B-SBAR O
the DT B-NP O
diameters NNS I-NP O
of IN B-PP O
particles NNS B-NP O
in IN B-PP O
the DT B-NP O
d NN I-NP O
less JJR B-ADJP O
than IN B-PP O
1 CD B-NP O
. . O O

006 CD B-NP O
g NN I-NP O
/ SYM B-NP O
ml NN I-NP O
lipoprotein NN I-NP O
fraction NN I-NP O
, , O O
in IN B-PP O
both CC B-NP O
the DT I-NP O
postprandial JJ I-NP O
and CC I-NP O
postabsorptive JJ I-NP O
state NN I-NP O
, , O O
are VBP B-VP O
bimodally RB I-VP O
distributed VBN I-VP O
. . O O

The DT B-NP O
molar JJ I-NP O
ratio NN I-NP O
of IN B-PP O
apoE NN B-NP O
to TO B-PP O
apoB NN B-NP O
in IN B-PP O
these DT B-NP O
particles NNS I-NP O
is VBZ B-VP O
3 CD B-NP O
. . O O

5 CD B-NP O
1 CD I-NP O
, , O O
similar JJ B-ADJP O
to TO B-PP O
normal JJ B-NP O
VLDL NN I-NP O
. . O O

The DT B-NP O
plasma NN I-NP O
LDL NN I-NP O
interval NN I-NP O
contains VBZ B-VP O
both CC O O
spherical JJ B-NP O
and CC I-NP O
cuboidal JJ I-NP O
particles NNS I-NP O
. . O O

Autologous JJ B-NP O
reinfusion NN I-NP O
of IN B-PP O
labeled VBN B-NP O
d NN I-NP O
less JJR B-ADJP O
than IN B-PP O
1 CD B-NP O
. . O O

006 CD B-NP O
g NN I-NP O
/ SYM B-NP O
ml NN I-NP O
lipoproteins NNS I-NP O
showed VBD B-VP O
exponential JJ B-NP O
disappearance NN I-NP O
from IN B-PP O
plasma NN B-NP O
, , O O
with IN B-PP O
an DT B-NP O
apparent JJ I-NP O
half NN I-NP O
- HYPH I-NP O
removal NN I-NP O
time NN I-NP O
of IN B-PP O
50 CD B-NP O
min NN I-NP O
, , O O
somewhat RB B-ADJP O
slower JJR I-ADJP O
than IN B-PP O
for IN B-PP O
normal JJ B-NP O
chylomicrons NNS I-NP O
but CC B-PP O
within IN B-PP O
the DT B-NP O
normal JJ I-NP O
range NN I-NP O
for IN B-PP O
VLDL NN B-NP O
. . O O

The DT B-NP O
calculated VBN I-NP O
production NN I-NP O
rate NN I-NP O
for IN B-PP O
apoB NN B-NP O
was VBD B-VP O
within IN B-PP O
the DT B-NP O
normal JJ I-NP O
range NN I-NP O
in IN B-PP O
this DT B-NP O
subject NN I-NP O
. . O O

A DT B-NP O
single JJ I-NP O
origin NN I-NP O
of IN B-PP O
phenylketonuria NN B-NP B-Disease
in IN B-PP O
Yemenite NNP B-NP O
Jews NNP I-NP O
. . O O

Phenylketonuria NN B-NP B-Disease
( ( O O
PKU NN B-NP B-Disease
) ) O O
is VBZ B-VP O
a DT B-NP O
metabolic JJ I-NP B-Disease
disease NN I-NP I-Disease
caused VBN B-VP O
by IN B-PP O
recessive JJ B-NP O
mutations NNS I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
encoding VBG B-VP O
the DT B-NP O
hepatic JJ I-NP O
enzyme NN I-NP O
phenylalanine NN I-NP O
hydroxylase NN I-NP O
( ( O O
PAH NN B-NP O
) ) O O
. . O O

The DT B-NP O
incidence NN I-NP O
of IN B-PP O
PKU NN B-NP B-Disease
varies VBZ B-VP O
widely RB B-ADVP O
across IN B-PP O
different JJ B-NP O
geographic JJ I-NP O
areas NNS I-NP O
, , O O
and CC O O
is VBZ B-VP O
highest JJS B-ADJP O
( ( O O
about RB B-NP O
1 CD I-NP O
in IN B-PP O
5 CD B-NP O
, , O O
000 CD B-NP O
live JJ I-NP O
births NNS I-NP O
) ) O O
in IN B-PP O
Ireland NNP B-NP O
and CC O O
western JJ B-NP O
Scotland NNP I-NP O
, , O O
and CC O O
among IN B-PP O
Yemenite NNP B-NP O
Jews NNPS I-NP O
. . O O

A DT B-NP O
limited JJ I-NP O
number NN I-NP O
of IN B-PP O
point NN B-NP O
mutations NNS I-NP O
account VBP B-VP O
for IN B-PP O
most JJS B-NP O
of IN B-PP O
the DT B-NP O
PKU NN I-NP B-Disease
cases NNS I-NP O
in IN B-PP O
the DT B-NP O
European JJ I-NP O
population NN I-NP O
. . O O

Here RB B-ADVP O
we PRP B-NP O
report VBP B-VP O
that IN B-SBAR O
a DT B-NP O
single JJ I-NP O
molecular JJ I-NP O
defect NN I-NP O
- HYPH B-NP O
- : O O
a DT B-NP O
deletion NN I-NP O
spanning VBG B-VP O
the DT B-NP O
third JJ I-NP O
exon NN I-NP O
of IN B-PP O
the DT B-NP O
PAH NN I-NP O
gene NN I-NP O
- HYPH O O
- HYPH B-NP O
is VBZ B-VP O
responsible JJ B-ADJP O
for IN B-PP O
all PDT B-NP O
the DT I-NP O
PKU NN I-NP B-Disease
cases NNS I-NP O
among IN B-PP O
the DT B-NP O
Yemenite NNP I-NP O
Jews NNPS I-NP O
. . O O

Examination NN B-NP O
of IN B-PP O
a DT B-NP O
random JJ I-NP O
sample NN I-NP O
of IN B-PP O
Yemenite NN B-NP O
Jews NNS I-NP O
using VBG B-VP O
a DT B-NP O
molecular JJ I-NP O
probe NN I-NP O
that WDT B-NP O
detects VBZ B-VP O
the DT B-NP O
carriers NNS I-NP O
of IN B-PP O
this DT B-NP O
deletion NN I-NP O
indicated VBD B-VP O
a DT B-NP O
high JJ I-NP O
frequency NN I-NP O
of IN B-PP O
the DT B-NP O
defective JJ I-NP O
gene NN I-NP O
in IN B-PP O
this DT B-NP O
community NN I-NP O
. . O O

Although IN B-SBAR O
the DT B-NP O
deleted VBN I-NP O
PAH NN I-NP O
gene NN I-NP O
was VBD B-VP O
traced VBN I-VP O
to TO B-PP O
25 CD B-NP O
different JJ I-NP O
locations NNS I-NP O
throughout IN B-PP O
Yemen NN B-NP O
, , O O
family NN B-NP O
histories NNS I-NP O
and CC O O
official JJ B-NP O
documents NNS I-NP O
of IN B-PP O
the DT B-NP O
Yemenite NN I-NP O
Jewish JJ I-NP O
community NN I-NP O
showed VBD B-VP O
that IN B-SBAR O
the DT B-NP O
common JJ I-NP O
ancestor NN I-NP O
of IN B-PP O
all PDT B-NP O
the DT I-NP O
carriers NNS I-NP O
of IN B-PP O
this DT B-NP O
genetic JJ I-NP B-Disease
defect NN I-NP I-Disease
lived VBD B-VP O
in IN B-PP O
Sana NNP B-NP O
, , O O
the DT B-NP O
capital NN I-NP O
of IN B-PP O
Yemen NNS B-NP O
, , O O
before IN B-PP O
the DT B-NP O
eighteenth JJ I-NP O
century NN I-NP O
. . O O

. . O O

Linkage NN B-NP O
of IN B-PP O
aspartylglucosaminuria NN B-NP B-Disease
( ( O O
AGU NN B-NP B-Disease
) ) O O
to TO B-PP O
marker NN B-NP O
loci NNS I-NP O
on IN B-PP O
the DT B-NP O
long JJ I-NP O
arm NN I-NP O
of IN B-PP O
chromosome NN B-NP O
4 CD I-NP O
. . O O

Aspartylglucosaminuria NN B-NP B-Disease
( ( O O
AGU NN B-NP B-Disease
) ) O O
is VBZ B-VP O
caused VBN I-VP O
by IN B-PP O
deficient JJ B-NP O
activity NN I-NP O
of IN B-PP O
the DT B-NP O
enzyme NN I-NP O
aspartylglucosaminidase NN I-NP O
( ( O O
AGA NN B-NP O
) ) O O
. . O O

The DT B-NP O
structural JJ I-NP O
gene NN I-NP O
for IN B-PP O
AGA NN B-NP O
has VBZ B-VP O
been VBN I-VP O
assigned VBN I-VP O
to TO B-PP O
the DT B-NP O
region NN I-NP O
4q21 CD I-NP O
- HYPH I-NP O
qter NN I-NP O
of IN B-PP O
chromosome NN B-NP O
4 CD I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
studied VBN I-VP O
the DT B-NP O
map NN I-NP O
position NN I-NP O
of IN B-PP O
the DT B-NP O
AGU NN I-NP O
locus NN I-NP O
in IN B-PP O
relation NN B-NP O
to TO B-PP O
other JJ B-NP O
marker NN I-NP O
loci NNS I-NP O
on IN B-PP O
the DT B-NP O
long JJ I-NP O
arm NN I-NP O
of IN B-PP O
chromosome NN B-NP O
4 CD I-NP O
using VBG B-VP O
linkage NN B-NP O
analyses NNS I-NP O
. . O O

Restriction NN B-NP O
fragment NN I-NP O
length NN I-NP O
polymorphism NN I-NP O
alleles NNS I-NP O
for IN B-PP O
the DT B-NP O
ADH2 NN I-NP O
, , O O
ADH3 NN B-NP O
, , O O
EGF NN B-NP O
, , O O
FG NN B-NP O
alpha NN I-NP O
and CC O O
FG NN B-NP O
beta NN I-NP O
loci NNS I-NP O
and CC O O
blood NN B-NP O
group NN I-NP O
antigens NNS I-NP O
for IN B-PP O
the DT B-NP O
MNS NN I-NP O
locus NN I-NP O
were VBD B-VP O
determined VBN I-VP O
in IN B-PP O
a DT B-NP O
panel NN I-NP O
of IN B-PP O
12 CD B-NP O
Finnish JJ I-NP O
AGU NN I-NP B-Disease
families NNS I-NP O
. . O O

The DT B-NP O
heterozygous JJ I-NP O
family NN I-NP O
members NNS I-NP O
were VBD B-VP O
identified VBN I-VP O
by IN B-PP O
reduced VBN B-NP O
activity NN I-NP O
of IN B-PP O
AGA NN B-NP O
in IN B-PP O
lymphocytes NNS B-NP O
. . O O

Linkage NN B-NP O
studies NNS I-NP O
were VBD B-VP O
performed VBN I-VP O
using VBG B-VP O
both CC O O
pairwise JJ B-NP O
and CC I-NP O
multipoint JJ I-NP O
analyses NNS I-NP O
. . O O

Loose JJ B-NP O
linkage NN I-NP O
of IN B-PP O
the DT B-NP O
AGU NN I-NP B-Disease
locus NN I-NP O
to TO B-PP O
the DT B-NP O
FG NN I-NP O
and CC I-NP O
MNS NN I-NP O
loci NNS I-NP O
was VBD B-VP O
observed VBN I-VP O
( ( O O
z NN B-NP O
= SYM B-VP O
1 CD B-NP O
. . O O

16 CD B-NP O
, , O O
z NN B-NP O
= SYM B-VP O
1 CD B-NP O
. SYM I-NP O

39 CD I-NP O
, , O O
respectively RB B-ADVP O
) ) O O
. . O O

Multipoint JJ B-NP O
analysis NN I-NP O
to TO B-PP O
the DT B-NP O
fixed VBN I-NP O
map NN I-NP O
[ ( O O
ADH NN B-NP O
- HYPH O O
( ( O O
0 CD B-NP O
. . I-NP O

03 CD I-NP O
) ) O O
- HYPH B-NP O
EGF NN I-NP O
- HYPH B-ADJP O
( ( O O
0 CD B-NP O
. . I-NP O

35 CD I-NP O
) ) O O
- HYPH B-NP O
FG NN I-NP O
- HYPH B-ADJP O
( ( O O
0 CD B-NP O
. . I-NP O

11 CD I-NP O
) ) O O
- HYPH B-NP O
MNS NN I-NP O
] ) O O
suggests VBZ B-VP O
that IN B-SBAR O
the DT B-NP O
location NN I-NP O
of IN B-PP O
the DT B-NP O
AGU NN I-NP O
locus NN I-NP O
is VBZ B-VP O
0 CD B-NP O
. . O O

05 CD B-NP O
- HYPH I-NP O
0 CD I-NP O
. . O O

30 CD B-NP O
recombination NN I-NP O
units NNS I-NP O
distal JJ B-ADJP O
to TO B-PP O
MNS NN B-NP O
( ( O O
z NN B-NP O
= SYM B-VP O
3 CD B-NP O
. SYM I-NP O

03 CD I-NP O
) ) O O
. . O O

The DT B-NP O
order NN I-NP O
cen NN I-NP O
- HYPH B-NP O
ADH NN I-NP O
- HYPH B-NP O
EGF NN I-NP O
- HYPH B-NP O
FG NN I-NP O
- HYPH B-NP O
MNS NN I-NP O
- HYPH B-NP O
AGU NN I-NP O
is VBZ B-VP O
35 CD B-NP O
times NNS I-NP O
more RBR B-ADJP O
likely JJ I-ADJP O
than IN B-PP O
the DT B-NP O
next JJ I-NP O
best JJS I-NP O
order NN I-NP O
cen NN I-NP O
- HYPH B-NP O
ADH NN I-NP O
- HYPH B-NP O
EGF NN I-NP O
- HYPH B-NP O
AGU NN I-NP O
- HYPH B-NP O
FG NN I-NP O
- HYPH B-NP O
MNS NN I-NP O
. . O O

Linkage NN B-NP O
relationships NNS I-NP O
of IN B-PP O
the DT B-NP O
apolipoprotein NN I-NP O
C1 NN I-NP O
gene NN I-NP O
and CC O O
a DT B-NP O
cytochrome NN I-NP O
P450 NN I-NP O
gene NN I-NP O
( ( O O
CYP2A NN B-NP O
) ) O O
to TO B-PP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
. . O O

We PRP B-NP O
have VBP B-VP O
studied VBN I-VP O
the DT B-NP O
genetic JJ I-NP O
linkage NN I-NP O
of IN B-PP O
two CD B-NP O
markers NNS I-NP O
, , O O
the DT B-NP O
apolipoprotein NN I-NP O
C1 NN I-NP O
( ( O O
APOC1 NN B-NP O
) ) O O
gene NN B-NP O
and CC O O
a DT B-NP O
cytochrome NN I-NP O
P450 NN I-NP O
( ( O O
CYP2A NN B-NP O
) ) O O
gene NN B-NP O
, , O O
in IN B-PP O
relation NN B-NP O
to TO B-PP O
the DT B-NP O
gene NN I-NP O
for IN B-PP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
( ( O O
DM NN B-NP B-Disease
) ) O O
. . O O

A DT B-NP O
peak JJ I-NP O
lod NN I-NP O
score NN I-NP O
of IN B-PP O
9 CD B-NP O
. . O O

29 CD B-NP O
at IN B-PP O
2 CD B-NP O
cM NN I-NP O
was VBD B-VP O
observed VBN I-VP O
for IN B-PP O
APOC1 NN B-NP O
- HYPH I-NP O
DM NN I-NP O
, , O O
with IN B-PP O
a DT B-NP O
lod NN I-NP O
score NN I-NP O
of IN B-PP O
8 CD B-NP O
. . O O

55 CD B-NP O
at IN B-PP O
4 CD B-NP O
cM NN I-NP O
for IN B-PP O
CYP2A NN B-NP O
- HYPH I-NP O
DM NN I-NP O
. . O O

These DT B-NP O
two CD I-NP O
markers NNS I-NP O
also RB B-ADVP O
show VBP B-VP O
close JJ B-NP O
linkage NN I-NP O
to TO B-PP O
each DT B-NP O
other JJ I-NP O
( ( O O
theta SYM O O
max NN B-NP O
= SYM B-VP O
0 CD B-NP O
. SYM I-NP O

05 CD I-NP O
, , O O
Zmax NN B-NP O
= SYM B-VP O
9 CD B-NP O
. SYM I-NP O

09 CD I-NP O
) ) O O
. . O O

From IN B-PP O
examination NN B-NP O
of IN B-PP O
the DT B-NP O
genotypes NNS I-NP O
of IN B-PP O
the DT B-NP O
recombinant JJ I-NP O
individuals NNS I-NP O
, , O O
CYP2A NN B-NP O
appears VBZ B-VP O
to TO I-VP O
map VB I-VP O
proximal JJ B-ADJP O
to TO B-PP O
DM NN B-NP O
because IN B-SBAR O
in IN B-PP O
one CD B-NP O
recombinant JJ I-NP O
individual JJ I-NP O
CYP2A NN I-NP O
, , I-NP O
APOC2 NN I-NP O
and CC I-NP O
CKMM NN I-NP O
had VBD B-VP O
all DT O O
recombined VBN B-VP O
with IN B-PP O
DM NN B-NP O
. . O O

Evidence NN B-NP O
from IN B-PP O
another DT B-NP O
CYP2A NN I-NP O
- HYPH B-NP O
DM NN I-NP O
recombinant JJ I-NP O
individual JJ I-NP O
places NNS I-NP O
CYP2A NN I-NP O
proximal JJ B-ADJP O
to TO B-PP O
APOC2 NN B-NP O
and CC I-NP O
CKMM NN I-NP O
. . O O

Localisation NN B-NP O
of IN B-PP O
CYP2A NN B-NP O
on IN B-PP O
a DT B-NP O
panel NN I-NP O
of IN B-PP O
somatic JJ B-NP O
cell NN I-NP O
hybrids NNS I-NP O
also RB B-ADVP O
suggests VBZ B-VP O
that IN B-SBAR O
it PRP B-NP O
is VBZ B-VP O
proximal JJ B-ADJP O
to TO B-PP O
DM NN B-NP O
and CC I-NP O
APOC2 NN I-NP O
/ SYM B-NP O
C1 NN I-NP O
/ SYM I-NP O
E NN I-NP O
gene NN I-NP O
cluster NN I-NP O
. . O O

Genetic JJ B-NP O
linkage NN I-NP O
map NN I-NP O
of IN B-PP O
six CD B-NP O
polymorphic JJ I-NP O
DNA NN I-NP O
markers NNS I-NP O
around IN B-PP O
the DT B-NP O
gene NN I-NP O
for IN B-PP O
familial JJ B-NP B-Disease
adenomatous JJ I-NP I-Disease
polyposis NN I-NP I-Disease
on IN B-PP O
chromosome NN B-NP O
5 CD I-NP O
. . O O

A DT B-NP O
genetic JJ I-NP O
linkage NN I-NP O
map NN I-NP O
of IN B-PP O
six CD B-NP O
polymorphic JJ I-NP O
DNA NN I-NP O
markers NNS I-NP O
close RB B-ADJP O
to TO B-PP O
the DT B-NP O
gene NN I-NP O
( ( O O
APC NN B-NP O
) ) O O
for IN B-PP O
familial JJ B-NP B-Disease
adenomatous JJ I-NP I-Disease
polyposis NN I-NP I-Disease
( ( O O
FAP NN B-NP B-Disease
) ) O O
on IN B-PP O
chromosome NN B-NP O
5q NN I-NP O
is VBZ B-VP O
reported VBN I-VP O
. . O O

One CD B-NP O
hundred CD I-NP O
fifty CD I-NP O
- HYPH O O
five CD B-NP O
typed VBN I-NP O
members NNS I-NP O
of IN B-PP O
nine CD B-NP O
FAP NN I-NP B-Disease
kindred NN I-NP O
provided VBD B-VP O
more JJR B-NP O
than IN I-NP O
90 CD I-NP O
meioses NNS I-NP O
for IN B-PP O
linkage NN B-NP O
analysis NN I-NP O
. . O O

A DT B-NP O
number NN I-NP O
of IN B-PP O
crucial JJ B-NP O
recombination NN I-NP O
events NNS I-NP O
have VBP B-VP O
been VBN I-VP O
identified VBN I-VP O
which WDT B-NP O
are VBP B-VP O
informative JJ B-ADJP O
at IN B-PP O
three CD B-NP O
or CC I-NP O
more JJR I-NP O
loci NNS I-NP O
, , O O
allowing VBG B-VP O
confident JJ B-NP O
ordering NN I-NP O
of IN B-PP O
parts NNS B-NP O
of IN B-PP O
the DT B-NP O
map NN I-NP O
. . O O

There EX B-NP O
was VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-PP O
genetic JJ B-NP O
heterogeneity NN I-NP O
, , O O
with IN B-PP O
all DT B-NP O
families NNS I-NP O
showing VBG B-VP O
linkage NN B-NP O
of IN B-PP O
at IN B-NP O
least JJS I-NP O
one CD I-NP O
chromosome NN I-NP O
5 CD B-NP O
marker NN I-NP O
to TO B-PP O
the DT B-NP O
gene NN I-NP O
. . O O

Recombination NN B-NP O
data NNS I-NP O
and CC O O
two CD B-NP O
- HYPH I-NP O
point NN I-NP O
linkage NN I-NP O
analysis NN I-NP O
support VBP B-VP O
a DT B-NP O
locus NN I-NP O
order NN I-NP O
of IN B-PP O
centromere NN B-NP O
- HYPH O O
pi SYM B-NP O
227 CD I-NP O
- HYPH I-NP O
C11P11 NN I-NP O
- HYPH B-NP O
ECB27 NN I-NP O
- HYPH I-NP O
L5 NN I-NP O
. . O O

62 CD B-NP O
- HYPH I-NP O
APC NN I-NP O
- HYPH O O
EF5 NN B-NP O
62 CD I-NP O
- HYPH I-NP O
APC NN I-NP O
- HYPH I-NP O
EF5 NN I-NP O
. . O O

44 CD B-NP O
- HYPH I-NP O
YN5 NN B-NP O
44 CD I-NP O
- HYPH I-NP O
YN5 NN I-NP O
. . O O

48 CD B-NP O
- HYPH I-NP O
telomer NN I-NP O
e NN I-NP O
, , O O
although IN B-SBAR O
EF5 NN B-NP O
. . O O

44 CD B-NP O
could MD B-VP O
lie VB I-VP O
in IN B-PP O
the DT B-NP O
interval JJ I-NP O
L5 NN I-NP O
. . O O

62 CD B-NP O
- HYPH I-NP O
APC NN I-NP O
or CC I-NP O
ECB27 NN I-NP O
- HYPH B-NP O
L5 NN I-NP O
. . O O

62 CD B-NP O
. . O O

No DT B-NP O
recombinants NNS I-NP O
were VBD B-VP O
identified VBN I-VP O
between IN B-PP O
APC NN B-NP O
and CC O O
either DT B-NP O
EF5 NN I-NP O
. . O O

44 CD B-NP O
or CC O O
YN5 NN B-NP O
. . O O

48 CD B-NP O
, , O O
but CC O O
published VBN B-NP O
deletion NN I-NP O
mapping NN I-NP O
in IN B-PP O
colorectal JJ B-NP B-Disease
carcinomas NNS I-NP I-Disease
and CC O O
linkage NN B-NP O
analysis NN I-NP O
in IN B-PP O
FAP NN B-NP B-Disease
suggest VBP B-VP O
that IN B-SBAR O
YN5 NN B-NP O
. . O O

48 CD B-NP O
is VBZ B-VP O
1 CD B-NP O
- HYPH I-NP O
3 CD I-NP O
cM NN I-NP O
from IN B-PP O
APC NN B-NP O
. . O O

The DT B-NP O
present JJ I-NP O
study NN I-NP O
suggests VBZ B-VP O
that IN B-SBAR O
YN5 NN B-NP O
. . O O

48 CD B-NP O
and CC O O
L5 NN B-NP O
. . O O

62 CD B-NP O
delineate VBP B-VP O
a DT B-NP O
small JJ I-NP O
region NN I-NP O
of IN B-PP O
chromosome NN B-NP O
5 CD I-NP O
within IN B-PP O
which WDT B-NP O
the DT B-NP O
EF5 NN I-NP O
. . O O

44 CD B-NP O
locus NN I-NP O
lies VBZ B-VP O
very RB B-ADJP O
close JJ I-ADJP O
to TO B-PP O
the DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
. . O O

These DT B-NP O
data NNS I-NP O
not RB B-CONJP O
only RB B-VP O
allow VB I-VP O
use NN B-NP O
of IN B-PP O
flanking NN B-NP O
markers NNS I-NP O
for IN B-PP O
presymptomatic JJ B-NP O
diagnosis NN I-NP O
of IN B-PP O
FAP NN B-NP B-Disease
but CC B-CONJP O
also RB I-CONJP O
provide VBP B-VP O
a DT B-NP O
high JJ I-NP O
- HYPH I-NP O
density NN I-NP O
map NN I-NP O
of IN B-PP O
the DT B-NP O
region NN I-NP O
for IN B-PP O
isolation NN B-NP O
of IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
itself PRP B-NP O
and CC B-PP O
for IN B-PP O
further JJ B-NP O
assessment NN I-NP O
of IN B-PP O
the DT B-NP O
role NN I-NP O
of IN B-PP O
chromosome NN B-NP O
5 CD B-NP O
deletions NNS I-NP O
in IN B-PP O
the DT B-NP O
biology NN I-NP O
of IN B-PP O
sporadic JJ B-NP O
colorectal JJ I-NP B-Disease
cancer NN I-NP I-Disease
. . O O

Serum NN B-NP O
amyloid NN I-NP O
A NN I-NP O
and CC I-NP O
P NN I-NP O
protein NN I-NP O
genes NNS I-NP O
in IN B-PP O
familial JJ B-NP B-Disease
Mediterranean JJ I-NP I-Disease
fever NN I-NP I-Disease
. . O O

Two CD B-NP O
recent JJ I-NP O
studies NNS I-NP O
have VBP B-VP O
suggested VBN I-VP O
the DT B-NP O
involvement NN I-NP O
of IN B-PP O
serum NN B-NP O
amyloid NN I-NP O
A NN I-NP O
( ( O O
SAA NN B-NP O
) ) O O
and CC O O
P NN B-NP O
( ( O O
APCS NN B-NP O
) ) O O
genes NNS B-NP O
in IN B-PP O
familial JJ B-NP B-Disease
Mediterranean JJ I-NP I-Disease
fever NN I-NP I-Disease
( ( O O
MEF NN B-NP B-Disease
) ) O O
. . O O

To TO B-VP O
test VB I-VP O
the DT B-NP O
role NN I-NP O
of IN B-PP O
SAA NN B-NP O
and CC I-NP O
APCS NN I-NP O
in IN B-PP O
MEF NN B-NP B-Disease
and CC I-NP O
MEF NN I-NP B-Disease
- HYPH O I-Disease
amyloidosis NN B-NP I-Disease
, , O O
we PRP B-NP O
studied VBD B-VP O
17 CD B-NP O
informative JJ I-NP O
families NNS I-NP O
( ( O O
15 CD B-NP O
Armenians NNPS I-NP O
, , O O
2 CD B-NP O
non AFX B-NP O
- HYPH I-NP O
Ashkenazi NNP I-NP O
Jews NNS I-NP O
) ) O O
and CC O O
8 CD B-NP O
MEF NN I-NP B-Disease
patients NNS I-NP O
with IN B-PP O
amyloidosis NN B-NP B-Disease
using VBG B-VP O
a DT B-NP O
candidate NN I-NP O
gene NN I-NP O
approach NN I-NP O
. . O O

No DT B-NP O
evidence NN I-NP O
for IN B-PP O
any DT B-NP O
MEF NN I-NP B-Disease
- HYPH B-VP O
associated VBN B-NP O
polymorphism NN I-NP O
was VBD B-VP O
found VBN I-VP O
in IN B-PP O
any DT B-NP O
of IN B-PP O
the DT B-NP O
41 CD I-NP O
Armenian JJ I-NP O
and CC I-NP O
Jewish JJ I-NP O
MEF NN I-NP B-Disease
patients NNS I-NP O
tested VBN B-VP O
. . O O

Our PRP$ B-NP O
family NN I-NP O
studies NNS I-NP O
allowed VBD B-VP O
us PRP B-NP O
to TO B-VP O
rule VB I-VP O
out RP B-PRT O
tight JJ B-NP O
linkage NN I-NP O
between IN B-PP O
SAA NN B-NP O
and CC O O
MEF NN B-NP B-Disease
( ( O O
lod NN B-NP O
score NN I-NP O
= SYM B-VP O
- SYM B-NP O
2 CD I-NP O
. . I-NP O

16 CD I-NP O
, , O O
theta DT O O
less JJR B-ADJP O
than IN B-PP O
or CC O O
equal JJ B-ADJP O
to TO B-PP O
0 CD B-NP O
. . O O

06 CD B-NP O
) ) O O
. . O O

For IN B-PP O
APCS NN B-NP O
we PRP B-NP O
found VBD B-VP O
that IN B-SBAR O
the DT B-NP O
allele NN I-NP O
frequency NN I-NP O
in IN B-PP O
the DT B-NP O
MEF NN I-NP B-Disease
- HYPH O I-Disease
amyloidosis NN B-NP I-Disease
patients NNS I-NP O
was VBD B-VP O
similar JJ B-ADJP O
to TO B-PP O
that DT B-NP O
in IN B-PP O
18 CD B-NP O
unrelated JJ I-NP O
MEF NN I-NP B-Disease
patients NNS I-NP O
without IN B-PP O
amyloidosis NN B-NP B-Disease
and CC O O
their PRP$ B-NP O
33 CD I-NP O
healthy JJ I-NP O
parents NNS I-NP O
. . O O

Some DT B-NP O
Mexican JJ I-NP O
glucose NN I-NP O
- HYPH B-NP O
6 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
dehydrogenase NN I-NP O
variants NNS I-NP O
revisited VBN B-VP O
. . O O

Glucose NN B-NP B-Disease
- HYPH B-NP I-Disease
6 CD I-NP I-Disease
- HYPH I-NP I-Disease
phosphate NN I-NP I-Disease
dehydrogenase NN I-NP I-Disease
( ( O I-Disease
G6PD NN B-NP I-Disease
) ) O I-Disease
deficiency NN B-NP I-Disease
appears VBZ B-VP O
to TO I-VP O
be VB I-VP O
fairly RB B-ADJP O
common JJ I-ADJP O
in IN B-PP O
Mexico NNP B-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
now RB I-VP O
examined VBN I-VP O
the DT B-NP O
DNA NN I-NP O
of IN B-PP O
three CD B-NP O
previously RB I-NP O
reported VBN I-NP O
electrophoretically RB I-NP O
fast RB I-NP O
Mexican JJ I-NP O
G6PD NN I-NP O
variants NNS I-NP O
, , O O
- HYPH B-NP O
G6PD NN I-NP O
Distrito NNP I-NP O
Federal NNP I-NP O
, , O O
G6PD NNP B-NP O
Tepic NNP I-NP O
, , O O
and CC O O
G6PD NN B-NP O
Castilla NNP I-NP O
. . O O

All DT B-NP O
three CD I-NP O
of IN B-PP O
these DT B-NP O
variants NNS I-NP O
, , O O
believed VBN B-VP O
on IN B-PP O
the DT B-NP O
basis NN I-NP O
of IN B-PP O
biochemical JJ B-NP O
characterization NN I-NP O
and CC I-NP O
population NN I-NP O
origin NN I-NP O
to TO B-VP O
be VB I-VP O
unique JJ B-ADJP O
, , O O
have VBP B-VP O
the DT B-NP O
G NN I-NP O
- SYM B-VP O
- SYM B-NP O
- SYM I-NP O
- HYPH I-NP O
A NN I-NP O
transition NN I-NP O
at IN B-PP O
nucleotide NN B-NP O
202 CD I-NP O
and CC O O
the DT B-NP O
A NN I-NP O
- SYM B-VP O
- SYM B-NP O
- SYM I-NP O
- HYPH I-NP O
G NN I-NP O
transition NN I-NP O
at IN B-PP O
nucleotide NN B-NP O
376 CD I-NP O
, , O O
mutations NNS B-NP O
that IN B-SBAR O
we PRP B-NP O
now RB B-ADVP O
recognize VBP B-VP O
to TO I-VP O
be VB I-VP O
characteristic JJ B-ADJP O
of IN B-PP O
G6PD NN B-NP O
A NN I-NP O
- HYPH B-ADJP O
. . O O

Two CD B-NP O
other JJ I-NP O
Mexican JJ I-NP O
males NNS I-NP O
with IN B-PP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
were VBD B-VP O
found VBN I-VP O
to TO I-VP O
have VB I-VP O
the DT B-NP O
same JJ I-NP O
mutation NN I-NP O
. . O O

All DT B-NP O
five CD I-NP O
have VBP B-VP O
the DT B-NP O
( ( I-NP O
NlaIII NN I-NP O
/ SYM I-NP O
FokI NN I-NP O
/ SYM I-NP O
PvuII NN I-NP O
/ SYM B-NP O
PstI NN I-NP O
) ) O O
haplotype NN B-NP O
characteristic JJ B-ADJP O
of IN B-PP O
G6PD NN B-NP O
A NN I-NP O
- HYPH B-ADJP O
in IN B-PP O
Africa NNP B-NP O
. . O O

Since IN B-SBAR O
the DT B-NP O
PvuII NN I-NP O
+ SYM B-NP O
genotype NN I-NP O
seems VBZ B-VP O
to TO I-VP O
be VB I-VP O
rare JJ B-ADJP O
in IN B-PP O
Europe NNP B-NP O
, , O O
we PRP B-NP O
conclude VBP B-VP O
that IN B-SBAR O
all DT B-NP O
of IN B-PP O
these DT B-NP O
G6PD NN I-NP O
A NN I-NP O
- HYPH O O
genes NNS B-NP O
had VBD B-VP O
their PRP$ B-NP O
ancient JJ I-NP O
origin NN I-NP O
in IN B-PP O
Africa NNP B-NP O
, , O O
although IN B-SBAR O
in IN B-PP O
many JJ B-NP O
of IN B-PP O
the DT B-NP O
Mexican JJ I-NP O
patients NNS I-NP O
with IN B-PP O
G6PD NN B-NP O
A NN I-NP O
- HYPH B-NP O
202A NN I-NP O
/ SYM I-NP O
376G NN I-NP O
the DT B-NP O
gene NN I-NP O
may MD B-VP O
have VB I-VP O
been VBN I-VP O
imported VBN I-VP O
more RBR B-ADVP O
recently RB I-ADVP O
from IN B-PP O
Spain NNP B-NP O
, , O O
where WRB B-ADVP O
this DT B-NP O
variant NN I-NP O
, , O O
formerly RB B-VP O
known VBN I-VP O
as IN B-PP O
G6PD NNP B-NP O
Betica NNP I-NP O
, , O O
is VBZ B-VP O
also RB B-ADVP O
prevalent JJ B-ADJP O
. . O O

. . O O

Hereditary JJ B-NP O
deficiency NN I-NP B-Disease
of IN B-PP I-Disease
C5 NN B-NP I-Disease
in IN B-PP O
association NN B-NP O
with IN B-PP O
discoid JJ B-NP B-Disease
lupus NN I-NP I-Disease
erythematosus NN I-NP I-Disease
. . O O

A DT B-NP O
29 CD I-NP O
- HYPH I-NP O
year NN I-NP O
- HYPH O O
old JJ B-NP O
woman NN I-NP O
with IN B-PP O
discoid JJ B-NP B-Disease
lupus NN I-NP I-Disease
erythematosus NN I-NP I-Disease
had VBD B-VP O
undetectable JJ B-NP O
classic JJ I-NP O
pathway NN I-NP O
complement NN I-NP O
activity NN I-NP O
. . O O

Hypocomplementemia NN B-NP B-Disease
was VBD B-VP O
due JJ B-ADJP O
to TO B-PP O
selective JJ B-NP O
deficiency NN I-NP B-Disease
of IN B-PP I-Disease
C5 NN B-NP I-Disease
. . O O

One CD B-NP O
of IN B-PP O
her PRP$ B-NP O
children NNS I-NP O
was VBD B-VP O
also RB B-ADVP O
deficient JJ B-ADJP O
. . O O

To TO B-PP O
our PRP$ B-NP O
knowledge NN I-NP O
this DT B-NP O
is VBZ B-VP O
the DT B-NP O
first JJ I-NP O
documented VBN I-NP O
case NN I-NP O
of IN B-PP O
an DT B-NP O
association NN I-NP O
between IN B-PP O
discoid JJ B-NP B-Disease
lupus NN I-NP I-Disease
erythematosus NN I-NP I-Disease
and CC O O
C5 NN B-NP B-Disease
deficiency NN I-NP I-Disease
. . O O

. . O O

Founder NN B-NP O
effect NN I-NP O
of IN B-PP O
a DT B-NP O
prevalent JJ I-NP O
phenylketonuria NN I-NP B-Disease
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
Oriental JJ I-NP O
population NN I-NP O
. . O O

A DT B-NP O
missense JJ I-NP O
mutation NN I-NP O
has VBZ B-VP O
been VBN I-VP O
identified VBN I-VP O
in IN B-PP O
the DT B-NP O
human JJ I-NP O
phenylalanine NN I-NP O
hydroxylase NN I-NP O
[ ( O O
PAH NN B-NP O
; : O O
phenylalanine NN B-NP O
4 CD I-NP O
- HYPH I-NP O
monooxygenase NN I-NP O
; : O O
L NN B-NP O
- HYPH O O
phenylalanine NN B-NP O
, , O O
tetrahydrobiopterin NN B-NP O
oxygen NN I-NP O
oxidoreductase NN I-NP O
( ( O O
4 CD B-NP O
- HYPH O O
hydroxylating VBG B-VP O
) ) O O
, , O O
EC NNP B-NP O
1 CD I-NP O
. . O O

14 CD B-NP O
. . I-NP O

16 CD I-NP O
. . I-NP O

1 CD I-NP O
] ) I-NP O
gene NN I-NP O
in IN B-PP O
a DT B-NP O
Chinese JJ I-NP O
patient NN I-NP O
with IN B-PP O
classic JJ B-NP O
phenylketonuria NN I-NP B-Disease
( ( O O
PKU NN B-NP B-Disease
) ) O O
. . O O

A DT B-NP O
G NN I-NP O
- HYPH B-ADJP O
to TO B-PP O
- HYPH B-NP O
C NN I-NP O
transition NN I-NP O
at IN B-PP O
the DT B-NP O
second JJ I-NP O
base NN I-NP O
of IN B-PP O
codon NN B-NP O
413 CD I-NP O
in IN B-PP O
exon NN B-NP O
12 CD I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
results VBZ B-VP O
in IN B-PP O
the DT B-NP O
substitution NN I-NP O
of IN B-PP O
Pro413 NN B-NP O
for IN B-PP O
Arg413 NN B-NP O
in IN B-PP O
the DT B-NP O
mutant JJ I-NP O
protein NN I-NP O
. . O O

This DT B-NP O
mutation NN I-NP O
( ( O O
R413P NN B-NP O
) ) O O
results VBZ B-VP O
in IN B-PP O
negligible JJ B-NP O
enzymatic JJ I-NP O
activity NN I-NP O
when WRB B-ADVP O
expressed VBN B-VP O
in IN B-PP O
heterologous JJ B-NP O
mammalian JJ I-NP O
cells NNS I-NP O
and CC O O
is VBZ B-VP O
compatible JJ B-ADJP O
with IN B-PP O
a DT B-NP O
classic JJ I-NP O
PKU NN I-NP B-Disease
phenotype NN I-NP O
in IN B-PP O
the DT B-NP O
patient NN I-NP O
. . O O

Population NN B-NP O
genetic JJ I-NP O
studies NNS I-NP O
reveal VBP B-VP O
that IN B-SBAR O
this DT B-NP O
mutation NN I-NP O
is VBZ B-VP O
tightly RB I-VP O
linked VBN I-VP O
to TO B-PP O
restriction NN B-NP O
fragment NN I-NP O
length NN I-NP O
polymorphism NN I-NP O
haplotype NN I-NP O
4 CD I-NP O
, , O O
which WDT B-NP O
is VBZ B-VP O
the DT B-NP O
predominant JJ I-NP O
haplotype NN I-NP O
of IN B-PP O
the DT B-NP O
PAH NN I-NP O
locus NN I-NP O
in IN B-PP O
the DT B-NP O
Oriental JJ I-NP O
population NN I-NP O
. . O O

It PRP B-NP O
accounts VBZ B-VP O
for IN B-PP O
13 CD B-NP O
. . O O

8 CD B-NP O
% NN I-NP O
of IN B-PP O
northern JJ B-NP O
Chinese JJ I-NP O
and CC I-NP O
27 CD I-NP O
% NN I-NP O
of IN B-PP O
Japanese JJ B-NP O
PKU NN I-NP B-Disease
alleles NNS I-NP O
, , O O
but CC O O
it PRP B-NP O
is VBZ B-VP O
rare JJ B-ADJP O
in IN B-PP O
southern JJ B-NP O
Chinese JJ I-NP O
( ( O O
2 CD B-NP O
. . O O

2 CD B-NP O
% NN I-NP O
) ) O O
and CC O O
is VBZ B-VP O
absent JJ B-ADJP O
in IN B-PP O
the DT B-NP O
Caucasian JJ I-NP O
population NN I-NP O
. . O O

The DT B-NP O
data NNS I-NP O
demonstrate VBP B-VP O
unambiguously RB B-ADVP O
that IN B-SBAR O
the DT B-NP O
mutation NN I-NP O
occurred VBD B-VP O
after IN B-PP O
racial JJ B-NP O
divergence NN I-NP O
of IN B-PP O
Orientals NNPS B-NP O
and CC I-NP O
Caucasians NNPS I-NP O
and CC O O
suggest VBP B-VP O
that IN B-SBAR O
the DT B-NP O
allele NN I-NP O
has VBZ B-VP O
spread VBN I-VP O
throughout IN B-PP O
the DT B-NP O
Orient NNP I-NP O
by IN B-PP O
a DT B-NP O
founder NN I-NP O
effect NN I-NP O
. . O O

Previous JJ B-NP O
protein NN I-NP O
polymorphism NN I-NP O
studies NNS I-NP O
in IN B-PP O
eastern JJ B-NP O
Asia NNP I-NP O
have VBP B-VP O
led VBN I-VP O
to TO B-PP O
the DT B-NP O
hypothesis NN I-NP O
that IN B-SBAR O
northern JJ B-NP O
Mongoloids NNS I-NP O
represented VBD B-VP O
a DT B-NP O
founding JJ I-NP O
population NN I-NP O
in IN B-PP O
Asia NNP B-NP O
. . O O

Our PRP$ B-NP O
results NNS I-NP O
are VBP B-VP O
compatible JJ B-ADJP O
with IN B-PP O
this DT B-NP O
hypothesis NN I-NP O
in IN B-PP O
that IN B-SBAR O
the DT B-NP O
PKU NN I-NP B-Disease
mutation NN I-NP O
might MD B-VP O
have VB I-VP O
occurred VBD I-VP O
in IN B-PP O
northern JJ B-NP O
Mongoloids NNS I-NP O
and CC O O
subsequently RB B-VP O
spread VBN I-VP O
to TO B-PP O
the DT B-NP O
Chinese JJ I-NP O
and CC I-NP O
Japanese JJ I-NP O
populations NNS I-NP O
. . O O

Glucose NN B-NP B-Disease
/ SYM I-NP I-Disease
galactose NN I-NP I-Disease
malabsorption NN I-NP I-Disease
caused VBN B-VP O
by IN B-PP O
a DT B-NP O
defect NN I-NP O
in IN B-PP O
the DT B-NP O
Na NN I-NP O
+ SYM O O
/ SYM O O
glucose NN B-NP O
cotransporter NN I-NP O
. . O O

Glucose NN B-NP B-Disease
/ SYM O I-Disease
galactose NN B-NP I-Disease
malabsorption NN I-NP I-Disease
( ( O O
GGM NN B-NP B-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
disease NN I-NP I-Disease
manifesting VBG B-VP O
within IN B-PP O
the DT B-NP O
first JJ I-NP O
weeks NNS I-NP O
of IN B-PP O
life NN B-NP O
and CC O O
characterized VBN B-VP O
by IN B-PP O
a DT B-NP O
selective JJ I-NP O
failure NN I-NP O
to TO B-VP O
absorb VB I-VP O
dietary JJ B-NP O
glucose NN I-NP O
and CC I-NP O
galactose NN I-NP O
from IN B-PP O
the DT B-NP O
intestine NN I-NP O
. . O O

The DT B-NP O
consequent JJ I-NP O
severe JJ I-NP O
diarrhoea NN I-NP B-Disease
and CC I-NP O
dehydration NN I-NP B-Disease
are VBP B-VP O
usually RB B-ADVP O
fatal JJ B-ADJP O
unless IN B-SBAR O
these DT B-NP O
sugars NNS I-NP O
are VBP B-VP O
eliminated VBN I-VP O
from IN B-PP O
the DT B-NP O
diet NN I-NP O
. . O O

Intestinal JJ B-NP O
biopsies NNS I-NP O
of IN B-PP O
GGM NN B-NP B-Disease
patients NNS I-NP O
have VBP B-VP O
revealed VBN I-VP O
a DT B-NP O
specific JJ I-NP O
defect NN I-NP O
in IN B-PP O
Na NN B-NP O
( ( O O
+ SYM B-NP O
) ) O O
- HYPH B-NP O
dependent JJ I-NP O
absorption NN I-NP O
of IN B-PP O
glucose NN B-NP O
in IN B-PP O
the DT B-NP O
brush JJ I-NP O
border NN I-NP O
. . O O

Normal JJ B-NP O
glucose NN I-NP O
absorption NN I-NP O
is VBZ B-VP O
mediated VBN I-VP O
by IN B-PP O
the DT B-NP O
Na NN I-NP O
+ SYM O O
/ SYM O O
glucose NN B-NP O
cotransporter NN I-NP O
in IN B-PP O
the DT B-NP O
brush JJ I-NP O
border NN I-NP O
membrane NN I-NP O
of IN B-PP O
the DT B-NP O
intestinal JJ I-NP O
epithelium NN I-NP O
. . O O

Cellular JJ B-NP O
influx NN I-NP O
is VBZ B-VP O
driven VBN I-VP O
by IN B-PP O
the DT B-NP O
transmembrane JJ I-NP O
Na NN I-NP O
+ SYM B-VP O
electrochemical JJ B-NP O
potential JJ I-NP O
gradient NN I-NP O
; : O O
thereafter RB B-ADVP O
the DT B-NP O
sugar NN I-NP O
moves VBZ B-VP O
to TO B-PP O
the DT B-NP O
blood NN I-NP O
across IN B-PP O
the DT B-NP O
basolateral JJ I-NP O
membrane NN I-NP O
via IN B-PP O
the DT B-NP O
facilitated VBN I-NP O
glucose NN I-NP O
carrier NN I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
previously RB I-VP O
cloned VBN I-VP O
and CC O O
sequenced VBN B-VP O
a DT B-NP O
Na NN I-NP O
+ SYM O O
/ SYM O O
glucose NN B-NP O
cotransporter NN I-NP O
from IN B-PP O
normal JJ B-NP O
human JJ I-NP O
ileum NN I-NP O
and CC O O
shown VBN B-VP O
that IN B-SBAR O
this DT B-NP O
gene NN I-NP O
, , O O
SGLT1 NN B-NP O
, , O O
resides VBZ B-VP O
on IN B-PP O
the DT B-NP O
distal JJ I-NP O
q NN I-NP O
arm NN I-NP O
of IN B-PP O
chromosome NN B-NP O
22 CD I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
now RB I-VP O
amplified VBN I-VP O
SGLT1 NN B-NP O
complementary JJ I-NP O
DNA NN I-NP O
and CC O O
genomic JJ B-NP O
DNA NN I-NP O
from IN B-PP O
members NNS B-NP O
of IN B-PP O
a DT B-NP O
family NN I-NP O
affected VBN B-VP O
with IN B-PP O
GGM NN B-NP B-Disease
by IN B-PP O
the DT B-NP O
polymerase NN I-NP O
chain NN I-NP O
reaction NN I-NP O
. . O O

Sequence NN B-NP O
analysis NN I-NP O
of IN B-PP O
the DT B-NP O
amplified VBN I-NP O
products NNS I-NP O
has VBZ B-VP O
revealed VBN I-VP O
a DT B-NP O
single JJ I-NP O
missense JJ I-NP O
mutation NN I-NP O
in IN B-PP O
SGLT1 NN B-NP O
which WDT B-NP O
cosegregates VBZ B-VP O
with IN B-PP O
the DT B-NP O
GGM NNP I-NP B-Disease
phenotype NN I-NP O
and CC O O
results VBZ B-VP O
in IN B-PP O
a DT B-NP O
complete JJ I-NP O
loss NN I-NP O
of IN B-PP O
Na NN B-NP O
( ( O O
+ SYM B-NP O
) ) O O
- HYPH B-NP O
dependent JJ I-NP O
glucose NN I-NP O
transport NN I-NP O
in IN B-PP O
Xenopus NNP B-NP O
oocytes NNS I-NP O
injected VBN B-VP O
with IN B-PP O
this DT B-NP O
complementary JJ I-NP O
RNA NN I-NP O
. . O O

. . O O

A DT B-NP O
de FW I-NP O
novo FW I-NP O
unbalanced JJ I-NP O
reciprocal JJ I-NP O
translocation NN I-NP O
identified VBN B-VP O
as IN B-PP O
paternal NN B-NP O
in IN B-PP O
origin NN B-NP O
in IN B-PP O
the DT B-NP O
Prader NNP I-NP B-Disease
- HYPH I-NP I-Disease
Willi NNP I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

Interstitial JJ B-NP O
cytogenetic JJ I-NP O
deletions NNS I-NP O
involving VBG B-VP O
the DT B-NP O
paternally RB I-NP O
derived VBN I-NP O
chromosome NN I-NP O
15q11 CD I-NP O
- HYPH I-NP O
13 CD I-NP O
have VBP B-VP O
been VBN I-VP O
described VBN I-VP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
the DT B-NP O
Prader NNP I-NP B-Disease
- HYPH I-NP I-Disease
Willi NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
PWS NN B-NP B-Disease
) ) O O
. . O O

We PRP B-NP O
report VBP B-VP O
a DT B-NP O
child NN I-NP O
with IN B-PP O
PWS NN B-NP B-Disease
and CC O O
a DT B-NP O
de FW I-NP O
novo FW I-NP O
unbalanced JJ I-NP O
karyotype NN I-NP O
- HYPH O O
45 CD B-NP O
, , O O
XY NN B-NP O
, , O O
- HYPH B-NP O
9 CD I-NP O
, , O O
- HYPH B-NP O
15 CD I-NP O
, , O O
+ CC O O
der NN B-NP O
( ( O O
9 CD B-NP O
) ) O O
t NN B-NP O
( ( O O
9 CD B-NP O
; : O O
15 CD B-NP O
) ) O O
( ( O O
q34 NN B-NP O
; : O O
q13 NN B-NP O
) ) O O
. . O O

Molecular JJ B-NP O
studies NNS I-NP O
with IN B-PP O
the DT B-NP O
DNA NN I-NP O
probe NN I-NP O
pML34 NN I-NP O
confirmed VBD B-VP O
that IN B-SBAR O
only RB B-NP O
a DT I-NP O
single JJ I-NP O
Prader NNP I-NP B-Disease
Willi NNP I-NP I-Disease
critical JJ I-NP O
region NN I-NP O
( ( O O
PWCR NN B-NP O
15q11 CD I-NP O
. . O O

2 CD B-NP O
- HYPH I-NP O
q12 NN I-NP O
) ) O O
copy NN B-NP O
was VBD B-VP O
present JJ B-ADJP O
. . O O

Hybridisation NN B-NP O
of IN B-PP O
patient NN B-NP O
and CC O O
parental JJ B-NP O
DNA NN I-NP O
with IN B-PP O
the DT B-NP O
multi AFX I-NP O
- HYPH I-NP O
allelic JJ I-NP O
probe NN I-NP O
CMW1 NN I-NP O
, , O O
which WDT B-NP O
maps VBZ B-VP O
to TO B-PP O
pter NN B-NP O
- HYPH B-NP O
15q13 CD I-NP O
, , O O
showed VBD B-VP O
that IN B-SBAR O
the DT B-NP O
chromosome NN I-NP O
involved VBN B-VP O
in IN B-PP O
the DT B-NP O
translocation NN I-NP O
was VBD B-VP O
paternal JJ B-ADJP O
in IN B-PP O
origin NN B-NP O
. . O O

This DT B-NP O
is VBZ B-VP O
the DT B-NP O
first JJ I-NP O
example NN I-NP O
of IN B-PP O
a DT B-NP O
paternally RB I-NP O
- HYPH I-NP O
derived VBN I-NP O
PWCR NN I-NP O
allele NN I-NP O
loss NN I-NP O
caused VBN B-VP O
by IN B-PP O
an DT B-NP O
unbalanced JJ I-NP O
translocation NN I-NP O
that WDT B-NP O
has VBZ B-VP O
arisen VBN I-VP O
de FW B-NP O
novo FW I-NP O
. . O O

Localisation NN B-NP O
of IN B-PP O
the DT B-NP O
myotonic JJ I-NP B-Disease
dystrophy NN I-NP I-Disease
locus NN I-NP O
to TO B-PP O
19q13 CD B-NP O
. . O O

2 CD B-NP O
- : O O
19q13 CD B-NP O
. . I-NP O

3 CD I-NP O
and CC O O
its PRP$ B-NP O
relationship NN I-NP O
to TO B-VP O
twelve VB I-VP O
polymorphic JJ B-NP O
loci NNS I-NP O
on IN B-PP O
19q NN B-NP O
. . O O

The DT B-NP O
order NN I-NP O
of IN B-PP O
fourteen CD B-NP O
polymorphic JJ I-NP O
markers NNS I-NP O
localised VBN B-VP O
to TO B-PP O
the DT B-NP O
long JJ I-NP O
arm NN I-NP O
of IN B-PP O
human JJ B-NP O
chromosome NN I-NP O
19 CD I-NP O
has VBZ B-VP O
been VBN I-VP O
established VBN I-VP O
by IN B-PP O
multipoint JJ B-NP O
mapping NN I-NP O
in IN B-PP O
a DT B-NP O
set NN I-NP O
of IN B-PP O
40 CD B-NP O
CEPH NN I-NP O
( ( O O
Centre NNP B-NP O
dEtude NNP I-NP O
de IN I-NP O
Polymorphisme NNP I-NP O
Humain NNP I-NP O
, , O O
Paris NNP B-NP O
) ) O O
reference NN B-NP O
families NNS I-NP O
. . O O

We PRP B-NP O
report VBP B-VP O
here RB B-ADVP O
the DT B-NP O
linkage NN I-NP O
relationship NN I-NP O
of IN B-PP O
the DT B-NP O
myotonic JJ I-NP B-Disease
dystrophy NN I-NP I-Disease
( ( O O
DM NN B-NP B-Disease
) ) O O
locus NN B-NP O
to TO B-VP O
twelve VB I-VP O
of IN B-PP O
these DT B-NP O
markers NNS I-NP O
as IN B-SBAR O
studied VBN B-VP O
in IN B-PP O
45 CD B-NP O
families NNS I-NP O
with IN B-PP O
DM NN B-NP B-Disease
. . O O

The DT B-NP O
resulting VBG I-NP O
genetic JJ I-NP O
map NN I-NP O
is VBZ B-VP O
supported VBN I-VP O
by IN B-PP O
the DT B-NP O
localisation NN I-NP O
of IN B-PP O
the DT B-NP O
DNA NN I-NP O
markers NNS I-NP O
in IN B-PP O
a DT B-NP O
panel NN I-NP O
of IN B-PP O
somatic JJ B-NP O
cell NN I-NP O
hybrids NNS I-NP O
. . O O

Ten CD B-NP O
of IN B-PP O
the DT B-NP O
twelve CD I-NP O
markers NNS I-NP O
have VBP B-VP O
been VBN I-VP O
shown VBN I-VP O
to TO I-VP O
be VB I-VP O
proximal JJ B-ADJP O
to TO B-PP O
the DT B-NP O
DM NN I-NP B-Disease
gene NN I-NP O
and CC O O
two CD B-NP O
, , O O
PRKCG NN B-NP O
and CC I-NP O
D19S22 NN I-NP O
, , O O
distal JJ B-ADJP O
but CC B-PP O
at IN B-PP O
distances NNS B-NP O
of IN B-PP O
approximately RB B-NP O
25 CD I-NP O
cM NN I-NP O
and CC O O
15 CD B-NP O
cM NN I-NP O
, , O O
respectively RB B-ADVP O
. . O O

The DT B-NP O
closest JJS I-NP O
proximal JJ I-NP O
markers NNS I-NP O
are VBP B-VP O
APOC2 NN B-NP O
( ( O O
apolipoprotein NN B-NP O
C NN I-NP O
- HYPH B-NP O
II CD I-NP O
) ) O O
and CC O O
CKM NN B-NP O
( ( O O
creatine NN B-NP O
kinase NN I-NP O
, , O O
muscle NN B-NP O
) ) O O
approximately RB B-NP O
3 CD I-NP O
cM NN I-NP O
and CC O O
2 CD B-NP O
cM NN I-NP O
from IN B-PP O
the DT B-NP O
DM NN I-NP B-Disease
gene NN I-NP O
respectively RB B-ADVP O
, , O O
in IN B-PP O
the DT B-NP O
order NN I-NP O
APOC2 NN I-NP O
- HYPH B-NP O
CKM NN I-NP O
- HYPH B-NP O
DM NN I-NP O
. . O O

The DT B-NP O
distance NN I-NP O
between IN B-PP O
APOC2 NN B-NP O
, , I-NP O
CKM NN I-NP O
and CC I-NP O
DM NN I-NP B-Disease
( ( O O
of IN B-PP O
the DT B-NP O
order NN I-NP O
of IN B-PP O
2 CD B-NP O
million CD I-NP O
base NN I-NP O
pairs NNS I-NP O
) ) O O
and CC O O
their PRP$ B-NP O
known VBN I-NP O
orientation NN I-NP O
should MD B-VP O
permit VB I-VP O
directional JJ B-NP O
chromosome NN I-NP O
walking NN I-NP O
and CC I-NP O
jumping NN I-NP O
. . O O

The DT B-NP O
data NNS I-NP O
presented VBN B-VP O
here RB B-ADVP O
should MD B-VP O
enable VB I-VP O
us PRP B-NP O
to TO B-VP O
determine VB I-VP O
whether IN B-SBAR O
or CC O O
not RB O O
new JJ B-NP O
markers NNS I-NP O
are VBP B-VP O
distal JJ B-ADJP O
to TO B-PP O
APOC2 NN B-NP O
/ SYM B-NP O
CKM NN I-NP O
and CC O O
thus RB B-VP O
potentially RB I-VP O
flank VB I-VP O
the DT B-NP O
DM NN I-NP B-Disease
gene NN I-NP O
. . O O

. . O O

Localization NN B-NP O
of IN B-PP O
histidase NN B-NP O
to TO B-PP O
human JJ B-NP O
chromosome NN I-NP O
region NN I-NP O
12q22 CD I-NP O
- HYPH B-NP O
- SYM I-NP O
- SYM I-NP O
- HYPH I-NP O
q24 NN I-NP O
. . I-NP O

1 CD I-NP O
and CC O O
mouse NN B-NP O
chromosome NN I-NP O
region NN I-NP O
10C2 CD I-NP O
- SYM B-VP O
- SYM B-NP O
- SYM B-NP O
- HYPH B-VP O
D1 NN B-NP O
. . O O

The DT B-NP O
human JJ I-NP O
gene NN I-NP O
for IN B-PP O
histidase NN B-NP O
( ( O O
histidine NN B-NP O
ammonia NN I-NP O
- HYPH B-NP O
lyase NN I-NP O
; : O O
HAL NN B-NP O
) ) O O
, , O O
the DT B-NP O
enzyme NN I-NP O
deficient JJ B-ADJP O
in IN B-PP O
histidinemia NN B-NP B-Disease
, , O O
was VBD B-VP O
assigned VBN I-VP O
to TO B-PP O
human JJ B-NP O
chromosome NN I-NP O
12 CD I-NP O
by IN B-PP O
Southern JJ B-NP O
blot NN I-NP O
analysis NN I-NP O
of IN B-PP O
human JJ B-NP O
X NN I-NP O
mouse NN I-NP O
somatic JJ I-NP O
cell NN I-NP O
hybrid NN I-NP O
DNA NN I-NP O
. . O O

The DT B-NP O
gene NN I-NP O
was VBD B-VP O
sublocalized VBN I-VP O
to TO B-PP O
region NN B-NP O
12q22 CD I-NP O
- HYPH O O
- SYM O O
- SYM O O
- HYPH O O
q24 NN B-NP O
. . O O

1 CD B-NP O
by IN B-PP O
in FW B-NP O
situ FW I-NP O
hybridization NN I-NP O
, , O O
using VBG B-VP O
a DT B-NP O
human JJ I-NP O
histidase NN I-NP O
cDNA NN I-NP O
. . O O

The DT B-NP O
homologous JJ I-NP O
locus NN I-NP O
in IN B-PP O
the DT B-NP O
mouse NN I-NP O
( ( O O
Hal NN B-NP O
) ) O O
was VBD B-VP O
mapped VBN I-VP O
to TO B-PP O
region NN B-NP O
10C2 CD I-NP O
- SYM O O
- SYM O O
- SYM O O
- HYPH O O
D1 NN B-NP O
by IN B-PP O
in FW B-NP O
situ FW I-NP O
hybridization NN I-NP O
, , O O
using VBG B-VP O
a DT B-NP O
cell NN I-NP O
line NN I-NP O
from IN B-PP O
a DT B-NP O
mouse NN I-NP O
homozygous JJ B-ADJP O
for IN B-PP O
a DT B-NP O
1 CD I-NP O
. . O O

10 CD B-NP O
Robertsonian JJ I-NP O
translocation NN I-NP O
. . O O

These DT B-NP O
assignments NNS I-NP O
extend VBP B-VP O
the DT B-NP O
conserved VBN I-NP O
syntenic JJ I-NP O
region NN I-NP O
between IN B-PP O
human JJ B-NP O
chromosome NN I-NP O
12 CD I-NP O
and CC O O
mouse NN B-NP O
chromosome NN I-NP O
10 CD B-NP O
that WDT B-NP O
includes VBZ B-VP O
the DT B-NP O
genes NNS I-NP O
for IN B-PP O
phenylalanine NN B-NP O
hydroxylase NN I-NP O
, , O O
gamma NN B-NP O
interferon NN I-NP O
, , O O
peptidase NN B-NP O
, , O O
and CC O O
citrate NN B-NP O
synthase NN I-NP O
. . O O

The DT B-NP O
localization NN I-NP O
of IN B-PP O
histidase NN B-NP O
to TO B-PP O
mouse NN B-NP O
chromosome NN I-NP O
10 CD I-NP O
suggests VBZ B-VP O
that IN B-SBAR O
the DT B-NP O
histidase NN I-NP O
regulatory JJ I-NP O
locus NN I-NP O
( ( O O
Hsd NN B-NP O
) ) O O
and CC O O
the DT B-NP O
histidinemia NN I-NP O
mutation NN I-NP O
( ( O O
his PRP$ B-NP O
) ) O O
, , O O
which WDT B-NP O
are VBP B-VP O
both DT O O
known VBN B-VP O
to TO I-VP O
be VB I-VP O
on IN B-PP O
chromosome NN B-NP O
10 CD I-NP O
, , O O
may MD B-VP O
be VB I-VP O
alleles NNS B-NP O
of IN B-PP O
the DT B-NP O
histidase NN I-NP O
structural JJ I-NP O
gene NN I-NP O
locus NN I-NP O
. . O O

Determination NN B-NP O
of IN B-PP O
the DT B-NP O
mutations NNS I-NP O
responsible JJ B-ADJP O
for IN B-PP O
the DT B-NP O
Lesch NNP I-NP B-Disease
- HYPH I-NP I-Disease
Nyhan NNP I-NP I-Disease
syndrome NN I-NP I-Disease
in IN B-PP O
17 CD B-NP O
subjects NNS I-NP O
. . O O

Hypoxanthine NN B-NP O
- HYPH O O
- HYPH O O
guanine NN B-NP O
phosphoribosyltransferase NN I-NP O
( ( O O
HPRT NN B-NP O
) ) O O
is VBZ B-VP O
a DT B-NP O
purine NN I-NP O
salvage NN I-NP O
enzyme NN I-NP O
that WDT B-NP O
catalyzes VBZ B-VP O
the DT B-NP O
conversion NN I-NP O
of IN B-PP O
hypoxanthine NN B-NP O
to TO B-PP O
inosine NN B-NP O
monophosphate NN I-NP O
and CC O O
guanine NN B-NP O
to TO B-PP O
guanosine NN B-NP O
monophosphate NN I-NP O
. . O O

Previous JJ B-NP O
studies NNS I-NP O
of IN B-PP O
mutant JJ B-NP O
HPRT NN I-NP O
proteins NNS I-NP O
analyzed VBN B-VP O
at IN B-PP O
the DT B-NP O
molecular JJ I-NP O
level NN I-NP O
have VBP B-VP O
shown VBN I-VP O
a DT B-NP O
significant JJ I-NP O
heterogeneity NN I-NP O
. . O O

This DT B-NP O
investigation NN I-NP O
further RBR B-ADVP O
verifies VBZ B-VP O
this DT B-NP O
heterogeneity NN I-NP O
and CC O O
identifies VBZ B-VP O
insertions NNS B-NP O
, , O O
deletions NNS B-NP O
, , O O
and CC O O
point NN B-NP O
mutations NNS I-NP O
. . O O

The DT B-NP O
direct JJ I-NP O
sequencing NN I-NP O
of IN B-PP O
the DT B-NP O
polymerase NN I-NP O
chain NN I-NP O
reaction NN I-NP O
- HYPH B-NP O
amplified VBN I-NP O
product NN I-NP O
of IN B-PP O
reverse NN B-NP O
- HYPH B-NP O
transcribed VBN I-NP O
HPRT NN I-NP O
mRNA NN I-NP O
enabled VBD B-VP O
the DT B-NP O
rapid JJ I-NP O
identification NN I-NP O
of IN B-PP O
the DT B-NP O
mutations NNS I-NP O
found VBN B-VP O
in IN B-PP O
17 CD B-NP O
previously RB I-NP O
uncharacterized JJ I-NP O
cell NN I-NP O
lines NNS I-NP O
derived VBN B-VP O
from IN B-PP O
patients NNS B-NP O
with IN B-PP O
the DT B-NP O
Lesch NNP I-NP B-Disease
- HYPH I-NP I-Disease
Nyhan NNP I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

. . O O

Linkage NN B-NP O
of IN B-PP O
DNA NN B-NP O
markers NNS I-NP O
at IN B-PP O
Xq28 NN B-NP O
to TO B-PP O
adrenoleukodystrophy NN B-NP B-Disease
and CC I-NP O
adrenomyeloneuropathy NN I-NP B-Disease
present JJ B-ADJP O
within IN B-PP O
the DT B-NP O
same JJ I-NP O
family NN I-NP O
. . O O

We PRP B-NP O
present VBP B-VP O
a DT B-NP O
large JJ I-NP O
kindred NN I-NP O
that WDT B-NP O
contained VBD B-VP O
patients NNS B-NP O
with IN B-PP O
either CC O O
adrenoleukodystrophy NN B-NP B-Disease
( ( O O
ALD NN B-NP B-Disease
) ) O O
or CC O O
adrenomyeloneuropathy NN B-NP B-Disease
( ( O O
AMN NN B-NP B-Disease
) ) O O
. . O O

The DT B-NP O
pedigree NN I-NP O
clearly RB B-ADVP O
supported VBD B-VP O
the DT B-NP O
X NN I-NP O
- HYPH B-VP O
linked VBN B-NP O
mode NN I-NP O
of IN B-PP O
inheritance NN B-NP O
of IN B-PP O
the DT B-NP O
nonneonatal JJ I-NP O
form NN I-NP O
of IN B-PP O
ALD NN B-NP B-Disease
/ SYM B-NP O
AMN NN I-NP B-Disease
. . O O

Analysis NN B-NP O
with IN B-PP O
DNA NN B-NP O
markers NNS I-NP O
at IN B-PP O
Xq28 NN B-NP O
suggested VBD B-VP O
segregation NN B-NP O
of IN B-PP O
both CC O O
ALD NN B-NP B-Disease
and CC O O
AMN NN B-NP B-Disease
with IN B-PP O
an DT B-NP O
identical JJ I-NP O
haplotype NN I-NP O
. . O O

This DT B-NP O
indicated VBD B-VP O
that IN B-SBAR O
nonneonatal JJ B-NP O
ALD NN I-NP B-Disease
and CC I-NP O
AMN NN I-NP B-Disease
are VBP B-VP O
caused VBN I-VP O
by IN B-PP O
a DT B-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
same JJ I-NP O
gene NN I-NP O
at IN B-PP O
Xq28 NN B-NP O
. . O O

It PRP B-NP O
showed VBD B-VP O
, , O O
furthermore RB B-ADVP O
, , O O
that IN B-SBAR O
phenotypic JJ B-NP O
differences NNS I-NP O
between IN B-PP O
ALD NN B-NP B-Disease
and CC I-NP O
AMN NN I-NP B-Disease
are VBP B-VP O
not RB O O
necessarily RB B-ADVP O
the DT B-NP O
consequence NN I-NP O
of IN B-PP O
allelic JJ B-NP O
heterogeneity NN I-NP O
due JJ B-PP O
to TO B-PP O
different JJ B-NP O
mutations NNS I-NP O
within IN B-PP O
the DT B-NP O
same JJ I-NP O
gene NN I-NP O
. . O O

The DT B-NP O
maximal JJ I-NP O
lod NN I-NP O
score NN I-NP O
for IN B-PP O
linkage NN B-NP O
of IN B-PP O
the DT B-NP O
ALD NN I-NP B-Disease
/ SYM B-NP O
AMN NN I-NP B-Disease
gene NN I-NP O
and CC O O
the DT B-NP O
multiallelic JJ I-NP O
anonymous JJ I-NP O
DNA NN I-NP O
marker NN I-NP O
at IN B-PP O
DXS52 NN B-NP O
was VBD B-VP O
3 CD B-NP O
. . O O

0 CD B-NP O
at IN B-PP O
a DT B-NP O
recombination NN I-NP O
fraction NN I-NP O
of IN B-PP O
0 CD B-NP O
. . O O

00 CD B-NP O
. . O O

This DT B-NP O
made VBD B-VP O
a DT B-NP O
prenatal JJ I-NP O
or CC I-NP O
presymptomatic JJ I-NP O
diagnosis NN I-NP O
and CC I-NP O
heterozygote NN I-NP O
detection NN I-NP O
by IN B-PP O
DNA NN B-NP O
analysis NN I-NP O
with IN B-PP O
this DT B-NP O
marker NN I-NP O
reliable JJ B-ADJP O
. . O O

Skewed VBN B-NP O
X NN I-NP O
inactivation NN I-NP O
in IN B-PP O
a DT B-NP O
female JJ I-NP O
MZ NN I-NP O
twin NN I-NP O
results VBZ B-VP O
in IN B-PP O
Duchenne NNP B-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
. . O O

One CD B-NP O
of IN B-PP O
female JJ B-NP O
MZ NN I-NP O
twins NNS I-NP O
presented VBD B-VP O
with IN B-PP O
muscular JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
. . O O

Physical JJ B-NP O
examination NN I-NP O
, , O O
creatine NN B-NP O
phosphokinase NN I-NP O
levels NNS I-NP O
, , O O
and CC O O
muscle NN B-NP O
biopsy NN I-NP O
were VBD B-VP O
consistent JJ B-ADJP O
with IN B-PP O
Duchenne JJ B-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
DMD NN B-NP B-Disease
) ) O O
. . O O

However RB B-ADVP O
, , O O
because IN B-PP O
of IN I-PP O
her PRP$ B-NP O
sex NN I-NP O
she PRP B-NP O
was VBD B-VP O
diagnosed VBN I-VP O
as IN B-PP O
having VBG B-VP O
limb NN B-NP B-Disease
- HYPH B-NP I-Disease
girdle NN I-NP I-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
. . O O

With IN B-PP O
cDNA NN B-NP O
probes NNS I-NP O
to TO B-PP O
the DT B-NP O
DMD NN I-NP B-Disease
gene NN I-NP O
, , O O
a DT B-NP O
gene NN I-NP O
deletion NN I-NP O
was VBD B-VP O
detected VBN I-VP O
in IN B-PP O
the DT B-NP O
twins NNS I-NP O
and CC O O
their PRP$ B-NP O
mother NN I-NP O
. . O O

The DT B-NP O
de FW I-NP O
novo FW I-NP O
mutation NN I-NP O
which WDT B-NP O
arose VBD B-VP O
in IN B-PP O
the DT B-NP O
mother NN I-NP O
was VBD B-VP O
shown VBN I-VP O
by IN B-PP O
novel JJ B-NP O
junction NN I-NP O
fragments NNS I-NP O
generated VBN B-VP O
by IN B-PP O
HindIII NN B-NP O
, , O O
PstI NN B-NP O
, , O O
or CC O O
TaqI NN B-NP O
when WRB B-ADVP O
probed VBN B-VP O
with IN B-PP O
cDNA8 NN B-NP O
. . O O

Additional JJ B-NP O
evidence NN I-NP O
of IN B-PP O
a DT B-NP O
large JJ I-NP O
gene NN I-NP O
deletion NN I-NP O
was VBD B-VP O
given VBN I-VP O
by IN B-PP O
novel JJ B-NP O
SfiI NN I-NP O
junction NN I-NP O
fragments NNS I-NP O
detected VBN B-VP O
by IN B-PP O
probes NNS B-NP O
p20 NN I-NP O
, , O O
J NN B-NP O
- HYPH B-NP O
Bir NN I-NP O
, , O O
and CC O O
J NN B-NP O
- HYPH O O
66 CD B-NP O
on IN B-PP O
pulsed JJ B-NP O
- HYPH I-NP O
field NN I-NP O
gel NN I-NP O
electrophoresis NN I-NP O
( ( O O
PFGE NN B-NP O
) ) O O
. . O O

Immunoblot NN B-NP O
analysis NN I-NP O
of IN B-PP O
muscle NN B-NP O
from IN B-PP O
the DT B-NP O
affected VBN I-NP O
twin NN I-NP O
showed VBD B-VP O
dystrophin NN B-NP O
of IN B-PP O
normal JJ B-NP O
size NN I-NP O
but CC B-PP O
of IN B-PP O
reduced VBN B-NP O
amount NN I-NP O
. . O O

Immunofluorescent JJ B-NP O
visualization NN I-NP O
of IN B-PP O
dystrophin NN B-NP O
revealed VBD B-VP O
foci NNS B-NP O
of IN B-PP O
dystrophin NN B-NP O
- HYPH B-NP O
positive JJ I-NP O
fibers NNS I-NP O
adjacent JJ B-ADJP O
to TO B-PP O
foci NNS B-NP O
of IN B-PP O
dystrophin NN B-NP O
- HYPH B-NP O
negative JJ I-NP O
fibers NNS I-NP O
. . O O

These DT B-NP O
data NNS I-NP O
indicate VBP B-VP O
that IN B-SBAR O
the DT B-NP O
affected VBN I-NP O
twin NN I-NP O
is VBZ B-VP O
a DT B-NP O
manifesting VBG I-NP O
carrier NN I-NP O
of IN B-PP O
an DT B-NP O
abnormal JJ I-NP O
DMD NN I-NP B-Disease
gene NN I-NP O
, , O O
her PRP$ B-NP O
myopathy NN I-NP B-Disease
being VBG B-VP O
a DT B-NP O
direct JJ I-NP O
result NN I-NP O
of IN B-PP O
underexpression NN B-NP O
of IN B-PP O
dystrophin NN B-NP O
. . O O

Cytogenetic JJ B-NP O
analysis NN I-NP O
revealed VBD B-VP O
normal JJ B-NP O
karyotypes NNS I-NP O
, , O O
eliminating VBG B-VP O
the DT B-NP O
possibility NN I-NP O
of IN B-PP O
a DT B-NP O
translocation NN I-NP O
affecting VBG B-VP O
DMD NN B-NP B-Disease
gene NN I-NP O
function NN I-NP O
. . O O

Both CC O O
linkage NN B-NP O
analysis NN I-NP O
and CC O O
DNA NN B-NP O
fingerprint NN I-NP O
analysis NN I-NP O
revealed VBD B-VP O
that IN B-SBAR O
each DT B-NP O
twin NN I-NP O
has VBZ B-VP O
two CD B-NP O
different JJ I-NP O
X NN I-NP O
chromosomes NNS I-NP O
, , O O
eliminating VBG B-VP O
the DT B-NP O
possibility NN I-NP O
of IN B-PP O
uniparental JJ B-NP B-Disease
disomy NN I-NP I-Disease
as IN B-PP O
a DT B-NP O
mechanism NN I-NP O
for IN B-PP O
DMD NN B-NP B-Disease
expression NN I-NP O
. . O O

On IN B-PP O
the DT B-NP O
basis NN I-NP O
of IN B-PP O
methylation NN B-NP O
differences NNS I-NP O
of IN B-PP O
the DT B-NP O
paternal JJ I-NP O
and CC I-NP O
maternal JJ I-NP O
X NN I-NP O
chromosomes NNS I-NP O
in IN B-PP O
these DT B-NP O
MZ NN I-NP O
twins NNS I-NP O
, , O O
we PRP B-NP O
propose VBP B-VP O
uneven JJ B-NP O
lyonization NN I-NP O
( ( O O
X NN B-NP O
chromosome NN I-NP O
inactivation NN I-NP O
) ) O O
as IN B-SBAR O
the DT B-NP O
underlying VBG I-NP O
mechanism NN I-NP O
for IN B-PP O
disease NN B-NP O
expression NN I-NP O
in IN B-PP O
the DT B-NP O
affected VBN I-NP O
female JJ I-NP O
. . O O

. . O O

Adrenoleukodystrophy NN B-NP B-Disease
and CC I-NP O
adrenomyeloneuropathy NN I-NP B-Disease
associated VBN B-VP O
with IN B-PP O
partial JJ B-NP O
adrenal JJ I-NP B-Disease
insufficiency NN I-NP I-Disease
in IN B-PP O
three CD B-NP O
generations NNS I-NP O
of IN B-PP O
a DT B-NP O
kindred NN I-NP O
. . O O

Four CD B-NP O
cases NNS I-NP O
of IN B-PP O
adrenoleukodystrophy NN B-NP B-Disease
( ( O O
ALD NN B-NP B-Disease
) ) O O
and CC O O
one CD B-NP O
case NN I-NP O
of IN B-PP O
adrenomyeloneuropathy NN B-NP B-Disease
( ( O O
AMN NN B-NP B-Disease
) ) O O
have VBP B-VP O
developed VBN I-VP O
in IN B-PP O
a DT B-NP O
kindred NN I-NP O
over IN B-PP O
three CD B-NP O
generations NNS I-NP O
demonstrating VBG B-VP O
that IN B-SBAR O
AMN NN B-NP B-Disease
is VBZ B-VP O
a DT B-NP O
clinical JJ I-NP O
variant NN I-NP O
of IN B-PP O
ALD NN B-NP B-Disease
. . O O

Pituitary JJ B-NP O
- HYPH I-NP O
adrenal JJ I-NP O
function NN I-NP O
studies NNS I-NP O
were VBD B-VP O
performed VBN I-VP O
in IN B-PP O
10 CD B-NP O
family NN I-NP O
members NNS I-NP O
, , O O
including VBG B-PP O
two CD B-NP O
affected VBN I-NP O
males NNS I-NP O
and CC O O
four CD B-NP O
females NNS I-NP O
identified VBN B-VP O
as IN B-PP O
carriers NNS B-NP O
of IN B-PP O
ALD NN B-NP B-Disease
/ SYM B-NP O
AMN NN I-NP B-Disease
. . O O

No DT B-NP O
pituitary NN I-NP B-Disease
- HYPH B-NP I-Disease
adrenal JJ I-NP I-Disease
abnormality NN I-NP I-Disease
was VBD B-VP O
found VBN I-VP O
in IN B-PP O
the DT B-NP O
carriers NNS I-NP O
. . O O

However RB B-ADVP O
, , O O
basal JJ B-NP O
morning NN I-NP O
plasma NN I-NP O
adrenocorticotropic JJ I-NP O
hormone NN I-NP O
( ( O O
ACTH NN B-NP O
) ) O O
levels NNS B-NP O
were VBD B-VP O
markedly RB B-ADJP O
elevated JJ I-ADJP O
in IN B-PP O
the DT B-NP O
two CD I-NP O
males NNS I-NP O
with IN B-PP O
ALD NN B-NP B-Disease
and CC I-NP O
AMN NN I-NP B-Disease
, , O O
despite IN B-PP O
the DT B-NP O
fact NN I-NP O
that IN B-SBAR O
they PRP B-NP O
had VBD B-VP O
no DT B-NP O
clinical JJ I-NP O
signs NNS I-NP O
of IN B-PP O
adrenal JJ B-NP B-Disease
insufficiency NN I-NP I-Disease
and CC O O
that IN B-SBAR O
morning NN B-NP O
plasma NN I-NP O
cortisol NN I-NP O
levels NNS I-NP O
and CC O O
their PRP$ B-NP O
response NN I-NP O
to TO B-PP O
maximal JJ B-NP O
exogenous JJ I-NP O
ACTH NN I-NP O
stimulation NN I-NP O
appeared VBD B-VP O
to TO I-VP O
be VB I-VP O
normal JJ B-ADJP O
. . O O

In IN B-PP O
addition NN B-NP O
, , O O
the DT B-NP O
integrated VBN I-NP O
24 CD I-NP O
- HYPH I-NP O
hour NN I-NP O
response NN I-NP O
to TO B-PP O
the DT B-NP O
administration NN I-NP O
were VBD B-VP O
also RB B-ADVP O
subnormal JJ B-ADJP O
in IN B-PP O
these DT B-NP O
two CD I-NP O
cases NNS I-NP O
. . O O

Thus RB B-ADVP O
, , O O
people NNS B-NP O
with IN B-PP O
ALD NN B-NP B-Disease
and CC I-NP O
AMN NN I-NP B-Disease
may MD B-VP O
have VB I-VP O
subclinical JJ B-NP O
partial JJ I-NP O
adrenocrotical JJ I-NP B-Disease
insufficiency NN I-NP I-Disease
. . O O

No DT B-NP O
other JJ I-NP O
endocrinologic JJ I-NP B-Disease
dysfunction NN I-NP I-Disease
was VBD B-VP O
identified VBN I-VP O
. . O O

. . O O

Regional JJ B-NP O
localisation NN I-NP O
of IN B-PP O
the DT B-NP O
Friedreich NNP I-NP B-Disease
ataxia NN I-NP I-Disease
locus NN I-NP O
to TO B-PP O
human JJ B-NP O
chromosome NN I-NP O
9q13 CD I-NP O
- HYPH B-NP O
- SYM I-NP O
- SYM I-NP O
- HYPH I-NP O
q21 NN I-NP O
. . I-NP O

1 CD I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
previously RB I-VP O
assigned VBN I-VP O
the DT B-NP O
Friedreich NNP I-NP B-Disease
ataxia NN I-NP I-Disease
locus NN I-NP O
( ( O O
FRDA NN B-NP O
) ) O O
to TO B-PP O
chromosome NN B-NP O
9 CD I-NP O
; : O O
the DT B-NP O
current JJ I-NP O
maximal JJ I-NP O
lod NN I-NP O
score NN I-NP O
between IN B-PP O
FRDA NN B-NP O
and CC O O
MCT112 NN B-NP O
( ( O O
D9S15 NN B-NP O
) ) O O
is VBZ B-VP O
greater JJR B-ADJP O
than IN B-PP O
50 CD B-NP O
at IN B-PP O
a DT B-NP O
recombination NN I-NP O
fraction NN I-NP O
of IN B-PP O
theta NN B-NP O
= SYM B-VP O
0 CD B-NP O
. . O O

The DT B-NP O
physical JJ I-NP O
assignment NN I-NP O
of IN B-PP O
the DT B-NP O
locus NN I-NP O
defined VBN B-VP O
by IN B-PP O
MCT112 NN B-NP O
, , O O
and CC O O
hence RB B-ADVP O
FRDA NN B-NP O
, , O O
has VBZ B-VP O
not RB I-VP O
been VBN I-VP O
determined VBN I-VP O
, , O O
although IN B-SBAR O
linkage NN B-NP O
analysis NN I-NP O
of IN B-PP O
MCT112 NN B-NP O
with IN B-PP O
other JJ B-NP O
chromosome NN I-NP O
9 CD B-NP O
markers NNS I-NP O
inferred VBD B-VP O
a DT B-NP O
location NN I-NP O
close RB B-ADVP O
to TO B-PP O
the DT B-NP O
centromere NN I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
used VBN I-VP O
in FW B-NP O
situ FW I-NP O
hybridisation NN I-NP O
with IN B-PP O
MCT112 NN B-NP O
, , O O
a DT B-NP O
corresponding JJ I-NP O
cosmid NN I-NP O
MJ1 NN I-NP O
, , O O
and CC O O
DR47 NN B-NP O
( ( O O
D9S5 NN B-NP O
) ) O O
, , O O
coupled VBN B-VP O
with IN B-PP O
mapping VBG B-VP O
studies NNS B-NP O
on IN B-PP O
hybrid NN B-NP O
cell NN I-NP O
panels NNS I-NP O
, , O O
to TO B-VP O
define VB I-VP O
more RBR B-ADVP O
precisely RB I-ADVP O
the DT B-NP O
location NN I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
locus NN I-NP O
. . O O

The DT B-NP O
in FW I-NP O
situ FW I-NP O
location NN I-NP O
of IN B-PP O
all DT B-NP O
three CD I-NP O
probes NNS I-NP O
is VBZ B-VP O
9q13 CD B-NP O
- HYPH O O
- SYM O O
- SYM O O
- HYPH O O
q21 NN B-NP O
. . O O

1 CD B-NP O
, , O O
distal JJ B-ADJP O
to TO B-PP O
the DT B-NP O
variable JJ I-NP O
heterochromatin NN I-NP O
region NN I-NP O
. . O O

Physical JJ B-NP O
assignment NN I-NP O
of IN B-PP O
FRDA NN B-NP O
will MD B-VP O
allow VB I-VP O
us PRP B-NP O
to TO B-VP O
identify VB I-VP O
hybrid NN B-NP O
cell NN I-NP O
lines NNS I-NP O
containing VBG B-VP O
the DT B-NP O
mutated VBN I-NP O
gene NN I-NP O
. . O O

Increased VBN B-NP O
high JJ I-NP O
- HYPH I-NP O
density NN I-NP O
lipoprotein NN I-NP O
levels NNS I-NP O
caused VBN B-VP O
by IN B-PP O
a DT B-NP O
common JJ I-NP O
cholesteryl NN I-NP O
- HYPH B-NP O
ester NN I-NP O
transfer NN I-NP O
protein NN I-NP O
gene NN I-NP O
mutation NN I-NP O
. . O O

BACKGROUND NN B-NP O
AND CC I-NP O
METHODS NNS I-NP O
. . O O

The DT B-NP O
plasma NN I-NP O
cholesteryl NN I-NP O
- HYPH B-NP O
ester NN I-NP O
transfer NN I-NP O
protein NN I-NP O
( ( O O
CETP NN B-NP O
) ) O O
catalyzes VBZ B-VP O
the DT B-NP O
transfer NN I-NP O
of IN B-PP O
cholesteryl NN B-NP O
esters NNS I-NP O
from IN B-PP O
high JJ B-NP O
- HYPH I-NP O
density NN I-NP O
lipoprotein NN I-NP O
( ( O O
HDL NN B-NP O
) ) O O
to TO B-PP O
other JJ B-NP O
lipoproteins NNS I-NP O
. . O O

We PRP B-NP O
recently RB B-ADVP O
described VBD B-VP O
a DT B-NP O
Japanese JJ I-NP O
family NN I-NP O
with IN B-PP O
increased VBN B-NP O
HDL NN I-NP O
levels NNS I-NP O
and CC O O
CETP NN B-NP B-Disease
deficiency NN I-NP I-Disease
due JJ B-ADJP O
to TO B-PP O
a DT B-NP O
splicing NN I-NP O
defect NN I-NP O
of IN B-PP O
the DT B-NP O
CETP NN I-NP O
gene NN I-NP O
. . O O

To TO B-VP O
assess VB I-VP O
the DT B-NP O
frequency NN I-NP O
and CC I-NP O
phenotype NN I-NP O
of IN B-PP O
this DT B-NP O
condition NN I-NP O
, , O O
we PRP B-NP O
screened VBD B-VP O
11 CD B-NP O
additional JJ I-NP O
families NNS I-NP O
with IN B-PP O
high JJ B-NP O
HDL NN I-NP O
levels NNS I-NP O
by IN B-PP O
means NNS B-NP O
of IN B-PP O
a DT B-NP O
radioimmunoassay NN I-NP O
for IN B-PP O
CETP NN B-NP O
and CC I-NP O
DNA NN I-NP O
analysis NN I-NP O
. . O O

RESULTS NNS B-NP O
. . O O

We PRP B-NP O
found VBD B-VP O
the DT B-NP O
same JJ I-NP O
CETP NN I-NP O
gene NN I-NP O
mutation NN I-NP O
in IN B-PP O
four CD B-NP O
families NNS I-NP O
from IN B-PP O
three CD B-NP O
different JJ I-NP O
regions NNS I-NP O
of IN B-PP O
Japan NNP B-NP O
. . O O

Analysis NN B-NP O
of IN B-PP O
restriction NN B-NP O
- HYPH B-NP O
fragment NN I-NP O
- HYPH B-NP O
length NN I-NP O
polymorphisms NNS I-NP O
of IN B-PP O
the DT B-NP O
mutant JJ I-NP O
CETP NN I-NP O
allele NN I-NP O
showed VBD B-VP O
that IN B-SBAR O
all DT B-NP O
probands NNS I-NP O
were VBD B-VP O
homozygous JJ B-ADJP O
for IN B-PP O
the DT B-NP O
identical JJ I-NP O
haplotype NN I-NP O
. . O O

Family RB B-NP O
members NNS I-NP O
homozygous JJ B-ADJP O
for IN B-PP O
CETP NN B-NP B-Disease
deficiency NN I-NP I-Disease
( ( O O
n NN B-NP O
= SYM B-VP O
10 CD B-NP O
) ) O O
had VBD B-VP O
moderate JJ B-NP O
hypercholesterolemia NN I-NP B-Disease
( ( O O
mean JJ B-NP O
total JJ I-NP O
cholesterol NN I-NP O
level NN I-NP O
[ ( O O
+ SYM O O
/ SYM O O
- HYPH B-NP O
SD NN I-NP O
] ) O O
, , O O
7 CD B-NP O
. . O O

01 CD B-NP O
+ SYM O O
/ SYM O O
- SYM B-NP O
0 CD B-NP O
. SYM I-NP O

83 CD I-NP O
mmol NN I-NP O
per IN B-PP O
liter NN B-NP O
) ) O O
, , O O
markedly RB B-NP O
increased VBN I-NP O
levels NNS I-NP O
of IN B-PP O
HDL NN B-NP O
cholesterol NN I-NP O
( ( O O
4 CD B-NP O
. . O O

24 CD B-NP O
+ SYM O O
/ SYM B-NP O
- SYM B-NP O
1 CD I-NP O
. SYM I-NP O

01 CD I-NP O
mmol NN I-NP O
per IN B-PP O
liter NN B-NP O
) ) O O
and CC O O
apolipoprotein NN B-NP O
A NN I-NP O
- HYPH B-NP O
I NN I-NP O
, , O O
and CC O O
decreased VBD B-VP O
levels NNS B-NP O
of IN B-PP O
low JJ B-NP O
- HYPH I-NP O
density NN I-NP O
lipoprotein NN I-NP O
cholesterol NN I-NP O
( ( O O
1 CD B-NP O
. . O O

99 CD B-NP O
+ SYM O O
/ SYM O O
- SYM B-NP O
0 CD B-NP O
. SYM I-NP O

80 CD I-NP O
mmol NN I-NP O
per IN B-PP O
liter NN B-NP O
) ) O O
and CC O O
apolipoprotein NN B-NP O
B NN I-NP O
. . O O

Members NNS B-NP O
heterozygous JJ B-ADJP O
for IN B-PP O
the DT B-NP O
deficiency NN I-NP O
( ( O O
n NN B-NP O
= SYM B-VP O
20 CD B-NP O
) ) O O
, , O O
whose WP$ B-NP O
CETP NN I-NP O
levels NNS I-NP O
were VBD B-VP O
in IN B-PP O
the DT B-NP O
lower JJR I-NP O
part NN I-NP O
of IN B-PP O
the DT B-NP O
normal JJ I-NP O
range NN I-NP O
, , O O
had VBD B-VP O
moderately RB I-VP O
increased VBN I-VP O
levels NNS B-NP O
of IN B-PP O
HDL NN B-NP O
cholesterol NN I-NP O
and CC O O
apolipoprotein NN B-NP O
A NN I-NP O
- HYPH B-NP O
I NN I-NP O
and CC O O
an DT B-NP O
increased VBN I-NP O
ratio NN I-NP O
of IN B-PP O
HDL NN B-NP O
subclass NN I-NP O
2 CD I-NP O
to TO I-NP O
HDL NN I-NP O
subclass NN I-NP O
3 CD I-NP O
, , O O
as IN B-SBAR O
compared VBN B-PP O
with IN B-PP O
unaffected JJ B-NP O
family NN I-NP O
members NNS I-NP O
( ( O O
1 CD B-NP O
. . I-NP O

5 CD I-NP O
+ SYM O O
/ SYM O O
- SYM B-NP O
0 CD B-NP O
. SYM I-NP O

8 CD I-NP O
vs NNS I-NP O
. . O O

0 CD B-NP O
. . I-NP O

7 CD I-NP O
+ SYM O O
/ SYM B-NP O
- SYM B-NP O
0 CD B-NP O
. . I-NP O

4 CD I-NP O
) ) O O
. . O O

CETP NN B-NP B-Disease
deficiency NN I-NP I-Disease
was VBD B-VP O
not RB I-VP O
found VBN I-VP O
in IN B-PP O
six CD B-NP O
unrelated JJ I-NP O
subjects NNS I-NP O
with IN B-PP O
elevated VBN B-NP O
HDL NN I-NP O
cholesterol NN I-NP O
levels NNS I-NP O
who WP B-NP O
were VBD B-VP O
from IN B-PP O
different JJ B-NP O
parts NNS I-NP O
of IN B-PP O
the DT B-NP O
United NNP I-NP O
States NNPS I-NP O
. . O O

CONCLUSIONS NNS B-NP O
. . O O

CETP NN B-NP B-Disease
deficiency NN I-NP I-Disease
appears VBZ B-VP O
to TO I-VP O
be VB I-VP O
a DT B-NP O
frequent JJ I-NP O
cause NN I-NP O
of IN B-PP O
increased VBN B-NP O
HDL NN I-NP O
levels NNS I-NP O
in IN B-PP O
the DT B-NP O
population NN I-NP O
of IN B-PP O
Japan NNP B-NP O
, , O O
possibly RB B-ADVP O
because IN B-PP O
of IN I-PP O
a DT B-NP O
founder NN I-NP O
effect NN I-NP O
. . O O

The DT B-NP O
results NNS I-NP O
that IN B-NP O
we PRP B-NP O
observed VBD B-VP O
in IN B-PP O
heterozygotes NNS B-NP O
suggest VBP B-VP O
that IN B-SBAR O
CETP NN B-NP O
normally RB B-ADVP O
plays VBZ B-VP O
a DT B-NP O
part NN I-NP O
in IN B-PP O
the DT B-NP O
regulation NN I-NP O
of IN B-PP O
levels NNS B-NP O
of IN B-PP O
HDL NN B-NP O
subclass NN I-NP O
2 CD I-NP O
. . O O

There EX B-NP O
was VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-PP O
premature JJ B-NP B-Disease
atherosclerosis NN I-NP I-Disease
in IN B-PP O
the DT B-NP O
families NNS I-NP O
with IN B-PP O
CETP NN B-NP B-Disease
deficiency NN I-NP I-Disease
. . O O

In IN B-PP O
fact NN B-NP O
, , O O
the DT B-NP O
lipoprotein NN I-NP O
profile NN I-NP O
of IN B-PP O
persons NNS B-NP O
with IN B-PP O
CETP NN B-NP B-Disease
deficiency NN I-NP I-Disease
is VBZ B-VP O
potentially RB B-ADJP O
antiatherogenic JJ I-ADJP O
and CC O O
may MD B-VP O
be VB I-VP O
associated VBN I-VP O
with IN B-PP O
an DT B-NP O
increased VBN I-NP O
life NN I-NP O
span NN I-NP O
. . O O

Further JJ B-NP O
mapping NN I-NP O
of IN B-PP O
an DT B-NP O
ataxia NN I-NP B-Disease
- HYPH I-NP I-Disease
telangiectasia NN I-NP I-Disease
locus NN I-NP O
to TO B-PP O
the DT B-NP O
chromosome NN I-NP O
11q23 NN I-NP O
region NN I-NP O
. . O O

We PRP B-NP O
recently RB B-ADVP O
mapped VBD B-VP O
the DT B-NP O
gene NN I-NP O
for IN B-PP O
ataxia NN B-NP B-Disease
- HYPH I-NP I-Disease
telangiectasia NN I-NP I-Disease
group NN I-NP O
A NN I-NP O
( ( O O
ATA NN B-NP O
) ) O O
to TO B-PP O
chromosome NN B-NP O
11q22 NN I-NP O
- HYPH O O
23 CD B-NP O
by IN B-PP O
linkage NN B-NP O
analysis NN I-NP O
, , O O
using VBG B-VP O
the DT B-NP O
genetic JJ I-NP O
markers NNS I-NP O
THY1 NN I-NP O
and CC I-NP O
pYNB3 NN I-NP O
. . O O

12 CD B-NP O
( ( O O
D11S144 NN B-NP O
) ) O O
. . O O

The DT B-NP O
most RBS I-NP O
likely JJ I-NP O
order NN I-NP O
was VBD B-VP O
cent JJ B-ADJP O
- HYPH B-NP O
AT NN I-NP O
- HYPH B-NP O
S144 NN I-NP O
- HYPH I-NP O
THY1 NN I-NP O
. . O O

The DT B-NP O
present JJ I-NP O
paper NN I-NP O
describes VBZ B-VP O
further JJR B-NP O
mapping NN I-NP O
of IN B-PP O
the DT B-NP O
AT NN I-NP B-Disease
locus NN I-NP O
by IN B-PP O
means NNS B-NP O
of IN B-PP O
a DT B-NP O
panel NN I-NP O
of IN B-PP O
10 CD B-NP O
markers NNS I-NP O
that WDT B-NP O
span VBP B-VP O
approximately RB B-NP O
60 CD I-NP O
cM NN I-NP O
in IN B-PP O
the DT B-NP O
11q22 NN I-NP O
- HYPH O O
23 CD B-NP O
region NN I-NP O
centered JJ B-ADJP O
around IN B-PP O
S144 NN B-NP O
and CC I-NP O
THY1 NN I-NP O
. . O O

Location NN B-NP O
scores NNS I-NP O
indicate VBP B-VP O
that IN B-SBAR O
three CD B-NP O
contiguous JJ I-NP O
subsegments NNS I-NP O
within IN B-PP O
the DT B-NP O
[ ( I-NP O
S144 NN I-NP O
- HYPH I-NP O
THY1 NN I-NP O
] ) I-NP O
segment NN I-NP O
, , O O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
three CD B-NP O
contiguous JJ I-NP O
segments NNS I-NP O
telomeric JJ B-ADJP O
to TO B-PP O
THY1 NN B-NP O
, , O O
are VBP B-VP O
each DT O O
unlikely JJ B-ADJP O
to TO B-VP O
contain VB I-VP O
the DT B-NP O
AT NN I-NP B-Disease
locus NN I-NP O
, , O O
while IN B-SBAR O
the DT B-NP O
more RBR I-NP O
centromeric JJ I-NP O
[ ( I-NP O
STMY NN I-NP O
- HYPH I-NP O
S144 NN I-NP O
] ) I-NP O
segment NN I-NP O
is VBZ B-VP O
most RBS B-ADJP O
likely JJ I-ADJP O
to TO B-VP O
contain VB I-VP O
the DT B-NP O
AT NN I-NP B-Disease
locus NN I-NP O
. . O O

These DT B-NP O
data NNS I-NP O
, , O O
together RB B-ADVP O
with IN B-PP O
recent JJ B-NP O
refinements NNS I-NP O
in IN B-PP O
the DT B-NP O
linkage NN I-NP O
and CC O O
physical JJ B-NP O
maps NNS I-NP O
of IN B-PP O
11q22 NN B-NP O
- HYPH O O
23 CD B-NP O
, , O O
place VBP B-VP O
the DT B-NP O
AT NN I-NP B-Disease
locus NN I-NP O
at IN B-PP O
11q23 NN B-NP O
. . O O

Recurrent JJ B-NP O
meningitis NN I-NP B-Disease
in IN B-PP O
a DT B-NP O
patient NN I-NP O
with IN B-PP O
congenital JJ B-NP B-Disease
deficiency NN I-NP I-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
C9 NN I-NP I-Disease
component NN I-NP I-Disease
of IN B-PP I-Disease
complement NN B-NP I-Disease
. . O O

First JJ B-NP O
case NN I-NP O
of IN B-PP O
C9 NN B-NP B-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
Europe NNP B-NP O
. . O O

We PRP B-NP O
describe VBP B-VP O
the DT B-NP O
first JJ I-NP O
cases NNS I-NP O
, , O O
to TO B-PP O
our PRP$ B-NP O
knowledge NN I-NP O
, , O O
of IN B-PP O
C9 NN B-NP B-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
Europe NNP B-NP O
that WDT B-NP O
were VBD B-VP O
detected VBN I-VP O
in IN B-PP O
a DT B-NP O
Swiss JJ I-NP O
family NN I-NP O
, , O O
of IN B-PP O
which WDT B-NP O
two CD B-NP O
members NNS I-NP O
- SYM B-NP O
- HYPH O O
one CD B-NP O
with IN B-PP O
a DT B-NP O
complete JJ I-NP O
deficiency NN I-NP O
and CC O O
the DT B-NP O
other JJ I-NP O
with IN B-PP O
approximately RB B-NP O
half RB I-NP O
- HYPH I-NP O
normal JJ I-NP O
C9 NN I-NP O
levels NNS I-NP O
- SYM B-NP O
- HYPH B-NP O
experienced JJ I-NP O
bacterial JJ I-NP B-Disease
meningitis NN I-NP I-Disease
. . O O

The DT B-NP O
index NN I-NP O
patient NN I-NP O
, , O O
a DT B-NP O
56 CD I-NP O
- HYPH I-NP O
year NN I-NP O
- HYPH B-NP O
old JJ I-NP O
white JJ I-NP O
man NN I-NP O
with IN B-PP O
a DT B-NP O
history NN I-NP O
of IN B-PP O
purulent JJ B-NP B-Disease
meningitis NN I-NP I-Disease
at IN B-PP O
the DT B-NP O
age NN I-NP O
of IN B-PP O
23 CD B-NP O
years NNS I-NP O
, , O O
presented VBD B-VP O
with IN B-PP O
an DT B-NP O
acute JJ I-NP B-Disease
meningococcal JJ I-NP I-Disease
meningitis NN I-NP I-Disease
. . O O

No DT B-NP O
impairment NN I-NP B-Disease
of IN B-PP I-Disease
cellular JJ B-NP I-Disease
immunity NN I-NP I-Disease
or CC O O
immunoglobulin NN B-NP B-Disease
deficiency NN I-NP I-Disease
could MD B-VP O
be VB I-VP O
found VBN I-VP O
. . O O

Complement NN B-NP O
assays NNS I-NP O
showed VBD B-VP O
a DT B-NP O
complete JJ I-NP B-Disease
deficiency NN I-NP I-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
C9 NN I-NP I-Disease
component NN I-NP I-Disease
, , O O
while IN B-SBAR O
the DT B-NP O
other JJ I-NP O
individual JJ I-NP O
component NN I-NP O
levels NNS I-NP O
were VBD B-VP O
normal JJ B-ADJP O
and CC O O
the DT B-NP O
hemolytic JJ I-NP O
activity NN I-NP O
( ( O O
measured VBN B-VP O
using VBG B-VP O
the DT B-NP O
CH50 NN I-NP O
assay NN I-NP O
) ) O O
was VBD B-VP O
only RB I-VP O
slightly RB I-VP O
reduced VBN I-VP O
. . O O

A DT B-NP O
family NN I-NP O
study NN I-NP O
revealed VBD B-VP O
complete JJ B-NP B-Disease
C9 NN I-NP I-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
the DT B-NP O
patients NNS I-NP O
healthy JJ B-NP O
brother NN I-NP O
and CC I-NP O
half NN I-NP O
- HYPH I-NP O
normal JJ I-NP O
C9 NN I-NP O
concentrations NNS I-NP O
in IN B-PP O
his PRP$ B-NP O
sister NN I-NP O
, , O O
his PRP$ B-NP O
son NN I-NP O
( ( O O
who WP B-NP O
also RB B-ADVP O
had VBD B-VP O
experienced VBN I-VP O
an DT B-NP O
episode NN I-NP O
of IN B-PP O
bacterial JJ B-NP B-Disease
meningitis NN I-NP I-Disease
) ) O O
, , O O
and CC O O
his PRP$ B-NP O
niece NN I-NP O
, , O O
consistent JJ B-ADJP O
with IN B-PP O
an DT B-NP O
inherited VBN I-NP O
C9 NN I-NP B-Disease
deficiency NN I-NP I-Disease
. . O O

This DT B-NP O
first JJ I-NP O
case NN I-NP O
of IN B-PP O
recurrent JJ B-NP B-Disease
meningitis NN I-NP I-Disease
in IN B-PP O
a DT B-NP O
white JJ I-NP O
patient NN I-NP O
with IN B-PP O
complete JJ B-NP B-Disease
C9 NN I-NP I-Disease
deficiency NN I-NP I-Disease
suggests VBZ B-VP O
that IN B-SBAR O
this DT B-NP O
complement NN I-NP B-Disease
defect NN I-NP I-Disease
may MD B-VP O
also RB I-VP O
be VB I-VP O
a DT B-NP O
risk NN I-NP O
factor NN I-NP O
for IN B-PP O
bacterial JJ B-NP B-Disease
, , O I-Disease
especially RB B-ADJP I-Disease
neisserial JJ I-ADJP I-Disease
, , O I-Disease
infections NNS B-NP I-Disease
. . O O

. . O O

Detection NN B-NP O
of IN B-PP O
98 CD B-NP O
% NN I-NP O
of IN B-PP O
DMD NN B-NP B-Disease
/ SYM B-NP O
BMD NN I-NP B-Disease
gene NN I-NP O
deletions NNS I-NP O
by IN B-PP O
polymerase NN B-NP O
chain NN I-NP O
reaction NN I-NP O
. . O O

We PRP B-NP O
describe VBP B-VP O
oligonucleotide NN B-NP O
primer NN I-NP O
sequences NNS I-NP O
that WDT B-NP O
can MD B-VP O
be VB I-VP O
used VBN I-VP O
to TO B-VP O
amplify VB I-VP O
eight CD B-NP O
exons NNS I-NP O
plus CC O O
the DT B-NP O
muscle NN I-NP O
promoter NN I-NP O
of IN B-PP O
the DT B-NP O
dystrophin NN I-NP O
gene NN I-NP O
in IN B-PP O
a DT B-NP O
single JJ I-NP O
multiplex JJ I-NP O
polymerase NN I-NP O
chain NN I-NP O
reaction NN I-NP O
( ( O O
PCR NN B-NP O
) ) O O
. . O O

When WRB B-ADVP O
used VBN B-VP O
in IN B-PP O
conjunction NN B-NP O
with IN B-PP O
an DT B-NP O
existing VBG I-NP O
primer NN I-NP O
set NN I-NP O
, , O O
these DT B-NP O
two CD I-NP O
multiplex JJ I-NP O
reactions NNS I-NP O
detect VBP B-VP O
about IN B-NP O
98 CD I-NP O
% NN I-NP O
of IN B-PP O
deletions NNS B-NP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
Duchenne NNP B-NP B-Disease
or CC I-NP I-Disease
Becker NNP I-NP I-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
DMD NN B-NP B-Disease
, , O O
BMD NN B-NP B-Disease
) ) O O
. . O O

Furthermore RB B-ADVP O
, , O O
these DT B-NP O
primers NNS I-NP O
amplify VBP B-VP O
most JJS B-NP O
of IN B-PP O
the DT B-NP O
exons NNS I-NP O
in IN B-PP O
the DT B-NP O
deletion NN I-NP O
prone NN I-NP O
hot JJ I-NP O
spot NN I-NP O
region NN I-NP O
around IN B-PP O
exons NNS B-NP O
44 CD B-NP O
to TO B-PP O
53 CD B-NP O
, , O O
allowing VBG B-VP O
determination NN B-NP O
of IN B-PP O
deletion NN B-NP O
endpoints NNS I-NP O
and CC O O
prediction NN B-NP O
of IN B-PP O
mutational JJ B-NP O
effects NNS I-NP O
on IN B-PP O
the DT B-NP O
translational JJ I-NP O
reading NN I-NP O
frame NN I-NP O
. . O O

Thus RB B-ADVP O
, , O O
use NN B-NP O
of IN B-PP O
these DT B-NP O
PCR NN I-NP O
- HYPH O O
based VBN B-NP O
assays NNS I-NP O
will MD B-VP O
allow VB I-VP O
deletion NN B-NP O
detection NN I-NP O
and CC O O
prenatal JJ B-NP O
diagnosis NN I-NP O
for IN B-PP O
most JJS B-NP O
DMD NN I-NP B-Disease
/ SYM B-NP O
BMD NN B-NP B-Disease
patients NNS I-NP O
in IN B-PP O
a DT B-NP O
fraction NN I-NP O
of IN B-PP O
the DT B-NP O
time NN I-NP O
required VBN B-VP O
for IN B-PP O
Southern JJ B-NP O
blot NN I-NP O
analysis NN I-NP O
. . O O

. . O O

Genetic JJ B-NP O
heterogeneity NN I-NP O
at IN B-PP O
the DT B-NP O
glucose NN I-NP O
- HYPH B-NP O
6 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
dehydrogenase NN I-NP O
locus NN I-NP O
in IN B-PP O
southern JJ B-NP O
Italy NNP I-NP O
: : O O
a DT B-NP O
study NN I-NP O
on IN B-PP O
a DT B-NP O
population NN I-NP O
from IN B-PP O
the DT B-NP O
Matera NNP I-NP O
district NN I-NP O
. . O O

Glucose NN B-NP O
- HYPH B-NP O
6 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
dehydrogenase NN I-NP O
( ( O O
G6PD NN B-NP O
) ) O O
has VBZ B-VP O
been VBN I-VP O
analyzed VBN I-VP O
by IN B-PP O
gel NN B-NP O
electrophoresis NN I-NP O
and CC B-PP O
by IN B-PP O
quantitative JJ B-NP O
assay NN I-NP O
in IN B-PP O
an DT B-NP O
unselected JJ I-NP O
sample NN I-NP O
of IN B-PP O
1524 CD B-NP O
schoolboys NNS I-NP O
from IN B-PP O
the DT B-NP O
province NN I-NP O
of IN B-PP O
Matera NNP B-NP O
( ( O O
Lucania NNP B-NP O
) ) O O
in IN B-PP O
southern JJ B-NP O
Italy NNP I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
identified VBN I-VP O
43 CD B-NP O
subjects NNS I-NP O
with IN B-PP O
a DT B-NP O
G6PD NN I-NP O
variant NN I-NP O
. . O O

Of IN B-PP O
these DT B-NP O
, , O O
31 CD B-NP O
had VBD B-VP O
severe JJ B-NP O
G6PD NN I-NP B-Disease
deficiency NN I-NP I-Disease
, , O O
nine CD B-NP O
had VBD B-VP O
mild JJ B-ADJP O
to TO B-PP O
moderate JJ B-NP O
deficiency NN I-NP O
, , O O
and CC O O
three CD B-NP O
had VBD B-VP O
a DT B-NP O
non AFX I-NP O
- HYPH I-NP O
deficient JJ I-NP O
electrophoretic JJ I-NP O
variant NN I-NP O
. . O O

The DT B-NP O
overall JJ I-NP O
rate NN I-NP O
of IN B-PP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
was VBD B-VP O
2 CD B-NP O
. . O O

6 CD B-NP O
% NN I-NP O
. . O O

The DT B-NP O
frequency NN I-NP O
of IN B-PP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
, , O O
ranging VBG B-VP O
from IN B-PP O
7 CD B-NP O
. . O O

2 CD B-NP O
% NN I-NP O
on IN B-PP O
the DT B-NP O
Ionian NNP I-NP O
Coast NNP I-NP O
to TO B-PP O
zero CD B-NP O
on IN B-PP O
the DT B-NP O
eastern JJ I-NP O
side NN I-NP O
of IN B-PP O
the DT B-NP O
Lucanian JJ I-NP O
Apennines NNS I-NP O
, , O O
appears VBZ B-VP O
to TO I-VP O
be VB I-VP O
inversely RB I-VP O
related VBN I-VP O
to TO B-PP O
the DT B-NP O
distance NN I-NP O
of IN B-PP O
each DT B-NP O
town NN I-NP O
examined VBN B-VP O
from IN B-PP O
the DT B-NP O
Ionian NNP I-NP O
Coast NNP I-NP O
, , O O
suggesting VBG B-VP O
that IN B-SBAR O
this DT B-NP O
geographic JJ I-NP O
distribution NN I-NP O
may MD B-VP O
reflect VB I-VP O
, , O O
at IN B-ADVP O
least JJS I-ADVP O
in IN B-PP O
part NN B-NP O
, , O O
gene NN B-NP O
flow NN I-NP O
from IN B-PP O
Greek JJ B-NP O
settlers NNS I-NP O
. . O O

Biochemical JJ B-NP O
characterization NN I-NP O
has VBZ B-VP O
shown VBN I-VP O
that IN B-SBAR O
most JJS B-NP O
of IN B-PP O
the DT B-NP O
G6PD NN I-NP B-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
this DT B-NP O
population NN I-NP O
is VBZ B-VP O
accounted VBN I-VP O
for IN B-PP O
by IN B-PP O
G6PD NN B-NP O
Mediterranean NNP I-NP O
. . O O

In IN B-PP O
addition NN B-NP O
, , O O
we PRP B-NP O
have VBP B-VP O
found VBN I-VP O
several JJ B-NP O
examples NNS I-NP O
of IN B-PP O
two CD B-NP O
other JJ I-NP O
known VBN I-NP O
polymorphic JJ I-NP O
variants NNS I-NP O
( ( O O
G6PD NN B-NP O
Cagliari NN I-NP O
and CC O O
G6PD NN B-NP O
A NN I-NP O
- SYM B-ADJP O
) ) O O
; : O O
three CD B-NP O
new JJ I-NP O
polymorphic JJ I-NP O
variants NNS I-NP O
, , O O
G6PD NN B-NP O
Metaponto NN I-NP O
( ( O O
class NN B-NP O
III CD I-NP O
) ) O O
, , O O
G6PD NN B-NP O
Montalbano NNP I-NP O
( ( O O
class NN B-NP O
III CD I-NP O
) ) O O
, , O O
and CC O O
G6PD NN B-NP O
Pisticci NNS I-NP O
( ( O O
class NN B-NP O
IV CD I-NP O
) ) O O
; : O O
and CC O O
two CD B-NP O
sporadic JJ I-NP O
variants NNS I-NP O
, , O O
G6PD NN B-NP O
Tursi NN I-NP O
( ( O O
class NN B-NP O
III CD I-NP O
) ) O O
and CC O O
G6PD NN B-NP O
Ferrandina NNP I-NP O
( ( O O
class NN B-NP O
II CD I-NP O
) ) O O
. . O O

These DT B-NP O
data NNS I-NP O
provide VBP B-VP O
further JJ B-NP O
evidence NN I-NP O
for IN B-PP O
the DT B-NP O
marked JJ I-NP O
genetic JJ I-NP O
heterogeneity NN I-NP O
of IN B-PP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
within IN B-PP O
a DT B-NP O
relatively RB I-NP O
narrow JJ I-NP O
geographic JJ I-NP O
area NN I-NP O
and CC O O
they PRP B-NP O
prove VBP B-VP O
the DT B-NP O
presence NN I-NP O
in IN B-PP O
the DT B-NP O
Italian JJ I-NP O
peninsula NN I-NP O
of IN B-PP O
a DT B-NP O
gene NN I-NP O
( ( O O
GdA NN B-NP O
- SYM O O
) ) O O
regarded VBN B-VP O
as IN B-PP O
characteristically RB B-ADJP O
African JJ I-ADJP O
. . O O

Deficiency NN B-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
murine JJ I-NP I-Disease
fifth JJ I-NP I-Disease
complement NN I-NP I-Disease
component NN I-NP I-Disease
( ( O I-Disease
C5 NN B-NP I-Disease
) ) O I-Disease
. . O O

A DT B-NP O
2 CD I-NP O
- HYPH I-NP O
base NN I-NP O
pair NN I-NP O
gene NN I-NP O
deletion NN I-NP O
in IN B-PP O
a DT B-NP O
5 CD I-NP O
' SYM I-NP O
- HYPH I-NP O
exon NN I-NP O
. . O O

To TO B-VP O
ascertain VB I-VP O
the DT B-NP O
molecular JJ I-NP O
mechanism NN I-NP O
that WDT B-NP O
causes VBZ B-VP O
murine JJ B-NP O
C5 NN I-NP B-Disease
deficiency NN I-NP I-Disease
, , O O
genomic JJ B-NP O
and CC I-NP O
cDNA NN I-NP O
libraries NNS I-NP O
were VBD B-VP O
constructed VBN I-VP O
from IN B-PP O
mouse NN B-NP O
liver NN I-NP O
DNA NN I-NP O
and CC O O
mRNA NN B-NP O
employing VBG B-VP O
the DT B-NP O
congenic JJ I-NP O
strains NNS I-NP O
B10 NN I-NP O
. . O O

D2 NN B-NP O
/ SYM I-NP O
nSnJ NN I-NP O
and CC I-NP O
B10 NN I-NP O
. . O O

D2 NN B-NP O
/ SYM I-NP O
oSnJ NN I-NP O
that WDT B-NP O
are VBP B-VP O
sufficient JJ B-ADJP O
and CC I-ADJP O
deficient JJ I-ADJP B-Disease
for IN B-PP I-Disease
C5 NN B-NP I-Disease
, , O O
respectively RB B-ADVP O
. . O O

Genomic JJ B-NP O
fragments NNS I-NP O
were VBD B-VP O
isolated VBN I-VP O
which WDT B-NP O
correspond VBP B-VP O
to TO B-PP O
PvuII NN B-NP O
and CC I-NP O
HindIII NN I-NP O
restriction NN I-NP O
fragment NN I-NP O
length NN I-NP O
polymorphisms NNS I-NP O
associated VBN B-VP O
with IN B-PP O
C5 NN B-NP B-Disease
deficiency NN I-NP I-Disease
. . O O

Sequence NN B-NP O
analyses NNS I-NP O
demonstrated VBD B-VP O
that IN B-SBAR O
each DT B-NP O
of IN B-PP O
these DT B-NP O
polymorphisms NNS I-NP O
resulted VBD B-VP O
from IN B-PP O
single JJ B-NP O
base NN I-NP O
pair NN I-NP O
substitutions NNS I-NP O
and CC O O
that IN B-SBAR O
neither DT B-NP O
substitution NN I-NP O
would MD B-VP O
probably RB I-VP O
cause VB I-VP O
or CC I-VP O
contribute VB I-VP O
to TO B-PP O
the DT B-NP O
C5 NN I-NP B-Disease
deficiency NN I-NP I-Disease
. . O O

Sequence NN B-NP O
analyses NNS I-NP O
of IN B-PP O
C5 NN B-NP O
sufficient JJ I-NP O
and CC I-NP O
deficient JJ I-NP O
cDNAs NNS I-NP O
revealed VBD B-VP O
a DT B-NP O
2 CD I-NP O
base NN I-NP O
- HYPH I-NP O
pair NN I-NP O
deletion NN I-NP O
in IN B-PP O
the DT B-NP O
deficient JJ I-NP O
cDNAs NNS I-NP O
. . O O

The DT B-NP O
TA NN I-NP O
deletion NN I-NP O
was VBD B-VP O
located JJ B-ADJP O
near IN B-PP O
the DT B-NP O
5 CD I-NP O
end NN I-NP O
of IN B-PP O
the DT B-NP O
cDNA NN I-NP O
. . O O

This DT B-NP O
deletion NN I-NP O
shifts VBZ B-VP O
the DT B-NP O
reading NN I-NP O
frame NN I-NP O
of IN B-PP O
the DT B-NP O
C5 NN I-NP O
mRNA NN I-NP O
so IN B-SBAR O
that IN I-SBAR O
the DT B-NP O
termination NN I-NP O
codon NN I-NP O
UGA NN I-NP O
is VBZ B-VP O
present JJ B-NP O
4 CD I-NP O
base NN I-NP O
pairs NNS I-NP O
downstream RB B-ADVP O
from IN B-PP O
the DT B-NP O
deletion NN I-NP O
. . O O

Genomic JJ B-NP O
DNA NN I-NP O
was VBD B-VP O
amplified VBN I-VP O
and CC O O
sequenced VBN B-VP O
corresponding VBG B-ADJP O
to TO B-PP O
the DT B-NP O
area NN I-NP O
surrounding VBG B-VP O
the DT B-NP O
2 CD I-NP O
- HYPH I-NP O
base NN I-NP O
pair NN I-NP O
deletion NN I-NP O
. . O O

Six CD B-NP O
C5 NN I-NP B-Disease
- HYPH B-NP I-Disease
deficient JJ I-NP I-Disease
strains NNS I-NP O
, , O O
A NN B-NP O
/ SYM I-NP O
HeJ NN I-NP O
, , O O
AKR NN B-NP O
/ SYM I-NP O
J NN I-NP O
, , O O
DBA NN B-NP O
/ SYM I-NP O
2J NN I-NP O
, , O O
NZB NN B-NP O
/ SYM I-NP O
B1NJ NN I-NP O
, , O O
SWR NN B-NP O
/ SYM I-NP O
J NN I-NP O
, , O O
and CC O O
B10 NN B-NP O
. . O O

D2 NN B-NP O
/ SYM I-NP O
oSnJ NN I-NP O
, , O O
and CC O O
four CD B-NP O
C5 NN I-NP O
- HYPH O O
sufficient JJ B-NP O
strains NNS I-NP O
, , O O
Balb NN B-NP O
/ SYM I-NP O
CJ NN I-NP O
, , O O
C57Bl NN B-NP O
/ SYM I-NP O
6J NN I-NP O
, , O O
DBA NN B-NP O
/ SYM I-NP O
1J NN I-NP O
, , O O
and CC O O
B10 NN B-NP O
. . O O

D2 NN B-NP O
/ SYM I-NP O
nSnJ NN I-NP O
, , O O
were VBD B-VP O
analyzed VBN I-VP O
. . O O

The DT B-NP O
sequencing NN I-NP O
data NNS I-NP O
revealed VBD B-VP O
that IN B-SBAR O
the DT B-NP O
2 CD I-NP O
base NN I-NP O
pairs NNS I-NP O
were VBD B-VP O
deleted VBN I-VP O
from IN B-PP O
the DT B-NP O
C5 NN I-NP O
gene NN I-NP O
of IN B-PP O
each DT B-NP O
deficient JJ I-NP O
mouse NN I-NP O
tested VBN B-VP O
but CC B-PP O
not RB I-PP O
from IN B-PP O
the DT B-NP O
C5 NN I-NP O
gene NN I-NP O
of IN B-PP O
any DT B-NP O
sufficient JJ I-NP O
mouse NN I-NP O
. . O O

These DT B-NP O
data NNS I-NP O
demonstrate VBP B-VP O
that IN B-SBAR O
1 LS B-LST O
) ) O O
there EX B-NP O
is VBZ B-VP O
an DT B-NP O
identical JJ I-NP O
2 CD I-NP O
- HYPH I-NP O
base NN I-NP O
pair NN I-NP O
deletion NN I-NP O
in IN B-PP O
an DT B-NP O
exon NN I-NP O
of IN B-PP O
the DT B-NP O
C5 NN I-NP O
gene NN I-NP O
in IN B-PP O
several JJ B-NP O
different JJ I-NP O
C5 NN I-NP B-Disease
- HYPH B-NP I-Disease
deficient JJ I-NP I-Disease
mouse NN I-NP O
strains NNS I-NP O
; : O O
2 LS B-LST O
) ) O O
the DT B-NP O
mRNA NN I-NP O
transcribed VBN B-VP O
from IN B-PP O
the DT B-NP O
C5D NN I-NP O
gene NN I-NP O
retains VBZ B-VP O
this DT B-NP O
deletion NN I-NP O
; : O O
and CC O O
3 LS B-LST O
) ) O O
this DT B-NP O
mutation NN I-NP O
should MD B-VP O
result VB I-VP O
in IN B-PP O
C5 NN B-NP B-Disease
protein NN I-NP I-Disease
deficiency NN I-NP I-Disease
. . O O

Molecular JJ B-NP O
genetics NNS I-NP O
of IN B-PP O
PKU NN B-NP B-Disease
in IN B-PP O
eastern JJ B-NP O
Europe NNP I-NP O
: : O O
a DT B-NP O
nonsense JJ I-NP O
mutation NN I-NP O
associated VBN B-VP O
with IN B-PP O
haplotype NN B-NP O
4 CD I-NP O
of IN B-PP O
the DT B-NP O
phenylalanine NN I-NP O
hydroxylase NN I-NP O
gene NN I-NP O
. . O O

Phenylketonuria NN B-NP B-Disease
( ( O O
PKU NN B-NP B-Disease
) ) O O
is VBZ B-VP O
a DT B-NP O
genetic JJ I-NP B-Disease
disorder NN I-NP I-Disease
secondary JJ B-ADJP O
to TO B-PP O
a DT B-NP O
deficiency NN I-NP B-Disease
of IN B-PP I-Disease
hepatic JJ B-NP I-Disease
phenylalanine NN I-NP I-Disease
hydroxylase NN I-NP I-Disease
( ( O O
PAH NN B-NP O
) ) O O
. . O O

Several JJ B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
PAH NN I-NP O
gene NN I-NP O
have VBP B-VP O
recently RB I-VP O
been VBN I-VP O
reported VBN I-VP O
, , O O
and CC O O
linkage NN B-NP O
disequilibrium NN I-NP O
was VBD B-VP O
observed VBN I-VP O
between IN B-PP O
RFLP NN B-NP O
haplotypes NNS I-NP O
and CC O O
specific JJ B-NP O
mutations NNS I-NP O
. . O O

A DT B-NP O
new JJ I-NP O
molecular JJ I-NP B-Disease
lesion NN I-NP I-Disease
has VBZ B-VP O
been VBN I-VP O
identified VBN I-VP O
in IN B-PP O
exon NN B-NP O
7 CD I-NP O
of IN B-PP O
the DT B-NP O
PAH NN I-NP O
gene NN I-NP O
in IN B-PP O
a DT B-NP O
Hungarian JJ I-NP O
PKU NN I-NP B-Disease
patient NN I-NP O
by IN B-PP O
direct JJ B-NP O
sequencing NN I-NP O
of IN B-PP O
PCR NN B-NP O
- HYPH O O
amplified VBN B-NP O
DNA NN I-NP O
. . O O

The DT B-NP O
C NN I-NP O
- HYPH B-ADVP O
to TO B-PP O
- HYPH B-NP O
T NN I-NP O
transition NN I-NP O
causes VBZ B-VP O
the DT B-NP O
substitution NN I-NP O
of IN B-PP O
Arg243 NN B-NP O
to TO B-PP O
a DT B-NP O
termination NN I-NP O
codon NN I-NP O
, , O O
and CC O O
the DT B-NP O
mutant JJ I-NP O
allele NN I-NP O
is VBZ B-VP O
associated VBN I-VP O
with IN B-PP O
haplotype NN B-NP O
4 CD I-NP O
of IN B-PP O
the DT B-NP O
PAH NN I-NP O
gene NN I-NP O
. . O O

The DT B-NP O
mutation NN I-NP O
is VBZ B-VP O
present JJ B-ADJP O
in IN B-PP O
two CD B-NP O
of IN I-NP O
nine CD I-NP O
mutant JJ I-NP O
haplotype NN I-NP O
4 CD B-NP O
alleles NNS I-NP O
among IN B-PP O
Eastern NNP B-NP O
Europeans NNPS I-NP O
and CC O O
is VBZ B-VP O
not RB O O
present JJ B-ADJP O
among IN B-PP O
Western JJ B-NP O
Europeans NNPS I-NP O
and CC I-NP O
Asians NNPS I-NP O
. . O O

The DT B-NP O
rarity NN I-NP O
of IN B-PP O
this DT B-NP O
mutant JJ I-NP O
allele NN I-NP O
and CC O O
its PRP$ B-NP O
restricted JJ I-NP O
geographic JJ I-NP O
distribution NN I-NP O
suggest VBP B-VP O
that IN B-SBAR O
the DT B-NP O
mutational JJ I-NP O
event NN I-NP O
occurred VBD B-VP O
recently RB B-ADVP O
on IN B-PP O
a DT B-NP O
normal JJ I-NP O
haplotype NN I-NP O
4 CD I-NP O
background NN I-NP O
in IN B-PP O
Eastern NNP B-NP O
Europe NNP I-NP O
. . O O

. . O O

The DT B-NP O
red JJ I-NP O
- HYPH I-NP O
green JJ I-NP O
visual JJ I-NP O
pigment NN I-NP O
gene NN I-NP O
region NN I-NP O
in IN B-PP O
adrenoleukodystrophy NN B-NP B-Disease
. . O O

Although IN B-SBAR O
recent JJ B-NP O
data NNS I-NP O
established VBD B-VP O
that IN B-SBAR O
a DT B-NP O
specific JJ I-NP O
very RB I-NP O
- HYPH I-NP O
long JJ I-NP O
- HYPH I-NP O
chain NN I-NP O
fatty JJ I-NP O
acyl NN I-NP O
- HYPH B-NP O
CoA NN I-NP O
synthetase NN I-NP O
is VBZ B-VP O
defective JJ B-ADJP O
in IN B-PP O
X NN B-NP B-Disease
- HYPH O I-Disease
linked VBN B-VP I-Disease
adrenoleukodystrophy NN B-NP I-Disease
( ( O O
ALD NN B-NP B-Disease
) ) O O
, , O O
the DT B-NP O
ALD NN I-NP B-Disease
gene NN I-NP O
is VBZ B-VP O
still RB B-ADVP O
unidentified JJ B-ADJP O
. . O O

The DT B-NP O
ALD NN I-NP B-Disease
locus NN I-NP O
has VBZ B-VP O
been VBN I-VP O
mapped VBN I-VP O
to TO B-PP O
Xq28 NN B-NP O
, , O O
like IN B-PP O
the DT B-NP O
red JJ I-NP O
and CC I-NP O
green JJ I-NP O
color NN I-NP O
pigment NN I-NP O
genes NNS I-NP O
. . O O

Abnormal JJ B-NP B-Disease
color NN I-NP I-Disease
vision NN I-NP I-Disease
has VBZ B-VP O
been VBN I-VP O
observed VBN I-VP O
in IN B-PP O
12 CD B-NP O
of IN B-PP O
27 CD B-NP O
patients NNS I-NP O
with IN B-PP O
adrenomyeloneuropathy NN B-NP B-Disease
( ( O O
AMN NN B-NP B-Disease
) ) O O
, , O O
a DT B-NP O
milder JJR I-NP O
form NN I-NP O
of IN B-PP O
ALD NN B-NP B-Disease
. . O O

Furthermore RB B-ADVP O
, , O O
rearrangements NNS B-NP O
of IN B-PP O
the DT B-NP O
color NN I-NP O
vision NN I-NP O
gene NN I-NP O
cluster NN I-NP O
were VBD B-VP O
found VBN I-VP O
in IN B-PP O
four CD B-NP O
of IN B-PP O
eight CD B-NP O
ALD NN I-NP B-Disease
kindreds NNS I-NP O
. . O O

This DT B-NP O
led VBD B-VP O
us PRP B-NP O
to TO B-VP O
propose VB I-VP O
that IN B-SBAR O
a DT B-NP O
single JJ I-NP O
DNA NN I-NP O
rearrangement NN I-NP O
could MD B-VP O
underlie VB I-VP O
both CC O O
ALD NN B-NP B-Disease
and CC O O
abnormal JJ B-NP B-Disease
color NN I-NP I-Disease
vision NN I-NP I-Disease
in IN B-PP O
these DT B-NP O
patients NNS I-NP O
. . O O

Study NN B-NP O
of IN B-PP O
34 CD B-NP O
French JJ I-NP O
ALD NN I-NP B-Disease
patients NNS I-NP O
failed VBD B-VP O
to TO I-VP O
reveal VB I-VP O
a DT B-NP O
higher JJR I-NP O
than IN B-PP O
expected VBN B-NP O
frequency NN I-NP O
of IN B-PP O
green JJ B-NP O
/ SYM I-NP O
red JJ I-NP O
visual JJ I-NP O
pigment NN I-NP O
rearrangements NNS I-NP O
3 CD B-NP O
to TO B-PP O
the DT B-NP O
red JJ I-NP O
/ SYM I-NP O
green JJ I-NP O
color NN I-NP O
vision NN I-NP O
gene NN I-NP O
complex NN I-NP O
. . O O

The DT B-NP O
previous JJ I-NP O
report NN I-NP O
of IN B-PP O
such JJ B-NP O
rearrangements NNS I-NP O
was VBD B-VP O
based VBN I-VP O
on IN B-PP O
small JJ B-NP O
numbers NNS I-NP O
and CC O O
lack NN B-NP O
of IN B-PP O
knowledge NN B-NP O
that IN B-SBAR O
the DT B-NP O
frequency NN I-NP O
of IN B-PP O
abnormal JJ I-NP O
color NN I-NP O
vision NN I-NP O
arrays NNS I-NP O
on IN B-PP O
molecular JJ B-NP O
analysis NN I-NP O
was VBD B-VP O
twice RB B-ADJP O
as RB I-ADJP O
high JJ I-ADJP O
as IN B-SBAR O
expected VBN B-VP O
on IN B-PP O
the DT B-NP O
basis NN I-NP O
of IN B-PP O
the DT B-NP O
frequency NN I-NP O
of IN B-PP O
phenotypic JJ B-NP B-Disease
color NN I-NP I-Disease
vision NN I-NP I-Disease
defects NNS I-NP I-Disease
. . O O

The DT B-NP O
red JJ I-NP O
/ SYM I-NP O
green JJ I-NP O
color NN I-NP O
pigment NN I-NP O
( ( O O
R NN B-NP O
/ SYM B-NP O
GCP NN I-NP O
) ) O O
region NN B-NP O
was VBD B-VP O
studied VBN I-VP O
by IN B-PP O
pulsed JJ B-NP O
- HYPH I-NP O
field NN I-NP O
gel NN I-NP O
electrophoresis NN I-NP O
in IN B-PP O
14 CD B-NP O
of IN B-PP O
these DT B-NP O
patients NNS I-NP O
, , O O
and CC O O
we PRP B-NP O
did VBD B-VP O
not RB I-VP O
find VB I-VP O
any DT B-NP O
fragment NN I-NP O
size NN I-NP O
difference NN I-NP O
between IN B-PP O
the DT B-NP O
patients NNS I-NP O
and CC O O
normal JJ B-NP O
individuals NNS I-NP O
who WP B-NP O
have VBP B-VP O
the DT B-NP O
same JJ I-NP O
number NN I-NP O
of IN B-PP O
pigment NN B-NP O
genes NNS I-NP O
. . O O

The DT B-NP O
R NN I-NP O
/ SYM B-VP O
GCP NN B-NP O
region NN I-NP O
was VBD B-VP O
also RB I-VP O
analyzed VBN I-VP O
in IN B-PP O
29 CD B-NP O
French NNP I-NP O
and CC O O
seven CD B-NP O
North JJ I-NP O
American JJ I-NP O
ALD NN I-NP B-Disease
patients NNS I-NP O
by IN B-PP O
using VBG B-VP O
six CD B-NP O
genomic JJ I-NP O
DNA NN I-NP O
probes NNS I-NP O
, , O O
isolated VBN B-VP O
from IN B-PP O
a DT B-NP O
cosmid NN I-NP O
walk NN I-NP O
, , O O
that WDT B-NP O
flank VBP B-VP O
the DT B-NP O
color NN I-NP O
vision NN I-NP O
genes NNS I-NP O
. . O O

No DT B-NP O
deletions NNS I-NP O
were VBD B-VP O
found VBN I-VP O
with IN B-PP O
probes NNS B-NP O
that WDT B-NP O
lie VBP B-VP O
3 CD B-NP O
of IN B-PP O
the DT B-NP O
green JJ I-NP O
pigment NN I-NP O
genes NNS I-NP O
. . O O

One CD B-NP O
of IN B-PP O
the DT B-NP O
eight CD I-NP O
previously RB I-NP O
reported VBN I-NP O
ALD NN I-NP B-Disease
individuals NNS I-NP O
has VBZ B-VP O
a DT B-NP O
long JJ I-NP O
deletion NN I-NP O
5 CD I-NP O
of IN B-PP O
the DT B-NP O
red JJ I-NP O
pigment NN I-NP O
gene NN I-NP O
, , O O
a DT B-NP O
deletion NN I-NP O
causing VBG B-VP O
blue JJ B-NP O
cone NN I-NP O
monochromacy NN I-NP O
. . O O

This DT B-NP O
finding NN I-NP O
and CC O O
the DT B-NP O
previous JJ I-NP O
findings NNS I-NP O
of IN B-PP O
a DT B-NP O
45 CD I-NP O
% NN I-NP O
frequency NN I-NP O
of IN B-PP O
phenotypic JJ B-NP O
color NN I-NP O
vision NN I-NP O
defects NNS I-NP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
AMN NN B-NP B-Disease
may MD B-VP O
suggest VB I-VP O
that IN B-SBAR O
the DT B-NP O
ALD NN I-NP B-Disease
/ SYM B-NP O
AMN NN I-NP B-Disease
gene NN I-NP O
lies NNS I-NP O
5 CD B-NP O
to TO B-PP O
the DT B-NP O
red JJ I-NP O
pigment NN I-NP O
gene NN I-NP O
and CC O O
that IN B-SBAR O
the DT B-NP O
frequent JJ I-NP O
phenotypic JJ I-NP O
color NN I-NP B-Disease
vision NN I-NP I-Disease
anomalies NNS I-NP I-Disease
owe VBP B-VP O
their PRP$ B-NP O
origin NN I-NP O
to TO B-PP O
deleted VBN B-NP O
DNA NN I-NP O
that WDT B-NP O
includes VBZ B-VP O
regulatory JJ B-NP O
genes NNS I-NP O
for IN B-PP O
color NN B-NP O
vision NN I-NP O
. . O O

It PRP B-NP O
is VBZ B-VP O
possible JJ B-ADJP O
, , O O
however RB B-ADVP O
, , O O
that IN B-SBAR O
phenotypic JJ B-NP O
color NN I-NP B-Disease
vision NN I-NP I-Disease
anomalies NNS I-NP I-Disease
in IN B-PP O
AMN NN B-NP B-Disease
may MD B-VP O
be VB I-VP O
phenocopies NNS B-NP O
secondary JJ B-ADJP O
to TO B-PP O
retinal JJ B-NP O
or CC I-NP O
neural JJ I-NP O
involvement NN I-NP O
by IN B-PP O
the DT B-NP O
disease NN I-NP O
. . O O

The DT B-NP O
single JJ I-NP O
case NN I-NP O
of IN B-PP O
blue JJ B-NP O
cone NN I-NP O
monochromacy NN I-NP O
may MD B-VP O
therefore RB I-VP O
be VB I-VP O
a DT B-NP O
fortuitous JJ I-NP O
coincidence NN I-NP O
of IN B-PP O
two CD B-NP O
diseases NNS I-NP O
. . O O

. . O O

Paroxysmal JJ B-NP B-Disease
nocturnal JJ I-NP I-Disease
haemoglobinuria NN I-NP I-Disease
with IN B-PP O
coexisting VBG B-VP O
deficiency NN B-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
ninth JJ I-NP I-Disease
component NN I-NP I-Disease
of IN B-PP I-Disease
complement NN B-NP I-Disease
: : O O
lack NN B-NP O
of IN B-PP O
massive JJ B-NP O
haemolytic JJ I-NP B-Disease
attack NN I-NP I-Disease
. . O O

A DT B-NP O
47 CD I-NP O
- HYPH I-NP O
year NN I-NP O
- HYPH O O
old JJ B-NP O
woman NN I-NP O
with IN B-PP O
paroxysmal JJ B-NP B-Disease
nocturnal JJ I-NP I-Disease
haemoglobinuria NN I-NP I-Disease
( ( O O
PNH NN B-NP B-Disease
) ) O O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
have VB I-VP O
an DT B-NP O
inherited VBN I-NP B-Disease
deficiency NN I-NP I-Disease
in IN B-PP I-Disease
the DT B-NP I-Disease
ninth JJ I-NP I-Disease
complement NN I-NP I-Disease
component NN I-NP I-Disease
( ( O O
C9 NN B-NP O
) ) O O
. . O O

In IN B-PP O
complement NN B-NP O
- HYPH B-NP O
sensitivity NN I-NP O
lysis NN I-NP O
tests NNS I-NP O
, , O O
80 CD B-NP O
% NN I-NP O
of IN B-PP O
her PRP$ B-NP O
erythrocytes NNS I-NP O
were VBD B-VP O
markedly RB B-NP O
complement NN I-NP O
- HYPH B-NP O
sensitive JJ I-NP O
( ( O O
PNH NN B-NP O
- HYPH O O
III CD B-NP O
) ) O O
. . O O

Laser NN B-NP O
cytofluorimetry NN I-NP O
with IN B-PP O
a DT B-NP O
monoclonal JJ I-NP O
antibody NN I-NP O
against IN B-PP O
decay NN B-NP O
- HYPH O O
accelerating VBG B-VP O
factor NN B-NP O
( ( O O
DAF NN B-NP O
) ) O O
revealed VBD B-VP O
that IN B-SBAR O
95 CD B-NP O
% NN I-NP O
of IN B-PP O
her PRP$ B-NP O
erythrocytes NNS I-NP O
were VBD B-VP O
DAF NN B-ADJP O
- HYPH I-ADJP O
negative JJ B-ADJP O
. . O O

Surprisingly RB B-ADVP O
, , O O
she PRP B-NP O
has VBZ B-VP O
suffered VBN I-VP O
only RB B-NP O
mild JJ I-NP O
haemolysis NN I-NP B-Disease
and CC O O
has VBZ B-VP O
never RB I-VP O
experienced VBN I-VP O
massive JJ B-NP O
spontaneous JJ I-NP O
haemolysis NN I-NP B-Disease
. . O O

Gross NN B-NP O
haemoglobinuria NN I-NP B-Disease
and CC I-NP O
jaundice NN I-NP B-Disease
occurred VBD B-VP O
only RB B-ADVP O
after IN B-PP O
receiving VBG B-VP O
postoperative JJ B-NP O
transfusion NN I-NP O
of IN B-PP O
whole JJ B-NP O
blood NN I-NP O
. . O O

In IN B-PP O
her PRP$ B-NP O
serum NN I-NP O
, , O O
C9 NN B-NP O
was VBD B-VP O
not RB O O
detectable JJ B-ADJP O
either CC O O
by IN B-PP O
immunological JJ B-ADJP O
or CC O O
by IN B-PP O
functional JJ B-NP O
assays NNS I-NP O
. . O O

Both DT B-NP O
the DT B-NP O
Ham NNP I-NP O
test NN I-NP O
and CC O O
the DT B-NP O
sugar NN I-NP O
water NN I-NP O
test NN I-NP O
using VBG B-VP O
normal JJ B-NP O
human JJ I-NP O
serum NN I-NP O
or CC I-NP O
plasma NN I-NP O
yielded VBD B-VP O
marked JJ B-NP O
haemolysis NN I-NP O
of IN B-PP O
the DT B-NP O
patients NNS I-NP O
erythrocytes NNS I-NP O
. . O O

When WRB B-ADVP O
the DT B-NP O
patients NNS I-NP O
serum NN I-NP O
or CC I-NP O
plasma NN I-NP O
was VBD B-VP O
used VBN I-VP O
, , O O
only RB B-NP O
a DT I-NP O
trace NN I-NP O
of IN B-PP O
lysis NN B-NP O
was VBD B-VP O
detected VBN I-VP O
. . O O

Addition NN B-NP O
of IN B-PP O
purified VBN B-NP O
human JJ I-NP O
C9 NN I-NP O
to TO B-PP O
her PRP$ B-NP O
plasma NN I-NP O
fully RB B-VP O
restored VBD I-VP O
haemolysis NN B-NP O
. . O O

These DT B-NP O
observations NNS I-NP O
indicated VBD B-VP O
that IN B-SBAR O
C9 NN B-NP O
may MD B-VP O
play VB I-VP O
a DT B-NP O
critical JJ I-NP O
role NN I-NP O
in IN B-PP O
haemolytic JJ B-NP B-Disease
attacks NNS I-NP I-Disease
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
PNH NN B-NP B-Disease
and CC O O
that IN B-SBAR O
characteristic JJ B-NP O
haemolysis NN I-NP B-Disease
in IN B-PP O
PNH NN B-NP B-Disease
may MD B-VP O
be VB I-VP O
tempered VBN I-VP O
by IN B-PP O
coexisting VBG B-VP O
C9 NN B-NP B-Disease
deficiency NN I-NP I-Disease
. . O O

. . O O

Duplicational JJ B-NP O
mutation NN I-NP O
at IN B-PP O
the DT B-NP O
Duchenne NNP I-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
locus NN I-NP O
: : O O
its PRP$ B-NP O
frequency NN I-NP O
, , O O
distribution NN B-NP O
, , O O
origin NN B-NP O
, , O O
and CC O O
phenotypegenotype NN B-NP O
correlation NN I-NP O
. . O O

Partial JJ B-NP O
gene NN I-NP O
deletion NN I-NP O
is VBZ B-VP O
the DT B-NP O
major JJ I-NP O
cause NN I-NP O
of IN B-PP O
mutation NN B-NP O
leading VBG B-VP O
to TO B-PP O
Duchenne NNP B-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
DMD NN B-NP B-Disease
) ) O O
and CC O O
Becker NNP B-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
BMD NN B-NP B-Disease
) ) O O
. . O O

Partial JJ B-NP O
gene NN I-NP O
duplication NN I-NP O
has VBZ B-VP O
also RB I-VP O
been VBN I-VP O
recognized VBN I-VP O
in IN B-PP O
a DT B-NP O
few JJ I-NP O
cases NNS I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
conducted VBN I-VP O
a DT B-NP O
survey NN I-NP O
for IN B-PP O
duplication NN B-NP O
in IN B-PP O
72 CD B-NP O
unrelated JJ I-NP O
nondeletion NN I-NP O
patients NNS I-NP O
, , O O
analyzed VBN B-VP O
by IN B-PP O
Southern JJ B-NP O
blot NN I-NP O
hybridization NN I-NP O
with IN B-PP O
clones NNS B-NP O
representing VBG B-VP O
the DT B-NP O
entire JJ I-NP O
DMD NN I-NP B-Disease
cDNA NN I-NP O
. . O O

With IN B-PP O
careful JJ B-NP O
quantitative JJ I-NP O
analysis NN I-NP O
of IN B-PP O
hybridization NN B-NP O
band NN I-NP O
intensity NN I-NP O
, , O O
10 CD B-NP O
cases NNS I-NP O
were VBD B-VP O
found VBN I-VP O
to TO I-VP O
carry VB I-VP O
a DT B-NP O
duplication NN I-NP O
of IN B-PP O
part NN B-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
, , O O
a DT B-NP O
frequency NN I-NP O
of IN B-PP O
14 CD B-NP O
% NN I-NP O
for IN B-PP O
nondeletion JJ B-NP O
cases NNS I-NP O
( ( O O
10 CD B-NP O
/ SYM I-NP O
72 CD I-NP O
) ) O O
, , O O
or CC O O
6 CD B-NP O
% NN I-NP O
for IN B-PP O
all DT B-NP O
cases NNS I-NP O
( ( O O
10 CD B-NP O
/ SYM I-NP O
181 CD I-NP O
) ) O O
. . O O

The DT B-NP O
extent NN I-NP O
of IN B-PP O
these DT B-NP O
duplications NNS I-NP O
has VBZ B-VP O
been VBN I-VP O
characterized VBN I-VP O
according VBG B-PP O
to TO B-PP O
the DT B-NP O
published VBN I-NP O
exon NN I-NP O
- HYPH O O
containing VBG B-VP O
HindIII NN B-NP O
fragment NN I-NP O
map NN I-NP O
, , O O
and CC O O
in IN B-PP O
six CD B-NP O
of IN B-PP O
the DT B-NP O
10 CD I-NP O
duplications NNS I-NP O
a DT B-NP O
novel JJ I-NP O
restriction NN I-NP O
fragment NN I-NP O
that WDT B-NP O
spanned VBD B-VP O
the DT B-NP O
duplication NN I-NP O
junction NN I-NP O
was VBD B-VP O
detected VBN I-VP O
. . O O

The DT B-NP O
resulting VBG I-NP O
translational JJ I-NP O
reading NN I-NP O
frame NN I-NP O
of IN B-PP O
mRNA NN B-NP O
has VBZ B-VP O
been VBN I-VP O
predicted VBN I-VP O
for IN B-PP O
nine CD B-NP O
duplications NNS I-NP O
. . O O

A DT B-NP O
shift NN I-NP O
of IN B-PP O
the DT B-NP O
reading NN I-NP O
frame NN I-NP O
was VBD B-VP O
predicted VBN I-VP O
in IN B-PP O
four CD B-NP O
of IN B-PP O
the DT B-NP O
six CD I-NP O
DMD NN I-NP B-Disease
cases NNS I-NP O
and CC O O
in IN B-PP O
one CD B-NP O
of IN B-PP O
the DT B-NP O
two CD I-NP O
intermediate JJ I-NP O
cases NNS I-NP O
, , O O
while IN B-SBAR O
the DT B-NP O
reading NN I-NP O
frame NN I-NP O
remained VBD B-VP O
uninterrupted JJ B-ADJP O
in IN B-PP O
both CC O O
BMD NN B-NP B-Disease
cases NNS I-NP O
. . O O

RFLP NN B-NP O
and CC I-NP O
quantitative JJ I-NP O
Southern JJ I-NP O
blot NN I-NP O
analyses NNS I-NP O
revealed VBD B-VP O
a DT B-NP O
grandpaternal JJ I-NP O
origin NN I-NP O
of IN B-PP O
duplication NN B-NP O
in IN B-PP O
four CD B-NP O
families NNS I-NP O
and CC O O
grandmaternal JJ B-NP O
origin NN I-NP O
in IN B-PP O
one CD B-NP O
family NN I-NP O
. . O O

In IN B-PP O
all DT B-NP O
five CD I-NP O
families NNS I-NP O
, , O O
the DT B-NP O
duplication NN I-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
originate VB I-VP O
from IN B-PP O
a DT B-NP O
single JJ I-NP O
X NN I-NP O
chromosome NN I-NP O
. . O O

Unequal JJ B-NP O
sister NN I-NP O
- HYPH I-NP O
chromatid NN I-NP O
exchange NN I-NP O
is VBZ B-VP O
proposed VBN I-VP O
to TO I-VP O
be VB I-VP O
the DT B-NP O
mechanism NN I-NP O
for IN B-PP O
the DT B-NP O
formation NN I-NP O
of IN B-PP O
these DT B-NP O
duplications NNS I-NP O
. . O O

. . O O

Glucose NN B-NP O
6 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
dehydrogenase NN I-NP O
variants NNS I-NP O
: : O O
Gd NN B-NP O
( ( O O
+ SYM O O
) ) O O
Alexandra NN B-NP O
associated VBN B-VP O
with IN B-PP O
neonatal JJ B-NP B-Disease
jaundice NN I-NP I-Disease
and CC O O
Gd NN B-NP O
( ( O O
- SYM B-NP O
) ) O O
Camperdown VBN B-VP O
in IN B-PP O
a DT B-NP O
young JJ I-NP O
man NN I-NP O
with IN B-PP O
lamellar JJ B-NP B-Disease
cataracts NNS I-NP I-Disease
. . O O

Two CD B-NP O
male JJ I-NP O
subjects NNS I-NP O
are VBP B-VP O
described VBN I-VP O
, , O O
with IN B-PP O
unusual JJ B-NP O
clinical JJ I-NP O
presentations NNS I-NP O
and CC B-PP O
with IN B-PP O
hitherto RB B-NP O
undescribed JJ I-NP O
G6PD NN I-NP O
variants NNS I-NP O
. . O O

The DT B-NP O
first JJ I-NP O
, , O O
of IN B-PP O
Italian JJ B-NP O
extraction NN I-NP O
, , O O
suffered VBN B-VP O
from IN B-PP O
severe JJ B-NP O
neonatal JJ I-NP B-Disease
jaundice NN I-NP I-Disease
following VBG B-PP O
maternal JJ B-NP O
ingestion NN I-NP O
of IN B-PP O
fresh JJ B-NP O
broad JJ I-NP O
beans NNS I-NP O
( ( O O
Vicia NNP B-NP O
fava NNP I-NP O
) ) O O
both CC O O
prenatally RB B-ADVP O
and CC I-ADVP O
postnatally RB I-ADVP O
the DT B-NP O
expression NN I-NP O
of IN B-PP O
the DT B-NP O
enzymatic JJ I-NP O
defect NN I-NP O
was VBD B-VP O
much RB B-ADJP O
more RBR I-ADJP O
severe JJ I-ADJP O
in IN B-PP O
the DT B-NP O
neonatal JJ I-NP O
period NN I-NP O
than IN B-PP O
on IN B-PP O
retesting VBG B-VP O
in IN B-PP O
adolescence NN B-NP O
, , O O
when WRB B-ADVP O
biochemical JJ B-NP O
characterization NN I-NP O
showed VBD B-VP O
unique JJ B-NP O
features NNS I-NP O
which WDT B-NP O
justify VBP B-VP O
designation NN B-NP O
as IN B-PP O
a DT B-NP O
new JJ I-NP O
variant JJ I-NP O
Gd NN I-NP O
( ( O O
+ SYM O O
) ) O O
Alexandra NNP B-NP O
. . O O

The DT B-NP O
second JJ I-NP O
patient NN I-NP O
, , O O
a DT B-NP O
boy NN I-NP O
of IN B-PP O
Maltese JJ B-NP O
extraction NN I-NP O
who WP B-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
have VB I-VP O
bilateral JJ B-NP B-Disease
lamellar JJ I-NP I-Disease
cataracts NNS I-NP I-Disease
at IN B-PP O
the DT B-NP O
age NN I-NP O
of IN B-PP O
4 CD B-NP O
years NNS I-NP O
, , O O
was VBD B-VP O
identified VBN I-VP O
as IN B-PP O
G6PD NN B-NP B-Disease
deficient JJ B-ADJP I-Disease
only RB B-ADVP O
as IN B-PP O
a DT B-NP O
result NN I-NP O
of IN B-PP O
a DT B-NP O
survey NN I-NP O
of IN B-PP O
children NNS B-NP O
of IN B-PP O
Mediterranean JJ B-NP O
origin NN I-NP O
with IN B-PP O
unexplained JJ B-NP O
cataract NN I-NP B-Disease
formation NN I-NP O
; : O O
he PRP B-NP O
has VBZ B-VP O
approximately RB B-NP O
15 CD I-NP O
% NN I-NP O
of IN B-PP O
normal JJ B-NP O
enzyme NN I-NP O
activity NN I-NP O
, , O O
with IN B-PP O
another DT B-NP O
unique JJ I-NP O
combination NN I-NP O
of IN B-PP O
biochemical JJ B-NP O
characteristics NNS I-NP O
which WDT B-NP O
has VBZ B-VP O
led VBN I-VP O
to TO B-PP O
its PRP$ B-NP O
designation NN I-NP O
as IN B-PP O
Gd NN B-NP O
( ( O O
- SYM O O
) ) O O
Camperdown NNP B-NP O
. . O O

Although IN B-SBAR O
this DT B-NP O
association NN I-NP O
may MD B-VP O
be VB I-VP O
coincidental JJ B-ADJP O
, , O O
it PRP B-NP O
prompts VBZ B-VP O
further JJ B-NP O
attention NN I-NP O
to TO B-PP O
the DT B-NP O
possibility NN I-NP O
that IN B-SBAR O
under IN B-PP O
certain JJ B-NP O
circumstances NNS I-NP O
G6PD NN I-NP B-Disease
deficiency NN I-NP I-Disease
may MD B-VP O
favor VB I-VP O
cataract NN B-NP B-Disease
formation NN I-NP O
. . O O

The DT B-NP O
two CD I-NP O
cases NNS I-NP O
illustrate VBP B-VP O
the DT B-NP O
value NN I-NP O
of IN B-PP O
characterization NN B-NP O
of IN B-PP O
the DT B-NP O
mutant JJ I-NP O
enzyme NN I-NP O
whenever WRB B-ADVP O
unexpected JJ B-NP O
clinical JJ I-NP O
or CC I-NP O
laboratory JJ I-NP O
results NNS I-NP O
are VBP B-VP O
obtained VBN I-VP O
. . O O

. . O O

Statistical JJ B-NP O
analysis NN I-NP O
of IN B-PP O
the DT B-NP O
two CD I-NP O
stage NN I-NP O
mutation NN I-NP O
model NN I-NP O
in IN B-PP O
von NNP B-NP B-Disease
Hippel NNP I-NP I-Disease
- HYPH B-NP I-Disease
Lindau NNP I-NP I-Disease
disease NN I-NP I-Disease
, , O O
and CC O O
in IN B-PP O
sporadic JJ B-NP B-Disease
cerebellar JJ I-NP I-Disease
haemangioblastoma NN I-NP I-Disease
and CC O O
renal JJ B-NP B-Disease
cell NN I-NP I-Disease
carcinoma NN I-NP I-Disease
. . O O

Analysis NN B-NP O
of IN B-PP O
the DT B-NP O
age NN I-NP O
incidence NN I-NP O
curves NNS I-NP O
for IN B-PP O
unilateral JJ B-NP B-Disease
and CC I-NP I-Disease
bilateral JJ I-NP I-Disease
retinoblastoma NN I-NP I-Disease
led VBD B-VP O
Knudson NNP B-NP O
to TO B-VP O
propose VB I-VP O
that IN B-SBAR O
hereditary JJ B-NP B-Disease
tumours NNS I-NP I-Disease
may MD B-VP O
arise VB I-VP O
by IN B-PP O
a DT B-NP O
single JJ I-NP O
event NN I-NP O
and CC O O
sporadic JJ B-NP B-Disease
tumours NNS I-NP I-Disease
by IN B-PP O
a DT B-NP O
two CD I-NP O
stage NN I-NP O
mutation NN I-NP O
process NN I-NP O
. . O O

It PRP B-NP O
has VBZ B-VP O
been VBN I-VP O
suggested VBN I-VP O
recently RB B-ADVP O
that IN B-SBAR O
sporadic JJ B-NP B-Disease
renal JJ I-NP I-Disease
cell NN I-NP I-Disease
carcinoma NN I-NP I-Disease
may MD B-VP O
arise VB I-VP O
from IN B-PP O
a DT B-NP O
two CD I-NP O
stage NN I-NP O
mutation NN I-NP O
process NN I-NP O
. . O O

We PRP B-NP O
analysed VBD B-VP O
the DT B-NP O
age NN I-NP O
incidence NN I-NP O
curves NNS I-NP O
for IN B-PP O
symptomatic JJ B-NP O
renal JJ I-NP B-Disease
cell NN I-NP I-Disease
carcinoma NN I-NP I-Disease
( ( O O
n NN B-NP O
= SYM B-VP O
26 CD B-NP O
) ) O O
and CC O O
cerebellar JJ B-NP B-Disease
haemangioblastoma NN I-NP I-Disease
( ( O O
n NN B-NP O
= SYM B-VP O
68 CD B-NP O
) ) O O
in IN B-PP O
109 CD B-NP O
patients NNS I-NP O
with IN B-PP O
von NNP B-NP B-Disease
Hippel NNP I-NP I-Disease
- HYPH I-NP I-Disease
Lindau NNP I-NP I-Disease
( ( O I-Disease
VHL NNP O I-Disease
) ) O I-Disease
disease NN B-NP I-Disease
, , O O
and CC O O
compared VBD B-VP O
them PRP B-NP O
to TO B-PP O
104 CD B-NP O
patients NNS I-NP O
with IN B-PP O
sporadic JJ B-NP B-Disease
renal JJ I-NP I-Disease
cell NN I-NP I-Disease
carcinoma NN I-NP I-Disease
and CC O O
43 CD B-NP O
patients NNS I-NP O
with IN B-PP O
sporadic JJ B-NP B-Disease
cerebellar JJ I-NP I-Disease
haemangioblastoma NN I-NP I-Disease
. . O O

The DT B-NP O
age NN I-NP O
incidence NN I-NP O
curves NNS I-NP O
for IN B-PP O
renal JJ B-NP B-Disease
cell NN I-NP I-Disease
carcinoma NN I-NP I-Disease
and CC O O
cerebellar JJ B-NP B-Disease
haemangioblastoma NN I-NP I-Disease
in IN B-PP O
VHL NN B-NP B-Disease
disease NN I-NP I-Disease
were VBD B-VP O
compatible JJ B-ADJP O
with IN B-PP O
a DT B-NP O
single JJ I-NP O
mutation NN I-NP O
model NN I-NP O
, , O O
whereas IN O O
the DT B-NP O
age NN I-NP O
incidence NN I-NP O
curves NNS I-NP O
for IN B-PP O
sporadic JJ B-NP B-Disease
renal JJ I-NP I-Disease
cell NN I-NP I-Disease
carcinoma NN I-NP I-Disease
and CC O O
cerebellar JJ B-NP B-Disease
haemangioblastoma NN I-NP I-Disease
suggested VBD B-VP O
a DT B-NP O
two CD I-NP O
stage NN I-NP O
mutation NN I-NP O
process NN I-NP O
. . O O

These DT B-NP O
data NNS I-NP O
are VBP B-VP O
compatible JJ B-ADJP O
with IN B-PP O
the DT B-NP O
VHL NN I-NP B-Disease
gene NN I-NP O
functioning VBG B-VP O
as IN B-PP O
a DT B-NP O
recessive JJ I-NP O
tumour NN I-NP B-Disease
suppressor NN I-NP O
gene NN I-NP O
. . O O

Sporadic JJ B-NP B-Disease
cerebellar JJ I-NP I-Disease
haemangioblastoma NN I-NP I-Disease
and CC O O
some DT B-NP O
renal JJ I-NP B-Disease
cell NN I-NP I-Disease
carcinoma NN I-NP I-Disease
may MD B-VP O
arise VB I-VP O
from IN B-PP O
somatic JJ B-NP O
mutations NNS I-NP O
inactivating VBG B-VP O
both DT B-NP O
alleles NNS I-NP O
at IN B-PP O
the DT B-NP O
VHL NN I-NP B-Disease
locus NN I-NP O
. . O O

. . O O

Screening NN B-NP O
for IN B-PP O
carriers NNS B-NP O
of IN B-PP O
Tay NNP B-NP B-Disease
- HYPH I-NP I-Disease
Sachs NNP I-NP I-Disease
disease NN I-NP I-Disease
among IN B-PP O
Ashkenazi NNP B-NP O
Jews NNP I-NP O
. . O O

A DT B-NP O
comparison NN I-NP O
of IN B-PP O
DNA NN B-NP O
- HYPH B-NP O
based VBN B-VP O
and CC O O
enzyme NN B-NP O
- HYPH B-NP O
based VBN I-NP O
tests NNS I-NP O
. . O O

BACKGROUND NN B-NP O
AND CC I-NP O
METHODS NNS I-NP O
. . O O

The DT B-NP O
prevention NN I-NP O
of IN B-PP O
Tay NNP B-NP B-Disease
- HYPH I-NP I-Disease
Sachs NNP I-NP I-Disease
disease NN I-NP I-Disease
( ( O O
GM2 NN B-NP B-Disease
gangliosidosis NN I-NP I-Disease
, , O I-Disease
type NN B-NP I-Disease
1 CD I-NP I-Disease
) ) O O
depends VBZ B-VP O
on IN B-PP O
the DT B-NP O
identification NN I-NP O
of IN B-PP O
carriers NNS B-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
for IN B-PP O
this DT B-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
disorder NN I-NP I-Disease
. . O O

We PRP B-NP O
compared VBD B-VP O
the DT B-NP O
enzyme NN I-NP O
- HYPH B-VP O
based VBN B-NP O
test NN I-NP O
widely RB B-VP O
used VBN I-VP O
in IN B-PP O
screening NN B-NP O
for IN B-PP O
Tay NNP B-NP B-Disease
- HYPH I-NP I-Disease
Sachs NNP I-NP I-Disease
disease NN I-NP I-Disease
with IN B-PP O
a DT B-NP O
test NN I-NP O
based VBN B-VP O
on IN B-PP O
analysis NN B-NP O
of IN B-PP O
DNA NN B-NP O
. . O O

We PRP B-NP O
developed VBD B-VP O
methods NNS B-NP O
to TO B-VP O
detect VB I-VP O
the DT B-NP O
three CD I-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
HEXA NN I-NP O
gene NN I-NP O
that WDT B-NP O
occur VBP B-VP O
with IN B-PP O
high JJ B-NP O
frequency NN I-NP O
among IN B-PP O
Ashkenazi NNP B-NP O
Jews NNP I-NP O
two CD B-NP O
mutations NNS I-NP O
cause VBP B-VP O
infantile JJ B-NP O
Tay NNP I-NP B-Disease
- HYPH I-NP I-Disease
Sachs NNP I-NP I-Disease
disease NN I-NP I-Disease
, , O O
and CC O O
the DT B-NP O
third JJ I-NP O
causes VBZ B-VP O
the DT B-NP O
adult JJ I-NP O
- HYPH I-NP O
onset NN I-NP O
form NN I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
. . O O

DNA NN B-NP O
segments NNS I-NP O
containing VBG B-VP O
these DT B-NP O
mutation NN I-NP O
sites NNS I-NP O
were VBD B-VP O
amplified VBN I-VP O
with IN B-PP O
the DT B-NP O
polymerase NN I-NP O
chain NN I-NP O
reaction NN I-NP O
and CC O O
analyzed VBN B-VP O
for IN B-PP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
the DT B-NP O
mutations NNS I-NP O
. . O O

RESULTS NNS B-NP O
. . O O

Among IN B-PP O
62 CD B-NP O
Ashkenazi NNP I-NP O
obligate JJ I-NP O
carriers NNS I-NP O
of IN B-PP O
Tay NNP B-NP B-Disease
- HYPH I-NP I-Disease
Sachs NNP I-NP I-Disease
disease NN I-NP I-Disease
, , O O
the DT B-NP O
three CD I-NP O
specific JJ I-NP O
mutations NNS I-NP O
accounted VBD B-VP O
for IN B-PP O
all DT B-NP O
but IN B-PP O
one CD B-NP O
of IN B-PP O
the DT B-NP O
mutant JJ I-NP O
alleles NNS I-NP O
( ( O O
98 CD B-NP O
percent NN I-NP O
) ) O O
. . O O

In IN B-PP O
216 CD B-NP O
Ashkenazi NNP I-NP O
carriers NNS I-NP O
identified VBN B-VP O
by IN B-PP O
the DT B-NP O
enzyme NN I-NP O
test NN I-NP O
, , O O
DNA NN B-NP O
analysis NN I-NP O
showed VBD B-VP O
that IN B-SBAR O
177 CD B-NP O
( ( O O
82 CD B-NP O
percent NN I-NP O
) ) O O
had VBD B-VP O
one CD B-NP O
of IN B-PP O
the DT B-NP O
identified VBN I-NP O
mutations NNS I-NP O
. . O O

Of IN B-PP O
the DT B-NP O
177 CD I-NP O
, , I-NP O
79 CD I-NP O
percent NN I-NP O
had VBD B-VP O
the DT B-NP O
exon NN I-NP O
11 CD I-NP O
insertion NN I-NP O
mutation NN I-NP O
, , O O
18 CD B-NP O
percent NN I-NP O
had VBD B-VP O
the DT B-NP O
intron NN I-NP O
12 CD I-NP O
splice NN I-NP O
- HYPH B-NP O
junction NN I-NP O
mutation NN I-NP O
, , O O
and CC O O
3 CD B-NP O
percent NN I-NP O
had VBD B-VP O
the DT B-NP O
less RBR I-NP O
severe JJ I-NP O
exon NN I-NP O
7 CD I-NP O
mutation NN I-NP O
associated VBN B-VP O
with IN B-PP O
adult JJ B-NP O
- HYPH I-NP O
onset NN I-NP O
disease NN I-NP O
. . O O

The DT B-NP O
results NNS I-NP O
of IN B-PP O
the DT B-NP O
enzyme NN I-NP O
tests NNS I-NP O
in IN B-PP O
the DT B-NP O
39 CD I-NP O
subjects NNS I-NP O
( ( O O
18 CD B-NP O
percent NN I-NP O
) ) O O
who WP B-NP O
were VBD B-VP O
defined VBN I-VP O
as IN B-PP O
carriers NNS B-NP O
but CC B-PP O
in IN B-PP O
whom WP B-NP O
DNA NN B-NP O
analysis NN I-NP O
did VBD B-VP O
not RB I-VP O
identify VB I-VP O
a DT B-NP O
mutant JJ I-NP O
allele NN I-NP O
were VBD B-VP O
probably RB B-ADVP O
false JJ B-NP O
positive JJ I-NP O
( ( O O
although IN B-SBAR O
there EX B-NP O
remains VBZ B-VP O
some DT B-NP O
possibility NN I-NP O
of IN B-PP O
unidentified JJ B-NP O
mutations NNS I-NP O
) ) O O
. . O O

In IN B-PP O
addition NN B-NP O
, , O O
of IN B-PP O
152 CD B-NP O
persons NNS I-NP O
defined VBN B-VP O
as IN B-PP O
noncarriers NNS B-NP O
by IN B-PP O
the DT B-NP O
enzyme NN I-NP O
- HYPH B-VP O
based VBN B-NP O
test NN I-NP O
, , O O
1 CD B-NP O
was VBD B-VP O
identified VBN I-VP O
as IN B-PP O
a DT B-NP O
carrier NN I-NP O
by IN B-PP O
DNA NN B-NP O
analysis NN I-NP O
( ( O O
i JJ O O
. . O O

e NNP B-NP O
e NNP I-NP O
. NN I-NP O

, , O O
a DT B-NP O
false JJ I-NP O
negative JJ I-NP O
enzyme NN I-NP O
- HYPH I-NP O
test NN I-NP O
result NN I-NP O
) ) O O
. . O O

CONCLUSIONS NNS B-NP O
. . O O

The DT B-NP O
increased VBN I-NP O
specificity NN I-NP O
and CC I-NP O
predictive JJ I-NP O
value NN I-NP O
of IN B-PP O
the DT B-NP O
DNA NN I-NP O
- HYPH B-VP O
based VBN B-NP O
test NN I-NP O
make VBP B-VP O
it PRP B-NP O
a DT B-NP O
useful JJ I-NP O
adjunct NN I-NP O
to TO B-PP O
the DT B-NP O
diagnostic JJ I-NP O
tests NNS I-NP O
currently RB B-VP O
used VBN I-VP O
to TO B-VP O
screen VB I-VP O
for IN B-PP O
carriers NNS B-NP O
of IN B-PP O
Tay NNP B-NP B-Disease
- HYPH I-NP I-Disease
Sachs NNP I-NP I-Disease
disease NN I-NP I-Disease
. . O O

Total JJ B-NP B-Disease
deficiency NN I-NP I-Disease
of IN B-PP I-Disease
plasma NN B-NP I-Disease
cholesteryl NN I-NP I-Disease
ester NN I-NP I-Disease
transfer NN I-NP I-Disease
protein NN I-NP I-Disease
in IN B-PP O
subjects NNS B-NP O
homozygous JJ B-ADJP O
and CC I-ADJP O
heterozygous JJ I-ADJP O
for IN B-PP O
the DT B-NP O
intron NN I-NP O
14 CD I-NP O
splicing NN I-NP O
defect NN I-NP O
. . O O

The DT B-NP O
molecular JJ I-NP O
basis NN I-NP O
of IN B-PP O
cholesteryl NN B-NP B-Disease
ester NN I-NP I-Disease
transfer NN I-NP I-Disease
protein NN I-NP I-Disease
( ( O I-Disease
CETP NN B-NP I-Disease
) ) O I-Disease
deficiency NN B-NP I-Disease
was VBD B-VP O
investigated VBN I-VP O
in IN B-PP O
4 CD B-NP O
unrelated JJ I-NP O
CETP NN I-NP B-Disease
- HYPH B-NP I-Disease
deficient JJ I-NP I-Disease
families NNS I-NP O
. . O O

The DT B-NP O
high JJ I-NP O
density NN I-NP O
lipoprotein NN I-NP O
- HYPH B-NP O
cholesterol NN I-NP O
levels NNS I-NP O
of IN B-PP O
the DT B-NP O
probands NNS I-NP O
exceeded VBD B-VP O
150 CD B-NP O
mg NN I-NP O
/ SYM B-NP O
dl NN I-NP O
. . O O

The DT B-NP O
plasma NN I-NP O
of IN B-PP O
the DT B-NP O
probands NNS I-NP O
was VBD B-VP O
totally RB B-ADJP O
deficient JJ I-ADJP O
in IN B-PP O
CETP NN B-NP O
activity NN I-NP O
and CC I-NP O
mass NN I-NP O
. . O O

The DT B-NP O
genomic JJ I-NP O
DNA NN I-NP O
of IN B-PP O
the DT B-NP O
patients NNS I-NP O
was VBD B-VP O
amplified VBN I-VP O
by IN B-PP O
polymerase NN B-NP O
chain NN I-NP O
reaction NN I-NP O
, , O O
using VBG B-VP O
two CD B-NP O
oligonucleotide NN I-NP O
primers NNS I-NP O
located VBN B-VP O
in IN B-PP O
the DT B-NP O
intron NN I-NP O
12 CD I-NP O
and CC I-NP O
14 CD I-NP O
of IN B-PP O
the DT B-NP O
CETP NN I-NP O
gene NN I-NP O
, , O O
and CC O O
the DT B-NP O
amplified VBN I-NP O
products NNS I-NP O
were VBD B-VP O
directly RB I-VP O
sequenced VBN I-VP O
. . O O

Two CD B-NP O
patients NNS I-NP O
were VBD B-VP O
homozygous JJ B-ADJP O
for IN B-PP O
a DT B-NP O
G NN I-NP O
- HYPH B-ADJP O
to TO B-PP O
- HYPH B-NP O
A NN I-NP O
change NN I-NP O
at IN B-PP O
the DT B-NP O
5 CD I-NP O
- HYPH I-NP O
splice NN I-NP O
donor NN I-NP O
site NN I-NP O
of IN B-PP O
the DT B-NP O
intron NN I-NP O
14 CD I-NP O
. . O O

The DT B-NP O
G NN I-NP O
- HYPH B-ADVP O
to TO B-PP O
- HYPH B-NP O
A NN I-NP O
change NN I-NP O
would MD B-VP O
cause VB I-VP O
impaired JJ B-NP O
splicing NN I-NP O
of IN B-PP O
pre AFX B-NP O
- HYPH I-NP O
messenger NN I-NP O
RNA NN I-NP O
. . O O

The DT B-NP O
other JJ I-NP O
two CD I-NP O
probands NNS I-NP O
were VBD B-VP O
heterozygous JJ B-ADJP O
for IN B-PP O
the DT B-NP O
mutation NN I-NP O
, , O O
but CC O O
totally RB B-VP O
lacked VBD I-VP O
CETP NN B-NP O
. . O O

Their PRP$ B-NP O
lipoprotein NN I-NP O
patterns NNS I-NP O
were VBD B-VP O
also RB B-ADVP O
similar JJ B-ADJP O
to TO B-PP O
those DT B-NP O
of IN B-PP O
the DT B-NP O
two CD I-NP O
homozygotes NNS I-NP O
. . O O

Thus RB B-ADVP O
, , O O
other JJ B-NP O
genetic JJ I-NP B-Disease
defects NNS I-NP I-Disease
or CC O O
metabolic JJ B-NP O
factors NNS I-NP O
influencing VBG B-VP O
CETP NN B-NP O
expression NN I-NP O
are VBP B-VP O
implicated VBN I-VP O
. . O O

The DT B-NP O
data NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
the DT B-NP O
G NN I-NP O
- HYPH B-ADJP O
to TO B-PP O
- HYPH B-NP O
A NN I-NP O
mutation NN I-NP O
may MD B-VP O
be VB I-VP O
common JJ B-ADJP O
in IN B-PP O
human JJ B-NP O
plasma NN I-NP O
CETP NN I-NP B-Disease
deficiency NN I-NP I-Disease
. . O O

Furthermore RB B-ADVP O
, , O O
there EX B-NP O
could MD B-VP O
be VB I-VP O
compound JJ B-NP O
heterozygotes NNS I-NP O
who WP B-NP O
totally RB B-VP O
lack VBP I-VP O
plasma NN B-NP O
CETP NN I-NP O
and CC O O
have VBP B-VP O
lipoprotein NN B-NP O
profiles NNS I-NP O
similar JJ B-ADJP O
to TO B-PP O
those DT B-NP O
of IN B-PP O
homozygotes NNS B-NP O
. . O O

. . O O

Molecular JJ B-NP O
genetics NNS I-NP O
of IN B-PP O
the DT B-NP O
glucose NN I-NP O
- HYPH B-NP O
6 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
dehydrogenase NN I-NP O
( ( O O
G6PD NN B-NP O
) ) O O
Mediterranean JJ B-NP O
variant NN I-NP O
and CC I-NP O
description NN I-NP O
of IN B-PP O
a DT B-NP O
new JJ I-NP O
G6PD NN I-NP O
mutant NN I-NP O
, , O O
G6PD NN B-NP O
Andalus1361A NN I-NP O
. . O O

Glucose NN B-NP B-Disease
- HYPH B-NP I-Disease
6 CD I-NP I-Disease
- HYPH I-NP I-Disease
phosphate NN I-NP I-Disease
dehydrogenase NN I-NP I-Disease
( ( O I-Disease
G6PD NN B-NP I-Disease
; : O I-Disease
E NN B-NP I-Disease
. . O I-Disease

C NN B-NP I-Disease
. . O I-Disease

1 CD B-NP I-Disease
. . O I-Disease

1 CD B-NP I-Disease
. . I-NP I-Disease

1 CD I-NP I-Disease
. . O I-Disease

49 CD O I-Disease
) ) O I-Disease
deficiency NN B-NP I-Disease
is VBZ B-VP O
the DT B-NP O
most RBS I-NP O
common JJ I-NP O
human JJ I-NP O
enzymopathy NN I-NP B-Disease
; : O O
more JJR B-NP O
than IN I-NP O
300 CD I-NP O
different JJ I-NP O
biochemical JJ I-NP O
variants NNS I-NP O
of IN B-PP O
the DT B-NP O
enzyme NN I-NP O
have VBP B-VP O
been VBN I-VP O
described VBN I-VP O
. . O O

In IN B-PP O
many JJ B-NP O
parts NNS I-NP O
of IN B-PP O
the DT B-NP O
world NN I-NP O
the DT B-NP O
Mediterranean JJ I-NP O
type NN I-NP O
of IN B-PP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
is VBZ B-VP O
prevalent JJ B-ADJP O
. . O O

However RB B-ADVP O
, , O O
G6PD NN B-NP O
Mediterranean NNP B-NP O
has VBZ B-VP O
come VBN I-VP O
to TO I-VP O
be VB I-VP O
regarded VBN I-VP O
as IN B-PP O
a DT B-NP O
generic JJ I-NP O
term NN I-NP O
applied VBN B-VP O
to TO B-PP O
similar JJ B-NP O
G6PD NN I-NP O
mutations NNS I-NP O
thought VBD B-VP O
, , O O
however RB B-ADVP O
, , O O
to TO B-VP O
represent VB I-VP O
a DT B-NP O
somewhat RB I-NP O
heterogeneous JJ I-NP O
group NN I-NP O
. . O O

A DT B-NP O
C NN I-NP O
- SYM B-VP O
- SYM B-NP O
- SYM I-NP O
- HYPH I-NP O
T NN I-NP O
mutation NN I-NP O
at IN B-PP O
nucleotide NN B-NP O
563 CD I-NP O
of IN B-PP O
G6PD NN B-NP O
Mediterranean NNP B-NP O
has VBZ B-VP O
been VBN I-VP O
identified VBN I-VP O
by IN B-PP O
Vulliamy NNP B-NP O
et FW I-NP O
al FW I-NP O
. FW I-NP O

, , O O
and CC O O
the DT B-NP O
same JJ I-NP O
mutation NN I-NP O
has VBZ B-VP O
been VBN I-VP O
found VBN I-VP O
by IN B-PP O
De NNP B-NP O
Vita NNP I-NP O
et FW I-NP O
al FW I-NP O
. . O O

in IN B-PP O
G6PD NN B-NP O
Mediterranean NNP I-NP O
, , O O
G6PD NNP B-NP O
Sassari NNP I-NP O
, , O O
and CC O O
G6PD NNP B-NP O
Cagliari NNP I-NP O
. . O O

The DT B-NP O
latter JJ I-NP O
subjects NNS I-NP O
had VBD B-VP O
an DT B-NP O
additional JJ I-NP O
mutation NN I-NP O
, , O O
at IN B-PP O
nucleotide NN B-NP O
1311 NN I-NP O
, , O O
that WDT B-NP O
did VBD B-VP O
not RB I-VP O
produce VB I-VP O
a DT B-NP O
coding VBG I-NP O
change NN I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
examined VBN I-VP O
genomic JJ B-NP O
DNA NN I-NP O
of IN B-PP O
five CD B-NP O
patients NNS I-NP O
- SYM O O
- SYM O O
four CD B-NP O
of IN B-PP O
Spanish JJ B-NP O
origin NN I-NP O
and CC O O
one CD B-NP O
of IN B-PP O
Jewish JJ B-NP O
origin NN I-NP O
- HYPH O O
- HYPH O O
having VBG B-VP O
enzymatically RB I-VP O
documented VBN I-VP O
G6PD NN B-NP O
Mediterranean NNP I-NP O
. . O O

All DT B-NP O
had VBD B-VP O
both CC O O
the DT B-NP O
mutation NN I-NP O
at IN B-PP O
nucleotide NN B-NP O
563 CD I-NP O
and CC O O
that DT B-NP O
at IN B-PP O
nucleotide NN B-NP O
1311 CD I-NP O
. . O O

A DT B-NP O
sixth JJ I-NP O
sample NN I-NP O
, , O O
resembling VBG B-VP O
G6PD NN B-NP O
Mediterranean NNP I-NP O
kinetically RB B-ADVP O
but CC O O
with IN B-PP O
a DT B-NP O
slightly RB I-NP O
rapid JJ I-NP O
electrophoretic JJ I-NP O
mobility NN I-NP O
, , O O
was VBD B-VP O
designated VBN I-VP O
G6PD NN B-NP O
Andalus NN I-NP O
and CC O O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
have VB I-VP O
a DT B-NP O
different JJ I-NP O
mutation NN I-NP O
, , O O
a DT B-NP O
G NN I-NP O
- SYM B-NP O
- SYM B-NP O
- SYM I-NP O
- HYPH I-NP O
A NN I-NP O
transition NN I-NP O
at IN B-PP O
nucleotide NN B-NP O
1361 CD I-NP O
, , O O
producing VBG B-VP O
an DT B-NP O
arginine NN I-NP O
- HYPH B-ADJP O
to TO B-PP O
- HYPH B-NP O
histidine NN I-NP O
substitution NN I-NP O
. . O O

These DT B-NP O
studies NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
G6PD NN B-NP O
Mediterranean NNP B-NP O
is VBZ B-VP O
, , O O
after IN B-PP O
all DT B-NP O
, , O O
relatively RB B-ADJP O
homogeneous JJ I-ADJP O
. . O O

A DT B-NP O
normal JJ I-NP O
male NN I-NP O
with IN B-PP O
an DT B-NP O
inherited VBN I-NP O
deletion NN I-NP O
of IN B-PP O
one CD B-NP O
exon NN I-NP O
within IN B-PP O
the DT B-NP O
DMD NN I-NP B-Disease
gene NN I-NP O
. . O O

We PRP B-NP O
describe VBP B-VP O
two CD B-NP O
brothers NNS I-NP O
with IN B-PP O
identical JJ B-NP O
inherited VBN I-NP O
deletions NNS I-NP O
of IN B-PP O
one CD B-NP O
single JJ I-NP O
exon NN I-NP O
within IN B-PP O
the DT B-NP O
middle NN I-NP O
of IN B-PP O
the DT B-NP O
DMD NN I-NP B-Disease
gene NN I-NP O
; : O O
one CD B-NP O
brother NN I-NP O
has VBZ B-VP O
Becker NNP B-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
diagnosed VBN B-VP O
at IN B-PP O
11 CD B-NP O
years NNS I-NP O
of IN B-PP O
age NN B-NP O
, , O O
whereas IN O O
the DT B-NP O
older JJR I-NP O
brother NN I-NP O
is VBZ B-VP O
normal JJ B-ADJP O
at IN B-PP O
18 CD B-NP O
. . O O

These DT B-NP O
results NNS I-NP O
have VBP B-VP O
implications NNS B-NP O
for IN B-PP O
genetic JJ B-NP O
counselling NN I-NP O
and CC O O
prenatal JJ B-NP O
diagnosis NN I-NP O
in IN B-PP O
families NNS B-NP O
with IN B-PP O
Becker NNP B-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
. . O O

. . O O

Duchenne JJ B-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
gene NN I-NP O
expression NN I-NP O
in IN B-PP O
normal JJ B-NP O
and CC I-NP O
diseased JJ I-NP O
human JJ I-NP O
muscle NN I-NP O
. . O O

A DT B-NP O
probe NN I-NP O
for IN B-PP O
the DT B-NP O
5 CD I-NP O
end NN I-NP O
of IN B-PP O
the DT B-NP O
Duchenne NNP I-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
DMD NN B-NP B-Disease
) ) O O
gene NN B-NP O
was VBD B-VP O
used VBN I-VP O
to TO B-VP O
study VB I-VP O
expression NN B-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
in IN B-PP O
normal JJ B-NP O
human JJ I-NP O
muscle NN I-NP O
, , O O
myogenic JJ B-NP O
cell NN I-NP O
cultures NNS I-NP O
, , O O
and CC O O
muscle NN B-NP O
from IN B-PP O
patients NNS B-NP O
with IN B-PP O
DMD NN B-NP B-Disease
. . O O

Expression NN B-NP O
was VBD B-VP O
found VBN I-VP O
in IN B-PP O
RNA NN B-NP O
from IN B-PP O
normal JJ B-NP O
fetal JJ I-NP O
muscle NN I-NP O
, , O O
adult JJ B-NP O
cardiac JJ I-NP O
and CC I-NP O
skeletal JJ I-NP O
muscle NN I-NP O
, , O O
and CC O O
cultured VBN B-NP O
muscle NN I-NP O
after IN B-PP O
myoblast NN B-NP O
fusion NN I-NP O
. . O O

In IN B-PP O
DMD NN B-NP B-Disease
muscle NN I-NP O
, , O O
expression NN B-NP O
of IN B-PP O
this DT B-NP O
portion NN I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
was VBD B-VP O
also RB I-VP O
revealed VBN I-VP O
by IN B-PP O
in FW B-NP O
situ FW I-NP O
RNA NN I-NP O
hybridization NN I-NP O
, , O O
particularly RB B-ADVP O
in IN B-PP O
regenerating VBG B-VP O
muscle NN B-NP O
fibers NNS I-NP O
. . O O

. . O O

Molecular JJ B-NP O
and CC I-NP O
phenotypic JJ I-NP O
analysis NN I-NP O
of IN B-PP O
patients NNS B-NP O
with IN B-PP O
deletions NNS B-NP O
within IN B-PP O
the DT B-NP O
deletion NN I-NP O
- HYPH B-NP O
rich JJ I-NP O
region NN I-NP O
of IN B-PP O
the DT B-NP O
Duchenne NNP I-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
DMD NN B-NP B-Disease
) ) O O
gene NN B-NP O
. . O O

Eighty CD B-NP O
unrelated JJ I-NP O
individuals NNS I-NP O
with IN B-PP O
Duchenne JJ B-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
DMD NN B-NP B-Disease
) ) O O
or CC B-NP O
Becker NNP I-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
BMD NN B-NP B-Disease
) ) O O
were VBD B-VP O
found VBN I-VP O
to TO I-VP O
have VB I-VP O
deletions NNS B-NP O
in IN B-PP O
the DT B-NP O
major JJ I-NP O
deletion NN I-NP O
- HYPH B-NP O
rich JJ I-NP O
region NN I-NP O
of IN B-PP O
the DT B-NP O
DMD NN I-NP B-Disease
locus NN I-NP O
. . O O

This DT B-NP O
region NN I-NP O
includes VBZ B-VP O
the DT B-NP O
last JJ I-NP O
five CD I-NP O
exons NNS I-NP O
detected VBN B-VP O
by IN B-PP O
cDNA5b NN B-NP O
- HYPH I-NP O
7 CD I-NP O
, , O O
all DT B-NP O
exons NNS I-NP O
detected VBN B-VP O
by IN B-PP O
cDNA8 NN B-NP O
, , O O
and CC O O
the DT B-NP O
first JJ I-NP O
two CD I-NP O
exons NNS I-NP O
detected VBN B-VP O
by IN B-PP O
cDNA9 NN B-NP O
. . O O

These DT B-NP O
80 CD I-NP O
individuals NNS I-NP O
account VBP B-VP O
for IN B-PP O
approximately RB B-NP O
75 CD I-NP O
% NN I-NP O
of IN B-PP O
109 CD B-NP O
deletions NNS I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
, , O O
detected VBN B-VP O
among IN B-PP O
181 CD B-NP O
patients NNS I-NP O
analyzed VBN B-VP O
with IN B-PP O
the DT B-NP O
entire JJ I-NP O
dystrophin NN I-NP O
cDNA NN I-NP O
. . O O

Endpoints NNS B-NP O
for IN B-PP O
many JJ B-NP O
of IN B-PP O
these DT B-NP O
deletions NNS I-NP O
were VBD B-VP O
further RBR I-VP O
characterized VBN I-VP O
using VBG B-VP O
two CD B-NP O
genomic JJ I-NP O
probes NNS I-NP O
, , O O
p20 NN B-NP O
( ( O O
DXS269 NN B-NP O
; : O O
Wapenaar NNP B-NP O
et FW I-NP O
al FW I-NP O
. . O O

) ) O O
and CC O O
GMGX11 NN B-NP O
( ( O O
DXS239 NN B-NP O
; : O O
present JJ B-NP O
paper NN I-NP O
) ) O O
. . O O

Clinical JJ B-NP O
findings NNS I-NP O
are VBP B-VP O
presented VBN I-VP O
for IN B-PP O
all DT B-NP O
80 CD I-NP O
patients NNS I-NP O
allowing VBG B-VP O
a DT B-NP O
correlation NN I-NP O
of IN B-PP O
phenotypic JJ B-NP O
severity NN I-NP O
with IN B-PP O
the DT B-NP O
genotype NN I-NP O
. . O O

Thirty CD B-NP O
- HYPH I-NP O
eight CD I-NP O
independent JJ I-NP O
patients NNS I-NP O
were VBD B-VP O
old JJ B-ADJP O
enough RB I-ADJP O
to TO B-VP O
be VB I-VP O
classified VBN I-VP O
as IN B-PP O
DMD NN B-NP B-Disease
, , O O
BMD NN B-NP B-Disease
, , O O
or CC O O
intermediate JJ B-NP O
phenotype NN I-NP O
and CC O O
had VBD B-VP O
deletions NNS B-NP O
of IN B-PP O
exons NNS B-NP O
with IN B-PP O
sequenced VBN B-NP O
intron NN I-NP O
/ SYM B-NP O
exon NN B-NP O
boundaries NNS I-NP O
. . O O

Of IN B-PP O
these DT B-NP O
, , O O
eight CD B-NP O
BMD NN I-NP B-Disease
patients NNS I-NP O
and CC O O
one CD B-NP O
intermediate JJ I-NP O
patient NN I-NP O
had VBD B-VP O
gene NN B-NP O
deletions NNS I-NP O
predicted VBN B-VP O
to TO I-VP O
leave VB I-VP O
the DT B-NP O
reading NN I-NP O
frame NN I-NP O
intact JJ B-ADJP O
, , O O
while IN B-SBAR O
21 CD B-NP O
DMD NN I-NP B-Disease
patients NNS I-NP O
, , O O
7 CD B-NP O
intermediate JJ I-NP O
patients NNS I-NP O
, , O O
and CC O O
1 CD B-NP O
BMD NN I-NP B-Disease
patient NN I-NP O
had VBD B-VP O
gene NN B-NP O
deletions NNS I-NP O
predicted VBN B-VP O
to TO B-VP O
disrupt VB I-VP O
the DT B-NP O
reading NN I-NP O
frame NN I-NP O
. . O O

Thus RB B-ADVP O
, , O O
with IN B-PP O
two CD B-NP O
exceptions NNS I-NP O
, , O O
frameshift NN B-NP O
deletions NNS I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
resulted VBD B-VP O
in IN B-PP O
more RBR B-NP O
severe JJ I-NP O
phenotype NN I-NP O
than IN B-SBAR O
did VBD B-VP O
in IN B-PP O
- HYPH B-NP O
frame NN I-NP O
deletions NNS I-NP O
. . O O

This DT B-NP O
is VBZ B-VP O
in IN B-PP O
agreement NN B-NP O
with IN B-PP O
recent JJ B-NP O
findings NNS I-NP O
by IN B-PP O
Baumbach NNP B-NP O
et FW I-NP O
al FW I-NP O
. . O O

and CC O O
Koenig NNP B-NP O
et FW I-NP O
al FW I-NP O
. . O O

but CC O O
is VBZ B-VP O
in IN B-PP O
contrast NN B-NP O
to TO B-PP O
findings NNS B-NP O
, , O O
by IN B-PP O
Malhotra NNP B-NP O
et FW I-NP O
al FW I-NP O
. . O O

at IN B-PP O
the DT B-NP O
5 CD I-NP O
' SYM I-NP O
end NN I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
. . O O

Cloning NN B-NP O
of IN B-PP O
breakpoints NNS B-NP O
of IN B-PP O
a DT B-NP O
chromosome NN I-NP O
translocation NN I-NP O
identifies VBZ B-VP O
the DT B-NP O
AN2 NN I-NP O
locus NN I-NP O
. . O O

Chromosome NN B-NP O
translocations NNS I-NP O
involving VBG B-VP O
11p13 NN B-NP O
have VBP B-VP O
been VBN I-VP O
associated VBN I-VP O
with IN B-PP O
familial JJ B-NP B-Disease
aniridia NN I-NP I-Disease
in IN B-PP O
two CD B-NP O
kindreds NNS I-NP O
highlighting VBG B-VP O
the DT B-NP O
chromosomal JJ I-NP O
localization NN I-NP O
of IN B-PP O
the DT B-NP O
AN2 NN I-NP O
locus NN I-NP O
. . O O

This DT B-NP O
locus NN I-NP O
is VBZ B-VP O
also RB B-ADVP O
part NN B-NP O
of IN B-PP O
the DT B-NP O
WAGR NN I-NP B-Disease
complex NN I-NP O
( ( O O
Wilms NNP B-NP B-Disease
tumor NN I-NP I-Disease
, , O O
aniridia NN B-NP B-Disease
, , O O
genitourinary JJ B-NP B-Disease
abnormalities NNS I-NP I-Disease
, , O O
and CC O O
mental JJ B-NP B-Disease
retardation NN I-NP I-Disease
) ) O O
. . O O

In IN B-PP O
one CD B-NP O
kindred NN I-NP O
, , O O
the DT B-NP O
translocation NN I-NP O
is VBZ B-VP O
associated VBN I-VP O
with IN B-PP O
a DT B-NP O
deletion NN I-NP O
, , O O
and CC O O
probes NNS B-NP O
for IN B-PP O
this DT B-NP O
region NN I-NP O
were VBD B-VP O
used VBN I-VP O
to TO B-VP O
identify VB I-VP O
and CC I-VP O
clone VB I-VP O
the DT B-NP O
breakpoints NNS I-NP O
of IN B-PP O
the DT B-NP O
translocation NN I-NP O
in IN B-PP O
the DT B-NP O
second JJ I-NP O
kindred NN I-NP O
. . O O

Comparison NN B-NP O
of IN B-PP O
phage NN B-NP O
restriction NN I-NP O
maps NNS I-NP O
exclude VBP B-VP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
any DT B-NP O
sizable JJ I-NP O
deletion NN I-NP O
in IN B-PP O
this DT B-NP O
case NN I-NP O
. . O O

Sequences NNS B-NP O
at IN B-PP O
the DT B-NP O
chromosome NN I-NP O
11 CD I-NP O
breakpoint NN I-NP O
are VBP B-VP O
conserved VBN I-VP O
in IN B-PP O
multiple JJ B-NP O
species NNS I-NP O
, , O O
suggesting VBG B-VP O
that IN B-SBAR O
the DT B-NP O
translocation NN I-NP O
falls VBZ B-VP O
within IN B-PP O
the DT B-NP O
AN2 NN I-NP O
gene NN I-NP O
. . O O

. . O O

Linkage NN B-NP O
analysis NN I-NP O
of IN B-PP O
the DT B-NP O
apolipoprotein NN I-NP O
C2 NN I-NP O
gene NN I-NP O
and CC O O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
on IN B-PP O
human JJ B-NP O
chromosome NN I-NP O
19 CD I-NP O
reveals VBZ B-VP O
linkage NN B-NP O
disequilibrium NN I-NP O
in IN B-PP O
a DT B-NP O
French JJ I-NP O
- HYPH I-NP O
Canadian JJ I-NP O
population NN I-NP O
. . O O

The DT B-NP O
gene NN I-NP O
for IN B-PP O
human JJ B-NP O
apolipoprotein NN I-NP O
C2 NN I-NP O
( ( O O
APOC2 NN B-NP O
) ) O O
, , O O
situated VBN B-VP O
on IN B-PP O
the DT B-NP O
proximal JJ I-NP O
long JJ I-NP O
arm NN I-NP O
of IN B-PP O
chromosome NN B-NP O
19 CD I-NP O
, , O O
is VBZ B-VP O
closely RB I-VP O
linked VBN I-VP O
to TO B-PP O
the DT B-NP O
gene NN I-NP O
for IN B-PP O
the DT B-NP O
most RBS I-NP O
common JJ I-NP O
form NN I-NP O
of IN B-PP O
adult JJ B-NP O
muscular JJ I-NP B-Disease
dystrophy NN I-NP I-Disease
, , O O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
( ( O O
DM NN B-NP B-Disease
) ) O O
. . O O

Six CD B-NP O
APOC2 NN I-NP O
RFLPs NNS I-NP O
( ( O O
TaqI NNP B-NP O
, , O O
BglI NNP B-NP O
, , O O
BanI NNP B-NP O
, , O O
BamHI NNP B-NP O
, , O O
NcoI NNP B-NP O
, , O O
and CC O O
AvaII NN B-NP O
) ) O O
have VBP B-VP O
been VBN I-VP O
identified VBN I-VP O
to TO B-PP O
date NN B-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
conducted VBN I-VP O
a DT B-NP O
comprehensive JJ I-NP O
DM NN I-NP B-Disease
linkage NN I-NP O
study NN I-NP O
utilizing VBG B-VP O
all DT B-NP O
six CD I-NP O
RFLPs NNS I-NP O
and CC O O
involving VBG B-VP O
50 CD B-NP O
families NNS I-NP O
and CC O O
372 CD B-NP O
individuals NNS I-NP O
. . O O

The DT B-NP O
most RBS I-NP O
informative JJ I-NP O
RFLPs NNS I-NP O
are VBP B-VP O
, , O O
in IN B-PP O
descending VBG B-VP O
order NN B-NP O
, , O O
NcoI NN B-NP O
( ( O O
lod NN B-NP O
= SYM B-VP O
6 CD B-NP O
. SYM I-NP O

64 CD I-NP O
, , I-NP O
theta NN I-NP O
= SYM B-VP O
0 CD B-NP O
. SYM I-NP O

05 CD I-NP O
) ) O O
, , O O
BglI NN B-NP O
( ( O O
lod NN B-NP O
= SYM B-VP O
6 CD B-NP O
. SYM I-NP O

12 CD I-NP O
, , I-NP O
theta NN I-NP O
= SYM B-VP O
0 CD B-NP O
. SYM I-NP O

05 CD I-NP O
) ) O O
, , O O
AvaII NN B-NP O
( ( O O
lod NN B-NP O
= SYM B-VP O
6 CD B-NP O
. SYM I-NP O

02 CD I-NP O
, , I-NP O
theta NN I-NP O
= SYM B-VP O
0 CD B-NP O
. SYM I-NP O

03 CD I-NP O
) ) O O
, , O O
BanI NN B-NP O
( ( O O
lod NN B-NP O
= SYM B-VP O
5 CD B-NP O
. SYM I-NP O

76 CD I-NP O
, , O O
theta NN B-NP O
= SYM B-VP O
0 CD B-NP O
. SYM I-NP O

04 CD I-NP O
) ) O O
, , O O
TaqI NN B-NP O
( ( O O
lod NN B-NP O
= SYM B-VP O
4 CD B-NP O
. SYM I-NP O

29 CD I-NP O
, , O O
theta NN B-NP O
= SYM B-VP O
0 CD B-NP O
. SYM I-NP O

06 CD I-NP O
) ) O O
, , O O
and CC O O
BamHI NN B-NP O
( ( O O
lod NN B-NP O
= SYM B-VP O
1 CD B-NP O
. SYM I-NP O

75 CD I-NP O
, , O O
theta NN B-NP O
= SYM B-VP O
0 CD B-NP O
. SYM I-NP O

01 CD I-NP O
) ) O O
. . O O

A DT B-NP O
substantial JJ I-NP O
increase NN I-NP O
in IN B-PP O
the DT B-NP O
lod NN I-NP O
scores NNS I-NP O
over IN B-PP O
those DT B-NP O
seen VBN B-VP O
with IN B-PP O
the DT B-NP O
individual JJ I-NP O
RFLPs NNS I-NP O
was VBD B-VP O
obtained VBN I-VP O
when WRB B-ADVP O
the DT B-NP O
linkage NN I-NP O
of IN B-PP O
the DT B-NP O
entire JJ I-NP O
APOC2 NN I-NP O
haplotype NN I-NP O
( ( O O
composed VBN B-VP O
of IN B-PP O
the DT B-NP O
six CD I-NP O
RFLPs NNS I-NP O
) ) O O
was VBD B-VP O
studied VBN I-VP O
( ( O O
lod NN B-NP O
= SYM B-VP O
17 CD B-NP O
. SYM I-NP O

87 CD I-NP O
, , O O
theta NN B-NP O
= SYM B-VP O
0 CD B-NP O
. SYM I-NP O

04 CD I-NP O
) ) O O
. . O O

We PRP B-NP O
have VBP B-VP O
observed VBN I-VP O
significant JJ B-NP O
inter AFX I-NP O
- HYPH I-NP O
APOC2 NN I-NP O
RFLP NN I-NP O
linkage NN I-NP O
disequilibrium NN I-NP O
. . O O

Consequently RB B-ADVP O
, , O O
the DT B-NP O
three CD I-NP O
most RBS I-NP O
informative JJ I-NP O
RFLPs NNS I-NP O
have VBP B-VP O
been VBN I-VP O
found VBN I-VP O
to TO I-VP O
be VB I-VP O
BanI NNP B-NP O
, , O O
TaqI NNP B-NP O
, , O O
and CC O O
either DT O O
BglI NNP B-NP O
, , O O
AvaII NNP B-NP O
, , O O
or CC O O
NcoI NN B-NP O
polymorphisms NNS I-NP O
. . O O

We PRP B-NP O
also RB B-ADVP O
demonstrate VBP B-VP O
linkage NN B-NP O
disequilibrium NN I-NP O
between IN B-PP O
DM NN B-NP O
and CC I-NP O
APOC2 NN I-NP O
in IN B-PP O
our PRP$ B-NP O
French JJ I-NP O
- HYPH I-NP O
Canadian JJ I-NP O
population NN I-NP O
( ( O O
standardized JJ B-NP O
disequilibrium NN I-NP O
constant NN I-NP O
phi NN I-NP O
= SYM B-VP O
. . O O

22 CD B-NP O
, , O O
chi NN B-NP O
2 CD I-NP O
= SYM B-VP O
5 CD B-NP O
. SYM I-NP O

12 CD I-NP O
, , O O
df NN B-NP O
= SYM B-VP O
1 CD B-NP O
, , O O
P NN B-VP O
less JJR B-NP O
than IN I-NP O
0 CD I-NP O
. . I-NP O

04 CD I-NP O
) ) O O
. . O O

This DT B-NP O
represents VBZ B-VP O
the DT B-NP O
first JJ I-NP O
evidence NN I-NP O
of IN B-PP O
linkage NN B-NP O
disequilibrium NN I-NP O
between IN B-PP O
APOC2 NN B-NP O
and CC O O
the DT B-NP O
DM NN I-NP B-Disease
locus NN I-NP O
. . O O

Phenylalanine NN B-NP O
hydroxylase NN I-NP O
gene NN I-NP O
haplotypes NNS I-NP O
in IN B-PP O
Polynesians NNPS B-NP O
: : O O
evolutionary JJ B-NP O
origins NNS I-NP O
and CC O O
absence NN B-NP O
of IN B-PP O
alleles NNS B-NP O
associated VBN B-VP O
with IN B-PP O
severe JJ B-NP O
phenylketonuria NN I-NP B-Disease
. . O O

A DT B-NP O
total NN I-NP O
of IN B-PP O
630 CD B-NP O
haplotypes NNS I-NP O
for IN B-PP O
the DT B-NP O
phenylalanine NN I-NP O
hydroxylase NN I-NP O
( ( O O
PAH NN B-NP O
) ) O O
gene NN B-NP O
locus NN I-NP O
were VBD B-VP O
established VBN I-VP O
in IN B-PP O
five CD B-NP O
groups NNS I-NP O
of IN B-PP O
Polynesians NNPS B-NP O
comprising VBG B-VP O
Samoans NNP B-NP O
, , O O
Tongans NNP B-NP O
, , O O
Cook NNP B-NP O
Islanders NNP I-NP O
, , O O
Maori NNP B-NP O
, , O O
and CC O O
Niueans NNS B-NP O
. . O O

Considerable JJ B-NP O
genetic JJ I-NP O
continuity NN I-NP O
was VBD B-VP O
demonstrated VBN I-VP O
between IN B-PP O
these DT B-NP O
widely RB I-NP O
dispersed JJ I-NP O
populations NNS I-NP O
, , O O
since IN B-SBAR O
three CD B-NP O
common JJ I-NP O
haplotypes NNS I-NP O
( ( O O
4 CD B-NP O
, , I-NP O
1 CD I-NP O
, , O O
and CC O O
7 CD B-NP O
) ) O O
constituted VBN B-VP O
over IN B-PP O
95 CD B-NP O
% NN I-NP O
of IN B-PP O
alleles NNS B-NP O
. . O O

A DT B-NP O
control NN I-NP O
group NN I-NP O
of IN B-PP O
individuals NNS B-NP O
from IN B-PP O
Southeast NNP B-NP O
Asia NNP I-NP O
shared VBD B-VP O
the DT B-NP O
same JJ I-NP O
major JJ I-NP O
haplotypes NNS I-NP O
, , O O
4 CD B-NP O
, , I-NP O
1 CD I-NP O
, , O O
and CC O O
7 CD B-NP O
, , O O
with IN B-PP O
Polynesians NNPS B-NP O
. . O O

These DT B-NP O
data NNS I-NP O
provide VBP B-VP O
further JJ B-NP O
support NN I-NP O
for IN B-PP O
the DT B-NP O
theories NNS I-NP O
of IN B-PP O
genetic JJ B-NP O
homogeneity NN I-NP O
and CC B-PP O
of IN B-PP O
Asian JJ B-NP O
affinities NNS I-NP O
of IN B-PP O
the DT B-NP O
Polynesian JJ I-NP O
precursor NN I-NP O
populations NNS I-NP O
. . O O

The DT B-NP O
absence NN I-NP O
of IN B-PP O
severe JJ B-NP O
phenylketonuria NN I-NP B-Disease
( ( O O
PKU NN B-NP B-Disease
) ) O O
in IN B-PP O
both CC O O
Polynesians NNPS B-NP O
and CC O O
Southeast NNP B-NP O
Asians NNPS I-NP O
is VBZ B-VP O
consistent JJ B-ADJP O
with IN B-PP O
the DT B-NP O
lack NN I-NP O
of IN B-PP O
PAH NN B-NP O
haplotypes NNS I-NP O
2 CD B-NP O
and CC I-NP O
3 CD I-NP O
, , O O
on IN B-PP O
which WDT B-NP O
the DT B-NP O
severe JJ I-NP O
PKU NN I-NP B-Disease
mutants NNS I-NP O
have VBP B-VP O
arisen VBN I-VP O
among IN B-PP O
Caucasians NNPS B-NP O
. . O O

. . O O

Preferential JJ B-NP O
germline NN I-NP O
mutation NN I-NP O
of IN B-PP O
the DT B-NP O
paternal JJ I-NP O
allele NN I-NP O
in IN B-PP O
retinoblastoma NN B-NP B-Disease
. . O O

The DT B-NP O
event NN I-NP O
triggering VBG B-VP O
malignant JJ B-NP O
proliferation NN I-NP O
in IN B-PP O
70 CD B-NP O
% NN I-NP O
of IN B-PP O
retinoblastoma NN B-NP B-Disease
tumours NNS I-NP I-Disease
is VBZ B-VP O
loss NN B-NP O
of IN B-PP O
heterozygosity NN B-NP O
for IN B-PP O
chromosome NN B-NP O
13q14 NN I-NP O
, , O O
whereby WRB B-ADVP O
the DT B-NP O
normal JJ I-NP O
retinoblastoma NN I-NP B-Disease
gene NN I-NP O
( ( O O
RB1 NN B-NP O
) ) O O
allele NN B-NP O
is VBZ B-VP O
lost VBN I-VP O
and CC O O
an DT B-NP O
already RB I-NP O
mutated VBN I-NP O
RB1 NN I-NP O
allele NN I-NP O
remains VBZ B-VP O
in IN B-PP O
the DT B-NP O
tumour NN I-NP B-Disease
. . O O

The DT B-NP O
first JJ I-NP O
allele NN I-NP O
suffers VBZ B-VP O
a DT B-NP O
mutational JJ I-NP O
event NN I-NP O
- HYPH O O
- HYPH O O
deletion NN B-NP O
, , O O
duplication NN B-NP O
or CC O O
point NN B-NP O
mutation NN I-NP O
( ( O O
manuscript NN B-NP O
in IN B-PP O
preparation NN B-NP O
) ) O O
- SYM B-NP O
- HYPH B-ADJP O
either CC O O
in IN B-PP O
the DT B-NP O
germ NN I-NP O
line NN I-NP O
( ( O O
all DT B-NP O
bilateral JJ I-NP O
patients NNS I-NP O
) ) O O
or CC O O
in IN B-PP O
a DT B-NP O
somatic JJ I-NP O
retinal NN I-NP O
cell NN I-NP O
( ( O O
most RBS B-NP O
unilateral JJ I-NP O
patients NNS I-NP O
) ) O O
. . O O

Most JJS B-NP O
bilateral JJ I-NP O
patients NNS I-NP O
have VBP B-VP O
no DT B-NP O
family NN I-NP O
history NN I-NP O
of IN B-PP O
retinoblastoma NN B-NP B-Disease
and CC O O
are VBP B-VP O
presumed VBN I-VP O
to TO I-VP O
have VB I-VP O
new JJ B-NP O
germline NN I-NP O
mutations NNS I-NP O
which WDT B-NP O
arose VBD B-VP O
in IN B-PP O
the DT B-NP O
egg NN I-NP O
, , O O
sperm NN B-NP O
or CC O O
early JJ B-NP O
embryo NN I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
determined VBN I-VP O
the DT B-NP O
parental JJ I-NP O
origin NN I-NP O
of IN B-PP O
the DT B-NP O
retained VBN I-NP O
allele NN I-NP O
in IN B-PP O
nine CD B-NP O
retinoblastoma NN I-NP B-Disease
tumours NNS I-NP I-Disease
from IN B-PP O
eight CD B-NP O
unrelated JJ I-NP O
non AFX I-NP O
- HYPH I-NP O
familial JJ I-NP O
cases NNS I-NP O
by IN B-PP O
using VBG B-VP O
RB1 NN B-NP O
- HYPH B-VP O
linked VBN B-NP O
genetic JJ I-NP O
markers NNS I-NP O
. . O O

Six CD B-NP O
tumours NNS I-NP B-Disease
retained VBD B-VP O
the DT B-NP O
paternal JJ I-NP O
allele NN I-NP O
and CC O O
three CD B-NP O
retained VBD B-VP O
the DT B-NP O
maternal JJ I-NP O
allele NN I-NP O
. . O O

Of IN B-PP O
the DT B-NP O
three CD I-NP O
unilateral JJ I-NP B-Disease
tumours NNS I-NP I-Disease
, , O O
only RB B-NP O
one CD I-NP O
retained VBD B-VP O
the DT B-NP O
paternal JJ I-NP O
RB1 NN I-NP O
allele NN I-NP O
. . O O

Thus RB B-ADVP O
, , O O
there EX B-NP O
is VBZ B-VP O
no DT B-NP O
evidence NN I-NP O
that IN B-SBAR O
the DT B-NP O
paternal JJ I-NP O
RB1 NN I-NP O
allele NN I-NP O
is VBZ B-VP O
preferentially RB I-VP O
retained VBN I-VP O
in IN B-PP O
retinoblastoma NN B-NP B-Disease
, , O O
as IN B-SBAR O
has VBZ B-VP O
been VBN I-VP O
suggested VBN I-VP O
to TO I-VP O
be VB I-VP O
the DT B-NP O
case NN I-NP O
in IN B-PP O
osteosarcoma NN B-NP B-Disease
. . O O

By IN B-PP O
contrast NN B-NP O
, , O O
tumours NNS B-NP B-Disease
from IN B-PP O
four CD B-NP O
of IN B-PP O
the DT B-NP O
five CD I-NP O
bilateral JJ I-NP O
patients NNS I-NP O
retained VBD B-VP O
the DT B-NP O
paternal JJ I-NP O
RB1 NN I-NP O
allele NN I-NP O
. . O O

This DT B-NP O
suggests VBZ B-VP O
either CC O O
that IN B-SBAR O
new JJ B-NP O
germline NN I-NP O
RB1 NN I-NP O
mutations NNS I-NP O
arise VBP B-VP O
more RBR B-ADVP O
frequently RB I-ADVP O
during IN B-PP O
spermatogenesis NN B-NP O
than IN B-PP O
during IN B-PP O
oogenesis NN B-NP O
, , O O
or CC O O
that IN B-SBAR O
imprinting NN B-NP O
in IN B-PP O
the DT B-NP O
early JJ I-NP O
embryo NN I-NP O
affects VBZ B-VP O
chromosomal JJ B-NP O
susceptibility NN I-NP O
to TO B-PP O
mutation NN B-NP O
. . O O

. . O O

Haplotype NN B-NP O
analysis NN I-NP O
of IN B-PP O
the DT B-NP O
phenylalanine NN I-NP O
hydroxylase NN I-NP O
gene NN I-NP O
in IN B-PP O
Turkish JJ B-NP O
phenylketonuria NN I-NP B-Disease
families NNS I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
estimated VBN I-VP O
the DT B-NP O
haplotype NN I-NP O
distribution NN I-NP O
of IN B-PP O
mutant JJ B-NP O
and CC I-NP O
normal JJ I-NP O
phenylalanine NN I-NP O
hydroxylase NN I-NP O
( ( O O
PAH NN B-NP O
) ) O O
alleles NNS B-NP O
for IN B-PP O
17 CD B-NP O
Turkish JJ I-NP O
phenylketonuria NN I-NP B-Disease
( ( O O
PKU NN B-NP B-Disease
) ) O O
families VBZ B-VP O
20 CD B-NP O
normal JJ I-NP O
and CC I-NP O
27 CD I-NP O
mutated VBN I-NP O
PAH NN I-NP O
alleles NNS I-NP O
could MD B-VP O
be VB I-VP O
identified VBN I-VP O
. . O O

Of IN B-PP O
the DT B-NP O
latter JJ I-NP O
, , O O
the DT B-NP O
most RBS I-NP O
prevalent JJ I-NP O
were VBD B-VP O
associated VBN I-VP O
with IN B-PP O
haplotype NN B-NP O
6 CD I-NP O
( ( O O
29 CD B-NP O
. . O O

6 CD B-NP O
% NN I-NP O
) ) O O
, , O O
1 CD B-NP O
( ( O O
18 CD B-NP O
. . O O

5 CD B-NP O
% NN I-NP O
) ) O O
and CC O O
36 CD B-NP O
( ( O O
11 CD B-NP O
. . O O

1 CD B-NP O
% NN I-NP O
) ) O O
, , O O
while IN B-SBAR O
the DT B-NP O
normal JJ I-NP O
alleles NNS I-NP O
were VBD B-VP O
preferentially RB I-VP O
associated VBN I-VP O
with IN B-PP O
haplotype NN B-NP O
1 CD I-NP O
( ( O O
20 CD B-NP O
% NN I-NP O
) ) O O
. . O O

Of IN B-PP O
the DT B-NP O
19 CD I-NP O
different JJ I-NP O
haplotypes NNS I-NP O
observed VBN B-VP O
, , O O
5 CD B-NP O
have VBP B-VP O
not RB I-VP O
been VBN I-VP O
described VBN I-VP O
previously RB B-ADVP O
. . O O

The DT B-NP O
haplotype NN I-NP O
distribution NN I-NP O
differed VBD B-VP O
significantly RB B-ADVP O
from IN B-PP O
that DT B-NP O
of IN B-PP O
the DT B-NP O
Northern JJ I-NP O
European JJ I-NP O
population NN I-NP O
. . O O

Two CD B-NP O
of IN B-PP O
the DT B-NP O
eight CD I-NP O
polymorphic JJ I-NP O
sites NNS I-NP O
were VBD B-VP O
in IN B-PP O
association NN B-NP O
with IN B-PP O
PKU NN B-NP B-Disease
. . O O

No DT B-NP O
deletions NNS I-NP O
of IN B-PP O
exon NN B-NP O
sequences NNS I-NP O
were VBD B-VP O
found VBN I-VP O
in IN B-PP O
the DT B-NP O
families NNS I-NP O
analysed VBN B-VP O
. . O O

Huntington NNP B-NP B-Disease
disease NN I-NP I-Disease
: : O O
no DT B-NP O
evidence NN I-NP O
for IN B-PP O
locus NN B-NP O
heterogeneity NN I-NP O
. . O O

A DT B-NP O
total NN I-NP O
of IN B-PP O
63 CD B-NP O
families NNS I-NP O
with IN B-PP O
Huntington NNP B-NP B-Disease
disease NN I-NP I-Disease
( ( O O
HD NN B-NP B-Disease
) ) O O
were VBD B-VP O
examined VBN I-VP O
for IN B-PP O
linkage NN B-NP O
between IN B-PP O
HD NN B-NP B-Disease
and CC O O
G8 NN B-NP O
( ( O O
D4S10 NN B-NP O
) ) O O
. . O O

The DT B-NP O
families NNS I-NP O
included VBD B-VP O
57 CD B-NP O
Caucasian JJ I-NP O
, , I-NP O
four CD I-NP O
Black NNP I-NP O
American NNP I-NP O
, , O O
and CC O O
two CD B-NP O
Japanese NNPS I-NP O
. . O O

The DT B-NP O
combined JJ I-NP O
maximum JJ I-NP O
lod NN I-NP O
score NN I-NP O
was VBD B-VP O
87 CD B-NP O
. . O O

69 CD B-NP O
at IN B-PP O
theta NN B-NP O
= SYM B-VP O
0 CD B-NP O
. . O O

04 CD B-NP O
( ( O O
99 CD B-NP O
% NN I-NP O
confidence NN I-NP O
interval NN I-NP O
0 CD I-NP O
. . I-NP O

018 CD I-NP O
- : O O
0 CD B-NP O
. . I-NP O

071 CD I-NP O
) ) O O
. . O O

The DT B-NP O
maximum JJ I-NP O
frequency NN I-NP O
of IN B-PP O
recombination NN B-NP O
was VBD B-VP O
0 CD B-NP O
. . O O

03 CD B-NP O
in IN B-PP O
males NNS B-NP O
and CC O O
0 CD B-NP O
. . O O

05 CD B-NP O
in IN B-PP O
females NNS B-NP O
. . O O

Fifty CD B-NP O
- HYPH I-NP O
seven CD I-NP O
families NNS I-NP O
gave VBD B-VP O
positive JJ B-NP O
lod NN I-NP O
scores NNS I-NP O
; : O O
five CD B-NP O
small JJ I-NP O
families NNS I-NP O
gave VBD B-VP O
mildly RB B-NP O
negative JJ I-NP O
lod NN I-NP O
scores NNS I-NP O
. . O O

The DT B-NP O
maximum JJ I-NP O
likelihood NN I-NP O
estimate NN I-NP O
of IN B-PP O
alpha NN B-NP O
, , O O
the DT B-NP O
proportion NN I-NP O
of IN B-PP O
linked VBN B-NP O
loci NNS I-NP O
, , O O
was VBD B-VP O
1 CD B-NP O
. . O O

0 CD B-NP O
with IN B-PP O
a DT B-NP O
lower JJR I-NP O
99 CD I-NP O
% NN I-NP O
confidence NN I-NP O
interval NN I-NP O
of IN B-PP O
0 CD B-NP O
. . O O

88 CD B-NP O
. . O O

These DT B-NP O
data NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
there EX B-NP O
is VBZ B-VP O
only RB B-NP O
one CD I-NP O
HD NN I-NP B-Disease
locus NN I-NP O
, , O O
although IN B-SBAR O
a DT B-NP O
second JJ I-NP O
rare JJ I-NP O
locus NN I-NP O
cannot MD B-VP O
be VB I-VP O
ruled VBN I-VP O
out RP B-PRT O
. . O O

Haplotype NN B-NP O
and CC I-NP O
multipoint JJ I-NP O
linkage NN I-NP O
analysis NN I-NP O
in IN B-PP O
Finnish JJ B-NP O
choroideremia NN I-NP B-Disease
families NNS I-NP O
. . O O

Multipoint JJ B-NP O
linkage NN I-NP O
analysis NN I-NP O
of IN B-PP O
choroideremia NN B-NP B-Disease
( ( O O
TCD NN B-NP B-Disease
) ) O O
and CC O O
seven CD B-NP O
X NN I-NP O
chromosomal JJ I-NP O
restriction NN I-NP O
fragment NN I-NP O
length NN I-NP O
polymorphisms NNS I-NP O
( ( O O
RFLPs NNS B-NP O
) ) O O
was VBD B-VP O
carried VBN I-VP O
out RP B-PRT O
in IN B-PP O
18 CD B-NP O
Finnish JJ I-NP O
TCD NN I-NP B-Disease
families NNS I-NP O
. . O O

The DT B-NP O
data NNS I-NP O
place NN I-NP O
TCD NN I-NP B-Disease
distal JJ B-ADJP O
to TO B-PP O
PGK NN B-NP O
and CC I-NP O
DXS72 NN I-NP O
, , O O
very RB B-ADVP O
close RB I-ADVP O
to TO B-PP O
DXYS1 NN B-NP O
and CC I-NP O
DXYS5 NN I-NP O
( ( O O
Zmax NN B-NP O
= SYM B-VP O
24 CD B-NP O
at IN B-PP O
theta NN B-NP O
= SYM B-VP O
0 CD B-NP O
) ) O O
and CC O O
proximal JJ B-ADJP O
to TO B-PP O
DXYS4 NN B-NP O
and CC I-NP O
DXYS12 NN I-NP O
. . O O

This DT B-NP O
agrees VBZ B-VP O
with IN B-PP O
the DT B-NP O
data NNS I-NP O
obtained VBN B-VP O
from IN B-PP O
other JJ B-NP O
linkage NN I-NP O
studies NNS I-NP O
and CC B-PP O
from IN B-PP O
physical JJ B-NP O
mapping NN I-NP O
. . O O

All PDT B-NP O
the DT I-NP O
TCD NN I-NP B-Disease
males NNS I-NP O
and CC O O
carrier NN B-NP O
females NNS I-NP O
studied VBN B-VP O
have VBP B-VP O
the DT B-NP O
same JJ I-NP O
DXYS1 NN I-NP O
allele NN I-NP O
in IN B-PP O
coupling VBG B-VP O
with IN B-PP O
TCD NN B-NP B-Disease
. . O O

In IN B-PP O
Northeastern NNP B-NP O
Finland NNP I-NP O
, , O O
66 CD B-NP O
/ SYM I-NP O
69 CD I-NP O
chromosomes NNS I-NP O
carrying VBG B-VP O
TCD NN B-NP B-Disease
had VBD B-VP O
the DT B-NP O
same JJ I-NP O
haplotype NN I-NP O
at IN B-PP O
loci NNS B-NP O
DXS72 NN I-NP O
, , O O
DXYS1 NN B-NP O
, , O O
DXYS4 NN B-NP O
, , O O
and CC O O
DXYS12 NN B-NP O
. . O O

The DT B-NP O
same JJ I-NP O
haplotype NN I-NP O
is VBZ B-VP O
seen VBN I-VP O
in IN B-PP O
only RB B-NP O
15 CD I-NP O
/ SYM I-NP O
99 CD I-NP O
chromosomes NNS I-NP O
not RB B-VP O
carrying VBG I-VP O
TCD NN B-NP B-Disease
. . O O

Moreover RB B-ADVP O
, , O O
in IN B-PP O
71 CD B-NP O
/ SYM I-NP O
104 CD I-NP O
non AFX B-NP O
- HYPH I-NP O
TCD NN I-NP O
chromosomes NNS I-NP O
, , O O
the DT B-NP O
haplotype NN I-NP O
at IN B-PP O
six CD B-NP O
marker NN I-NP O
loci NNS I-NP O
is VBZ B-VP O
different JJ B-ADJP O
from IN B-PP O
those DT B-NP O
seen VBN B-VP O
in IN B-PP O
any DT B-NP O
of IN B-PP O
the DT B-NP O
76 CD I-NP O
TCD NN I-NP B-Disease
chromosomes NNS I-NP O
. . O O

This DT B-NP O
supports VBZ B-VP O
the DT B-NP O
previously RB I-NP O
described VBN I-NP O
hypothesis NN I-NP O
that IN B-SBAR O
the DT B-NP O
large JJ I-NP O
Northern JJ I-NP O
Finnish JJ I-NP O
choroideremia NN I-NP B-Disease
pedigrees NNS I-NP O
, , O O
comprising VBG B-VP O
a DT B-NP O
total NN I-NP O
of IN B-PP O
over IN B-NP O
80 CD I-NP O
living NN I-NP O
patients NNS I-NP O
representing VBG B-VP O
more JJR B-NP O
than IN B-PP O
a DT B-NP O
fifth NN I-NP O
of IN B-PP O
all DT B-NP O
TCD NN I-NP B-Disease
patients NNS I-NP O
described VBN B-VP O
worldwide RB B-ADVP O
, , O O
carry VBP B-VP O
the DT B-NP O
same JJ I-NP O
mutation NN I-NP O
. . O O

These DT B-NP O
linkage NN I-NP O
and CC I-NP O
haplotype NN I-NP O
data NNS I-NP O
provide VBP B-VP O
improved JJ B-NP O
opportunities NNS I-NP O
for IN B-PP O
prenatal JJ B-NP O
diagnosis NN I-NP O
based VBN B-VP O
on IN B-PP O
RFLP NN B-NP O
studies NNS I-NP O
. . O O

. . O O

Autosomal JJ B-NP O
dominant JJ I-NP O
aniridia NN I-NP B-Disease
linked VBN B-VP O
to TO B-PP O
the DT B-NP O
chromosome NN I-NP O
11p13 NN I-NP O
markers NNS I-NP O
catalase NN I-NP O
and CC I-NP O
D11S151 NN I-NP O
in IN B-PP O
a DT B-NP O
large JJ I-NP O
Dutch JJ I-NP O
family NN I-NP O
. . O O

In IN B-PP O
a DT B-NP O
large JJ I-NP O
pedigree NN I-NP O
with IN B-PP O
autosomal JJ B-NP O
dominant JJ I-NP O
aniridia NN I-NP B-Disease
, , O O
we PRP B-NP O
found VBD B-VP O
close JJ B-NP O
linkage NN I-NP O
between IN B-PP O
the DT B-NP O
aniridia NN I-NP B-Disease
locus NN I-NP O
AN2 NN I-NP O
and CC O O
the DT B-NP O
markers NNS I-NP O
catalase NN I-NP O
( ( O O
CAT NN B-NP O
) ) O O
( ( O O
zeta NN B-NP O
= SYM B-VP O
7 CD B-NP O
. SYM I-NP O

27 CD I-NP O
at IN B-PP O
theta NN B-NP O
= SYM B-VP O
0 CD B-NP O
. SYM I-NP O

00 CD I-NP O
) ) O O
and CC O O
D11S151 NN B-NP O
( ( O O
zeta NN B-NP O
= SYM B-VP O
3 CD B-NP O
. SYM I-NP O

86 CD I-NP O
at IN B-PP O
theta NN B-NP O
= SYM B-VP O
0 CD B-NP O
. . O O

10 CD B-NP O
) ) O O
flanking VBG B-VP O
the DT B-NP O
AN2 NN I-NP O
locus NN I-NP O
on IN B-PP O
11p13 NN B-NP O
. . O O

Positive JJ B-NP O
lod NN I-NP O
scores NNS I-NP O
were VBD B-VP O
also RB I-VP O
obtained VBN I-VP O
for IN B-PP O
the DT B-NP O
11p13 NN I-NP O
- SYM B-VP O
- SYM B-NP O
- SYM I-NP O
- HYPH I-NP O
11p14 CD I-NP O
markers NNS I-NP O
D11S16 NN I-NP O
and CC I-NP O
FSHB NN I-NP O
with IN B-PP O
the DT B-NP O
linkage NN I-NP O
group NN I-NP O
CAT NN I-NP O
/ SYM B-NP O
AN2 NN I-NP O
/ SYM B-NP O
D11S151 NN I-NP O
. . O O

We PRP B-NP O
conclude VBP B-VP O
that IN B-SBAR O
the DT B-NP O
autosomal JJ I-NP O
dominant JJ I-NP O
aniridia NN I-NP B-Disease
in IN B-PP O
this DT B-NP O
family NN I-NP O
is VBZ B-VP O
due IN B-PP O
to TO B-PP O
a DT B-NP O
mutation NN I-NP O
at IN B-PP O
the DT B-NP O
AN2 NN I-NP O
locus NN I-NP O
on IN B-PP O
11p13 NN B-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
excluded VBN I-VP O
linkage NN B-NP O
( ( O O
zeta NN B-NP O
less JJR B-ADJP O
than IN B-PP O
- SYM B-NP O
2 CD I-NP O
at IN B-PP O
theta NN B-NP O
less JJR B-NP O
than IN I-NP O
0 CD I-NP O
. . I-NP O

18 CD I-NP O
) ) O O
between IN B-PP O
the DT B-NP O
aniridia NN I-NP B-Disease
and CC O O
the DT B-NP O
chromosome NN I-NP O
2p25 CD I-NP O
marker NN I-NP O
D2S1 NN I-NP O
( ( O O
linked VBN B-VP O
to TO B-PP O
ACP1 NN B-NP O
) ) O O
. . O O

Recombination NN B-NP O
events NNS I-NP O
that WDT B-NP O
locate VBP B-VP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
distal JJ B-ADJP O
to TO B-PP O
APOC2 NN B-NP O
on IN B-PP O
19q NN B-NP O
. . O O

We PRP B-NP O
previously RB B-ADVP O
reported VBD B-VP O
a DT B-NP O
recombination NN I-NP O
in IN B-PP O
an DT B-NP O
individual NN I-NP O
with IN B-PP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
( ( O O
DM NN B-NP B-Disease
) ) O O
which WDT B-NP O
placed VBD B-VP O
the DT B-NP O
markers NNS I-NP O
D19S19 NN I-NP O
and CC I-NP O
APOC2 NN I-NP O
on IN B-PP O
the DT B-NP O
same JJ I-NP O
side NN I-NP O
of IN B-PP O
the DT B-NP O
DM NN I-NP B-Disease
locus NN I-NP O
. . O O

Haplotyping NN B-NP O
of IN B-PP O
this DT B-NP O
family NN I-NP O
with IN B-PP O
more RBR B-ADVP O
recently RB I-ADVP O
characterized VBN B-NP O
probes NNS I-NP O
which WDT B-NP O
are VBP B-VP O
either RB B-VP O
tightly RB I-VP O
linked VBN I-VP O
to TO B-PP O
DM NN B-NP B-Disease
or CC O O
distal JJ B-ADJP O
to TO B-PP O
the DT B-NP O
linkage NN I-NP O
group NN I-NP O
at IN B-PP O
q13 NN B-NP O
. . O O

2 CD B-NP O
shows VBZ B-VP O
that IN B-SBAR O
the DT B-NP O
DM NN I-NP B-Disease
locus NN I-NP O
is VBZ B-VP O
distal JJ B-ADJP O
to TO B-PP O
APOC2 NN B-NP O
. . O O

This DT B-NP O
is VBZ B-VP O
confirmed VBN I-VP O
by IN B-PP O
other JJ B-NP O
recombinants NNS I-NP O
where WRB B-ADVP O
DM NN B-NP B-Disease
segregates VBZ B-VP O
with IN B-PP O
distal JJ B-NP O
probes NNS I-NP O
. . O O

Additional JJ B-NP O
marker NN I-NP O
to TO B-PP O
marker NN B-NP O
recombinations NNS I-NP O
in IN B-PP O
unaffected JJ B-NP O
individuals NNS I-NP O
are VBP B-VP O
reported VBN I-VP O
and CC O O
support VBP B-VP O
the DT B-NP O
order NN I-NP O
and CC I-NP O
orientation NN I-NP O
of IN B-PP O
the DT B-NP O
DM NN I-NP B-Disease
linkage NN I-NP O
group NN I-NP O
as IN B-PP O
pter NN B-NP O
- HYPH O O
( ( O O
INSR NN B-NP O
, , O O
LDLR NN B-NP O
, , O O
S9 NN B-NP O
) ) O O
- HYPH O O
( ( O O
S19 NN B-NP O
, , O O
BCL3 NN B-NP O
, , O O
APOC2 NN B-NP O
) ) O O
- HYPH O O
( ( O O
CKMM NN B-NP O
, , O O
DM NN B-NP O
) ) O O
- HYPH O O
( ( O O
S22 NN B-NP O
, , O O
+ SYM B-NP O
+ SYM B-VP O
+ SYM B-NP O
PRKCG NN I-NP O
) ) O O
- HYPH B-NP O
qter NN I-NP O
. . O O

The DT B-NP O
data NNS I-NP O
presented VBN B-VP O
here RB B-ADVP O
cannot MD B-VP O
determine VB I-VP O
whether IN B-SBAR O
DM NN B-NP B-Disease
is VBZ B-VP O
proximal JJ B-ADJP O
or CC I-ADJP O
distal JJ I-ADJP O
to TO B-PP O
CKMM NN B-NP O
. . O O

The DT B-NP O
consequences NNS I-NP O
of IN B-PP O
this DT B-NP O
probe NN I-NP O
order NN I-NP O
for IN B-PP O
antenatal JJ B-NP O
diagnosis NN I-NP O
and CC O O
future JJ B-NP O
research NN I-NP O
aiming VBG B-VP O
to TO I-VP O
isolate VB I-VP O
the DT B-NP O
gene NN I-NP O
which WDT B-NP O
is VBZ B-VP O
affected VBN I-VP O
in IN B-PP O
DM NN B-NP B-Disease
are VBP B-VP O
discussed VBN I-VP O
. . O O

Mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
RB1 NN I-NP O
gene NN I-NP O
and CC O O
their PRP$ B-NP O
effects NNS I-NP O
on IN B-PP O
transcription NN B-NP O
. . O O

Inactivation NN B-NP O
of IN B-PP O
both DT B-NP O
alleles NNS I-NP O
of IN B-PP O
the DT B-NP O
RB1 NN I-NP O
gene NN I-NP O
during IN B-PP O
normal JJ B-NP O
retinal JJ I-NP O
development NN I-NP O
initiates VBZ B-VP O
the DT B-NP O
formation NN I-NP O
of IN B-PP O
a DT B-NP O
retinoblastoma NN I-NP B-Disease
( ( O I-Disease
RB NN B-NP I-Disease
) ) O I-Disease
tumor NN B-NP I-Disease
. . O O

To TO B-VP O
identify VB I-VP O
the DT B-NP O
mutations NNS I-NP O
which WDT B-NP O
inactivate VBP B-VP O
RB1 NN B-NP O
, , O O
21 CD B-NP O
RB NN I-NP B-Disease
tumors NNS I-NP I-Disease
isolated VBN B-VP O
from IN B-PP O
19 CD B-NP O
patients NNS I-NP O
were VBD B-VP O
analyzed VBN I-VP O
with IN B-PP O
the DT B-NP O
polymerase NN I-NP O
chain NN I-NP O
reaction NN I-NP O
or CC O O
an DT B-NP O
RNase NN I-NP O
protection NN I-NP O
assay NN I-NP O
or CC O O
both DT B-NP O
. . O O

Mutations NNS B-NP O
were VBD B-VP O
identified VBN I-VP O
in IN B-PP O
13 CD B-NP O
of IN B-PP O
21 CD B-NP O
RB NN I-NP B-Disease
tumors NNS I-NP I-Disease
; : O O
in IN B-PP O
8 CD B-NP O
tumors NNS I-NP B-Disease
, , O O
the DT B-NP O
precise JJ I-NP O
errors NNS I-NP O
in IN B-PP O
nucleotide NN B-NP O
sequence NN I-NP O
were VBD B-VP O
characterized VBN I-VP O
. . O O

Each DT B-NP O
of IN B-PP O
four CD B-NP O
germ NN I-NP O
line NN I-NP O
mutations NNS I-NP O
involved VBD B-VP O
a DT B-NP O
small JJ I-NP O
deletion NN I-NP O
or CC I-NP O
duplication NN I-NP O
, , O O
while IN B-SBAR O
three CD B-NP O
somatic JJ I-NP O
mutations NNS I-NP O
were VBD B-VP O
point NN B-NP O
mutations NNS I-NP O
leading VBG B-VP O
to TO B-PP O
splice NN B-NP O
alterations NNS I-NP O
and CC O O
loss NN B-NP O
of IN B-PP O
an DT B-NP O
exon NN I-NP O
from IN B-PP O
the DT B-NP O
mature JJ I-NP O
RB1 NN I-NP O
mRNA NN I-NP O
. . O O

We PRP B-NP O
were VBD B-VP O
unable JJ B-ADJP O
to TO B-VP O
detect VB I-VP O
expression NN B-NP O
of IN B-PP O
the DT B-NP O
mutant JJ I-NP O
allele NN I-NP O
in IN B-PP O
lymphoblasts NNS B-NP O
of IN B-PP O
three CD B-NP O
bilaterally RB I-NP O
affected VBN I-NP O
patients NNS I-NP O
, , O O
although IN B-SBAR O
the DT B-NP O
mutation NN I-NP O
was VBD B-VP O
present JJ B-ADJP O
in IN B-PP O
the DT B-NP O
genomic JJ I-NP O
DNA NN I-NP O
and CC O O
transcripts NNS B-NP O
containing VBG B-VP O
the DT B-NP O
mutations NNS I-NP O
were VBD B-VP O
obvious JJ B-ADJP O
in IN B-PP O
the DT B-NP O
RB NN I-NP B-Disease
tumors NNS I-NP I-Disease
in IN B-PP O
the DT B-NP O
absence NN I-NP O
of IN B-PP O
a DT B-NP O
normal JJ I-NP O
RB1 NN I-NP O
allele NN I-NP O
. . O O

The DT B-NP O
variations NNS I-NP O
in IN B-PP O
the DT B-NP O
level NN I-NP O
of IN B-PP O
expression NN B-NP O
of IN B-PP O
mutant JJ B-NP O
transcripts NNS I-NP O
suggest VBP B-VP O
deregulation NN B-NP O
of IN B-PP O
RB1 NN B-NP O
transcription NN I-NP O
in IN B-PP O
the DT B-NP O
absence NN I-NP O
of IN B-PP O
a DT B-NP O
functional JJ I-NP O
RB1 NN I-NP O
gene NN I-NP O
product NN I-NP O
. . O O

. . O O

Partial JJ B-NP O
deletion NN I-NP O
8q NN I-NP O
without IN B-PP O
Langer NNP B-NP B-Disease
- HYPH I-NP I-Disease
Giedion NNP I-NP I-Disease
syndrome NN I-NP I-Disease
: : O O
a DT B-NP O
recognisable JJ I-NP O
syndrome NN I-NP O
. . O O

We PRP B-NP O
report VBP B-VP O
two CD B-NP O
de FW I-NP O
novo FW I-NP O
cases NNS I-NP O
of IN B-PP O
del NN B-NP O
( ( O O
8 CD B-NP O
) ) O O
( ( O O
pter NN B-NP O
- SYM O O
- SYM B-NP O
- SYM I-NP O
- HYPH I-NP O
q24 NN I-NP O
. . I-NP O

1 CD I-NP O
) ) O O
with IN B-PP O
breakpoints NNS B-NP O
involving VBG B-VP O
the DT B-NP O
distal JJ I-NP O
part NN I-NP O
of IN B-PP O
band NN B-NP O
8q24 CD I-NP O
. . O O

1 CD B-NP O
1 CD I-NP O
. . O O

The DT B-NP O
clinical JJ I-NP O
features NNS I-NP O
were VBD B-VP O
similar JJ B-ADJP O
and CC O O
there EX B-NP O
were VBD B-VP O
no DT B-NP O
obvious JJ I-NP O
stigmata NN I-NP O
of IN B-PP O
Langer NNP B-NP B-Disease
- HYPH I-NP I-Disease
Giedion NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
LGS NN B-NP B-Disease
) ) O O
. . O O

There EX B-NP O
are VBP B-VP O
three CD B-NP O
other JJ I-NP O
cases NNS I-NP O
reported VBN B-VP O
with IN B-PP O
a DT B-NP O
deletion NN I-NP O
of IN B-PP O
chromosome NN B-NP O
8 CD I-NP O
at IN B-PP O
approximately RB B-NP O
the DT I-NP O
same JJ I-NP O
breakpoint NN I-NP O
, , O O
one CD B-NP O
without IN B-PP O
LGS NN B-NP B-Disease
and CC O O
some DT B-NP O
similarities NNS I-NP O
to TO B-PP O
our PRP$ B-NP O
cases NNS I-NP O
, , O O
the DT B-NP O
other JJ I-NP O
two CD I-NP O
with IN B-PP O
LGS NN B-NP B-Disease
. . O O

Our PRP$ B-NP O
findings NNS I-NP O
would MD B-VP O
support VB I-VP O
the DT B-NP O
observation NN I-NP O
that IN B-SBAR O
the DT B-NP O
critical JJ I-NP O
segment NN I-NP O
for IN B-PP O
the DT B-NP O
assignment NN I-NP O
of IN B-PP O
LGS NN B-NP B-Disease
is VBZ B-VP O
proximal JJ B-ADJP O
to TO B-PP O
or CC O O
involves VBZ B-VP O
the DT B-NP O
proximal JJ I-NP O
part NN I-NP O
of IN B-PP O
8q24 CD B-NP O
. . O O

1 CD B-NP O
, , O O
but CC O O
a DT B-NP O
review NN I-NP O
of IN B-PP O
published VBN B-NP O
reports NNS I-NP O
suggests VBZ B-VP O
that IN B-SBAR O
the DT B-NP O
aetiology NN I-NP O
of IN B-PP O
LGS NN B-NP B-Disease
may MD B-VP O
be VB I-VP O
a DT B-NP O
more RBR I-NP O
complex JJ I-NP O
issue NN I-NP O
Myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
is VBZ B-VP O
closely RB I-VP O
linked VBN I-VP O
to TO B-PP O
the DT B-NP O
gene NN I-NP O
for IN B-PP O
muscle NN B-NP O
- HYPH I-NP O
type NN I-NP O
creatine NN I-NP O
kinase NN I-NP O
( ( O O
CKMM NN B-NP O
) ) O O
. . O O

We PRP B-NP O
have VBP B-VP O
studied VBN I-VP O
genetic JJ B-NP O
linkage NN I-NP O
between IN B-PP O
the DT B-NP O
gene NN I-NP O
for IN B-PP O
creatine NN B-NP O
kinase NN I-NP O
muscle NN I-NP O
type NN I-NP O
( ( O O
CKMM NN B-NP O
) ) O O
and CC O O
the DT B-NP O
gene NN I-NP O
for IN B-PP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
( ( O O
DM NN B-NP B-Disease
) ) O O
. . O O

In IN B-PP O
a DT B-NP O
panel NN I-NP O
of IN B-PP O
65 CD B-NP O
myotonic JJ I-NP B-Disease
dystrophy NN I-NP I-Disease
families NNS I-NP O
from IN B-PP O
Canada NNP B-NP O
and CC O O
the DT B-NP O
Netherlands NNP I-NP O
, , O O
a DT B-NP O
maximum NN I-NP O
lod NN I-NP O
score NN I-NP O
( ( O O
Zmax NN B-NP O
) ) O O
of IN B-PP O
22 CD B-NP O
. . O O

8 CD B-NP O
at IN B-PP O
a DT B-NP O
recombination NN I-NP O
frequency NN I-NP O
( ( O O
theta NN B-NP O
) ) O O
of IN B-PP O
0 CD B-NP O
. . O O

03 CD B-NP O
was VBD B-VP O
obtained VBN I-VP O
. . O O

Tight NN B-NP O
linkage NN I-NP O
was VBD B-VP O
also RB I-VP O
demonstrated VBN I-VP O
for IN B-PP O
CKMM NN B-NP O
and CC O O
the DT B-NP O
gene NN I-NP O
for IN B-PP O
apolipoprotein NN B-NP O
C2 NN I-NP O
( ( O O
ApoC2 NN B-NP O
) ) O O
. . O O

This DT B-NP O
establishes VBZ B-VP O
CKMM NN B-NP O
as IN B-PP O
a DT B-NP O
useful JJ I-NP O
marker NN I-NP O
for IN B-PP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
Color NN B-NP B-Disease
vision NN I-NP I-Disease
defects NNS I-NP I-Disease
in IN B-PP O
adrenomyeloneuropathy NN B-NP B-Disease
. . O O

The DT B-NP O
relationship NN I-NP O
between IN B-PP O
abnormal JJ B-NP B-Disease
color NN I-NP I-Disease
vision NN I-NP I-Disease
and CC O O
adrenomyeloneuropathy NN B-NP B-Disease
( ( O O
AMN NN B-NP B-Disease
) ) O O
was VBD B-VP O
investigated VBN I-VP O
in IN B-PP O
27 CD B-NP O
AMN NN I-NP B-Disease
patients NNS I-NP O
and CC O O
31 CD B-NP O
age NN I-NP O
- HYPH B-NP O
matched VBN I-NP O
controls NNS I-NP O
by IN B-PP O
using VBG B-VP O
the DT B-NP O
Farnsworth NNP I-NP O
- HYPH I-NP O
Munsell NNP I-NP O
100 CD I-NP O
Hue NNP I-NP O
test NN I-NP O
. . O O

Twelve CD B-NP O
( ( O O
44 CD B-NP O
% NN I-NP O
) ) O O
of IN B-PP O
27 CD B-NP O
patients NNS I-NP O
showed VBD B-VP O
test NN B-NP O
scores NNS I-NP O
significantly RB B-ADVP O
above IN B-PP O
normal JJ B-ADJP O
. . O O

The DT B-NP O
axes NNS I-NP O
of IN B-PP O
bipolarity NN B-NP O
determined VBN B-VP O
by IN B-PP O
the DT B-NP O
testing NN I-NP O
differed VBD B-VP O
widely RB B-ADVP O
between IN B-PP O
the DT B-NP O
patients NNS I-NP O
with IN B-PP O
abnormal JJ B-NP O
scores NNS I-NP O
, , O O
compatible JJ B-ADJP O
with IN B-PP O
the DT B-NP O
notion NN I-NP O
that IN B-SBAR O
different JJ B-NP O
alterations NNS I-NP O
in IN B-PP O
visual JJ B-NP O
pigment NN I-NP O
genes NNS I-NP O
occur VBP B-VP O
in IN B-PP O
different JJ B-NP O
AMN NN I-NP B-Disease
kindreds NNS I-NP O
. . O O

These DT B-NP O
observations NNS I-NP O
confirm VBP B-VP O
our PRP$ B-NP O
earlier JJR I-NP O
impression NN I-NP O
that IN B-SBAR O
the DT B-NP O
frequency NN I-NP O
of IN B-PP O
abnormal JJ B-NP B-Disease
color NN I-NP I-Disease
vision NN I-NP I-Disease
is VBZ B-VP O
increased VBN I-VP O
in IN B-PP O
these DT B-NP O
kindreds NNS I-NP O
, , O O
and CC O O
it PRP B-NP O
supports VBZ B-VP O
our PRP$ B-NP O
contentions NNS I-NP O
that WDT B-NP O
( ( B-LST O
1 LS I-LST O
) ) O O
AMN NN B-NP B-Disease
( ( O O
and CC O O
its PRP$ B-NP O
companion NN I-NP O
, , I-NP O
adrenoleukodystrophy NN I-NP B-Disease
) ) O O
are VBP B-VP O
very RB I-VP O
closely RB I-VP O
linked VBN I-VP O
to TO B-PP O
the DT B-NP O
visual JJ I-NP O
pigment NN I-NP O
loci NNS I-NP O
at IN B-PP O
Xq28 NN B-NP O
and CC O O
( ( B-LST O
2 LS I-LST O
) ) O O
this DT B-NP O
proximity NN I-NP O
might MD B-VP O
provide VB I-VP O
the DT B-NP O
opportunity NN I-NP O
to TO B-VP O
observe VB I-VP O
contiguous JJ B-NP B-Disease
gene NN I-NP I-Disease
defects NNS I-NP I-Disease
. . O O

. . O O

Molecular JJ B-NP O
analysis NN I-NP O
of IN B-PP O
a DT B-NP O
female JJ I-NP O
Lesch NNP I-NP B-Disease
- HYPH I-NP I-Disease
Nyhan NNP I-NP I-Disease
patient NN I-NP O
. . O O

We PRP B-NP O
report VBP B-VP O
the DT B-NP O
identification NN I-NP O
of IN B-PP O
a DT B-NP O
female JJ I-NP O
patient NN I-NP O
with IN B-PP O
the DT B-NP O
X NN I-NP O
- HYPH O O
linked VBN B-VP O
recessive JJ B-NP O
Lesch NNP I-NP B-Disease
- HYPH I-NP I-Disease
Nyhan NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
hypoxanthine NN B-NP B-Disease
phosphoribosyltransferase NN I-NP I-Disease
[ ( O I-Disease
HPRT NN B-NP I-Disease
] ) O I-Disease
deficiency NN B-NP I-Disease
) ) O O
. . O O

Cytogenetic JJ B-NP O
and CC I-NP O
carrier NN I-NP O
studies NNS I-NP O
revealed VBD B-VP O
structurally RB B-NP O
normal JJ I-NP O
chromosomes NNS I-NP O
for IN B-PP O
this DT B-NP O
patient NN I-NP O
and CC O O
her PRP$ B-NP O
parents NNS I-NP O
and CC O O
demonstrated VBD B-VP O
that IN B-SBAR O
this DT B-NP O
mutation NN I-NP O
arose VBD B-VP O
through IN B-PP O
a DT B-NP O
de FW I-NP O
novo FW I-NP O
gametic JJ I-NP O
event NN I-NP O
. . O O

Comparison NN B-NP O
of IN B-PP O
this DT B-NP O
patients NNS I-NP O
DNA NN I-NP O
with IN B-PP O
the DT B-NP O
DNA NN I-NP O
of IN B-PP O
her PRP$ B-NP O
parents NNS I-NP O
revealed VBD B-VP O
that IN B-SBAR O
a DT B-NP O
microdeletion NN I-NP O
, , O O
which WDT B-NP O
occurred VBD B-VP O
within IN B-PP O
a DT B-NP O
maternal JJ I-NP O
gamete NN I-NP O
and CC O O
involved VBD B-VP O
the DT B-NP O
entire JJ I-NP O
HPRT NN I-NP O
gene NN I-NP O
, , O O
was VBD B-VP O
partially RB B-ADJP O
responsible JJ I-ADJP O
for IN B-PP O
the DT B-NP O
disease NN I-NP O
in IN B-PP O
this DT B-NP O
patient NN I-NP O
. . O O

Somatic JJ B-NP O
cell NN I-NP O
hybrids NNS I-NP O
, , O O
generated VBN B-VP O
to TO I-VP O
separate VB I-VP O
maternal JJ B-NP O
and CC I-NP O
paternal JJ I-NP O
X NN I-NP O
chromosomes NNS I-NP O
, , O O
showed VBD B-VP O
that IN B-SBAR O
expression NN B-NP O
of IN B-PP O
two CD B-NP O
additional JJ I-NP O
X NN I-NP O
- HYPH B-NP O
linked VBN I-NP O
enzymes NNS I-NP O
, , O O
phosphoglycerate JJ B-NP O
kinase NN I-NP O
and CC I-NP O
glucose NN I-NP O
- HYPH B-NP O
6 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
dehydrogenase NN I-NP O
, , O O
were VBD B-VP O
expressed VBN I-VP O
only RB B-ADVP O
in IN B-PP O
cells NNS B-NP O
that WDT B-NP O
contained VBD B-VP O
the DT B-NP O
maternal JJ I-NP O
X NN I-NP O
chromosome NN I-NP O
, , O O
suggesting VBG B-VP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
a DT B-NP O
functionally RB I-NP O
inactive JJ I-NP O
paternal JJ I-NP O
X NN I-NP O
chromosome NN I-NP O
. . O O

Furthermore RB B-ADVP O
, , O O
comparison NN B-NP O
of IN B-PP O
methylation NN B-NP O
patterns NNS I-NP O
within IN B-PP O
a DT B-NP O
region NN I-NP O
of IN B-PP O
the DT B-NP O
HPRT NN I-NP O
gene NN I-NP O
known VBN B-VP O
to TO I-VP O
be VB I-VP O
important JJ B-ADJP O
in IN B-PP O
gene NN B-NP O
regulation NN I-NP O
revealed VBD B-VP O
differences NNS B-NP O
between IN B-PP O
DNA NN B-NP O
from IN B-PP O
the DT B-NP O
father NN I-NP O
and CC O O
the DT B-NP O
patient NN I-NP O
, , O O
in IN B-PP O
keeping VBG B-NP O
with IN B-PP O
an DT B-NP O
active JJ I-NP O
HPRT NN I-NP O
locus NN I-NP O
in IN B-PP O
the DT B-NP O
father NN I-NP O
and CC O O
an DT B-NP O
inactive JJ I-NP O
HPRT NN I-NP O
locus NN I-NP O
in IN B-PP O
the DT B-NP O
patient NN I-NP O
. . O O

Together RB B-ADVP O
these DT B-NP O
data NNS I-NP O
indicate VBP B-VP O
that IN B-SBAR O
nonrandom JJ B-NP O
inactivation NN I-NP O
of IN B-PP O
the DT B-NP O
cytogenetically RB I-NP O
normal JJ I-NP O
paternal JJ I-NP O
X NN I-NP O
chromosome NN I-NP O
and CC O O
a DT B-NP O
microdeletion NN I-NP O
of IN B-PP O
the DT B-NP O
HPRT NN I-NP O
gene NN I-NP O
on IN B-PP O
an DT B-NP O
active JJ I-NP O
maternal JJ I-NP O
X NN I-NP O
chromosome NN I-NP O
were VBD B-VP O
responsible JJ B-ADJP O
for IN B-PP O
the DT B-NP O
absence NN I-NP O
of IN B-PP O
HPRT NN B-NP O
in IN B-PP O
this DT B-NP O
patient NN I-NP O
. . O O

. . O O

Pelizaeus NNP B-NP B-Disease
- HYPH I-NP I-Disease
Merzbacher NNP I-NP I-Disease
disease NN I-NP I-Disease
: : O O
an DT B-NP O
X NN I-NP B-Disease
- HYPH O I-Disease
linked VBN B-VP I-Disease
neurologic JJ B-NP I-Disease
disorder NN I-NP I-Disease
of IN B-PP I-Disease
myelin NN B-NP I-Disease
metabolism NN I-NP I-Disease
with IN B-PP O
a DT B-NP O
novel JJ I-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
gene NN I-NP O
encoding VBG B-VP O
proteolipid NN B-NP O
protein NN I-NP O
. . O O

The DT B-NP O
nosology NN I-NP O
of IN B-PP O
the DT B-NP O
inborn JJ I-NP B-Disease
errors NNS I-NP I-Disease
of IN B-PP I-Disease
myelin NN B-NP I-Disease
metabolism NN I-NP I-Disease
has VBZ B-VP O
been VBN I-VP O
stymied VBN I-VP O
by IN B-PP O
the DT B-NP O
lack NN I-NP O
of IN B-PP O
molecular JJ B-NP O
genetic JJ I-NP O
analysis NN I-NP O
. . O O

Historically RB B-ADVP O
, , O O
Pelizaeus NNP B-NP B-Disease
- HYPH B-NP I-Disease
Merzbacher NNP I-NP I-Disease
disease NN I-NP I-Disease
has VBZ B-VP O
encompassed VBN I-VP O
a DT B-NP O
host NN I-NP O
of IN B-PP O
neurologic JJ B-NP B-Disease
disorders NNS I-NP I-Disease
that WDT B-NP O
present VBP B-VP O
with IN B-PP O
a DT B-NP O
deficit NN I-NP B-Disease
of IN B-PP I-Disease
myelin NN B-NP I-Disease
, , O O
the DT B-NP O
membrane NN I-NP O
elaborated VBN B-VP O
by IN B-PP O
glial JJ B-NP O
cells NNS I-NP O
that WDT B-NP O
encircles VBZ B-VP O
and CC O O
successively RB B-VP O
enwraps VBZ I-VP O
axons NNS B-NP O
. . O O

We PRP B-NP O
describe VBP B-VP O
here RB B-ADVP O
a DT B-NP O
Pelizaeus NNP I-NP B-Disease
- HYPH I-NP I-Disease
Merzbacher NNP I-NP I-Disease
pedigree NN I-NP O
of IN B-PP O
the DT B-NP O
classical JJ I-NP O
type NN I-NP O
, , O O
with IN B-PP O
X NN B-NP O
- HYPH B-NP O
linked VBN I-NP O
inheritance NN I-NP O
, , O O
a DT B-NP O
typical JJ I-NP O
clinical JJ I-NP O
progression NN I-NP O
, , O O
and CC O O
a DT B-NP O
pathologic JJ I-NP O
loss NN I-NP O
of IN B-PP O
myelinating JJ B-NP O
cells NNS I-NP O
and CC O O
myelin NN B-NP O
in IN B-PP O
the DT B-NP O
central JJ I-NP O
nervous JJ I-NP O
system NN I-NP O
. . O O

To TO B-VP O
discriminate VB I-VP O
variants NNS B-NP O
of IN B-PP O
Pelizaeus NNP B-NP B-Disease
- HYPH I-NP I-Disease
Merzbacher NNP I-NP I-Disease
disease NN I-NP I-Disease
, , O O
a DT B-NP O
set NN I-NP O
of IN B-PP O
oligonucleotide NN B-NP O
primers NNS I-NP O
was VBD B-VP O
constructed VBN I-VP O
to TO B-PP O
polymerase NN B-NP O
- HYPH B-NP O
chain NN I-NP O
- HYPH O O
reaction NN B-NP O
( ( O O
PCR NN B-NP O
) ) O O
amplify VB B-VP O
and CC I-VP O
sequence VB I-VP O
the DT B-NP O
gene NN I-NP O
encoding VBG B-VP O
proteolipid NN B-NP O
protein NN I-NP O
( ( O O
PLP NN B-NP O
) ) O O
, , O O
a DT B-NP O
structural JJ I-NP O
protein NN I-NP O
that WDT B-NP O
comprises VBZ B-VP O
half NN B-NP O
of IN B-PP O
the DT B-NP O
protein NN I-NP O
of IN B-PP O
the DT B-NP O
myelin NN I-NP O
sheath NN I-NP O
. . O O

The DT B-NP O
PLP NN I-NP O
gene NN I-NP O
in IN B-PP O
one CD B-NP O
of IN B-PP O
two CD B-NP O
affected VBN I-NP O
males NNS I-NP O
and CC O O
the DT B-NP O
carrier NN I-NP O
mother NN I-NP O
of IN B-PP O
this DT B-NP O
family NN I-NP O
exhibited VBD B-VP O
a DT B-NP O
single JJ I-NP O
base NN I-NP O
difference NN I-NP O
in IN B-PP O
the DT B-NP O
more JJR I-NP O
than IN I-NP O
2 CD I-NP O
kb NN I-NP O
of IN B-PP O
the DT B-NP O
PLP NN I-NP O
gene NN I-NP O
sequenced VBN B-VP O
, , O O
a DT B-NP O
C NN I-NP O
- SYM B-NP O
- SYM B-NP O
- SYM I-NP O
- HYPH I-NP O
T NN I-NP O
transition NN I-NP O
that WDT B-NP O
would MD B-VP O
create VB I-VP O
a DT B-NP O
serine NN I-NP O
substitution NN I-NP O
for IN B-PP O
proline NN B-NP O
at IN B-PP O
the DT B-NP O
carboxy NN I-NP O
end NN I-NP O
of IN B-PP O
the DT B-NP O
protein NN I-NP O
. . O O

Our PRP$ B-NP O
results NNS I-NP O
delineate VBP B-VP O
the DT B-NP O
clinical JJ I-NP O
features NNS I-NP O
of IN B-PP O
Pelizaeus NNP B-NP B-Disease
- HYPH I-NP I-Disease
Merzbacher NNP I-NP I-Disease
disease NN I-NP I-Disease
, , O O
define VBP B-VP O
the DT B-NP O
possible JJ I-NP O
molecular JJ I-NP O
pathology NN I-NP O
of IN B-PP O
this DT B-NP O
dysmyelinating VBG I-NP B-Disease
disorder NN I-NP I-Disease
, , O O
and CC O O
address VBP B-VP O
the DT B-NP O
molecular JJ I-NP O
classification NN I-NP O
of IN B-PP O
inborn JJ B-NP B-Disease
errors NNS I-NP I-Disease
of IN B-PP I-Disease
myelin NN B-NP I-Disease
metabolism NN I-NP I-Disease
. . O O

Patients NNS B-NP O
with IN B-PP O
the DT B-NP O
classical JJ I-NP O
form NN I-NP O
( ( O O
type NN B-NP O
I CD I-NP O
) ) O O
and CC O O
the DT O O
more RBR B-ADVP O
severely RB B-VP O
affected VBN I-VP O
, , O O
connatal JJ B-NP O
variant NN I-NP O
of IN B-PP O
Pelizaeus NNP B-NP B-Disease
- HYPH I-NP I-Disease
Merzbacher NNP I-NP I-Disease
disease NN I-NP I-Disease
( ( O I-Disease
type NN B-NP I-Disease
II CD I-NP I-Disease
) ) O I-Disease
would MD B-VP O
be VB I-VP O
predicted VBN I-VP O
to TO I-VP O
display VB I-VP O
mutation NN B-NP O
at IN B-PP O
the DT B-NP O
PLP NN I-NP O
locus NN I-NP O
. . O O

The DT B-NP O
other JJ I-NP O
variants NNS I-NP O
( ( O O
types NNS B-NP O
III CD B-NP O
- HYPH I-NP O
VI NN I-NP O
) ) O O
, , O O
which WDT B-NP O
have VBP B-VP O
sometimes RB I-VP O
been VBN I-VP O
categorized VBN I-VP O
as IN B-PP O
Pelizaeus NNP B-NP B-Disease
- HYPH I-NP I-Disease
Merzbacher NNP I-NP I-Disease
disease NN I-NP I-Disease
, , O O
may MD B-VP O
represent VB I-VP O
mutations NNS B-NP O
in IN B-PP O
genes NNS B-NP O
encoding VBG B-VP O
other JJ B-NP O
structural JJ I-NP O
myelin NN I-NP O
proteins NNS I-NP O
or CC I-NP O
proteins NNS I-NP O
critical JJ B-ADJP O
to TO B-PP O
myelination NN B-NP O
. . O O

. . O O

Molecular JJ B-NP O
basis NN I-NP O
of IN B-PP O
human JJ B-NP O
von NN I-NP B-Disease
Willebrand NN I-NP I-Disease
disease NN I-NP I-Disease
: : O O
analysis NN B-NP O
of IN B-PP O
platelet NN B-NP O
von NN I-NP B-Disease
Willebrand NN I-NP I-Disease
factor NN I-NP O
mRNA NN I-NP O
. . O O

von NN B-NP B-Disease
Willebrand NN I-NP I-Disease
disease NN I-NP I-Disease
( ( O O
vWD NN B-NP B-Disease
) ) O O
, , O O
the DT B-NP O
most RBS I-NP O
common JJ I-NP O
inherited VBN I-NP B-Disease
bleeding VBG I-NP I-Disease
disorder NN I-NP I-Disease
in IN B-PP O
humans NNS B-NP O
, , O O
can MD B-VP O
result VB I-VP O
from IN B-PP O
either CC O O
a DT B-NP O
quantitative JJ I-NP O
or CC O O
a DT B-NP O
qualitative JJ I-NP O
defect NN I-NP O
in IN B-PP O
the DT B-NP O
adhesive JJ I-NP O
glycoprotein NN I-NP O
, , O O
von NN B-NP B-Disease
Willebrand NN I-NP I-Disease
factor NN I-NP O
( ( O O
vWF NN B-NP O
) ) O O
. . O O

Molecular JJ B-NP O
studies NNS I-NP O
of IN B-PP O
vWD NN B-NP B-Disease
have VBP B-VP O
been VBN I-VP O
limited VBN I-VP O
by IN B-PP O
the DT B-NP O
large JJ I-NP O
size NN I-NP O
of IN B-PP O
the DT B-NP O
vWF NN I-NP O
gene NN I-NP O
and CC I-NP O
difficulty NN I-NP O
in IN B-PP O
obtaining VBG B-VP O
the DT B-NP O
vWF NN I-NP O
mRNA NN I-NP O
from IN B-PP O
patients NNS B-NP O
. . O O

By IN B-PP O
use NN B-NP O
of IN B-PP O
an DT B-NP O
adaptation NN I-NP O
of IN B-PP O
the DT B-NP O
polymerase NN I-NP O
chain NN I-NP O
reaction NN I-NP O
, , O O
vWF NN B-NP O
mRNA NN I-NP O
was VBD B-VP O
amplified VBN I-VP O
and CC O O
sequenced VBN B-VP O
from IN B-PP O
peripheral JJ B-NP O
blood NN I-NP O
platelets NNS I-NP O
. . O O

A DT B-NP O
silent JJ I-NP O
vWF NN I-NP O
allele NN I-NP O
was VBD B-VP O
identified VBN I-VP O
, , O O
resulting VBG B-VP O
from IN B-PP O
a DT B-NP O
cis JJ I-NP O
defect NN I-NP O
in IN B-PP O
vWF NN B-NP O
mRNA NN I-NP O
transcription NN I-NP O
or CC I-NP O
processing NN I-NP O
. . O O

In IN B-PP O
two CD B-NP O
type NN I-NP B-Disease
IIA NN I-NP I-Disease
vWD NN I-NP I-Disease
patients NNS I-NP O
, , O O
two CD B-NP O
different JJ I-NP O
but CC I-NP O
adjacent JJ I-NP O
missense JJ I-NP O
mutations NNS I-NP O
were VBD B-VP O
identified VBN I-VP O
, , O O
the DT B-NP O
locations NNS I-NP O
of IN B-PP O
which WDT B-NP O
may MD B-VP O
identify VB I-VP O
an DT B-NP O
important JJ I-NP O
vWF NN I-NP O
functional JJ I-NP O
domain NN I-NP O
. . O O

Expression NN B-NP O
in IN B-PP O
heterologous JJ B-NP O
cells NNS I-NP O
of IN B-PP O
recombinant JJ B-NP O
vWF NN I-NP O
containing VBG B-VP O
one CD B-NP O
of IN B-PP O
these DT B-NP O
latter JJ I-NP O
mutations NNS I-NP O
reproduced VBD B-VP O
the DT B-NP O
characteristic JJ I-NP O
structural JJ I-NP O
abnormality NN I-NP O
seen VBN B-VP O
in IN B-PP O
type NN B-NP B-Disease
IIA NN I-NP I-Disease
vWD NN I-NP I-Disease
plasma NN I-NP O
. . O O

. . O O

Familial JJ B-NP B-Disease
deficiency NN I-NP I-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
seventh JJ I-NP I-Disease
component NN I-NP I-Disease
of IN B-PP I-Disease
complement NN B-NP I-Disease
associated VBN B-VP O
with IN B-PP O
recurrent JJ B-NP O
meningococcal JJ I-NP B-Disease
infections NNS I-NP I-Disease
. . O O

We PRP B-NP O
describe VBP B-VP O
an DT B-NP O
11 CD I-NP O
- HYPH I-NP O
year NN I-NP O
- HYPH O O
old JJ B-NP O
girl NN I-NP O
suffering VBG B-VP O
from IN B-PP O
recurrent JJ B-NP B-Disease
meningitis NN I-NP I-Disease
with IN B-PP O
a DT B-NP O
complete JJ I-NP O
absence NN I-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
seventh JJ I-NP I-Disease
component NN I-NP I-Disease
of IN B-PP I-Disease
complement NN B-NP I-Disease
( ( O O
C7 NN B-NP O
) ) O O
. . O O

Diagnosis NN B-NP O
was VBD B-VP O
established VBN I-VP O
by IN B-PP O
haemolytic JJ B-NP O
titration NN I-NP O
and CC O O
western JJ B-NP O
blotting NN I-NP O
. . O O

The DT B-NP O
patients NNS I-NP O
serum NN I-NP O
lacked VBD B-VP O
the DT B-NP O
85 CD I-NP O
kDa NN I-NP O
C7 NN I-NP O
chain NN I-NP O
. . O O

Haemolytic JJ B-NP O
activity NN I-NP O
of IN B-PP O
serum NN B-NP O
was VBD B-VP O
reconstituted VBN I-VP O
with IN B-PP O
either CC O O
pooled VBN B-VP O
normal JJ B-NP O
human JJ I-NP O
serum NN I-NP O
or CC B-PP O
with IN B-PP O
purified VBN B-NP O
C7 NN I-NP O
. . O O

The DT B-NP O
relatives NNS I-NP O
( ( O O
parents NNS B-NP O
and CC O O
one CD B-NP O
sister NN I-NP O
) ) O O
had VBD B-VP O
half RB B-NP O
- HYPH I-NP O
normal JJ I-NP O
levels NNS I-NP O
of IN B-PP O
both CC O O
immunochemically RB B-ADVP O
and CC O O
functionally RB B-NP O
determined VBN I-NP O
C7 NN I-NP O
, , O O
indicating VBG B-VP O
a DT B-NP O
heterozygous JJ I-NP O
state NN I-NP O
for IN B-PP O
C7 NN B-NP B-Disease
deficiency NN I-NP I-Disease
. . O O

. . O O

Translocation NN B-NP O
t NN I-NP O
( ( O O
5 CD B-NP O
; : O O
11 CD B-NP O
) ) O O
( ( O O
q13 NN B-NP O
. . B-NP O

1 CD I-NP O
; : O O
p13 NN B-NP O
) ) O O
associated VBN B-VP O
with IN B-PP O
familial JJ B-NP O
isolated VBN I-NP B-Disease
aniridia NN I-NP I-Disease
. . O O

A DT B-NP O
father NN I-NP O
and CC I-NP O
daughter NN I-NP O
with IN B-PP O
isolated VBN B-NP B-Disease
aniridia NN I-NP I-Disease
were VBD B-VP O
observed VBN I-VP O
to TO I-VP O
have VB I-VP O
an DT B-NP O
apparently RB I-NP O
balanced JJ I-NP O
, , I-NP O
reciprocal JJ I-NP O
translocation NN I-NP O
involving VBG B-VP O
chromosomes NNS B-NP O
5 CD B-NP O
and CC I-NP O
11 CD I-NP O
[ ( O O
t NN B-NP O
( ( O O
5 CD B-NP O
; : O O
11 CD B-NP O
) ) O O
( ( O O
q13 NN B-NP O
. . B-NP O

1 CD I-NP O
; : O O
p13 NN B-NP O
) ) O O
] ) O O
. . O O

No DT B-NP O
other JJ I-NP O
clinical JJ I-NP O
characteristics NNS I-NP O
often RB B-VP O
associated VBN I-VP O
with IN B-PP O
the DT B-NP O
deletion NN I-NP O
of IN B-PP O
11p13 NN B-NP O
were VBD B-VP O
observed VBN I-VP O
in IN B-PP O
this DT B-NP O
family NN I-NP O
. . O O

This DT B-NP O
finding NN I-NP O
, , O O
in IN B-PP O
association NN B-NP O
with IN B-PP O
3 CD B-NP O
other JJ I-NP O
instances NNS I-NP O
of IN B-PP O
single JJ B-NP O
breaks NNS I-NP O
at IN B-PP O
11p13 NN B-NP O
and CC I-NP O
aniridia NN I-NP B-Disease
, , O O
supports VBZ B-VP O
the DT B-NP O
assignment NN I-NP O
of IN B-PP O
AN2 NN B-NP O
to TO B-PP O
11p13 NN B-NP O
. . O O

Homozygous JJ B-NP B-Disease
hypobetalipoproteinemia NN I-NP I-Disease
: : O O
a DT B-NP O
disease NN I-NP O
distinct JJ B-ADJP O
from IN B-PP O
abetalipoproproteinemia NN B-NP B-Disease
at IN B-PP O
the DT B-NP O
molecular JJ I-NP O
level NN I-NP O
. . O O

apoB NN B-NP O
DNA NN I-NP O
, , O O
RNA NN B-NP O
, , O O
and CC O O
protein NN B-NP O
from IN B-PP O
two CD B-NP O
patients NNS I-NP O
with IN B-PP O
homozygous JJ B-NP B-Disease
hypobetalipoproteinemia NN I-NP I-Disease
( ( O O
HBL NN B-NP B-Disease
) ) O O
were VBD B-VP O
evaluated VBN I-VP O
and CC O O
compared VBN B-PP O
with IN B-PP O
normal JJ B-NP O
individuals NNS I-NP O
. . O O

Southern NN B-NP O
blot NN I-NP O
analysis NN I-NP O
with IN B-PP O
10 CD B-NP O
different JJ I-NP O
cDNA NN I-NP O
probes NNS I-NP O
revealed VBD B-VP O
a DT B-NP O
normal JJ I-NP O
gene NN I-NP O
without IN B-PP O
major JJ B-NP O
insertions NNS I-NP O
, , O O
deletions NNS B-NP O
, , O O
or CC O O
rearrangements NNS B-NP O
. . O O

Northern NN B-NP O
and CC I-NP O
slot NN I-NP O
blot NN I-NP O
analyses NNS I-NP O
of IN B-PP O
total JJ B-NP O
liver NN I-NP O
mRNA NN I-NP O
from IN B-PP O
HBL NN B-NP B-Disease
patients NNS I-NP O
documented VBD B-VP O
a DT B-NP O
normal JJ I-NP O
size NN I-NP O
apoB NN I-NP O
mRNA NN I-NP O
that WDT B-NP O
was VBD B-VP O
present JJ B-ADJP O
in IN B-PP O
greatly RB B-NP O
reduced VBN I-NP O
quantities NNS I-NP O
. . O O

ApoB NN B-NP O
protein NN I-NP O
was VBD B-VP O
detected VBN I-VP O
within IN B-PP O
HBL NN B-NP B-Disease
hepatocytes NNS I-NP O
utilizing VBG B-VP O
immunohistochemical JJ B-NP O
techniques NNS I-NP O
; : O O
however RB B-ADVP O
, , O O
it PRP B-NP O
was VBD B-VP O
markedly RB I-VP O
reduced VBN I-VP O
in IN B-PP O
quantity NN B-NP O
when WRB B-ADVP O
compared VBN B-PP O
with IN B-PP O
control NN B-NP O
samples NNS I-NP O
. . O O

No DT B-NP O
apoB NN I-NP O
was VBD B-VP O
detectable JJ B-ADJP O
in IN B-PP O
the DT B-NP O
plasma NN I-NP O
of IN B-PP O
HBL NN B-NP B-Disease
individuals NNS I-NP O
with IN B-PP O
an DT B-NP O
ELISA NN I-NP O
assay NN I-NP O
. . O O

These DT B-NP O
data NNS I-NP O
are VBP B-VP O
most RBS B-ADJP O
consistent JJ I-ADJP O
with IN B-PP O
a DT B-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
coding VBG I-NP O
portion NN I-NP O
of IN B-PP O
the DT B-NP O
apoB NN I-NP O
gene NN I-NP O
in IN B-PP O
HBL NN B-NP B-Disease
patients NNS I-NP O
, , O O
leading VBG B-VP O
to TO B-PP O
an DT B-NP O
abnormal JJ I-NP O
apoB NN I-NP O
protein NN I-NP O
and CC O O
apoB NN B-NP O
mRNA NN I-NP O
instability NN I-NP O
. . O O

These DT B-NP O
results NNS I-NP O
are VBP B-VP O
distinct JJ B-ADJP O
from IN B-PP O
those DT B-NP O
previously RB B-VP O
noted VBN I-VP O
in IN B-PP O
abetalipoproteinemia NN B-NP B-Disease
, , O O
which WDT B-NP O
was VBD B-VP O
characterized VBN I-VP O
by IN B-PP O
an DT B-NP O
elevated JJ I-NP O
level NN I-NP O
of IN B-PP O
hepatic JJ B-NP O
apoB NN I-NP O
mRNA NN I-NP O
and CC I-NP O
accumulation NN I-NP O
of IN B-PP O
intracellular JJ B-NP O
hepatic JJ I-NP O
apoB NN I-NP O
protein NN I-NP O
. . O O

. . O O

Spontaneous JJ B-NP O
reversion NN I-NP O
of IN B-PP O
novel JJ B-NP O
Lesch NNP I-NP B-Disease
- HYPH I-NP I-Disease
Nyhan NNP I-NP I-Disease
mutation NN I-NP O
by IN B-PP O
HPRT NN B-NP O
gene NN I-NP O
rearrangement NN I-NP O
. . O O

Molecular JJ B-NP O
analysis NN I-NP O
of IN B-PP O
an DT B-NP O
unusual JJ I-NP O
patient NN I-NP O
with IN B-PP O
the DT B-NP O
Lesch NNP I-NP B-Disease
- HYPH I-NP I-Disease
Nyhan NNP I-NP I-Disease
syndrome NN I-NP I-Disease
has VBZ B-VP O
suggested VBN I-VP O
that IN B-SBAR O
the DT B-NP O
mutation NN I-NP O
is VBZ B-VP O
due IN B-PP O
to TO B-PP O
a DT B-NP O
partial JJ I-NP O
HPRT NN I-NP O
gene NN I-NP O
duplication NN I-NP O
. . O O

We PRP B-NP O
now RB B-ADVP O
report VBP B-VP O
the DT B-NP O
cloning NN I-NP O
and CC I-NP O
sequencing NN I-NP O
of IN B-PP O
the DT B-NP O
mutant JJ I-NP O
HPRT NN I-NP O
cDNA NN I-NP O
which WDT B-NP O
shows VBZ B-VP O
the DT B-NP O
precise JJ I-NP O
duplication NN I-NP O
of IN B-PP O
exons NNS B-NP O
2 CD I-NP O
and CC I-NP O
3 CD I-NP O
. . O O

This DT B-NP O
mutation NN I-NP O
is VBZ B-VP O
the DT B-NP O
result NN I-NP O
of IN B-PP O
an DT B-NP O
internal JJ I-NP O
duplication NN I-NP O
of IN B-PP O
16 CD B-NP O
- HYPH I-NP O
20 CD I-NP O
kilobases NNS I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
. . O O

The DT B-NP O
structure NN I-NP O
of IN B-PP O
the DT B-NP O
mutant JJ I-NP O
gene NN I-NP O
suggests VBZ B-VP O
that IN B-SBAR O
the DT B-NP O
duplication NN I-NP O
was VBD B-VP O
not RB I-VP O
generated VBN I-VP O
by IN B-PP O
a DT B-NP O
single JJ I-NP O
unequal JJ I-NP O
crossing VBG I-NP O
- HYPH B-VP O
over RP B-PRT O
event NN B-NP O
between IN B-PP O
two CD B-NP O
normal JJ I-NP O
HPRT NN I-NP O
alleles NNS I-NP O
. . O O

Growth NN B-NP O
of IN B-PP O
Epstein NNP B-NP B-Disease
- HYPH I-NP I-Disease
Barr NNP I-NP I-Disease
virus NN I-NP O
- HYPH B-NP O
transformed VBN I-NP O
lymphoblasts NNS I-NP O
from IN B-PP O
this DT B-NP O
patient NN I-NP O
in IN B-PP O
selective JJ B-NP O
medium NN I-NP O
has VBZ B-VP O
permitted VBN I-VP O
isolation NN B-NP O
of IN B-PP O
spontaneous JJ B-NP O
HPRT NN I-NP O
+ SYM B-NP O
revertants NNS I-NP O
of IN B-PP O
this DT B-NP O
mutation NN I-NP O
. . O O

The DT B-NP O
reversion NN I-NP O
event NN I-NP O
involves VBZ B-VP O
a DT B-NP O
second JJ I-NP O
major JJ I-NP O
HPRT NN I-NP O
gene NN I-NP O
rearrangement NN I-NP O
where WRB B-ADVP O
most JJS B-NP O
or CC O O
all DT B-NP O
of IN B-PP O
the DT B-NP O
duplicated JJ I-NP O
portion NN I-NP O
of IN B-PP O
the DT B-NP O
mutant JJ I-NP O
gene NN I-NP O
is VBZ B-VP O
deleted VBN I-VP O
. . O O

The DT B-NP O
original JJ I-NP O
mutation NN I-NP O
therefore RB B-ADVP O
has VBZ B-VP O
the DT B-NP O
potential NN I-NP O
for IN B-PP O
spontaneous JJ B-NP O
somatic JJ I-NP O
reversion NN I-NP O
. . O O

This DT B-NP O
may MD B-VP O
explain VB I-VP O
the DT B-NP O
relatively RB I-NP O
mild JJ I-NP O
symptoms NNS I-NP O
of IN B-PP O
the DT B-NP O
Lesch NNP I-NP B-Disease
- HYPH I-NP I-Disease
Nyhan NNP I-NP I-Disease
syndrome NN I-NP I-Disease
exhibited VBN B-VP O
by IN B-PP O
this DT B-NP O
patient NN I-NP O
. . O O

. . O O

Complex NN B-NP B-Disease
glycerol NN I-NP I-Disease
kinase NN I-NP I-Disease
deficiency NN I-NP I-Disease
: : O O
molecular JJ B-NP O
- HYPH I-NP O
genetic JJ I-NP O
, , I-NP O
cytogenetic JJ I-NP O
, , O O
and CC O O
clinical JJ B-NP O
studies NNS I-NP O
of IN B-PP O
five CD B-NP O
Japanese JJ I-NP O
patients NNS I-NP O
. . O O

Five CD B-NP O
male JJ I-NP O
Japanese JJ I-NP O
patients NNS I-NP O
with IN B-PP O
complex JJ B-NP B-Disease
glycerol NN I-NP I-Disease
kinase NN I-NP I-Disease
deficiency NN I-NP I-Disease
( ( O O
CGKD NN B-NP B-Disease
) ) O O
and CC O O
their PRP$ B-NP O
relatives NNS I-NP O
were VBD B-VP O
studied VBN I-VP O
clinically RB B-ADVP O
, , O O
cytogenetically RB B-ADVP O
, , O O
and CC O O
molecular JJ B-ADJP O
- HYPH O O
genetically RB B-ADVP O
. . O O

All DT B-NP O
patients NNS I-NP O
had VBD B-VP O
muscular JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
or CC I-NP O
muscle NN I-NP B-Disease
weakness NN I-NP I-Disease
, , O O
mental JJ B-NP B-Disease
retardation NN I-NP I-Disease
, , O O
congenital JJ B-NP B-Disease
adrenal JJ I-NP I-Disease
hypoplasia NN I-NP I-Disease
, , O O
and CC O O
glycerol NN B-NP B-Disease
kinase NN I-NP I-Disease
deficiency NN I-NP I-Disease
. . O O

High JJ B-NP O
- HYPH I-NP O
resolution NN I-NP O
GTG NN I-NP O
- HYPH B-NP O
banded VBN I-NP O
chromosomes NNS I-NP O
showed VBD B-VP O
a DT B-NP O
microdeletion NN I-NP O
in IN B-PP O
the DT B-NP O
Xp21 NN I-NP O
region NN I-NP O
in IN B-PP O
all DT B-NP O
four CD I-NP O
patients NNS I-NP O
examined VBN B-VP O
and CC O O
in IN B-PP O
all DT B-NP O
five CD I-NP O
mothers NNS I-NP O
. . O O

Southern JJ B-NP O
hybridizations NNS I-NP O
, , O O
after IN B-PP O
digestions NNS B-NP O
by IN B-PP O
restriction NN B-NP O
endonucleases VBZ B-VP O
, , O O
with IN B-PP O
various JJ B-NP O
cloned VBN I-NP O
DNAs NNS I-NP O
( ( O O
D2 NN B-NP O
, , O O
99 CD B-NP O
- HYPH I-NP O
6 CD I-NP O
, , O O
B24 NN B-NP O
, , O O
C7 NN B-NP O
, , O O
L1 NN B-NP O
- HYPH O O
4 CD B-NP O
, , O O
cDMD13 NN B-NP O
- HYPH O O
14 CD B-NP O
, , O O
J66 NN B-NP O
- HYPH O O
HI NN B-NP O
, , O O
P20 NN B-NP O
, , O O
J NN B-NP O
- HYPH B-NP O
Bir NN I-NP O
, , O O
ERT87 NN B-NP O
- HYPH O O
30 CD B-NP O
, , O O
ERT87 NN B-NP O
- HYPH B-NP O
15 CD I-NP O
, , O O
ERT87 NN B-NP O
- HYPH O O
8 CD B-NP O
, , O O
ERT87 NN B-NP O
- HYPH B-NP O
1 CD I-NP O
, , O O
XJ NN B-NP O
- HYPH B-NP O
1 CD I-NP O
. . I-NP O

1 CD I-NP O
, , I-NP O
754 CD I-NP O
, , I-NP O
cx5 CD I-NP O
. . I-NP O

7 CD I-NP O
, , O O
and CC O O
OTC NNP B-NP O
- HYPH B-NP O
1 CD I-NP O
) ) O O
that WDT B-NP O
are VBP B-VP O
located JJ B-ADJP O
around IN B-PP O
Xp21 NN B-NP O
also RB B-ADVP O
showed VBD B-VP O
a DT B-NP O
deletion NN I-NP O
in IN B-PP O
the DT B-NP O
genome NN I-NP O
of IN B-PP O
all DT B-NP O
patients NNS I-NP O
and CC I-NP O
mothers NNS I-NP O
. . O O

Although IN B-SBAR O
the DT B-NP O
deletion NN I-NP O
differed VBD B-VP O
in IN B-PP O
size NN B-NP O
among IN B-PP O
patients NNS B-NP O
, , O O
a DT B-NP O
segment NN I-NP O
commonly RB B-ADJP O
absent JJ I-ADJP O
was VBD B-VP O
located JJ B-ADJP O
between IN B-PP O
the DT B-NP O
genomic JJ I-NP O
sequences NNS I-NP O
corresponding VBG B-VP O
to TO B-PP O
L1 NN B-NP O
- HYPH B-NP O
4 CD I-NP O
and CC I-NP O
cDMD13 NN I-NP O
- : O O
14 CD B-NP O
. . O O

This DT B-NP O
finding NN I-NP O
indicated VBD B-VP O
that IN B-SBAR O
the DT B-NP O
gene NN I-NP O
coding VBG B-VP O
for IN B-PP O
glycerol NN B-NP O
kinase NN I-NP O
( ( O O
GK NN B-NP O
) ) O O
is VBZ B-VP O
located JJ B-ADJP O
within IN B-PP O
this DT B-NP O
segment NN I-NP O
. . O O

A DT B-NP O
comparison NN I-NP O
of IN B-PP O
the DT B-NP O
clinical JJ I-NP O
manifestations NNS I-NP O
of IN B-PP O
the DT B-NP O
present JJ I-NP O
five CD I-NP O
patients NNS I-NP O
and CC O O
reported VBD B-VP O
CGKD NN B-NP B-Disease
or CC O O
Duchenne JJ B-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
DMD NN B-NP B-Disease
) ) O O
patients NNS B-NP O
with IN B-PP O
DNA NN B-NP O
deletion NN I-NP O
suggests VBZ B-VP O
the DT B-NP O
existence NN I-NP O
of IN B-PP O
a DT B-NP O
certain JJ I-NP O
gene NN I-NP O
responsible JJ B-ADJP O
for IN B-PP O
gonadotropin NN B-NP B-Disease
deficiency NN I-NP I-Disease
( ( O O
GTD NN B-NP B-Disease
) ) O O
. . O O

The DT B-NP O
result NN I-NP O
of IN B-PP O
the DT B-NP O
present JJ I-NP O
study NN I-NP O
and CC O O
results NNS B-NP O
of IN B-PP O
previous JJ B-NP O
studies NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
genes NNS B-NP O
for IN B-PP O
ornithine NN B-NP O
transcarbamylase NN I-NP O
( ( O O
OTC NNP B-NP O
) ) O O
, , O O
DMD NN B-NP B-Disease
, , O O
and CC O O
GK NN B-NP O
and CC O O
putative JJ B-NP O
genes NNS I-NP O
responsible JJ B-ADJP O
for IN B-PP O
congenital JJ B-NP B-Disease
adrenal JJ I-NP I-Disease
hypoplasia NN I-NP I-Disease
( ( O O
AHC NN B-NP B-Disease
) ) O O
and CC O O
GTD NN B-NP B-Disease
are VBP B-VP O
arranged VBN I-VP O
from IN B-PP O
telomere NN B-NP O
to TO B-VP O
centromere VB I-VP O
as IN B-PP O
pter NN B-NP O
- HYPH O O
- HYPH B-NP O
GTD NN I-NP O
- HYPH O O
- HYPH B-NP O
AHC NN I-NP O
- HYPH O O
- HYPH B-NP O
GK NN I-NP O
- HYPH O O
- HYPH B-NP O
DMD NN I-NP O
- HYPH O O
- SYM B-NP O
OTC NN I-NP O
- SYM O O
- HYPH O O
cen NN B-NP O
Genetically RB B-NP O
determined VBN I-NP O
low JJ I-NP O
C4 NN I-NP O
: : O O
a DT B-NP O
predisposing VBG I-NP O
factor NN I-NP O
to TO B-PP O
autoimmune JJ B-NP B-Disease
chronic JJ I-NP I-Disease
active JJ I-NP I-Disease
hepatitis NN I-NP I-Disease
. . O O

Of IN B-PP O
26 CD B-NP O
patients NNS I-NP O
with IN B-PP O
autoimmune JJ B-NP B-Disease
chronic JJ I-NP I-Disease
active JJ I-NP I-Disease
hepatitis NN I-NP I-Disease
( ( O O
CAH NN B-NP B-Disease
) ) O O
starting VBG B-VP O
in IN B-PP O
childhood NN B-NP O
18 CD I-NP O
( ( O O
69 CD B-NP O
% NN I-NP O
) ) O O
had VBD B-VP O
low JJ B-NP O
C4 NN I-NP O
and CC O O
5 CD B-NP O
( ( O O
19 CD B-NP O
% NN I-NP O
) ) O O
had VBD B-VP O
low JJ B-NP O
C3 NN I-NP O
serum NN I-NP O
levels NNS I-NP O
. . O O

Impaired JJ B-NP O
hepatic JJ I-NP O
synthesis NN I-NP O
and CC O O
immune JJ B-NP O
- HYPH I-NP O
consumption NN I-NP O
were VBD B-VP O
unlikely JJ B-ADJP O
since IN B-SBAR O
transferrin NN B-NP O
levels NNS I-NP O
were VBD B-VP O
normal JJ B-ADJP O
in IN B-PP O
all DT B-NP O
patients NNS I-NP O
, , O O
albumin NN B-NP O
levels NNS I-NP O
were VBD B-VP O
persistently RB B-ADJP O
low JJ I-ADJP O
in IN B-PP O
only RB B-NP O
3 CD I-NP O
, , O O
and CC O O
only RB B-NP O
3 CD I-NP O
had VBD B-VP O
raised VBN I-VP O
levels NNS B-NP O
of IN B-PP O
activation NN B-NP O
fragment NN I-NP O
C3d NN I-NP O
. . O O

C4d NN B-NP O
was VBD B-VP O
normal JJ B-ADJP O
in IN B-PP O
all DT B-NP O
patients NNS I-NP O
studied VBN B-VP O
. . O O

In IN B-PP O
the DT B-NP O
families NNS I-NP O
of IN B-PP O
12 CD B-NP O
probands NNS I-NP O
with IN B-PP O
low JJ B-NP O
C4 NN I-NP O
, , O O
7 CD B-NP O
parents NNS I-NP O
had VBD B-VP O
low JJ B-NP O
C4 NN I-NP O
and CC O O
2 CD B-NP O
had VBD B-VP O
levels NNS B-NP O
which WDT B-NP O
were VBD B-VP O
at IN B-PP O
the DT B-NP O
lower JJR I-NP O
limit NN I-NP O
of IN B-PP O
normal JJ B-NP O
. . O O

5 CD B-NP O
of IN B-PP O
10 CD B-NP O
siblings NNS I-NP O
from IN B-PP O
5 CD B-NP O
families NNS I-NP O
had VBD B-VP O
low JJ B-NP O
C4 NN I-NP O
. . O O

These DT B-NP O
results NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
low JJ B-NP O
C4 NN I-NP O
levels NNS I-NP O
in IN B-PP O
CAH NN B-NP B-Disease
are VBP B-VP O
genetically RB I-VP O
determined VBN I-VP O
. . O O

C4 NN B-NP O
phenotyping NN I-NP O
in IN B-PP O
20 CD B-NP O
patients NNS I-NP O
and CC O O
in IN B-PP O
26 CD B-NP O
parents NNS I-NP O
showed VBD B-VP O
that IN B-SBAR O
90 CD B-NP O
% NN I-NP O
and CC O O
81 CD B-NP O
% NN I-NP O
, , O O
respectively RB B-ADVP O
, , O O
had VBD B-VP O
allotypes NNS I-NP O
at IN B-PP O
either CC O O
the DT B-NP O
C4A NN I-NP O
or CC I-NP O
C4B NN I-NP O
locus NN I-NP O
compared VBN B-PP O
with IN B-PP O
59 CD B-NP O
% NN I-NP O
in IN B-PP O
controls NNS B-NP O
, , O O
indicating VBG B-VP O
that IN B-SBAR O
defective JJ B-NP O
expression NN I-NP O
of IN B-PP O
structural JJ B-NP O
genes NNS I-NP O
may MD B-VP O
contribute VB I-VP O
to TO B-PP O
the DT B-NP O
observed VBN I-NP O
C4 NN I-NP B-Disease
deficiency NN I-NP I-Disease
. . O O

. . O O

An DT B-NP O
amino JJ I-NP O
- HYPH I-NP O
acid NN I-NP O
substitution NN I-NP O
involved VBN B-VP O
in IN B-PP O
phenylketonuria NN B-NP B-Disease
is VBZ B-VP O
in IN B-PP O
linkage NN B-NP O
disequilibrium NN I-NP O
with IN B-PP O
DNA NN B-NP O
haplotype NN I-NP O
2 CD I-NP O
. . O O

Phenylketonuria NN B-NP B-Disease
( ( O O
PKU NN B-NP B-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
human JJ I-NP I-Disease
genetic JJ I-NP I-Disease
disorder NN I-NP I-Disease
caused VBN B-VP O
by IN B-PP O
a DT B-NP O
deficiency NN I-NP B-Disease
of IN B-PP I-Disease
hepatic JJ B-NP I-Disease
phenylalanine NN I-NP I-Disease
hydroxylase NN I-NP I-Disease
( ( O O
PAH NN B-NP O
, , O O
phenylalanine NN B-NP O
4 CD I-NP O
- HYPH I-NP O
monooxygenase NN I-NP O
, , O O
EC NNP B-NP O
1 CD I-NP O
. . O O

14 CD B-NP O
. . I-NP O

16 CD I-NP O
. . I-NP O

1 CD I-NP O
) ) O O
. . O O

PKU NN B-NP B-Disease
is VBZ B-VP O
a DT B-NP O
common JJ I-NP O
inborn JJ I-NP B-Disease
error NN I-NP I-Disease
of IN B-PP I-Disease
amino JJ B-NP I-Disease
- HYPH I-NP I-Disease
acid NN I-NP I-Disease
metabolism NN I-NP I-Disease
in IN B-PP O
caucasian JJ B-NP O
populations NNS I-NP O
and CC O O
approximately RB B-NP O
1 CD I-NP O
in IN B-PP O
50 CD B-NP O
individuals NNS I-NP O
are VBP B-VP O
carriers NNS B-NP O
of IN B-PP O
a DT B-NP O
PKU NN I-NP B-Disease
allele NN I-NP O
. . O O

To TO B-VP O
define VB I-VP O
the DT B-NP O
molecular JJ I-NP O
basis NN I-NP O
of IN B-PP O
PKU NN B-NP B-Disease
, , O O
we PRP B-NP O
characterized VBD B-VP O
twelve CD B-NP O
restriction NN I-NP O
fragment NN I-NP O
- HYPH B-NP O
length NN I-NP O
polymorphism NN I-NP O
( ( O O
RFLP NN B-NP O
) ) O O
haplotypes NNS B-NP O
of IN B-PP O
the DT B-NP O
PAH NN I-NP O
locus NN I-NP O
in IN B-PP O
the DT B-NP O
northern JJ I-NP O
European JJ I-NP O
population NN I-NP O
and CC O O
observed VBD B-VP O
that IN B-SBAR O
90 CD B-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
PKU NN I-NP B-Disease
alleles NNS I-NP O
in IN B-PP O
this DT B-NP O
population NN I-NP O
are VBP B-VP O
confined VBN I-VP O
to TO B-PP O
four CD B-NP O
common JJ I-NP O
RFLP NN I-NP O
haplotypes NNS I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
recently RB I-VP O
reported VBN I-VP O
a DT B-NP O
splicing NN I-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
PAH NN I-NP O
gene NN I-NP O
that WDT B-NP O
is VBZ B-VP O
associated VBN I-VP O
with IN B-PP O
RFLP NN B-NP O
haplotype NN I-NP O
3 CD I-NP O
which WDT B-NP O
is VBZ B-VP O
present JJ B-ADJP O
at IN B-PP O
about RB B-NP O
40 CD I-NP O
% NN I-NP O
of IN B-PP O
mutant JJ B-NP O
alleles NNS I-NP O
. . O O

We PRP B-NP O
now RB B-ADVP O
report VBP B-VP O
the DT B-NP O
molecular JJ I-NP B-Disease
lesion NN I-NP I-Disease
associated VBN B-VP O
with IN B-PP O
the DT B-NP O
RFLP NN I-NP O
haplotype NN I-NP O
2 CD I-NP O
mutant JJ I-NP O
allele NN I-NP O
. . O O

This DT B-NP O
defect NN I-NP O
is VBZ B-VP O
caused VBN I-VP O
by IN B-PP O
a DT B-NP O
C NN I-NP O
- HYPH B-ADJP O
to TO B-PP O
- HYPH B-NP O
T NN I-NP O
transition NN I-NP O
in IN B-PP O
exon NN B-NP O
12 CD I-NP O
resulting VBG B-VP O
in IN B-PP O
an DT B-NP O
amino JJ I-NP O
- HYPH I-NP O
acid NN I-NP O
substitution NN I-NP O
( ( O O
Arg NN B-NP O
to TO B-PP O
Trp NN B-NP O
) ) O O
at IN B-PP O
residue NN B-NP O
408 CD I-NP O
of IN B-PP O
PAH NN B-NP O
. . O O

Direct JJ B-NP O
hybridization NN I-NP O
analysis NN I-NP O
of IN B-PP O
the DT B-NP O
point NN I-NP O
mutation NN I-NP O
using VBG B-VP O
a DT B-NP O
specific JJ I-NP O
oligonucleotide NN I-NP O
probe NN I-NP O
demonstrated VBD B-VP O
that IN B-SBAR O
this DT B-NP O
mutation NN I-NP O
is VBZ B-VP O
also RB B-ADVP O
in IN B-PP O
linkage NN B-NP O
disequilibrium NN I-NP O
with IN B-PP O
RFLP NN B-NP O
haplotype NN I-NP O
2 CD B-NP O
alleles NNS I-NP O
that WDT B-NP O
make VBP B-VP O
up RP B-PRT O
about IN B-NP O
20 CD I-NP O
% NN I-NP O
of IN B-PP O
mutant JJ B-NP O
PAH NN I-NP O
genes NNS I-NP O
Choroideremia NN B-NP B-Disease
: : O O
close JJ B-NP O
linkage NN I-NP O
to TO B-PP O
DXYS1 NN B-NP O
and CC I-NP O
DXYS12 NN I-NP O
demonstrated VBN B-VP O
by IN B-PP O
segregation NN B-NP O
analysis NN I-NP O
and CC O O
historical JJ B-NP O
- HYPH I-NP O
genealogical JJ I-NP O
evidence NN I-NP O
. . O O

Linkage NN B-NP O
studies NNS I-NP O
using VBG B-VP O
restriction NN B-NP O
fragment NN I-NP O
length NN I-NP O
polymorphisms NNS I-NP O
were VBD B-VP O
conducted VBN I-VP O
in IN B-PP O
the DT B-NP O
X NN I-NP B-Disease
- HYPH B-VP I-Disease
linked VBN I-VP I-Disease
disorder NN B-NP I-Disease
, , O O
choroideremia NN B-NP B-Disease
, , O O
designated VBN B-VP O
TCD NN B-NP B-Disease
for IN B-PP O
Progressive JJ B-NP B-Disease
Tapeto NNP I-NP I-Disease
- HYPH I-NP I-Disease
Choroidal NNP I-NP I-Disease
Dystrophy NNP I-NP I-Disease
. . O O

Previously RB B-NP O
demonstrated VBN I-NP O
close JJ I-NP O
linkage NN I-NP O
with IN B-PP O
locus NN B-NP O
DXYS1 NN I-NP O
was VBD B-VP O
confirmed VBN I-VP O
( ( O O
lod NN B-NP O
11 CD I-NP O
. . O O

44 CD B-NP O
at IN B-PP O
0 CD B-NP O
recombination NN I-NP O
distance NN I-NP O
) ) O O
. . O O

In IN B-PP O
addition NN B-NP O
, , O O
locus NN B-NP O
DXYS12 NN I-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
be VB I-VP O
closely RB I-VP O
linked VBN I-VP O
with IN B-PP O
TCD NN B-NP B-Disease
( ( O O
lod NN B-NP O
3 CD I-NP O
. . O O

31 CD B-NP O
at IN B-PP O
0 CD B-NP O
recombination NN I-NP O
distance NN I-NP O
) ) O O
. . O O

The DT B-NP O
disease NN I-NP O
mainly RB B-ADVP O
occurs VBZ B-VP O
in IN B-PP O
three CD B-NP O
large JJ I-NP O
kindreds NNS I-NP O
in IN B-PP O
remote JJ B-NP O
Northern NNP I-NP O
Finland NNP I-NP O
. . O O

While IN B-SBAR O
formal JJ B-NP O
genealogical JJ I-NP O
proof NN I-NP O
is VBZ B-VP O
lacking VBG I-VP O
, , O O
all DT B-NP O
presently RB I-NP O
living VBG I-NP O
( ( O O
more JJR B-NP O
than IN I-NP O
80 CD I-NP O
affected VBN I-NP O
males NNS I-NP O
and CC O O
120 CD B-NP O
carrier NN I-NP O
females NNS I-NP O
) ) O O
probably RB B-ADVP O
originate VBP B-VP O
from IN B-PP O
a DT B-NP O
common JJ I-NP O
founder NN I-NP O
couple NN I-NP O
born VBN B-VP O
in IN B-PP O
1644 CD B-NP O
and CC I-NP O
1646 CD I-NP O
, , O O
twelve CD B-NP O
generations NNS I-NP O
ago RB B-ADVP O
. . O O

All DT B-NP O
36 CD I-NP O
patients NNS I-NP O
and CC O O
48 CD B-NP O
carriers NNS I-NP O
tested VBN B-VP O
from IN B-PP O
the DT B-NP O
three CD I-NP O
kindreds NNS I-NP O
had VBD B-VP O
the DT B-NP O
same JJ I-NP O
haplotype NN I-NP O
( ( O O
TCD NN B-NP B-Disease
/ SYM O O
DXYS1 NN B-NP O
, , O O
11kb NN B-NP O
/ SYM I-NP O
DXYS12 NN I-NP O
, , O O
1 CD B-NP O
. . I-NP O

6kb CD I-NP O
) ) O O
. . O O

Given VBN B-VP O
that IN B-SBAR O
at IN B-NP O
least JJS I-NP O
105 CD I-NP O
female JJ I-NP O
meioses NNS I-NP O
transmitting VBG B-VP O
TCD NN B-NP B-Disease
have VBP B-VP O
occurred VBN I-VP O
since IN B-PP O
1650 CD B-NP O
in IN B-PP O
these DT B-NP O
kindreds NNS I-NP O
, , O O
extremely RB B-NP O
close JJ I-NP O
linkage NN I-NP O
between IN B-PP O
TCD NN B-NP B-Disease
, , I-NP O
DXYS1 NN I-NP O
and CC I-NP O
DXYS12 NN I-NP O
is VBZ B-VP O
suggested VBN I-VP O
. . O O

The DT B-NP O
above JJ I-NP O
haplotype NN I-NP O
is VBZ B-VP O
a DT B-NP O
very RB I-NP O
useful JJ I-NP O
diagnostic JJ I-NP O
tool NN I-NP O
in IN B-PP O
these DT B-NP O
TCD NN I-NP B-Disease
families NNS I-NP O
. . O O

We PRP B-NP O
suggest VBP B-VP O
that IN B-SBAR O
our PRP$ B-NP O
historical JJ I-NP O
- HYPH I-NP O
genealogical JJ I-NP O
approach NN I-NP O
to TO B-PP O
linkage NN B-NP O
analysis NN I-NP O
may MD B-VP O
be VB I-VP O
possible JJ B-ADJP O
elsewhere RB B-ADVP O
in IN B-PP O
similar JJ B-NP O
isolated VBN I-NP O
populations NNS I-NP O
Von NNP B-NP B-Disease
Hippel NNP I-NP I-Disease
- HYPH B-NP I-Disease
Lindau NNP I-NP I-Disease
disease NN I-NP I-Disease
maps VBZ B-VP O
to TO B-PP O
the DT B-NP O
region NN I-NP O
of IN B-PP O
chromosome NN B-NP O
3 CD I-NP O
associated VBN B-VP O
with IN B-PP O
renal JJ B-NP B-Disease
cell NN I-NP I-Disease
carcinoma NN I-NP I-Disease
. . O O

Von NNP B-NP B-Disease
Hippel NNP I-NP I-Disease
- HYPH B-NP I-Disease
Lindau NNP I-NP I-Disease
disease NN I-NP I-Disease
( ( O O
VHL NN B-NP B-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
autosomal JJ I-NP B-Disease
dominant JJ I-NP I-Disease
disorder NN I-NP I-Disease
with IN B-PP O
inherited VBN B-NP O
susceptibility NN I-NP O
to TO B-PP O
various JJ B-NP O
forms NNS I-NP O
of IN B-PP O
cancer NN B-NP B-Disease
, , O O
including VBG B-PP O
hemangioblastomas NNS B-NP B-Disease
of IN B-PP O
the DT B-NP O
central JJ I-NP O
nervous JJ I-NP O
system NN I-NP O
, , O O
phaeochromocytomas NNS B-NP B-Disease
, , O O
pancreatic JJ B-NP B-Disease
malignancies NNS I-NP I-Disease
, , O O
and CC O O
renal JJ B-NP B-Disease
cell NN I-NP I-Disease
carcinomas NNS I-NP I-Disease
. . O O

Renal JJ B-NP B-Disease
cell NN I-NP I-Disease
carcinomas NNS I-NP I-Disease
constitute VBP B-VP O
a DT B-NP O
particularly RB I-NP O
frequent JJ I-NP O
cause NN I-NP O
of IN B-PP O
death NN B-NP O
in IN B-PP O
this DT B-NP O
disorder NN I-NP O
, , O O
occurring VBG B-VP O
as IN B-PP O
bilateral JJ B-NP B-Disease
and CC I-NP I-Disease
multifocal JJ I-NP I-Disease
tumours NNS I-NP I-Disease
, , O O
and CC O O
presenting VBG B-VP O
at IN B-PP O
an DT B-NP O
earlier JJR I-NP O
age NN I-NP O
than IN B-PP O
in IN B-PP O
sporadic JJ B-NP O
, , O O
non AFX O O
- HYPH O O
familial JJ B-NP O
cases NNS I-NP O
of IN B-PP O
this DT B-NP O
tumour NN I-NP B-Disease
type NN I-NP O
. . O O

We PRP B-NP O
report VBP B-VP O
here RB B-ADVP O
that IN B-SBAR O
the DT B-NP O
VHL NN I-NP B-Disease
gene NN I-NP O
is VBZ B-VP O
linked VBN I-VP O
to TO B-PP O
the DT B-NP O
locus NN I-NP O
encoding VBG B-VP O
the DT B-NP O
human JJ I-NP O
homologoue NN I-NP O
of IN B-PP O
the DT B-NP O
RAF1 NN I-NP O
oncogene NN I-NP O
, , O O
which WDT B-NP O
maps VBZ B-VP O
to TO B-PP O
chromosome NN B-NP O
3p25 CD I-NP O
( ( O O
ref NN B-NP O
. . O O

4 CD B-NP O
) ) O O
. . O O

Crossovers NNS B-NP O
with IN B-PP O
the DT B-NP O
VHL NN I-NP B-Disease
locus NN I-NP O
suggest VBP B-VP O
that IN B-SBAR O
the DT B-NP O
defect NN I-NP O
responsible JJ B-ADJP O
for IN B-PP O
the DT B-NP O
VHL NN I-NP B-Disease
phenotype NN I-NP O
is VBZ B-VP O
not RB O O
a DT B-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
RAF1 NN I-NP O
gene NN I-NP O
itself PRP B-NP O
. . O O

An DT B-NP O
alternative JJ I-NP O
or CC I-NP O
prior JJ I-NP O
event NN I-NP O
to TO B-PP O
oncogene NN B-NP O
activation NN I-NP O
in IN B-PP O
tumour NN B-NP B-Disease
formation NN I-NP O
may MD B-VP O
be VB I-VP O
the DT B-NP O
inactivation NN I-NP O
of IN B-PP O
a DT B-NP O
putative JJ I-NP O
tumour NN I-NP B-Disease
suppressor NN I-NP O
which WDT B-NP O
can MD B-VP O
be VB I-VP O
associated VBN I-VP O
with IN B-PP O
both CC O O
the DT B-NP O
inherited VBN I-NP B-Disease
and CC I-NP I-Disease
sporadic JJ I-NP I-Disease
forms NNS I-NP I-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
cancer NN I-NP I-Disease
. . O O

Sporadic JJ B-NP B-Disease
renal JJ I-NP I-Disease
cell NN I-NP I-Disease
carcinomas NNS I-NP I-Disease
have VBP B-VP O
previously RB I-VP O
been VBN I-VP O
associated VBN I-VP O
with IN B-PP O
the DT B-NP O
loss NN I-NP O
of IN B-PP O
regions NNS B-NP O
on IN B-PP O
chromosome NN B-NP O
3p NN I-NP O
( ( O O
refs NNS B-NP O
5 CD B-NP O
, , I-NP O
6 CD I-NP O
) ) O O
. . O O

Consequently RB B-ADVP O
, , O O
sporadic JJ B-NP O
and CC I-NP O
VHL NN I-NP O
- HYPH B-NP O
associated VBN I-NP O
forms NNS I-NP O
of IN B-PP O
renal JJ B-NP B-Disease
cell NN I-NP I-Disease
carcinoma NN I-NP I-Disease
might MD B-VP O
both DT O O
result VB B-VP O
from IN B-PP O
alterations NNS B-NP O
causing VBG B-VP O
loss NN B-NP O
of IN B-PP O
function NN B-NP O
of IN B-PP O
the DT B-NP O
same JJ I-NP O
tumour NN I-NP B-Disease
suppressor NN I-NP O
gene NN I-NP O
on IN B-PP O
this DT B-NP O
chromosome NN I-NP O
. . O O

. . O O

Tightly RB B-NP O
linked VBN I-NP O
flanking NN I-NP O
markers NNS I-NP O
for IN B-PP O
the DT B-NP O
Lowe JJ I-NP B-Disease
oculocerebrorenal JJ I-NP I-Disease
syndrome NN I-NP I-Disease
, , O O
with IN B-PP O
application NN B-NP O
to TO B-PP O
carrier NN B-NP O
assessment NN I-NP O
. . O O

The DT B-NP O
Lowe JJ I-NP B-Disease
oculocerebrorenal JJ I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
OCRL NN B-NP B-Disease
) ) O O
is VBZ B-VP O
characterized VBN I-VP O
by IN B-PP O
congenital JJ B-NP O
cataract NN I-NP B-Disease
, , O O
mental JJ B-NP B-Disease
retardation NN I-NP I-Disease
, , O O
and CC O O
defective JJ B-NP B-Disease
renal JJ I-NP I-Disease
tubular JJ I-NP I-Disease
function NN I-NP I-Disease
. . O O

A DT B-NP O
map NN I-NP O
assignment NN I-NP O
of IN B-PP O
OCRL NN B-NP B-Disease
to TO B-PP O
Xq24 NN B-NP O
- HYPH B-NP O
q26 NN I-NP O
has VBZ B-VP O
been VBN I-VP O
made VBN I-VP O
previously RB B-ADVP O
by IN B-PP O
linkage NN B-NP O
analysis NN I-NP O
with IN B-PP O
DXS42 NN B-NP O
at IN B-PP O
Xq24 NN B-NP O
- HYPH O O
q26 NN B-NP O
( ( O O
theta NN B-NP O
= SYM B-VP O
0 CD B-NP O
, , O O
z NN B-NP O
= SYM B-VP O
5 CD B-NP O
. . O O

09 CD B-NP O
) ) O O
and CC O O
with IN B-PP O
DXS10 NN B-NP O
at IN B-PP O
Xq26 NN B-NP O
( ( O O
theta NN B-NP O
= SYM B-VP O
0 CD B-NP O
, , O O
z NN B-NP O
= SYM B-VP O
6 CD B-NP O
. SYM I-NP O

45 CD I-NP O
) ) O O
. . O O

Two CD B-NP O
additional JJ I-NP O
families NNS I-NP O
were VBD B-VP O
studied VBN I-VP O
and CC O O
three CD B-NP O
additional JJ I-NP O
polymorphisms NNS I-NP O
were VBD B-VP O
identified VBN I-VP O
at IN B-PP O
DXS42 NN B-NP O
by IN B-PP O
using VBG B-VP O
a DT B-NP O
35 CD I-NP O
- HYPH I-NP O
kb NN I-NP O
sequence NN I-NP O
isolated VBN B-VP O
with IN B-PP O
the DT B-NP O
probe NN I-NP O
detecting VBG B-VP O
the DT B-NP O
original JJ I-NP O
polymorphism NN I-NP O
at IN B-PP O
DXS42 NN B-NP O
. . O O

With IN B-PP O
additional JJ B-NP O
OCRL NN I-NP B-Disease
families NNS I-NP O
made VBD B-VP O
informative JJ B-ADJP O
for IN B-PP O
DXS42 NN B-NP O
, , O O
theta NN B-NP O
remained VBD B-VP O
0 CD B-NP O
with IN B-PP O
z NN B-NP O
= SYM B-VP O
6 CD B-NP O
. . O O

63 CD B-NP O
; : O O
and CC O O
for IN B-PP O
DXS10 NN B-NP O
theta NN I-NP O
= SYM B-VP O
0 CD B-NP O
. . O O

03 CD B-NP O
and CC O O
z NN B-NP O
= SYM B-VP O
7 CD B-NP O
. . O O

07 CD B-NP O
. . O O

Evidence NN B-NP O
for IN B-PP O
placing VBG B-VP O
OCRL NN B-NP O
at IN B-PP O
Xq25 NN B-NP O
also RB B-ADVP O
comes VBZ B-VP O
from IN B-PP O
a DT B-NP O
female NN I-NP O
with IN B-PP O
Lowe JJ B-NP B-Disease
syndrome NN I-NP I-Disease
and CC O O
an DT B-NP O
X NN I-NP O
; : O O
3 CD B-NP O
translocation NN I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
used VBN I-VP O
the DT B-NP O
Xq25 NN I-NP O
breakpoint NN I-NP O
in IN B-PP O
this DT B-NP O
patient NN I-NP O
to TO B-VP O
determine VB I-VP O
the DT B-NP O
position NN I-NP O
of IN B-PP O
OCRL NN B-NP O
relative JJ B-ADVP O
to TO B-PP O
the DT B-NP O
two CD I-NP O
linked VBN I-NP O
markers NNS I-NP O
. . O O

Each DT B-NP O
derivative JJ I-NP O
chromosome NN I-NP O
was VBD B-VP O
isolated VBN I-VP O
away RB B-ADVP O
from IN B-PP O
its PRP$ B-NP O
normal JJ I-NP O
counterpart NN I-NP O
in IN B-PP O
somatic JJ B-NP O
cell NN I-NP O
hybrids NNS I-NP O
. . O O

DXS42 NN B-NP O
was VBD B-VP O
mapped VBN I-VP O
to TO B-PP O
the DT B-NP O
derivative JJ I-NP O
chromosome NN I-NP O
X NN I-NP O
containing VBG B-VP O
Xpterq25 NN B-NP O
, , O O
and CC O O
DXS10 NN B-NP O
was VBD B-VP O
mapped VBN I-VP O
to TO B-PP O
the DT B-NP O
derivative JJ I-NP O
chromosome NN I-NP O
3 CD I-NP O
containing VBG I-NP O
Xq25 NN I-NP O
- HYPH B-NP O
qter NN I-NP O
. . O O

The DT B-NP O
markers NNS I-NP O
DXS10 NN I-NP O
and CC I-NP O
DXS42 NN I-NP O
therefore RB B-ADVP O
show VBP B-VP O
tight JJ B-NP O
linkage NN I-NP O
with IN B-PP O
OCRL NN B-NP B-Disease
in IN B-PP O
six CD B-NP O
families NNS I-NP O
and CC O O
flank VB B-VP O
the DT B-NP O
Xq25 NN I-NP O
breakpoint NN I-NP O
in IN B-PP O
a DT B-NP O
female JJ I-NP O
patient NN I-NP O
with IN B-PP O
an DT B-NP O
X NN I-NP O
; : O O
3 CD B-NP O
translocation NN I-NP O
. . O O

Linkage NN B-NP O
analysis NN I-NP O
with IN B-PP O
flanking NN B-NP O
markers NNS I-NP O
was VBD B-VP O
used VBN I-VP O
to TO B-VP O
assess VB I-VP O
OCRL NN B-NP B-Disease
carrier NN I-NP O
status NN I-NP O
in IN B-PP O
women NNS B-NP O
at IN B-PP O
risk NN B-NP O
. . O O

Results NNS B-NP O
, , O O
when WRB B-ADVP O
compared VBN B-PP O
with IN B-PP O
carrier NN B-NP O
determination NN I-NP O
by IN B-PP O
ophthalmologic JJ B-NP O
examination NN I-NP O
, , O O
indicated VBD B-VP O
that IN B-SBAR O
the DT B-NP O
slit JJ I-NP O
- HYPH I-NP O
lamp NN I-NP O
exam NN I-NP O
can MD B-VP O
be VB I-VP O
a DT B-NP O
sensitive JJ I-NP O
and CC I-NP O
specific JJ I-NP O
method NN I-NP O
of IN B-PP O
carrier NN B-NP O
determination NN I-NP O
in IN B-PP O
many JJ B-NP O
cases NNS I-NP O
Identification NN B-NP O
of IN B-PP O
a DT B-NP O
single JJ I-NP O
nucleotide NN I-NP O
change NN I-NP O
in IN B-PP O
the DT B-NP O
hypoxanthine NN I-NP O
- HYPH B-NP O
guanine NN I-NP O
phosphoribosyltransferase NN I-NP O
gene NN I-NP O
( ( O O
HPRTYale NN B-NP O
) ) O O
responsible JJ B-ADJP O
for IN B-PP O
Lesch NNP B-NP B-Disease
- HYPH I-NP I-Disease
Nyhan NNP I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

Complete JJ B-NP O
deficiency NN I-NP B-Disease
of IN B-PP I-Disease
hypoxanthine NN B-NP I-Disease
- HYPH O I-Disease
guanine NN B-NP I-Disease
phosphoribosyltransferase NN I-NP I-Disease
( ( O O
HPRT NN B-NP O
) ) O O
causes VBZ B-VP O
the DT B-NP O
Lesch NNP I-NP B-Disease
- HYPH I-NP I-Disease
Nyhan NNP I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

Previous JJ B-NP O
characterization NN I-NP O
of IN B-PP O
a DT B-NP O
mutant JJ I-NP O
form NN I-NP O
of IN B-PP O
HPRT NN B-NP O
, , O O
HPRTYale NNP B-NP O
, , O O
from IN B-PP O
a DT B-NP O
subject NN I-NP O
with IN B-PP O
the DT B-NP O
Lesch NNP I-NP B-Disease
- HYPH I-NP I-Disease
Nyhan NNP I-NP I-Disease
syndrome NN I-NP I-Disease
revealed VBD B-VP O
normal JJ B-NP O
mRNA NN I-NP O
and CC I-NP O
protein NN I-NP O
concentrations NNS I-NP O
, , O O
no DT B-NP O
residual JJ I-NP O
catalytic JJ I-NP O
activity NN I-NP O
, , O O
and CC O O
cathodal JJ B-NP O
migration NN I-NP O
upon IN B-PP O
PAGE NN B-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
cloned VBN I-VP O
and CC I-VP O
sequenced VBN I-VP O
HPRTYale NN B-NP O
cDNA NN I-NP O
. . O O

The DT B-NP O
nucleotide NN I-NP O
sequence NN I-NP O
of IN B-PP O
full JJ B-NP O
- HYPH I-NP O
length NN I-NP O
HPRTYale NN I-NP O
cDNA NN I-NP O
revealed VBD B-VP O
a DT B-NP O
single JJ I-NP O
nucleotide NN I-NP O
substitution NN I-NP O
compared VBN B-PP O
with IN B-PP O
normal JJ B-NP O
HPRT NN I-NP O
cDNA NN I-NP O
G NN I-NP O
- SYM O O
- SYM O O
- SYM O O
- HYPH O O
C NN B-NP O
at IN B-PP O
nucleotide NN B-NP O
position NN I-NP O
211 CD I-NP O
. . O O

This DT B-NP O
transversion NN I-NP O
predicts VBZ B-VP O
substitution NN B-NP O
of IN B-PP O
arginine NN B-NP O
for IN B-PP O
glycine NN B-NP O
at IN B-PP O
amino JJ B-NP O
acid NN I-NP O
position NN I-NP O
71 CD I-NP O
, , O O
explaining VBG B-VP O
the DT B-NP O
cathodal JJ I-NP O
migration NN I-NP O
of IN B-PP O
HPRTYale NN B-NP O
. . O O

Chou NN B-NP O
- HYPH I-NP O
Fasman NN I-NP O
secondary JJ I-NP O
structure NN I-NP O
analysis NN I-NP O
predicts VBZ B-VP O
a DT B-NP O
change NN I-NP O
in IN B-PP O
the DT B-NP O
probability NN I-NP O
of IN B-PP O
beta SYM B-NP O
- HYPH I-NP O
turn NN I-NP O
formation NN I-NP O
in IN B-PP O
the DT B-NP O
region NN I-NP O
containing VBG B-VP O
the DT B-NP O
mutation NN I-NP O
. . O O

Inclusion NN B-NP O
of IN B-PP O
the DT B-NP O
bulky JJ I-NP O
arginine NN I-NP O
side NN I-NP O
chain NN I-NP O
in IN B-PP O
place NN B-NP O
of IN B-PP O
glycine NN B-NP O
probably RB B-ADVP O
disrupts VBZ B-VP O
protein NN B-NP O
folding NN I-NP O
as RB B-ADVP O
well RB I-ADVP O
. . O O

Cloning VBG B-VP O
mutant JJ B-NP O
forms NNS I-NP O
of IN B-PP O
cDNA NN B-NP O
allows VBZ B-VP O
identification NN B-NP O
of IN B-PP O
specific JJ B-NP O
mutations NNS I-NP O
, , O O
provides VBZ B-VP O
insight NN B-NP O
into IN B-PP O
mutational JJ B-NP O
mechanisms NNS I-NP O
, , O O
and CC O O
facilitates VBZ B-VP O
structure NN B-NP O
- HYPH B-NP O
function NN I-NP O
analysis NN I-NP O
of IN B-PP O
mutant JJ B-NP O
proteins NNS I-NP O
. . O O

. . O O

Two CD B-NP O
point NN I-NP O
mutations NNS I-NP O
are VBP B-VP O
responsible JJ B-ADJP O
for IN B-PP O
G6PD NN B-NP O
polymorphism NN I-NP O
in IN B-PP O
Sardinia NNP B-NP O
. . O O

The DT B-NP O
human JJ I-NP O
X NN I-NP O
- HYPH B-VP O
linked VBN I-VP O
gene NN B-NP O
encoding VBG B-VP O
glucose NN B-NP O
6 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
dehydrogenase NN I-NP O
( ( O O
G6PD NN B-NP O
) ) O O
is VBZ B-VP O
highly RB B-ADJP O
polymorphic JJ I-ADJP O
; : O O
more JJR B-NP O
than IN I-NP O
300 CD I-NP O
G6PD NN I-NP O
variants NNS I-NP O
have VBP B-VP O
been VBN I-VP O
identified VBN I-VP O
. . O O

G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
different JJ B-NP O
geographical JJ I-NP O
areas NNS I-NP O
appears VBZ B-VP O
to TO I-VP O
have VB I-VP O
arisen VBN I-VP O
through IN B-PP O
independent JJ B-NP O
mutational JJ I-NP O
events NNS I-NP O
, , O O
but CC O O
within IN B-PP O
the DT B-NP O
same JJ I-NP O
population NN I-NP O
it PRP B-NP O
may MD B-VP O
also RB I-VP O
be VB I-VP O
heterogeneous JJ B-ADJP O
. . O O

One CD B-NP O
example NN I-NP O
is VBZ B-VP O
the DT B-NP O
island NN I-NP O
of IN B-PP O
Sardinia NNP B-NP O
, , O O
where WRB B-ADVP O
careful JJ B-NP O
clinical JJ I-NP O
and CC I-NP O
biochemical JJ I-NP O
studies NNS I-NP O
have VBP B-VP O
identified VBN I-VP O
four CD B-NP O
different JJ I-NP O
G6PD NN I-NP O
variants NNS I-NP O
. . O O

We PRP B-NP O
cloned VBD B-VP O
and CC O O
sequenced VBD B-VP O
the DT B-NP O
four CD I-NP O
G6PD NN I-NP O
variants NNS I-NP O
from IN B-PP O
Sardinia NNP B-NP O
and CC O O
found VBD B-VP O
that IN B-SBAR O
only RB B-NP O
two CD I-NP O
mutations NNS I-NP O
are VBP B-VP O
responsible JJ B-ADJP O
for IN B-PP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
this DT B-NP O
area NN I-NP O
one CD B-NP O
mutation NN I-NP O
is VBZ B-VP O
the DT B-NP O
cause NN I-NP O
of IN B-PP O
the DT B-NP O
G6PD NN I-NP B-Disease
Seattle NN I-NP I-Disease
- HYPH B-NP I-Disease
like JJ I-NP I-Disease
phenotype NN I-NP I-Disease
, , O O
a DT B-NP O
milder JJR I-NP O
form NN I-NP O
of IN B-PP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
; : O O
the DT B-NP O
other JJ I-NP O
mutation NN I-NP O
is VBZ B-VP O
responsible JJ B-ADJP O
for IN B-PP O
all DT B-NP O
forms NNS I-NP O
of IN B-PP O
very RB B-NP O
severe JJ I-NP O
G6PD NN I-NP B-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
Sardinia NNP B-NP O
and CC O O
, , O O
possibly RB B-ADVP O
, , O O
in IN B-PP O
the DT B-NP O
Mediterranean NNP I-NP O
. . O O

. . O O

Chronic JJ B-NP B-Disease
nonspherocytic JJ I-NP I-Disease
hemolytic JJ I-NP I-Disease
anemia NN I-NP I-Disease
( ( O O
CNSHA NN B-NP B-Disease
) ) O O
and CC O O
glucose NN B-NP B-Disease
6 CD I-NP I-Disease
phosphate NN I-NP I-Disease
dehydrogenase NN I-NP I-Disease
( ( O I-Disease
G6PD NN B-NP I-Disease
) ) O I-Disease
deficiency NN B-NP I-Disease
in IN B-PP O
a DT B-NP O
patient NN I-NP O
with IN B-PP O
familial JJ B-NP B-Disease
amyloidotic JJ I-NP I-Disease
polyneuropathy NN I-NP I-Disease
( ( O O
FAP NN B-NP B-Disease
) ) O O
. . O O

Molecular JJ B-NP O
study NN I-NP O
of IN B-PP O
a DT B-NP O
new JJ I-NP O
variant NN I-NP O
( ( O O
G6PD NN B-NP O
Clinic NN I-NP O
) ) O O
with IN B-PP O
markedly RB B-NP O
acidic JJ I-NP O
pH NN I-NP O
optimum NN I-NP O
. . O O

A DT B-NP O
new JJ I-NP O
glucose NN I-NP O
- HYPH B-NP O
6 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
dehydrogenase NN I-NP O
( ( O O
G6PD NN B-NP O
) ) O O
variant NN B-NP O
with IN B-PP O
severe JJ B-NP O
erythrocytic JJ I-NP B-Disease
G6PD NN I-NP I-Disease
deficiency NN I-NP I-Disease
and CC O O
a DT B-NP O
unique JJ I-NP O
pH NN I-NP O
optimum NN I-NP O
is VBZ B-VP O
described VBN I-VP O
in IN B-PP O
a DT B-NP O
young JJ I-NP O
patient NN I-NP O
with IN B-PP O
chronic JJ B-NP B-Disease
nonspherocytic JJ I-NP I-Disease
hemolytic JJ I-NP I-Disease
anemia NN I-NP I-Disease
( ( O O
CNSHA NN B-NP B-Disease
) ) O O
and CC O O
familial JJ B-NP B-Disease
amyloidotic JJ I-NP I-Disease
polyneuropathy NN I-NP I-Disease
( ( O O
FAP NN B-NP B-Disease
) ) O O
. . O O

Chronic JJ B-NP B-Disease
hemolysis NN I-NP I-Disease
was VBD B-VP O
present JJ B-ADJP O
in IN B-PP O
the DT B-NP O
absence NN I-NP O
of IN B-PP O
infections NNS B-NP O
, , O O
oxidant JJ B-NP O
drugs NNS I-NP O
or CC O O
ingestion NN B-NP O
of IN B-PP O
faba NN B-NP O
beans NNS I-NP O
. . O O

Residual JJ B-NP O
enzyme NN I-NP O
activity NN I-NP O
was VBD B-VP O
about IN B-PP O
2 CD B-NP O
. . O O

6 CD B-NP O
% NN I-NP O
and CC I-NP O
63 CD I-NP O
% NN I-NP O
of IN B-PP O
normal JJ B-NP O
activity NN I-NP O
in IN B-PP O
erythrocytes NNS B-NP O
and CC I-NP O
leucocytes NNS I-NP O
, , O O
respectively RB B-ADVP O
. . O O

A DT B-NP O
molecular JJ I-NP O
study NN I-NP O
using VBG B-VP O
standard JJ B-NP O
methods NNS I-NP O
showed VBD B-VP O
G6PD NN B-NP O
in IN B-PP O
the DT B-NP O
patient NN I-NP O
to TO B-VP O
have VB I-VP O
normal JJ B-NP O
electrophoretic JJ I-NP O
mobility NN I-NP O
( ( O O
at IN B-PP O
pH NN B-NP O
7 CD I-NP O
. . O O

0 CD B-NP O
, , I-NP O
8 CD I-NP O
. . I-NP O

0 CD I-NP O
and CC I-NP O
8 CD I-NP O
. . I-NP O

8 CD I-NP O
) ) O O
, , O O
normal JJ B-NP O
apparent JJ I-NP O
affinity NN I-NP O
for IN B-PP O
substrates NNS B-NP O
( ( O O
Km NN B-NP O
, , O O
G6P NN B-NP O
and CC O O
NADP NN B-NP O
) ) O O
and CC O O
a DT B-NP O
slightly RB I-NP O
abnormal JJ I-NP O
utilization NN I-NP O
of IN B-PP O
substrate NN B-NP O
analogues NNS I-NP O
( ( O O
decreased VBN B-VP O
deamino AFX O O
- HYPH O O
NADP NN B-NP O
and CC O O
increased VBD B-VP O
2 CD B-NP O
- HYPH I-NP O
deoxyglucose NN I-NP O
- HYPH B-NP O
6 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
utilization NN I-NP O
) ) O O
. . O O

Heat NN B-NP O
stability NN I-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
be VB I-VP O
markedly RB I-VP O
decreased VBN I-VP O
( ( O O
8 CD B-NP O
% NN I-NP O
of IN B-PP O
residual JJ B-NP O
activity NN I-NP O
after IN B-PP O
20 CD B-NP O
min NN I-NP O
of IN B-PP O
incubation NN B-NP O
at IN B-PP O
46 CD B-NP O
degrees NNS I-NP O
C NN I-NP O
) ) O O
and CC O O
a DT B-NP O
particular JJ I-NP O
characteristic NN I-NP O
of IN B-PP O
this DT B-NP O
enzyme NN I-NP O
was VBD B-VP O
a DT B-NP O
biphasic JJ I-NP O
pH NN I-NP O
curve NN I-NP O
with IN B-PP O
a DT B-NP O
greatly RB I-NP O
increased VBN I-NP O
activity NN I-NP O
at IN B-PP O
low JJ B-NP O
pH NN I-NP O
. . O O

Although IN B-SBAR O
molecular JJ B-NP O
characteristics NNS I-NP O
of IN B-PP O
this DT B-NP O
variant NN I-NP O
closely RB B-ADVP O
resemble VBP B-VP O
those DT B-NP O
of IN B-PP O
G6PD NN B-NP O
Bangkok NN I-NP O
and CC I-NP O
G6PD NN I-NP O
Duarte NNP I-NP O
, , O O
it PRP B-NP O
can MD B-VP O
be VB I-VP O
distinguished VBN I-VP O
from IN B-PP O
these DT B-NP O
and CC I-NP O
all DT I-NP O
other JJ I-NP O
previously RB I-NP O
reported VBN I-NP O
variants NNS I-NP O
by IN B-PP O
virtue NN B-NP O
of IN B-PP O
its PRP$ B-NP O
unusual JJ I-NP O
pH NN I-NP O
curve NN I-NP O
. . O O

Therefore RB B-ADVP O
the DT B-NP O
present JJ I-NP O
variant NN I-NP O
has VBZ B-VP O
been VBN I-VP O
designated VBN I-VP O
G6PD NN B-NP O
Clinic NN I-NP O
to TO B-VP O
distinguish VB I-VP O
it PRP B-NP O
from IN B-PP O
other JJ B-NP O
G6PD NN I-NP O
variants NNS I-NP O
previously RB B-VP O
described VBN I-VP O
Molecular JJ B-NP O
detection NN I-NP O
of IN B-PP O
chromosomal JJ B-NP O
translocations NNS I-NP O
that WDT B-NP O
disrupt VBP B-VP O
the DT B-NP O
putative JJ I-NP O
retinoblastoma NN I-NP B-Disease
susceptibility NN I-NP O
locus NN I-NP O
. . O O

A DT B-NP O
candidate NN I-NP O
DNA NN I-NP O
sequence NN I-NP O
with IN B-PP O
many JJ B-NP O
of IN B-PP O
the DT B-NP O
properties NNS I-NP O
predicted VBN B-VP O
for IN B-PP O
the DT B-NP O
retinoblastoma NN I-NP B-Disease
susceptibility NN I-NP O
( ( O O
RB1 NN B-NP O
) ) O O
locus NN B-NP O
has VBZ B-VP O
been VBN I-VP O
cloned VBN I-VP O
( ( O O
S NNP B-NP O
. . I-NP O

H NNP I-NP O
. VBD B-VP O

Friend NNP B-NP O
, , O O
R NNP B-NP O
. . I-NP O

Bernards NNP I-NP O
, , O O
S NNP B-NP O
. . I-NP O

Rogelj NNP I-NP O
, , O O
R NNP B-NP O
. . I-NP O

A NNP I-NP O
. . I-NP O

Weinberg NNP I-NP O
, , O O
J NNP B-NP O
. . I-NP O

M NNP I-NP O
. . I-NP O

Rapaport NNP I-NP O
, , O O
D NNP B-NP O
. . I-NP O

M NNP I-NP O
. . I-NP O

Albert NNP I-NP O
, , O O
and CC O O
T NN B-NP O
. VBD B-VP O

P NNP B-NP O
. . I-NP O

Dryja NNP I-NP O
, , O O
Nature NNP B-NP O
[ ( O O
London NNP B-NP O
] ) O O
323 CD B-NP O
643 CD I-NP O
- HYPH B-NP O
645 CD I-NP O
, , I-NP O
1986 CD I-NP O
) ) O O
. . O O

The DT B-NP O
large JJ I-NP O
size NN I-NP O
of IN B-PP O
this DT B-NP O
gene NN I-NP O
( ( O O
ca NN B-NP O
. . O O

200 CD B-NP O
kilobases NNS I-NP O
[ ( O O
kb NN B-NP O
] ) O O
) ) O O
and CC O O
its PRP$ B-NP O
multiple JJ I-NP O
dispersed JJ I-NP O
exons NNS I-NP O
( ( O O
Wiggs NNP B-NP O
et FW I-NP O
al FW I-NP O
. FW I-NP O

, , O O
N NNP B-NP O
. . I-NP O

Engl NNP I-NP O
. . I-NP O

J NNP I-NP O
. . I-NP O

Med NNP I-NP O
. . O O

318 CD B-NP O
151 CD I-NP O
- HYPH B-NP O
157 CD I-NP O
, , I-NP O
1988 CD I-NP O
) ) O O
complicate VBP B-VP O
molecular JJ B-NP O
screening NN I-NP O
strategies NNS I-NP O
important JJ B-ADJP O
in IN B-PP O
prenatal JJ B-NP O
and CC I-NP O
presymptomatic JJ I-NP O
diagnosis NN I-NP O
and CC B-PP O
in IN B-PP O
carrier NN B-NP O
detection NN I-NP O
. . O O

Here RB B-ADVP O
we PRP B-NP O
used VBD B-VP O
field NN B-NP O
inversion NN I-NP O
gel NN I-NP O
electrophoresis NN I-NP O
( ( O O
FIGE NN B-NP O
) ) O O
to TO B-VP O
construct VB I-VP O
a DT B-NP O
restriction NN I-NP O
map NN I-NP O
of IN B-PP O
approximately RB B-NP O
1 CD I-NP O
, , I-NP O
000 CD I-NP O
kb NN I-NP O
of IN B-PP O
DNA NN B-NP O
surrounding VBG B-VP O
the DT B-NP O
RB1 NN I-NP O
locus NN I-NP O
and CC O O
to TO B-VP O
detect VB I-VP O
the DT B-NP O
translocation NN I-NP O
breakpoints NNS I-NP O
in IN B-PP O
three CD B-NP O
retinoblastoma NN I-NP B-Disease
patients NNS I-NP O
. . O O

DNA NN B-NP O
probes NNS I-NP O
from IN B-PP O
either CC O O
the DT B-NP O
5 CD I-NP O
or CC I-NP O
3 CD I-NP O
end NN I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
were VBD B-VP O
used VBN I-VP O
to TO B-VP O
detect VB I-VP O
a DT B-NP O
250 CD I-NP O
- HYPH I-NP O
kb NN I-NP O
EagI NN I-NP O
restriction NN I-NP O
fragment NN I-NP O
in IN B-PP O
DNA NN B-NP O
from IN B-PP O
unaffected JJ B-NP O
individuals NNS I-NP O
. . O O

Both DT B-NP O
probes NNS I-NP O
identified VBD B-VP O
an DT B-NP O
additional JJ I-NP O
hybridizing VBG I-NP O
fragment NN I-NP O
in IN B-PP O
the DT B-NP O
DNA NN I-NP O
from IN B-PP O
each DT B-NP O
patient NN I-NP O
, , O O
permitting VBG B-VP O
the DT B-NP O
breakpoints NNS I-NP O
in IN B-PP O
all DT B-NP O
three CD I-NP O
to TO B-VP O
be VB I-VP O
mapped VBN I-VP O
within IN B-PP O
the DT B-NP O
cloned VBN I-NP O
RB1 NN I-NP O
gene NN I-NP O
. . O O

Analysis NN B-NP O
of IN B-PP O
the DT B-NP O
breakpoint NN I-NP O
in IN B-PP O
one CD B-NP O
translocation NN I-NP O
cell NN I-NP O
line NN I-NP O
allowed VBD B-VP O
the DT B-NP O
RB1 NN I-NP O
gene NN I-NP O
to TO B-VP O
be VB I-VP O
oriented VBN I-VP O
with IN B-PP O
its PRP$ B-NP O
5 CD I-NP O
end NN I-NP O
toward IN B-PP O
the DT B-NP O
centromere NN I-NP O
. . O O

The DT B-NP O
5 CD I-NP O
end NN I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
also RB B-ADVP O
appeared VBD B-VP O
to TO I-VP O
be VB I-VP O
associated VBN I-VP O
with IN B-PP O
a DT B-NP O
clustering NN I-NP O
of IN B-PP O
sites NNS B-NP O
for IN B-PP O
several JJ B-NP O
infrequently RB I-NP O
cleaving VBG I-NP O
restriction NN I-NP O
enzymes NNS I-NP O
, , O O
indicating VBG B-VP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
an DT B-NP O
HpaII NN I-NP O
tiny JJ I-NP O
fragment NN I-NP O
island NN I-NP O
. . O O

The DT B-NP O
detection NN I-NP O
and CC I-NP O
mapping NN I-NP O
of IN B-PP O
the DT B-NP O
translocation NN I-NP O
breakpoints NNS I-NP O
of IN B-PP O
all DT B-NP O
three CD I-NP O
retinoblastoma NN I-NP B-Disease
patients NNS I-NP O
to TO B-PP O
within IN B-PP O
the DT B-NP O
putative JJ I-NP O
RB1 NN I-NP O
gene NN I-NP O
substantiated VBD B-VP O
the DT B-NP O
authenticity NN I-NP O
of IN B-PP O
this DT B-NP O
candidate NN I-NP O
sequence NN I-NP O
and CC O O
demonstrated VBD B-VP O
the DT B-NP O
utility NN I-NP O
of IN B-PP O
FIGE NN B-NP O
in IN B-PP O
detecting VBG B-VP O
chromosomal JJ B-NP O
rearrangements NNS I-NP O
affecting VBG B-VP O
this DT B-NP O
locus NN I-NP O
. . O O

Inherited VBN B-NP O
C3 NN I-NP B-Disease
deficiency NN I-NP I-Disease
with IN B-PP O
recurrent JJ B-NP O
infections NNS I-NP O
and CC I-NP O
glomerulonephritis NN I-NP B-Disease
. . O O

A DT B-NP O
10 CD I-NP O
- HYPH I-NP O
year NN I-NP O
- HYPH O O
old JJ B-NP O
Laotian JJ I-NP O
boy NN I-NP O
had VBD B-VP O
homozygous JJ B-NP O
deficiency NN I-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
third JJ I-NP I-Disease
component NN I-NP I-Disease
of IN B-PP I-Disease
complement NN B-NP I-Disease
and CC O O
recurrent JJ B-NP O
bacterial JJ I-NP B-Disease
infections NNS I-NP I-Disease
beginning VBG B-VP O
at IN B-PP O
age NN B-NP O
5 CD B-NP O
months NNS I-NP O
. . O O

Cellular JJ B-NP O
and CC I-NP O
humoral JJ I-NP O
immunity NN I-NP O
were VBD B-VP O
normal JJ B-ADJP O
, , O O
as IN B-SBAR O
were VBD B-VP O
polymorphonuclear JJ B-NP O
leukocyte NN I-NP O
chemotaxis NN I-NP O
and CC O O
bactericidal JJ B-NP O
activities NNS I-NP O
. . O O

Serum NN B-NP O
complement NN I-NP O
- HYPH O O
mediated VBN B-VP O
hemolytic JJ B-ADJP O
, , O O
chemotactic JJ B-ADJP O
, , O O
and CC O O
opsonic JJ B-NP O
activities NNS I-NP O
were VBD B-VP O
deficient JJ B-ADJP O
. . O O

In FW B-NP O
vitro FW I-NP O
addition NN I-NP O
of IN B-PP O
purified VBN B-NP O
C3 NN I-NP O
to TO B-PP O
patient NN B-NP O
serum NN I-NP O
restored VBD B-VP O
hemolytic JJ B-NP O
complement NN I-NP O
to TO B-PP O
normal JJ B-NP O
levels NNS I-NP O
, , O O
and CC O O
plasma NN B-NP O
infusion NN I-NP O
during IN B-PP O
each DT B-NP O
of IN B-PP O
four CD B-NP O
episodes NNS I-NP O
of IN B-PP O
pneumonia NN B-NP B-Disease
significantly RB B-ADVP O
enhanced VBD B-VP O
serum NN B-NP O
opsonic JJ I-NP O
activity NN I-NP O
for IN B-PP O
as RB B-ADVP O
long JJ I-ADVP O
as IN B-PP O
36 CD B-NP O
hours NNS I-NP O
. . O O

A DT B-NP O
renal JJ I-NP O
biopsy NN I-NP O
specimen NN I-NP O
revealed VBD B-VP O
mesangiopathic JJ B-NP B-Disease
glomerulonephritis NN I-NP I-Disease
, , O O
although IN B-SBAR O
significant JJ B-NP O
levels NNS I-NP O
of IN B-PP O
circulating VBG B-VP O
IgG NN B-NP O
immune JJ I-NP O
complexes NNS I-NP O
were VBD B-VP O
not RB I-VP O
detected VBN I-VP O
. . O O

These DT B-NP O
findings NNS I-NP O
further RB B-ADVP O
support VBP B-VP O
the DT B-NP O
association NN I-NP O
of IN B-PP O
C3 NN B-NP B-Disease
deficiency NN I-NP I-Disease
with IN B-PP O
immune JJ B-NP B-Disease
- HYPH I-NP I-Disease
complex NN I-NP I-Disease
disease NN I-NP I-Disease
and CC O O
suggest VBP B-VP O
that IN B-SBAR O
plasma NN B-NP O
infusion NN I-NP O
may MD B-VP O
be VB I-VP O
an DT B-NP O
adjunct NN I-NP O
to TO B-PP O
antibiotic JJ B-NP O
therapy NN I-NP O
in IN B-PP O
the DT B-NP O
management NN I-NP O
of IN B-PP O
severe JJ B-NP O
pyogenic JJ I-NP B-Disease
infections NNS I-NP I-Disease
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
C3 NN B-NP B-Disease
deficiency NN I-NP I-Disease
. . O O

. . O O

DNA NN B-NP O
restriction NN I-NP O
fragments NNS I-NP O
associated VBN B-VP O
with IN B-PP O
alpha SYM B-NP O
1 CD I-NP O
- HYPH I-NP O
antitrypsin NN I-NP O
indicate VBP B-VP O
a DT B-NP O
single JJ I-NP O
origin NN I-NP O
for IN B-PP O
deficiency NN B-NP O
allele NN I-NP O
PI NN I-NP O
Z NN I-NP O
. . O O

The DT B-NP O
alpha SYM I-NP O
1 CD I-NP O
- HYPH I-NP O
protease NN I-NP O
inhibitor NN I-NP O
, , O O
or CC O O
alpha SYM B-ADJP O
- HYPH I-ADJP O
antitrypsin JJ I-ADJP O
( ( O O
AAT NN B-NP O
) ) O O
, , O O
a DT B-NP O
major JJ I-NP O
plasma NN I-NP O
inhibitor NN I-NP O
of IN B-PP O
leukocyte NN B-NP O
elastase NN I-NP O
and CC O O
bacterial JJ B-NP O
proteases NNS I-NP O
, , O O
is VBZ B-VP O
encoded VBN I-VP O
at IN B-PP O
the DT B-NP O
PI NN I-NP O
locus NN I-NP O
on IN B-PP O
chromosome NN B-NP O
14 CD I-NP O
( ( O O
14q24 CD B-NP O
. . O O

3 CD B-NP O
- HYPH I-NP O
q32 NN I-NP O
. . I-NP O

1 CD I-NP O
) ) O O
. . O O

A DT B-NP O
deficiency NN I-NP B-Disease
of IN B-PP I-Disease
AAT NN B-NP I-Disease
in IN B-PP O
individuals NNS B-NP O
homozygous JJ B-ADJP O
for IN B-PP O
the DT B-NP O
PI NN I-NP O
Z NN I-NP O
allele NN I-NP O
occurs VBZ B-VP O
in IN B-PP O
about RB B-NP O
1 CD I-NP O
in IN B-PP O
2 CD B-NP O
, , I-NP O
000 CD I-NP O
- HYPH I-NP O
8 CD I-NP O
, , I-NP O
000 CD I-NP O
caucasians NNS I-NP O
and CC O O
is VBZ B-VP O
associated VBN I-VP O
with IN B-PP O
an DT B-NP O
increased VBN I-NP O
risk NN I-NP O
of IN B-PP O
early JJ B-NP O
adult JJ I-NP O
onset NN I-NP O
emphysema NN I-NP B-Disease
and CC O O
liver NN B-NP B-Disease
disease NN I-NP I-Disease
in IN B-PP O
childhood NN B-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
now RB I-VP O
used VBN I-VP O
DNA NN B-NP O
polymorphisms NNS I-NP O
associated VBN B-VP O
with IN B-PP O
the DT B-NP O
AAT NN I-NP O
gene NN I-NP O
to TO B-VP O
investigate VB I-VP O
the DT B-NP O
origin NN I-NP O
of IN B-PP O
the DT B-NP O
PI NN I-NP O
Z NN I-NP O
allele NN I-NP O
. . O O

Using VBG B-VP O
two CD B-NP O
genomic JJ I-NP O
probes NNS I-NP O
extending VBG B-VP O
into IN B-PP O
the DT B-NP O
5 CD I-NP O
and CC I-NP O
3 CD I-NP O
flanking NN I-NP O
regions NNS I-NP O
, , O O
respectively RB B-ADVP O
, , O O
we PRP B-NP O
have VBP B-VP O
identified VBN I-VP O
eight CD B-NP O
polymorphic JJ I-NP O
restriction NN I-NP O
sites NNS I-NP O
. . O O

Extensive JJ B-NP O
linkage NN I-NP O
disequilibrium NN I-NP O
occurs VBZ B-VP O
throughout IN B-PP O
the DT B-NP O
probed JJ I-NP O
region NN I-NP O
with IN B-PP O
the DT B-NP O
PI NN I-NP O
Z NN I-NP O
allele NN I-NP O
, , O O
but CC O O
not RB B-PP O
with IN I-PP O
normal JJ B-NP O
PI NN I-NP O
M NN I-NP O
alleles NNS I-NP O
. . O O

The DT B-NP O
Z NN I-NP O
allele NN I-NP O
occurs VBZ B-VP O
mainly RB B-ADVP O
with IN B-PP O
one CD B-NP O
haplotype NN I-NP O
, , O O
indicating VBG B-VP O
a DT B-NP O
single JJ I-NP O
, , I-NP O
relatively RB I-NP O
recent JJ I-NP O
, , I-NP O
origin NN I-NP O
in IN B-PP O
caucasians NNS B-NP O
Segregation NN B-NP O
analysis NN I-NP O
of IN B-PP O
a DT B-NP O
marker NN I-NP O
localised JJ I-NP O
Xp21 NN I-NP O
. . O O

2 CD B-NP O
- HYPH I-NP O
Xp21 NN I-NP O
. . I-NP O

3 CD I-NP O
in IN B-PP O
Duchenne NNP B-NP B-Disease
and CC I-NP I-Disease
Becker NNP I-NP I-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
families NNS I-NP O
. . O O

A DT B-NP O
DNA NN I-NP O
marker NN I-NP O
C7 NN I-NP O
, , O O
localised JJ B-NP O
Xp21 NN I-NP O
. . O O

1 CD B-NP O
- HYPH I-NP O
Xp21 NN I-NP O
. . O O

3 CD B-NP O
, , O O
has VBZ B-VP O
been VBN I-VP O
studied VBN I-VP O
in IN B-PP O
kindreds NNS B-NP O
segregating VBG B-VP O
for IN B-PP O
Duchenne NNP B-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
DMD NN B-NP B-Disease
) ) O O
and CC O O
Becker NNP B-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
BMD NN B-NP B-Disease
) ) O O
. . O O

In IN B-PP O
DMD NN B-NP B-Disease
families NNS I-NP O
four CD B-NP O
crossovers NNS I-NP O
were VBD B-VP O
observed VBN I-VP O
in IN B-PP O
38 CD B-NP O
informative JJ I-NP O
meioses NNS I-NP O
between IN B-PP O
C7 NN B-NP O
and CC O O
the DT B-NP O
DMD NN I-NP B-Disease
locus NN I-NP O
( ( O O
theta NN B-NP O
= SYM B-VP O
0 CD B-NP O
. SYM I-NP O

12 CD I-NP O
, , O O
z NN B-NP O
max NN I-NP O
= SYM B-VP O
+ SYM B-NP O
2 CD I-NP O
. . I-NP O

72 CD I-NP O
) ) O O
. . O O

In IN B-PP O
BMD NN B-NP B-Disease
families NNS I-NP O
no DT B-NP O
recombinants NNS I-NP O
were VBD B-VP O
observed VBN I-VP O
in IN B-PP O
the DT B-NP O
16 CD I-NP O
informative JJ I-NP O
meioses NNS I-NP O
studied VBN B-VP O
. . O O

These DT B-NP O
data NNS I-NP O
are VBP B-VP O
consistent JJ B-ADJP O
with IN B-PP O
the DT B-NP O
localisation NN I-NP O
of IN B-PP O
the DT B-NP O
mutations NNS I-NP O
in IN B-PP O
these DT B-NP O
disorders NNS I-NP O
being VBG B-VP O
in IN B-PP O
the DT B-NP O
same JJ I-NP O
region NN I-NP O
of IN B-PP O
Xp21 NN B-NP O
. . O O

Studies NNS B-NP O
in IN B-PP O
families NNS B-NP O
also RB B-ADVP O
segregating VBG B-VP O
for IN B-PP O
the DT B-NP O
DNA NN I-NP O
marker NN I-NP O
754 CD I-NP O
support NN I-NP O
the DT B-NP O
previously RB I-NP O
reported VBN I-NP O
physical JJ I-NP O
order NN I-NP O
of IN B-PP O
these DT B-NP O
loci NNS I-NP O
as IN B-PP O
X NN B-NP O
centromere NN I-NP O
- HYPH B-NP O
754 CD I-NP O
- HYPH I-NP O
DMD NN I-NP O
- HYPH B-NP O
BMD NN I-NP O
- HYPH B-NP O
C7 NN I-NP O
- HYPH I-NP O
X NN I-NP O
telomere NN I-NP O
. . O O

A DT B-NP O
recombination NN I-NP O
fraction NN I-NP O
of IN B-PP O
0 CD B-NP O
. . O O

11 CD B-NP O
( ( O O
z NN B-NP O
max NN I-NP O
= SYM B-VP O
+ SYM B-NP O
5 CD I-NP O
. SYM I-NP O

58 CD I-NP O
) ) O O
was VBD B-VP O
found VBN I-VP O
between IN B-PP O
DMD NN B-NP O
- HYPH O O
754 CD B-NP O
by IN B-PP O
combining VBG B-VP O
our PRP$ B-NP O
previously RB I-NP O
published VBN I-NP O
data NNS I-NP O
with IN B-PP O
the DT B-NP O
data NNS I-NP O
presented VBN B-VP O
here RB B-ADVP O
. . O O

C7 NN B-NP O
and CC O O
754 CD B-NP O
thus RB B-ADVP O
provide VBP B-VP O
good JJ B-NP O
bridging NN I-NP O
markers NNS I-NP O
for IN B-PP O
the DT B-NP O
diagnosis NN I-NP O
of IN B-PP O
DMD NN B-NP B-Disease
and CC I-NP O
BMD NN I-NP B-Disease
Isolation NN B-NP O
of IN B-PP O
molecular JJ B-NP O
probes NNS I-NP O
associated VBN B-VP O
with IN B-PP O
the DT B-NP O
chromosome NN I-NP O
15 CD I-NP O
instability NN I-NP O
in IN B-PP O
the DT B-NP O
Prader NNP I-NP B-Disease
- HYPH I-NP I-Disease
Willi NNP I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

Flow NN B-NP O
cytometry NN I-NP O
and CC O O
recombinant JJ B-NP O
DNA NN I-NP O
techniques NNS I-NP O
have VBP B-VP O
been VBN I-VP O
used VBN I-VP O
to TO B-VP O
obtain VB I-VP O
reagents NNS B-NP O
for IN B-PP O
a DT B-NP O
molecular JJ I-NP O
analysis NN I-NP O
of IN B-PP O
the DT B-NP O
Prader NNP I-NP B-Disease
- HYPH I-NP I-Disease
Willi NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
PWS NN B-NP B-Disease
) ) O O
. . O O

HindIII LS B-NP O
total JJ I-NP O
- HYPH I-NP O
digest NN I-NP O
libraries NNS I-NP O
were VBD B-VP O
prepared VBN I-VP O
in IN B-PP O
lambda NN B-NP O
phage NN I-NP O
Charon NNP I-NP O
21A NN I-NP O
from IN B-PP O
flow NN B-NP O
- HYPH O O
sorted VBN B-VP O
inverted VBN I-VP O
duplicated VBN B-VP O
no DT B-NP O
. . I-NP O

15 CD I-NP O
human JJ I-NP O
chromosomes NNS I-NP O
and CC O O
propagated VBN B-VP O
on IN B-PP O
recombination NN B-NP O
- HYPH O O
proficient JJ O O
( ( O O
LE392 NN B-NP O
) ) O O
and CC O O
recBC NN B-NP O
- HYPH B-ADJP O
, , O O
sbcB NN B-NP O
- HYPH O O
( ( O O
DB1257 NN B-NP O
) ) O O
bacteria NNS B-NP O
. . O O

Twelve CD B-NP O
distinct JJ I-NP O
chromosome NN I-NP O
15 CD I-NP O
- HYPH I-NP O
specific JJ I-NP O
probes NNS I-NP O
have VBP B-VP O
been VBN I-VP O
isolated VBN I-VP O
. . O O

Eight CD B-NP O
localized VBD B-VP O
to TO B-PP O
the DT B-NP O
region NN I-NP O
15q11 CD I-NP O
- SYM O O
- SYM O O
- SYM O O
- SYM B-NP O
13 CD B-NP O
. . O O

Four CD B-NP O
of IN B-PP O
these DT B-NP O
eight CD I-NP O
sublocalized VBD B-VP O
to TO B-PP O
band NN B-NP O
15q11 CD I-NP O
. . O O

2 CD B-NP O
and CC O O
are VBP B-VP O
shown VBN I-VP O
to TO I-VP O
be VB I-VP O
deleted VBN I-VP O
in IN B-PP O
DNA NN B-NP O
of IN B-PP O
one CD B-NP O
of IN B-PP O
two CD B-NP O
patients NNS I-NP O
examined VBN B-VP O
with IN B-PP O
the DT B-NP O
PWS NN I-NP B-Disease
. . O O

Heteroduplex NN B-NP O
analysis NN I-NP O
of IN B-PP O
two CD B-NP O
of IN B-PP O
these DT B-NP O
clones NNS I-NP O
, , O O
which WDT B-NP O
grew VBD B-VP O
on IN B-PP O
DB1257 NN B-NP O
but CC B-PP O
not RB B-PP O
on IN I-PP O
LE392 NN B-NP O
, , O O
revealed VBD B-VP O
stem NN B-NP O
- HYPH B-NP O
loop NN I-NP O
structures NNS I-NP O
in IN B-PP O
the DT B-NP O
inserts NNS I-NP O
, , O O
indicative JJ B-ADJP O
of IN B-PP O
inverted VBN B-VP O
, , O O
repeated VBN B-NP O
DNA NN I-NP O
elements NNS I-NP O
. . O O

Such JJ B-NP O
DNA NN I-NP O
repeats NNS I-NP O
might MD B-VP O
account VB I-VP O
for IN B-PP O
some DT B-NP O
of IN B-PP O
the DT B-NP O
cloning NN I-NP O
instability NN I-NP O
of IN B-PP O
DNA NN B-NP O
segments NNS I-NP O
from IN B-PP O
proximal JJ B-NP O
15q NN I-NP O
. . O O

Analysis NN B-NP O
of IN B-PP O
the DT B-NP O
genetic JJ I-NP O
and CC I-NP O
physical JJ I-NP O
instability NN I-NP O
associated VBN B-VP O
with IN B-PP O
the DT B-NP O
repeated VBN I-NP O
sequences NNS I-NP O
we PRP B-NP O
have VBP B-VP O
isolated VBN I-VP O
from IN B-PP O
band NN B-NP O
15q11 CD I-NP O
. . O O

2 LS B-NP O
may MD B-VP O
elucidate VB I-VP O
the DT B-NP O
molecular JJ I-NP O
basis NN I-NP O
for IN B-PP O
the DT B-NP O
instability NN I-NP O
of IN B-PP O
this DT B-NP O
chromosomal JJ I-NP O
region NN I-NP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
the DT B-NP O
PWS NN I-NP B-Disease
or CC O O
other JJ B-NP O
diseases NNS I-NP O
associated VBN B-VP O
with IN B-PP O
chromosomal JJ B-NP B-Disease
abnormalities NNS I-NP I-Disease
in IN B-PP O
the DT B-NP O
proximal JJ I-NP O
long JJ I-NP O
arm NN I-NP O
of IN B-PP O
human JJ B-NP O
chromosome NN I-NP O
15 CD I-NP O
Analysis NN B-NP O
of IN B-PP O
deletions NNS B-NP O
in IN B-PP O
DNA NN B-NP O
from IN B-PP O
patients NNS B-NP O
with IN B-PP O
Becker NNP B-NP B-Disease
and CC I-NP I-Disease
Duchenne NNP I-NP I-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
. . O O

Duchenne JJ B-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
DMD NN B-NP B-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
X NN I-NP B-Disease
- HYPH O I-Disease
linked VBN B-VP I-Disease
recessive JJ B-NP I-Disease
genetic JJ I-NP I-Disease
disorder NN I-NP I-Disease
for IN B-PP O
which WDT B-NP O
the DT B-NP O
biochemical JJ I-NP O
defect NN I-NP O
is VBZ B-VP O
as RB B-PP O
yet RB B-ADJP O
unknown JJ I-ADJP O
. . O O

Recently RB B-ADVP O
, , O O
two CD B-NP O
cloned VBN I-NP O
segments NNS I-NP O
of IN B-PP O
human JJ B-NP O
X NN I-NP O
- HYPH I-NP O
chromosome NN I-NP O
DNA NN I-NP O
have VBP B-VP O
been VBN I-VP O
described VBN I-VP O
which WDT B-NP O
detect VBP B-VP O
structural JJ B-NP O
alterations NNS I-NP O
within IN B-PP O
or CC I-PP O
near IN I-PP O
the DT B-NP O
genetic JJ I-NP O
locus NN I-NP O
responsible JJ B-ADJP O
for IN B-PP O
the DT B-NP O
disorder NN I-NP O
. . O O

Both DT B-NP O
of IN B-PP O
these DT B-NP O
cloned VBN I-NP O
segments NNS I-NP O
were VBD B-VP O
described VBN I-VP O
as IN B-PP O
tightly RB B-ADVP O
linked VBN B-VP O
to TO B-PP O
the DT B-NP O
locus NN I-NP O
and CC O O
were VBD B-VP O
capable JJ B-ADJP O
of IN B-PP O
detecting VBG B-VP O
deletions NNS B-NP O
in IN B-PP O
the DT B-NP O
DNA NN I-NP O
of IN B-PP O
boys NNS B-NP O
affected VBN B-VP O
with IN B-PP O
DMD NN B-NP B-Disease
. . O O

In IN B-PP O
an DT B-NP O
attempt NN I-NP O
to TO B-VP O
determine VB I-VP O
more RBR B-ADVP O
precisely RB I-ADVP O
the DT B-NP O
occurrence NN I-NP O
of IN B-PP O
these DT B-NP O
deletions NNS I-NP O
within IN B-PP O
a DT B-NP O
large JJ I-NP O
population NN I-NP O
of IN B-PP O
DMD NN B-NP B-Disease
patients NNS I-NP O
and CC O O
the DT B-NP O
accuracy NN I-NP O
of IN B-PP O
one CD B-NP O
of IN B-PP O
the DT B-NP O
segments NNS I-NP O
, , O O
DXS164 NN B-NP O
( ( O O
pERT87 NN B-NP O
) ) O O
, , O O
in IN B-PP O
determining VBG B-VP O
the DT B-NP O
inheritance NN I-NP O
of IN B-PP O
the DT B-NP O
DMD NN I-NP B-Disease
X NN I-NP O
chromosome NN I-NP O
, , O O
the DT B-NP O
subclones NNS I-NP O
1 CD I-NP O
, , I-NP O
8 CD I-NP O
and CC I-NP O
15 CD I-NP O
were VBD B-VP O
made VBN I-VP O
available JJ B-ADJP O
to TO B-PP O
many JJ B-NP O
investigators NNS I-NP O
throughout IN B-PP O
the DT B-NP O
world NN I-NP O
. . O O

Here RB B-ADVP O
we PRP B-NP O
describe VBP B-VP O
the DT B-NP O
combined VBN I-NP O
results NNS I-NP O
of IN B-PP O
more JJR B-NP O
than IN I-NP O
20 CD I-NP O
research NN I-NP O
laboratories NNS I-NP O
with IN B-PP O
respect NN B-NP O
to TO B-PP O
the DT B-NP O
occurrence NN I-NP O
of IN B-PP O
deletions NNS B-NP O
at IN B-PP O
the DT B-NP O
DXS164 NN I-NP O
locus NN I-NP O
in IN B-PP O
DNA NN B-NP O
samples NNS I-NP O
isolated VBN B-VP O
from IN B-PP O
patients NNS B-NP O
with IN B-PP O
DMD NN B-NP B-Disease
and CC O O
Becker NNP B-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
BMD NN B-NP B-Disease
) ) O O
. . O O

The DT B-NP O
results NNS I-NP O
indicate VBP B-VP O
that IN B-SBAR O
the DT B-NP O
DXS164 NN I-NP O
locus NN I-NP O
apparently RB B-ADVP O
recombines VBZ B-VP O
with IN B-PP O
DMD NN B-NP B-Disease
5 CD B-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
time NN I-NP O
, , O O
but CC O O
is VBZ B-VP O
probably RB B-ADVP O
located JJ B-ADJP O
between IN B-PP O
independent JJ B-NP O
sites NNS I-NP O
of IN B-PP O
mutation NN B-NP O
which WDT B-NP O
yield VBP B-VP O
DMD NN B-NP B-Disease
. . O O

The DT B-NP O
breakpoints NNS I-NP O
of IN B-PP O
some DT B-NP O
deletions NNS I-NP O
are VBP B-VP O
delineated VBN I-VP O
within IN B-PP O
the DT B-NP O
DXS164 NN I-NP O
locus NN I-NP O
, , O O
and CC O O
it PRP B-NP O
is VBZ B-VP O
evident JJ B-ADJP O
that IN B-SBAR O
the DT B-NP O
deletions NNS I-NP O
at IN B-PP O
the DT B-NP O
DMD NN I-NP B-Disease
locus NN I-NP O
are VBP B-VP O
frequent JJ B-ADJP O
and CC O O
extremely RB B-ADJP O
large JJ I-ADJP O
. . O O

. . O O

A DT B-NP O
potential JJ I-NP O
animal NN I-NP O
model NN I-NP O
for IN B-PP O
Lesch NNP B-NP B-Disease
- HYPH I-NP I-Disease
Nyhan NNP I-NP I-Disease
syndrome NN I-NP I-Disease
through IN B-PP O
introduction NN B-NP O
of IN B-PP O
HPRT NN B-NP O
mutations NNS I-NP O
into IN B-PP O
mice NNS B-NP O
. . O O

The DT B-NP O
human JJ I-NP O
Lesch NNP I-NP B-Disease
- HYPH I-NP I-Disease
Nyhan NNP I-NP I-Disease
syndrome NN I-NP I-Disease
is VBZ B-VP O
a DT B-NP O
rare JJ I-NP O
neurological JJ I-NP B-Disease
and CC I-NP I-Disease
behavioural JJ I-NP I-Disease
disorder NN I-NP I-Disease
, , O O
affecting VBG B-VP O
only JJ B-NP O
males NNS I-NP O
, , O O
which WDT B-NP O
is VBZ B-VP O
caused VBN I-VP O
by IN B-PP O
an DT B-NP O
inherited VBN I-NP B-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
the DT B-NP O
level NN I-NP O
of IN B-PP O
activity NN B-NP O
of IN B-PP O
the DT B-NP O
purine NN I-NP O
salvage NN I-NP O
enzyme NN I-NP O
hypoxanthine NN I-NP O
- HYPH B-NP O
guanosine NN I-NP O
phosphoribosyl NN I-NP O
transferase NN I-NP O
( ( O O
HPRT NN B-NP O
) ) O O
. . O O

How WRB B-ADVP O
the DT B-NP O
resulting VBG I-NP O
alterations NNS I-NP O
in IN B-PP O
purine NN B-NP O
metabolism NN I-NP O
lead VBP B-VP O
to TO B-PP O
the DT B-NP O
severe JJ I-NP O
symptoms NNS I-NP O
characteristic JJ B-ADJP O
of IN B-PP O
Lesch NNP B-NP B-Disease
- HYPH B-NP I-Disease
Nyhan NNP I-NP I-Disease
patients NNS I-NP O
is VBZ B-VP O
still RB B-ADVP O
not RB O O
understood VBN B-VP O
. . O O

No DT B-NP O
mutations NNS I-NP O
at IN B-PP O
the DT B-NP O
Hprt NN I-NP O
locus NN I-NP O
leading VBG B-VP O
to TO B-PP O
loss NN B-NP O
of IN B-PP O
activity NN B-NP O
have VBP B-VP O
been VBN I-VP O
described VBN I-VP O
in IN B-PP O
laboratory NN B-NP O
animals NNS I-NP O
. . O O

To TO B-VP O
derive VB I-VP O
an DT B-NP O
animal NN I-NP O
model NN I-NP O
for IN B-PP O
the DT B-NP O
Lesch NNP I-NP B-Disease
- HYPH I-NP I-Disease
Nyhan NNP I-NP I-Disease
syndrome NN I-NP I-Disease
, , O O
we PRP B-NP O
have VBP B-VP O
used VBN I-VP O
cultured VBN B-NP O
mouse NN I-NP O
embryonic JJ I-NP O
stem NN I-NP O
cells NNS I-NP O
, , O O
mutagenized VBN B-VP O
by IN B-PP O
retroviral JJ B-NP O
insertion NN I-NP O
and CC O O
selected VBN B-VP O
for IN B-PP O
loss NN B-NP O
of IN B-PP O
HPRT NN B-NP O
activity NN I-NP O
, , O O
to TO B-VP O
construct VB I-VP O
chimaeric JJ B-NP O
mice NNS I-NP O
. . O O

Two CD B-NP O
clonal JJ I-NP O
lines NNS I-NP O
carrying VBG B-VP O
different JJ B-NP O
mutant JJ I-NP O
Hprt NN I-NP O
alleles NNS I-NP O
have VBP B-VP O
given VBN I-VP O
rise NN B-NP O
to TO B-PP O
germ NN B-NP O
cells NNS I-NP O
in IN B-PP O
chimaeras NNS B-NP O
, , O O
allowing VBG B-VP O
the DT B-NP O
derivation NN I-NP O
of IN B-PP O
strains NNS B-NP O
of IN B-PP O
mutant JJ B-NP O
mice NNS I-NP O
having VBG B-VP O
the DT B-NP O
same JJ I-NP O
biochemical JJ I-NP O
defect NN I-NP O
as IN B-PP O
Lesch NNP B-NP B-Disease
- HYPH B-NP I-Disease
Nyhan NNP I-NP I-Disease
patients NNS I-NP O
. . O O

Male JJ B-NP O
mice NNS I-NP O
carrying VBG B-VP O
the DT B-NP O
mutant JJ I-NP O
alleles NNS I-NP O
are VBP B-VP O
viable JJ B-ADJP O
and CC O O
analysis NN B-NP O
of IN B-PP O
their PRP$ B-NP O
cells NNS I-NP O
shows VBZ B-VP O
a DT B-NP O
total JJ I-NP O
lack NN I-NP O
of IN B-PP O
HPRT NN B-NP O
activity NN I-NP O
. . O O

. . O O

Re NN B-NP O
- HYPH I-NP O
evaluation NN I-NP O
of IN B-PP O
the DT B-NP O
sublocalization NN I-NP O
of IN B-PP O
esterase NN B-NP O
D NN I-NP O
and CC O O
its PRP$ B-NP O
relation NN I-NP O
to TO B-PP O
the DT B-NP O
retinoblastoma NN I-NP B-Disease
locus NN I-NP O
by IN B-PP O
in FW B-NP O
situ FW I-NP O
hybridization NN I-NP O
. . O O

In FW B-NP O
situ FW I-NP O
hybridization NN I-NP O
of IN B-PP O
a DT B-NP O
cDNA NN I-NP O
probe NN I-NP O
for IN B-PP O
the DT B-NP O
esterase NN I-NP O
D NN I-NP O
gene NN I-NP O
( ( O O
ESD NN B-NP O
) ) O O
was VBD B-VP O
carried VBN I-VP O
out RP B-PRT O
on IN B-PP O
human JJ B-NP O
chromosomes NNS I-NP O
. . O O

The DT B-NP O
probe NN I-NP O
hybridized VBD B-VP O
most RBS B-ADVP O
strongly RB I-ADVP O
to TO B-PP O
13q14 CD B-NP O
. . O O

2 CD B-NP O
and CC I-NP O
13q14 CD I-NP O
. . O O

3 LS B-LST O
. . O O

This DT B-NP O
observation NN I-NP O
raises VBZ B-VP O
doubts NNS B-NP O
concerning VBG B-VP O
the DT B-NP O
most RBS I-NP O
recently RB I-NP O
published VBN I-NP O
assignment NN I-NP O
of IN B-PP O
ESD NN B-NP O
to TO B-PP O
13q14 CD B-NP O
. . O O

1 LS B-LST O
. . O O

A DT B-NP O
deletion NN I-NP O
in IN B-PP O
an DT B-NP O
individual NN I-NP O
with IN B-PP O
retinoblastoma NN B-NP B-Disease
was VBD B-VP O
reported VBN I-VP O
to TO I-VP O
separate VB I-VP O
the DT B-NP O
closely RB I-NP O
linked VBN I-NP O
ESD NN I-NP O
and CC I-NP O
retinoblastoma NN I-NP B-Disease
( ( O O
RB1 NN B-NP O
) ) O O
loci NNS B-NP O
, , O O
placing VBG B-VP O
ESD NN B-NP O
proximal JJ B-ADJP O
to TO B-PP O
RB1 NN B-NP O
. . O O

Quantitative JJ B-NP O
in FW I-NP O
situ FW I-NP O
hybridization NN I-NP O
studies NNS I-NP O
of IN B-PP O
this DT B-NP O
deletion NN I-NP O
do VBP B-VP O
not RB I-VP O
confirm VB I-VP O
this DT B-NP O
interpretation NN I-NP O
. . O O

Rather RB B-ADVP O
, , O O
they PRP B-NP O
suggest VBP B-VP O
that IN B-SBAR O
ESD NN B-NP O
is VBZ B-VP O
missing VBG B-ADJP O
from IN B-PP O
the DT B-NP O
deleted VBN I-NP O
chromosome NN I-NP O
13 CD I-NP O
and CC O O
duplicated VBN B-VP O
on IN B-PP O
the DT B-NP O
normal JJ I-NP O
homolog NN I-NP O
. . O O

From IN B-PP O
these DT B-NP O
findings NNS I-NP O
, , O O
we PRP B-NP O
conclude VBP B-VP O
that IN B-SBAR O
the DT B-NP O
deletion NN I-NP O
in IN B-PP O
this DT B-NP O
individual NN I-NP O
cannot MD B-VP O
be VB I-VP O
used VBN I-VP O
to TO B-VP O
determine VB I-VP O
the DT B-NP O
orientation NN I-NP O
nor CC O O
the DT B-NP O
sublocalization NN I-NP O
of IN B-PP O
ESD NN B-NP O
and CC I-NP O
RB1 NN I-NP O
within IN B-PP O
the DT B-NP O
13q14 CD I-NP O
region NN I-NP O
. . O O

Hereditary JJ B-NP B-Disease
C2 NN I-NP I-Disease
deficiency NN I-NP I-Disease
associated VBN B-VP O
with IN B-PP O
common JJ B-NP O
variable JJ I-NP O
immunodeficiency NN I-NP B-Disease
. . O O

Homozygous JJ B-NP O
C2 NN I-NP B-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
a DT B-NP O
19 CD I-NP O
- HYPH I-NP O
year NN I-NP O
- HYPH O O
old JJ B-NP O
boy NN I-NP O
was VBD B-VP O
associated VBN I-VP O
with IN B-PP O
variable JJ B-NP O
immunodeficiency NN I-NP B-Disease
manifested VBN B-VP O
by IN B-PP O
marked JJ B-NP O
hypoimmunoglobulinemia NN I-NP B-Disease
and CC O O
impaired JJ B-NP O
antibody NN I-NP O
responses NNS I-NP O
, , O O
normal JJ B-NP O
circulating VBG I-NP O
B NN I-NP O
lymphocytes NNS I-NP O
, , O O
and CC O O
subnormal JJ B-NP O
T NN I-NP O
- HYPH B-NP O
cell NN I-NP O
functions NNS I-NP O
. . O O

Neither DT B-NP O
antilymphocytic JJ I-NP O
autoantibodies NNS I-NP O
nor CC O O
chromosomal JJ B-NP B-Disease
abnormalities NNS I-NP I-Disease
were VBD B-VP O
found VBN I-VP O
. . O O

Serum NN B-NP O
immunoglobulin NN I-NP O
levels NNS I-NP O
were VBD B-VP O
within IN B-PP O
normal JJ B-NP O
limits NNS I-NP O
in IN B-PP O
his PRP$ B-NP O
parents NNS I-NP O
and CC I-NP O
brother NN I-NP O
who WP B-NP O
were VBD B-VP O
heterozygous JJ B-ADJP O
for IN B-PP O
C2 NN B-NP B-Disease
deficiency NN I-NP I-Disease
. . O O

The DT B-NP O
patients NNS I-NP O
lymphocytes NNS I-NP O
were VBD B-VP O
homozygous JJ B-ADJP O
at IN B-PP O
the DT B-NP O
HLA NN I-NP O
- HYPH B-NP O
D NN I-NP O
locus NN I-NP O
but CC O O
expressed VBD B-VP O
an DT B-NP O
antigen NN I-NP O
different JJ B-ADJP O
from IN B-PP O
DW2 NN B-NP O
. . O O

. . O O

Mild JJ B-NP O
and CC I-NP O
severe JJ I-NP O
muscular JJ I-NP B-Disease
dystrophy NN I-NP I-Disease
associated VBN B-VP O
with IN B-PP O
deletions NNS B-NP O
in IN B-PP O
Xp21 NN B-NP O
of IN B-PP O
the DT B-NP O
human JJ I-NP O
X NN I-NP O
chromosome NN I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
analysed VBN I-VP O
over IN B-PP O
300 CD B-NP O
patients NNS I-NP O
suffering VBG B-VP O
from IN B-PP O
Duchenne NNP B-NP B-Disease
or CC I-NP I-Disease
Becker NNP I-NP I-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
DMD NN B-NP B-Disease
or CC O O
BMD NN B-NP B-Disease
) ) O O
. . O O

Deletions NNS B-NP O
have VBP B-VP O
been VBN I-VP O
characterised VBN I-VP O
which WDT B-NP O
encompass VBP B-VP O
either CC O O
the DT B-NP O
pERT87 NN I-NP O
( ( O O
DXS164 NN B-NP O
) ) O O
locus NN B-NP O
only RB B-ADVP O
, , O O
the DT B-NP O
XJ1 NN I-NP O
. . O O

1 CD B-NP O
( ( O O
DXS206 NN B-NP O
) ) O O
and CC O O
HIP25 NN B-NP O
loci NNS I-NP O
only RB B-ADVP O
, , O O
or CC O O
all DT B-NP O
three CD I-NP O
loci NNS I-NP O
. . O O

These DT B-NP O
loci NNS I-NP O
have VBP B-VP O
been VBN I-VP O
shown VBN I-VP O
to TO I-VP O
lie VB I-VP O
within IN B-PP O
the DT B-NP O
DMD NN I-NP B-Disease
region NN I-NP O
covering VBG B-VP O
several JJ B-NP O
hundred CD I-NP O
kilobases NNS I-NP O
( ( O O
kb NN B-NP O
) ) O O
of IN B-PP O
DNA NN B-NP O
. . O O

One CD B-NP O
mildly RB B-VP O
affected VBD I-VP O
BMD NN B-NP B-Disease
patient NN I-NP O
possesses VBZ B-VP O
a DT B-NP O
deletion NN I-NP O
of IN B-PP O
at IN B-NP O
least JJS I-NP O
110 CD I-NP O
kb NN I-NP O
including VBG B-PP O
exons NNS B-NP O
of IN B-PP O
the DT B-NP O
DMD NN I-NP B-Disease
gene NN I-NP O
. . O O

Other JJ B-NP O
patients NNS I-NP O
with IN B-PP O
similar JJ B-NP O
exon NN I-NP O
deletions NNS I-NP O
, , O O
or CC O O
smaller JJR B-NP O
deletions NNS I-NP O
, , O O
show VBP B-VP O
the DT B-NP O
more RBR I-NP O
severe JJ I-NP O
phenotype NN I-NP O
typical JJ B-ADJP O
of IN B-PP O
DMD NN B-NP B-Disease
. . O O

We PRP B-NP O
conclude VBP B-VP O
from IN B-PP O
these DT B-NP O
studies NNS I-NP O
that IN B-SBAR O
the DT B-NP O
severity NN I-NP O
of IN B-PP O
the DT B-NP O
clinical JJ I-NP O
phenotype NN I-NP O
cannot MD B-VP O
be VB I-VP O
explained VBN I-VP O
on IN B-PP O
the DT B-NP O
basis NN I-NP O
of IN B-PP O
the DT B-NP O
size NN I-NP O
of IN B-PP O
the DT B-NP O
deletion NN I-NP O
. . O O

We PRP B-NP O
discuss VBP B-VP O
this DT B-NP O
in IN B-PP O
the DT B-NP O
context NN I-NP O
of IN B-PP O
candidate NN B-NP O
gene NN I-NP O
sequences NNS I-NP O
. . O O

Patterns NNS B-NP O
of IN B-PP O
exon NN B-NP O
deletions NNS I-NP O
in IN B-PP O
Duchenne NNP B-NP B-Disease
and CC I-NP I-Disease
Becker NNP I-NP I-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
. . O O

A DT B-NP O
panel NN I-NP O
of IN B-PP O
patients NNS B-NP O
with IN B-PP O
Duchenne NNP B-NP B-Disease
and CC I-NP I-Disease
Becker NNP I-NP I-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
DMD NN B-NP B-Disease
and CC O O
BMD NN B-NP B-Disease
) ) O O
has VBZ B-VP O
been VBN I-VP O
screened VBN I-VP O
with IN B-PP O
the DT B-NP O
cDNA NN I-NP O
probes NNS I-NP O
Cf56a NN I-NP O
and CC I-NP O
Cf23a NN I-NP O
, , O O
which WDT B-NP O
detect VBP B-VP O
exons NNS B-NP O
in IN B-PP O
the DT B-NP O
central JJ I-NP O
part NN I-NP O
of IN B-PP O
the DT B-NP O
DMD NN I-NP B-Disease
gene NN I-NP O
. . O O

One CD B-NP O
or CC I-NP O
more JJR I-NP O
exons NNS I-NP O
were VBD B-VP O
deleted VBN I-VP O
in IN B-PP O
60 CD B-NP O
% NN I-NP O
of IN B-PP O
patients NNS B-NP O
. . O O

The DT B-NP O
deletions NNS I-NP O
were VBD B-VP O
mapped VBN I-VP O
and CC O O
prove VBP B-VP O
to TO I-VP O
be VB I-VP O
heterogeneous JJ B-ADJP O
in IN B-PP O
size NN B-NP O
and CC I-NP O
extent NN I-NP O
, , O O
particularly RB B-ADVP O
in IN B-PP O
DMD NN B-NP B-Disease
. . O O

Deletions NNS B-NP O
specific JJ B-ADJP O
to TO B-PP O
DMD NN B-NP B-Disease
and CC B-PP O
to TO B-PP O
BMD NN B-NP B-Disease
are VBP B-VP O
described VBN I-VP O
. . O O

Half NN B-NP O
of IN B-PP O
all DT B-NP O
BMD NN I-NP B-Disease
patients NNS I-NP O
have VBP B-VP O
a DT B-NP O
deletion NN I-NP O
of IN B-PP O
one CD B-NP O
particular JJ I-NP O
small JJ I-NP O
group NN I-NP O
of IN B-PP O
exons NNS B-NP O
; : O O
smaller JJR B-NP O
deletions NNS I-NP O
within IN B-PP O
this DT B-NP O
same JJ I-NP O
group NN I-NP O
produce VBP B-VP O
the DT B-NP O
more RBR I-NP O
severe JJ I-NP O
DMD NN I-NP B-Disease
. . O O

. . O O

Hereditary JJ B-NP B-Disease
deficiency NN I-NP I-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
third JJ I-NP I-Disease
component NN I-NP I-Disease
of IN B-PP I-Disease
complement NN B-NP I-Disease
in IN B-PP O
a DT B-NP O
child NN I-NP O
with IN B-PP O
fever NN B-NP B-Disease
, , O O
skin NN B-NP B-Disease
rash NN I-NP I-Disease
, , O O
and CC O O
arthralgias NNS B-NP B-Disease
: : O O
response NN B-NP O
to TO B-PP O
transfusion NN B-NP O
of IN B-PP O
whole JJ B-NP O
blood NN I-NP O
. . O O

A DT B-NP O
previously RB I-NP O
well RB I-NP O
34 CD I-NP O
- HYPH I-NP O
month NN I-NP O
- HYPH O O
old JJ B-NP O
male NN I-NP O
presenting VBG B-VP O
with IN B-PP O
fever NN B-NP B-Disease
, , O O
skin NN B-NP B-Disease
rash NN I-NP I-Disease
, , O O
and CC O O
arthralgias NNS B-NP B-Disease
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
lack VB I-VP O
C3 NN B-NP O
by IN B-PP O
immunochemical JJ O O
( ( O O
undetectable JJ B-ADJP O
) ) O O
and CC O O
hemolytic JJ B-ADJP O
( ( O O
1 CD B-NP O
% NN I-NP O
normal JJ B-ADJP O
) ) O O
assays NNS B-NP O
. . O O

No DT B-NP O
infectious JJ I-NP O
agent NN I-NP O
could MD B-VP O
be VB I-VP O
demonstrated VBN I-VP O
. . O O

Protein NN B-NP O
levels NNS I-NP O
of IN B-PP O
Clq NN B-NP O
. . O O

C4 NN B-NP O
, , O O
C5 NN B-NP O
, , O O
properdin NN B-NP O
, , O O
and CC O O
C3b NN B-NP O
- HYPH B-NP O
INA NN I-NP O
and CC O O
hemolytic JJ B-NP O
activities NNS I-NP O
of IN B-PP O
complement NN B-NP O
components NNS I-NP O
C1 NN I-NP O
to TO B-PP O
C9 NN B-NP O
except IN B-PP O
C3 NN B-NP O
were VBD B-VP O
normal JJ B-ADJP O
or CC I-ADJP O
elevated JJ I-ADJP O
; : O O
total JJ B-NP O
hemolytic JJ I-NP O
complement NN I-NP O
activity NN I-NP O
was VBD B-VP O
13 CD B-NP O
% NN I-NP O
of IN B-PP O
normal JJ B-NP O
and CC O O
was VBD B-VP O
reconstituted VBN I-VP O
by IN B-PP O
purified VBN B-NP O
C3 NN I-NP O
. . O O

Properdin NN B-NP O
factor NN I-NP O
B NN I-NP O
was VBD B-VP O
702 CD B-NP O
( ( O O
normal JJ B-ADJP O
175 CD B-NP O
to TO B-PP O
275 CD B-NP O
) ) O O
mug NN B-NP O
/ SYM B-NP O
ml NN I-NP O
, , O O
and CC O O
was VBD B-VP O
not RB I-VP O
cleaver VB I-VP O
upon IN B-PP O
addition NN B-NP O
of IN B-PP O
zymosan NN B-NP O
or CC I-NP O
cobra NN I-NP O
venom NN I-NP O
factor NN I-NP O
. . O O

The DT B-NP O
serum NN I-NP O
had VBD B-VP O
normal JJ B-NP O
immune JJ I-NP O
adherence NN I-NP O
activity NN I-NP O
, , O O
but CC O O
was VBD B-VP O
deficient JJ B-ADJP O
in IN B-PP O
ability NN B-NP O
to TO B-VP O
opsonize VB I-VP O
Candida NNP B-NP O
albicans NNS I-NP O
for IN B-PP O
uptake NN B-NP O
and CC O O
Escherichia FW B-NP O
coli FW I-NP O
for IN B-PP O
killing NN B-NP O
by IN B-PP O
neurophils NNS B-NP O
, , O O
generate JJ B-NP O
neutrophil NN I-NP O
chemotactic JJ I-NP O
factors NNS I-NP O
and CC O O
inhibit VBP B-VP O
the DT B-NP O
growth NN I-NP O
of IN B-PP O
E NN B-NP O
. . O O

coli NN B-NP O
; : O O
these DT B-NP O
activities NNS I-NP O
were VBD B-VP O
restored VBN I-VP O
by IN B-PP O
purified VBN B-NP O
C3 NN I-NP O
. . O O

A DT B-NP O
transfusion NN I-NP O
of IN B-PP O
320 CD B-NP O
ml NN I-NP O
1 CD B-NP O
- HYPH I-NP O
hour NN I-NP O
- HYPH I-NP O
old JJ I-NP O
normal JJ I-NP O
whole JJ I-NP O
blood NN I-NP O
on IN B-PP O
the DT B-NP O
fifty CD I-NP O
- HYPH I-NP O
second JJ I-NP O
day NN I-NP O
resulted VBD B-VP O
in IN B-PP O
transitory JJ B-NP O
elevation NN I-NP O
of IN B-PP O
the DT B-NP O
C3 NN I-NP O
level NN I-NP O
to TO B-PP O
25 CD B-NP O
mg NN I-NP O
/ SYM B-NP O
dl NN I-NP O
with IN B-PP O
a DT B-NP O
fall NN I-NP O
- HYPH B-VP O
off RP B-PRT O
( ( O O
approximately RB B-NP O
2 CD I-NP O
1 CD I-NP O
/ SYM B-NP O
2 CD B-NP O
% NN I-NP O
per IN B-PP O
hour NN B-NP O
) ) O O
to TO B-PP O
undetectable JJ B-NP O
levels NNS I-NP O
by IN B-PP O
69 CD B-NP O
hours NNS I-NP O
; : O O
it PRP B-NP O
was VBD B-VP O
followed VBN I-VP O
by IN B-PP O
disappearance NN B-NP O
of IN B-PP O
the DT B-NP O
skin NN I-NP B-Disease
rash NN I-NP I-Disease
and CC I-NP O
arthralgias NNS I-NP B-Disease
and CC O O
return VB B-VP O
to TO B-PP O
normal JJ B-NP O
of IN B-PP O
the DT B-NP O
previously RB I-NP O
elevated VBN I-NP O
temperature NN I-NP O
and CC I-NP O
CRP NN I-NP O
levels NNS I-NP O
. . O O

C3 NN B-NP O
levels NNS I-NP O
in IN B-PP O
family NN B-NP O
members NNS I-NP O
( ( O O
seven CD B-NP O
of IN I-NP O
24 CD I-NP O
half NN I-NP O
- HYPH B-NP O
normal JJ I-NP O
) ) O O
, , O O
lack NN B-NP O
of IN B-PP O
anti AFX B-NP O
- HYPH I-NP O
C3 NN I-NP O
activity NN I-NP O
, , O O
normal JJ B-NP O
C3b NN I-NP O
- HYPH B-NP O
INA NN I-NP O
levels NNS I-NP O
and CC O O
a DT B-NP O
normal JJ I-NP O
rate NN I-NP O
of IN B-PP O
catabolism NN B-NP O
of IN B-PP O
transfused VBN B-NP O
C3 NN I-NP O
indicated VBD B-VP O
that IN B-SBAR O
the DT B-NP O
deficiency NN I-NP O
was VBD B-VP O
inherited VBN I-VP O
with IN B-PP O
autosomal JJ B-NP O
codominance NN I-NP O
and CC O O
involved VBN B-VP O
decreased VBD B-VP B-Disease
synthesis NN B-NP I-Disease
of IN B-PP I-Disease
C3 NN B-NP I-Disease
. . O O

Thus RB B-ADVP O
, , O O
this DT B-NP O
child NN I-NP O
is VBZ B-VP O
a DT B-NP O
unique JJ I-NP O
individual NN I-NP O
with IN B-PP O
inherited VBN B-NP B-Disease
C3 NN I-NP I-Disease
deficiency NN I-NP I-Disease
presenting VBG B-VP O
with IN B-PP O
absence NN B-NP O
of IN B-PP O
repeated JJ B-NP O
infections NNS I-NP O
, , O O
whose WP$ B-NP O
symptoms NNS I-NP O
of IN B-PP O
fever NN B-NP B-Disease
, , O O
skin NN B-NP B-Disease
rash NN I-NP I-Disease
, , O O
and CC O O
arthralgia NN B-NP B-Disease
were VBD B-VP O
abated VBN I-VP O
by IN B-PP O
whole JJ B-NP O
blood NN I-NP O
transfusion NN I-NP O
. . O O

. . O O

Glucose NN B-NP O
- HYPH B-NP O
6 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
dehydrogenase NN I-NP O
variants NNS I-NP O
and CC O O
their PRP$ B-NP O
frequency NN I-NP O
in IN B-PP O
Guangdong NNP B-NP O
, , O O
China NNP B-NP O
. . O O

Erythrocyte NN B-NP O
glucose NN I-NP O
- HYPH B-NP O
6 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
dehydrogenase NN I-NP O
( ( O O
G6PD NN B-NP O
) ) O O
was VBD B-VP O
characterized VBN I-VP O
in IN B-PP O
blood NN B-NP O
samples NNS I-NP O
obtained VBN B-VP O
from IN B-PP O
97 CD B-NP O
randomly RB I-NP O
selected VBN I-NP O
males NNS I-NP O
with IN B-PP O
enzyme NN B-NP B-Disease
deficiency NN I-NP I-Disease
from IN B-PP O
various JJ B-NP O
regions NNS I-NP O
of IN B-PP O
Guangdong NNP B-NP O
Province NNP I-NP O
, , O O
China NNP B-NP O
. . O O

Nine CD B-NP O
new JJ I-NP O
variants NNS I-NP O
( ( O O
Gd NNP B-NP O
Kaiping NNP I-NP O
, , O O
Gd NNP B-NP O
Boluo NNP I-NP O
, , O O
Gd NNP B-NP O
Huiyang NNP I-NP O
, , O O
Gd NNP B-NP O
Gaomin NNP I-NP O
, , O O
Gd NNP B-NP O
Qing NNP I-NP O
- HYPH O O
Baijiang NNP B-NP O
, , O O
Gd NNP B-NP O
Gaozhou NNP I-NP O
, , O O
Gd NNP B-NP O
Huazhou NNP I-NP O
, , O O
Gd NNP B-NP O
Nanhai NNP I-NP O
, , O O
and CC O O
Gd NNP B-NP O
Guangzhou NNP I-NP O
) ) O O
were VBD B-VP O
identified VBN I-VP O
. . O O

Of IN B-PP O
the DT B-NP O
31 CD I-NP O
variants NNS I-NP O
found VBN B-VP O
in IN B-PP O
this DT B-NP O
province NN I-NP O
, , O O
Gd NNP B-NP O
Kaiping NNP I-NP O
, , O O
Gd NNP B-NP O
Taiwan NNP I-NP O
- HYPH O O
Hakka NNP B-NP O
, , O O
Gd NNP B-NP O
Haad NNP I-NP O
Yai NNP I-NP O
, , O O
Gd NNP B-NP O
Haad NNP I-NP O
Yai NNP I-NP O
- HYPH B-NP O
like JJ I-NP O
and CC I-NP O
Gd NNP I-NP O
Huiyang NNP I-NP O
occurred VBD B-VP O
most RBS B-ADVP O
frequently RB I-ADVP O
. . O O

The DT B-NP O
frequency NN I-NP O
of IN B-PP O
each DT B-NP O
variant NN I-NP O
was VBD B-VP O
calculated VBN I-VP O
. . O O

The DT B-NP O
results NNS I-NP O
demonstrated VBD B-VP O
that IN B-SBAR O
the DT B-NP O
genetic JJ I-NP O
heterogeneity NN I-NP O
of IN B-PP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
was VBD B-VP O
high JJ B-ADJP O
in IN B-PP O
this DT B-NP O
area NN I-NP O
. . O O

. . O O

Homozygous JJ B-NP O
and CC I-NP O
heterozygous JJ I-NP O
deletions NNS I-NP O
of IN B-PP O
the DT B-NP O
von NN I-NP B-Disease
Willebrand NN I-NP I-Disease
factor NN I-NP O
gene NN I-NP O
in IN B-PP O
patients NNS B-NP O
and CC I-NP O
carriers NNS I-NP O
of IN B-PP O
severe JJ B-NP B-Disease
von NN I-NP I-Disease
Willebrand NN I-NP I-Disease
disease NN I-NP I-Disease
. . O O

Severe JJ B-NP B-Disease
von NN I-NP I-Disease
Willebrand NN I-NP I-Disease
disease NN I-NP I-Disease
is VBZ B-VP O
characterized VBN I-VP O
by IN B-PP O
undetectable JJ B-NP O
or CC I-NP O
trace NN I-NP O
quantities NNS I-NP O
of IN B-PP O
von NN B-NP B-Disease
Willebrand NN I-NP I-Disease
factor NN I-NP O
in IN B-PP O
plasma NN B-NP O
and CC I-NP O
tissue NN I-NP O
stores NNS I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
studied VBN I-VP O
the DT B-NP O
genomic JJ I-NP O
DNA NN I-NP O
of IN B-PP O
10 CD B-NP O
affected VBN I-NP O
individuals NNS I-NP O
from IN B-PP O
six CD B-NP O
families NNS I-NP O
with IN B-PP O
this DT B-NP O
disorder NN I-NP O
using VBG B-VP O
probes NNS B-NP O
from IN B-PP O
the DT B-NP O
5 CD I-NP O
and CC I-NP O
3 CD I-NP O
ends NNS I-NP O
of IN B-PP O
the DT B-NP O
vWF NN I-NP O
cDNA NN I-NP O
and CC B-PP O
with IN B-PP O
a DT B-NP O
probe NN I-NP O
extending VBG B-VP O
from IN B-PP O
the DT B-NP O
5 CD I-NP O
end NN I-NP O
into IN B-PP O
the DT B-NP O
central JJ I-NP O
region NN I-NP O
. . O O

Southern JJ B-NP O
blots NNS I-NP O
of IN B-PP O
restriction NN B-NP O
endonuclease NN I-NP O
digests NNS I-NP O
and CC O O
gene NN B-NP O
dosage NN I-NP O
analysis NN I-NP O
measurements NNS I-NP O
carried VBN B-VP O
out RP B-PRT O
with IN B-PP O
quantitative JJ B-NP O
slot NN I-NP O
blots NNS I-NP O
of IN B-PP O
undigested JJ B-NP O
genomic JJ I-NP O
DNA NN I-NP O
separated VBD B-VP O
these DT B-NP O
patients NNS I-NP O
into IN B-PP O
three CD B-NP O
groups NNS I-NP O
. . O O

The DT B-NP O
first JJ I-NP O
group NN I-NP O
consisted VBD B-VP O
of IN B-PP O
a DT B-NP O
family NN I-NP O
with IN B-PP O
complete JJ B-NP O
homozygous JJ I-NP O
deletions NNS I-NP O
of IN B-PP O
the DT B-NP O
vWF NN I-NP O
gene NN I-NP O
in IN B-PP O
the DT B-NP O
four CD I-NP O
probands NNS I-NP O
. . O O

Gene NN B-NP O
dosage NN I-NP O
analysis NN I-NP O
was VBD B-VP O
consistent JJ B-ADJP O
with IN B-PP O
heterozygous JJ B-NP O
deletions NNS I-NP O
in IN B-PP O
both DT B-NP O
of IN B-PP O
the DT B-NP O
asymptomatic JJ I-NP O
parents NNS I-NP O
and CC O O
four CD B-NP O
asymptomatic JJ I-NP O
siblings NNS I-NP O
of IN B-PP O
this DT B-NP O
kindred NN I-NP O
( ( O O
P NN B-NP O
less JJR B-NP O
than IN I-NP O
0 CD I-NP O
. . I-NP O

01 CD I-NP O
) ) O O
. . O O

The DT B-NP O
second JJ I-NP O
group NN I-NP O
was VBD B-VP O
comprised VBN I-VP O
of IN B-PP O
a DT B-NP O
family NN I-NP O
in IN B-PP O
which WDT B-NP O
there EX B-NP O
was VBD B-VP O
a DT B-NP O
complete JJ I-NP O
heterozygous JJ I-NP O
deletion NN I-NP O
of IN B-PP O
the DT B-NP O
vWF NN I-NP O
gene NN I-NP O
in IN B-PP O
the DT B-NP O
proband NN I-NP O
and CC O O
one CD B-NP O
asymptomatic JJ I-NP O
parent NN I-NP O
, , O O
suggesting VBG B-VP O
that IN B-SBAR O
a DT B-NP O
different JJ I-NP O
type NN I-NP O
of IN B-PP O
genetic JJ B-NP B-Disease
abnormality NN I-NP I-Disease
was VBD B-VP O
inherited VBN I-VP O
from IN B-PP O
the DT B-NP O
other JJ I-NP O
parent NN I-NP O
. . O O

Thus RB B-ADVP O
, , O O
the DT B-NP O
patient NN I-NP O
appeared VBD B-VP O
to TO I-VP O
be VB I-VP O
doubly RB B-ADJP O
heterozygous JJ I-ADJP O
for IN B-PP O
interacting VBG B-VP O
genetic JJ B-NP B-Disease
abnormalities NNS I-NP I-Disease
affecting VBG B-VP O
vWF NN B-NP O
expression NN I-NP O
. . O O

In IN B-PP O
the DT B-NP O
third JJ I-NP O
group NN I-NP O
, , O O
no DT B-NP O
gene NN I-NP O
deletions NNS I-NP O
could MD B-VP O
be VB I-VP O
detected VBN I-VP O
. . O O

Alloantibodies NNS B-NP O
developed VBD B-VP O
only RB B-ADVP O
in IN B-PP O
the DT B-NP O
kindred NN I-NP O
with IN B-PP O
homozygous JJ B-NP O
deletions NNS I-NP O
. . O O

These DT B-NP O
techniques NNS I-NP O
should MD B-VP O
prove VB I-VP O
useful JJ B-ADJP O
in IN B-PP O
identifying VBG B-VP O
carriers NNS B-NP O
of IN B-PP O
severe JJ B-NP B-Disease
von NN I-NP I-Disease
Willebrand NN I-NP I-Disease
disease NN I-NP I-Disease
and CC O O
also RB B-ADVP O
in IN B-PP O
defining VBG B-VP O
patients NNS B-NP O
predictably RB B-ADVP O
at IN B-PP O
risk NN B-NP O
of IN B-PP O
developing VBG B-VP O
alloantibodies NNS B-NP O
to TO B-PP O
vWF NN B-NP O
. . O O

Sjogren NN B-NP B-Disease
- HYPH I-NP I-Disease
Larsson NN I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

Impaired JJ B-NP O
fatty JJ I-NP O
alcohol NN I-NP O
oxidation NN I-NP O
in IN B-PP O
cultured VBN B-NP O
fibroblasts NNS I-NP O
due JJ B-ADJP O
to TO B-PP O
deficient JJ B-NP O
fatty JJ I-NP O
alcohol NN I-NP O
: : O O
nicotinamide NN B-NP O
adenine NN I-NP O
dinucleotide NN I-NP O
oxidoreductase NN I-NP O
activity NN I-NP O
. . O O

Lipid NN B-NP O
metabolism NN I-NP O
was VBD B-VP O
studied VBN I-VP O
in IN B-PP O
cultured VBN B-NP O
skin NN I-NP O
fibroblasts NNS I-NP O
from IN B-PP O
patients NNS B-NP O
with IN B-PP O
the DT B-NP O
inherited VBN I-NP B-Disease
disorder NN I-NP I-Disease
, , O O
Sjogren NN B-NP B-Disease
- HYPH O I-Disease
Larsson NN B-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
SLS NN B-NP B-Disease
) ) O O
. . O O

Intact JJ B-NP O
SLS NN I-NP B-Disease
fibroblasts NNS I-NP O
incubated VBN B-VP O
in IN B-PP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
[ ( B-NP O
1 CD I-NP O
- HYPH I-NP O
14C NN I-NP O
] ) I-NP O
palmitate NN I-NP O
accumulated VBD B-VP O
more RBR B-NP O
radioactive JJ I-NP O
hexadecanol NN I-NP O
than IN B-SBAR O
did VBD O O
normal JJ B-NP O
cells NNS I-NP O
, , O O
whereas IN O O
incorporation NN B-NP O
of IN B-PP O
radioactivity NN B-NP O
into IN B-PP O
other JJ B-NP O
cellular JJ I-NP O
lipids NNS I-NP O
was VBD B-VP O
unaltered JJ B-ADJP O
. . O O

The DT B-NP O
hexadecanol NN I-NP O
content NN I-NP O
of IN B-PP O
SLS NN B-NP B-Disease
fibroblasts NNS I-NP O
was VBD B-VP O
abnormally RB B-ADJP O
elevated JJ I-ADJP O
. . O O

Hexadecanol NN B-NP O
accumulation NN I-NP O
was VBD B-VP O
not RB O O
due JJ B-ADJP O
to TO B-PP O
increased VBN B-NP O
fatty JJ I-NP O
alcohol NN I-NP O
synthesis NN I-NP O
nor CC O O
its PRP$ B-NP O
deficient JJ I-NP O
utilization NN I-NP O
for IN B-PP O
glycerol NN B-NP O
ether NN I-NP O
synthesis NN I-NP O
. . O O

The DT B-NP O
half NN I-NP O
- HYPH I-NP O
life NN I-NP O
of IN B-PP O
intracellular JJ B-NP O
hexadecanol NN I-NP O
loaded VBN B-VP O
into IN B-PP O
SLS NN B-NP B-Disease
fibroblasts NNS I-NP O
was VBD B-VP O
increased VBN I-VP O
( ( O O
70 CD B-NP O
min NN I-NP O
) ) O O
compared VBN B-PP O
with IN B-PP O
normal JJ B-ADJP O
( ( O O
15 CD B-NP O
min NN I-NP O
) ) O O
, , O O
and CC O O
intact JJ B-NP O
SLS NN I-NP B-Disease
fibroblasts NNS I-NP O
showed VBD B-VP O
impaired JJ B-NP O
oxidation NN I-NP O
of IN B-PP O
[ ( O O
14C NN B-NP O
] ) O O
- HYPH B-NP O
hexadecanol NN I-NP O
to TO B-PP O
fatty JJ B-NP O
acid NN I-NP O
. . O O

Fatty JJ B-NP O
alcohol NN I-NP O
NAD NN I-NP O
+ SYM B-NP O
oxidoreductase NN I-NP O
, , O O
the DT B-NP O
enzyme NN I-NP O
catalyzing VBG B-VP O
this DT B-NP O
reaction NN I-NP O
, , O O
was VBD B-VP O
deficient JJ B-ADJP O
in IN B-PP O
SLS NN B-NP B-Disease
fibroblasts NNS I-NP O
. . O O

Mean JJ B-NP O
total JJ I-NP O
activity NN I-NP O
in IN B-PP O
SLS NN B-NP B-Disease
fibroblasts NNS I-NP O
( ( O O
n NN B-NP O
= SYM B-VP O
5 CD B-NP O
) ) O O
was VBD B-VP O
13 CD B-NP O
% NN I-NP O
of IN B-PP O
that DT B-NP O
in IN B-PP O
normal JJ B-NP O
fibroblasts NNS I-NP O
, , O O
and CC O O
palmitoyl NN B-NP O
CoA NN I-NP O
- HYPH B-NP O
inhibitable JJ I-NP O
activity NN I-NP O
was VBD B-VP O
1 CD B-NP O
% NN I-NP O
of IN B-PP O
normal JJ B-NP O
. . O O

Fibroblasts NNS B-NP O
from IN B-PP O
two CD B-NP O
obligate JJ I-NP O
SLS NN I-NP B-Disease
heterozygotes NNS I-NP O
had VBD B-VP O
enzyme NN B-NP O
activities NNS I-NP O
intermediate VBP B-VP O
between IN B-PP O
that DT B-NP O
in IN B-PP O
normal JJ B-NP O
fibroblasts NNS I-NP O
and CC I-NP O
individuals NNS I-NP O
with IN B-PP O
SLS NN B-NP B-Disease
. . O O

These DT B-NP O
results NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
the DT B-NP O
primary JJ I-NP O
defect NN I-NP O
in IN B-PP O
SLS NN B-NP B-Disease
is VBZ B-VP O
deficiency NN B-NP B-Disease
of IN B-PP I-Disease
fatty JJ B-NP I-Disease
alcohol NN I-NP I-Disease
NAD NN I-NP I-Disease
+ SYM B-NP I-Disease
oxidoreductase NN I-NP I-Disease
. . O O

SLS NN B-NP B-Disease
represents VBZ B-VP O
the DT B-NP O
first JJ I-NP O
inherited VBN I-NP B-Disease
disorder NN I-NP I-Disease
in IN B-PP O
man NN B-NP O
associated VBN B-VP O
with IN B-PP O
an DT B-NP O
isolated VBN I-NP O
abnormality NN I-NP B-Disease
in IN B-PP I-Disease
fatty JJ B-NP I-Disease
alcohol NN I-NP I-Disease
metabolism NN I-NP I-Disease
. . O O

. . O O

Germinal JJ B-NP O
mosaicism NN I-NP O
in IN B-PP O
Duchenne NNP B-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
. . O O

We PRP B-NP O
have VBP B-VP O
identified VBN I-VP O
a DT B-NP O
Duchenne NNP I-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
DMD NN B-NP B-Disease
) ) O O
pedigree VBP B-VP O
where WRB B-ADVP O
the DT B-NP O
disease NN I-NP O
is VBZ B-VP O
associated VBN I-VP O
with IN B-PP O
a DT B-NP O
molecular JJ I-NP O
deletion NN I-NP O
within IN B-PP O
the DT B-NP O
DMD NN I-NP B-Disease
locus NN I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
examined VBN I-VP O
the DT B-NP O
meiotic JJ I-NP O
segregation NN I-NP O
products NNS I-NP O
of IN B-PP O
the DT B-NP O
common JJ I-NP O
female JJ I-NP O
ancestor NN I-NP O
using VBG B-VP O
marker NN B-NP O
restriction NN I-NP O
fragment NN I-NP O
length NN I-NP O
polymorphisms NNS I-NP O
( ( O O
RFLPs NNS B-NP O
) ) O O
detected VBN B-VP O
by IN B-PP O
probes NNS B-NP O
that WDT B-NP O
lie VBP B-VP O
within IN B-PP O
this DT B-NP O
deletion NN I-NP O
. . O O

These DT B-NP O
studies NNS I-NP O
show VBP B-VP O
that IN B-SBAR O
this DT B-NP O
female NN I-NP O
has VBZ B-VP O
transmitted VBN I-VP O
three CD B-NP O
distinct JJ I-NP O
types NNS I-NP O
of IN B-PP O
X NN B-NP O
chromosome NN I-NP O
to TO B-PP O
her PRP$ B-NP O
offspring NN I-NP O
. . O O

This DT B-NP O
observation NN I-NP O
may MD B-VP O
be VB I-VP O
explained VBN I-VP O
by IN B-PP O
postulating VBG B-VP O
that IN B-SBAR O
the DT B-NP O
mutation NN I-NP O
arose VBD B-VP O
as IN B-PP O
a DT B-NP O
postzygotic JJ I-NP O
deletion NN I-NP O
within IN B-PP O
this DT B-NP O
common JJ I-NP O
ancestor NN I-NP O
, , O O
who WP B-NP O
was VBD B-VP O
consequently RB B-ADJP O
germinally RB I-ADJP O
mosaic JJ I-ADJP O
. . O O

. . O O

Nebulin NN B-NP O
seen VBN B-VP O
in IN B-PP O
DMD NN B-NP B-Disease
males NNS I-NP O
including VBG B-PP O
one CD B-NP O
patient NN I-NP O
with IN B-PP O
a DT B-NP O
large JJ I-NP O
DNA NN I-NP O
deletion NN I-NP O
encompassing VBG B-VP O
the DT B-NP O
DMD NN I-NP B-Disease
gene NN I-NP O
. . O O

The DT B-NP O
presence NN I-NP O
of IN B-PP O
nebulin NN B-NP O
in IN B-PP O
a DT B-NP O
muscle NN I-NP O
specimen NN I-NP O
from IN B-PP O
a DT B-NP O
patient NN I-NP O
with IN B-PP O
Duchenne JJ B-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
DMD NN B-NP B-Disease
) ) O O
due IN B-PP O
to TO B-PP O
a DT B-NP O
large JJ I-NP O
deletion NN I-NP O
precludes VBZ B-VP O
the DT B-NP O
possibility NN I-NP O
that IN B-SBAR O
this DT B-NP O
protein NN I-NP O
is VBZ B-VP O
the DT B-NP O
DMD NN I-NP B-Disease
gene NN I-NP O
product NN I-NP O
. . O O

. . O O

Expression NN B-NP O
of IN B-PP O
the DT B-NP O
murine JJ I-NP O
Duchenne NNP I-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
gene NN I-NP O
in IN B-PP O
muscle NN B-NP O
and CC I-NP O
brain NN I-NP O
. . O O

Complementary JJ B-NP O
DNA NN I-NP O
clones NNS I-NP O
were VBD B-VP O
isolated VBN I-VP O
that WDT B-NP O
represent VBP B-VP O
the DT B-NP O
5 CD I-NP O
terminal JJ I-NP O
2 CD I-NP O
. . O O

5 CD B-NP O
kilobases NNS I-NP O
of IN B-PP O
the DT B-NP O
murine JJ I-NP O
Duchenne NNP I-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
Dmd NN B-NP O
) ) O O
messenger NN B-NP O
RNA NN I-NP O
( ( O O
mRNA NN B-NP O
) ) O O
. . O O

Mouse NN B-NP O
Dmd NN I-NP O
mRNA NN I-NP O
was VBD B-VP O
detectable JJ B-ADJP O
in IN B-PP O
skeletal JJ B-NP O
and CC I-NP O
cardiac JJ I-NP O
muscle NN I-NP O
and CC B-PP O
at IN B-PP O
a DT B-NP O
level NN I-NP O
approximately RB B-NP O
90 CD I-NP O
percent NN I-NP O
lower JJR B-ADJP O
in IN B-PP O
brain NN B-NP O
. . O O

Dmd NN B-NP O
mRNA NN I-NP O
is VBZ B-VP O
also RB B-ADVP O
present JJ B-ADJP O
, , O O
but CC O O
at IN B-PP O
much RB B-ADJP O
lower JJR I-ADJP O
than IN B-PP O
normal JJ B-NP O
levels NNS I-NP O
, , O O
in IN B-PP O
both CC B-NP O
the DT I-NP O
muscle NN I-NP O
and CC I-NP O
brain NN I-NP O
of IN B-PP O
three CD B-NP O
different JJ I-NP O
strains NNS I-NP O
of IN B-PP O
dystrophic JJ B-NP B-Disease
mdx NN I-NP O
mice NNS I-NP O
. . O O

The DT B-NP O
identification NN I-NP O
of IN B-PP O
Dmd NN B-NP O
mRNA NN I-NP O
in IN B-PP O
brain NN B-NP O
raises VBZ B-VP O
the DT B-NP O
possibility NN I-NP O
of IN B-PP O
a DT B-NP O
relation NN I-NP O
between IN B-PP O
human JJ B-NP O
Duchenne NNP I-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
DMD NN B-NP B-Disease
) ) O O
gene NN B-NP O
expression NN I-NP O
and CC O O
the DT B-NP O
mental JJ I-NP B-Disease
retardation NN I-NP I-Disease
found VBN B-VP O
in IN B-PP O
some DT B-NP O
DMD NN I-NP B-Disease
males NNS I-NP O
. . O O

These DT B-NP O
results NNS I-NP O
also RB B-ADVP O
provide VBP B-VP O
evidence NN B-NP O
that IN B-SBAR O
the DT B-NP O
mdx NN I-NP O
mutations NNS I-NP O
are VBP B-VP O
allelic JJ B-NP O
variants NNS I-NP O
of IN B-PP O
mouse NN B-NP O
Dmd NN I-NP O
gene NN I-NP O
mutations NNS I-NP O
. . O O

Glucose NN B-NP B-Disease
6 CD I-NP I-Disease
- HYPH I-NP I-Disease
phosphate NN I-NP I-Disease
dehydrogenase NN I-NP I-Disease
deficiency NN I-NP I-Disease
and CC I-NP O
incidence NN I-NP O
of IN B-PP O
hematologic JJ B-NP B-Disease
malignancy NN I-NP I-Disease
. . O O

We PRP B-NP O
have VBP B-VP O
evaluated VBN I-VP O
the DT B-NP O
hypothesis NN I-NP O
of IN B-PP O
a DT B-NP O
negative JJ I-NP O
association NN I-NP O
between IN B-PP O
glucose NN B-NP B-Disease
6 CD I-NP I-Disease
- HYPH I-NP I-Disease
phosphate NN I-NP I-Disease
dehydrogenase NN I-NP I-Disease
( ( O I-Disease
G6PD NN B-NP I-Disease
) ) O I-Disease
deficiency NN B-NP I-Disease
and CC I-NP O
cancer NN I-NP B-Disease
in IN B-PP O
a DT B-NP O
cohort NN I-NP O
of IN B-PP O
481 CD B-NP O
Sardinian JJ I-NP O
males NNS I-NP O
with IN B-PP O
hematological JJ B-NP B-Disease
malignancies NNS I-NP I-Disease
. . O O

The DT B-NP O
frequency NN I-NP O
of IN B-PP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
the DT B-NP O
patients NNS I-NP O
was VBD B-VP O
not RB O O
different JJ B-ADJP O
from IN B-PP O
the DT B-NP O
incidence NN I-NP O
in IN B-PP O
a DT B-NP O
group NN I-NP O
of IN B-PP O
16 CD B-NP O
, , I-NP O
219 CD I-NP O
controls NNS I-NP O
. . O O

The DT B-NP O
same JJ I-NP O
conclusion NN I-NP O
resulted VBD B-VP O
from IN B-PP O
the DT B-NP O
comparison NN I-NP O
of IN B-PP O
the DT B-NP O
frequency NN I-NP O
of IN B-PP O
expression NN B-NP O
of IN B-PP O
the DT B-NP O
GdB NN I-NP O
gene NN I-NP O
in IN B-PP O
23 CD B-NP O
heterozygous JJ I-NP O
women NNS I-NP O
having VBG B-VP O
a DT B-NP O
clonal JJ I-NP O
hematologic JJ I-NP B-Disease
disease NN I-NP I-Disease
and CC O O
a DT B-NP O
control NN I-NP O
group NN I-NP O
of IN B-PP O
37 CD B-NP O
healthy JJ I-NP O
heterozygotes NNS I-NP O
. . O O

Therefore RB B-ADVP O
at IN B-PP O
present JJ B-ADJP O
there EX B-NP O
is VBZ B-VP O
no DT B-NP O
evidence NN I-NP O
that IN B-SBAR O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
has VBZ B-VP O
a DT B-NP O
protective JJ I-NP O
effect NN I-NP O
against IN B-PP O
development NN B-NP O
of IN B-PP O
hematologic JJ B-NP B-Disease
neoplasms NNS I-NP I-Disease
. . O O

. . O O

Hepatoblastoma NN B-NP B-Disease
, , O O
pigmented VBD B-VP B-Disease
ocular JJ B-NP I-Disease
fundus NN I-NP I-Disease
lesions NNS I-NP I-Disease
and CC O O
jaw NN B-NP B-Disease
lesions NNS I-NP I-Disease
in IN B-PP O
Gardner NN B-NP B-Disease
syndrome NN I-NP I-Disease
. . O O

Hepatoblastoma NN B-NP B-Disease
is VBZ B-VP O
a DT B-NP O
rare JJ I-NP O
neoplasm NN I-NP B-Disease
of IN B-PP O
infants NNS B-NP O
and CC I-NP O
children NNS I-NP O
only RB B-VP O
recently RB I-VP O
documented VBN I-VP O
in IN B-PP O
association NN B-NP O
with IN B-PP O
hereditary JJ B-NP B-Disease
adenomatous JJ I-NP I-Disease
polyposis NN I-NP I-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
colon NN I-NP I-Disease
[ ( O O
Kingston NNP B-NP O
et FW I-NP O
al FW I-NP O
. FW I-NP O

, , O O
1983 CD B-NP O
] ) O O
. . O O

We PRP B-NP O
report VBP B-VP O
four CD B-NP O
children NNS I-NP O
with IN B-PP O
hepatoblastoma NN B-NP B-Disease
from IN B-PP O
four CD B-NP O
unrelated JJ I-NP O
families NNS I-NP O
with IN B-PP O
Gardner NN B-NP B-Disease
syndrome NN I-NP I-Disease
( ( O O
GS NN B-NP B-Disease
) ) O O
. . O O

One CD B-NP O
child NN I-NP O
, , O O
now RB B-NP O
19 CD B-NP O
years NNS I-NP O
old JJ B-ADJP O
, , O O
survived VBD B-VP O
after IN B-PP O
a DT B-NP O
resection NN I-NP O
of IN B-PP O
a DT B-NP O
hepatoblastoma NN I-NP B-Disease
in IN B-PP O
infancy NN B-NP O
and CC O O
recently RB B-ADVP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
have VB I-VP O
GS NN B-NP B-Disease
. . O O

He PRP B-NP O
has VBZ B-VP O
an DT B-NP O
associated VBN I-NP O
odontoma NN I-NP B-Disease
and CC O O
pigmented VBD B-VP B-Disease
ocular JJ B-NP I-Disease
fundus NN I-NP I-Disease
lesions NNS I-NP I-Disease
, , O O
both DT B-NP O
of IN B-PP O
which WDT B-NP O
have VBP B-VP O
been VBN I-VP O
shown VBN I-VP O
to TO I-VP O
be VB I-VP O
clinical JJ B-NP O
markers NNS I-NP O
of IN B-PP O
GS NN B-NP B-Disease
. . O O

Many JJ B-NP O
individuals NNS I-NP O
in IN B-PP O
these DT B-NP O
four CD I-NP O
GS NN I-NP B-Disease
families NNS I-NP O
, , O O
both CC O O
affected VBN B-VP O
and CC O O
at IN B-PP O
risk NN B-NP O
, , O O
have VBP B-VP O
osteomatous JJ B-NP B-Disease
jaw NN I-NP I-Disease
lesions NNS I-NP I-Disease
and CC O O
pigmented VBN B-VP B-Disease
ocular JJ B-NP I-Disease
fundus NN I-NP I-Disease
lesions NNS I-NP I-Disease
. . O O

A DT B-NP O
search NN I-NP O
for IN B-PP O
colonic JJ B-NP B-Disease
polyps NNS I-NP I-Disease
should MD B-VP O
be VB I-VP O
made VBN I-VP O
in IN B-PP O
families NNS B-NP O
of IN B-PP O
infants NNS B-NP O
and CC I-NP O
children NNS I-NP O
with IN B-PP O
hepatoblastoma NN B-NP B-Disease
. . O O

If IN B-SBAR O
the DT B-NP O
child NN I-NP O
survives VBZ B-VP O
, , O O
he PRP B-NP O
or CC I-NP O
she PRP I-NP O
should MD B-VP O
be VB I-VP O
monitored VBN I-VP O
for IN B-PP O
the DT B-NP O
later JJ I-NP O
appearance NN I-NP O
of IN B-PP O
colonic JJ B-NP B-Disease
polyps NNS I-NP I-Disease
. . O O

The DT B-NP O
finding NN I-NP O
of IN B-PP O
jaw NN B-NP B-Disease
lesions NNS I-NP I-Disease
and CC O O
/ SYM B-NP O
or CC O O
pigmented VBN B-VP B-Disease
ocular JJ B-NP I-Disease
fundus NN I-NP I-Disease
lesions NNS I-NP I-Disease
in IN B-PP O
relatives NNS B-NP O
at IN B-PP O
risk NN B-NP O
are VBP B-VP O
indications NNS B-NP O
of IN B-PP O
the DT B-NP O
possible JJ I-NP O
presence NN I-NP O
of IN B-PP O
the DT B-NP O
GS NN I-NP B-Disease
gene NN I-NP O
. . O O

Identification NN B-NP O
of IN B-PP O
an DT B-NP O
altered JJ I-NP O
splice NN I-NP O
site NN I-NP O
in IN B-PP O
Ashkenazi NNP B-NP O
Tay NNP I-NP B-Disease
- HYPH B-NP I-Disease
Sachs NNP I-NP I-Disease
disease NN I-NP I-Disease
. . O O

Tay NNP B-NP B-Disease
- HYPH I-NP I-Disease
Sachs NNP I-NP I-Disease
disease NN I-NP I-Disease
is VBZ B-VP O
an DT B-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
genetic JJ I-NP I-Disease
disorder NN I-NP I-Disease
resulting VBG B-VP O
from IN B-PP O
mutation NN B-NP O
of IN B-PP O
the DT B-NP O
HEXA NN I-NP O
gene NN I-NP O
encoding VBG B-VP O
the DT B-NP O
alpha SYM I-NP O
- HYPH I-NP O
subunit NN I-NP O
of IN B-PP O
the DT B-NP O
lysosomal JJ I-NP O
enzyme NN I-NP O
, , O O
beta SYM B-NP O
- HYPH B-NP O
N NN I-NP O
- HYPH O O
acetylhexosaminidase NN B-NP O
A NN I-NP O
( ( O O
ref NN B-NP O
. . I-NP O

1 CD I-NP O
) ) O O
. . O O

A DT B-NP O
relatively RB I-NP O
high JJ I-NP O
frequency NN I-NP O
of IN B-PP O
carriers NNS B-NP O
( ( O O
1 CD B-NP O
/ SYM I-NP O
27 CD I-NP O
) ) O O
of IN B-PP O
a DT B-NP O
lethal JJ I-NP O
, , I-NP O
infantile JJ I-NP O
form NN I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
is VBZ B-VP O
found VBN I-VP O
in IN B-PP O
the DT B-NP O
Ashkenazi NNP I-NP O
Jewish NNP I-NP O
population NN I-NP O
, , O O
but CC O O
it PRP B-NP O
is VBZ B-VP O
not RB O O
yet RB B-ADJP O
evident JJ I-ADJP O
whether IN B-SBAR O
this DT B-NP O
has VBZ B-VP O
resulted VBN I-VP O
from IN B-PP O
a DT B-NP O
founder NN I-NP O
effect NN I-NP O
and CC O O
random JJ B-NP O
genetic JJ I-NP O
drift NN I-NP O
or CC B-PP O
from IN B-PP O
a DT B-NP O
selective JJ I-NP O
advantage NN I-NP O
of IN B-PP O
heterozygotes NNS B-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
identified VBN I-VP O
a DT B-NP O
single JJ I-NP O
- HYPH I-NP O
base NN I-NP O
mutation NN I-NP O
in IN B-PP O
a DT B-NP O
cloned VBN I-NP O
fragment NN I-NP O
of IN B-PP O
the DT B-NP O
HEXA NN I-NP O
gene NN I-NP O
from IN B-PP O
an DT B-NP O
Ashkenazi NNP I-NP O
Jewish JJ I-NP O
patient NN I-NP O
. . O O

This DT B-NP O
change NN I-NP O
, , O O
the DT B-NP O
substitution NN I-NP O
of IN B-PP O
a DT B-NP O
C NN I-NP O
for IN B-PP O
G NN B-NP O
in IN B-PP O
the DT B-NP O
first JJ I-NP O
nucleotide NN I-NP O
of IN B-PP O
intron NN B-NP O
12 CD I-NP O
is VBZ B-VP O
expected VBN I-VP O
to TO I-VP O
result VB I-VP O
in IN B-PP O
defective JJ B-NP O
splicing NN I-NP O
of IN B-PP O
the DT B-NP O
messenger NN I-NP O
RNA NN I-NP O
. . O O

A DT B-NP O
test NN I-NP O
for IN B-PP O
the DT B-NP O
mutant JJ I-NP O
allele NN I-NP O
based VBN B-VP O
on IN B-PP O
amplification NN B-NP O
of IN B-PP O
DNA NN B-NP O
by IN B-PP O
the DT B-NP O
polymerase NN I-NP O
chain NN I-NP O
rection NN I-NP O
and CC I-NP O
cleavage NN I-NP O
of IN B-PP O
a DT B-NP O
DdeI NN I-NP O
restriction NN I-NP O
site NN I-NP O
generated VBN B-VP O
by IN B-PP O
the DT B-NP O
mutation NN I-NP O
revealed VBD B-VP O
that IN B-SBAR O
this DT B-NP O
case NN I-NP O
and CC O O
two CD B-NP O
other JJ I-NP O
cases NNS I-NP O
of IN B-PP O
the DT B-NP O
Ashkenazi NNP I-NP O
, , O O
infantile JJ B-NP O
form NN I-NP O
of IN B-PP O
Tay NNP B-NP B-Disease
- HYPH I-NP I-Disease
Sachs NNP I-NP I-Disease
disease NN I-NP I-Disease
are VBP B-VP O
heterozygous JJ B-ADJP O
for IN B-PP O
two CD B-NP O
different JJ I-NP O
mutations NNS I-NP O
. . O O

The DT B-NP O
occurrence NN I-NP O
of IN B-PP O
multiple JJ B-NP O
mutant JJ I-NP O
alleles NNS I-NP O
warrants VBZ B-VP O
further JJR B-NP O
examination NN I-NP O
of IN B-PP O
the DT B-NP O
selective JJ I-NP O
advantage NN I-NP O
hypothesis NN I-NP O
. . O O

. . O O

X NN B-NP B-Disease
- HYPH B-PP I-Disease
linked VBN B-NP I-Disease
glucose NN I-NP I-Disease
- HYPH B-NP I-Disease
6 CD I-NP I-Disease
- HYPH I-NP I-Disease
phosphate NN I-NP I-Disease
dehydrogenase NN I-NP I-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
Mus NNP B-NP O
musculus NN I-NP O
. . O O

A DT B-NP O
mouse NN I-NP O
with IN B-PP O
X NN B-NP B-Disease
- HYPH O I-Disease
linked VBN B-NP I-Disease
glucose NN I-NP I-Disease
- HYPH B-NP I-Disease
6 CD I-NP I-Disease
- HYPH I-NP I-Disease
phosphate NN I-NP I-Disease
dehydrogenase NN I-NP I-Disease
( ( O I-Disease
G6PD NN B-NP I-Disease
) ) O I-Disease
deficiency NN B-NP I-Disease
has VBZ B-VP O
been VBN I-VP O
recovered VBN I-VP O
in IN B-PP O
offspring NN B-NP O
of IN B-PP O
1 CD B-NP O
- HYPH I-NP O
ethyl NN I-NP O
- HYPH B-NP O
1 CD I-NP O
- HYPH I-NP O
nitrosourea NN I-NP O
- HYPH O O
treated VBN B-NP O
male JJ I-NP O
mice NNS I-NP O
. . O O

The DT B-NP O
activity NN I-NP O
alteration NN I-NP O
was VBD B-VP O
detected VBN I-VP O
in IN B-PP O
blood NN B-NP O
but CC O O
can MD B-VP O
also RB I-VP O
be VB I-VP O
observed VBN I-VP O
in IN B-PP O
other JJ B-NP O
tissue NN I-NP O
extracts NNS I-NP O
. . O O

Hemizygous JJ B-NP O
, , I-NP O
heterozygous JJ I-NP O
, , O O
and CC O O
homozygous JJ B-NP O
mutants NNS I-NP O
have VBP B-VP O
, , O O
respectively RB B-ADVP O
, , O O
about RB B-NP O
15 CD I-NP O
, , I-NP O
60 CD I-NP O
, , O O
and CC O O
15 CD B-NP O
% NN I-NP O
G6PD NN I-NP O
remaining VBG I-NP O
activity NN I-NP O
in IN B-PP O
the DT B-NP O
blood NN I-NP O
as IN B-SBAR O
compared VBN B-PP O
to TO B-PP O
the DT B-NP O
wild JJ I-NP O
type NN I-NP O
. . O O

Erythrocyte NN B-NP O
indices NNS I-NP O
did VBD B-VP O
not RB I-VP O
show VB I-VP O
differences NNS B-NP O
between IN B-PP O
mutants NNS B-NP O
and CC O O
wild JJ B-NP O
types NNS I-NP O
. . O O

The DT B-NP O
mutation NN I-NP O
does VBZ B-VP O
not RB I-VP O
affect VB I-VP O
the DT B-NP O
electrophoretic JJ I-NP O
migration NN I-NP O
, , O O
the DT B-NP O
isoelectric JJ I-NP O
point NN I-NP O
, , O O
or CC O O
the DT B-NP O
thermal JJ I-NP O
stability NN I-NP O
. . O O

Kinetic JJ B-NP O
properties NNS I-NP O
, , O O
such JJ B-PP O
as IN I-PP O
the DT B-NP O
Km NN I-NP O
for IN B-PP O
glucose NN B-NP O
- HYPH B-NP O
6 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
or CC B-PP O
for IN B-PP O
NADP NN B-NP O
and CC O O
the DT B-NP O
relative JJ I-NP O
utilization NN I-NP O
of IN B-PP O
substrate NN B-NP O
analogues NNS I-NP O
, , O O
showed VBD B-VP O
no DT B-NP O
differences NNS I-NP O
between IN B-PP O
wild JJ B-NP O
types NNS I-NP O
and CC I-NP O
mutants NNS I-NP O
with IN B-PP O
the DT B-NP O
exception NN I-NP O
of IN B-PP O
the DT B-NP O
relative JJ I-NP O
utilization NN I-NP O
of IN B-PP O
deamino NN B-NP O
- HYPH I-NP O
NADP NN I-NP O
which WDT B-NP O
was VBD B-VP O
significantly RB B-ADJP O
lower JJR I-ADJP O
in IN B-PP O
mutants NNS B-NP O
. . O O

This DT B-NP O
is VBZ B-VP O
presently RB B-ADVP O
the DT B-NP O
only JJ I-NP O
animal NN I-NP O
model NN I-NP O
for IN B-PP O
X NN B-NP B-Disease
- HYPH O I-Disease
linked VBN B-NP I-Disease
G6PD NN I-NP I-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
humans NNS B-NP O
. . O O

. . O O

Diverse JJ B-NP O
point NN I-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
human JJ I-NP O
glucose NN I-NP O
- HYPH B-NP O
6 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
dehydrogenase NN I-NP O
gene NN I-NP O
cause VBP B-VP O
enzyme NN B-NP B-Disease
deficiency NN I-NP I-Disease
and CC O O
mild JJ B-NP O
or CC I-NP O
severe JJ I-NP O
hemolytic JJ I-NP B-Disease
anemia NN I-NP I-Disease
. . O O

Glucose NN B-NP B-Disease
- HYPH B-NP I-Disease
6 CD I-NP I-Disease
- HYPH I-NP I-Disease
phosphate NN I-NP I-Disease
dehydrogenase NN I-NP I-Disease
( ( O I-Disease
G6PD NN B-NP I-Disease
; : O I-Disease
EC NNP B-NP I-Disease
1 CD I-NP I-Disease
. . O I-Disease

1 CD B-NP I-Disease
. . I-NP I-Disease

1 CD I-NP I-Disease
. . O I-Disease

49 CD O I-Disease
) ) O I-Disease
deficiency NN B-NP I-Disease
is VBZ B-VP O
a DT B-NP O
common JJ I-NP O
genetic JJ I-NP B-Disease
abnormality NN I-NP I-Disease
affecting VBG B-VP O
an DT B-NP O
estimated VBN I-NP O
400 CD I-NP O
million CD I-NP O
people NNS I-NP O
worldwide RB B-ADVP O
. . O O

Clinical JJ B-NP O
and CC I-NP O
biochemical JJ I-NP O
analyses NNS I-NP O
have VBP B-VP O
identified VBN I-VP O
many JJ B-NP O
variants NNS I-NP O
exhibiting VBG B-VP O
a DT B-NP O
range NN I-NP O
of IN B-PP O
phenotypes NNS B-NP O
, , O O
which WDT B-NP O
have VBP B-VP O
been VBN I-VP O
well RB I-VP O
characterized VBN I-VP O
from IN B-PP O
the DT B-NP O
hematological JJ I-NP O
point NN I-NP O
of IN B-PP O
view NN B-NP O
. . O O

However RB B-ADVP O
, , O O
until IN B-PP O
now RB B-ADVP O
, , O O
their PRP$ B-NP O
precise JJ I-NP O
molecular JJ I-NP O
basis NN I-NP O
has VBZ B-VP O
remained VBN I-VP O
unknown JJ B-ADJP O
. . O O

We PRP B-NP O
have VBP B-VP O
cloned VBN I-VP O
and CC I-VP O
sequenced VBN I-VP O
seven CD B-NP O
mutant JJ I-NP O
G6PD NN I-NP O
alleles NNS I-NP O
. . O O

In IN B-PP O
the DT B-NP O
nondeficient JJ I-NP O
polymorphic JJ I-NP O
African JJ I-NP O
variant JJ I-NP O
G6PD NN I-NP O
A NN I-NP O
we PRP B-NP O
have VBP B-VP O
found VBN I-VP O
a DT B-NP O
single JJ I-NP O
point NN I-NP O
mutation NN I-NP O
. . O O

The DT B-NP O
other JJ I-NP O
six CD I-NP O
mutants NNS I-NP O
investigated VBN B-VP O
were VBD B-VP O
all DT O O
associated VBN B-VP O
with IN B-PP O
enzyme NN B-NP B-Disease
deficiency NN I-NP I-Disease
. . O O

In IN B-PP O
one CD B-NP O
of IN B-PP O
the DT B-NP O
commonest NN I-NP O
, , O O
G6PD NN B-NP O
Mediterranean NNP I-NP O
, , O O
which WDT B-NP O
is VBZ B-VP O
associated VBN I-VP O
with IN B-PP O
favism NN B-NP B-Disease
among IN B-PP O
other JJ B-NP O
clinical JJ I-NP O
manifestations NNS I-NP O
, , O O
a DT B-NP O
single JJ I-NP O
amino NN I-NP O
acid NN I-NP O
replacement NN I-NP O
was VBD B-VP O
found VBN I-VP O
( ( O O
serine NN B-NP O
- SYM O O
- SYM O O
- SYM O O
- HYPH O O
phenylalanine NN B-NP O
) ) O O
it PRP B-NP O
must MD B-VP O
be VB I-VP O
responsible JJ B-ADJP O
for IN B-PP O
the DT B-NP O
decreased VBN I-NP O
stability NN I-NP O
and CC O O
the DT B-NP O
reduced VBN I-NP O
catalytic JJ I-NP O
efficiency NN I-NP O
of IN B-PP O
this DT B-NP O
enzyme NN I-NP O
. . O O

Single JJ B-NP O
point NN I-NP O
mutations NNS I-NP O
were VBD B-VP O
also RB I-VP O
found VBN I-VP O
in IN B-PP O
G6PD NN B-NP O
Metaponto NNP I-NP O
( ( O O
Southern NNP B-NP O
Italy NNP I-NP O
) ) O O
and CC O O
in IN B-PP O
G6PD NN B-NP O
Ilesha NN I-NP O
( ( O O
Nigeria NN B-NP O
) ) O O
, , O O
which WDT B-NP O
are VBP B-VP O
asymptomatic JJ B-ADJP O
, , O O
and CC O O
in IN B-PP O
G6PD NNP B-NP O
Chatham NNP I-NP O
, , O O
which WDT B-NP O
was VBD B-VP O
observed VBN I-VP O
in IN B-PP O
an DT B-NP O
Indian JJ I-NP O
boy NN I-NP O
with IN B-PP O
neonatal JJ B-NP B-Disease
jaundice NN I-NP I-Disease
. . O O

In IN B-PP O
G6PD NN B-NP O
Matera NNP B-NP O
, , O O
which WDT B-NP O
is VBZ B-VP O
now RB I-VP O
known VBN I-VP O
to TO I-VP O
be VB I-VP O
the DT B-NP O
same JJ I-NP O
as IN B-PP O
G6PD NN B-NP O
A NN I-NP O
- HYPH B-ADVP O
, , O O
two CD B-NP O
separate JJ I-NP O
point NN I-NP O
mutations NNS I-NP O
were VBD B-VP O
found VBN I-VP O
, , O O
one CD B-NP O
of IN B-PP O
which WDT B-NP O
is VBZ B-VP O
the DT B-NP O
same JJ I-NP O
as IN B-PP O
in IN B-PP O
G6PD NN B-NP O
A NN I-NP O
. . O O

In IN B-PP O
G6PD NNP B-NP O
Santiago NNP I-NP O
, , O O
a DT B-NP O
de FW I-NP O
novo FW I-NP O
mutation NN I-NP O
( ( O O
glycine NN B-NP O
- SYM O O
- SYM B-NP O
- SYM I-NP O
- HYPH I-NP O
arginine NN I-NP O
) ) O O
is VBZ B-VP O
associated VBN I-VP O
with IN B-PP O
severe JJ B-NP O
chronic JJ I-NP O
hemolytic JJ I-NP B-Disease
anemia NN I-NP I-Disease
. . O O

The DT B-NP O
mutations NNS I-NP O
observed VBN B-VP O
show VBP B-VP O
a DT B-NP O
striking JJ I-NP O
predominance NN I-NP O
of IN B-PP O
C NN B-NP O
- HYPH O O
- SYM B-NP O
- SYM I-NP O
- HYPH I-NP O
T NN I-NP O
transitions NNS I-NP O
, , O O
with IN B-PP O
CG NN B-NP O
doublets NNS I-NP O
involved VBN B-VP O
in IN B-PP O
four CD B-NP O
of IN B-PP O
seven CD B-NP O
cases NNS I-NP O
. . O O

Thus RB B-ADVP O
, , O O
diverse JJ B-NP O
point NN I-NP O
mutations NNS I-NP O
may MD B-VP O
account VB I-VP O
largely RB B-ADVP O
for IN B-PP O
the DT B-NP O
phenotypic JJ I-NP O
heterogeneity NN I-NP O
of IN B-PP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
. . O O

Tight NN B-NP O
linkage NN I-NP O
between IN B-PP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
and CC I-NP O
apolipoprotein NN I-NP O
E NN I-NP O
genes NNS I-NP O
revealed VBD B-VP O
with IN B-PP O
allele NN B-NP O
- HYPH B-NP O
specific JJ I-NP O
oligonucleotides NNS I-NP O
. . O O

In IN B-PP O
16 CD B-NP O
families NNS I-NP O
with IN B-PP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
( ( O O
DM NN B-NP B-Disease
) ) O O
a DT B-NP O
novel JJ I-NP O
approach NN I-NP O
based VBN B-VP O
on IN B-PP O
use NN B-NP O
of IN B-PP O
allele NN B-NP O
- HYPH B-NP O
specific JJ I-NP O
oligonucleotides NNS I-NP O
has VBZ B-VP O
been VBN I-VP O
employed VBN I-VP O
to TO I-VP O
study VB I-VP O
the DT B-NP O
linkage NN I-NP O
relationship NN I-NP O
between IN B-PP O
the DT B-NP O
apolipoprotein NN I-NP O
E NN I-NP O
( ( O O
APOE NN B-NP O
) ) O O
gene NN B-NP O
and CC I-NP O
DM NN I-NP B-Disease
. . O O

Synthetic JJ B-NP O
oligonucleotides NNS I-NP O
, , O O
designed VBN B-VP O
to TO I-VP O
discriminate VB I-VP O
between IN B-PP O
APOE NN B-NP O
alleles NNS I-NP O
epsilon NN B-NP O
3 CD I-NP O
and CC O O
epsilon NN B-NP O
4 CD I-NP O
, , O O
enabled VBD B-VP O
us PRP B-NP O
to TO B-VP O
distinguish VB I-VP O
heterozygous JJ B-NP O
carriers NNS I-NP O
in IN B-PP O
a DT B-NP O
hybridization NN I-NP O
assay NN I-NP O
. . O O

In IN B-PP O
a DT B-NP O
subset NN I-NP O
of IN B-PP O
families NNS B-NP O
, , O O
the DT B-NP O
relevant JJ I-NP O
segment NN I-NP O
of IN B-PP O
the DT B-NP O
APOE NN I-NP O
gene NN I-NP O
was VBD B-VP O
enzymatically RB I-VP O
amplified VBN I-VP O
to TO I-VP O
increase VB I-VP O
the DT B-NP O
sensitivity NN I-NP O
of IN B-PP O
the DT B-NP O
method NN I-NP O
. . O O

For IN B-PP O
DM NN B-NP O
and CC I-NP O
APOE NN I-NP O
, , O O
a DT B-NP O
maximum NN I-NP O
lod NN I-NP O
score NN I-NP O
( ( O O
zmax NN B-NP O
of IN B-PP O
7 CD B-NP O
. . O O

47 CD B-NP O
was VBD B-VP O
obtained VBN I-VP O
at IN B-PP O
a DT B-NP O
recombination NN I-NP O
frequency NN I-NP O
( ( O O
theta NN B-NP O
) ) O O
of IN B-PP O
0 CD B-NP O
. . O O

047 CD B-NP O
( ( O O
male JJ B-NP O
theta NN I-NP O
= JJ I-NP O
female JJ I-NP O
theta NN I-NP O
) ) O O
. . O O

No DT B-NP O
recombination NN I-NP O
( ( O O
maximum JJ B-NP O
lod NN I-NP O
score NN I-NP O
of IN B-PP O
5 CD B-NP O
. . O O

61 CD B-NP O
at IN B-PP O
theta NN B-NP O
= SYM B-VP O
0 CD B-NP O
. SYM I-NP O

0 CD I-NP O
) ) O O
was VBD B-VP O
found VBN I-VP O
between IN B-PP O
APOE NN B-NP O
and CC O O
the DT B-NP O
apolipoprotein NN I-NP O
CII NN I-NP O
( ( O O
APOC2 NN B-NP O
) ) O O
gene NN B-NP O
. . O O

These DT B-NP O
results NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
, , O O
in IN B-PP O
addition NN B-NP O
to TO B-PP O
APOC2 NN B-NP O
, , O O
APOE NNP B-NP O
is VBZ B-VP O
a DT B-NP O
useful JJ I-NP O
marker NN I-NP O
for IN B-PP O
presymptomatic JJ B-NP O
DM NN I-NP B-Disease
diagnosis NN I-NP O
. . O O

Regional JJ B-NP O
localization NN I-NP O
of IN B-PP O
polymorphic JJ B-NP O
DNA NN I-NP O
loci NNS I-NP O
on IN B-PP O
the DT B-NP O
proximal JJ I-NP O
long JJ I-NP O
arm NN I-NP O
of IN B-PP O
the DT B-NP O
X NN I-NP O
chromosome NN I-NP O
using VBG B-VP O
deletions NNS B-NP O
associated VBN B-VP O
with IN B-PP O
choroideremia NN B-NP B-Disease
. . O O

In IN B-PP O
two CD B-NP O
unrelated JJ I-NP O
families NNS I-NP O
, , O O
males NNS B-NP O
have VBP B-VP O
been VBN I-VP O
identified VBN I-VP O
who WP B-NP O
suffer VBP B-VP O
from IN B-PP O
choroideremia NN B-NP B-Disease
and CC B-PP O
at IN B-PP O
the DT B-NP O
same JJ I-NP O
time NN I-NP O
have VBP B-VP O
an DT B-NP O
interstitial JJ I-NP O
deletion NN I-NP O
on IN B-PP O
the DT B-NP O
proximal JJ I-NP O
long JJ I-NP O
arm NN I-NP O
of IN B-PP O
the DT B-NP O
X NN I-NP O
chromosome NN I-NP O
. . O O

By IN B-PP O
high JJ B-NP O
- HYPH I-NP O
resolution NN I-NP O
banding NN I-NP O
we PRP B-NP O
have VBP B-VP O
characterized VBN I-VP O
the DT B-NP O
deletion NN I-NP O
chromosomes NNS I-NP O
as IN B-PP O
del NN B-NP O
( ( O O
X NN B-NP O
) ) O O
( ( O O
q21 NN B-NP O
. . O O

1 CD B-NP O
- HYPH O O
q21 NN B-NP O
1 CD I-NP O
- HYPH I-NP O
q21 NN I-NP O
. . O O

33 CD B-NP O
) ) O O
and CC O O
del NN B-NP O
( ( O O
X NN B-NP O
) ) O O
( ( O O
q21 NN B-NP O
. . O O

2 CD O O
- HYPH O O
q21 NN B-NP O
2 CD I-NP O
- HYPH I-NP O
q21 NN I-NP O
. . O O

31 CD B-NP O
) ) O O
respectively RB B-ADVP O
. . O O

By IN B-PP O
Southern JJ B-NP O
blot NN I-NP O
analysis NN I-NP O
we PRP B-NP O
have VBP B-VP O
mapped VBN I-VP O
ten CD B-NP O
different JJ I-NP O
polymorphic JJ I-NP O
DNA NN I-NP O
loci NNS I-NP O
relative JJ B-ADVP O
to TO B-PP O
the DT B-NP O
position NN I-NP O
of IN B-PP O
the DT B-NP O
deletion NN I-NP O
and CC O O
the DT B-NP O
choroideremia NN I-NP B-Disease
locus NN I-NP O
TCD NN I-NP O
. . O O

One CD B-NP O
probe NN I-NP O
, , O O
p31 NN B-NP O
, , O O
was VBD B-VP O
shown VBN I-VP O
to TO I-VP O
cover VB I-VP O
one CD B-NP O
of IN B-PP O
the DT B-NP O
breakpoints NNS I-NP O
of IN B-PP O
the DT B-NP O
smallest JJS I-NP O
deletion NN I-NP O
. . O O

The DT B-NP O
following VBG I-NP O
order NN I-NP O
of IN B-PP O
the DT B-NP O
loci NNS I-NP O
was VBD B-VP O
suggested VBN I-VP O
by IN B-PP O
deletion NN B-NP O
mapping NN I-NP O
cen NN I-NP O
- HYPH B-NP O
DXS106 NN I-NP O
- HYPH B-NP O
DXS72 NN I-NP O
- HYPH B-NP O
TCD NN I-NP O
- HYPH O O
( ( O O
DXYS1 NN B-NP O
/ SYM B-NP O
DXYS23 NN I-NP O
/ SYM I-NP O
DXYS5 NN I-NP O
) ) O O
- HYPH B-NP O
DXYS2 NN I-NP O
- HYPH O O
( ( O O
DXYS12 NN B-NP O
/ SYM B-NP O
DXS3 NN I-NP O
) ) O O
- HYPH O O
( ( O O
DXS17 NN B-NP O
/ SYM B-NP O
DXS101 NN I-NP O
) ) O O
- HYPH B-NP O
Xqter NN I-NP O
. . O O

Retroviral JJ B-NP O
- HYPH I-NP O
mediated VBN I-NP O
gene NN I-NP O
transfer NN I-NP O
of IN B-PP O
human JJ B-NP O
phenylalanine NN I-NP O
hydroxylase NN I-NP O
into IN B-PP O
NIH NN B-NP O
3T3 NN I-NP O
and CC O O
hepatoma NN B-NP B-Disease
cells NNS I-NP O
. . O O

Phenylketonuria NN B-NP B-Disease
( ( O O
PKU NN B-NP B-Disease
) ) O O
is VBZ B-VP O
caused VBN I-VP O
by IN B-PP O
deficiency NN B-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
hepatic JJ I-NP I-Disease
enzyme NN I-NP I-Disease
phenylalanine NN I-NP I-Disease
hydroxylase NN I-NP I-Disease
( ( O O
PAH NN B-NP O
) ) O O
. . O O

A DT B-NP O
full JJ I-NP O
- HYPH I-NP O
length NN I-NP O
human JJ I-NP O
PAH NN I-NP O
cDNA NN I-NP O
sequence NN I-NP O
has VBZ B-VP O
been VBN I-VP O
inserted VBN I-VP O
into IN B-PP O
pzip NN B-NP O
- HYPH O O
neoSV NN B-NP O
( ( O O
X NN B-NP O
) ) O O
, , O O
which WDT B-NP O
is VBZ B-VP O
a DT B-NP O
retroviral JJ I-NP O
vector NN I-NP O
containing VBG B-VP O
the DT B-NP O
bacterial JJ I-NP O
neo NN I-NP O
gene NN I-NP O
. . O O

The DT B-NP O
recombinant NN I-NP O
has VBZ B-VP O
been VBN I-VP O
transfected VBN I-VP O
into IN B-PP O
psi NN B-NP O
2 CD B-NP O
cells NNS I-NP O
, , O O
which WDT B-NP O
provide VBP B-VP O
synthesis NN B-NP O
of IN B-PP O
the DT B-NP O
retroviral JJ I-NP O
capsid NN I-NP O
. . O O

Recombinant JJ B-NP O
virus NN I-NP O
was VBD B-VP O
detected VBN I-VP O
in IN B-PP O
the DT B-NP O
culture NN I-NP O
medium NN I-NP O
of IN B-PP O
the DT B-NP O
transfected VBN I-NP O
psi NN I-NP O
2 CD B-NP O
cells NNS I-NP O
, , O O
which WDT B-NP O
is VBZ B-VP O
capable JJ B-ADJP O
of IN B-PP O
transmitting VBG B-VP O
the DT B-NP O
human JJ I-NP O
PAH NN I-NP O
gene NN I-NP O
into IN B-PP O
mouse NN B-NP O
NIH NN I-NP O
3T3 NN I-NP O
cells NNS I-NP O
by IN B-PP O
infection NN B-NP O
leading VBG B-VP O
to TO B-PP O
stable JJ B-NP O
incorporation NN I-NP O
of IN B-PP O
the DT B-NP O
recombinant JJ I-NP O
provirus NN I-NP O
. . O O

Infected JJ B-NP O
cells NNS I-NP O
express VBP B-VP O
PAH NN B-NP O
mRNA NN I-NP O
, , O O
immunoreactive JJ B-NP O
PAH NN I-NP O
protein NN I-NP O
, , O O
and CC O O
exhibit VBP B-VP O
pterin NN B-NP O
- HYPH B-NP O
dependent JJ I-NP O
phenylalanine NN I-NP O
hydroxylase NN I-NP O
activity NN I-NP O
. . O O

The DT B-NP O
recombinant JJ I-NP O
virus NN I-NP O
is VBZ B-VP O
also RB B-ADVP O
capable JJ B-ADJP O
of IN B-PP O
infecting VBG B-VP O
a DT B-NP O
mouse NN I-NP O
hepatoma NN I-NP B-Disease
cell NN I-NP O
line NN I-NP O
that WDT B-NP O
does VBZ B-VP O
not RB I-VP O
normally RB I-VP O
synthesize VB I-VP O
PAH NN B-NP O
. . O O

PAH NN B-NP O
activity NN I-NP O
is VBZ B-VP O
present JJ B-ADJP O
in IN B-PP O
the DT B-NP O
cellular JJ I-NP O
extracts NNS I-NP O
and CC O O
the DT B-NP O
entire JJ I-NP O
hydroxylation NN I-NP O
system NN I-NP O
is VBZ B-VP O
reconstituted VBN I-VP O
in IN B-PP O
the DT B-NP O
hepatoma NN I-NP B-Disease
cells NNS I-NP O
infected VBN B-VP O
with IN B-PP O
the DT B-NP O
recombinant JJ I-NP O
viruses NNS I-NP O
. . O O

Thus RB B-ADVP O
, , O O
recombinant JJ B-NP O
viruses NNS I-NP O
containing VBG B-VP O
human JJ B-NP O
PAH NN I-NP O
cDNA NN I-NP O
provide VBP B-VP O
a DT B-NP O
means NN I-NP O
for IN B-PP O
introducing VBG B-VP O
functional JJ B-NP O
PAH NN I-NP O
into IN B-PP O
mammalian JJ B-NP O
cells NNS I-NP O
of IN B-PP O
hepatic JJ B-NP O
origin NN I-NP O
and CC O O
can MD B-VP O
potentially RB I-VP O
be VB I-VP O
introduced VBN I-VP O
into IN B-PP O
whole JJ B-NP O
animals NNS I-NP O
as IN B-PP O
a DT B-NP O
model NN I-NP O
for IN B-PP O
somatic JJ B-NP O
gene NN I-NP O
therapy NN I-NP O
for IN B-PP O
PKU NN B-NP B-Disease
. . O O

. . O O

Estimation NN B-NP O
of IN B-PP O
the DT B-NP O
male JJ I-NP O
to TO B-PP O
female JJ B-NP O
ratio NN I-NP O
of IN B-PP O
mutation NN B-NP O
rates NNS I-NP O
from IN B-PP O
the DT B-NP O
segregation NN I-NP O
of IN B-PP O
X NN B-NP O
- HYPH B-NP O
chromosomal JJ I-NP O
DNA NN I-NP O
haplotypes NNS I-NP O
in IN B-PP O
Duchenne NNP B-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
families NNS I-NP O
. . O O

A DT B-NP O
novel JJ I-NP O
procedure NN I-NP O
is VBZ B-VP O
presented VBN I-VP O
to TO I-VP O
estimate VB I-VP O
the DT B-NP O
ratio NN I-NP O
of IN B-PP O
male JJ B-NP O
to TO B-PP O
female JJ B-NP O
mutation NN I-NP O
rates NNS I-NP O
for IN B-PP O
Duchenne NNP B-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
DMD NN B-NP B-Disease
) ) O O
. . O O

X NN B-NP O
- HYPH I-NP O
specific JJ I-NP O
restriction NN I-NP O
fragment NN I-NP O
length NN I-NP O
polymorphisms NNS I-NP O
are VBP B-VP O
used VBN I-VP O
to TO B-VP O
establish VB I-VP O
DNA NN B-NP O
haplotypes NNS I-NP O
in IN B-PP O
three CD B-NP O
- HYPH I-NP O
generation NN I-NP O
DMD NN I-NP B-Disease
families NNS I-NP O
. . O O

From IN B-PP O
the DT B-NP O
proportion NN I-NP O
of IN B-PP O
DMD NN B-NP B-Disease
patients NNS I-NP O
who WP B-NP O
have VBP B-VP O
inherited VBN I-VP O
their PRP$ B-NP O
maternal JJ I-NP O
grandfathers NNS I-NP O
X NN I-NP O
chromosome NN I-NP O
, , O O
the DT B-NP O
ratio NN I-NP O
of IN B-PP O
mutation NN B-NP O
rates NNS I-NP O
can MD B-VP O
be VB I-VP O
calculated VBN I-VP O
. . O O

In IN B-PP O
contrast NN B-NP O
to TO B-PP O
classical JJ B-NP O
methods NNS I-NP O
, , O O
the DT B-NP O
proposed VBN I-NP O
procedure NN I-NP O
is VBZ B-VP O
not RB O O
restricted JJ B-ADJP O
to TO B-PP O
sporadic JJ B-NP O
or CC I-NP O
familiar JJ I-NP O
cases NNS I-NP O
nor CC O O
is VBZ B-VP O
any DT B-NP O
information NN I-NP O
on IN B-PP O
the DT B-NP O
carrier NN I-NP O
status NN I-NP O
of IN B-PP O
female JJ B-NP O
relatives NNS I-NP O
required VBN B-VP O
. . O O

. . O O

Deletions NNS B-NP O
of IN B-PP O
a DT B-NP O
DNA NN I-NP O
sequence NN I-NP O
in IN B-PP O
retinoblastomas NNS B-NP B-Disease
and CC O O
mesenchymal JJ B-NP B-Disease
tumors NNS I-NP I-Disease
: : O O
organization NN B-NP O
of IN B-PP O
the DT B-NP O
sequence NN I-NP O
and CC O O
its PRP$ B-NP O
encoded VBN I-NP O
protein NN I-NP O
. . O O

Retinoblastoma NN B-NP B-Disease
is VBZ B-VP O
a DT B-NP O
childhood NN I-NP B-Disease
tumor NN I-NP I-Disease
that WDT B-NP O
can MD B-VP O
arise VB I-VP O
because IN B-PP O
of IN I-PP O
mutant JJ B-NP O
alleles NNS I-NP O
acquired VBN B-VP O
as IN B-PP O
somatic JJ B-NP O
or CC I-NP O
germinal JJ I-NP O
mutations NNS I-NP O
. . O O

The DT B-NP O
mutant JJ I-NP O
allele NN I-NP O
can MD B-VP O
be VB I-VP O
carried VBN I-VP O
in IN B-PP O
the DT B-NP O
germ NN I-NP O
line NN I-NP O
. . O O

The DT B-NP O
mutations NNS I-NP O
creating VBG B-VP O
these DT B-NP O
alleles NNS I-NP O
act VBP B-VP O
by IN B-PP O
inactivating VBG B-VP O
copies NNS B-NP O
of IN B-PP O
a DT B-NP O
recessive JJ I-NP O
oncogene NN I-NP O
located JJ B-ADJP O
within IN B-PP O
band NN B-NP O
q14 NN I-NP O
of IN B-PP O
chromosome NN B-NP O
13 CD I-NP O
and CC O O
termed VBN B-VP O
the DT B-NP O
RB1 NN I-NP O
locus NN I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
reported VBN I-VP O
isolation NN B-NP O
of IN B-PP O
a DT B-NP O
cDNA NN I-NP O
fragment NN I-NP O
that WDT B-NP O
recognizes VBZ B-VP O
chromosomal JJ B-NP O
sequences NNS I-NP O
possessing VBG B-VP O
many JJ B-NP O
of IN B-PP O
the DT B-NP O
attributes NNS I-NP O
of IN B-PP O
the DT B-NP O
retinoblastoma NN I-NP B-Disease
gene NN I-NP O
associated VBN B-VP O
with IN B-PP O
the DT B-NP O
RB1 NN I-NP O
locus NN I-NP O
. . O O

We PRP B-NP O
now RB B-ADVP O
report VBP B-VP O
that IN B-SBAR O
this DT B-NP O
segment NN I-NP O
is VBZ B-VP O
additionally RB B-ADVP O
the DT B-NP O
target NN I-NP O
of IN B-PP O
somatic JJ B-NP O
mutations NNS I-NP O
in IN B-PP O
mesenchymal JJ B-NP B-Disease
tumors NNS I-NP I-Disease
among IN B-PP O
patients NNS B-NP O
having VBG B-VP O
no DT B-NP O
apparent JJ I-NP O
predisposition NN I-NP O
to TO B-PP O
retinoblastoma NN B-NP B-Disease
and CC O O
no DT B-NP O
previous JJ I-NP O
evidence NN I-NP O
of IN B-PP O
retinoblastoma NN B-NP B-Disease
. . O O

These DT B-NP O
tumors NNS I-NP B-Disease
provide VBP B-VP O
additional JJ B-NP O
evidence NN I-NP O
that IN B-SBAR O
the DT B-NP O
cloned VBN I-NP O
sequences NNS I-NP O
are VBP B-VP O
representative JJ B-ADJP O
of IN B-PP O
a DT B-NP O
gene NN I-NP O
that WDT B-NP O
is VBZ B-VP O
a DT B-NP O
frequent JJ I-NP O
target NN I-NP O
of IN B-PP O
inactivation NN B-NP O
during IN B-PP O
tumorigenesis NN B-NP O
. . O O

Sequence NN B-NP O
analysis NN I-NP O
of IN B-PP O
this DT B-NP O
cDNA NN I-NP O
provides VBZ B-VP O
little JJ B-NP O
insight NN I-NP O
into IN B-PP O
its PRP$ B-NP O
normal JJ I-NP O
functional JJ I-NP O
role NN I-NP O
. . O O

. . O O

Treatment NN B-NP O
of IN B-PP O
Duchenne NNP B-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
with IN B-PP O
growth NN B-NP O
hormone NN I-NP O
inhibitors NNS I-NP O
. . O O

A DT B-NP O
controlled JJ I-NP O
, , I-NP O
double JJ I-NP O
- HYPH I-NP O
blind JJ I-NP O
therapeutic JJ I-NP O
trial NN I-NP O
with IN B-PP O
the DT B-NP O
drug NN I-NP O
mazindol NN I-NP O
, , O O
a DT B-NP O
growth NN I-NP O
hormone NN I-NP O
inhibitor NN I-NP O
, , O O
was VBD B-VP O
performed VBN I-VP O
in IN B-PP O
a DT B-NP O
pair NN I-NP O
of IN B-PP O
7 CD B-NP O
1 CD I-NP O
/ SYM I-NP O
2 CD I-NP O
year NN I-NP O
- HYPH O O
old JJ B-NP O
monozygotic JJ I-NP O
twins NNS I-NP O
, , O O
with IN B-PP O
Duchenne JJ B-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
DMD NN B-NP B-Disease
) ) O O
. . O O

The DT B-NP O
rationale NN I-NP O
for IN B-PP O
this DT B-NP O
trial NN I-NP O
was VBD B-VP O
based VBN I-VP O
on IN B-PP O
a DT B-NP O
patient NN I-NP O
( ( O O
reported VBN B-VP O
previously RB B-ADVP O
) ) O O
affected VBN B-VP O
simultaneously RB B-ADVP O
with IN B-PP O
DMD NN B-NP B-Disease
and CC I-NP O
growth NN I-NP B-Disease
hormone NN I-NP I-Disease
( ( O I-Disease
GH NN B-NP I-Disease
) ) O I-Disease
deficiency NN B-NP I-Disease
, , O O
who WP B-NP O
is VBZ B-VP O
showing VBG I-VP O
a DT B-NP O
benign JJ I-NP O
course NN I-NP O
of IN B-PP O
the DT B-NP O
dystrophic JJ I-NP B-Disease
process NN I-NP I-Disease
and CC O O
is VBZ B-VP O
still RB I-VP O
walking VBG I-VP O
at IN B-PP O
18 CD B-NP O
years NNS I-NP O
. . O O

One CD B-NP O
of IN B-PP O
the DT B-NP O
twins NNS I-NP O
received VBD B-VP O
2 CD B-NP O
mg NN I-NP O
of IN B-PP O
mazindol NN B-NP O
daily RB B-ADVP O
, , O O
while IN B-SBAR O
the DT B-NP O
other JJ I-NP O
received VBD B-VP O
a DT B-NP O
placebo NN I-NP O
. . O O

The DT B-NP O
assessment NN I-NP O
, , O O
repeated VBD B-VP O
every DT B-NP O
2 CD I-NP O
months NNS I-NP O
, , O O
included VBD B-VP O
weight NN B-NP O
and CC I-NP O
height NN I-NP O
measurements NNS I-NP O
, , O O
functional JJ B-NP O
and CC I-NP O
motor NN I-NP O
ability NN I-NP O
tests NNS I-NP O
, , O O
ergometry NN B-NP O
and CC I-NP O
determinations NNS I-NP O
of IN B-PP O
serum NN B-NP O
enzymes NNS I-NP O
and CC O O
GH NN B-NP O
levels NNS I-NP O
. . O O

After IN B-PP O
one CD B-NP O
year NN I-NP O
of IN B-PP O
trial NN B-NP O
the DT B-NP O
code NN I-NP O
was VBD B-VP O
broken VBN I-VP O
and CC O O
it PRP B-NP O
was VBD B-VP O
seen VBN I-VP O
that IN B-SBAR O
the DT B-NP O
twin NN I-NP O
under IN B-PP O
placebo NN B-NP O
treatment NN I-NP O
was VBD B-VP O
strikingly RB B-ADJP O
worse JJR I-ADJP O
than IN B-PP O
his PRP$ B-NP O
brother NN I-NP O
, , O O
the DT B-NP O
progression NN I-NP O
of IN B-PP O
whose WP$ B-NP O
condition NN I-NP O
was VBD B-VP O
practically RB I-VP O
arrested VBN I-VP O
. . O O

These DT B-NP O
results NNS I-NP O
strongly RB B-VP O
suggest VBP I-VP O
that IN B-SBAR O
treatment NN B-NP O
with IN B-PP O
a DT B-NP O
GH NN I-NP O
inhibitor NN I-NP O
is VBZ B-VP O
beneficial JJ B-ADJP O
for IN B-PP O
DMD NN B-NP B-Disease
patients NNS I-NP O
. . O O

. . O O

Identification NN B-NP O
and CC I-NP O
localization NN I-NP O
of IN B-PP O
mutations NNS B-NP O
at IN B-PP O
the DT B-NP O
Lesch NNP I-NP B-Disease
- HYPH I-NP I-Disease
Nyhan NNP I-NP I-Disease
locus NN I-NP O
by IN B-PP O
ribonuclease NN B-NP O
A NN I-NP O
cleavage NN I-NP O
. . O O

Many JJ B-NP O
mutations NNS I-NP O
leading VBG B-VP O
to TO B-PP O
human JJ B-NP O
disease NN I-NP O
are VBP B-VP O
the DT B-NP O
result NN I-NP O
of IN B-PP O
single JJ B-NP O
DNA NN I-NP O
base NN I-NP O
pair NN I-NP O
changes NNS I-NP O
that WDT B-NP O
cannot MD B-VP O
be VB I-VP O
identified VBN I-VP O
by IN B-PP O
Southern JJ B-NP O
analysis NN I-NP O
. . O O

This DT B-NP O
has VBZ B-VP O
prompted VBN I-VP O
the DT B-NP O
development NN I-NP O
of IN B-PP O
alternative JJ B-NP O
assays NNS I-NP O
for IN B-PP O
point NN B-NP O
mutation NN I-NP O
detection NN I-NP O
. . O O

The DT B-NP O
recently RB I-NP O
described VBN I-NP O
ribonuclease NN I-NP O
A NN I-NP O
cleavage NN I-NP O
procedure NN I-NP O
, , O O
with IN B-PP O
a DT B-NP O
polyuridylic JJ I-NP O
acid NN I-NP O
- HYPH B-NP O
paper NN I-NP O
affinity NN I-NP O
chromatography NN I-NP O
step NN I-NP O
, , O O
has VBZ B-VP O
been VBN I-VP O
used VBN I-VP O
to TO I-VP O
identify VB I-VP O
the DT B-NP O
mutational JJ I-NP O
lesions NNS I-NP O
in IN B-PP O
the DT B-NP O
hypoxanthine NN I-NP O
phosphoribosyltransferase NN I-NP O
( ( O O
HPRT NN B-NP O
) ) O O
messenger NN B-NP O
RNAs NNS I-NP O
of IN B-PP O
patients NNS B-NP O
with IN B-PP O
Lesch NNP B-NP B-Disease
- HYPH B-NP I-Disease
Nyhan NNP I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

Distinctive JJ B-NP O
ribonuclease NN I-NP O
A NN I-NP O
cleavage NN I-NP O
patterns NNS I-NP O
were VBD B-VP O
identified VBN I-VP O
in IN B-PP O
messenger NN B-NP O
RNA NN I-NP O
from IN B-PP O
5 CD B-NP O
of IN B-PP O
14 CD B-NP O
Lesch NNP I-NP B-Disease
- HYPH I-NP I-Disease
Nyhan NNP I-NP I-Disease
patients NNS I-NP O
who WP B-NP O
were VBD B-VP O
chosen VBN I-VP O
because IN B-SBAR O
no DT B-NP O
HPRT NN I-NP O
Southern JJ I-NP O
or CC I-NP O
Northern JJ I-NP O
blotting NN I-NP O
pattern NN I-NP O
changes NNS I-NP O
had VBD B-VP O
been VBN I-VP O
found VBN I-VP O
. . O O

This DT B-NP O
approach NN I-NP O
now RB B-ADVP O
allows VBZ B-VP O
HPRT NN B-NP O
mutation NN I-NP O
detection NN I-NP O
in IN B-PP O
50 CD B-NP O
percent NN I-NP O
of IN B-PP O
the DT B-NP O
cases NNS I-NP O
of IN B-PP O
Lesch NNP B-NP B-Disease
- HYPH I-NP I-Disease
Nyhan NNP I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

The DT B-NP O
polyuridylic JJ I-NP O
acid NN I-NP O
- HYPH B-NP O
paper NN I-NP O
affinity NN I-NP O
procedure NN I-NP O
provides VBZ B-VP O
a DT B-NP O
general JJ I-NP O
method NN I-NP O
for IN B-PP O
analysis NN B-NP O
of IN B-PP O
low JJ B-NP O
abundance NN I-NP O
messenger NN I-NP O
RNAs NNS I-NP O
. . O O

. . O O

Two CD B-NP O
new JJ I-NP O
variants NNS I-NP O
of IN B-PP O
glucose NN B-NP O
- HYPH B-NP O
6 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
dehydrogenase NN I-NP O
associated VBN B-VP O
with IN B-PP O
hereditary JJ B-NP B-Disease
non AFX I-NP I-Disease
- HYPH I-NP I-Disease
spherocytic JJ I-NP I-Disease
hemolytic JJ I-NP I-Disease
anemia NN I-NP I-Disease
: : O O
G6PD NN B-NP O
Wayne NN I-NP O
and CC O O
G6PD NN B-NP O
Huron NNP I-NP O
. . O O

Two CD B-NP O
new JJ I-NP O
deficient JJ I-NP O
variants NNS I-NP O
of IN B-PP O
glucose NN B-NP O
- HYPH B-NP O
6 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
dehydrogenase NN I-NP O
( ( O O
G6PD NN B-NP O
) ) O O
causing VBG B-VP O
hereditary JJ B-NP B-Disease
nonspherocytic JJ I-NP I-Disease
hemolytic JJ I-NP I-Disease
anemia NN I-NP I-Disease
( ( O O
HNSHA NN B-NP B-Disease
) ) O O
are VBP B-VP O
described VBN I-VP O
. . O O

Both DT B-NP O
of IN B-PP O
these DT B-NP O
are VBP B-VP O
unique JJ B-ADJP O
and CC O O
they PRP B-NP O
have VBP B-VP O
been VBN I-VP O
named VBN I-VP O
G6PD NN B-NP O
Wayne NNP I-NP O
and CC O O
G6PD NNP B-NP O
Huron NNP I-NP O
. . O O

Patients NNS B-NP O
with IN B-PP O
G6PD NN B-NP O
Wayne NNP I-NP O
underwent VBD B-VP O
splenectomy NN B-NP O
and CC O O
no DT B-NP O
objective JJ I-NP O
improvement NN I-NP O
was VBD B-VP O
noted VBN I-VP O
. . O O

The DT B-NP O
patients NNS I-NP O
with IN B-PP O
G6PD NN B-NP O
Huron NNP B-NP O
were VBD B-VP O
under IN B-PP O
medical JJ B-NP O
observation NN I-NP O
for IN B-PP O
a DT B-NP O
considerable JJ I-NP O
period NN I-NP O
of IN B-PP O
time NN B-NP O
without IN B-PP O
the DT B-NP O
diagnosis NN I-NP O
of IN B-PP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
being VBG B-VP O
entertained VBN I-VP O
because IN B-SBAR O
the DT B-NP O
family NN I-NP O
was VBD B-VP O
of IN B-PP O
Northern JJ B-NP O
European JJ I-NP O
origin NN I-NP O
. . O O

Since IN B-SBAR O
sporadic JJ B-NP O
variants NNS I-NP O
of IN B-PP O
G6PD NN B-NP O
causing VBG B-VP O
HNSHA NN B-NP B-Disease
show VBP B-VP O
no DT B-NP O
special JJ I-NP O
racial JJ I-NP O
predilection NN I-NP O
, , O O
the DT B-NP O
diagnosis NN I-NP O
of IN B-PP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
should MD B-VP O
always RB I-VP O
be VB I-VP O
considered VBN I-VP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
this DT B-NP O
syndrome NN I-NP O
. . O O

. . O O

Sialophorin NN B-NP O
, , O O
a DT B-NP O
surface NN I-NP O
sialoglycoprotein NN I-NP O
defective JJ B-ADJP O
in IN B-PP O
the DT B-NP O
Wiskott NNP I-NP B-Disease
- HYPH I-NP I-Disease
Aldrich NNP I-NP I-Disease
syndrome NN I-NP I-Disease
, , O O
is VBZ B-VP O
involved VBN I-VP O
in IN B-PP O
human JJ B-NP O
T NN I-NP O
lymphocyte NN I-NP O
proliferation NN I-NP O
. . O O

The DT B-NP O
mAb NN I-NP O
L10 NN I-NP O
was VBD B-VP O
used VBN I-VP O
to TO B-VP O
determine VB I-VP O
the DT B-NP O
distribution NN I-NP O
and CC O O
the DT B-NP O
function NN I-NP O
of IN B-PP O
sialophorin NN B-NP O
, , O O
the DT B-NP O
heavily RB I-NP O
glycosylated VBN I-NP O
surface NN I-NP O
molecule NN I-NP O
that WDT B-NP O
is VBZ B-VP O
deficient JJ B-ADJP O
/ SYM O O
defective JJ B-ADJP O
in IN B-PP O
lymphocytes NNS B-NP O
of IN B-PP O
patients NNS B-NP O
with IN B-PP O
the DT B-NP O
X NN I-NP B-Disease
- HYPH B-VP I-Disease
linked VBN B-NP I-Disease
immunodeficiency NN I-NP I-Disease
Wiskott NNP I-NP I-Disease
- HYPH I-NP I-Disease
Aldrich NNP I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

Dual JJ B-NP O
- HYPH I-NP O
parameter NN I-NP O
FACS NN I-NP O
analysis NN I-NP O
indicated VBD B-VP O
that IN B-SBAR O
sialophorin NN B-NP O
is VBZ B-VP O
expressed VBN I-VP O
on IN B-PP O
CD4 NN B-NP O
+ SYM B-NP O
and CC O O
CD8 NN B-NP O
+ SYM O O
lymphocytes NNS B-NP O
, , O O
on IN B-PP O
a DT B-NP O
subpopulation NN I-NP O
of IN B-PP O
peripheral JJ B-NP O
blood NN I-NP O
B NN I-NP O
lymphocytes NNS I-NP O
, , O O
on IN B-PP O
all DT B-NP O
thymocytes NNS I-NP O
, , O O
and CC O O
on IN B-PP O
a DT B-NP O
subpopulation NN I-NP O
of IN B-PP O
bone NN B-NP O
marrow NN I-NP O
cells NNS I-NP O
. . O O

Functional JJ B-NP O
studies NNS I-NP O
demonstrated VBD B-VP O
that IN B-SBAR O
L10 NN B-NP O
mAb NN I-NP O
stimulates VBZ B-VP O
the DT B-NP O
proliferation NN I-NP O
of IN B-PP O
peripheral JJ B-NP O
blood NN I-NP O
T NN I-NP O
lymphocytes NNS I-NP O
as IN B-SBAR O
measured VBN B-VP O
by IN B-PP O
stimulation NN B-NP O
of IN B-PP O
[ ( B-NP O
3H NN I-NP O
] ) I-NP O
thymidine NN I-NP O
incorporation NN I-NP O
. . O O

The DT B-NP O
time NN I-NP O
course NN I-NP O
and CC I-NP O
magnitude NN I-NP O
of IN B-PP O
increased VBN B-NP O
[ ( I-NP O
3H NN I-NP O
] ) I-NP O
thymidine NN I-NP O
incorporation NN I-NP O
by IN B-PP O
T NN B-NP O
lymphocytes NNS I-NP O
in IN B-PP O
response NN B-NP O
to TO B-PP O
L10 NN B-NP O
mAb NN I-NP O
paralleled VBD B-VP O
that IN B-SBAR O
induced VBN B-VP O
by IN B-PP O
anti AFX B-NP O
- HYPH I-NP O
CD3 NN I-NP O
mAb NN I-NP O
. . O O

Effective JJ B-NP O
stimulation NN I-NP O
was VBD B-VP O
dependent JJ B-ADJP O
on IN B-PP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
monocytes NNS B-NP O
and CC O O
the DT B-NP O
Fc NN I-NP O
portion NN I-NP O
of IN B-PP O
L10 NN B-NP O
mAb NN I-NP O
. . O O

Stimulation NN B-NP O
of IN B-PP O
lymphocytes NNS B-NP O
by IN B-PP O
L10 NN B-NP O
, , O O
like IN B-PP O
stimulation NN B-NP O
by IN B-PP O
anti AFX B-NP O
- HYPH I-NP O
CD3 NN I-NP O
mAb NN I-NP O
, , O O
involves VBZ B-VP O
increased VBN I-VP O
expression NN B-NP O
of IN B-PP O
4F2 NN B-NP O
, , O O
HLA NN B-NP O
- HYPH B-NP O
DR NN I-NP O
, , O O
and CC O O
IL NN B-NP O
- HYPH B-NP O
2 CD I-NP O
- HYPH I-NP O
R NN I-NP O
. . O O

These DT B-NP O
observations NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
sialophorin NN B-NP O
functions NNS I-NP O
in IN B-PP O
T NN B-NP O
cell NN I-NP O
activation NN I-NP O
. . O O

. . O O

Hypopigmentation NN B-NP B-Disease
in IN B-PP O
the DT B-NP O
Prader NNP I-NP B-Disease
- HYPH I-NP I-Disease
Willi NNP I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

Cutaneous JJ B-NP B-Disease
and CC I-NP I-Disease
ocular JJ I-NP I-Disease
pigmentation NN I-NP I-Disease
were VBD B-VP O
evaluated VBN I-VP O
in IN B-PP O
29 CD B-NP O
individuals NNS I-NP O
with IN B-PP O
the DT B-NP O
Prader NNP I-NP B-Disease
- HYPH I-NP I-Disease
Willi NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
PWS NN B-NP B-Disease
) ) O O
. . O O

Criteria NNS B-NP O
for IN B-PP O
hypopigmentation NN B-NP B-Disease
included VBD B-VP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
type NN B-NP O
I CD I-NP O
or CC I-NP O
II CD I-NP O
skin NN I-NP O
, , O O
the DT B-NP O
lightest JJS I-NP O
skin NN I-NP O
type NN I-NP O
in IN B-PP O
the DT B-NP O
family NN I-NP O
by IN B-PP O
history NN B-NP O
, , O O
and CC O O
iris NN B-NP O
translucency NN I-NP O
on IN B-PP O
globe NN B-NP O
transillumination NN I-NP O
. . O O

On IN B-PP O
the DT B-NP O
basis NN I-NP O
of IN B-PP O
these DT B-NP O
criteria NNS I-NP O
, , O O
48 CD B-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
PWS NN I-NP B-Disease
individuals NNS I-NP O
were VBD B-VP O
hypopigmented VBN I-VP B-Disease
. . O O

The DT B-NP O
presence NN I-NP O
of IN B-PP O
hypopigmentation NN B-NP B-Disease
correlated VBD B-VP O
with IN B-PP O
a DT B-NP O
small JJ I-NP O
interstitial JJ I-NP O
deletion NN I-NP O
on IN B-PP O
the DT B-NP O
proximal JJ I-NP O
long JJ I-NP O
arm NN I-NP O
of IN B-PP O
chromosome NN B-NP O
15 CD I-NP O
; : O O
however RB O O
, , O O
this DT B-NP O
deletion NN I-NP O
was VBD B-VP O
also RB I-VP O
found VBN I-VP O
in IN B-PP O
individuals NNS B-NP O
who WP B-NP O
did VBD B-VP O
not RB I-VP O
meet VB I-VP O
the DT B-NP O
full JJ I-NP O
criteria NNS I-NP O
for IN B-PP O
hypopigmentation NN B-NP B-Disease
. . O O

Hairbulb NN B-NP O
tyrosinase NN I-NP O
activity NN I-NP O
and CC O O
glutathione NN B-NP O
content NN I-NP O
, , O O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
urine NN B-NP O
cysteinyldopa NN I-NP O
excretion NN I-NP O
, , O O
were VBD B-VP O
low JJ B-ADJP O
in IN B-PP O
PWS NN B-NP B-Disease
individuals NNS I-NP O
with IN B-PP O
and CC I-PP O
without IN I-PP O
hypopigmentation NN B-NP B-Disease
and CC O O
did VBD B-VP O
not RB I-VP O
separate VB I-VP O
these DT B-NP O
two CD I-NP O
groups NNS I-NP O
. . O O

We PRP B-NP O
conclude VBP B-VP O
that IN B-SBAR O
hypopigmentation NN B-NP B-Disease
is VBZ B-VP O
found VBN I-VP O
in IN B-PP O
a DT B-NP O
significant JJ I-NP O
proportion NN I-NP O
of IN B-PP O
individuals NNS B-NP O
with IN B-PP O
PWS NN B-NP B-Disease
and CC O O
that IN B-SBAR O
the DT B-NP O
hypopigmentation NN I-NP B-Disease
may MD B-VP O
be VB I-VP O
associated VBN I-VP O
with IN B-PP O
a DT B-NP O
deletion NN I-NP O
of IN B-PP O
the DT B-NP O
long JJ I-NP O
arm NN I-NP O
of IN B-PP O
chromosome NN B-NP O
15 CD I-NP O
. . O O

The DT B-NP O
mechanism NN I-NP O
for IN B-PP O
the DT B-NP O
hypopigmentation NN I-NP B-Disease
is VBZ B-VP O
unknown JJ B-ADJP O
. . O O

. . O O

Phenotype NN B-NP O
heterogeneity NN I-NP O
among IN B-PP O
hemizygotes NNS B-NP O
in IN B-PP O
a DT B-NP O
family NN I-NP O
biochemically RB B-ADVP O
screened VBD B-VP O
for IN B-PP O
adrenoleukodystrophy NN B-NP B-Disease
. . O O

We PRP B-NP O
report VBP B-VP O
on IN B-PP O
two CD B-NP O
clinically RB I-NP O
, , O O
neurologically RB B-NP O
normal JJ I-NP O
relatives NNS I-NP O
of IN B-PP O
a DT B-NP O
boy NN I-NP O
affected VBN B-VP O
by IN B-PP O
adrenoleukodystrophy NN B-NP B-Disease
( ( O O
ALD NN B-NP B-Disease
) ) O O
; : O O
they PRP B-NP O
were VBD B-VP O
found VBN I-VP O
repeatedly RB B-ADVP O
to TO B-VP O
have VB I-VP O
the DT B-NP O
biochemical JJ I-NP O
defect NN I-NP O
of IN B-PP O
an DT B-NP O
ALD NN I-NP B-Disease
hemizygote NN I-NP O
. . O O

The DT B-NP O
assay NN I-NP O
consisted VBD B-VP O
in IN B-PP O
the DT B-NP O
determination NN I-NP O
of IN B-PP O
very RB B-NP O
- HYPH I-NP O
long JJ I-NP O
- HYPH I-NP O
chain NN I-NP O
fatty JJ I-NP O
acids NNS I-NP O
in IN B-PP O
lyophilized VBN B-NP O
and CC I-NP O
reconstituted VBN I-NP O
plasma NN I-NP O
. . O O

While IN B-SBAR O
no DT B-NP O
evidence NN I-NP O
of IN B-PP O
neurologic JJ B-NP B-Disease
disease NN I-NP I-Disease
( ( O O
leukodystrophy NN B-NP B-Disease
or CC O O
myeloneuropathy NN B-NP B-Disease
) ) O O
was VBD B-VP O
present JJ B-ADJP O
in IN B-PP O
these DT B-NP O
hemizygotes NNS I-NP O
, , O O
adrenocortical JJ B-NP B-Disease
insufficiency NN I-NP I-Disease
provoking VBG B-VP O
compensatory JJ B-NP O
high JJ I-NP O
ACTH NN I-NP O
release NN I-NP O
was VBD B-VP O
found VBN I-VP O
in IN B-PP O
both DT B-NP O
. . O O

These DT B-NP O
findings NNS I-NP O
should MD B-VP O
be VB I-VP O
taken VBN I-VP O
into IN B-PP O
consideration NN B-NP O
when WRB B-ADVP O
counseling VBG B-VP O
families NNS B-NP O
in IN B-PP O
which WDT B-NP O
cases NNS B-NP O
with IN B-PP O
clinically RB B-NP O
expressed VBN I-NP O
ALD NN I-NP B-Disease
are VBP B-VP O
represented VBN I-VP O
in IN B-PP O
several JJ B-NP O
generations NNS I-NP O
. . O O

. . O O

The DT B-NP O
mapping NN I-NP O
of IN B-PP O
a DT B-NP O
cDNA NN I-NP O
from IN B-PP O
the DT B-NP O
human JJ I-NP O
X NN I-NP B-Disease
- HYPH B-VP I-Disease
linked VBN I-VP I-Disease
Duchenne NNP B-NP I-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
gene NN I-NP O
to TO B-PP O
the DT B-NP O
mouse NN I-NP O
X NN I-NP O
chromosome NN I-NP O
. . O O

The DT B-NP O
recent JJ I-NP O
discovery NN I-NP O
of IN B-PP O
sequences NNS B-NP O
at IN B-PP O
the DT B-NP O
site NN I-NP O
of IN B-PP O
the DT B-NP O
Duchenne NNP I-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
DMD NN B-NP B-Disease
) ) O O
gene NN B-NP O
in IN B-PP O
humans NNS B-NP O
has VBZ B-VP O
opened VBN I-VP O
up RP B-PRT O
the DT B-NP O
possibility NN I-NP O
of IN B-PP O
a DT B-NP O
detailed JJ I-NP O
molecular JJ I-NP O
analysis NN I-NP O
of IN B-PP O
the DT B-NP O
genes NNS I-NP O
in IN B-PP O
humans NNS B-NP O
and CC B-PP O
in IN B-PP O
related JJ B-NP O
mammalian JJ I-NP O
species NNS I-NP O
. . O O

Until IN B-PP O
relatively RB B-ADVP O
recently RB I-ADVP O
, , O O
there EX B-NP O
was VBD B-VP O
no DT B-NP O
obvious JJ I-NP O
mouse NN I-NP O
model NN I-NP O
of IN B-PP O
this DT B-NP O
genetic JJ I-NP B-Disease
disease NN I-NP I-Disease
for IN B-PP O
the DT B-NP O
development NN I-NP O
of IN B-PP O
therapeutic JJ B-NP O
strategies NNS I-NP O
. . O O

The DT B-NP O
identification NN I-NP O
of IN B-PP O
a DT B-NP O
mouse NN I-NP O
X NN I-NP O
- HYPH B-VP O
linked VBN B-NP O
mutant NN I-NP O
showing VBG B-VP O
muscular JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
, , O O
mdx NN B-NP O
, , O O
has VBZ B-VP O
provided VBN I-VP O
a DT B-NP O
candidate NN I-NP O
mouse NN I-NP O
genetic JJ I-NP O
homologue NN I-NP O
to TO B-PP O
the DT B-NP O
DMD NN I-NP B-Disease
locus NN I-NP O
; : O O
the DT B-NP O
relatively RB I-NP O
mild JJ I-NP O
pathological JJ I-NP O
features NNS I-NP O
of IN B-PP O
mdx NN B-NP O
suggest VBP B-VP O
it PRP B-NP O
may MD B-VP O
have VB I-VP O
more RBR B-NP O
in IN B-PP O
common JJ B-ADJP O
with IN B-PP O
mutations NNS B-NP O
of IN B-PP O
the DT B-NP O
Becker NNP I-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
type NN I-NP O
at IN B-PP O
the DT B-NP O
same JJ I-NP O
human JJ I-NP O
locus NN I-NP O
, , O O
however RB B-ADVP O
. . O O

But CC O O
the DT B-NP O
close JJ I-NP O
genetic JJ I-NP O
linkage NN I-NP O
of IN B-PP O
mdx NN B-NP O
to TO B-PP O
G6PD NN B-NP O
and CC I-NP O
Hprt NN I-NP O
on IN B-PP O
the DT B-NP O
mouse NN I-NP O
X NN I-NP O
chromosome NN I-NP O
, , O O
coupled VBN B-VP O
with IN B-PP O
its PRP$ B-NP O
comparatively RB I-NP O
mild JJ I-NP O
pathology NN I-NP O
, , O O
have VBP B-VP O
suggested VBN I-VP O
that IN B-SBAR O
the DT B-NP O
mdx NN I-NP O
mutation NN I-NP O
may MD B-VP O
instead RB I-VP O
correspond VB I-VP O
to TO B-PP O
Emery NNP B-NP B-Disease
Dreifuss NNP I-NP I-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
which WDT B-NP O
itself PRP B-NP O
is VBZ B-VP O
closely RB I-VP O
linked VBN I-VP O
to TO B-PP O
DNA NN B-NP O
markers NNS I-NP O
at IN B-PP O
Xq28 NN B-NP O
- HYPH B-NP O
qter NN I-NP O
in IN B-PP O
the DT B-NP O
region NN I-NP O
of IN B-PP O
G6PD NN B-NP O
on IN B-PP O
the DT B-NP O
human JJ I-NP O
X NN I-NP O
chromosome NN I-NP O
. . O O

Using VBG B-VP O
an DT B-NP O
interspecific JJ I-NP O
mouse NN I-NP O
domesticus NN I-NP O
/ SYM B-NP O
spretus NN I-NP O
cross RB B-ADVP O
, , O O
segregating VBG B-VP O
for IN B-PP O
a DT B-NP O
variety NN I-NP O
of IN B-PP O
markers NNS B-NP O
on IN B-PP O
the DT B-NP O
mouse NN I-NP O
X NN I-NP O
chromosome NN I-NP O
, , O O
we PRP B-NP O
have VBP B-VP O
positioned VBN I-VP O
on IN B-PP O
the DT B-NP O
mouse NN I-NP O
X NN I-NP O
chromosome NN I-NP O
sequences NNS I-NP O
homologous JJ B-ADJP O
to TO B-PP O
a DT B-NP O
DMD NN I-NP B-Disease
cDNA NN I-NP O
clone NN I-NP O
. . O O

These DT B-NP O
sequences NNS I-NP O
map VBP B-VP O
provocatively RB B-ADVP O
close RB B-ADVP O
to TO B-PP O
the DT B-NP O
mdx NN I-NP O
mutation NN I-NP O
and CC O O
unexpectedly RB B-ADJP O
distant JJ I-ADJP O
from IN B-PP O
sparse JJ B-NP O
fur NN I-NP O
, , O O
spf NN B-NP O
, , O O
the DT B-NP O
mouse NN I-NP O
homologue NN I-NP O
of IN B-PP O
OTC NNP B-NP O
( ( O O
ornithine NN B-NP O
transcarbamylase NN I-NP O
) ) O O
which WDT B-NP O
is VBZ B-VP O
closely RB I-VP O
linked VBN I-VP O
to TO B-PP O
DMD NN B-NP B-Disease
on IN B-PP O
the DT B-NP O
human JJ I-NP O
X NN I-NP O
chromosome NN I-NP O
. . O O

. . O O

Localization NN B-NP O
of IN B-PP O
the DT B-NP O
region NN I-NP O
homologous JJ B-ADJP O
to TO B-PP O
the DT B-NP O
Duchenne NNP I-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
locus NN I-NP O
on IN B-PP O
the DT B-NP O
mouse NN I-NP O
X NN I-NP O
chromosome NN I-NP O
. . O O

Recent JJ B-NP O
progress NN I-NP O
has VBZ B-VP O
resulted VBN I-VP O
in IN B-PP O
part NN B-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
mutated VBN B-VP O
in IN B-PP O
Duchenne NNP B-NP B-Disease
and CC O I-Disease
the DT B-NP I-Disease
milder JJR I-NP I-Disease
Becker NNP I-NP I-Disease
muscular JJ I-NP I-Disease
dystrophies NNS I-NP I-Disease
being VBG B-VP O
cloned VBN I-VP O
and CC O O
has VBZ B-VP O
suggested VBN I-VP O
that IN B-SBAR O
the DT B-NP O
gene NN I-NP O
itself PRP B-NP O
extends VBZ B-VP O
over IN B-NP O
1 CD I-NP O
, , I-NP O
000 CD I-NP O
to TO I-NP O
2 CD I-NP O
, , I-NP O
000 CD I-NP O
kilobases NNS I-NP O
( ( O O
kb NN B-NP O
) ) O O
. . O O

To TO B-VP O
study VB I-VP O
how WRB B-ADVP O
mutations NNS B-NP O
in IN B-PP O
this DT B-NP O
gene NN I-NP O
affect NN I-NP O
muscle NN I-NP O
development NN I-NP O
and CC O O
integrity NN B-NP O
, , O O
it PRP B-NP O
would MD B-VP O
be VB I-VP O
of IN B-PP O
interest NN B-NP O
to TO B-VP O
have VB I-VP O
available JJ B-ADJP O
a DT B-NP O
mouse NN I-NP O
model NN I-NP O
of IN B-PP O
the DT B-NP O
human JJ I-NP O
disease NN I-NP O
. . O O

The DT B-NP O
mouse NN I-NP O
mdx NN I-NP O
mutation NN I-NP O
affects VBZ B-VP O
muscle NN B-NP O
and CC O O
confers VBZ B-VP O
a DT B-NP O
mild JJ I-NP O
dystrophic JJ I-NP B-Disease
syndrome NN I-NP I-Disease
, , O O
but CC O O
it PRP B-NP O
is VBZ B-VP O
not RB O O
clear JJ B-ADJP O
whether IN B-SBAR O
this DT B-NP O
mutation NN I-NP O
is VBZ B-VP O
equivalent JJ B-ADJP O
to TO B-PP O
Duchenne NN B-NP B-Disease
/ SYM B-NP I-Disease
Becker NN I-NP I-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
in IN B-PP O
man NN B-NP O
. . O O

Here RB B-ADVP O
we PRP B-NP O
describe VBP B-VP O
the DT B-NP O
use NN I-NP O
of IN B-PP O
two CD B-NP O
sequences NNS I-NP O
from IN B-PP O
the DT B-NP O
human JJ I-NP O
Duchenne NNP I-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
DMD NN B-NP B-Disease
) ) O O
gene NN B-NP O
that IN B-SBAR O
cross AFX B-NP O
- HYPH I-NP O
hybridize NN I-NP O
to TO B-PP O
mouse NN B-NP O
X NN I-NP O
- HYPH O O
linked VBN B-VP O
sequences NNS B-NP O
to TO B-VP O
localize VB I-VP O
the DT B-NP O
gene NN I-NP O
homologous JJ B-ADJP O
to TO B-PP O
DMD NN B-NP B-Disease
in IN B-PP O
the DT B-NP O
mouse NN I-NP O
. . O O

Both DT B-NP O
sequences NNS I-NP O
map VBP B-VP O
to TO B-PP O
the DT B-NP O
region NN I-NP O
of IN B-PP O
10 CD B-NP O
centimorgan NN I-NP O
lying VBG B-VP O
between IN B-PP O
the DT B-NP O
Tabby NNP I-NP O
( ( O O
Ta NNP B-NP O
) ) O O
and CC O O
St14 NN B-NP O
- HYPH B-NP O
1 CD I-NP O
( ( O O
DxPas8 NN B-NP O
) ) O O
loci NNS B-NP O
, , O O
close RB B-ADVP O
to TO B-PP O
the DT B-NP O
phosphorylase NN I-NP O
b NN I-NP O
kinase NN I-NP O
locus NN I-NP O
( ( O O
Phk NN B-NP O
) ) O O
. . O O

By IN B-PP O
analogy NN B-NP O
with IN B-PP O
the DT B-NP O
human JJ I-NP O
X NN I-NP O
- HYPH O O
chromosome NN B-NP O
, , O O
we PRP B-NP O
conclude VBP B-VP O
that IN B-SBAR O
the DT B-NP O
region NN I-NP O
in IN B-PP O
the DT B-NP O
mouse NN I-NP O
around IN B-PP O
the DT B-NP O
G6pd NN I-NP O
and CC I-NP O
St14 NN I-NP O
- HYPH B-NP O
1 CD I-NP O
loci NNS I-NP O
may MD B-VP O
contain VB I-VP O
two CD B-NP O
genes NNS I-NP O
corresponding VBG B-VP O
to TO B-PP O
distinct JJ B-NP O
human JJ I-NP O
myopathies NNS I-NP B-Disease
Emery NNP I-NP B-Disease
Dreifuss NNP I-NP I-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
which WDT B-NP O
is VBZ B-VP O
known VBN I-VP O
to TO I-VP O
be VB I-VP O
closely RB I-VP O
linked VBN I-VP O
to TO B-PP O
St14 NN B-NP O
- HYPH B-NP O
1 CD I-NP O
in IN B-PP O
man NN B-NP O
and CC O O
the DT B-NP O
DMD NN I-NP B-Disease
homologue NN I-NP O
described VBN B-VP O
here RB B-ADVP O
. . O O

. . O O

GT NN B-NP O
to TO B-PP O
AT NN B-NP O
transition NN I-NP O
at IN B-PP O
a DT B-NP O
splice NN I-NP O
donor NN I-NP O
site NN I-NP O
causes VBZ B-VP O
skipping NN B-NP O
of IN B-PP O
the DT B-NP O
preceding VBG I-NP O
exon NN I-NP O
in IN B-PP O
phenylketonuria NN B-NP B-Disease
. . O O

Classical JJ B-NP B-Disease
Phenylketonuria NN I-NP I-Disease
( ( O O
PKU NN B-NP B-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
human JJ I-NP I-Disease
genetic JJ I-NP I-Disease
disorder NN I-NP I-Disease
caused VBN B-VP O
by IN B-PP O
a DT B-NP O
deficiency NN I-NP B-Disease
of IN B-PP I-Disease
hepatic JJ B-NP I-Disease
phenylalanine NN I-NP I-Disease
hydroxylase NN I-NP I-Disease
( ( O O
PAH NN B-NP O
) ) O O
. . O O

We PRP B-NP O
isolated VBD B-VP O
several JJ B-NP O
mutant JJ I-NP O
PAH NN I-NP O
cDNA NN I-NP O
clones NNS I-NP O
from IN B-PP O
a DT B-NP O
PKU NN I-NP B-Disease
carrier NN I-NP O
individual NN I-NP O
and CC O O
showed VBD B-VP O
that IN B-SBAR O
they PRP B-NP O
contained VBD B-VP O
an DT B-NP O
internal JJ I-NP O
116 CD I-NP O
base NN I-NP O
pair NN I-NP O
deletion NN I-NP O
, , O O
corresponding VBG B-VP O
precisely RB B-ADVP O
to TO B-PP O
exon NN B-NP O
12 CD I-NP O
of IN B-PP O
the DT B-NP O
human JJ I-NP O
chromosomal JJ I-NP O
PAH NN I-NP O
gene NN I-NP O
. . O O

The DT B-NP O
deletion NN I-NP O
causes VBZ B-VP O
the DT B-NP O
synthesis NN I-NP O
of IN B-PP O
a DT B-NP O
truncated VBN I-NP O
protein NN I-NP O
lacking VBG B-VP O
the DT B-NP O
C NN I-NP O
- HYPH B-NP O
terminal JJ I-NP O
52 CD I-NP O
amino NN I-NP O
acids NNS I-NP O
. . O O

Gene NN B-NP O
transfer NN I-NP O
and CC O O
expression NN B-NP O
studies NNS I-NP O
using VBG B-VP O
the DT B-NP O
mutant JJ I-NP O
PAH NN I-NP O
cDNA NN I-NP O
indicated VBD B-VP O
that IN B-SBAR O
the DT B-NP O
deletion NN I-NP O
abolishes VBZ B-VP O
PAH NN B-NP O
activity NN I-NP O
in IN B-PP O
the DT B-NP O
cell NN I-NP O
as IN B-PP O
a DT B-NP O
result NN I-NP O
of IN B-PP O
protein NN B-NP O
instability NN I-NP O
. . O O

To TO B-VP O
determine VB I-VP O
the DT B-NP O
molecular JJ I-NP O
basis NN I-NP O
of IN B-PP O
the DT B-NP O
deletion NN I-NP O
, , O O
the DT B-NP O
mutant JJ I-NP O
chromosomal JJ I-NP O
PAH NN I-NP O
gene NN I-NP O
was VBD B-VP O
isolated VBN I-VP O
from IN B-PP O
this DT B-NP O
individual JJ I-NP O
and CC O O
shown VBN B-VP O
to TO I-VP O
contain VB I-VP O
a DT B-NP O
GT NN I-NP O
- HYPH B-ADJP O
- HYPH I-ADJP O
greater JJR B-ADJP O
than IN B-PP O
AT NN B-NP O
substitution NN I-NP O
at IN B-PP O
the DT B-NP O
5 CD I-NP O
splice NN I-NP O
donor NN I-NP O
site NN I-NP O
of IN B-PP O
intron NN B-NP O
12 CD I-NP O
. . O O

Thus RB B-ADVP O
, , O O
the DT B-NP O
consequence NN I-NP O
of IN B-PP O
the DT B-NP O
splice NN I-NP O
donor NN I-NP O
site NN I-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
human JJ I-NP O
liver NN I-NP O
is VBZ B-VP O
the DT B-NP O
skipping NN I-NP O
of IN B-PP O
the DT B-NP O
preceding VBG I-NP O
exon NN I-NP O
during IN B-PP O
RNA NN B-NP O
splicing NN I-NP O
. . O O

. . O O

Conservation NN B-NP O
of IN B-PP O
the DT B-NP O
Duchenne NNP I-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
gene NN I-NP O
in IN B-PP O
mice NNS B-NP O
and CC I-NP O
humans NNS I-NP O
. . O O

A DT B-NP O
portion NN I-NP O
of IN B-PP O
the DT B-NP O
Duchenne NNP I-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
DMD NN B-NP B-Disease
) ) O O
gene NN B-NP O
transcript NN I-NP O
from IN B-PP O
human JJ B-NP O
fetal JJ I-NP O
skeletal JJ I-NP O
muscle NN I-NP O
and CC O O
mouse NN B-NP O
adult JJ I-NP O
heart NN I-NP O
was VBD B-VP O
sequenced VBN I-VP O
, , O O
representing VBG B-VP O
approximately RB B-NP O
25 CD I-NP O
percent NN I-NP O
of IN B-PP O
the DT B-NP O
total NN I-NP O
, , O O
14 CD B-NP O
- HYPH I-NP O
kb NN I-NP O
DMD NN I-NP B-Disease
transcript NN I-NP O
. . O O

The DT B-NP O
nucleic JJ I-NP O
acid NN I-NP O
and CC O O
predicted VBD B-VP O
amino JJ B-NP O
acid NN I-NP O
sequences NNS I-NP O
from IN B-PP O
the DT B-NP O
two CD I-NP O
species NNS I-NP O
are VBP B-VP O
nearly RB B-NP O
90 CD I-NP O
percent NN I-NP O
homologous JJ B-ADJP O
. . O O

The DT B-NP O
amino JJ I-NP O
acid NN I-NP O
sequence NN I-NP O
that WDT B-NP O
is VBZ B-VP O
predicted VBN I-VP O
from IN B-PP O
this DT B-NP O
portion NN I-NP O
of IN B-PP O
the DT B-NP O
DMD NN I-NP B-Disease
gene NN I-NP O
indicates VBZ B-VP O
that IN B-SBAR O
the DT B-NP O
protein NN I-NP O
product NN I-NP O
might MD B-VP O
serve VB I-VP O
a DT B-NP O
structural JJ I-NP O
role NN I-NP O
in IN B-PP O
muscle NN B-NP O
, , O O
but CC O O
the DT B-NP O
abundance NN I-NP O
and CC I-NP O
tissue NN I-NP O
distribution NN I-NP O
of IN B-PP O
the DT B-NP O
messenger NN I-NP O
RNA NN I-NP O
suggests VBZ B-VP O
that IN B-SBAR O
the DT B-NP O
DMD NN I-NP B-Disease
protein NN I-NP O
is VBZ B-VP O
not RB O O
nebulin NN B-NP O
. . O O

. . O O

Familial JJ B-NP O
Prader NNP I-NP B-Disease
- HYPH I-NP I-Disease
Willi NNP I-NP I-Disease
syndrome NN I-NP I-Disease
with IN B-PP O
apparently RB B-NP O
normal JJ I-NP O
chromosomes NNS I-NP O
. . O O

We PRP B-NP O
report VBP B-VP O
on IN B-PP O
4 CD B-NP O
sibs NNS I-NP O
( ( O O
2F NN B-NP O
, , O O
2M NN B-NP O
) ) O O
with IN B-PP O
Prader NNP B-NP B-Disease
- HYPH I-NP I-Disease
Willi NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
PWS NN B-NP B-Disease
) ) O O
. . O O

Diagnosis NN B-NP O
was VBD B-VP O
made VBN I-VP O
clinically RB B-ADVP O
on IN B-PP O
the DT B-NP O
basis NN I-NP O
of IN B-PP O
history NN B-NP O
, , O O
behavior NN B-NP O
, , O O
and CC O O
physical JJ B-NP O
findings NNS I-NP O
in IN B-PP O
3 CD B-NP O
of IN B-PP O
the DT B-NP O
sibs NNS I-NP O
. . O O

The DT B-NP O
other JJ I-NP O
child NN I-NP O
had VBD B-VP O
died VBN I-VP O
at IN B-PP O
age NN B-NP O
10 CD B-NP O
months NNS I-NP O
with IN B-PP O
a DT B-NP O
history NN I-NP O
and CC O O
clinical JJ B-NP O
findings NNS I-NP O
typical JJ B-ADJP O
of IN B-PP O
first JJ B-NP O
phase NN I-NP O
of IN B-PP O
PWS NN B-NP B-Disease
. . O O

Results NNS B-NP O
of IN B-PP O
chromosome NN B-NP O
studies NNS I-NP O
on IN B-PP O
the DT B-NP O
parents NNS I-NP O
and CC O O
surviving VBG B-NP O
sibs NNS I-NP O
were VBD B-VP O
normal JJ B-ADJP O
. . O O

The DT B-NP O
implications NNS I-NP O
of IN B-PP O
this DT B-NP O
unusual JJ I-NP O
familial JJ I-NP O
occurrence NN I-NP O
for IN B-PP O
our PRP$ B-NP O
understanding NN I-NP O
of IN B-PP O
PWS NN B-NP B-Disease
are VBP B-VP O
discussed VBN I-VP O
. . O O

. . O O

Nebulin NN B-NP O
and CC I-NP O
titin NN I-NP O
expression NN I-NP O
in IN B-PP O
Duchenne NNP B-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
appears VBZ B-VP O
normal JJ B-ADJP O
. . O O

Monoclonal JJ B-NP O
antibodies NNS I-NP O
which WDT B-NP O
recognize VBP B-VP O
different JJ B-NP O
epitopes NNS I-NP O
on IN B-PP O
either CC O O
titin NN B-NP O
or CC I-NP O
nebulin NN I-NP O
show VBP B-VP O
normal JJ B-NP O
staining VBG I-NP O
patterns NNS I-NP O
on IN B-PP O
frozen VBN B-NP O
sections NNS I-NP O
of IN B-PP O
three CD B-NP O
muscle NN I-NP O
biopsies NNS I-NP O
of IN B-PP O
Duchenne NNP B-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
DMD NN B-NP B-Disease
) ) O O
. . O O

Gel NN B-NP O
electrophoresis NN I-NP O
and CC I-NP O
immunoblotting NN I-NP O
performed VBN B-VP O
on IN B-PP O
two CD B-NP O
of IN B-PP O
these DT B-NP O
muscle NN I-NP O
biopsies NNS I-NP O
show VBP B-VP O
the DT B-NP O
normal JJ I-NP O
pattern NN I-NP O
of IN B-PP O
titin NN B-NP O
and CC I-NP O
nebulin NN I-NP O
polypeptides NNS I-NP O
. . O O

Since IN B-SBAR O
the DT B-NP O
donor NN I-NP O
of IN B-PP O
one CD B-NP O
of IN B-PP O
these DT B-NP O
biopsies NNS I-NP O
has VBZ B-VP O
a DT B-NP O
large JJ I-NP O
deletion NN I-NP O
of IN B-PP O
the DT B-NP O
5 CD I-NP O
- HYPH I-NP O
region NN I-NP O
of IN B-PP O
the DT B-NP O
DMD NN I-NP B-Disease
gene NN I-NP O
, , O O
our PRP$ B-NP O
results NNS I-NP O
argue VBP B-VP O
against IN B-PP O
the DT B-NP O
recent JJ I-NP O
proposal NN I-NP O
that IN B-SBAR O
nebulin NN B-NP O
is VBZ B-VP O
the DT B-NP O
gene NN I-NP O
mutated VBN B-VP O
in IN B-PP O
DMD NN B-NP B-Disease
. . O O

. . O O

Heterozygous JJ B-NP B-Disease
C2 NN I-NP I-Disease
deficiency NN I-NP I-Disease
associated VBN B-VP O
with IN B-PP O
angioedema NN B-NP B-Disease
, , O O
myasthenia NN B-NP B-Disease
gravis NN I-NP I-Disease
, , O O
and CC O O
systemic JJ B-NP B-Disease
lupus NN I-NP I-Disease
erythematosus NN I-NP I-Disease
. . O O

We PRP B-NP O
describe VBP B-VP O
a DT B-NP O
patient NN I-NP O
with IN B-PP O
myasthenia NN B-NP B-Disease
gravis NN I-NP I-Disease
, , O O
systemic JJ B-NP B-Disease
lupus NN I-NP I-Disease
erythematosus NN I-NP I-Disease
, , O O
and CC O O
angioedema NN B-NP B-Disease
associated VBN B-VP O
with IN B-PP O
heterozygous JJ B-NP O
complement NN I-NP B-Disease
factor NN I-NP I-Disease
2 CD I-NP I-Disease
( ( O I-Disease
C2 NN B-NP I-Disease
) ) O I-Disease
deficiency NN B-NP I-Disease
. . O O

The DT B-NP O
significance NN I-NP O
of IN B-PP O
this DT B-NP O
association NN I-NP O
is VBZ B-VP O
controversial JJ B-ADJP O
, , O O
though IN B-SBAR O
the DT B-NP O
association NN I-NP O
of IN B-PP O
C2 NN B-NP B-Disease
deficiency NN I-NP I-Disease
with IN B-PP O
certain JJ B-NP O
histocompatibility NN I-NP O
antigens NNS I-NP O
suggests VBZ B-VP O
possible JJ B-NP O
linkage NN I-NP O
to TO B-PP O
immune JJ B-NP O
response NN I-NP O
genes NNS I-NP O
. . O O

To TO B-PP O
our PRP$ B-NP O
knowledge NN I-NP O
this DT B-NP O
is VBZ B-VP O
the DT B-NP O
first JJ I-NP O
report NN I-NP O
of IN B-PP O
heterozygous JJ B-NP O
C2 NN I-NP B-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
association NN B-NP O
with IN B-PP O
this DT B-NP O
combination NN I-NP O
of IN B-PP O
autoimmune JJ B-NP B-Disease
disorders NNS I-NP I-Disease
, , O O
and CC O O
we PRP B-NP O
discuss VBP B-VP O
the DT B-NP O
aetiological JJ I-NP O
implications NNS I-NP O
. . O O

. . O O

Genetic JJ B-NP O
analysis NN I-NP O
of IN B-PP O
an DT B-NP O
inherited VBN I-NP O
deficiency NN I-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
third JJ I-NP I-Disease
component NN I-NP I-Disease
of IN B-PP I-Disease
complement NN B-NP I-Disease
in IN B-PP O
Brittany NNP B-NP O
spaniel NN I-NP O
dogs NNS I-NP O
. . O O

Genetically RB B-NP O
determined VBN I-NP O
C3 NN I-NP B-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
Brittany NNP B-NP O
spaniel NN I-NP O
dogs VBZ B-VP O
shares NNS B-NP O
a DT B-NP O
number NN I-NP O
of IN B-PP O
biochemical JJ B-NP O
and CC I-NP O
clinical JJ I-NP O
characteristics NNS I-NP O
with IN B-PP O
the DT B-NP O
human JJ I-NP O
disorder NN I-NP O
. . O O

In IN B-PP O
humans NNS B-NP O
, , O O
the DT B-NP O
gene NN I-NP O
for IN B-PP O
C3 NN B-NP B-Disease
deficiency NN I-NP I-Disease
is VBZ B-VP O
a DT B-NP O
gene NN I-NP O
that WDT B-NP O
is VBZ B-VP O
allelic JJ B-ADJP O
to TO B-PP O
the DT B-NP O
structural JJ I-NP O
gene NN I-NP O
for IN B-PP O
C3 NN B-NP O
and CC O O
is VBZ B-VP O
not RB I-VP O
linked VBN I-VP O
to TO B-PP O
the DT B-NP O
major JJ I-NP O
histocompatibility NN I-NP O
locus NN I-NP O
. . O O

The DT B-NP O
current JJ I-NP O
study NN I-NP O
used VBD B-VP O
allotype NN B-NP O
analysis NN I-NP O
of IN B-PP O
canine JJ B-NP O
C3 NN I-NP O
in IN B-SBAR O
order NN O O
to TO B-VP O
demonstrate VB I-VP O
that IN B-SBAR O
the DT B-NP O
gene NN I-NP O
for IN B-PP O
C3 NN B-NP B-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
these DT B-NP O
dogs NNS I-NP O
is VBZ B-VP O
also RB B-ADVP O
a DT B-NP O
gene NN I-NP O
allelic JJ B-ADJP O
to TO B-PP O
the DT B-NP O
structural JJ I-NP O
gene NN I-NP O
for IN B-PP O
C3 NN B-NP O
. . O O

In IN B-PP O
addition NN B-NP O
, , O O
preliminary JJ B-NP O
pedigree NN I-NP O
analysis NN I-NP O
suggests VBZ B-VP O
that IN B-SBAR O
the DT B-NP O
gene NN I-NP O
for IN B-PP O
canine JJ B-NP O
C3 NN I-NP B-Disease
deficiency NN I-NP I-Disease
is VBZ B-VP O
apparently RB B-ADVP O
not RB O O
closely RB B-VP O
linked VBN I-VP O
to TO B-PP O
the DT B-NP O
major JJ I-NP O
histocompatibility NN I-NP O
complex NN I-NP O
of IN B-PP O
the DT B-NP O
dog NN I-NP O
. . O O

Thus RB B-ADVP O
, , O O
it PRP B-NP O
appears VBZ B-VP O
that IN B-SBAR O
C3 NN B-NP B-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
Brittany NNP B-NP O
spaniel NN I-NP O
dogs VBZ B-VP O
not RB B-CONJP O
only RB I-CONJP O
shares VBZ B-VP O
biochemical JJ B-NP O
and CC I-NP O
clinical JJ I-NP O
features NNS I-NP O
with IN B-PP O
C3 NN B-NP B-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
humans NNS B-NP O
, , O O
but CC O O
also RB B-VP O
shares VBZ I-VP O
some DT B-NP O
genetic JJ I-NP O
characteristics NNS I-NP O
with IN B-PP O
the DT B-NP O
human JJ I-NP O
disorder NN I-NP O
. . O O

. . O O

Gene NN B-NP O
transfer NN I-NP O
and CC O O
expression NN B-NP O
of IN B-PP O
human JJ B-NP O
phenylalanine NN I-NP O
hydroxylase NN I-NP O
. . O O

Phenylketonuria NN B-NP B-Disease
( ( O O
PKU NN B-NP B-Disease
) ) O O
is VBZ B-VP O
caused VBN I-VP O
by IN B-PP O
a DT B-NP O
genetic JJ I-NP O
deficiency NN I-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
enzyme NN I-NP I-Disease
phenylalanine NN I-NP I-Disease
hydroxylase NN I-NP I-Disease
( ( O O
PAH NN B-NP O
) ) O O
. . O O

A DT B-NP O
full JJ I-NP O
- HYPH I-NP O
length NN I-NP O
complementary JJ I-NP O
DNA NN I-NP O
clone NN I-NP O
of IN B-PP O
human JJ B-NP O
PAH NN I-NP O
was VBD B-VP O
inserted VBN I-VP O
into IN B-PP O
a DT B-NP O
eukaryotic JJ I-NP O
expression NN I-NP O
vector NN I-NP O
and CC O O
transferred VBN B-VP O
into IN B-PP O
mouse NN B-NP O
NIH3T3 NN I-NP O
cells NNS I-NP O
which WDT B-NP O
do VBP B-VP O
not RB I-VP O
normally RB I-VP O
express VB I-VP O
PAH NN B-NP O
. . O O

The DT B-NP O
transformed VBN I-NP O
mouse NN I-NP O
cells NNS I-NP O
expressed VBD B-VP O
PAH NN B-NP O
messenger NN I-NP O
RNA NN I-NP O
, , O O
immunoreactive JJ B-NP O
protein NN I-NP O
, , O O
and CC O O
enzymatic JJ B-NP O
activity NN I-NP O
that WDT B-NP O
are VBP B-VP O
characteristic JJ B-ADJP O
of IN B-PP O
the DT B-NP O
normal JJ I-NP O
human JJ I-NP O
liver NN I-NP O
products NNS I-NP O
, , O O
demonstrating VBG B-VP O
that IN B-SBAR O
a DT B-NP O
single JJ I-NP O
gene NN I-NP O
contains VBZ B-VP O
all DT B-NP O
of IN B-PP O
the DT B-NP O
necessary JJ I-NP O
genetic JJ I-NP O
information NN I-NP O
to TO B-VP O
code VB I-VP O
for IN B-PP O
functional JJ B-NP O
PAH NN I-NP O
. . O O

These DT B-NP O
results NNS I-NP O
support VBP B-VP O
the DT B-NP O
use NN I-NP O
of IN B-PP O
the DT B-NP O
human JJ I-NP O
PAH NN I-NP O
probe NN I-NP O
in IN B-PP O
prenatal JJ B-NP O
diagnosis NN I-NP O
and CC I-NP O
detection NN I-NP O
of IN B-PP O
carriers NNS B-NP O
, , O O
to TO B-VP O
provide VB I-VP O
new JJ B-NP O
opportunities NNS I-NP O
for IN B-PP O
the DT B-NP O
biochemical JJ I-NP O
characterization NN I-NP O
of IN B-PP O
normal JJ B-NP O
and CC I-NP O
mutant JJ I-NP O
enzymes NNS I-NP O
, , O O
and CC O O
in IN B-PP O
the DT B-NP O
investigation NN I-NP O
of IN B-PP O
alternative JJ B-NP O
genetic JJ I-NP O
therapies NNS I-NP O
for IN B-PP O
PKU NN B-NP B-Disease
. . O O

. . O O

Regional JJ B-NP O
mapping NN I-NP O
of IN B-PP O
the DT B-NP O
phenylalanine NN I-NP O
hydroxylase NN I-NP O
gene NN I-NP O
and CC O O
the DT B-NP O
phenylketonuria NN I-NP B-Disease
locus NN I-NP O
in IN B-PP O
the DT B-NP O
human JJ I-NP O
genome NN I-NP O
. . O O

Phenylketonuria NN B-NP B-Disease
( ( O O
PKU NN B-NP B-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
disorder NN I-NP I-Disease
of IN B-PP O
amino JJ B-NP O
acid NN I-NP O
metabolism NN I-NP O
caused VBN B-VP O
by IN B-PP O
a DT B-NP O
deficiency NN I-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
hepatic JJ I-NP I-Disease
enzyme NN I-NP I-Disease
phenylalanine NN I-NP I-Disease
hydroxylase NN I-NP I-Disease
( ( O O
PAH NN B-NP O
; : O O
phenylalanine NN B-NP O
4 CD I-NP O
- HYPH I-NP O
monooxygenase NN I-NP O
, , O O
EC NNP B-NP O
1 CD I-NP O
. . O O

14 CD B-NP O
. . I-NP O

16 CD I-NP O
. . I-NP O

1 CD I-NP O
) ) O O
. . O O

A DT B-NP O
cDNA NN I-NP O
clone NN I-NP O
for IN B-PP O
human JJ B-NP O
PAH NN I-NP O
has VBZ B-VP O
previously RB I-VP O
been VBN I-VP O
used VBN I-VP O
to TO B-VP O
assign VB I-VP O
the DT B-NP O
corresponding VBG I-NP O
gene NN I-NP O
to TO B-PP O
human JJ B-NP O
chromosome NN I-NP O
12 CD I-NP O
. . O O

To TO B-VP O
define VB I-VP O
the DT B-NP O
regional JJ I-NP O
map NN I-NP O
position NN I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
locus NN I-NP O
and CC O O
the DT B-NP O
PAH NN I-NP O
gene NN I-NP O
on IN B-PP O
human JJ B-NP O
chromosome NN I-NP O
12 CD I-NP O
, , O O
DNA NN B-NP O
was VBD B-VP O
isolated VBN I-VP O
from IN B-PP O
human JJ B-NP O
- HYPH I-NP O
hamster NN I-NP O
somatic JJ I-NP O
cell NN I-NP O
hybrids NNS I-NP O
with IN B-PP O
various JJ B-NP O
deletions NNS I-NP O
of IN B-PP O
human JJ B-NP O
chromosome NN I-NP O
12 CD I-NP O
and CC O O
was VBD B-VP O
analyzed VBN I-VP O
by IN B-PP O
Southern JJ B-NP O
blot NN I-NP O
analysis NN I-NP O
using VBG B-VP O
the DT B-NP O
human JJ I-NP O
cDNA NN I-NP O
PAH NN I-NP O
clone NN I-NP O
as IN B-PP O
a DT B-NP O
hybridization NN I-NP O
probe NN I-NP O
. . O O

From IN B-PP O
these DT B-NP O
results NNS I-NP O
, , O O
together RB B-ADVP O
with IN B-PP O
detailed JJ B-NP O
biochemical JJ I-NP O
and CC I-NP O
cytogenetic JJ I-NP O
characterization NN I-NP O
of IN B-PP O
the DT B-NP O
hybrid NN I-NP O
cells NNS I-NP O
, , O O
the DT B-NP O
region NN I-NP O
on IN B-PP O
chromosome NN B-NP O
12 CD I-NP O
containing VBG B-VP O
the DT B-NP O
human JJ I-NP O
PAH NN I-NP O
gene NN I-NP O
has VBZ B-VP O
been VBN I-VP O
defined VBN I-VP O
as IN B-PP O
12q14 CD B-NP O
. . O O

3 CD B-NP O
- HYPH I-NP O
- SYM I-NP O
- SYM I-NP O
- HYPH I-NP O
qter SYM B-NP O
3 CD I-NP O
- HYPH O O
- SYM O O
- SYM O O
- HYPH O O
qter NN B-NP O
. . O O

The DT B-NP O
PAH NN I-NP O
map NN I-NP O
position NN I-NP O
on IN B-PP O
chromosome NN B-NP O
12 CD I-NP O
was VBD B-VP O
further RB I-VP O
localized VBN I-VP O
by IN B-PP O
in FW B-NP O
situ FW I-NP O
hybridization NN I-NP O
of IN B-PP O
125I NN B-NP O
- HYPH O O
labeled VBN B-NP O
human JJ I-NP O
PAH NN I-NP O
cDNA NN I-NP O
to TO B-PP O
chromosomes NNS B-NP O
prepared VBN B-VP O
from IN B-PP O
a DT B-NP O
human JJ I-NP O
lymphoblastoid JJ I-NP O
cell NN I-NP O
line NN I-NP O
. . O O

Results NNS B-NP O
of IN B-PP O
these DT B-NP O
experiments NNS I-NP O
demonstrated VBD B-VP O
that IN B-SBAR O
the DT B-NP O
region NN I-NP O
on IN B-PP O
chromosome NN B-NP O
12 CD I-NP O
containing VBG B-VP O
the DT B-NP O
PAH NN I-NP O
gene NN I-NP O
and CC O O
the DT B-NP O
PKU NN I-NP B-Disease
locus NN I-NP O
in IN B-PP O
man NN B-NP O
is VBZ B-VP O
12q22 CD B-NP O
- HYPH O O
- SYM B-NP O
- SYM B-NP O
- SYM B-NP O
12q24 CD B-NP O
. . O O

1 LS B-LST O
. . O O

These DT B-NP O
results NNS I-NP O
not RB B-VP O
only RB I-VP O
provide VB I-VP O
a DT B-NP O
regionalized JJ I-NP O
map NN I-NP O
position NN I-NP O
for IN B-PP O
a DT B-NP O
major JJ I-NP O
human JJ I-NP O
disease NN I-NP O
locus NN I-NP O
but CC B-CONJP O
also RB I-CONJP O
can MD B-VP O
serve VB I-VP O
as IN B-PP O
a DT B-NP O
reference NN I-NP O
point NN I-NP O
for IN B-PP O
linkage NN B-NP O
analysis NN I-NP O
with IN B-PP O
other JJ B-NP O
DNA NN I-NP O
markers NNS I-NP O
on IN B-PP O
human JJ B-NP O
chromosome NN I-NP O
12 CD I-NP O
Heterogeneity NN B-NP O
of IN B-PP O
type NN B-NP B-Disease
I CD I-NP I-Disease
von NN I-NP I-Disease
Willebrand NN I-NP I-Disease
disease NN I-NP I-Disease
: : O O
evidence NN B-NP O
for IN B-PP O
a DT B-NP O
subgroup NN I-NP O
with IN B-PP O
an DT B-NP O
abnormal JJ I-NP O
von NN I-NP B-Disease
Willebrand NN I-NP I-Disease
factor NN I-NP O
. . O O

Type NN B-NP B-Disease
I CD I-NP I-Disease
von NN I-NP I-Disease
Willebrand NN I-NP I-Disease
disease NN I-NP I-Disease
( ( O O
vWD NN B-NP B-Disease
) ) O O
is VBZ B-VP O
characterized VBN I-VP O
by IN B-PP O
equally RB B-NP O
low JJ I-NP O
plasma NN I-NP O
concentrations NNS I-NP O
of IN B-PP O
von NN B-NP B-Disease
Willebrand NN I-NP I-Disease
factor NN I-NP O
antigen NN I-NP O
( ( O O
vWF NN B-NP O
Ag NN I-NP O
) ) O O
and CC O O
ristocetin NN B-NP O
cofactor NN I-NP O
( ( O O
RiCof NN B-NP O
) ) O O
and CC O O
by IN B-PP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
all DT B-NP O
vWF NN I-NP O
multimers NNS I-NP O
in IN B-PP O
sodium NN B-NP O
dodecyl NN I-NP O
sulfate NN I-NP O
( ( O O
SDS NN B-NP O
) ) O O
- HYPH B-NP O
agarose NN I-NP O
gel NN I-NP O
electrophoresis NN I-NP O
. . O O

For IN B-PP O
17 CD B-NP O
patients NNS I-NP O
( ( O O
13 CD B-NP O
kindreds NNS I-NP O
) ) O O
diagnosed VBN B-VP O
with IN B-PP O
these DT B-NP O
criteria NNS I-NP O
, , O O
we PRP B-NP O
have VBP B-VP O
studied VBN I-VP O
the DT B-NP O
platelet NN I-NP O
contents NNS I-NP O
of IN B-PP O
vWF NN B-NP O
Ag NN I-NP O
and CC I-NP O
RiCof NN I-NP O
and CC O O
the DT B-NP O
changes NNS I-NP O
of IN B-PP O
these DT B-NP O
in IN B-PP O
plasma NN B-NP O
after IN B-PP O
DDAVP NN B-NP O
infusion NN I-NP O
. . O O

Platelet NN B-NP O
vWF NN I-NP O
Ag NN I-NP O
and CC I-NP O
RiCof NN I-NP O
were VBD B-VP O
normal JJ B-ADJP O
in IN B-PP O
four CD B-NP O
kindreds NNS I-NP O
( ( O O
called VBN B-VP O
platelet NN B-NP O
normal JJ I-NP O
subgroup NN I-NP O
) ) O O
; : O O
following VBG B-PP O
1 CD B-NP O
- HYPH I-NP O
deamino NN I-NP O
- HYPH B-NP O
8 CD I-NP O
- HYPH I-NP O
D NN I-NP O
- HYPH I-NP O
arginine NN I-NP O
vasopressin NN I-NP O
; : O O
plasma NN B-NP O
vWF NN I-NP O
Ag NN I-NP O
, , O O
RiCof NN B-NP O
and CC O O
the DT B-NP O
bleeding NN I-NP O
time NN I-NP O
( ( O O
BT NN B-NP O
) ) O O
became VBD B-VP O
normal JJ B-ADJP O
. . O O

In IN B-PP O
six CD B-NP O
kindreds NNS I-NP O
, , O O
platelet NN B-NP O
vWF NN I-NP O
Ag NN I-NP O
and CC I-NP O
RiCof NN I-NP O
were VBD B-VP O
equally RB B-ADJP O
low JJ I-ADJP O
( ( O O
platelet NN B-NP O
low NN I-NP O
) ) O O
; : O O
after IN B-PP O
DDAVP NN B-NP O
, , O O
plasma NN B-NP O
vWF NN I-NP O
Ag NN I-NP O
and CC I-NP O
RiCof NN I-NP O
remained VBD B-VP O
low JJ B-ADJP O
, , O O
and CC O O
the DT B-NP O
BT NN I-NP O
was VBD B-VP O
prolonged VBN I-VP O
. . O O

In IN B-PP O
three CD B-NP O
additional JJ I-NP O
kindreds NNS I-NP O
, , O O
platelets NNS B-NP O
contained VBD B-VP O
normal JJ B-NP O
concentrations NNS I-NP O
of IN B-PP O
vWF NN B-NP O
Ag NN I-NP O
, , O O
but CC O O
RiCof NNP B-NP O
was VBD B-VP O
very RB B-ADJP O
low JJ I-ADJP O
( ( O O
platelet NN B-NP O
discordant NN I-NP O
) ) O O
; : O O
even RB B-SBAR O
though IN I-SBAR O
a DT B-NP O
complete JJ I-NP O
set NN I-NP O
of IN B-PP O
multimers NNS B-NP O
was VBD B-VP O
found VBN I-VP O
in IN B-PP O
plasma NN B-NP O
and CC I-NP O
platelets NNS I-NP O
, , O O
there EX B-NP O
was VBD B-VP O
a DT B-NP O
relatively RB I-NP O
small JJ I-NP O
amount NN I-NP O
of IN B-PP O
large JJ B-NP O
multimers NNS I-NP O
. . O O

After IN B-PP O
DDAVP NN B-NP O
, , O O
plasma NN B-NP O
vWF NN I-NP O
Ag NN I-NP O
became VBD B-VP O
normal JJ B-ADJP O
, , O O
but CC O O
RiCof NNP B-NP O
remained VBD B-VP O
low JJ B-ADJP O
and CC O O
the DT B-NP O
BT NN I-NP O
was VBD B-VP O
very RB B-ADJP O
prolonged JJ I-ADJP O
. . O O

These DT B-NP O
findings NNS I-NP O
demonstrated VBD B-VP O
that IN B-SBAR O
there EX B-NP O
can MD B-VP O
be VB I-VP O
an DT B-NP O
abnormal JJ I-NP O
vWF NN I-NP O
( ( O O
RiCof NN B-NP O
less JJR B-ADJP O
than IN B-PP O
vWF NN B-NP O
Ag NN I-NP O
) ) O O
even RB B-ADVP O
in IN B-PP O
type NN B-NP B-Disease
I CD I-NP I-Disease
vWD NN I-NP I-Disease
, , O O
coexisting VBG B-VP O
with IN B-PP O
a DT B-NP O
complete JJ I-NP O
set NN I-NP O
of IN B-PP O
vWF NN B-NP O
multimers NNS I-NP O
( ( O O
platelet NN B-NP O
discordant NN I-NP O
) ) O O
; : O O
that IN B-SBAR O
the DT B-NP O
abnormal JJ I-NP O
vWF NN I-NP O
can MD B-VP O
be VB I-VP O
shown VBN I-VP O
more RBR B-ADVP O
clearly RB I-ADVP O
in IN B-PP O
platelets NNS B-NP O
than IN B-PP O
in IN B-PP O
plasma NN B-NP O
or CC B-NP O
else RB I-NP O
in IN B-PP O
plasma NN B-NP O
after IN B-PP O
DDAVP NN B-NP O
infusion NN I-NP O
; : O O
and CC O O
that IN B-SBAR O
DDAVP NN B-NP O
normalizes VBZ B-VP O
the DT B-NP O
BT NN I-NP O
only RB B-ADVP O
in IN B-PP O
those DT B-NP O
patients NNS I-NP O
with IN B-PP O
normal JJ B-NP O
platelet NN I-NP O
levels NNS I-NP O
of IN B-PP O
both CC O O
vWF NN B-NP O
Ag NN I-NP O
and CC O O
RiCof NN B-NP O
( ( O O
platelet NN B-NP O
normal JJ B-ADJP O
) ) O O
. . O O

. . O O

Genetic JJ B-NP O
analysis NN I-NP O
in IN B-PP O
families NNS B-NP O
with IN B-PP O
van NNP B-NP B-Disease
der NNP I-NP I-Disease
Woude NNP I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

We PRP B-NP O
have VBP B-VP O
brought VBN I-VP O
together RB B-NP O
information NN I-NP O
on IN B-PP O
864 CD B-NP O
affected VBN I-NP O
individuals NNS I-NP O
in IN B-PP O
164 CD B-NP O
families NNS I-NP O
( ( O O
including VBG B-PP O
three CD B-NP O
new JJ I-NP O
pedigrees NNS I-NP O
) ) O O
reported VBN B-VP O
in IN B-PP O
the DT B-NP O
137 CD I-NP O
year NN I-NP O
period NN I-NP O
since IN B-PP O
1845 CD B-NP O
when WRB B-ADVP O
Demarquay NNP B-NP O
first RB B-ADVP O
described VBD B-VP O
a DT B-NP O
family NN I-NP O
with IN B-PP O
what WP B-NP O
was VBD B-VP O
later RB I-VP O
called VBN I-VP O
van NNP B-NP B-Disease
der NNP I-NP I-Disease
Woude NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
VWS NN B-NP B-Disease
) ) O O
. . O O

Both DT B-NP O
types NNS I-NP O
of IN B-PP O
oral JJ B-NP B-Disease
cleft NN I-NP I-Disease
, , O O
cleft NN B-NP B-Disease
palate NN I-NP I-Disease
( ( O O
CP NN B-NP B-Disease
) ) O O
and CC O O
cleft NN B-NP B-Disease
lip NN I-NP I-Disease
with IN B-PP O
or CC B-PP O
without IN B-PP O
CP NN B-NP B-Disease
( ( O O
CLP NN B-NP B-Disease
) ) O O
, , O O
segregate VBP B-VP O
in IN B-PP O
these DT B-NP O
families NNS I-NP O
together RB B-ADVP O
with IN B-PP O
lower JJR B-NP O
lip NN I-NP B-Disease
pits NNS I-NP I-Disease
or CC I-NP O
fistulae NNS I-NP B-Disease
in IN B-PP O
an DT B-NP O
autosomal JJ I-NP O
dominant JJ I-NP O
mode NN I-NP O
with IN B-PP O
high JJ B-NP O
penetrance NN I-NP O
estimated VBN B-VP O
to TO I-VP O
be VB I-VP O
K NN B-NP O
= SYM B-VP O
. . O O

89 CD B-NP O
and CC O O
. . O O

99 CD B-NP O
by IN B-PP O
different JJ B-NP O
methods NNS I-NP O
. . O O

Cleft NN B-NP O
types NNS I-NP O
( ( O O
CLP NN B-NP B-Disease
and CC O O
CP NN B-NP B-Disease
) ) O O
occur VBP B-VP O
in IN B-PP O
VWS NN B-NP B-Disease
in IN B-PP O
the DT B-NP O
same JJ I-NP O
proportions NNS I-NP O
as IN B-PP O
in IN B-PP O
the DT B-NP O
general JJ I-NP O
non AFX B-NP O
- HYPH I-NP O
VWS NN I-NP O
population NN I-NP O
, , O O
ie FW B-NP O
, , O O
about RB B-NP O
twice RB I-NP O
as IN I-NP O
many JJ I-NP O
cleft NN I-NP O
- HYPH O O
bearing VBG B-VP O
individuals NNS B-NP O
have VBP B-VP O
CLP NN B-NP B-Disease
as IN B-SBAR O
have VBP B-VP O
CP NN B-NP B-Disease
. . O O

On IN B-PP O
the DT B-NP O
other JJ I-NP O
hand NN I-NP O
, , O O
we PRP B-NP O
do VBP B-VP O
not RB I-VP O
find VB I-VP O
the DT B-NP O
usually RB I-NP O
observed VBN I-NP O
excess NN I-NP O
of IN B-PP O
females NNS B-NP O
with IN B-PP O
CP NN B-NP B-Disease
and CC I-NP O
excess NN I-NP O
of IN B-PP O
males NNS B-NP O
with IN B-PP O
CLP NN B-NP B-Disease
; : O O
in IN B-PP O
VWS NN B-NP B-Disease
the DT B-NP O
sex NN I-NP O
ratios NNS I-NP O
are VBP B-VP O
more RBR B-ADJP O
nearly RB I-ADJP O
equal JJ I-ADJP O
. . O O

Lip NN B-NP B-Disease
pits NNS I-NP I-Disease
also RB B-ADVP O
are VBP B-VP O
equally RB I-VP O
distributed VBN I-VP O
between IN B-PP O
the DT B-NP O
sexes NNS I-NP O
. . O O

Affected VBN B-NP O
males NNS I-NP O
and CC I-NP O
females NNS I-NP O
are VBP B-VP O
equally RB B-ADJP O
likely JJ I-ADJP O
to TO B-VP O
transmit VB I-VP O
VWS NN B-NP B-Disease
. . O O

However RB B-ADVP O
, , O O
there EX B-NP O
is VBZ B-VP O
an DT B-NP O
excess NN I-NP O
of IN B-PP O
less RBR B-VP O
severely RB I-VP O
affected VBN I-VP O
individuals NNS B-NP O
among IN B-PP O
transmitters NNS B-NP O
and CC O O
a DT B-NP O
deficiency NN I-NP O
of IN B-PP O
more RBR B-VP O
severely RB I-VP O
affected VBN I-VP O
, , O O
brought VBN B-VP O
about RP B-PRT O
by IN B-PP O
a DT B-NP O
proband NN I-NP O
bias NN I-NP O
and CC O O
differential JJ B-NP O
fecundity NN I-NP O
. . O O

The DT B-NP O
expression NN I-NP O
of IN B-PP O
VWS NN B-NP B-Disease
is VBZ B-VP O
significantly RB I-VP O
modified VBN I-VP O
by IN B-PP O
the DT B-NP O
genetic JJ I-NP O
background NN I-NP O
More JJR B-NP O
extreme JJ I-NP O
phenotypes NNS I-NP O
in IN B-PP O
parents NNS B-NP O
tend VBP B-VP O
to TO I-VP O
produce VB I-VP O
more RBR B-NP O
extreme JJ I-NP O
expression NN I-NP O
in IN B-PP O
their PRP$ B-NP O
children NNS I-NP O
. . O O

For IN B-PP O
a DT B-NP O
VWS NN I-NP B-Disease
gene NN I-NP O
carrier NN I-NP O
the DT B-NP O
relative JJ I-NP O
risk NN I-NP O
of IN B-PP O
transmitting VBG B-VP O
a DT B-NP O
cleft NN I-NP O
is VBZ B-VP O
26 CD B-NP O
. . O O

45 CD B-NP O
% NN I-NP O
; : O O
that DT B-NP O
of IN B-PP O
transmitting VBG B-VP O
lower JJR B-NP O
lip NN I-NP B-Disease
pits NNS I-NP I-Disease
is VBZ B-VP O
23 CD B-NP O
. . O O

55 CD B-NP O
% NN I-NP O
. . O O

Three CD B-NP O
pedigrees NNS I-NP O
of IN B-PP O
lip NN B-NP B-Disease
pits NNS I-NP I-Disease
in IN B-PP O
the DT B-NP O
literature NN I-NP O
show VBP B-VP O
no DT B-NP O
clefts NNS I-NP O
among IN B-PP O
a DT B-NP O
significant JJ I-NP O
number NN I-NP O
of IN B-PP O
affected VBN B-NP O
individuals NNS I-NP O
. . O O

Control NN B-NP O
of IN B-PP O
gene NN B-NP O
expression NN I-NP O
in IN B-PP O
VWS NN B-NP B-Disease
in IN B-PP O
the DT B-NP O
three CD I-NP O
target NN I-NP O
tissues NNS I-NP O
appears VBZ B-VP O
to TO I-VP O
be VB I-VP O
independent JJ B-ADJP O
and CC O O
separately RB B-ADJP O
designated VBN I-ADJP O
. . O O

Mutation NN B-NP O
rate NN I-NP O
of IN B-PP O
the DT B-NP O
VWS NN I-NP B-Disease
gene NN I-NP O
is VBZ B-VP O
calculated VBN I-VP O
to TO I-VP O
be VB I-VP O
1 CD B-NP O
. . O O

8 CD B-NP O
X SYM I-NP O
10 CD I-NP O
( ( O O
- SYM O O
5 CD B-NP O
) ) O O
Hereditary JJ B-NP B-Disease
C7 NN I-NP I-Disease
deficiency NN I-NP I-Disease
. . O O

Diagnosis NN B-NP O
and CC I-NP O
HLA NN I-NP O
studies NNS I-NP O
in IN B-PP O
a DT B-NP O
French JJ I-NP O
- HYPH I-NP O
Canadian JJ I-NP O
family NN I-NP O
. . O O

The DT B-NP O
serum NN I-NP O
of IN B-PP O
a DT B-NP O
44 CD I-NP O
- HYPH I-NP O
yr NN I-NP O
- HYPH I-NP O
old JJ I-NP O
woman NN I-NP O
of IN B-PP O
French JJ B-NP O
- HYPH I-NP O
Canadian JJ I-NP O
descent NN I-NP O
having VBG B-VP O
a DT B-NP O
B NN I-NP O
- HYPH B-NP O
27 CD I-NP O
positive JJ I-NP O
ankylosing VBG I-NP B-Disease
spondylitis NN I-NP I-Disease
was VBD B-VP O
deficient JJ B-ADJP B-Disease
in IN B-PP I-Disease
the DT B-NP I-Disease
seventh JJ I-NP I-Disease
component NN I-NP I-Disease
of IN B-PP I-Disease
complement NN B-NP I-Disease
( ( O O
C7 NN B-NP O
) ) O O
as IN B-SBAR O
determined VBN B-VP O
by IN B-PP O
hemolytic JJ B-NP O
and CC I-NP O
immunochemical JJ I-NP O
methods NNS I-NP O
. . O O

No DT B-NP O
inhibitor NN I-NP O
against IN B-PP O
C7 NN B-NP O
was VBD B-VP O
detected VBN I-VP O
, , O O
and CC O O
the DT B-NP O
levels NNS I-NP O
of IN B-PP O
all DT B-NP O
other JJ I-NP O
complement NN I-NP O
components NNS I-NP O
were VBD B-VP O
normal JJ B-ADJP O
. . O O

No DT B-NP O
deficiency NN I-NP O
in IN B-PP O
the DT B-NP O
opsonic JJ I-NP O
activity NN I-NP O
of IN B-PP O
the DT B-NP O
serum NN I-NP O
was VBD B-VP O
found VBN I-VP O
, , O O
and CC O O
the DT B-NP O
results NNS I-NP O
of IN B-PP O
basic JJ B-NP O
coagulation NN I-NP O
studies NNS I-NP O
of IN B-PP O
the DT B-NP O
plasma NN I-NP O
were VBD B-VP O
normal JJ B-ADJP O
. . O O

On IN B-PP O
investigation NN B-NP O
of IN B-PP O
the DT B-NP O
patients NNS I-NP O
family NN I-NP O
, , O O
two CD B-NP O
sisters NNS I-NP O
were VBD B-VP O
found VBN I-VP O
to TO I-VP O
have VB I-VP O
the DT B-NP O
same JJ I-NP O
deficiency NN I-NP O
but CC O O
were VBD B-VP O
otherwise RB B-ADVP O
in IN B-PP O
good JJ B-NP O
health NN I-NP O
. . O O

The DT B-NP O
seven CD I-NP O
other JJ I-NP O
siblings NNS I-NP O
were VBD B-VP O
heterozygous JJ B-ADJP O
for IN B-PP O
C7 NN B-NP B-Disease
deficiency NN I-NP I-Disease
, , O O
while IN B-SBAR O
the DT B-NP O
paternal JJ I-NP O
aunt NN I-NP O
had VBD B-VP O
a DT B-NP O
normal JJ I-NP O
C7 NN I-NP O
level NN I-NP O
. . O O

In IN B-PP O
the DT B-NP O
third JJ I-NP O
generation NN I-NP O
, , O O
six CD B-NP O
children NNS I-NP O
of IN B-PP O
the DT B-NP O
three CD I-NP O
homozygous JJ I-NP O
sisters NNS I-NP O
and CC O O
five CD B-NP O
children NNS I-NP O
of IN B-PP O
heterozygotes NNS B-NP O
were VBD B-VP O
available JJ B-ADJP O
for IN B-PP O
testing NN B-NP O
. . O O

Studies NNS B-NP O
of IN B-PP O
the DT B-NP O
HLA NN I-NP O
antigens NNS I-NP O
in IN B-PP O
all PDT B-NP O
the DT I-NP O
22 CD I-NP O
subjects NNS I-NP O
and CC O O
in IN B-PP O
three CD B-NP O
spouses NNS I-NP O
indicated VBD B-VP O
no DT B-NP O
close JJ I-NP O
linkage NN I-NP O
between IN B-PP O
the DT B-NP O
CM NN I-NP B-Disease
deficienty NN I-NP I-Disease
and CC O O
the DT B-NP O
HLA NN I-NP O
system NN I-NP O
. . O O

In IN B-PP O
addition NN B-NP O
, , O O
the DT B-NP O
simultaneous JJ I-NP O
occurrence NN I-NP O
of IN B-PP O
two CD B-NP O
hereditary JJ I-NP O
complement NN I-NP B-Disease
deficiencies NNS I-NP I-Disease
( ( O I-Disease
C2 NN B-NP I-Disease
and CC O I-Disease
C7 NN B-NP I-Disease
) ) O I-Disease
was VBD B-VP O
discovered VBN I-VP O
in IN B-PP O
one CD B-NP O
family NN I-NP O
of IN B-PP O
this DT B-NP O
remarkable JJ I-NP O
kindred NN I-NP O
. . O O

. . O O

Genetic JJ B-NP O
defect NN I-NP B-Disease
in IN B-PP I-Disease
secretion NN B-NP I-Disease
of IN B-PP I-Disease
complement NN B-NP I-Disease
C5 NN I-NP I-Disease
in IN B-PP O
mice NNS B-NP O
. . O O

A DT B-NP O
genetic JJ I-NP O
deficiency NN I-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
fifth JJ I-NP I-Disease
( ( O I-Disease
C5 NN B-NP I-Disease
) ) O I-Disease
component NN B-NP I-Disease
of IN B-PP I-Disease
complement1 NN B-NP I-Disease
- HYPH B-NP I-Disease
3 CD I-NP I-Disease
, , O O
a DT B-NP O
serum NN I-NP O
glycoprotein NN I-NP O
of IN B-PP O
molecular JJ B-NP O
weight NN I-NP O
( ( O O
MW NN B-NP O
) ) O O
220 CD B-NP O
, , O O
000 CD B-NP O
( ( O O
ref NN B-NP O
. . O O

4 CD B-NP O
) ) O O
, , O O
has VBZ B-VP O
been VBN I-VP O
found VBN I-VP O
in IN B-PP O
39 CD B-NP O
% NN I-NP O
of IN B-PP O
inbred JJ B-NP O
strains NNS I-NP O
of IN B-PP O
mice3 NN B-NP O
. . O O

Sera NN B-NP O
of IN B-PP O
deficient JJ B-NP O
mice NNS I-NP O
lack VBP B-VP O
detectable JJ B-NP O
C5 NN I-NP O
activity NN I-NP O
and CC I-NP O
protein2 NN I-NP O
, , O O
3 CD B-NP O
. . O O

In IN B-PP O
addition NN B-NP O
deficient JJ I-NP O
mice NNS I-NP O
produce VBP B-VP O
antibody NN B-NP O
to TO B-PP O
mouse NN B-NP O
C5 NN I-NP O
when WRB B-ADVP O
injected VBN B-VP O
with IN B-PP O
sera NN B-NP O
from IN B-PP O
C5 NN B-NP O
sufficient JJ B-ADVP O
( ( O O
normal JJ B-ADJP O
) ) O O
strains NNS B-NP O
. . O O

Levy NNP B-NP O
et FW I-NP O
al FW I-NP O
. . O O

5 CD B-NP O
showed VBD B-VP O
that IN B-SBAR O
somatic JJ B-NP O
cell NN I-NP O
hybrids NNS I-NP O
between IN B-PP O
C5 NN B-NP O
deficient JJ B-ADJP O
( ( O O
B10 NN B-NP O
. SYM I-NP O

D2 NN I-NP O
/ SYM B-VP O
old JJ B-NP O
line NN I-NP O
) ) O O
macrophages NNS B-NP O
and CC O O
either CC O O
C5 NN B-NP O
sufficient JJ B-ADJP O
( ( O O
B10 NN B-NP O
. SYM I-NP O

D2 NN I-NP O
/ SYM B-NP O
new JJ I-NP O
line NN I-NP O
) ) O O
mouse NN B-NP O
kidney NN I-NP O
or CC I-NP O
chicken NN I-NP O
erythroblasts NNS I-NP O
secreted VBN B-VP O
haemolytically RB B-NP O
active JJ I-NP O
mouse NN I-NP O
C5 NN I-NP O
in FW B-ADVP O
vitro FW I-ADVP O
. . O O

Several JJ B-NP O
possible JJ I-NP O
molecular JJ I-NP O
mechanisms NNS I-NP O
to TO B-VP O
account VB I-VP O
for IN B-PP O
the DT B-NP O
findings NNS I-NP O
were VBD B-VP O
considered VBN I-VP O
, , O O
but CC O O
insufficient JJ B-NP O
direct JJ I-NP O
data NNS I-NP O
were VBD B-VP O
available JJ B-ADJP O
to TO B-VP O
choose VB I-VP O
among IN B-PP O
them PRP B-NP O
. . O O

We PRP B-NP O
recently RB B-ADVP O
reported VBD B-VP O
that IN B-SBAR O
mouse NN B-NP O
( ( O O
CD NNP B-NP O
. . O O

1 CD B-NP O
strain NN I-NP O
) ) O O
peritoneal JJ B-NP O
cells NNS I-NP O
in IN B-PP O
culture NN B-NP O
synthesise NN I-NP O
and CC O O
secrete VB B-VP O
a DT B-NP O
single JJ I-NP O
chain NN I-NP O
precursor NN I-NP O
, , O O
pro AFX O O
- HYPH O O
C5 NN B-NP O
( ( O O
MW NN B-NP O
approximately RB B-NP O
210 CD I-NP O
, , I-NP O
000 CD I-NP O
) ) O O
, , O O
of IN B-PP O
the DT B-NP O
two CD I-NP O
- HYPH I-NP O
chain NN I-NP O
( ( O O
alpha NN B-NP O
chain NN I-NP O
, , O O
125 CD B-NP O
, , I-NP O
000 CD I-NP O
and CC O O
beta SYM B-NP O
chain NN B-NP O
83 CD I-NP O
, , O O
000 CD B-NP O
MW NN I-NP O
) ) O O
C5 NN B-NP O
protein6 NN I-NP O
. . O O

Radiolabelled VBN B-NP O
precursor NN I-NP O
C5 NN I-NP O
was VBD B-VP O
contained VBN I-VP O
within IN B-PP O
the DT B-NP O
cells NNS I-NP O
and CC O O
was VBD B-VP O
secreted VBN I-VP O
into IN B-PP O
the DT B-NP O
tissue NN I-NP O
culture NN I-NP O
media NNS I-NP O
. . O O

Using VBG B-VP O
similar JJ B-NP O
methods NNS I-NP O
, , O O
we PRP B-NP O
now RB B-ADVP O
find VBP B-VP O
that IN B-SBAR O
C5 NN B-NP B-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
each DT B-NP O
of IN B-PP O
five CD B-NP O
different JJ I-NP O
mouse NN I-NP O
strains NNS I-NP O
( ( O O
AKR NN B-NP O
, , O O
SWR NN B-NP O
, , O O
DBA NN B-NP O
/ SYM I-NP O
2J8 NN I-NP O
A NN I-NP O
/ SYM B-NP O
HeJ NN I-NP O
and CC I-NP O
B10 NN I-NP O
. . I-NP O

D2 NN I-NP O
/ SYM B-VP O
old JJ B-NP O
line NN I-NP O
) ) O O
is VBZ B-VP O
due JJ B-ADJP O
to TO B-PP O
a DT B-NP O
failure NN I-NP O
in IN B-PP O
secretion NN B-NP O
of IN B-PP O
C5 NN B-NP O
protein NN I-NP O
and CC O O
not RB O O
to TO B-PP O
a DT B-NP O
failure NN I-NP O
in IN B-PP O
biosynthesis NN B-NP O
of IN B-PP O
pro AFX B-NP O
- HYPH I-NP O
C5 NN I-NP O
Recurrent JJ B-NP O
meningococcal JJ I-NP B-Disease
meningitis NN I-NP I-Disease
with IN B-PP O
absence NN B-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
sixth JJ I-NP I-Disease
component NN I-NP I-Disease
of IN B-PP I-Disease
complement NN B-NP I-Disease
: : O O
an DT B-NP O
evaluation NN I-NP O
of IN B-PP O
underlying VBG B-VP O
immunologic JJ B-NP O
mechanisms NNS I-NP O
. . O O

A DT B-NP O
51 CD I-NP O
/ SYM I-NP O
2 CD I-NP O
- HYPH I-NP O
year NN I-NP O
- HYPH B-NP O
old JJ I-NP O
black JJ I-NP O
girl NN I-NP O
with IN B-PP O
recurrent JJ B-NP O
meningococcal JJ I-NP B-Disease
meningitis NN I-NP I-Disease
and CC I-NP O
absence NN I-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
sixth JJ I-NP I-Disease
component NN I-NP I-Disease
of IN B-PP I-Disease
complement NN B-NP I-Disease
( ( O O
C6 NN B-NP O
) ) O O
is VBZ B-VP O
reported VBN I-VP O
. . O O

To TO B-VP O
explore VB I-VP O
the DT B-NP O
pathogenesis NN I-NP O
of IN B-PP O
recurrent JJ B-NP O
neisserial JJ I-NP B-Disease
infections NNS I-NP I-Disease
in IN B-PP O
C6 NN B-NP B-Disease
deficiency NN I-NP I-Disease
, , O O
a DT B-NP O
detailed JJ I-NP O
analysis NN I-NP O
of IN B-PP O
her PRP$ B-NP O
immune JJ I-NP O
competence NN I-NP O
was VBD B-VP O
conducted VBN I-VP O
. . O O

Her PRP$ B-NP O
serum NN I-NP O
had VBD B-VP O
normal JJ B-NP O
chemotactic JJ I-NP O
, , I-NP O
opsonic JJ I-NP O
, , I-NP O
alternative JJ I-NP O
complement NN I-NP O
pathway NN I-NP O
, , O O
and CC O O
specific JJ B-NP O
antibody NN I-NP O
activity NN I-NP O
, , O O
but CC O O
lacked VBD B-VP O
complement NN B-NP O
- HYPH O O
mediated VBN B-NP O
bacteriolytic JJ I-NP O
activity NN I-NP O
. . O O

In IN B-PP O
addition NN B-NP O
, , O O
her PRP$ B-NP O
C6 NN I-NP B-Disease
- HYPH B-NP I-Disease
deficient JJ I-NP I-Disease
serum NN I-NP O
was VBD B-VP O
indistinguishable JJ B-ADJP O
from IN B-PP O
normal JJ B-NP O
serum NN I-NP O
in IN B-PP O
a DT B-NP O
complement NN I-NP O
- HYPH B-NP O
dependent JJ I-NP O
assay NN I-NP O
of IN B-PP O
phagocyte NN B-NP O
bactericidal JJ I-NP O
activity NN I-NP O
. . O O

Absent JJ B-NP O
bacteriolysis NN I-NP O
remains VBZ B-VP O
the DT B-NP O
only RB I-NP O
consistent JJ I-NP O
defect NN I-NP O
associated VBN B-VP O
with IN B-PP O
recurrent JJ B-NP O
neisserial JJ I-NP B-Disease
infections NNS I-NP I-Disease
and CC O O
absence NN B-NP O
of IN B-PP O
one CD B-NP O
of IN B-PP O
the DT B-NP O
late JJ I-NP O
- HYPH I-NP O
acting VBG I-NP O
complement NN I-NP O
components NNS I-NP O
. . O O

. . O O

Deficiency NN B-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
fifth JJ I-NP I-Disease
component NN I-NP I-Disease
of IN B-PP I-Disease
complement NN B-NP I-Disease
in IN B-PP O
human JJ B-NP O
subjects NNS I-NP O
. . O O

Clinical JJ B-NP O
, , I-NP O
genetic JJ I-NP O
and CC I-NP O
immunologic JJ I-NP O
studies NNS I-NP O
in IN B-PP O
a DT B-NP O
large JJ I-NP O
kindred NN I-NP O
. . O O

The DT B-NP O
discovery NN I-NP O
of IN B-PP O
a DT B-NP O
large JJ I-NP O
kindred NN I-NP O
with IN B-PP O
a DT B-NP O
heritable JJ I-NP O
deficiency NN I-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
fifth JJ I-NP I-Disease
component NN I-NP I-Disease
of IN B-PP I-Disease
complement NN B-NP I-Disease
( ( O O
C5 NN B-NP O
) ) O O
has VBZ B-VP O
permitted VBN I-VP O
the DT B-NP O
accumulation NN I-NP O
of IN B-PP O
new JJ B-NP O
clinical JJ I-NP O
, , I-NP O
genetic JJ I-NP O
and CC I-NP O
immunologic JJ I-NP O
data NNS I-NP O
concerning VBG B-VP O
the DT B-NP O
role NN I-NP O
of IN B-PP O
C5 NN B-NP O
in IN B-PP O
human JJ B-NP O
subjects NNS I-NP O
. . O O

The DT B-NP O
proband NN I-NP O
, , O O
who WP B-NP O
has VBZ B-VP O
had VBD I-VP O
nine CD B-NP O
episodes NNS I-NP O
of IN B-PP O
disseminated VBN B-NP O
gonococcal JJ I-NP B-Disease
infection NN I-NP I-Disease
, , O O
has VBZ B-VP O
a DT B-NP O
hemolytic JJ I-NP O
C5 NN I-NP O
level NN I-NP O
of IN B-PP O
approximately RB B-NP O
0 CD I-NP O
. . O O

5 CD B-NP O
per IN B-PP O
cent NN B-NP O
of IN B-PP O
normal JJ B-NP O
. . O O

No DT B-NP O
C5 NN I-NP O
protein NN I-NP O
was VBD B-VP O
detectable JJ B-ADJP O
, , O O
but CC O O
low JJ B-NP O
levels NNS I-NP O
of IN B-PP O
functional JJ B-NP O
C5 NN I-NP O
activity NN I-NP O
could MD B-VP O
be VB I-VP O
found VBN I-VP O
using VBG B-VP O
a DT B-NP O
sensitive JJ I-NP O
bactericidal JJ I-NP O
assay NN I-NP O
. . O O

The DT B-NP O
probands NNS I-NP O
twin VBP B-VP O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
another DT B-NP O
sister NN I-NP O
also RB B-ADVP O
had VBD B-VP O
extremely RB B-NP O
low JJ I-NP O
levels NNS I-NP O
of IN B-PP O
hemolytic JJ B-NP O
C5 NN I-NP O
( ( O O
approximately RB B-NP O
0 CD I-NP O
. . I-NP O

5 CD I-NP O
per IN B-PP O
cent NN B-NP O
normal JJ B-ADJP O
) ) O O
, , O O
but CC O O
both PDT O O
these DT B-NP O
subjects NNS I-NP O
have VBP B-VP O
been VBN I-VP O
healthy JJ B-ADJP O
. . O O

Hemolytic JJ B-NP O
complement NN I-NP O
and CC O O
bacteriolytic JJ B-NP O
activity NN I-NP O
could MD B-VP O
be VB I-VP O
restored VBN I-VP O
by IN B-PP O
the DT B-NP O
addition NN I-NP O
of IN B-PP O
purified VBN B-NP O
C5 NN I-NP O
. . O O

No DT B-NP O
chemotactic JJ I-NP O
activity NN I-NP O
for IN B-PP O
polymorphonuclear JJ B-NP O
leukocytes NNS I-NP O
could MD B-VP O
be VB I-VP O
generated VBN I-VP O
in IN B-PP O
the DT B-NP O
C5 NN I-NP B-Disease
- HYPH B-NP I-Disease
deficient JJ I-NP I-Disease
serums NNS I-NP O
upon IN B-PP O
activation NN B-NP O
of IN B-PP O
either CC O O
the DT B-NP O
classic JJ I-NP O
or CC I-NP O
alternative JJ I-NP O
pathways NNS I-NP O
, , O O
again RB B-ADVP O
demonstrating VBG B-VP O
the DT B-NP O
importance NN I-NP O
of IN B-PP O
C5 NN B-NP O
in IN B-PP O
human JJ B-NP O
subjects NNS I-NP O
for IN B-PP O
the DT B-NP O
production NN I-NP O
of IN B-PP O
chemotactic JJ B-NP O
factors NNS I-NP O
. . O O

The DT B-NP O
chemotactic JJ I-NP O
responsiveness NN I-NP O
of IN B-PP O
the DT B-NP O
patients NNS I-NP O
polymorphonuclear JJ B-NP O
leukocytes NNS I-NP O
and CC I-NP O
monocytes NNS I-NP O
to TO B-PP O
preformed JJ B-NP O
chemotactic JJ I-NP O
factors NNS I-NP O
was VBD B-VP O
not RB I-VP O
depressed VBN I-VP O
. . O O

Twenty CD B-NP O
- HYPH I-NP O
two CD I-NP O
of IN B-PP O
32 CD B-NP O
other JJ I-NP O
family NN I-NP O
members NNS I-NP O
from IN B-PP O
three CD B-NP O
generations NNS I-NP O
had VBD B-VP O
depressed VBN I-VP O
whole JJ B-NP O
hemolytic JJ I-NP O
complement NN I-NP O
levels NNS I-NP O
. . O O

In IN B-PP O
19 CD B-NP O
of IN B-PP O
30 CD B-NP O
family NN I-NP O
members NNS I-NP O
, , O O
levels NNS B-NP O
of IN B-PP O
hemolytic JJ B-NP O
C5 NN I-NP O
ranged VBD B-VP O
from IN B-PP O
13 CD B-NP O
to TO B-PP O
64 CD B-NP O
per IN B-PP O
cent NN B-NP O
of IN B-PP O
normal JJ B-NP O
. . O O

No DT B-NP O
linkage NN I-NP O
for IN B-PP O
C5 NN B-NP B-Disease
deficiency NN I-NP I-Disease
and CC O O
the DT B-NP O
A NN I-NP O
or CC I-NP O
B NN I-NP O
loci NNS I-NP O
of IN B-PP O
the DT B-NP O
major JJ I-NP O
histocompatibility NN I-NP O
complex NN I-NP O
could MD B-VP O
be VB I-VP O
found VBN I-VP O
. . O O

These DT B-NP O
data NNS I-NP O
suggest VBP B-VP O
an DT B-NP O
autosomal JJ I-NP O
codominant JJ I-NP O
mode NN I-NP O
of IN B-PP O
inheritance NN B-NP O
of IN B-PP O
C5 NN B-NP B-Disease
deficiency NN I-NP I-Disease
. . O O

Deficiency NN B-NP B-Disease
of IN B-PP I-Disease
C5 NN B-NP I-Disease
is VBZ B-VP O
compatible JJ B-ADJP O
with IN B-PP O
good JJ B-NP O
health NN I-NP O
, , O O
but CC O O
it PRP B-NP O
can MD B-VP O
be VB I-VP O
associated VBN I-VP O
with IN B-PP O
repeated VBN B-NP O
disseminated VBN I-NP O
gonococcal JJ I-NP B-Disease
infection NN I-NP I-Disease
Incidence NN B-NP O
and CC I-NP O
characteristics NNS I-NP O
of IN B-PP O
glucose NN B-NP O
- HYPH B-NP O
6 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
dehydrogenase NN I-NP O
variants NNS I-NP O
in IN B-PP O
Japan NNP B-NP O
. . O O

A DT B-NP O
total NN I-NP O
of IN B-PP O
3000 CD B-NP O
men NNS I-NP O
living VBG B-VP O
in IN B-PP O
Yamaguchi NNP B-NP O
were VBD B-VP O
screened VBN I-VP O
for IN B-PP O
glucose NN B-NP B-Disease
- HYPH B-NP I-Disease
6 CD I-NP I-Disease
- HYPH I-NP I-Disease
phosphate NN I-NP I-Disease
dehydrogenase NN I-NP I-Disease
( ( O I-Disease
G6PD NN B-NP I-Disease
) ) O I-Disease
deficiency NN B-NP I-Disease
using VBG B-VP O
Beutlers NNS B-NP O
spot NN I-NP O
test NN I-NP O
and CC O O
three CD B-NP O
types NNS I-NP O
of IN B-PP O
starch NN B-NP O
gel NN I-NP O
electrophoresis NN I-NP O
. . O O

These DT B-NP O
electrophoresis NN I-NP O
used VBD B-VP O
a DT B-NP O
phosphate NN I-NP O
buffer NN I-NP O
system NN I-NP O
at IN B-PP O
pH NN B-NP O
7 CD I-NP O
. . O O

0 CD B-NP O
, , O O
a DT B-NP O
TRIS NN I-NP O
- HYPH B-NP O
EDTA NN I-NP O
- HYPH I-NP O
borate JJ I-NP O
buffer NN I-NP O
system NN I-NP O
at IN B-PP O
pH NN B-NP O
8 CD I-NP O
. . O O

6 CD B-NP O
, , O O
and CC O O
a DT B-NP O
TRIS NN I-NP O
- HYPH I-NP O
hydrochloride NN I-NP O
buffer NN I-NP O
system NN I-NP O
at IN B-PP O
pH NN B-NP O
8 CD I-NP O
. . O O

. . O O

Fifteen CD B-NP O
G6PD NN I-NP B-Disease
- HYPH B-NP I-Disease
deficient JJ I-NP I-Disease
variants NNS I-NP O
were VBD B-VP O
found VBN I-VP O
at IN B-PP O
the DT B-NP O
rate NN I-NP O
of IN B-PP O
0 CD B-NP O
. . O O

5 CD B-NP O
% NN I-NP O
and CC O O
classified VBN B-VP O
into IN B-PP O
four CD B-NP O
groups NNS I-NP O
. . O O

As IN B-SBAR O
new JJ B-NP O
variants NNS I-NP O
, , O O
G6PD NN B-NP O
Konan NNP I-NP O
, , O O
Kamiube NNP B-NP O
, , O O
and CC O O
Kiwa NN B-NP O
were VBD B-VP O
identified VBN I-VP O
. . O O

These DT B-NP O
three CD I-NP O
variants NNS I-NP O
had VBD B-VP O
a DT B-NP O
mild JJ I-NP O
to TO I-NP O
moderate JJ I-NP O
G6PD NN I-NP B-Disease
deficiency NN I-NP I-Disease
and CC O O
were VBD B-VP O
not RB I-VP O
associated VBN I-VP O
with IN B-PP O
any DT B-NP O
clinical JJ I-NP O
signs NNS I-NP O
. . O O

G6PD NN B-NP O
Konan NNP I-NP O
had VBD B-VP O
fast JJ B-NP O
electrophoretic JJ I-NP O
mobility NN I-NP O
as IN B-PP O
compared VBN B-PP O
with IN B-PP O
normal JJ B-NP O
levels NNS I-NP O
, , O O
G6PD NN B-NP O
Kiwa NNP B-NP O
had VBD B-VP O
slightly RB B-NP O
elevated JJ I-NP O
electrophoretic JJ I-NP O
mobility NN I-NP O
, , O O
and CC O O
G6PD NNP B-NP O
Kamiube NNP I-NP O
had VBD B-VP O
normal JJ B-NP O
electrophoretic JJ I-NP O
mobility NN I-NP O
. . O O

These DT B-NP O
three CD I-NP O
variants NNS I-NP O
had VBD B-VP O
normal JJ B-NP O
levels NNS I-NP O
of IN B-PP O
Km NN B-NP O
G6P NN I-NP O
, , O O
Km NN B-NP O
NADP NN I-NP O
, , O O
and CC O O
Ki NN B-NP O
NADPH NN I-NP O
, , O O
normal JJ B-NP O
utilizations NNS I-NP O
of IN B-PP O
both CC B-NP O
2 CD I-NP O
- HYPH I-NP O
deoxy NN I-NP O
- HYPH I-NP O
G6P NN I-NP O
and CC I-NP O
deamino NN I-NP O
- HYPH B-NP O
NAPD NN I-NP O
, , O O
normal JJ B-NP O
heat NN I-NP O
stability NN I-NP O
, , O O
and CC O O
a DT B-NP O
normal JJ I-NP O
pH NN I-NP O
curve NN I-NP O
. . O O

The DT B-NP O
other JJ I-NP O
variant NN I-NP O
was VBD B-VP O
G6PD NN B-NP O
Ube NNP I-NP O
, , O O
which WDT B-NP O
we PRP B-NP O
had VBD B-VP O
previously RB I-VP O
found VBN I-VP O
in IN B-PP O
Yamaguchi NNP B-NP O
( ( O O
Nakashima NNP B-NP O
et FW I-NP O
al FW I-NP O
. FW I-NP O

, , O O
1977 CD B-NP O
) ) O O
. . O O

One CD B-NP O
boy NN I-NP O
with IN B-PP O
G6PD NN B-NP O
Ube NNP I-NP O
was VBD B-VP O
Korean JJ B-ADJP O
Utilization NN B-NP O
of IN B-PP O
purines NNS B-NP O
by IN B-PP O
an DT B-NP O
HPRT NN I-NP O
variant NN I-NP O
in IN B-PP O
an DT B-NP O
intelligent JJ I-NP O
, , I-NP O
nonmutilative JJ I-NP O
patient NN I-NP O
with IN B-PP O
features NNS B-NP O
of IN B-PP O
the DT B-NP O
Lesch NNP I-NP B-Disease
- HYPH I-NP I-Disease
Nyhan NNP I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

The DT B-NP O
patient NN I-NP O
, , O O
H NN B-NP O
. . O O

Chr NN B-NP O
. . O O

B NN B-NP O
. NN I-NP O

, , O O
was VBD B-VP O
among IN B-PP O
the DT B-NP O
first JJ I-NP O
reported VBN B-VP O
with IN B-PP O
hyperuricemia NN B-NP B-Disease
and CC I-NP O
central JJ I-NP B-Disease
nervous JJ I-NP I-Disease
system NN I-NP I-Disease
symptoms NNS I-NP I-Disease
. . O O

He PRP B-NP O
has VBZ B-VP O
been VBN I-VP O
found VBN I-VP O
to TO I-VP O
have VB I-VP O
a DT B-NP O
variant NN I-NP O
of IN B-PP O
hypoxanthine NN B-NP O
guanine NN I-NP O
phosphoribosyl NN I-NP O
transferase NN I-NP O
( ( O O
HPRT NN B-NP O
; : O O
E NN B-NP O
. . O O

C NN B-NP O
. . O O

2 CD B-NP O
. . O O

4 CD B-NP O
. . I-NP O

2 CD I-NP O
. . I-NP O

8 CD I-NP O
) ) O O
distinct JJ B-ADJP O
from IN B-PP O
the DT B-NP O
enzyme NN I-NP O
present JJ B-ADJP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
the DT B-NP O
Lesch NNP I-NP B-Disease
- HYPH I-NP I-Disease
Nyhan NNP I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

The DT B-NP O
patient NN I-NP O
had VBD B-VP O
chroeoathetosis NN B-NP B-Disease
, , O O
spasticity NN B-NP B-Disease
, , O O
dysarthric JJ B-NP B-Disease
speech NN I-NP I-Disease
, , O O
and CC O O
hyperuricemia NN B-NP B-Disease
. . O O

However RB B-ADVP O
, , O O
his PRP$ B-NP O
intelligence NN I-NP O
was VBD B-VP O
normal JJ B-ADJP O
and CC O O
he PRP B-NP O
had VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-PP O
self AFX B-NP O
- HYPH I-NP O
mutilation NN I-NP O
. . O O

There EX B-NP O
was VBD B-VP O
no DT B-NP O
activity NN I-NP O
of IN B-PP O
HPRT NN B-NP O
in IN B-PP O
the DT B-NP O
lysates NNS I-NP O
of IN B-PP O
erythrocytes NNS B-NP O
and CC O O
cultured VBN B-NP O
fibroblasts NNS I-NP O
when WRB B-ADVP O
analyzed VBN B-VP O
in IN B-PP O
the DT B-NP O
usual JJ I-NP O
manner NN I-NP O
. . O O

Using VBG B-VP O
a DT B-NP O
newly RB I-NP O
developed VBN I-NP O
method NN I-NP O
for IN B-PP O
the DT B-NP O
study NN I-NP O
of IN B-PP O
purine NN B-NP O
metabolism NN I-NP O
in IN B-PP O
intact JJ B-NP O
cultured VBN I-NP O
cells NNS I-NP O
, , O O
this DT B-NP O
patient NN I-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
metabolize VB I-VP O
some DT B-NP O
9 CD I-NP O
% NN I-NP O
of IN B-PP O
8 CD B-NP O
- HYPH I-NP O
14C NN I-NP O
- HYPH I-NP O
hypoxanthine NN I-NP O
, , O O
and CC O O
90 CD B-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
isotope NN I-NP O
utilized VBN B-VP O
was VBD B-VP O
converted VBN I-VP O
to TO B-PP O
adenine NN B-NP O
and CC I-NP O
guanine NN I-NP O
nucleotides NNS I-NP O
. . O O

In IN B-PP O
contrast NN B-NP O
, , O O
cells NNS B-NP O
from IN B-PP O
patients NNS B-NP O
with IN B-PP O
the DT B-NP O
Lesch NNP I-NP B-Disease
- HYPH I-NP I-Disease
Nyhan NNP I-NP I-Disease
syndrome NN I-NP I-Disease
were VBD B-VP O
virtually RB B-ADJP O
completely RB I-ADJP O
unable JJ I-ADJP O
to TO B-VP O
convert VB I-VP O
hypoxanthine NN B-NP O
to TO B-PP O
nucleotides NNS B-NP O
. . O O

The DT B-NP O
patients NNS I-NP O
fibroblasts NNS I-NP O
were VBD B-VP O
even RB B-ADJP O
more RBR I-ADJP O
efficient JJ I-ADJP O
in IN B-PP O
the DT B-NP O
metabolism NN I-NP O
of IN B-PP O
8 CD B-NP O
- HYPH I-NP O
14C NN I-NP O
- HYPH O O
guanine NN B-NP O
, , O O
which WDT B-NP O
was VBD B-VP O
utilized VBN I-VP O
to TO B-PP O
the DT B-NP O
extent NN I-NP O
of IN B-PP O
27 CD B-NP O
% NN I-NP O
, , O O
over IN B-NP O
80 CD I-NP O
% NN I-NP O
of IN B-PP O
which WDT B-NP O
was VBD B-VP O
converted VBN I-VP O
to TO B-PP O
guanine NN B-NP O
and CC I-NP O
adenine NN I-NP O
nucleotides NNS I-NP O
. . O O

The DT B-NP O
growth NN I-NP O
of IN B-PP O
the DT B-NP O
cultured VBN I-NP O
fibroblasts NNS I-NP O
of IN B-PP O
this DT B-NP O
patient NN I-NP O
was VBD B-VP O
intermediate JJ B-ADJP O
in IN B-PP O
media NNS B-NP O
containing VBG B-VP O
hypoxanthine NN B-NP O
aminopterin NN I-NP O
thymidine NN I-NP O
( ( O O
HAT NN B-NP O
) ) O O
, , O O
whereas IN O O
the DT B-NP O
growth NN I-NP O
of IN B-PP O
Lesch NN B-NP B-Disease
- HYPH B-NP I-Disease
Nyhan NN I-NP I-Disease
cells NNS I-NP O
was VBD B-VP O
inhibited VBN I-VP O
and CC O O
normal JJ B-NP O
cells NNS I-NP O
grew VBD B-VP O
normally RB B-ADVP O
. . O O

Similarly RB B-ADVP O
in IN B-PP O
8 CD B-NP O
- HYPH I-NP O
azaguanine NN I-NP O
, , O O
6 CD B-NP O
- HYPH I-NP O
thioguanine NN I-NP O
, , O O
and CC O O
8 CD B-NP O
- HYPH I-NP O
azahypoxanthine NN I-NP O
, , O O
the DT B-NP O
growth NN I-NP O
of IN B-PP O
the DT B-NP O
patients NNS I-NP O
cells NNS I-NP O
was VBD B-VP O
intermediate JJ B-ADJP O
between IN B-PP O
normal JJ B-NP O
and CC I-NP O
Lesch JJ I-NP B-Disease
- HYPH I-NP I-Disease
Nyhan NN I-NP I-Disease
cells NNS I-NP O
. . O O

These DT B-NP O
observations NNS I-NP O
provide VBP B-VP O
further JJ B-NP O
evidence NN I-NP O
for IN B-PP O
genetic JJ B-NP O
heterogeneity NN I-NP O
among IN B-PP O
patients NNS B-NP O
with IN B-PP O
disorders NNS B-NP O
in IN B-PP O
purine NN B-NP O
metabolism NN I-NP O
involving VBG B-VP O
the DT B-NP O
HPRT NN I-NP O
gene NN I-NP O
. . O O

They PRP B-NP O
document VBP B-VP O
that IN B-SBAR O
this DT B-NP O
famous JJ I-NP O
patient NN I-NP O
did VBD B-VP O
not RB I-VP O
have VB I-VP O
the DT B-NP O
Lesch NNP I-NP B-Disease
- HYPH I-NP I-Disease
Nyhan NNP I-NP I-Disease
syndrome NN I-NP I-Disease
Localisation NN B-NP O
of IN B-PP O
the DT B-NP O
Becker NNP I-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
gene NN I-NP O
on IN B-PP O
the DT B-NP O
short JJ I-NP O
arm NN I-NP O
of IN B-PP O
the DT B-NP O
X NN I-NP O
chromosome NN I-NP O
by IN B-PP O
linkage NN B-NP O
to TO B-PP O
cloned VBN B-NP O
DNA NN I-NP O
sequences NNS I-NP O
. . O O

A DT B-NP O
linkage NN I-NP O
study NN I-NP O
in IN B-PP O
30 CD B-NP O
Becker NNP I-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
BMD NN B-NP B-Disease
) ) O O
kindreds NNS B-NP O
using VBG B-VP O
three CD B-NP O
cloned VBN I-NP O
DNA NN I-NP O
sequences NNS I-NP O
from IN B-PP O
the DT B-NP O
X NN I-NP O
chromosome NN I-NP O
which WDT B-NP O
demonstrate VBP B-VP O
restriction NN B-NP O
fragment NN I-NP O
length NN I-NP O
polymorphisms NNS I-NP O
( ( O O
RFLPs NNS B-NP O
) ) O O
, , O O
suggests VBZ B-VP O
that IN B-SBAR O
the DT B-NP O
BMD NN I-NP B-Disease
gene NN I-NP O
is VBZ B-VP O
located JJ B-ADJP O
on IN B-PP O
the DT B-NP O
short JJ I-NP O
arm NN I-NP O
of IN B-PP O
the DT B-NP O
X NN I-NP O
chromosome NN I-NP O
, , O O
in IN B-PP O
the DT B-NP O
p21 NN I-NP O
region NN I-NP O
. . O O

The DT B-NP O
genes NNS I-NP O
for IN B-PP O
Becker NNP B-NP B-Disease
and CC I-NP I-Disease
Duchenne NNP I-NP I-Disease
dystrophies NNS I-NP I-Disease
must MD B-VP O
therefore RB I-VP O
be VB I-VP O
closely RB I-VP O
linked VBN I-VP O
, , O O
if IN B-CONJP O
not RB I-CONJP O
allelic JJ B-ADJP O
, , O O
and CC O O
any DT B-NP O
future JJ I-NP O
DNA NN I-NP O
probes NNS I-NP O
found VBN B-VP O
to TO I-VP O
be VB I-VP O
of IN B-PP O
practical JJ B-NP O
use NN I-NP O
in IN B-PP O
one CD B-NP O
disorder NN I-NP O
should MD B-VP O
be VB I-VP O
equally RB B-ADJP O
applicable JJ I-ADJP O
to TO B-PP O
the DT B-NP O
other JJ I-NP O
. . O O

The DT B-NP O
linkage NN I-NP O
analysis NN I-NP O
also RB B-ADVP O
provides VBZ B-VP O
data NN B-NP O
on IN B-PP O
the DT B-NP O
frequency NN I-NP O
of IN B-PP O
recombination NN B-NP O
along IN B-PP O
the DT B-NP O
short JJ I-NP O
arm NN I-NP O
of IN B-PP O
the DT B-NP O
X NN I-NP O
chromosome NN I-NP O
, , O O
and CC O O
across IN B-PP O
the DT B-NP O
centromeric JJ I-NP O
region NN I-NP O
. . O O

. . O O

Molecular JJ B-NP O
evidence NN I-NP O
for IN B-PP O
new JJ B-NP O
mutation NN I-NP O
at IN B-PP O
the DT B-NP O
hprt NN I-NP O
locus NN I-NP O
in IN B-PP O
Lesch NNP B-NP B-Disease
- HYPH B-NP I-Disease
Nyhan NNP I-NP I-Disease
patients NNS I-NP O
. . O O

Hypoxanthine NN B-NP O
- HYPH I-NP O
guanine NN I-NP O
phosphoribosyltransferase NN I-NP O
( ( O O
HPRT NN B-NP O
; : O O
EC2 NN B-NP O
. . O O

4 CD B-NP O
. . I-NP O

2 CD I-NP O
. . I-NP O

8 CD I-NP O
) ) O O
, , O O
which WDT B-NP O
functions VBZ B-VP O
in IN B-PP O
the DT B-NP O
metabolic JJ I-NP O
salvage NN I-NP O
of IN B-PP O
purines NNS B-NP O
, , O O
is VBZ B-VP O
encoded VBN I-VP O
by IN B-PP O
an DT B-NP O
X NN I-NP O
- HYPH B-VP O
linked VBN B-NP O
gene NN I-NP O
in IN B-PP O
man NN B-NP O
. . O O

Partial JJ B-NP O
HPRT NN I-NP B-Disease
deficiencies NNS I-NP I-Disease
are VBP B-VP O
associated VBN I-VP O
with IN B-PP O
gouty NN B-NP B-Disease
arthritis NN I-NP I-Disease
, , O O
while IN B-SBAR O
absence NN B-NP O
of IN B-PP O
activity NN B-NP O
results VBZ B-VP O
in IN B-PP O
Lesch NNP B-NP B-Disease
- HYPH B-NP I-Disease
Nyhan NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
L NN B-NP B-Disease
- HYPH O I-Disease
N NN B-NP I-Disease
) ) O O
. . O O

L NN B-NP B-Disease
- HYPH O I-Disease
N NN B-NP I-Disease
patients NNS I-NP O
fail VBP B-VP O
to TO I-VP O
reproduce VB I-VP O
and CC O O
the DT B-NP O
heterozygous JJ I-NP O
state NN I-NP O
appears VBZ B-VP O
to TO I-VP O
confer VB I-VP O
no DT B-NP O
selective JJ I-NP O
advantage NN I-NP O
. . O O

Thus RB B-ADVP O
, , O O
Haldanes NNP B-NP O
principle NN I-NP O
predicts VBZ B-VP O
that IN B-SBAR O
new JJ B-NP O
mutations NNS I-NP O
at IN B-PP O
the DT B-NP O
hprt NN I-NP O
locus NN I-NP O
must MD B-VP O
occur VB I-VP O
frequently RB B-ADVP O
in IN B-PP O
order NN B-NP O
for IN B-PP O
L NN B-NP B-Disease
- HYPH B-NP I-Disease
N NN I-NP I-Disease
syndrome NN I-NP I-Disease
to TO B-VP O
be VB I-VP O
maintained VBN I-VP O
in IN B-PP O
the DT B-NP O
population NN I-NP O
. . O O

This DT B-NP O
constant JJ I-NP O
introduction NN I-NP O
of IN B-PP O
new JJ B-NP O
mutations NNS I-NP O
would MD B-VP O
be VB I-VP O
expected VBN I-VP O
to TO I-VP O
result VB I-VP O
in IN B-PP O
a DT B-NP O
heterogeneous JJ I-NP O
collection NN I-NP O
of IN B-PP O
genetic JJ B-NP B-Disease
lesions NNS I-NP I-Disease
, , O O
some DT B-NP O
of IN B-PP O
which WDT B-NP O
may MD B-VP O
be VB I-VP O
novel JJ B-ADJP O
. . O O

As IN B-SBAR O
we PRP B-NP O
report VBP B-VP O
here RB B-ADVP O
, , O O
the DT B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
hprt NN I-NP O
gene NN I-NP O
of IN B-PP O
seven CD B-NP O
L NN I-NP B-Disease
- HYPH B-NP I-Disease
N NN I-NP I-Disease
patients NNS I-NP O
, , O O
selected VBN B-VP O
from IN B-PP O
an DT B-NP O
initial JJ I-NP O
survey NN I-NP O
of IN B-PP O
28 CD B-NP O
patients NNS I-NP O
, , O O
have VBP B-VP O
been VBN I-VP O
characterized VBN I-VP O
and CC O O
all DT B-NP O
were VBD B-VP O
found VBN I-VP O
to TO I-VP O
be VB I-VP O
distinctly RB B-ADJP O
different JJ I-ADJP O
, , O O
as IN B-SBAR O
predicted VBN B-VP O
. . O O

The DT B-NP O
origin NN I-NP O
of IN B-PP O
one CD B-NP O
unusual JJ I-NP O
mutation NN I-NP O
has VBZ B-VP O
been VBN I-VP O
identified VBN I-VP O
by IN B-PP O
analysis NN B-NP O
of IN B-PP O
DNA NN B-NP O
from IN B-PP O
four CD B-NP O
generations NNS I-NP O
of IN B-PP O
family NN B-NP O
members NNS I-NP O
. . O O

Further JJ B-NP O
molecular JJ I-NP O
analysis NN I-NP O
of IN B-PP O
the DT B-NP O
origin NN I-NP O
of IN B-PP O
new JJ B-NP O
mutations NNS I-NP O
at IN B-PP O
the DT B-NP O
hprt NN I-NP O
locus NN I-NP O
should MD B-VP O
aid VB I-VP O
in IN B-PP O
resolving VBG B-VP O
the DT B-NP O
issue NN I-NP O
of IN B-PP O
an DT B-NP O
apparent JJ I-NP O
difference NN I-NP O
in IN B-PP O
the DT B-NP O
frequency NN I-NP O
of IN B-PP O
hprt NN B-NP O
mutations NNS I-NP O
in IN B-PP O
males NNS B-NP O
and CC I-NP O
females NNS I-NP O
Allelic JJ B-NP O
exclusion NN I-NP O
of IN B-PP O
glucose NN B-NP O
- HYPH B-NP O
6 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
dehydrogenase NN I-NP O
in IN B-PP O
platelets NNS B-NP O
and CC O O
T NN B-NP O
lymphocytes NNS B-NP O
from IN B-PP O
a DT B-NP O
Wiskott NNP I-NP B-Disease
- HYPH I-NP I-Disease
Aldrich NNP I-NP I-Disease
syndrome NN I-NP I-Disease
carrier NN I-NP O
. . O O

An DT B-NP O
obligate JJ I-NP O
carrier NN I-NP O
of IN B-PP O
the DT B-NP O
Wiskott NNP I-NP B-Disease
- HYPH I-NP I-Disease
Aldrich NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
WAS NN B-NP B-Disease
) ) O O
who WP B-NP O
was VBD B-VP O
also RB B-ADVP O
heterozygous JJ B-ADJP O
for IN B-PP O
the DT B-NP O
A NN I-NP O
and CC I-NP O
B NN I-NP O
types NNS I-NP O
of IN B-PP O
X NN B-NP O
- HYPH O O
linked VBN B-NP O
glucose NN I-NP O
- HYPH B-NP O
6 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
dehydrogenase NN I-NP O
was VBD B-VP O
found VBN I-VP O
. . O O

With IN B-PP O
her PRP B-NP O
it PRP B-NP O
became VBD B-VP O
possible JJ B-ADJP O
to TO B-VP O
determine VB I-VP O
whether IN B-SBAR O
allelic JJ B-NP O
exclusion NN I-NP O
occurs VBZ B-VP O
in IN B-PP O
particular JJ B-NP O
cell NN I-NP O
- HYPH O O
types NNS B-NP O
of IN B-PP O
the DT B-NP O
WAS NNP I-NP B-Disease
carrier NN I-NP O
. . O O

If IN B-SBAR O
so RB B-ADVP O
, , O O
the DT B-NP O
remaining VBG I-NP O
cells NNS I-NP O
of IN B-PP O
a DT B-NP O
particular JJ I-NP O
cell NN I-NP O
- HYPH I-NP O
type NN B-NP O
would MD B-VP O
express VB I-VP O
only RB B-NP O
the DT I-NP O
normal JJ I-NP O
X NN I-NP O
chromosome NN I-NP O
and CC O O
only RB B-NP O
one CD I-NP O
glucose NN I-NP O
- HYPH B-NP O
6 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
dehydrogenase NN I-NP O
isoenzyme NN I-NP O
would MD B-VP O
be VB I-VP O
demonstrable JJ B-ADJP O
. . O O

This DT B-NP O
carrier NN I-NP O
had VBD B-VP O
only RB B-NP O
the DT I-NP O
B NN I-NP O
isoenzyme NN I-NP O
of IN B-PP O
glucose NN B-NP O
- HYPH B-NP O
6 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
dehydrogenase NN I-NP O
in IN B-PP O
platelets NNS B-NP O
and CC I-NP O
thymus NN I-NP O
- HYPH O O
derived VBN B-NP O
T NN I-NP O
lymphocytes NNS I-NP O
, , O O
although IN B-SBAR O
both DT B-NP O
isoenzymes NNS I-NP O
A NN I-NP O
and CC I-NP O
B NN I-NP O
were VBD B-VP O
present JJ B-ADJP O
in IN B-PP O
erythrocytes NNS B-NP O
and CC I-NP O
neutrophils NNS I-NP O
. . O O

These DT B-NP O
findings NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
selection NN B-NP O
against IN B-PP O
the DT B-NP O
WAS NN I-NP B-Disease
gene NN I-NP O
occurs VBZ B-VP O
in IN B-PP O
platelets NNS B-NP O
and CC I-NP O
thymus NN I-NP O
- HYPH O O
derived VBN B-NP O
T NN I-NP O
lymphocytes NNS I-NP O
and CC O O
that IN B-SBAR O
the DT B-NP O
defects NNS I-NP O
associated VBN B-VP O
with IN B-PP O
WAS NN B-NP B-Disease
expressed VBN B-VP O
in IN B-PP O
these DT B-NP O
cell NN I-NP O
- HYPH O O
types NNS B-NP O
may MD B-VP O
be VB I-VP O
implicated VBN I-VP O
in IN B-PP O
the DT B-NP O
genesis NN I-NP O
of IN B-PP O
the DT B-NP O
Wiskott NNP I-NP B-Disease
- HYPH I-NP I-Disease
Aldrich NNP I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

. . O O

Complement NN B-NP B-Disease
deficiency NN I-NP I-Disease
and CC I-NP O
nephritis NN I-NP B-Disease
. . O O

A DT B-NP O
report NN I-NP O
of IN B-PP O
a DT B-NP O
family NN I-NP O
. . O O

A DT B-NP O
family NN I-NP O
is VBZ B-VP O
described VBN I-VP O
in IN B-PP O
which WDT B-NP O
three CD B-NP O
children NNS I-NP O
had VBD B-VP O
homozygous JJ B-NP O
deficiency NN I-NP B-Disease
of IN B-PP I-Disease
C3 NN B-NP I-Disease
and CC O O
in IN B-PP O
which WDT B-NP O
both DT B-NP O
parents NNS I-NP O
and CC O O
two CD B-NP O
other JJ I-NP O
children NNS I-NP O
were VBD B-VP O
heterozygous JJ B-ADJP O
for IN B-PP O
the DT B-NP O
C3 NN I-NP O
gene NN I-NP O
. . O O

One CD B-NP O
child NN I-NP O
with IN B-PP O
heterozygous JJ B-NP O
C3 NN I-NP B-Disease
deficiency NN I-NP I-Disease
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
have VB I-VP O
membranoproliferative JJ B-NP O
glomerulonephritis NN I-NP B-Disease
; : O O
proteinuria NN B-NP B-Disease
and CC O O
/ SYM B-NP O
or CC O O
microscopical JJ B-NP O
haematuria NN I-NP B-Disease
was VBD B-VP O
present JJ B-ADJP O
in IN B-PP O
all DT B-NP O
three CD I-NP O
homozygous JJ I-NP O
C3 NN I-NP B-Disease
- HYPH B-NP I-Disease
deficient JJ I-NP I-Disease
children NNS I-NP O
. . O O

All DT B-NP O
children NNS I-NP O
with IN B-PP O
homozygous JJ B-NP O
or CC I-NP O
heterozygous JJ I-NP O
C3 NN I-NP B-Disease
deficiency NN I-NP I-Disease
were VBD B-VP O
, , O O
to TO B-PP O
a DT B-NP O
varying VBG I-NP O
degree NN I-NP O
, , O O
susceptible JJ B-ADJP O
to TO B-PP O
infection NN B-NP O
. . O O

The DT B-NP O
only JJ I-NP O
child NN I-NP O
of IN B-PP O
the DT B-NP O
family NN I-NP O
with IN B-PP O
normal JJ B-NP O
complement NN I-NP O
had VBD B-VP O
no DT B-NP O
increased VBN I-NP O
risk NN I-NP O
of IN B-PP O
infection NN B-NP O
and CC O O
no DT B-NP O
renal JJ I-NP B-Disease
disease NN I-NP I-Disease
. . O O

This DT B-NP O
family NN I-NP O
study NN I-NP O
provides VBZ B-VP O
further JJ B-NP O
support NN I-NP O
for IN B-PP O
the DT B-NP O
proposal NN I-NP O
that IN B-SBAR O
C3 NN B-NP B-Disease
deficiency NN I-NP I-Disease
predisposes VBZ B-VP O
to TO B-PP O
nephritis NN B-NP B-Disease
. . O O

. . O O

Heterogeneity NN B-NP O
of IN B-PP O
glucose NN B-NP B-Disease
- HYPH B-NP I-Disease
6 CD I-NP I-Disease
- HYPH I-NP I-Disease
phosphate NN I-NP I-Disease
dehydrogenase NN I-NP I-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
Algeria NNP B-NP O
. . O O

Study NN B-NP O
in IN B-PP O
Northern JJ B-NP O
Algeria NNP I-NP O
with IN B-PP O
description NN B-NP O
of IN B-PP O
five CD B-NP O
new JJ I-NP O
variants NNS I-NP O
. . O O

Glucose NN B-NP B-Disease
- HYPH B-NP I-Disease
6 CD I-NP I-Disease
- HYPH I-NP I-Disease
phosphate NN I-NP I-Disease
dehydrogenase NN I-NP I-Disease
( ( O I-Disease
G6PD NN B-NP I-Disease
) ) O I-Disease
deficiency NN B-NP I-Disease
was VBD B-VP O
found VBN I-VP O
in IN B-PP O
3 CD B-NP O
. . O O

2 CD B-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
male JJ I-NP O
population NN I-NP O
living VBG B-VP O
in IN B-PP O
the DT B-NP O
urban JJ I-NP O
area NN I-NP O
of IN B-PP O
Algiers NNS B-NP O
. . O O

The DT B-NP O
deficient JJ I-NP O
subjects NNS I-NP O
originated VBN B-VP O
from IN B-PP O
multiple JJ B-NP O
geographic JJ I-NP O
regions NNS I-NP O
of IN B-PP O
Northern NNP B-NP O
Algeria NNP I-NP O
, , O O
with IN B-PP O
prevalence NN B-NP O
of IN B-PP O
individuals NNS B-NP O
of IN B-PP O
Berber NNP B-NP O
- HYPH I-NP O
Kabyle NNP I-NP O
origin NN I-NP O
. . O O

Red JJ B-NP O
blood NN I-NP O
cell NN I-NP O
G6PD NN I-NP O
was VBD B-VP O
partially RB I-VP O
purified VBN I-VP O
and CC I-VP O
characterized VBN I-VP O
in IN B-PP O
deficient JJ B-NP O
males NNS I-NP O
from IN B-PP O
17 CD B-NP O
families NNS I-NP O
, , O O
and CC O O
six CD B-NP O
different JJ I-NP O
variants NNS I-NP O
were VBD B-VP O
found VBN I-VP O
. . O O

Among IN B-PP O
them PRP B-NP O
, , O O
only RB B-NP O
one CD I-NP O
, , O O
the DT B-NP O
Gd NN I-NP O
( ( O O
- SYM O O
) ) O O
Kabyle NNP B-NP O
variant NN I-NP O
, , O O
had VBD B-VP O
been VBN I-VP O
previously RB I-VP O
described VBN I-VP O
. . O O

It PRP B-NP O
was VBD B-VP O
detected VBN I-VP O
in IN B-PP O
nine CD B-NP O
families NNS I-NP O
. . O O

The DT B-NP O
other JJ I-NP O
five CD I-NP O
variants NNS I-NP O
were VBD B-VP O
new JJ B-NP O
Gd NN I-NP O
( ( O O
- SYM O O
) ) O O
Laghouat NN B-NP O
( ( O O
four CD B-NP O
cases NNS I-NP O
) ) O O
, , O O
Gd NN B-NP O
( ( O O
- SYM O O
) ) O O
Blida NNP B-NP O
( ( O O
one CD B-NP O
case NN I-NP O
) ) O O
, , O O
Gd NN B-NP O
( ( O O
- SYM O O
) ) O O
Thenia NN B-NP O
( ( O O
one CD B-NP O
case NN I-NP O
) ) O O
, , O O
Gd NN B-NP O
( ( O O
- SYM O O
) ) O O
Titteri NNP B-NP O
( ( O O
one CD B-NP O
case NN I-NP O
) ) O O
, , O O
and CC O O
Gd NN B-NP O
( ( O O
- SYM O O
) ) O O
Alger NNP B-NP O
( ( O O
two CD B-NP O
brothers NNS I-NP O
) ) O O
. . O O

Strikingly RB B-ADVP O
, , O O
the DT B-NP O
common JJ I-NP O
Mediterranean NNP I-NP O
variant NN I-NP O
was VBD B-VP O
not RB I-VP O
found VBN I-VP O
. . O O

G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
is VBZ B-VP O
heterogeneous JJ B-ADJP O
in IN B-PP O
northern JJ B-NP O
Algeria NNP I-NP O
where WRB B-ADVP O
autochtonous JJ B-NP O
variants NNS I-NP O
seem VBP B-VP O
to TO I-VP O
prevail VB I-VP O
. . O O

The DT B-NP O
Kabyle NNP I-NP O
variant NN I-NP O
may MD B-VP O
be VB I-VP O
common JJ B-ADJP O
in IN B-PP O
this DT B-NP O
country NN I-NP O
. . O O

Glucose NN B-NP B-Disease
- HYPH B-NP I-Disease
6 CD I-NP I-Disease
- HYPH I-NP I-Disease
phosphate NN I-NP I-Disease
dehydrogenase NN I-NP I-Disease
deficiency NN I-NP I-Disease
inhibits VBZ B-VP O
in FW B-NP O
vitro FW I-NP O
growth NN I-NP O
of IN B-PP O
Plasmodium NNP B-NP O
falciparum NNP I-NP O
. . O O

Glucose NN B-NP B-Disease
- HYPH B-NP I-Disease
6 CD I-NP I-Disease
- HYPH I-NP I-Disease
phosphate NN I-NP I-Disease
dehydrogenase NN I-NP I-Disease
( ( O I-Disease
G6PD NN B-NP I-Disease
; : O I-Disease
EC NNP B-NP I-Disease
1 CD I-NP I-Disease
. . I-NP I-Disease

1 CD I-NP I-Disease
. . O I-Disease

1 CD B-NP I-Disease
. . I-NP I-Disease

49 CD I-NP I-Disease
) ) O I-Disease
- HYPH B-NP I-Disease
deficient JJ I-NP I-Disease
red JJ I-NP O
blood NN I-NP O
cells NNS I-NP O
from IN B-PP O
male JJ B-NP O
hemizygotes NNS I-NP O
and CC O O
female JJ B-NP O
heterozygotes NNS I-NP O
from IN B-PP O
the DT B-NP O
island NN I-NP O
of IN B-PP O
Sardinia NNP B-NP O
were VBD B-VP O
studied VBN I-VP O
for IN B-PP O
their PRP$ B-NP O
ability NN I-NP O
to TO B-VP O
support VB I-VP O
growth NN B-NP O
in FW B-PP O
vitro FW B-NP O
of IN B-PP O
the DT B-NP O
malaria NN I-NP B-Disease
- HYPH B-VP O
causing VBG B-NP O
organism NN I-NP O
Plasmodium NNP I-NP O
falciparum NNP I-NP O
. . O O

Parasite NN B-NP O
growth NN I-NP O
was VBD B-VP O
approximately RB B-NP O
one CD I-NP O
- HYPH I-NP O
third JJ I-NP O
of IN B-PP O
normal JJ B-NP O
in IN B-PP O
both CC O O
hemi AFX O O
- HYPH O O
and CC O O
heterozygotes NNS B-NP O
for IN B-PP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
. . O O

In IN B-PP O
Sardinians NNS B-NP O
with IN B-PP O
the DT B-NP O
beta SYM I-NP O
0 CD I-NP O
- HYPH I-NP O
thalassemia NN I-NP O
trait NN I-NP O
, , O O
parasite NN B-NP O
growth NN I-NP O
was VBD B-VP O
normal JJ B-ADJP O
except IN B-PP O
when WRB B-ADVP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
occurred VBD B-VP O
together RB B-ADVP O
with IN B-PP O
the DT B-NP O
thalassemia NN I-NP B-Disease
trait NN I-NP O
. . O O

The DT B-NP O
data NNS I-NP O
support VBP B-VP O
the DT B-NP O
hypothesis NN I-NP O
that IN B-SBAR O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
may MD B-VP O
confer VB I-VP O
a DT B-NP O
selective JJ I-NP O
advantage NN I-NP O
in IN B-PP O
a DT B-NP O
malarious JJ I-NP B-Disease
area NN I-NP O
; : O O
the DT B-NP O
female JJ I-NP O
heterozygote NN I-NP O
may MD B-VP O
be VB I-VP O
at IN B-PP O
a DT B-NP O
particular JJ I-NP O
advantage NN I-NP O
because IN B-SBAR O
resistance NN B-NP O
to TO B-PP O
malaria NN B-NP B-Disease
equals NNS I-NP O
that DT B-NP O
of IN B-PP O
male JJ B-NP O
hemizygotes NNS I-NP O
, , O O
but CC O O
the DT B-NP O
risk NN I-NP O
of IN B-PP O
fatal JJ B-NP B-Disease
hemolysis NN I-NP I-Disease
may MD B-VP O
be VB I-VP O
less JJR B-ADJP O
. . O O

However RB B-ADVP O
, , O O
more RBR B-NP O
female JJ I-NP O
heterozygotes NNS I-NP O
must MD B-VP O
be VB I-VP O
studied VBN I-VP O
to TO B-VP O
confirm VB I-VP O
this DT B-NP O
hypothesis NN I-NP O
. . O O

No DT B-NP O
protective JJ I-NP O
effect NN I-NP O
of IN B-PP O
beta SYM B-NP O
0 CD I-NP O
- HYPH I-NP O
thalassemia NN I-NP O
trait NN I-NP O
could MD B-VP O
be VB I-VP O
demonstrated VBN I-VP O
in FW B-ADVP O
vitro FW I-ADVP O
. . O O

Bone NN B-NP O
marrow NN I-NP O
transplant NN I-NP O
in IN B-PP O
adrenoleukodystrophy NN B-NP B-Disease
. . O O

An DT B-NP O
allogeneic JJ I-NP O
bone NN I-NP O
marrow NN I-NP O
transplant NN I-NP O
( ( O O
BMT NN B-NP O
) ) O O
from IN B-PP O
a DT B-NP O
normal JJ I-NP O
HLA NN I-NP O
identical JJ I-NP O
sibling NN I-NP O
donor NN I-NP O
was VBD B-VP O
performed VBN I-VP O
in IN B-PP O
a DT B-NP O
13 CD I-NP O
- HYPH I-NP O
year NN I-NP O
- HYPH O O
old JJ B-NP O
boy NN I-NP O
with IN B-PP O
rapidly RB B-NP O
progressive JJ I-NP O
adrenoleukodystrophy NN I-NP B-Disease
( ( O O
ALD NN B-NP B-Disease
) ) O O
. . O O

Engraftment NN B-NP O
and CC I-NP O
complete JJ I-NP O
hematologic JJ I-NP O
recovery NN I-NP O
occurred VBD B-VP O
within IN B-PP O
4 CD B-NP O
weeks NNS I-NP O
, , O O
but CC O O
neurologic JJ B-NP B-Disease
deterioration NN I-NP I-Disease
continued VBN B-VP O
. . O O

The DT B-NP O
patient NN I-NP O
died VBD B-VP O
of IN B-PP O
an DT B-NP O
adenovirus NN I-NP B-Disease
infection NN I-NP I-Disease
141 CD B-NP O
days NNS I-NP O
after IN B-PP O
BMT NN B-NP O
. . O O

ALD NN B-NP B-Disease
is VBZ B-VP O
characterized VBN I-VP O
by IN B-PP O
abnormally RB B-NP O
high JJ I-NP O
plasma NN I-NP O
levels NNS I-NP O
of IN B-PP O
very RB B-NP O
long JJ I-NP O
chain NN I-NP O
fatty JJ I-NP O
acids NNS I-NP O
( ( O O
VLCFA NN B-NP O
) ) O O
as IN B-PP O
a DT B-NP O
result NN I-NP O
of IN B-PP O
impaired JJ B-NP O
capacity NN I-NP O
to TO B-VP O
degrade VB I-VP O
them PRP B-NP O
. . O O

Ten CD B-NP O
days NNS I-NP O
after IN B-PP O
BMT NN B-NP O
, , O O
the DT B-NP O
white JJ I-NP O
blood NN I-NP O
cell NN I-NP O
VLCFA NN I-NP O
levels NNS I-NP O
and CC O O
enzyme NN B-NP O
activity NN I-NP O
became VBD B-VP O
normal JJ B-ADJP O
; : O O
after IN B-PP O
3 CD B-NP O
months NNS I-NP O
, , O O
there EX B-NP O
was VBD B-VP O
progressive JJ B-NP O
reduction NN I-NP O
of IN B-PP O
plasma NN B-NP O
VLCFA NN I-NP O
to TO B-PP O
levels NNS B-NP O
only RB B-ADVP O
slightly RB I-ADVP O
above IN B-PP O
normal JJ B-ADJP O
. . O O

. . O O

[ ( O O
Gd NN B-NP O
- HYPH I-NP O
allele NN I-NP O
distribution NN I-NP O
patterns NNS I-NP O
in IN B-PP O
Azerbaijan NNP B-NP O
. . I-NP O

III CD I-NP O
. . O O

The DT B-NP O
identification NN I-NP O
of IN B-PP O
mutant JJ B-NP O
forms NNS I-NP O
of IN B-PP O
glucose NN B-NP O
- HYPH B-NP O
6 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
dehydrogenase NN I-NP O
] ) O O
In IN B-PP O
28 CD B-NP O
families NNS I-NP O
with IN B-PP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
living VBG B-VP O
in IN B-PP O
3 CD B-NP O
settlements NNS I-NP O
of IN B-PP O
Shekii NNP B-NP O
district NN I-NP O
of IN B-PP O
Azerbaijan NN B-NP O
11 CD I-NP O
G6PD NN I-NP O
variants NNS I-NP O
of IN B-PP O
II CD B-NP O
and CC I-NP O
III CD I-NP O
classes NNS I-NP O
differing VBG B-VP O
by IN B-PP O
kinetic JJ B-NP O
properties NNS I-NP O
were VBD B-VP O
identified VBN I-VP O
according VBG B-PP O
WHO WP B-NP O
program NN I-NP O
. . O O

9 CD B-NP O
of IN B-PP O
them PRP B-NP O
are VBP B-VP O
characterized VBN I-VP O
with IN B-PP O
the DT B-NP O
same JJ I-NP O
electrophoretic JJ I-NP O
mobility NN I-NP O
. . O O

Comparison NN B-NP O
of IN B-PP O
G6PD NN B-NP O
spectra NNS I-NP O
in IN B-PP O
two CD B-NP O
subpopulations NNS I-NP O
and CC B-PP O
in IN B-PP O
a DT B-NP O
mixed VBN I-NP O
group NN I-NP O
permits VBZ B-VP O
to TO I-VP O
make VB I-VP O
a DT B-NP O
conclusion NN I-NP O
about IN B-PP O
existence NN B-NP O
of IN B-PP O
common JJ B-NP O
and CC I-NP O
rare JJ I-NP O
G6PD NN I-NP O
alleles NNS I-NP O
in IN B-PP O
examined VBN B-NP O
population NN I-NP O
. . O O

They PRP B-NP O
distribute VBP B-VP O
by IN B-PP O
gene NN B-NP O
drift NN I-NP O
supported VBN B-VP O
by IN B-PP O
natural JJ B-NP O
selection NN I-NP O
. . O O

Among IN B-PP O
7 CD B-NP O
samples NNS I-NP O
of IN B-PP O
G6PD NN B-NP O
with IN B-PP O
normal JJ B-ADJP O
and CC O O
increased VBN B-NP O
activity NN I-NP O
two CD B-NP O
new JJ I-NP O
variants NNS I-NP O
of IN B-PP O
IV CD B-NP O
class NN I-NP O
- HYPH B-NP O
- SYM I-NP O
Nukha NN I-NP O
and CC I-NP O
Bash NN I-NP O
- HYPH B-NP O
Kungut NN I-NP O
- HYPH B-NP O
- SYM B-NP O
were VBD B-VP O
found VBN I-VP O
. . O O

. . O O

Adrenoleukodystrophy NN B-NP B-Disease
: : O O
survey NN B-NP O
of IN B-PP O
303 CD B-NP O
cases NNS I-NP O
: : O O
biochemistry NN B-NP O
, , O O
diagnosis NN B-NP O
, , O O
and CC O O
therapy NN B-NP O
. . O O

Adrenoleukodystrophy NN B-NP B-Disease
( ( O O
ALD NN B-NP B-Disease
) ) O O
is VBZ B-VP O
a DT B-NP O
genetically RB I-NP O
determined VBN I-NP O
disorder NN I-NP O
associated VBN B-VP O
with IN B-PP O
progressive JJ B-NP B-Disease
central JJ I-NP I-Disease
demyelination NN I-NP I-Disease
and CC O O
adrenal JJ B-NP B-Disease
cortical JJ I-NP I-Disease
insufficiency NN I-NP I-Disease
. . O O

All DT B-NP O
affected JJ I-NP O
persons NNS I-NP O
show VBP B-VP O
increased VBN B-NP O
levels NNS I-NP O
of IN B-PP O
saturated VBN B-NP O
unbranched JJ I-NP O
very RB I-NP O
- HYPH I-NP O
long JJ I-NP O
- HYPH I-NP O
chain NN I-NP O
fatty JJ I-NP O
acids NNS I-NP O
, , O O
particularly RB B-ADVP O
hexacosanoate NN B-NP O
( ( O O
C26 NN B-NP O
0 CD I-NP O
) ) O O
, , O O
because IN B-PP O
of IN I-PP O
impaired JJ B-NP O
capacity NN I-NP O
to TO B-VP O
degrade VB I-VP O
these DT B-NP O
acids NNS I-NP O
. . O O

This DT B-NP O
degradation NN I-NP O
normally RB B-ADVP O
takes VBZ B-VP O
place NN B-NP O
in IN B-PP O
a DT B-NP O
subcellular JJ I-NP O
organelle NN I-NP O
called VBN B-VP O
the DT B-NP O
peroxisome NN I-NP O
, , O O
and CC O O
ALD NN B-NP B-Disease
, , O O
together RB B-ADVP O
with IN B-PP O
Zellwegers NNP B-NP B-Disease
cerebrohepatorenal JJ I-NP I-Disease
syndrome NN I-NP I-Disease
, , O O
is VBZ B-VP O
now RB I-VP O
considered VBN I-VP O
to TO I-VP O
belong VB I-VP O
to TO B-PP O
the DT B-NP O
newly RB I-NP O
formed VBN I-NP O
category NN I-NP O
of IN B-PP O
peroxisomal JJ B-NP B-Disease
disorders NNS I-NP I-Disease
. . O O

Biochemical JJ B-NP O
assays NNS I-NP O
permit VBP B-VP O
prenatal JJ B-NP O
diagnosis NN I-NP O
, , O O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
identification NN B-NP O
of IN B-PP O
most JJS B-NP O
heterozygotes NNS I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
identified VBN I-VP O
303 CD B-NP O
patients NNS I-NP O
with IN B-PP O
ALD NN B-NP B-Disease
in IN B-PP O
217 CD B-NP O
kindreds NNS I-NP O
. . O O

These DT B-NP O
patients NNS I-NP O
show VBP B-VP O
a DT B-NP O
wide JJ I-NP O
phenotypic JJ I-NP O
variation NN I-NP O
. . O O

Sixty CD B-NP O
percent NN I-NP O
of IN B-PP O
patients NNS B-NP O
had VBD B-VP O
childhood NN B-NP O
ALD NN I-NP B-Disease
and CC O O
17 CD B-NP O
% NN I-NP O
adrenomyeloneuropathy NN I-NP B-Disease
, , O O
both DT B-NP O
of IN B-PP O
which WDT B-NP O
are VBP B-VP O
X NN B-NP O
- HYPH O O
linked VBN B-VP O
, , O O
with IN B-PP O
the DT B-NP O
gene NN I-NP O
mapped VBN B-VP O
to TO B-PP O
Xq28 NN B-NP O
. . O O

Neonatal JJ B-NP B-Disease
ALD NN I-NP I-Disease
, , O O
a DT B-NP O
distinct JJ I-NP O
entity NN I-NP O
with IN B-PP O
autosomal JJ B-NP O
recessive JJ I-NP O
inheritance NN I-NP O
and CC I-NP O
points NNS I-NP O
of IN B-PP O
resemblance NN B-NP O
to TO B-PP O
Zellwegers NNP B-NP B-Disease
syndrome NN I-NP I-Disease
, , O O
accounted VBD B-VP O
for IN B-PP O
7 CD B-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
cases NNS I-NP O
. . O O

Although IN B-SBAR O
excess JJ B-NP O
C26 NN I-NP O
0 CD I-NP O
in IN B-PP O
the DT B-NP O
brain NN I-NP O
of IN B-PP O
patients NNS B-NP O
with IN B-PP O
ALD NN B-NP B-Disease
is VBZ B-VP O
partially RB B-ADVP O
of IN B-PP O
dietary JJ B-NP O
origin NN I-NP O
, , O O
dietary JJ B-NP O
C26 NN I-NP O
0 CD I-NP O
restriction NN I-NP O
did VBD B-VP O
not RB I-VP O
produce VB I-VP O
clear JJ B-NP O
benefit NN I-NP O
. . O O

Bone NN B-NP O
marrow NN I-NP O
transplant NN I-NP O
lowered VBD B-VP O
the DT B-NP O
plasma NN I-NP O
C26 NN I-NP O
0 CD I-NP O
level NN I-NP O
but CC O O
failed VBD B-VP O
to TO I-VP O
arrest VB I-VP O
neurological JJ B-NP O
progression NN I-NP O
. . O O

. . O O

Genetic JJ B-NP O
polymorphism NN I-NP O
of IN B-PP O
G6PD NN B-NP O
in IN B-PP O
a DT B-NP O
Bulgarian JJ I-NP O
population NN I-NP O
. . O O

Considerable JJ B-NP O
genetic JJ I-NP O
heterogeneity NN I-NP O
in IN B-PP O
G6PD NN B-NP O
was VBD B-VP O
found VBN I-VP O
in IN B-PP O
the DT B-NP O
Bulgarian JJ I-NP O
population NN I-NP O
- HYPH B-NP O
14 CD I-NP O
G6PD NN I-NP O
variants NNS I-NP O
isolated VBN B-VP O
from IN B-PP O
117 CD B-NP O
hemizygous JJ I-NP O
carriers NNS I-NP O
of IN B-PP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
. . O O

Of IN B-PP O
these DT B-NP O
, , O O
G6PD NN B-NP O
Mediterranean NNP I-NP O
type NN I-NP O
was VBD B-VP O
a DT B-NP O
polymorphic JJ I-NP O
variant NN I-NP O
and CC I-NP O
G6PD NN I-NP O
Corinth NNP B-NP O
occurred VBD B-VP O
with IN B-PP O
high JJ B-NP O
frequency NN I-NP O
. . O O

Two CD B-NP O
new JJ I-NP O
variants NNS I-NP O
were VBD B-VP O
identified VBN I-VP O
- HYPH B-NP O
G6PD NN I-NP O
Rudosem NN I-NP O
and CC O O
G6PD NN B-NP O
Nedelino NN I-NP O
. . O O

In IN B-PP O
a DT B-NP O
selected VBN I-NP O
group NN I-NP O
of IN B-PP O
78 CD B-NP O
subjects NNS I-NP O
with IN B-PP O
clinical JJ B-NP O
manifestations NNS I-NP O
, , O O
four CD B-NP O
variants NNS I-NP O
were VBD B-VP O
established VBN I-VP O
G6PD NN B-NP O
Mediterranian NNP I-NP O
, , O O
G6PD NNP B-NP O
Corinth NNP I-NP O
, , O O
G6PD NN B-NP O
Seattle NN I-NP O
and CC O O
G6PD NN B-NP O
Ohut NN I-NP O
II CD I-NP O
. . O O

. . O O

Clinical JJ B-NP O
use NN I-NP O
of IN B-PP O
DNA NN B-NP O
markers NNS I-NP O
linked VBN B-VP O
to TO B-PP O
the DT B-NP O
gene NN I-NP O
for IN B-PP O
Duchenne NNP B-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
. . O O

Seventy CD B-NP O
families NNS I-NP O
with IN B-PP O
Duchenne JJ B-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
DMD NN B-NP B-Disease
) ) O O
known VBN B-VP O
to TO B-PP O
the DT B-NP O
Institute NNP I-NP O
of IN B-PP O
Child NNP B-NP O
Health NNP I-NP O
fall VBP B-VP O
into IN B-PP O
three CD B-NP O
categories NNS I-NP O
with IN B-PP O
respect NN B-NP O
to TO B-PP O
potential JJ B-NP O
linkage NN I-NP O
analysis NN I-NP O
with IN B-PP O
the DT B-NP O
X NN I-NP O
chromosome NN I-NP O
DNA NN I-NP O
markers NNS I-NP O
RC8 NN I-NP O
and CC I-NP O
L1 NN I-NP O
. . O O

28 CD B-NP O
that WDT B-NP O
bridge VBP B-VP O
the DT B-NP O
DMD NN I-NP B-Disease
gene NN I-NP O
. . O O

Families NNS B-NP O
in IN B-PP O
which WDT B-NP O
there EX B-NP O
is VBZ B-VP O
at IN B-NP O
least JJS I-NP O
one CD I-NP O
obligatory JJ I-NP O
female JJ I-NP O
heterozygote NN I-NP O
( ( O O
n NN B-NP O
= SYM B-VP O
13 CD B-NP O
) ) O O
. . O O

Here RB B-NP O
prediction NN I-NP O
and CC I-NP O
exclusion NN I-NP O
of IN B-PP O
DMD NN B-NP B-Disease
gene NN I-NP O
transmission NN I-NP O
may MD B-VP O
be VB I-VP O
possible JJ B-ADJP O
, , O O
the DT B-NP O
accuracy NN I-NP O
being VBG B-VP O
dependent JJ B-ADJP O
on IN B-PP O
the DT B-NP O
closeness NN I-NP O
of IN B-PP O
the DT B-NP O
linkage NN I-NP O
of IN B-PP O
the DT B-NP O
DNA NN I-NP O
marker NN I-NP O
( ( I-NP O
s NNS I-NP O
) ) O O
to TO B-PP O
the DT B-NP O
DMD NN I-NP B-Disease
gene NN I-NP O
; : O O
an DT B-NP O
illustrative JJ I-NP O
case NN I-NP O
is VBZ B-VP O
reported VBN I-VP O
. . O O

Families NNS B-NP O
in IN B-PP O
which WDT B-NP O
there EX B-NP O
is VBZ B-VP O
a DT B-NP O
single JJ I-NP O
affected VBN I-NP O
boy NN I-NP O
, , O O
who WP B-NP O
also RB B-ADVP O
has VBZ B-VP O
one CD B-NP O
or CC I-NP O
more JJR I-NP O
healthy JJ I-NP O
brothers NNS I-NP O
( ( O O
n NN B-NP O
= SYM B-VP O
26 CD B-NP O
) ) O O
. . O O

Given VBN B-PP O
an DT B-NP O
informative JJ I-NP O
restriction NN I-NP O
fragment NN I-NP O
length NN I-NP O
polymorphism NN I-NP O
( ( O O
RFLP NN B-NP O
) ) O O
, , O O
the DT B-NP O
probability NN I-NP O
that IN B-SBAR O
the DT B-NP O
boy NN I-NP O
represents VBZ B-VP O
a DT B-NP O
new JJ I-NP O
mutation NN I-NP O
can MD B-VP O
be VB I-VP O
reassessed VBN I-VP O
; : O O
it PRP B-NP O
is VBZ B-VP O
also RB B-ADVP O
possible JJ B-ADJP O
to TO B-VP O
exclude VB I-VP O
the DT B-NP O
DMD NN I-NP B-Disease
gene NN I-NP O
in IN B-PP O
a DT B-NP O
sister NN I-NP O
. . O O

Families NNS B-NP O
with IN B-PP O
a DT B-NP O
single JJ I-NP O
affected VBN I-NP O
boy NN I-NP O
with IN B-PP O
no DT B-NP O
brother NN I-NP O
( ( O O
n NN B-NP O
= SYM B-VP O
30 CD B-NP O
) ) O O
. . O O

Here RB B-NP O
exclusion NN I-NP O
of IN B-PP O
the DT B-NP O
DMD NN I-NP B-Disease
gene NN I-NP O
in IN B-PP O
a DT B-NP O
sister NN I-NP O
may MD B-VP O
be VB I-VP O
possible JJ B-ADJP O
. . O O

Only RB B-ADVP O
in IN B-PP O
one CD B-NP O
family NN I-NP O
was VBD B-VP O
there RB B-ADVP O
no DT B-NP O
possibility NN I-NP O
of IN B-PP O
useful JJ B-NP O
linkage NN I-NP O
analysis NN I-NP O
. . O O

The DT B-NP O
linkage NN I-NP O
analysis NN I-NP O
required VBN B-VP O
is VBZ B-VP O
described VBN I-VP O
, , O O
and CC O O
the DT B-NP O
need NN I-NP O
to TO B-VP O
check VB I-VP O
DMD NN B-NP B-Disease
families NNS I-NP O
for IN B-PP O
informative JJ B-NP O
RFLPs NNS I-NP O
is VBZ B-VP O
stressed VBN I-VP O
. . O O

Family RB B-NP O
studies NNS I-NP O
in IN B-PP O
Bechterew NNP B-NP B-Disease
' POS B-NP I-Disease
s NN I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
ankylosing VBG B-VP B-Disease
spondylitis NN B-NP I-Disease
) ) O O
III CD B-NP O
. . O O

Genetics NNS B-NP O
. . O O

The DT B-NP O
results NNS I-NP O
of IN B-PP O
segregation NN B-NP O
analyses NNS I-NP O
in IN B-PP O
75 CD B-NP O
families NNS I-NP O
where WRB B-ADVP O
the DT B-NP O
proband NN I-NP O
had VBD B-VP O
ankylosing VBG I-VP B-Disease
spondylitis NN B-NP I-Disease
, , O O
are VBP B-VP O
presented VBN I-VP O
. . O O

Of IN B-PP O
the DT B-NP O
278 CD I-NP O
adult NN I-NP O
, , O O
living VBG B-VP O
first JJ B-NP O
degree NN I-NP O
relatives NNS I-NP O
, , O O
approximately RB B-NP O
85 CD I-NP O
% NN I-NP O
cooperated VBD B-VP O
in IN B-PP O
the DT B-NP O
study NN I-NP O
. . O O

Clinical JJ B-NP O
and CC I-NP O
radiographical JJ I-NP O
examinations NNS I-NP O
were VBD B-VP O
performed VBN I-VP O
and CC O O
HLA NN B-NP O
typing NN I-NP O
was VBD B-VP O
conducted VBN I-VP O
. . O O

The DT B-NP O
results NNS I-NP O
were VBD B-VP O
in IN B-PP O
agreement NN B-NP O
with IN B-PP O
our PRP$ B-NP O
hypothesis NN I-NP O
that IN B-SBAR O
ankylosing VBG B-VP B-Disease
spondylitis NN B-NP I-Disease
is VBZ B-VP O
part NN B-NP O
of IN B-PP O
a DT B-NP O
syndrome NN I-NP O
where WRB B-ADVP O
different JJ B-NP O
genetic JJ I-NP O
factors NNS I-NP O
interact VBP B-VP O
. . O O

Such JJ B-NP O
known VBN I-NP O
factors NNS I-NP O
are VBP B-VP O
HLA NN B-NP O
B27 NN I-NP O
associated VBN B-VP O
disease NN B-NP O
susceptibility NN I-NP O
, , O O
susceptibility NN B-NP O
to TO B-PP O
psoriatic JJ B-NP B-Disease
arthropathy NN I-NP I-Disease
and CC I-NP O
susceptibility NN I-NP O
to TO B-PP O
entero AFX B-NP B-Disease
- HYPH I-NP I-Disease
arthropathy NN I-NP I-Disease
. . O O

Radiographical JJ B-NP O
sacro AFX I-NP B-Disease
- HYPH I-NP I-Disease
iliitis NN B-NP I-Disease
was VBD B-VP O
restricted JJ B-ADJP O
to TO B-PP O
HLA NN B-NP O
B27 NN I-NP O
positive JJ I-NP O
relatives NNS I-NP O
, , O O
and CC O O
was VBD B-VP O
more RBR I-VP O
frequently RB I-VP O
found VBN I-VP O
in IN B-PP O
relatives NNS B-NP O
to TO B-PP O
probands NNS B-NP O
with IN B-PP O
psoriasis NN B-NP B-Disease
than IN B-PP O
in IN B-PP O
relatives NNS B-NP O
to TO B-PP O
probands NNS B-NP O
without IN B-PP O
psoriasis NN B-NP B-Disease
. . O O

Environmental JJ B-NP O
factors NNS I-NP O
( ( O O
intestinal JJ B-NP O
bacteria NNS I-NP O
) ) O O
are VBP B-VP O
known VBN I-VP O
to TO I-VP O
trigger VB I-VP O
the DT B-NP O
disease NN I-NP O
at IN B-ADVP O
least JJS I-ADVP O
in IN B-PP O
some DT B-NP O
persons NNS I-NP O
, , O O
and CC O O
we PRP B-NP O
have VBP B-VP O
postulated VBN I-VP O
that IN B-SBAR O
all DT B-NP O
or CC I-NP O
most JJS I-NP O
of IN B-PP O
them PRP B-NP O
have VBP B-VP O
the DT B-NP O
predisposition NN I-NP O
to TO B-VP O
develop VB I-VP O
disease NN B-NP O
. . O O

Thus RB B-ADVP O
, , O O
the DT B-NP O
syndrome NN I-NP O
has VBZ B-VP O
a DT B-NP O
multifactorial JJ I-NP O
etiology NN I-NP O
. . O O

The DT B-NP O
phenotypic JJ I-NP O
expressions NNS I-NP O
of IN B-PP O
the DT B-NP O
different JJ I-NP O
genetic JJ I-NP O
predispositions NNS I-NP O
involved VBN B-VP O
, , O O
include VBP B-VP O
sacro AFX B-NP B-Disease
- HYPH I-NP I-Disease
iliitis NN B-NP I-Disease
, , O O
psoriasis NN B-NP B-Disease
, , O O
acute JJ B-NP B-Disease
anterior JJ I-NP I-Disease
uveitis NN I-NP I-Disease
, , O O
peripheral JJ B-NP O
arthropathy NN I-NP B-Disease
and CC O O
inflammatory JJ B-NP B-Disease
bowel NN I-NP I-Disease
disease NN I-NP I-Disease
. . O O

We PRP B-NP O
suggest VBP B-VP O
the DT B-NP O
descriptive JJ I-NP O
name NN I-NP O
HEREDITARY NN I-NP B-Disease
MULTIFOCAL NN I-NP I-Disease
RELAPSING NN I-NP I-Disease
INFLAMMATION NN I-NP I-Disease
( ( O O
HEMRI NN B-NP B-Disease
) ) O O
for IN B-PP O
this DT B-NP O
syndrome NN I-NP O
. . O O

Ankylosing VBG B-NP B-Disease
spondylitis NN I-NP I-Disease
, , O O
psoriatic JJ B-NP B-Disease
arthropathy NN I-NP I-Disease
and CC O O
entero AFX O B-Disease
- HYPH O I-Disease
arthropathy NN B-NP I-Disease
may MD B-VP O
be VB I-VP O
regarded VBN I-VP O
as IN B-PP O
clinical JJ B-NP O
sub AFX I-NP O
- HYPH I-NP O
types NNS I-NP O
of IN B-PP O
the DT B-NP O
syndrome NN I-NP O
. . O O

. . O O

Prader NNP B-NP B-Disease
- HYPH I-NP I-Disease
Willi NNP I-NP I-Disease
syndrome NN I-NP I-Disease
and CC I-NP O
chromosome NN I-NP O
15 CD I-NP O
. . O O

A DT B-NP O
clinical JJ I-NP O
discussion NN I-NP O
of IN B-PP O
20 CD B-NP O
cases NNS I-NP O
. . O O

A DT B-NP O
chromosome NN I-NP B-Disease
15 CD I-NP I-Disease
anomaly RB B-ADVP I-Disease
was VBD B-VP O
observed VBN I-VP O
in IN B-PP O
12 CD B-NP O
of IN B-PP O
20 CD B-NP O
patients NNS I-NP O
, , O O
17 CD B-NP O
of IN B-PP O
whom WP B-NP O
were VBD B-VP O
clinically RB I-VP O
suspected VBN I-VP O
of IN B-PP O
having VBG B-VP O
Prader NNP B-NP B-Disease
- HYPH B-NP I-Disease
Willi NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
PWS NN B-NP B-Disease
) ) O O
. . O O

The DT B-NP O
clinical JJ I-NP O
features NNS I-NP O
of IN B-PP O
eight CD B-NP O
cases NNS I-NP O
with IN B-PP O
15q11 CD B-NP O
- HYPH I-NP O
12 CD I-NP O
deletion NN I-NP O
were VBD B-VP O
very RB B-ADJP O
similar JJ I-ADJP O
to TO B-PP O
those DT B-NP O
originally RB B-VP O
described VBN I-VP O
in IN B-PP O
PWS NN B-NP B-Disease
. . O O

On IN B-PP O
the DT B-NP O
other JJ I-NP O
hand NN I-NP O
, , O O
the DT B-NP O
group NN I-NP O
of IN B-PP O
normal JJ B-NP O
karyotype NN I-NP O
patients NNS I-NP O
is VBZ B-VP O
heterogeneous JJ B-ADJP O
, , O O
and CC O O
their PRP$ B-NP O
features NNS I-NP O
do VBP B-VP O
not RB I-VP O
strictly RB I-VP O
correspond VBP I-VP O
to TO B-PP O
the DT B-NP O
clinical JJ I-NP O
definition NN I-NP O
of IN B-PP O
PWS NN B-NP B-Disease
. . O O

However RB B-ADVP O
, , O O
the DT B-NP O
hypothesis NN I-NP O
that IN B-SBAR O
PWS NN B-NP B-Disease
is VBZ B-VP O
associated VBN I-VP O
with IN B-PP O
deletion NN B-NP O
of IN B-PP O
15q11 CD B-NP O
- HYPH I-NP O
12 CD I-NP O
can MD B-VP O
neither CC I-VP O
explain VB I-VP O
the DT B-NP O
apparently RB I-NP O
balanced JJ I-NP O
translocations NNS I-NP O
of IN B-PP O
chromosome NN B-NP O
15 CD I-NP O
nor CC O O
account VBP B-VP O
for IN B-PP O
the DT B-NP O
small JJ I-NP O
supernumerary JJ I-NP O
metacentric JJ I-NP O
chromosomes NNS I-NP O
corresponding VBG B-VP O
to TO B-PP O
an DT B-NP O
isochromosome NN I-NP O
15 CD I-NP O
for IN B-PP O
band NN B-NP O
15q11 CD I-NP O
observed VBN B-VP O
in IN B-PP O
some DT B-NP O
cases NNS I-NP O
. . O O

. . O O

The DT B-NP O
Tay NNP I-NP B-Disease
- HYPH I-NP I-Disease
Sachs NNP I-NP I-Disease
disease NN I-NP I-Disease
gene NN I-NP O
in IN B-PP O
North JJ B-NP O
American JJ I-NP O
Jewish JJ I-NP O
populations NNS I-NP O
: : O O
geographic JJ B-NP O
variations NNS I-NP O
and CC I-NP O
origin NN I-NP O
. . O O

From IN B-PP O
data NNS B-NP O
collected VBN B-VP O
in IN B-PP O
a DT B-NP O
North NNP I-NP O
American NNP I-NP O
Tay NNP I-NP B-Disease
- HYPH I-NP I-Disease
Sachs NNP I-NP I-Disease
disease NN I-NP I-Disease
( ( O O
TSD NN B-NP B-Disease
) ) O O
heterozygote NN B-NP O
screening NN I-NP O
program NN I-NP O
, , O O
the DT B-NP O
TSD NN I-NP B-Disease
carrier NN I-NP O
frequency NN I-NP O
among IN B-PP O
46 CD B-NP O
, , O O
304 CD B-NP O
Jewish JJ I-NP O
individuals NNS I-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
be VB I-VP O
. . O O

0324 CD B-NP O
( ( O O
1 CD B-NP O
in IN B-PP O
31 CD B-NP O
individuals NNS I-NP O
) ) O O
. . O O

This DT B-NP O
frequency NN I-NP O
is VBZ B-VP O
consistent JJ B-ADJP O
with IN B-PP O
earlier JJR B-NP O
estimates NNS I-NP O
based VBN B-VP O
on IN B-PP O
TSD NN B-NP B-Disease
incidence NN I-NP O
data NNS I-NP O
. . O O

TSD NN B-NP B-Disease
carrier NN I-NP O
frequencies NNS I-NP O
were VBD B-VP O
then RB I-VP O
examined VBN I-VP O
by IN B-PP O
single JJ B-NP O
country NN I-NP O
and CC O O
single JJ B-NP O
region NN I-NP O
of IN B-PP O
origin NN B-NP O
in IN B-PP O
28 CD B-NP O
, , O O
029 CD B-NP O
Jews NNS I-NP O
within IN B-PP O
this DT B-NP O
sample NN I-NP O
for IN B-PP O
whom WP B-NP O
such JJ B-NP O
data NNS I-NP O
were VBD B-VP O
available JJ B-ADJP O
for IN B-PP O
analysis NN B-NP O
. . O O

Jews NNS B-NP O
with IN B-PP O
Polish JJ O O
and CC O O
/ SYM B-NP O
or CC O O
Russian JJ B-NP O
ancestry NN I-NP O
constituted VBD B-VP O
88 CD B-NP O
% NN I-NP O
of IN B-PP O
this DT B-NP O
sample NN I-NP O
and CC O O
had VBD B-VP O
a DT B-NP O
TSD NN I-NP B-Disease
carrier NN I-NP O
frequency NN I-NP O
of IN B-PP O
. . O O

0327 CD B-NP O
. . O O

No DT B-NP O
TSD NN I-NP B-Disease
carriers NNS I-NP O
were VBD B-VP O
observed VBN I-VP O
among IN B-PP O
the DT B-NP O
166 CD I-NP O
Jews NNPS I-NP O
of IN B-PP O
Near NNP B-NP O
Eastern NNP I-NP O
origins NNS I-NP O
. . O O

Relative JJ B-ADJP O
to TO B-PP O
Jews NNS B-NP O
of IN B-PP O
Polish JJ B-NP O
and CC I-NP O
Russian JJ I-NP O
origins NNS I-NP O
, , O O
there EX B-NP O
was VBD B-VP O
at IN B-ADVP O
least JJS I-ADVP O
a DT B-NP O
twofold JJ I-NP O
increase NN I-NP O
in IN B-PP O
the DT B-NP O
TSD NN I-NP B-Disease
carrier NN I-NP O
frequency NN I-NP O
in IN B-PP O
Jews NNP B-NP O
of IN B-PP O
Austrian NNP B-NP O
, , O O
Hungarian NNP B-NP O
, , O O
and CC O O
Czechoslovakian JJ B-NP O
origins NNS I-NP O
( ( O O
P NN B-NP O
less JJR B-ADJP O
than IN B-PP O
. . B-NP O

005 CD I-NP O
) ) O O
. . O O

These DT B-NP O
findings NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
the DT B-NP O
TSD NN I-NP B-Disease
gene NN I-NP O
proliferated VBD B-VP O
among IN B-PP O
the DT B-NP O
antecedents NNS I-NP O
of IN B-PP O
modern JJ B-NP O
Ashkenazi NNP I-NP O
Jewry NNP I-NP O
after IN B-PP O
the DT B-NP O
Second NNP I-NP O
Diaspora NNP I-NP O
( ( O O
70 CD B-NP O
A NN I-NP O
. . I-NP O

D NNP I-NP O
. . O O

) ) O O
and CC O O
before IN B-SBAR O
their PRP$ B-NP O
major JJ I-NP O
migrations NNS I-NP O
to TO B-PP O
regions NNS B-NP O
of IN B-PP O
Poland NNP B-NP O
and CC I-NP O
Russia NNP I-NP O
( ( O O
before IN O O
1100 CD B-NP O
A NNP I-NP O
. . I-NP O

D NNP I-NP O
. . O O

) ) O O
. . O O

Human JJ B-NP O
deficiency NN I-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
sixth JJ I-NP I-Disease
component NN I-NP I-Disease
of IN B-PP I-Disease
complement NN B-NP I-Disease
in IN B-PP O
a DT B-NP O
patient NN I-NP O
with IN B-PP O
meningococcal JJ B-NP B-Disease
meningitis NN I-NP I-Disease
and CC O O
no DT B-NP O
haemostasis NN I-NP B-Disease
abnormality NN I-NP I-Disease
. . O O

A DT B-NP O
case NN I-NP O
of IN B-PP O
human JJ B-NP O
complete JJ I-NP O
C6 NN I-NP B-Disease
deficiency NN I-NP I-Disease
is VBZ B-VP O
reported VBN I-VP O
. . O O

The DT B-NP O
patient NN I-NP O
, , O O
a DT B-NP O
31 CD I-NP O
year NN I-NP O
old JJ I-NP O
white JJ I-NP O
male NN I-NP O
, , O O
was VBD B-VP O
seen VBN I-VP O
on IN B-PP O
the DT B-NP O
occasion NN I-NP O
of IN B-PP O
an DT B-NP O
isolated VBN I-NP O
episode NN I-NP O
of IN B-PP O
meningococcal JJ B-NP B-Disease
meningitis NN I-NP I-Disease
. . O O

Serum NN B-NP O
complement NN I-NP O
hemolytic JJ I-NP O
and CC I-NP O
bactericidal JJ I-NP O
activities NNS I-NP O
were VBD B-VP O
lacking VBG I-VP O
and CC O O
could MD B-VP O
be VB I-VP O
restored VBN I-VP O
to TO B-PP O
normal JJ B-ADJP O
by IN B-PP O
addition NN B-NP O
of IN B-PP O
appropriate JJ B-NP O
amounts NNS I-NP O
of IN B-PP O
purified VBN B-NP O
C6 NN I-NP O
. . O O

No DT B-NP O
hemostatic JJ I-NP B-Disease
abnormalities NNS I-NP I-Disease
were VBD B-VP O
observed VBN I-VP O
. . O O

. . O O

Absence NN B-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
seventh JJ I-NP I-Disease
component NN I-NP I-Disease
of IN B-PP I-Disease
complement NN B-NP I-Disease
in IN B-PP O
a DT B-NP O
patient NN I-NP O
with IN B-PP O
chronic JJ B-NP B-Disease
meningococcemia NN I-NP I-Disease
presenting VBG B-VP O
as IN B-PP O
vasculitis NN B-NP B-Disease
. . O O

A DT B-NP O
previously RB I-NP O
healthy JJ I-NP O
40 CD I-NP O
- HYPH I-NP O
year NN I-NP O
- HYPH O O
old JJ B-NP O
man NN I-NP O
presenting VBG B-VP O
with IN B-PP O
fever NN B-NP B-Disease
, , O O
arthritis NN B-NP B-Disease
, , O O
and CC O O
cutaneous JJ B-NP B-Disease
vasculitis NN I-NP I-Disease
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
have VB I-VP O
chronic JJ B-NP B-Disease
meningococcemia NN I-NP I-Disease
. . O O

Evaluation NN B-NP O
of IN B-PP O
his PRP$ B-NP O
complement NN I-NP O
system NN I-NP O
showed VBD B-VP O
an DT B-NP O
absence NN I-NP O
of IN B-PP O
functional JJ B-NP O
and CC I-NP O
antigenic JJ I-NP O
C7 NN I-NP O
, , O O
compatible JJ B-ADJP O
with IN B-PP O
a DT B-NP O
complete JJ I-NP O
deficiency NN I-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
seventh JJ I-NP I-Disease
component NN I-NP I-Disease
of IN B-PP I-Disease
complement NN B-NP I-Disease
. . O O

Study NN B-NP O
of IN B-PP O
the DT B-NP O
patients NNS I-NP O
family NN I-NP O
spanning VBG B-VP O
four CD B-NP O
generations NNS I-NP O
showed VBD B-VP O
heterozygous JJ B-NP O
deficiency NN I-NP B-Disease
of IN B-PP I-Disease
C7 NN B-NP I-Disease
in IN B-PP O
five CD B-NP O
members NNS I-NP O
. . O O

Chronic JJ B-NP B-Disease
neisserial JJ I-NP I-Disease
infection NN I-NP I-Disease
can MD B-VP O
be VB I-VP O
associated VBN I-VP O
with IN B-PP O
C7 NN B-NP B-Disease
deficiency NN I-NP I-Disease
and CC O O
must MD B-VP O
be VB I-VP O
distinguished VBN I-VP O
from IN B-PP O
other JJ B-NP O
causes NNS I-NP O
of IN B-PP O
cutaneous JJ B-NP B-Disease
vasculitis NN I-NP I-Disease
. . O O

. . O O

Familial JJ B-NP B-Disease
discoid JJ I-NP I-Disease
lupus NN I-NP I-Disease
erythematosus NN I-NP I-Disease
associated VBN B-VP O
with IN B-PP O
heterozygote NN B-NP O
C2 NN I-NP B-Disease
deficiency NN I-NP I-Disease
. . O O

Two CD B-NP O
siblings NNS I-NP O
with IN B-PP O
chronic JJ B-NP B-Disease
discoid JJ I-NP I-Disease
lupus NN I-NP I-Disease
erythematosus NN I-NP I-Disease
and CC O O
several JJ B-NP O
family NN I-NP O
members NNS I-NP O
were VBD B-VP O
found VBN I-VP O
with IN B-PP O
heterozygous JJ B-NP O
C2 NN I-NP B-Disease
deficiency NN I-NP I-Disease
. . O O

An DT B-NP O
association NN I-NP O
with IN B-PP O
histocompatibility NN B-NP O
markers NNS I-NP O
HLA NN I-NP O
- HYPH B-NP O
B18 NN I-NP O
and CC I-NP O
HLA NN I-NP O
- HYPH B-NP O
Dw2 NN I-NP O
was VBD B-VP O
demonstrated VBN I-VP O
, , O O
and CC O O
the DT B-NP O
slow JJ I-NP O
allotype NN I-NP O
of IN B-PP O
factor NN B-NP O
B NN I-NP O
was VBD B-VP O
present JJ B-ADJP O
. . O O

Linkage NN B-NP O
studies NNS I-NP O
in IN B-PP O
this DT B-NP O
family NN I-NP O
suggested VBD B-VP O
a DT B-NP O
close JJ I-NP O
linkage NN I-NP O
between IN B-PP O
the DT B-NP O
C2 NN I-NP B-Disease
deficiency NN I-NP I-Disease
gene NN I-NP O
and CC O O
genes NNS B-NP O
coding VBG B-VP O
for IN B-PP O
B18 NN B-NP O
, , O O
Dw2 NN B-NP O
, , O O
and CC O O
BfS NN B-NP O
antigens NNS I-NP O
. . O O

One CD B-NP O
HLA NN I-NP O
- HYPH B-NP O
ACB NN I-NP O
/ SYM B-NP O
DBf NN I-NP O
recombinant JJ B-ADJP O
was VBD B-VP O
observed VBN I-VP O
showing VBG B-VP O
closer JJR B-NP O
linkage NN I-NP O
between IN B-PP O
HLA NN B-NP O
- HYPH B-NP O
D NN I-NP O
and CC I-NP O
Bf NN I-NP O
than IN B-PP O
between IN B-PP O
HLA NN B-NP O
- HYPH I-NP O
B NN I-NP O
and CC I-NP O
Bf NN I-NP O
. . O O

. . O O

Severe JJ B-NP B-Disease
- HYPH I-NP I-Disease
glucose NN I-NP I-Disease
- HYPH B-NP I-Disease
6 CD I-NP I-Disease
- HYPH I-NP I-Disease
phosphate NN I-NP I-Disease
dehydrogenase NN I-NP I-Disease
( ( O I-Disease
G6PD NN B-NP I-Disease
) ) O I-Disease
deficiency NN B-NP I-Disease
associated VBN B-VP O
with IN B-PP O
chronic JJ B-NP O
hemolytic JJ I-NP B-Disease
anemia NN I-NP I-Disease
, , O O
granulocyte NN B-NP B-Disease
dysfunction NN I-NP I-Disease
, , O O
and CC O O
increased VBD B-VP O
susceptibility NN B-NP O
to TO B-PP O
infections NNS B-NP O
: : O O
description NN B-NP O
of IN B-PP O
a DT B-NP O
new JJ I-NP O
molecular JJ I-NP O
variant NN I-NP O
( ( O O
G6PD NN B-NP O
Barcelona NNP I-NP O
) ) O O
. . O O

Molecular JJ B-NP O
, , I-NP O
kinetic JJ I-NP O
, , O O
and CC O O
functional JJ B-NP O
studies NNS I-NP O
were VBD B-VP O
carried VBN I-VP O
out RP B-PRT O
on IN B-PP O
erythrocytes NNS B-NP O
and CC I-NP O
leukocytes NNS I-NP O
in IN B-PP O
a DT B-NP O
Spanish JJ I-NP O
male NN I-NP O
with IN B-PP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
, , O O
congenital JJ B-NP B-Disease
nonspherocytic JJ I-NP I-Disease
hemolytic JJ I-NP I-Disease
anemia NN I-NP I-Disease
( ( O O
CNSHA NN B-NP B-Disease
) ) O O
, , O O
and CC O O
increased VBD B-VP O
susceptibility NN B-NP O
to TO B-PP O
infections NNS B-NP O
. . O O

G6PD NN B-NP O
activity NN I-NP O
was VBD B-VP O
absent JJ B-ADJP O
in IN B-PP O
patients NNS B-NP O
red JJ B-NP O
cells NNS I-NP O
and CC O O
was VBD B-VP O
about RB B-NP O
2 CD I-NP O
% NN I-NP O
of IN B-PP O
normal JJ B-NP O
in IN B-PP O
leukocytes NNS B-NP O
. . O O

Molecular JJ B-NP O
studies NNS I-NP O
using VBG B-VP O
standard JJ B-NP O
methods NNS I-NP O
( ( O O
WHO NN B-NP O
, , O O
1967 CD B-NP O
) ) O O
showed VBD B-VP O
G6PD NN B-NP O
in IN B-PP O
the DT B-NP O
patient NN I-NP O
to TO B-VP O
have VB I-VP O
a DT B-NP O
slightly RB I-NP O
fast JJ I-NP O
electrophoretic JJ I-NP O
mobility NN I-NP O
at IN B-PP O
pH NN B-NP O
8 CD I-NP O
. . O O

0 CD B-NP O
with IN B-PP O
otherwise RB B-NP O
normal JJ I-NP O
properties NNS I-NP O
( ( O O
heat NN B-NP O
stability NN I-NP O
at IN B-PP O
46 CD B-NP O
degrees NNS I-NP O
C JJ B-NP O
, , I-NP O
apparent JJ I-NP O
affinity NN I-NP O
for IN B-PP O
substrates NNS B-NP O
, , O O
optimum JJ B-NP O
pH NN I-NP O
, , O O
and CC O O
utilization NN B-NP O
of IN B-PP O
substrate NN B-NP O
analogues NNS I-NP O
) ) O O
. . O O

Other JJ B-NP O
tests NNS I-NP O
showed VBD B-VP O
the DT B-NP O
patients NNS I-NP O
granulocytes NNS I-NP O
to TO B-VP O
engulf VB I-VP O
latex JJ B-NP O
particles NNS I-NP O
normally RB B-ADVP O
, , O O
but CC O O
to TO B-VP O
have VB I-VP O
impaired VBN I-VP O
reduction NN B-NP O
of IN B-PP O
nitroblue JJ B-NP O
tetrazolium NN I-NP O
and CC I-NP O
ferricytochrome NN I-NP O
- HYPH B-NP O
c NN I-NP O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
reduced VBN B-NP O
iodination NN I-NP O
. . O O

Chemotaxis NNP B-NP O
and CC O O
random JJ B-NP O
migration NN I-NP O
of IN B-PP O
the DT B-NP O
patients NNS I-NP O
granulocytes NNS I-NP O
were VBD B-VP O
normal JJ B-ADJP O
as IN B-SBAR O
were VBD B-VP O
myeloperoxidase NN B-NP O
, , O O
leukocyte NN B-NP O
alkaline NN I-NP O
phosphatase NN I-NP O
( ( O O
LAP NN B-NP O
) ) O O
, , O O
and CC O O
ultrastructural JJ B-NP O
features NNS I-NP O
. . O O

The DT B-NP O
molecular JJ I-NP O
characteristics NNS I-NP O
of IN B-PP O
G6PD NN B-NP O
in IN B-PP O
the DT B-NP O
patient NN I-NP O
differed VBD B-VP O
from IN B-PP O
those DT B-NP O
of IN B-PP O
all DT B-NP O
previously RB I-NP O
reported VBN I-NP O
variants NNS I-NP O
associated VBN B-VP O
with IN B-PP O
CNSHA NN B-NP B-Disease
, , O O
so IN O O
the DT B-NP O
present JJ I-NP O
variant NN I-NP O
was VBD B-VP O
provisionally RB I-VP O
called VBN I-VP O
G6PD NNP B-NP O
Barcelona NNP I-NP O
to TO B-VP O
distinguish VB I-VP O
it PRP B-NP O
from IN B-PP O
other JJ B-NP O
G6PD NN I-NP O
variants NNS I-NP O
previously RB B-VP O
described VBN I-VP O
. . O O

Possible JJ B-NP O
mechanisms NNS I-NP O
for IN B-PP O
the DT B-NP O
severe JJ I-NP O
deficiency NN I-NP B-Disease
of IN B-PP I-Disease
G6PD NN B-NP I-Disease
in IN B-PP O
erythrocytes NNS B-NP O
and CC I-NP O
granulocytes NNS I-NP O
was VBD B-VP O
investigated VBN I-VP O
by IN B-PP O
studies NNS B-NP O
on IN B-PP O
the DT B-NP O
immunologic JJ I-NP O
specific JJ I-NP O
activity NN I-NP O
of IN B-PP O
the DT B-NP O
mutant JJ I-NP O
enzyme NN I-NP O
. . O O

Glucose NN B-NP B-Disease
- HYPH B-NP I-Disease
6 CD I-NP I-Disease
- HYPH I-NP I-Disease
phosphate NN I-NP I-Disease
dehydrogenase NN I-NP I-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
Papua NNP B-NP O
New NNP I-NP O
Guinea NNP I-NP O
. . O O

The DT B-NP O
description NN I-NP O
of IN B-PP O
13 CD B-NP O
new JJ I-NP O
variants NNS I-NP O
. . O O

A DT B-NP O
total NN I-NP O
of IN B-PP O
362 CD B-NP O
males NNS I-NP O
from IN B-PP O
various JJ B-NP O
regions NNS I-NP O
of IN B-PP O
Papua NNP B-NP O
New NNP I-NP O
Guinea NNP I-NP O
were VBD B-VP O
screened VBN I-VP O
for IN B-PP O
red JJ B-NP O
cell NN I-NP O
glucose NN I-NP O
- HYPH B-NP O
6 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
dehydrogenase NN I-NP O
( ( O O
G6PD NN B-NP O
) ) O O
activity NN B-NP O
. . O O

Twenty CD B-NP O
- HYPH I-NP O
six CD I-NP O
G6PD NN I-NP B-Disease
deficient JJ I-NP I-Disease
individuals NNS I-NP O
were VBD B-VP O
identified VBN I-VP O
. . O O

Biochemical JJ B-NP O
characterization NN I-NP O
of IN B-PP O
G6PD NN B-NP O
purified VBN B-VP O
from IN B-PP O
these DT B-NP O
subjects NNS I-NP O
has VBZ B-VP O
revealed VBN I-VP O
13 CD B-NP O
new JJ I-NP O
variants NNS I-NP O
and CC O O
several JJ B-NP O
copies NNS I-NP O
of IN B-PP O
previously RB B-NP O
described VBN I-NP O
forms NNS I-NP O
of IN B-PP O
G6PD NN B-NP O
. . O O

This DT B-NP O
study NN I-NP O
illustrates VBZ B-VP O
the DT B-NP O
extreme JJ I-NP O
heterogeneity NN I-NP O
of IN B-PP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
among IN B-PP O
the DT B-NP O
people NNS I-NP O
of IN B-PP O
Papua NNP B-NP O
New NNP I-NP O
Guinea NNP I-NP O
. . O O

. . O O

Heterogeneity NN B-NP O
of IN B-PP O
Mediterranean JJ B-NP O
type NN I-NP O
glucose NN B-NP B-Disease
- HYPH I-NP I-Disease
6 CD I-NP I-Disease
- HYPH I-NP I-Disease
phosphate NN I-NP I-Disease
dehydrogenase NN I-NP I-Disease
( ( O I-Disease
G6PD NN B-NP I-Disease
) ) O I-Disease
deficiency NN B-NP I-Disease
in IN B-PP O
Spain NNP B-NP O
and CC O O
description NN B-NP O
of IN B-PP O
two CD B-NP O
new JJ I-NP O
variants NNS I-NP O
associated VBN B-VP O
with IN B-PP O
favism NN B-NP B-Disease
. . O O

Glucose NN B-NP O
- HYPH B-NP O
6 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
dehydrogenase NN I-NP O
( ( O O
G6PD NN B-NP O
) ) O O
; : O O
EC NN B-NP O
1 CD I-NP O
. . O O

1 LS B-LST O
. . O O

1 LS B-LST O
. . O O

49 CD B-NP O
from IN B-PP O
thirty CD B-NP O
- HYPH I-NP O
six CD I-NP O
unrelated JJ I-NP O
Spanish JJ I-NP O
males NNS I-NP O
was VBD B-VP O
partially RB I-VP O
purified VBN I-VP O
from IN B-PP O
blood NN B-NP O
, , O O
and CC O O
the DT B-NP O
variants NNS I-NP O
were VBD B-VP O
characterized VBN I-VP O
biochemically RB B-VP O
and CC I-VP O
electrophoretically RB I-VP O
according VBG B-PP O
to TO B-PP O
the DT B-NP O
methods NNS I-NP O
recommended VBN B-VP O
by IN B-PP O
the DT B-NP O
world NN I-NP O
Health NNP I-NP O
Organization NNP I-NP O
. . O O

Subjects NNS B-NP O
were VBD B-VP O
from IN B-PP O
multiple JJ B-NP O
geographic JJ I-NP O
regions NNS I-NP O
within IN B-PP O
Spain NNP B-NP O
, , O O
and CC O O
all DT B-NP O
suffered VBD B-VP O
from IN B-PP O
hemolytic JJ B-NP B-Disease
anemia NN I-NP I-Disease
, , O O
either CC O O
acute JJ O O
( ( O O
34 CD B-NP O
cases NNS I-NP O
) ) O O
or CC O O
chronic JJ B-NP O
nonspherocytic JJ I-NP O
( ( O O
2 CD B-NP O
cases NNS I-NP O
) ) O O
. . O O

Almost RB B-NP O
all PDT I-NP O
the DT I-NP O
variants NNS I-NP O
studied VBN B-VP O
presented VBD B-VP O
residual JJ B-NP O
erythrocyte NN I-NP O
G6PD NN I-NP O
activity NN I-NP O
ranging VBG B-VP O
from IN B-PP O
0 CD B-NP O
to TO I-NP O
10 CD I-NP O
% NN I-NP O
of IN B-PP O
normal JJ B-NP O
, , O O
and CC O O
five CD B-NP O
different JJ I-NP O
mutants NNS I-NP O
were VBD B-VP O
responsible JJ B-ADJP O
for IN B-PP O
the DT B-NP O
deficient JJ I-NP O
phenotype NN I-NP O
. . O O

Three CD B-NP O
variants NNS I-NP O
were VBD B-VP O
similar JJ B-ADJP O
to TO B-PP O
others NNS B-NP O
previously RB B-ADVP O
described VBD B-VP O
G6PD NN B-NP O
Mediterranean NN I-NP O
( ( O O
11 CD B-NP O
cases NNS I-NP O
) ) O O
, , O O
G6PD NN B-NP O
Athens NNP I-NP O
- HYPH O O
like JJ O O
( ( O O
3 CD B-NP O
cases NNS I-NP O
) ) O O
, , O O
and CC O O
G6PD NN B-NP O
Union NN I-NP O
( ( O O
2 CD B-NP O
cases NNS I-NP O
) ) O O
. . O O

The DT B-NP O
remaining VBG I-NP O
variants NNS I-NP O
were VBD B-VP O
different JJ B-ADJP O
from IN B-PP O
the DT B-NP O
numerous JJ I-NP O
variants NNS I-NP O
already RB B-VP O
reported VBN I-VP O
and CC O O
have VBP B-VP O
been VBN I-VP O
considered VBN I-VP O
as IN B-PP O
new JJ B-NP O
mutants NNS I-NP O
. . O O

Provisionally RB B-ADVP O
they PRP B-NP O
are VBP B-VP O
called VBN I-VP O
G6PD NNP B-NP O
Betica NNP I-NP O
( ( O O
19 CD B-NP O
cases NNS I-NP O
) ) O O
and CC O O
G6PD NN B-NP O
Menorca NN I-NP O
( ( O O
1 CD B-NP O
case NN I-NP O
) ) O O
. . O O

The DT B-NP O
present JJ I-NP O
study NN I-NP O
constitutes VBZ B-VP O
the DT B-NP O
first JJ I-NP O
attempt NN I-NP O
to TO B-VP O
characterize VB I-VP O
the DT B-NP O
deficient JJ I-NP B-Disease
G6PD NN I-NP I-Disease
variants NNS I-NP O
found VBN B-VP O
in IN B-PP O
Spain NNP B-NP O
and CC O O
supplies VBZ B-VP O
new JJ B-NP O
data NNS I-NP O
on IN B-PP O
the DT B-NP O
relationship NN I-NP O
between IN B-PP O
molecular JJ B-NP O
characteristics NNS I-NP O
of IN B-PP O
deficient JJ B-NP O
variants NNS I-NP O
and CC O O
their PRP$ B-NP O
clinical JJ I-NP O
manifestations NNS I-NP O
. . O O

The DT B-NP O
most RBS I-NP O
important JJ I-NP O
findings NNS I-NP O
can MD B-VP O
be VB I-VP O
summarized VBN I-VP O
as IN B-SBAR O
follows VBZ B-VP O
( ( B-LST O
1 LS I-LST O
) ) O O
The DT B-NP O
Spanish JJ I-NP O
population NN I-NP O
is VBZ B-VP O
characterized VBN I-VP O
by IN B-PP O
an DT B-NP O
important JJ I-NP O
heterogeneity NN I-NP O
in IN B-PP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
. . O O

( ( B-LST O
2 LS I-LST O
) ) O O
Although IN B-SBAR O
G6PD NN B-NP O
Mediterranean NNP I-NP O
is VBZ B-VP O
very RB B-ADJP O
frequent JJ I-ADJP O
, , O O
it PRP B-NP O
presents VBZ B-VP O
a DT B-NP O
relatively RB I-NP O
high JJ I-NP O
degree NN I-NP O
of IN B-PP O
polymorphism NN B-NP O
. . O O

( ( B-LST O
3 LS I-LST O
) ) O O
Favism NNP B-NP B-Disease
has VBZ B-VP O
been VBN I-VP O
observed VBN I-VP O
associated VBN I-VP O
with IN B-PP O
all DT B-NP O
kinds NNS I-NP O
of IN B-PP O
variants NNS B-NP O
described VBN B-VP O
here RB B-ADVP O
. . O O

( ( B-LST O
4 LS I-LST O
) ) O O
G6PD NN B-NP O
Betica NNP I-NP O
, , O O
which WDT B-NP O
is VBZ B-VP O
the DT B-NP O
most RBS I-NP O
frequent JJ I-NP O
variant NN I-NP O
found VBN B-VP O
in IN B-PP O
subjects NNS B-NP O
of IN B-PP O
Southern JJ B-NP O
Spanish JJ I-NP O
origin NN I-NP O
, , O O
has VBZ B-VP O
been VBN I-VP O
observed VBN I-VP O
associated VBN I-VP O
with IN B-PP O
favism NN B-NP B-Disease
in IN B-PP O
all DT B-NP O
cases NNS I-NP O
except IN B-PP O
one CD B-NP O
. . O O

A DT B-NP O
new JJ I-NP O
glucose NN I-NP O
- HYPH B-NP O
6 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
dehydrogenase NN I-NP O
variant NN I-NP O
( ( O O
G6PD NN B-NP O
Nagano NNP I-NP O
) ) O O
associated VBN B-VP O
with IN B-PP O
congenital JJ B-NP B-Disease
hemolytic JJ I-NP I-Disease
anemia NN I-NP I-Disease
. . O O

A DT B-NP O
new JJ I-NP O
glucose NN I-NP O
- HYPH B-NP O
6 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
dehydrogenase NN I-NP O
( ( O O
G6PD NN B-NP O
) ) O O
variant NN B-NP O
associated VBN B-VP O
with IN B-PP O
chronic JJ B-NP B-Disease
nonspherocytic JJ I-NP I-Disease
hemolytic JJ I-NP I-Disease
anemia NN I-NP I-Disease
was VBD B-VP O
reported VBN I-VP O
. . O O

The DT B-NP O
patient NN I-NP O
, , O O
a DT B-NP O
6 CD I-NP O
- HYPH I-NP O
year NN I-NP O
- HYPH O O
old JJ B-NP O
Japanese JJ I-NP O
male NN I-NP O
, , O O
was VBD B-VP O
noticed VBN I-VP O
to TO I-VP O
have VB I-VP O
hemolytic JJ B-NP B-Disease
anemia NN I-NP I-Disease
soon RB B-ADVP O
after IN B-PP O
birth NN B-NP O
, , O O
and CC O O
a DT B-NP O
diagnosis NN I-NP O
of IN B-PP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
was VBD B-VP O
made VBN I-VP O
at IN B-PP O
the DT B-NP O
age NN I-NP O
of IN B-PP O
2 CD B-NP O
. . O O

He PRP B-NP O
had VBD B-VP O
episodes NNS B-NP O
of IN B-PP O
hemolytic JJ B-NP B-Disease
crisis NN I-NP I-Disease
several JJ B-NP O
times NNS I-NP O
after IN B-PP O
upper JJ B-NP B-Disease
respiratory JJ I-NP I-Disease
infection NN I-NP I-Disease
. . O O

G6PD NN B-NP O
activity NN I-NP O
of IN B-PP O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
5 CD B-NP O
. . O O

5 CD B-NP O
% NN I-NP O
of IN B-PP O
normal JJ B-NP O
. . O O

The DT B-NP O
enzymatic JJ I-NP O
characteristics NNS I-NP O
were VBD B-VP O
examined VBN I-VP O
when WRB B-ADVP O
he PRP B-NP O
was VBD B-VP O
5 CD B-NP O
years NNS I-NP O
old JJ B-ADJP O
, , O O
and CC O O
his PRP$ B-NP O
G6PD NN I-NP O
showed VBD B-VP O
faster RBR B-ADVP O
- HYPH B-NP O
than IN B-PP O
- HYPH B-NP O
normal JJ I-NP O
electrophoretic JJ I-NP O
mobility NN I-NP O
, , O O
low JJ B-NP O
Km NN I-NP O
G6P NN I-NP O
, , O O
high JJ B-NP O
Km NN I-NP O
NADP NN I-NP O
, , O O
low JJ B-NP O
Ki NN I-NP O
NADPH NN I-NP O
, , O O
normal JJ B-NP O
utilization NN I-NP O
of IN B-PP O
substrate NN B-NP O
analogues NNS I-NP O
, , O O
heat NN B-NP O
instability NN I-NP O
, , O O
and CC O O
a DT B-NP O
normal JJ I-NP O
pH NN I-NP O
optimum JJ I-NP O
curve NN I-NP O
. . O O

From IN B-PP O
these DT B-NP O
results NNS I-NP O
, , O O
this DT B-NP O
was VBD B-VP O
considered VBN I-VP O
to TO I-VP O
be VB I-VP O
a DT B-NP O
new JJ I-NP O
variant NN I-NP O
and CC O O
was VBD B-VP O
designated VBN I-VP O
G6PD NN B-NP O
Nagano NNP I-NP O
. . O O

Infection NN B-NP O
- HYPH B-NP O
induced VBN I-NP O
hemolysis NN I-NP B-Disease
and CC I-NP O
chronic JJ I-NP B-Disease
hemolytic JJ I-NP I-Disease
anemia NN I-NP I-Disease
seem VBP B-VP O
to TO I-VP O
be VB I-VP O
due IN B-PP O
to TO B-PP O
markedly RB B-NP O
impaired JJ I-NP O
enzyme NN I-NP O
activity NN I-NP O
and CC O O
thermal JJ B-NP O
instability NN I-NP O
. . O O

Heterozygous JJ B-NP O
C2 NN I-NP B-Disease
- HYPH B-NP I-Disease
deficiency NN I-NP I-Disease
and CC I-NP O
myasthenia NN I-NP B-Disease
gravis NN I-NP I-Disease
. . O O

Complement NN B-NP B-Disease
deficiency NN I-NP I-Disease
states NNS I-NP O
in IN B-PP O
myasthenia NN B-NP B-Disease
gravis NN I-NP I-Disease
( ( O O
MG NN B-NP B-Disease
) ) O O
have VBP B-VP O
not RB I-VP O
been VBN I-VP O
reported VBN I-VP O
previously RB B-ADVP O
. . O O

We PRP B-NP O
describe VBP B-VP O
a DT B-NP O
19 CD I-NP O
- HYPH I-NP O
year NN I-NP O
- HYPH O O
old JJ B-NP O
woman NN I-NP O
with IN B-PP O
typical JJ B-NP O
MG NN I-NP B-Disease
and CC O O
heterozygous JJ B-NP O
C2 NN I-NP B-Disease
deficiency NN I-NP I-Disease
, , O O
along IN B-PP O
with IN B-PP O
HLA NN B-NP O
typing NN I-NP O
of IN B-PP O
the DT B-NP O
patient NN I-NP O
and CC O O
her PRP$ B-NP O
immediate JJ I-NP O
family NN I-NP O
. . O O

. . O O

Adrenoleukodystrophy NN B-NP B-Disease
: : O O
increased VBN B-NP O
plasma NN I-NP O
content NN I-NP O
of IN B-PP O
saturated VBN B-NP O
very RB I-NP O
long JJ I-NP O
chain NN I-NP O
fatty JJ I-NP O
acids NNS I-NP O
. . O O

With IN B-PP O
a DT B-NP O
new JJ I-NP O
method NN I-NP O
we PRP B-NP O
measured VBD B-VP O
the DT B-NP O
saturated VBN I-NP O
very RB I-NP O
long JJ I-NP O
chain NN I-NP O
fatty JJ I-NP O
acids NNS I-NP O
in IN B-PP O
the DT B-NP O
plasma NN I-NP O
of IN B-PP O
adrenoleukodystrophy NN B-NP B-Disease
( ( O O
ALD NN B-NP B-Disease
) ) O O
hemizygotes NNS B-NP O
, , O O
ALD NN B-NP B-Disease
heterozygotes NNS I-NP O
, , O O
and CC O O
controls NNS B-NP O
. . O O

ALD NN B-NP B-Disease
hemizygotes NNS I-NP O
showed VBD B-VP O
increased VBN B-NP O
levels NNS I-NP O
of IN B-PP O
hexacosanoate NN B-NP O
( ( O O
C26 NN B-NP O
fatty JJ I-NP O
acid NN I-NP O
) ) O O
which WDT B-NP O
represented VBD B-VP O
0 CD B-NP O
. . O O

081 CD B-NP O
+ SYM O O
/ SYM O O
- SYM B-NP O
0 CD B-NP O
. . O O

0066 CD B-NP O
% NN I-NP O
( ( O O
SEM NN B-NP O
) ) O O
of IN B-PP O
total JJ B-NP O
fatty JJ I-NP O
acids NNS I-NP O
, , O O
compared VBN B-VP O
to TO B-PP O
0 CD B-NP O
. . O O

015 CD B-NP O
+ SYM O O
/ SYM O O
- SYM B-NP O
0 CD B-NP O
. . O O

0032 CD B-NP O
% NN I-NP O
in IN B-PP O
the DT B-NP O
controls NNS I-NP O
. . O O

C25 NN B-NP O
, , O O
C24 NN B-NP O
, , O O
and CC O O
C23 NN B-NP O
fatty JJ I-NP O
acids NNS I-NP O
were VBD B-VP O
also RB I-VP O
increased VBN I-VP O
, , O O
but CC O O
the DT B-NP O
C22 NN I-NP O
and CC I-NP O
C20 NN I-NP O
fatty JJ I-NP O
acids NNS I-NP O
were VBD B-VP O
normal JJ B-ADJP O
. . O O

C26 NN B-NP O
levels NNS I-NP O
were VBD B-VP O
also RB I-VP O
increased VBN I-VP O
in IN B-PP O
most JJS B-NP O
ALD NN I-NP B-Disease
heterozygotes NNS I-NP O
, , O O
with IN B-PP O
a DT B-NP O
mean JJ I-NP O
level NN I-NP O
0 CD I-NP O
. . O O

057 CD B-NP O
+ SYM O O
/ SYM O O
- SYM B-NP O
0 CD B-NP O
. . O O

0063 CD B-NP O
% NN I-NP O
of IN B-PP O
total JJ B-NP O
fatty JJ I-NP O
acids NNS I-NP O
. . O O

The DT B-NP O
technique NN I-NP O
can MD B-VP O
be VB I-VP O
used VBN I-VP O
for IN B-PP O
diagnosis NN B-NP O
and CC I-NP O
carrier NN I-NP O
identification NN I-NP O
, , O O
and CC O O
in IN B-PP O
the DT B-NP O
evaluation NN I-NP O
of IN B-PP O
therapy NN B-NP O
. . O O

Abnormal JJ B-NP O
high JJ I-NP O
density NN I-NP O
lipoproteins NNS I-NP O
in IN B-PP O
cerebrotendinous JJ B-NP B-Disease
xanthomatosis NN I-NP I-Disease
. . O O

The DT B-NP O
plasma NN I-NP O
lipoprotein NN I-NP O
profiles NNS I-NP O
and CC O O
high JJ B-NP O
density NN I-NP O
lipoproteins NNS I-NP O
( ( O O
HDL NN B-NP O
) ) O O
were VBD B-VP O
characterized VBN I-VP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
the DT B-NP O
genetic JJ I-NP B-Disease
disease NN I-NP I-Disease
cerebrotendinous JJ I-NP B-Disease
xanthomatosis NN I-NP I-Disease
( ( O O
CTX NN B-NP B-Disease
) ) O O
. . O O

Abnormalities NNS B-NP B-Disease
in IN B-PP I-Disease
the DT B-NP I-Disease
HDL NN I-NP I-Disease
may MD B-VP O
contribute VB I-VP O
to TO B-PP O
their PRP$ B-NP O
increased VBN I-NP O
atherogenesis NN I-NP O
and CC O O
excessive JJ B-NP O
deposits NNS I-NP O
of IN B-PP O
tissue NN B-NP O
sterols NNS I-NP O
in IN B-PP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
low JJ B-NP O
or CC I-NP O
low JJ I-NP O
- HYPH I-NP O
normal JJ I-NP O
concentrations NNS I-NP O
of IN B-PP O
plasma NN B-NP O
cholesterol NN I-NP O
( ( O O
165 CD B-NP O
+ SYM O O
/ SYM O O
- SYM O O
25 CD B-NP O
mg NN I-NP O
/ SYM B-NP O
dl NN I-NP O
) ) O O
and CC O O
low JJ B-NP O
density NN I-NP O
lipoproteins NNS I-NP O
( ( O O
LDL NN B-NP O
) ) O O
. . O O

The DT B-NP O
mean JJ I-NP O
HDL NN I-NP O
- HYPH B-NP O
cholesterol NN I-NP O
concentration NN I-NP O
in IN B-PP O
the DT B-NP O
CTX NN I-NP B-Disease
plasmas NN I-NP O
was VBD B-VP O
14 CD B-NP O
. . O O

5 CD B-NP O
+ SYM O O
/ SYM O O
- SYM B-NP O
3 CD I-NP O
. . O O

2 CD B-NP O
mg NN I-NP O
/ SYM B-NP O
dl NN I-NP O
, , O O
about RB B-NP O
one CD I-NP O
- HYPH I-NP O
third JJ I-NP O
the DT B-NP O
normal JJ I-NP O
value NN I-NP O
. . O O

The DT B-NP O
low JJ I-NP O
HDL NN I-NP O
- HYPH O O
cholesterol NN B-NP O
reflects VBZ B-VP O
a DT B-NP O
low JJ I-NP O
concentration NN I-NP O
and CC O O
an DT B-NP O
abnormal JJ I-NP O
lipid NN I-NP O
composition NN I-NP O
of IN B-PP O
the DT B-NP O
plasma NN I-NP O
HDL NN I-NP O
. . O O

Relative JJ B-ADJP O
to TO B-PP O
normal JJ B-NP O
HDL NN I-NP O
, , O O
the DT B-NP O
cholesteryl NN I-NP O
esters NNS I-NP O
are VBP B-VP O
low JJ B-NP O
, , I-NP O
free JJ I-NP O
cholesterol NN I-NP O
and CC I-NP O
phospholipids NNS I-NP O
essentially RB B-ADJP O
normal JJ I-ADJP O
, , O O
and CC O O
triglycerides NNS B-NP O
increased VBD B-VP O
. . O O

The DT B-NP O
ratio NN I-NP O
of IN B-PP O
apoprotein NN B-NP O
( ( O O
apo NN B-NP O
) ) O O
to TO B-PP O
total JJ B-NP O
cholesterol NN I-NP O
in IN B-PP O
the DT B-NP O
HDL NN I-NP O
of IN B-PP O
CTX NN B-NP B-Disease
was VBD B-VP O
two CD B-NP O
to TO I-NP O
three CD I-NP O
times NNS I-NP O
greater JJR I-NP O
than IN B-PP O
normal JJ B-ADJP O
. . O O

In IN B-PP O
the DT B-NP O
CTX NN I-NP B-Disease
HDL NN I-NP O
, , O O
the DT B-NP O
ratio NN I-NP O
of IN B-PP O
apoAI NN B-NP O
to TO B-PP O
apoAII NN B-NP O
was VBD B-VP O
high JJ B-ADJP O
, , O O
the DT B-NP O
proportion NN I-NP O
of IN B-PP O
apoC NN B-NP O
low JJ I-NP O
, , O O
and CC O O
a DT B-NP O
normally RB I-NP O
minor JJ I-NP O
form NN I-NP O
of IN B-PP O
apoAI NN B-NP O
increased VBD B-VP O
relative JJ B-ADVP O
to TO B-PP O
other JJ B-NP O
forms NNS I-NP O
. . O O

The DT B-NP O
HDL NN I-NP O
in IN B-PP O
electron NN B-NP O
micrographs NNS I-NP O
appeared VBD B-VP O
normal JJ B-ADJP O
morphologically RB B-ADVP O
and CC O O
in IN B-PP O
particle NN B-NP O
size NN I-NP O
. . O O

The DT B-NP O
abnormalities NNS I-NP O
in IN B-PP O
lipoprotein NN B-NP O
distribution NN I-NP O
profile NN I-NP O
and CC I-NP O
composition NN I-NP O
of IN B-PP O
the DT B-NP O
plasma NN I-NP O
HDL NN I-NP O
result VBP B-VP O
from IN B-PP O
metabolic JJ B-NP O
defects NNS I-NP O
that WDT B-NP O
are VBP B-VP O
not RB I-VP O
understood VBN I-VP O
but CC O O
may MD B-VP O
be VB I-VP O
linked VBN I-VP O
to TO B-PP O
the DT B-NP O
genetic JJ I-NP B-Disease
defect NN I-NP I-Disease
in IN B-PP O
bile NN B-NP O
acid NN I-NP O
synthesis NN I-NP O
in IN B-PP O
CTX NN B-NP B-Disease
. . O O

As IN B-PP O
a DT B-NP O
consequence NN I-NP O
, , O O
it PRP B-NP O
is VBZ B-VP O
probable JJ B-ADJP O
that IN B-SBAR O
the DT B-NP O
normal JJ I-NP O
functions NNS I-NP O
of IN B-PP O
the DT B-NP O
HDL NN I-NP O
, , O O
possibly RB B-ADVP O
including VBG B-PP O
modulation NN B-NP O
of IN B-PP O
LDL NN B-NP O
- HYPH B-NP O
cholesterol NN I-NP O
uptake NN I-NP O
and CC O O
the DT B-NP O
removal NN I-NP O
of IN B-PP O
excess JJ B-NP O
cholesterol NN I-NP O
from IN B-PP O
peripheral JJ B-NP O
tissues NNS I-NP O
, , O O
are VBP B-VP O
perturbed VBN I-VP O
significantly RB B-ADVP O
in IN B-PP O
this DT B-NP O
disease NN I-NP O
. . O O

Genetics NNS B-NP O
of IN B-PP O
cerebrotendinous JJ B-NP B-Disease
xanthomatosis NN I-NP I-Disease
( ( O O
CTX NN B-NP B-Disease
) ) O O
: : O O
an DT B-NP O
autosomal JJ I-NP O
recessive JJ I-NP O
trait NN I-NP O
with IN B-PP O
high JJ B-NP O
gene NN I-NP O
frequency NN I-NP O
in IN B-PP O
Sephardim NN B-NP O
of IN B-PP O
Moroccan NNP B-NP O
origin NN I-NP O
. . O O

We PRP B-NP O
described VBD B-VP O
6 CD B-NP O
patients NNS I-NP O
( ( O O
from IN B-PP O
3 CD B-NP O
families NNS I-NP O
) ) O O
affected VBN B-VP O
with IN B-PP O
cerebrotendinous JJ B-NP B-Disease
xanthomatosis NN I-NP I-Disease
( ( O O
CTX NN B-NP B-Disease
) ) O O
. . O O

All DT B-NP O
are VBP B-VP O
Sephardic JJ B-NP O
Jews NNS I-NP O
of IN B-PP O
Moroccan NN B-NP O
extraction NN I-NP O
. . O O

In IN B-PP O
view NN B-NP O
of IN B-PP O
the DT B-NP O
small JJ I-NP O
number NN I-NP O
of IN B-PP O
CTX NN B-NP B-Disease
patients NNS I-NP O
diagnosed VBN B-VP O
in IN B-PP O
the DT B-NP O
world NN I-NP O
( ( O O
a DT B-NP O
total NN I-NP O
of IN B-PP O
50 CD B-NP O
including VBG B-PP O
our PRP$ B-NP O
6 CD I-NP O
patients NNS I-NP O
) ) O O
, , O O
we PRP B-NP O
are VBP B-VP O
probably RB I-VP O
dealing VBG I-VP O
with IN B-PP O
an DT B-NP O
ethnic JJ I-NP O
subgroup NN I-NP O
with IN B-PP O
a DT B-NP O
high JJ I-NP O
CTX NN I-NP O
gene NN I-NP O
frequency NN I-NP O
, , O O
which WDT B-NP O
we PRP B-NP O
have VBP B-VP O
estimated VBN I-VP O
to TO I-VP O
be VB I-VP O
1 CD B-NP O
/ SYM I-NP O
108 CD I-NP O
. . O O

Since IN B-SBAR O
there EX B-NP O
are VBP B-VP O
differences NNS B-NP O
in IN B-PP O
expression NN B-NP O
in IN B-PP O
this DT B-NP O
disease NN I-NP O
, , O O
we PRP B-NP O
recommend VBP B-VP O
cholestanol NN B-NP O
study NN I-NP O
in IN B-PP O
cases NNS B-NP O
of IN B-PP O
undiagnosed JJ B-NP O
cataract NN I-NP B-Disease
or CC O O
tendinous JJ B-NP B-Disease
xanthomas NNS I-NP I-Disease
in IN B-PP O
childhood NN B-NP O
or CC O O
early JJ B-NP O
adolescence NN I-NP O
. . O O

The DT B-NP O
diagnosis NN I-NP O
in IN B-PP O
CTX NN B-NP B-Disease
is VBZ B-VP O
important JJ B-ADJP O
not RB B-CONJP O
only RB I-CONJP O
for IN B-PP O
genetic JJ B-NP O
counseling NN I-NP O
, , O O
but CC B-CONJP O
also RB I-CONJP O
in IN B-PP O
veiw NN B-NP O
of IN B-PP O
possible JJ B-NP O
treatment NN I-NP O
. . O O

. . O O

New JJ B-NP O
genetic JJ I-NP O
variants NNS I-NP O
of IN B-PP O
glucose NN B-NP O
6 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
dehydrogenase NN I-NP O
( ( O O
G6PD NN B-NP O
) ) O O
in IN B-PP O
Italy NNP B-NP O
. . O O

Six CD B-NP O
new JJ I-NP O
variants NNS I-NP O
of IN B-PP O
human JJ B-NP O
erythrocyte NN I-NP O
G6PD NN I-NP O
have VBP B-VP O
been VBN I-VP O
characterized VBN I-VP O
. . O O

All DT B-NP O
of IN B-PP O
them PRP B-NP O
were VBD B-VP O
found VBN I-VP O
in IN B-PP O
Italian JJ B-NP O
males NNS I-NP O
and CC O O
all DT B-NP O
were VBD B-VP O
associated VBN I-VP O
with IN B-PP O
enzyme NN B-NP B-Disease
deficiency NN I-NP I-Disease
, , O O
but CC O O
only RB B-NP O
two CD I-NP O
with IN B-PP O
signs NNS B-NP O
of IN B-PP O
haemolysis NN B-NP B-Disease
. . O O

These DT B-NP O
and CC O O
other JJ B-NP O
variants NNS I-NP O
reported VBN B-VP O
in IN B-PP O
the DT B-NP O
literature NN I-NP O
, , O O
which WDT B-NP O
must MD B-VP O
thus RB I-VP O
far RB I-VP O
be VB I-VP O
regarded VBN I-VP O
as IN B-PP O
sporadic JJ B-ADJP O
, , O O
are VBP B-VP O
found VBN I-VP O
to TO I-VP O
map VB I-VP O
in IN B-PP O
parts NNS B-NP O
of IN B-PP O
Italy NNP B-NP O
where WRB B-ADVP O
common JJ B-NP O
types NNS I-NP O
of IN B-PP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
are VBP B-VP O
also RB B-ADVP O
prevalent JJ B-ADJP O
. . O O

. . O O

Variants NNS B-NP O
of IN B-PP O
erythrocyte NN B-NP O
glucose NN I-NP O
- HYPH B-NP O
6 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
dehydrogenase NN I-NP O
( ( O O
G6PD NN B-NP O
) ) O O
in IN B-PP O
Bulgarian JJ B-NP O
populations NNS I-NP O
. . O O

Ten CD B-NP O
variants NNS I-NP O
of IN B-PP O
erythrocyte NN B-NP O
glucose NN I-NP O
- HYPH B-NP O
6 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
dehydrogenase NN I-NP O
were VBD B-VP O
identified VBN I-VP O
in IN B-PP O
22 CD B-NP O
patients NNS I-NP O
with IN B-PP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
from IN B-PP O
three CD B-NP O
districts NNS I-NP O
of IN B-PP O
Bulgaria NNP B-NP O
. . O O

Corinth NN B-NP O
- HYPH B-NP O
like JJ I-NP O
and CC I-NP O
Fayoum NN I-NP O
- HYPH B-NP O
like JJ I-NP O
variants NNS I-NP O
were VBD B-VP O
the DT B-NP O
most RBS I-NP O
frequent JJ I-NP O
; : O O
Mediterranean NNP B-NP O
, , O O
Ohut NNP B-NP O
II NNP I-NP O
, , O O
Kilgore NNP B-NP O
, , O O
Boston NNP B-NP O
, , O O
Poznan NNP B-NP O
, , O O
and CC O O
Panay NNP B-NP O
variants NNS I-NP O
and CC O O
two CD B-NP O
new JJ I-NP O
variants NNS I-NP O
, , O O
Petrich NNP B-NP O
and CC O O
Gotze NNP B-NP O
Delchev NNP I-NP O
, , O O
were VBD B-VP O
each DT B-NP O
found VBN B-VP O
in IN B-PP O
one CD B-NP O
or CC I-NP O
two CD I-NP O
carriers NNS I-NP O
. . O O

No DT B-NP O
correlation NN I-NP O
was VBD B-VP O
revealed VBN I-VP O
between IN B-PP O
clinical JJ B-NP O
and CC I-NP O
biochemical JJ I-NP O
polymorphism NN I-NP O
. . O O

. . O O

Nephropathy NN B-NP B-Disease
in IN B-PP O
the DT B-NP O
Wiskott NNP I-NP B-Disease
- HYPH I-NP I-Disease
Aldrich NNP I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

Nephropathy NN B-NP B-Disease
was VBD B-VP O
detected VBN I-VP O
in IN B-PP O
five CD B-NP O
of IN B-PP O
32 CD B-NP O
patients NNS I-NP O
with IN B-PP O
the DT B-NP O
Wiskott NNP I-NP B-Disease
- HYPH I-NP I-Disease
Aldrich NNP I-NP I-Disease
syndrome NN I-NP I-Disease
who WP B-NP O
were VBD B-VP O
participating VBG I-VP O
in IN B-PP O
a DT B-NP O
study NN I-NP O
of IN B-PP O
transfer NN B-NP O
factor NN I-NP O
( ( O O
TF NN B-NP O
) ) O O
therapy NN B-NP O
. . O O

In IN B-PP O
two CD B-NP O
patients NNS I-NP O
, , O O
nephropathy NN B-NP B-Disease
was VBD B-VP O
present JJ B-ADJP O
before IN B-PP O
TF NN B-NP O
and CC O O
did VBD B-VP O
not RB I-VP O
appear VB I-VP O
changed VBN I-VP O
by IN B-PP O
TF NN B-NP O
therapy NN I-NP O
. . O O

One CD B-NP O
of IN B-PP O
these DT B-NP O
patients NNS I-NP O
subsequently RB B-ADVP O
developed VBD B-VP O
progressive JJ B-NP O
renal JJ I-NP B-Disease
failure NN I-NP I-Disease
requiring VBG I-NP O
dialysis NN I-NP O
beginning VBG B-VP O
5 CD B-NP O
1 CD I-NP O
/ SYM B-NP O
2 CD B-NP O
years NNS I-NP O
after IN B-PP O
TF NN B-NP O
therapy NN I-NP O
. . O O

In IN B-PP O
two CD B-NP O
patients NNS I-NP O
, , O O
decreased VBD B-VP O
renal JJ B-NP O
function NN I-NP O
appeared VBD B-VP O
very RB B-ADVP O
soon RB I-ADVP O
after IN B-SBAR O
the DT B-NP O
administration NN I-NP O
of IN B-PP O
TF NN B-NP O
. . O O

One CD B-NP O
patient NN I-NP O
showed VBD B-VP O
gradually RB I-VP O
decreasing VBG I-VP O
renal JJ B-NP O
function NN I-NP O
beginning VBG B-VP O
after IN B-PP O
two CD B-NP O
years NNS I-NP O
of IN B-PP O
TF NN B-NP O
therapy NN I-NP O
. . O O

An DT B-NP O
additional JJ I-NP O
patient NN I-NP O
was VBD B-VP O
identified VBN I-VP O
who WP B-NP O
died VBD B-VP O
with IN B-PP O
renal JJ B-NP B-Disease
failure NN I-NP I-Disease
without IN B-PP O
having VBG B-VP O
received VBN B-NP O
TF NN I-NP O
. . O O

The DT B-NP O
results NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
renal JJ B-NP B-Disease
failure NN I-NP I-Disease
occurs VBZ B-VP O
in IN B-PP O
the DT B-NP O
Wiskott NNP I-NP B-Disease
- HYPH I-NP I-Disease
Aldrich NNP I-NP I-Disease
syndrome NN I-NP I-Disease
more RBR B-ADVP O
frequently RB I-ADVP O
than IN B-SBAR O
generally RB B-ADVP O
recognized VBN B-VP O
and CC O O
that IN B-SBAR O
administration NN B-NP O
of IN B-PP O
TF NN B-NP O
may MD B-VP O
precipitate VB I-VP O
or CC I-VP O
accelerate VB I-VP O
the DT B-NP O
renal JJ I-NP B-Disease
disease NN I-NP I-Disease
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
this DT B-NP O
syndrome NN I-NP O
. . O O

. . O O

Wiskott NNP B-NP B-Disease
- HYPH I-NP I-Disease
Aldrich NNP I-NP I-Disease
syndrome NN I-NP I-Disease
: : O O
cellular JJ B-NP O
impairments NNS I-NP O
and CC O O
their PRP$ B-NP O
implication NN I-NP O
for IN B-PP O
carrier NN B-NP O
detection NN I-NP O
. . O O

A DT B-NP O
family NN I-NP O
in IN B-PP O
which WDT B-NP O
two CD B-NP O
male JJ I-NP O
siblings NNS I-NP O
were VBD B-VP O
affected VBN I-VP O
with IN B-PP O
Wiskott NNP B-NP B-Disease
- HYPH I-NP I-Disease
Aldrich NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
WAS NN B-NP B-Disease
) ) O O
was VBD B-VP O
studied VBN I-VP O
using VBG B-VP O
G NN B-NP O
- HYPH O O
6 CD B-NP O
- HYPH I-NP O
PD NN I-NP O
isoenzymes NNS I-NP O
as IN B-PP O
an DT B-NP O
X NN I-NP O
- HYPH B-VP O
linked VBN B-NP O
marker NN I-NP O
in IN B-SBAR O
order NN O O
to TO B-VP O
investigate VB I-VP O
the DT B-NP O
nature NN I-NP O
of IN B-PP O
cellular JJ B-NP O
abnormalities NNS I-NP O
. . O O

Isolated VBN B-NP O
peripheral JJ I-NP O
blood NN I-NP O
cell NN I-NP O
types NNS I-NP O
from IN B-PP O
the DT B-NP O
doubly RB I-NP O
heterozygous JJ I-NP O
mother NN I-NP O
of IN B-PP O
the DT B-NP O
affected VBN I-NP O
males NNS I-NP O
seemingly RB B-ADVP O
failed VBD B-VP O
to TO I-VP O
express VB I-VP O
the DT B-NP O
G NN I-NP O
- HYPH B-NP O
6 CD I-NP O
- HYPH I-NP O
PD NN I-NP O
allele NN I-NP O
in IN B-PP O
cis NN B-NP O
position NN I-NP O
with IN B-PP O
the DT B-NP O
WAS NNP I-NP B-Disease
allele NN I-NP O
while IN B-SBAR O
her PRP$ B-NP O
cultured VBN I-NP O
skin NN I-NP O
fibroblasts NNS I-NP O
expressed VBD B-VP O
both CC O O
G NN B-NP O
- HYPH B-NP O
6 CD I-NP O
- HYPH I-NP O
PD NN I-NP O
alleles NNS I-NP O
. . O O

Additionally RB B-ADVP O
, , O O
a DT B-NP O
histogram NN I-NP O
analysis NN I-NP O
of IN B-PP O
platelet NN B-NP O
size NN I-NP O
revealed VBD B-VP O
a DT B-NP O
single JJ I-NP O
population NN I-NP O
of IN B-PP O
abnormally RB B-NP O
small JJ I-NP O
platelets NNS I-NP O
in IN B-PP O
the DT B-NP O
affected VBN I-NP O
propositus NN I-NP O
, , O O
whereas IN O O
the DT B-NP O
heterozygous JJ I-NP O
mother NN I-NP O
had VBD B-VP O
no DT B-NP O
appreciable JJ I-NP O
small JJ I-NP O
platelet NN I-NP O
subpopulation NN I-NP O
. . O O

In FW B-NP O
vitro FW I-NP O
culture NN I-NP O
of IN B-PP O
hemopoietic JJ B-NP O
progenitor NN I-NP O
cells NNS I-NP O
of IN B-PP O
the DT B-NP O
heterozygous JJ I-NP O
mother NN I-NP O
showed VBD B-VP O
that IN B-SBAR O
the DT B-NP O
majority NN I-NP O
of IN B-PP O
progenitor NN B-NP O
cells NNS I-NP O
did VBD B-VP O
not RB I-VP O
express VB I-VP O
the DT B-NP O
WAS NNP I-NP B-Disease
allele NN I-NP O
. . O O

However RB B-ADVP O
, , O O
a DT B-NP O
small JJ I-NP O
number NN I-NP O
of IN B-PP O
cells NNS B-NP O
expressing VBG B-VP O
the DT B-NP O
G NN I-NP O
- HYPH B-NP O
6 CD I-NP O
- HYPH I-NP O
PD NN I-NP O
type NN I-NP O
linked VBN B-VP O
with IN B-PP O
the DT B-NP O
WAS NN I-NP B-Disease
allele NN I-NP O
were VBD B-VP O
detected VBN I-VP O
. . O O

The DT B-NP O
proportion NN I-NP O
of IN B-PP O
the DT B-NP O
latter JJ I-NP O
progenitors NNS I-NP O
was VBD B-VP O
significantly RB B-ADJP O
higher JJR I-ADJP O
among IN B-PP O
more JJR B-NP O
primitive JJ I-NP O
progenitors NNS I-NP O
( ( O O
those DT B-NP O
giving VBG I-NP O
rise NN I-NP O
to TO B-PP O
later RB B-VP O
appearing VBG I-VP O
colonies NNS B-NP O
) ) O O
. . O O

This DT B-NP O
observation NN I-NP O
suggests VBZ B-VP O
that IN B-SBAR O
selection NN B-NP O
against IN B-PP O
cells NNS B-NP O
expressing VBG B-VP O
the DT B-NP O
Wiskott NNP I-NP B-Disease
- HYPH I-NP I-Disease
Aldrich NNP I-NP I-Disease
defect NN I-NP I-Disease
takes VBZ B-VP O
place NN B-NP O
in IN B-PP O
the DT B-NP O
hemopoietic JJ I-NP O
system NN I-NP O
of IN B-PP O
the DT B-NP O
heterozygous JJ I-NP O
female NN I-NP O
and CC O O
offers VBZ B-VP O
a DT B-NP O
possible JJ I-NP O
means NNS I-NP O
of IN B-PP O
carrier NN B-NP O
detection NN I-NP O
in IN B-PP O
some DT B-NP O
women NNS I-NP O
. . O O

Linkage NN B-NP O
studies NNS I-NP O
in IN B-PP O
this DT B-NP O
family NN I-NP O
revealed VBD B-VP O
one CD B-NP O
example NN I-NP O
of IN B-PP O
probable JJ B-NP O
recombination NN I-NP O
between IN B-PP O
the DT B-NP O
loci NNS I-NP O
for IN B-PP O
WAS NN B-NP B-Disease
and CC I-NP O
G NN I-NP O
- HYPH B-NP O
6 CD I-NP O
- HYPH I-NP O
PD NN I-NP O
among IN B-PP O
three CD B-NP O
informative JJ I-NP O
subjects NNS I-NP O
, , O O
suggesting VBG B-VP O
that IN B-SBAR O
these DT B-NP O
two CD I-NP O
loci NNS I-NP O
may MD B-VP O
not RB I-VP O
be VB I-VP O
closely RB I-VP O
linked VBN I-VP O
on IN B-PP O
the DT B-NP O
X NN I-NP O
- HYPH B-NP O
chromosome NN I-NP O
. . O O

. . O O

A DT B-NP O
new JJ I-NP O
CT NN I-NP O
pattern NN I-NP O
in IN B-PP O
adrenoleukodystrophy NN B-NP B-Disease
. . O O

A DT B-NP O
new JJ I-NP O
CT NN I-NP O
pattern NN I-NP O
was VBD B-VP O
observed VBN I-VP O
in IN B-PP O
2 CD B-NP O
patients NNS I-NP O
with IN B-PP O
adrenoleukodystrophy NN B-NP B-Disease
( ( O O
ALD NN B-NP B-Disease
) ) O O
. . O O

This DT B-NP O
pattern NN I-NP O
, , O O
which WDT B-NP O
the DT B-NP O
authors NNS I-NP O
call VBP B-VP O
Type NN B-NP O
II CD I-NP O
, , O O
is VBZ B-VP O
characterized VBN I-VP O
by IN B-PP O
the DT B-NP O
absence NN I-NP O
of IN B-PP O
posterior JJ B-NP O
periventricular JJ I-NP O
areas NNS I-NP O
of IN B-PP O
decreased VBN B-NP O
attenuation NN I-NP O
around IN B-PP O
the DT B-NP O
trigone NN I-NP O
on IN B-PP O
non AFX B-NP O
- HYPH I-NP O
contrast NN I-NP O
scans NNS I-NP O
after IN B-PP O
contrast NN B-NP O
infusion NN I-NP O
, , O O
however RB B-ADVP O
, , O O
there EX B-NP O
is VBZ B-VP O
striking JJ B-NP O
enhancement NN I-NP O
of IN B-PP O
various JJ B-NP O
white JJ I-NP O
- HYPH I-NP O
matter NN I-NP O
structures NNS I-NP O
( ( O O
tracts NNS B-NP O
or CC O O
fiber NN B-NP O
systems NNS I-NP O
) ) O O
such JJ B-PP O
as IN I-PP O
the DT B-NP O
internal JJ I-NP O
capsules NNS I-NP O
, , O O
corpus NN B-NP O
callosum NN I-NP O
, , O O
corona NN B-NP O
radiata NN I-NP O
, , O O
forceps VBZ B-VP O
major JJ B-ADJP O
, , O O
and CC O O
cerebral JJ B-NP O
peduncles NNS I-NP O
. . O O

This DT B-NP O
is VBZ B-VP O
different JJ B-ADJP O
from IN B-PP O
numerous JJ B-NP O
previous JJ I-NP O
descriptions NNS I-NP O
of IN B-PP O
the DT B-NP O
CT NN I-NP O
pattern NN I-NP O
in IN B-PP O
ALD NN B-NP B-Disease
. . O O

Type NN B-NP B-Disease
II CD I-NP I-Disease
ALD NN I-NP I-Disease
does VBZ B-VP O
not RB I-VP O
appear VB I-VP O
to TO I-VP O
have VB I-VP O
been VBN I-VP O
seen VBN I-VP O
in IN B-PP O
any DT B-NP O
other JJ I-NP O
leukoencephalopathy NN I-NP B-Disease
and CC O O
is VBZ B-VP O
probably RB B-ADVP O
specific JJ B-ADJP O
for IN B-PP O
a DT B-NP O
phenotypic JJ I-NP O
variant NN I-NP O
or CC O O
an DT B-NP O
evolving VBG I-NP O
stage NN I-NP O
of IN B-PP O
ALD NN B-NP B-Disease
. . O O

. . O O

Further JJ B-NP O
evidence NN I-NP O
for IN B-PP O
heterogeneity NN B-NP O
of IN B-PP O
glucose NN B-NP B-Disease
- HYPH B-NP I-Disease
6 CD I-NP I-Disease
- HYPH I-NP I-Disease
phosphate NN I-NP I-Disease
dehydrogenase NN I-NP I-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
Papua NNP B-NP O
New NNP I-NP O
Guinea NNP I-NP O
. . O O

Four CD B-NP O
new JJ I-NP O
G6PD NN I-NP O
variants NNS I-NP O
have VBP B-VP O
been VBN I-VP O
characterized VBN I-VP O
in IN B-PP O
individuals NNS B-NP O
from IN B-PP O
Papua NNP B-NP O
New NNP I-NP O
Guinea NNP I-NP O
. . O O

This DT B-NP O
study NN I-NP O
demonstrates VBZ B-VP O
that IN B-SBAR O
the DT B-NP O
previously RB I-NP O
reported VBN I-NP O
Markham NNP I-NP O
variant NN I-NP O
and CC O O
the DT B-NP O
newly RB I-NP O
characterized VBN I-NP O
Salata NNP I-NP O
variant NN I-NP O
may MD B-VP O
be VB I-VP O
widely RB I-VP O
distributed VBN I-VP O
in IN B-PP O
Papua NNP B-NP O
New NNP I-NP O
Guinea NNP I-NP O
. . O O

Th NN B-NP O
data NNS I-NP O
presented VBN B-VP O
here RB B-ADVP O
together RB B-ADVP O
with IN B-PP O
those DT B-NP O
of IN B-PP O
previously RB B-NP O
published VBN I-NP O
studies NNS I-NP O
demonstrate VBP B-VP O
a DT B-NP O
degree NN I-NP O
of IN B-PP O
heterogeneity NN B-NP O
of IN B-PP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
that WDT B-NP O
is VBZ B-VP O
much RB B-ADJP O
higher JJR I-ADJP O
than IN B-PP O
that DT B-NP O
in IN B-PP O
other JJ B-NP O
regions NNS I-NP O
of IN B-PP O
the DT B-NP O
world NN I-NP O
where WRB B-ADVP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
is VBZ B-VP O
common JJ B-ADJP O
. . O O

. . O O

Increased VBN B-NP O
incidence NN I-NP O
of IN B-PP O
cataracts NNS B-NP B-Disease
in IN B-PP O
male JJ B-NP O
subjects NNS I-NP O
deficient JJ B-ADJP B-Disease
in IN B-PP I-Disease
glucose NN B-NP I-Disease
- HYPH B-NP I-Disease
6 CD I-NP I-Disease
- HYPH I-NP I-Disease
phosphate NN I-NP I-Disease
dehydrogenase NN I-NP I-Disease
. . O O

Glucose NN B-NP B-Disease
- HYPH B-NP I-Disease
6 CD I-NP I-Disease
- HYPH I-NP I-Disease
phosphate NN I-NP I-Disease
dehydrogenase NN I-NP I-Disease
( ( O I-Disease
G6PD NN B-NP I-Disease
) ) O I-Disease
deficiency NN B-NP I-Disease
in IN B-PP O
RBCs NNS B-NP O
was VBD B-VP O
found VBN I-VP O
significantly RB B-ADVP O
more RBR I-ADVP O
frequently RB I-ADVP O
in IN B-PP O
210 CD B-NP O
male JJ I-NP O
cataractous JJ I-NP B-Disease
patients NNS I-NP O
than IN B-PP O
in IN B-PP O
672 CD B-NP O
control NN I-NP O
subjects NNS I-NP O
of IN B-PP O
Sardinian JJ B-NP O
origin NN I-NP O
. . O O

The DT B-NP O
frequency NN I-NP O
of IN B-PP O
the DT B-NP O
deficiency NN I-NP O
was VBD B-VP O
increasingly RB B-ADJP O
higher JJR I-ADJP O
in IN B-PP O
presenile JJ B-NP O
cataracts NNS I-NP B-Disease
. . O O

In IN B-PP O
the DT B-NP O
G6PD NN I-NP B-Disease
- HYPH B-NP I-Disease
deficient JJ I-NP I-Disease
group NN I-NP O
, , O O
the DT B-NP O
incidence NN I-NP O
of IN B-PP O
cortical JJ B-NP B-Disease
and CC I-NP I-Disease
total JJ I-NP I-Disease
cataracts NNS I-NP I-Disease
was VBD B-VP O
also RB I-VP O
increased VBN I-VP O
. . O O

It PRP B-NP O
is VBZ B-VP O
suggested VBN I-VP O
that IN B-SBAR O
decrease NN B-NP O
of IN B-PP O
the DT B-NP O
G6PD NN I-NP O
activity NN I-NP O
in IN B-PP O
the DT B-NP O
lens NN I-NP O
, , O O
which WDT B-NP O
accompanies VBZ B-VP O
its PRP$ B-NP O
deficiency NN I-NP O
in IN B-PP O
the DT B-NP O
erythrocyte NN I-NP O
, , O O
might MD B-VP O
play VB I-VP O
a DT B-NP O
role NN I-NP O
in IN B-PP O
the DT B-NP O
cataracto AFX I-NP O
- HYPH I-NP O
genesis NN I-NP O
of IN B-PP O
these DT B-NP O
patients NNS I-NP O
. . O O

Moreover RB B-ADVP O
, , O O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
should MD B-VP O
be VB I-VP O
added VBN I-VP O
to TO B-PP O
other JJ B-NP O
conditions NNS I-NP O
, , O O
such JJ B-PP O
as IN I-PP O
the DT B-NP O
galactosemic JJ I-NP B-Disease
states NNS I-NP O
and CC O O
riboflavin NN B-NP B-Disease
deficiency NN I-NP I-Disease
, , O O
where WRB B-ADVP O
cataracts NNS B-NP B-Disease
represent VBP B-VP O
a DT B-NP O
sensitive JJ I-NP O
indicator NN I-NP O
of IN B-PP O
metabolic JJ B-NP B-Disease
abnormalities NNS I-NP I-Disease
of IN B-PP O
the DT B-NP O
RBC NN I-NP O
. . O O

. . O O

Molecular JJ B-NP O
basis NN I-NP O
of IN B-PP O
human JJ B-NP O
mitochondrial JJ I-NP O
very RB I-NP B-Disease
- HYPH I-NP I-Disease
long JJ I-NP I-Disease
- HYPH I-NP I-Disease
chain NN I-NP I-Disease
acyl NN I-NP I-Disease
- HYPH B-NP I-Disease
CoA NN I-NP I-Disease
dehydrogenase NN I-NP I-Disease
deficiency NN I-NP I-Disease
causing VBG B-VP O
cardiomyopathy NN B-NP B-Disease
and CC O O
sudden JJ B-NP B-Disease
death NN I-NP I-Disease
in IN B-PP O
childhood NN B-NP O
. . O O

beta SYM B-NP O
- : O O
Oxidation NN B-NP O
of IN B-PP O
long JJ B-NP O
- HYPH I-NP O
chain NN I-NP O
fatty JJ I-NP O
acids NNS I-NP O
provides VBZ B-VP O
the DT B-NP O
major JJ I-NP O
source NN I-NP O
of IN B-PP O
energy NN B-NP O
in IN B-PP O
the DT B-NP O
heart NN I-NP O
. . O O

Defects NNS B-NP O
in IN B-PP O
enzymes NNS B-NP O
of IN B-PP O
the DT B-NP O
beta SYM I-NP O
- HYPH I-NP O
oxidation NN I-NP O
pathway NN I-NP O
cause VBP B-VP O
sudden JJ B-NP B-Disease
, , I-NP I-Disease
unexplained JJ I-NP I-Disease
death NN I-NP I-Disease
in IN B-PP O
childhood NN B-NP O
, , O O
acute JJ B-NP O
hepatic JJ I-NP B-Disease
encephalopathy NN I-NP I-Disease
or CC I-NP O
liver NN I-NP B-Disease
failure NN I-NP I-Disease
, , O O
skeletal JJ B-NP B-Disease
myopathy NN I-NP I-Disease
, , O O
and CC O O
cardiomyopathy NN B-NP B-Disease
. . O O

Very NN B-NP O
- HYPH B-NP O
long JJ I-NP O
- HYPH I-NP O
chain NN I-NP O
acyl NN I-NP O
- HYPH O O
CoA NN B-NP O
dehydrogenase NN I-NP O
[ ( O O
VLCAD NN B-NP O
; : O O
very RB B-NP O
- HYPH I-NP O
long JJ I-NP O
- HYPH I-NP O
chain NN I-NP O
- HYPH B-NP O
acyl NN I-NP O
- HYPH O O
CoA NN B-NP O
( ( O O
acceptor NN B-NP O
) ) O O
2 CD B-NP O
, , O O
3 CD B-NP O
- HYPH I-NP O
oxidoreductase NN I-NP O
, , O O
EC NNP B-NP O
1 CD I-NP O
. . O O

3 CD B-NP O
3 CD I-NP O
. . O O

99 CD B-NP O
99 CD I-NP O
. . B-NP O

13 CD I-NP O
] ) O O
catalyzes VBZ B-VP O
the DT B-NP O
first JJ I-NP O
step NN I-NP O
in IN B-PP O
beta SYM B-NP O
- HYPH B-NP O
oxidation NN I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
isolated VBN I-VP O
the DT B-NP O
human JJ I-NP O
VLCAD NN I-NP O
cDNA NN I-NP O
and CC O O
gene NN B-NP O
and CC O O
determined VBD B-VP O
the DT B-NP O
complete JJ I-NP O
nucleotide NN I-NP O
sequences NNS I-NP O
. . O O

Polymerase NN B-NP O
chain NN I-NP O
reaction NN I-NP O
amplification NN I-NP O
of IN B-PP O
VLCAD NN B-NP O
mRNA NN I-NP O
and CC O O
genomic JJ B-NP O
exons NNS I-NP O
defined VBD B-VP O
the DT B-NP O
molecular JJ I-NP O
defects NNS I-NP O
in IN B-PP O
two CD B-NP O
patients NNS I-NP O
with IN B-PP O
VLCAD NN B-NP B-Disease
deficiency NN I-NP I-Disease
who WP B-NP O
presented VBD B-VP O
with IN B-PP O
unexplained JJ B-NP O
cardiac JJ I-NP B-Disease
arrest NN I-NP I-Disease
and CC I-NP O
cardiomyopathy NN I-NP B-Disease
. . O O

In IN B-PP O
one CD B-NP O
, , O O
a DT B-NP O
homozygous JJ I-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
consensus NN I-NP O
dinucleotide NN I-NP O
of IN B-PP O
the DT B-NP O
donor NN I-NP O
splice NN I-NP O
site NN I-NP O
( ( O O
g NN B-NP O
+ SYM O O
1 CD O O
- SYM O O
- HYPH O O
> SYM O O
a DT O O
) ) O O
was VBD B-VP O
associated VBN I-VP O
with IN B-PP O
universal JJ B-NP O
skipping NN I-NP O
of IN B-PP O
the DT B-NP O
prior JJ I-NP O
exon NN I-NP O
( ( O O
exon NN B-NP O
11 CD I-NP O
) ) O O
. . O O

The DT B-NP O
second JJ I-NP O
patient NN I-NP O
was VBD B-VP O
a DT B-NP O
compound NN I-NP O
heterozygote NN I-NP O
, , O O
with IN B-PP O
a DT B-NP O
missense JJ I-NP O
mutation NN I-NP O
, , O O
C1837 NN B-NP O
- SYM B-VP O
- SYM B-NP O
> SYM B-VP O
T NN B-NP O
, , O O
changing VBG B-VP O
the DT B-NP O
arginine NN I-NP O
at IN B-PP O
residue NN B-NP O
613 CD I-NP O
to TO B-VP O
tryptophan VB I-VP O
on IN B-PP O
one CD B-NP O
allele NN I-NP O
and CC O O
a DT B-NP O
single JJ I-NP O
base NN I-NP O
deletion NN I-NP O
at IN B-PP O
the DT B-NP O
intron NN I-NP O
- HYPH O O
exon NN B-NP O
6 CD I-NP O
boundary NN I-NP O
as IN B-PP O
the DT B-NP O
second JJ I-NP O
mutation NN I-NP O
. . O O

This DT B-NP O
initial JJ I-NP O
delineation NN I-NP O
of IN B-PP O
human JJ B-NP O
mutations NNS I-NP O
in IN B-PP O
VLCAD NN B-NP O
suggests VBZ B-VP O
that IN B-SBAR O
VLCAD NN B-NP B-Disease
deficiency NN I-NP I-Disease
reduces VBZ B-VP O
myocardial JJ B-NP O
fatty JJ I-NP O
acid NN I-NP O
beta SYM B-NP O
- HYPH I-NP O
oxidation NN I-NP O
and CC I-NP O
energy NN I-NP O
production NN I-NP O
and CC O O
is VBZ B-VP O
associated VBN I-VP O
with IN B-PP O
cardiomyopathy NN B-NP B-Disease
and CC O O
sudden JJ B-NP B-Disease
death NN I-NP I-Disease
in IN B-PP O
childhood NN B-NP O
. . O O

Aberrant JJ B-NP O
subcellular JJ I-NP O
localization NN I-NP O
of IN B-PP O
BRCA1 NN B-NP O
in IN B-PP O
breast NN B-NP B-Disease
cancer NN I-NP I-Disease
. . O O

The DT B-NP O
BRCA1 NN I-NP O
gene NN I-NP O
product NN I-NP O
was VBD B-VP O
identified VBN I-VP O
as IN B-PP O
a DT B-NP O
220 CD I-NP O
- HYPH I-NP O
kilodalton NN I-NP O
nuclear JJ I-NP O
phosphoprotein NN I-NP O
in IN B-PP O
normal JJ B-NP O
cells NNS I-NP O
, , O O
including VBG B-PP O
breast NN B-NP O
ductal JJ I-NP O
epithelial JJ I-NP O
cells NNS I-NP O
, , O O
and CC O O
in IN B-PP O
18 CD B-NP O
of IN B-PP O
20 CD B-NP O
tumor NN I-NP B-Disease
cell NN I-NP O
lines NNS I-NP O
derived VBN B-VP O
from IN B-PP O
tissues NNS B-NP O
other JJ B-ADJP O
than IN B-PP O
breast NN B-NP O
and CC I-NP O
ovary NN I-NP O
. . O O

In IN B-PP O
16 CD B-NP O
of IN B-PP O
17 CD B-NP O
breast NN I-NP B-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
lines NNS I-NP O
and CC O O
17 CD B-NP O
of IN B-PP O
17 CD B-NP O
samples NNS I-NP O
of IN B-PP O
cells NNS B-NP O
obtained VBN B-VP O
from IN B-PP O
malignant JJ B-NP O
effusions NNS I-NP O
, , O O
however RB B-ADVP O
, , O O
BRCA1 NN B-NP O
localized VBD B-VP O
mainly RB B-ADVP O
in IN B-PP O
cytoplasm NN B-NP O
. . O O

Absence NN B-NP O
of IN B-PP O
BRCA1 NN B-NP O
or CC O O
aberrant JJ B-NP O
subcellular JJ I-NP O
location NN I-NP O
was VBD B-VP O
also RB I-VP O
observed VBN I-VP O
to TO B-PP O
a DT B-NP O
variable JJ I-NP O
extent NN I-NP O
in IN B-PP O
histological JJ B-NP O
sections NNS I-NP O
of IN B-PP O
many JJ B-NP O
breast NN I-NP B-Disease
cancer NN I-NP I-Disease
biopsies NNS I-NP O
. . O O

These DT B-NP O
findings NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
BRCA1 NN B-NP B-Disease
abnormalities NNS I-NP I-Disease
may MD B-VP O
be VB I-VP O
involved VBN I-VP O
in IN B-PP O
the DT B-NP O
pathogenesis NN I-NP O
of IN B-PP O
many JJ B-NP O
breast NN I-NP B-Disease
cancers NNS I-NP I-Disease
, , O O
sporadic JJ O O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
familial JJ B-ADJP O
. . O O

. . O O

Mapping NN B-NP O
of IN B-PP O
the DT B-NP O
mouse NN I-NP O
homologue NN I-NP O
of IN B-PP O
the DT B-NP O
Wilson NNP I-NP B-Disease
disease NN I-NP I-Disease
gene NN I-NP O
to TO B-PP O
mouse NN B-NP O
chromosome NN I-NP O
8 CD I-NP O
. . O O

ATP7B NN B-NP O
, , O O
the DT B-NP O
gene NN I-NP O
altered VBN B-VP O
in IN B-PP O
Wilson NNP B-NP B-Disease
disease NN I-NP I-Disease
( ( O O
WD JJ O B-Disease
) ) O O
patients NNS B-NP O
, , O O
lies VBZ B-VP O
in IN B-PP O
a DT B-NP O
block NN I-NP O
of IN B-PP O
homology NN B-NP O
shared VBN B-VP O
between IN B-PP O
human JJ B-NP O
chromosome NN I-NP O
13q14 NN I-NP O
and CC O O
the DT B-NP O
central JJ I-NP O
region NN I-NP O
of IN B-PP O
mouse NN B-NP O
chromosome NN I-NP O
14 CD I-NP O
. . O O

However RB B-ADVP O
, , O O
we PRP B-NP O
have VBP B-VP O
mapped VBN I-VP O
the DT B-NP O
murine JJ I-NP O
homologue NN I-NP O
of IN B-PP O
ATP7B NN B-NP O
( ( O O
Atp7b NN B-NP O
) ) O O
to TO B-PP O
mouse NN B-NP O
chromosome NN I-NP O
8 CD I-NP O
by IN B-PP O
somatic JJ B-NP O
cell NN I-NP O
hybrid NN I-NP O
analysis NN I-NP O
. . O O

Analysis NN B-NP O
of IN B-PP O
80 CD B-NP O
interspecific JJ I-NP O
backcross NN I-NP O
offspring NN I-NP O
was VBD B-VP O
used VBN I-VP O
to TO B-PP O
position NN B-NP O
Atp7b NN I-NP O
close RB B-ADVP O
to TO B-PP O
D8Mit3 NN B-NP O
and CC O O
another DT B-NP O
ATPase NN I-NP O
locus NN I-NP O
, , O O
Atp4b NN B-NP O
, , O O
on IN B-PP O
mouse NN B-NP O
chromosome NN I-NP O
8 CD I-NP O
. . O O

ATP4B NN B-NP O
lies VBZ B-VP O
in IN B-PP O
13q34 CD B-NP O
and CC O O
is VBZ B-VP O
separated VBN I-VP O
from IN B-PP O
ATP7B NN B-NP O
by IN B-PP O
several JJ B-NP O
loci NNS I-NP O
whose WP$ B-NP O
mouse NN I-NP O
homologues NNS I-NP O
map VBP B-VP O
to TO B-PP O
mouse NN B-NP O
chromosome NN I-NP O
14 CD I-NP O
. . O O

The DT B-NP O
assignment NN I-NP O
of IN B-PP O
Atp7b NN B-NP O
to TO B-PP O
mouse NN B-NP O
chromosome NN I-NP O
8 CD I-NP O
identifies VBZ B-VP O
a DT B-NP O
previously RB I-NP O
unrecognized JJ I-NP O
region NN I-NP O
of IN B-PP O
homology NN B-NP O
between IN B-PP O
this DT B-NP O
chromosome NN I-NP O
and CC O O
human JJ O O
chromosome NN B-NP O
13 CD I-NP O
. . O O

This DT B-NP O
assignment NN I-NP O
suggests VBZ B-VP O
a DT B-NP O
possible JJ I-NP O
location NN I-NP O
for IN B-PP O
the DT B-NP O
toxic JJ I-NP O
milk NN I-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
mouse NN I-NP O
, , O O
which WDT B-NP O
has VBZ B-VP O
been VBN I-VP O
proposed VBN I-VP O
as IN B-PP O
a DT B-NP O
homologue NN I-NP O
of IN B-PP O
WD NN B-NP B-Disease
. . O O

. . O O

Germline NN B-NP O
mutations NNS I-NP O
of IN B-PP O
the DT B-NP O
BRCA1 NN I-NP O
gene NN I-NP O
in IN B-PP O
breast NN B-NP B-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
families NNS I-NP O
provide VBP B-VP O
evidence NN B-NP O
for IN B-PP O
a DT B-NP O
genotype NN I-NP O
- HYPH I-NP O
phenotype NN I-NP O
correlation NN I-NP O
. . O O

Mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
BRCA1 NN I-NP O
gene NN I-NP O
, , O O
discovered VBN B-VP O
in IN B-PP O
1994 CD B-NP O
, , O O
are VBP B-VP O
associated VBN I-VP O
with IN B-PP O
an DT B-NP O
80 CD I-NP O
- HYPH I-NP O
90 CD I-NP O
% NN I-NP O
lifetime NN I-NP O
risk NN I-NP O
of IN B-PP O
breast NN B-NP B-Disease
cancer NN I-NP I-Disease
. . O O

We PRP B-NP O
have VBP B-VP O
analysed VBN I-VP O
60 CD B-NP O
families NNS I-NP O
with IN B-PP O
a DT B-NP O
history NN I-NP O
of IN B-PP O
breast NN B-NP B-Disease
and CC O I-Disease
/ SYM B-NP I-Disease
or CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
for IN B-PP O
germline NN B-NP O
mutations NNS I-NP O
in IN B-PP O
BRCA1 NN B-NP O
. . O O

Twenty CD B-NP O
- HYPH I-NP O
two CD I-NP O
different JJ I-NP O
mutations NNS I-NP O
were VBD B-VP O
detected VBN I-VP O
in IN B-PP O
32 CD B-NP O
families NNS I-NP O
( ( O O
53 CD B-NP O
% NN I-NP O
) ) O O
, , O O
of IN B-PP O
which WDT B-NP O
14 CD B-NP O
are VBP B-VP O
previously RB B-ADJP O
unreported JJ I-ADJP O
. . O O

We PRP B-NP O
observed VBD B-VP O
a DT B-NP O
significant JJ I-NP O
correlation NN I-NP O
between IN B-PP O
the DT B-NP O
location NN I-NP O
of IN B-PP O
the DT B-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
gene NN I-NP O
and CC O O
the DT B-NP O
ratio NN I-NP O
of IN B-PP O
breast NN B-NP B-Disease
to TO B-PP I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
incidence NN I-NP O
within IN B-PP O
each DT B-NP O
family NN I-NP O
. . O O

Our PRP$ B-NP O
data NNS I-NP O
suggest VBP B-VP O
a DT B-NP O
transition NN I-NP O
in IN B-PP O
risk NN B-NP O
such JJ B-NP O
that IN I-NP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
3 CD I-NP O
third NN I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
are VBP B-VP O
associated VBN I-VP O
with IN B-PP O
a DT B-NP O
lower JJR I-NP O
proportion NN I-NP O
of IN B-PP O
ovarian JJ B-NP B-Disease
cancer NN I-NP I-Disease
. . O O

Haplotype NN B-NP O
analysis NN I-NP O
supports VBZ B-VP O
previous JJ B-NP O
data NNS I-NP O
which WDT B-NP O
suggest VBP B-VP O
some DT B-NP O
BRCA1 NN I-NP O
mutation NN I-NP O
carriers NNS I-NP O
have VBP B-VP O
common JJ B-NP O
ancestors NNS I-NP O
; : O O
however RB B-ADVP O
, , O O
we PRP B-NP O
have VBP B-VP O
found VBN I-VP O
at IN B-NP O
least JJS I-NP O
two CD I-NP O
examples NNS I-NP O
where WRB B-ADVP O
recurrent JJ B-NP O
mutations NNS I-NP O
appear VBP B-VP O
to TO I-VP O
have VB I-VP O
arisen VBN I-VP O
independently RB B-ADVP O
. . O O

. . O O

Hereditary JJ B-NP O
deficiency NN I-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
seventh JJ I-NP I-Disease
component NN I-NP I-Disease
of IN B-PP I-Disease
complement NN B-NP I-Disease
and CC O O
recurrent JJ B-NP O
meningococcal JJ I-NP B-Disease
infection NN I-NP I-Disease
: : O O
investigations NNS B-NP O
of IN B-PP O
an DT B-NP O
Irish JJ I-NP O
family NN I-NP O
using VBG B-VP O
a DT B-NP O
novel JJ I-NP O
haemolytic JJ I-NP O
screening NN I-NP O
assay NN I-NP O
for IN B-PP O
complement NN B-NP O
activity NN I-NP O
and CC O O
C7 NN B-NP O
M NN I-NP O
/ SYM B-NP O
N NN I-NP O
allotyping NN I-NP O
. . O O

Terminal JJ B-NP B-Disease
complement NN I-NP I-Disease
component NN I-NP I-Disease
deficiency NN I-NP I-Disease
predisposes VBZ B-VP O
to TO B-PP O
meningococcal JJ B-NP B-Disease
infection NN I-NP I-Disease
and CC O O
is VBZ B-VP O
inherited VBN I-VP O
in IN B-PP O
an DT B-NP O
autosomal JJ I-NP O
co AFX I-NP O
- HYPH I-NP O
dominant JJ I-NP O
manner NN I-NP O
. . O O

An DT B-NP O
Irish JJ I-NP O
family NN I-NP O
is VBZ B-VP O
described VBN I-VP O
, , O O
in IN B-PP O
which WDT B-NP O
2 CD B-NP O
of IN B-PP O
3 CD B-NP O
brothers NNS I-NP O
had VBD B-VP O
recurrent JJ B-NP O
meningococcal JJ I-NP B-Disease
infection NN I-NP I-Disease
. . O O

A DT B-NP O
novel JJ I-NP O
screening NN I-NP O
assay NN I-NP O
was VBD B-VP O
used VBN I-VP O
to TO B-VP O
investigate VB I-VP O
for IN B-PP O
terminal JJ B-NP B-Disease
complement NN I-NP I-Disease
deficiency NN I-NP I-Disease
and CC O O
the DT B-NP O
2 CD I-NP O
affected VBN I-NP O
brothers NNS I-NP O
were VBD B-VP O
found VBN I-VP O
to TO I-VP O
be VB I-VP O
completely RB B-ADJP B-Disease
deficient JJ I-ADJP I-Disease
in IN B-PP I-Disease
the DT B-NP I-Disease
seventh JJ I-NP I-Disease
component NN I-NP I-Disease
of IN B-PP I-Disease
complement NN B-NP I-Disease
( ( O O
C7 NN B-NP O
) ) O O
. . O O

Enzyme NN B-NP O
- HYPH B-PP O
linked VBN B-NP O
immunosorbent NN I-NP O
assay NN I-NP O
for IN B-PP O
C7 NN B-NP O
revealed VBD B-VP O
lower JJR B-ADVP O
than IN B-PP O
normal JJ B-NP O
levels NNS I-NP O
in IN B-PP O
the DT B-NP O
remaining VBG I-NP O
brother NN I-NP O
and CC I-NP O
parents NNS I-NP O
. . O O

C7 NN B-NP O
M NN I-NP O
/ SYM B-NP O
N NN I-NP O
protein NN I-NP O
polymorphism NN I-NP O
allotyping NN I-NP O
, , O O
used VBN B-VP O
to TO B-VP O
investigate VB I-VP O
the DT B-NP O
segregation NN I-NP O
of IN B-PP O
the DT B-NP O
C7 NN I-NP B-Disease
deficiency NN I-NP I-Disease
genes NNS I-NP O
, , O O
showed VBD B-VP O
that IN B-SBAR O
the DT B-NP O
apparently RB I-NP O
complement JJ I-NP O
sufficient JJ I-NP O
brother NN I-NP O
was VBD B-VP O
heterozygous JJ B-NP O
C7 NN I-NP B-Disease
deficient JJ B-ADJP I-Disease
and CC O O
a DT B-NP O
carrier NN I-NP O
of IN B-PP O
one CD B-NP O
of IN B-PP O
the DT B-NP O
deficiency NN I-NP O
genes NNS I-NP O
. . O O

Complement NN B-NP O
screening NN I-NP O
should MD B-VP O
be VB I-VP O
carried VBN I-VP O
out RP B-PRT O
in IN B-PP O
any DT B-NP O
individual JJ I-NP O
suffering VBG I-NP O
recurrent JJ I-NP O
meningococcal JJ I-NP B-Disease
infection NN I-NP I-Disease
or CC I-NP O
infection NN I-NP O
with IN B-PP O
an DT B-NP O
uncommon JJ I-NP O
meningococcal JJ I-NP B-Disease
serogroup NN I-NP O
. . O O

Identification NN B-NP O
of IN B-PP O
complement NN B-NP B-Disease
deficient JJ I-NP I-Disease
patients NNS I-NP O
allows VBZ B-VP O
the DT B-NP O
implementation NN I-NP O
of IN B-PP O
strategies NNS B-NP O
to TO B-VP O
prevent VB I-VP O
recurrent JJ B-NP O
infection NN I-NP O
. . O O

. . O O

Molecular JJ B-NP O
basis NN I-NP O
of IN B-PP O
subtotal JJ B-NP B-Disease
complement NN I-NP I-Disease
C6 NN I-NP I-Disease
deficiency NN I-NP I-Disease
. . O O

A DT O O
carboxy AFX O O
- HYPH B-VP O
terminally RB I-VP O
truncated VBN I-VP O
but CC O O
functionally RB B-NP O
active JJ I-NP O
C6 NN I-NP O
. . O O

Individuals NNS B-NP O
with IN B-PP O
subtotal JJ B-NP B-Disease
complement NN I-NP I-Disease
C6 NN I-NP I-Disease
deficiency NN I-NP I-Disease
possess VBP B-VP O
a DT B-NP O
C6 NN I-NP O
molecule NN I-NP O
that WDT B-NP O
is VBZ B-VP O
14 CD B-NP O
% NN I-NP O
shorter JJR B-ADJP O
than IN B-PP O
normal JJ B-NP O
C6 NN I-NP O
and CC O O
present JJ B-ADJP O
in IN B-PP O
low JJ B-NP O
but CC I-NP O
detectable JJ I-NP O
concentrations NNS I-NP O
( ( O O
1 CD B-NP O
- HYPH I-NP O
2 CD I-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
normal JJ I-NP O
mean NN I-NP O
) ) O O
. . O O

We PRP B-NP O
now RB B-ADVP O
show VBP B-VP O
that IN B-SBAR O
this DT B-NP O
dysmorphic JJ I-NP O
C6 NN I-NP O
is VBZ B-VP O
bactericidally RB B-ADJP O
active JJ I-ADJP O
and CC O O
lacks VBZ B-VP O
an DT B-NP O
epitope NN I-NP O
that WDT B-NP O
was VBD B-VP O
mapped VBN I-VP O
to TO B-PP O
the DT B-NP O
most RBS I-NP O
carboxy AFX I-NP O
- HYPH I-NP O
terminal JJ I-NP O
part NN I-NP O
of IN B-PP O
C6 NN B-NP O
using VBG B-VP O
C6 NN B-NP O
cDNA NN I-NP O
fragments NNS I-NP O
expressed VBN B-VP O
as IN B-PP O
fusion NN B-NP O
proteins NNS I-NP O
in IN B-PP O
the DT B-NP O
pUEX NN I-NP O
expression NN I-NP O
system NN I-NP O
. . O O

We PRP B-NP O
thus RB B-ADVP O
predicted VBD B-VP O
that IN B-SBAR O
the DT B-NP O
abnormal JJ I-NP O
C6 NN I-NP O
molecule NN I-NP O
might MD B-VP O
be VB I-VP O
carboxy AFX O O
- HYPH O O
terminally RB B-VP O
truncated VBN I-VP O
and CC O O
sought VBN B-VP O
a DT B-NP O
mutation NN I-NP O
in IN B-PP O
an DT B-NP O
area NN I-NP O
approximately RB B-NP O
14 CD I-NP O
% NN I-NP O
from IN B-PP O
the DT B-NP O
carboxy NN I-NP O
- HYPH B-NP O
terminal JJ I-NP O
end NN I-NP O
of IN B-PP O
the DT B-NP O
coding VBG I-NP O
sequence NN I-NP O
. . O O

By IN B-PP O
sequencing VBG B-VP O
PCR NN B-NP O
- HYPH B-NP O
amplified VBN I-NP O
products NNS I-NP O
from IN B-PP O
this DT B-NP O
region NN I-NP O
, , O O
we PRP B-NP O
found VBD B-VP O
, , O O
in IN B-PP O
three CD B-NP O
individuals NNS I-NP O
from IN B-PP O
two CD B-NP O
families NNS I-NP O
, , O O
a DT B-NP O
mutation NN I-NP O
that WDT B-NP O
might MD B-VP O
plausibly RB I-VP O
be VB I-VP O
responsible JJ B-ADJP O
for IN B-PP O
the DT B-NP O
defect NN I-NP O
. . O O

All DT B-NP O
three CD I-NP O
have VBP B-VP O
an DT B-NP O
abnormal JJ I-NP O
5 CD I-NP O
splice NN I-NP O
donor NN I-NP O
site NN I-NP O
of IN B-PP O
intron NN B-NP O
15 CD I-NP O
, , O O
which WDT B-NP O
would MD B-VP O
probably RB I-VP O
prevent VB I-VP O
splicing NN B-NP O
. . O O

An DT B-NP O
in IN B-PP O
- HYPH B-NP O
frame NN I-NP O
stop NN I-NP O
codon NN I-NP O
is VBZ B-VP O
found VBN I-VP O
17 CD B-NP O
codons NNS I-NP O
downstream RB B-ADVP O
from IN B-PP O
the DT B-NP O
intron NN I-NP O
boundary NN I-NP O
, , O O
which WDT B-NP O
would MD B-VP O
lead VB I-VP O
to TO B-PP O
a DT B-NP O
truncated VBN I-NP O
polypeptide NN I-NP O
13 CD I-NP O
. . O O

5 CD B-NP O
% NN I-NP O
smaller JJR B-ADJP O
than IN B-PP O
normal JJ B-NP O
C6 NN I-NP O
. . O O

This DT B-NP O
result NN I-NP O
was VBD B-VP O
unexpected JJ B-ADJP O
, , O O
as IN B-SBAR O
earlier JJR B-NP O
studies NNS I-NP O
mapped VBD B-VP O
the DT B-NP O
C5b NN I-NP O
binding NN I-NP O
site NN I-NP O
, , O O
or CC O O
a DT B-NP O
putative JJ I-NP O
enzymatic JJ I-NP O
region NN I-NP O
, , O O
to TO B-PP O
this DT B-NP O
part NN I-NP O
of IN B-PP O
C6 NN B-NP O
. . O O

Interestingly RB B-ADVP O
, , O O
all DT B-NP O
three CD I-NP O
subjects NNS I-NP O
were VBD B-VP O
probably RB B-ADVP O
heterozygous JJ B-ADJP O
for IN B-PP O
both CC B-NP O
subtotal JJ I-NP B-Disease
C6 NN I-NP I-Disease
and CC O I-Disease
complete JJ B-NP I-Disease
C6 NN I-NP I-Disease
deficiency NN I-NP I-Disease
. . O O

Myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
: : O O
evidence NN B-NP O
for IN B-PP O
a DT B-NP O
possible JJ I-NP O
dominant JJ I-NP O
- HYPH I-NP O
negative JJ I-NP O
RNA NN I-NP O
mutation NN I-NP O
. . O O

The DT B-NP O
trinucleotide NN I-NP O
expansion NN I-NP O
mutation NN I-NP O
causing VBG B-VP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
is VBZ B-VP O
in IN B-PP O
the DT B-NP O
3 CD I-NP O
untranslated JJ I-NP O
region NN I-NP O
of IN B-PP O
a DT B-NP O
protein NN I-NP O
kinase NN I-NP O
gene NN I-NP O
. . O O

The DT B-NP O
molecular JJ I-NP O
mechanisms NNS I-NP O
by IN B-PP O
which WDT B-NP O
the DT B-NP O
expanded VBN I-NP O
repeat NN I-NP O
causes VBZ B-VP O
the DT B-NP O
clinically RB I-NP O
variable JJ I-NP O
and CC I-NP O
multisystemic JJ I-NP B-Disease
disease NN I-NP I-Disease
, , O O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
, , O O
are VBP B-VP O
not RB I-VP O
understood VBN I-VP O
. . O O

It PRP B-NP O
has VBZ B-VP O
been VBN I-VP O
particularly RB B-ADJP O
difficult JJ I-ADJP O
to TO B-VP O
rationalize VB I-VP O
the DT B-NP O
dominant JJ I-NP O
inheritance NN I-NP O
with IN B-PP O
the DT B-NP O
fact NN I-NP O
that IN B-SBAR O
the DT B-NP O
expansion NN I-NP O
mutation NN I-NP O
lies VBZ B-VP O
outside IN B-ADVP O
of IN B-PP O
the DT B-NP O
protein NN I-NP O
- HYPH O O
encoding VBG B-VP O
gene NN B-NP O
elements NNS I-NP O
, , O O
and CC O O
should MD B-VP O
not RB I-VP O
be VB I-VP O
translated VBN I-VP O
into IN B-PP O
protein NN B-NP O
. . O O

Here RB B-ADVP O
we PRP B-NP O
use VBP B-VP O
muscle NN B-NP O
biopsies NNS I-NP O
from IN B-PP O
classical JJ B-NP O
adult JJ I-NP O
- HYPH I-NP O
onset NN I-NP O
myotonic JJ I-NP B-Disease
dystrophy NN I-NP I-Disease
patients NNS I-NP O
to TO B-VP O
study VB I-VP O
the DT B-NP O
accumulation NN I-NP O
of IN B-PP O
transcripts NNS B-NP O
from IN B-PP O
both CC O O
the DT B-NP O
normal JJ I-NP O
and CC I-NP O
expanded VBN I-NP O
DM NN I-NP B-Disease
kinase NN I-NP O
genes NNS I-NP O
in IN B-PP O
patient NN B-NP O
muscle NN I-NP O
, , O O
and CC O O
compare VBP B-VP O
the DT B-NP O
results NNS I-NP O
to TO B-PP O
normal JJ B-NP O
and CC I-NP O
myopathic JJ I-NP B-Disease
controls NNS I-NP O
. . O O

We PRP B-NP O
found VBD B-VP O
relatively RB B-NP O
small JJ I-NP O
decreases NNS I-NP O
of IN B-PP O
DM NN B-NP B-Disease
kinase NN I-NP O
RNA NN I-NP O
in IN B-PP O
the DT B-NP O
total JJ I-NP O
RNA NN I-NP O
pool NN I-NP O
from IN B-PP O
muscle NN B-NP O
; : O O
however RB B-ADVP O
, , O O
these DT B-NP O
reductions NNS I-NP O
were VBD B-VP O
not RB O O
disease NN B-NP O
specific JJ B-ADJP O
. . O O

Analysis NN B-NP O
of IN B-PP O
poly NN B-NP O
( ( I-NP O
A NN I-NP O
) ) I-NP O
+ JJ I-NP O
RNA NN I-NP O
showed VBD B-VP O
dramatic JJ B-NP O
decreases NNS I-NP O
of IN B-PP O
both CC O O
the DT B-NP O
mutant JJ I-NP O
and CC I-NP O
normal JJ I-NP O
DM NN I-NP B-Disease
kinase NN I-NP O
RNAs NNS I-NP O
, , O O
and CC O O
these DT B-NP O
changes NNS I-NP O
were VBD B-VP O
disease NN B-ADJP O
- HYPH I-ADJP O
specific JJ B-ADJP O
. . O O

Our PRP$ B-NP O
findings NNS I-NP O
are VBP B-VP O
consistent JJ B-ADJP O
with IN B-PP O
a DT B-NP O
novel JJ I-NP O
molecular JJ I-NP O
pathogenetic JJ I-NP O
mechanism NN I-NP O
for IN B-PP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
both CC O O
the DT B-NP O
normal JJ I-NP O
and CC I-NP O
expanded VBN I-NP O
DM NN I-NP B-Disease
kinase NN I-NP O
genes NNS I-NP O
are VBP B-VP O
transcribed VBN I-VP O
in IN B-PP O
patient NN B-NP O
muscle NN I-NP O
, , O O
but CC O O
the DT B-NP O
abnormal JJ I-NP O
expansion NN I-NP O
- HYPH O O
containing VBG B-VP O
RNA NN B-NP O
has VBZ B-VP O
a DT B-NP O
dominant JJ I-NP O
effect NN I-NP O
on IN B-PP O
RNA NN B-NP O
metabolism NN I-NP O
by IN B-PP O
preventing VBG B-VP O
the DT B-NP O
accumulation NN I-NP O
of IN B-PP O
poly NN B-NP O
( ( I-NP O
A NN I-NP O
) ) I-NP O
+ JJ I-NP O
RNA NN I-NP O
. . O O

The DT B-NP O
ability NN I-NP O
of IN B-PP O
the DT B-NP O
expansion NN I-NP O
mutation NN I-NP O
to TO B-VP O
alter VB I-VP O
accumulation NN B-NP O
of IN B-PP O
poly NN B-NP O
( ( I-NP O
A NN I-NP O
) ) I-NP O
+ JJ I-NP O
RNA NN I-NP O
in IN B-PP O
trans NNS B-NP O
suggests VBZ B-VP O
that IN B-SBAR O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
may MD B-VP O
be VB I-VP O
the DT B-NP O
first JJ I-NP O
example NN I-NP O
of IN B-PP O
a DT B-NP O
dominant JJ I-NP O
- HYPH I-NP O
negative JJ I-NP O
mutation NN I-NP O
manifested VBN B-VP O
at IN B-PP O
the DT B-NP O
RNA NN I-NP O
level NN I-NP O
. . O O

. . O O

A DT B-NP O
strong JJ I-NP O
candidate NN I-NP O
for IN B-PP O
the DT B-NP O
breast NN I-NP B-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
susceptibility NN I-NP O
gene NN I-NP O
BRCA1 NN I-NP O
. . O O

A DT B-NP O
strong JJ I-NP O
candidate NN I-NP O
for IN B-PP O
the DT B-NP O
17q NN I-NP O
- HYPH B-VP O
linked VBN B-NP O
BRCA1 NN I-NP O
gene NN I-NP O
, , O O
which WDT B-NP O
influences VBZ B-VP O
susceptibility NN B-NP O
to TO B-PP O
breast NN B-NP B-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
, , O O
has VBZ B-VP O
been VBN I-VP O
identified VBN I-VP O
by IN B-PP O
positional JJ B-NP O
cloning NN I-NP O
methods NNS I-NP O
. . O O

Probable JJ B-NP O
predisposing VBG I-NP O
mutations NNS I-NP O
have VBP B-VP O
been VBN I-VP O
detected VBN I-VP O
in IN B-PP O
five CD B-NP O
of IN I-NP O
eight CD I-NP O
kindreds NNS I-NP O
presumed VBN B-VP O
to TO B-VP O
segregate VB I-VP O
BRCA1 NN B-NP O
susceptibility NN I-NP O
alleles NNS I-NP O
. . O O

The DT B-NP O
mutations NNS I-NP O
include VBP B-VP O
an DT B-NP O
11 CD I-NP O
- HYPH I-NP O
base NN I-NP O
pair NN I-NP O
deletion NN I-NP O
, , O O
a DT B-NP O
1 CD I-NP O
- HYPH I-NP O
base NN I-NP O
pair NN I-NP O
insertion NN I-NP O
, , O O
a DT B-NP O
stop NN I-NP O
codon NN I-NP O
, , O O
a DT B-NP O
missense JJ I-NP O
substitution NN I-NP O
, , O O
and CC O O
an DT B-NP O
inferred JJ I-NP O
regulatory JJ I-NP O
mutation NN I-NP O
. . O O

The DT B-NP O
BRCA1 NN I-NP O
gene NN I-NP O
is VBZ B-VP O
expressed VBN I-VP O
in IN B-PP O
numerous JJ B-NP O
tissues NNS I-NP O
, , O O
including VBG B-PP O
breast NN B-NP O
and CC I-NP O
ovary NN I-NP O
, , O O
and CC O O
encodes VBZ B-VP O
a DT B-NP O
predicted VBN I-NP O
protein NN I-NP O
of IN B-PP O
1863 CD B-NP O
amino NN I-NP O
acids NNS I-NP O
. . O O

This DT B-NP O
protein NN I-NP O
contains VBZ B-VP O
a DT B-NP O
zinc NN I-NP O
finger NN I-NP O
domain NN I-NP O
in IN B-PP O
its PRP$ B-NP O
amino JJ I-NP O
- HYPH I-NP O
terminal JJ I-NP O
region NN I-NP O
, , O O
but CC O O
is VBZ B-VP O
otherwise RB B-ADJP O
unrelated JJ I-ADJP O
to TO B-PP O
previously RB B-NP O
described VBN I-NP O
proteins NNS I-NP O
. . O O

Identification NN B-NP O
of IN B-PP O
BRCA1 NN B-NP O
should MD B-VP O
facilitate VB I-VP O
early JJ B-NP O
diagnosis NN I-NP O
of IN B-PP O
breast NN B-NP B-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
susceptibility NN I-NP O
in IN B-PP O
some DT B-NP O
individuals NNS I-NP O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
a DT B-NP O
better JJR I-NP O
understanding NN I-NP O
of IN B-PP O
breast NN B-NP B-Disease
cancer NN I-NP I-Disease
biology NN I-NP O
. . O O

. . O O

Molecular JJ B-NP O
characterization NN I-NP O
of IN B-PP O
galactosemia NN B-NP B-Disease
( ( O O
type NN B-NP O
1 CD I-NP O
) ) O O
mutations NNS B-NP O
in IN B-PP O
Japanese NNPS B-NP O
. . O O

We PRP B-NP O
characterized VBD B-VP O
two CD B-NP O
novel JJ I-NP O
mutations NNS I-NP O
of IN B-PP O
the DT B-NP O
galactose NN I-NP O
- HYPH B-NP O
1 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
uridyltransferase NN I-NP O
( ( O O
GALT NN B-NP O
) ) O O
gene NN B-NP O
in IN B-PP O
two CD B-NP O
Japanese JJ I-NP O
patients NNS I-NP O
with IN B-PP O
GALT NN B-NP B-Disease
deficiency NN I-NP I-Disease
and CC O O
identified VBD B-VP O
N314D NN B-NP O
and CC I-NP O
R333W NN I-NP O
mutations NNS I-NP O
, , O O
previously RB B-VP O
found VBN I-VP O
in IN B-PP O
Caucasians NNS B-NP O
. . O O

One CD B-NP O
novel JJ I-NP O
missense JJ I-NP O
mutation NN I-NP O
was VBD B-VP O
an DT B-NP O
G NN I-NP O
- HYPH B-ADJP O
to TO B-PP O
- HYPH B-NP O
A NN I-NP O
transition NN I-NP O
in IN B-PP O
exon NN B-NP O
8 CD I-NP O
, , O O
resulting VBG B-VP O
in IN B-PP O
the DT B-NP O
substitution NN I-NP O
of IN B-PP O
arginine NN B-NP O
by IN B-PP O
histidine NN B-NP O
at IN B-PP O
the DT B-NP O
codon NN I-NP O
231 CD I-NP O
( ( O O
R231H NN B-NP O
) ) O O
. . O O

GALT NN B-NP O
activity NN I-NP O
of IN B-PP O
the DT B-NP O
R231H NN I-NP O
mutant JJ I-NP O
construct NN I-NP O
was VBD B-VP O
reduced VBN I-VP O
to TO B-PP O
15 CD B-NP O
% NN I-NP O
of IN B-PP O
normal JJ B-NP O
controls NNS I-NP O
in IN B-PP O
a DT B-NP O
COS NN I-NP O
cell NN I-NP O
expression NN I-NP O
system NN I-NP O
. . O O

The DT B-NP O
other JJ I-NP O
was VBD B-VP O
a DT B-NP O
splicing NN I-NP O
mutation NN I-NP O
, , O O
an DT B-NP O
A NN I-NP O
- HYPH B-ADJP O
to TO B-PP O
- HYPH B-NP O
G NN I-NP O
transition NN I-NP O
at IN B-PP O
the DT B-NP O
38th JJ I-NP O
nucleotide NN I-NP O
in IN B-PP O
exon NN B-NP O
3 CD I-NP O
( ( O O
318A NN B-NP O
- SYM O O
- HYPH B-NP O
> SYM I-NP O
G NN I-NP O
) ) O O
, , O O
resulting VBG B-VP O
in IN B-PP O
a DT B-NP O
38 CD I-NP O
- HYPH I-NP O
bp NN I-NP O
deletion NN I-NP O
in IN B-PP O
the DT B-NP O
GALT NN I-NP O
cDNA NN I-NP O
by IN B-PP O
activating VBG B-VP O
a DT B-NP O
cryptic JJ I-NP O
splice NN I-NP O
acceptor NN I-NP O
site NN I-NP O
. . O O

In IN B-PP O
seven CD B-NP O
Japanese JJ I-NP O
families NNS I-NP O
( ( O O
14 CD B-NP O
alleles NNS I-NP O
for IN B-PP O
classic JJ B-NP O
form NN I-NP O
and CC O O
one CD B-NP O
allele NN I-NP O
for IN B-PP O
Duarte JJ B-NP O
variant NN I-NP O
) ) O O
with IN B-PP O
GALT NN B-NP B-Disease
deficiency NN I-NP I-Disease
, , O O
the DT B-NP O
R231H NN I-NP O
and CC I-NP O
318A NN I-NP O
- SYM B-NP O
- HYPH B-NP O
> SYM I-NP O
G NN I-NP O
mutations NNS I-NP O
were VBD B-VP O
found VBN I-VP O
only RB B-ADVP O
on IN B-PP O
both DT B-NP O
alleles NNS I-NP O
of IN B-PP O
the DT B-NP O
proband NN I-NP O
. . O O

The DT B-NP O
N314D NN I-NP O
and CC I-NP O
R333W NN I-NP O
mutations NNS I-NP O
were VBD B-VP O
found VBN I-VP O
on IN B-PP O
one CD B-NP O
allele NN I-NP O
each DT B-NP O
. . O O

The DT B-NP O
Q188R NN I-NP O
was VBD B-VP O
prevalent JJ B-ADJP O
in IN B-PP O
the DT B-NP O
United NNP I-NP O
States NNPS I-NP O
but CC B-PP O
not RB B-PP O
in IN I-PP O
Japanese JJ B-NP O
patients NNS I-NP O
. . O O

The DT B-NP O
N314D NN I-NP O
mutation NN I-NP O
was VBD B-VP O
associated VBN I-VP O
with IN B-PP O
the DT B-NP O
Duarte NNP I-NP O
variant NN I-NP O
in IN B-PP O
Japanese JJ B-NP O
persons NNS I-NP O
, , O O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
in IN B-PP O
the DT B-NP O
United NNP I-NP O
States NNPS I-NP O
. . O O

We PRP B-NP O
speculate VBP B-VP O
that IN B-SBAR O
classic JJ B-NP B-Disease
galactosemia NN I-NP I-Disease
mutations NNS I-NP O
appear VBP B-VP O
to TO I-VP O
differ VB I-VP O
between IN B-PP O
Japanese JJ B-NP O
and CC I-NP O
Caucasian JJ I-NP O
patients NNS I-NP O
. . O O

Our PRP$ B-NP O
limited JJ I-NP O
data NNS I-NP O
set VBN B-VP O
on IN B-PP O
galactosemia NN B-NP B-Disease
mutations NNS I-NP O
in IN B-PP O
Japanese JJ B-NP O
suggests NNS I-NP O
that IN B-SBAR O
the DT B-NP O
N314D NN I-NP O
GALT NN I-NP O
mutation NN I-NP O
encoding VBG B-VP O
the DT B-NP O
Duarte NNP I-NP O
variant NN I-NP O
arose VBD B-VP O
before RB B-NP O
Asian JJ I-NP O
and CC I-NP O
Caucasian JJ I-NP O
people NNS I-NP O
diverged VBD B-VP O
and CC O O
that IN B-SBAR O
classic JJ B-NP B-Disease
galactosemia NN I-NP I-Disease
mutations NNS I-NP O
arose VBD B-VP O
and CC O O
/ SYM B-NP O
or CC O O
accumulated VBN B-VP O
after IN B-PP O
the DT B-NP O
divergence NN I-NP O
of IN B-PP O
Asian JJ B-NP O
and CC I-NP O
Caucasian JJ I-NP O
populations NNS I-NP O
. . O O

. . O O

Three CD B-NP O
novel JJ I-NP O
aniridia NN I-NP B-Disease
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
human JJ I-NP O
PAX6 NN I-NP O
gene NN I-NP O
. . O O

Aniridia NNP B-NP B-Disease
( ( O O
iris NN B-NP B-Disease
hypoplasia NN I-NP I-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
autosomal JJ I-NP B-Disease
dominant JJ I-NP I-Disease
congenital JJ I-NP I-Disease
disorder NN I-NP I-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
eye NN I-NP I-Disease
. . O O

Mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
human JJ I-NP O
aniridia NN I-NP B-Disease
( ( O O
PAX6 NN B-NP O
) ) O O
gene NN B-NP O
have VBP B-VP O
now RB I-VP O
been VBN I-VP O
identified VBN I-VP O
in IN B-PP O
many JJ B-NP O
patients NNS I-NP O
from IN B-PP O
various JJ B-NP O
ethnic JJ I-NP O
groups NNS I-NP O
. . O O

In IN B-PP O
the DT B-NP O
study NN I-NP O
reported VBD B-VP O
here RB B-ADVP O
we PRP B-NP O
describe VBP B-VP O
PAX6 NN B-NP O
mutations NNS I-NP O
in IN B-PP O
one CD B-NP O
sporadic JJ I-NP O
and CC O O
five CD B-NP O
familial JJ I-NP O
cases NNS I-NP O
with IN B-PP O
aniridia NN B-NP B-Disease
. . O O

Of IN B-PP O
the DT B-NP O
four CD I-NP O
different JJ I-NP O
mutations NNS I-NP O
identified VBD B-VP O
, , O O
one CD B-NP O
was VBD B-VP O
identical JJ B-ADJP O
to TO B-PP O
a DT B-NP O
previously RB I-NP O
reported VBN I-NP O
mutation NN I-NP O
( ( O O
C NN B-NP O
- SYM O O
- HYPH B-NP O
> SYM I-NP O
T NN I-NP O
transition NN I-NP O
at IN B-PP O
codon NN B-NP O
240 CD I-NP O
) ) O O
, , O O
and CC O O
three CD B-NP O
were VBD B-VP O
novel JJ B-ADJP O
two CD B-NP O
in IN B-PP O
the DT B-NP O
glycine NN I-NP O
- HYPH B-NP O
rich JJ I-NP O
region NN I-NP O
and CC O O
one CD B-NP O
in IN B-PP O
the DT B-NP O
proline NN I-NP O
/ SYM B-NP O
serine NN I-NP O
/ SYM B-NP O
threonine NN I-NP O
- HYPH B-NP O
rich JJ I-NP O
( ( O O
PST NN B-NP O
) ) O O
region NN B-NP O
. . O O

One CD B-NP O
PAX6 NN I-NP O
mutation NN I-NP O
found VBN B-VP O
in IN B-PP O
the DT B-NP O
PST NN I-NP O
region NN I-NP O
was VBD B-VP O
associated VBN I-VP O
with IN B-PP O
cataracts NNS B-NP B-Disease
in IN B-PP O
an DT B-NP O
aniridia NN I-NP B-Disease
family NN I-NP O
. . O O

Another DT B-NP O
splice NN I-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
PST NN I-NP O
domain NN I-NP O
occurred VBD B-VP O
in IN B-PP O
an DT B-NP O
aniridia NN I-NP B-Disease
patient NN I-NP O
with IN B-PP O
anosmia NN B-NP B-Disease
( ( O O
inability NN B-NP O
to TO B-VP O
smell VB I-VP O
) ) O O
. . O O

The DT B-NP O
six CD I-NP O
new JJ I-NP O
aniridia NN I-NP B-Disease
cases NNS I-NP O
reported VBN B-VP O
here RB B-ADVP O
have VBP B-VP O
mutations NNS B-NP O
predicted VBN B-VP O
to TO B-VP O
generate VB I-VP O
incomplete JJ B-NP O
PAX6 NN I-NP O
proteins NNS I-NP O
. . O O

These DT B-NP O
results NNS I-NP O
support VBP B-VP O
the DT B-NP O
theory NN I-NP O
that IN B-SBAR O
human JJ B-NP O
aniridia NN I-NP B-Disease
is VBZ B-VP O
caused VBN I-VP O
by IN B-PP O
haploinsufficiency NN B-NP B-Disease
of IN B-PP I-Disease
PAX6 NN B-NP I-Disease
. . O O

. . O O

The DT B-NP O
carrier NN I-NP O
frequency NN I-NP O
of IN B-PP O
the DT B-NP O
BRCA1 NN I-NP O
185delAG NN I-NP O
mutation NN I-NP O
is VBZ B-VP O
approximately RB B-NP O
1 CD I-NP O
percent NN I-NP O
in IN B-PP O
Ashkenazi NNP B-NP O
Jewish JJ I-NP O
individuals NNS I-NP O
. . O O

Since IN B-PP O
BRCA1 NN B-NP O
, , O O
the DT B-NP O
first JJ I-NP O
major JJ I-NP O
gene NN I-NP O
responsible JJ B-ADJP O
for IN B-PP O
inherited VBN B-NP B-Disease
breast NN I-NP I-Disease
cancer NN I-NP I-Disease
, , O O
was VBD B-VP O
cloned VBN I-VP O
, , O O
more JJR B-NP O
than IN I-NP O
50 CD I-NP O
unique JJ I-NP O
mutations NNS I-NP O
have VBP B-VP O
been VBN I-VP O
detected VBN I-VP O
in IN B-PP O
the DT B-NP O
germline NN I-NP O
of IN B-PP O
individuals NNS B-NP O
with IN B-PP O
breast NN B-NP B-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
. . O O

In IN B-PP O
high JJ B-NP O
- HYPH I-NP O
risk NN I-NP O
pedigrees NNS I-NP O
, , O O
female JJ B-NP O
carriers NNS I-NP O
of IN B-PP O
BRCA1 NN B-NP O
mutations NNS I-NP O
have VBP B-VP O
an DT B-NP O
80 CD I-NP O
- HYPH I-NP O
90 CD I-NP O
% NN I-NP O
lifetime NN I-NP O
risk NN I-NP O
of IN B-PP O
breast NN B-NP B-Disease
cancer NN I-NP I-Disease
, , O O
and CC O O
a DT B-NP O
40 CD I-NP O
- HYPH I-NP O
50 CD I-NP O
% NN I-NP O
risk NN I-NP O
of IN B-PP O
ovarian JJ B-NP B-Disease
cancer NN I-NP I-Disease
. . O O

However RB B-ADVP O
, , O O
the DT B-NP O
mutation NN I-NP O
stats NNS I-NP O
of IN B-PP O
individuals NNS B-NP O
unselected JJ B-ADJP O
for IN B-PP O
breast NN B-NP B-Disease
or CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
has VBZ B-VP O
not RB I-VP O
been VBN I-VP O
determined VBN I-VP O
, , O O
and CC O O
it PRP B-NP O
is VBZ B-VP O
not RB I-VP O
known VBN I-VP O
whether IN B-SBAR O
mutations NNS B-NP O
in IN B-PP O
such JJ B-NP O
individuals NNS I-NP O
confer VBP B-VP O
the DT B-NP O
same JJ I-NP O
risk NN I-NP O
of IN B-PP O
cancer NN B-NP B-Disease
as IN B-PP O
in IN B-PP O
individuals NNS B-NP O
from IN B-PP O
the DT B-NP O
high JJ I-NP O
- HYPH I-NP O
risk NN I-NP O
families NNS I-NP O
studied VBN B-VP O
so RB B-ADVP O
far RB I-ADVP O
. . O O

Following VBG B-PP O
the DT B-NP O
finding NN I-NP O
of IN B-PP O
a DT B-NP O
185delAG NN I-NP O
frameshift NN I-NP O
mutation NN I-NP O
in IN B-PP O
several JJ B-NP O
Ashkenazi NNP I-NP O
Jewish JJ I-NP O
breast NN I-NP O
/ SYM B-NP O
ovarian JJ B-NP O
families NNS I-NP O
, , O O
we PRP B-NP O
have VBP B-VP O
determined VBN I-VP O
the DT B-NP O
frequency NN I-NP O
of IN B-PP O
this DT B-NP O
mutation NN I-NP O
in IN B-PP O
858 CD B-NP O
Ashkenazim NN I-NP O
seeking VBG B-VP O
genetic JJ B-NP O
testing NN I-NP O
for IN B-PP O
conditions NNS B-NP O
unrelated JJ B-ADJP O
to TO B-PP O
cancer NN B-NP B-Disease
, , O O
and CC O O
in IN B-PP O
815 CD B-NP O
reference NN I-NP O
individuals NNS I-NP O
not RB B-VP O
selected VBN I-VP O
for IN B-PP O
ethnic JJ B-NP O
origin NN I-NP O
. . O O

We PRP B-NP O
observed VBD B-VP O
the DT B-NP O
185delAG NN I-NP O
mutation NN I-NP O
in IN B-PP O
0 CD B-NP O
. . O O

9 CD B-NP O
% NN I-NP O
of IN B-PP O
Ashkenazim NN B-NP O
( ( O O
95 CD B-NP O
% NN I-NP O
confidence NN I-NP O
limit NN I-NP O
, , O O
0 CD B-NP O
. . O O

4 CD B-NP O
- HYPH B-NP O
1 CD I-NP O
. . O O

8 CD B-NP O
% NN I-NP O
) ) O O
and CC O O
in IN B-PP O
none NN B-NP O
of IN B-PP O
the DT B-NP O
reference NN I-NP O
samples NNS I-NP O
. . O O

Our PRP$ B-NP O
results NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
one CD B-NP O
in IN B-PP O
a DT B-NP O
hundred CD I-NP O
women NNS I-NP O
of IN B-PP O
Ashkenazi NNP B-NP O
descent NN I-NP O
may MD B-VP O
be VB I-VP O
at IN B-PP O
especially RB B-NP O
high JJ I-NP O
risk NN I-NP O
of IN B-PP O
developing VBG B-VP O
breast NN B-NP B-Disease
and CC O I-Disease
/ SYM B-NP I-Disease
or CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
. . O O

Identification NN B-NP O
and CC I-NP O
localization NN I-NP O
of IN B-PP O
huntingtin NN B-NP O
in IN B-PP O
brain NN B-NP O
and CC O O
human JJ B-NP O
lymphoblastoid JJ I-NP O
cell NN I-NP O
lines NNS I-NP O
with IN B-PP O
anti AFX B-NP O
- HYPH I-NP O
fusion NN I-NP O
protein NN I-NP O
antibodies NNS I-NP O
. . O O

The DT B-NP O
Huntington NNP I-NP B-Disease
disease NN I-NP I-Disease
( ( O O
HD NN B-NP B-Disease
) ) O O
phenotype NN B-NP O
is VBZ B-VP O
associated VBN I-VP O
with IN B-PP O
expansion NN B-NP O
of IN B-PP O
a DT B-NP O
trinucleotide NN I-NP O
repeat NN I-NP O
in IN B-PP O
the DT B-NP O
IT15 NN I-NP O
gene NN I-NP O
, , O O
which WDT B-NP O
is VBZ B-VP O
predicted VBN I-VP O
to TO I-VP O
encode VB I-VP O
a DT B-NP O
348 CD I-NP O
- HYPH I-NP O
kDa NN I-NP O
protein NN I-NP O
named VBN B-VP O
huntington NN B-NP O
. . O O

We PRP B-NP O
used VBD B-VP O
polyclonal JJ B-NP O
and CC I-NP O
monoclonal JJ I-NP O
anti AFX I-NP O
- HYPH I-NP O
fusion NN I-NP O
protein NN I-NP O
antibodies NNS I-NP O
to TO B-VP O
identify VB I-VP O
native JJ B-NP O
huntingtin NN I-NP O
in IN B-PP O
rat NN B-NP O
, , O O
monkey NN B-NP O
, , O O
and CC O O
human JJ B-ADJP O
. . O O

Western JJ B-NP O
blots NNS I-NP O
revealed VBD B-VP O
a DT B-NP O
protein NN I-NP O
with IN B-PP O
the DT B-NP O
expected VBN I-NP O
molecular JJ I-NP O
weight NN I-NP O
which WDT B-NP O
is VBZ B-VP O
present JJ B-ADJP O
in IN B-PP O
the DT B-NP O
soluble JJ I-NP O
fraction NN I-NP O
of IN B-PP O
rat NN B-NP O
and CC I-NP O
monkey NN I-NP O
brain NN I-NP O
tissues NNS I-NP O
and CC O O
lymphoblastoid JJ B-NP O
cells NNS I-NP O
from IN B-PP O
control NN B-NP O
cases NNS I-NP O
. . O O

In IN B-PP O
lymphoblastoid JJ B-NP O
cell NN I-NP O
lines NNS I-NP O
from IN B-PP O
juvenile JJ B-NP O
- HYPH I-NP O
onset NN I-NP O
heterozygote NN I-NP O
HD NN I-NP B-Disease
cases NNS I-NP O
, , O O
both DT B-NP O
normal JJ I-NP O
and CC I-NP O
mutant JJ I-NP O
huntingtin NN I-NP O
are VBP B-VP O
expressed VBN I-VP O
, , O O
and CC O O
increasing VBG B-VP O
repeat NN B-NP O
expansion NN I-NP O
leads VBZ B-VP O
to TO B-PP O
lower JJR B-NP O
levels NNS I-NP O
of IN B-PP O
the DT B-NP O
mutant JJ I-NP O
protein NN I-NP O
. . O O

Immunocytochemistry NN B-NP O
indicates VBZ B-VP O
that IN B-SBAR O
huntingtin NN B-NP O
is VBZ B-VP O
located VBN I-VP O
in IN B-PP O
neurons NNS B-NP O
throughout IN B-PP O
the DT B-NP O
brain NN I-NP O
, , O O
with IN B-PP O
the DT B-NP O
highest JJS I-NP O
levels NNS I-NP O
evident JJ B-ADJP O
in IN B-PP O
larger JJR B-NP O
neurons NNS I-NP O
. . O O

In IN B-PP O
the DT B-NP O
human JJ I-NP O
striatum NN I-NP O
, , O O
huntingtin NN B-NP O
is VBZ B-VP O
enriched VBN I-VP O
in IN B-PP O
a DT B-NP O
patch NN I-NP O
- HYPH B-NP O
like JJ I-NP O
distribution NN I-NP O
, , O O
potentially RB B-VP O
corresponding VBG I-VP O
to TO B-PP O
the DT B-NP O
first JJ I-NP O
areas NNS I-NP O
affected VBN B-VP O
in IN B-PP O
HD NN B-NP B-Disease
. . O O

Subcellular JJ B-NP O
localization NN I-NP O
of IN B-PP O
huntingtin NN B-NP O
is VBZ B-VP O
consistent JJ B-ADJP O
with IN B-PP O
a DT B-NP O
cytosolic JJ I-NP O
protein NN I-NP O
primarily RB B-VP O
found VBN I-VP O
in IN B-PP O
somatodendritic JJ B-NP O
regions NNS I-NP O
. . O O

Huntingtin NN B-NP O
appears VBZ B-VP O
to TO I-VP O
particularly RB I-VP O
associate VB I-VP O
with IN B-PP O
microtubules NNS B-NP O
, , O O
although IN B-SBAR O
some DT B-NP O
is VBZ B-VP O
also RB I-VP O
associated VBN I-VP O
with IN B-PP O
synaptic JJ B-NP O
vesicles NNS I-NP O
. . O O

On IN B-PP O
the DT B-NP O
basis NN I-NP O
of IN B-PP O
the DT B-NP O
localization NN I-NP O
of IN B-PP O
huntingtin NN B-NP O
in IN B-PP O
association NN B-NP O
with IN B-PP O
microtubules NNS B-NP O
, , O O
we PRP B-NP O
speculate VBP B-VP O
that IN B-SBAR O
the DT B-NP O
mutation NN I-NP O
impairs VBZ B-VP O
the DT B-NP O
cytoskeletal JJ I-NP O
anchoring NN I-NP O
or CC I-NP O
transport NN I-NP O
of IN B-PP O
mitochondria NNS B-NP O
, , O O
vesicles NNS B-NP O
, , O O
or CC O O
other JJ B-NP O
organelles NNS I-NP O
or CC I-NP O
molecules NNS I-NP O
. . O O

. . O O

Marked VBN B-NP O
phenotypic JJ I-NP O
heterogeneity NN I-NP O
associated VBN B-VP O
with IN B-PP O
expansion NN B-NP O
of IN B-PP O
a DT B-NP O
CAG NN I-NP O
repeat NN I-NP O
sequence NN I-NP O
at IN B-PP O
the DT B-NP O
spinocerebellar JJ I-NP B-Disease
ataxia NN I-NP I-Disease
3 CD I-NP I-Disease
/ SYM I-NP I-Disease
Machado NNP I-NP I-Disease
- HYPH I-NP I-Disease
Joseph NNP I-NP I-Disease
disease NN I-NP I-Disease
locus NN I-NP O
. . O O

The DT B-NP O
spinocerebellar JJ I-NP B-Disease
ataxia NN I-NP I-Disease
3 CD I-NP I-Disease
locus NN I-NP O
( ( O O
SCA3 NN B-NP B-Disease
) ) O O
for IN B-PP O
type NN B-NP B-Disease
I CD I-NP I-Disease
autosomal JJ I-NP I-Disease
dominant JJ I-NP I-Disease
cerebellar JJ I-NP I-Disease
ataxia NN I-NP I-Disease
( ( O O
ADCA NN B-NP B-Disease
type NN I-NP I-Disease
I CD I-NP I-Disease
) ) O O
, , O O
a DT B-NP O
clinically RB I-NP O
and CC O O
genetically RB B-NP O
heterogeneous JJ I-NP O
group NN I-NP O
of IN B-PP O
neurodegenerative JJ B-NP B-Disease
disorders NNS I-NP I-Disease
, , O O
has VBZ B-VP O
been VBN I-VP O
mapped VBN I-VP O
to TO B-PP O
chromosome NN B-NP O
14q32 NN I-NP O
. . O O

1 CD B-NP O
1 CD I-NP O
. . O O

ADCA NN B-NP B-Disease
type NN I-NP I-Disease
I CD B-NP I-Disease
patients NNS I-NP O
from IN B-PP O
families NNS B-NP O
segregating VBG B-VP O
SCA3 NN B-NP B-Disease
share NN I-NP O
clinical JJ B-NP O
features NNS I-NP O
in IN B-PP O
common JJ B-ADJP O
with IN B-PP O
those DT B-NP O
with IN B-PP O
Machado NNP B-NP B-Disease
- HYPH I-NP I-Disease
Joseph NNP I-NP I-Disease
disease NN I-NP I-Disease
( ( O O
MJD NN B-NP B-Disease
) ) O O
, , O O
the DT B-NP O
gene NN I-NP O
of IN B-PP O
which WDT B-NP O
maps VBZ B-VP O
to TO B-PP O
the DT B-NP O
same JJ I-NP O
region NN I-NP O
. . O O

We PRP B-NP O
show VBP B-VP O
here RB B-ADVP O
that IN B-SBAR O
the DT B-NP O
disease NN I-NP O
gene NN I-NP O
segregating VBG B-VP O
in IN B-PP O
each DT B-NP O
of IN B-PP O
three CD B-NP O
French JJ I-NP O
ADCA NN I-NP B-Disease
type NN I-NP I-Disease
I CD I-NP I-Disease
kindreds NNS I-NP O
and CC B-PP O
in IN B-PP O
a DT B-NP O
French JJ I-NP O
family NN I-NP O
with IN B-PP O
neuropathological JJ B-NP O
findings NNS I-NP O
suggesting VBG B-VP O
the DT B-NP O
ataxochoreic JJ I-NP O
form NN I-NP O
of IN B-PP O
dentatorubropallidoluysian JJ B-NP B-Disease
atrophy NN I-NP I-Disease
carries VBZ B-VP O
an DT B-NP O
expanded VBN I-NP O
CAG NN I-NP O
repeat NN I-NP O
sequence NN I-NP O
located JJ B-ADJP O
at IN B-PP O
the DT B-NP O
same JJ I-NP O
locus NN I-NP O
as IN B-PP O
that DT B-NP O
for IN B-PP O
MJD NN B-NP B-Disease
. . O O

Analysis NN B-NP O
of IN B-PP O
the DT B-NP O
mutation NN I-NP O
in IN B-PP O
these DT B-NP O
families NNS I-NP O
shows VBZ B-VP O
a DT B-NP O
strong JJ I-NP O
negative JJ I-NP O
correlation NN I-NP O
between IN B-PP O
size NN B-NP O
of IN B-PP O
the DT B-NP O
expanded VBN I-NP O
CAG NN I-NP O
repeat NN I-NP O
and CC I-NP O
age NN I-NP O
at IN B-PP O
onset NN B-NP O
of IN B-PP O
clinical JJ B-NP O
disease NN I-NP O
. . O O

Instability NN B-NP O
of IN B-PP O
the DT B-NP O
expanded VBN I-NP O
triplet NN I-NP O
repeat NN I-NP O
was VBD B-VP O
not RB I-VP O
found VBN I-VP O
to TO I-VP O
be VB I-VP O
affected VBN I-VP O
by IN B-PP O
sex NN B-NP O
of IN B-PP O
the DT B-NP O
parent NN I-NP O
transmitting VBG B-VP O
the DT B-NP O
mutation NN I-NP O
. . O O

Evidence NN B-NP O
was VBD B-VP O
found VBN I-VP O
for IN B-PP O
somatic JJ B-NP O
and CC I-NP O
gonadal JJ I-NP O
mosaicism NN I-NP O
for IN B-PP O
alleles NNS B-NP O
carrying VBG B-VP O
expanded VBN B-NP O
trinucleotide NN I-NP O
repeats NNS I-NP O
. . O O

Overexpression NN B-NP O
of IN B-PP O
DM20 NN B-NP O
messenger NN I-NP O
RNA NN I-NP O
in IN B-PP O
two CD B-NP O
brothers NNS I-NP O
with IN B-PP O
Pelizaeus NNP B-NP B-Disease
- HYPH I-NP I-Disease
Merzbacher NNP I-NP I-Disease
disease NN I-NP I-Disease
. . O O

Pelizaeus NNP B-NP B-Disease
- HYPH I-NP I-Disease
Merzbacher NNP I-NP I-Disease
disease NN I-NP I-Disease
is VBZ B-VP O
a DT B-NP O
rare JJ I-NP B-Disease
, , I-NP I-Disease
sex NN I-NP I-Disease
- HYPH I-NP I-Disease
linked VBN B-VP I-Disease
recessive JJ B-ADJP I-Disease
, , O I-Disease
dysmyelinating VBG B-VP I-Disease
disease NN B-NP I-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
central JJ I-NP I-Disease
nervous JJ I-NP I-Disease
system NN I-NP I-Disease
that WDT B-NP O
has VBZ B-VP O
been VBN I-VP O
associated VBN I-VP O
with IN B-PP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
myelin NN I-NP O
proteolipid NN I-NP O
protein NN I-NP O
( ( O O
PLP NN B-NP O
) ) O O
gene NN B-NP O
. . O O

Only RB B-NP O
25 CD I-NP O
% NN I-NP O
of IN B-PP O
patients NNS B-NP O
studied VBN B-VP O
with IN B-PP O
Pelizaeus NNP B-NP B-Disease
- HYPH I-NP I-Disease
Merzbacher NNP I-NP I-Disease
disease NN I-NP I-Disease
have VBP B-VP O
exonic JJ B-NP O
mutations NNS I-NP O
in IN B-PP O
this DT B-NP O
gene NN I-NP O
, , O O
the DT B-NP O
underlying JJ I-NP O
cause NN I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
in IN B-PP O
the DT B-NP O
remaining VBG I-NP O
patients NNS I-NP O
is VBZ B-VP O
unknown JJ B-ADJP O
. . O O

The DT B-NP O
PLP NN I-NP O
gene NN I-NP O
encodes VBZ B-VP O
two CD B-NP O
major JJ I-NP O
alternatively RB I-NP O
spliced VBN I-NP O
transcripts NNS I-NP O
called VBN B-VP O
PLP NN B-NP O
and CC I-NP O
DM20 NN I-NP O
. . O O

PLP NN B-NP O
messenger NN I-NP O
RNA NN I-NP O
is VBZ B-VP O
specifically RB I-VP O
expressed VBN I-VP O
in IN B-PP O
central JJ B-NP O
nervous JJ I-NP O
system NN I-NP O
tissue NN I-NP O
, , O O
whereas IN O O
DM20 NN B-NP O
messenger NN I-NP O
RNA NN I-NP O
is VBZ B-VP O
found VBN I-VP O
in IN B-PP O
central JJ B-NP O
nervous JJ I-NP O
system NN I-NP O
, , O O
cardiac NN B-NP O
, , O O
and CC O O
other JJ B-NP O
tissues NNS I-NP O
. . O O

We PRP B-NP O
studied VBD B-VP O
cultured VBN I-VP O
skin NN B-NP O
fibroblasts NNS I-NP O
from IN B-PP O
2 CD B-NP O
brothers NNS I-NP O
with IN B-PP O
Pelizaeus NNP B-NP B-Disease
- HYPH I-NP I-Disease
Merzbacher NNP I-NP I-Disease
disease NN I-NP I-Disease
who WP B-NP O
exhibited VBD B-VP O
no DT B-NP O
detectable JJ I-NP O
exonic JJ I-NP O
mutation NN I-NP O
of IN B-PP O
the DT B-NP O
PLP NN I-NP O
gene NN I-NP O
. . O O

Examination NN B-NP O
of IN B-PP O
RNA NN B-NP O
from IN B-PP O
these DT B-NP O
cells NNS I-NP O
showed VBD B-VP O
that IN B-SBAR O
the DT B-NP O
level NN I-NP O
of IN B-PP O
DM20 NN B-NP O
messenger NN I-NP O
RNA NN I-NP O
is VBZ B-VP O
elevated VBN I-VP O
sixfold RB B-ADVP O
relative JJ B-ADVP O
to TO B-PP O
male JJ B-NP O
control NN I-NP O
skin NN I-NP O
fibroblasts NNS I-NP O
. . O O

An DT B-NP O
unrelated JJ I-NP O
female JJ I-NP O
carrier NN I-NP O
, , O O
also RB B-ADVP O
with IN B-PP O
no DT B-NP O
detectable JJ I-NP O
exonic JJ I-NP O
mutation NN I-NP O
, , O O
showed VBD B-VP O
a DT B-NP O
threefold JJ I-NP O
increase NN I-NP O
in IN B-PP O
DM20 NN B-NP O
messenger NN I-NP O
RNA NN I-NP O
in IN B-PP O
cultured VBN B-NP O
skin NN I-NP O
fibroblasts NNS I-NP O
. . O O

Our PRP$ B-NP O
findings NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
in IN B-PP O
some DT B-NP O
patients NNS I-NP O
, , O O
Pelizaeus NNP B-NP B-Disease
- HYPH I-NP I-Disease
Merzbacher NNP I-NP I-Disease
disease NN I-NP I-Disease
is VBZ B-VP O
caused VBN I-VP O
by IN B-PP O
overexpression NN B-NP O
of IN B-PP O
PLP NN B-NP O
gene NN I-NP O
transcripts NNS I-NP O
, , O O
and CC O O
that IN B-SBAR O
in IN B-PP O
these DT B-NP O
families NNS I-NP O
a DT B-NP O
50 CD I-NP O
% NN I-NP O
increase NN I-NP O
of IN B-PP O
DM20 NN B-NP O
messenger NN I-NP O
RNA NN I-NP O
in IN B-PP O
females NNS B-NP O
, , O O
relative JJ B-ADVP O
to TO B-PP O
the DT B-NP O
increase NN I-NP O
in IN B-PP O
affected VBN B-NP O
males NNS I-NP O
, , O O
can MD B-VP O
identify VB I-VP O
a DT B-NP O
female JJ I-NP O
carrier NN I-NP O
. . O O

. . O O

The DT B-NP O
Wiskott NNP I-NP B-Disease
- HYPH I-NP I-Disease
Aldrich NNP I-NP I-Disease
syndrome NN I-NP I-Disease
and CC I-NP O
X NN I-NP B-Disease
- HYPH B-VP I-Disease
linked VBN B-NP I-Disease
congenital JJ I-NP I-Disease
thrombocytopenia NN I-NP I-Disease
are VBP B-VP O
caused VBN I-VP O
by IN B-PP O
mutations NNS B-NP O
of IN B-PP O
the DT B-NP O
same JJ I-NP O
gene NN I-NP O
. . O O

The DT B-NP O
Wiskott NNP I-NP B-Disease
- HYPH I-NP I-Disease
Aldrich NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
WAS NN B-NP B-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
X NN I-NP B-Disease
- HYPH O I-Disease
linked VBN B-VP I-Disease
recessive JJ B-NP I-Disease
disorder NN I-NP I-Disease
characterized VBN B-VP O
by IN B-PP O
thrombocytopenia NN B-NP B-Disease
, , O O
small JJ B-NP O
platelets NNS I-NP O
, , O O
eczema NN B-NP B-Disease
, , O O
recurrent JJ B-NP O
infections NNS I-NP O
, , O O
and CC O O
immunodeficiency NN B-NP B-Disease
. . O O

Besides IN B-PP O
the DT B-NP O
classic JJ I-NP O
WAS NN I-NP B-Disease
phenotype NN I-NP O
, , O O
there EX B-NP O
is VBZ B-VP O
a DT B-NP O
group NN I-NP O
of IN B-PP O
patients NNS B-NP O
with IN B-PP O
congenital JJ B-NP B-Disease
X NN I-NP I-Disease
- HYPH O I-Disease
linked VBN B-VP I-Disease
thrombocytopenia NN B-NP I-Disease
( ( O O
XLT NN B-NP B-Disease
) ) O O
who WP B-NP O
have VBP B-VP O
small JJ B-NP O
platelets NNS I-NP O
but CC O O
only RB B-NP O
transient JJ I-NP O
eczema NN I-NP B-Disease
, , O O
if IN B-SBAR O
any DT B-NP O
, , O O
and CC O O
minimal JJ B-NP O
immune JJ I-NP B-Disease
deficiency NN I-NP I-Disease
. . O O

Because IN B-SBAR O
the DT B-NP O
gene NN I-NP O
responsible JJ B-ADJP O
for IN B-PP O
WAS NNP B-NP B-Disease
has VBZ B-VP O
been VBN I-VP O
sequenced VBN I-VP O
, , O O
it PRP B-NP O
was VBD B-VP O
possible JJ B-ADJP O
to TO B-VP O
correlate VB I-VP O
the DT B-NP O
WAS NNP I-NP B-Disease
phenotypes NNS I-NP O
with IN B-PP O
WAS NN B-NP B-Disease
gene NN I-NP O
mutations NNS I-NP O
. . O O

Using VBG B-VP O
a DT B-NP O
fingerprinting NN I-NP O
screening NN I-NP O
technique NN I-NP O
, , O O
we PRP B-NP O
determined VBD B-VP O
the DT B-NP O
approximate JJ I-NP O
location NN I-NP O
of IN B-PP O
the DT B-NP O
mutation NN I-NP O
in IN B-PP O
13 CD B-NP O
unrelated JJ I-NP O
WAS NN I-NP B-Disease
patients NNS I-NP O
with IN B-PP O
mild JJ B-ADJP O
to TO B-PP O
severe JJ B-NP O
clinical JJ I-NP O
symptoms NNS I-NP O
. . O O

Direct JJ B-NP O
sequence NN I-NP O
analysis NN I-NP O
of IN B-PP O
cDNA NN B-NP O
and CC O O
genomic JJ B-NP O
DNA NN I-NP O
obtained VBN B-VP O
from IN B-PP O
patient NN B-NP O
- HYPH B-PP O
derived VBN B-NP O
cell NN I-NP O
lines NNS I-NP O
showed VBD B-VP O
12 CD B-NP O
unique JJ I-NP O
mutations NNS I-NP O
distributed VBN B-VP O
throughout IN B-PP O
the DT B-NP O
WAS NN I-NP B-Disease
gene NN I-NP O
, , O O
including VBG B-PP O
insertions NNS B-NP O
, , O O
deletions NNS B-NP O
, , O O
and CC O O
point NN B-NP O
mutations NNS I-NP O
resulting VBG B-VP O
in IN B-PP O
amino JJ B-NP O
acid NN I-NP O
substitutions NNS I-NP O
, , O O
termination NN B-NP O
, , O O
exon NN B-NP O
skipping NN I-NP O
, , O O
or CC O O
splicing NN B-NP O
defects NNS I-NP O
. . O O

Of IN B-PP O
4 CD B-NP O
unrelated JJ I-NP O
patients NNS I-NP O
with IN B-PP O
the DT B-NP O
XLT NN I-NP B-Disease
phenotype NN I-NP O
, , O O
3 CD B-NP O
had VBD B-VP O
missense JJ B-NP O
mutations NNS I-NP O
affecting VBG B-VP O
exon NN B-NP O
2 CD I-NP O
and CC I-NP O
1 CD I-NP O
had VBD B-VP O
a DT B-NP O
splice NN I-NP O
- HYPH B-NP O
site NN I-NP O
mutation NN I-NP O
affecting VBG B-VP O
exon NN B-NP O
9 CD I-NP O
. . O O

Patients NNS B-NP O
with IN B-PP O
classic JJ B-NP O
WAS NN I-NP B-Disease
had VBD B-VP O
more RBR B-NP O
complex JJ I-NP O
mutations NNS I-NP O
, , O O
resulting VBG B-VP O
in IN B-PP O
termination NN B-NP O
codons NNS I-NP O
, , O O
frameshift NN B-NP O
, , O O
and CC O O
early JJ B-NP O
termination NN I-NP O
. . O O

These DT B-NP O
findings NNS I-NP O
provide VBP B-VP O
direct JJ B-NP O
evidence NN I-NP O
that IN B-SBAR O
XLT NN B-NP B-Disease
and CC I-NP O
WAS NN I-NP B-Disease
are VBP B-VP O
caused VBN I-VP O
by IN B-PP O
mutations NNS B-NP O
of IN B-PP O
the DT B-NP O
same JJ I-NP O
gene NN I-NP O
and CC O O
suggest VBP B-VP O
that IN B-SBAR O
severe JJ B-NP O
clinical JJ I-NP O
phenotypes NNS I-NP O
are VBP B-VP O
associated VBN I-VP O
with IN B-PP O
complex JJ B-NP O
mutations NNS I-NP O
. . O O

. . O O

Myotonia NN B-NP B-Disease
levior NN I-NP I-Disease
is VBZ B-VP O
a DT B-NP O
chloride NN I-NP B-Disease
channel NN I-NP I-Disease
disorder NN I-NP I-Disease
. . O O

The DT B-NP O
group NN I-NP O
of IN B-PP O
dominant JJ B-NP B-Disease
non AFX I-NP I-Disease
- HYPH I-NP I-Disease
dystrophic JJ I-NP I-Disease
myotonias NNS I-NP I-Disease
, , O O
comprising VBG B-VP O
disorders NNS B-NP O
characterized VBN B-VP O
by IN B-PP O
clinically RB B-NP O
similar JJ I-NP O
forms NNS I-NP O
of IN B-PP O
myogenic JJ B-NP O
muscle NN I-NP O
stiffness NN I-NP O
, , O O
is VBZ B-VP O
genetically RB B-ADJP O
inhomogeneous JJ I-ADJP O
. . O O

Dominant JJ B-NP B-Disease
myotonia NN I-NP I-Disease
congenita NN I-NP I-Disease
( ( O O
Thomsens NNP B-NP B-Disease
disease NN I-NP I-Disease
) ) O O
is VBZ B-VP O
linked VBN I-VP O
to TO B-PP O
CLCN1 NN B-NP O
, , O O
the DT B-NP O
gene NN I-NP O
encoding VBG B-VP O
the DT B-NP O
major JJ I-NP O
muscle NN I-NP O
chloride NN I-NP O
channel NN I-NP O
, , O O
localized VBN B-VP O
on IN B-PP O
chromosome NN B-NP O
7q35 CD I-NP O
. . O O

In IN B-PP O
contrast NN B-NP O
, , O O
dominant JJ B-NP B-Disease
myotonias NNS I-NP I-Disease
sensitive JJ B-ADJP O
to TO B-PP O
potassium NN B-NP O
are VBP B-VP O
caused VBN I-VP O
by IN B-PP O
point NN B-NP O
mutations NNS I-NP O
in IN B-PP O
SCN4A NN B-NP O
on IN B-PP O
chromosome NN B-NP O
17q NN I-NP O
, , O O
the DT B-NP O
gene NN I-NP O
for IN B-PP O
the DT B-NP O
alpha NN I-NP O
subunit NN I-NP O
of IN B-PP O
the DT B-NP O
adult JJ I-NP O
skeletal JJ I-NP O
muscle NN I-NP O
sodium NN I-NP O
channel NN I-NP O
. . O O

No DT B-NP O
linkage NN I-NP O
or CC O O
molecular JJ B-NP O
genetic JJ I-NP O
data NNS I-NP O
are VBP B-VP O
as IN B-SBAR O
yet RB B-ADJP O
available JJ I-ADJP O
on IN B-PP O
myotonia NN B-NP B-Disease
levior NN I-NP I-Disease
characterized VBN B-VP O
by IN B-PP O
milder JJR B-NP O
symptoms NNS I-NP O
and CC O O
later JJ B-NP O
onset NN I-NP O
of IN B-PP O
myotonia NN B-NP B-Disease
than IN B-PP O
in IN B-PP O
Thomsens NNP B-NP B-Disease
disease NN I-NP I-Disease
, , O O
and CC O O
absence NN B-NP O
of IN B-PP O
muscle NN B-NP B-Disease
hypertrophy NN I-NP I-Disease
. . O O

We PRP B-NP O
report VBP B-VP O
a DT B-NP O
CLCN1 NN I-NP O
Gln NN I-NP O
- HYPH B-NP O
552 CD I-NP O
- HYPH I-NP O
Arg NN I-NP O
substitution NN I-NP O
for IN B-PP O
a DT B-NP O
family NN I-NP O
with IN B-PP O
dominant JJ B-NP O
inheritance NN I-NP O
previously RB B-VP O
diagnosed VBN I-VP O
to TO I-VP O
have VB I-VP O
myotonia NN B-NP B-Disease
levior NN I-NP I-Disease
. . O O

Thus RB B-ADVP O
, , O O
this DT B-NP O
disorder NN I-NP O
appears VBZ B-VP O
as IN B-PP O
a DT B-NP O
variant NN I-NP O
of IN B-PP O
Thomsens NNP B-NP B-Disease
disease NN I-NP I-Disease
due JJ B-ADJP O
to TO B-PP O
mutations NNS B-NP O
leading VBG B-VP O
to TO B-PP O
low JJ B-NP O
clinical JJ I-NP O
expressivity NN I-NP O
. . O O

In IN B-PP O
addition NN B-NP O
, , O O
we PRP B-NP O
report VBP B-VP O
a DT B-NP O
novel JJ I-NP O
Ile NNP I-NP O
- HYPH B-NP O
290 CD I-NP O
- HYPH I-NP O
Met NN I-NP O
CLCN1 NN I-NP O
mutation NN I-NP O
for IN B-PP O
a DT B-NP O
typical JJ I-NP O
Thomsen NNP I-NP O
pedigree NN I-NP O
. . O O

In IN B-PP O
another DT B-NP O
family NN I-NP O
previously RB B-VP O
diagnosed VBN I-VP O
as IN B-PP O
having VBG B-VP O
Thomsens NNP B-NP B-Disease
disease NN I-NP I-Disease
, , O O
we PRP B-NP O
unexpectedly RB B-ADVP O
found VBD B-VP O
a DT B-NP O
CLCN1 NN I-NP O
14 CD I-NP O
bp NN I-NP O
deletion NN I-NP O
known VBN B-VP O
to TO I-VP O
cause VB I-VP O
recessive JJ B-NP B-Disease
myotonia NN I-NP I-Disease
, , O O
and CC O O
a DT B-NP O
rare JJ I-NP O
Trp NN I-NP O
- HYPH B-NP O
118 CD I-NP O
- HYPH I-NP O
Gly NN I-NP O
polymorphism NN I-NP O
. . O O

. . O O

Southern JJ B-NP O
analysis NN I-NP O
reveals VBZ B-VP O
a DT B-NP O
large JJ I-NP O
deletion NN I-NP O
at IN B-PP O
the DT B-NP O
hypoxanthine NN I-NP O
phosphoribosyltransferase NN I-NP O
locus NN I-NP O
in IN B-PP O
a DT B-NP O
patient NN I-NP O
with IN B-PP O
Lesch NNP B-NP B-Disease
- HYPH I-NP I-Disease
Nyhan NNP I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

Whole JJ B-NP O
genomic JJ I-NP O
hprt NN I-NP O
clones NNS I-NP O
were VBD B-VP O
used VBN I-VP O
in IN B-PP O
Southern JJ B-NP O
analysis NN I-NP O
to TO B-VP O
screen VB I-VP O
the DT B-NP O
integrity NN I-NP O
of IN B-PP O
the DT B-NP O
hprt NN I-NP O
gene NN I-NP O
in IN B-PP O
a DT B-NP O
family NN I-NP O
that WDT B-NP O
includes VBZ B-VP O
a DT B-NP O
patient NN I-NP O
with IN B-PP O
HPRT NN B-NP B-Disease
enzyme NN I-NP I-Disease
deficiency NN I-NP I-Disease
causal JJ B-ADJP O
to TO B-PP O
Lesch NNP B-NP B-Disease
- HYPH I-NP I-Disease
Nyhan NNP I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

A DT B-NP O
5 CD I-NP O
kb NN I-NP O
DNA NN I-NP O
sequence NN I-NP O
deletion NN I-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
have VB I-VP O
its PRP$ B-NP O
endpoints NNS I-NP O
in IN B-PP O
the DT B-NP O
first JJ I-NP O
and CC I-NP O
third JJ I-NP O
introns NNS I-NP O
. . O O

The DT B-NP O
probes NNS I-NP O
identified VBD B-VP O
the DT B-NP O
carrier NN I-NP O
status NN I-NP O
of IN B-PP O
female JJ B-NP O
family NN I-NP O
members NNS I-NP O
, , O O
aided VBN B-VP O
by IN B-PP O
an DT B-NP O
RFLP NN I-NP O
carried VBN B-VP O
by IN B-PP O
the DT B-NP O
mothers NNS I-NP O
normal JJ B-NP O
X NN I-NP O
- HYPH B-NP O
chromosome NN I-NP O
. . O O

. . O O

Characterisation NN B-NP O
of IN B-PP O
molecular JJ B-NP O
defects NNS I-NP O
in IN B-PP O
X NN B-NP B-Disease
- HYPH B-NP I-Disease
linked VBN I-NP I-Disease
amelogenesis NN I-NP I-Disease
imperfecta NN I-NP I-Disease
( ( O O
AIH1 NN B-NP O
) ) O O
. . O O

Amelogenins NNS B-NP O
are VBP B-VP O
an DT B-NP O
heterogenous JJ I-NP O
family NN I-NP O
of IN B-PP O
proteins NNS B-NP O
produced VBN B-VP O
by IN B-PP O
ameloblasts NNS B-NP O
of IN B-PP O
the DT B-NP O
enamel NN I-NP O
organ NN I-NP O
during IN B-PP O
tooth DT B-NP O
development NN I-NP O
. . O O

Disturbances NNS B-NP O
of IN B-PP O
enamel NN B-NP O
formation NN I-NP O
occur VBP B-VP O
in IN B-PP O
amelogenesis NN B-NP B-Disease
imperfecta NN I-NP I-Disease
, , O O
a DT B-NP O
clinically RB I-NP O
heterogenous JJ I-NP O
group NN I-NP O
of IN B-PP O
inherited VBN B-NP B-Disease
disorders NNS I-NP I-Disease
characterised VBN B-VP O
by IN B-PP O
defective JJ B-NP O
enamel NN I-NP O
biomineralisation NN I-NP O
. . O O

An DT B-NP O
amelogenin NN I-NP O
gene NN I-NP O
, , O O
AMGX NN B-NP O
, , O O
has VBZ B-VP O
been VBN I-VP O
mapped VBN I-VP O
to TO B-PP O
the DT B-NP O
short JJ I-NP O
of IN B-PP O
the DT B-NP O
X NN I-NP O
chromosome NN I-NP O
( ( O O
Xp22 NN B-NP O
. . O O

1 CD B-NP O
- HYPH I-NP O
p22 NN I-NP O
. . I-NP O

3 CD I-NP O
) ) O O
and CC O O
has VBZ B-VP O
been VBN I-VP O
implicated VBN I-VP O
in IN B-PP O
the DT B-NP O
molecular JJ I-NP O
pathology NN I-NP O
of IN B-PP O
X NN B-NP B-Disease
- HYPH O I-Disease
linked VBN B-NP I-Disease
amelogenesis NN I-NP I-Disease
imperfecta NN I-NP I-Disease
( ( O O
AIH1 NN B-NP B-Disease
) ) O O
. . O O

We PRP B-NP O
have VBP B-VP O
identified VBN I-VP O
three CD B-NP O
families NNS I-NP O
exhibiting VBG B-VP O
AIH1 NN B-NP B-Disease
and CC O O
screened VBD B-VP O
the DT B-NP O
AMGX NN I-NP O
gene NN I-NP O
for IN B-PP O
mutations NNS B-NP O
using VBG B-VP O
single JJ B-NP O
- HYPH I-NP O
strand NN I-NP O
conformational JJ I-NP O
polymorphism NN I-NP O
analysis NN I-NP O
and CC O O
DNA NN B-NP O
sequencing NN I-NP O
. . O O

Three CD B-NP O
novel JJ I-NP O
mutations NNS I-NP O
were VBD B-VP O
identified VBN I-VP O
a DT B-NP O
C NN I-NP O
- HYPH I-NP O
T NN I-NP O
substitution NN I-NP O
in IN B-PP O
exon NN B-NP O
5 CD I-NP O
, , O O
and CC O O
a DT B-NP O
G NN I-NP O
- HYPH I-NP O
T NN I-NP O
substitution NN I-NP O
and CC O O
single JJ B-NP O
cytosine NN I-NP O
deletion NN I-NP O
in IN B-PP O
exon NN B-NP O
6 CD I-NP O
, , O O
confirming VBG B-VP O
the DT B-NP O
existence NN I-NP O
of IN B-PP O
extensive JJ B-NP O
allelic JJ I-NP O
heterogeneity NN I-NP O
in IN B-PP O
this DT B-NP O
condition NN I-NP O
. . O O

The DT B-NP O
identification NN I-NP O
of IN B-PP O
family NN B-NP O
- HYPH I-NP O
specific JJ I-NP O
mutations NNS I-NP O
will MD B-VP O
enable VB I-VP O
early JJ B-NP O
identification NN I-NP O
of IN B-PP O
affected VBN B-NP O
individuals NNS I-NP O
and CC O O
correlation NN B-NP O
of IN B-PP O
clinical JJ B-NP O
phenotype NN I-NP O
with IN B-PP O
genotype NN B-NP O
will MD B-VP O
facilitate VB I-VP O
an DT B-NP O
objective JJ I-NP O
system NN I-NP O
of IN B-PP O
disease NN B-NP O
classification NN I-NP O
. . O O

Frequency NN B-NP O
of IN B-PP O
exon NN B-NP O
15 CD I-NP O
missense JJ I-NP O
mutation NN I-NP O
( ( O O
442D NN B-NP O
: : O O
G NN B-NP O
) ) O O
in IN B-PP O
cholesteryl NN B-NP O
ester NN I-NP O
transfer NN I-NP O
protein NN I-NP O
gene NN I-NP O
in IN B-PP O
hyperalphalipoproteinemic JJ B-NP B-Disease
Japanese JJ I-NP O
subjects NNS I-NP O
. . O O

Cholesteryl NN B-NP O
ester NN I-NP O
transfer NN I-NP O
protein NN I-NP O
( ( O O
CETP NN B-NP O
) ) O O
transfers VBZ B-VP O
cholesteryl NN B-NP O
ester NN I-NP O
from IN B-PP O
high JJ B-NP O
density NN I-NP O
lipoprotein NN I-NP O
( ( O O
HDL NN B-NP O
) ) O O
to TO B-VP O
apo VB I-VP O
B NN B-NP O
- HYPH O O
containing VBG B-VP O
lipoproteins NNS B-NP O
. . O O

The DT B-NP O
hyperalphalipoproteinemia NN I-NP B-Disease
caused VBN B-VP O
by IN B-PP O
CETP NN B-NP B-Disease
deficiency NN I-NP I-Disease
is VBZ B-VP O
fairly RB B-ADJP O
common JJ I-ADJP O
in IN B-PP O
Japan NNP B-NP O
and CC O O
one CD B-NP O
of IN B-PP O
the DT B-NP O
most RBS I-NP O
common JJ I-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
CETP NN I-NP O
gene NN I-NP O
is VBZ B-VP O
the DT B-NP O
splicing NN I-NP O
defect NN I-NP O
of IN B-PP O
the DT B-NP O
intron NN I-NP O
14 CD I-NP O
, , O O
the DT B-NP O
allelic JJ I-NP O
frequency NN I-NP O
of IN B-PP O
which WDT B-NP O
has VBZ B-VP O
been VBN I-VP O
shown VBN I-VP O
to TO I-VP O
be VB I-VP O
0 CD B-NP O
. . O O

0049 CD B-NP O
in IN B-PP O
the DT B-NP O
Japanese JJ I-NP O
general JJ I-NP O
population NN I-NP O
. . O O

Recently RB B-ADVP O
, , O O
we PRP B-NP O
have VBP B-VP O
reported VBN I-VP O
a DT B-NP O
missense JJ I-NP O
mutation NN I-NP O
in IN B-PP O
exon NN B-NP O
15 CD I-NP O
of IN B-PP O
the DT B-NP O
CETP NN I-NP O
gene NN I-NP O
( ( O O
442D NN B-NP O
G NN I-NP O
) ) O O
, , O O
showing VBG B-VP O
a DT B-NP O
dominant JJ I-NP O
effect NN I-NP O
on IN B-PP O
the DT B-NP O
CETP NN I-NP O
activity NN I-NP O
and CC I-NP O
HDL NN I-NP O
- HYPH I-NP O
cholesterol NN I-NP O
level NN I-NP O
. . O O

In IN B-PP O
the DT B-NP O
current JJ I-NP O
study NN I-NP O
, , O O
we PRP B-NP O
determined VBD B-VP O
the DT B-NP O
frequency NN I-NP O
of IN B-PP O
this DT B-NP O
new JJ I-NP O
mutation NN I-NP O
in IN B-PP O
Japanese JJ B-NP O
hyperalphalipoproteinemic JJ I-NP B-Disease
( ( O O
HDL NN B-NP O
- HYPH I-NP O
cholesterol NN I-NP O
> SYM B-VP O
or CC O O
= SYM B-VP O
100 CD B-NP O
mg NN I-NP O
/ SYM B-NP O
dl NN I-NP O
) ) O O
subjects NNS B-NP O
. . O O

A DT B-NP O
rapid JJ I-NP O
and CC I-NP O
easy JJ I-NP O
screening NN I-NP O
method NN I-NP O
for IN B-PP O
this DT B-NP O
new JJ I-NP O
mutation NN I-NP O
was VBD B-VP O
developed VBN I-VP O
using VBG B-VP O
a DT B-NP O
polymerase NN I-NP O
chain NN I-NP O
reaction NN I-NP O
( ( O O
PCR NN B-NP O
) ) O O
- HYPH O O
mediated VBN B-NP O
site NN I-NP O
- HYPH O O
directed VBN B-NP O
mutagenesis NN I-NP O
. . O O

Among IN B-PP O
117 CD B-NP O
Japanese JJ I-NP O
hyperalphalipoproteinemic JJ I-NP B-Disease
subjects NNS I-NP O
( ( O O
HDL NN B-NP O
- HYPH O O
cholesterol NN B-NP O
; : O O
116 CD B-NP O
. . I-NP O

7 CD I-NP O
+ SYM O O
/ SYM B-NP O
- SYM B-NP O
16 CD B-NP O
. SYM I-NP O

5 CD I-NP O
mg NN I-NP O
/ SYM B-VP O
dl NN B-NP O
, , O O
mean NN B-NP O
+ SYM B-VP O
/ SYM B-NP O
- HYPH I-NP O
S NN I-NP O
. . I-NP O

D NN I-NP O
. . O O

) ) O O
without IN B-PP O
the DT B-NP O
intron NN I-NP O
14 CD I-NP O
splice NN I-NP O
defect NN I-NP O
, , O O
three CD B-NP O
homozygotes NNS I-NP O
( ( O O
2 CD B-NP O
. . O O

5 CD B-NP O
% NN I-NP O
) ) O O
and CC O O
34 CD B-NP O
heterozygotes NNS I-NP O
( ( O O
29 CD B-NP O
. . O O

1 CD B-NP O
% NN I-NP O
) ) O O
were VBD B-VP O
found VBN I-VP O
to TO I-VP O
have VB I-VP O
the DT B-NP O
442D NN I-NP O
G NN I-NP O
mutation NN I-NP O
. . O O

The DT B-NP O
relative JJ I-NP O
allelic JJ I-NP O
frequency NN I-NP O
of IN B-PP O
this DT B-NP O
mutation NN I-NP O
was VBD B-VP O
calculated VBN I-VP O
to TO I-VP O
be VB I-VP O
0 CD B-NP O
. . O O

17 CD B-NP O
. . O O

One CD B-NP O
of IN B-PP O
the DT B-NP O
homozygotes NNS I-NP O
for IN B-PP O
the DT B-NP O
442D NN I-NP O
G NN I-NP O
mutation NN I-NP O
was VBD B-VP O
the DT B-NP O
patient NN I-NP O
previously RB B-VP O
described VBN I-VP O
by IN B-PP O
us PRP B-NP O
as IN B-PP O
having VBG B-VP O
hyperalphalipoproteinemia NN B-NP B-Disease
with IN B-PP O
corneal JJ B-NP B-Disease
opacity NN I-NP I-Disease
and CC O O
coronary JJ B-NP B-Disease
heart NN I-NP I-Disease
disease NN I-NP I-Disease
. . O O

This DT B-NP O
was VBD B-VP O
the DT B-NP O
first JJ I-NP O
reported VBN I-NP O
subject NN I-NP O
homozygous JJ B-ADJP O
for IN B-PP O
the DT B-NP O
CETP NN I-NP B-Disease
deficiency NN I-NP I-Disease
who WP B-NP O
also RB B-ADVP O
demonstrated VBD B-VP O
atherosclerotic JJ B-NP B-Disease
symptoms NNS I-NP I-Disease
. . O O

In IN B-PP O
homozygous JJ B-NP O
subjects NNS I-NP O
, , O O
CETP NN B-NP O
activity NN I-NP O
ranged VBD B-VP O
from IN B-PP O
37 CD B-NP O
% NN I-NP O
to TO B-PP O
62 CD B-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
normal JJ I-NP O
value NN I-NP O
, , O O
which WDT B-NP O
was VBD B-VP O
consistent JJ B-ADJP O
with IN B-PP O
the DT B-NP O
results NNS I-NP O
obtained VBN B-VP O
from IN B-PP O
the DT B-NP O
transient JJ I-NP O
expression NN I-NP O
experiment NN I-NP O
previously RB B-ADVP O
reported VBN B-VP O
; : O O
however RB B-ADVP O
, , O O
the DT B-NP O
specific JJ I-NP O
activity NN I-NP O
of IN B-PP O
CETP NN B-NP O
was VBD B-VP O
not RB O O
as RB B-ADJP O
low JJ I-ADJP O
as IN B-SBAR O
expected VBN B-VP O
. . O O

( ( O O
ABSTRACT NN B-NP O
TRUNCATED VBN B-VP O
AT IN B-PP O
250 CD B-NP O
WORDS NNS I-NP O
) ) O O
Mucopolysaccharidosis NN B-NP B-Disease
type NN I-NP I-Disease
IVA NN I-NP I-Disease
: : O O
common JJ B-NP O
double JJ I-NP O
deletion NN I-NP O
in IN B-PP O
the DT B-NP O
N NN I-NP O
- HYPH B-NP O
acetylgalactosamine NN I-NP O
- HYPH B-NP O
6 CD I-NP O
- HYPH I-NP O
sulfatase NN I-NP O
gene NN I-NP O
( ( O O
GALNS NN B-NP O
) ) O O
. . O O

Mucopolysaccharidosis NN B-NP B-Disease
IVA NN I-NP I-Disease
( ( O O
MPS NN B-NP B-Disease
IVA NN I-NP I-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
disorder NN I-NP I-Disease
caused VBN B-VP O
by IN B-PP O
a DT B-NP O
deficiency NN I-NP B-Disease
in IN B-PP I-Disease
N NN B-NP I-Disease
- HYPH B-NP I-Disease
acetylgalactosamine NN I-NP I-Disease
- HYPH B-NP I-Disease
6 CD I-NP I-Disease
- HYPH I-NP I-Disease
sulfatase NN I-NP I-Disease
( ( O O
GALNS NN B-NP O
) ) O O
. . O O

We PRP B-NP O
found VBD B-VP O
two CD B-NP O
separate JJ I-NP O
deletions NNS I-NP O
of IN B-PP O
nearly RB B-NP O
8 CD I-NP O
. . O O

0 CD B-NP O
and CC I-NP O
6 CD I-NP O
. . O O

0 CD B-NP O
kb NN I-NP O
in IN B-PP O
the DT B-NP O
GALNS NN I-NP O
gene NN I-NP O
, , O O
including VBG B-PP O
some DT B-NP O
exons NNS I-NP O
. . O O

There EX B-NP O
are VBP B-VP O
Alu NNP B-NP O
repetitive JJ I-NP O
elements NNS I-NP O
near IN B-PP O
the DT B-NP O
breakpoints NNS I-NP O
of IN B-PP O
the DT B-NP O
8 CD I-NP O
. . O O

0 CD B-NP O
- HYPH I-NP O
kb NN I-NP O
deletion NN I-NP O
, , O O
and CC O O
this DT B-NP O
deletion NN I-NP O
resulted VBD B-VP O
from IN B-PP O
an DT B-NP O
Alu NN I-NP O
- HYPH I-NP O
Alu NN I-NP O
recombination NN I-NP O
. . O O

The DT B-NP O
other JJ I-NP O
6 CD I-NP O
. . O O

0 CD B-NP O
- HYPH I-NP O
kb NN I-NP O
deletion NN I-NP O
involved VBD B-VP O
illegitimate JJ B-NP O
recombinational JJ I-NP O
events NNS I-NP O
between IN B-PP O
incomplete JJ B-NP O
short JJ I-NP O
direct JJ I-NP O
repeats NNS I-NP O
of IN B-PP O
8 CD B-NP O
bp NN I-NP O
at IN B-PP O
deletion NN B-NP O
breakpoints NNS I-NP O
. . O O

The DT B-NP O
same JJ I-NP O
rearrangement NN I-NP O
has VBZ B-VP O
been VBN I-VP O
observed VBN I-VP O
in IN B-PP O
a DT B-NP O
heteroallelic JJ I-NP O
state NN I-NP O
in IN B-PP O
four CD B-NP O
unrelated JJ I-NP O
patients NNS I-NP O
. . O O

This DT B-NP O
is VBZ B-VP O
the DT B-NP O
first JJ I-NP O
documentation NN I-NP O
of IN B-PP O
a DT B-NP O
common JJ I-NP O
double JJ I-NP O
deletion NN I-NP O
a DT B-NP O
gene NN I-NP O
that WDT B-NP O
is VBZ B-VP O
not RB O O
a DT B-NP O
member NN I-NP O
of IN B-PP O
a DT B-NP O
gene NN I-NP O
cluster NN I-NP O
. . O O

Detection NN B-NP O
of IN B-PP O
eight CD B-NP O
BRCA1 NN I-NP O
mutations NNS I-NP O
in IN B-PP O
10 CD B-NP O
breast NN I-NP B-Disease
/ SYM B-NP I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
families NNS I-NP O
, , O O
including VBG B-PP O
1 CD B-NP O
family NN I-NP O
with IN B-PP O
male JJ B-NP B-Disease
breast NN I-NP I-Disease
cancer NN I-NP I-Disease
. . O O

Genetic JJ B-NP O
epidemiological JJ I-NP O
evidence NN I-NP O
suggests VBZ B-VP O
that IN B-SBAR O
mutations NNS B-NP O
in IN B-PP O
BRCA1 NN B-NP O
may MD B-VP O
be VB I-VP O
responsible JJ B-ADJP O
for IN B-PP O
approximately RB B-NP O
one CD I-NP O
half NN I-NP O
of IN B-PP O
early JJ B-NP O
onset NN I-NP O
familial JJ I-NP B-Disease
breast NN I-NP I-Disease
cancer NN I-NP I-Disease
and CC O O
the DT B-NP O
majority NN I-NP O
of IN B-PP O
familial JJ B-NP B-Disease
breast NN I-NP I-Disease
/ SYM B-NP I-Disease
ovarian JJ I-NP I-Disease
cancer NN I-NP I-Disease
. . O O

The DT B-NP O
recent JJ I-NP O
cloning NN I-NP O
of IN B-PP O
BRCA1 NN B-NP O
allows VBZ B-VP O
for IN B-PP O
the DT B-NP O
direct JJ I-NP O
detection NN I-NP O
of IN B-PP O
mutations NNS B-NP O
, , O O
but CC O O
the DT B-NP O
feasibility NN I-NP O
of IN B-PP O
presymptomatic JJ B-NP O
screening NN I-NP O
for IN B-PP O
cancer NN B-NP B-Disease
susceptibility NN I-NP O
is VBZ B-VP O
unknown JJ B-ADJP O
. . O O

We PRP B-NP O
analyzed VBD B-VP O
genomic JJ B-NP O
DNA NN I-NP O
from IN B-PP O
one CD B-NP O
affected VBN B-VP O
individual JJ B-ADJP O
from IN B-PP O
each DT B-NP O
of IN B-PP O
24 CD B-NP O
families NNS I-NP O
with IN B-PP O
at IN B-NP O
least JJS I-NP O
three CD I-NP O
cases NNS I-NP O
of IN B-PP O
ovarian JJ B-NP B-Disease
or CC I-NP I-Disease
breast NN I-NP I-Disease
cancer NN I-NP I-Disease
, , O O
using VBG B-VP O
SSCP NN B-NP O
assays NNS I-NP O
. . O O

Variant JJ B-NP O
SSCP NN I-NP O
bands NNS I-NP O
were VBD B-VP O
subcloned VBN I-VP O
and CC O O
sequenced VBN B-VP O
. . O O

Allele NN B-NP O
- HYPH I-NP O
specific JJ I-NP O
oligonucleotide NN I-NP O
hybridization NN I-NP O
was VBD B-VP O
used VBN I-VP O
to TO B-VP O
verify VB I-VP O
sequence NN B-NP O
changes NNS I-NP O
and CC O O
to TO B-VP O
screen VB I-VP O
DNA NN B-NP O
from IN B-PP O
control NN B-NP O
individuals NNS I-NP O
. . O O

Six CD B-NP O
frameshift NN I-NP O
and CC O O
two CD B-NP O
missense JJ I-NP O
mutations NNS I-NP O
were VBD B-VP O
detected VBN I-VP O
in IN B-PP O
10 CD B-NP O
different JJ I-NP O
families NNS I-NP O
. . O O

A DT B-NP O
frameshift NN I-NP O
mutation NN I-NP O
was VBD B-VP O
detected VBN I-VP O
in IN B-PP O
a DT B-NP O
male JJ I-NP O
proband NN I-NP O
affected VBN B-VP O
with IN B-PP O
both CC O O
breast NN B-NP B-Disease
and CC O I-Disease
prostate NN B-NP I-Disease
cancer NN I-NP I-Disease
. . O O

A DT B-NP O
40 CD I-NP O
- HYPH I-NP O
bp NN I-NP O
deletion NN I-NP O
was VBD B-VP O
detected VBN I-VP O
in IN B-PP O
a DT B-NP O
patient NN I-NP O
who WP B-NP O
developed VBD B-VP O
intra AFX B-NP B-Disease
- HYPH I-NP I-Disease
abdominal JJ I-NP I-Disease
carcinomatosis NN I-NP I-Disease
1 CD I-NP O
year NN I-NP O
after IN B-PP O
prophylactic JJ B-NP O
oophorectomy NN I-NP O
. . O O

Mutations NNS B-NP O
were VBD B-VP O
detected VBN I-VP O
throughout IN B-PP O
the DT B-NP O
gene NN I-NP O
, , O O
and CC O O
only RB B-NP O
one CD I-NP O
was VBD B-VP O
detected VBN I-VP O
in IN B-PP O
more JJR B-NP O
than IN B-PP O
a DT B-NP O
single JJ I-NP O
family NN I-NP O
. . O O

These DT B-NP O
results NNS I-NP O
provide VBP B-VP O
further JJ B-NP O
evidence NN I-NP O
that IN B-SBAR O
inherited VBN B-NP B-Disease
breast NN I-NP I-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
can MD B-VP O
occur VB I-VP O
as IN B-PP O
a DT B-NP O
consequence NN I-NP O
of IN B-PP O
a DT B-NP O
wide JJ I-NP O
array NN I-NP O
of IN B-PP O
BRCA1 NN B-NP O
mutations NNS I-NP O
. . O O

These DT B-NP O
results NNS I-NP O
suggests VBZ B-VP O
that IN B-SBAR O
development NN B-NP O
of IN B-PP O
a DT B-NP O
screening NN I-NP O
test NN I-NP O
for IN B-PP O
BRCA1 NN B-NP O
mutations NNS I-NP O
will MD B-VP O
be VB I-VP O
technically RB B-ADJP O
challenging JJ I-ADJP O
. . O O

The DT B-NP O
finding NN I-NP O
of IN B-PP O
a DT B-NP O
mutation NN I-NP O
in IN B-PP O
a DT B-NP O
family NN I-NP O
with IN B-PP O
male JJ B-NP B-Disease
breast NN I-NP I-Disease
cancer NN I-NP I-Disease
, , O O
not RB O O
previously RB B-VP O
thought VBN I-VP O
to TO I-VP O
be VB I-VP O
related VBN I-VP O
to TO B-PP O
BRCA1 NN B-NP O
, , O O
also RB B-ADVP O
illustrates VBZ B-VP O
the DT B-NP O
potential JJ I-NP O
difficulties NNS I-NP O
of IN B-PP O
genetic JJ B-NP O
counseling NN I-NP O
for IN B-PP O
individuals NNS B-NP O
known VBN B-VP O
to TO B-VP O
carry VB I-VP O
mutations NNS B-NP O
. . O O

. . O O

Natural JJ B-NP O
selection NN I-NP O
of IN B-PP O
hemi AFX B-NP O
- HYPH I-NP O
and CC O O
heterozygotes NNS B-NP O
for IN B-PP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
Africa NNP B-NP O
by IN B-PP O
resistance NN B-NP O
to TO B-PP O
severe JJ B-NP O
malaria NN I-NP B-Disease
. . O O

Glucose NN B-NP B-Disease
- HYPH B-NP I-Disease
6 CD I-NP I-Disease
- HYPH I-NP I-Disease
phosphate NN I-NP I-Disease
dehydrogenase NN I-NP I-Disease
( ( O I-Disease
G6PD NN B-NP I-Disease
) ) O I-Disease
deficiency NN B-NP I-Disease
, , O O
the DT B-NP O
most RBS I-NP O
common JJ I-NP O
enzymopathy NN I-NP B-Disease
of IN B-PP O
humans NNS B-NP O
, , O O
affects VBZ B-VP O
over IN B-NP O
400 CD I-NP O
million CD I-NP O
people NNS I-NP O
. . O O

The DT B-NP O
geographical JJ I-NP O
correlation NN I-NP O
of IN B-PP O
its PRP$ B-NP O
distribution NN I-NP O
with IN B-PP O
the DT B-NP O
historical JJ I-NP O
endemicity NN I-NP O
of IN B-PP O
malaria NN B-NP B-Disease
suggests VBZ B-VP O
that IN B-SBAR O
this DT B-NP O
disorder NN I-NP O
has VBZ B-VP O
risen VBN I-VP O
in IN B-PP O
frequency NN B-NP O
through IN B-PP O
natural JJ B-NP O
selection NN I-NP O
by IN B-PP O
malaria NN B-NP B-Disease
. . O O

However RB B-ADVP O
, , O O
attempts VBZ B-VP O
to TO I-VP O
confirm VB I-VP O
that IN B-SBAR O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
is VBZ B-VP O
protective JJ B-ADJP O
in IN B-SBAR O
case NN O O
- HYPH O O
control NN B-NP O
studies NNS I-NP O
of IN B-PP O
malaria NN B-NP B-Disease
have VBP B-VP O
yielded VBN I-VP O
conflicting VBG I-VP O
results NNS B-NP O
. . O O

Hence RB B-ADVP O
, , O O
for IN B-PP O
this DT B-NP O
X NN I-NP B-Disease
- HYPH B-VP I-Disease
linked VBN I-VP I-Disease
disorder NN B-NP I-Disease
, , O O
it PRP B-NP O
is VBZ B-VP O
unclear JJ B-ADJP O
whether IN B-SBAR O
both CC O O
male JJ B-NP O
hemizygotes NNS I-NP O
and CC O O
female JJ B-NP O
heterozygotes NNS I-NP O
are VBP B-VP O
protected VBN I-VP O
or CC O O
, , O O
as RB O O
frequently RB B-VP O
suggested VBN I-VP O
, , O O
only RB B-NP O
females NNS I-NP O
. . O O

Furthermore RB B-ADVP O
, , O O
how WRB B-ADVP O
much JJ O O
protection NN B-NP O
may MD B-VP O
be VB I-VP O
afforded VBN I-VP O
is VBZ B-VP O
unknown JJ B-ADJP O
. . O O

Here RB B-ADVP O
we PRP B-NP O
report VBP B-VP O
that IN B-SBAR O
, , O O
in IN B-PP O
two CD B-NP O
large JJ I-NP O
case NN I-NP O
- HYPH B-NP O
control NN I-NP O
studies NNS I-NP O
of IN B-PP O
over IN B-NP O
2 CD I-NP O
, , I-NP O
000 CD I-NP O
African JJ I-NP O
children NNS I-NP O
, , O O
the DT B-NP O
common JJ I-NP O
African JJ I-NP O
form NN I-NP O
of IN B-PP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
( ( O O
G6PD NN B-NP B-Disease
A NN I-NP I-Disease
- SYM B-NP I-Disease
) ) O O
is VBZ B-VP O
associated VBN I-VP O
with IN B-PP O
a DT B-NP O
46 CD I-NP O
- HYPH I-NP O
58 CD I-NP O
% NN I-NP O
reduction NN I-NP O
in IN B-PP O
risk NN B-NP O
of IN B-PP O
severe JJ B-NP O
malaria NN I-NP B-Disease
for IN B-PP O
both DT B-NP O
female JJ I-NP O
heterozygotes NNS I-NP O
and CC O O
male JJ B-NP O
hemizygotes NNS I-NP O
. . O O

A DT B-NP O
mathematical JJ I-NP O
model NN I-NP O
incorporating VBG B-VP O
the DT B-NP O
measured VBN I-NP O
selective JJ I-NP O
advantage NN I-NP O
against IN B-PP O
malaria NN B-NP B-Disease
suggests VBZ B-VP O
that IN B-SBAR O
a DT B-NP O
counterbalancing VBG I-NP O
selective JJ I-NP O
disadvantage NN I-NP O
, , O O
associated VBN B-VP O
with IN B-PP O
this DT B-NP O
enzyme NN I-NP B-Disease
deficiency NN I-NP I-Disease
, , O O
has VBZ B-VP O
retarded VBN I-VP O
its PRP$ B-NP O
rise NN I-NP O
in IN B-PP O
frequency NN B-NP O
in IN B-PP O
malaria NN B-NP B-Disease
- HYPH B-NP O
endemic JJ I-NP O
regions NNS I-NP O
. . O O

Although IN B-SBAR O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
is VBZ B-VP O
now RB I-VP O
regarded VBN I-VP O
as IN B-PP O
a DT B-NP O
generally RB I-NP O
benign JJ I-NP O
disorder NN I-NP O
, , O O
in IN B-PP O
earlier JJR B-NP O
environmental JJ I-NP O
conditions NNS I-NP O
it PRP B-NP O
could MD B-VP O
have VB I-VP O
been VBN I-VP O
significantly RB B-ADJP O
disadvantageous JJ I-ADJP O
. . O O

. . O O

The DT B-NP O
alveolar JJ I-NP B-Disease
rhabdomyosarcoma NN I-NP I-Disease
PAX3 NN I-NP O
/ SYM B-NP O
FKHR NN I-NP O
fusion NN I-NP O
protein NN I-NP O
is VBZ B-VP O
a DT B-NP O
transcriptional JJ I-NP O
activator NN I-NP O
. . O O

Chimeric JJ B-NP O
transcription NN I-NP O
factors NNS I-NP O
, , O O
created VBN B-VP O
by IN B-PP O
gene NN B-NP O
fusions NNS I-NP O
as IN B-PP O
the DT B-NP O
result NN I-NP O
of IN B-PP O
chromosomal JJ B-NP O
translocations NNS I-NP O
, , O O
have VBP B-VP O
been VBN I-VP O
implicated VBN I-VP O
in IN B-PP O
the DT B-NP O
pathogenesis NN I-NP O
of IN B-PP O
several JJ B-NP O
pathologically RB I-NP O
disparate JJ I-NP O
solid JJ I-NP B-Disease
tumors NNS I-NP I-Disease
. . O O

The DT B-NP O
PAX3 NN I-NP O
/ SYM B-VP O
FKHR NN B-NP O
fusion NN I-NP O
gene NN I-NP O
, , O O
formed VBN B-VP O
by IN B-PP O
a DT B-NP O
t NN I-NP O
( ( O O
2 CD B-NP O
; : O O
13 CD B-NP O
) ) O O
( ( O O
q35 NN B-NP O
; : O O
q14 NN B-NP O
) ) O O
in IN B-PP O
alveolar JJ B-NP B-Disease
rhabdomyosarcoma NN I-NP I-Disease
, , O O
encodes VBZ B-VP O
a DT B-NP O
hybrid NN I-NP O
protein NN I-NP O
that WDT B-NP O
contains VBZ B-VP O
both CC O O
PAX3 NN B-NP O
DNA NN I-NP O
binding NN I-NP O
domains NNS I-NP O
, , O O
the DT B-NP O
paired JJ I-NP O
box NN I-NP O
and CC I-NP O
homeodomain NN I-NP O
, , O O
linked VBN B-VP O
to TO B-PP O
the DT B-NP O
bisected VBN I-NP O
DNA NN I-NP O
binding NN I-NP O
domain NN I-NP O
of IN B-PP O
FKHR NN B-NP O
, , O O
a DT B-NP O
member NN I-NP O
of IN B-PP O
the DT B-NP O
forkhead NN I-NP O
family NN I-NP O
of IN B-PP O
transcription NN B-NP O
factors NNS I-NP O
. . O O

Here RB B-ADVP O
we PRP B-NP O
report VBP B-VP O
that IN B-SBAR O
PAX3 NN B-NP O
and CC I-NP O
PAX3 NN I-NP O
/ SYM O O
FKHR NN B-NP O
display NN I-NP O
similar JJ B-ADJP O
, , O O
but CC O O
not RB O O
identical JJ B-NP O
transactivation NN I-NP O
activities NNS I-NP O
when WRB B-ADVP O
tested VBN B-VP O
with IN B-PP O
model NN B-NP O
Pax NN I-NP O
recognition NN I-NP O
sequences NNS I-NP O
. . O O

No DT B-NP O
functional JJ I-NP O
role NN I-NP O
could MD B-VP O
be VB I-VP O
ascribed VBN I-VP O
solely RB B-ADVP O
to TO B-PP O
the DT B-NP O
residual JJ I-NP O
FKHR NN I-NP O
binding NN I-NP O
domain NN I-NP O
present JJ B-ADJP O
in IN B-PP O
the DT B-NP O
fusion NN I-NP O
protein NN I-NP O
, , O O
but CC O O
FKHR NN B-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
contribute VB I-VP O
a DT B-NP O
strong JJ I-NP O
carboxyl NN I-NP O
terminal JJ I-NP O
activation NN I-NP O
domain NN I-NP O
replacing VBG B-VP O
the DT B-NP O
one CD I-NP O
located VBN B-VP O
in IN B-PP O
the DT B-NP O
unrearranged JJ I-NP O
PAX3 NN I-NP O
gene NN I-NP O
. . O O

We PRP B-NP O
show VBP B-VP O
that IN B-SBAR O
the DT B-NP O
native JJ I-NP O
PAX3 NN I-NP O
/ SYM B-VP O
FKHR NN B-NP O
protein NN I-NP O
present JJ B-ADJP O
in IN B-PP O
tumor NN B-NP B-Disease
cells NNS I-NP O
with IN B-PP O
this DT B-NP O
translocation NN I-NP O
has VBZ B-VP O
transcriptional JJ B-NP O
characteristics NNS I-NP O
similar JJ B-ADJP O
to TO B-PP O
the DT B-NP O
in FW I-NP O
vitro FW I-NP O
expressed VBN I-NP O
protein NN I-NP O
. . O O

The DT B-NP O
ability NN I-NP O
of IN B-PP O
the DT B-NP O
PAX3 NN I-NP O
/ SYM B-NP O
FKHR NN I-NP O
hybrid JJ I-NP O
protein NN I-NP O
to TO B-VP O
bind VB I-VP O
DNA NN B-NP O
in IN B-PP O
a DT B-NP O
sequence NN I-NP O
specific JJ I-NP O
manner NN I-NP O
and CC O O
to TO B-VP O
transactivate VB I-VP O
the DT B-NP O
expression NN I-NP O
of IN B-PP O
artificial JJ B-NP O
reporter NN I-NP O
genes NNS I-NP O
suggests VBZ B-VP O
that IN B-SBAR O
its PRP$ B-NP O
aberrant JJ I-NP O
expression NN I-NP O
could MD B-VP O
subvert VB I-VP O
the DT B-NP O
transcriptional JJ I-NP O
programs NNS I-NP O
that WDT B-NP O
normally RB B-ADVP O
control VBP B-VP O
the DT B-NP O
growth NN I-NP O
, , O O
differentiation NN B-NP O
, , O O
and CC O O
survival NN B-NP O
of IN B-PP O
primitive JJ B-NP O
myogenic JJ I-NP O
precursors NNS I-NP O
in FW B-ADVP O
vivo FW I-ADVP O
. . O O

. . O O

A DT B-NP O
p16INK4a NN I-NP O
- HYPH B-NP O
insensitive JJ I-NP O
CDK4 NN I-NP O
mutant NN I-NP O
targeted VBN B-VP O
by IN B-PP O
cytolytic JJ B-NP O
T NN I-NP O
lymphocytes NNS I-NP O
in IN B-PP O
a DT B-NP O
human JJ I-NP O
melanoma NN I-NP B-Disease
. . O O

A DT B-NP O
mutated VBN I-NP O
cyclin NN I-NP O
- HYPH I-NP O
dependent JJ I-NP O
kinase NN I-NP O
4 CD I-NP O
( ( O O
CDK4 NN B-NP O
) ) O O
was VBD B-VP O
identified VBN I-VP O
as IN B-PP O
a DT B-NP O
tumor NN I-NP B-Disease
- HYPH B-NP O
specific JJ I-NP O
antigen NN I-NP O
recognized VBN B-VP O
by IN B-PP O
HLA NN B-NP O
- HYPH B-NP O
A2 NN I-NP O
. . O O

1 CD B-NP O
- HYPH I-NP O
restricted JJ I-NP O
autologous JJ I-NP O
cytolytic JJ I-NP O
T NN I-NP O
lymphocytes NNS I-NP O
( ( O O
CTLs NNS B-NP O
) ) O O
in IN B-PP O
a DT B-NP O
human JJ I-NP O
melanoma NN I-NP B-Disease
. . O O

The DT B-NP O
mutated VBN I-NP O
CDK4 NN I-NP O
allele NN I-NP O
was VBD B-VP O
present JJ B-ADJP O
in IN B-PP O
autologous JJ B-NP O
cultured VBN I-NP O
melanoma NN I-NP B-Disease
cells NNS I-NP O
and CC O O
metastasis NN B-NP O
tissue NN I-NP O
, , O O
but CC B-PP O
not RB B-PP O
in IN I-PP O
the DT B-NP O
patients NNS I-NP O
lymphocytes NNS I-NP O
. . O O

The DT B-NP O
mutation NN I-NP O
, , O O
an DT B-NP O
arginine NN I-NP O
- HYPH B-ADJP O
to TO B-PP O
- HYPH B-NP O
cysteine NN I-NP O
exchange NN I-NP O
at IN B-PP O
residue NN B-NP O
24 CD I-NP O
, , O O
was VBD B-VP O
part NN B-NP O
of IN B-PP O
the DT B-NP O
CDK4 NN I-NP O
peptide NN I-NP O
recognized VBN B-VP O
by IN B-PP O
CTLs NNS B-NP O
and CC O O
prevented VBD B-VP O
binding NN B-NP O
of IN B-PP O
the DT B-NP O
CDK4 NN I-NP O
inhibitor NN I-NP O
p16INK4a NN I-NP O
, , O O
but CC O O
not RB B-PP O
of IN I-PP O
p21 NN B-NP O
or CC B-PP O
of IN B-PP O
p27KIP1 NN B-NP O
. . O O

The DT B-NP O
same JJ I-NP O
mutation NN I-NP O
was VBD B-VP O
found VBN I-VP O
in IN B-PP O
one CD B-NP O
additional JJ I-NP O
melanoma NN I-NP B-Disease
among IN B-PP O
28 CD B-NP O
melanomas NNS I-NP B-Disease
analyzed VBN B-VP O
. . O O

These DT B-NP O
results NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
mutation NN B-NP O
of IN B-PP O
CDK4 NN B-NP O
can MD B-VP O
create VB I-VP O
a DT B-NP O
tumor NN I-NP B-Disease
- HYPH B-NP O
specific JJ I-NP O
antigen NN I-NP O
and CC O O
can MD B-VP O
disrupt VB I-VP O
the DT B-NP O
cell NN I-NP O
- HYPH B-NP O
cycle NN I-NP O
regulation NN I-NP O
exerted VBN B-VP O
by IN B-PP O
the DT B-NP O
tumor NN I-NP B-Disease
suppressor NN I-NP O
p16INK4a NN I-NP O
. . O O

. . O O

Rapid JJ B-NP O
detection NN I-NP O
of IN B-PP O
BRCA1 NN B-NP O
mutations NNS I-NP O
by IN B-PP O
the DT B-NP O
protein NN I-NP O
truncation NN I-NP O
test NN I-NP O
. . O O

More JJR B-NP O
than IN I-NP O
75 CD I-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
reported VBN I-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
hereditary JJ I-NP B-Disease
breast NN I-NP I-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
gene NN I-NP O
, , O O
BRCA1 NN B-NP O
, , O O
result VBP B-VP O
in IN B-PP O
truncated VBN B-NP O
proteins NNS I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
used VBN I-VP O
the DT B-NP O
protein NN I-NP O
truncation NN I-NP O
test NN I-NP O
( ( O O
PTT NN B-NP O
) ) O O
to TO B-VP O
screen VB I-VP O
for IN B-PP O
mutations NNS B-NP O
in IN B-PP O
exon NN B-NP O
11 CD I-NP O
, , O O
which WDT B-NP O
encodes VBZ B-VP O
61 CD B-NP O
% NN I-NP O
of IN B-PP O
BRCA1 NN B-NP O
. . O O

In IN B-PP O
45 CD B-NP O
patients NNS I-NP O
from IN B-PP O
breast NN B-NP B-Disease
and CC O I-Disease
/ SYM B-NP I-Disease
or CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
families NNS I-NP O
we PRP B-NP O
found VBD B-VP O
six CD B-NP O
novel JJ I-NP O
mutations NNS I-NP O
two CD B-NP O
single JJ I-NP O
nucleotide NN I-NP O
insertions NNS I-NP O
, , O O
three CD B-NP O
small JJ I-NP O
deletions NNS I-NP O
( ( O O
1 CD B-NP O
- HYPH I-NP O
5 CD I-NP O
bp NN I-NP O
) ) O O
and CC O O
a DT B-NP O
nonsense JJ I-NP O
mutation NN I-NP O
identified VBD B-VP O
two CD B-NP O
unrelated JJ I-NP O
families NNS I-NP O
. . O O

Furthermore RB B-ADVP O
, , O O
we PRP B-NP O
were VBD B-VP O
able JJ B-ADJP O
to TO B-VP O
amplify VB I-VP O
the DT B-NP O
remaining VBG I-NP O
coding VBG I-NP O
region NN I-NP O
by IN B-PP O
RT NN B-NP O
- HYPH O O
PCR NN B-NP O
using VBG B-VP O
lymphocyte NN B-NP O
RNA NN I-NP O
. . O O

Combined VBN B-VP O
with IN B-PP O
PTT NN B-NP O
, , O O
we PRP B-NP O
detected VBD B-VP O
aberrantly RB B-NP O
spliced VBN I-NP O
products NNS I-NP O
affecting VBG B-VP O
exons NNS B-NP O
5 CD B-NP O
and CC I-NP O
6 CD I-NP O
in IN B-PP O
one CD B-NP O
of IN B-PP O
two CD B-NP O
BRCA1 NN I-NP O
- HYPH B-NP O
linked VBN I-NP O
families NNS I-NP O
examined VBN B-VP O
. . O O

The DT B-NP O
protein NN I-NP O
truncation NN I-NP O
test NN I-NP O
promises VBZ B-VP O
to TO I-VP O
become VB I-VP O
a DT B-NP O
valuable JJ I-NP O
technique NN I-NP O
in IN B-PP O
detecting VBG B-VP O
BRCA1 NN B-NP O
mutations NNS I-NP O
. . O O

. . O O

Cloning NN B-NP O
of IN B-PP O
human JJ B-NP O
very RB I-NP O
- HYPH I-NP O
long JJ I-NP O
- HYPH I-NP O
chain NN I-NP O
acyl NN I-NP O
- HYPH B-NP O
coenzyme NN I-NP O
A NN I-NP O
dehydrogenase NN I-NP O
and CC O O
molecular JJ B-NP O
characterization NN I-NP O
of IN B-PP O
its PRP$ B-NP O
deficiency NN I-NP O
in IN B-PP O
two CD B-NP O
patients NNS I-NP O
. . O O

Two CD B-NP O
overlapping VBG I-NP O
cDNA NN I-NP O
clones NNS I-NP O
( ( O O
1 CD B-NP O
, , O O
991 CD B-NP O
bp NN I-NP O
and CC O O
736 CD B-NP O
bp NN I-NP O
, , O O
respectively RB B-ADVP O
) ) O O
encoding VBG B-VP O
the DT B-NP O
precursor NN I-NP O
of IN B-PP O
human JJ B-NP O
mitochondrial JJ I-NP O
very RB I-NP O
- HYPH I-NP O
long JJ I-NP O
- HYPH I-NP O
chain NN I-NP O
acyl NN I-NP O
- HYPH B-NP O
coenzyme NN I-NP O
A NN I-NP O
dehydrogenase NN I-NP O
( ( O O
VLCAD NN B-NP O
) ) O O
were VBD B-VP O
cloned VBN I-VP O
and CC O O
sequenced VBN B-VP O
. . O O

The DT B-NP O
cDNA NN I-NP O
inserts NNS I-NP O
of IN B-PP O
these DT B-NP O
clones NNS I-NP O
together RB B-ADVP O
encompass VBP B-VP O
a DT B-NP O
region NN I-NP O
of IN B-PP O
2 CD B-NP O
, , O O
177 CD B-NP O
bases NNS I-NP O
, , O O
encoding VBG B-VP O
the DT B-NP O
entire JJ I-NP O
protein NN I-NP O
of IN B-PP O
655 CD B-NP O
amino NN I-NP O
acids NNS I-NP O
, , O O
including VBG B-PP O
a DT B-NP O
40 CD I-NP O
- HYPH I-NP O
amino NN I-NP O
acid NN I-NP O
leader NN I-NP O
peptide NN I-NP O
and CC O O
a DT B-NP O
615 CD I-NP O
- HYPH I-NP O
amino NN I-NP O
acid NN I-NP O
mature JJ I-NP O
polypeptide NN I-NP O
. . O O

PCR NN B-NP O
- HYPH B-PP O
amplified VBN B-NP O
VLCAD NN I-NP O
cDNAs NNS I-NP O
were VBD B-VP O
sequenced VBN I-VP O
in IN B-PP O
cultured VBN B-NP O
fibroblasts NNS I-NP O
from IN B-PP O
two CD B-NP O
VLCAD NN I-NP B-Disease
- HYPH B-NP I-Disease
deficient JJ I-NP I-Disease
patients NNS I-NP O
. . O O

In IN B-PP O
both DT B-NP O
patients NNS I-NP O
, , O O
a DT B-NP O
105 CD I-NP O
- HYPH I-NP O
bp NN I-NP O
deletion NN I-NP O
encompassing VBG B-VP O
bases NNS B-NP O
1078 CD B-NP O
- HYPH I-NP O
1182 CD I-NP O
in IN B-PP O
VLCAD NN B-NP O
cDNA NN I-NP O
was VBD B-VP O
identified VBN I-VP O
. . O O

The DT B-NP O
deletion NN I-NP O
seems VBZ B-VP O
to TO I-VP O
occur VB I-VP O
due IN B-PP O
to TO B-PP O
exon NN B-NP O
skipping NN I-NP O
during IN B-PP O
processing NN B-NP O
of IN B-PP O
VLCAD NN B-NP O
pre AFX B-NP O
- HYPH I-NP O
mRNA NN B-NP O
. . O O

This DT B-NP O
is VBZ B-VP O
the DT B-NP O
first JJ I-NP O
demonstration NN I-NP O
of IN B-PP O
a DT B-NP O
mutation NN I-NP O
causing VBG B-VP O
VLCAD NN B-NP B-Disease
deficiency NN I-NP I-Disease
. . O O

Quantitative JJ B-NP O
cDNA NN I-NP O
expression NN I-NP O
of IN B-PP O
normal JJ B-NP O
human JJ I-NP O
VLCAD NN I-NP O
was VBD B-VP O
performed VBN I-VP O
in IN B-PP O
the DT B-NP O
patients NNS I-NP O
fibroblasts NNS I-NP O
, , O O
using VBG B-VP O
vaccinia NN B-NP O
viral JJ I-NP O
system NN I-NP O
, , O O
which WDT B-NP O
demonstrated VBD B-VP O
that IN B-SBAR O
the DT B-NP O
deficiency NN I-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
normal JJ I-NP I-Disease
VLCAD NN I-NP I-Disease
protein NN I-NP I-Disease
causes VBZ B-VP O
impaired JJ B-NP O
long JJ I-NP O
- HYPH I-NP O
chain NN I-NP O
fatty JJ I-NP O
acid NN I-NP O
beta SYM B-NP O
- HYPH B-NP O
oxidation NN I-NP O
activity NN I-NP O
in IN B-PP O
the DT B-NP O
patients NNS I-NP O
fibroblasts NNS I-NP O
. . O O

In IN B-PP O
patient NN B-NP O
fibroblasts NNS I-NP O
, , O O
raising VBG B-VP O
VLCAD NN B-NP O
activity NN I-NP O
to TO B-PP O
approximately RB B-NP O
20 CD I-NP O
% NN I-NP O
of IN B-PP O
normal JJ B-NP O
control NN I-NP O
fibroblast NN I-NP O
activity NN I-NP O
raised VBD B-VP O
palmitic JJ B-NP O
acid NN I-NP O
beta SYM B-NP O
- HYPH B-NP O
oxidation NN I-NP O
flux NN I-NP O
to TO B-PP O
the DT B-NP O
level NN I-NP O
found VBN B-VP O
in IN B-PP O
control NN B-NP O
fibroblasts NNS I-NP O
, , O O
which WDT B-NP O
may MD B-VP O
offer VB I-VP O
important JJ B-NP O
information NN I-NP O
for IN B-PP O
the DT B-NP O
rational JJ I-NP O
design NN I-NP O
of IN B-PP O
future JJ B-NP O
somatic JJ I-NP O
gene NN I-NP O
therapy NN I-NP O
for IN B-PP O
VLCAD NN B-NP B-Disease
deficiency NN I-NP I-Disease
. . O O

. . O O

Brain NN B-NP B-Disease
disease NN I-NP I-Disease
and CC O O
molecular JJ B-NP O
analysis NN I-NP O
in IN B-PP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
. . O O

Abnormal JJ B-NP O
amplification NN I-NP O
of IN B-PP O
a DT B-NP O
CTG NN I-NP O
repeat NN I-NP O
on IN B-PP O
chromosome NN B-NP O
19 CD I-NP O
is VBZ B-VP O
the DT B-NP O
molecular JJ I-NP O
basis NN I-NP O
of IN B-PP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
( ( O O
DM NN B-NP B-Disease
) ) O O
. . O O

Expansion NN B-NP O
of IN B-PP O
the DT B-NP O
repeat NN I-NP O
has VBZ B-VP O
been VBN I-VP O
correlated VBN I-VP O
with IN B-PP O
severity NN B-NP O
of IN B-PP O
several JJ B-NP O
clinical JJ I-NP O
features NNS I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
. . O O

We PRP B-NP O
performed VBD B-VP O
extensive JJ B-NP O
cognitive JJ I-NP O
testing NN I-NP O
, , O O
cerebral JJ B-NP O
magnetic JJ I-NP O
resonance NN I-NP O
imaging NN I-NP O
( ( O O
MRI NN B-NP O
) ) O O
and CC O O
a DT B-NP O
molecular JJ I-NP O
analysis NN I-NP O
in IN B-PP O
28 CD B-NP O
cases NNS I-NP O
of IN B-PP O
DM NN B-NP B-Disease
to TO B-VP O
determine VB I-VP O
the DT B-NP O
relationship NN I-NP O
between IN B-PP O
the DT B-NP O
molecular JJ I-NP O
defect NN I-NP O
and CC I-NP O
brain NN I-NP B-Disease
disease NN I-NP I-Disease
. . O O

Performance NN B-NP O
in IN B-PP O
two CD B-NP O
or CC I-NP O
more JJR I-NP O
cognitive JJ I-NP O
tests NNS I-NP O
was VBD B-VP O
pathological JJ B-ADJP O
in IN B-PP O
10 CD B-NP O
cases NNS I-NP O
. . O O

Fourteen CD B-NP O
patients NNS I-NP O
had VBD B-VP O
subcortical JJ B-NP O
white JJ I-NP B-Disease
matter NN I-NP I-Disease
lesions NNS I-NP I-Disease
on IN B-PP O
MRI NN B-NP O
, , O O
14 CD B-NP O
had VBD B-VP O
cerebral JJ B-NP B-Disease
atrophy NN I-NP I-Disease
. . O O

Amplification NN B-NP O
of IN B-PP O
the DT B-NP O
CTG NN I-NP O
repeat NN I-NP O
showed VBD B-VP O
a DT B-NP O
strong JJ I-NP O
correlation NN I-NP O
with IN B-PP O
cognitive JJ B-NP O
test NN I-NP O
deficits NNS I-NP O
when WRB B-ADVP O
exceeding VBG B-VP O
a DT B-NP O
length NN I-NP O
of IN B-PP O
over IN B-NP O
1000 CD I-NP O
trinucleotides NNS I-NP O
. . O O

MRI NN B-NP O
lesions NNS I-NP O
were VBD B-VP O
associated VBN I-VP O
with IN B-PP O
impaired JJ B-NP O
psychometric JJ I-NP O
performance NN I-NP O
, , O O
but CC O O
MRI NN B-NP O
and CC O O
molecular JJ B-NP O
findings NNS I-NP O
were VBD B-VP O
only RB B-ADVP O
weakly RB B-ADJP O
related VBN I-ADJP O
. . O O

Disease NN B-NP O
duration NN I-NP O
influenced VBD B-VP O
the DT B-NP O
appearance NN I-NP O
and CC I-NP O
amount NN I-NP O
of IN B-PP O
white JJ B-NP B-Disease
matter NN I-NP I-Disease
lesions NNS I-NP I-Disease
on IN B-PP O
MRI NN B-NP O
. . O O

Quantification NN B-NP O
of IN B-PP O
CTG NN B-NP O
repeat NN I-NP O
size NN I-NP O
may MD B-VP O
allow VB I-VP O
an DT B-NP O
early JJ I-NP O
estimate NN I-NP O
on IN B-PP O
the DT B-NP O
probability NN I-NP O
of IN B-PP O
brain NN B-NP O
involvement NN I-NP O
in IN B-PP O
DM NN B-NP B-Disease
; : O O
cognitive JJ B-NP B-Disease
dysfunction NN I-NP I-Disease
is VBZ B-VP O
associated VBN I-VP O
with IN B-PP O
white JJ B-NP B-Disease
matter NN I-NP I-Disease
lesions NNS I-NP I-Disease
and CC O O
cerebral JJ B-NP B-Disease
atrophy NN I-NP I-Disease
later RB B-ADVP O
on IN B-PP O
in IN B-PP O
the DT B-NP O
course NN I-NP O
. . O O

. . O O

Mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
gene NN I-NP O
for IN B-PP O
X NN B-NP B-Disease
- HYPH O I-Disease
linked VBN B-VP I-Disease
adrenoleukodystrophy NN B-NP I-Disease
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
different JJ B-NP O
clinical JJ I-NP O
phenotypes NNS I-NP O
. . O O

Recently RB B-ADVP O
, , O O
the DT B-NP O
gene NN I-NP O
for IN B-PP O
the DT B-NP O
most RBS I-NP O
common JJ I-NP O
peroxisomal JJ I-NP B-Disease
disorder NN I-NP I-Disease
, , O O
X NN B-NP B-Disease
- HYPH B-VP I-Disease
linked VBN I-VP I-Disease
adrenoleukodystrophy NN B-NP I-Disease
( ( O O
X NN B-NP B-Disease
- HYPH B-NP I-Disease
ALD NN I-NP I-Disease
) ) O O
, , O O
has VBZ B-VP O
been VBN I-VP O
described VBN I-VP O
encoding VBG B-VP O
a DT B-NP O
peroxisomal JJ I-NP O
membrane NN I-NP O
transporter NN I-NP O
protein NN I-NP O
. . O O

We PRP B-NP O
analyzed VBD B-VP O
the DT B-NP O
entire JJ I-NP O
protein NN I-NP O
- HYPH O O
coding VBG B-VP O
sequence NN B-NP O
of IN B-PP O
this DT B-NP O
gene NN I-NP O
by IN B-PP O
reverse JJ B-NP O
- HYPH I-NP O
transcription NN I-NP O
PCR NN I-NP O
, , O O
SSCP NN B-NP O
, , O O
and CC O O
DNA NN B-NP O
sequencing NN I-NP O
in IN B-PP O
five CD B-NP O
patients NNS I-NP O
with IN B-PP O
different JJ B-NP O
clinical JJ I-NP O
expression NN I-NP O
of IN B-PP O
X NN B-NP B-Disease
- HYPH B-NP I-Disease
ALD NN I-NP I-Disease
and CC B-PP O
in IN B-PP O
their PRP$ B-NP O
female JJ I-NP O
relatives NNS I-NP O
; : O O
these DT B-NP O
clinical JJ I-NP O
expressions NNS I-NP O
were VBD B-VP O
cerebral JJ B-NP O
childhood NN I-NP O
ALD NN I-NP B-Disease
, , O O
adrenomyeloneuropathy NN B-NP B-Disease
( ( O O
AMN NN B-NP B-Disease
) ) O O
, , O O
and CC O O
Addison NN B-NP B-Disease
disease NN I-NP I-Disease
only RB B-ADVP I-Disease
( ( O O
ADO NN B-NP B-Disease
) ) O O
phenotype NN B-NP O
. . O O

In IN B-PP O
the DT B-NP O
three CD I-NP O
patients NNS I-NP O
exhibiting VBG B-VP O
the DT B-NP O
classical JJ I-NP O
picture NN I-NP O
of IN B-PP O
severe JJ B-NP O
childhood NN I-NP O
ALD NN I-NP B-Disease
we PRP B-NP O
identified VBD B-VP O
in IN B-PP O
the DT B-NP O
5 CD I-NP O
portion NN I-NP O
of IN B-PP O
the DT B-NP O
X NN I-NP B-Disease
- HYPH B-NP I-Disease
ALD NN I-NP I-Disease
gene NN I-NP O
a DT B-NP O
38 CD I-NP O
- HYPH I-NP O
bp NN I-NP O
deletion NN I-NP O
that WDT B-NP O
causes VBZ B-VP O
a DT B-NP O
frameshift NN I-NP O
mutation NN I-NP O
, , O O
a DT B-NP O
3 CD I-NP O
- HYPH I-NP O
bp NN I-NP O
deletion NN I-NP O
leading VBG B-VP O
to TO B-PP O
a DT B-NP O
deletion NN I-NP O
of IN B-PP O
an DT B-NP O
amino JJ I-NP O
acid NN I-NP O
in IN B-PP O
the DT B-NP O
ATP NN I-NP O
- HYPH B-PP O
binding VBG B-NP O
domain NN I-NP O
of IN B-PP O
the DT B-NP O
ALD NN I-NP B-Disease
protein NN I-NP O
, , O O
and CC O O
a DT B-NP O
missense JJ I-NP O
mutation NN I-NP O
. . O O

In IN B-PP O
the DT B-NP O
patient NN I-NP O
with IN B-PP O
the DT B-NP O
clinical JJ I-NP O
phenotype NN I-NP O
of IN B-PP O
AMN NN B-NP B-Disease
, , O O
a DT B-NP O
nonsense JJ I-NP O
mutation NN I-NP O
in IN B-PP O
codon NN B-NP O
212 CD I-NP O
, , O O
along IN B-ADVP O
with IN B-PP O
a DT B-NP O
second JJ I-NP O
site NN I-NP O
mutation NN I-NP O
at IN B-PP O
codon NN B-NP O
178 CD I-NP O
, , O O
was VBD B-VP O
observed VBN I-VP O
. . O O

Analysis NN B-NP O
of IN B-PP O
the DT B-NP O
patient NN I-NP O
with IN B-PP O
the DT B-NP O
ADO NN I-NP B-Disease
phenotype NN I-NP O
revealed VBD B-VP O
a DT B-NP O
further JJ I-NP O
missense JJ I-NP O
mutation NN I-NP O
at IN B-PP O
a DT B-NP O
highly RB I-NP O
conserved VBN I-NP O
position NN I-NP O
in IN B-PP O
the DT B-NP O
ALDP NN I-NP O
/ SYM B-NP O
PMP70 NN I-NP O
comparison NN I-NP O
. . O O

The DT B-NP O
disruptive JJ I-NP O
nature NN I-NP O
of IN B-PP O
two CD B-NP O
mutations NNS I-NP O
( ( O O
i NN B-NP O
. . O O

e NN B-NP O
. NN I-NP O

, , O O
the DT B-NP O
frameshift NN I-NP O
and CC O O
the DT B-NP O
nonsense JJ I-NP O
mutation NN I-NP O
) ) O O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
biochemically RB B-NP O
proved VBN I-NP O
childhood NN I-NP O
ALD NN I-NP B-Disease
and CC I-NP O
AMN NN I-NP B-Disease
further RB B-ADVP O
strongly RB B-VP O
supports VBZ I-VP O
the DT B-NP O
hypothesis NN I-NP O
that IN B-SBAR O
alterations NNS B-NP O
in IN B-PP O
this DT B-NP O
gene NN I-NP O
play VBP B-VP O
a DT B-NP O
crucial JJ I-NP O
role NN I-NP O
in IN B-PP O
the DT B-NP O
pathogenesis NN I-NP O
of IN B-PP O
X NN B-NP B-Disease
- HYPH B-NP I-Disease
ALD NN I-NP I-Disease
. . O O

Since IN B-SBAR O
the DT B-NP O
current JJ I-NP O
biochemical JJ I-NP O
techniques NNS I-NP O
for IN B-PP O
X NN B-NP B-Disease
- HYPH I-NP I-Disease
ALD NN I-NP I-Disease
carrier NN I-NP O
detection NN I-NP O
in IN B-PP O
affected VBN B-NP O
families NNS I-NP O
lack VBP B-VP O
sufficient JJ B-NP O
reliability NN I-NP O
, , O O
our PRP$ B-NP O
procedure NN I-NP O
described VBN B-VP O
for IN B-PP O
systematic JJ B-NP O
mutation NN I-NP O
scanning NN I-NP O
is VBZ B-VP O
also RB B-ADVP O
capable JJ B-ADJP O
of IN B-PP O
improving VBG B-VP O
genetic JJ B-NP O
counseling NN I-NP O
and CC O O
prenatal JJ B-NP O
diagnosis NN I-NP O
Duchenne JJ B-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
and CC O O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
in IN B-PP O
the DT B-NP O
same JJ I-NP O
patient NN I-NP O
. . O O

We PRP B-NP O
report VBP B-VP O
on IN B-PP O
the DT B-NP O
first JJ I-NP O
patient NN I-NP O
identified VBN B-VP O
with IN B-PP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
and CC O O
Duchenne JJ B-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
DMD NN B-NP B-Disease
) ) O O
. . O O

The DT B-NP O
family NN I-NP O
of IN B-PP O
the DT B-NP O
propositus NN I-NP O
had VBD B-VP O
a DT B-NP O
strong JJ I-NP O
history NN I-NP O
of IN B-PP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
, , O O
and CC O O
there EX B-NP O
was VBD B-VP O
an DT B-NP O
intrafamilial JJ I-NP O
pathological JJ I-NP O
expansion NN I-NP O
of IN B-PP O
the DT B-NP O
responsible JJ I-NP O
CTG NN I-NP O
repeat NN I-NP O
between IN B-PP O
the DT B-NP O
mildly RB I-NP O
affected VBN I-NP O
mother NN I-NP O
( ( O O
160 CD B-NP O
repeats NNS I-NP O
; : O O
normal JJ B-NP O
27 CD I-NP O
repeats NNS I-NP O
) ) O O
and CC O O
her PRP B-NP O
more RBR B-VP O
severely RB I-VP O
affected VBN I-VP O
son NN B-NP O
( ( O O
650 CD B-NP O
repeats NNS I-NP O
) ) O O
, , O O
and CC O O
his PRP$ B-NP O
sister NN I-NP O
( ( O O
650 CD B-NP O
repeats NNS I-NP O
) ) O O
. . O O

The DT B-NP O
propositus NN I-NP O
was VBD B-VP O
an DT B-NP O
isolated VBN I-NP O
case NN I-NP O
of IN B-PP O
Duchenne NNP B-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
with IN B-PP O
marked JJ B-NP O
dystrophin NN I-NP B-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
muscle NN B-NP O
biopsy NN I-NP O
. . O O

The DT B-NP O
patient NN I-NP O
was VBD B-VP O
still RB B-ADVP O
ambulatory JJ B-ADJP O
post IN B-PP O
age NN B-NP O
16 CD I-NP O
. . O O

Myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
could MD B-VP O
interfere VB I-VP O
to TO B-PP O
some DT B-NP O
extent NN I-NP O
with IN B-PP O
the DT B-NP O
progression NN I-NP O
of IN B-PP O
Duchenne NNP B-NP B-Disease
dystrophy NN I-NP I-Disease
. . O O

However RB B-ADVP O
, , O O
other JJ B-NP O
interpretations NNS I-NP O
are VBP B-VP O
possible JJ B-ADJP O
. . O O

Twelve CD B-NP O
percent NN I-NP O
of IN B-PP O
dystrophin NN B-NP O
revertant NN I-NP O
fibers NNS I-NP O
as IN B-SBAR O
observed VBN B-VP O
by IN B-PP O
immunohistochemistry NN B-NP O
could MD B-VP O
be VB I-VP O
sufficient JJ B-ADJP O
to TO B-VP O
ameliorate VB I-VP O
typical JJ B-NP O
DMD NN I-NP B-Disease
clinical JJ I-NP O
severity NN I-NP O
, , O O
or CC O O
the DT B-NP O
patient NN I-NP O
may MD B-VP O
present VB I-VP O
a DT B-NP O
somatic JJ I-NP O
mosaic NN I-NP O
. . O O

The DT B-NP O
pathophysiological JJ I-NP O
interactions NNS I-NP O
of IN B-PP O
these DT B-NP O
two CD I-NP O
unlinked JJ I-NP O
disorders NNS I-NP O
are VBP B-VP O
discussed VBN I-VP O
at IN B-PP O
the DT B-NP O
clinical JJ I-NP O
and CC I-NP O
histopathological JJ I-NP O
levels NNS I-NP O
. . O O

. . O O

Age NN B-NP O
at IN B-PP O
diagnosis NN B-NP O
as IN B-PP O
an DT B-NP O
indicator NN I-NP O
of IN B-PP O
eligibility NN B-NP O
for IN B-PP O
BRCA1 NN B-NP O
DNA NN I-NP O
testing NN I-NP O
in IN B-PP O
familial JJ B-NP B-Disease
breast NN I-NP I-Disease
cancer NN I-NP I-Disease
. . O O

We PRP B-NP O
searched VBD B-VP O
for IN B-PP O
criteria NNS B-NP O
that WDT B-NP O
could MD B-VP O
indicate VB I-VP O
breast NN B-NP B-Disease
cancer NN I-NP I-Disease
families NNS I-NP O
with IN B-PP O
a DT B-NP O
high JJ I-NP O
prior JJ I-NP O
probability NN I-NP O
of IN B-PP O
being VBG B-VP O
caused VBN I-VP O
by IN B-PP O
the DT B-NP O
breast NN I-NP B-Disease
/ SYM B-NP I-Disease
ovarian JJ I-NP I-Disease
cancer NN I-NP I-Disease
susceptibility NN I-NP O
locus NN I-NP O
BRCA1 NN I-NP O
on IN B-PP O
chromosome NN B-NP O
17 CD I-NP O
. . O O

To TO B-PP O
this DT B-NP O
end NN I-NP O
, , O O
we PRP B-NP O
performed VBD B-VP O
a DT B-NP O
linkage NN I-NP O
study NN I-NP O
with IN B-PP O
59 CD B-NP O
consecutively RB I-NP O
collected VBN I-NP O
Dutch JJ I-NP O
breast NN I-NP B-Disease
cancer NN I-NP I-Disease
families NNS I-NP O
, , O O
including VBG B-PP O
16 CD B-NP O
with IN B-PP O
at IN B-NP O
least JJS I-NP O
one CD I-NP O
case NN I-NP O
of IN B-PP O
ovarian JJ B-NP B-Disease
cancer NN I-NP I-Disease
. . O O

We PRP B-NP O
used VBD B-VP O
an DT B-NP O
intake NN I-NP O
cut NN I-NP O
- HYPH B-VP O
off RP B-PRT O
of IN B-PP O
at IN B-NP O
least JJS I-NP O
three CD I-NP O
first JJ I-NP O
- HYPH I-NP O
degree NN I-NP O
relatives NNS I-NP O
with IN B-PP O
breast NN B-NP B-Disease
and CC O I-Disease
/ SYM B-NP I-Disease
or CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
at IN B-PP O
any DT B-NP O
age NN I-NP O
. . O O

Significant JJ B-NP O
evidence NN I-NP O
for IN B-PP O
linkage NN B-NP O
was VBD B-VP O
found VBN I-VP O
only RB B-ADVP O
among IN B-PP O
the DT B-NP O
13 CD I-NP O
breast NN I-NP B-Disease
cancer NN I-NP I-Disease
families NNS I-NP O
with IN B-PP O
a DT B-NP O
mean JJ I-NP O
age NN I-NP O
at IN B-PP O
diagnosis NN B-NP O
of IN B-PP O
less JJR B-NP O
than IN I-NP O
45 CD I-NP O
years NNS I-NP O
. . O O

An DT B-NP O
unexpectedly RB I-NP O
low JJ I-NP O
proportion NN I-NP O
of IN B-PP O
the DT B-NP O
breast NN I-NP B-Disease
- HYPH B-NP I-Disease
ovarian JJ I-NP I-Disease
cancer NN I-NP I-Disease
families NNS I-NP O
were VBD B-VP O
estimated VBN I-VP O
to TO I-VP O
be VB I-VP O
linked VBN I-VP O
to TO B-PP O
BRCA1 NN B-NP O
, , O O
which WDT B-NP O
could MD B-VP O
be VB I-VP O
due JJ B-ADVP O
to TO B-PP O
a DT B-NP O
founder NN I-NP O
effect NN I-NP O
in IN B-PP O
the DT B-NP O
Dutch JJ I-NP O
population NN I-NP O
. . O O

Given VBN B-PP O
the DT B-NP O
expected VBN I-NP O
logistical JJ I-NP O
problems NNS I-NP O
in IN B-PP O
clinical JJ B-NP O
management NN I-NP O
now RB B-ADVP O
that IN B-SBAR O
BRCA1 NN B-NP O
has VBZ B-VP O
been VBN I-VP O
identified VBN I-VP O
, , O O
we PRP B-NP O
propose VBP B-VP O
an DT B-NP O
interim JJ I-NP O
period NN I-NP O
in IN B-PP O
which WDT B-NP O
only RB B-ADVP O
families VBZ B-VP O
with IN B-PP O
a DT B-NP O
strong JJ I-NP O
positive JJ I-NP O
family NN I-NP O
history NN I-NP O
for IN B-PP O
early JJ B-NP O
onset NN I-NP O
breast NN I-NP B-Disease
and CC O I-Disease
/ SYM B-NP I-Disease
or CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
will MD B-VP O
be VB I-VP O
offered VBN I-VP O
BRCA1 NN B-NP O
mutation NN I-NP O
testing NN I-NP O
. . O O

. . O O

Linkage NN B-NP O
analysis NN I-NP O
of IN B-PP O
26 CD B-NP O
Canadian JJ I-NP O
breast NN I-NP B-Disease
and CC I-NP I-Disease
breast NN I-NP I-Disease
- HYPH B-NP I-Disease
ovarian JJ I-NP I-Disease
cancer NN I-NP I-Disease
families NNS I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
examined VBN I-VP O
26 CD B-NP O
Canadian JJ I-NP O
families NNS I-NP O
with IN B-PP O
hereditary JJ B-NP B-Disease
breast NN I-NP I-Disease
or CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
for IN B-PP O
linkage NN B-NP O
to TO B-PP O
markers NNS B-NP O
flanking VBG B-VP O
the DT B-NP O
BRCA1 NN I-NP O
gene NN I-NP O
on IN B-PP O
chromosome NN B-NP O
17q12 CD I-NP O
- HYPH I-NP O
q21 NN I-NP O
. . O O

Of IN B-PP O
the DT B-NP O
15 CD I-NP O
families NNS I-NP O
that WDT B-NP O
contain VBP B-VP O
cases NNS B-NP O
of IN B-PP O
ovarian JJ B-NP B-Disease
cancer NN I-NP I-Disease
, , O O
94 CD B-NP O
% NN I-NP O
were VBD B-VP O
estimated VBN I-VP O
to TO I-VP O
be VB I-VP O
linked VBN I-VP O
to TO B-PP O
BRCA1 NN B-NP O
. . O O

In IN B-PP O
contrast NN B-NP O
, , O O
there EX B-NP O
was VBD B-VP O
no DT B-NP O
overall JJ I-NP O
evidence NN I-NP O
of IN B-PP O
linkage NN B-NP O
in IN B-PP O
the DT B-NP O
group NN I-NP O
of IN B-PP O
10 CD B-NP O
families NNS I-NP O
with IN B-PP O
breast NN B-NP B-Disease
cancer NN I-NP I-Disease
without IN B-PP O
ovarian JJ B-NP B-Disease
cancer NN I-NP I-Disease
. . O O

A DT B-NP O
genetic JJ I-NP O
recombinant NN I-NP O
in IN B-PP O
a DT B-NP O
breast NN I-NP B-Disease
- HYPH B-NP I-Disease
ovarian JJ I-NP I-Disease
cancer NN I-NP I-Disease
family NN I-NP O
indicates VBZ B-VP O
a DT B-NP O
placement NN I-NP O
of IN B-PP O
BRCA1 NN B-NP O
telomeric JJ B-ADJP O
to TO B-PP O
D17S776 NN B-NP O
, , O O
and CC O O
helps VBZ B-VP O
to TO I-VP O
define VB I-VP O
the DT B-NP O
region NN I-NP O
of IN B-PP O
assignment NN B-NP O
of IN B-PP O
the DT B-NP O
cancer NN I-NP B-Disease
susceptibility NN I-NP O
gene NN I-NP O
. . O O

Other JJ B-NP O
cancers NNS I-NP B-Disease
of IN B-PP O
interest NN B-NP O
that WDT B-NP O
appeared VBD B-VP O
in IN B-PP O
the DT B-NP O
BRCA1 NN I-NP O
- HYPH B-NP O
linked VBN I-NP O
families NNS I-NP O
included VBD B-VP O
primary JJ B-NP B-Disease
peritoneal JJ I-NP I-Disease
cancer NN I-NP I-Disease
, , O O
cancer NN B-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
fallopian JJ I-NP I-Disease
tube NN I-NP I-Disease
, , O O
and CC O O
malignant JJ B-NP B-Disease
melanoma NN I-NP I-Disease
. . O O

. . O O

Structural JJ B-NP O
analysis NN I-NP O
of IN B-PP O
the DT B-NP O
5 CD I-NP O
' SYM I-NP O
region NN I-NP O
of IN B-PP O
mouse NN B-NP O
and CC O O
human JJ B-NP O
Huntington NNP I-NP B-Disease
disease NN I-NP I-Disease
genes NNS I-NP O
reveals VBZ B-VP O
conservation NN B-NP O
of IN B-PP O
putative JJ B-NP O
promoter NN I-NP O
region NN I-NP O
and CC O O
di AFX B-NP O
- HYPH I-NP O
and CC I-NP O
trinucleotide NN I-NP O
polymorphisms NNS I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
previously RB I-VP O
cloned VBN I-VP O
and CC O O
characterized VBN B-VP O
the DT B-NP O
murine JJ I-NP O
homologue NN I-NP O
of IN B-PP O
the DT B-NP O
Huntington NNP I-NP B-Disease
disease NN I-NP I-Disease
( ( O O
HD NN B-NP B-Disease
) ) O O
gene NN B-NP O
and CC O O
shown VBN B-VP O
that IN B-SBAR O
it PRP B-NP O
maps VBZ B-VP O
to TO B-PP O
mouse NN B-NP O
chromosome NN I-NP O
5 CD I-NP O
within IN B-PP O
a DT B-NP O
region NN I-NP O
of IN B-PP O
conserved VBN B-NP O
synteny NN I-NP O
with IN B-PP O
human JJ B-NP O
chromosome NN I-NP O
4p16 CD I-NP O
. . O O

3 CD B-NP O
3 CD I-NP O
. . O O

Here RB B-ADVP O
we PRP B-NP O
present VBP B-VP O
a DT B-NP O
detailed JJ I-NP O
comparison NN I-NP O
of IN B-PP O
the DT B-NP O
sequence NN I-NP O
of IN B-PP O
the DT B-NP O
putative JJ I-NP O
promoter NN I-NP O
and CC O O
the DT B-NP O
organization NN I-NP O
of IN B-PP O
the DT B-NP O
5 CD I-NP O
genomic JJ I-NP O
region NN I-NP O
of IN B-PP O
the DT B-NP O
murine NN I-NP O
( ( O O
Hdh NN B-NP O
) ) O O
and CC O O
human JJ B-NP O
HD NN I-NP B-Disease
genes NNS I-NP O
encompassing VBG B-VP O
the DT B-NP O
first JJ I-NP O
five CD I-NP O
exons NNS I-NP O
. . O O

We PRP B-NP O
show VBP B-VP O
that IN B-SBAR O
in IN B-PP O
this DT B-NP O
region NN I-NP O
these DT B-NP O
two CD I-NP O
genes NNS I-NP O
share VBP B-VP O
identical JJ B-NP O
exon NN I-NP O
boundaries NNS I-NP O
, , O O
but CC O O
have VBP B-VP O
different JJ B-NP O
- HYPH I-NP O
size NN I-NP O
introns NNS I-NP O
. . O O

Two CD B-NP O
dinucleotide NN I-NP O
( ( O O
CT NN B-NP O
) ) O O
and CC O O
one CD B-NP O
trinucleotide NN I-NP O
intronic JJ I-NP O
polymorphism NN I-NP O
in IN B-PP O
Hdh NN B-NP O
and CC O O
an DT B-NP O
intronic JJ I-NP O
CA NN I-NP O
polymorphism NN I-NP O
in IN B-PP O
the DT B-NP O
HD NN I-NP B-Disease
gene NN I-NP O
were VBD B-VP O
identified VBN I-VP O
. . O O

Comparison NN B-NP O
of IN B-PP O
940 CD B-NP O
- HYPH I-NP O
bp NN I-NP O
sequence NN I-NP O
5 CD I-NP O
to TO B-PP O
the DT B-NP O
putative JJ I-NP O
translation NN I-NP O
start NN I-NP O
site NN I-NP O
reveals VBZ B-VP O
a DT B-NP O
highly RB I-NP O
conserved VBN I-NP O
region NN I-NP O
( ( O O
78 CD B-NP O
. . O O

8 CD B-NP O
% NN I-NP O
nucleotide NN I-NP O
identity NN I-NP O
) ) O O
between IN B-PP O
Hdh NN B-NP O
and CC O O
the DT B-NP O
HD NN I-NP B-Disease
gene NN I-NP O
from IN B-PP O
nucleotide NN B-NP O
- HYPH B-ADVP O
56 CD B-NP O
to TO B-PP O
- SYM B-NP O
206 CD I-NP O
( ( O O
of IN B-PP O
Hdh NN B-NP O
) ) O O
. . O O

Neither CC O O
Hdh NN B-NP O
nor CC O O
the DT B-NP O
HD NN I-NP B-Disease
gene NN I-NP O
have VBP B-VP O
typical JJ B-NP O
TATA NN I-NP O
or CC I-NP O
CCAAT NN I-NP O
elements NNS I-NP O
, , O O
but CC O O
both DT B-NP O
show VBP B-VP O
one CD B-NP O
putative JJ I-NP O
AP2 NN I-NP O
binding NN I-NP O
site NN I-NP O
and CC O O
numerous JJ B-NP O
potential JJ I-NP O
Sp1 NN I-NP O
binding NN I-NP O
sites NNS I-NP O
. . O O

The DT B-NP O
high JJ I-NP O
sequence NN I-NP O
identity NN I-NP O
between IN B-PP O
Hdh NN B-NP O
and CC O O
the DT B-NP O
HD NN I-NP B-Disease
gene NN I-NP O
for IN B-PP O
approximately RB B-NP O
200 CD I-NP O
bp NN I-NP O
5 CD B-NP O
to TO B-PP O
the DT B-NP O
putative JJ I-NP O
translation NN I-NP O
start NN I-NP O
site NN I-NP O
indicates VBZ B-VP O
that IN B-SBAR O
these DT B-NP O
sequences NNS I-NP O
may MD B-VP O
play VB I-VP O
a DT B-NP O
role NN I-NP O
in IN B-PP O
regulating VBG B-VP O
expression NN B-NP O
of IN B-PP O
the DT B-NP O
Huntington NNP I-NP B-Disease
disease NN I-NP I-Disease
gene NN I-NP O
The DT B-NP O
protein NN I-NP O
deficient JJ B-ADJP O
in IN B-PP O
Lowe JJ B-NP B-Disease
syndrome NN I-NP I-Disease
is VBZ B-VP O
a DT B-NP O
phosphatidylinositol NN I-NP O
- HYPH B-NP O
4 CD I-NP O
, , I-NP O
5 CD I-NP O
- HYPH I-NP O
bisphosphate NN B-NP O
5 CD I-NP O
- HYPH I-NP O
phosphatase NN I-NP O
. . O O

Lowe JJ B-NP B-Disease
syndrome NN I-NP I-Disease
, , O O
also RB B-VP O
known VBN I-VP O
as IN B-PP O
oculocerebrorenal JJ B-NP B-Disease
syndrome NN I-NP I-Disease
, , O O
is VBZ B-VP O
caused VBN I-VP O
by IN B-PP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
X NN I-NP O
chromosome NN I-NP O
- HYPH B-VP O
encoded VBN B-NP O
OCRL NN I-NP O
gene NN I-NP O
. . O O

The DT B-NP O
OCRL NN I-NP O
protein NN I-NP O
is VBZ B-VP O
51 CD B-NP O
% NN I-NP O
identical JJ B-ADJP O
to TO B-PP O
inositol NN B-NP O
polyphosphate NN I-NP O
5 CD I-NP O
- HYPH I-NP O
phosphatase NN I-NP O
II CD I-NP O
( ( O O
5 CD B-NP O
- HYPH I-NP O
phosphatase NN I-NP O
II CD I-NP O
) ) O O
from IN B-PP O
human JJ B-NP O
platelets NNS I-NP O
over IN B-PP O
a DT B-NP O
span NN I-NP O
of IN B-PP O
744 CD B-NP O
aa NN I-NP O
, , O O
suggesting VBG B-VP O
that IN B-SBAR O
OCRL NN B-NP O
may MD B-VP O
be VB I-VP O
a DT B-NP O
similar JJ I-NP O
enzyme NN I-NP O
. . O O

We PRP B-NP O
engineered VBD B-VP O
a DT B-NP O
construct NN I-NP O
of IN B-PP O
the DT B-NP O
OCRL NN I-NP O
cDNA NN I-NP O
that WDT B-NP O
encodes VBZ B-VP O
amino JJ B-NP O
acids NNS I-NP O
homologous JJ B-ADJP O
to TO B-PP O
the DT B-NP O
platelet NN I-NP O
5 CD I-NP O
- HYPH I-NP O
phosphatase NN I-NP O
for IN B-PP O
expression NN B-NP O
in IN B-PP O
baculovirus NN B-NP O
- HYPH B-NP O
infected VBN I-NP O
Sf9 NN I-NP O
insect NN I-NP O
cells NNS I-NP O
. . O O

This DT B-NP O
cDNA NN I-NP O
encodes VBZ B-VP O
aa SYM B-NP O
264 CD I-NP O
- HYPH I-NP O
968 CD I-NP O
of IN B-PP O
the DT B-NP O
OCRL NN I-NP O
protein NN I-NP O
. . O O

The DT B-NP O
recombinant JJ I-NP O
protein NN I-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
catalyze VB I-VP O
the DT B-NP O
reactions NNS I-NP O
also RB B-ADVP O
carried VBD B-VP O
out RP B-PRT O
by IN B-PP O
platelet NN B-NP O
5 CD I-NP O
- HYPH I-NP O
phosphatase NN B-NP O
II CD I-NP O
. . O O

Thus RB B-NP O
OCRL NN I-NP O
converts VBZ B-VP O
inositol NN B-NP O
1 CD I-NP O
, , I-NP O
4 CD I-NP O
, , I-NP O
5 CD I-NP O
- HYPH I-NP O
trisphosphate NN I-NP O
to TO B-PP O
inositol NN B-NP O
1 CD I-NP O
, , I-NP O
4 CD I-NP O
- HYPH I-NP O
bisphosphate NN I-NP O
, , O O
and CC O O
it PRP B-NP O
converts VBZ B-VP O
inositol NN B-NP O
1 CD I-NP O
, , I-NP O
3 CD I-NP O
, , I-NP O
4 CD I-NP O
, , I-NP O
5 CD I-NP O
- HYPH I-NP O
tetrakisphosphate NN I-NP O
to TO B-PP O
inositol NN B-NP O
1 CD I-NP O
, , I-NP O
3 CD I-NP O
, , I-NP O
4 CD I-NP O
- HYPH I-NP O
trisphosphate NN I-NP O
. . O O

Most RBS B-ADJP O
important JJ I-ADJP O
, , O O
the DT B-NP O
enzyme NN I-NP O
converts VBZ B-VP O
phosphatidylinositol NN B-NP O
4 CD I-NP O
, , I-NP O
5 CD I-NP O
- HYPH I-NP O
bisphosphate NN I-NP O
to TO B-PP O
phosphatidylinositol NN B-NP O
4 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
. . O O

The DT B-NP O
relative JJ I-NP O
ability NN I-NP O
of IN B-PP O
OCRL NN B-NP O
to TO B-VP O
catalyze VB I-VP O
the DT B-NP O
three CD I-NP O
reactions NNS I-NP O
is VBZ B-VP O
different JJ B-ADJP O
from IN B-PP O
that DT B-NP O
of IN B-PP O
5 CD B-NP O
- HYPH I-NP O
phosphatase NN I-NP O
II CD I-NP O
and CC B-PP O
from IN B-PP O
that DT B-NP O
of IN B-PP O
another DT B-NP O
5 CD I-NP O
- HYPH I-NP O
phosphatase NN I-NP O
isoenzyme NN I-NP O
from IN B-PP O
platelets NNS B-NP O
, , O O
5 CD B-NP O
- HYPH O O
phosphatase NN B-NP O
I CD I-NP O
. . O O

The DT B-NP O
recombinant JJ I-NP O
OCRL NN I-NP O
protein NN I-NP O
hydrolyzes VBZ B-VP O
the DT B-NP O
phospholipid NN I-NP O
substrate NN I-NP O
10 CD I-NP O
- HYPH B-ADJP O
to TO B-PP O
30 CD B-NP O
- HYPH B-ADJP O
fold RB I-ADJP O
better JJR I-ADJP O
than IN B-PP O
5 CD B-NP O
- HYPH I-NP O
phosphatase NN I-NP O
II CD I-NP O
, , O O
and CC O O
5 CD B-NP O
- HYPH I-NP O
phosphatase NN I-NP O
I CD I-NP O
does VBZ B-VP O
not RB I-VP O
cleave VB I-VP O
the DT B-NP O
lipid NN I-NP O
at IN B-ADVP O
all DT I-ADVP O
. . O O

We PRP B-NP O
also RB B-ADVP O
show VBP B-VP O
that IN B-SBAR O
OCRL NN B-NP O
functions VBZ B-VP O
as IN B-PP O
a DT B-NP O
phosphatidylinositol NN I-NP O
4 CD I-NP O
, , I-NP O
5 CD I-NP O
- HYPH I-NP O
bisphosphate NN B-NP O
5 CD I-NP O
- HYPH I-NP O
phosphatase NN I-NP O
in IN B-PP O
OCRL NN B-NP O
- HYPH O O
expressing VBG B-VP O
Sf9 NN B-NP O
cells NNS I-NP O
. . O O

These DT B-NP O
results NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
OCRL NN B-NP O
is VBZ B-VP O
mainly RB B-ADVP O
a DT B-NP O
lipid NN I-NP O
phosphatase NN I-NP O
that WDT B-NP O
may MD B-VP O
control VB I-VP O
cellular JJ B-NP O
levels NNS I-NP O
of IN B-PP O
a DT B-NP O
critical JJ I-NP O
metabolite NN I-NP O
, , O O
phosphatidylinositol NN B-NP O
4 CD I-NP O
, , I-NP O
5 CD I-NP O
- HYPH I-NP O
bisphosphate NN I-NP O
. . O O

Deficiency NN B-NP O
of IN B-PP O
this DT B-NP O
enzyme NN I-NP O
apparently RB B-ADVP O
causes VBZ B-VP O
the DT B-NP O
protean JJ I-NP O
manifestations NNS I-NP O
of IN B-PP O
Lowe JJ B-NP B-Disease
syndrome NN I-NP I-Disease
. . O O

. . O O

New JJ B-NP O
founder NN I-NP O
haplotypes NNS I-NP O
at IN B-PP O
the DT B-NP O
myotonic JJ I-NP B-Disease
dystrophy NN I-NP I-Disease
locus NN I-NP O
in IN B-PP O
southern JJ B-NP O
Africa NNP I-NP O
. . O O

The DT B-NP O
association NN I-NP O
between IN B-PP O
normal JJ B-NP O
alleles NNS I-NP O
at IN B-PP O
the DT B-NP O
CTG NN I-NP O
repeat NN I-NP O
and CC O O
two CD B-NP O
nearby JJ I-NP O
polymorphisms NNS I-NP O
in IN B-PP O
the DT B-NP O
myotonin NN I-NP O
protein NN I-NP O
kinase NN I-NP O
gene NN I-NP O
, , O O
the DT B-NP O
Alu NN I-NP O
insertion NN I-NP O
/ SYM B-VP O
deletion NN B-NP O
polymorphism NN I-NP O
and CC O O
the DT B-NP O
myotonic JJ I-NP B-Disease
dystrophy NN I-NP I-Disease
kinase NN I-NP O
( ( O O
DMK NN B-NP O
) ) O O
( ( O O
G NN B-NP O
/ SYM I-NP O
T NN I-NP O
) ) O O
intron NN B-NP O
9 CD I-NP O
/ SYM I-NP O
HinfI NN I-NP O
polymorphism NN I-NP O
, , O O
has VBZ B-VP O
been VBN I-VP O
analyzed VBN I-VP O
in IN B-PP O
South JJ B-NP O
African JJ I-NP O
Negroids NNS I-NP O
, , O O
a DT B-NP O
population NN I-NP O
in IN B-PP O
which WDT B-NP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
( ( O O
DM NN B-NP B-Disease
) ) O O
has VBZ B-VP O
not RB I-VP O
been VBN I-VP O
described VBN I-VP O
. . O O

South JJ B-NP O
African JJ I-NP O
Negroids NNS I-NP O
have VBP B-VP O
a DT B-NP O
CTG NN I-NP O
allelic JJ I-NP O
distribution NN I-NP O
that WDT B-NP O
is VBZ B-VP O
significantly RB B-ADJP O
different JJ I-ADJP O
from IN B-PP O
that DT B-NP O
in IN B-PP O
Caucasoids NNS B-NP O
and CC O O
Japanese VB B-VP O
the DT B-NP O
CTG NN I-NP O
repeat NN I-NP O
lengths NNS I-NP O
of IN B-PP O
> SYM B-NP O
or CC O O
= SYM B-VP O
19 CD B-NP O
are VBP B-VP O
very RB B-ADJP O
rare JJ I-ADJP O
. . O O

The DT B-NP O
striking JJ I-NP O
linkage NN I-NP O
disequilibrium NN I-NP O
between IN B-PP O
specific JJ B-NP O
alleles NNS I-NP O
at IN B-PP O
the DT B-NP O
Alu NN I-NP O
polymorphism NN I-NP O
( ( O O
Alu NN B-NP O
( ( O O
ins NNS B-NP O
) ) O O
and CC O O
Alu NN B-NP O
( ( O O
del NN B-NP O
) ) O O
) ) O O
, , O O
the DT B-NP O
HinfI NN I-NP O
polymorphism NN I-NP O
( ( O O
HinfI NN B-NP O
- HYPH B-NP O
1 CD I-NP O
and CC I-NP O
HinfI NN I-NP O
- HYPH O O
2 CD B-NP O
) ) O O
, , O O
and CC O O
the DT B-NP O
CTG NN I-NP O
repeat NN I-NP O
polymorphism NN I-NP O
seen VBN B-VP O
in IN B-PP O
Caucasoid NNP B-NP O
( ( O O
Europeans NNPS B-NP O
and CC I-NP O
Canadians NNPS I-NP O
) ) O O
populations NNS B-NP O
was VBD B-VP O
also RB I-VP O
found VBN I-VP O
in IN B-PP O
the DT B-NP O
South JJ I-NP O
African JJ I-NP O
Negroid JJ I-NP O
population NN I-NP O
. . O O

Numerous JJ B-NP O
haplotypes NNS I-NP O
, , O O
not RB B-VP O
previously RB I-VP O
described VBN I-VP O
in IN B-PP O
Europeans NNPS B-NP O
, , O O
were VBD B-VP O
, , O O
however RB B-ADVP O
, , O O
found VBN B-VP O
. . O O

It PRP B-NP O
thus RB B-ADVP O
seems VBZ B-VP O
likely JJ B-ADJP O
that IN B-SBAR O
only RB B-NP O
a DT I-NP O
small JJ I-NP O
number NN I-NP O
of IN B-PP O
these DT B-NP O
African JJ I-NP O
chromosomes NNS I-NP O
were VBD B-VP O
present JJ B-ADJP O
in IN B-PP O
the DT B-NP O
progenitors NNS I-NP O
of IN B-PP O
all DT B-NP O
non AFX I-NP O
- HYPH I-NP O
African JJ I-NP O
peoples NNS I-NP O
. . O O

These DT B-NP O
data NNS I-NP O
provide VBP B-VP O
support NN B-NP O
for IN B-PP O
the DT B-NP O
out IN B-PP O
of IN B-PP O
Africa NNP B-NP O
model NN I-NP O
for IN B-PP O
the DT B-NP O
origin NN I-NP O
of IN B-PP O
modern JJ B-NP O
humans NNS I-NP O
and CC O O
suggest VBP B-VP O
that IN B-SBAR O
the DT B-NP O
rare JJ I-NP O
ancestral JJ I-NP O
DM NN I-NP B-Disease
mutation NN I-NP O
event NN I-NP O
may MD B-VP O
have VB I-VP O
occurred VBD I-VP O
after IN B-PP O
the DT B-NP O
migration NN I-NP O
from IN B-PP O
Africa NNP B-NP O
, , O O
hence RB B-ADVP O
the DT B-NP O
absence NN I-NP O
of IN B-PP O
DM NN B-NP B-Disease
in IN B-PP O
sub AFX B-NP O
- HYPH I-NP O
Saharan NNP I-NP O
Negroid NNP I-NP O
peoples NNS I-NP O
. . O O

. . O O

Discordant JJ B-NP O
clinical JJ I-NP O
outcome NN I-NP O
in IN B-PP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
relatives NNS I-NP O
showing VBG B-VP O
( ( O O
CTG NN B-NP O
) ) O O
n NN B-NP O
> SYM O O
700 CD B-NP O
repeats NNS I-NP O
. . O O

A DT B-NP O
myotonic JJ I-NP B-Disease
dystrophy NN I-NP I-Disease
( ( O O
DM NN B-NP B-Disease
) ) O O
family NN B-NP O
is VBZ B-VP O
described VBN I-VP O
in IN B-PP O
which WDT B-NP O
discordant JJ B-NP O
DM NN I-NP B-Disease
phenotypes NNS I-NP O
were VBD B-VP O
found VBN I-VP O
in IN B-PP O
the DT B-NP O
children NNS I-NP O
of IN B-PP O
two CD B-NP O
affected VBN I-NP O
sisters NNS I-NP O
with IN B-PP O
similar JJ B-NP O
CTG NN I-NP O
expansion NN I-NP O
and CC O O
clinical JJ B-NP O
manifestations NNS I-NP O
. . O O

In IN B-PP O
this DT B-NP O
family NN I-NP O
, , O O
congenital JJ O O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
early JJ B-NP O
severe JJ I-NP O
childhood NN I-NP O
and CC O O
later JJ B-NP O
childhood NN I-NP O
onset NN I-NP O
DM NN I-NP B-Disease
coexist NN I-NP O
. . O O

This DT B-NP O
observation NN I-NP O
strengthens VBZ B-VP O
the DT B-NP O
limited VBN I-NP O
ability NN I-NP O
of IN B-PP O
lymphocytes NNS B-NP O
CTG NN I-NP O
repeat NN I-NP O
number NN I-NP O
analysis NN I-NP O
in IN B-PP O
predicting VBG B-VP O
genotype NN B-NP O
- HYPH B-NP O
phenotype NN I-NP O
correlations NNS I-NP O
in IN B-PP O
DM NN B-NP B-Disease
patients NNS I-NP O
. . O O

. . O O

Purification NN B-NP O
of IN B-PP O
human JJ B-NP O
very RB I-NP O
- HYPH I-NP O
long JJ I-NP O
- HYPH I-NP O
chain NN I-NP O
acyl NN I-NP O
- HYPH B-NP O
coenzyme NN I-NP O
A NN I-NP O
dehydrogenase NN I-NP O
and CC O O
characterization NN B-NP O
of IN B-PP O
its PRP$ B-NP O
deficiency NN I-NP O
in IN B-PP O
seven CD B-NP O
patients NNS I-NP O
. . O O

Mitochondrial JJ B-NP O
very RB I-NP O
- HYPH I-NP O
long JJ I-NP O
- HYPH I-NP O
chain NN I-NP O
acyl NN I-NP O
- HYPH B-NP O
coenzyme NN I-NP O
A NN I-NP O
dehydrogenase NN I-NP O
( ( O O
VLCAD NN B-NP O
) ) O O
was VBD B-VP O
purified VBN I-VP O
from IN B-PP O
human JJ B-NP O
liver NN I-NP O
. . O O

The DT B-NP O
molecular JJ I-NP O
masses NNS I-NP O
of IN B-PP O
the DT B-NP O
native JJ I-NP O
enzyme NN I-NP O
and CC O O
the DT B-NP O
subunit NN I-NP O
were VBD B-VP O
estimated VBN I-VP O
to TO I-VP O
be VB I-VP O
154 CD B-NP O
and CC O O
70 CD B-NP O
kD NN I-NP O
, , O O
respectively RB B-ADVP O
. . O O

The DT B-NP O
enzyme NN I-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
catalyze VB I-VP O
the DT B-NP O
major JJ I-NP O
part NN I-NP O
of IN B-PP O
mitochondrial JJ B-NP O
palmitoylcoenzyme NN I-NP O
A NN I-NP O
dehydrogenation NN I-NP O
in IN B-PP O
liver NN B-NP O
, , O O
heart NN B-NP O
, , O O
skeletal JJ B-NP O
muscle NN I-NP O
, , O O
and CC O O
skin NN B-NP O
fibroblasts NNS I-NP O
( ( O O
89 CD B-NP O
- HYPH I-NP O
97 CD I-NP O
, , I-NP O
86 CD I-NP O
- HYPH B-NP O
99 CD I-NP O
, , I-NP O
96 CD I-NP O
- HYPH B-NP O
99 CD I-NP O
, , O O
and CC O O
78 CD B-NP O
- HYPH I-NP O
87 CD I-NP O
% NN I-NP O
, , O O
respectively RB B-ADVP O
) ) O O
. . O O

Skin NN B-NP O
fibroblasts NNS I-NP O
from IN B-PP O
26 CD B-NP O
patients NNS I-NP O
suspected VBN B-VP O
of IN B-PP O
having VBG B-VP O
a DT B-NP O
disorder NN I-NP O
of IN B-PP O
mitochondrial JJ B-NP O
beta SYM I-NP O
- HYPH I-NP O
oxidation NN I-NP O
were VBD B-VP O
analyzed VBN I-VP O
for IN B-PP O
VLCAD NN B-NP O
protein NN I-NP O
using VBG B-VP O
immunoblotting NN B-NP O
, , O O
and CC O O
7 CD B-NP O
of IN B-PP O
them PRP B-NP O
contained VBD B-VP O
undetectable JJ B-NP O
or CC I-NP O
trace NN I-NP O
levels NNS I-NP O
of IN B-PP O
the DT B-NP O
enzyme NN I-NP O
. . O O

The DT B-NP O
seven CD I-NP O
deficient JJ I-NP O
fibroblast NN I-NP O
lines NNS I-NP O
were VBD B-VP O
characterized VBN I-VP O
by IN B-PP O
measuring VBG B-VP O
acyl NN B-NP O
- HYPH B-NP O
coenzyme NN I-NP O
A NN I-NP O
dehydrogenation NN I-NP O
activities NNS I-NP O
, , O O
overall JJ B-NP O
palmitic JJ I-NP O
acid NN I-NP O
oxidation NN I-NP O
, , O O
and CC O O
VLCAD NN B-NP O
protein NN I-NP O
synthesis NN I-NP O
using VBG B-VP O
pulse NN B-NP O
- HYPH I-NP O
chase NN I-NP O
, , O O
further RB B-ADVP O
confirming VBG B-VP O
the DT B-NP O
diagnosis NN I-NP O
of IN B-PP O
VLCAD NN B-NP B-Disease
deficiency NN I-NP I-Disease
. . O O

These DT B-NP O
results NNS I-NP O
suggested VBD B-VP O
the DT B-NP O
heterogenous JJ I-NP O
nature NN I-NP O
of IN B-PP O
the DT B-NP O
mutations NNS I-NP O
causing VBG B-VP O
the DT B-NP O
deficiency NN I-NP O
in IN B-PP O
the DT B-NP O
seven CD I-NP O
patients NNS I-NP O
. . O O

Clinically RB B-ADVP O
, , O O
all DT B-NP O
patients NNS I-NP O
with IN B-PP O
VLCAD NN B-NP B-Disease
deficiency NN I-NP I-Disease
exhibited VBD B-VP O
cardiac JJ B-NP B-Disease
disease NN I-NP I-Disease
. . O O

At IN B-NP O
least JJS I-NP O
four CD I-NP O
of IN B-PP O
them PRP B-NP O
presented VBD B-VP O
with IN B-PP O
hypertrophic JJ B-NP B-Disease
cardiomyopathy NN I-NP I-Disease
. . O O

This DT B-NP O
frequency NN I-NP O
( ( O O
> SYM B-NP O
57 CD B-NP O
% NN I-NP O
) ) O O
was VBD B-VP O
much RB B-ADJP O
higher JJR I-ADJP O
than IN B-PP O
that DT B-NP O
observed VBN B-VP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
other JJ B-NP O
disorders NNS I-NP O
of IN B-PP O
mitochondrial JJ B-NP O
long JJ I-NP O
- HYPH I-NP O
chain NN I-NP O
fatty JJ I-NP O
acid NN I-NP O
oxidation NN I-NP O
that WDT B-NP O
may MD B-VP O
be VB I-VP O
accompanied VBN I-VP O
by IN B-PP O
cardiac JJ B-NP B-Disease
disease NN I-NP I-Disease
in IN B-PP O
infants NNS B-NP O
. . O O

. . O O

Hereditary JJ B-NP B-Disease
deficiency NN I-NP I-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
fifth JJ I-NP I-Disease
component NN I-NP I-Disease
of IN B-PP I-Disease
complement NN B-NP I-Disease
in IN B-PP O
man NN B-NP O
. . O O

II CD B-NP O
. . O O

Biological JJ B-NP O
properties NNS I-NP O
of IN B-PP O
C5 NN B-NP B-Disease
- HYPH B-NP I-Disease
deficient JJ I-NP I-Disease
human JJ I-NP O
serum NN I-NP O
. . O O

The DT B-NP O
first JJ I-NP O
known VBN I-NP O
human JJ I-NP O
kindred NN I-NP O
with IN B-PP O
hereditary JJ B-NP B-Disease
deficiency NN I-NP I-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
fifth JJ I-NP I-Disease
component NN I-NP I-Disease
of IN B-PP I-Disease
complement NN B-NP I-Disease
( ( O O
C5 NN B-NP O
) ) O O
was VBD B-VP O
documented VBN I-VP O
in IN B-PP O
the DT B-NP O
accompanying VBG I-NP O
report NN I-NP O
. . O O

This DT B-NP O
study NN I-NP O
examines VBZ B-VP O
several JJ B-NP O
biological JJ I-NP O
properties NNS I-NP O
of IN B-PP O
C5 NN B-NP B-Disease
- HYPH B-NP I-Disease
deficient JJ I-NP I-Disease
( ( O O
C5D NN B-NP B-Disease
) ) I-NP O
human JJ I-NP O
serum NN I-NP O
, , O O
particularly RB B-ADVP O
sera NNS B-NP O
obtained VBN B-VP O
from IN B-PP O
two CD B-NP O
C5D NN I-NP B-Disease
homozygotes NNS I-NP O
. . O O

The DT B-NP O
proband NN I-NP O
, , O O
who WP B-NP O
has VBZ B-VP O
inactive JJ B-NP O
systemic JJ I-NP B-Disease
lupus NN I-NP I-Disease
erythematosus NN I-NP I-Disease
is VBZ B-VP O
completely RB I-VP O
lacking VBG I-VP O
C5 NN B-NP O
, , O O
while IN B-SBAR O
her PRP$ B-NP O
healthy JJ I-NP O
half NN I-NP O
- HYPH I-NP O
sister NN I-NP O
has VBZ B-VP O
1 CD B-NP O
- HYPH I-NP O
2 CD I-NP O
% NN I-NP O
of IN B-PP O
normal JJ B-NP O
levels NNS I-NP O
. . O O

Both DT B-NP O
sera NNS I-NP O
were VBD B-VP O
severely RB B-ADJP O
impaired JJ I-ADJP O
in IN B-PP O
their PRP$ B-NP O
ability NN I-NP O
to TO B-VP O
generate VB I-VP O
chemotactic JJ B-NP O
activity NN I-NP O
for IN B-PP O
normal JJ B-NP O
human JJ I-NP O
neutrophils NNS I-NP O
upon IN B-PP O
incubation NN B-NP O
with IN B-PP O
aggregated VBN B-NP O
human JJ I-NP O
gamma SYM I-NP O
- HYPH I-NP O
globulin NN B-NP O
or CC O O
Escherichia FW B-NP O
coli FW I-NP O
endotoxin NN I-NP O
. . O O

This DT B-NP O
function NN I-NP O
was VBD B-VP O
fully RB I-VP O
restored VBN I-VP O
in IN B-PP O
the DT B-NP O
siblings NNS I-NP O
serum NN I-NP O
, , O O
and CC O O
substantially RB B-VP O
improved VBN I-VP O
in IN B-PP O
the DT B-NP O
probands NNS I-NP O
serum NN I-NP O
, , O O
by IN B-PP O
addition NN B-NP O
of IN B-PP O
highly RB B-NP O
purified VBN I-NP O
human JJ I-NP O
C5 NN I-NP O
to TO B-PP O
normal JJ B-NP O
serum NN I-NP O
concentrations NNS I-NP O
. . O O

Sera NN B-NP O
from IN B-PP O
eight CD B-NP O
family NN I-NP O
members NNS I-NP O
who WP B-NP O
were VBD B-VP O
apparently RB B-ADJP O
heterozygous JJ I-ADJP O
for IN B-PP O
C5 NN B-NP B-Disease
deficiency NN I-NP I-Disease
gave VBD B-VP O
normal JJ B-NP O
chemotactic JJ I-NP O
scores NNS I-NP O
. . O O

The DT B-NP O
ability NN I-NP O
of IN B-PP O
C5D NN B-NP B-Disease
serum NN I-NP O
to TO B-VP O
opsonize VB I-VP O
Saccharomyces NNP B-NP O
cerevisiae NNS I-NP O
( ( O O
bakers NNS B-NP O
yeast NN I-NP O
) ) O O
or CC O O
Candida NN B-NP O
albicans NNS I-NP O
for IN B-PP O
ingestion NN B-NP O
by IN B-PP O
normal JJ B-NP O
neutrophils NNS I-NP O
was VBD B-VP O
completely RB B-ADJP O
normal JJ I-ADJP O
. . O O

In IN B-PP O
addition NN B-NP O
, , O O
C5D NN B-NP B-Disease
serum NN I-NP O
was VBD B-VP O
capable JJ B-ADJP O
of IN B-PP O
promoting VBG B-VP O
normal JJ B-NP O
phagocytosis NN I-NP O
and CC O O
intracellular JJ B-NP O
killing NN I-NP O
of IN B-PP O
Staphylococcus FW B-NP O
aureus FW I-NP O
. . O O

The DT B-NP O
probands NNS I-NP O
serum NN I-NP O
was VBD B-VP O
incapable JJ B-ADJP O
of IN B-PP O
mediating VBG B-VP O
lysis NN B-NP O
of IN B-PP O
erythrocytes NNS B-NP O
from IN B-PP O
a DT B-NP O
patient NN I-NP O
with IN B-PP O
paroxysmal JJ B-NP B-Disease
nocturnal JJ I-NP I-Disease
hemoglobinuria NN I-NP I-Disease
in IN B-PP O
both CC O O
the DT B-NP O
sucrose NN I-NP O
hemolysia NN I-NP O
and CC O O
acid NN B-NP O
hemolysis NN I-NP O
tests NNS I-NP O
, , O O
and CC O O
also RB B-ADVP O
lacked VBD B-VP O
bactericidal JJ B-NP O
activity NN I-NP O
against IN B-PP O
sensitized VBN B-NP O
or CC I-NP O
unsensitized JJ I-NP O
Salmonella NNP I-NP O
typhi NN I-NP O
. . O O

The DT B-NP O
siblings NNS I-NP O
serum NN I-NP O
, , O O
containing VBG B-VP O
only RB B-NP O
1 CD I-NP O
- HYPH I-NP O
2 CD I-NP O
% NN I-NP O
of IN B-PP O
normal JJ B-NP O
C5 NN I-NP O
, , O O
effectively RB B-NP O
lysed VBN I-NP O
S NN I-NP O
. . I-NP O

typhi NN I-NP O
, , O O
but CC O O
only RB B-ADVP O
at IN B-PP O
eightfold RB B-NP O
lower JJR I-NP O
serum NN I-NP O
dilutions NNS I-NP O
as IN B-SBAR O
compared VBN B-VP O
to TO B-PP O
normals NNS B-NP O
. . O O

These DT B-NP O
findings NNS I-NP O
underscore VBP B-VP O
the DT B-NP O
critical JJ I-NP O
role NN I-NP O
of IN B-PP O
C5 NN B-NP O
in IN B-PP O
the DT B-NP O
generation NN I-NP O
of IN B-PP O
chemotactic JJ B-NP O
activity NN I-NP O
and CC B-PP O
in IN B-PP O
cytolytic JJ B-NP O
reactions NNS I-NP O
, , O O
as IN B-SBAR O
opposed VBN B-VP O
to TO B-PP O
a DT B-NP O
nonobligatory JJ I-NP O
or CC I-NP O
minimal JJ I-NP O
role NN I-NP O
in IN B-PP O
opsonization NN B-NP O
, , O O
at IN B-ADVP O
least JJS I-ADVP O
for IN B-PP O
the DT B-NP O
organisms NNS I-NP O
under IN B-PP O
study NN B-NP O
. . O O

. . O O

Human JJ B-NP O
peroxisomal JJ I-NP O
targeting NN I-NP O
signal NN I-NP O
- HYPH B-NP O
1 CD I-NP O
receptor NN I-NP O
restores VBZ B-VP O
peroxisomal JJ B-NP O
protein NN I-NP O
import NN I-NP O
in IN B-PP O
cells NNS B-NP O
from IN B-PP O
patients NNS B-NP O
with IN B-PP O
fatal JJ B-NP O
peroxisomal JJ I-NP B-Disease
disorders NNS I-NP I-Disease
. . O O

Two CD B-NP O
peroxisomal JJ I-NP O
targeting NN I-NP O
signals NNS I-NP O
, , O O
PTS1 NN B-NP O
and CC I-NP O
PTS2 NN I-NP O
, , O O
are VBP B-VP O
involved VBN I-VP O
in IN B-PP O
the DT B-NP O
import NN I-NP O
of IN B-PP O
proteins NNS B-NP O
into IN B-PP O
the DT B-NP O
peroxisome NN I-NP O
matrix NN I-NP O
. . O O

Human JJ B-NP O
patients NNS I-NP O
with IN B-PP O
fatal JJ B-NP O
generalized VBN I-NP O
peroxisomal JJ I-NP B-Disease
deficiency NN I-NP I-Disease
disorders NNS I-NP I-Disease
fall VBP B-VP O
into IN B-PP O
at IN B-NP O
least JJS I-NP O
nine CD I-NP O
genetic JJ I-NP O
complementation NN I-NP O
groups NNS I-NP O
. . O O

Cells NNS B-NP O
from IN B-PP O
many JJ B-NP O
of IN B-PP O
these DT B-NP O
patients NNS I-NP O
are VBP B-VP O
deficient JJ B-ADJP O
in IN B-PP O
the DT B-NP O
import NN I-NP O
of IN B-PP O
PTS1 NN B-NP O
- HYPH O O
containing VBG B-VP O
proteins NNS B-NP O
, , O O
but CC O O
the DT B-NP O
causes NNS I-NP O
of IN B-PP O
the DT B-NP O
protein NN I-NP O
- HYPH B-NP O
import NN I-NP O
defect NN I-NP O
in IN B-PP O
these DT B-NP O
patients NNS I-NP O
are VBP B-VP O
unknown JJ B-ADJP O
. . O O

We PRP B-NP O
have VBP B-VP O
cloned VBN I-VP O
and CC I-VP O
sequenced VBN I-VP O
the DT B-NP O
human JJ I-NP O
cDNA NN I-NP O
homologue NN I-NP O
( ( O O
PTS1R NN B-NP O
) ) O O
of IN B-PP O
the DT B-NP O
Pichia NNP I-NP O
pastoris NN I-NP O
PAS8 NN I-NP O
gene NN I-NP O
, , O O
the DT B-NP O
PTS1 NN I-NP O
receptor NN I-NP O
( ( O O
McCollum NNP B-NP O
, , O O
D NNP B-NP O
. . O O

, , O O
E NNP B-NP O
. . I-NP O

Monosov NNP I-NP O
, , O O
and CC O O
S NNP B-NP O
. . I-NP O

Subramani NNP I-NP O
. . I-NP O

1993 CD I-NP O
. . I-NP O

J NNP I-NP O
. . I-NP O

Cell NNP I-NP O
Biol NNP I-NP O
. . O O

121 CD B-NP O
761 CD I-NP O
- HYPH B-NP O
774 CD I-NP O
) ) O O
. . O O

The DT B-NP O
PTS1R NN I-NP O
mRNA NN I-NP O
is VBZ B-VP O
expressed VBN I-VP O
in IN B-PP O
all DT B-NP O
human JJ I-NP O
tissues NNS I-NP O
examined VBN B-VP O
. . O O

Antibodies NNS B-NP O
to TO B-PP O
the DT B-NP O
human JJ I-NP O
PTS1R NN I-NP O
recognize VBP B-VP O
this DT B-NP O
protein NN I-NP O
in IN B-PP O
human JJ B-NP O
, , I-NP O
monkey NN I-NP O
, , O O
rat NN B-NP O
, , O O
and CC O O
hamster NN B-NP O
cells NNS I-NP O
. . O O

The DT B-NP O
protein NN I-NP O
is VBZ B-VP O
localized VBN I-VP O
mainly RB B-ADVP O
in IN B-PP O
the DT B-NP O
cytosol NN I-NP O
but CC O O
is VBZ B-VP O
also RB I-VP O
found VBN I-VP O
to TO I-VP O
be VB I-VP O
associated VBN I-VP O
with IN B-PP O
peroxisomes NNS B-NP O
. . O O

Part NN B-NP O
of IN B-PP O
the DT B-NP O
peroxisomal JJ I-NP O
PTS1R NN I-NP O
protein NN I-NP O
is VBZ B-VP O
tightly RB B-ADJP O
bound VBN I-ADJP O
to TO B-PP O
the DT B-NP O
peroxisomal JJ I-NP O
membrane NN I-NP O
. . O O

Antibodies NNS B-NP O
to TO B-PP O
PTS1R NN B-NP O
inhibit VBP B-VP O
peroxisomal JJ B-NP O
protein NN I-NP O
- HYPH B-NP O
import NN I-NP O
of IN B-PP O
PTS1 NN B-NP O
- HYPH O O
containing VBG B-VP O
proteins NNS B-NP O
in IN B-PP O
a DT B-NP O
permeabilized JJ I-NP O
CHO NN I-NP O
cell NN I-NP O
system NN I-NP O
. . O O

In FW B-NP O
vitro FW I-NP O
- HYPH B-NP O
translated VBN I-NP O
PTS1R NN I-NP O
protein NN I-NP O
specifically RB B-ADVP O
binds VBZ B-VP O
a DT B-NP O
serine NN I-NP O
- HYPH B-NP O
lysine NN I-NP O
- HYPH B-NP O
leucine NN I-NP O
- HYPH I-NP O
peptide NN I-NP O
. . O O

A DT B-NP O
PAS8 NN I-NP O
- HYPH I-NP O
PTS1R NN I-NP O
fusion NN I-NP O
protein NN I-NP O
complements VBZ B-VP O
the DT B-NP O
P NN I-NP O
. . O O

pastoris NN B-NP O
pas8 NN I-NP O
mutant NN I-NP O
. . O O

The DT B-NP O
PTS1R NN I-NP O
cDNA NN I-NP O
also RB B-ADVP O
complements VBZ B-VP O
the DT B-NP O
PTS1 NN I-NP B-Disease
protein NN I-NP I-Disease
- HYPH B-NP I-Disease
import NN I-NP I-Disease
defect NN I-NP I-Disease
in IN B-PP O
skin NN B-NP O
fibroblasts NNS I-NP O
from IN B-PP O
patients NNS B-NP O
- HYPH B-ADJP O
- HYPH O O
belonging VBG B-VP O
to TO B-PP O
complementation NN B-NP O
group NN I-NP O
two CD B-NP O
- HYPH I-NP O
- HYPH B-NP O
diagnosed VBN B-VP O
as IN B-PP O
having VBG B-VP O
neonatal JJ B-NP B-Disease
adrenoleukodystrophy NN I-NP I-Disease
or CC I-NP O
Zellweger NN I-NP B-Disease
syndrome NN I-NP I-Disease
. . O O

The DT B-NP O
PTS1R NN I-NP O
gene NN I-NP O
has VBZ B-VP O
been VBN I-VP O
localized JJ B-ADJP O
to TO B-PP O
a DT B-NP O
chromosomal JJ I-NP O
location NN I-NP O
where WRB B-ADVP O
no DT B-NP O
other JJ I-NP O
peroxisomal JJ I-NP B-Disease
disorder NN I-NP I-Disease
genes NNS I-NP O
are VBP B-VP O
known VBN I-VP O
to TO I-VP O
map VB I-VP O
. . O O

Our PRP$ B-NP O
findings NNS I-NP O
represent VBP B-VP O
the DT B-NP O
only JJ I-NP O
case NN I-NP O
in IN B-PP O
which WDT B-NP O
the DT B-NP O
molecular JJ I-NP O
basis NN I-NP O
of IN B-PP O
the DT B-NP O
protein NN I-NP B-Disease
- HYPH B-NP I-Disease
import NN I-NP I-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
human JJ B-NP O
peroxisomal JJ I-NP B-Disease
disorders NNS I-NP I-Disease
is VBZ B-VP O
understood VBN I-VP O
. . O O

Spectrum NN B-NP O
of IN B-PP O
germline NN B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
RB1 NN I-NP O
gene NN I-NP O
: : O O
a DT B-NP O
study NN I-NP O
of IN B-PP O
232 CD B-NP O
patients NNS I-NP O
with IN B-PP O
hereditary JJ B-NP B-Disease
and CC I-NP I-Disease
non JJ I-NP I-Disease
hereditary JJ I-NP I-Disease
retinoblastoma NN I-NP I-Disease
. . O O

Germline NN B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
RB1 NN I-NP O
gene NN I-NP O
confer VBP B-VP O
hereditary JJ B-NP O
predisposition NN I-NP O
to TO B-PP O
retinoblastoma NN B-NP B-Disease
. . O O

We PRP B-NP O
have VBP B-VP O
performed VBN I-VP O
a DT B-NP O
mutation NN I-NP O
survey NN I-NP O
of IN B-PP O
the DT B-NP O
RB1 NN I-NP O
gene NN I-NP O
in IN B-PP O
232 CD B-NP O
patients NNS I-NP O
with IN B-PP O
hereditary JJ B-NP B-Disease
or CC I-NP I-Disease
non JJ I-NP I-Disease
hereditary JJ I-NP I-Disease
retinoblastoma NN I-NP I-Disease
. . O O

We PRP B-NP O
systematically RB B-ADVP O
explored VBD B-VP O
all DT B-NP O
27 CD I-NP O
exons NNS I-NP O
and CC O O
flanking VBG B-VP O
sequences NNS B-NP O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
the DT B-NP O
promotor NN I-NP O
. . O O

All DT B-NP O
types NNS I-NP O
of IN B-PP O
point NN B-NP O
mutations NNS I-NP O
are VBP B-VP O
represented VBN I-VP O
and CC O O
are VBP B-VP O
found VBN I-VP O
unequally RB I-VP O
distributed VBN I-VP O
along IN B-PP O
the DT B-NP O
RB1 NN I-NP O
gene NN I-NP O
sequence NN I-NP O
. . O O

In IN B-PP O
the DT B-NP O
population NN I-NP O
we PRP B-NP O
studied VBD B-VP O
, , O O
exons NNS B-NP O
3 CD I-NP O
, , I-NP O
8 CD I-NP O
, , I-NP O
18 CD I-NP O
and CC I-NP O
19 CD I-NP O
are VBP B-VP O
preferentially RB I-VP O
altered VBN I-VP O
. . O O

The DT B-NP O
range NN I-NP O
of IN B-PP O
frequency NN B-NP O
of IN B-PP O
detection NN B-NP O
of IN B-PP O
germline NN B-NP O
mutations NNS I-NP O
is VBZ B-VP O
about RB B-NP O
20 CD I-NP O
% NN I-NP O
, , O O
indicating VBG B-VP O
that IN B-SBAR O
other JJ B-NP O
mechanisms NNS I-NP O
of IN B-PP O
inactivation NN B-NP O
of IN B-PP O
RB1 NN B-NP O
should MD B-VP O
be VB I-VP O
involved VBN I-VP O
. . O O

The DT B-NP O
spectrum NN I-NP O
of IN B-PP O
mutations NNS B-NP O
presented VBN B-VP O
here RB B-ADVP O
should MD B-VP O
help VB I-VP O
to TO I-VP O
improve VB I-VP O
the DT B-NP O
clinical JJ I-NP O
management NN I-NP O
of IN B-PP O
retinoblastoma NN B-NP B-Disease
and CC O O
to TO B-VP O
understand VB I-VP O
the DT B-NP O
molecular JJ I-NP O
mechanisms NNS I-NP O
leading VBG B-VP O
to TO B-PP O
tumorigenesis NN B-NP O
. . O O

. . O O

Aniridia NN B-NP B-Disease
- HYPH O O
associated VBN B-VP O
cytogenetic JJ B-NP O
rearrangements NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
a DT B-NP O
position NN I-NP O
effect NN I-NP O
may MD B-VP O
cause VB I-VP O
the DT B-NP O
mutant JJ I-NP O
phenotype NN I-NP O
. . O O

Current JJ B-NP O
evidence NN I-NP O
suggests VBZ B-VP O
that IN B-SBAR O
aniridia NN B-NP B-Disease
( ( O O
absence NN B-NP B-Disease
of IN B-PP I-Disease
iris NN B-NP I-Disease
) ) O O
is VBZ B-VP O
caused VBN I-VP O
by IN B-PP O
loss NN B-NP O
of IN B-PP O
function NN B-NP O
of IN B-PP O
one CD B-NP O
copy NN I-NP O
of IN B-PP O
the DT B-NP O
PAX6 NN I-NP O
gene NN I-NP O
, , O O
which WDT B-NP O
maps VBZ B-VP O
to TO B-PP O
11p13 NN B-NP O
. . O O

We PRP B-NP O
present VBP B-VP O
the DT B-NP O
further JJ I-NP O
characterisation NN I-NP O
of IN B-PP O
two CD B-NP O
aniridia NN I-NP B-Disease
pedigrees NNS I-NP O
in IN B-PP O
which WDT B-NP O
the DT B-NP O
disease NN I-NP O
segregates VBZ B-VP O
with IN B-PP O
chromosomal JJ B-NP O
rearrangements NNS I-NP O
which WDT B-NP O
involve VBP B-VP O
11p13 NN B-NP O
but CC O O
do VBP B-VP O
not RB I-VP O
disrupt VB I-VP O
the DT B-NP O
PAX6 NN I-NP O
gene NN I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
isolated VBN I-VP O
three CD B-NP O
human JJ I-NP O
YAC NN I-NP O
clones NNS I-NP O
which WDT B-NP O
encompass VBP B-VP O
the DT B-NP O
PAX6 NN I-NP O
locus NN I-NP O
and CC O O
we PRP B-NP O
have VBP B-VP O
used VBN I-VP O
these DT B-NP O
to TO B-VP O
show VB I-VP O
that IN B-SBAR O
in IN B-PP O
both DT B-NP O
cases NNS I-NP O
the DT B-NP O
chromosomal JJ I-NP O
breakpoint NN I-NP O
is VBZ B-VP O
at IN B-NP O
least JJS I-NP O
85 CD I-NP O
kb NN I-NP O
distal JJ B-ADJP O
of IN B-PP O
the DT B-NP O
3 CD I-NP O
end NN I-NP O
of IN B-PP O
PAX6 NN B-NP O
. . O O

In IN B-PP O
addition NN B-NP O
, , O O
the DT B-NP O
open JJ I-NP O
reading NN I-NP O
frame NN I-NP O
of IN B-PP O
PAX6 NN B-NP O
is VBZ B-VP O
apparently RB B-ADJP O
free JJ I-ADJP O
of IN B-PP O
mutations NNS B-NP O
. . O O

We PRP B-NP O
propose VBP B-VP O
that IN B-SBAR O
the DT B-NP O
PAX6 NN I-NP O
gene NN I-NP O
on IN B-PP O
the DT B-NP O
rearranged VBN I-NP O
chromosome NN I-NP O
11 CD I-NP O
is VBZ B-VP O
in IN B-PP O
an DT B-NP O
inappropriate JJ I-NP O
chromatin NN I-NP O
environment NN I-NP O
for IN B-PP O
normal JJ B-NP O
expression NN I-NP O
and CC O O
therefore RB B-ADVP O
that IN B-SBAR O
a DT B-NP O
position NN I-NP O
effect NN I-NP O
is VBZ B-VP O
the DT B-NP O
underlying VBG I-NP O
mechanism NN I-NP O
of IN B-PP O
disease NN B-NP O
in IN B-PP O
these DT B-NP O
families NNS I-NP O
. . O O

. . O O

Somatic JJ B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
BRCA1 NN I-NP O
gene NN I-NP O
in IN B-PP O
sporadic JJ B-NP B-Disease
ovarian JJ I-NP I-Disease
tumours NNS I-NP I-Disease
. . O O

The DT B-NP O
BRCA1 NN I-NP O
gene NN I-NP O
on IN B-PP O
chromosome NN B-NP O
17q21 NN I-NP O
is VBZ B-VP O
responsible JJ B-ADJP O
for IN B-PP O
an DT B-NP O
autosomal JJ I-NP B-Disease
dominant JJ I-NP I-Disease
syndrome NN I-NP I-Disease
of IN B-PP O
increased VBN B-NP O
susceptibility NN I-NP O
to TO B-PP O
breast NN B-NP B-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
but CC O O
no DT B-NP O
somatic JJ I-NP O
mutations NNS I-NP O
in IN B-PP O
tumours NNS B-NP B-Disease
have VBP B-VP O
yet RB I-VP O
been VBN I-VP O
described VBN I-VP O
. . O O

To TO B-VP O
study VB I-VP O
the DT B-NP O
potential JJ I-NP O
role NN I-NP O
of IN B-PP O
BRCA1 NN B-NP O
in IN B-PP O
sporadic JJ B-NP O
carcinogenesis NN I-NP O
, , O O
we PRP B-NP O
analysed VBD B-VP O
the DT B-NP O
genomic JJ I-NP O
DNA NN I-NP O
of IN B-PP O
tumour NN B-NP B-Disease
and CC O O
normal JJ B-NP O
fractions NNS I-NP O
of IN B-PP O
47 CD B-NP O
ovarian JJ I-NP B-Disease
cancers NNS I-NP I-Disease
for IN B-PP O
mutations NNS B-NP O
in IN B-PP O
BRCA1 NN B-NP O
using VBG B-VP O
the DT B-NP O
single JJ I-NP O
- HYPH I-NP O
strand NN I-NP O
conformation NN I-NP O
polymorphism NN I-NP O
technique NN I-NP O
. . O O

We PRP B-NP O
now RB B-ADVP O
describe VBP B-VP O
somatic JJ B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
DNA NN I-NP O
of IN B-PP O
four CD B-NP O
tumours NNS I-NP B-Disease
which WDT B-NP O
also RB B-ADVP O
had VBD B-VP O
loss NN B-NP O
of IN B-PP O
heterozygosity NN B-NP O
( ( O O
LOH NN B-NP O
) ) O O
at IN B-PP O
a DT B-NP O
BRCA1 NN I-NP O
intragenic JJ I-NP O
marker NN I-NP O
. . O O

Our PRP$ B-NP O
data NNS I-NP O
support VBP B-VP O
a DT B-NP O
tumour NN I-NP B-Disease
suppressor NN I-NP O
mechanism NN I-NP O
for IN B-PP O
BRCA1 NN B-NP O
; : O O
somatic JJ B-NP O
mutations NNS I-NP O
and CC I-NP O
LOH NN I-NP O
may MD B-VP O
result VB I-VP O
in IN B-PP O
inactivation NN B-NP O
of IN B-PP O
BRCA1 NN B-NP O
in IN B-PP O
at IN B-ADVP O
least JJS I-ADVP O
a DT B-NP O
small JJ I-NP O
number NN I-NP O
of IN B-PP O
ovarian JJ B-NP B-Disease
cancers NNS I-NP I-Disease
. . O O

. . O O

Decreased VBN B-NP O
expression NN I-NP O
of IN B-PP O
BRCA1 NN B-NP O
accelerates VBZ B-VP O
growth NN B-NP O
and CC O O
is VBZ B-VP O
often RB B-ADVP O
present JJ B-ADJP O
during IN B-PP O
sporadic JJ B-NP B-Disease
breast NN I-NP I-Disease
cancer NN I-NP I-Disease
progression NN I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
characterized VBN I-VP O
expression NN B-NP O
of IN B-PP O
the DT B-NP O
familial JJ I-NP B-Disease
breast NN I-NP I-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
gene NN I-NP O
, , O O
BRCA1 NN B-NP O
, , O O
in IN B-PP O
cases NNS B-NP O
of IN B-PP O
non AFX O B-Disease
- HYPH O I-Disease
hereditary JJ O I-Disease
( ( O I-Disease
sporadic JJ B-ADJP I-Disease
) ) O I-Disease
breast NN B-NP I-Disease
cancer NN I-NP I-Disease
and CC O O
analyzed VBD B-VP O
the DT B-NP O
effect NN I-NP O
of IN B-PP O
antisense JJ B-NP O
inhibition NN I-NP O
of IN B-PP O
BRCA1 NN B-NP O
on IN B-PP O
the DT B-NP O
proliferative JJ I-NP O
rate NN I-NP O
of IN B-PP O
mammary JJ B-NP O
epithelial JJ I-NP O
cells NNS I-NP O
. . O O

BRCA1 NN B-NP O
mRNA NN I-NP O
levels NNS I-NP O
are VBP B-VP O
markedly RB I-VP O
decreased VBN I-VP O
during IN B-PP O
the DT B-NP O
transition NN I-NP O
from IN B-PP O
carcinoma NN B-NP B-Disease
in FW B-ADVP I-Disease
situ FW I-ADVP I-Disease
to TO B-PP O
invasive JJ B-NP B-Disease
cancer NN I-NP I-Disease
. . O O

Experimental JJ B-NP O
inhibition NN I-NP O
of IN B-PP O
BRCA1 NN B-NP O
expression NN I-NP O
with IN B-PP O
antisense JJ B-NP O
oligonucleotides NNS I-NP O
produced VBD B-VP O
accelerated VBN B-NP O
growth NN I-NP O
of IN B-PP O
normal JJ B-NP O
and CC I-NP O
malignant JJ I-NP O
mammary JJ I-NP O
cells NNS I-NP O
, , O O
but CC O O
had VBD B-VP O
no DT B-NP O
effect NN I-NP O
on IN B-PP O
non AFX B-NP O
- HYPH I-NP O
mammary JJ I-NP O
epithelial JJ I-NP O
cells NNS I-NP O
. . O O

These DT B-NP O
studies NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
BRCA1 NN B-NP O
may MD B-VP O
normally RB I-VP O
serve VB I-VP O
as IN B-PP O
a DT B-NP O
negative JJ I-NP O
regulator NN I-NP O
of IN B-PP O
mammary JJ B-NP O
epithelial JJ I-NP O
cell NN I-NP O
growth NN I-NP O
whose WP$ B-NP O
function NN I-NP O
is VBZ B-VP O
compromised VBN I-VP O
in IN B-PP O
breast NN B-NP B-Disease
cancer NN I-NP I-Disease
either CC B-PP O
by IN B-PP O
direct JJ B-NP O
mutation NN I-NP O
or CC O O
alterations NNS B-NP O
in IN B-PP O
gene NN B-NP O
expression NN I-NP O
. . O O

. . O O

Additional JJ B-NP O
case NN I-NP O
of IN B-PP O
female JJ B-NP O
monozygotic JJ I-NP O
twins NNS I-NP O
discordant JJ B-ADJP O
for IN B-PP O
the DT B-NP O
clinical JJ I-NP O
manifestations NNS I-NP O
of IN B-PP O
Duchenne NNP B-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
due JJ B-PP O
to TO B-PP O
opposite JJ B-NP O
X NN I-NP O
- HYPH B-NP O
chromosome NN I-NP O
inactivation NN I-NP O
. . O O

A DT B-NP O
pair NN I-NP O
of IN B-PP O
female JJ B-NP O
monozygotic JJ I-NP O
( ( O O
MZ JJ B-ADJP O
) ) O O
twins NNS B-NP O
, , O O
heterozygous JJ B-NP O
carriers NNS I-NP O
for IN B-PP O
a DT B-NP O
deletion NN I-NP O
in IN B-PP O
the DT B-NP O
DMD NN I-NP B-Disease
gene NN I-NP O
and CC I-NP O
discordant NN I-NP O
for IN B-PP O
the DT B-NP O
clinical JJ I-NP O
manifestations NNS I-NP O
of IN B-PP O
Duchenne NNP B-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
, , O O
were VBD B-VP O
analyzed VBN I-VP O
by IN B-PP O
molecular JJ B-NP O
studies NNS I-NP O
, , O O
in FW B-NP O
situ FW I-NP O
hybridization NN I-NP O
, , O O
and CC O O
methylation NN B-NP O
pattern NN I-NP O
of IN B-PP O
X NN B-NP O
chromosomes NNS I-NP O
to TO B-VP O
search VB I-VP O
for IN B-PP O
opposite JJ B-NP O
X NN I-NP O
inactivation NN I-NP O
as IN B-PP O
an DT B-NP O
explanation NN I-NP O
of IN B-PP O
their PRP$ B-NP O
clinical JJ I-NP O
discordance NN I-NP O
. . O O

Results NNS B-NP O
in IN B-PP O
lymphocytes NNS B-NP O
and CC O O
skin NN B-NP O
fibroblast NN I-NP O
cell NN I-NP O
lines NNS I-NP O
suggest VBP B-VP O
a DT B-NP O
partial JJ I-NP O
mirror NN I-NP O
inactivation NN I-NP O
with IN B-PP O
the DT B-NP O
normal JJ I-NP O
X NN I-NP O
chromosome NN I-NP O
preferentially RB B-ADJP O
active JJ I-ADJP O
in IN B-PP O
the DT B-NP O
unaffected JJ I-NP O
twin NN I-NP O
, , O O
and CC O O
the DT B-NP O
maternal JJ I-NP O
deleted VBN I-NP O
X NN I-NP O
chromosome NN I-NP O
preferentially RB B-ADJP O
active JJ I-ADJP O
in IN B-PP O
the DT B-NP O
affected VBN I-NP O
twin NN I-NP O
. . O O

A DT B-NP O
review NN I-NP O
shows VBZ B-VP O
that IN B-SBAR O
MZ JJ B-NP O
female JJ I-NP O
twins NNS I-NP O
discordant JJ B-ADJP O
for IN B-PP O
X NN B-NP B-Disease
- HYPH B-NP I-Disease
linked VBN I-NP I-Disease
diseases NNS I-NP I-Disease
are VBP B-VP O
not RB O O
uncommon JJ B-ADJP O
. . O O

Twinning NN B-NP O
and CC I-NP O
X NN I-NP O
inactivation NN I-NP O
may MD B-VP O
be VB I-VP O
interrelated VBN I-VP O
and CC O O
could MD B-VP O
explain VB I-VP O
the DT B-NP O
female JJ I-NP O
twins NNS I-NP O
discordant JJ B-ADJP O
for IN B-PP O
X NN B-NP O
- HYPH B-NP O
linked VBN I-NP O
traits NNS I-NP O
. . O O

. . O O

X NN B-NP B-Disease
- HYPH O I-Disease
linked VBN B-VP I-Disease
adrenoleukodystrophy NN B-NP I-Disease
( ( O O
ALD NN B-NP B-Disease
) ) O O
: : O O
a DT B-NP O
novel JJ I-NP O
mutation NN I-NP O
of IN B-PP O
the DT B-NP O
ALD NN I-NP B-Disease
gene NN I-NP O
in IN B-PP O
6 CD B-NP O
members NNS I-NP O
of IN B-PP O
a DT B-NP O
family NN I-NP O
presenting VBG B-VP O
with IN B-PP O
5 CD B-NP O
different JJ I-NP O
phenotypes NNS I-NP O
. . O O

Fragments NNS B-NP O
of IN B-PP O
the DT B-NP O
adrenoleukodystrophy NN I-NP B-Disease
( ( O O
ALD NN B-NP B-Disease
) ) O O
cDNA NN B-NP O
from IN B-PP O
a DT B-NP O
patient NN I-NP O
with IN B-PP O
adolescent JJ B-NP B-Disease
ALD NN I-NP I-Disease
were VBD B-VP O
amplified VBN I-VP O
by IN B-PP O
polymerase NN B-NP O
chain NN I-NP O
reaction NN I-NP O
and CC O O
subcloned VBN B-VP O
. . O O

Bidirectional JJ B-NP O
sequencing NN I-NP O
of IN B-PP O
the DT B-NP O
entire JJ I-NP O
coding VBG I-NP O
ALD NN I-NP B-Disease
gene NN I-NP O
disclosed VBD B-VP O
a DT B-NP O
cytosine NN I-NP O
to TO B-PP O
guanine NN B-NP O
transversion NN I-NP O
at IN B-PP O
nucleotide NN B-NP O
1451 CD I-NP O
in IN B-PP O
exon NN B-NP O
five CD I-NP O
, , O O
resulting VBG B-VP O
in IN B-PP O
substitution NN B-NP O
of IN B-PP O
proline NN B-NP O
484 CD I-NP O
by IN B-PP O
arginine NN B-NP O
. . O O

Five CD B-NP O
of IN B-PP O
nine CD B-NP O
siblings NNS I-NP O
of IN B-PP O
the DT B-NP O
patient NN I-NP O
, , O O
comprising VBG B-VP O
two CD B-NP O
cerebral JJ I-NP B-Disease
ALD NN I-NP I-Disease
, , O O
one CD B-NP O
adrenomyeloneuropathy NN I-NP B-Disease
, , O O
one CD B-NP O
Addison NN I-NP B-Disease
only RB O I-Disease
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
the DT B-NP O
symptomatic JJ I-NP O
mother NN I-NP O
( ( O O
all DT B-NP O
accumulating VBG B-VP O
very RB B-NP O
long JJ I-NP O
chain NN I-NP O
fatty JJ I-NP O
acids NNS I-NP O
) ) O O
carried VBD B-VP O
this DT B-NP O
mutation NN I-NP O
, , O O
which WDT B-NP O
was VBD B-VP O
not RB I-VP O
found VBN I-VP O
in IN B-PP O
the DT B-NP O
unaffected JJ I-NP O
persons NNS I-NP O
, , O O
in IN B-PP O
five CD B-NP O
unrelated JJ I-NP O
ALD NN I-NP B-Disease
patients NNS I-NP O
, , O O
and CC O O
in IN B-PP O
twenty CD B-NP O
controls NNS I-NP O
. . O O

We PRP B-NP O
propose VBP B-VP O
that IN B-SBAR O
this DT B-NP O
missense JJ I-NP O
mutation NN I-NP O
generated VBD B-VP O
the DT B-NP O
disease NN I-NP O
per FW B-ADVP O
se FW I-ADVP O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
the DT B-NP O
metabolic JJ I-NP O
defect NN I-NP O
; : O O
the DT B-NP O
different JJ I-NP O
phenotypes NNS I-NP O
, , O O
however RB B-ADVP O
, , O O
must MD B-VP O
have VB I-VP O
originated VBN I-VP O
by IN B-PP O
means NNS B-NP O
of IN B-PP O
additional JJ B-NP O
pathogenetic JJ I-NP O
factors NNS I-NP O
. . O O

. . O O

Novel JJ B-NP O
mutation NN I-NP O
at IN B-PP O
the DT B-NP O
initiation NN I-NP O
codon NN I-NP O
in IN B-PP O
the DT B-NP O
Norrie NNP I-NP B-Disease
disease NN I-NP I-Disease
gene NN I-NP O
in IN B-PP O
two CD B-NP O
Japanese JJ I-NP O
families NNS I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
identified VBN I-VP O
a DT B-NP O
new JJ I-NP O
mutation NN I-NP O
of IN B-PP O
Norrie NNP B-NP B-Disease
disease NN I-NP I-Disease
( ( O O
ND NN B-NP B-Disease
) ) O O
gene NN B-NP O
in IN B-PP O
two CD B-NP O
Japanese JJ I-NP O
males NNS I-NP O
from IN B-PP O
unrelated JJ B-NP O
families NNS I-NP O
; : O O
they PRP B-NP O
showed VBD B-VP O
typical JJ B-NP O
ocular JJ I-NP O
features NNS I-NP O
of IN B-PP O
ND NN B-NP B-Disease
but CC O O
no DT B-NP O
mental JJ I-NP B-Disease
retardation NN I-NP I-Disease
or CC I-NP O
hearing NN I-NP B-Disease
impairment NN I-NP I-Disease
. . O O

A DT B-NP O
mutation NN I-NP O
was VBD B-VP O
found VBN I-VP O
in IN B-PP O
both DT B-NP O
patients NNS I-NP O
at IN B-PP O
the DT B-NP O
initiation NN I-NP O
codon NN I-NP O
of IN B-PP O
exon NN B-NP O
2 CD I-NP O
of IN B-PP O
the DT B-NP O
ND NN I-NP B-Disease
gene NN I-NP O
( ( O O
ATG NN B-NP O
to TO B-PP O
GTG NN B-NP O
) ) O O
, , O O
with IN B-PP O
otherwise RB B-NP O
normal JJ I-NP O
nucleotide NN I-NP O
sequences NNS I-NP O
. . O O

Their PRP$ B-NP O
mothers NNS I-NP O
had VBD B-VP O
the DT B-NP O
normal JJ I-NP O
and CC I-NP O
mutant JJ I-NP O
types NNS I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
, , O O
which WDT B-NP O
was VBD B-VP O
expected VBN I-VP O
for IN B-PP O
heterozygotes NNS B-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
. . O O

The DT B-NP O
mutation NN I-NP O
of IN B-PP O
the DT B-NP O
initiation NN I-NP O
codon NN I-NP O
would MD B-VP O
cause VB I-VP O
the DT B-NP O
failure NN I-NP O
of IN B-PP O
ND NN B-NP B-Disease
gene NN I-NP O
expression NN I-NP O
or CC O O
a DT B-NP O
defect NN I-NP O
in IN B-PP O
translation NN B-NP O
thereby RB B-VP O
truncating VBG I-VP O
the DT B-NP O
amino JJ I-NP O
terminus NN I-NP O
of IN B-PP O
ND NN B-NP B-Disease
protein NN I-NP O
. . O O

In IN B-PP O
view NN B-NP O
of IN B-PP O
the DT B-NP O
rarity NN I-NP O
and CC I-NP O
marked JJ I-NP O
heterogeneity NN I-NP O
of IN B-PP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
ND NN I-NP B-Disease
gene NN I-NP O
, , O O
the DT B-NP O
present JJ I-NP O
apparently RB I-NP O
unrelated JJ I-NP O
Japanese JJ I-NP O
families NNS I-NP O
who WP B-NP O
have VBP B-VP O
lived VBN I-VP O
in IN B-PP O
the DT B-NP O
same JJ I-NP O
area NN I-NP O
for IN B-PP O
over IN B-NP O
two CD I-NP O
centuries NNS I-NP O
presumably RB B-ADVP O
share VBP B-VP O
the DT B-NP O
origin NN I-NP O
of IN B-PP O
the DT B-NP O
mutation NN I-NP O
. . O O

. . O O

Anticipation NN B-NP O
resulting VBG B-VP O
in IN B-PP O
elimination NN B-NP O
of IN B-PP O
the DT B-NP O
myotonic JJ I-NP B-Disease
dystrophy NN I-NP I-Disease
gene NN I-NP O
: : O O
a DT B-NP O
follow NN I-NP O
up RP B-PRT O
study NN B-NP O
of IN B-PP O
one CD B-NP O
extended VBN I-NP O
family NN I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
re AFX B-PP O
- HYPH B-NP O
examined VBN B-VP O
an DT B-NP O
extended JJ I-NP O
myotonic JJ I-NP B-Disease
dystrophy NN I-NP I-Disease
( ( O O
DM NN B-NP B-Disease
) ) O O
family NN B-NP O
, , O O
previously RB B-VP O
described VBN I-VP O
in IN B-PP O
1955 CD B-NP O
, , O O
in IN B-SBAR O
order NN O O
to TO B-VP O
study VB I-VP O
the DT B-NP O
long JJ I-NP O
term NN I-NP O
effects NNS I-NP O
of IN B-PP O
anticipation NN B-NP O
in IN B-PP O
DM NN B-NP B-Disease
and CC B-PP O
in IN B-PP O
particular JJ B-ADJP O
the DT B-NP O
implications NNS I-NP O
for IN B-PP O
families NNS B-NP O
affected VBN B-VP O
by IN B-PP O
this DT B-NP O
disease NN I-NP O
. . O O

This DT B-NP O
follow NN I-NP O
up RP B-PRT O
study NN B-NP O
provides VBZ B-VP O
data NNS B-NP O
on IN B-PP O
35 CD B-NP O
gene NN I-NP O
carriers NNS I-NP O
and CC O O
46 CD B-NP O
asymptomatic JJ I-NP O
at IN B-PP O
risk NN B-NP O
family NN I-NP O
members NNS I-NP O
in IN B-PP O
five CD B-NP O
generations NNS I-NP O
. . O O

Clinical JJ B-NP O
anticipation NN I-NP O
, , O O
defined VBN B-VP O
as IN B-PP O
the DT B-NP O
cascade NN I-NP O
of IN B-PP O
mild JJ B-NP O
, , I-NP O
adult JJ I-NP O
, , I-NP O
childhood NN I-NP O
, , I-NP O
or CC I-NP O
congenital JJ I-NP B-Disease
disease NN I-NP I-Disease
in IN B-PP O
subsequent JJ B-NP O
generations NNS I-NP O
, , O O
appeared VBD B-VP O
to TO I-VP O
be VB I-VP O
a DT B-NP O
relentless JJ I-NP O
process NN I-NP O
, , O O
occurring VBG B-VP O
in IN B-PP O
all DT B-NP O
affected VBN I-NP O
branches NNS I-NP O
of IN B-PP O
the DT B-NP O
family NN I-NP O
. . O O

The DT B-NP O
cascade NN I-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
proceed VB I-VP O
asynchronously RB B-ADVP O
in IN B-PP O
the DT B-NP O
different JJ I-NP O
branches NNS I-NP O
, , O O
mainly RB B-ADVP O
because IN B-PP O
of IN I-PP O
an DT B-NP O
unequal JJ I-NP O
number NN I-NP O
of IN B-PP O
generations NNS B-NP O
with IN B-PP O
mild JJ B-NP O
disease NN I-NP O
. . O O

The DT B-NP O
transition NN I-NP O
from IN B-PP O
the DT B-NP O
mild NN I-NP O
to TO B-PP O
the DT B-NP O
adult JJ I-NP O
type NN I-NP O
was VBD B-VP O
associated VBN I-VP O
with IN B-PP O
transmission NN B-NP O
through IN B-PP O
a DT B-NP O
male JJ I-NP O
parent NN I-NP O
. . O O

Stable JJ B-NP O
transmission NN I-NP O
of IN B-PP O
the DT B-NP O
asymptomatic JJ I-NP O
/ SYM I-NP O
mild JJ I-NP O
phenotype NN I-NP O
showed VBD B-VP O
a DT B-NP O
female JJ I-NP O
transmission NN I-NP O
bias NN I-NP O
. . O O

We PRP B-NP O
further RB B-ADVP O
examined VBD B-VP O
the DT B-NP O
extent NN I-NP O
and CC I-NP O
causes NNS I-NP O
of IN B-PP O
gene NN B-NP O
loss NN I-NP O
in IN B-PP O
this DT B-NP O
pedigree NN I-NP O
. . O O

Gene NN B-NP O
loss NN I-NP O
in IN B-PP O
the DT B-NP O
patient NN I-NP O
group NN I-NP O
was VBD B-VP O
complete JJ B-ADJP O
, , O O
owing VBG B-VP O
to TO B-PP O
infertility NN B-NP B-Disease
of IN B-PP O
the DT B-NP O
male JJ I-NP O
patients NNS I-NP O
with IN B-PP O
adult JJ B-NP O
onset NN I-NP O
disease NN I-NP O
and CC O O
the DT B-NP O
fact NN I-NP O
that IN B-SBAR O
mentally RB B-NP B-Disease
retarded JJ I-NP I-Disease
patients NNS I-NP O
did VBD B-VP O
not RB I-VP O
procreate VB I-VP O
. . O O

Out IN B-PP O
of IN B-PP O
the DT B-NP O
46 CD I-NP O
at IN B-PP O
risk NN B-NP O
subjects NNS I-NP O
in IN B-PP O
the DT B-NP O
two CD I-NP O
youngest JJS I-NP O
generations NNS I-NP O
, , O O
only RB B-NP O
one CD I-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
have VB I-VP O
a DT B-NP O
full JJ I-NP O
mutation NN I-NP O
. . O O

This DT B-NP O
is VBZ B-VP O
the DT B-NP O
only JJ I-NP O
subject NN I-NP O
who WP B-NP O
may MD B-VP O
transmit VB I-VP O
the DT B-NP O
gene NN I-NP O
to TO B-PP O
the DT B-NP O
sixth JJ I-NP O
generation NN I-NP O
. . O O

No DT B-NP O
protomutation NN I-NP O
carriers NNS I-NP O
were VBD B-VP O
found VBN I-VP O
in IN B-PP O
the DT B-NP O
fourth JJ I-NP O
and CC I-NP O
fifth JJ I-NP O
generations NNS I-NP O
. . O O

Therefore RB B-ADVP O
it PRP B-NP O
is VBZ B-VP O
highly RB B-ADJP O
probable JJ I-ADJP O
that IN B-SBAR O
the DT B-NP O
DM NN I-NP B-Disease
gene NN I-NP O
will MD B-VP O
be VB I-VP O
eliminated VBN I-VP O
from IN B-PP O
this DT B-NP O
pedigree NN I-NP O
within IN B-PP O
one CD B-NP O
generation NN I-NP O
. . O O

The DT B-NP O
high JJ I-NP O
population NN I-NP O
frequency NN I-NP O
of IN B-PP O
DM NN B-NP B-Disease
can MD B-VP O
at IN B-PP O
present JJ B-ADJP O
not RB O O
be VB B-VP O
explained VBN I-VP O
by IN B-PP O
the DT B-NP O
contribution NN I-NP O
of IN B-PP O
asymptomatic JJ B-NP O
cases NNS I-NP O
in IN B-PP O
the DT B-NP O
younger JJR I-NP O
generations NNS I-NP O
of IN B-PP O
known JJ B-NP O
families NNS I-NP O
, , O O
but CC O O
is VBZ B-VP O
probably RB I-VP O
caused VBN I-VP O
by IN B-PP O
the DT B-NP O
events NNS I-NP O
in IN B-PP O
the DT B-NP O
ancestral JJ I-NP O
generations NNS I-NP O
. . O O

. . O O

The DT B-NP O
gene NN I-NP O
for IN B-PP O
spinal JJ B-NP B-Disease
cerebellar JJ I-NP I-Disease
ataxia NN I-NP I-Disease
3 CD I-NP O
( ( O O
SCA3 NN B-NP O
) ) O O
is VBZ B-VP O
located VBN I-VP O
in IN B-PP O
a DT B-NP O
region NN I-NP O
of IN B-PP O
approximately RB B-NP O
3 CD I-NP O
cM NN I-NP O
on IN B-PP O
chromosome NN B-NP O
14q24 CD I-NP O
. . O O

3 CD B-NP O
- HYPH I-NP O
q32 NN I-NP O
. . I-NP O

2 CD I-NP O
. . O O

SCA3 NN B-NP O
, , O O
the DT B-NP O
gene NN I-NP O
for IN B-PP O
spinal JJ B-NP B-Disease
cerebellar JJ I-NP I-Disease
ataxia NN I-NP I-Disease
3 CD I-NP O
, , O O
was VBD B-VP O
recently RB I-VP O
mapped VBN I-VP O
to TO B-PP O
a DT B-NP O
15 CD I-NP O
- HYPH I-NP O
cM NN I-NP O
interval NN I-NP O
between IN B-PP O
D14S67 NN B-NP O
and CC I-NP O
D14S81 NN I-NP O
on IN B-PP O
chromosome NN B-NP O
14q NN I-NP O
, , O O
by IN B-PP O
linkage NN B-NP O
analysis NN I-NP O
in IN B-PP O
two CD B-NP O
families NNS I-NP O
of IN B-PP O
French JJ B-NP O
ancestry NN I-NP O
. . O O

The DT B-NP O
SCA3 NN I-NP O
candidate NN I-NP O
region NN I-NP O
has VBZ B-VP O
now RB I-VP O
been VBN I-VP O
refined VBN I-VP O
by IN B-PP O
linkage NN B-NP O
analysis NN I-NP O
with IN B-PP O
four CD B-NP O
new JJ I-NP O
microsatellite NN I-NP O
markers NNS I-NP O
( ( O O
D14S256 NN B-NP O
, , O O
D14S291 NN B-NP O
, , O O
D14S280 NN B-NP O
, , O O
and CC O O
AFM343vf1 NN B-NP O
) ) O O
in IN B-PP O
the DT B-NP O
same JJ I-NP O
two CD I-NP O
families NNS I-NP O
, , O O
in IN B-PP O
which WDT B-NP O
19 CD B-NP O
additional JJ I-NP O
individuals NNS I-NP O
were VBD B-VP O
genotyped VBN I-VP O
, , O O
and CC O O
in IN B-PP O
a DT B-NP O
third JJ I-NP O
French JJ I-NP O
family NN I-NP O
. . O O

Combined VBN B-VP O
two CD B-NP O
- HYPH I-NP O
point NN I-NP O
linkage NN I-NP O
analyses NNS I-NP O
show VBP B-VP O
that IN B-SBAR O
the DT B-NP O
new JJ I-NP O
markers NNS I-NP O
, , O O
D14S280 NN B-NP O
and CC I-NP O
AFM343vf1 NN I-NP O
, , O O
are VBP B-VP O
tightly RB I-VP O
linked VBN I-VP O
to TO B-PP O
the DT B-NP O
SCA3 NN I-NP O
locus NN I-NP O
, , O O
with IN B-PP O
maximal JJ B-NP O
lod NN I-NP O
scores NNS I-NP O
, , O O
at IN B-PP O
recombination NN B-NP O
fraction NN I-NP O
, , O O
( ( O O
theta SYM O O
) ) O O
= SYM B-NP O
. . O O

00 CD B-NP O
, , O O
of IN B-PP O
7 CD B-NP O
. . O O

05 CD B-NP O
and CC I-NP O
13 CD I-NP O
. . O O

70 CD B-NP O
, , O O
respectively RB B-ADVP O
. . O O

Combined VBN B-NP O
multipoint JJ I-NP O
and CC I-NP O
recombinant JJ I-NP O
haplotype NN I-NP O
analyses NNS I-NP O
localize VBP B-VP O
the DT B-NP O
SCA3 NN I-NP O
locus NN I-NP O
to TO B-PP O
a DT B-NP O
3 CD I-NP O
- HYPH I-NP O
cM NN I-NP O
interval NN I-NP O
flanked VBN B-VP O
by IN B-PP O
D14S291 NN B-NP O
and CC I-NP O
D14S81 NN I-NP O
. . O O

The DT B-NP O
same JJ I-NP O
allele NN I-NP O
for IN B-PP O
D14S280 NN B-NP O
segregates NNS I-NP O
with IN B-PP O
the DT B-NP O
disease NN I-NP O
locus NN I-NP O
in IN B-PP O
the DT B-NP O
three CD I-NP O
kindreds NNS I-NP O
. . O O

This DT B-NP O
allele NN I-NP O
is VBZ B-VP O
frequent JJ B-ADJP O
in IN B-PP O
the DT B-NP O
French JJ I-NP O
population NN I-NP O
, , O O
however RB B-ADVP O
, , O O
and CC O O
linkage NN B-NP O
disequilibrium NN I-NP O
is VBZ B-VP O
not RB I-VP O
clearly RB I-VP O
established VBN I-VP O
. . O O

The DT B-NP O
SCA3 NN I-NP O
locus NN I-NP O
remains VBZ B-VP O
within IN B-PP O
the DT B-NP O
29 CD I-NP O
- HYPH I-NP O
cM NN I-NP O
region NN I-NP O
on IN B-PP O
14q24 NN B-NP O
. . O O

3 CD B-NP O
- HYPH I-NP O
q32 NN I-NP O
. . O O

2 CD B-NP O
containing VBG B-VP O
the DT B-NP O
gene NN I-NP O
for IN B-PP O
the DT B-NP O
Machado NNP I-NP B-Disease
- HYPH I-NP I-Disease
Joseph NNP I-NP I-Disease
disease NN I-NP I-Disease
, , O O
which WDT B-NP O
is VBZ B-VP O
clinically RB I-VP O
related VBN I-VP O
to TO B-PP O
the DT B-NP O
phenotype NN I-NP O
determined VBN B-VP O
by IN B-PP O
SCA3 NN B-NP O
, , O O
but CC O O
it PRP B-NP O
cannot MD B-VP O
yet RB I-VP O
be VB I-VP O
concluded VBN I-VP O
that IN B-SBAR O
both DT B-NP O
diseases NNS I-NP O
result VBP B-VP O
from IN B-PP O
alterations NNS B-NP O
of IN B-PP O
the DT B-NP O
same JJ I-NP O
gene NN I-NP O
An DT B-NP O
evaluation NN I-NP O
of IN B-PP O
genetic JJ B-NP O
heterogeneity NN I-NP O
in IN B-PP O
145 CD B-NP O
breast NN I-NP B-Disease
- HYPH B-NP I-Disease
ovarian JJ I-NP I-Disease
cancer NN I-NP I-Disease
families NNS I-NP O
. . O O

Breast NNP B-NP B-Disease
Cancer NNP I-NP I-Disease
Linkage NNP I-NP O
Consortium NNP I-NP O
. . O O

The DT B-NP O
breast NN I-NP B-Disease
- HYPH O I-Disease
ovary NN B-NP I-Disease
cancer NN I-NP I-Disease
- HYPH B-NP I-Disease
family NN I-NP I-Disease
syndrome NN I-NP I-Disease
is VBZ B-VP O
a DT B-NP O
dominant JJ I-NP O
predisposition NN I-NP O
to TO B-PP O
cancer NN B-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
breast NN I-NP I-Disease
and CC I-NP I-Disease
ovaries NNS I-NP I-Disease
which WDT B-NP O
has VBZ B-VP O
been VBN I-VP O
mapped VBN I-VP O
to TO B-PP O
chromosome NN B-NP O
region NN I-NP O
17q12 CD I-NP O
- HYPH I-NP O
q21 NN I-NP O
. . O O

The DT B-NP O
majority NN I-NP O
, , O O
but CC O O
not RB B-NP O
all DT I-NP O
, , O O
of IN B-PP O
breast NN B-NP B-Disease
- HYPH B-NP I-Disease
ovary NN I-NP I-Disease
cancer NN I-NP I-Disease
families NNS I-NP O
show VBP B-VP O
linkage NN B-NP O
to TO B-PP O
this DT B-NP O
susceptibility NN I-NP O
locus NN I-NP O
, , O O
designated VBN B-VP O
BRCA1 NN B-NP O
. . O O

We PRP B-NP O
report VBP B-VP O
here RB B-ADVP O
the DT B-NP O
results NNS I-NP O
of IN B-PP O
a DT B-NP O
linkage NN I-NP O
analysis NN I-NP O
of IN B-PP O
145 CD B-NP O
families NNS I-NP O
with IN B-PP O
both CC O O
breast NN B-NP B-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
. . O O

These DT B-NP O
families NNS I-NP O
contain VBP B-VP O
either CC O O
a DT B-NP O
total NN I-NP O
of IN B-PP O
three CD B-NP O
or CC I-NP O
more JJR I-NP O
cases NNS I-NP O
of IN B-PP O
early JJ B-NP O
- HYPH I-NP O
onset NN I-NP O
( ( O O
before IN B-PP O
age NN B-NP O
60 CD B-NP O
years NNS I-NP O
) ) O O
breast NN B-NP B-Disease
cancer NN I-NP I-Disease
or CC O O
ovarian JJ B-NP B-Disease
cancer NN I-NP I-Disease
. . O O

All DT B-NP O
families NNS I-NP O
contained VBD B-VP O
at IN B-NP O
least JJS I-NP O
one CD I-NP O
case NN I-NP O
of IN B-PP O
ovarian JJ B-NP B-Disease
cancer NN I-NP I-Disease
. . O O

Overall RB B-ADVP O
, , O O
an DT B-NP O
estimated VBN I-NP O
76 CD I-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
145 CD I-NP O
families NNS I-NP O
are VBP B-VP O
linked VBN I-VP O
to TO B-PP O
the DT B-NP O
BRCA1 NN I-NP O
locus NN I-NP O
. . O O

None NN B-NP O
of IN B-PP O
the DT B-NP O
13 CD I-NP O
families NNS I-NP O
with IN B-PP O
cases NNS B-NP O
of IN B-PP O
male JJ B-NP B-Disease
breast NN I-NP I-Disease
cancer NN I-NP I-Disease
appear VBP B-VP O
to TO I-VP O
be VB I-VP O
linked VBN I-VP O
, , O O
but CC O O
it PRP B-NP O
is VBZ B-VP O
estimated VBN I-VP O
that IN B-SBAR O
92 CD B-NP O
% NN I-NP O
( ( O O
95 CD B-NP O
% NN I-NP O
confidence NN I-NP O
interval NN I-NP O
76 CD B-NP O
% NN I-NP O
- HYPH O O
100 CD B-NP O
% NN I-NP O
) ) O O
of IN B-PP O
families NNS B-NP O
with IN B-PP O
no DT B-NP O
male JJ I-NP B-Disease
breast NN I-NP I-Disease
cancer NN I-NP I-Disease
and CC O O
with IN B-PP O
two CD B-NP O
or CC I-NP O
more JJR I-NP O
ovarian JJ I-NP B-Disease
cancers NNS I-NP I-Disease
are VBP B-VP O
linked VBN I-VP O
to TO B-PP O
BRCA1 NN B-NP O
. . O O

These DT B-NP O
data NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
the DT B-NP O
breast NN I-NP B-Disease
- HYPH O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
- HYPH B-NP I-Disease
family NN I-NP I-Disease
syndrome NN I-NP I-Disease
is VBZ B-VP O
genetically RB B-ADJP O
heterogeneous JJ I-ADJP O
. . O O

However RB B-ADVP O
, , O O
the DT B-NP O
large JJ I-NP O
majority NN I-NP O
of IN B-PP O
families NNS B-NP O
with IN B-PP O
early JJ B-NP O
- HYPH I-NP O
onset NN I-NP O
breast NN I-NP B-Disease
cancer NN I-NP I-Disease
and CC O O
with IN B-PP O
two CD B-NP O
or CC I-NP O
more JJR I-NP O
cases NNS I-NP O
of IN B-PP O
ovarian JJ B-NP B-Disease
cancer NN I-NP I-Disease
are VBP B-VP O
likely JJ B-ADJP O
to TO B-VP O
be VB I-VP O
due IN B-PP O
to TO B-PP O
BRCA1 NN B-NP O
mutations NNS I-NP O
. . O O

. . O O

Molecular JJ B-NP O
basis NN I-NP O
of IN B-PP O
essential JJ B-NP B-Disease
fructosuria NN I-NP I-Disease
: : O O
molecular JJ B-NP O
cloning NN I-NP O
and CC O O
mutational JJ B-NP O
analysis NN I-NP O
of IN B-PP O
human JJ B-NP O
ketohexokinase NN I-NP O
( ( O O
fructokinase NN B-NP O
) ) O O
. . O O

Essential JJ B-NP B-Disease
fructosuria NN I-NP I-Disease
is VBZ B-VP O
one CD B-NP O
of IN B-PP O
the DT B-NP O
oldest JJS I-NP O
known VBN I-NP O
inborn JJ I-NP B-Disease
errors NNS I-NP I-Disease
of IN B-PP I-Disease
metabolism NN B-NP I-Disease
. . O O

It PRP B-NP O
is VBZ B-VP O
a DT B-NP O
benign JJ I-NP O
condition NN I-NP O
which WDT B-NP O
is VBZ B-VP O
believed VBN I-VP O
to TO I-VP O
result VB I-VP O
from IN B-PP O
deficiency NN B-NP B-Disease
of IN B-PP I-Disease
hepatic JJ B-NP I-Disease
fructokinase NN I-NP I-Disease
( ( O O
ketohexokinase NN B-NP O
, , O O
KHK NN B-NP O
, , O O
E NN B-NP O
. . I-NP O

C NN I-NP O
. . O O

2 CD B-NP O
. . O O

7 CD B-NP O
. . I-NP O

1 CD I-NP O
. . I-NP O

3 CD I-NP O
) ) O O
. . O O

This DT B-NP O
enzyme NN I-NP O
catalyses VBZ B-VP O
the DT B-NP O
first JJ I-NP O
step NN I-NP O
of IN B-PP O
metabolism NN B-NP O
of IN B-PP O
dietary JJ B-NP O
fructose NN I-NP O
, , O O
conversion NN B-NP O
of IN B-PP O
fructose NN B-NP O
to TO B-PP O
fructose NN B-NP O
- HYPH B-NP O
1 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
. . O O

Despite IN B-PP O
the DT B-NP O
early JJ I-NP O
recognition NN I-NP O
of IN B-PP O
this DT B-NP O
disorder NN I-NP O
, , O O
the DT B-NP O
primary JJ I-NP O
structure NN I-NP O
of IN B-PP O
human JJ B-NP O
KHK NN I-NP O
and CC O O
the DT B-NP O
molecular JJ I-NP O
basis NN I-NP O
of IN B-PP O
essential JJ B-NP B-Disease
fructosuria NNS I-NP I-Disease
have VBP B-VP O
not RB I-VP O
been VBN I-VP O
previously RB B-ADJP O
defined VBN I-ADJP O
. . O O

In IN B-PP O
this DT B-NP O
report NN I-NP O
, , O O
the DT B-NP O
isolation NN I-NP O
and CC I-NP O
sequencing NN I-NP O
of IN B-PP O
full JJ B-NP O
- HYPH I-NP O
length NN I-NP O
cDNA NN I-NP O
clones NNS I-NP O
encoding VBG B-VP O
human JJ B-NP O
ketohexokinase NN I-NP O
are VBP B-VP O
described VBN I-VP O
. . O O

Alternative JJ B-NP O
mRNA NN I-NP O
species NNS I-NP O
and CC O O
alternative JJ B-NP O
KHK NN I-NP O
isozymes NNS I-NP O
are VBP B-VP O
produced VBN I-VP O
by IN B-PP O
alternative JJ B-NP O
polyadenylation NN I-NP O
and CC I-NP O
splicing NN I-NP O
of IN B-PP O
the DT B-NP O
KHK NN I-NP O
gene NN I-NP O
. . O O

The DT B-NP O
KHK NN I-NP O
proteins NNS I-NP O
show VBP B-VP O
a DT B-NP O
high JJ I-NP O
level NN I-NP O
of IN B-PP O
sequence NN B-NP O
conservation NN I-NP O
relative JJ B-ADJP O
to TO B-PP O
rat NN B-NP O
KHK NN I-NP O
. . O O

Direct JJ B-NP O
evidence NN I-NP O
that IN B-SBAR O
mutation NN B-NP O
of IN B-PP O
the DT B-NP O
KHK NN I-NP O
structural JJ I-NP O
gene NN I-NP O
is VBZ B-VP O
the DT B-NP O
cause NN I-NP O
of IN B-PP O
essential JJ B-NP B-Disease
fructosuria NN I-NP I-Disease
was VBD B-VP O
also RB I-VP O
obtained VBN I-VP O
. . O O

In IN B-PP O
a DT B-NP O
well RB I-NP O
- HYPH I-NP O
characterized VBN I-NP O
family NN I-NP O
, , O O
in IN B-PP O
which WDT B-NP O
three CD B-NP O
of IN I-NP O
eight CD I-NP O
siblings NNS I-NP O
have VBP B-VP O
fructosuria NN B-NP B-Disease
, , O O
all DT B-NP O
affected VBN I-NP O
individuals NNS I-NP O
are VBP B-VP O
compound JJ B-NP O
heterozygotes NNS I-NP O
for IN B-PP O
two CD B-NP O
mutations NNS I-NP O
Gly40Arg NN I-NP O
and CC I-NP O
Ala43Thr NN I-NP O
. . O O

Both DT B-NP O
mutations NNS I-NP O
result VBP B-VP O
from IN B-PP O
G NN B-NP O
- SYM B-NP O
- HYPH B-NP O
> SYM I-NP O
A NN I-NP O
transitions NNS I-NP O
, , O O
and CC O O
each DT B-NP O
alters VBZ B-VP O
the DT B-NP O
same JJ I-NP O
conserved VBN I-NP O
region NN I-NP O
of IN B-PP O
the DT B-NP O
KHK NN I-NP O
protein NN I-NP O
. . O O

Neither DT B-NP O
mutation NN I-NP O
was VBD B-VP O
seen VBN I-VP O
in IN B-PP O
a DT B-NP O
sample NN I-NP O
of IN B-PP O
52 CD B-NP O
unrelated JJ I-NP O
control NN I-NP O
individuals NNS I-NP O
. . O O

An DT B-NP O
additional JJ I-NP O
conservative JJ I-NP O
amino JJ I-NP O
acid NN I-NP O
change NN I-NP O
( ( O O
Val49IIe NN B-NP O
) ) O O
was VBD B-VP O
present JJ B-ADJP O
on IN B-PP O
the DT B-NP O
KHK NN I-NP O
allele NN I-NP O
bearing VBG B-VP O
Ala43Thr NN B-NP O
Homozygous JJ B-NP O
presence NN I-NP O
of IN B-PP O
the DT B-NP O
crossover NN I-NP O
( ( O O
fusion NN B-NP O
gene NN I-NP O
) ) O O
mutation NN B-NP O
identified VBN B-VP O
in IN B-PP O
a DT B-NP O
type NN I-NP B-Disease
II CD I-NP I-Disease
Gaucher NNP I-NP I-Disease
disease NN I-NP I-Disease
fetus NN I-NP O
: : O O
is VBZ B-VP O
this DT B-NP O
analogous JJ B-ADJP O
to TO B-PP O
the DT B-NP O
Gaucher NNP I-NP O
knock VB B-VP O
- HYPH O O
out RP B-PRT O
mouse NN B-NP O
model NN I-NP O
? . O O

Gaucher NN B-NP B-Disease
disease NN I-NP I-Disease
( ( O O
GD NN B-NP B-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
inherited VBN I-NP O
deficiency NN I-NP B-Disease
of IN B-PP I-Disease
beta SYM O I-Disease
- HYPH O I-Disease
glucocerebrosidase NN B-NP I-Disease
( ( O O
EC NNP B-NP O
3 CD I-NP O
. . O O

1 CD B-NP O
. . I-NP O

2 CD I-NP O
. . I-NP O

45 CD I-NP O
, , O O
gene NN B-NP O
symbol NN I-NP O
GBA NN I-NP O
) ) O O
. . O O

In IN B-PP O
type NN B-NP B-Disease
I CD I-NP I-Disease
GD NN I-NP I-Disease
, , O O
the DT B-NP O
CNS NN I-NP O
is VBZ B-VP O
not RB I-VP O
involved VBN I-VP O
( ( O O
nonneuronopathic JJ B-ADVP O
) ) O O
, , O O
whereas IN O O
in IN B-PP O
type NN B-NP B-Disease
II CD I-NP I-Disease
GD NN I-NP I-Disease
( ( O O
acute JJ B-NP O
neuronopathic JJ I-NP O
) ) I-NP O
CNS NN I-NP O
involvement NN I-NP O
is VBZ B-VP O
early JJ B-ADJP O
and CC O O
rapidly RB B-ADJP O
progressive JJ I-ADJP O
, , O O
while IN B-SBAR O
in IN B-PP O
type NN B-NP B-Disease
III CD I-NP I-Disease
GD NN I-NP I-Disease
( ( O O
subacute JJ B-NP O
neuronopathic JJ I-NP O
) ) I-NP O
CNS NN I-NP O
involvement NN I-NP O
occurs VBZ B-VP O
later RB B-ADVP O
and CC O O
is VBZ B-VP O
slowly RB B-ADJP O
progressive JJ I-ADJP O
. . O O

The DT B-NP O
T6433C NN I-NP O
( ( O O
L444P NN B-NP O
) ) O O
substitution NN B-NP O
is VBZ B-VP O
prevalent JJ B-ADJP O
in IN B-PP O
type NN B-NP B-Disease
GD NN I-NP I-Disease
II CD I-NP I-Disease
. . O O

It PRP B-NP O
may MD B-VP O
occur VB I-VP O
alone RB B-ADVP O
as IN B-PP O
a DT B-NP O
single JJ I-NP O
base NN I-NP O
- HYPH I-NP O
pair NN I-NP O
mutation NN I-NP O
but CC O O
often RB B-ADVP O
is VBZ B-VP O
found VBN I-VP O
as IN B-PP O
part NN B-NP O
of IN B-PP O
a DT B-NP O
complex JJ I-NP O
allele NN I-NP O
containing VBG B-VP O
additional JJ B-NP O
GBA NN I-NP O
nucleotide NN I-NP O
substitutions NNS I-NP O
, , O O
G6468C NN B-NP O
( ( O O
A456P NN B-NP O
) ) O O
and CC O O
G6482C NN B-NP O
( ( O O
V460V NN B-NP O
) ) O O
, , O O
without IN B-PP O
( ( O O
recNciI NN B-NP O
) ) O O
or CC O O
with IN B-PP O
( ( O O
recTL NN B-NP O
) ) O O
G5957C NN B-NP O
( ( O O
D409H NN B-NP O
) ) O O
. . O O

This DT B-NP O
complex JJ I-NP O
allele NN I-NP O
is VBZ B-VP O
presumed VBN I-VP O
to TO I-VP O
have VB I-VP O
formed VBN I-VP O
by IN B-PP O
recombination NN B-NP O
( ( O O
crossover NN B-NP O
, , O O
fusion NN B-NP O
) ) O O
of IN B-PP O
the DT B-NP O
structural JJ I-NP O
gene NN I-NP O
with IN B-PP O
the DT B-NP O
pseudogene NN I-NP O
, , O O
which WDT B-NP O
contains VBZ B-VP O
the DT B-NP O
mutated VBN I-NP O
sequences NNS I-NP O
. . O O

Two CD B-NP O
complex JJ I-NP O
alleles NNS I-NP O
have VBP B-VP O
never RB I-VP O
been VBN I-VP O
demonstrated VBN I-VP O
to TO B-VP O
coexist VB I-VP O
in IN B-PP O
any DT B-NP O
individual NN I-NP O
. . O O

We PRP B-NP O
devised VBD B-VP O
a DT B-NP O
selective JJ I-NP O
PCR NN I-NP O
method NN I-NP O
for IN B-PP O
the DT B-NP O
specific JJ I-NP O
amplification NN I-NP O
of IN B-PP O
the DT B-NP O
normal JJ I-NP O
and CC O O
/ SYM B-NP O
or CC O O
fusion NN B-NP O
gene NN I-NP O
. . O O

Using VBG B-VP O
this DT B-NP O
procedure NN I-NP O
we PRP B-NP O
demonstrated VBD B-VP O
the DT B-NP O
fusion NN I-NP O
gene NN I-NP O
in IN B-PP O
homozygous JJ B-NP O
form NN I-NP O
for IN B-PP O
the DT B-NP O
first JJ I-NP O
time NN I-NP O
, , O O
in IN B-PP O
a DT B-NP O
Macedonian JJ I-NP O
/ SYM I-NP O
Ashkenazi JJ I-NP O
Jewish JJ I-NP O
GD NN I-NP B-Disease
type NN I-NP I-Disease
II CD I-NP I-Disease
fetus NN I-NP O
. . O O

Both DT B-NP O
parents NNS I-NP O
were VBD B-VP O
carriers NNS B-NP O
of IN B-PP O
the DT B-NP O
recombination NN I-NP O
. . O O

This DT B-NP O
was VBD B-VP O
confirmed VBN I-VP O
by IN B-PP O
direct JJ B-NP O
sequence NN I-NP O
analysis NN I-NP O
. . O O

A DT B-NP O
previous JJ I-NP O
conceptus NN I-NP O
in IN B-PP O
this DT B-NP O
family NN I-NP O
was VBD B-VP O
stillborn VBN I-VP B-Disease
at IN B-PP O
36 CD B-NP O
weeks NNS I-NP O
, , O O
with IN B-PP O
features NNS B-NP O
of IN B-PP O
severe JJ B-NP O
type NN I-NP B-Disease
II CD I-NP I-Disease
GD NN I-NP I-Disease
. . O O

Neonates NNS B-NP O
showing VBG B-VP O
a DT B-NP O
severe JJ I-NP O
clinical JJ I-NP O
phenotype NN I-NP O
, , O O
analogous JJ B-ADJP O
to TO B-PP O
the DT B-NP O
early JJ I-NP O
neonatal JJ I-NP O
lethal JJ I-NP O
disease NN I-NP O
occurring VBG B-VP O
in IN B-PP O
mice NNS B-NP O
homozygous JJ B-ADJP O
for IN B-PP O
a DT B-NP O
allele NN I-NP O
produced VBN B-VP O
by IN B-PP O
targeted VBN B-NP O
disruption NN I-NP O
of IN B-PP O
GBA NN B-NP O
, , O O
have VBP B-VP O
been VBN I-VP O
described VBN I-VP O
elsewhere RB B-ADVP O
, , O O
but CC O O
the DT B-NP O
specific JJ I-NP O
mutations NNS I-NP O
in IN B-PP O
these DT B-NP O
cases NNS I-NP O
have VBP B-VP O
not RB I-VP O
yet RB I-VP O
been VBN I-VP O
characterized VBN I-VP O
. . O O

( ( O O
ABSTRACT NN B-NP O
TRUNCATED VBN B-VP O
AT IN B-PP O
250 CD B-NP O
WORDS NNS I-NP O
) ) O O
Late JJ B-NP O
infantile JJ I-NP O
metachromatic JJ I-NP B-Disease
leukodystrophy NN I-NP I-Disease
in IN B-PP O
Israel NNP B-NP O
. . O O

Metachromatic JJ B-NP B-Disease
Leukodystrophy NN I-NP I-Disease
( ( O O
MLD NN B-NP B-Disease
) ) O O
is VBZ B-VP O
a DT B-NP O
neurodegenerative JJ I-NP B-Disease
disease NN I-NP I-Disease
in IN B-PP O
which WDT B-NP O
the DT B-NP O
lysosomal JJ I-NP O
enzyme NN I-NP O
, , O O
Aryl NN B-NP O
sulfatase NN I-NP O
A NN I-NP O
( ( O O
ARSA NN B-NP O
) ) O O
is VBZ B-VP O
deficient JJ B-ADJP O
. . O O

The DT B-NP O
disease NN I-NP O
is VBZ B-VP O
inherited VBN I-VP O
as IN B-PP O
an DT B-NP O
autosomal JJ I-NP O
recessive JJ I-NP O
trait NN I-NP O
and CC O O
its PRP$ B-NP O
frequency NN I-NP O
is VBZ B-VP O
estimated VBN I-VP O
to TO I-VP O
be VB I-VP O
1 CD B-NP O
/ SYM I-NP O
40 CD I-NP O
, , I-NP O
000 CD I-NP O
live JJ I-NP O
births NNS I-NP O
. . O O

The DT B-NP O
gene NN I-NP O
of IN B-PP O
ARSA NN B-NP O
has VBZ B-VP O
been VBN I-VP O
cloned VBN I-VP O
and CC O O
up RB B-ADVP O
to TO B-PP O
now RB B-ADVP O
eight CD B-NP O
mutations NNS I-NP O
causing VBG B-VP O
MLD NN B-NP B-Disease
have VBP B-VP O
been VBN I-VP O
reported VBN I-VP O
. . O O

Another DT B-NP O
mutation NN I-NP O
, , O O
PD NN B-NP O
, , O O
leads VBZ B-VP O
to TO B-PP O
the DT B-NP O
deficiency NN I-NP O
of IN B-PP O
the DT B-NP O
enzyme NN I-NP O
in FW B-ADVP O
vitro FW I-ADVP O
( ( O O
pseudodeficiency NN B-NP O
) ) O O
without IN B-PP O
any DT B-NP O
known JJ I-NP O
clinical JJ I-NP O
effect NN I-NP O
. . O O

The DT B-NP O
PD NN I-NP O
mutation NN I-NP O
is VBZ B-VP O
frequent JJ B-ADJP O
in IN B-PP O
all DT B-NP O
populations NNS I-NP O
. . O O

In IN B-PP O
Israel NNP B-NP O
, , O O
late JJ B-NP O
infantile JJ I-NP O
MLD NN I-NP B-Disease
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
be VB I-VP O
very RB B-ADJP O
frequent JJ I-ADJP O
in IN B-PP O
a DT B-NP O
small JJ I-NP O
Jewish JJ I-NP O
isolate NN I-NP O
, , O O
the DT B-NP O
Habbanite NNP I-NP O
Jews NNPS I-NP O
( ( O O
1 CD B-NP O
/ SYM O O
75 CD B-NP O
live JJ I-NP O
births NNS I-NP O
) ) O O
. . O O

The DT B-NP O
molecular JJ I-NP O
analysis NN I-NP O
demonstrated VBD B-VP O
that IN B-SBAR O
in IN B-PP O
the DT B-NP O
Habbanite NNP I-NP O
population NN I-NP O
, , O O
the DT B-NP O
mutation NN I-NP O
occurred VBD B-VP O
on IN B-PP O
an DT B-NP O
allele NN I-NP O
with IN B-PP O
the DT B-NP O
PD NN I-NP O
mutation NN I-NP O
. . O O

The DT B-NP O
loss NN I-NP O
of IN B-PP O
ARSA NN B-NP O
activity NN I-NP O
is VBZ B-VP O
due IN B-PP O
to TO B-PP O
a DT B-NP O
point NN I-NP O
mutation NN I-NP O
C NN I-NP O
> SYM O O
T NN B-NP O
leading VBG B-VP O
to TO B-PP O
a DT B-NP O
change NN I-NP O
of IN B-PP O
proline NN B-NP O
to TO B-PP O
leucine NN B-NP O
. . O O

MLD NN B-NP B-Disease
is VBZ B-VP O
also RB B-ADVP O
frequent JJ B-ADJP O
among IN B-PP O
Moslem NNP B-NP O
Arabs NNP I-NP O
in IN B-PP O
Jerusalem NNP B-NP O
. . O O

The DT B-NP O
mutation NN I-NP O
is VBZ B-VP O
a DT B-NP O
transition NN I-NP O
G NN I-NP O
> SYM B-NP O
A NN I-NP O
destroying VBG B-VP O
the DT B-NP O
splice NN I-NP O
donor NN I-NP O
site NN I-NP O
of IN B-PP O
exon NN B-NP O
2 CD I-NP O
. . O O

This DT B-NP O
mutation NN I-NP O
has VBZ B-VP O
been VBN I-VP O
reported VBN I-VP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
the DT B-NP O
late JJ I-NP O
infantile JJ I-NP O
MLD NN I-NP B-Disease
from IN B-PP O
different JJ B-NP O
ethnic JJ I-NP O
groups NNS I-NP O
. . O O

The DT B-NP O
Christian NNP I-NP O
Arabs NNPS I-NP O
in IN B-PP O
Israel NNP B-NP O
also RB B-ADVP O
have VBP B-VP O
a DT B-NP O
high JJ I-NP O
incidence NN I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
( ( O O
1 CD B-NP O
/ SYM O O
10 CD B-NP O
, , I-NP O
000 CD I-NP O
live JJ I-NP O
births NNS I-NP O
) ) O O
; : O O
the DT B-NP O
mutation NN I-NP O
in IN B-PP O
this DT B-NP O
population NN I-NP O
is VBZ B-VP O
still RB B-ADVP O
unknown JJ B-ADJP O
. . O O

Knowledge NN B-NP O
of IN B-PP O
the DT B-NP O
different JJ I-NP O
mutations NNS I-NP O
causing VBG B-VP O
MLD NN B-NP B-Disease
in IN B-PP O
these DT B-NP O
defined VBN I-NP O
populations NNS I-NP O
will MD B-VP O
allow VB I-VP O
a DT B-NP O
carrier NN I-NP O
screening NN I-NP O
program NN I-NP O
to TO B-VP O
be VB I-VP O
carried VBN I-VP O
out RP B-PRT O
and CC O O
prevent VB B-VP O
the DT B-NP O
birth NN I-NP O
of IN B-PP O
additional JJ B-NP O
affected VBN I-NP O
children NNS I-NP O
. . O O

. . O O

A DT B-NP O
single JJ I-NP O
amino NN I-NP O
acid NN I-NP O
substitution NN I-NP O
( ( O O
G103D NN B-NP O
) ) O O
in IN B-PP O
the DT B-NP O
type NN I-NP O
II CD I-NP O
collagen NN I-NP O
triple JJ I-NP O
helix NN I-NP O
produces VBZ B-VP O
Kniest JJS B-NP B-Disease
dysplasia NN I-NP I-Disease
. . O O

Kniest JJS B-NP B-Disease
dysplasia NN I-NP I-Disease
is VBZ B-VP O
a DT B-NP O
moderately RB I-NP O
severe JJ I-NP O
chondrodysplasia NN I-NP B-Disease
phenotype NN I-NP O
that WDT B-NP O
results VBZ B-VP O
from IN B-PP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
gene NN I-NP O
for IN B-PP O
type NN B-NP O
II CD I-NP O
collagen NN I-NP O
, , O O
COL2A1 NN B-NP O
. . O O

Characteristics NNS B-NP O
of IN B-PP O
the DT B-NP O
disorder NN I-NP O
include VBP B-VP O
a DT B-NP O
short JJ I-NP B-Disease
trunk NN I-NP I-Disease
and CC I-NP I-Disease
extremities NNS I-NP I-Disease
, , O O
mid JJ B-NP B-Disease
- HYPH I-NP I-Disease
face NN I-NP I-Disease
hypoplasia NN I-NP I-Disease
, , O O
cleft NN B-NP B-Disease
palate NN I-NP I-Disease
, , O O
myopia NN B-NP B-Disease
, , O O
retinal JJ B-NP B-Disease
detachment NN I-NP I-Disease
, , O O
and CC O O
hearing NN B-NP B-Disease
loss NN I-NP I-Disease
. . O O

Recently RB B-ADVP O
, , O O
deletions NNS B-NP O
of IN B-PP O
all DT B-NP O
or CC I-NP O
part NN I-NP O
of IN B-PP O
exon NN B-NP O
12 CD I-NP O
have VBP B-VP O
been VBN I-VP O
identified VBN I-VP O
in IN B-PP O
individuals NNS B-NP O
with IN B-PP O
Kniest JJS B-NP B-Disease
dysplasia NN I-NP I-Disease
, , O O
suggesting VBG B-VP O
that IN B-SBAR O
mutations NNS B-NP O
within IN B-PP O
this DT B-NP O
region NN I-NP O
of IN B-PP O
the DT B-NP O
protein NN I-NP O
may MD B-VP O
primarily RB I-VP O
result VB I-VP O
in IN B-PP O
the DT B-NP O
Kniest JJS I-NP B-Disease
dysplasia NN I-NP I-Disease
phenotype NN I-NP O
. . O O

We PRP B-NP O
used VBD B-VP O
SSCP NN B-NP O
to TO B-VP O
analyze VB I-VP O
an DT B-NP O
amplified VBN I-NP O
genomic JJ I-NP O
DNA NN I-NP O
fragment NN I-NP O
containing VBG B-VP O
exon NN B-NP O
12 CD I-NP O
from IN B-PP O
seven CD B-NP O
individuals NNS I-NP O
with IN B-PP O
Kniest JJS B-NP B-Disease
dysplasia NN I-NP I-Disease
. . O O

An DT B-NP O
abnormality NN I-NP O
was VBD B-VP O
identified VBN I-VP O
in IN B-PP O
one CD B-NP O
patient NN I-NP O
. . O O

DNA NN B-NP O
sequence NN I-NP O
analysis NN I-NP O
demonstrated VBD B-VP O
that IN B-SBAR O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
heterozygous JJ B-ADJP O
for IN B-PP O
a DT B-NP O
G NN I-NP O
to TO B-PP O
A NN B-NP O
transition NN I-NP O
that WDT B-NP O
implied VBD B-VP O
substitution NN B-NP O
of IN B-PP O
glycine103 NN B-NP O
of IN B-PP O
the DT B-NP O
triple JJ I-NP O
helical JJ I-NP O
domain NN I-NP O
by IN B-PP O
aspartate NN B-NP O
. . O O

The DT B-NP O
mutation NN I-NP O
was VBD B-VP O
not RB I-VP O
observed VBN I-VP O
in IN B-PP O
DNA NN B-NP O
from IN B-PP O
either DT B-NP O
of IN B-PP O
the DT B-NP O
clinically RB I-NP O
unaffected JJ I-NP O
parents NNS I-NP O
of IN B-PP O
the DT B-NP O
proband NN I-NP O
. . O O

Protein NN B-NP O
microsequencing NN I-NP O
demonstrated VBD B-VP O
expression NN B-NP O
of IN B-PP O
the DT B-NP O
abnormal JJ I-NP O
allele NN I-NP O
in IN B-PP O
cartilage NN B-NP O
. . O O

These DT B-NP O
data NNS I-NP O
demonstrate VBP B-VP O
that IN B-SBAR O
point NN B-NP O
mutations NNS I-NP O
which WDT B-NP O
result VBP B-VP O
in IN B-PP O
single JJ B-NP O
amino JJ I-NP O
acid NN I-NP O
substitutions NNS I-NP O
can MD B-VP O
produce VB I-VP O
Kniest JJS B-NP B-Disease
dysplasia NN I-NP I-Disease
and CC O O
further RB B-VP O
support VBP I-VP O
the DT B-NP O
hypothesis NN I-NP O
that IN B-SBAR O
alteration NN B-NP O
of IN B-PP O
a DT B-NP O
domain NN I-NP O
, , O O
which WDT B-NP O
includes VBZ B-VP O
the DT B-NP O
region NN I-NP O
encoded VBN B-VP O
by IN B-PP O
exon NN B-NP O
12 CD I-NP O
, , O O
in IN B-PP O
the DT B-NP O
type NN I-NP O
II CD I-NP O
collagen NN I-NP O
protein NN I-NP O
leads VBZ B-VP O
to TO B-PP O
this DT B-NP O
disorder NN I-NP O
. . O O

. . O O

CAG NN B-NP O
expansions NNS I-NP O
in IN B-PP O
a DT B-NP O
novel JJ I-NP O
gene NN I-NP O
for IN B-PP O
Machado NNP B-NP B-Disease
- HYPH I-NP I-Disease
Joseph NNP I-NP I-Disease
disease NN I-NP I-Disease
at IN B-PP O
chromosome NN B-NP O
14q32 NN I-NP O
. . O O

1 CD B-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
identified VBN I-VP O
a DT B-NP O
novel JJ I-NP O
gene NN I-NP O
containing VBG B-VP O
CAG NN B-NP O
repeats NNS I-NP O
and CC O O
mapped VBD B-VP O
it PRP B-NP O
to TO B-PP O
chromosome NN B-NP O
14q32 NN I-NP O
. . O O

1 CD B-NP O
, , O O
the DT B-NP O
genetic JJ I-NP O
locus NN I-NP O
for IN B-PP O
Machado NNP B-NP B-Disease
- HYPH I-NP I-Disease
Joseph NNP I-NP I-Disease
disease NN I-NP I-Disease
( ( O O
MJD NN B-NP B-Disease
) ) O O
. . O O

In IN B-PP O
normal JJ B-NP O
individuals NNS I-NP O
the DT B-NP O
gene NN I-NP O
contains VBZ B-VP O
between IN B-NP O
13 CD I-NP O
and CC I-NP O
36 CD I-NP O
CAG NN I-NP O
repeats NNS I-NP O
, , O O
whereas IN O O
most JJS B-NP O
of IN B-PP O
the DT B-NP O
clinically RB I-NP O
diagnosed VBN I-NP O
patients NNS I-NP O
and CC O O
all DT B-NP O
of IN B-PP O
the DT B-NP O
affected VBN I-NP O
members NNS I-NP O
of IN B-PP O
a DT B-NP O
family NN I-NP O
with IN B-PP O
the DT B-NP O
clinical JJ I-NP O
and CC I-NP O
pathological JJ I-NP O
diagnosis NN I-NP O
of IN B-PP O
MJD NN B-NP B-Disease
show VBP B-VP O
expansion NN B-NP O
of IN B-PP O
the DT B-NP O
repeat NN I-NP O
- HYPH B-NP O
number NN I-NP O
( ( O O
from IN B-PP O
68 CD B-NP O
- HYPH I-NP O
79 CD I-NP O
) ) O O
. . O O

Southern NN B-NP O
blot NN I-NP O
analyses NNS I-NP O
and CC O O
genomic JJ B-NP O
cloning NN I-NP O
demonstrates VBZ B-VP O
the DT B-NP O
existence NN I-NP O
of IN B-PP O
related JJ B-NP O
genes NNS I-NP O
. . O O

These DT B-NP O
results NNS I-NP O
raise VBP B-VP O
the DT B-NP O
possibility NN I-NP O
that IN B-SBAR O
similar JJ B-NP O
abnormalities NNS I-NP O
in IN B-PP O
related JJ B-NP O
genes NNS I-NP O
may MD B-VP O
give VB I-VP O
rise NN B-NP O
to TO B-PP O
diseases NNS B-NP O
similar JJ B-ADJP O
to TO B-PP O
MJD NN B-NP B-Disease
. . O O

Mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
BRCA1 NN I-NP O
gene NN I-NP O
in IN B-PP O
families NNS B-NP O
with IN B-PP O
early JJ B-NP O
- HYPH I-NP O
onset NN I-NP O
breast NN I-NP B-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
. . O O

We PRP B-NP O
analysed VBD B-VP O
50 CD B-NP O
probands NNS I-NP O
with IN B-PP O
a DT B-NP O
family NN I-NP O
history NN I-NP O
of IN B-PP O
breast NN B-NP B-Disease
and CC O I-Disease
/ SYM B-NP I-Disease
or CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
for IN B-PP O
germline NN B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
coding VBG I-NP O
region NN I-NP O
of IN B-PP O
the DT B-NP O
BRCA1 NN I-NP O
candidate NN I-NP O
gene NN I-NP O
, , O O
using VBG B-VP O
single JJ B-NP O
- HYPH I-NP O
strand NN I-NP O
conformation NN I-NP O
polymorphism NN I-NP O
( ( O O
SSCP NN B-NP O
) ) O O
analysis NN B-NP O
on IN B-PP O
PCR NN B-NP O
- HYPH O O
amplified VBN B-VP O
genomic JJ B-NP O
DNA NN I-NP O
. . O O

A DT B-NP O
total NN I-NP O
of IN B-PP O
eight CD B-NP O
putative JJ I-NP O
disease NN I-NP O
- HYPH B-VP O
causing VBG B-NP O
alterations NNS I-NP O
were VBD B-VP O
identified VBN I-VP O
four CD B-NP O
of IN B-PP O
these DT B-NP O
are VBP B-VP O
frameshifts NNS B-NP O
and CC O O
two CD B-NP O
are VBP B-VP O
nonsense JJ B-NP O
mutations NNS I-NP O
. . O O

In IN B-PP O
addition NN B-NP O
, , O O
we PRP B-NP O
found VBD B-VP O
two CD B-NP O
missense JJ I-NP O
mutations NNS I-NP O
, , O O
one CD B-NP O
of IN B-PP O
which WDT B-NP O
changes VBZ B-VP O
the DT B-NP O
final JJ I-NP O
cysteine NN I-NP O
of IN B-PP O
the DT B-NP O
BRCA1 NN I-NP O
zinc NN I-NP O
finger NN I-NP O
motif NN I-NP O
to TO B-PP O
glycine NN B-NP O
. . O O

These DT B-NP O
data NNS I-NP O
are VBP B-VP O
consistent JJ B-ADJP O
with IN B-PP O
a DT B-NP O
tumour NN I-NP B-Disease
suppressor NN I-NP O
model NN I-NP O
, , O O
and CC O O
support VBP B-VP O
the DT B-NP O
notion NN I-NP O
that IN B-SBAR O
this DT B-NP O
candidate NN I-NP O
gene NN I-NP O
is VBZ B-VP O
in IN B-PP O
fact NN B-NP O
BRCA1 NN I-NP O
. . O O

The DT B-NP O
heterogeneity NN I-NP O
of IN B-PP O
mutations NNS B-NP O
, , O O
coupled VBN B-VP O
with IN B-PP O
the DT B-NP O
large JJ I-NP O
size NN I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
, , O O
indicates VBZ B-VP O
that IN B-SBAR O
clinical JJ B-NP O
application NN I-NP O
of IN B-PP O
BRCA1 NN B-NP O
mutation NN I-NP O
testing NN I-NP O
will MD B-VP O
be VB I-VP O
technically RB B-ADJP O
challenging JJ I-ADJP O
. . O O

. . O O

Confirmation NN B-NP O
of IN B-PP O
BRCA1 NN B-NP O
by IN B-PP O
analysis NN B-NP O
of IN B-PP O
germline NN B-NP O
mutations NNS I-NP O
linked VBN B-VP O
to TO B-PP O
breast NN B-NP B-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
in IN B-PP O
ten CD B-NP O
families NNS I-NP O
. . O O

We PRP B-NP O
provide VBP B-VP O
genetic JJ B-NP O
evidence NN I-NP O
supporting VBG B-VP O
the DT B-NP O
identity NN I-NP O
of IN B-PP O
the DT B-NP O
candidate NN I-NP O
gene NN I-NP O
for IN B-PP O
BRCA1 NN B-NP O
through IN B-PP O
the DT B-NP O
characterization NN I-NP O
of IN B-PP O
germline NN B-NP O
mutations NNS I-NP O
in IN B-PP O
63 CD B-NP O
breast NN I-NP B-Disease
cancer NN I-NP I-Disease
patients NNS I-NP O
and CC O O
10 CD B-NP O
ovarian JJ I-NP B-Disease
cancer NN I-NP I-Disease
patients NNS I-NP O
in IN B-PP O
ten CD B-NP O
families NNS I-NP O
with IN B-PP O
cancer NN B-NP B-Disease
linked VBN B-VP O
to TO B-PP O
chromosome NN B-NP O
17q21 NN I-NP O
. . O O

Nine CD B-NP O
different JJ I-NP O
mutations NNS I-NP O
were VBD B-VP O
detected VBN I-VP O
by IN B-PP O
screening VBG B-VP O
BRCA1 NN B-NP O
DNA NN I-NP O
and CC O O
RNA NN B-NP O
by IN B-PP O
single JJ B-NP O
- HYPH I-NP O
strand NN I-NP O
conformation NN I-NP O
polymorphism NN I-NP O
analysis NN I-NP O
and CC O O
direct JJ B-NP O
sequencing NN I-NP O
. . O O

Seven CD B-NP O
mutations NNS I-NP O
lead VBP B-VP O
to TO B-PP O
protein NN B-NP O
truncations NNS I-NP O
at IN B-PP O
sites NNS B-NP O
throughout IN B-PP O
the DT B-NP O
gene NN I-NP O
. . O O

One CD B-NP O
missense JJ I-NP O
mutation NN I-NP O
( ( O O
which WDT B-NP O
occurred VBD B-VP O
independently RB B-ADVP O
in IN B-PP O
two CD B-NP O
families NNS I-NP O
) ) O O
leads VBZ B-VP O
to TO B-PP O
loss NN B-NP O
of IN B-PP O
a DT B-NP O
cysteine NN I-NP O
in IN B-PP O
the DT B-NP O
zinc NN I-NP O
binding NN I-NP O
domain NN I-NP O
. . O O

An DT B-NP O
intronic JJ I-NP O
single JJ I-NP O
basepair NN I-NP O
substitution NN I-NP O
destroys VBZ B-VP O
an DT B-NP O
acceptor NN I-NP O
site NN I-NP O
and CC O O
activates VBZ B-VP O
a DT B-NP O
cryptic JJ I-NP O
splice NN I-NP O
site NN I-NP O
, , O O
leading VBG B-VP O
to TO B-PP O
a DT B-NP O
59 CD I-NP O
basepair NN I-NP O
insertion NN I-NP O
and CC O O
chain NN B-NP O
termination NN I-NP O
. . O O

The DT B-NP O
four CD I-NP O
families NNS I-NP O
with IN B-PP O
both CC O O
breast NN B-NP B-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
had VBD B-VP O
chain NN B-NP O
termination NN I-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
N NN I-NP O
- HYPH B-NP O
terminal JJ I-NP O
half NN I-NP O
of IN B-PP O
the DT B-NP O
protein NN I-NP O
. . O O

. . O O

High JJ B-NP O
resolution NN I-NP O
genetic JJ I-NP O
analysis NN I-NP O
suggests VBZ B-VP O
one CD B-NP O
ancestral JJ I-NP O
predisposing VBG I-NP O
haplotype NN I-NP O
for IN B-PP O
the DT B-NP O
origin NN I-NP O
of IN B-PP O
the DT B-NP O
myotonic JJ I-NP B-Disease
dystrophy NN I-NP I-Disease
mutation NN I-NP O
. . O O

The DT B-NP O
mutation NN I-NP O
causing VBG B-VP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
( ( O O
DM NN B-NP B-Disease
) ) O O
has VBZ B-VP O
been VBN I-VP O
identified VBN I-VP O
as IN B-PP O
an DT B-NP O
amplification NN I-NP O
of IN B-PP O
an DT B-NP O
unstable JJ I-NP O
trinucleotide NN I-NP O
( ( O O
CTG NN B-NP O
) ) O O
n NN B-NP O
repeat NN I-NP O
in IN B-PP O
over IN B-NP O
99 CD I-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
global JJ I-NP O
DM NN I-NP B-Disease
population NN I-NP O
. . O O

It PRP B-NP O
is VBZ B-VP O
in IN B-PP O
complete JJ B-NP O
linkage NN I-NP O
disequilibrium NN I-NP O
with IN B-PP O
an DT B-NP O
Alu NN I-NP O
element NN I-NP O
polymorphism NN I-NP O
within IN B-PP O
the DT B-NP O
DM NN I-NP B-Disease
kinase NN I-NP O
gene NN I-NP O
, , O O
suggesting VBG B-VP O
that IN B-SBAR O
DM NN B-NP B-Disease
is VBZ B-VP O
a DT B-NP O
consequence NN I-NP O
of IN B-PP O
one CD B-NP O
or CC I-NP O
few JJ I-NP O
ancestral JJ I-NP O
mutations NNS I-NP O
. . O O

A DT B-NP O
recent JJ I-NP O
analysis NN I-NP O
utilizing VBG B-VP O
this DT B-NP O
polymorphism NN I-NP O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
a DT B-NP O
flanking NN I-NP O
dinucleotide NN I-NP O
marker NN I-NP O
, , O O
suggested VBD B-VP O
that IN B-SBAR O
similar JJ B-ADJP O
to TO B-VP O
Fragile VB I-VP B-Disease
X NN B-NP I-Disease
syndrome NN I-NP I-Disease
, , O O
DM NN B-NP B-Disease
exhibited VBD B-VP O
a DT B-NP O
founder NN I-NP O
effect NN I-NP O
( ( O O
Imbert NNP B-NP O
et FW I-NP O
al FW I-NP O
. FW I-NP O

, , O O
1993 CD B-NP O
Nature NNP I-NP O
Genet NNP I-NP O
. . I-NP O

4 CD I-NP O
, , I-NP O
72 CD I-NP O
- HYPH I-NP O
76 CD I-NP O
) ) O O
. . O O

In IN B-PP O
contrast NN B-NP O
, , O O
the DT B-NP O
low JJ I-NP O
reproductive JJ I-NP O
fitness NN I-NP O
of IN B-PP O
individuals NNS B-NP O
with IN B-PP O
congenital JJ B-NP O
DM NN I-NP B-Disease
( ( O O
the DT B-NP O
endpoint NN I-NP O
of IN B-PP O
genetic JJ B-NP O
anticipation NN I-NP O
in IN B-PP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
) ) O O
suggests VBZ B-VP O
a DT B-NP O
higher JJR I-NP O
rate NN I-NP O
of IN B-PP O
new JJ B-NP O
mutations NNS I-NP O
. . O O

We PRP B-NP O
present VBP B-VP O
a DT B-NP O
high JJ I-NP O
resolution NN I-NP O
genetic JJ I-NP O
analysis NN I-NP O
of IN B-PP O
the DT B-NP O
DM NN I-NP B-Disease
locus NN I-NP O
using VBG B-VP O
PCR NN B-NP O
based JJ I-NP O
assays NNS I-NP O
of IN B-PP O
nine CD B-NP O
polymorphisms NNS I-NP O
, , O O
spanning VBG B-VP O
a DT B-NP O
physical JJ I-NP O
distance NN I-NP O
of IN B-PP O
30 CD B-NP O
kb NN I-NP O
, , O O
within IN B-PP O
and CC O O
immediately RB B-VP O
flanking VBG I-VP O
the DT B-NP O
DM NN I-NP B-Disease
kinase NN I-NP O
gene NN I-NP O
. . O O

The DT B-NP O
persistent JJ I-NP O
complete JJ I-NP O
allelic JJ I-NP O
association NN I-NP O
of IN B-PP O
the DT B-NP O
DM NN I-NP B-Disease
mutation NN I-NP O
with IN B-PP O
all PDT B-NP O
these DT I-NP O
polymorphisms NNS I-NP O
provides VBZ B-VP O
further JJ B-NP O
support NN I-NP O
to TO B-PP O
previous JJ B-NP O
observations NNS I-NP O
and CC O O
suggests VBZ B-VP O
more RBR B-ADVP O
strongly RB I-ADVP O
that IN B-SBAR O
the DT B-NP O
DM NN I-NP B-Disease
mutation NN I-NP O
occurred VBD B-VP O
on IN B-PP O
the DT B-NP O
background NN I-NP O
of IN B-PP O
a DT B-NP O
particular JJ I-NP O
haplotype NN I-NP O
in IN B-PP O
which WDT B-NP O
the DT B-NP O
( ( I-NP O
CTG NN I-NP O
) ) I-NP O
n NN I-NP O
repeat NN I-NP O
became VBD B-VP O
inherently RB B-ADJP O
unstable JJ I-ADJP O
and CC O O
therefore RB B-ADVP O
predisposed VBN B-VP O
to TO B-PP O
amplification NN B-NP O
. . O O

Genetic JJ B-NP O
instability NN I-NP O
in IN B-PP O
human JJ B-NP O
ovarian JJ I-NP B-Disease
cancer NN I-NP I-Disease
cell NN I-NP O
lines NNS I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
analyzed VBN I-VP O
the DT B-NP O
stability NN I-NP O
of IN B-PP O
microsatellites NNS B-NP O
in IN B-PP O
cell NN B-NP O
lines NNS I-NP O
derived VBN B-VP O
from IN B-PP O
human JJ B-NP O
ovarian JJ I-NP B-Disease
cancers NNS I-NP I-Disease
and CC O O
found VBD B-VP O
that IN B-SBAR O
5 CD B-NP O
out IN I-NP O
of IN I-NP O
10 CD I-NP O
of IN B-PP O
the DT B-NP O
ovarian JJ I-NP B-Disease
tumor NN I-NP I-Disease
cell NN I-NP O
lines NNS I-NP O
are VBP B-VP O
genetically RB B-ADJP O
unstable JJ I-ADJP O
at IN B-PP O
the DT B-NP O
majority NN I-NP O
of IN B-PP O
the DT B-NP O
loci NNS I-NP O
analyzed VBN B-VP O
. . O O

In IN B-PP O
clones NNS B-NP O
and CC I-NP O
subclones NNS I-NP O
derived VBN B-VP O
serially RB B-ADVP O
from IN B-PP O
one CD B-NP O
of IN B-PP O
these DT B-NP O
cell NN I-NP O
lines NNS I-NP O
( ( O O
2774 CD B-NP O
; : O O
serous JJ B-NP B-Disease
cystadenocarcinoma NN I-NP I-Disease
) ) O O
, , O O
a DT B-NP O
very RB I-NP O
high JJ I-NP O
proportion NN I-NP O
of IN B-PP O
microsatellites NNS B-NP O
distributed VBN B-VP O
in IN B-PP O
many JJ B-NP O
different JJ I-NP O
regions NNS I-NP O
of IN B-PP O
the DT B-NP O
genome NN I-NP O
change VB B-VP O
their PRP$ B-NP O
size NN I-NP O
in IN B-PP O
a DT B-NP O
mercurial JJ I-NP O
fashion NN I-NP O
. . O O

We PRP B-NP O
conclude VBP B-VP O
that IN B-SBAR O
genomic JJ B-NP O
instability NN I-NP O
in IN B-PP O
ovarian JJ B-NP B-Disease
tumors NNS I-NP I-Disease
is VBZ B-VP O
a DT B-NP O
dynamic JJ I-NP O
and CC I-NP O
ongoing JJ I-NP O
process NN I-NP O
whose WP$ B-NP O
high JJ I-NP O
frequency NN I-NP O
may MD B-VP O
have VB I-VP O
been VBN I-VP O
previously RB I-VP O
underestimated VBN I-VP O
by IN B-PP O
PCR NN B-NP O
- HYPH O O
based VBN B-NP O
allelotyping NN I-NP O
of IN B-PP O
bulk NN B-NP O
tumor NN I-NP B-Disease
tissue NN I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
identified VBN I-VP O
the DT B-NP O
source NN I-NP O
of IN B-PP O
the DT B-NP O
genetic JJ I-NP O
instability NN I-NP O
in IN B-PP O
one CD B-NP O
ovarian JJ I-NP B-Disease
tumor NN I-NP I-Disease
as IN B-PP O
a DT B-NP O
point NN I-NP O
mutation NN I-NP O
( ( O O
R524P NN B-NP O
) ) O O
in IN B-PP O
the DT B-NP O
human JJ I-NP O
mismatch NN I-NP O
- HYPH I-NP O
repair NN I-NP O
gene NN I-NP O
MSH2 NN I-NP O
( ( O O
Salmonella NN B-NP O
MutS NN I-NP O
homologue NN I-NP O
) ) O O
, , O O
which WDT B-NP O
has VBZ B-VP O
recently RB I-VP O
been VBN I-VP O
shown VBN I-VP O
to TO I-VP O
be VB I-VP O
involved VBN I-VP O
in IN B-PP O
hereditary JJ B-NP B-Disease
nonpolyposis NN I-NP I-Disease
colorectal JJ I-NP I-Disease
cancer NN I-NP I-Disease
. . O O

Patient NN B-NP O
2774 CD I-NP O
was VBD B-VP O
a DT B-NP O
38 CD I-NP O
- HYPH I-NP O
year NN I-NP O
- HYPH O O
old JJ B-NP O
heterozygote NN I-NP O
, , O O
and CC O O
her PRP$ B-NP O
normal JJ I-NP O
tissue NN I-NP O
carried VBD B-VP O
both CC O O
mutant JJ B-NP O
and CC I-NP O
wild JJ I-NP O
- HYPH I-NP O
type NN I-NP O
alleles NNS I-NP O
of IN B-PP O
the DT B-NP O
human JJ I-NP O
MSH2 NN I-NP O
gene NN I-NP O
. . O O

However RB B-ADVP O
the DT B-NP O
wild JJ I-NP O
- HYPH I-NP O
type NN I-NP O
allele NN I-NP O
was VBD B-VP O
lost VBN I-VP O
at IN B-PP O
some DT B-NP O
point NN I-NP O
early RB B-ADVP O
during IN B-PP O
tumorigenesis NN B-NP O
so IN B-SBAR O
that IN I-SBAR O
DNA NN B-NP O
isolated VBN B-VP O
either CC O O
from IN B-PP O
the DT B-NP O
patients NNS I-NP O
ovarian JJ B-NP B-Disease
tumor NN I-NP I-Disease
or CC B-PP O
from IN B-PP O
the DT B-NP O
2774 CD I-NP O
cell NN I-NP O
line NN I-NP O
carries VBZ B-VP O
only RB B-NP O
the DT I-NP O
mutant JJ I-NP O
allele NN I-NP O
of IN B-PP O
the DT B-NP O
human JJ I-NP O
MSH2 NN I-NP O
gene NN I-NP O
. . O O

The DT B-NP O
genetic JJ I-NP O
instability NN I-NP O
observed VBN B-VP O
in IN B-PP O
the DT B-NP O
tumor NN I-NP B-Disease
and CC I-NP O
cell NN I-NP O
line NN I-NP O
DNA NN I-NP O
, , O O
together RB B-ADVP O
with IN B-PP O
the DT B-NP O
germ NN I-NP O
- HYPH I-NP O
line NN I-NP O
mutation NN I-NP O
in IN B-PP O
a DT B-NP O
mismatch NN I-NP O
- HYPH I-NP O
repair NN I-NP O
gene NN I-NP O
, , O O
suggest VBP B-VP O
that IN B-SBAR O
the DT B-NP O
MSH2 NN I-NP O
gene NN I-NP O
is VBZ B-VP O
involved VBN I-VP O
in IN B-PP O
the DT B-NP O
onset NN I-NP O
and CC O O
/ SYM B-NP O
or CC O O
progression NN B-NP O
in IN B-PP O
a DT B-NP O
subset NN I-NP O
of IN B-PP O
ovarian JJ B-NP B-Disease
cancer NN I-NP I-Disease
. . O O

. . O O

BRCA1 NN B-NP O
mutations NNS I-NP O
in IN B-PP O
primary JJ B-NP O
breast NN I-NP B-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
carcinomas NNS I-NP I-Disease
. . O O

Loss NN B-NP O
of IN B-PP O
heterozygosity NN B-NP O
data NNS I-NP O
from IN B-PP O
familial JJ B-NP B-Disease
tumors NNS I-NP I-Disease
suggest VBP B-VP O
that IN B-SBAR O
BRCA1 NN B-NP O
, , O O
a DT B-NP O
gene NN I-NP O
that WDT B-NP O
confers VBZ B-VP O
susceptibility NN B-NP O
to TO B-PP O
ovarian JJ B-NP B-Disease
and CC I-NP I-Disease
early JJ I-NP I-Disease
- HYPH I-NP I-Disease
onset NN I-NP I-Disease
breast NN I-NP B-Disease
cancer NN I-NP I-Disease
, , O O
encodes VBZ B-VP O
a DT B-NP O
tumor NN I-NP B-Disease
suppressor NN I-NP O
. . O O

The DT B-NP O
BRCA1 NN I-NP O
region NN I-NP O
is VBZ B-VP O
also RB B-ADVP O
subject JJ B-ADJP O
to TO B-PP O
allelic JJ B-NP O
loss NN I-NP O
in IN B-PP O
sporadic JJ B-NP B-Disease
breast NN I-NP I-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancers NNS I-NP I-Disease
, , O O
an DT B-NP O
indication NN I-NP O
that IN B-SBAR O
BRCA1 NN B-NP O
mutations NNS I-NP O
may MD B-VP O
occur VB I-VP O
somatically RB B-ADVP O
in IN B-PP O
these DT B-NP O
tumors NNS I-NP B-Disease
. . O O

The DT B-NP O
BRCA1 NN I-NP O
coding NN I-NP O
region NN I-NP O
was VBD B-VP O
examined VBN I-VP O
for IN B-PP O
mutations NNS B-NP O
in IN B-PP O
primary JJ B-NP O
breast NN I-NP B-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
tumors NNS I-NP I-Disease
that WDT B-NP O
show VBP B-VP O
allele NN B-NP O
loss NN I-NP O
at IN B-PP O
the DT B-NP O
BRCA1 NN I-NP O
locus NN I-NP O
. . O O

Mutations NNS B-NP O
were VBD B-VP O
detected VBN I-VP O
in IN B-PP O
3 CD B-NP O
of IN B-PP O
32 CD B-NP O
breast NN I-NP O
and CC O O
1 CD B-NP O
of IN B-PP O
12 CD B-NP O
ovarian JJ I-NP B-Disease
carcinomas NNS I-NP I-Disease
; : O O
all DT B-NP O
four CD I-NP O
mutations NNS I-NP O
were VBD B-VP O
germline NN B-NP O
alterations NNS I-NP O
and CC O O
occurred VBD B-VP O
in IN B-PP O
early JJ B-NP O
- HYPH I-NP O
onset NN I-NP O
cancers NNS I-NP B-Disease
. . O O

These DT B-NP O
results NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
mutation NN B-NP O
of IN B-PP O
BRCA1 NN B-NP O
may MD B-VP O
not RB I-VP O
be VB I-VP O
critical JJ B-ADJP O
in IN B-PP O
the DT B-NP O
development NN I-NP O
of IN B-PP O
the DT B-NP O
majority NN I-NP O
of IN B-PP O
breast NN B-NP B-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancers NNS I-NP I-Disease
that WDT B-NP O
arise VBP B-VP O
in IN B-PP O
the DT B-NP O
absence NN I-NP O
of IN B-PP O
a DT B-NP O
mutant JJ I-NP O
germline NN I-NP O
allele NN I-NP O
. . O O

. . O O

PAX6 NN B-NP O
gene NN I-NP O
dosage NN I-NP O
effect NN I-NP O
in IN B-PP O
a DT B-NP O
family NN I-NP O
with IN B-PP O
congenital JJ B-NP B-Disease
cataracts NNS I-NP I-Disease
, , O O
aniridia NN B-NP B-Disease
, , O O
anophthalmia NN B-NP B-Disease
and CC O O
central JJ B-NP B-Disease
nervous JJ I-NP I-Disease
system NN I-NP I-Disease
defects NNS I-NP I-Disease
. . O O

The DT B-NP O
human JJ I-NP O
eye NN I-NP O
malformation NN I-NP O
aniridia NN I-NP B-Disease
results VBZ B-VP O
from IN B-PP O
haploinsufficiency NN B-NP B-Disease
of IN B-PP I-Disease
PAX6 NN B-NP I-Disease
, , O O
a DT B-NP O
paired JJ I-NP O
box NN I-NP O
DNA NN I-NP O
- HYPH O O
binding VBG B-NP O
protein NN I-NP O
. . O O

To TO B-VP O
study VB I-VP O
this DT B-NP O
dosage NN I-NP O
effect NN I-NP O
, , O O
we PRP B-NP O
characterized VBD B-VP O
two CD B-NP O
PAX6 NN I-NP O
mutations NNS I-NP O
in IN B-PP O
a DT B-NP O
family NN I-NP O
segregating VBG B-VP O
aniridia NN B-NP B-Disease
and CC O O
a DT B-NP O
milder JJR I-NP O
syndrome NN I-NP O
consisting VBG B-VP O
of IN B-PP O
congenital JJ B-NP B-Disease
cataracts NNS I-NP I-Disease
and CC O O
late JJ B-NP O
onset NN I-NP O
corneal NN I-NP B-Disease
dystrophy NN I-NP I-Disease
. . O O

The DT B-NP O
nonsense JJ I-NP O
mutations NNS I-NP O
, , O O
at IN B-PP O
codons NNS B-NP O
103 CD I-NP O
and CC I-NP O
353 CD I-NP O
, , O O
truncate NN B-NP O
PAX6 NN I-NP O
within IN B-PP O
the DT B-NP O
N NN I-NP O
- HYPH B-NP O
terminal JJ I-NP O
paired VBN I-NP O
and CC I-NP O
C NN I-NP O
- HYPH B-NP O
terminal JJ I-NP O
PST NN I-NP O
domains NNS I-NP O
, , O O
respectively RB B-ADVP O
. . O O

The DT B-NP O
wild JJ I-NP O
- HYPH I-NP O
type NN I-NP O
PST NN I-NP O
domain NN I-NP O
activates VBZ B-VP O
transcription NN B-NP O
autonomously RB B-ADVP O
and CC O O
the DT B-NP O
mutant JJ I-NP O
form NN I-NP O
has VBZ B-VP O
partial JJ B-NP O
activity NN I-NP O
. . O O

A DT B-NP O
compound NN I-NP O
heterozygote NN I-NP O
had VBD B-VP O
severe JJ B-NP O
craniofacial JJ I-NP B-Disease
and CC I-NP I-Disease
central JJ I-NP I-Disease
nervous JJ I-NP I-Disease
system NN I-NP I-Disease
defects NNS I-NP I-Disease
and CC O O
no DT B-NP B-Disease
eyes NNS I-NP I-Disease
. . O O

The DT B-NP O
pattern NN I-NP O
of IN B-PP O
malformations NNS B-NP O
is VBZ B-VP O
similar JJ B-ADJP O
to TO B-PP O
that DT B-NP O
in IN B-PP O
homozygous JJ B-NP O
Sey NNP I-NP O
mice NNS I-NP O
and CC O O
suggests VBZ B-VP O
a DT B-NP O
critical JJ I-NP O
role NN I-NP O
for IN B-PP O
PAX6 NN B-NP O
in IN B-PP O
controlling VBG B-VP O
the DT B-NP O
migration NN I-NP O
and CC I-NP O
differentiation NN I-NP O
of IN B-PP O
specific JJ B-NP O
neuronal JJ I-NP O
progenitor NN I-NP O
cells NNS I-NP O
in IN B-PP O
the DT B-NP O
brain NN I-NP O
. . O O

. . O O

A DT B-NP O
physical JJ I-NP O
map NN I-NP O
and CC I-NP O
candidate NN I-NP O
genes NNS I-NP O
in IN B-PP O
the DT B-NP O
BRCA1 NN I-NP O
region NN I-NP O
on IN B-PP O
chromosome NN B-NP O
17q12 CD I-NP O
- HYPH I-NP O
21 CD I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
constructed VBN I-VP O
a DT B-NP O
physical JJ I-NP O
map NN I-NP O
of IN B-PP O
a DT B-NP O
4 CD I-NP O
cM NN I-NP O
region NN I-NP O
on IN B-PP O
chromosome NN B-NP O
17q12 CD I-NP O
- HYPH I-NP O
21 CD I-NP O
that WDT B-NP O
contains VBZ B-VP O
the DT B-NP O
hereditary JJ I-NP B-Disease
breast NN I-NP I-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
gene NN I-NP O
BRCA1 NN I-NP O
. . O O

The DT B-NP O
map NN I-NP O
comprises VBZ B-VP O
a DT B-NP O
contig NN I-NP O
of IN B-PP O
137 CD B-NP O
overlapping VBG I-NP O
yeast NN I-NP O
artificial JJ I-NP O
chromosomes NNS I-NP O
and CC O O
P1 NN B-NP O
clones NNS I-NP O
, , O O
onto IN B-PP O
which WDT B-NP O
we PRP B-NP O
have VBP B-VP O
placed VBN I-VP O
112 CD B-NP O
PCR NN I-NP O
markers NNS I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
localized VBN I-VP O
more JJR B-NP O
than IN I-NP O
20 CD I-NP O
genes NNS I-NP O
on IN B-PP O
this DT B-NP O
map NN I-NP O
, , O O
ten CD B-NP O
of IN B-PP O
which WDT B-NP O
had VBD B-VP O
not RB I-VP O
been VBN I-VP O
mapped VBN I-VP O
to TO B-PP O
the DT B-NP O
region NN I-NP O
previously RB B-ADVP O
, , O O
and CC O O
have VBP B-VP O
isolated VBN I-VP O
30 CD B-NP O
cDNA NN I-NP O
clones NNS I-NP O
representing VBG B-VP O
partial JJ B-NP O
sequences NNS I-NP O
of IN B-PP O
as RB B-NP O
yet RB I-NP O
unidentified JJ I-NP O
genes NNS I-NP O
. . O O

Two CD B-NP O
genes NNS I-NP O
that WDT B-NP O
lie VBP B-VP O
within IN B-PP O
a DT B-NP O
narrow JJ I-NP O
region NN I-NP O
defined VBN B-VP O
by IN B-PP O
meiotic JJ B-NP O
breakpoints NNS I-NP O
in IN B-PP O
BRCA1 NN B-NP O
patients NNS I-NP O
have VBP B-VP O
been VBN I-VP O
sequenced VBN I-VP O
in IN B-PP O
breast NN B-NP B-Disease
cancer NN I-NP I-Disease
patients NNS I-NP O
without IN B-PP O
revealing VBG B-VP O
any DT B-NP O
deleterious JJ I-NP O
mutations NNS I-NP O
. . O O

These DT B-NP O
new JJ I-NP O
reagents NNS I-NP O
should MD B-VP O
facilitate VB I-VP O
the DT B-NP O
identification NN I-NP O
of IN B-PP O
BRCA1 NN B-NP O
. . O O

. . O O

The DT B-NP O
LEC NNP I-NP O
rat NN I-NP O
has VBZ B-VP O
a DT B-NP O
deletion NN I-NP O
in IN B-PP O
the DT B-NP O
copper NN I-NP O
transporting VBG B-VP O
ATPase NN B-NP O
gene NN I-NP O
homologous JJ B-ADJP O
to TO B-PP O
the DT B-NP O
Wilson NNP I-NP B-Disease
disease NN I-NP I-Disease
gene NN I-NP O
. . O O

The DT B-NP O
Long NNP I-NP O
- HYPH I-NP O
Evans NNP I-NP O
Cinnamon NNP I-NP O
( ( O O
LEC NNP O O
) ) O O
rat NN B-NP O
shows VBZ B-VP O
similarity NN B-NP O
to TO B-PP O
Wilson NNP B-NP B-Disease
disease NN I-NP I-Disease
in IN B-PP O
many JJ B-NP O
clinical JJ I-NP O
and CC I-NP O
biochemical JJ I-NP O
features NNS I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
cloned VBN I-VP O
cDNAs NNS B-NP O
for IN B-PP O
the DT B-NP O
rat NN I-NP O
gene NN I-NP O
( ( O O
Atp7b NN B-NP O
) ) O O
homologous JJ B-ADJP O
to TO B-PP O
the DT B-NP O
human JJ I-NP O
Wilson NNP I-NP B-Disease
disease NN I-NP I-Disease
gene NN I-NP O
( ( O O
ATP7B NN B-NP O
) ) O O
and CC O O
have VBP B-VP O
used VBN I-VP O
them PRP B-NP O
to TO B-VP O
identify VB I-VP O
a DT B-NP O
partial JJ I-NP O
deletion NN I-NP O
in IN B-PP O
the DT B-NP O
Atp7b NN I-NP O
gene NN I-NP O
in IN B-PP O
the DT B-NP O
LEC NNP I-NP O
rat NN I-NP O
. . O O

The DT B-NP O
deletion NN I-NP O
removes VBZ B-VP O
at IN B-NP O
least JJS I-NP O
900 CD I-NP O
bp NN I-NP O
of IN B-PP O
the DT B-NP O
coding VBG I-NP O
region NN I-NP O
at IN B-PP O
the DT B-NP O
3 CD I-NP O
end NN I-NP O
, , O O
includes VBZ B-VP O
the DT B-NP O
crucial JJ I-NP O
ATP NN I-NP O
binding NN I-NP O
domain NN I-NP O
and CC O O
extends VBZ B-VP O
downstream RB B-ADVP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
. . O O

Our PRP$ B-NP O
results NNS I-NP O
provide VBP B-VP O
convincing VBG I-VP O
evidence NN B-NP O
for IN B-PP O
defining VBG B-VP O
the DT B-NP O
LEC NNP I-NP O
rat NN I-NP O
as IN B-PP O
an DT B-NP O
animal NN I-NP O
model NN I-NP O
for IN B-PP O
Wilson NNP B-NP B-Disease
disease NN I-NP I-Disease
. . O O

This DT B-NP O
model NN I-NP O
will MD B-VP O
be VB I-VP O
important JJ B-ADJP O
for IN B-PP O
studying VBG B-VP O
liver NN B-NP O
pathophysiology NN I-NP O
, , O O
for IN B-PP O
developing VBG B-VP O
therapy NN B-NP O
for IN B-PP O
Wilson NNP B-NP B-Disease
disease NN I-NP I-Disease
and CC B-PP O
for IN B-PP O
studying VBG B-VP O
the DT B-NP O
pathway NN I-NP O
of IN B-PP O
copper NN B-NP O
transport NN I-NP O
and CC O O
its PRP$ B-NP O
possible JJ I-NP O
interaction NN I-NP O
with IN B-PP O
other JJ B-NP O
heavy JJ I-NP O
metals NNS I-NP O
. . O O

. . O O

Genomic JJ B-NP O
organization NN I-NP O
of IN B-PP O
the DT B-NP O
adrenoleukodystrophy NN I-NP B-Disease
gene NN I-NP O
. . O O

Adrenoleukodystrophy NN B-NP B-Disease
( ( O O
ALD NN B-NP B-Disease
) ) O O
, , O O
the DT B-NP O
most RBS I-NP O
frequent JJ I-NP O
peroxisomal JJ I-NP B-Disease
disorder NN I-NP I-Disease
, , O O
is VBZ B-VP O
a DT B-NP O
severe JJ I-NP O
neurodegenerative JJ I-NP B-Disease
disease NN I-NP I-Disease
associated VBN B-VP O
with IN B-PP O
an DT B-NP O
impairment NN I-NP B-Disease
of IN B-PP I-Disease
very RB B-NP I-Disease
long JJ I-NP I-Disease
chain NN I-NP I-Disease
fatty JJ I-NP I-Disease
acids NNS I-NP I-Disease
beta SYM B-NP I-Disease
- HYPH B-NP I-Disease
oxidation NN I-NP I-Disease
. . O O

We PRP B-NP O
have VBP B-VP O
recently RB I-VP O
identified VBN I-VP O
by IN B-PP O
positional JJ B-NP O
cloning VBG B-VP O
the DT B-NP O
gene NN I-NP O
responsible JJ B-ADJP O
for IN B-PP O
ALD NN B-NP B-Disease
, , O O
located JJ B-ADJP O
in IN B-PP O
Xq28 NN B-NP O
. . O O

It PRP B-NP O
encodes VBZ B-VP O
a DT B-NP O
new JJ I-NP O
member NN I-NP O
of IN B-PP O
the DT B-NP O
ABC NNP I-NP O
superfamily NN I-NP O
of IN B-PP O
membrane NN B-NP O
- HYPH B-NP O
associated VBN I-NP O
transporters NNS I-NP O
that WDT B-NP O
shows VBZ B-VP O
, , O O
in IN B-PP O
particular JJ B-NP O
, , I-NP O
significant JJ I-NP O
homology NN I-NP O
to TO B-PP O
the DT B-NP O
70 CD I-NP O
- HYPH I-NP O
kDa NN I-NP O
peroxisomal JJ I-NP O
membrane NN I-NP O
protein NN I-NP O
( ( O O
PMP70 NN B-NP O
) ) O O
. . O O

We PRP B-NP O
report VBP B-VP O
here RB B-ADVP O
a DT B-NP O
detailed JJ I-NP O
characterization NN I-NP O
of IN B-PP O
the DT B-NP O
ALD NN I-NP B-Disease
gene NN I-NP O
structure NN I-NP O
. . O O

It PRP B-NP O
extends VBZ B-VP O
over IN B-NP O
21 CD I-NP O
kb NN I-NP O
and CC O O
consists VBZ B-VP O
of IN B-PP O
10 CD B-NP O
exons NNS I-NP O
. . O O

To TO B-VP O
facilitate VB I-VP O
the DT B-NP O
detection NN I-NP O
of IN B-PP O
mutations NNS B-NP O
in IN B-PP O
ALD NN B-NP B-Disease
patients NNS I-NP O
, , O O
we PRP B-NP O
have VBP B-VP O
determined VBN I-VP O
the DT B-NP O
intronic JJ I-NP O
sequences NNS I-NP O
flanking VBG B-VP O
the DT B-NP O
exons NNS I-NP O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
the DT B-NP O
sequence NN I-NP O
of IN B-PP O
the DT B-NP O
3 CD I-NP O
untranslated JJ I-NP O
region NN I-NP O
and CC B-PP O
of IN B-PP O
the DT B-NP O
immediate JJ I-NP O
5 CD I-NP O
promoter NN I-NP O
region NN I-NP O
. . O O

Sequences NNS B-NP O
present JJ B-ADJP O
in IN B-PP O
distal JJ B-NP O
exons NNS I-NP O
cross AFX O O
- HYPH O O
hybridize VB B-VP O
strongly RB B-ADVP O
to TO B-PP O
additional JJ B-NP O
sequences NNS I-NP O
in IN B-PP O
the DT B-NP O
human JJ I-NP O
genome NN I-NP O
. . O O

The DT B-NP O
ALD NN I-NP B-Disease
gene NN I-NP O
has VBZ B-VP O
been VBN I-VP O
positioned VBN I-VP O
on IN B-PP O
a DT B-NP O
pulsed JJ I-NP O
- HYPH I-NP O
field NN I-NP O
map NN I-NP O
between IN B-PP O
DXS15 NN B-NP O
and CC O O
the DT B-NP O
L1CAM NN I-NP O
gene NN I-NP O
, , O O
about RB B-NP O
650 CD I-NP O
kb NN I-NP O
upstream RB B-ADVP O
from IN B-PP O
the DT B-NP O
color NN I-NP O
pigment NN I-NP O
genes NNS I-NP O
. . O O

The DT B-NP O
frequent JJ I-NP O
occurrence NN I-NP O
of IN B-PP O
color NN B-NP O
vision NN I-NP O
anomalies NNS I-NP O
observed VBN B-VP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
adrenomyeloneuropathy NN B-NP B-Disease
( ( O O
the DT B-NP O
adult JJ I-NP O
onset NN I-NP O
form NN I-NP O
of IN B-PP O
ALD NN B-NP B-Disease
) ) O O
thus RB B-ADVP O
does VBZ B-VP O
not RB I-VP O
represent VB I-VP O
a DT B-NP O
contiguous JJ I-NP B-Disease
gene NN I-NP I-Disease
syndrome NN I-NP I-Disease
but CC O O
a DT B-NP O
secondary JJ I-NP O
manifestation NN I-NP O
of IN B-PP O
ALD NN B-NP B-Disease
. . O O

. . O O

The DT B-NP O
murine JJ I-NP O
homologues NNS I-NP O
of IN B-PP O
the DT B-NP O
Huntington NNP I-NP B-Disease
disease NN I-NP I-Disease
gene NN I-NP O
( ( O O
Hdh NN B-NP O
) ) O O
and CC O O
the DT B-NP O
alpha SYM I-NP O
- HYPH I-NP O
adducin NN I-NP O
gene NN I-NP O
( ( O O
Add1 NN B-NP O
) ) O O
map NN B-NP O
to TO B-PP O
mouse NN B-NP O
chromosome NN I-NP O
5 CD I-NP O
within IN B-PP O
a DT B-NP O
region NN I-NP O
of IN B-PP O
conserved VBN B-NP O
synteny NN I-NP O
with IN B-PP O
human JJ B-NP O
chromosome NN I-NP O
4p16 CD I-NP O
. . I-NP O

3 CD I-NP O
. . O O

Huntington NNP B-NP B-Disease
disease NN I-NP I-Disease
( ( O O
HD NN B-NP B-Disease
) ) O O
is VBZ B-VP O
a DT B-NP O
severe JJ I-NP O
autosomal JJ I-NP B-Disease
dominant JJ I-NP I-Disease
neurodegenerative JJ I-NP I-Disease
disorder NN I-NP I-Disease
associated VBN B-VP O
with IN B-PP O
a DT B-NP O
novel JJ I-NP O
gene NN I-NP O
( ( O O
IT15 NN B-NP O
) ) O O
. . O O

Recently RB B-ADVP O
, , O O
we PRP B-NP O
reported VBD B-VP O
the DT B-NP O
cloning NN I-NP O
of IN B-PP O
Hdh NN B-NP O
, , O O
the DT B-NP O
murine JJ I-NP O
homologue NN I-NP O
of IN B-PP O
IT15 NN B-NP O
. . O O

Here RB B-ADVP O
, , O O
using VBG B-VP O
an DT B-NP O
interspecific JJ I-NP O
backcross NN I-NP O
, , O O
we PRP B-NP O
have VBP B-VP O
mapped VBN I-VP O
both CC O O
Hdh NN B-NP O
and CC O O
the DT B-NP O
mouse NN I-NP O
homologue NN I-NP O
of IN B-PP O
human JJ O O
alpha SYM O O
- HYPH O O
adducin NN B-NP O
( ( O O
Add1 NN B-NP O
) ) O O
, , O O
a DT B-NP O
membrane NN I-NP O
- HYPH B-VP O
associated VBN B-NP O
cytoskeletal JJ I-NP O
protein NN I-NP O
gene NN I-NP O
. . O O

Both DT B-NP O
of IN B-PP O
these DT B-NP O
genes NNS I-NP O
map VBP B-VP O
in IN B-PP O
the DT B-NP O
same JJ I-NP O
position NN I-NP O
on IN B-PP O
mouse NN B-NP O
chromosome NN I-NP O
5 CD I-NP O
in IN B-PP O
a DT B-NP O
region NN I-NP O
associated VBN B-VP O
with IN B-PP O
ancestral JJ B-NP O
chromosomal JJ I-NP O
rearrangements NNS I-NP O
and CC O O
show VBP B-VP O
no DT B-NP O
recombination NN I-NP O
with IN B-PP O
D5H4S43 NN B-NP O
, , O O
D5H4S115 NN B-NP O
, , O O
and CC O O
D5H4S62 NN B-NP O
, , O O
the DT B-NP O
murine JJ I-NP O
homologues NNS I-NP O
of IN B-PP O
D4S43 NN B-NP O
, , O O
D4S115 NN B-NP O
, , O O
and CC O O
D4S62 NN B-NP O
, , O O
respectively RB B-ADVP O
. . O O

Further JJ B-NP O
mapping NN I-NP O
studies NNS I-NP O
of IN B-PP O
humans NNS B-NP O
, , O O
mice NNS B-NP O
, , O O
and CC O O
other JJ B-NP O
mammalian JJ I-NP O
species NNS I-NP O
should MD B-VP O
reveal VB I-VP O
the DT B-NP O
nature NN I-NP O
of IN B-PP O
the DT B-NP O
rearrangements NNS I-NP O
affecting VBG B-VP O
this DT B-NP O
chromosomal JJ I-NP O
segment NN I-NP O
during IN B-PP O
mammalian JJ B-NP O
evolution NN I-NP O
. . O O

. . O O

Genetic JJ B-NP O
cholesteryl NN I-NP B-Disease
ester NN I-NP I-Disease
transfer NN I-NP I-Disease
protein NN I-NP I-Disease
deficiency NN I-NP I-Disease
caused VBN B-VP O
by IN B-PP O
two CD B-NP O
prevalent JJ I-NP O
mutations NNS I-NP O
as IN B-PP O
a DT B-NP O
major JJ I-NP O
determinant NN I-NP O
of IN B-PP O
increased VBN B-NP O
levels NNS I-NP O
of IN B-PP O
high JJ B-NP O
density NN I-NP O
lipoprotein NN I-NP O
cholesterol NN I-NP O
. . O O

Genetic JJ B-NP O
determinants NNS I-NP O
of IN B-PP O
HDL NN B-NP O
cholesterol NN I-NP O
( ( O O
HDL NN B-NP O
- HYPH B-NP O
C NN I-NP O
) ) O O
levels NNS B-NP O
in IN B-PP O
the DT B-NP O
general JJ I-NP O
population NN I-NP O
are VBP B-VP O
poorly RB I-VP O
understood VBN I-VP O
. . O O

We PRP B-NP O
previously RB B-ADVP O
described VBD B-VP O
plasma NN B-NP O
cholesteryl NN I-NP B-Disease
ester NN I-NP I-Disease
transfer NN I-NP I-Disease
protein NN I-NP I-Disease
( ( O I-Disease
CETP NN B-NP I-Disease
) ) O I-Disease
deficiency NN B-NP I-Disease
due JJ B-ADJP O
to TO B-PP O
an DT B-NP O
intron NN I-NP O
14 CD I-NP O
G NN I-NP O
( ( O O
+ SYM B-NP O
1 CD I-NP O
) ) O O
- HYPH O O
to TO B-PP O
- HYPH B-NP O
A NN I-NP O
mutation NN I-NP O
( ( O O
Int14 NN B-NP O
A NN I-NP O
) ) O O
in IN B-PP O
several JJ B-NP O
families NNS I-NP O
with IN B-PP O
very RB B-NP O
high JJ I-NP O
HDL NN I-NP O
- HYPH B-NP O
C NN I-NP O
levels NNS I-NP O
in IN B-PP O
Japan NNP B-NP O
. . O O

Subjects NNS B-NP O
with IN B-PP O
HDL NN B-NP O
- HYPH I-NP O
C NN I-NP O
> SYM B-VP O
or CC O O
= SYM B-VP O
100 CD B-NP O
mg NN I-NP O
/ SYM B-NP O
dl NN B-NP O
( ( O O
n NN B-NP O
= SYM B-VP O
130 CD B-NP O
) ) O O
were VBD B-VP O
screened VBN I-VP O
by IN B-PP O
PCR NN B-NP O
single JJ I-NP O
strand NN I-NP O
conformational JJ I-NP O
polymorphism NN I-NP O
analysis NN I-NP O
of IN B-PP O
the DT B-NP O
CETP NN I-NP O
gene NN I-NP O
. . O O

Two CD B-NP O
other JJ I-NP O
mutations NNS I-NP O
were VBD B-VP O
identified VBN I-VP O
by IN B-PP O
DNA NN B-NP O
sequencing NN I-NP O
or CC I-NP O
primer NN I-NP O
- HYPH O O
mediated VBN B-NP O
restriction NN I-NP O
map NN I-NP O
modification NN I-NP O
of IN B-PP O
PCR NN B-NP O
products NNS I-NP O
a DT B-NP O
novel JJ I-NP O
intron NN I-NP O
14 CD I-NP O
splice NN I-NP O
donor NN I-NP O
site NN I-NP O
mutation NN I-NP O
caused VBN B-VP O
by IN B-PP O
a DT B-NP O
T NN I-NP O
insertion NN I-NP O
at IN B-PP O
position NN B-NP O
+ SYM B-NP O
3 CD I-NP O
from IN B-PP O
the DT B-NP O
exon14 NN I-NP O
/ SYM B-VP O
intron14 NN B-NP O
boundary NN I-NP O
( ( O O
Int14 NN B-NP O
T NN I-NP O
) ) O O
and CC O O
a DT B-NP O
missense JJ I-NP O
mutation NN I-NP O
( ( O O
Asp442 NN B-NP O
to TO B-PP O
Gly NN B-NP O
) ) O O
within IN B-PP O
exon NN B-NP O
15 CD I-NP O
( ( O O
D442G NN B-NP O
) ) O O
. . O O

The DT B-NP O
Int14 NN I-NP O
T NN I-NP O
mutation NN I-NP O
was VBD B-VP O
only RB I-VP O
found VBN I-VP O
in IN B-PP O
one CD B-NP O
family NN I-NP O
. . O O

However RB B-ADVP O
, , O O
the DT B-NP O
D442G NN I-NP O
and CC I-NP O
Int14 NN I-NP O
A NN I-NP O
mutations NNS I-NP O
were VBD B-VP O
highly RB B-ADJP O
prevalent JJ I-ADJP O
in IN B-PP O
subjects NNS B-NP O
with IN B-PP O
HDL NN B-NP O
- HYPH I-NP O
C NN I-NP O
> SYM B-VP O
or CC O O
= SYM B-VP O
60 CD B-NP O
mg NN I-NP O
/ SYM B-NP O
dl NN I-NP O
, , O O
with IN B-PP O
combined VBN B-NP O
allele NN I-NP O
frequencies NNS I-NP O
of IN B-PP O
9 CD B-NP O
% NN I-NP O
, , O O
12 CD B-NP O
% NN I-NP O
, , O O
21 CD B-NP O
% NN I-NP O
and CC O O
43 CD B-NP O
% NN I-NP O
for IN B-PP O
HDL NN B-NP O
- HYPH O O
C NN B-NP O
60 CD I-NP O
- HYPH I-NP O
79 CD I-NP O
, , I-NP O
80 CD I-NP O
- HYPH I-NP O
99 CD I-NP O
, , I-NP O
100 CD I-NP O
- HYPH I-NP O
119 CD I-NP O
, , O O
and CC O O
> SYM B-NP O
or CC O O
= SYM B-VP O
120 CD B-NP O
mg NN I-NP O
/ SYM O O
dl NN B-NP O
, , O O
respectively RB B-ADVP O
. . O O

Furthermore RB B-ADVP O
, , O O
prevalences NNS B-NP O
of IN B-PP O
the DT B-NP O
D442G NN I-NP O
and CC I-NP O
Int14 NN I-NP O
A NN I-NP O
mutations NNS I-NP O
were VBD B-VP O
extremely RB B-ADJP O
high JJ I-ADJP O
in IN B-PP O
a DT B-NP O
general JJ I-NP O
sample NN I-NP O
of IN B-PP O
Japanese JJ B-NP O
men NNS I-NP O
( ( O O
n NN B-NP O
= SYM B-VP O
236 CD B-NP O
) ) O O
, , O O
with IN B-PP O
heterozygote JJ B-NP O
frequencies NNS I-NP O
of IN B-PP O
7 CD B-NP O
% NN I-NP O
and CC O O
2 CD B-NP O
% NN I-NP O
, , O O
respectively RB B-ADVP O
. . O O

These DT B-NP O
two CD I-NP O
mutations NNS I-NP O
accounted VBD B-VP O
for IN B-PP O
about IN B-NP O
10 CD I-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
total JJ I-NP O
variance NN I-NP O
of IN B-PP O
HDL NN B-NP O
- HYPH I-NP O
C NN I-NP O
in IN B-PP O
this DT B-NP O
population NN I-NP O
. . O O

The DT B-NP O
phenotype NN I-NP O
in IN B-PP O
a DT B-NP O
genetic JJ I-NP O
compound NN I-NP O
heterozygote NN I-NP O
( ( O O
Int14 NN B-NP O
T NN I-NP O
and CC I-NP O
Int14 NN I-NP O
A NN I-NP O
) ) O O
was VBD B-VP O
similar JJ B-ADJP O
to TO B-PP O
that DT B-NP O
of IN B-PP O
Int14 NN B-NP O
A NN I-NP O
homozygotes NNS I-NP O
( ( O O
no DT B-NP O
detectable JJ I-NP O
CETP NN I-NP O
and CC O O
markedly RB B-VP O
increased VBD I-VP O
HDL NN B-NP O
- HYPH B-NP O
C NN I-NP O
) ) O O
, , O O
indicating VBG B-VP O
that IN B-SBAR O
the DT B-NP O
Int14 NN I-NP O
T NN I-NP O
produces VBZ B-VP O
a DT B-NP O
allele NN I-NP O
. . O O

In IN B-PP O
four CD B-NP O
D442G NN I-NP O
homozygotes NNS I-NP O
, , O O
mean JJ B-NP O
HDL NN I-NP O
- HYPH B-NP O
C NN I-NP O
levels NNS I-NP O
( ( O O
86 CD B-NP O
+ SYM O O
/ SYM O O
- SYM O O
26 CD B-NP O
mg NN I-NP O
/ SYM B-NP O
dl NN I-NP O
) ) O O
were VBD B-VP O
lower JJR B-ADJP O
than IN B-PP O
in IN B-PP O
Int14 NN B-NP O
A NN I-NP O
homozygotes NNS I-NP O
( ( O O
158 CD B-NP O
+ SYM O O
/ SYM O O
- SYM O O
35 CD B-NP O
mg NN I-NP O
/ SYM B-NP O
dl NN I-NP O
) ) O O
, , O O
reflecting VBG B-VP O
residual JJ B-NP O
CETP NN I-NP O
activity NN I-NP O
in IN B-PP O
plasma NN B-NP O
. . O O

In IN B-PP O
47 CD B-NP O
D442G NN I-NP O
heterozygotes NNS I-NP O
, , O O
mean JJ B-NP O
HDL NN I-NP O
- HYPH B-NP O
C NN I-NP O
levels NNS I-NP O
were VBD B-VP O
91 CD B-NP O
+ SYM O O
/ SYM O O
- SYM O O
23 CD B-NP O
mg NN I-NP O
/ SYM B-NP O
dl NN I-NP O
, , O O
similar JJ B-ADJP O
to TO B-PP O
the DT B-NP O
level NN I-NP O
in IN B-PP O
D442G NN B-NP O
homozygotes NNS I-NP O
, , O O
and CC O O
significantly RB B-ADJP O
greater JJR I-ADJP O
than IN B-PP O
mean JJ B-NP O
HDL NN I-NP O
- HYPH B-NP O
C NN I-NP O
levels NNS I-NP O
in IN B-PP O
Int14 NN B-NP O
A NN I-NP O
heterozygotes NNS I-NP O
( ( O O
69 CD B-NP O
+ SYM O O
/ SYM O O
- SYM O O
15 CD B-NP O
mg NN I-NP O
/ SYM B-NP O
dl NN I-NP O
) ) O O
. . O O

Thus RB B-ADVP O
, , O O
the DT B-NP O
D442G NN I-NP O
mutation NN I-NP O
acts VBZ B-VP O
differently RB B-ADVP O
to TO B-PP O
the DT B-NP O
mutations NNS I-NP O
with IN B-PP O
weaker JJR B-NP O
effects NNS I-NP O
on IN B-PP O
HDL NN B-NP O
in IN B-PP O
the DT B-NP O
homozygous JJ I-NP O
state NN I-NP O
and CC O O
stronger JJR B-NP O
effects NNS I-NP O
in IN B-PP O
the DT B-NP O
heterozygotes NNS I-NP O
, , O O
suggesting VBG B-VP O
dominant JJ B-NP O
expression NN I-NP O
of IN B-PP O
a DT B-NP O
partially RB I-NP O
defective JJ I-NP O
allele NN I-NP O
. . O O

CETP NN B-NP B-Disease
deficiency NN I-NP I-Disease
, , O O
reflecting VBG B-VP O
two CD B-NP O
prevalent JJ I-NP O
mutations NNS I-NP O
( ( O O
D442G NN B-NP O
and CC O O
Int14 NN B-NP O
A NN I-NP O
) ) O O
, , O O
is VBZ B-VP O
the DT B-NP O
first JJ I-NP O
example NN I-NP O
of IN B-PP O
a DT B-NP O
genetic JJ I-NP B-Disease
deficiency NN I-NP I-Disease
state NN I-NP O
which WDT B-NP O
is VBZ B-VP O
sufficiently RB B-ADJP O
common JJ I-ADJP O
to TO B-VP O
explain VB I-VP O
a DT B-NP O
significant JJ I-NP O
fraction NN I-NP O
of IN B-PP O
the DT B-NP O
variation NN I-NP O
in IN B-PP O
HDL NN B-NP O
- HYPH B-NP O
C NN I-NP O
in IN B-PP O
the DT B-NP O
general JJ I-NP O
population NN I-NP O
. . O O

. . O O

Treatment NN B-NP O
of IN B-PP O
cerebrotendinous JJ B-NP B-Disease
xanthomatosis NN I-NP I-Disease
: : O O
effects NNS B-NP O
of IN B-PP O
chenodeoxycholic JJ B-NP O
acid NN I-NP O
, , O O
pravastatin NN B-NP O
, , O O
and CC O O
combined VBN B-NP O
use NN I-NP O
. . O O

Treatments NNS B-NP O
by IN B-PP O
oral JJ B-NP O
administration NN I-NP O
of IN B-PP O
chenodeoxycholic JJ B-NP O
acid NN I-NP O
( ( O O
CDCA NN B-NP O
) ) O O
alone RB B-ADVP O
, , O O
3 CD B-NP O
- HYPH I-NP O
hydroxy NN I-NP O
- HYPH B-NP O
3 CD I-NP O
- HYPH I-NP O
methylglutaryl NN I-NP O
( ( O O
HMG NN B-NP O
) ) O O
CoA NN B-NP O
reductase NN I-NP O
inhibitor NN I-NP O
( ( O O
pravastatin NN B-NP O
) ) O O
alone RB B-ADVP O
, , O O
and CC O O
combination NN B-NP O
of IN B-PP O
the DT B-NP O
two CD I-NP O
drugs NNS I-NP O
were VBD B-VP O
attempted VBN I-VP O
for IN B-PP O
7 CD B-NP O
patients NNS I-NP O
with IN B-PP O
cerebrotendinous JJ B-NP B-Disease
xanthomatosis NN I-NP I-Disease
( ( O O
CTX NN B-NP B-Disease
) ) O O
. . O O

CDCA NN B-NP O
treatment NN I-NP O
at IN B-PP O
a DT B-NP O
dose NN I-NP O
of IN B-PP O
300 CD B-NP O
mg NN I-NP O
/ SYM B-NP O
day NN I-NP O
reduced VBD B-VP O
serum NN B-NP O
cholestanol NN I-NP O
( ( O O
67 CD B-NP O
. . O O

3 CD B-NP O
% NN I-NP O
reduction NN I-NP O
) ) O O
, , O O
lathosterol NN B-NP O
( ( O O
50 CD B-NP O
. . O O

8 CD B-NP O
% NN I-NP O
) ) O O
, , O O
campesterol NN B-NP O
( ( O O
61 CD B-NP O
. . O O

7 CD B-NP O
% NN I-NP O
) ) O O
and CC O O
sitosterol NN B-NP O
( ( O O
12 CD B-NP O
. . O O

7 CD B-NP O
% NN I-NP O
) ) O O
. . O O

However RB B-ADVP O
, , O O
the DT B-NP O
sera NNS I-NP O
of IN B-PP O
the DT B-NP O
patients NNS I-NP O
changed VBD B-VP O
to TO I-VP O
be VB I-VP O
atherogenic JJ I-ADJP O
; : O O
total JJ B-NP O
cholesterol NN I-NP O
, , O O
triglyceride NN B-NP O
and CC O O
low JJ B-NP O
- HYPH I-NP O
density NN I-NP O
lipoprotein NN I-NP O
( ( O O
LDL NN B-NP O
) ) O O
- HYPH B-NP O
cholesterol NN I-NP O
were VBD B-VP O
increased VBN I-VP O
, , O O
while IN B-SBAR O
high JJ B-NP O
- HYPH I-NP O
density NN I-NP O
lipoprotein NN I-NP O
( ( O O
HDL NN B-NP O
) ) O O
- HYPH B-NP O
cholesterol NN I-NP O
was VBD B-VP O
decreased VBN I-VP O
. . O O

Contrarily RB B-ADVP O
, , O O
pravastatin NN B-NP O
at IN B-PP O
a DT B-NP O
dose NN I-NP O
of IN B-PP O
10 CD B-NP O
mg NN I-NP O
/ SYM B-NP O
day NN I-NP O
improved VBD B-VP O
the DT B-NP O
sera NNS I-NP O
of IN B-PP O
the DT B-NP O
patients NNS I-NP O
to TO B-VP O
be VB I-VP O
markedly RB B-ADVP O
anti AFX B-NP O
- HYPH I-NP O
atherogenic JJ I-NP O
, , O O
but CC O O
the DT B-NP O
reductions NNS I-NP O
of IN B-PP O
cholestanol NN B-NP O
( ( O O
30 CD B-NP O
. . O O

4 CD B-NP O
% NN I-NP O
) ) O O
, , O O
lathosterol NN B-NP O
( ( O O
44 CD B-NP O
. . O O

0 CD B-NP O
% NN I-NP O
) ) O O
, , O O
campesterol NN B-NP O
( ( O O
22 CD B-NP O
. . O O

9 CD B-NP O
% NN I-NP O
) ) O O
and CC O O
sitosterol NN B-NP O
( ( O O
9 CD B-NP O
. . O O

6 CD B-NP O
% NN I-NP O
) ) O O
were VBD B-VP O
inadequate JJ B-ADJP O
. . O O

Combined VBN B-NP O
treatment NN I-NP O
with IN B-PP O
CDCA NN B-NP O
and CC I-NP O
pravastatin NN I-NP O
showed VBD B-VP O
good JJ B-NP O
overlapping NN I-NP O
of IN B-PP O
the DT B-NP O
effects NNS I-NP O
of IN B-PP O
each DT B-NP O
drug NN I-NP O
alone RB B-ADVP O
. . O O

The DT B-NP O
sera NNS I-NP O
of IN B-PP O
the DT B-NP O
patients NNS I-NP O
were VBD B-VP O
apparently RB B-ADJP O
more JJR I-ADJP O
anti AFX B-NP O
- HYPH I-NP O
atherogenic JJ I-NP O
than IN B-PP O
those DT B-NP O
after IN B-PP O
CDCA NN B-NP O
treatment NN I-NP O
. . O O

Serum NN B-NP O
cholestanol NN I-NP O
concentration NN I-NP O
was VBD B-VP O
still RB B-ADVP O
2 CD B-NP O
. . O O

7 CD B-NP O
times NNS I-NP O
higher JJR B-ADJP O
than IN B-PP O
in IN B-PP O
controls NNS B-NP O
, , O O
but CC O O
the DT B-NP O
serum NN I-NP O
lathosterol NN I-NP O
level NN I-NP O
was VBD B-VP O
within IN B-PP O
the DT B-NP O
normal JJ I-NP O
range NN I-NP O
, , O O
indicating VBG B-VP O
that IN B-SBAR O
the DT B-NP O
enhancement NN I-NP O
of IN B-PP O
overall JJ B-NP O
cholesterol NN I-NP O
synthesis NN I-NP O
in IN B-PP O
the DT B-NP O
patients NNS I-NP O
was VBD B-VP O
sufficiently RB B-ADJP O
suppressed VBN I-ADJP O
. . O O

Plant JJ B-NP O
sterol NN I-NP O
levels NNS I-NP O
were VBD B-VP O
also RB B-ADVP O
within IN B-PP O
the DT B-NP O
normal JJ I-NP O
range NN I-NP O
. . O O

The DT B-NP O
combination NN I-NP O
of IN B-PP O
CDCA NN B-NP O
and CC I-NP O
pravastatin NN I-NP O
was VBD B-VP O
a DT B-NP O
good JJ I-NP O
treatment NN I-NP O
for IN B-PP O
CTX NN B-NP B-Disease
, , O O
based VBN B-PP O
on IN B-PP O
the DT B-NP O
improvement NN I-NP O
of IN B-PP O
serum NN B-NP O
lipoprotein NN I-NP O
metabolism NN I-NP O
, , O O
the DT B-NP O
suppression NN I-NP O
of IN B-PP O
cholesterol NN B-NP O
synthesis NN I-NP O
, , O O
and CC O O
reductions NNS B-NP O
of IN B-PP O
cholestanol NN B-NP O
and CC I-NP O
plant NN I-NP O
sterol NN I-NP O
levels NNS I-NP O
. . O O

In IN B-PP O
all DT B-NP O
of IN B-PP O
7 CD B-NP O
patients NNS I-NP O
, , O O
the DT B-NP O
progression NN I-NP O
of IN B-PP O
disease NN B-NP O
was VBD B-VP O
arrested VBN I-VP O
, , O O
but CC O O
dramatic JJ B-NP O
effects NNS I-NP O
on IN B-PP O
clinical JJ B-NP O
manifestations NNS I-NP O
, , O O
xanthoma NN B-NP B-Disease
, , O O
and CC O O
electrophysiological JJ B-NP O
findings NNS I-NP O
could MD B-VP O
not RB I-VP O
be VB I-VP O
found VBN I-VP O
after IN B-PP O
the DT B-NP O
treatment NN I-NP O
of IN B-PP O
these DT B-NP O
drugs NNS I-NP O
Mutation NN B-NP O
spectrum NN I-NP O
in IN B-PP O
the DT B-NP O
CHM NN I-NP B-Disease
gene NN I-NP O
of IN B-PP O
Danish JJ B-NP O
and CC I-NP O
Swedish JJ I-NP O
choroideremia NN I-NP B-Disease
patients NNS I-NP O
. . O O

The DT B-NP O
recent JJ I-NP O
isolation NN I-NP O
of IN B-PP O
the DT B-NP O
complete JJ I-NP O
open JJ I-NP O
reading NN I-NP O
frame NN I-NP O
of IN B-PP O
the DT B-NP O
choroideremia NN I-NP B-Disease
( ( O O
CHM NN B-NP B-Disease
) ) O O
gene NN B-NP O
and CC O O
the DT B-NP O
characterization NN I-NP O
of IN B-PP O
the DT B-NP O
exon NN I-NP O
- HYPH B-NP O
intron NN I-NP O
boundaries NNS I-NP O
has VBZ B-VP O
paved VBN I-VP O
the DT B-NP O
way NN I-NP O
to TO B-PP O
mutation NN B-NP O
detection NN I-NP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
classical JJ B-NP O
choroideremia NN I-NP B-Disease
. . O O

We PRP B-NP O
have VBP B-VP O
performed VBN I-VP O
mutation NN B-NP O
screening NN I-NP O
in IN B-PP O
patients NNS B-NP O
from IN B-PP O
15 CD B-NP O
Danish NN I-NP O
and CC O O
Swedish JJ B-NP O
families NNS I-NP O
by IN B-PP O
using VBG B-VP O
Southern JJ B-NP O
blot NN I-NP O
hybridization NN I-NP O
and CC O O
the DT B-NP O
polymerase NN I-NP O
chain NN I-NP O
reaction NN I-NP O
single JJ I-NP O
- HYPH I-NP O
strand NN I-NP O
conformation NN I-NP O
polymorphism NN I-NP O
( ( O O
PCR NN B-NP O
- HYPH B-NP O
SSCP NN I-NP O
) ) O O
technique NN B-NP O
. . O O

Causative JJ B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
CHM NN I-NP B-Disease
gene NN I-NP O
were VBD B-VP O
detected VBN I-VP O
in IN B-PP O
at IN B-NP O
least JJS I-NP O
12 CD I-NP O
families NNS I-NP O
, , O O
indicating VBG B-VP O
that IN B-SBAR O
a DT B-NP O
substantial JJ I-NP O
part NN I-NP O
of IN B-PP O
the DT B-NP O
mutations NNS I-NP O
can MD B-VP O
be VB I-VP O
identified VBN I-VP O
by IN B-PP O
this DT B-NP O
approach NN I-NP O
. . O O

In IN B-PP O
four CD B-NP O
of IN B-PP O
these DT B-NP O
families NNS I-NP O
deletions NNS I-NP O
of IN B-PP O
different JJ B-NP O
sizes NNS I-NP O
were VBD B-VP O
found VBN I-VP O
. . O O

Thus RB B-ADVP O
, , O O
in IN B-PP O
one CD B-NP O
patient NN I-NP O
, , O O
the DT B-NP O
deletion NN I-NP O
resulted VBD B-VP O
in IN B-PP O
the DT B-NP O
absence NN I-NP O
of IN B-PP O
only RB B-NP O
one CD I-NP O
exon NN I-NP O
, , O O
while IN B-SBAR O
in IN B-PP O
another DT B-NP O
the DT B-NP O
deletion NN I-NP O
comprised VBD B-VP O
the DT B-NP O
entire JJ I-NP O
CHM NN I-NP B-Disease
gene NN I-NP O
. . O O

Mapping NN B-NP O
of IN B-PP O
the DT B-NP O
deletion NN I-NP O
endpoints NNS I-NP O
in IN B-PP O
these DT B-NP O
four CD I-NP O
patients NNS I-NP O
and CC B-PP O
in IN B-PP O
another DT B-NP O
11 CD I-NP O
male JJ I-NP O
patients NNS I-NP O
with IN B-PP O
sizeable JJ B-NP O
deletions NNS I-NP O
enabled VBD B-VP O
us PRP B-NP O
to TO B-VP O
construct VB I-VP O
a DT B-NP O
very RB I-NP O
detailed JJ I-NP O
map NN I-NP O
of IN B-PP O
intervals NNS B-NP O
2 CD I-NP O
and CC I-NP O
3 CD I-NP O
of IN B-PP O
Xq21 NN B-NP O
. . O O

In IN B-PP O
the DT B-NP O
remaining VBG I-NP O
11 CD I-NP O
Danish JJ I-NP O
and CC I-NP O
Swedish JJ I-NP O
families NNS I-NP O
at IN B-NP O
least JJS I-NP O
8 CD I-NP O
causative JJ I-NP O
mutations NNS I-NP O
were VBD B-VP O
found VBN I-VP O
by IN B-PP O
PCR NN B-NP O
- HYPH I-NP O
SSCP NN I-NP O
analysis NN I-NP O
and CC O O
direct JJ B-NP O
sequencing NN I-NP O
. . O O

Interestingly RB B-ADVP O
, , O O
all DT B-NP O
CHM NN I-NP B-Disease
gene NN I-NP O
mutations NNS I-NP O
detected VBD B-VP O
thus RB B-ADVP O
far RB I-ADVP O
in IN B-PP O
choroideremia NN B-NP B-Disease
patients NNS I-NP O
give VBP B-VP O
rise NN B-NP O
to TO B-PP O
the DT B-NP O
introduction NN I-NP O
of IN B-PP O
a DT B-NP O
premature JJ I-NP O
stop NN I-NP O
codon NN I-NP O
. . O O

. . O O

Predominance NN B-NP O
of IN B-PP O
the DT B-NP O
adrenomyeloneuropathy JJ I-NP B-Disease
phenotype NN I-NP O
of IN B-PP O
X NN B-NP B-Disease
- HYPH O I-Disease
linked VBN B-NP I-Disease
adrenoleukodystrophy NN I-NP I-Disease
in IN B-PP O
The DT B-NP O
Netherlands NNP I-NP O
: : O O
a DT B-NP O
survey NN I-NP O
of IN B-PP O
30 CD B-NP O
kindreds NNS I-NP O
. . O O

X NN B-NP B-Disease
- HYPH O I-Disease
linked VBN B-VP I-Disease
adrenoleukodystrophy NN B-NP I-Disease
( ( O O
X NN B-NP B-Disease
- HYPH B-NP I-Disease
ALD NN I-NP I-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
inherited VBN I-NP B-Disease
disorder NN I-NP I-Disease
of IN B-PP O
peroxisomal JJ B-NP O
beta SYM I-NP O
- HYPH I-NP O
oxidation NN I-NP O
associated VBN B-VP O
with IN B-PP O
accumulation NN B-NP O
of IN B-PP O
saturated VBN B-NP O
very RB I-NP O
long JJ I-NP O
- HYPH I-NP O
chain NN I-NP O
fatty JJ I-NP O
acids NNS I-NP O
, , O O
which WDT B-NP O
results VBZ B-VP O
in IN B-PP O
central JJ B-NP O
and CC I-NP O
peripheral JJ I-NP O
demyelination NN I-NP B-Disease
and CC B-PP O
in IN B-PP O
impaired VBN B-NP B-Disease
function NN I-NP I-Disease
of IN B-PP I-Disease
adrenal JJ B-NP I-Disease
cortex NN I-NP I-Disease
and CC I-NP I-Disease
testes NNS I-NP I-Disease
. . O O

The DT B-NP O
phenotypic JJ I-NP O
expression NN I-NP O
is VBZ B-VP O
highly RB B-ADJP O
variable JJ I-ADJP O
, , O O
childhood NN B-NP B-Disease
cerebral JJ I-NP I-Disease
ALD NN I-NP I-Disease
( ( O O
CCALD NN B-NP B-Disease
) ) O O
and CC O O
adrenomyeloneuropathy NN B-NP B-Disease
( ( O O
AMN NN B-NP B-Disease
) ) O O
being VBG B-VP O
the DT B-NP O
main JJ I-NP O
variants NNS I-NP O
. . O O

We PRP B-NP O
explored VBD B-VP O
the DT B-NP O
30 CD I-NP O
Dutch JJ I-NP O
kindreds NNS I-NP O
well RB B-VP O
known VBN I-VP O
to TO B-PP O
the DT B-NP O
Dutch JJ I-NP O
X NN I-NP B-Disease
- HYPH B-NP I-Disease
ALD NN I-NP I-Disease
/ SYM I-NP O
AMN NN I-NP B-Disease
Study NN I-NP O
Group NN I-NP O
and CC O O
phenotyped VBD B-VP O
77 CD B-NP O
male JJ I-NP O
patients NNS I-NP O
35 CD B-NP O
( ( O O
46 CD B-NP O
% NN I-NP O
) ) O O
had VBD B-VP O
AMN NN B-NP B-Disease
and CC O O
24 CD B-NP O
( ( O O
31 CD B-NP O
% NN I-NP O
) ) O O
CCALD NN B-NP B-Disease
or CC O O
adolescent JJ B-NP B-Disease
cerebral JJ I-NP I-Disease
ALD NN I-NP I-Disease
( ( O O
AdolCALD NN B-NP B-Disease
) ) O O
. . O O

These DT B-NP O
percentages NNS I-NP O
differ VBP B-VP O
significantly RB B-ADVP O
from IN B-PP O
previous JJ B-NP O
reports NNS I-NP O
, , O O
in IN B-PP O
which WDT B-NP O
25 CD B-NP O
to TO I-NP O
28 CD I-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
patients NNS I-NP O
developed VBD B-VP O
AMN NN B-NP B-Disease
and CC O O
53 CD B-NP O
to TO I-NP O
57 CD I-NP O
% NN I-NP O
CCALD NN I-NP B-Disease
or CC I-NP O
AdolCALD NN I-NP B-Disease
. . O O

Our PRP$ B-NP O
findings NNS I-NP O
indicate VBP B-VP O
that IN B-SBAR O
- SYM O O
- HYPH O O
at IN B-ADVP O
least JJS I-ADVP O
in IN B-PP O
the DT B-NP O
Netherlands NNP I-NP O
- HYPH O O
- HYPH O O
AMN NN B-NP B-Disease
may MD B-VP O
be VB I-VP O
the DT B-NP O
most RBS I-NP O
frequent JJ I-NP O
phenotype NN I-NP O
of IN B-PP O
X NN B-NP B-Disease
- HYPH B-NP I-Disease
ALD NN I-NP I-Disease
. . O O

. . O O

Adrenoleukodystrophy NN B-NP B-Disease
gene NN I-NP O
encodes VBZ B-VP O
an DT B-NP O
80 CD I-NP O
kDa NN I-NP O
membrane NN I-NP O
protein NN I-NP O
. . O O

An DT B-NP O
antibody NN I-NP O
against IN B-PP O
the DT B-NP O
synthetic JJ I-NP O
C NN I-NP O
- HYPH B-NP O
terminal JJ I-NP O
peptides NNS I-NP O
deduced VBN B-VP O
from IN B-PP O
the DT B-NP O
cDNA NN I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
responsible JJ B-ADJP O
for IN B-PP O
X NN B-NP B-Disease
- HYPH O I-Disease
linked VBN B-VP I-Disease
adrenoleukodystrophy NN B-NP I-Disease
( ( O O
ALD NN B-NP B-Disease
) ) O O
was VBD B-VP O
produced VBN I-VP O
to TO I-VP O
characterize VB I-VP O
the DT B-NP O
product NN I-NP O
of IN B-PP O
the DT B-NP O
ALD NN I-NP B-Disease
gene NN I-NP O
. . O O

The DT B-NP O
antibody NN I-NP O
reacted VBD B-VP O
with IN B-PP O
the DT B-NP O
80 CD I-NP O
kDa NN I-NP O
band NN I-NP O
protein NN I-NP O
in IN B-PP O
control NN B-NP O
fibroblasts NNS I-NP O
, , O O
while IN B-SBAR O
no DT B-NP O
bands NNS I-NP O
were VBD B-VP O
detected VBN I-VP O
in IN B-PP O
the DT B-NP O
fibroblasts NNS I-NP O
from IN B-PP O
a DT B-NP O
patient NN I-NP O
with IN B-PP O
ALD NN B-NP B-Disease
( ( O O
# # B-NP O
163 CD I-NP O
) ) O O
, , O O
in IN B-PP O
which WDT B-NP O
mRNA NN B-NP O
of IN B-PP O
the DT B-NP O
ALD NN I-NP B-Disease
gene NN I-NP O
was VBD B-VP O
undetectable JJ B-ADJP O
based VBN B-PP O
on IN B-PP O
Northern NN B-NP O
blot NN I-NP O
analysis NN I-NP O
. . O O

The DT B-NP O
293T NN I-NP O
cells NNS I-NP O
transfected VBN B-VP O
with IN B-PP O
the DT B-NP O
full JJ I-NP O
- HYPH I-NP O
coding VBG B-VP O
cDNA NN B-NP O
inserted VBN B-VP O
in IN B-PP O
the DT B-NP O
expression NN I-NP O
vector NN I-NP O
produced VBD B-VP O
a DT B-NP O
new JJ I-NP O
80 CD I-NP O
kDa NN I-NP O
protein NN I-NP O
, , O O
as IN B-SBAR O
detected VBN B-VP O
by IN B-PP O
Western JJ B-NP O
blot NN I-NP O
. . O O

In IN B-PP O
an DT B-NP O
immunocytological JJ I-NP O
study NN I-NP O
, , O O
the DT B-NP O
staining NN I-NP O
was VBD B-VP O
in IN B-PP O
a DT B-NP O
punctate NN I-NP O
pattern NN I-NP O
, , O O
in IN B-PP O
the DT B-NP O
normal JJ I-NP O
fibroblasts NNS I-NP O
. . O O

However RB B-ADVP O
, , O O
there EX B-NP O
was VBD B-VP O
no DT B-NP O
punctate NN I-NP O
staining NN I-NP O
in IN B-PP O
the DT B-NP O
# # I-NP O
163 CD I-NP O
cells NNS I-NP O
. . O O

These DT B-NP O
data NNS I-NP O
thus RB B-ADVP O
indicate VBP B-VP O
that IN B-SBAR O
the DT B-NP O
ALD NN I-NP B-Disease
gene NN I-NP O
encodes VBZ B-VP O
an DT B-NP O
80 CD I-NP O
kDa NN I-NP O
membrane NN I-NP O
protein NN I-NP O
. . O O

. . O O

Isolation NN B-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
for IN B-PP O
McLeod NNP B-NP B-Disease
syndrome NN I-NP I-Disease
that WDT B-NP O
encodes VBZ B-VP O
a DT B-NP O
novel JJ I-NP O
membrane NN I-NP O
transport NN I-NP O
protein NN I-NP O
. . O O

McLeod NN B-NP B-Disease
syndrome NN I-NP I-Disease
is VBZ B-VP O
an DT B-NP O
X NN I-NP B-Disease
- HYPH B-VP I-Disease
linked VBN B-NP I-Disease
multisystem NN I-NP I-Disease
disorder NN I-NP I-Disease
characterized VBN B-VP O
by IN B-PP O
abnormalities NNS B-NP O
in IN B-PP O
the DT B-NP O
neuromuscular JJ I-NP O
and CC I-NP O
hematopoietic JJ I-NP O
systems NNS I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
assembled VBN I-VP O
a DT B-NP O
cosmid NN I-NP O
contig NN I-NP O
of IN B-PP O
360 CD B-NP O
kb NN I-NP O
that WDT B-NP O
encompasses VBZ B-VP O
the DT B-NP O
McLeod NN I-NP B-Disease
gene NN I-NP O
locus NN I-NP O
. . O O

A DT B-NP O
50 CD I-NP O
kb NN I-NP O
deletion NN I-NP O
was VBD B-VP O
detected VBN I-VP O
by IN B-PP O
screening VBG B-VP O
DNA NN B-NP O
from IN B-PP O
patients NNS B-NP O
with IN B-PP O
radiolabeled VBN B-NP O
whole JJ I-NP O
cosmids NNS I-NP O
, , O O
and CC O O
two CD B-NP O
transcription NN I-NP O
units NNS I-NP O
were VBD B-VP O
identified VBN I-VP O
within IN B-PP O
this DT B-NP O
deletion NN I-NP O
. . O O

The DT B-NP O
mRNA NN I-NP O
expression NN I-NP O
pattern NN I-NP O
of IN B-PP O
one CD B-NP O
of IN B-PP O
them PRP B-NP O
, , O O
designated VBN B-VP O
as IN B-PP O
XK NN B-NP O
, , O O
correlates VBZ B-VP O
closely RB B-ADVP O
to TO B-PP O
the DT B-NP O
McLeod NNP I-NP B-Disease
phenotype NN I-NP O
. . O O

XK NN B-NP O
encodes VBZ B-VP O
a DT B-NP O
novel JJ I-NP O
protein NN I-NP O
with IN B-PP O
structural JJ B-NP O
characteristics NNS I-NP O
of IN B-PP O
prokaryotic JJ B-NP O
and CC I-NP O
eukaryotic JJ I-NP O
membrane NN I-NP O
transport NN I-NP O
proteins NNS I-NP O
. . O O

Nucleotide NN B-NP O
sequence NN I-NP O
analysis NN I-NP O
of IN B-PP O
XK NN B-NP O
from IN B-PP O
two CD B-NP O
unrelated JJ I-NP O
McLeod NN I-NP B-Disease
patients NNS I-NP O
has VBZ B-VP O
identified VBN I-VP O
point NN B-NP O
mutations NNS I-NP O
at IN B-PP O
conserved VBN B-NP O
splice NN I-NP O
donor NN I-NP O
and CC I-NP O
acceptor NN I-NP O
sites NNS I-NP O
. . O O

These DT B-NP O
findings NNS I-NP O
provide VBP B-VP O
direct JJ B-NP O
evidence NN I-NP O
that IN B-SBAR O
XK NN B-NP O
is VBZ B-VP O
responsible JJ B-ADJP O
for IN B-PP O
McLeod NN B-NP B-Disease
syndrome NN I-NP I-Disease
. . O O

. . O O

X NN B-NP B-Disease
- HYPH O I-Disease
linked VBN B-VP I-Disease
spastic JJ B-NP I-Disease
paraplegia NN I-NP I-Disease
and CC O O
Pelizaeus NNP B-NP B-Disease
- HYPH B-NP I-Disease
Merzbacher NNP I-NP I-Disease
disease NN I-NP I-Disease
are VBP B-VP O
allelic JJ B-NP B-Disease
disorders NNS I-NP I-Disease
at IN B-PP O
the DT B-NP O
proteolipid NN I-NP O
protein NN I-NP O
locus NN I-NP O
. . O O

Three CD B-NP O
forms NNS I-NP O
of IN B-PP O
X NN B-NP B-Disease
- HYPH O I-Disease
linked VBN B-VP I-Disease
spastic JJ B-NP I-Disease
paraplegia NN I-NP I-Disease
( ( O O
SPG NN B-NP B-Disease
) ) O O
have VBP B-VP O
been VBN I-VP O
defined VBN I-VP O
. . O O

One CD B-NP O
locus NN I-NP O
( ( O O
SPG NN B-NP O
1 CD I-NP O
) ) O O
maps VBZ B-VP O
to TO B-PP O
Xq28 NN B-NP O
while IN B-SBAR O
two CD B-NP O
clinically RB I-NP O
distinct JJ I-NP O
forms NNS I-NP O
map VBP B-VP O
to TO B-PP O
Xq22 NN B-NP O
( ( O O
SPG2 NN B-NP O
) ) O O
. . O O

A DT B-NP O
rare JJ I-NP O
X NN I-NP B-Disease
- HYPH B-VP I-Disease
linked VBN I-VP I-Disease
dysmyelinating VBG B-VP I-Disease
disorder NN B-NP I-Disease
of IN B-PP O
the DT B-NP O
central JJ I-NP O
nervous JJ I-NP O
system NN I-NP O
, , O O
Pelizaeus NNP B-NP B-Disease
- HYPH I-NP I-Disease
Merzbacher NNP I-NP I-Disease
disease NN I-NP I-Disease
( ( O O
PMD NN B-NP B-Disease
) ) O O
, , O O
has VBZ B-VP O
also RB I-VP O
been VBN I-VP O
mapped VBN I-VP O
to TO B-PP O
Xq21 NN B-NP O
- HYPH B-NP O
q22 NN I-NP O
, , O O
and CC O O
is VBZ B-VP O
caused VBN I-VP O
by IN B-PP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
proteolipid NN I-NP O
protein NN I-NP O
gene NN I-NP O
( ( O O
PLP NN B-NP O
) ) O O
which WDT B-NP O
encodes VBZ B-VP O
two CD B-NP O
myelin NN I-NP O
proteins NNS I-NP O
, , O O
PLP NN B-NP O
and CC I-NP O
DM20 NN I-NP O
. . O O

While IN B-SBAR O
narrowing VBG B-VP O
the DT B-NP O
genetic JJ I-NP O
interval NN I-NP O
containing VBG B-VP O
SPG2 NN B-NP O
in IN B-PP O
a DT B-NP O
large JJ I-NP O
pedigree NN I-NP O
, , O O
we PRP B-NP O
found VBD B-VP O
that IN B-SBAR O
PLP NN B-NP O
was VBD B-VP O
the DT B-NP O
closest JJS I-NP O
marker NN I-NP O
to TO B-PP O
the DT B-NP O
disease NN I-NP O
locus NN I-NP O
, , O O
implicating VBG B-VP O
PLP NN B-NP O
as IN B-PP O
a DT B-NP O
possible JJ I-NP O
candidate NN I-NP O
gene NN I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
found VBN I-VP O
that IN B-SBAR O
a DT B-NP O
point NN I-NP O
mutation NN I-NP O
( ( O O
His139Tyr NN B-NP O
) ) O O
in IN B-PP O
exon NN B-NP O
3B NN I-NP O
of IN B-PP O
an DT B-NP O
affected VBN I-NP O
male NN I-NP O
produces VBZ B-VP O
a DT B-NP O
mutant JJ I-NP O
PLP NN I-NP O
but CC O O
a DT B-NP O
normal JJ I-NP O
DM20 NN I-NP O
, , O O
and CC O O
segregates NNS B-NP O
with IN B-PP O
the DT B-NP O
disease NN I-NP O
( ( O O
Zmax NN B-NP O
= SYM B-VP O
6 CD B-NP O
. SYM I-NP O

63 CD I-NP O
, , I-NP O
theta NN I-NP O
= SYM B-VP O
0 CD B-NP O
. SYM I-NP O

00 CD I-NP O
) ) O O
. . O O

It PRP B-NP O
appears VBZ B-VP O
, , O O
therefore RB B-ADVP O
, , O O
that IN B-SBAR O
SPG2 NN B-NP O
and CC I-NP O
PMD NN I-NP B-Disease
are VBP B-VP O
allelic JJ B-NP B-Disease
disorders NNS I-NP I-Disease
Canavan NNP B-NP B-Disease
disease NN I-NP I-Disease
: : O O
mutations NNS B-NP O
among IN B-PP O
Jewish JJ O O
and CC O O
non AFX O O
- HYPH B-NP O
Jewish JJ B-NP O
patients NNS I-NP O
. . O O

Canavan NN B-NP B-Disease
disease NN I-NP I-Disease
is VBZ B-VP O
an DT B-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
leukodystrophy NN I-NP I-Disease
caused VBN B-VP O
by IN B-PP O
the DT B-NP O
deficiency NN I-NP B-Disease
of IN B-PP I-Disease
aspartoacylase NN B-NP I-Disease
( ( O O
ASPA NN B-NP O
) ) O O
. . O O

Sixty CD B-NP O
- HYPH I-NP O
four CD I-NP O
probands NNS I-NP O
were VBD B-VP O
analyzed VBN I-VP O
for IN B-PP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
ASPA NN I-NP O
gene NN I-NP O
. . O O

Three CD B-NP O
point NN I-NP O
mutations NNS I-NP O
- SYM B-VP O
- HYPH B-NP O
693C NN I-NP O
- SYM O O
- HYPH O O
> SYM O O
A NN B-NP O
, , I-NP O
854A NN I-NP O
- SYM I-NP O
- SYM I-NP O
> SYM I-NP O
C NN I-NP O
, , O O
and CC O O
914C NN B-NP O
- SYM B-NP O
- HYPH B-VP O
> SYM B-NP O
A NN I-NP O
- SYM B-NP O
- HYPH B-NP O
were VBD B-VP O
identified VBN I-VP O
in IN B-PP O
the DT B-NP O
coding VBG I-NP O
sequence NN I-NP O
. . O O

The DT B-NP O
693C NN I-NP O
- SYM B-VP O
- SYM B-NP O
> SYM I-NP O
A NN I-NP O
and CC I-NP O
914C NN I-NP O
- SYM B-NP O
- HYPH B-NP O
> SYM I-NP O
A NN I-NP O
base NN I-NP O
changes NNS I-NP O
, , O O
resulting VBG B-VP O
in IN B-PP O
nonsense JJ B-NP O
tyr231 NN I-NP O
- SYM B-NP O
- SYM B-NP O
> SYM B-NP O
ter NN B-NP O
and CC O O
missense JJ B-NP O
ala305 NN I-NP O
- SYM B-NP O
- SYM B-NP O
> SYM I-NP O
glu NN I-NP O
mutations NNS I-NP O
, , O O
respectively RB B-ADVP O
, , O O
lead VBP B-VP O
to TO B-PP O
complete JJ B-NP O
loss NN I-NP O
of IN B-PP O
ASPA NN B-NP O
activity NN I-NP O
in IN B-PP O
in FW B-NP O
vitro FW I-NP O
expression NN I-NP O
studies NNS I-NP O
. . O O

The DT B-NP O
854A NN I-NP O
- SYM B-VP O
- SYM B-NP O
> SYM I-NP O
C NN I-NP O
transversion NN I-NP O
converted VBD B-VP O
glu NN B-NP O
to TO B-PP O
ala NN B-NP O
in IN B-PP O
codon NN B-NP O
285 CD I-NP O
. . O O

The DT B-NP O
glu285 NN I-NP O
- SYM B-VP O
- SYM B-NP O
> SYM I-NP O
ala NN I-NP O
mutant JJ I-NP O
ASPA NNP I-NP O
has VBZ B-VP O
2 CD B-NP O
. . O O

5 CD B-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
activity NN I-NP O
expressed VBN B-VP O
by IN B-PP O
the DT B-NP O
wild JJ I-NP O
- HYPH I-NP O
type NN I-NP O
enzyme NN I-NP O
. . O O

A DT B-NP O
fourth JJ I-NP O
mutation NN I-NP O
, , O O
433 CD B-NP O
- HYPH O O
- SYM O O
2 CD B-NP O
( ( O O
A NN B-NP O
- SYM O O
- HYPH O O
> SYM O O
G NN O O
) ) O O
transition NN B-NP O
, , O O
was VBD B-VP O
identified VBN I-VP O
at IN B-PP O
the DT B-NP O
splice NN I-NP O
- HYPH B-NP O
acceptor NN I-NP O
site NN I-NP O
in IN B-PP O
intron NN B-NP O
2 CD I-NP O
. . O O

The DT B-NP O
splice NN I-NP O
- HYPH I-NP O
site NN I-NP O
mutation NN I-NP O
would MD B-VP O
lead VB I-VP O
to TO B-PP O
skipping NN B-NP O
of IN B-PP O
exon NN B-NP O
3 CD I-NP O
, , O O
accompanied VBN B-VP O
by IN B-PP O
a DT B-NP O
frameshift NN I-NP O
, , O O
and CC O O
thus RB O O
would MD B-VP O
produce VB I-VP O
aberrant JJ B-NP O
ASPA NN I-NP O
. . O O

Of IN B-PP O
the DT B-NP O
128 CD I-NP O
unrelated JJ I-NP O
Canavan NNP I-NP B-Disease
chromosomes NNS I-NP O
analyzed VBN B-VP O
, , O O
88 CD B-NP O
were VBD B-VP O
from IN B-PP O
probands NNS B-NP O
of IN B-PP O
Ashkenazi NNP B-NP O
Jewish NNP I-NP O
descent NNP I-NP O
. . O O

The DT B-NP O
glu285 NN I-NP O
- SYM B-VP O
- SYM B-NP O
> SYM I-NP O
ala NN I-NP O
mutation NN I-NP O
was VBD B-VP O
predominant JJ B-ADJP O
( ( O O
82 CD B-NP O
. . O O

9 CD B-NP O
% NN I-NP O
) ) O O
in IN B-PP O
this DT B-NP O
population NN I-NP O
, , O O
followed VBN B-VP O
by IN B-PP O
the DT B-NP O
tyr231 NN I-NP O
- SYM O O
- SYM O O
> SYM O O
ter NN B-NP O
( ( O O
14 CD B-NP O
. . O O

8 CD B-NP O
% NN I-NP O
) ) O O
and CC O O
433 CD B-NP O
- HYPH I-NP O
- SYM I-NP O
2 CD I-NP O
( ( I-NP O
A NN I-NP O
- SYM I-NP O
- HYPH I-NP O
> SYM I-NP O
G NN I-NP O
) ) O O
( ( O O
1 CD B-NP O
. . O O

1 CD B-NP O
% NN I-NP O
) ) O O
mutations NNS B-NP O
. . O O

The DT B-NP O
three CD I-NP O
mutations NNS I-NP O
account VBP B-VP O
for IN B-PP O
98 CD B-NP O
. . O O

8 CD B-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
Canavan NNP I-NP B-Disease
chromosomes NNS I-NP O
of IN B-PP O
Ashkenazi NNP B-NP O
Jewish JJ I-NP O
origin NN I-NP O
. . O O

The DT B-NP O
ala305 NN I-NP O
- SYM B-VP O
- SYM B-NP O
> SYM I-NP O
glu NN I-NP O
mutation NN I-NP O
was VBD B-VP O
found VBN I-VP O
exclusively RB B-ADVP O
in IN B-PP O
non AFX B-NP O
- HYPH I-NP O
Jewish JJ I-NP O
probands NNS I-NP O
of IN B-PP O
European JJ B-NP O
descent NN I-NP O
and CC O O
constituted VBD B-VP O
60 CD B-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
40 CD I-NP O
mutant JJ I-NP O
chromosomes NNS I-NP O
. . O O

Predominant JJ B-NP O
occurrence NN I-NP O
of IN B-PP O
certain JJ B-NP O
mutations NNS I-NP O
among IN B-PP O
Ashkenazi NNP B-NP O
Jewish NNP I-NP O
and CC O O
non AFX B-NP O
- HYPH I-NP O
Jewish JJ B-NP O
patients NNS I-NP O
with IN B-PP O
Canavan NNP B-NP B-Disease
disease NN I-NP I-Disease
would MD B-VP O
suggest VB I-VP O
a DT B-NP O
founding JJ I-NP O
- HYPH I-NP O
father NN I-NP O
effect NN I-NP O
in IN B-PP O
propagation NN B-NP O
of IN B-PP O
these DT B-NP O
mutant JJ I-NP O
chromosomes NNS I-NP O
Intelligence NN B-NP O
quotient NN I-NP O
profile NN I-NP O
in IN B-PP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
, , O O
intergenerational JJ B-NP O
deficit NN I-NP O
, , O O
and CC O O
correlation NN B-NP O
with IN B-PP O
CTG NN B-NP O
amplification NN I-NP O
. . O O

An DT B-NP O
abbreviated VBN I-NP O
Wechsler NNP I-NP O
Adult NNP I-NP O
Intelligence NNP I-NP O
Scale NNP I-NP O
Revised NNP I-NP O
( ( O O
WAIS NN B-NP O
- HYPH B-NP O
R NN I-NP O
) ) O O
was VBD B-VP O
used VBN I-VP O
to TO B-VP O
assess VB I-VP O
verbal JJ B-NP O
and CC I-NP O
arithmetical JJ I-NP O
cognitive JJ I-NP O
performance NN I-NP O
in IN B-PP O
55 CD B-NP O
subjects NNS I-NP O
with IN B-PP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
( ( O O
DM NN B-NP B-Disease
) ) O O
, , O O
covering VBG B-VP O
all DT B-NP O
grades NNS I-NP O
of IN B-PP O
disease NN B-NP O
severity NN I-NP O
, , O O
and CC O O
31 CD B-NP O
controls NNS I-NP O
at IN B-PP O
50 CD B-NP O
% NN I-NP O
risk NN I-NP O
of IN B-PP O
inheriting VBG B-VP O
DM NN B-NP B-Disease
. . O O

Scaled JJ B-NP O
scores NNS I-NP O
from IN B-PP O
the DT B-NP O
assessment NN I-NP O
were VBD B-VP O
converted VBN I-VP O
into IN B-PP O
an DT B-NP O
intelligence NN I-NP O
quotient NN I-NP O
( ( O O
IQ NN B-NP O
) ) O O
estimation NN B-NP O
on IN B-PP O
each DT B-NP O
person NN I-NP O
. . O O

Significant JJ B-NP O
IQ NN I-NP O
differences NNS I-NP O
were VBD B-VP O
found VBN I-VP O
between IN B-PP O
( ( B-LST O
1 LS I-LST O
) ) O O
all DT B-NP O
55 CD I-NP O
DM NN I-NP B-Disease
subjects NNS I-NP O
( ( O O
mean NN B-NP O
90 CD I-NP O
. . O O

2 CD B-NP O
, , O O
SD NNP B-NP O
16 CD I-NP O
. . I-NP O

1 CD I-NP O
) ) O O
and CC O O
31 CD B-NP O
controls NNS I-NP O
( ( O O
102 CD B-NP O
. . O O

6 CD B-NP O
, , O O
SD NN B-NP O
9 CD I-NP O
. . O O

4 CD B-NP O
) ) O O
, , O O
with IN B-PP O
no DT B-NP O
sex NN I-NP O
differences NNS I-NP O
in IN B-PP O
either DT B-NP O
group NN I-NP O
; : O O
( ( O O
2 CD B-NP O
) ) O O
15 CD B-NP O
affected VBN I-NP O
parents NNS I-NP O
( ( O O
99 CD B-NP O
. . I-NP O

3 CD I-NP O
, , O O
SD NNP B-NP O
12 CD I-NP O
. . I-NP O

2 CD I-NP O
) ) O O
and CC O O
their PRP$ B-NP O
affected VBN I-NP O
children NNS I-NP O
( ( O O
88 CD B-NP O
. . I-NP O

1 CD I-NP O
, , O O
SD NNP B-NP O
17 CD I-NP O
. . I-NP O

2 CD I-NP O
) ) O O
, , O O
where WRB B-ADVP O
significance NN B-NP O
was VBD B-VP O
dependent JJ B-ADJP O
on IN B-PP O
parental JJ B-NP O
sex NN I-NP O
being VBG B-VP O
female JJ B-ADJP O
; : O O
and CC O O
( ( O O
3 CD B-NP O
) ) O O
15 CD B-NP O
pairs NNS I-NP O
of IN B-PP O
affected VBN B-NP O
sibs NNS I-NP O
( ( O O
89 CD B-NP O
. . I-NP O

6 CD I-NP O
, , O O
SD NNP B-NP O
13 CD I-NP O
. . O O

2 CD B-NP O
) ) O O
and CC O O
their PRP$ B-NP O
normal JJ I-NP O
sibs NNS I-NP O
( ( O O
100 CD B-NP O
. . I-NP O

2 CD I-NP O
, , O O
SD NNP B-NP O
7 CD I-NP O
. . O O

6 CD B-NP O
) ) O O
. . O O

IQ NN B-NP O
steadily RB B-ADVP O
declined VBD B-VP O
as IN B-SBAR O
( ( B-LST O
1 LS I-LST O
) ) O O
the DT B-NP O
age NN I-NP O
of IN B-PP O
onset NN B-NP O
of IN B-PP O
signs NNS B-NP O
and CC I-NP O
symptoms NNS I-NP O
decreased VBD B-VP O
, , O O
and CC O O
( ( B-LST O
2 LS I-LST O
) ) O O
the DT B-NP O
CTG NN I-NP O
expansion NN I-NP O
size NN I-NP O
increased VBD B-VP O
. . O O

The DT B-NP O
correlation NN I-NP O
appeared VBD B-VP O
to TO I-VP O
be VB I-VP O
more RBR B-ADJP O
linear JJ I-ADJP O
with IN B-PP O
age NN B-NP O
of IN B-PP O
onset NN B-NP O
. . O O

The DT B-NP O
correlation NN I-NP O
of IN B-PP O
IQ NN B-NP O
difference NN I-NP O
and CC O O
CTG NN B-NP O
expansion NN I-NP O
difference NN I-NP O
in IN B-PP O
both CC O O
the DT B-NP O
DM NN I-NP B-Disease
parent NN I-NP O
- HYPH B-NP O
child NN I-NP O
pairs NNS I-NP O
and CC O O
normal JJ B-NP O
sib NN I-NP O
- HYPH B-VP O
affected VBN B-NP O
sib NN I-NP O
pairs NNS I-NP O
was VBD B-VP O
poor JJ B-ADJP O
, , O O
indicating VBG B-VP O
that IN B-SBAR O
CTG NN B-NP O
expansion NN I-NP O
is VBZ B-VP O
not RB O O
a DT B-NP O
reliable JJ I-NP O
predictor NN I-NP O
of IN B-PP O
IQ NN B-NP O
either CC O O
in IN B-PP O
individual JJ B-NP O
persons NNS I-NP O
or CC I-NP O
families NNS I-NP O
. . O O

Further JJ B-NP O
analysis NN I-NP O
of IN B-PP O
cognitive JJ B-NP O
function NN I-NP O
in IN B-PP O
DM NN B-NP B-Disease
is VBZ B-VP O
required VBN I-VP O
to TO I-VP O
clarify VB I-VP O
specific JJ B-NP O
deficits NNS I-NP O
characteristic JJ B-ADJP O
of IN B-PP O
this DT B-NP O
patient NN I-NP O
group NN I-NP O
Adenomatous JJ B-NP B-Disease
polyposis NN I-NP I-Disease
coli NN I-NP I-Disease
and CC O O
a DT B-NP O
cytogenetic JJ I-NP O
deletion NN I-NP O
of IN B-PP O
chromosome NN B-NP O
5 CD I-NP O
resulting VBG B-VP O
from IN B-PP O
a DT B-NP O
maternal JJ I-NP O
intrachromosomal JJ I-NP O
insertion NN I-NP O
. . O O

We PRP B-NP O
present VBP B-VP O
the DT B-NP O
clinical JJ I-NP O
and CC I-NP O
laboratory JJ I-NP O
findings NNS I-NP O
in IN B-PP O
an DT B-NP O
institutionalised JJ I-NP O
adult JJ I-NP O
patient NN I-NP O
originally RB B-ADVP O
referred VBD B-VP O
for IN B-PP O
autism NN B-NP B-Disease
. . O O

A DT B-NP O
high JJ I-NP O
risk NN I-NP O
of IN B-PP O
colorectal JJ B-NP B-Disease
cancer NN I-NP I-Disease
was VBD B-VP O
predicted VBN I-VP O
when WRB B-ADVP O
an DT B-NP O
interstitial JJ I-NP O
deletion NN I-NP O
of IN B-PP O
the DT B-NP O
long JJ I-NP O
arm NN I-NP O
of IN B-PP O
chromosome NN B-NP O
5 CD I-NP O
, , O O
del NN B-NP O
( ( O O
5 CD B-NP O
) ) O O
( ( O O
q15q22 NN B-NP O
. . I-NP O

3 CD I-NP O
) ) O O
, , O O
was VBD B-VP O
detected VBN I-VP O
in IN B-PP O
her PRP$ B-NP O
lymphocytes NNS I-NP O
and CC O O
deletion NN B-NP O
of IN B-PP O
the DT B-NP O
MCC NN I-NP O
and CC I-NP O
APC NN I-NP B-Disease
genes NNS I-NP O
confirmed VBN B-VP O
by IN B-PP O
molecular JJ B-NP O
analysis NN I-NP O
. . O O

Adenomatous JJ B-NP B-Disease
polyposis NN I-NP I-Disease
coli NN I-NP I-Disease
and CC I-NP O
carcinoma NN I-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
rectum NN I-NP I-Disease
were VBD B-VP O
subsequently RB I-VP O
diagnosed VBN I-VP O
in IN B-PP O
the DT B-NP O
patient NN I-NP O
. . O O

She PRP B-NP O
was VBD B-VP O
profoundly RB B-ADVP O
mentally RB B-ADJP B-Disease
retarded JJ I-ADJP I-Disease
, , O O
autistic JJ B-ADJP B-Disease
, , O O
and CC O O
had VBD B-VP O
minor JJ B-NP O
dysmorphic JJ I-NP B-Disease
features NNS I-NP I-Disease
consistent JJ B-ADJP O
with IN B-PP O
those DT B-NP O
of IN B-PP O
previous JJ B-NP O
patients NNS I-NP O
with IN B-PP O
similar JJ B-NP O
deletions NNS I-NP O
. . O O

The DT B-NP O
deletion NN I-NP O
arose VBD B-VP O
as IN B-PP O
a DT B-NP O
result NN I-NP O
of IN B-PP O
recombination NN B-NP O
within IN B-PP O
the DT B-NP O
small JJ I-NP O
insertion NN I-NP O
loop NN I-NP O
formed VBN B-VP O
at IN B-PP O
meiosis NN B-NP O
by IN B-PP O
the DT B-NP O
direct JJ I-NP O
insertion NN I-NP O
( ( O O
dir NN B-NP O
ins NNS I-NP O
( ( O O
5 CD B-NP O
) ) O O
( ( O O
q22 NN B-NP O
. . O O

3q14 CD B-NP O
. . O O

2q15 CD B-NP O
) ) O O
) ) O O
found VBN B-VP O
in IN B-PP O
the DT B-NP O
patients NNS I-NP O
mother NN I-NP O
. . O O

This DT B-NP O
family NN I-NP O
further RBR B-ADVP O
confirms VBZ B-VP O
the DT B-NP O
cytogenetic JJ I-NP O
mapping NN I-NP O
of IN B-PP O
both CC O O
MCC NN B-NP O
and CC I-NP O
APC NN I-NP B-Disease
genes NNS I-NP O
to TO B-PP O
5q22 NN B-NP O
and CC I-NP O
comparison NN I-NP O
with IN B-PP O
other JJ B-NP O
recent JJ I-NP O
cases NNS I-NP O
suggests VBZ B-VP O
that IN B-SBAR O
both CC O O
genes NNS B-NP O
and CC O O
their PRP$ B-NP O
closely RB I-NP O
linked VBN I-NP O
markers NNS I-NP O
lie VBP B-VP O
within IN B-PP O
the DT B-NP O
5q22 NN I-NP O
. . O O

1 CD B-NP O
subband NN I-NP O
Familial JJ B-NP B-Disease
male JJ I-NP I-Disease
breast NN I-NP I-Disease
cancer NN I-NP I-Disease
is VBZ B-VP O
not RB I-VP O
linked VBN I-VP O
to TO B-PP O
the DT B-NP O
BRCA1 NN I-NP O
locus NN I-NP O
on IN B-PP O
chromosome NN B-NP O
17q NN I-NP O
. . O O

Breast NN B-NP B-Disease
cancer NN I-NP I-Disease
in IN B-PP O
men NNS B-NP O
is VBZ B-VP O
about IN B-PP O
a DT B-NP O
hundredfold RB I-NP O
less RBR I-NP O
common JJ I-ADJP O
than IN B-PP O
in IN B-PP O
women NNS B-NP O
and CC O O
this DT B-NP O
has VBZ B-VP O
hindered VBN I-VP O
research NN B-NP O
into IN B-PP O
its PRP$ B-NP O
genetic JJ I-NP O
basis NN I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
examined VBN I-VP O
22 CD B-NP O
families NNS I-NP O
with IN B-PP O
at IN B-NP O
least JJS I-NP O
one CD I-NP O
case NN I-NP O
of IN B-PP O
male JJ B-NP B-Disease
breast NN I-NP I-Disease
cancer NN I-NP I-Disease
for IN B-PP O
linkage NN B-NP O
to TO B-PP O
the DT B-NP O
hereditary JJ I-NP B-Disease
breast NN I-NP I-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
locus NN I-NP O
, , O O
BRCA1 NN B-NP O
, , O O
on IN B-PP O
chromosome NN B-NP O
17q NN I-NP O
. . O O

We PRP B-NP O
found VBD B-VP O
strong JJ B-NP O
evidence NN I-NP O
against IN B-PP O
linkage NN B-NP O
to TO B-PP O
BRCA1 NN B-NP O
( ( O O
lod NN B-NP O
score NN I-NP O
- HYPH B-NP O
16 CD I-NP O
. . I-NP O

63 CD I-NP O
) ) O O
and CC O O
the DT B-NP O
best JJS I-NP O
estimate NN I-NP O
of IN B-PP O
the DT B-NP O
proportion NN I-NP O
of IN B-PP O
linked VBN B-NP O
families NNS I-NP O
was VBD B-VP O
0 CD B-NP O
% NN I-NP O
( ( O O
95 CD B-NP O
% NN I-NP O
CI NN I-NP O
0 CD I-NP O
- HYPH I-NP O
18 CD I-NP O
% NN I-NP O
) ) O O
. . O O

Our PRP$ B-NP O
results NNS I-NP O
indicate VBP B-VP O
that IN B-SBAR O
there EX B-NP O
is VBZ B-VP O
a DT B-NP O
gene NN I-NP O
( ( I-NP O
s NNS I-NP O
) ) O O
other JJ B-ADJP O
than IN B-PP O
BRCA1 NN B-NP O
which WDT B-NP O
predisposes VBZ B-VP O
to TO B-PP O
early JJ B-NP O
- HYPH I-NP O
onset NN I-NP O
breast NN I-NP B-Disease
cancer NN I-NP I-Disease
in IN B-PP O
women NNS B-NP O
and CC O O
which WDT B-NP O
confers VBZ B-VP O
a DT B-NP O
higher JJR I-NP O
risk NN I-NP O
of IN B-PP O
male JJ B-NP B-Disease
breast NN I-NP I-Disease
cancer NN I-NP I-Disease
. . O O

Identification NN B-NP O
of IN B-PP O
additional JJ B-NP O
pedigrees NNS I-NP O
that WDT B-NP O
include VBP B-VP O
cases NNS B-NP O
of IN B-PP O
male JJ B-NP B-Disease
breast NN I-NP I-Disease
cancer NN I-NP I-Disease
may MD B-VP O
therefore RB I-VP O
facilitate VB I-VP O
the DT B-NP O
mapping NN I-NP O
and CC I-NP O
isolation NN I-NP O
of IN B-PP O
this DT B-NP O
gene NN I-NP O
. . O O

The DT B-NP O
EWS NN I-NP O
gene NN I-NP O
, , O O
involved VBN B-VP O
in IN B-PP O
Ewing NNP B-NP B-Disease
family NN I-NP I-Disease
of IN B-PP I-Disease
tumors NNS B-NP I-Disease
, , O O
malignant JJ B-NP B-Disease
melanoma NN I-NP I-Disease
of IN B-PP I-Disease
soft JJ B-NP I-Disease
parts NNS I-NP I-Disease
and CC O O
desmoplastic JJ B-NP B-Disease
small JJ I-NP I-Disease
round JJ I-NP I-Disease
cell NN I-NP I-Disease
tumors NNS I-NP I-Disease
, , O O
codes VBZ B-VP O
for IN B-PP O
an DT B-NP O
RNA NN I-NP O
binding NN I-NP O
protein NN I-NP O
with IN B-PP O
novel JJ B-NP O
regulatory JJ I-NP O
domains NNS I-NP O
. . O O

The DT B-NP O
EWS NN I-NP O
gene NN I-NP O
, , O O
which WDT B-NP O
maps VBZ B-VP O
to TO B-PP O
band NN B-NP O
q12 NN I-NP O
of IN B-PP O
human JJ B-NP O
chromosome NN I-NP O
22 CD I-NP O
, , O O
is VBZ B-VP O
involved VBN I-VP O
in IN B-PP O
a DT B-NP O
wide JJ I-NP O
variety NN I-NP O
of IN B-PP O
human JJ B-NP O
solid JJ I-NP B-Disease
tumors NNS I-NP I-Disease
including VBG B-PP O
Ewing NNP B-NP B-Disease
sarcoma NN I-NP I-Disease
, , O O
related VBN B-VP O
primitive JJ B-NP O
neuroectodermal JJ I-NP B-Disease
tumors NNS I-NP I-Disease
, , O O
malignant JJ B-NP B-Disease
melanoma NN I-NP I-Disease
of IN B-PP I-Disease
soft JJ B-NP I-Disease
parts NNS I-NP I-Disease
and CC O O
desmoplastic JJ B-NP B-Disease
small JJ I-NP I-Disease
round JJ I-NP I-Disease
cell NN I-NP I-Disease
tumors NNS I-NP I-Disease
. . O O

In IN B-PP O
these DT B-NP O
tumors NNS I-NP B-Disease
, , O O
the DT B-NP O
EWS NN I-NP O
is VBZ B-VP O
fused VBN I-VP O
to TO B-PP O
genes NNS B-NP O
encoding VBG B-VP O
transcriptional JJ B-NP O
activators NNS I-NP O
/ SYM B-NP O
repressors NNS I-NP O
, , O O
like IN B-PP O
Fli NNP B-NP O
- HYPH B-NP O
1 CD I-NP O
or CC O O
erg NN B-NP O
or CC O O
ATF NN B-NP O
1 CD I-NP O
or CC I-NP O
wt1 NN I-NP O
. . O O

To TO B-VP O
better RBR I-VP O
understand VB I-VP O
the DT B-NP O
function NN I-NP O
of IN B-PP O
the DT B-NP O
EWS NN I-NP O
protein NN I-NP O
, , O O
we PRP B-NP O
cloned VBD B-VP O
the DT B-NP O
EWS NN I-NP O
cDNA NN I-NP O
. . O O

Sequence NN B-NP O
analysis NN I-NP O
of IN B-PP O
this DT B-NP O
cDNA NN I-NP O
revealed VBD B-VP O
differential JJ B-NP O
splicing NN I-NP O
involving VBG B-VP O
two CD B-NP O
exons NNS I-NP O
encoding VBG B-VP O
72 CD B-NP O
amino NN I-NP O
acids NNS I-NP O
. . O O

Both DT B-NP O
alternatively RB I-NP O
spliced VBN I-NP O
transcripts NNS I-NP O
, , I-NP O
EWS NN I-NP O
and CC I-NP O
EWS NN I-NP O
- HYPH B-NP O
b NN I-NP O
, , O O
are VBP B-VP O
expressed VBN I-VP O
in IN B-PP O
a DT B-NP O
variety NN I-NP O
of IN B-PP O
cells NNS B-NP O
. . O O

Because IN B-SBAR O
EWS NN B-NP O
proteins NNS I-NP O
contain VBP B-VP O
putative JJ B-NP O
conserved VBN I-NP O
RNA NN I-NP O
binding NN I-NP O
motifs NNS I-NP O
, , O O
we PRP B-NP O
studied VBD B-VP O
the DT B-NP O
RNA NN I-NP O
binding NN I-NP O
properties NNS I-NP O
of IN B-PP O
the DT B-NP O
EWS NN I-NP O
protein NN I-NP O
. . O O

The DT B-NP O
EWS NN I-NP O
- HYPH I-NP O
b NN I-NP O
protein NN I-NP O
binds VBZ B-VP O
to TO B-PP O
RNA NN B-NP O
in FW B-ADVP O
vitro FW I-ADVP O
and CC O O
, , O O
specifically RB B-ADVP O
, , O O
to TO B-PP O
poly NN B-NP O
G NN I-NP O
and CC O O
poly NN B-NP O
U NN I-NP O
. . O O

The DT B-NP O
RNA NN I-NP O
binding NN I-NP O
activity NN I-NP O
was VBD B-VP O
localized JJ B-ADJP O
to TO B-PP O
the DT B-NP O
carboxy NN I-NP O
terminal JJ I-NP O
86 CD I-NP O
amino NN I-NP O
acids NNS I-NP O
, , O O
which WDT B-NP O
constitute VBP B-VP O
RGG NN B-NP O
box NN I-NP O
. . O O

Thus RB B-ADVP O
the DT B-NP O
amino JJ I-NP O
terminal JJ I-NP O
domain NN I-NP O
of IN B-PP O
EWS NN B-NP O
( ( O O
NTD NN B-NP O
- HYPH B-NP O
EWS NN I-NP O
) ) O O
, , O O
which WDT B-NP O
is VBZ B-VP O
involved VBN I-VP O
in IN B-PP O
chromosome NN B-NP O
translocation NN I-NP O
may MD B-VP O
regulate VB I-VP O
the DT B-NP O
specificity NN I-NP O
of IN B-PP O
RNA NN B-NP O
binding NN I-NP O
activity NN I-NP O
of IN B-PP O
EWS NN B-NP O
. . O O

An DT B-NP O
EWS NN I-NP O
- HYPH B-NP O
erg NN I-NP O
chimeric JJ I-NP O
protein NN I-NP O
, , O O
which WDT B-NP O
is VBZ B-VP O
found VBN I-VP O
in IN B-PP O
Ewings NNP B-NP B-Disease
sarcoma NN I-NP I-Disease
cells NNS I-NP O
, , O O
functions VBZ B-VP O
as IN B-PP O
a DT B-NP O
transcriptional JJ I-NP O
activator NN I-NP O
. . O O

Mutational JJ B-NP O
analysis NN I-NP O
of IN B-PP O
EWS NN B-NP O
- HYPH B-NP O
erg NN I-NP O
chimeric JJ I-NP O
protein NN I-NP O
revealed VBD B-VP O
that IN B-SBAR O
NTD NN B-NP O
- HYPH B-NP O
EWS NN I-NP O
functions VBZ B-VP O
as IN B-PP O
a DT B-NP O
regulatory JJ I-NP O
domain NN I-NP O
for IN B-PP O
the DT B-NP O
transcriptional JJ I-NP O
activation NN I-NP O
properties NNS I-NP O
of IN B-PP O
EWS NN B-NP O
- HYPH B-NP O
erg NN I-NP O
chimeric JJ I-NP O
protein NN I-NP O
. . O O

. . O O

Canavan NNP B-NP B-Disease
disease NN I-NP I-Disease
: : O O
genomic JJ B-NP O
organization NN I-NP O
and CC I-NP O
localization NN I-NP O
of IN B-PP O
human JJ B-NP O
ASPA NN I-NP O
to TO B-PP O
17p13 CD B-NP O
- HYPH I-NP O
ter NN I-NP O
and CC I-NP O
conservation NN I-NP O
of IN B-PP O
the DT B-NP O
ASPA NN I-NP O
gene NN I-NP O
during IN B-PP O
evolution NN B-NP O
. . O O

Canavan NNP B-NP B-Disease
disease NN I-NP I-Disease
, , O O
or CC O O
spongy JJ B-NP B-Disease
degeneration NN I-NP I-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
brain NN I-NP I-Disease
, , O O
is VBZ B-VP O
a DT B-NP O
severe JJ I-NP O
leukodystrophy NN I-NP B-Disease
caused VBN B-VP O
by IN B-PP O
the DT B-NP O
deficiency NN I-NP B-Disease
of IN B-PP I-Disease
aspartoacylase NN B-NP I-Disease
( ( O O
ASPA NN B-NP O
) ) O O
. . O O

Recently RB B-ADVP O
, , O O
a DT B-NP O
missense JJ I-NP O
mutation NN I-NP O
was VBD B-VP O
identified VBN I-VP O
in IN B-PP O
human JJ B-NP O
ASPA NN I-NP O
coding NN I-NP O
sequence NN I-NP O
from IN B-PP O
patients NNS B-NP O
with IN B-PP O
Canavan NN B-NP B-Disease
disease NN I-NP I-Disease
. . O O

The DT B-NP O
human JJ I-NP O
ASPA NN I-NP O
gene NN I-NP O
has VBZ B-VP O
been VBN I-VP O
cloned VBN I-VP O
and CC O O
found VBN B-VP O
to TO I-VP O
span VB I-VP O
29 CD B-NP O
kb NN I-NP O
of IN B-PP O
the DT B-NP O
genome NN I-NP O
. . O O

Human JJ B-NP O
aspartoacylase NN I-NP O
is VBZ B-VP O
coded VBN I-VP O
by IN B-PP O
six CD B-NP O
exons NNS I-NP O
intervened VBN B-VP O
by IN B-PP O
five CD B-NP O
introns NNS I-NP O
. . O O

The DT B-NP O
exons NNS I-NP O
vary VBP B-VP O
from IN B-PP O
94 CD B-NP O
( ( O O
exon NN B-NP O
III CD I-NP O
) ) O O
to TO B-PP O
514 CD B-NP O
( ( O O
exon NN B-NP O
VI CD I-NP O
) ) O O
bases NNS B-NP O
. . O O

The DT B-NP O
exon NN I-NP O
/ SYM B-VP O
intron NN B-NP O
splice NN I-NP O
junction NN I-NP O
sites NNS I-NP O
follow VBP B-VP O
the DT B-NP O
gt NN I-NP O
/ SYM B-NP O
ag NN I-NP O
consensus NN I-NP O
sequence NN I-NP O
rule NN I-NP O
. . O O

Southern NN B-NP O
blot NN I-NP O
analysis NN I-NP O
of IN B-PP O
genomic JJ B-NP O
DNA NN I-NP O
from IN B-PP O
human JJ B-NP O
/ SYM I-NP O
mouse NN I-NP O
somatic JJ I-NP O
cell NN I-NP O
hybrid NN I-NP O
cell NN I-NP O
lines NNS I-NP O
localized VBD B-VP O
ASPA NN B-NP O
to TO B-PP O
human JJ B-NP O
chromosome NN I-NP O
17 CD I-NP O
. . O O

The DT B-NP O
human JJ I-NP O
ASPA NN I-NP O
locus NN I-NP O
was VBD B-VP O
further RBR I-VP O
mapped VBN I-VP O
in IN B-PP O
the DT B-NP O
17p13 CD I-NP O
- HYPH I-NP O
ter NN I-NP O
region NN I-NP O
by IN B-PP O
fluorescence NN B-NP O
in FW B-NP O
situ FW I-NP O
hybridization NN I-NP O
. . O O

The DT B-NP O
bovine JJ I-NP O
aspa NN I-NP O
gene NN I-NP O
has VBZ B-VP O
also RB I-VP O
been VBN I-VP O
cloned VBN I-VP O
, , O O
and CC O O
its PRP$ B-NP O
exon NN I-NP O
/ SYM I-NP O
intron NN I-NP O
organization NN I-NP O
is VBZ B-VP O
identical JJ B-ADJP O
to TO B-PP O
that DT B-NP O
of IN B-PP O
the DT B-NP O
human JJ I-NP O
gene NN I-NP O
. . O O

The DT B-NP O
500 CD I-NP O
- HYPH I-NP O
base NN I-NP O
sequence NN I-NP O
upstream JJ B-ADJP O
of IN B-PP O
the DT B-NP O
initiator NN I-NP O
ATG NN I-NP O
codon NN I-NP O
in IN B-PP O
the DT B-NP O
human JJ I-NP O
gene NN I-NP O
and CC O O
that IN B-SBAR O
in IN B-PP O
the DT B-NP O
bovine JJ I-NP O
gene NN I-NP O
are VBP B-VP O
77 CD B-NP O
% NN I-NP O
identical JJ B-ADJP O
. . O O

Human JJ B-NP O
ASPA NN I-NP O
coding NN I-NP O
sequences NNS I-NP O
cross AFX O O
- HYPH O O
hybridize NN B-NP O
with IN B-PP O
genomic JJ B-NP O
DNA NN I-NP O
from IN B-PP O
yeast NN B-NP O
, , O O
chicken NN B-NP O
, , O O
rabbit NN B-NP O
, , O O
cow NN B-NP O
, , O O
dog NN B-NP O
, , O O
mouse NN B-NP O
, , O O
rat NN B-NP O
, , O O
and CC O O
monkey NN B-NP O
. . O O

The DT B-NP O
specificity NN I-NP O
of IN B-PP O
cross AFX B-NP O
- HYPH I-NP O
species NN I-NP O
hybridization NN I-NP O
of IN B-PP O
coding VBG B-VP O
sequences NNS B-NP O
suggests VBZ B-VP O
that IN B-SBAR O
aspartoacylase NN B-NP O
has VBZ B-VP O
been VBN I-VP O
conserved VBN I-VP O
during IN B-PP O
evolution NN B-NP O
. . O O

It PRP B-NP O
should MD B-VP O
now RB I-VP O
be VB I-VP O
possible JJ B-ADJP O
to TO B-VP O
identify VB I-VP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
noncoding JJ I-NP O
genomic JJ I-NP O
sequences NNS I-NP O
that WDT B-NP O
lead VBP B-VP O
to TO B-PP O
Canavan NNP B-NP B-Disease
disease NN I-NP I-Disease
and CC O O
to TO B-VP O
study VB I-VP O
the DT B-NP O
regulation NN I-NP O
of IN B-PP O
ASPA NN B-NP O
. . O O

. . O O

Myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
: : O O
size NN B-NP O
- HYPH B-NP O
and CC I-NP O
sex NN I-NP O
- HYPH I-NP O
dependent JJ I-NP O
dynamics NNS I-NP O
of IN B-PP O
CTG NN B-NP O
meiotic JJ I-NP O
instability NN I-NP O
, , O O
and CC O O
somatic JJ B-NP O
mosaicism NN I-NP O
. . O O

Myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
( ( O O
DM NN B-NP B-Disease
) ) O O
is VBZ B-VP O
a DT B-NP O
progressive JJ I-NP O
neuromuscular JJ I-NP B-Disease
disorder NN I-NP I-Disease
which WDT B-NP O
results VBZ B-VP O
from IN B-PP O
elongations NNS B-NP O
of IN B-PP O
an DT B-NP O
unstable JJ I-NP O
( ( O O
CTG NN B-NP O
) ) O O
n NN B-NP O
repeat NN I-NP O
, , O O
located JJ B-ADJP O
in IN B-PP O
the DT B-NP O
3 CD I-NP O
untranslated JJ I-NP O
region NN I-NP O
of IN B-PP O
the DT B-NP O
DM NN I-NP B-Disease
gene NN I-NP O
. . O O

A DT B-NP O
correlation NN I-NP O
has VBZ B-VP O
been VBN I-VP O
demonstrated VBN I-VP O
between IN B-PP O
the DT B-NP O
increase NN I-NP O
in IN B-PP O
the DT B-NP O
repeat NN I-NP O
number NN I-NP O
of IN B-PP O
this DT B-NP O
sequence NN I-NP O
and CC O O
the DT B-NP O
severity NN I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
. . O O

However RB B-ADVP O
, , O O
the DT B-NP O
clinical JJ I-NP O
status NN I-NP O
of IN B-PP O
patients NNS B-NP O
cannot MD B-VP O
be VB I-VP O
unambiguously RB I-VP O
ascertained VBN I-VP O
solely RB B-ADVP O
on IN B-PP O
the DT B-NP O
basis NN I-NP O
of IN B-PP O
the DT B-NP O
number NN I-NP O
of IN B-PP O
CTG NN B-NP O
repeats NNS I-NP O
. . O O

Moreover RB B-ADVP O
, , O O
the DT B-NP O
exclusive JJ I-NP O
maternal JJ I-NP O
inheritance NN I-NP O
of IN B-PP O
the DT B-NP O
congenital JJ I-NP O
form NN I-NP O
remains VBZ B-VP O
unexplained JJ B-ADJP O
. . O O

Our PRP$ B-NP O
observation NN I-NP O
of IN B-PP O
differently RB B-NP O
sized VBN I-NP O
repeats NNS I-NP O
in IN B-PP O
various JJ B-NP O
DM NN I-NP B-Disease
tissues NNS I-NP O
from IN B-PP O
the DT B-NP O
same JJ I-NP O
individual NN I-NP O
may MD B-VP O
explain VB I-VP O
why WRB B-ADVP O
the DT B-NP O
size NN I-NP O
of IN B-PP O
the DT B-NP O
mutation NN I-NP O
observed VBN B-VP O
in IN B-PP O
lymphocytes NNS B-NP O
does VBZ B-VP O
not RB I-VP O
necessarily RB I-VP O
correlate VB I-VP O
with IN B-PP O
the DT B-NP O
severity NN I-NP O
and CC I-NP O
nature NN I-NP O
of IN B-PP O
symptoms NNS B-NP O
. . O O

Through IN B-PP O
a DT B-NP O
molecular JJ I-NP O
and CC I-NP O
genetic JJ I-NP O
study NN I-NP O
of IN B-PP O
142 CD B-NP O
families NNS I-NP O
including VBG B-PP O
418 CD B-NP O
DM NN I-NP B-Disease
patients NNS I-NP O
, , O O
we PRP B-NP O
have VBP B-VP O
investigated VBN I-VP O
the DT B-NP O
dynamics NNS I-NP O
of IN B-PP O
the DT B-NP O
CTG NN I-NP O
repeat NN I-NP O
meiotic JJ I-NP O
instability NN I-NP O
. . O O

A DT B-NP O
positive JJ I-NP O
correlation NN I-NP O
between IN B-PP O
the DT B-NP O
size NN I-NP O
of IN B-PP O
the DT B-NP O
repeat NN I-NP O
and CC O O
the DT B-NP O
intergenerational JJ I-NP O
enlargement NN I-NP O
was VBD B-VP O
observed VBN I-VP O
similarly RB B-ADVP O
through IN B-PP O
male JJ B-NP O
and CC I-NP O
female JJ I-NP O
meioses NNS I-NP O
for IN B-PP O
< SYM B-NP O
or CC O O
= SYM B-VP O
0 CD B-NP O
. . O O

5 CD B-NP O
- HYPH I-NP O
kb NN I-NP O
CTG NN I-NP O
sequences NNS I-NP O
. . O O

Beyond IN B-PP O
0 CD B-NP O
. . O O

5 CD B-NP O
kb NN I-NP O
, , O O
the DT B-NP O
intergenerational JJ I-NP O
variation NN I-NP O
was VBD B-VP O
more RBR B-ADJP O
important JJ I-ADJP O
through IN B-PP O
female JJ B-NP O
meioses NNS I-NP O
, , O O
whereas IN O O
a DT B-NP O
tendency NN I-NP O
to TO B-PP O
compression NN B-NP O
was VBD B-VP O
observed VBN I-VP O
almost RB B-ADVP O
exclusively RB I-ADVP O
in IN B-PP O
male JJ B-NP O
meioses NNS I-NP O
, , O O
for IN B-PP O
> SYM B-NP O
or CC O O
= SYM B-VP O
1 CD B-NP O
. . O O

5 CD B-NP O
- HYPH I-NP O
kb NN I-NP O
fragments NNS I-NP O
. . O O

This DT B-NP O
implies VBZ B-VP O
a DT B-NP O
size NN I-NP O
- HYPH I-NP O
and CC I-NP O
sex NN I-NP O
- HYPH B-NP O
dependent JJ I-NP O
meiotic JJ I-NP O
instability NN I-NP O
. . O O

Moreover RB B-ADVP O
, , O O
segregation NN B-NP O
analysis NN I-NP O
supports VBZ B-VP O
the DT B-NP O
hypothesis NN I-NP O
of IN B-PP O
a DT B-NP O
maternal JJ I-NP O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
a DT B-NP O
familial JJ I-NP O
predisposition NN I-NP O
for IN B-PP O
the DT B-NP O
occurrence NN I-NP O
of IN B-PP O
the DT B-NP O
congenital JJ I-NP O
form NN I-NP O
. . O O

Finally RB B-ADVP O
, , O O
this DT B-NP O
analysis NN I-NP O
reveals VBZ B-VP O
a DT B-NP O
significant JJ I-NP O
excess NN I-NP O
of IN B-PP O
transmitting VBG B-VP O
grandfathers NNS B-NP O
partially RB B-ADVP O
accounted VBD B-VP O
for IN B-PP O
by IN B-PP O
increased VBN B-NP O
fertility NN I-NP O
in IN B-PP O
affected VBN B-NP O
males NNS I-NP O
Illegitimate JJ B-NP O
transcription NN I-NP O
of IN B-PP O
the DT B-NP O
phenylalanine NN I-NP O
hydroxylase NN I-NP O
gene NN I-NP O
in IN B-PP O
lymphocytes NNS B-NP O
for IN B-PP O
identification NN B-NP O
of IN B-PP O
mutations NNS B-NP O
in IN B-PP O
phenylketonuria NN B-NP B-Disease
. . O O

Taking VBG B-VP O
advantage NN B-NP O
of IN B-PP O
the DT B-NP O
illegitimate JJ I-NP O
transcription NN I-NP O
of IN B-PP O
the DT B-NP O
phenylalanine NN I-NP O
hydroxylase NN I-NP O
( ( O O
PAH NN B-NP O
) ) O O
gene NN B-NP O
, , O O
we PRP B-NP O
have VBP B-VP O
been VBN I-VP O
able JJ B-ADJP O
to TO B-VP O
analyse VB I-VP O
the DT B-NP O
PAH NN I-NP O
cDNA NN I-NP O
sequence NN I-NP O
of IN B-PP O
hyperphenylalaninemic JJ B-NP B-Disease
children NNS I-NP O
in IN B-PP O
circulating VBG B-VP O
lymphocytes NNS B-NP O
. . O O

Using VBG B-VP O
this DT B-NP O
approach NN I-NP O
, , O O
we PRP B-NP O
have VBP B-VP O
also RB I-VP O
identified VBN I-VP O
3 CD B-NP O
novel JJ I-NP O
mutations NNS I-NP O
in IN B-PP O
cDNA NN B-NP O
from IN B-PP O
liver NN B-NP O
and CC I-NP O
lymphocytes NNS I-NP O
of IN B-PP O
two CD B-NP O
patients NNS I-NP O
. . O O

One CD B-NP O
mutation NN I-NP O
, , O O
detected VBN B-VP O
by IN B-PP O
the DT B-NP O
abnormal JJ I-NP O
pattern NN I-NP O
of IN B-PP O
migration NN B-NP O
of IN B-PP O
an DT B-NP O
amplified VBN I-NP O
fragment NN I-NP O
, , O O
is VBZ B-VP O
a DT B-NP O
C NN I-NP O
to TO B-PP O
T NN B-NP O
transition NN I-NP O
in IN B-PP O
the DT B-NP O
splice NN I-NP O
acceptor NN I-NP O
site NN I-NP O
of IN B-PP O
intron NN B-NP O
10 CD I-NP O
, , O O
which WDT B-NP O
resulted VBD B-VP O
in IN B-PP O
the DT B-NP O
skipping NN I-NP O
of IN B-PP O
exon NN B-NP O
11 CD I-NP O
with IN B-PP O
the DT B-NP O
premature JJ I-NP O
termination NN I-NP O
of IN B-PP O
RNA NN B-NP O
translation NN I-NP O
downstream RB B-ADVP O
from IN B-PP O
exon NN B-NP O
12 CD I-NP O
( ( O O
- SYM O O
3 CD B-NP O
IVS10 NN I-NP O
) ) O O
. . O O

The DT B-NP O
other JJ I-NP O
two CD I-NP O
mutations NNS I-NP O
are VBP B-VP O
missense JJ B-NP O
mutations NNS I-NP O
in IN B-PP O
exons NNS B-NP O
10 CD B-NP O
and CC I-NP O
11 CD I-NP O
( ( O O
respectively RB B-ADVP O
, , O O
L333F NN B-NP O
and CC O O
E390G NN B-NP O
) ) O O
. . O O

The DT B-NP O
present JJ I-NP O
study NN I-NP O
supports VBZ B-VP O
the DT B-NP O
view NN I-NP O
that IN B-SBAR O
circulating VBG B-VP O
lymphocytes NNS B-NP O
give VBP B-VP O
easy JJ B-NP O
access NN I-NP O
to TO B-PP O
PAH NN B-NP O
gene NN I-NP O
transcripts NNS I-NP O
whose WP$ B-NP O
nucleotide NN I-NP O
sequence NN I-NP O
is VBZ B-VP O
identical JJ B-ADJP O
to TO B-PP O
that DT B-NP O
reported VBN B-VP O
in IN B-PP O
liver NN B-NP O
and CC O O
therefore RB B-ADVP O
represent VBP B-VP O
a DT B-NP O
useful JJ I-NP O
tool NN I-NP O
for IN B-PP O
molecular JJ B-NP O
genetic JJ I-NP O
studies NNS I-NP O
in IN B-PP O
phenylketonuria NN B-NP B-Disease
. . O O

. . O O

High JJ B-NP O
residual JJ I-NP O
arylsulfatase NN I-NP O
A NN I-NP O
( ( O O
ARSA NN B-NP O
) ) O O
activity NN B-NP O
in IN B-PP O
a DT B-NP O
patient NN I-NP O
with IN B-PP O
late JJ B-NP B-Disease
- HYPH I-NP I-Disease
infantile JJ I-NP I-Disease
metachromatic JJ I-NP I-Disease
leukodystrophy NN I-NP I-Disease
. . O O

We PRP B-NP O
identified VBD B-VP O
a DT B-NP O
patient NN I-NP O
suffering VBG B-VP O
from IN B-PP O
late JJ B-NP B-Disease
- HYPH I-NP I-Disease
infantile JJ I-NP I-Disease
metachromatic JJ I-NP I-Disease
leukodystrophy NN I-NP I-Disease
( ( O O
MLD NN B-NP B-Disease
) ) O O
who WP B-NP O
has VBZ B-VP O
a DT B-NP O
residual JJ I-NP O
arylsulfatase NN I-NP O
A NN I-NP O
( ( O O
ARSA NN B-NP O
) ) O O
activity NN B-NP O
of IN B-PP O
about IN B-NP O
10 CD I-NP O
% NN I-NP O
. . O O

Fibroblasts NNS B-NP O
of IN B-PP O
the DT B-NP O
patient NN I-NP O
show VBP B-VP O
significant JJ B-NP O
sulfatide NN I-NP O
degradation NN I-NP O
activity NN I-NP O
exceeding VBG B-VP O
that DT B-NP O
of IN B-PP O
adult JJ B-NP B-Disease
MLD NN I-NP I-Disease
patients NNS I-NP O
. . O O

Analysis NN B-NP O
of IN B-PP O
the DT B-NP O
ARSA NN I-NP O
gene NN I-NP O
in IN B-PP O
this DT B-NP O
patient NN I-NP O
revealed VBD B-VP O
heterozygosity NN B-NP O
for IN B-PP O
two CD B-NP O
new JJ I-NP O
mutant JJ I-NP O
alleles NNS I-NP O
in IN B-PP O
one CD B-NP O
allele NN I-NP O
, , O O
deletion NN B-NP O
of IN B-PP O
C NN B-NP O
447 CD I-NP O
in IN B-PP O
exon NN B-NP O
2 CD I-NP O
leads VBZ B-VP O
to TO B-PP O
a DT B-NP O
frameshift NN I-NP O
and CC B-PP O
to TO B-PP O
a DT B-NP O
premature JJ I-NP O
stop NN I-NP O
codon NN I-NP O
at IN B-PP O
amino JJ B-NP O
acid NN I-NP O
position NN I-NP O
105 CD I-NP O
; : O O
in IN B-PP O
the DT B-NP O
second JJ I-NP O
allele NN I-NP O
, , O O
a DT B-NP O
G NN I-NP O
- SYM B-NP O
- HYPH B-NP O
> SYM I-NP O
A NN I-NP O
transition NN I-NP O
in IN B-PP O
exon NN B-NP O
5 CD I-NP O
causes VBZ B-VP O
a DT B-NP O
Gly309 NN I-NP O
- SYM B-NP O
- SYM B-NP O
> SYM I-NP O
Ser NN I-NP O
substitution NN I-NP O
. . O O

Transient JJ B-NP O
expression NN I-NP O
of IN B-PP O
the DT B-NP O
mutant JJ I-NP O
Ser309 NN I-NP O
- HYPH B-NP O
ARSA NN I-NP O
resulted VBD B-VP O
in IN B-PP O
only RB B-NP O
13 CD I-NP O
% NN I-NP O
enzyme NN I-NP O
activity NN I-NP O
of IN B-PP O
that DT B-NP O
observed VBN B-VP O
in IN B-PP O
cells NNS B-NP O
expressing VBG B-VP O
normal JJ B-NP O
ARSA NN I-NP O
. . O O

The DT B-NP O
mutant JJ I-NP O
ARSA NN I-NP O
is VBZ B-VP O
correctly RB I-VP O
targeted VBN I-VP O
to TO B-PP O
the DT B-NP O
lysosomes NNS I-NP O
but CC O O
is VBZ B-VP O
unstable JJ B-ADJP O
. . O O

These DT B-NP O
findings NNS I-NP O
are VBP B-VP O
in IN B-PP O
contrast NN B-NP O
to TO B-PP O
previous JJ B-NP O
results NNS I-NP O
showing VBG B-VP O
that IN B-SBAR O
the DT B-NP O
late JJ I-NP B-Disease
- HYPH I-NP I-Disease
infantile JJ I-NP I-Disease
type NN I-NP I-Disease
of IN B-PP I-Disease
MLD NN B-NP I-Disease
is VBZ B-VP O
always RB I-VP O
associated VBN I-VP O
with IN B-PP O
the DT B-NP O
complete JJ I-NP O
absence NN I-NP O
of IN B-PP O
ARSA NN B-NP O
activity NN I-NP O
. . O O

The DT B-NP O
expression NN I-NP O
of IN B-PP O
the DT B-NP O
mutant JJ I-NP O
ARSA NN I-NP O
protein NN I-NP O
may MD B-VP O
be VB I-VP O
influenced VBN I-VP O
by IN B-PP O
particular JJ B-NP O
features NNS I-NP O
of IN B-PP O
oligodendrocytes NNS B-NP O
, , O O
such JJ B-ADJP O
that IN B-SBAR O
the DT B-NP O
level NN I-NP O
of IN B-PP O
mutant JJ B-NP O
enzyme NN I-NP O
is VBZ B-VP O
lower JJR B-ADJP O
in IN B-PP O
these DT B-NP O
cells NNS I-NP O
than IN B-PP O
in IN B-PP O
others NNS B-NP O
. . O O

. . O O

An DT B-NP O
arylsulfatase NN I-NP O
A NN I-NP O
( ( I-NP O
ARSA NN I-NP O
) ) I-NP O
missense JJ I-NP O
mutation NN I-NP O
( ( O O
T274M NN B-NP O
) ) O O
causing VBG B-VP O
late JJ B-NP B-Disease
- HYPH I-NP I-Disease
infantile JJ I-NP I-Disease
metachromatic JJ I-NP I-Disease
leukodystrophy NN I-NP I-Disease
. . O O

Metachromatic JJ B-NP B-Disease
leukodystrophy NN I-NP I-Disease
( ( O O
MLD NN B-NP B-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
lysosomal JJ I-NP I-Disease
storage NN I-NP I-Disease
disorder NN I-NP I-Disease
caused VBN B-VP O
by IN B-PP O
a DT B-NP O
deficiency NN I-NP B-Disease
of IN B-PP I-Disease
arylsulfatase NN B-NP I-Disease
A NN I-NP I-Disease
( ( O O
ARSA NN B-NP O
; : O O
EC NNP B-NP O
3 CD I-NP O
. SYM I-NP O

1 CD I-NP O
. SYM I-NP O

6 CD I-NP O
. SYM I-NP O

8 CD I-NP O
) ) O O
. . O O

The DT B-NP O
8 CD I-NP O
ARSA NN I-NP O
exons NNS I-NP O
and CC O O
adjacent JJ B-NP O
intron NN I-NP O
boundaries NNS I-NP O
from IN B-PP O
a DT B-NP O
patient NN I-NP O
with IN B-PP O
late JJ B-NP B-Disease
- HYPH I-NP I-Disease
infantile JJ I-NP I-Disease
metachromatic JJ I-NP I-Disease
leukodystrophy NN I-NP I-Disease
were VBD B-VP O
polymerase NN B-NP O
chain NN I-NP O
reaction NN I-NP O
( ( O O
PCR NN B-NP O
) ) O O
amplified VBN B-VP O
in IN B-PP O
seven CD B-NP O
discrete JJ I-NP O
reactions NNS I-NP O
. . O O

Amplified VBN B-NP O
ARSA NN I-NP O
exons NNS I-NP O
were VBD B-VP O
analysed VBN I-VP O
for IN B-PP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
sequence NN B-NP O
alterations NNS I-NP O
by IN B-PP O
single JJ B-NP O
- HYPH I-NP O
strand NN I-NP O
conformation NN I-NP O
polymorphism NN I-NP O
analysis NN I-NP O
, , O O
followed VBN B-VP O
by IN B-PP O
direct JJ B-NP O
sequencing NN I-NP O
of IN B-PP O
PCR NN B-NP O
products NNS I-NP O
. . O O

The DT B-NP O
patient NN I-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
be VB I-VP O
homozygous JJ B-ADJP O
for IN B-PP O
a DT B-NP O
C NN I-NP O
- SYM B-NP O
- SYM B-NP O
> SYM I-NP O
T NN I-NP O
transition NN I-NP O
in IN B-PP O
exon NN B-NP O
IV CD I-NP O
that WDT B-NP O
results VBZ B-VP O
in IN B-PP O
the DT B-NP O
substitution NN I-NP O
of IN B-PP O
a DT B-NP O
highly RB I-NP O
conserved VBN I-NP O
threonine NN I-NP O
residue NN I-NP O
at IN B-PP O
amino NN B-NP O
acid NN I-NP O
274 CD I-NP O
with IN B-PP O
a DT B-NP O
methionine NN I-NP O
( ( O O
T274M NN B-NP O
) ) O O
. . O O

Analysis NN B-NP O
of IN B-PP O
a DT B-NP O
further JJ I-NP O
29 CD I-NP O
MLD NN I-NP B-Disease
patients NNS I-NP O
revealed VBD B-VP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
five CD B-NP O
additional JJ I-NP O
homozygotes NNS I-NP O
for IN B-PP O
T274M NN B-NP O
. . O O

All DT B-NP O
6 CD I-NP O
T274M NN I-NP O
homozygotes NNS I-NP O
( ( O O
representing VBG B-VP O
four CD B-NP O
families NNS I-NP O
) ) O O
were VBD B-VP O
of IN B-PP O
Lebanese JJ B-NP O
descent NN I-NP O
, , O O
and CC O O
all DT B-NP O
were VBD B-VP O
known VBN I-VP O
to TO I-VP O
be VB I-VP O
the DT B-NP O
result NN I-NP O
of IN B-PP O
consanguineous JJ B-NP O
marriages NNS I-NP O
. . O O

The DT B-NP O
altered JJ I-NP O
amino NN I-NP O
acid NN I-NP O
is VBZ B-VP O
rigidly RB I-VP O
conserved VBN I-VP O
among IN B-PP O
10 CD B-NP O
sulfatases NNS I-NP O
from IN B-PP O
Escherichia FW B-NP O
coli FW I-NP O
to TO B-PP O
humans NNS B-NP O
; : O O
therefore RB B-ADVP O
, , O O
it PRP B-NP O
is VBZ B-VP O
most RBS B-ADJP O
likely JJ I-ADJP O
that IN B-SBAR O
the DT B-NP O
resultant JJ I-NP O
mutant JJ I-NP O
protein NN I-NP O
will MD B-VP O
have VB I-VP O
little JJ B-NP O
or CC I-NP O
no DT I-NP O
enzyme NN I-NP O
activity NN I-NP O
. . O O

This DT B-NP O
is VBZ B-VP O
consistent JJ B-ADJP O
with IN B-PP O
the DT B-NP O
very RB I-NP O
low JJ I-NP O
ARSA NN I-NP O
activity NN I-NP O
measured VBN B-VP O
in IN B-PP O
these DT B-NP O
patients NNS I-NP O
and CC O O
their PRP$ B-NP O
uniformly JJ I-NP O
severe JJ I-NP O
clinical JJ I-NP O
presentation NN I-NP O
Mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
PAX6 NN I-NP O
gene NN I-NP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
hereditary JJ B-NP O
aniridia NN I-NP B-Disease
. . O O

The DT B-NP O
14 CD I-NP O
exons NNS I-NP O
of IN B-PP O
the DT B-NP O
PAX6 NN I-NP O
gene NN I-NP O
have VBP B-VP O
been VBN I-VP O
analysed VBN B-NP O
exon NN I-NP O
- HYPH B-ADJP O
by IN B-PP O
- HYPH B-NP O
exon NN I-NP O
using VBG B-VP O
SSCP NN B-NP O
in IN B-PP O
6 CD B-NP O
aniridia NN I-NP B-Disease
families NNS I-NP O
. . O O

In IN B-PP O
each DT B-NP O
family NN I-NP O
band NN I-NP O
shifts NNS I-NP O
were VBD B-VP O
observed VBN I-VP O
on IN B-PP O
the DT B-NP O
SSCP NN I-NP O
gels NNS I-NP O
for IN B-PP O
only RB B-NP O
one CD I-NP O
exon NN I-NP O
and CC O O
direct JJ B-NP O
PCR NN I-NP O
- HYPH I-NP O
sequencing NN I-NP O
revealed VBD B-VP O
mutations NNS B-NP O
in IN B-PP O
each DT B-NP O
case NN I-NP O
. . O O

Two CD B-NP O
mutations NNS I-NP O
involved VBD B-VP O
C NN B-NP O
- SYM O O
- SYM B-NP O
> SYM I-NP O
T NN I-NP O
transitions NNS I-NP O
in IN B-PP O
CGAarg NN B-NP O
codons NNS I-NP O
in IN B-PP O
exons NNS B-NP O
9 CD B-NP O
and CC I-NP O
11 CD I-NP O
. . O O

Another DT B-NP O
C NN I-NP O
- SYM B-VP O
- SYM B-NP O
> SYM I-NP O
T NN I-NP O
transition NN I-NP O
converted VBD B-VP O
a DT B-NP O
CAG NN I-NP O
- HYPH B-NP O
glutamine NN I-NP O
to TO B-PP O
a DT B-NP O
TAG NN I-NP O
- HYPH B-NP O
stop NN I-NP O
in IN B-PP O
exon NN B-NP O
7 CD I-NP O
. . O O

Small JJ B-NP O
insertions NNS I-NP O
created VBD B-VP O
frameshifts NNS B-NP O
which WDT B-NP O
produced VBD B-VP O
downstream JJ B-NP O
stop NN I-NP O
codons NNS I-NP O
in IN B-PP O
another DT B-NP O
two CD I-NP O
patients NNS I-NP O
and CC O O
an DT B-NP O
A NN I-NP O
- SYM B-NP O
- HYPH I-NP O
> SYM I-NP O
T NN I-NP O
mutation NN I-NP O
disrupted VBD B-VP O
the DT B-NP O
splice NN I-NP O
donor NN I-NP O
site NN I-NP O
of IN B-PP O
exon NN B-NP O
5 CD I-NP O
in IN B-PP O
the DT B-NP O
remaining VBG I-NP O
family NN I-NP O
. . O O

Thus RB B-ADVP O
, , O O
complete JJ B-NP O
inactivation NN I-NP O
of IN B-PP O
the DT B-NP O
PAX6 NN I-NP O
gene NN I-NP O
is VBZ B-VP O
predicted VBN I-VP O
in IN B-PP O
all DT B-NP O
cases NNS I-NP O
. . O O

Analysis NN B-NP O
of IN B-PP O
other JJ B-NP O
affected VBN I-NP O
members NNS I-NP O
of IN B-PP O
the DT B-NP O
families NNS I-NP O
showed VBD B-VP O
that IN B-SBAR O
, , O O
in IN B-PP O
each DT B-NP O
case NN I-NP O
, , O O
all DT B-NP O
affected VBN I-NP O
individuals NNS I-NP O
carried VBD B-VP O
the DT B-NP O
same JJ I-NP O
family NN I-NP O
- HYPH B-NP O
specific JJ I-NP O
mutation NN I-NP O
. . O O

One CD B-NP O
polymorphism NN I-NP O
was VBD B-VP O
found VBN I-VP O
in IN B-PP O
exon NN B-NP O
7 CD I-NP O
. . O O

This DT B-NP O
data NNS I-NP O
strongly RB B-VP O
supports VBZ I-VP O
the DT B-NP O
candidature NN I-NP O
of IN B-PP O
PAX6 NN B-NP O
as IN B-PP O
the DT B-NP O
gene NN I-NP O
responsible JJ B-ADJP O
for IN B-PP O
hereditary JJ B-NP O
aniridia NN I-NP B-Disease
. . O O

. . O O

Three CD B-NP O
novel JJ I-NP O
mutations NNS I-NP O
in IN B-PP O
five CD B-NP O
unrelated JJ I-NP O
subjects NNS I-NP O
with IN B-PP O
hereditary JJ B-NP O
protein NN I-NP B-Disease
S NN I-NP I-Disease
deficiency NN I-NP I-Disease
type NN I-NP I-Disease
I CD I-NP I-Disease
. . O O

A DT B-NP O
panel NN I-NP O
of IN B-PP O
eight CD B-NP O
unrelated JJ I-NP O
subjects NNS I-NP O
with IN B-PP O
inherited VBN B-NP O
type NN I-NP B-Disease
I CD I-NP I-Disease
protein NN I-NP I-Disease
S NN I-NP I-Disease
deficiency NN I-NP I-Disease
was VBD B-VP O
screened VBN I-VP O
for IN B-PP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
PROS1 NN I-NP O
gene NN I-NP O
. . O O

In IN B-PP O
five CD B-NP O
subjects NNS I-NP O
an DT B-NP O
abnormality NN I-NP O
was VBD B-VP O
found VBN I-VP O
but CC O O
mutations NNS B-NP O
were VBD B-VP O
not RB I-VP O
detected VBN I-VP O
in IN B-PP O
the DT B-NP O
remaining VBG I-NP O
three CD I-NP O
subjects NNS I-NP O
. . O O

Two CD B-NP O
subjects NNS I-NP O
shared VBD B-VP O
a DT B-NP O
G NN I-NP O
- SYM B-NP O
- HYPH B-NP O
> SYM I-NP O
A NN I-NP O
transition NN I-NP O
at IN B-PP O
position NN B-NP O
+ SYM O O
5 CD B-NP O
of IN B-PP O
the DT B-NP O
donor NN I-NP O
splice NN I-NP O
site NN I-NP O
consensus NN I-NP O
sequence NN I-NP O
of IN B-PP O
intron NN B-NP O
10 CD I-NP O
. . O O

Also RB B-ADVP O
in IN B-PP O
two CD B-NP O
subjects NNS I-NP O
an DT B-NP O
A NN I-NP O
- SYM B-NP O
- HYPH I-NP O
> SYM I-NP O
T NN I-NP O
transversion NN I-NP O
was VBD B-VP O
detected VBN I-VP O
in IN B-PP O
the DT B-NP O
stopcodon NN I-NP O
of IN B-PP O
the DT B-NP O
PROS1 NN I-NP O
gene NN I-NP O
; : O O
this DT B-NP O
transversion NN I-NP O
predicts VBZ B-VP O
a DT B-NP O
protein NN I-NP O
S NN I-NP O
molecule NN I-NP O
that WDT B-NP O
is VBZ B-VP O
extended VBN I-VP O
by IN B-PP O
14 CD B-NP O
amino NN I-NP O
acids NNS I-NP O
. . O O

The DT B-NP O
fifth JJ I-NP O
subject NN I-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
possess VB I-VP O
two CD B-NP O
sequence NN I-NP O
abnormalities NNS I-NP O
. . O O

One CD B-NP O
allele NN I-NP O
carried VBD B-VP O
a DT B-NP O
G NN I-NP O
- SYM B-NP O
- HYPH B-NP O
> SYM I-NP O
A NN I-NP O
transition NN I-NP O
near IN B-PP O
the DT B-NP O
donor NN I-NP O
splice NN I-NP O
junction NN I-NP O
of IN B-PP O
intron NN B-NP O
2 CD I-NP O
, , O O
but CC O O
this DT B-NP O
abnormality NN I-NP O
is VBZ B-VP O
probably RB B-ADVP O
neutral JJ B-ADJP O
, , O O
since IN B-SBAR O
it PRP B-NP O
was VBD B-VP O
inherited VBN I-VP O
from IN B-PP O
the DT B-NP O
parent NN I-NP O
with IN B-PP O
normal JJ B-NP O
protein NN I-NP O
S NN I-NP O
antigen NN I-NP O
levels NNS I-NP O
. . O O

In IN B-PP O
the DT B-NP O
other JJ I-NP O
allele NN I-NP O
a DT B-NP O
single JJ I-NP O
T NN I-NP O
insertion NN I-NP O
in IN B-PP O
codon NN B-NP O
- HYPH B-NP O
25 CD I-NP O
was VBD B-VP O
found VBN I-VP O
. . O O

Analysis NN B-NP O
of IN B-PP O
platelet NN B-NP O
RNA NN I-NP O
showed VBD B-VP O
that IN B-SBAR O
only RB B-NP O
the DT I-NP O
mRNA NN I-NP O
with IN B-PP O
the DT B-NP O
A NN I-NP O
- SYM B-NP O
- HYPH I-NP O
> SYM I-NP O
T NN I-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
stopcodon NN I-NP O
is VBZ B-VP O
present JJ B-ADJP O
in IN B-PP O
amounts NNS B-NP O
comparable JJ B-ADJP O
to TO B-PP O
wildtype JJ B-NP O
RNA NN I-NP O
. . O O

mRNA NN B-NP O
from IN B-PP O
the DT B-NP O
alleles NNS I-NP O
with IN B-PP O
the DT B-NP O
other JJ I-NP O
two CD I-NP O
mutations NNS I-NP O
was VBD B-VP O
either CC O O
undetectable JJ B-NP O
or CC O O
present JJ B-ADJP O
in IN B-PP O
greatly RB B-NP O
reduced VBN I-NP O
amounts NNS I-NP O
. . O O

The DT B-NP O
latter JJ I-NP O
indicates VBZ B-VP O
that IN B-SBAR O
a DT B-NP O
mRNA NN I-NP O
based JJ I-NP O
approach NN I-NP O
is VBZ B-VP O
not RB O O
feasible JJ B-ADJP O
for IN B-PP O
the DT B-NP O
genetic JJ I-NP O
analysis NN I-NP O
of IN B-PP O
protein NN B-NP B-Disease
S NN I-NP I-Disease
deficiency NN I-NP I-Disease
type NN I-NP I-Disease
I CD I-NP I-Disease
. . O O

. . O O

Characteristics NNS B-NP O
of IN B-PP O
intergenerational JJ B-NP O
contractions NNS I-NP O
of IN B-PP O
the DT B-NP O
CTG NN I-NP O
repeat NN I-NP O
in IN B-PP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
. . O O

In IN B-PP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
( ( O O
DM NN B-NP B-Disease
) ) O O
, , O O
the DT B-NP O
size NN I-NP O
of IN B-PP O
a DT B-NP O
CTG NN I-NP O
repeat NN I-NP O
in IN B-PP O
the DT B-NP O
DM NN I-NP B-Disease
kinase NN I-NP O
gene NN I-NP O
generally RB B-ADVP O
increases VBZ B-VP O
in IN B-PP O
successive JJ B-NP O
generations NNS I-NP O
with IN B-PP O
clinical JJ B-NP O
evidence NN I-NP O
of IN B-PP O
anticipation NN B-NP O
. . O O

However RB B-ADVP O
, , O O
there EX B-NP O
have VBP B-VP O
also RB I-VP O
been VBN I-VP O
cases NNS B-NP O
with IN B-PP O
an DT B-NP O
intergenerational JJ I-NP O
contraction NN I-NP O
of IN B-PP O
the DT B-NP O
repeat NN I-NP O
. . O O

We PRP B-NP O
examined VBD B-VP O
1 CD B-NP O
, , O O
489 CD B-NP O
DM NN I-NP B-Disease
parent NN I-NP O
- HYPH O O
offspring VBG B-VP O
pairs NNS B-NP O
, , O O
of IN B-PP O
which WDT B-NP O
95 CD B-NP O
( ( O O
6 CD B-NP O
. . O O

4 CD B-NP O
% NN I-NP O
) ) O O
showed VBD B-VP O
such JJ B-NP O
contractions NNS I-NP O
in IN B-PP O
peripheral JJ B-NP O
blood NN I-NP O
leukocytes NNS I-NP O
( ( O O
PBL NN B-NP O
) ) O O
. . O O

In IN B-PP O
56 CD B-NP O
of IN B-PP O
the DT B-NP O
95 CD I-NP O
pairs NNS I-NP O
, , O O
clinical JJ B-NP O
data NNS I-NP O
allowed VBD B-VP O
an DT B-NP O
analysis NN I-NP O
of IN B-PP O
their PRP$ B-NP O
anticipation NN I-NP O
status NN I-NP O
. . O O

It PRP B-NP O
is VBZ B-VP O
surprising JJ B-ADJP O
that IN B-SBAR O
anticipation NN B-NP O
occurred VBD B-VP O
in IN B-PP O
27 CD B-NP O
( ( O O
48 CD B-NP O
% NN I-NP O
) ) O O
of IN B-PP O
these DT B-NP O
56 CD I-NP O
pairs NNS I-NP O
, , O O
while IN B-SBAR O
none NN B-NP O
clearly RB B-ADVP O
showed VBD B-VP O
a DT B-NP O
later JJ I-NP O
onset NN I-NP O
of IN B-PP O
DM NN B-NP B-Disease
in IN B-PP O
the DT B-NP O
symptomatic JJ I-NP O
offspring NN I-NP O
. . O O

The DT B-NP O
contraction NN I-NP O
occurred VBD B-VP O
in IN B-PP O
76 CD B-NP O
( ( O O
10 CD B-NP O
% NN I-NP O
) ) O O
of IN B-PP O
753 CD B-NP O
paternal JJ I-NP O
transmissions NNS I-NP O
and CC O O
in IN B-PP O
19 CD B-NP O
( ( O O
3 CD B-NP O
% NN I-NP O
) ) O O
of IN B-PP O
736 CD B-NP O
maternal JJ I-NP O
transmissions NNS I-NP O
. . O O

Anticipation NN B-NP O
was VBD B-VP O
observed VBN I-VP O
more RBR B-ADVP O
frequently RB I-ADVP O
in IN B-PP O
maternal JJ B-NP O
( ( O O
85 CD B-NP O
% NN I-NP O
) ) O O
than IN B-PP O
in IN B-PP O
paternal JJ B-NP O
( ( O O
37 CD B-NP O
% NN I-NP O
) ) O O
transmissions NNS B-NP O
( ( O O
P NN B-NP O
< SYM B-NP O
. . I-NP O

001 CD I-NP O
) ) O O
. . O O

The DT B-NP O
parental JJ I-NP O
repeat NN I-NP O
size NN I-NP O
correlated VBD B-VP O
with IN B-PP O
the DT B-NP O
size NN I-NP O
of IN B-PP O
intergenerational JJ B-NP O
contraction NN I-NP O
( ( O O
r2 NN B-NP O
= SYM B-VP O
. . O O

50 CD B-NP O
, , O O
P NN B-NP O
< SYM B-VP O
< SYM B-NP O
. . I-NP O

001 CD I-NP O
) ) O O
, , O O
and CC O O
the DT B-NP O
slope NN I-NP O
of IN B-PP O
linear JJ B-NP O
regression NN I-NP O
was VBD B-VP O
steeper JJR B-ADJP O
in IN B-PP O
paternal JJ B-ADJP O
( ( O O
- SYM B-NP O
. . I-NP O

62 CD I-NP O
) ) O O
than IN B-PP O
in IN B-PP O
maternal JJ B-NP O
( ( O O
- SYM O O
. . O O

30 CD O O
) ) O O
transmissions NNS B-NP O
( ( O O
P NN B-NP O
< SYM O O
< SYM B-NP O
. . I-NP O

001 CD I-NP O
) ) O O
. . O O

Sixteen CD B-NP O
DM NN I-NP B-Disease
parents NNS I-NP O
had VBD B-VP O
multiple JJ B-NP O
DM NN I-NP B-Disease
offspring NN I-NP O
with IN B-PP O
the DT B-NP O
CTG NN I-NP O
repeat NN I-NP O
contractions NNS I-NP O
. . O O

This DT B-NP O
frequency NN I-NP O
was VBD B-VP O
higher JJR B-ADJP O
than IN B-PP O
the DT B-NP O
frequency NN I-NP O
expected VBN B-VP O
from IN B-PP O
the DT B-NP O
probability NN I-NP O
of IN B-PP O
the DT B-NP O
repeat NN I-NP O
contractions NNS I-NP O
( ( O O
6 CD B-NP O
. . O O

4 CD B-NP O
% NN I-NP O
) ) O O
and CC O O
the DT B-NP O
size NN I-NP O
of IN B-PP O
DM NN B-NP B-Disease
sib NN I-NP O
population NN I-NP O
( ( O O
1 CD B-NP O
. . O O

54 CD B-NP O
DM NN I-NP B-Disease
offspring NN I-NP O
per IN B-PP O
DM NN B-NP B-Disease
parent NN I-NP O
, , O O
in IN B-PP O
968 CD B-NP O
DM NN I-NP B-Disease
parents NNS I-NP O
) ) O O
. . O O

We PRP B-NP O
conclude VBP B-VP O
that IN B-SBAR O
( ( B-LST O
1 LS I-LST O
) ) O O
intergenerational JJ B-NP O
contractions NNS I-NP O
of IN B-PP O
the DT B-NP O
CTG NN I-NP O
repeat NN I-NP O
in IN B-PP O
leukocyte NN B-NP O
DNA NN I-NP O
frequently RB B-ADVP O
accompanies VBZ B-VP O
apparent JJ B-NP O
anticipation NN I-NP O
, , O O
especially RB B-ADVP O
when WRB B-ADVP O
DM NN B-NP B-Disease
is VBZ B-VP O
maternally RB I-VP O
transmitted VBN I-VP O
, , O O
and CC O O
( ( B-LST O
2 LS I-LST O
) ) O O
the DT B-NP O
paternal JJ I-NP O
origin NN I-NP O
of IN B-PP O
the DT B-NP O
repeat NN I-NP O
and CC O O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
the DT B-NP O
repeat NN I-NP O
contraction NN I-NP O
in IN B-PP O
a DT B-NP O
sibling NN I-NP O
increase VBP B-VP O
the DT B-NP O
probability NN I-NP O
of IN B-PP O
the DT B-NP O
CTG NN I-NP O
repeat NN I-NP O
contraction NN I-NP O
Gonosomal JJ B-NP O
mosaicism NN I-NP O
in IN B-PP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
patients NNS I-NP O
: : O O
involvement NN B-NP O
of IN B-PP O
mitotic JJ B-NP O
events NNS I-NP O
in IN B-PP O
( ( O O
CTG NN B-NP O
) ) O O
n NN B-NP O
repeat NN I-NP O
variation NN I-NP O
and CC I-NP O
selection NN I-NP O
against IN B-PP O
extreme JJ B-NP O
expansion NN I-NP O
in IN B-PP O
sperm NN B-NP O
. . O O

Myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
( ( O O
DM NN B-NP B-Disease
) ) O O
is VBZ B-VP O
caused VBN I-VP O
by IN B-PP O
abnormal JJ B-NP O
expansion NN I-NP O
of IN B-PP O
a DT B-NP O
polymorphic JJ I-NP O
( ( O O
CTG NN B-NP O
) ) O O
n NN B-NP O
repeat NN I-NP O
, , O O
located JJ B-ADJP O
in IN B-PP O
the DT B-NP O
DM NN I-NP B-Disease
protein NN I-NP O
kinase NN I-NP O
gene NN I-NP O
. . O O

We PRP B-NP O
determined VBD B-VP O
the DT O O
( ( O O
CTG NN O O
) ) O O
n NN B-NP O
repeat NN I-NP O
lengths NNS I-NP O
in IN B-PP O
a DT B-NP O
broad JJ I-NP O
range NN I-NP O
of IN B-PP O
tissue NN B-NP O
DNAs NNS I-NP O
from IN B-PP O
patients NNS B-NP O
with IN B-PP O
mild JJ B-NP O
, , I-NP O
classical JJ I-NP O
, , I-NP O
or CC I-NP O
congenital JJ I-NP O
manifestation NN I-NP O
of IN B-PP O
DM NN B-NP B-Disease
. . O O

Differences NNS B-NP O
in IN B-PP O
the DT B-NP O
repeat NN I-NP O
length NN I-NP O
were VBD B-VP O
seen VBN I-VP O
in IN B-PP O
somatic JJ B-NP O
tissues NNS I-NP O
from IN B-PP O
single JJ B-NP O
DM NN I-NP B-Disease
individuals NNS I-NP O
and CC I-NP O
twins NNS I-NP O
. . O O

Repeats NNS B-NP O
appeared VBD B-VP O
to TO I-VP O
expand VB I-VP O
to TO B-PP O
a DT B-NP O
similar JJ I-NP O
extent NN I-NP O
in IN B-PP O
tissues NNS B-NP O
originating VBG B-VP O
from IN B-PP O
the DT B-NP O
same JJ I-NP O
embryonal JJ I-NP O
origin NN I-NP O
. . O O

In IN B-PP O
most JJS B-NP O
male JJ I-NP O
patients NNS I-NP O
carrying VBG B-VP O
intermediate JJ B-NP O
- HYPH I-NP O
or CC I-NP O
small JJ I-NP O
- HYPH I-NP O
sized VBN I-NP O
expansions NNS I-NP O
in IN B-PP O
blood NN B-NP O
, , O O
the DT B-NP O
repeat NN I-NP O
lengths NNS I-NP O
covered VBD B-VP O
a DT B-NP O
markedly RB I-NP O
wider JJR I-NP O
range NN I-NP O
in IN B-PP O
sperm NN B-NP O
. . O O

In IN B-PP O
contrast NN B-NP O
, , O O
male JJ B-NP O
patients NNS I-NP O
with IN B-PP O
large JJ B-NP O
allele NN I-NP O
expansions NNS I-NP O
in IN B-PP O
blood NN B-NP O
( ( O O
> SYM B-NP O
700 CD B-NP O
CTGs NNS I-NP O
) ) O O
had VBD B-VP O
similar JJ B-NP O
or CC I-NP O
smaller JJR I-NP O
repeats NNS I-NP O
in IN B-PP O
sperm NN B-NP O
, , O O
when WRB B-ADVP O
detectable JJ B-ADJP O
. . O O

Sperm NN B-NP O
alleles NNS I-NP O
with IN B-PP O
> SYM B-NP O
1 CD I-NP O
, , I-NP O
000 CD I-NP O
CTGs NNS I-NP O
were VBD B-VP O
not RB I-VP O
seen VBN I-VP O
. . O O

We PRP B-NP O
conclude VBP B-VP O
that IN B-SBAR O
DM NN B-NP B-Disease
patients NNS I-NP O
can MD B-VP O
be VB I-VP O
considered VBN I-VP O
gonosomal JJ B-NP O
mosaics NNS I-NP O
, , O O
i NN B-NP O
. . O O

e NN B-NP O
e NN I-NP O
. . O O

, , O O
combined VBD B-VP O
somatic JJ B-NP O
and CC I-NP O
germ NN I-NP O
- HYPH I-NP O
line NN I-NP O
tissue NN I-NP O
mosaics NNS I-NP O
. . O O

Most RBS B-ADVP O
remarkably RB I-ADVP O
, , O O
we PRP B-NP O
observed VBD B-VP O
multiple JJ B-NP O
cases NNS I-NP O
where WRB B-ADVP O
the DT B-NP O
length NN I-NP O
distributions NNS I-NP O
of IN B-PP O
intermediate JJ B-NP O
- HYPH I-NP O
or CC I-NP O
small JJ I-NP O
- HYPH I-NP O
sized VBN I-NP O
alleles NNS I-NP O
in IN B-PP O
fathers NNS B-NP O
sperm NN I-NP O
were VBD B-VP O
significantly RB B-ADJP O
different JJ I-ADJP O
from IN B-PP O
that DT B-NP O
in IN B-PP O
their PRP$ B-NP O
offsprings NNS I-NP O
blood NN I-NP O
. . O O

Our PRP$ B-NP O
combined JJ I-NP O
findings NNS I-NP O
indicate VBP B-VP O
that IN B-SBAR O
intergenerational JJ B-NP O
length NN I-NP O
changes NNS I-NP O
in IN B-PP O
the DT B-NP O
unstable JJ I-NP O
CTG NN I-NP O
repeat NN I-NP O
are VBP B-VP O
most RBS B-ADJP O
likely JJ I-ADJP O
to TO B-VP O
occur VB I-VP O
during IN B-PP O
early JJ B-NP O
embryonic JJ I-NP O
mitotic JJ I-NP O
divisions NNS I-NP O
in IN B-PP O
both CC B-NP O
somatic JJ I-NP O
and CC I-NP O
germ NN I-NP O
- HYPH I-NP O
line NN I-NP O
tissue NN I-NP O
formation NN I-NP O
. . O O

Both CC O O
the DT B-NP O
initial JJ I-NP O
CTG NN I-NP O
length NN I-NP O
, , O O
the DT B-NP O
overall JJ I-NP O
number NN I-NP O
of IN B-PP O
cell NN B-NP O
divisions NNS I-NP O
involved VBN B-VP O
in IN B-PP O
tissue NN B-NP O
formation NN I-NP O
, , O O
and CC O O
perhaps RB B-ADVP O
a DT B-NP O
specific JJ I-NP O
selection NN I-NP O
process NN I-NP O
in IN B-PP O
spermatogenesis NN B-NP O
may MD B-VP O
influence VB I-VP O
the DT B-NP O
dynamics NNS I-NP O
of IN B-PP O
this DT B-NP O
process NN I-NP O
. . O O

A DT B-NP O
model NN I-NP O
explaining VBG B-VP O
mitotic JJ B-NP O
instability NN I-NP O
and CC I-NP O
sex NN I-NP O
- HYPH B-NP O
dependent JJ I-NP O
segregation NN I-NP O
phenomena NNS I-NP O
in IN B-PP O
DM NN B-NP B-Disease
manifestation NN I-NP O
is VBZ B-VP O
discussed VBN I-VP O
Regionally RB B-NP O
clustered VBN I-NP O
APC NN I-NP B-Disease
mutations NNS I-NP O
are VBP B-VP O
associated VBN I-VP O
with IN B-PP O
a DT B-NP O
severe JJ I-NP O
phenotype NN I-NP O
and CC O O
occur VBP B-VP O
at IN B-PP O
a DT B-NP O
high JJ I-NP O
frequency NN I-NP O
in IN B-PP O
new JJ B-NP O
mutation NN I-NP O
cases NNS I-NP O
of IN B-PP O
adenomatous JJ B-NP B-Disease
polyposis NN I-NP I-Disease
coli NN I-NP I-Disease
. . O O

Germline NN B-NP O
mutation NN I-NP O
in IN B-PP O
APC NN B-NP O
at IN B-PP O
5q21 NN B-NP O
- HYPH O O
22 CD B-NP O
results NNS I-NP O
in IN B-PP O
the DT B-NP O
dominantly RB I-NP O
inherited VBN I-NP O
syndrome NN I-NP O
adenomatous JJ I-NP B-Disease
polyposis NN I-NP I-Disease
coli NN I-NP I-Disease
( ( O O
APC NN B-NP B-Disease
) ) O O
. . O O

Somatic JJ B-NP O
mutation NN I-NP O
in IN B-PP O
this DT B-NP O
gene NN I-NP O
is VBZ B-VP O
an DT B-NP O
early JJ I-NP O
event NN I-NP O
in IN B-PP O
colorectal JJ B-NP O
tumourigenesis NN I-NP O
. . O O

Both DT B-NP O
types NNS I-NP O
of IN B-PP O
mutation NN B-NP O
are VBP B-VP O
concentrated VBN I-VP O
in IN B-PP O
the DT B-NP O
5 CD I-NP O
half NN I-NP O
of IN B-PP O
exon NN B-NP O
15 CD I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
used VBN I-VP O
single JJ B-NP O
strand NN I-NP O
conformational JJ I-NP O
polymorphism NN I-NP O
( ( O O
SSCP NN B-NP O
) ) O O
and CC O O
heteroduplex NN B-NP O
analysis NN I-NP O
to TO B-VP O
screen VB I-VP O
for IN B-PP O
variants NNS B-NP O
in IN B-PP O
this DT B-NP O
region NN I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
in IN B-PP O
a DT B-NP O
total NN I-NP O
of IN B-PP O
45 CD B-NP O
affected VBN B-VP O
but CC O O
unrelated JJ B-NP O
individuals NNS I-NP O
. . O O

Eighteen CD B-NP O
patients NNS I-NP O
had VBD B-VP O
no DT B-NP O
family NN I-NP O
history NN I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
; : O O
of IN B-PP O
these DT B-NP O
11 CD I-NP O
were VBD B-VP O
classified VBN I-VP O
as IN B-PP O
having VBG B-VP O
a DT B-NP O
severe JJ I-NP O
phenotype NN I-NP O
, , O O
based VBN B-PP O
on IN B-PP O
an DT B-NP O
early JJ I-NP O
age NN I-NP O
at IN B-PP O
presentation NN B-NP O
or CC I-NP O
cancer NN I-NP B-Disease
development NN I-NP O
. . O O

This DT B-NP O
compared VBN B-PP O
with IN B-PP O
6 CD B-NP O
of IN B-PP O
27 CD B-NP O
familial JJ I-NP O
cases NNS I-NP O
. . O O

A DT B-NP O
5 CD I-NP O
bp NN I-NP O
deletion NN I-NP O
at IN B-PP O
codon NN B-NP O
1309 CD I-NP O
reported VBD B-VP O
to TO I-VP O
occur VB I-VP O
in IN B-PP O
10 CD B-NP O
- HYPH I-NP O
15 CD I-NP O
% NN I-NP O
of IN B-PP O
unselected JJ B-NP O
APC NN I-NP B-Disease
patients NNS I-NP O
worldwide RB B-ADVP O
, , O O
was VBD B-VP O
found VBN I-VP O
in IN B-PP O
5 CD B-NP O
of IN B-PP O
the DT B-NP O
18 CD I-NP O
new JJ I-NP O
mutation NN I-NP O
cases NNS I-NP O
and CC O O
4 CD B-NP O
of IN B-PP O
the DT B-NP O
27 CD I-NP O
familial JJ I-NP O
cases NNS I-NP O
all DT B-NP O
nine CD I-NP O
were VBD B-VP O
classed VBN I-VP O
as IN B-PP O
severe JJ B-ADJP O
. . O O

A DT B-NP O
further JJ I-NP O
3 CD I-NP O
new JJ I-NP O
mutations NNS I-NP O
and CC O O
1 CD B-NP O
familial JJ I-NP O
mutation NN I-NP O
were VBD B-VP O
located JJ B-ADJP O
downstream RB B-ADVP O
from IN B-PP O
codon NN B-NP O
1309 CD I-NP O
, , O O
these DT B-NP O
individuals NNS I-NP O
similarly RB B-VP O
being VBG I-VP O
classed VBN I-VP O
as IN B-PP O
phenotypically RB B-ADJP O
severe JJ I-ADJP O
. . O O

In IN B-PP O
contrast NN B-NP O
all DT B-NP O
of IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
mutations NNS I-NP O
detected VBN B-VP O
in IN B-PP O
affected VBN B-NP O
individuals NNS I-NP O
with IN B-PP O
an DT B-NP O
average JJ I-NP O
phenotype NN I-NP O
were VBD B-VP O
located JJ B-ADJP O
prior RB I-ADJP O
to TO B-PP O
codon NN B-NP O
1309 CD I-NP O
. . O O

The DT B-NP O
frequent JJ I-NP O
association NN I-NP O
of IN B-PP O
a DT B-NP O
severe JJ I-NP O
phenotype NN I-NP O
with IN B-PP O
fresh JJ B-NP O
mutation NN I-NP O
may MD B-VP O
explain VB I-VP O
the DT B-NP O
apparent JJ I-NP O
conflict NN I-NP O
of IN B-PP O
a DT B-NP O
high JJ I-NP O
mutation NN I-NP O
rate NN I-NP O
( ( O O
20 CD B-NP O
- HYPH I-NP O
30 CD I-NP O
% NN I-NP O
) ) O O
in IN B-PP O
a DT B-NP O
condition NN I-NP O
, , O O
which WDT B-NP O
on IN B-PP O
average NN B-NP O
, , O O
is VBZ B-VP O
lethal JJ B-ADJP O
at IN B-PP O
a DT B-NP O
post AFX I-NP O
- HYPH I-NP O
reproductive JJ I-NP O
age NN I-NP O
. . O O

. . O O

Mutations NNS B-NP O
at IN B-PP O
the DT B-NP O
PAX6 NN I-NP O
locus NN I-NP O
are VBP B-VP O
found VBN I-VP O
in IN B-PP O
heterogeneous JJ B-NP O
anterior JJ I-NP B-Disease
segment NN I-NP I-Disease
malformations NNS I-NP I-Disease
including VBG B-PP O
Peters NNP B-NP B-Disease
' POS B-NP I-Disease
anomaly RB B-ADVP I-Disease
. . O O

Mutation NN B-NP O
or CC I-NP O
deletion NN I-NP O
of IN B-PP O
the DT B-NP O
PAX6 NN I-NP O
gene NN I-NP O
underlies VBZ B-VP O
many JJ B-NP O
cases NNS I-NP O
of IN B-PP O
aniridia NN B-NP B-Disease
. . O O

Three CD B-NP O
lines NNS I-NP O
of IN B-PP O
evidence NN B-NP O
now RB B-ADVP O
converge VBP B-VP O
to TO I-VP O
implicate VB I-VP O
PAX6 NN B-NP O
more RBR B-ADVP O
widely RB I-ADVP O
in IN B-PP O
anterior JJ B-NP B-Disease
segment NN I-NP I-Disease
malformations NNS I-NP I-Disease
including VBG B-PP O
Peters NNP B-NP B-Disease
anomaly RB B-ADVP I-Disease
. . O O

First RB B-ADVP O
, , O O
a DT B-NP O
child NN I-NP O
with IN B-PP O
Peters NNP B-NP B-Disease
anomaly RB B-ADVP I-Disease
is VBZ B-VP O
deleted VBN I-VP O
for IN B-PP O
one CD B-NP O
copy NN I-NP O
of IN B-PP O
PAX6 NN B-NP O
. . O O

Second RB B-ADVP O
, , O O
affected VBN B-VP O
members NNS B-NP O
of IN B-PP O
a DT B-NP O
family NN I-NP O
with IN B-PP O
dominantly RB B-NP O
inherited VBN I-NP O
anterior JJ I-NP B-Disease
segment NN I-NP I-Disease
malformations NNS I-NP I-Disease
, , O O
including VBG B-PP O
Peters NNP B-NP B-Disease
anomaly RB B-ADVP I-Disease
are VBP B-VP O
heterozygous JJ B-ADJP O
for IN B-PP O
an DT B-NP O
R26G NN I-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
PAX6 NN I-NP O
paired JJ I-NP O
box NN I-NP O
. . O O

Third RB B-ADVP O
, , O O
a DT B-NP O
proportion NN I-NP O
of IN B-PP O
Sey NN B-NP O
/ SYM B-NP O
+ SYM B-VP O
Smalleye NN B-NP O
mice NNS I-NP O
, , O O
heterozygous JJ B-ADJP O
for IN B-PP O
a DT B-NP O
nonsense JJ I-NP O
mutation NN I-NP O
in IN B-PP O
murine JJ B-NP O
Pax NN I-NP O
- HYPH O O
6 CD B-NP O
, , O O
have VBP B-VP O
an DT B-NP O
ocular JJ I-NP O
phenotype NN I-NP O
resembling VBG B-VP O
Peters NNP B-NP B-Disease
anomaly RB B-ADVP I-Disease
. . O O

We PRP B-NP O
therefore RB B-ADVP O
propose VBP B-VP O
that IN B-SBAR O
a DT B-NP O
variety NN I-NP O
of IN B-PP O
anterior JJ B-NP B-Disease
segment NN I-NP I-Disease
anomalies NNS I-NP I-Disease
may MD B-VP O
be VB I-VP O
associated VBN I-VP O
with IN B-PP O
PAX6 NN B-NP O
mutations NNS I-NP O
. . O O

. . O O

Huntington NNP B-NP B-Disease
disease NN I-NP I-Disease
without IN B-PP O
CAG NN B-NP O
expansion NN I-NP O
: : O O
phenocopies NNS B-NP O
or CC I-NP O
errors NNS I-NP O
in IN B-PP O
assignment NN B-NP O
? . O O

Huntington NNP B-NP B-Disease
disease NN I-NP I-Disease
( ( O O
HD NN B-NP B-Disease
) ) O O
has VBZ B-VP O
been VBN I-VP O
shown VBN I-VP O
to TO I-VP O
be VB I-VP O
associated VBN I-VP O
with IN B-PP O
an DT B-NP O
expanded VBN I-NP O
CAG NN I-NP O
repeat NN I-NP O
within IN B-PP O
a DT B-NP O
novel JJ I-NP O
gene NN I-NP O
on IN B-PP O
4p16 CD B-NP O
. . O O

3 CD B-NP O
( ( O O
IT15 NN B-NP O
) ) O O
. . O O

A DT B-NP O
total NN I-NP O
of IN B-PP O
30 CD B-NP O
of IN I-NP O
1 CD I-NP O
, , I-NP O
022 CD I-NP O
affected VBN I-NP O
persons NNS I-NP O
( ( O O
2 CD B-NP O
. . O O

9 CD B-NP O
% NN I-NP O
of IN B-PP O
our PRP$ B-NP O
cohort NN I-NP O
) ) O O
did VBD B-VP O
not RB I-VP O
have VB I-VP O
an DT B-NP O
expanded VBN I-NP O
CAG NN I-NP O
in IN B-PP O
the DT B-NP O
disease NN I-NP O
range NN I-NP O
. . O O

The DT B-NP O
reasons NNS I-NP O
for IN B-PP O
not RB O O
observing VBG B-VP O
expansion NN B-NP O
in IN B-PP O
affected VBN B-NP O
individuals NNS I-NP O
are VBP B-VP O
important JJ B-ADJP O
for IN B-PP O
determining VBG B-VP O
the DT B-NP O
sensitivity NN I-NP O
of IN B-PP O
using VBG B-VP O
repeat NN B-NP O
length NN I-NP O
both CC B-PP O
for IN I-PP O
diagnosis NN B-NP O
of IN B-PP O
affected VBN B-NP O
patients NNS I-NP O
and CC B-PP O
for IN B-PP O
predictive JJ B-NP O
testing NN I-NP O
programs NNS I-NP O
and CC O O
may MD B-VP O
have VB I-VP O
biological JJ B-NP O
relevance NN I-NP O
for IN B-PP O
the DT B-NP O
understanding NN I-NP O
of IN B-PP O
the DT B-NP O
molecular JJ I-NP O
mechanism NN I-NP O
underlying VBG I-NP O
HD NN I-NP B-Disease
. . O O

Here RB B-ADVP O
we PRP B-NP O
show VBP B-VP O
that IN B-SBAR O
the DT B-NP O
majority NN I-NP O
( ( O O
18 CD B-NP O
) ) O O
of IN B-PP O
the DT B-NP O
individuals NNS I-NP O
with IN B-PP O
normal JJ B-NP O
sized JJ I-NP O
alleles NNS I-NP O
represent VBP B-VP O
misdiagnosis NN B-NP O
, , O O
sample NN B-NP O
mix NN I-NP O
- HYPH B-VP O
up RP B-PRT O
, , O O
or CC O O
clerical JJ B-NP O
error NN I-NP O
. . O O

The DT B-NP O
remaining VBG I-NP O
12 CD I-NP O
patients NNS I-NP O
represent VBP B-VP O
possible JJ B-NP O
phenocopies NNS I-NP O
for IN B-PP O
HD NN B-NP B-Disease
. . O O

In IN B-PP O
at IN B-NP O
least JJS I-NP O
four CD I-NP O
cases NNS I-NP O
, , O O
family NN B-NP O
studies NNS I-NP O
of IN B-PP O
these DT B-NP O
phenocopies NNS I-NP O
excluded VBD B-VP O
4p16 CD B-NP O
. . O O

3 CD B-NP O
as IN B-PP O
the DT B-NP O
region NN I-NP O
responsible JJ B-ADJP O
for IN B-PP O
the DT B-NP O
phenotype NN I-NP O
. . O O

Mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
HD NN I-NP B-Disease
gene NN I-NP O
that WDT B-NP O
are VBP B-VP O
other JJ B-ADJP O
than IN B-PP O
CAG NN B-NP O
expansion NN I-NP O
have VBP B-VP O
not RB I-VP O
been VBN I-VP O
excluded VBN I-VP O
for IN B-PP O
the DT B-NP O
remaining VBG I-NP O
eight CD I-NP O
cases NNS I-NP O
; : O O
however RB B-ADVP O
, , O O
in IN B-PP O
as RB B-NP O
many JJ I-NP O
as IN I-NP O
seven CD I-NP O
of IN B-PP O
these DT B-NP O
persons NNS I-NP O
, , O O
retrospective JJ B-NP O
review NN I-NP O
of IN B-PP O
these DT B-NP O
patients NNS I-NP O
clinical JJ B-NP O
features NNS I-NP O
identified VBD B-VP O
characteristics NNS B-NP O
not RB B-ADJP O
typical JJ I-ADJP O
for IN B-PP O
HD NN B-NP B-Disease
. . O O

This DT B-NP O
study NN I-NP O
shows VBZ B-VP O
that IN B-SBAR O
on IN B-PP O
rare JJ B-NP O
occasions NNS I-NP O
mutations NNS I-NP O
in IN B-PP O
other JJ B-NP O
, , O O
as IN B-SBAR O
- HYPH B-ADVP O
yet RB B-ADVP O
- HYPH B-NP O
undefined JJ I-NP O
genes NNS I-NP O
can MD B-VP O
present VB I-VP O
with IN B-PP O
a DT B-NP O
clinical JJ I-NP O
phenotype NN I-NP O
very RB B-ADJP O
similar JJ I-ADJP O
to TO B-PP O
that DT B-NP O
of IN B-PP O
HD NN B-NP B-Disease
Frequent JJ B-NP O
detection NN I-NP O
of IN B-PP O
codon NN B-NP O
877 CD I-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
androgen NN I-NP O
receptor NN I-NP O
gene NN I-NP O
in IN B-PP O
advanced VBN B-NP B-Disease
prostate NN I-NP I-Disease
cancers NNS I-NP I-Disease
. . O O

Prostatic JJ B-NP O
tissue NN I-NP O
specimens NNS I-NP O
derived VBN B-VP O
from IN B-PP O
transurethral JJ B-NP O
resections NNS I-NP O
of IN B-PP O
patients NNS B-NP O
with IN B-PP O
metastatic JJ B-NP B-Disease
prostate NN I-NP I-Disease
cancer NN I-NP I-Disease
were VBD B-VP O
analyzed VBN I-VP O
for IN B-PP O
genetic JJ B-NP O
alterations NNS I-NP O
in IN B-PP O
the DT B-NP O
hormone NN I-NP O
- HYPH B-PP O
binding VBG B-NP O
domain NN I-NP O
of IN B-PP O
the DT B-NP O
androgen NN I-NP O
receptor NN I-NP O
( ( O O
AR NN B-NP O
) ) O O
gene NN B-NP O
. . O O

Direct JJ B-NP O
sequencing NN I-NP O
of IN B-PP O
the DT B-NP O
polymerase NN I-NP O
chain NN I-NP O
reaction NN I-NP O
- HYPH B-NP O
derived VBN I-NP O
DNAs NNS I-NP O
of IN B-PP O
6 CD B-NP O
of IN I-NP O
24 CD I-NP O
specimens NNS I-NP O
revealed VBD B-VP O
a DT B-NP O
codon NN I-NP O
877 CD I-NP O
mutation NN I-NP O
( ( O O
ACT NN B-NP O
- SYM O O
- HYPH O O
> SYM O O
GCT NN B-NP O
, , O O
Thr NN B-NP O
- SYM B-VP O
- SYM B-NP O
> SYM B-NP O
Ala NN I-NP O
) ) O O
in IN B-PP O
the DT B-NP O
hormone NN I-NP O
- HYPH B-PP O
binding VBG B-NP O
domain NN I-NP O
of IN B-PP O
the DT B-NP O
AR NN I-NP O
gene NN I-NP O
. . O O

This DT B-NP O
same JJ I-NP O
AR NN I-NP O
mutation NN I-NP O
has VBZ B-VP O
been VBN I-VP O
reported VBN I-VP O
previously RB B-ADVP O
in IN B-PP O
a DT B-NP O
metastatic JJ I-NP B-Disease
prostate NN I-NP I-Disease
cancer NN I-NP I-Disease
cell NN I-NP O
line NN I-NP O
, , O O
LNCaP NN B-NP O
, , O O
where WRB B-ADVP O
this DT B-NP O
mutation NN I-NP O
confers VBZ B-VP O
upon IN B-PP O
the DT B-NP O
AR NN I-NP O
an DT B-NP O
altered JJ I-NP O
ligand NN I-NP O
- HYPH B-PP O
binding VBG B-NP O
specificity NN I-NP O
which WDT B-NP O
is VBZ B-VP O
stimulated VBN I-VP O
by IN B-PP O
estrogens NNS B-NP O
, , O O
progestagens NNS B-NP O
, , O O
and CC O O
antiandrogens NNS B-NP O
. . O O

It PRP B-NP O
is VBZ B-VP O
possible JJ B-ADJP O
that IN B-SBAR O
analogous JJ B-ADJP O
to TO B-PP O
an DT B-NP O
activated VBN I-NP O
/ SYM I-NP O
altered VBN I-NP O
growth NN I-NP O
factor NN I-NP O
receptor NN I-NP O
oncogene NN I-NP O
, , O O
codon NN B-NP O
877 CD I-NP O
mutant JJ I-NP O
AR NNS I-NP O
with IN B-PP O
altered VBN B-NP O
ligand NN I-NP O
binding NN I-NP O
may MD B-VP O
provide VB I-VP O
a DT B-NP O
selective JJ I-NP O
growth NN I-NP O
advantage NN I-NP O
in IN B-PP O
the DT B-NP O
genesis NN I-NP O
of IN B-PP O
a DT B-NP O
subset NN I-NP O
of IN B-PP O
advanced VBN B-NP B-Disease
prostate NN I-NP I-Disease
cancer NN I-NP I-Disease
. . O O

Although IN B-SBAR O
estrogens NNS B-NP O
are VBP B-VP O
used VBN I-VP O
infrequently RB B-ADVP O
, , O O
antiandrogens NNS B-NP O
are VBP B-VP O
used VBN I-VP O
increasingly RB B-ADVP O
in IN B-PP O
hormonal JJ B-NP O
therapy NN I-NP O
for IN B-PP O
patients NNS B-NP O
with IN B-PP O
advanced VBN B-NP B-Disease
prostate NN I-NP I-Disease
cancer NN I-NP I-Disease
. . O O

The DT B-NP O
stimulatory JJ I-NP O
effect NN I-NP O
of IN B-PP O
these DT B-NP O
therapeutic JJ I-NP O
agents NNS I-NP O
on IN B-PP O
the DT B-NP O
codon NN I-NP O
877 CD I-NP O
mutant JJ I-NP O
AR NNS I-NP O
further RBR B-ADVP O
suggests VBZ B-VP O
that IN B-SBAR O
this DT B-NP O
frequently RB I-NP O
observed VBN I-NP O
AR NN I-NP O
mutation NN I-NP O
may MD B-VP O
contribute VB I-VP O
to TO B-PP O
the DT B-NP O
treatment NN I-NP O
refractory JJ I-NP O
disease NN I-NP O
. . O O

. . O O

The DT B-NP O
human JJ I-NP O
gene NN I-NP O
for IN B-PP O
alkaptonuria NN B-NP B-Disease
( ( O O
AKU NN B-NP B-Disease
) ) O O
maps VBZ B-VP O
to TO B-PP O
chromosome NN B-NP O
3q NN I-NP O
. . O O

Alkaptonuria NN B-NP B-Disease
( ( O O
AKU NN B-NP B-Disease
; : O O
McKusick NNP B-NP O
no DT B-NP O
. . I-NP O

203500 CD I-NP O
) ) O O
is VBZ B-VP O
a DT B-NP O
rare JJ I-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
disorder NN I-NP I-Disease
caused VBN B-VP O
by IN B-PP O
the DT B-NP O
lack NN I-NP O
of IN B-PP O
homogentisic JJ B-NP O
acid NN I-NP O
oxidase NN I-NP O
activity NN I-NP O
. . O O

Patients NNS B-NP O
excrete VBP B-VP O
large JJ B-NP O
amounts NNS I-NP O
of IN B-PP O
homogentisic JJ B-NP O
acid NN I-NP O
in IN B-PP O
their PRP$ B-NP O
urine NN I-NP O
and CC O O
a DT B-NP O
black JJ I-NP O
ochronotic JJ I-NP O
pigment NN I-NP O
is VBZ B-VP O
deposited VBN I-VP O
in IN B-PP O
their PRP$ B-NP O
cartilage NN I-NP O
and CC I-NP O
collagenous JJ I-NP O
tissues NNS I-NP O
. . O O

Ochronosis NN B-NP B-Disease
is VBZ B-VP O
the DT B-NP O
predominant JJ I-NP O
clinical JJ I-NP O
complication NN I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
leading VBG B-VP O
to TO B-PP O
ochronotic JJ B-NP B-Disease
arthropathy NN I-NP I-Disease
, , O O
dark JJ B-NP O
urine NN I-NP O
, , O O
pigment NN B-NP O
changes NNS I-NP O
of IN B-PP O
the DT B-NP O
skin NN I-NP O
, , O O
and CC O O
other JJ B-NP O
clinical JJ I-NP O
features NNS I-NP O
. . O O

A DT B-NP O
mutation NN I-NP O
causing VBG B-VP O
alkaptonuria NN B-NP B-Disease
in IN B-PP O
the DT B-NP O
mouse NN I-NP O
has VBZ B-VP O
mapped VBN I-VP O
to TO B-PP O
chromosome NN B-NP O
16 CD I-NP O
. . O O

Considering VBG B-VP O
conserved VBN B-NP O
synteny NN I-NP O
, , O O
we PRP B-NP O
were VBD B-VP O
able JJ B-ADJP O
to TO B-VP O
map VB I-VP O
the DT B-NP O
human JJ I-NP O
gene NN I-NP O
to TO B-PP O
chromosome NN B-NP O
3q NN I-NP O
in IN B-PP O
six CD B-NP O
alkaptonuria NN I-NP B-Disease
pedigrees NNS I-NP O
of IN B-PP O
Slovak NN B-NP O
origin NN I-NP O
. . O O

. . O O

Structure NN B-NP O
of IN B-PP O
the DT B-NP O
human JJ I-NP O
Na NN I-NP O
+ SYM O O
/ SYM O O
glucose NN B-NP O
cotransporter NN I-NP O
gene NN I-NP O
SGLT1 NN I-NP O
. . O O

Intestinal JJ B-NP O
uptake NN I-NP O
of IN B-PP O
dietary JJ B-NP O
glucose NN I-NP O
and CC I-NP O
galactose NN I-NP O
is VBZ B-VP O
mediated VBN I-VP O
by IN B-PP O
the DT B-NP O
SGLT1 NN I-NP O
Na NN I-NP O
+ SYM O O
/ SYM O O
glucose NN B-NP O
cotransporter NN I-NP O
of IN B-PP O
the DT B-NP O
brush JJ I-NP O
border NN I-NP O
. . O O

An DT B-NP O
SGLT1 NN I-NP O
missense JJ I-NP O
mutation NN I-NP O
underlies VBZ B-VP O
hereditary JJ B-NP B-Disease
glucose NN I-NP I-Disease
/ SYM B-NP I-Disease
galactose NN I-NP I-Disease
malabsorption NN I-NP I-Disease
, , O O
characterized VBN B-VP O
by IN B-PP O
potentially RB B-NP O
fatal JJ I-NP O
diarrhea NN I-NP B-Disease
; : O O
conversely RB B-ADVP O
, , O O
oral JJ B-NP O
rehydration NN I-NP O
therapy NN I-NP O
exploits VBZ B-VP O
normal JJ B-NP O
transport NN I-NP O
to TO B-VP O
alleviate VB I-VP O
life NN B-NP O
- HYPH O O
threatening VBG B-VP O
diarrhea NN B-NP B-Disease
of IN B-PP O
infectious JJ B-NP O
origin NN I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
mapped VBN I-VP O
the DT B-NP O
entire JJ I-NP O
human JJ I-NP O
SGLT1 NN I-NP O
Na NN I-NP O
+ SYM O O
/ SYM O O
glucose NN B-NP O
cotransporter NN I-NP O
gene NN I-NP O
from IN B-PP O
cosmid NN B-NP O
and CC I-NP O
lambda NN I-NP O
phage NN I-NP O
clones NNS I-NP O
representing VBG B-VP O
a DT B-NP O
genomic JJ I-NP O
region NN I-NP O
of IN B-PP O
112 CD B-NP O
kilobases NNS I-NP O
. . O O

Transcription NN B-NP O
initiation NN I-NP O
occurred VBD B-VP O
from IN B-PP O
a DT B-NP O
site NN I-NP O
27 CD I-NP O
base NN I-NP O
pairs NNS I-NP O
3 CD B-NP O
of IN B-PP O
a DT B-NP O
TATAA NN I-NP O
sequence NN I-NP O
. . O O

All DT B-NP O
exon NN I-NP O
- HYPH B-VP O
flanking VBG B-NP O
regions NNS I-NP O
were VBD B-VP O
sequenced VBN I-VP O
, , O O
and CC O O
the DT B-NP O
entire JJ I-NP O
112 CD I-NP O
- HYPH I-NP O
kilobase NN I-NP O
region NN I-NP O
mapped VBN B-VP O
with IN B-PP O
four CD B-NP O
restriction NN I-NP O
enzymes NNS I-NP O
. . O O

SGLT1 NN B-NP O
is VBZ B-VP O
comprised VBN I-VP O
of IN B-PP O
15 CD B-NP O
exons NNS I-NP O
( ( O O
spanning VBG B-VP O
72 CD B-NP O
kilobases NNS I-NP O
) ) O O
; : O O
a DT B-NP O
possible JJ I-NP O
evolutionary JJ I-NP O
origin NN I-NP O
from IN B-PP O
a DT B-NP O
six CD I-NP O
- HYPH I-NP O
membrane NN I-NP O
- HYPH I-NP O
span NN I-NP O
ancestral JJ I-NP O
precursor NN I-NP O
via IN B-PP O
a DT B-NP O
gene NN I-NP O
duplication NN I-NP O
event NN I-NP O
is VBZ B-VP O
suggested VBN I-VP O
from IN B-PP O
comparison NN B-NP O
of IN B-PP O
exons NNS B-NP O
against IN B-PP O
protein NN B-NP O
secondary JJ I-NP O
structure NN I-NP O
and CC B-PP O
from IN B-PP O
sequence NN B-NP O
considerations NNS I-NP O
. . O O

A DT B-NP O
new JJ I-NP O
missense JJ I-NP O
mutation NN I-NP O
in IN B-PP O
exon NN B-NP O
1 CD I-NP O
causing VBG I-NP O
glucose NN I-NP B-Disease
/ SYM I-NP I-Disease
galactose NN I-NP I-Disease
malabsorption NN I-NP I-Disease
is VBZ B-VP O
also RB I-VP O
described VBN I-VP O
. . O O

This DT B-NP O
is VBZ B-VP O
the DT B-NP O
first JJ I-NP O
Na NN I-NP O
( ( O O
+ SYM B-NP O
) ) O O
- HYPH B-NP O
dependent JJ I-NP O
cotransporter NN I-NP O
gene NN I-NP O
structure NN I-NP O
reported VBD B-VP O
. . O O

These DT B-NP O
data NNS I-NP O
facilitate VBP B-VP O
the DT B-NP O
search NN I-NP O
for IN B-PP O
new JJ B-NP O
glucose NN I-NP B-Disease
/ SYM B-VP I-Disease
galactose NN B-NP I-Disease
malabsorption NN I-NP I-Disease
- HYPH B-NP O
related VBN I-NP O
mutations NNS I-NP O
in IN B-PP O
this DT B-NP O
important JJ I-NP O
gene NN I-NP O
and CC O O
provide VBP B-VP O
a DT B-NP O
basis NN I-NP O
for IN B-PP O
future JJ B-NP O
evolutionary JJ I-NP O
comparisons NNS I-NP O
with IN B-PP O
other JJ B-NP O
Na NN I-NP O
( ( O O
+ SYM B-NP O
) ) O O
- HYPH B-NP O
dependent JJ I-NP O
cotransporters NNS I-NP O
. . O O

. . O O

Four CD B-NP O
novel JJ I-NP O
PEPD NN I-NP O
alleles NNS I-NP O
causing VBG B-VP O
prolidase NN B-NP B-Disease
deficiency NN I-NP I-Disease
. . O O

Mutations NNS B-NP O
at IN B-PP O
the DT B-NP O
PEPD NN I-NP O
locus NN I-NP O
cause VBP B-VP O
prolidase NN B-NP B-Disease
deficiency NN I-NP I-Disease
( ( O O
McKusick NNP B-NP O
170100 CD I-NP O
) ) O O
, , O O
a DT B-NP O
rare JJ I-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
disorder NN I-NP I-Disease
characterized VBN B-VP O
by IN B-PP O
iminodipeptiduria NN B-NP B-Disease
, , O O
skin NN B-NP B-Disease
ulcers NNS I-NP I-Disease
, , O O
mental JJ B-NP B-Disease
retardation NN I-NP I-Disease
, , O O
and CC O O
recurrent JJ B-NP O
infections NNS I-NP O
. . O O

Four CD B-NP O
PEPD NN I-NP O
mutations NNS I-NP O
from IN B-PP O
five CD B-NP O
severely RB I-NP O
affected VBN I-NP O
individuals NNS I-NP O
were VBD B-VP O
characterized VBN I-VP O
by IN B-PP O
analysis NN B-NP O
of IN B-PP O
reverse NN B-NP O
- HYPH O O
transcribed VBN B-VP O
, , O O
PCR NN B-NP O
- HYPH O O
amplified VBN B-VP O
( ( O O
RT NN B-NP O
- HYPH B-NP O
PCR NN I-NP O
) ) O O
cDNA NN B-NP O
. . O O

We PRP B-NP O
used VBD B-VP O
SSCP NN B-NP O
analysis NN I-NP O
on IN B-PP O
four CD B-NP O
overlapping VBG I-NP O
cDNA NN I-NP O
fragments NNS I-NP O
covering VBG B-VP O
the DT B-NP O
entire JJ I-NP O
coding VBG I-NP O
region NN I-NP O
of IN B-PP O
the DT B-NP O
PEPD NN I-NP O
gene NN I-NP O
and CC O O
detected VBD B-VP O
abnormal JJ B-NP O
SSCP NN I-NP O
bands NNS I-NP O
for IN B-PP O
the DT B-NP O
fragment NN I-NP O
spanning VBG B-VP O
all DT B-NP O
or CC I-NP O
part NN I-NP O
of IN B-PP O
exons NNS B-NP O
13 CD B-NP O
- HYPH I-NP O
15 CD I-NP O
in IN B-PP O
three CD B-NP O
of IN B-PP O
the DT B-NP O
probands NNS I-NP O
. . O O

Direct JJ B-NP O
sequencing NN I-NP O
of IN B-PP O
the DT B-NP O
mutant JJ I-NP O
cDNAs NNS I-NP O
showed VBD B-VP O
a DT B-NP O
G NN I-NP O
- SYM B-NP O
- HYPH B-NP O
> SYM I-NP O
A NN I-NP O
, , O O
1342 CD B-NP O
substitution NN I-NP O
( ( O O
G448R NN B-NP O
) ) O O
in IN B-PP O
two CD B-NP O
patients NNS I-NP O
and CC O O
a DT B-NP O
3 CD I-NP O
- HYPH I-NP O
bp NN I-NP O
deletion NN I-NP O
( ( O O
delta SYM B-NP O
E452 NN B-NP O
or CC O O
delta SYM B-NP O
E453 NN I-NP O
) ) O O
in IN B-PP O
another DT B-NP O
. . O O

In IN B-PP O
the DT B-NP O
other JJ I-NP O
two CD I-NP O
probands NNS I-NP O
the DT B-NP O
amplified VBN I-NP O
products NNS I-NP O
were VBD B-VP O
of IN B-PP O
reduced VBN B-NP O
size NN I-NP O
. . O O

Direct JJ B-NP O
sequencing NN I-NP O
of IN B-PP O
these DT B-NP O
mutant JJ I-NP O
cDNAs NNS I-NP O
revealed VBD B-VP O
a DT B-NP O
deletion NN I-NP O
of IN B-PP O
exon NN B-NP O
5 CD I-NP O
in IN B-PP O
one CD B-NP O
patient NN I-NP O
and CC B-PP O
of IN B-PP O
exon NN B-NP O
7 CD I-NP O
in IN B-PP O
the DT B-NP O
other JJ I-NP O
. . O O

Intronic JJ B-NP O
sequences NNS I-NP O
flanking VBG B-VP O
exons NNS B-NP O
5 CD B-NP O
and CC I-NP O
7 CD I-NP O
were VBD B-VP O
identified VBN I-VP O
using VBG B-VP O
inverse JJ B-NP O
PCR NN I-NP O
followed VBN B-VP O
by IN B-PP O
direct JJ B-NP O
sequencing NN I-NP O
. . O O

Conventional JJ B-NP O
PCR NN I-NP O
and CC O O
direct JJ B-NP O
sequencing NN I-NP O
then RB B-ADVP O
established VBD B-VP O
the DT B-NP O
intron NN I-NP O
- HYPH B-NP O
exon NN I-NP O
borders NNS I-NP O
of IN B-PP O
the DT B-NP O
mutant JJ I-NP O
genomic JJ I-NP O
DNA NN I-NP O
revealing VBG B-VP O
two CD B-NP O
splice NN I-NP O
acceptor NN I-NP O
mutations NNS I-NP O
a DT B-NP O
G NN I-NP O
- SYM B-NP O
- HYPH B-NP O
> SYM I-NP O
C NN I-NP O
substitution NN I-NP O
at IN B-PP O
position NN B-NP O
- HYPH B-NP O
1 CD I-NP O
of IN B-PP O
intron NN B-NP O
4 CD I-NP O
and CC O O
an DT B-NP O
A NN I-NP O
- SYM B-NP O
- HYPH I-NP O
> SYM I-NP O
G NN I-NP O
substitution NN I-NP O
at IN B-PP O
position NN B-NP O
- HYPH O O
2 CD B-NP O
of IN B-PP O
intron NN B-NP O
6 CD I-NP O
. . O O

Our PRP$ B-NP O
results NNS I-NP O
indicate VBP B-VP O
that IN B-SBAR O
the DT B-NP O
severe JJ I-NP O
form NN I-NP O
of IN B-PP O
prolidase NN B-NP B-Disease
deficiency NN I-NP I-Disease
is VBZ B-VP O
caused VBN I-VP O
by IN B-PP O
multiple JJ B-NP O
PEPD NN I-NP O
alleles NNS I-NP O
. . O O

In IN B-PP O
this DT B-NP O
report NN I-NP O
we PRP B-NP O
attempt VBP B-VP O
to TO I-VP O
begin VB I-VP O
the DT B-NP O
process NN I-NP O
of IN B-PP O
describing VBG B-VP O
these DT B-NP O
alleles NNS I-NP O
and CC O O
cataloging VBG B-VP O
their PRP$ B-NP O
phenotypic JJ I-NP O
expression NN I-NP O
. . O O

. . O O

Recombinations NNS B-NP O
in IN B-PP O
individuals NNS B-NP O
homozygous JJ B-ADJP O
by IN B-PP O
descent JJ B-NP O
localize VBP B-VP O
the DT B-NP O
Friedreich NNP I-NP B-Disease
ataxia NN I-NP I-Disease
locus NN I-NP O
in IN B-PP O
a DT B-NP O
cloned VBN I-NP O
450 CD I-NP O
- HYPH I-NP O
kb NN I-NP O
interval NN I-NP O
. . O O

The DT B-NP O
locus NN I-NP O
for IN B-PP O
Friedreich NNP B-NP B-Disease
ataxia NN I-NP I-Disease
( ( O O
FRDA NN B-NP B-Disease
) ) O O
, , O O
a DT B-NP O
severe JJ I-NP O
neurodegenerative JJ I-NP B-Disease
disease NN I-NP I-Disease
, , O O
is VBZ B-VP O
tightly RB I-VP O
linked VBN I-VP O
to TO B-PP O
markers NNS B-NP O
D9S5 NN I-NP O
and CC I-NP O
D9S15 NN I-NP O
, , O O
and CC O O
analysis NN B-NP O
of IN B-PP O
rare JJ B-NP O
recombination NN I-NP O
events NNS I-NP O
has VBZ B-VP O
suggested VBN I-VP O
the DT B-NP O
order NN I-NP O
cen NN I-NP O
- HYPH B-NP O
FRDA NN I-NP O
- HYPH B-NP O
D9S5 NN I-NP O
- HYPH B-NP O
D9S15 NN I-NP O
- HYPH B-NP O
qter NN I-NP O
. . O O

We PRP B-NP O
report VBP B-VP O
here RB B-ADVP O
the DT B-NP O
construction NN I-NP O
of IN B-PP O
a DT B-NP O
YAC NN I-NP O
contig NN I-NP O
extending VBG B-VP O
800 CD B-NP O
kb NN I-NP O
centromeric JJ B-ADJP O
to TO B-PP O
D9S5 NN B-NP O
and CC O O
the DT B-NP O
isolation NN I-NP O
of IN B-PP O
five CD B-NP O
new JJ I-NP O
microsatellite NN I-NP O
markers NNS I-NP O
from IN B-PP O
this DT B-NP O
region NN I-NP O
. . O O

In IN B-SBAR O
order NN O O
to TO B-VP O
map VB I-VP O
these DT B-NP O
markers NNS I-NP O
with IN B-PP O
respect NN B-NP O
to TO B-PP O
the DT B-NP O
FRDA NN I-NP B-Disease
locus NN I-NP O
, , O O
all DT B-NP O
within IN B-PP O
a DT B-NP O
1 CD I-NP O
- HYPH I-NP O
cM NN I-NP O
confidence NN I-NP O
interval NN I-NP O
, , O O
we PRP B-NP O
sought VBD B-VP O
to TO I-VP O
increase VB I-VP O
the DT B-NP O
genetic JJ I-NP O
information NN I-NP O
of IN B-PP O
available JJ B-NP O
FRDA NN I-NP B-Disease
families NNS I-NP O
by IN B-PP O
considering VBG B-VP O
homozygosity NN B-NP O
by IN B-PP O
descent JJ B-NP O
and CC I-NP O
association NN I-NP O
with IN B-PP O
founder NN B-NP O
haplotypes NNS I-NP O
in IN B-PP O
isolated VBN B-NP O
populations NNS I-NP O
. . O O

This DT B-NP O
approach NN I-NP O
allowed VBD B-VP O
us PRP B-NP O
to TO B-VP O
identify VB I-VP O
one CD B-NP O
phase NN I-NP O
- HYPH O O
known VBN B-NP O
recombination NN I-NP O
and CC O O
one CD B-NP O
probable JJ I-NP O
historic JJ I-NP O
recombination NN I-NP O
on IN B-PP O
haplotypes NNS B-NP O
from IN B-PP O
Reunion NNP B-NP O
Island NNP I-NP O
patients NNS I-NP O
, , O O
both DT B-NP O
of IN B-PP O
which WDT B-NP O
place VBP B-VP O
three CD B-NP O
of IN B-PP O
the DT B-NP O
five CD I-NP O
markers NNS I-NP O
proximal JJ B-ADJP O
to TO B-PP O
FRDA NN B-NP B-Disease
. . O O

This DT B-NP O
represents VBZ B-VP O
the DT B-NP O
first JJ I-NP O
identification NN I-NP O
of IN B-PP O
close JJ B-NP O
FRDA NN I-NP B-Disease
flanking NN I-NP O
markers NNS I-NP O
on IN B-PP O
the DT B-NP O
centromeric JJ I-NP O
side NN I-NP O
. . O O

The DT B-NP O
two CD I-NP O
other JJ I-NP O
markers NNS I-NP O
allowed VBD B-VP O
us PRP B-NP O
to TO B-VP O
narrow VB I-VP O
the DT B-NP O
breakpoint NN I-NP O
of IN B-PP O
a DT B-NP O
previously RB I-NP O
identified VBN I-NP O
distal JJ I-NP O
recombination NN I-NP O
that WDT B-NP O
is VBZ B-VP O
> JJR B-NP O
180 CD I-NP O
kb NN I-NP O
from IN B-PP O
D9S5 NN B-NP O
( ( O O
26P NN B-NP O
) ) O O
. . O O

Taken VBN B-VP O
together RB B-ADVP O
, , O O
the DT B-NP O
results NNS I-NP O
place VBP B-VP O
the DT B-NP O
FRDA NN I-NP B-Disease
locus NN I-NP O
in IN B-PP O
a DT B-NP O
450 CD I-NP O
- HYPH I-NP O
kb NN I-NP O
interval NN I-NP O
, , O O
which WDT B-NP O
is VBZ B-VP O
small JJ B-ADJP O
enough RB I-ADJP O
for IN B-PP O
direct JJ B-NP O
search NN I-NP O
of IN B-PP O
candidate NN B-NP O
genes NNS I-NP O
. . O O

A DT B-NP O
detailed JJ I-NP O
rare JJ I-NP O
cutter NN I-NP O
restriction NN I-NP O
map NN I-NP O
and CC O O
a DT B-NP O
cosmid NN I-NP O
contig NN I-NP O
covering VBG B-VP O
this DT B-NP O
interval NN I-NP O
were VBD B-VP O
constructed VBN I-VP O
and CC O O
should MD B-VP O
facilitate VB I-VP O
the DT B-NP O
search NN I-NP O
of IN B-PP O
genes NNS B-NP O
in IN B-PP O
this DT B-NP O
region NN I-NP O
. . O O

. . O O

Investigation NN B-NP O
of IN B-PP O
thermoregulatory JJ B-NP O
characteristics NNS I-NP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
Prader NNP B-NP B-Disease
- HYPH B-NP I-Disease
Willi NNP I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

A DT B-NP O
survey NN I-NP O
instrument NN I-NP O
is VBZ B-VP O
used VBN I-VP O
to TO B-VP O
assess VB I-VP O
temperature NN B-NP O
regulation NN I-NP O
characteristics NNS I-NP O
in IN B-PP O
children NNS B-NP O
with IN B-PP O
Prader NNP B-NP B-Disease
- HYPH I-NP I-Disease
Willi NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
PWS NN B-NP B-Disease
) ) O O
compared VBN B-VP O
to TO B-PP O
3 CD B-NP O
control NN I-NP O
groups NNS I-NP O
sibs NNS I-NP O
of IN B-PP O
PWS NN B-NP B-Disease
patients NNS I-NP O
( ( O O
SIB NN B-NP O
) ) O O
, , O O
neurodevelopmentally RB B-NP B-Disease
handicapped VBN I-NP I-Disease
children NNS I-NP O
( ( O O
ND NN B-NP O
) ) O O
, , O O
and CC O O
age NN B-NP O
and CC I-NP O
gender NN I-NP O
matched VBD B-VP O
well RB B-ADVP O
children NNS B-NP O
( ( O O
WC NN B-NP O
) ) O O
. . O O

Significant JJ B-NP O
differences NNS I-NP O
were VBD B-VP O
found VBN I-VP O
between IN B-PP O
PWS NN B-NP B-Disease
patients NNS I-NP O
, , O O
SIB NN B-NP O
controls NNS I-NP O
, , O O
and CC O O
WC NN B-NP O
controls NNS I-NP O
in IN B-PP O
the DT B-NP O
prevalence NN I-NP O
of IN B-PP O
febrile JJ B-NP O
convulsions NNS I-NP O
, , O O
fever NN B-NP O
- HYPH B-NP O
associated VBN I-NP O
symptoms NNS I-NP O
, , O O
and CC O O
temperature NN B-NP O
less JJR B-NP O
than IN I-NP O
94 CD I-NP O
degrees NNS I-NP O
F NN I-NP O
. . O O

No DT B-NP O
differences NNS I-NP O
were VBD B-VP O
noted VBN I-VP O
in IN B-PP O
any DT B-NP O
variable JJ I-NP O
between IN B-PP O
the DT B-NP O
PWS NN I-NP B-Disease
patients NNS I-NP O
and CC O O
the DT B-NP O
ND NN I-NP O
controls NNS I-NP O
, , O O
suggesting VBG B-VP O
that IN B-SBAR O
these DT B-NP O
abnormalities NNS I-NP O
are VBP B-VP O
not RB O O
unique JJ B-ADJP O
to TO B-PP O
PWS NN B-NP B-Disease
, , O O
but CC O O
can MD B-VP O
occur VB I-VP O
in IN B-PP O
any DT B-NP O
neurodevelopmentally RB I-NP B-Disease
handicapped VBN I-NP I-Disease
individual JJ I-NP O
, , O O
further RB B-ADVP O
suggesting VBG B-VP O
these DT B-NP O
do VBP B-VP O
not RB I-VP O
necessarily RB I-VP O
reflect VB I-VP O
syndrome NN B-NP O
- HYPH B-NP O
specific JJ I-NP O
hypothalamic JJ I-NP B-Disease
abnormalities NNS I-NP I-Disease
. . O O

. . O O

Phenotypic JJ B-NP O
variation NN I-NP O
including VBG B-PP O
retinitis NN B-NP B-Disease
pigmentosa NN I-NP I-Disease
, , O O
pattern NN B-NP B-Disease
dystrophy NN I-NP I-Disease
, , O O
and CC O O
fundus NN B-NP B-Disease
flavimaculatus NN I-NP I-Disease
in IN B-PP O
a DT B-NP O
single JJ I-NP O
family NN I-NP O
with IN B-PP O
a DT B-NP O
deletion NN I-NP O
of IN B-PP O
codon NN B-NP O
153 CD I-NP O
or CC I-NP O
154 CD I-NP O
of IN B-PP O
the DT B-NP O
peripherin NN I-NP O
/ SYM B-NP O
RDS NN I-NP O
gene NN I-NP O
. . O O

BACKGROUND NN B-NP O
AND CC O O
OBJECTIVES VBZ B-VP O
Mutations NNS B-NP O
of IN B-PP O
the DT B-NP O
peripherin NN I-NP O
/ SYM B-NP O
RDS NN I-NP O
gene NN I-NP O
have VBP B-VP O
been VBN I-VP O
reported VBN I-VP O
in IN B-PP O
autosomal JJ B-NP B-Disease
dominant JJ I-NP I-Disease
retinitis NN I-NP I-Disease
pigmentosa NN I-NP I-Disease
, , O O
pattern NN B-NP O
macular JJ I-NP B-Disease
dystrophy NN I-NP I-Disease
, , O O
and CC O O
retinitis NN B-NP B-Disease
punctata NN I-NP I-Disease
albescens NNP I-NP I-Disease
. . O O

We PRP B-NP O
report VBP B-VP O
herein RB B-ADVP O
the DT B-NP O
occurrence NN I-NP O
of IN B-PP O
three CD B-NP O
separate JJ I-NP O
phenotypes NNS I-NP O
within IN B-PP O
a DT B-NP O
single JJ I-NP O
family NN I-NP O
with IN B-PP O
a DT B-NP O
novel JJ I-NP O
3 CD I-NP O
- HYPH I-NP O
base NN I-NP O
pair NN I-NP O
deletion NN I-NP O
of IN B-PP O
codon NN B-NP O
153 CD I-NP O
or CC I-NP O
154 CD I-NP O
of IN B-PP O
the DT B-NP O
peripherin NN I-NP O
/ SYM B-NP O
RDS NN I-NP O
gene NN I-NP O
. . O O

DESIGN NN B-NP O
Case NN I-NP O
reports NNS I-NP O
with IN B-PP O
clinical JJ B-NP O
features NNS I-NP O
, , O O
fluorescein NN B-NP O
angiography NN I-NP O
, , O O
kinetic JJ B-NP O
perimetry NN I-NP O
, , O O
electrophysiological JJ B-NP O
studies NNS I-NP O
, , O O
and CC O O
molecular JJ B-NP O
genetics NNS I-NP O
. . O O

SETTING VBG B-VP O
University NNP B-NP O
medical JJ I-NP O
centers NNS I-NP O
. . O O

PATIENTS NNS B-NP O
A DT B-NP O
75 CD I-NP O
- HYPH I-NP O
year NN I-NP O
- HYPH O O
old JJ B-NP O
woman NN I-NP O
, , O O
her PRP$ B-NP O
two CD I-NP O
daughters NNS I-NP O
( ( O O
aged VBN B-VP O
44 CD B-NP O
and CC I-NP O
50 CD I-NP O
years NNS I-NP O
) ) O O
, , O O
and CC O O
her PRP B-NP O
49 CD I-NP O
- HYPH I-NP O
year NN I-NP O
- HYPH O O
old JJ B-NP O
son NN I-NP O
were VBD B-VP O
screened VBN I-VP O
for IN B-PP O
peripherin NN B-NP O
/ SYM B-VP O
RDS NN B-NP O
mutations NNS I-NP O
because IN B-PP O
of IN I-PP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
multiple JJ B-NP O
phenotypes NNS I-NP O
within IN B-PP O
the DT B-NP O
same JJ I-NP O
family NN I-NP O
. . O O

RESULTS NNS B-NP O
The DT B-NP O
mother NN I-NP O
presented VBD B-VP O
at IN B-PP O
age NN B-NP O
63 CD B-NP O
years NNS I-NP O
with IN B-PP O
a DT B-NP O
profoundly RB I-NP O
abnormal JJ I-NP O
electroretinogram NN I-NP O
( ( O O
ERG NN B-NP O
) ) O O
and CC O O
adult JJ B-NP O
- HYPH I-NP O
onset NN I-NP O
retinitis NN I-NP B-Disease
pigmentosa NN I-NP I-Disease
that WDT B-NP O
progressed VBD B-VP O
dramatically RB B-NP O
over IN I-NP O
12 CD I-NP O
years NNS I-NP O
, , O O
with IN B-PP O
marked JJ B-NP O
loss NN I-NP O
of IN B-PP O
peripheral JJ B-NP O
visual JJ I-NP O
field NN I-NP O
. . O O

One CD B-NP O
daughter NN I-NP O
developed VBD B-VP O
pattern NN B-NP B-Disease
macular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
at IN B-PP O
age NN B-NP O
31 CD B-NP O
years NNS I-NP O
. . O O

At IN B-PP O
age NN B-NP O
44 CD B-NP O
years NNS I-NP O
, , O O
her PRP$ B-NP O
ERG NN I-NP O
was VBD B-VP O
moderately RB B-ADJP O
abnormal JJ I-ADJP O
but CC O O
her PRP$ B-NP O
clinical JJ I-NP O
disease NN I-NP O
was VBD B-VP O
limited VBN I-VP O
to TO B-PP O
the DT B-NP O
macula NN I-NP O
. . O O

Another DT B-NP O
daughter NN I-NP O
presented VBD B-VP O
at IN B-PP O
age NN B-NP O
42 CD B-NP O
years NNS I-NP O
with IN B-PP O
macular JJ B-NP B-Disease
degeneration NN I-NP I-Disease
and CC O O
over IN B-PP O
10 CD B-NP O
years NNS I-NP O
developed VBD B-VP O
the DT B-NP O
clinical JJ I-NP O
picture NN I-NP O
of IN B-PP O
fundus NN B-NP B-Disease
flavimaculatus NN I-NP I-Disease
. . O O

Her PRP$ B-NP O
peripheral JJ I-NP O
visual JJ I-NP O
field NN I-NP O
was VBD B-VP O
preserved VBN I-VP O
but CC O O
her PRP$ B-NP O
ERG NN I-NP O
was VBD B-VP O
moderately RB B-ADJP O
abnormal JJ I-ADJP O
. . O O

The DT B-NP O
son NN I-NP O
had VBD B-VP O
onset NN B-NP O
of IN B-PP O
macular JJ B-NP B-Disease
degeneration NN I-NP I-Disease
at IN B-PP O
age NN B-NP O
44 CD B-NP O
years NNS I-NP O
. . O O

Pericentral JJ B-NP B-Disease
scotomas NNS I-NP I-Disease
were VBD B-VP O
present JJ B-ADJP O
and CC O O
the DT B-NP O
ERG NN I-NP O
was VBD B-VP O
markedly RB B-ADJP O
abnormal JJ I-ADJP O
. . O O

Fluorescein NN B-NP O
angiography NN I-NP O
revealed VBD B-VP O
punctate NN B-NP O
pigment NN I-NP O
epithelial JJ I-NP O
transmission NN I-NP O
defects NNS I-NP O
. . O O

CONCLUSIONS NNS B-NP O
A DT B-NP O
3 CD I-NP O
- HYPH I-NP O
base NN I-NP O
pair NN I-NP O
deletion NN I-NP O
of IN B-PP O
codon NN B-NP O
153 CD I-NP O
or CC I-NP O
154 CD I-NP O
of IN B-PP O
the DT B-NP O
peripherin NN I-NP O
/ SYM B-NP O
RDS NN I-NP O
gene NN I-NP O
can MD B-VP O
produce VB I-VP O
clinically RB B-NP O
disparate JJ I-NP O
phenotypes NNS I-NP O
even RB B-ADVP O
within IN B-PP O
the DT B-NP O
same JJ I-NP O
family NN I-NP O
. . O O

. . O O

Assignment NN B-NP O
of IN B-PP O
the DT B-NP O
human JJ I-NP O
Na NN I-NP O
+ SYM O O
/ SYM O O
glucose NN B-NP O
cotransporter NN I-NP O
gene NN I-NP O
SGLT1 NN I-NP O
to TO B-PP O
chromosome NN B-NP O
22q13 CD I-NP O
. . I-NP O

1 CD I-NP O
. . O O

The DT B-NP O
Na NN I-NP O
+ SYM O O
/ SYM O O
glucose NN B-NP O
cotransporter NN I-NP O
gene NN I-NP O
SGLT1 NN I-NP O
encodes VBZ B-VP O
the DT B-NP O
primary JJ I-NP O
carrier NN I-NP O
protein NN I-NP O
responsible JJ B-ADJP O
for IN B-PP O
the DT B-NP O
uptake NN I-NP O
of IN B-PP O
the DT B-NP O
dietary JJ I-NP O
sugars NNS I-NP O
glucose NN I-NP O
and CC I-NP O
galactose NN I-NP O
from IN B-PP O
the DT B-NP O
intestinal JJ I-NP O
lumen NN I-NP O
. . O O

SGLT1 NN B-NP O
transport NN I-NP O
activity NN I-NP O
is VBZ B-VP O
currently RB I-VP O
exploited VBN I-VP O
in IN B-PP O
oral JJ B-NP O
rehydration NN I-NP O
therapy NN I-NP O
. . O O

The DT B-NP O
75 CD I-NP O
- HYPH I-NP O
kDa NN I-NP O
glycoprotein NN I-NP O
is VBZ B-VP O
localized VBN I-VP O
in IN B-PP O
the DT B-NP O
brush JJ I-NP O
border NN I-NP O
of IN B-PP O
the DT B-NP O
intestinal JJ I-NP O
epithelium NN I-NP O
and CC O O
is VBZ B-VP O
predicted VBN I-VP O
to TO I-VP O
comprise VB I-VP O
12 CD B-NP O
membrane NN I-NP O
spans NNS I-NP O
. . O O

In IN B-PP O
two CD B-NP O
patients NNS I-NP O
with IN B-PP O
the DT B-NP O
autosomal JJ I-NP B-Disease
recessive JJ I-NP I-Disease
disease NN I-NP I-Disease
glucose NN I-NP I-Disease
/ SYM B-NP I-Disease
galactose NN I-NP I-Disease
malabsorption NN I-NP I-Disease
, , O O
the DT B-NP O
underlying JJ I-NP O
cause NN I-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
be VB I-VP O
a DT B-NP O
missense JJ I-NP O
mutation NN I-NP O
in IN B-PP O
SGLT1 NN B-NP O
, , O O
and CC O O
the DT B-NP O
Asp28 NN I-NP O
- SYM B-VP O
- SYM B-NP O
> SYM I-NP O
Asn NN I-NP O
change NN I-NP O
was VBD B-VP O
demonstrated VBN I-VP O
in FW B-ADVP O
vitro FW I-ADVP O
to TO B-VP O
eliminate VB I-VP O
SGLT1 NN B-NP O
transport NN I-NP O
activity NN I-NP O
. . O O

The DT B-NP O
SGLT1 NN I-NP O
gene NN I-NP O
was VBD B-VP O
previously RB I-VP O
shown VBN I-VP O
to TO I-VP O
reside VB I-VP O
on IN B-PP O
the DT B-NP O
distal JJ I-NP O
q NN I-NP O
arm NN I-NP O
of IN B-PP O
chromosome NN B-NP O
22 CD I-NP O
( ( O O
11 CD B-NP O
. . O O

2 CD B-NP O
- HYPH B-NP O
- HYPH I-NP O
> SYM I-NP O
qter NN I-NP O
) ) O O
. . O O

We PRP B-NP O
have VBP B-VP O
used VBN I-VP O
a DT B-NP O
cosmid NN I-NP O
probe NN I-NP O
for IN B-PP O
fluorescence NN B-NP O
in FW B-NP O
situ FW I-NP O
hybridization NN I-NP O
, , O O
which WDT B-NP O
refines VBZ B-VP O
the DT B-NP O
localization NN I-NP O
to TO B-PP O
22q13 CD B-NP O
. . O O

1 CD B-NP O
, , O O
and CC O O
provide VBP B-VP O
an DT B-NP O
example NN I-NP O
of IN B-PP O
the DT B-NP O
utility NN I-NP O
of IN B-PP O
the DT B-NP O
SGLT1 NN I-NP O
probe NN I-NP O
as IN B-PP O
a DT B-NP O
diagnostic NN I-NP O
for IN B-PP O
genetic JJ B-NP B-Disease
diseases NNS I-NP I-Disease
associated VBN B-VP O
with IN B-PP O
translocations NNS B-NP O
of IN B-PP O
chromosome NN B-NP O
22 CD I-NP O
. . O O

Restriction NN B-NP O
of IN B-PP O
ocular JJ B-NP O
fundus NN I-NP O
lesions NNS I-NP O
to TO B-PP O
a DT B-NP O
specific JJ I-NP O
subgroup NN I-NP O
of IN B-PP O
APC NN B-NP B-Disease
mutations NNS I-NP O
in IN B-PP O
adenomatous JJ B-NP B-Disease
polyposis NN I-NP I-Disease
coli NN I-NP I-Disease
patients NNS I-NP O
. . O O

In IN B-PP O
humans NNS B-NP O
, , O O
alteration NN B-NP O
of IN B-PP O
the DT B-NP O
tumor NN I-NP B-Disease
suppressor NN I-NP O
gene NN I-NP O
, , O O
APC NN B-NP B-Disease
, , O O
causes VBZ B-VP O
adenomatous JJ B-NP B-Disease
polyposis NN I-NP I-Disease
coli NN I-NP I-Disease
, , O O
a DT B-NP O
condition NN I-NP O
causing VBG B-VP O
predisposition NN B-NP O
to TO B-PP O
colorectal JJ B-NP B-Disease
cancer NN I-NP I-Disease
. . O O

The DT B-NP O
syndrome NN I-NP O
inconsistently RB B-ADVP O
associates VBZ B-VP O
characteristic JJ B-NP O
patches NNS I-NP O
of IN B-PP O
congenital JJ B-NP B-Disease
hypertrophy NN I-NP I-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
retinal JJ I-NP I-Disease
pigment NN I-NP I-Disease
epithelium NN I-NP I-Disease
( ( O O
CHRPE NN B-NP B-Disease
) ) O O
. . O O

Ocular JJ B-NP O
examination NN I-NP O
revealed VBD B-VP O
that IN B-SBAR O
patients NNS B-NP O
expressing VBG B-VP O
CHRPE NN B-NP B-Disease
tend NN I-NP O
to TO B-VP O
cluster VB I-VP O
within IN B-PP O
specific JJ B-NP O
families NNS I-NP O
. . O O

The DT B-NP O
exact JJ I-NP O
APC NN I-NP B-Disease
mutation NN I-NP O
was VBD B-VP O
identified VBN I-VP O
in IN B-PP O
42 CD B-NP O
unrelated JJ I-NP O
patients NNS I-NP O
. . O O

In IN B-PP O
all DT B-NP O
cases NNS I-NP O
these DT B-NP O
mutations NNS I-NP O
were VBD B-VP O
predicted VBN I-VP O
to TO I-VP O
lead VB I-VP O
to TO B-PP O
the DT B-NP O
synthesis NN I-NP O
of IN B-PP O
a DT B-NP O
truncated VBN I-NP O
protein NN I-NP O
. . O O

The DT B-NP O
extent NN I-NP O
of IN B-PP O
CHRPE NN B-NP B-Disease
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
be VB I-VP O
dependent JJ B-ADJP O
on IN B-PP O
the DT B-NP O
position NN I-NP O
of IN B-PP O
the DT B-NP O
mutation NN I-NP O
along IN B-PP O
the DT B-NP O
coding VBG I-NP O
sequence NN I-NP O
. . O O

CHRPE NN B-NP B-Disease
lesions NNS I-NP O
are VBP B-VP O
almost RB B-ADJP O
always RB I-ADJP O
absent JJ I-ADJP O
if IN B-SBAR O
the DT B-NP O
mutation NN I-NP O
occurs VBZ B-VP O
before IN B-PP O
exon NN B-NP O
9 CD I-NP O
, , O O
but CC O O
are VBP B-VP O
systematically RB B-ADJP O
present JJ I-ADJP O
if IN B-SBAR O
it PRP B-NP O
occurs VBZ B-VP O
after IN B-SBAR O
this DT B-NP O
exon NN I-NP O
. . O O

Thus RB B-ADVP O
, , O O
the DT B-NP O
range NN I-NP O
of IN B-PP O
phenotypic JJ B-NP O
expression NN I-NP O
observed VBN B-VP O
among IN B-PP O
affected JJ B-NP O
patients NNS I-NP O
may MD B-VP O
result VB I-VP O
in IN B-PP O
part NN B-NP O
from IN B-PP O
different JJ B-NP O
allelic JJ I-NP O
manifestations NNS I-NP O
of IN B-PP O
APC NN B-NP B-Disease
mutations NNS I-NP O
. . O O

. . O O

The DT B-NP O
effects NNS I-NP O
of IN B-PP O
dystrophin NN B-NP O
gene NN I-NP O
mutations NNS I-NP O
on IN B-PP O
the DT B-NP O
ERG NN I-NP O
in IN B-PP O
mice NNS B-NP O
and CC I-NP O
humans NNS I-NP O
. . O O

PURPOSE NN B-NP O
. . O O

The DT B-NP O
authors NNS I-NP O
earlier JJR B-NP O
findings NNS I-NP O
of IN B-PP O
a DT B-NP O
negative JJ I-NP O
electroretinogram NN I-NP O
( ( O O
ERG NN B-NP O
) ) O O
in IN B-PP O
a DT B-NP O
boy NN I-NP O
with IN B-PP O
Duchenne JJ B-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
DMD NN B-NP B-Disease
) ) O O
led VBD B-VP O
them PRP B-NP O
to TO B-VP O
investigate VB I-VP O
dystrophin NN B-NP O
gene NN I-NP O
deletions NNS I-NP O
and CC I-NP O
ERGs NNS I-NP O
in IN B-PP O
five CD B-NP O
boys NNS I-NP O
with IN B-PP O
DMD NN B-NP B-Disease
. . O O

The DT B-NP O
authors NNS I-NP O
wanted VBD B-VP O
to TO I-VP O
determined VB I-VP O
whether IN B-SBAR O
there EX B-NP O
were VBD B-VP O
similar JJ B-NP O
ERG NN I-NP O
findings NNS I-NP O
in IN B-PP O
an DT B-NP O
animal NN I-NP O
model NN I-NP O
for IN B-PP O
DMD NN B-NP B-Disease
, , O O
the DT B-NP O
mdx NN I-NP O
mouse NN I-NP O
. . O O

METHODS NNS B-NP O
. . O O

Ganzfeld JJ B-NP O
ERGs NNS I-NP O
were VBD B-VP O
recorded VBN I-VP O
in IN B-PP O
five CD B-NP O
boys NNS I-NP O
with IN B-PP O
DMD NN B-NP B-Disease
after IN B-PP O
a DT B-NP O
complete JJ I-NP O
ophthalmic JJ I-NP O
examination NN I-NP O
. . O O

The DT B-NP O
dystrophin NN I-NP O
gene NN I-NP O
was VBD B-VP O
analyzed VBN I-VP O
by IN B-PP O
Southern JJ B-NP O
blot NN I-NP O
hybridization NN I-NP O
. . O O

ERGs NNS B-NP O
were VBD B-VP O
recorded VBN I-VP O
in IN B-PP O
anesthetized VBN B-NP O
mdx NN I-NP O
and CC I-NP O
control NN I-NP O
mice NNS I-NP O
with IN B-PP O
a DT B-NP O
modified VBN I-NP O
Grass NN I-NP O
photostimulator NN I-NP O
( ( O O
Grass NNP B-NP O
Instrument NNP I-NP O
Company NNP I-NP O
, , O O
Quincy NNP B-NP O
, , O O
MA JJ B-ADJP O
) ) O O
. . O O

RESULTS NNS B-NP O
. . O O

Ophthalmic JJ B-NP O
examinations NNS I-NP O
in IN B-PP O
all DT B-NP O
five CD I-NP O
boys NNS I-NP O
had VBD B-VP O
normal JJ B-NP O
findings NNS I-NP O
, , O O
yet RB B-ADVP O
an DT B-NP O
abnormal JJ I-NP O
negative JJ I-NP O
ERG NN I-NP O
was VBD B-VP O
recorded VBN I-VP O
for IN B-PP O
each DT B-NP O
subject NN I-NP O
. . O O

The DT B-NP O
subjects NNS I-NP O
gene NN I-NP O
deletions NNS I-NP O
were VBD B-VP O
variable JJ B-ADJP O
, , O O
ranging VBG B-VP O
from IN B-PP O
large JJ B-NP O
deletions NNS I-NP O
to TO B-PP O
no DT B-NP O
detectable JJ I-NP O
deletions NNS I-NP O
. . O O

The DT B-NP O
ERGs NNS I-NP O
of IN B-PP O
the DT B-NP O
mdx NN I-NP O
mice NNS I-NP O
were VBD B-VP O
normal JJ B-ADJP O
and CC O O
did VBD B-VP O
not RB I-VP O
differ VB I-VP O
significantly RB B-ADVP O
from IN B-PP O
those DT B-NP O
of IN B-PP O
the DT B-NP O
control NN I-NP O
mice NNS I-NP O
. . O O

CONCLUSIONS NNS B-NP O
. . O O

The DT B-NP O
authors NNS I-NP O
believe VBP B-VP O
the DT B-NP O
unique JJ I-NP O
ERG NN I-NP O
recorded VBN B-VP O
for IN B-PP O
the DT B-NP O
human JJ I-NP O
subjects NNS I-NP O
is VBZ B-VP O
a DT B-NP O
manifestation NN I-NP O
of IN B-PP O
DMD NN B-NP B-Disease
associated VBN B-VP O
with IN B-PP O
defects NNS B-NP O
at IN B-PP O
the DT B-NP O
dystrophin NN I-NP O
gene NN I-NP O
locus NN I-NP O
and CC O O
represents VBZ B-VP O
a DT B-NP O
new JJ I-NP O
clinical JJ I-NP O
entity NN I-NP O
. . O O

The DT B-NP O
ERG NN I-NP O
of IN B-PP O
the DT B-NP O
mdx NN I-NP O
mouse NN I-NP O
may MD B-VP O
be VB I-VP O
spared VBN I-VP O
for IN B-PP O
several JJ B-NP O
reasons NNS I-NP O
, , O O
including VBG B-PP O
milder JJR B-NP O
effects NNS I-NP O
of IN B-PP O
the DT B-NP O
mouse NN I-NP O
gene NN I-NP O
defect NN I-NP O
, , O O
differences NNS B-NP O
in IN B-PP O
muscle NN B-NP O
and CC O O
retinal JJ B-NP O
gene NN I-NP O
product NN I-NP O
, , O O
or CC O O
species NN B-NP O
differences NNS I-NP O
in IN B-PP O
the DT B-NP O
biochemical JJ I-NP O
role NN I-NP O
of IN B-PP O
dystrophin NN B-NP O
. . O O

The DT B-NP O
ERG NN I-NP O
shows VBZ B-VP O
promise NN B-NP O
of IN B-PP O
becoming VBG B-VP O
a DT B-NP O
noninvasive JJ I-NP O
diagnostic JJ I-NP O
tool NN I-NP O
for IN B-PP O
DMD NN B-NP B-Disease
and CC O O
its PRP$ B-NP O
milder JJR I-NP O
allelic JJ I-NP O
forms NNS I-NP O
. . O O

. . O O

Association NN B-NP O
of IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
tumor NN I-NP I-Disease
suppressor NN I-NP O
protein NN I-NP O
with IN B-PP O
catenins NNS B-NP O
. . O O

Mutations NNS B-NP O
of IN B-PP O
APC NN B-NP O
appear VBP B-VP O
to TO I-VP O
initiate VB I-VP O
sporadic JJ B-NP O
and CC I-NP O
inherited JJ I-NP O
forms NNS I-NP O
of IN B-PP O
human JJ B-NP O
colorectal JJ I-NP B-Disease
cancer NN I-NP I-Disease
. . O O

Although IN B-SBAR O
these DT B-NP O
mutations NNS I-NP O
have VBP B-VP O
been VBN I-VP O
well RB I-VP O
characterized VBN I-VP O
, , O O
little JJ B-NP O
is VBZ B-VP O
known VBN I-VP O
about IN B-PP O
the DT B-NP O
function NN I-NP O
of IN B-PP O
the DT B-NP O
APC NN I-NP B-Disease
gene NN I-NP O
product NN I-NP O
. . O O

Two CD B-NP O
cellular JJ I-NP O
proteins NNS I-NP O
that WDT B-NP O
associate VBP B-VP O
with IN B-PP O
APC NN B-NP B-Disease
were VBD B-VP O
identified VBN I-VP O
by IN B-PP O
nucleotide NN B-NP O
sequence NN I-NP O
analysis NN I-NP O
and CC I-NP O
peptide NN I-NP O
mapping NN I-NP O
as IN B-PP O
the DT B-NP O
E NN I-NP O
- HYPH B-NP O
cadherin NN I-NP O
- HYPH B-NP O
associated VBN I-NP O
proteins NNS I-NP O
alpha SYM O O
- HYPH O O
and CC O O
beta SYM O O
- HYPH O O
catenin NN B-NP O
. . O O

A DT B-NP O
27 CD I-NP O
- HYPH I-NP O
residue NN I-NP O
fragment NN I-NP O
of IN B-PP O
APC NN B-NP O
containing VBG B-VP O
a DT B-NP O
15 CD I-NP O
- HYPH I-NP O
amino NN I-NP O
acid NN I-NP O
repeat NN I-NP O
was VBD B-VP O
sufficient JJ B-ADJP O
for IN B-PP O
the DT B-NP O
interaction NN I-NP O
with IN B-PP O
the DT B-NP O
catenins NNS I-NP O
. . O O

These DT B-NP O
results NNS I-NP O
suggest VBP B-VP O
an DT B-NP O
important JJ I-NP O
link NN I-NP O
between IN B-PP O
tumor NN B-NP B-Disease
initiation NN I-NP O
and CC I-NP O
cell NN I-NP O
adhesion NN I-NP O
. . O O

. . O O

Difference NN B-NP O
in IN B-PP O
methylation NN B-NP O
patterns NNS I-NP O
within IN B-PP O
the DT B-NP O
D15S9 NN I-NP O
region NN I-NP O
of IN B-PP O
chromosome NN B-NP O
15q11 CD I-NP O
- HYPH I-NP O
13 CD I-NP O
in IN B-PP O
first JJ B-NP O
cousins NNS I-NP O
with IN B-PP O
Angelman NNP B-NP B-Disease
syndrome NN I-NP I-Disease
and CC O O
Prader NNP B-NP B-Disease
- HYPH B-NP I-Disease
Willi NNP I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

Abnormalities NNS B-NP O
of IN B-PP O
chromosome NN B-NP O
region NN I-NP O
15q11 CD I-NP O
- HYPH I-NP O
13 CD I-NP O
are VBP B-VP O
associated VBN I-VP O
with IN B-PP O
Angelman NNP B-NP B-Disease
syndrome NN I-NP I-Disease
( ( O O
AS NN B-NP B-Disease
) ) O O
and CC O O
Prader NNP B-NP B-Disease
- HYPH I-NP I-Disease
Willi NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
PWS NN B-NP B-Disease
) ) O O
. . O O

Differences NNS B-NP O
between IN B-PP O
the DT B-NP O
methylation NN I-NP O
patterns NNS I-NP O
of IN B-PP O
the DT B-NP O
region NN I-NP O
of IN B-PP O
chromosome NN B-NP O
15q11 CD I-NP O
- HYPH I-NP O
13 CD I-NP O
which WDT B-NP O
hybridizes VBZ B-VP O
to TO B-PP O
the DT B-NP O
highly RB I-NP O
conserved VBN I-NP O
DNA NN I-NP O
, , O O
DN34 NN B-NP O
, , O O
in IN B-PP O
normal JJ B-NP O
individuals NNS I-NP O
and CC B-PP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
AS NN B-NP B-Disease
and CC I-NP O
PWS NN I-NP B-Disease
have VBP B-VP O
been VBN I-VP O
described VBN I-VP O
. . O O

We PRP B-NP O
report VBP B-VP O
on IN B-PP O
a DT B-NP O
family NN I-NP O
in IN B-PP O
which WDT B-NP O
first JJ B-NP O
cousins NNS I-NP O
are VBP B-VP O
affected VBN I-VP O
by IN B-PP O
AS NN B-NP B-Disease
and CC I-NP O
PWS NN I-NP B-Disease
as IN B-PP O
a DT B-NP O
result NN I-NP O
of IN B-PP O
a DT B-NP O
familial JJ I-NP O
paracentric JJ I-NP O
inversion NN I-NP O
of IN B-PP O
15q11 CD B-NP O
- HYPH I-NP O
q13 NN I-NP O
. . O O

The DT B-NP O
results NNS I-NP O
of IN B-PP O
the DT B-NP O
studies NNS I-NP O
on IN B-PP O
this DT B-NP O
family NN I-NP O
demonstrate VBP B-VP O
the DT B-NP O
differences NNS I-NP O
in IN B-PP O
the DT B-NP O
methylation NN I-NP O
patterns NNS I-NP O
in IN B-PP O
the DT B-NP O
2 CD I-NP O
conditions NNS I-NP O
and CC O O
the DT B-NP O
phenomenon NN I-NP O
of IN B-PP O
genomic JJ B-NP O
imprinting NN I-NP O
, , O O
whereby WRB B-ADVP O
genetic JJ B-NP O
information NN I-NP O
is VBZ B-VP O
expressed VBN I-VP O
differently RB B-ADJP O
dependent JJ I-ADJP O
on IN B-PP O
the DT B-NP O
parent NN I-NP O
of IN B-PP O
origin NN B-NP O
. . O O

. . O O

Haplotype NN B-NP O
studies NNS I-NP O
in IN B-PP O
Wilson NNP B-NP B-Disease
disease NN I-NP I-Disease
. . O O

In IN B-PP O
51 CD B-NP O
families NNS I-NP O
with IN B-PP O
Wilson NNP B-NP B-Disease
disease NN I-NP I-Disease
, , O O
we PRP B-NP O
have VBP B-VP O
studied VBN I-VP O
DNA NN B-NP O
haplotypes NNS I-NP O
of IN B-PP O
dinucleotide NN B-NP O
repeat NN I-NP O
polymorphisms NNS I-NP O
( ( O O
CA NN B-NP O
repeats NNS I-NP O
) ) O O
in IN B-PP O
the DT B-NP O
13q14 NN I-NP O
. . O O

3 CD B-NP O
region NN I-NP O
, , O O
to TO B-VP O
examine VB I-VP O
these DT B-NP O
markers NNS I-NP O
for IN B-PP O
association NN B-NP O
with IN B-PP O
the DT B-NP O
Wilson NNP I-NP B-Disease
disease NN I-NP I-Disease
gene NN I-NP O
( ( O O
WND NN B-NP B-Disease
) ) O O
. . O O

In IN B-PP O
addition NN B-NP O
to TO B-PP O
a DT B-NP O
marker NN I-NP O
( ( O O
D13S133 NN B-NP O
) ) O O
described VBN B-VP O
elsewhere RB B-ADVP O
, , O O
we PRP B-NP O
have VBP B-VP O
developed VBN I-VP O
three CD B-NP O
new JJ I-NP O
highly RB I-NP O
polymorphic JJ I-NP O
markers NNS I-NP O
( ( O O
D13S314 NN B-NP O
, , O O
D13S315 NN B-NP O
, , O O
and CC O O
D13S316 NN B-NP O
) ) O O
close RB B-ADVP O
to TO B-PP O
the DT B-NP O
WND NN I-NP B-Disease
locus NN I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
examined VBN I-VP O
the DT B-NP O
distribution NN I-NP O
of IN B-PP O
marker NN B-NP O
alleles NNS I-NP O
at IN B-PP O
the DT B-NP O
loci NNS I-NP O
studied VBN B-VP O
and CC O O
have VBP B-VP O
found VBN I-VP O
that IN B-SBAR O
D13S314 NN B-NP O
, , O O
D13S133 NN B-NP O
, , O O
and CC O O
D13S316 NN B-NP O
each DT B-NP O
show VBP B-VP O
nonrandom JJ B-NP O
distribution NN I-NP O
on IN B-PP O
chromosomes NNS B-NP O
carrying VBG B-VP O
the DT B-NP O
WND NN I-NP B-Disease
mutation NN I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
studied VBN I-VP O
haplotypes NNS B-NP O
of IN B-PP O
these DT B-NP O
three CD I-NP O
markers NNS I-NP O
and CC O O
have VBP B-VP O
found VBN I-VP O
that IN B-SBAR O
there EX B-NP O
are VBP B-VP O
highly RB B-NP O
significant JJ I-NP O
differences NNS I-NP O
between IN B-PP O
WND NN B-NP B-Disease
and CC O O
normal JJ B-NP O
haplotypes NNS I-NP O
in IN B-PP O
northern JJ B-NP O
European JJ I-NP O
families NNS I-NP O
. . O O

These DT B-NP O
findings NNS I-NP O
have VBP B-VP O
important JJ B-NP O
implications NNS I-NP O
for IN B-PP O
mutation NN B-NP O
detection NN I-NP O
and CC O O
molecular JJ B-NP O
diagnosis NN I-NP O
in IN B-PP O
families NNS B-NP O
with IN B-PP O
Wilson NNP B-NP B-Disease
disease NN I-NP I-Disease
. . O O

Genetic JJ B-NP O
analysis NN I-NP O
of IN B-PP O
the DT B-NP O
BRCA1 NN I-NP O
region NN I-NP O
in IN B-PP O
a DT B-NP O
large JJ I-NP O
breast NN I-NP O
/ SYM B-VP O
ovarian JJ B-NP O
family NN I-NP O
: : O O
refinement NN B-NP O
of IN B-PP O
the DT B-NP O
minimal JJ I-NP O
region NN I-NP O
containing VBG B-VP O
BRCA1 NN B-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
analyzed VBN I-VP O
a DT B-NP O
single JJ I-NP O
multi AFX I-NP O
- HYPH I-NP O
affected VBN I-NP O
breast NN I-NP B-Disease
/ SYM B-NP I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
pedigree NN I-NP O
( ( O O
BOV3 NN B-NP O
) ) O O
and CC O O
have VBP B-VP O
shown VBN I-VP O
consistent JJ B-NP O
inheritance NN I-NP O
of IN B-PP O
markers NNS B-NP O
on IN B-PP O
chromosome NN B-NP O
17q NN I-NP O
with IN B-PP O
the DT B-NP O
disease NN I-NP O
confirming VBG B-VP O
that IN B-SBAR O
this DT B-NP O
family NN I-NP O
is VBZ B-VP O
due IN B-PP O
to TO B-PP O
the DT B-NP O
BRCA1 NN I-NP O
gene NN I-NP O
. . O O

Analysis NN B-NP O
of IN B-PP O
17q NN B-NP O
haplotypes NNS I-NP O
shows VBZ B-VP O
a DT B-NP O
recombination NN I-NP O
event NN I-NP O
in IN B-PP O
a DT B-NP O
bilateral JJ I-NP O
breast NN I-NP B-Disease
cancer NN I-NP I-Disease
case NN I-NP O
which WDT B-NP O
suggests VBZ B-VP O
that IN B-SBAR O
the DT B-NP O
BRCA1 NN I-NP O
gene NN I-NP O
lies VBZ B-VP O
distal JJ B-ADJP O
to TO B-PP O
D17S857 NN B-NP O
; : O O
D17S857 NN B-NP O
is VBZ B-VP O
thus RB B-ADVP O
the DT B-NP O
new JJ I-NP O
proximal JJ I-NP O
boundary NN I-NP O
for IN B-PP O
the DT B-NP O
region NN I-NP O
containing VBG B-VP O
BRCA1 NN B-NP O
. . O O

Combining VBG B-VP O
this DT B-NP O
information NN I-NP O
with IN B-PP O
previously RB B-NP O
published VBN I-NP O
mapping NN I-NP O
information NN I-NP O
suggests VBZ B-VP O
that IN B-SBAR O
BRCA1 NN B-NP O
is VBZ B-VP O
contained VBN I-VP O
in IN B-PP O
a DT B-NP O
region NN I-NP O
estimated VBN B-VP O
at IN B-PP O
1 CD B-NP O
- HYPH I-NP O
1 CD I-NP O
. . O O

5 CD B-NP O
Mb NN I-NP O
in IN B-PP O
length NN B-NP O
. . O O

All DT B-NP O
seven CD I-NP O
breast NN I-NP B-Disease
tumour NN I-NP I-Disease
/ SYM B-VP O
blood NN B-NP O
pairs NNS I-NP O
examined VBN B-VP O
from IN B-PP O
this DT B-NP O
family NN I-NP O
show NN I-NP O
loss NN I-NP O
of IN B-PP O
heterozygosity NN B-NP O
in IN B-PP O
the DT B-NP O
tumours NNS I-NP B-Disease
. . O O

The DT B-NP O
allel NN I-NP O
retained VBN B-VP O
in IN B-PP O
each DT B-NP O
tumour NN I-NP B-Disease
was VBD B-VP O
from IN B-PP O
the DT B-NP O
disease NN I-NP O
- HYPH O O
bearing VBG B-VP O
chromosome NN B-NP O
implicating VBG B-VP O
BRCA1 NN B-NP O
as IN B-PP O
a DT B-NP O
tumour NN I-NP B-Disease
suppressor NN I-NP O
gene NN I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
sequenced VBN I-VP O
the DT B-NP O
17 CD I-NP O
beta SYM I-NP O
- HYPH I-NP O
oestradiol NN I-NP O
dehydrogenase NN I-NP O
genes NNS I-NP O
( ( O O
EDH17B1 NN B-NP O
and CC O O
EDH17B2 NN B-NP O
) ) O O
which WDT B-NP O
have VBP B-VP O
been VBN I-VP O
suggested VBN I-VP O
as IN B-PP O
candidate NN B-NP O
genes NNS I-NP O
for IN B-PP O
BRCA1 NN B-NP O
in IN B-PP O
four CD B-NP O
members NNS I-NP O
of IN B-PP O
this DT B-NP O
family NN I-NP O
. . O O

No DT B-NP O
germline NN I-NP O
mutations NNS I-NP O
were VBD B-VP O
detected VBN I-VP O
. . O O

Myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
kinase NN I-NP O
is VBZ B-VP O
a DT B-NP O
component NN I-NP O
of IN B-PP O
neuromuscular JJ B-NP O
junctions NNS I-NP O
. . O O

The DT B-NP O
clinical JJ I-NP O
manifestation NN I-NP O
of IN B-PP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
( ( O O
DM NN B-NP B-Disease
) ) O O
is VBZ B-VP O
correlated VBN I-VP O
to TO B-PP O
the DT B-NP O
extent NN I-NP O
of IN B-PP O
expansion NN B-NP O
of IN B-PP O
an DT B-NP O
unstable JJ I-NP O
[ ( I-NP O
CTG NN I-NP O
] ) I-NP O
n NN I-NP O
DNA NN I-NP O
motif NN I-NP O
. . O O

Recent JJ B-NP O
studies NNS I-NP O
have VBP B-VP O
demonstrated VBN I-VP O
that IN B-SBAR O
this DT B-NP O
trinucleotide NN I-NP O
motif NN I-NP O
forms VBZ B-VP O
part NN B-NP O
of IN B-PP O
the DT B-NP O
last JJ I-NP O
, , O O
3 CD B-NP O
untranslated JJ I-NP O
exon NN I-NP O
of IN B-PP O
a DT B-NP O
gene NN I-NP O
which WDT B-NP O
potentially RB B-ADVP O
encodes VBZ B-VP O
multiple JJ B-NP O
protein NN I-NP O
isoforms NNS I-NP O
of IN B-PP O
a DT B-NP O
serine NN I-NP O
/ SYM B-NP O
threonine NN I-NP O
protein NN I-NP O
kinase NN I-NP O
( ( O O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
protein NN I-NP O
kinase NN I-NP O
, , O O
DM NN B-NP O
- HYPH B-NP O
PK NN I-NP O
) ) O O
. . O O

We PRP B-NP O
report VBP B-VP O
here RB B-ADVP O
on IN B-PP O
the DT B-NP O
development NN I-NP O
of IN B-PP O
antisera NNS B-NP O
against IN B-PP O
synthetic JJ B-NP O
DM NN I-NP O
- HYPH B-NP O
PK NN I-NP O
peptide NN I-NP O
antigens NNS I-NP O
and CC O O
their PRP$ B-NP O
use NN I-NP O
in IN B-PP O
biochemical JJ B-NP O
and CC I-NP O
histochemical JJ I-NP O
studies NNS I-NP O
. . O O

Immunoreactive JJ B-NP O
DM NN I-NP O
- HYPH B-NP O
kinase NN I-NP O
protein NN I-NP O
of IN B-PP O
53 CD B-NP O
kD NN I-NP O
is VBZ B-VP O
present JJ B-ADJP O
at IN B-PP O
low JJ B-NP O
levels NNS I-NP O
in IN B-PP O
skeletal JJ B-NP O
and CC I-NP O
cardiac JJ I-NP O
muscle NN I-NP O
extracts NNS I-NP O
of IN B-PP O
DM NN B-NP B-Disease
patients NNS I-NP O
and CC O O
normal JJ B-NP O
controls NNS I-NP O
. . O O

Immunohistochemical JJ B-NP O
staining NN I-NP O
revealed VBD B-VP O
that IN B-SBAR O
DM NN B-NP O
- HYPH B-NP O
PK NN I-NP O
is VBZ B-VP O
localised VBN I-VP O
prominently RB B-ADVP O
at IN B-PP O
sites NNS B-NP O
of IN B-PP O
neuromuscular JJ B-NP O
and CC I-NP O
myotendinous JJ I-NP O
junctions NNS I-NP O
( ( O O
NMJs NNS B-NP O
and CC I-NP O
MTJs NNS I-NP O
) ) O O
of IN B-PP O
human JJ B-NP O
and CC I-NP O
rodent JJ I-NP O
skeletal JJ I-NP O
muscles NNS I-NP O
. . O O

Furthermore RB B-ADVP O
, , O O
very RB B-NP O
low JJ I-NP O
levels NNS I-NP O
of IN B-PP O
immunoreactive JJ B-NP O
DM NN I-NP O
- HYPH B-NP O
PK NN I-NP O
protein NN I-NP O
are VBP B-VP O
present JJ B-ADJP O
in IN B-PP O
the DT B-NP O
sarcoplasm NN I-NP O
of IN B-PP O
predominantly RB B-NP O
type NN I-NP O
I CD I-NP O
fibres NNS I-NP O
in IN B-PP O
various JJ B-NP O
muscles NNS I-NP O
. . O O

Strikingly RB B-ADVP O
, , O O
presence NN B-NP O
of IN B-PP O
the DT B-NP O
protein NN I-NP O
can MD B-VP O
also RB I-VP O
be VB I-VP O
demonstrated VBN I-VP O
for IN B-PP O
NMJs NNS B-NP O
of IN B-PP O
muscular JJ B-NP O
tissues NNS I-NP O
of IN B-PP O
adult JJ B-NP O
and CC I-NP O
congenital JJ I-NP O
cases NNS I-NP O
of IN B-PP O
DM NN B-NP B-Disease
, , O O
with IN B-PP O
no DT B-NP O
gross JJ I-NP O
changes NNS I-NP O
in IN B-PP O
structural JJ B-NP O
organisation NN I-NP O
. . O O

Our PRP$ B-NP O
findings NNS I-NP O
provide VBP B-VP O
a DT B-NP O
basis NN I-NP O
for IN B-PP O
further JJ B-NP O
characterisation NN I-NP O
of IN B-PP O
the DT B-NP O
role NN I-NP O
of IN B-PP O
the DT B-NP O
kinase NN I-NP O
in IN B-PP O
protein NN B-NP O
assembly NN I-NP O
processes NNS I-NP O
or CC O O
signal NN B-NP O
mediation NN I-NP O
at IN B-PP O
synaptic JJ B-NP O
sites NNS I-NP O
and CC O O
ultimately RB B-ADVP O
for IN B-PP O
the DT B-NP O
understanding NN I-NP O
of IN B-PP O
the DT B-NP O
complex JJ I-NP O
pathophysiology NN I-NP O
of IN B-PP O
DM NN B-NP B-Disease
. . O O

. . O O

Markedly RB B-NP O
accelerated VBN I-NP O
catabolism NN I-NP O
of IN B-PP O
apolipoprotein NN B-NP O
A NN I-NP O
- HYPH O O
II CD B-NP O
( ( O O
ApoA NN B-NP O
- HYPH O O
II CD B-NP O
) ) O O
and CC O O
high JJ B-NP O
density NN I-NP O
lipoproteins NNS I-NP O
containing VBG B-VP O
ApoA NN B-NP O
- HYPH B-NP O
II CD I-NP O
in IN B-PP O
classic JJ B-NP O
lecithin NN I-NP O
: : O O
cholesterol NN B-NP B-Disease
acyltransferase NN I-NP I-Disease
deficiency NN I-NP I-Disease
and CC I-NP O
fish NN I-NP B-Disease
- HYPH B-NP I-Disease
eye NN I-NP I-Disease
disease NN I-NP I-Disease
. . O O

Classic JJ O B-Disease
( ( O I-Disease
complete JJ B-ADJP I-Disease
) ) O I-Disease
lecithin JJ B-NP I-Disease
cholesterol NN I-NP I-Disease
acyltransferase NN I-NP I-Disease
( ( O I-Disease
LCAT NN B-NP I-Disease
) ) O I-Disease
deficiency NN B-NP I-Disease
and CC O O
Fish JJ B-NP B-Disease
- HYPH I-NP I-Disease
eye NN I-NP I-Disease
disease NN I-NP I-Disease
( ( O O
partial JJ B-NP B-Disease
LCAT NN I-NP I-Disease
deficiency NN I-NP I-Disease
) ) O O
are VBP B-VP O
genetic JJ B-NP O
syndromes NNS I-NP O
associated VBN B-VP O
with IN B-PP O
markedly RB B-NP O
decreased VBN I-NP O
plasma NN I-NP O
levels NNS I-NP O
of IN B-PP O
high JJ B-NP O
density NN I-NP O
lipoprotein NN I-NP O
( ( O O
HDL NN B-NP O
) ) O O
cholesterol NN B-NP O
but CC B-PP O
not RB B-NP O
with IN B-PP O
an DT B-NP O
increased VBN I-NP O
risk NN I-NP O
of IN B-PP O
atherosclerotic JJ B-NP B-Disease
cardiovascular JJ I-NP I-Disease
disease NN I-NP I-Disease
. . O O

We PRP B-NP O
investigated VBD B-VP O
the DT B-NP O
metabolism NN I-NP O
of IN B-PP O
the DT B-NP O
HDL NN I-NP O
apolipoproteins NNS I-NP O
( ( O O
apo NN B-NP O
) ) O O
apoA NN B-NP O
- HYPH I-NP O
I NN I-NP O
and CC I-NP O
apoA NN I-NP O
- HYPH O O
II CD B-NP O
in IN B-PP O
a DT B-NP O
total NN I-NP O
of IN B-PP O
five CD B-NP O
patients NNS I-NP O
with IN B-PP O
LCAT NN B-NP B-Disease
deficiency NN I-NP I-Disease
, , O O
one CD B-NP O
with IN B-PP O
classic JJ B-NP B-Disease
LCAT NN I-NP I-Disease
deficiency NN I-NP I-Disease
and CC O O
four CD B-NP O
with IN B-PP O
Fish JJ B-NP B-Disease
- HYPH I-NP I-Disease
eye NN I-NP I-Disease
disease NN I-NP I-Disease
. . O O

Plasma NN B-NP O
levels NNS I-NP O
of IN B-PP O
apoA NN B-NP O
- HYPH B-NP O
II CD I-NP O
were VBD B-VP O
decreased VBN I-VP O
to TO B-PP O
a DT B-NP O
proportionately RB I-NP O
greater JJR I-NP O
extent NN I-NP O
( ( O O
23 CD B-NP O
% NN I-NP O
of IN B-PP O
normal JJ B-NP O
) ) O O
than IN B-SBAR O
apoA NN B-NP O
- HYPH B-NP O
I CD I-NP O
( ( O O
30 CD B-NP O
% NN I-NP O
of IN B-PP O
normal JJ B-NP O
) ) O O
. . O O

In IN B-PP O
addition NN B-NP O
, , O O
plasma NN B-NP O
concentrations NNS I-NP O
of IN B-PP O
HDL NN B-NP O
particles NNS I-NP O
containing VBG B-VP O
both CC O O
apoA NN B-NP O
- HYPH I-NP O
I NN I-NP O
and CC I-NP O
apoA NN I-NP O
- HYPH O O
II CD B-NP O
( ( O O
LpA NN B-NP O
- HYPH B-NP O
I NN I-NP O
A NN I-NP O
- HYPH B-NP O
II CD I-NP O
) ) O O
were VBD B-VP O
much RB B-ADJP O
lower JJR I-ADJP O
( ( O O
18 CD B-NP O
% NN I-NP O
of IN B-PP O
normal JJ B-NP O
) ) O O
than IN B-PP O
those DT B-NP O
of IN B-PP O
particles NNS B-NP O
containing VBG B-VP O
only RB B-NP O
apoA NN I-NP O
- HYPH O O
I NN B-NP O
( ( O O
LpA NN B-NP O
- HYPH B-NP O
I NN I-NP O
) ) O O
( ( O O
51 CD B-NP O
% NN I-NP O
of IN B-PP O
normal JJ B-NP O
) ) O O
. . O O

The DT B-NP O
metabolic JJ I-NP O
basis NN I-NP O
for IN B-PP O
the DT B-NP O
low JJ I-NP O
levels NNS I-NP O
of IN B-PP O
apoA NN B-NP O
- HYPH B-NP O
II CD I-NP O
and CC I-NP O
LpA NN I-NP O
- HYPH I-NP O
I NN I-NP O
A NN I-NP O
- HYPH O O
II CD B-NP O
was VBD B-VP O
investigated VBN I-VP O
in IN B-PP O
all DT B-NP O
five CD I-NP O
patients NNS I-NP O
using VBG B-VP O
both CC O O
exogenous JJ B-NP O
radiotracer NN I-NP O
and CC O O
endogenous JJ B-NP O
stable JJ I-NP O
isotope NN I-NP O
labeling NN I-NP O
techniques NNS I-NP O
. . O O

The DT B-NP O
mean JJ I-NP O
plasma NN I-NP O
residence NN I-NP O
time NN I-NP O
of IN B-PP O
apoA NN B-NP O
- HYPH O O
I PRP B-NP O
was VBD B-VP O
decreased VBN I-VP O
at IN B-PP O
2 CD B-NP O
. . O O

08 CD B-NP O
+ SYM O O
/ SYM O O
- SYM B-NP O
0 CD B-NP O
. . O O

27 CD B-NP O
d NN I-NP O
( ( O O
controls NNS B-NP O
4 CD B-NP O
. . I-NP O

74 CD I-NP O
+ SYM O O
/ SYM O O
- SYM B-NP O
0 CD B-NP O
. SYM I-NP O

65 CD I-NP O
days NNS I-NP O
) ) O O
; : O O
however RB B-ADVP O
, , O O
the DT B-NP O
residence NN I-NP O
time NN I-NP O
of IN B-PP O
apoA NN B-NP O
- HYPH B-NP O
II CD I-NP O
was VBD B-VP O
even RB B-ADJP O
shorter JJR I-ADJP O
at IN B-PP O
1 CD B-NP O
. . O O

66 CD B-NP O
+ SYM O O
/ SYM O O
- SYM B-NP O
0 CD B-NP O
. . O O

24 CD B-NP O
d NN I-NP O
( ( O O
controls NNS B-NP O
5 CD B-NP O
. . I-NP O

25 CD I-NP O
+ SYM O O
/ SYM B-NP O
- SYM B-NP O
0 CD B-NP O
. SYM I-NP O

61 CD I-NP O
d NN I-NP O
) ) O O
. . O O

In IN B-PP O
addition NN B-NP O
, , O O
the DT B-NP O
catabolism NN I-NP O
of IN B-PP O
apoA NN B-NP O
- HYPH I-NP O
I NN I-NP O
in IN B-PP O
LpA NN B-NP O
- HYPH I-NP O
I NN I-NP O
A NN I-NP O
- HYPH O O
II CD B-NP O
was VBD B-VP O
substantially RB B-ADJP O
faster RBR I-ADJP O
than IN B-PP O
that DT B-NP O
of IN B-PP O
apoA NN B-NP O
- HYPH I-NP O
I NN I-NP O
in IN B-PP O
LpA NN B-NP O
- HYPH I-NP O
I NN I-NP O
. . O O

In IN B-PP O
summary NN B-NP O
, , O O
genetic JJ B-NP O
syndromes NNS I-NP O
of IN B-PP O
either CC B-NP O
complete JJ I-NP B-Disease
or CC I-NP I-Disease
partial JJ I-NP I-Disease
LCAT NN I-NP I-Disease
deficiency NN I-NP I-Disease
result VBP B-VP O
in IN B-PP O
low JJ B-NP O
levels NNS I-NP O
of IN B-PP O
HDL NN B-NP O
through IN B-PP O
preferential JJ B-NP O
hypercatabolism NN I-NP O
of IN B-PP O
apoA NN B-NP O
- HYPH B-NP O
II CD I-NP O
and CC O O
HDL NN B-NP O
particles NNS I-NP O
containing VBG B-VP O
apoA NN B-NP O
- HYPH B-NP O
II CD I-NP O
. . O O

Because IN B-SBAR O
LpA NN B-NP O
- HYPH O O
I PRP B-NP O
has VBZ B-VP O
been VBN I-VP O
proposed VBN I-VP O
to TO I-VP O
be VB I-VP O
more RBR B-ADJP O
protective JJ I-ADJP O
than IN B-PP O
LpA NN B-NP O
- HYPH I-NP O
I NN I-NP O
A NN I-NP O
- HYPH O O
II CD B-NP O
against IN B-PP O
atherosclerosis NN B-NP B-Disease
, , O O
this DT B-NP O
selective JJ I-NP O
effect NN I-NP O
on IN B-PP O
the DT B-NP O
metabolism NN I-NP O
of IN B-PP O
LpA NN B-NP O
- HYPH I-NP O
I NN I-NP O
A NN I-NP O
- HYPH O O
II CD B-NP O
may MD B-VP O
provide VB I-VP O
a DT B-NP O
potential JJ I-NP O
explanation NN I-NP O
why WRB B-ADVP O
patients NNS B-NP O
with IN B-PP O
classic JJ B-NP B-Disease
LCAT NN I-NP I-Disease
deficiency NN I-NP I-Disease
and CC O O
Fish JJ B-NP B-Disease
- HYPH I-NP I-Disease
eye NN I-NP I-Disease
disease NN I-NP I-Disease
are VBP B-VP O
not RB O O
at IN B-PP O
increased VBN B-NP O
risk NN I-NP O
for IN B-PP O
premature JJ B-NP O
atherosclerosis NN I-NP B-Disease
despite IN B-PP O
markedly RB B-NP O
decreased VBN I-NP O
levels NNS I-NP O
of IN B-PP O
HDL NN B-NP O
cholesterol NN I-NP O
and CC I-NP O
apoA NN I-NP O
- HYPH O O
I PRP B-NP O
X NN B-NP B-Disease
linked VBD B-VP I-Disease
recessive JJ B-NP I-Disease
thrombocytopenia NN I-NP I-Disease
. . O O

A DT B-NP O
Saudi NNP I-NP O
Arab NNP I-NP O
boy NN I-NP O
presented VBN B-VP O
in IN B-PP O
early JJ B-NP O
childhood NN I-NP O
with IN B-PP O
thrombocytopenia NN B-NP B-Disease
, , O O
morphologically RB B-NP O
large JJ I-NP O
and CC I-NP O
normal JJ I-NP O
sized JJ I-NP O
platelets NNS I-NP O
, , O O
increased VBN B-NP O
mean JJ I-NP O
platelet NN I-NP O
volume NN I-NP O
, , O O
and CC O O
a DT B-NP O
hypermegakaryocytic JJ I-NP O
bone NN I-NP O
marrow NN I-NP O
. . O O

There EX B-NP O
was VBD B-VP O
no DT B-NP O
clinical JJ I-NP O
and CC I-NP O
laboratory JJ I-NP O
evidence NN I-NP O
of IN B-PP O
any DT B-NP O
significant JJ I-NP O
immunological JJ I-NP B-Disease
abnormalities NNS I-NP I-Disease
. . O O

Similar JJ B-NP O
findings NNS I-NP O
in IN B-PP O
two CD B-NP O
other JJ I-NP O
brothers NNS I-NP O
suggested VBD B-VP O
strongly RB B-ADVP O
that IN B-SBAR O
they PRP B-NP O
were VBD B-VP O
all DT O O
suffering VBG B-VP O
from IN B-PP O
an DT B-NP O
X NN I-NP B-Disease
linked VBD B-VP I-Disease
recessive JJ B-NP I-Disease
thrombocytopenic JJ I-NP I-Disease
disorder NN I-NP I-Disease
. . O O

Results NNS B-NP O
of IN B-PP O
DNA NN B-NP O
analysis NN I-NP O
with IN B-PP O
the DT B-NP O
probe NN I-NP O
M27 NN I-NP O
beta NN I-NP O
are VBP B-VP O
consistent JJ B-ADJP O
with IN B-PP O
X NN B-NP O
linkage NN I-NP O
and CC O O
indicate VBP B-VP O
also RB B-ADVP O
that IN B-SBAR O
the DT B-NP O
locus NN I-NP O
of IN B-PP O
the DT B-NP O
relevant JJ I-NP O
gene NN I-NP O
lies VBZ B-VP O
close JJ B-ADJP O
to TO B-PP O
or CC O O
is VBZ B-VP O
identical JJ B-ADJP O
to TO B-PP O
the DT B-NP O
locus NN I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
for IN B-PP O
the DT B-NP O
Wiskott NNP I-NP B-Disease
- HYPH I-NP I-Disease
Aldrich NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
WAS NN B-NP B-Disease
) ) O O
. . O O

Because IN B-PP O
of IN I-PP O
various JJ B-NP O
features NNS I-NP O
which WDT B-NP O
include VBP B-VP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
large JJ B-NP O
and CC I-NP O
normal JJ I-NP O
sized JJ I-NP O
platelets NNS I-NP O
( ( O O
rather RB B-PP O
than IN I-PP O
small JJ B-NP O
platelets NNS I-NP O
) ) O O
and CC O O
freedom NN B-NP O
from IN B-PP O
significant JJ B-NP O
immune JJ I-NP B-Disease
deficiencies NNS I-NP I-Disease
, , O O
it PRP B-NP O
is VBZ B-VP O
likely JJ B-ADJP O
that IN B-SBAR O
the DT B-NP O
X NN I-NP B-Disease
linked VBD B-VP I-Disease
recessive JJ B-NP I-Disease
thrombocytopenia NN I-NP I-Disease
in IN B-PP O
this DT B-NP O
family NN I-NP O
is VBZ B-VP O
an DT B-NP O
isolated VBN I-NP O
entity NN I-NP O
quite RB B-ADJP O
distinct JJ I-ADJP O
from IN B-PP O
the DT B-NP O
classical JJ I-NP O
WAS NN I-NP B-Disease
phenotype NN I-NP O
. . O O

However RB B-ADVP O
, , O O
a DT B-NP O
modified VBN I-NP O
expression NN I-NP O
of IN B-PP O
the DT B-NP O
WAS NN I-NP B-Disease
gene NN I-NP O
producing VBG B-VP O
a DT B-NP O
mild JJ I-NP O
phenotypic JJ I-NP O
variant NN I-NP O
cannot MD B-VP O
be VB I-VP O
excluded VBN I-VP O
entirely RB B-ADVP O
. . O O

. . O O

Macular JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
associated VBN B-VP O
with IN B-PP O
mutations NNS B-NP O
at IN B-PP O
codon NN B-NP O
172 CD I-NP O
in IN B-PP O
the DT B-NP O
human JJ I-NP O
retinal JJ I-NP B-Disease
degeneration NN I-NP I-Disease
slow JJ I-NP O
gene NN I-NP O
. . O O

BACKGROUND NN B-NP O
Recently RB B-ADVP O
, , O O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
retinal JJ I-NP B-Disease
degeneration NN I-NP I-Disease
slow JJ B-ADJP O
( ( O O
rds NNS B-NP O
) ) O O
gene NN B-NP O
which WDT B-NP O
codes VBZ B-VP O
for IN B-PP O
peripherin NN B-NP O
- HYPH B-NP O
rds NNS I-NP O
have VBP B-VP O
been VBN I-VP O
implicated VBN I-VP O
as IN B-PP O
a DT B-NP O
cause NN I-NP O
of IN B-PP O
autosomal JJ B-NP B-Disease
dominant JJ I-NP I-Disease
retinitis NN I-NP I-Disease
pigmentosa NN I-NP I-Disease
. . O O

Because IN B-SBAR O
this DT B-NP O
gene NN I-NP O
is VBZ B-VP O
expressed VBN I-VP O
in IN B-PP O
both CC B-NP O
rods NNS I-NP O
and CC I-NP O
cones NNS I-NP O
, , O O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
rds NNS I-NP O
gene NN I-NP O
might MD B-VP O
be VB I-VP O
expected VBN I-VP O
to TO I-VP O
cause VB I-VP O
degeneration NN B-NP O
affecting VBG B-VP O
either CC O O
the DT B-NP O
scotopic JJ I-NP O
or CC I-NP O
photopic JJ I-NP O
systems NNS I-NP O
. . O O

Mutations NNS B-NP O
at IN B-PP O
codon NN B-NP O
172 CD I-NP O
of IN B-PP O
the DT B-NP O
rds NNS I-NP O
gene NN I-NP O
have VBP B-VP O
been VBN I-VP O
identified VBN I-VP O
in IN B-PP O
three CD B-NP O
families NNS I-NP O
with IN B-PP O
autosomal JJ B-NP O
dominantly RB B-VP O
inherited VBN I-VP O
, , O O
progressive JJ B-NP O
macular JJ I-NP B-Disease
dystrophy NN I-NP I-Disease
. . O O

METHODS NNS B-NP O
Affected VBD B-VP O
individuals NNS B-NP O
underwent VBD B-VP O
ophthalmic JJ B-NP O
examination NN I-NP O
, , O O
scotopic JJ B-NP O
perimetry NN I-NP O
, , O O
dark JJ B-NP O
adaptometry NN I-NP O
, , O O
measurement NN B-NP O
of IN B-PP O
color NN B-NP O
- HYPH B-NP O
contrast NN I-NP O
sensitivity NN I-NP O
, , O O
and CC O O
electroretinography NN B-NP O
to TO B-VP O
characterize VB I-VP O
the DT B-NP O
photoreceptor NN I-NP O
dysfunction NN I-NP O
. . O O

RESULTS NNS B-NP O
In IN B-PP O
all DT B-NP O
but IN B-PP O
one CD B-NP O
affected JJ I-NP O
member NN I-NP O
, , O O
symptoms NNS B-NP O
of IN B-PP O
progressive JJ B-NP O
central JJ I-NP O
visual JJ I-NP B-Disease
loss NN I-NP I-Disease
developed VBN B-VP O
in IN B-PP O
the DT B-NP O
third JJ I-NP O
or CC I-NP O
fourth JJ I-NP O
decade NN I-NP O
of IN B-PP O
life NN B-NP O
accompanied VBN B-VP O
by IN B-PP O
central JJ B-NP B-Disease
scotoma NN I-NP I-Disease
and CC O O
well RB B-ADVP O
- HYPH I-ADVP O
demarcated VBN B-NP O
atrophy NN I-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
retinal JJ I-NP I-Disease
pigment NN I-NP I-Disease
epithelium NN I-NP I-Disease
and CC I-NP O
choriocapillaris NN I-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
macula NN I-NP I-Disease
. . O O

In IN B-PP O
general JJ B-NP O
, , I-NP O
cone NN I-NP O
and CC I-NP O
rod NN I-NP O
thresholds NNS I-NP O
were VBD B-VP O
elevated VBN I-VP O
, , O O
and CC O O
color NN B-NP O
- HYPH I-NP O
contrast NN I-NP O
sensitivity NN I-NP O
was VBD B-VP O
absent JJ B-ADJP O
in IN B-PP O
the DT B-NP O
central JJ I-NP O
visual JJ I-NP O
field NN I-NP O
. . O O

Peripherally RB B-ADVP O
, , O O
the DT B-NP O
scotopic JJ I-NP O
sensitivities NNS I-NP O
were VBD B-VP O
normal JJ B-ADJP O
, , O O
as IN B-SBAR O
was VBD B-VP O
the DT B-NP O
recovery NN I-NP O
from IN B-PP O
bleach NN B-NP O
. . O O

Cone NN B-NP O
electroretinograms NNS I-NP O
were VBD B-VP O
diminished VBN I-VP O
in IN B-PP O
amplitude NN B-NP O
, , O O
and CC O O
delayed VBN B-VP O
in IN B-PP O
all DT B-NP O
affected VBN I-NP O
adults NNS I-NP O
except IN B-PP O
one CD B-NP O
. . O O

Rod NN B-NP O
electroretinograms NNS I-NP O
were VBD B-VP O
normal JJ B-ADJP O
or CC O O
near RB B-ADJP O
normal JJ I-ADJP O
in IN B-PP O
amplitude NN B-NP O
, , O O
and CC O O
had VBD B-VP O
normal JJ B-NP O
implicit JJ I-NP O
times NNS I-NP O
. . O O

Affected VBN B-NP O
asymptomatic JJ I-NP O
children NNS I-NP O
had VBD B-VP O
macular JJ B-NP O
changes NNS I-NP O
, , O O
abnormal JJ B-NP O
color NN I-NP O
- HYPH B-NP O
contrast NN I-NP O
sensitivity NN I-NP O
, , O O
and CC O O
reduced VBD B-VP O
pattern NN B-NP O
and CC I-NP O
cone NN I-NP O
electroretinograms NNS I-NP O
. . O O

CONCLUSION NN B-NP O
These DT B-NP O
results NNS I-NP O
indicate VBP B-VP O
that IN B-SBAR O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
rds NNS I-NP O
gene NN I-NP O
can MD B-VP O
be VB I-VP O
expressed VBN I-VP O
as IN B-PP O
a DT B-NP O
macular JJ I-NP B-Disease
dystrophy NN I-NP I-Disease
, , O O
with IN B-PP O
evidence NN B-NP O
of IN B-PP O
primary JJ B-NP O
cone NN I-NP B-Disease
dysfunction NN I-NP I-Disease
and CC I-NP O
preservation NN I-NP O
of IN B-PP O
peripheral JJ B-NP O
rod NN I-NP O
function NN I-NP O
. . O O

. . O O

Anonymous JJ B-NP O
marker NN I-NP O
loci NNS I-NP O
within IN B-PP O
400 CD B-NP O
kb NN I-NP O
of IN B-PP O
HLA NN B-NP O
- HYPH B-NP O
A NN I-NP O
generate NN I-NP O
haplotypes NNS I-NP O
in IN B-PP O
linkage NN B-NP O
disequilibrium NN I-NP O
with IN B-PP O
the DT B-NP O
hemochromatosis NN I-NP B-Disease
gene NN I-NP O
( ( O O
HFE NN B-NP O
) ) O O
The DT B-NP O
hemochromatosis NN I-NP B-Disease
gene NN I-NP O
( ( O O
HFE NN B-NP O
) ) O O
maps VBZ B-VP O
to TO B-PP O
6p21 CD B-NP O
. . O O

3 CD B-NP O
and CC O O
is VBZ B-VP O
less JJR B-NP O
than IN I-NP O
1 CD I-NP O
cM NN I-NP O
from IN B-PP O
the DT B-NP O
HLA NN I-NP O
class NN I-NP O
I CD B-NP O
genes NNS I-NP O
; : O O
however RB B-ADVP O
, , O O
the DT B-NP O
precise JJ I-NP O
physical JJ I-NP O
location NN I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
has VBZ B-VP O
remained VBN I-VP O
elusive JJ B-ADJP O
and CC I-ADJP O
controversial JJ I-ADJP O
. . O O

The DT B-NP O
unambiguous JJ I-NP O
identification NN I-NP O
of IN B-PP O
a DT B-NP O
crossover NN I-NP O
event NN I-NP O
within IN B-PP O
hemochromatosis NN B-NP B-Disease
families NNS I-NP O
is VBZ B-VP O
very RB B-ADJP O
difficult JJ I-ADJP O
; : O O
it PRP B-NP O
is VBZ B-VP O
particularly RB I-VP O
hampered VBN I-VP O
by IN B-PP O
the DT B-NP O
variability NN I-NP O
of IN B-PP O
the DT B-NP O
phenotypic JJ I-NP O
expression NN I-NP O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
by IN B-PP O
the DT B-NP O
sex NN I-NP O
- HYPH B-ADJP O
and CC O O
age NN B-NP O
- HYPH O O
related VBN B-NP O
penetrance NN I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
. . O O

For IN B-PP O
these DT B-NP O
practical JJ I-NP O
considerations NNS I-NP O
, , O O
traditional JJ B-NP O
linkage NN I-NP O
analysis NN I-NP O
could MD B-VP O
prove VB I-VP O
of IN B-PP O
limited JJ B-NP O
value NN I-NP O
in IN B-PP O
further RBR O O
refining VBG B-VP O
the DT B-NP O
extrapolated VBN I-NP O
physical JJ I-NP O
position NN I-NP O
of IN B-PP O
HFE NN B-NP O
. . O O

We PRP B-NP O
therefore RB B-ADVP O
embarked VBD B-VP O
upon IN B-PP O
a DT B-NP O
linkage NN I-NP O
- HYPH B-NP O
disequilibrium NN I-NP O
analysis NN I-NP O
of IN B-PP O
HFE NN B-NP O
and CC O O
normal JJ B-NP O
chromosomes NNS I-NP O
from IN B-PP O
the DT B-NP O
Brittany NNP I-NP O
population NN I-NP O
. . O O

In IN B-PP O
the DT B-NP O
present JJ I-NP O
report NN I-NP O
, , O O
66 CD B-NP O
hemochromatosis NN I-NP B-Disease
families NNS I-NP O
yielding VBG B-VP O
151 CD B-NP O
hemochromatosis NN I-NP B-Disease
chromosomes NNS I-NP O
and CC O O
182 CD B-NP O
normal JJ I-NP O
chromosomes NNS I-NP O
were VBD B-VP O
RFLP NN B-NP O
- HYPH O O
typed VBN B-VP O
with IN B-PP O
a DT B-NP O
battery NN I-NP O
of IN B-PP O
probes NNS B-NP O
, , O O
including VBG B-PP O
two CD B-NP O
newly RB I-NP O
derived VBN I-NP O
polymorphic JJ I-NP O
markers NNS I-NP O
from IN B-PP O
the DT B-NP O
6 CD I-NP O
. . O O

7 CD B-NP O
and CC I-NP O
HLA NN I-NP O
- HYPH B-NP O
F NN I-NP O
loci NNS I-NP O
located JJ B-NP O
150 CD I-NP O
and CC I-NP O
250 CD I-NP O
kb NN I-NP O
telomeric JJ B-ADJP O
to TO B-PP O
HLA NN B-NP O
- HYPH I-NP O
A NN I-NP O
, , O O
respectively RB B-ADVP O
. . O O

The DT B-NP O
results NNS I-NP O
suggest VBP B-VP O
a DT B-NP O
strong JJ I-NP O
peak NN I-NP O
of IN B-PP O
existing VBG B-NP O
linkage NN I-NP O
disequilibrium NN I-NP O
focused VBD B-VP O
within IN B-PP O
the DT B-NP O
i82 NN I-NP O
- HYPH B-ADJP O
to TO B-PP O
- SYM B-NP O
6 CD I-NP O
. . O O

7 CD B-NP O
interval NN I-NP O
( ( O O
approximately RB B-NP O
250 CD I-NP O
kb NN I-NP O
) ) O O
. . O O

The DT B-NP O
zone NN I-NP O
of IN B-PP O
linkage NN B-NP O
disequilibrium NN I-NP O
is VBZ B-VP O
flanked VBN I-VP O
by IN B-PP O
the DT B-NP O
i97 NN I-NP O
locus NN I-NP O
, , O O
positioned VBD B-VP O
30 CD B-NP O
kb NN I-NP O
proximal JJ B-ADJP O
to TO B-PP O
i82 NN B-NP O
, , O O
and CC O O
the DT B-NP O
HLA NN I-NP O
- HYPH B-NP O
F NN I-NP O
gene NN I-NP O
, , O O
found VBD B-VP O
250 CD B-NP O
kb NN I-NP O
distal JJ B-ADJP O
to TO B-PP O
HLA NN B-NP O
- HYPH I-NP O
A NN I-NP O
, , O O
markers NNS B-NP O
of IN B-PP O
which WDT B-NP O
display VBP B-VP O
no DT B-NP O
significant JJ I-NP O
association NN I-NP O
with IN B-PP O
HFE NN B-NP O
. . O O

These DT B-NP O
data NNS I-NP O
support VBP B-VP O
the DT B-NP O
possibility NN I-NP O
that IN B-SBAR O
HFE NN B-NP O
resides VBZ B-VP O
within IN B-PP O
the DT B-NP O
400 CD I-NP O
- HYPH I-NP O
kb NN I-NP O
expanse NN I-NP O
of IN B-PP O
DNA NN B-NP O
between IN B-PP O
i97 NN B-NP O
and CC I-NP O
HLA NN I-NP O
- HYPH B-NP O
F NN I-NP O
. . O O

Alternatively RB B-ADVP O
, , O O
the DT B-NP O
very RB I-NP O
tight JJ I-NP O
association NN I-NP O
of IN B-PP O
HLA NN B-NP O
- HYPH O O
A3 NN B-NP O
and CC O O
allele NN B-NP O
1 CD I-NP O
of IN B-PP O
the DT B-NP O
6 CD I-NP O
. . O O

7 CD B-NP O
locus NN I-NP O
, , O O
both DT B-NP O
of IN B-PP O
which WDT B-NP O
are VBP B-VP O
comprised VBN I-VP O
by IN B-PP O
the DT B-NP O
major JJ I-NP O
ancestral JJ I-NP O
or CC I-NP O
founder NN I-NP O
HFE NN I-NP O
haplotype NN I-NP O
in IN B-PP O
Brittany NNP B-NP O
, , O O
supports VBZ B-VP O
the DT B-NP O
possibility NN I-NP O
that IN B-SBAR O
the DT B-NP O
disease NN I-NP O
gene NN I-NP O
may MD B-VP O
reside VB I-VP O
immediately RB B-ADJP O
telomeric JJ I-ADJP O
to TO B-PP O
the DT B-NP O
6 CD I-NP O
. . O O

7 CD B-NP O
locus NN I-NP O
within IN B-PP O
the DT B-NP O
linkage NN I-NP O
- HYPH B-NP O
disequilibrium NN I-NP O
zone NN I-NP O
. . O O

Additionally RB B-ADVP O
, , O O
hemochromatosis NN B-NP B-Disease
haplotypes NNS I-NP O
possessing VBG B-VP O
HLA NN B-NP O
- HYPH B-NP O
A11 NN I-NP O
and CC O O
the DT B-NP O
low JJ I-NP O
- HYPH I-NP O
frequency NN I-NP O
HLA NN I-NP O
- HYPH O O
F NN B-NP O
polymorphism NN I-NP O
( ( O O
allele NN B-NP O
2 CD I-NP O
) ) O O
are VBP B-VP O
supportive JJ B-ADJP O
of IN B-PP O
a DT B-NP O
separate JJ I-NP O
founder NN I-NP O
chromosome NN I-NP O
containing VBG B-VP O
a DT B-NP O
second JJ I-NP O
, , O O
independently RB B-VP O
arising VBG I-VP O
mutant JJ B-NP O
allele NN I-NP O
. . O O

Overall RB B-ADVP O
, , O O
the DT B-NP O
establishment NN I-NP O
of IN B-PP O
a DT B-NP O
likely JJ I-NP O
hemochromatosis NN I-NP B-Disease
critical JJ I-NP O
region NN I-NP O
centromeric JJ B-NP O
boundary NN I-NP O
and CC O O
the DT B-NP O
identification NN I-NP O
of IN B-PP O
a DT B-NP O
linkage NN I-NP O
- HYPH B-NP O
disequilibrium NN I-NP O
zone NN I-NP O
both CC O O
significantly RB B-VP O
contribute VBP I-VP O
to TO B-PP O
a DT B-NP O
reduction NN I-NP O
in IN B-PP O
the DT B-NP O
amount NN I-NP O
of IN B-PP O
DNA NN B-NP O
required VBN B-VP O
to TO I-VP O
be VB I-VP O
searched VBN I-VP O
for IN B-PP O
novel JJ B-NP O
coding NN I-NP O
sequences NNS I-NP O
constituting VBG B-VP O
the DT B-NP O
HFE NN I-NP B-Disease
defect NN I-NP I-Disease
Genomic JJ B-NP O
structure NN I-NP O
of IN B-PP O
the DT B-NP O
EWS NN I-NP O
gene NN I-NP O
and CC O O
its PRP$ B-NP O
relationship NN I-NP O
to TO B-PP O
EWSR1 NN B-NP O
, , O O
a DT B-NP O
site NN I-NP O
of IN B-PP O
tumor NN B-NP B-Disease
- HYPH B-NP O
associated VBN I-NP O
chromosome NN I-NP O
translocation NN I-NP O
. . O O

The DT B-NP O
EWS NN I-NP O
gene NN I-NP O
has VBZ B-VP O
been VBN I-VP O
identified VBN I-VP O
based VBN B-PP O
on IN B-PP O
its PRP$ B-NP O
location NN I-NP O
at IN B-PP O
the DT B-NP O
chromosome NN I-NP O
22 CD I-NP O
breakpoint NN I-NP O
of IN B-PP O
the DT B-NP O
t NN I-NP O
( ( O O
11 CD B-NP O
; : O O
22 CD B-NP O
) ) O O
( ( O O
q24 NN B-NP O
; : O O
q12 NN B-NP O
) ) O O
translocation NN B-NP O
that WDT B-NP O
characterizes VBZ B-VP O
Ewing NNP B-NP B-Disease
sarcoma NN I-NP I-Disease
and CC O O
related JJ B-NP O
neuroectodermal JJ I-NP B-Disease
tumors NNS I-NP I-Disease
. . O O

The DT B-NP O
EWS NN I-NP O
gene NN I-NP O
spans NNS I-NP O
about IN B-NP O
40 CD I-NP O
kb NN I-NP O
of IN B-PP O
DNA NN B-NP O
and CC O O
is VBZ B-VP O
encoded VBN I-VP O
by IN B-PP O
17 CD B-NP O
exons NNS I-NP O
. . O O

The DT B-NP O
nucleotide NN I-NP O
sequence NN I-NP O
of IN B-PP O
the DT B-NP O
exons NNS I-NP O
is VBZ B-VP O
identical JJ B-ADJP O
to TO B-PP O
that DT B-NP O
of IN B-PP O
the DT B-NP O
previously RB I-NP O
described VBN I-NP O
cDNA NN I-NP O
. . O O

The DT B-NP O
first JJ I-NP O
7 CD I-NP O
exons NNS I-NP O
encode VBP B-VP O
the DT B-NP O
N NN I-NP O
- HYPH B-NP O
terminal JJ I-NP O
domain NN I-NP O
of IN B-PP O
EWS NN B-NP O
, , O O
which WDT B-NP O
consists VBZ B-VP O
of IN B-PP O
a DT B-NP O
repeated VBN I-NP O
degenerated VBD B-VP O
polypeptide NN B-NP O
of IN B-PP O
7 CD B-NP O
to TO I-NP O
12 CD I-NP O
residues NNS I-NP O
rich JJ B-ADJP O
in IN B-PP O
tyrosine NN B-NP O
, , O O
serine NN B-NP O
, , O O
threonine NN B-NP O
, , O O
glycine NN B-NP O
, , O O
and CC O O
glutamine NN B-NP O
. . O O

Exons NNS B-NP O
11 CD I-NP O
, , I-NP O
12 CD I-NP O
, , O O
and CC O O
13 CD B-NP O
encode VBP B-VP O
the DT B-NP O
putative JJ I-NP O
RNA NN I-NP O
binding NN I-NP O
domain NN I-NP O
. . O O

The DT B-NP O
three CD I-NP O
glycine NN I-NP O
- HYPH I-NP O
and CC I-NP O
arginine NN I-NP O
- HYPH B-NP O
rich JJ I-NP O
motifs NNS I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
are VBP B-VP O
mainly RB I-VP O
encoded VBN I-VP O
by IN B-PP O
exons NNS B-NP O
8 CD B-NP O
- HYPH I-NP O
9 CD I-NP O
, , I-NP O
14 CD I-NP O
, , O O
and CC O O
16 CD B-NP O
. . O O

The DT B-NP O
DNA NN I-NP O
sequence NN I-NP O
in IN B-PP O
the DT B-NP O
5 CD I-NP O
region NN I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
has VBZ B-VP O
features NNS B-NP O
of IN B-PP O
a DT B-NP O
CpG NN I-NP O
- HYPH B-NP O
rich JJ I-NP O
island NN I-NP O
and CC O O
lacks VBZ B-VP O
canonical JJ B-NP O
promoter NN I-NP O
elements NNS I-NP O
, , O O
such JJ B-PP O
as IN I-PP O
TATA NN B-NP O
and CC I-NP O
CCAAT NN I-NP O
consensus NN I-NP O
sequences NNS I-NP O
. . O O

Positions NNS B-NP O
of IN B-PP O
the DT B-NP O
chromosome NN I-NP O
22 CD B-NP O
breakpoints NNS I-NP O
were VBD B-VP O
determined VBN I-VP O
for IN B-PP O
19 CD B-NP O
Ewing NNP I-NP B-Disease
tumors NNS I-NP I-Disease
. . O O

They PRP B-NP O
were VBD B-VP O
localized VBN I-VP O
in IN B-PP O
introns NNS B-NP O
7 CD B-NP O
or CC I-NP O
8 CD I-NP O
in IN B-PP O
18 CD B-NP O
cases NNS I-NP O
and CC B-PP O
in IN B-PP O
intron NN B-NP O
10 CD I-NP O
in IN B-PP O
1 CD B-NP O
case NN I-NP O
. . O O

. . O O

Norrie NN B-NP B-Disease
disease NN I-NP I-Disease
gene NN I-NP O
: : O O
characterization NN B-NP O
of IN B-PP O
deletions NNS B-NP O
and CC O O
possible JJ B-NP O
function NN I-NP O
. . O O

Positional JJ B-NP O
cloning NN I-NP O
experiments NNS I-NP O
have VBP B-VP O
resulted VBN I-VP O
recently RB B-ADVP O
in IN B-PP O
the DT B-NP O
isolation NN I-NP O
of IN B-PP O
a DT B-NP O
candidate NN I-NP O
gene NN I-NP O
for IN B-PP O
Norrie NNP B-NP B-Disease
disease NN I-NP I-Disease
( ( O O
pseudoglioma NN B-NP B-Disease
; : O O
NDP NN B-NP B-Disease
) ) O O
, , O O
a DT B-NP O
severe JJ I-NP O
X NN I-NP B-Disease
- HYPH O I-Disease
linked VBN B-VP I-Disease
neurodevelopmental JJ B-NP I-Disease
disorder NN I-NP I-Disease
. . O O

Here RB B-ADVP O
we PRP B-NP O
report VBP B-VP O
the DT B-NP O
isolation NN I-NP O
and CC I-NP O
analysis NN I-NP O
of IN B-PP O
human JJ B-NP O
genomic JJ I-NP O
DNA NN I-NP O
clones NNS I-NP O
encompassing VBG B-VP O
the DT B-NP O
NDP NN I-NP B-Disease
gene NN I-NP O
. . O O

The DT B-NP O
gene NN I-NP O
spans VBZ B-VP O
28 CD B-NP O
kb NN I-NP O
and CC O O
consists VBZ B-VP O
of IN B-PP O
3 CD B-NP O
exons NNS I-NP O
, , O O
the DT B-NP O
first JJ I-NP O
of IN B-PP O
which WDT B-NP O
is VBZ B-VP O
entirely RB I-VP O
contained VBN I-VP O
within IN B-PP O
the DT B-NP O
5 CD I-NP O
untranslated JJ I-NP O
region NN I-NP O
. . O O

Detailed JJ B-NP O
analysis NN I-NP O
of IN B-PP O
genomic JJ B-NP O
deletions NNS I-NP O
in IN B-PP O
Norrie NNP B-NP B-Disease
patients NNS I-NP O
shows VBZ B-VP O
that IN B-SBAR O
they PRP B-NP O
are VBP B-VP O
heterogeneous JJ B-ADJP O
, , O O
both CC B-PP O
in IN I-PP O
size NN B-NP O
and CC B-PP O
in IN B-PP O
position NN B-NP O
. . O O

By IN B-PP O
PCR NN B-NP O
analysis NN I-NP O
, , O O
we PRP B-NP O
found VBD B-VP O
that IN B-SBAR O
expression NN B-NP O
of IN B-PP O
the DT B-NP O
NDP NN I-NP B-Disease
gene NN I-NP O
was VBD B-VP O
not RB I-VP O
confined VBN I-VP O
to TO B-PP O
the DT B-NP O
eye NN I-NP O
or CC B-PP O
to TO B-PP O
the DT B-NP O
brain NN I-NP O
. . O O

An DT B-NP O
extensive JJ I-NP O
DNA NN I-NP O
and CC I-NP O
protein NN I-NP O
sequence NN I-NP O
comparison NN I-NP O
between IN B-PP O
the DT B-NP O
human JJ I-NP O
NDP NN I-NP B-Disease
gene NN I-NP O
and CC O O
related JJ B-NP O
genes NNS I-NP O
from IN B-PP O
the DT B-NP O
database NN I-NP O
revealed VBD B-VP O
homology NN B-NP O
with IN B-PP O
cysteine NN B-NP O
- HYPH O O
rich JJ B-NP O
protein NN I-NP O
- HYPH B-VP O
binding VBG B-NP O
domains NNS I-NP O
of IN B-PP O
immediate JJ B-NP O
- HYPH I-NP O
- HYPH I-NP O
early JJ B-NP O
genes NNS I-NP O
implicated VBN B-VP O
in IN B-PP O
the DT B-NP O
regulation NN I-NP O
of IN B-PP O
cell NN B-NP O
proliferation NN I-NP O
. . O O

We PRP B-NP O
propose VBP B-VP O
that IN B-SBAR O
NDP NN B-NP O
is VBZ B-VP O
a DT B-NP O
molecule NN I-NP O
related VBN B-VP O
in IN B-PP O
function NN B-NP O
to TO B-PP O
these DT B-NP O
genes NNS I-NP O
and CC O O
may MD B-VP O
be VB I-VP O
involved VBN I-VP O
in IN B-PP O
a DT B-NP O
pathway NN I-NP O
that WDT B-NP O
regulates VBZ B-VP O
neural JJ B-NP O
cell NN I-NP O
differentiation NN I-NP O
and CC I-NP O
proliferation NN I-NP O
. . O O

. . O O

The DT B-NP O
normal JJ I-NP O
Huntington NNP I-NP B-Disease
disease NN I-NP I-Disease
( ( O O
HD NN B-NP B-Disease
) ) O O
allele NN B-NP O
, , O O
or CC O O
a DT B-NP O
closely RB I-NP O
linked VBN I-NP O
gene NN I-NP O
, , O O
influences VBZ B-VP O
age NN B-NP O
at IN B-PP O
onset NN B-NP O
of IN B-PP O
HD NN B-NP B-Disease
. . O O

We PRP B-NP O
evaluated VBD B-VP O
the DT B-NP O
hypothesis NN I-NP O
that IN B-SBAR O
Huntington NNP B-NP B-Disease
disease NN I-NP I-Disease
( ( O O
HD NN B-NP B-Disease
) ) O O
is VBZ B-VP O
influenced VBN I-VP O
by IN B-PP O
the DT B-NP O
normal JJ I-NP O
HD NN I-NP B-Disease
allele NN I-NP O
by IN B-PP O
comparing VBG B-VP O
transmission NN B-NP O
patterns NNS I-NP O
of IN B-PP O
genetically RB B-NP O
linked VBN I-NP O
markers NNS I-NP O
at IN B-PP O
the DT B-NP O
D4S10 NN I-NP O
locus NN I-NP O
in IN B-PP O
the DT B-NP O
normal JJ I-NP O
parent NN I-NP O
against IN B-PP O
age NN B-NP O
at IN B-PP O
onset NN B-NP O
in IN B-PP O
the DT B-NP O
affected VBN I-NP O
offspring NN I-NP O
. . O O

Analysis NN B-NP O
of IN B-PP O
information NN B-NP O
from IN B-PP O
21 CD B-NP O
sibships NNS I-NP O
in IN B-PP O
14 CD B-NP O
kindreds NNS I-NP O
showed VBD B-VP O
a DT B-NP O
significant JJ I-NP O
tendency NN I-NP O
for IN B-PP O
sibs NNS B-NP O
who WP B-NP O
have VBP B-VP O
similar JJ B-NP O
onset NN I-NP O
ages NNS I-NP O
to TO B-VP O
share VB I-VP O
the DT B-NP O
same JJ I-NP O
D4S10 NN I-NP O
allele NN I-NP O
from IN B-PP O
the DT B-NP O
normal JJ I-NP O
parent NN I-NP O
. . O O

Affected VBN B-NP O
sibs NNS I-NP O
who WP B-NP O
inherited VBD B-VP O
different JJ B-NP O
D4S10 NN I-NP O
alleles NNS I-NP O
from IN B-PP O
the DT B-NP O
normal JJ I-NP O
parent NN I-NP O
tended VBD B-VP O
to TO I-VP O
have VB I-VP O
more RBR B-NP O
variable JJ I-NP O
ages NNS I-NP O
at IN B-PP O
onset NN B-NP O
. . O O

These DT B-NP O
findings NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
the DT B-NP O
expression NN I-NP O
of IN B-PP O
HD NN B-NP B-Disease
is VBZ B-VP O
modulated VBN I-VP O
by IN B-PP O
the DT B-NP O
normal JJ I-NP O
HD NN I-NP B-Disease
allele NN I-NP O
or CC B-PP O
by IN B-PP O
a DT B-NP O
closely RB I-NP O
linked VBN I-NP O
locus NN I-NP O
. . O O

. . O O

Further JJ B-NP O
investigation NN I-NP O
of IN B-PP O
the DT B-NP O
HEXA NN I-NP O
gene NN I-NP O
intron NN I-NP O
9 CD I-NP O
donor NN I-NP O
splice NN I-NP O
site NN I-NP O
mutation NN I-NP O
frequently RB B-VP O
found VBN I-VP O
in IN B-PP O
non AFX B-NP O
- HYPH I-NP O
Jewish JJ I-NP O
Tay NNP I-NP B-Disease
- HYPH I-NP I-Disease
Sachs NNP I-NP I-Disease
disease NN I-NP I-Disease
patients NNS I-NP O
from IN B-PP O
the DT B-NP O
British JJ I-NP O
Isles NNPS I-NP O
. . O O

In IN B-PP O
a DT B-NP O
previous JJ I-NP O
study NN I-NP O
we PRP B-NP O
found VBD B-VP O
that IN B-SBAR O
a DT B-NP O
Tay NNP I-NP B-Disease
- HYPH I-NP I-Disease
Sachs NNP I-NP I-Disease
disease NN I-NP I-Disease
( ( O O
TSD NN B-NP B-Disease
) ) O O
causing VBG B-VP O
mutation NN B-NP O
in IN B-PP O
the DT B-NP O
intron NN I-NP O
9 CD I-NP O
donor NN I-NP O
splice NN I-NP O
site NN I-NP O
of IN B-PP O
the DT B-NP O
HEXA NN I-NP O
gene NN I-NP O
occurs VBZ B-VP O
at IN B-PP O
high JJ B-NP O
frequency NN I-NP O
in IN B-PP O
non AFX B-NP O
- HYPH I-NP O
Jewish JJ B-NP O
patients NNS I-NP O
and CC O O
carriers NNS B-NP O
from IN B-PP O
the DT B-NP O
British JJ I-NP O
Isles NNPS I-NP O
. . O O

It PRP B-NP O
was VBD B-VP O
found VBN I-VP O
more RBR B-ADVP O
frequently RB I-ADVP O
in IN B-PP O
subjects NNS B-NP O
of IN B-PP O
Irish NNP B-NP O
, , O O
Scottish NNP B-NP O
, , O O
and CC O O
Welsh JJ B-NP O
origin NN I-NP O
compared VBN B-PP O
with IN B-PP O
English JJ B-NP O
origin NN I-NP O
( ( O O
63 CD B-NP O
% NN I-NP O
and CC O O
31 CD B-NP O
% NN I-NP O
respectively RB B-ADVP O
) ) O O
. . O O

We PRP B-NP O
have VBP B-VP O
now RB I-VP O
tested VBN I-VP O
, , O O
in IN B-PP O
a DT B-NP O
blind JJ I-NP O
study NN I-NP O
, , O O
26 CD B-NP O
American JJ I-NP O
TSD NN I-NP B-Disease
carriers NNS I-NP O
and CC O O
28 CD B-NP O
non AFX O O
- HYPH O O
carriers NNS B-NP O
who WP B-NP O
have VBP B-VP O
British JJ B-NP O
ancestry NN I-NP O
for IN B-PP O
the DT B-NP O
intron NN I-NP O
9 CD I-NP O
splice NN I-NP O
site NN I-NP O
mutation NN I-NP O
. . O O

Six CD B-NP O
of IN B-PP O
the DT B-NP O
carriers NNS I-NP O
and CC I-NP O
none NN I-NP O
of IN B-PP O
the DT B-NP O
controls NNS I-NP O
were VBD B-VP O
positive JJ B-ADJP O
for IN B-PP O
the DT B-NP O
mutation NN I-NP O
. . O O

All DT B-NP O
six CD I-NP O
had VBD B-VP O
Irish JJ B-NP O
ancestry NN I-NP O
, , O O
compared VBN B-PP O
with IN B-PP O
nine CD B-NP O
of IN B-PP O
the DT B-NP O
20 CD I-NP O
other JJ I-NP O
( ( O O
intron NN B-NP O
9 CD I-NP O
mutation NN I-NP O
negative JJ B-ADJP O
) ) O O
TSD NN B-NP B-Disease
carriers NNS I-NP O
( ( O O
p NN B-NP O
< SYM B-ADJP O
0 CD B-NP O
. . I-NP O

05 CD I-NP O
) ) O O
. . O O

These DT B-NP O
results NNS I-NP O
confirm VBP B-VP O
the DT B-NP O
previously RB I-NP O
found VBN I-NP O
high JJ I-NP O
frequency NN I-NP O
of IN B-PP O
the DT B-NP O
intron NN I-NP O
9 CD I-NP O
mutation NN I-NP O
in IN B-PP O
non AFX B-NP O
- HYPH I-NP O
Jewish JJ I-NP O
TSD NN I-NP B-Disease
families NNS I-NP O
of IN B-PP O
British NNP B-NP O
Isles NNP I-NP O
, , O O
particularly RB B-NP O
Irish JJ I-NP O
, , I-NP O
origin NN I-NP O
, , O O
and CC O O
reinforce VB B-VP O
the DT B-NP O
need NN I-NP O
to TO B-VP O
screen VB I-VP O
such JJ B-NP O
families NNS I-NP O
for IN B-PP O
this DT B-NP O
mutation NN I-NP O
. . O O

Molecular JJ B-NP O
mechanisms NNS I-NP O
of IN B-PP O
oncogenic JJ B-NP O
mutations NNS I-NP O
in IN B-PP O
tumors NNS B-NP B-Disease
from IN B-PP O
patients NNS B-NP O
with IN B-PP O
bilateral JJ B-NP B-Disease
and CC I-NP I-Disease
unilateral JJ I-NP I-Disease
retinoblastoma NN I-NP I-Disease
. . O O

The DT B-NP O
RB1 NN I-NP O
gene NN I-NP O
from IN B-PP O
12 CD B-NP O
human JJ I-NP O
retinoblastoma NN I-NP B-Disease
tumors NNS I-NP I-Disease
has VBZ B-VP O
been VBN I-VP O
analyzed VBN I-VP O
exon NN B-NP O
- HYPH B-ADJP O
by IN B-PP O
- HYPH B-NP O
exon NN I-NP O
with IN B-PP O
the DT B-NP O
single JJ I-NP O
- HYPH I-NP O
strand NN I-NP O
conformation NN I-NP O
polymorphism NN I-NP O
technique NN I-NP O
. . O O

Mutations NNS B-NP O
were VBD B-VP O
found VBN I-VP O
in IN B-PP O
all DT B-NP O
tumors NNS I-NP B-Disease
, , O O
and CC O O
one CD B-NP O
- HYPH I-NP O
third JJ I-NP O
of IN B-PP O
the DT B-NP O
tumors NNS I-NP B-Disease
had VBD B-VP O
independent JJ B-NP O
mutations NNS I-NP O
in IN B-PP O
both DT B-NP O
alleles NNS I-NP O
neither DT B-NP O
of IN B-PP O
which WDT B-NP O
were VBD B-VP O
found VBN I-VP O
in IN B-PP O
the DT B-NP O
germ NN I-NP O
line NN I-NP O
, , O O
confirming VBG B-VP O
their PRP$ B-NP O
true JJ I-NP O
sporadic JJ I-NP O
nature NN I-NP O
. . O O

In IN B-PP O
the DT B-NP O
remaining VBG I-NP O
two CD I-NP O
- HYPH I-NP O
thirds NNS I-NP O
of IN B-PP O
the DT B-NP O
tumors NNS I-NP B-Disease
only RB B-NP O
one CD I-NP O
mutation NN I-NP O
was VBD B-VP O
found VBN I-VP O
, , O O
consistent JJ B-ADJP O
with IN B-PP O
the DT B-NP O
loss NN I-NP O
- HYPH B-VP O
of IN B-PP O
- HYPH B-NP O
heterozygosity NN I-NP O
theory NN I-NP O
of IN B-PP O
tumorigenesis NN B-NP O
. . O O

Point NN B-NP O
mutations NNS I-NP O
, , O O
the DT B-NP O
majority NN I-NP O
of IN B-PP O
which WDT B-NP O
were VBD B-VP O
C NN B-NP O
- SYM O O
- SYM B-NP O
> SYM I-NP O
T NN I-NP O
transitions NNS I-NP O
, , O O
were VBD B-VP O
the DT B-NP O
most RBS I-NP O
common JJ I-NP O
abnormality NN I-NP O
and CC O O
usually RB B-VP O
resulted VBD I-VP O
in IN B-PP O
the DT B-NP O
conversion NN I-NP O
of IN B-PP O
an DT B-NP O
arginine NN I-NP O
codon NN I-NP O
to TO B-PP O
a DT B-NP O
stop NN I-NP O
codon NN I-NP O
. . O O

Small JJ B-NP O
deletions NNS I-NP O
were VBD B-VP O
the DT B-NP O
second JJ I-NP O
most RBS I-NP O
common JJ I-NP O
abnormality NN I-NP O
and CC O O
most RBS B-VP O
often RB I-VP O
created VBN I-VP O
a DT B-NP O
downstream JJ I-NP O
stop NN I-NP O
codon NN I-NP O
as IN B-PP O
the DT B-NP O
result NN I-NP O
of IN B-PP O
a DT B-NP O
reading NN I-NP O
frameshift NN I-NP O
. . O O

Deletions NNS B-NP O
and CC O O
point NN B-NP O
mutations NNS I-NP O
also RB B-ADVP O
affected VBD B-VP O
splice NN B-NP O
junctions NNS I-NP O
. . O O

Direct JJ B-NP O
repeats NNS I-NP O
were VBD B-VP O
present JJ B-ADJP O
at IN B-PP O
the DT B-NP O
breakpoint NN I-NP O
junctions NNS I-NP O
in IN B-PP O
the DT B-NP O
majority NN I-NP O
of IN B-PP O
deletions NNS B-NP O
, , O O
supporting VBG B-VP O
a DT B-NP O
slipped VBN I-NP O
- HYPH I-NP O
mispairing VBG I-NP O
mechanism NN I-NP O
. . O O

Point NN B-NP O
mutations NNS I-NP O
generally RB B-ADVP O
produced VBD B-VP O
DNA NN B-NP O
sequences NNS I-NP O
which WDT B-NP O
resulted VBD B-VP O
in IN B-PP O
perfect JJ B-NP O
homology NN I-NP O
with IN B-PP O
endogenous JJ B-NP O
sequences NNS I-NP O
which WDT B-NP O
lay VBP B-VP O
within IN B-PP O
14 CD B-NP O
bp NN I-NP O
. . O O

. . O O

PAX6 NN B-NP O
mutations NNS I-NP O
in IN B-PP O
aniridia NN B-NP B-Disease
. . O O

Aniridia NNP B-NP B-Disease
is VBZ B-VP O
a DT B-NP O
congenital JJ I-NP B-Disease
malformation NN I-NP I-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
eye NN I-NP I-Disease
, , O O
chiefly RB B-VP O
characterised VBN I-VP O
by IN B-PP O
iris NN B-NP B-Disease
hypoplasia NN I-NP I-Disease
, , O O
which WDT B-NP O
can MD B-VP O
cause VB I-VP O
blindness NN B-NP B-Disease
. . O O

The DT B-NP O
PAX6 NN I-NP O
gene NN I-NP O
was VBD B-VP O
isolated VBN I-VP O
as IN B-PP O
a DT B-NP O
candidate NN I-NP O
aniridia NN I-NP B-Disease
gene NN I-NP O
by IN B-PP O
positional JJ B-NP O
cloning NN I-NP O
from IN B-PP O
the DT B-NP O
smallest JJS I-NP O
region NN I-NP O
of IN B-PP O
overlap NN B-NP O
of IN B-PP O
aniridia NN B-NP B-Disease
- HYPH B-NP O
associated VBN I-NP O
deletions NNS I-NP O
. . O O

Subsequently RB B-NP O
PAX6 NN I-NP O
intragenic JJ I-NP O
mutations NNS I-NP O
were VBD B-VP O
demonstrated VBN I-VP O
in IN B-PP O
Smalleye NNP B-NP O
, , O O
a DT B-NP O
mouse NN I-NP O
mutant NN I-NP O
which WDT B-NP O
is VBZ B-VP O
an DT B-NP O
animal NN I-NP O
model NN I-NP O
for IN B-PP O
aniridia NN B-NP B-Disease
, , O O
and CC O O
six CD B-NP O
human JJ I-NP O
aniridia NN I-NP B-Disease
patients NNS I-NP O
. . O O

In IN B-PP O
this DT B-NP O
paper NN I-NP O
we PRP B-NP O
describe VBP B-VP O
four CD B-NP O
additional JJ I-NP O
PAX6 NN I-NP O
point NN I-NP O
mutations NNS I-NP O
in IN B-PP O
aniridia NN B-NP B-Disease
patients NNS I-NP O
, , O O
both DT B-ADJP O
sporadic JJ I-ADJP O
and CC I-ADJP O
familial JJ I-ADJP O
. . O O

These DT B-NP O
mutations NNS I-NP O
highlight VBP B-VP O
regions NNS B-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
which WDT B-NP O
are VBP B-VP O
essential JJ B-ADJP O
for IN B-PP O
normal JJ B-NP O
PAX6 NN I-NP O
function NN I-NP O
. . O O

In IN B-PP O
addition NN B-NP O
, , O O
the DT B-NP O
frequency NN I-NP O
at IN B-PP O
which WDT B-NP O
we PRP B-NP O
have VBP B-VP O
found VBN I-VP O
PAX6 NN B-NP O
mutations NNS I-NP O
suggests VBZ B-VP O
that IN B-SBAR O
lesions NNS B-NP O
in IN B-PP O
PAX6 NN B-NP O
will MD B-VP O
account VB I-VP O
for IN B-PP O
most JJS B-NP O
cases NNS I-NP O
of IN B-PP O
aniridia NN B-NP B-Disease
. . O O

. . O O

Detection NN B-NP O
of IN B-PP O
a DT B-NP O
novel JJ I-NP O
arginine NN I-NP O
vasopressin NN I-NP O
defect NN I-NP O
by IN B-PP O
dideoxy NN B-NP O
fingerprinting NN I-NP O
. . O O

Autosomal JJ B-NP B-Disease
dominant JJ I-NP I-Disease
neurohypophyseal JJ I-NP I-Disease
diabetes NN I-NP I-Disease
insipidus NN I-NP I-Disease
is VBZ B-VP O
a DT B-NP O
familial JJ I-NP O
form NN I-NP O
of IN B-PP O
diabetes NN B-NP B-Disease
insipidus NN I-NP I-Disease
. . O O

This DT B-NP O
disorder NN I-NP O
is VBZ B-VP O
associated VBN I-VP O
with IN B-PP O
variable JJ B-NP O
levels NNS I-NP O
of IN B-PP O
arginine NN B-NP O
vasopressin NN I-NP O
( ( O O
AVP NN B-NP O
) ) O O
and CC O O
diabetes VBZ B-VP B-Disease
insipidus NN B-NP I-Disease
of IN B-PP O
varying VBG B-NP O
severity NN I-NP O
, , O O
which WDT B-NP O
responds VBZ B-VP O
to TO B-PP O
exogenous JJ B-NP O
AVP NN I-NP O
. . O O

To TO B-VP O
determine VB I-VP O
the DT B-NP O
molecular JJ I-NP O
basis NN I-NP O
of IN B-PP O
autosomal JJ B-NP B-Disease
dominant JJ I-NP I-Disease
neurohypophyseal JJ I-NP I-Disease
diabetes NN I-NP I-Disease
insipidus NN I-NP I-Disease
, , O O
the DT B-NP O
AVP NN I-NP O
genes NNS I-NP O
of IN B-PP O
members NNS B-NP O
of IN B-PP O
a DT B-NP O
large JJ I-NP O
kindred NN I-NP O
were VBD B-VP O
analyzed VBN I-VP O
. . O O

A DT B-NP O
new JJ I-NP O
method NN I-NP O
, , O O
called VBN B-VP O
dideoxy NN B-NP O
fingerprinting NN I-NP O
, , O O
was VBD B-VP O
used VBN I-VP O
to TO B-VP O
detect VB I-VP O
an DT B-NP O
AVP NN I-NP O
mutation NN I-NP O
that WDT B-NP O
was VBD B-VP O
characterized VBN I-VP O
by IN B-PP O
DNA NN B-NP O
sequencing NN I-NP O
. . O O

The DT B-NP O
novel JJ I-NP O
defect NN I-NP O
found VBN B-VP O
changes VBZ B-VP O
the DT B-NP O
last JJ I-NP O
codon NN I-NP O
of IN B-PP O
the DT B-NP O
AVP NN I-NP O
signal NN I-NP O
peptide NN I-NP O
from IN B-PP O
alanine NN B-NP O
to TO B-PP O
threonine NN B-NP O
, , O O
which WDT B-NP O
should MD B-VP O
perturb VB I-VP O
cleavage NN B-NP O
of IN B-PP O
mature JJ B-NP O
AVP NN I-NP O
from IN B-PP O
its PRP$ B-NP O
precursor NN I-NP O
protein NN I-NP O
and CC O O
inhibit VBP B-VP O
its PRP$ B-NP O
secretion NN I-NP O
or CC I-NP O
action NN I-NP O
. . O O

. . O O

Germinal JJ B-NP O
mosaicism NN I-NP O
in IN B-PP O
a DT B-NP O
Duchenne NNP I-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
family NN I-NP O
: : O O
implications NNS B-NP O
for IN B-PP O
genetic JJ B-NP O
counselling NN I-NP O
. . O O

In IN B-PP O
this DT B-NP O
study NN I-NP O
we PRP B-NP O
describe VBP B-VP O
a DT B-NP O
three CD I-NP O
- HYPH I-NP O
generation NN I-NP O
family NN I-NP O
in IN B-PP O
which WDT B-NP O
two CD B-NP O
siblings NNS I-NP O
were VBD B-VP O
affected VBN I-VP O
by IN B-PP O
Duchenne NNP B-NP B-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
DMD NN B-NP B-Disease
) ) O O
. . O O

Immunohistochemical JJ B-NP O
analysis NN I-NP O
of IN B-PP O
muscle NN B-NP O
dystrophin NN I-NP O
and CC I-NP O
haplotype NN I-NP O
analysis NN I-NP O
of IN B-PP O
the DT B-NP O
DMD NN I-NP B-Disease
locus NN I-NP O
revealed VBD B-VP O
that IN B-SBAR O
the DT B-NP O
X NN I-NP O
chromosome NN I-NP O
carrying VBG B-VP O
the DT B-NP O
DMD NN I-NP B-Disease
gene NN I-NP O
was VBD B-VP O
transmitted VBN I-VP O
from IN B-PP O
the DT B-NP O
healthy JJ I-NP O
maternal JJ I-NP O
grandfather NN I-NP O
to TO B-PP O
his PRP$ B-NP O
three CD I-NP O
daughters NNS I-NP O
, , O O
including VBG B-PP O
the DT B-NP O
probands NNS I-NP O
mother NN I-NP O
. . O O

These DT B-NP O
findings NNS I-NP O
indicate VBP B-VP O
that IN B-SBAR O
the DT B-NP O
grandfather NN I-NP O
was VBD B-VP O
a DT B-NP O
germinal JJ I-NP O
mosaic NN I-NP O
for IN B-PP O
the DT B-NP O
DMD NN I-NP B-Disease
gene NN I-NP O
. . O O

The DT B-NP O
definition NN I-NP O
of IN B-PP O
the DT B-NP O
carrier NN I-NP O
status NN I-NP O
in IN B-PP O
two CD B-NP O
possible JJ I-NP O
carriers NNS I-NP O
led VBD B-VP O
us PRP B-NP O
to TO B-VP O
give VB I-VP O
accurate JJ B-NP O
genetic JJ I-NP O
counselling NN I-NP O
and CC O O
to TO B-VP O
prevent VB I-VP O
the DT B-NP O
birth NN I-NP O
of IN B-PP O
an DT B-NP O
affected VBN I-NP O
boy NN I-NP O
. . O O

The DT B-NP O
results NNS I-NP O
of IN B-PP O
this DT B-NP O
study NN I-NP O
demonstrate VBP B-VP O
the DT B-NP O
usefulness NN I-NP O
of IN B-PP O
haplotype NN B-NP O
analysis NN I-NP O
and CC O O
immunohistochemical JJ B-NP O
muscle NN I-NP O
dystrophin NN I-NP O
studies NNS I-NP O
to TO B-VP O
detect VB I-VP O
hidden JJ B-NP O
germinal JJ I-NP O
mosaicism NN I-NP O
and CC O O
to TO B-VP O
improve VB I-VP O
genetic JJ B-NP O
counselling NN I-NP O
. . O O

. . O O

Genetic JJ B-NP O
mapping NN I-NP O
of IN B-PP O
the DT B-NP O
breast NN I-NP B-Disease
- HYPH B-NP I-Disease
ovarian JJ I-NP I-Disease
cancer NN I-NP I-Disease
syndrome NN I-NP I-Disease
to TO B-PP O
a DT B-NP O
small JJ I-NP O
interval NN I-NP O
on IN B-PP O
chromosome NN B-NP O
17q12 CD I-NP O
- HYPH I-NP O
21 CD I-NP O
: : O O
exclusion NN B-NP O
of IN B-PP O
candidate NN B-NP O
genes NNS I-NP O
EDH17B2 NN I-NP O
and CC I-NP O
RARA NN I-NP O
. . O O

A DT B-NP O
susceptibility NN I-NP O
gene NN I-NP O
for IN B-PP O
hereditary JJ B-NP B-Disease
breast NN I-NP I-Disease
- HYPH B-NP I-Disease
ovarian JJ I-NP I-Disease
cancer NN I-NP I-Disease
, , O O
BRCA1 NN B-NP O
, , O O
has VBZ B-VP O
been VBN I-VP O
assigned VBN I-VP O
by IN B-PP O
linkage NN B-NP O
analysis NN I-NP O
to TO B-PP O
chromosome NN B-NP O
17q21 NN I-NP O
. . O O

Candidate NN B-NP O
genes NNS I-NP O
in IN B-PP O
this DT B-NP O
region NN I-NP O
include VBP B-VP O
EDH17B2 NN B-NP O
, , O O
which WDT B-NP O
encodes VBZ B-VP O
estradiol NN B-NP O
17 CD I-NP O
beta SYM O O
- HYPH O O
hydroxysteroid NN B-NP O
dehydrogenase NN I-NP O
II CD I-NP O
( ( O O
17 CD B-NP O
beta SYM O O
- HYPH O O
HSD NN B-NP O
II CD I-NP O
) ) O O
, , O O
and CC O O
RARA NN B-NP O
, , O O
the DT B-NP O
gene NN I-NP O
for IN B-PP O
retinoic JJ B-NP O
acid NN I-NP O
receptor NN I-NP O
alpha NN I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
typed VBN I-VP O
22 CD B-NP O
breast NN I-NP B-Disease
and CC I-NP I-Disease
breast NN I-NP I-Disease
- HYPH B-NP I-Disease
ovarian JJ I-NP I-Disease
cancer NN I-NP I-Disease
families NNS I-NP O
with IN B-PP O
eight CD B-NP O
polymorphisms NNS I-NP O
from IN B-PP O
the DT B-NP O
chromosome NN I-NP O
17q12 CD I-NP O
- HYPH I-NP O
21 CD I-NP O
region NN I-NP O
, , O O
including VBG B-PP O
two CD B-NP O
in IN B-PP O
the DT B-NP O
EDH17B2 NN I-NP O
gene NN I-NP O
. . O O

Genetic JJ B-NP O
recombination NN I-NP O
with IN B-PP O
the DT B-NP O
breast NN I-NP B-Disease
cancer NN I-NP I-Disease
trait NN I-NP O
excludes VBZ B-VP O
RARA NN B-NP O
from IN B-PP O
further JJ B-NP O
consideration NN I-NP O
as IN B-PP O
a DT B-NP O
candidate NN I-NP O
gene NN I-NP O
for IN B-PP O
BRCA1 NN B-NP O
. . O O

Both CC O O
BRCA1 NN B-NP O
and CC I-NP O
EDH17B2 NN I-NP O
map VBP B-VP O
to TO B-PP O
a DT B-NP O
6 CD I-NP O
cM NN I-NP O
interval NN I-NP O
( ( O O
between IN B-PP O
THRA1 NN B-NP O
and CC I-NP O
D17S579 NN I-NP O
) ) O O
and CC O O
no DT B-NP O
recombination NN I-NP O
was VBD B-VP O
observed VBN I-VP O
between IN B-PP O
the DT B-NP O
two CD I-NP O
genes NNS I-NP O
. . O O

However RB B-ADVP O
, , O O
direct JJ B-NP O
sequencing NN I-NP O
of IN B-PP O
overlapping VBG B-VP O
PCR NN B-NP O
products NNS I-NP O
containing VBG B-VP O
the DT B-NP O
entire JJ I-NP O
EDH17B2 NN I-NP O
gene NN I-NP O
in IN B-PP O
four CD B-NP O
unrelated JJ I-NP O
affected JJ I-NP O
women NNS I-NP O
did VBD B-VP O
not RB I-VP O
uncover VB I-VP O
any DT B-NP O
sequence NN I-NP O
variation NN I-NP O
, , O O
other JJ B-ADJP O
than IN B-SBAR O
previously RB B-NP O
described VBN I-NP O
polymorphisms NNS I-NP O
. . O O

Mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
EDH17B2 NN I-NP O
gene NN I-NP O
, , O O
therefore RB B-ADVP O
do VBP B-VP O
not RB I-VP O
appear VB I-VP O
to TO I-VP O
be VB I-VP O
responsible JJ B-ADJP O
for IN B-PP O
the DT B-NP O
hereditary JJ I-NP B-Disease
breast NN I-NP I-Disease
- HYPH B-NP I-Disease
ovarian JJ I-NP I-Disease
cancer NN I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

Single JJ B-NP O
meiotic JJ I-NP O
crossovers NNS I-NP O
in IN B-PP O
affected VBN B-NP O
women NNS I-NP O
suggest VBP B-VP O
that IN B-SBAR O
BRCA1 NN B-NP O
is VBZ B-VP O
flanked VBN I-VP O
by IN B-PP O
the DT B-NP O
loci NNS I-NP O
RARA NN I-NP O
and CC I-NP O
D17S78 NN I-NP O
. . O O

. . O O

A DT B-NP O
missense JJ I-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
cholesteryl NN I-NP O
ester NN I-NP O
transfer NN I-NP O
protein NN I-NP O
gene NN I-NP O
with IN B-PP O
possible JJ B-NP O
dominant JJ I-NP O
effects NNS I-NP O
on IN B-PP O
plasma NN B-NP O
high JJ I-NP O
density NN I-NP O
lipoproteins NNS I-NP O
. . O O

Plasma NN B-NP O
HDL NN I-NP O
are VBP B-VP O
a DT B-NP O
negative JJ I-NP O
risk NN I-NP O
factor NN I-NP O
for IN B-PP O
atherosclerosis NN B-NP B-Disease
. . O O

Cholesteryl NN B-NP O
ester NN I-NP O
transfer NN I-NP O
protein NN I-NP O
( ( O O
CETP NN B-NP O
; : O O
476 CD B-NP O
amino JJ I-NP O
acids NNS I-NP O
) ) O O
transfers VBZ B-VP O
cholesteryl NN B-NP O
ester NN I-NP O
from IN B-PP O
HDL NN B-NP O
to TO B-PP O
other JJ B-NP O
lipoproteins NNS I-NP O
. . O O

Subjects NNS B-NP O
with IN B-PP O
homozygous JJ B-NP O
CETP NN I-NP B-Disease
deficiency NN I-NP I-Disease
caused VBN B-VP O
by IN B-PP O
a DT B-NP O
gene NN I-NP O
splicing NN I-NP O
defect NN I-NP O
have VBP B-VP O
markedly RB I-VP O
elevated VBN I-VP O
HDL NN B-NP O
; : O O
however RB B-ADVP O
, , O O
heterozygotes NNS B-NP O
have VBP B-VP O
only RB B-NP O
mild JJ I-NP O
increases NNS I-NP O
in IN B-PP O
HDL NN B-NP O
. . O O

We PRP B-NP O
describe VBP B-VP O
two CD B-NP O
probands NNS I-NP O
with IN B-PP O
a DT B-NP O
CETP NN I-NP O
missense JJ I-NP O
mutation NN I-NP O
( ( O O
442 CD B-NP O
D NN I-NP O
G NN I-NP O
) ) O O
. . O O

Although IN B-SBAR O
heterozygous JJ B-ADJP O
, , O O
they PRP B-NP O
have VBP B-VP O
threefold JJ B-NP O
increases NNS I-NP O
in IN B-PP O
HDL NN B-NP O
concentration NN I-NP O
and CC O O
markedly RB B-NP O
decreased VBN I-NP O
plasma NN I-NP O
CETP NN I-NP O
mass NN I-NP O
and CC I-NP O
activity NN I-NP O
, , O O
suggesting VBG B-VP O
that IN B-SBAR O
the DT B-NP O
mutation NN I-NP O
has VBZ B-VP O
dominant JJ B-NP O
effects NNS I-NP O
on IN B-PP O
CETP NN B-NP O
and CC I-NP O
HDL NN I-NP O
in FW B-ADVP O
vivo FW I-ADVP O
. . O O

Cellular JJ B-NP O
expression NN I-NP O
of IN B-PP O
mutant JJ B-NP O
cDNA NN I-NP O
results VBZ B-VP O
in IN B-PP O
secretion NN B-NP O
of IN B-PP O
only RB B-NP O
30 CD I-NP O
% NN I-NP O
of IN B-PP O
wild JJ B-NP O
type NN I-NP O
CETP NN I-NP O
activity NN I-NP O
. . O O

Moreover RB B-ADVP O
, , O O
coexpression NN B-NP O
of IN B-PP O
wild JJ B-NP O
type NN I-NP O
and CC O O
mutant JJ B-NP O
cDNAs NNS I-NP O
leads VBZ B-VP O
to TO B-PP O
inhibition NN B-NP O
of IN B-PP O
wild JJ B-NP O
type NN I-NP O
secretion NN I-NP O
and CC I-NP O
activity NN I-NP O
. . O O

The DT B-NP O
dominant JJ I-NP O
effects NNS I-NP O
of IN B-PP O
the DT B-NP O
CETP NN I-NP O
missense JJ I-NP O
mutation NN I-NP O
during IN B-PP O
cellular JJ B-NP O
expression NN I-NP O
probably RB B-ADVP O
explains VBZ B-VP O
why WRB B-ADVP O
the DT B-NP O
probands NNS I-NP O
have VBP B-VP O
markedly RB I-VP O
increased VBN I-VP O
HDL NN B-NP O
in IN B-PP O
the DT B-NP O
heterozygous JJ I-NP O
state NN I-NP O
, , O O
and CC O O
suggests VBZ B-VP O
that IN B-SBAR O
the DT B-NP O
active JJ I-NP O
molecular JJ I-NP O
species NNS I-NP O
of IN B-PP O
CETP NN B-NP O
may MD B-VP O
be VB I-VP O
multimeric JJ B-ADJP O
. . O O

. . O O

Familial JJ B-NP B-Disease
Mediterranean JJ I-NP I-Disease
fever NN I-NP I-Disease
in IN B-PP O
the DT B-NP O
colchicine NN I-NP O
era NN I-NP O
: : O O
the DT B-NP O
fate NN I-NP O
of IN B-PP O
one CD B-NP O
family NN I-NP O
. . O O

In IN B-SBAR O
order NN O O
to TO B-VP O
demonstrate VB I-VP O
the DT B-NP O
effect NN I-NP O
of IN B-PP O
prophylactic JJ B-NP O
colchicine NN I-NP O
treatment NN I-NP O
on IN B-PP O
the DT B-NP O
natural JJ I-NP O
history NN I-NP O
of IN B-PP O
familial JJ B-NP B-Disease
Mediterranean JJ I-NP I-Disease
fever NN I-NP I-Disease
( ( O O
FMF NN B-NP B-Disease
) ) O O
, , O O
a DT B-NP O
family NN I-NP O
is VBZ B-VP O
presented VBN I-VP O
with IN B-PP O
6 CD B-NP O
out IN I-NP O
of IN I-NP O
9 CD I-NP O
siblings NNS I-NP O
affected VBN B-VP O
by IN B-PP O
FMF NN B-NP B-Disease
. . O O

Each DT B-NP O
patient NN I-NP O
represents VBZ B-VP O
a DT B-NP O
different JJ I-NP O
stage NN I-NP O
of IN B-PP O
the DT B-NP O
amyloidotic JJ I-NP B-Disease
kidney NN I-NP I-Disease
disease NN I-NP I-Disease
of IN B-PP O
FMF NN B-NP B-Disease
and CC O O
the DT B-NP O
effect NN I-NP O
of IN B-PP O
continuous JJ B-NP O
colchicine NN I-NP O
treatment NN I-NP O
on IN B-PP O
its PRP$ B-NP O
course NN I-NP O
. . O O

Considered VBN B-VP O
together RB B-ADVP O
, , O O
the DT B-NP O
members NNS I-NP O
of IN B-PP O
this DT B-NP O
family NN I-NP O
present VBP B-VP O
an DT B-NP O
almost RB I-NP O
complete JJ I-NP O
clinical JJ I-NP O
, , I-NP O
genetic JJ I-NP O
, , O O
and CC O O
behavioral JJ B-NP O
picture NN I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
. . O O

. . O O

Detection NN B-NP O
of IN B-PP O
a DT B-NP O
new JJ I-NP O
submicroscopic JJ I-NP O
Norrie NNP I-NP B-Disease
disease NN I-NP I-Disease
deletion NN I-NP O
interval NN I-NP O
with IN B-PP O
a DT B-NP O
novel JJ I-NP O
DNA NN I-NP O
probe NN I-NP O
isolated VBN B-VP O
by IN B-PP O
differential JJ B-NP O
Alu NN I-NP O
PCR NN I-NP O
fingerprint NN I-NP O
cloning NN I-NP O
. . O O

Differential JJ B-NP O
Alu NN I-NP O
PCR NN I-NP O
fingerprint NN I-NP O
cloning NN I-NP O
was VBD B-VP O
used VBN I-VP O
to TO B-VP O
isolate VB I-VP O
a DT B-NP O
DNA NN I-NP O
probe NN I-NP O
from IN B-PP O
the DT B-NP O
Xp11 NN I-NP O
. . O O

4 CD B-NP O
- HYPH I-NP O
- HYPH I-NP O
> SYM I-NP O
p11 NN I-NP O
. . O O

21 CD B-NP O
region NN I-NP O
of IN B-PP O
the DT B-NP O
human JJ I-NP O
X NN I-NP O
chromosome NN I-NP O
. . O O

This DT B-NP O
novel JJ I-NP O
sequence NN I-NP O
, , O O
cpXr318 NN B-NP O
( ( O O
DXS742 NN B-NP O
) ) O O
, , O O
detects VBZ B-VP O
a DT B-NP O
new JJ I-NP O
submicroscopic JJ I-NP O
deletion NN I-NP O
interval NN I-NP O
at IN B-PP O
the DT B-NP O
Norrie NNP I-NP B-Disease
disease NN I-NP I-Disease
locus NN I-NP O
( ( O O
NDP NN B-NP O
) ) O O
. . O O

Combining VBG B-VP O
our PRP$ B-NP O
data NNS I-NP O
with IN B-PP O
the DT B-NP O
consensus NN I-NP O
genetic JJ I-NP O
map NN I-NP O
of IN B-PP O
the DT B-NP O
proximal JJ I-NP O
short JJ I-NP O
arm NN I-NP O
of IN B-PP O
the DT B-NP O
X NN I-NP O
chromosome NN I-NP O
, , O O
we PRP B-NP O
propose VBP B-VP O
the DT B-NP O
physical JJ I-NP O
order NN I-NP O
Xcen NN I-NP O
- HYPH B-NP O
DXS14 NN I-NP O
- HYPH B-NP O
DXS255 NN I-NP O
- HYPH O O
( ( O O
DXS426 NN B-NP O
, , O O
TIMP NN B-NP O
) ) O O
- HYPH O O
( ( O O
DXS742 NN O O
- HYPH O O
( ( O O
[ ( O O
MAOB NN B-NP O
- HYPH B-NP O
MAOA NN I-NP O
- HYPH I-NP O
DXS7 NN I-NP O
] ) O O
, , O O
NDP NN B-NP O
) ) O O
- HYPH B-NP O
DXS77 NN I-NP O
- HYPH B-NP O
DXS228 NN I-NP O
) ) O O
- HYPH B-NP O
DXS209 NN I-NP O
- HYPH B-NP O
DXS148 NN I-NP O
- HYPH B-NP O
DXS196 NN I-NP O
- HYPH O O
+ SYM B-NP O
+ SYM B-VP O
+ SYM B-NP O
Xpter NN I-NP O
. . O O

The DT B-NP O
cpXr318 NN I-NP O
probe NN I-NP O
and CC O O
a DT B-NP O
subclone NN I-NP O
from IN B-PP O
a DT B-NP O
cosmid NN I-NP O
corresponding VBG B-VP O
to TO B-PP O
the DT B-NP O
DXS7 NN I-NP O
locus NN I-NP O
were VBD B-VP O
converted VBN I-VP O
into IN B-PP O
sequence NN B-NP O
- HYPH B-NP O
tagged VBN I-NP O
sites NNS I-NP O
. . O O

Finally RB B-ADVP O
, , O O
DXS742 NN B-NP O
, , O O
DSX7 NN B-NP O
, , O O
DXS77 NN B-NP O
, , O O
and CC O O
MAOA NN B-NP O
were VBD B-VP O
integrated VBN I-VP O
into IN B-PP O
a DT B-NP O
physical JJ I-NP O
map NN I-NP O
spanning VBG B-VP O
the DT B-NP O
Norrie NNP I-NP B-Disease
disease NN I-NP I-Disease
locus NN I-NP O
Putative JJ B-NP O
X NN I-NP B-Disease
- HYPH B-VP I-Disease
linked VBN B-NP I-Disease
adrenoleukodystrophy NN I-NP I-Disease
gene NN I-NP O
shares VBZ B-VP O
unexpected JJ B-NP O
homology NN I-NP O
with IN B-PP O
ABC NNP B-NP O
transporters NNS I-NP O
. . O O

Adrenoleukodystrophy NN B-NP B-Disease
( ( O O
ALD NN B-NP B-Disease
) ) O O
is VBZ B-VP O
an DT B-NP O
X NN I-NP B-Disease
- HYPH B-VP I-Disease
linked VBN B-NP I-Disease
disease NN I-NP I-Disease
affecting VBG B-VP O
1 CD B-NP O
/ SYM I-NP O
20 CD I-NP O
, , I-NP O
000 CD I-NP O
males NNS I-NP O
either CC B-PP O
as IN B-PP O
cerebral JJ B-NP B-Disease
ALD NN I-NP I-Disease
in IN B-PP O
childhood NN B-NP O
or CC B-PP O
as IN B-PP O
adrenomyeloneuropathy NN B-NP B-Disease
( ( O O
AMN NN B-NP B-Disease
) ) O O
in IN B-PP O
adults NNS B-NP O
. . O O

Childhood NN B-NP O
ALD NN I-NP B-Disease
is VBZ B-VP O
the DT B-NP O
more RBR I-NP O
severe JJ I-NP O
form NN I-NP O
, , O O
with IN B-PP O
onset NN B-NP O
of IN B-PP O
neurological JJ B-NP O
symptoms NNS I-NP O
between IN B-PP O
5 CD B-NP O
- HYPH I-NP O
12 CD I-NP O
years NNS I-NP O
of IN B-PP O
age NN B-NP O
. . O O

Central JJ B-NP B-Disease
nervous JJ I-NP I-Disease
system NN I-NP I-Disease
demyelination NN I-NP I-Disease
progresses VBZ B-VP O
rapidly RB B-ADVP O
and CC O O
death NN B-NP O
occurs VBZ B-VP O
within IN B-PP O
a DT B-NP O
few JJ I-NP O
years NNS I-NP O
. . O O

AMN NN B-NP B-Disease
is VBZ B-VP O
a DT B-NP O
milder JJR I-NP O
form NN I-NP O
of IN B-PP O
the DT B-NP O
disease NN I-NP O
with IN B-PP O
onset NN B-NP O
at IN B-PP O
15 CD B-NP O
- HYPH I-NP O
30 CD I-NP O
years NNS I-NP O
of IN B-PP O
age NN B-NP O
and CC O O
a DT B-NP O
more RBR I-NP O
progressive JJ I-NP O
course NN I-NP O
. . O O

Adrenal JJ B-NP B-Disease
insufficiency NN I-NP I-Disease
( ( O O
Addisons NNS B-NP B-Disease
disease NN I-NP I-Disease
) ) O O
may MD B-VP O
remain VB I-VP O
the DT B-NP O
only RB I-NP O
clinical JJ I-NP O
manifestation NN I-NP O
of IN B-PP O
ALD NN B-NP B-Disease
. . O O

The DT B-NP O
principal JJ I-NP O
biochemical JJ I-NP O
abnormality NN I-NP O
of IN B-PP O
ALD NN B-NP B-Disease
is VBZ B-VP O
the DT B-NP O
accumulation NN I-NP O
of IN B-PP O
very RB B-NP O
- HYPH I-NP O
long JJ I-NP O
- HYPH I-NP O
chain NN I-NP O
fatty JJ I-NP O
acids NNS I-NP O
( ( O O
VLCFA NN B-NP O
) ) O O
because IN B-PP O
of IN I-PP O
impaired JJ B-NP O
beta SYM I-NP O
- HYPH I-NP O
oxidation NN I-NP O
in IN B-PP O
peroxisomes NNS B-NP O
. . O O

The DT B-NP O
normal JJ I-NP O
oxidation NN I-NP O
of IN B-PP O
VLCFA NN B-NP O
- HYPH O O
CoA NN B-NP O
in IN B-PP O
patients NNS B-NP O
fibroblasts NNS I-NP O
suggested VBD B-VP O
that IN B-SBAR O
the DT B-NP O
gene NN I-NP O
coding VBG B-VP O
for IN B-PP O
the DT B-NP O
VLCFA NN I-NP O
- HYPH O O
CoA NN B-NP O
synthetase NN I-NP O
could MD B-VP O
be VB I-VP O
a DT B-NP O
candidate NN I-NP O
gene NN I-NP O
for IN B-PP O
ALD NN B-NP B-Disease
. . O O

Here RB B-ADVP O
we PRP B-NP O
use VBP B-VP O
positional JJ B-NP O
cloning NN I-NP O
to TO B-VP O
identify VB I-VP O
a DT B-NP O
gene NN I-NP O
partially RB B-VP O
deleted VBN I-VP O
in IN B-PP O
6 CD B-NP O
of IN B-PP O
85 CD B-NP O
independent JJ I-NP O
patients NNS I-NP O
with IN B-PP O
ALD NN B-NP B-Disease
. . O O

In IN B-PP O
familial JJ B-NP O
cases NNS I-NP O
, , O O
the DT B-NP O
deletions NNS I-NP O
segregated VBD B-VP O
with IN B-PP O
the DT B-NP O
disease NN I-NP O
. . O O

An DT B-NP O
identical JJ I-NP O
deletion NN I-NP O
was VBD B-VP O
detected VBN I-VP O
in IN B-PP O
two CD B-NP O
brothers NNS I-NP O
presenting VBG B-VP O
with IN B-PP O
different JJ B-NP O
clinical JJ I-NP O
ALD NN I-NP B-Disease
phenotypes NNS I-NP O
. . O O

Candidate NN B-NP O
exons NNS I-NP O
were VBD B-VP O
identified VBN I-VP O
by IN B-PP O
computer NN B-NP O
analysis NN I-NP O
of IN B-PP O
genomic JJ B-NP O
sequences NNS I-NP O
and CC O O
used VBN B-VP O
to TO B-VP O
isolate VB I-VP O
complementary JJ B-NP O
DNAs NNS I-NP O
by IN B-PP O
exon NN B-NP O
connection NN I-NP O
and CC I-NP O
screening NN I-NP O
of IN B-PP O
cDNA NN B-NP O
libraries NNS I-NP O
. . O O

The DT B-NP O
deduced VBN I-NP O
protein NN I-NP O
sequence NN I-NP O
shows VBZ B-VP O
significant JJ B-NP O
sequence NN I-NP O
identity NN I-NP O
to TO B-PP O
a DT B-NP O
peroxisomal JJ I-NP O
membrane NN I-NP O
protein NN I-NP O
of IN B-PP O
M NN B-NP O
( ( O O
r NN B-NP O
) ) O O
70K NN B-NP O
that WDT B-NP O
is VBZ B-VP O
involved VBN I-VP O
in IN B-PP O
peroxisome NN B-NP O
biogenesis NN I-NP O
and CC O O
belongs VBZ B-VP O
to TO B-PP O
the DT B-NP O
ATP NN I-NP O
- HYPH O O
binding VBG B-VP O
cassette NN B-NP O
superfamily NN I-NP O
of IN B-PP O
transporters NNS B-NP O
. . O O

. . O O

Targeted VBN B-NP O
modification NN I-NP O
of IN B-PP O
the DT B-NP O
apolipoprotein NN I-NP O
B NN I-NP O
gene NN I-NP O
results VBZ B-VP O
in IN B-PP O
hypobetalipoproteinemia NN B-NP B-Disease
and CC O O
developmental JJ B-NP B-Disease
abnormalities NNS I-NP I-Disease
in IN B-PP O
mice NNS B-NP O
. . O O

Familial JJ B-NP B-Disease
hypobetalipoproteinemia NN I-NP I-Disease
is VBZ B-VP O
an DT B-NP O
autosomal JJ I-NP B-Disease
codominant JJ I-NP I-Disease
disorder NN I-NP I-Disease
resulting VBG B-VP O
in IN B-PP O
a DT B-NP O
dramatic JJ I-NP O
reduction NN I-NP O
in IN B-PP O
plasma NN B-NP O
concentrations NNS I-NP O
of IN B-PP O
apolipoprotein NN B-NP O
( ( O O
apo NN B-NP O
) ) O O
B NN B-NP O
, , O O
cholesterol NN B-NP O
, , O O
and CC O O
beta SYM O O
- HYPH O O
migrating VBG B-VP O
lipoproteins NNS B-NP O
. . O O

A DT B-NP O
benefit NN I-NP O
of IN B-PP O
hypobetalipoproteinemia NN B-NP B-Disease
is VBZ B-VP O
that IN B-SBAR O
mildly RB B-NP O
affected VBN I-NP O
individuals NNS I-NP O
may MD B-VP O
be VB I-VP O
protected VBN I-VP O
from IN B-PP O
coronary JJ B-NP B-Disease
vascular JJ I-NP I-Disease
disease NN I-NP I-Disease
. . O O

We PRP B-NP O
have VBP B-VP O
used VBN I-VP O
gene NN B-NP O
targeting VBG B-VP O
to TO I-VP O
generate VB I-VP O
mice NNS B-NP O
with IN B-PP O
a DT B-NP O
modified VBN I-NP O
Apob NN I-NP O
allele NN I-NP O
. . O O

Mice NNS B-NP O
containing VBG B-VP O
this DT B-NP O
allele NN I-NP O
display VBP B-VP O
all DT B-NP O
of IN B-PP O
the DT B-NP O
hallmarks NNS I-NP O
of IN B-PP O
human JJ B-NP O
hypobetalipoproteinemia NN I-NP B-Disease
they PRP B-NP O
produce VBP B-VP O
a DT B-NP O
truncated VBN I-NP O
apoB NN I-NP O
protein NN I-NP O
, , O O
apoB70 NN B-NP O
, , O O
and CC O O
have VBP B-VP O
markedly RB I-VP O
decreased VBN I-VP O
plasma NN B-NP O
concentrations NNS I-NP O
of IN B-PP O
apoB NN B-NP O
, , O O
beta SYM B-NP O
- HYPH B-VP O
lipoproteins NNS B-NP O
, , O O
and CC O O
total JJ B-NP O
cholesterol NN I-NP O
. . O O

In IN B-PP O
addition NN B-NP O
, , O O
the DT B-NP O
mice NNS I-NP O
manifest VBP B-VP O
several JJ B-NP O
characteristics NNS I-NP O
that WDT B-NP O
are VBP B-VP O
occasionally RB I-VP O
observed VBN I-VP O
in IN B-PP O
human JJ B-NP O
hypobetalipoproteinemia NN I-NP B-Disease
, , O O
including VBG B-PP O
reduced VBN B-NP O
plasma NN I-NP O
triglyceride NN I-NP O
concentrations NNS I-NP O
, , O O
fasting VBG B-VP O
chylomicronemia NN B-NP B-Disease
, , O O
and CC O O
reduced VBN B-NP O
high JJ I-NP O
density NN I-NP O
lipoprotein NN I-NP O
cholesterol NN I-NP O
. . O O

An DT B-NP O
unexpected JJ I-NP O
finding NN I-NP O
is VBZ B-VP O
that IN B-SBAR O
the DT B-NP O
modified VBN I-NP O
Apob NN I-NP O
allele NN I-NP O
is VBZ B-VP O
strongly RB I-VP O
associated VBN I-VP O
with IN B-PP O
exencephalus NN B-NP B-Disease
and CC I-NP O
hydrocephalus NN I-NP B-Disease
. . O O

These DT B-NP O
mice NNS I-NP O
should MD B-VP O
help VB I-VP O
increase VB I-VP O
our PRP$ B-NP O
understanding NN I-NP O
of IN B-PP O
hypobetalipoproteinemia NN B-NP B-Disease
, , O O
atherogenesis NN B-NP B-Disease
, , O O
and CC O O
the DT B-NP O
etiology NN I-NP O
of IN B-PP O
exencephalus NN B-NP B-Disease
and CC I-NP O
hydrocephalus NN I-NP B-Disease
. . O O

. . O O

A DT B-NP O
novel JJ I-NP O
disease NN I-NP O
with IN B-PP O
deficiency NN B-NP B-Disease
of IN B-PP I-Disease
mitochondrial JJ B-NP I-Disease
very RB I-NP I-Disease
- HYPH I-NP I-Disease
long JJ I-NP I-Disease
- HYPH I-NP I-Disease
chain NN I-NP I-Disease
acyl NN I-NP I-Disease
- HYPH B-NP I-Disease
CoA NN I-NP I-Disease
dehydrogenase NN I-NP I-Disease
. . O O

Palmitoyl NN B-NP O
- HYPH I-NP O
CoA NN I-NP O
dehydrogenase NN I-NP O
activity NN I-NP O
in IN B-PP O
skin NN B-NP O
fibroblasts NNS I-NP O
from IN B-PP O
seven CD B-NP O
patients NNS I-NP O
with IN B-PP O
unidentified JJ B-NP O
defects NNS I-NP O
of IN B-PP O
fatty JJ B-NP O
acid NN I-NP O
oxidation NN I-NP O
was VBD B-VP O
measured VBN I-VP O
in IN B-PP O
the DT B-NP O
presence NN I-NP O
and CC I-NP O
absence NN I-NP O
of IN B-PP O
antibodies NNS B-NP O
against IN B-PP O
medium JJ B-NP O
- HYPH I-NP O
chain NN I-NP O
, , O O
long JJ B-NP O
- HYPH I-NP O
chain NN I-NP O
, , O O
and CC O O
very RB B-NP O
- HYPH I-NP O
long JJ I-NP O
- HYPH I-NP O
chain NN I-NP O
acyl NN I-NP O
- HYPH B-NP O
CoA NN I-NP O
dehydrogenases NNS I-NP O
( ( O O
VLCAD NN B-NP O
) ) O O
. . O O

Two CD B-NP O
of IN B-PP O
the DT B-NP O
patients NNS I-NP O
, , O O
4 CD B-NP O
- HYPH I-NP O
5 CD I-NP O
month NN I-NP O
old JJ I-NP O
boys NNS I-NP O
, , O O
were VBD B-VP O
found VBN I-VP O
to TO I-VP O
have VB I-VP O
a DT B-NP O
novel JJ I-NP O
disease NN I-NP O
, , O O
VLCAD NN B-NP B-Disease
deficiency NN I-NP I-Disease
, , O O
as IN B-SBAR O
judged VBN B-VP O
from IN B-PP O
the DT B-NP O
results NNS I-NP O
of IN B-PP O
very RB B-NP O
low JJ I-NP O
palmitoyl NN I-NP O
- HYPH B-NP O
CoA NN I-NP O
dehydrogenase NN I-NP O
activity NN I-NP O
and CC O O
the DT B-NP O
lack NN I-NP O
of IN B-PP O
immunoreactivity NN B-NP O
toward IN B-PP O
antibody NN B-NP O
raised VBN B-VP O
to TO B-PP O
purified VBN B-NP O
VLCAD NN I-NP O
. . O O

. . O O

Molecular JJ B-NP O
characterization NN I-NP O
of IN B-PP O
glucose NN B-NP B-Disease
- HYPH B-NP I-Disease
6 CD I-NP I-Disease
- HYPH I-NP I-Disease
phosphate NN I-NP I-Disease
dehydrogenase NN I-NP I-Disease
( ( O I-Disease
G6PD NN B-NP I-Disease
) ) O I-Disease
deficiency NN B-NP I-Disease
in IN B-PP O
patients NNS B-NP O
of IN B-PP O
Chinese JJ B-NP O
descent NN I-NP O
and CC I-NP O
identification NN I-NP O
of IN B-PP O
new JJ B-NP O
base NN I-NP O
substitutions NNS I-NP O
in IN B-PP O
the DT B-NP O
human JJ I-NP O
G6PD NN I-NP O
gene NN I-NP O
. . O O

The DT B-NP O
underlying VBG I-NP O
DNA NN I-NP O
changes NNS I-NP O
associated VBN B-VP O
with IN B-PP O
glucose NN B-NP B-Disease
- HYPH B-NP I-Disease
6 CD I-NP I-Disease
- HYPH I-NP I-Disease
phosphate NN I-NP I-Disease
dehydrogenase NN I-NP I-Disease
( ( O I-Disease
G6PD NN B-NP I-Disease
) ) O I-Disease
- HYPH B-NP I-Disease
deficient JJ I-NP I-Disease
Asians NNPS I-NP O
have VBP B-VP O
not RB I-VP O
been VBN I-VP O
extensively RB I-VP O
investigated VBN I-VP O
. . O O

To TO B-VP O
fill VB I-VP O
this DT B-NP O
gap NN I-NP O
, , O O
we PRP B-NP O
sequenced VBD B-VP O
the DT B-NP O
G6PD NN I-NP O
gene NN I-NP O
of IN B-PP O
43 CD B-NP O
G6PD NN I-NP B-Disease
- HYPH B-NP I-Disease
deficient JJ I-NP I-Disease
Chinese NNPS I-NP O
whose WP$ B-NP O
G6PD NN I-NP O
was VBD B-VP O
well RB I-VP O
characterized VBN I-VP O
biochemically RB B-ADVP O
. . O O

DNA NN B-NP O
samples NNS I-NP O
were VBD B-VP O
obtained VBN I-VP O
from IN B-PP O
peripheral JJ B-NP O
blood NN I-NP O
of IN B-PP O
these DT B-NP O
individuals NNS I-NP O
for IN B-PP O
sequencing NN B-NP O
using VBG B-VP O
a DT B-NP O
direct JJ I-NP O
polymerase NN I-NP O
chain NN I-NP O
reaction NN I-NP O
( ( O O
PCR NN B-NP O
) ) O O
sequencing NN B-NP O
procedure NN I-NP O
. . O O

From IN B-PP O
these DT B-NP O
43 CD I-NP O
samples NNS I-NP O
, , O O
we PRP B-NP O
have VBP B-VP O
identified VBN I-VP O
five CD B-NP O
different JJ I-NP O
types NNS I-NP O
of IN B-PP O
nucleotide NN B-NP O
substitutions NNS I-NP O
in IN B-PP O
the DT B-NP O
G6PD NN I-NP O
gene NN I-NP O
at IN B-PP O
cDNA NN B-NP O
1388 CD I-NP O
from IN B-PP O
G NN B-NP O
to TO B-PP O
A NN B-NP O
( ( O O
Arg NN B-NP O
to TO B-PP O
His NNP B-NP O
) ) O O
; : O O
at IN B-PP O
cDNA NN B-NP O
1376 CD I-NP O
from IN B-PP O
G NN B-NP O
to TO B-PP O
T NN B-NP O
( ( O O
Arg NN B-NP O
to TO B-PP O
Leu NN B-NP O
) ) O O
; : O O
at IN B-PP O
cDNA NN B-NP O
1024 CD I-NP O
from IN B-PP O
C NN B-NP O
to TO B-PP O
T NN B-NP O
( ( O O
Leu NN B-NP O
to TO B-PP O
Phe NN B-NP O
) ) O O
; : O O
at IN B-PP O
cDNA NN B-NP O
392 CD I-NP O
from IN B-PP O
G NN B-NP O
to TO B-PP O
T NN B-NP O
( ( O O
Gly NN B-NP O
to TO B-PP O
Val NN B-NP O
) ) O O
; : O O
at IN B-PP O
cDNA NN B-NP O
95 CD I-NP O
from IN B-PP O
A NN B-NP O
to TO B-PP O
G NN B-NP O
( ( O O
His NN B-NP O
to TO B-PP O
Arg NN B-NP O
) ) O O
. . O O

These DT B-NP O
five CD I-NP O
nucleotide NN I-NP O
substitutions NNS I-NP O
account VBP B-VP O
for IN B-PP O
over IN B-NP O
83 CD I-NP O
% NN I-NP O
of IN B-PP O
our PRP$ B-NP O
43 CD I-NP O
G6PD NN I-NP B-Disease
- HYPH B-NP I-Disease
deficient JJ I-NP I-Disease
samples NNS I-NP O
and CC O O
these DT B-NP O
substitutions NNS I-NP O
have VBP B-VP O
not RB I-VP O
been VBN I-VP O
reported VBN I-VP O
in IN B-PP O
non AFX B-NP O
- HYPH I-NP O
Asians NNPS I-NP O
. . O O

The DT B-NP O
substitutions NNS I-NP O
found VBN B-VP O
at IN B-PP O
cDNA NN B-NP O
392 CD I-NP O
and CC O O
cDNA NN B-NP O
1024 CD I-NP O
are VBP B-VP O
new JJ B-NP O
findings NNS I-NP O
. . O O

The DT B-NP O
substitutions NNS I-NP O
at IN B-PP O
cDNA NN B-NP O
1376 CD I-NP O
and CC I-NP O
1388 CD I-NP O
account NN I-NP O
for IN B-PP O
over IN B-NP O
50 CD I-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
43 CD I-NP O
samples NNS I-NP O
examined VBN B-VP O
indicating VBG B-VP O
a DT B-NP O
high JJ I-NP O
prevalence NN I-NP O
of IN B-PP O
these DT B-NP O
two CD I-NP O
alleles NNS I-NP O
among IN B-PP O
G6PD NN B-NP B-Disease
- HYPH B-NP I-Disease
deficient JJ I-NP I-Disease
Chinese NNS I-NP O
. . O O

Our PRP$ B-NP O
findings NNS I-NP O
add VBP B-VP O
support NN B-NP O
to TO B-PP O
the DT B-NP O
notion NN I-NP O
that IN B-SBAR O
diverse JJ B-NP O
point NN I-NP O
mutations NNS I-NP O
may MD B-VP O
account VB I-VP O
largely RB B-ADVP O
for IN B-PP O
much JJ B-NP O
of IN B-PP O
the DT B-NP O
phenotypic JJ I-NP O
heterogeneity NN I-NP O
of IN B-PP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
. . O O

. . O O

Identification NN B-NP O
of IN B-PP O
mutations NNS B-NP O
in IN B-PP O
Danish JJ B-NP O
choroideremia NN I-NP B-Disease
families NNS I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
searched VBN I-VP O
for IN B-PP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
choroideremia NN I-NP B-Disease
gene NN I-NP O
( ( O O
CHM NN B-NP B-Disease
) ) O O
in IN B-PP O
patients NNS B-NP O
from IN B-PP O
12 CD B-NP O
Danish JJ I-NP O
families NNS I-NP O
in IN B-PP O
which WDT B-NP O
CHM NNP B-NP B-Disease
is VBZ B-VP O
segregating VBG I-VP O
. . O O

Employing VBG B-VP O
polymerase NN B-NP O
chain NN I-NP O
reaction NN I-NP O
( ( O O
PCR NN B-NP O
) ) O O
, , O O
single JJ B-NP O
strand NN I-NP O
conformation NN I-NP O
polymorphism NN I-NP O
( ( O O
SSCP NN B-NP O
) ) O O
analysis NN B-NP O
, , O O
and CC O O
direct JJ B-NP O
DNA NN I-NP O
sequencing NN I-NP O
, , O O
different JJ B-NP O
mutations NNS I-NP O
have VBP B-VP O
been VBN I-VP O
identified VBN I-VP O
in IN B-PP O
6 CD B-NP O
patients NNS I-NP O
. . O O

All PDT B-NP O
the DT I-NP O
mutations NNS I-NP O
will MD B-VP O
interfere VB I-VP O
with IN B-PP O
the DT B-NP O
correct JJ I-NP O
translation NN I-NP O
of IN B-PP O
the DT B-NP O
mRNA NN I-NP O
predicting VBG B-VP O
a DT B-NP O
truncated VBN I-NP O
protein NN I-NP O
or CC O O
no DT B-NP O
gene NN I-NP O
product NN I-NP O
at IN B-ADVP O
all DT I-ADVP O
. . O O

. . O O

Structure NN B-NP O
and CC I-NP O
genomic JJ I-NP O
sequence NN I-NP O
of IN B-PP O
the DT B-NP O
myotonic JJ I-NP B-Disease
dystrophy NN I-NP I-Disease
( ( O O
DM NN B-NP B-Disease
kinase NN I-NP O
) ) O O
gene NN B-NP O
. . O O

The DT B-NP O
mutation NN I-NP O
causing VBG B-VP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
( ( O O
DM NN B-NP B-Disease
) ) O O
has VBZ B-VP O
recently RB I-VP O
been VBN I-VP O
identified VBN I-VP O
as IN B-PP O
an DT B-NP O
unstable JJ I-NP O
CTG NN I-NP O
trinucleotide NN I-NP O
repeat NN I-NP O
located JJ B-ADJP O
in IN B-PP O
the DT B-NP O
3 CD I-NP O
untranslated JJ I-NP O
region NN I-NP O
of IN B-PP O
a DT B-NP O
gene NN I-NP O
encoding VBG B-VP O
for IN B-PP O
a DT B-NP O
protein NN I-NP O
with IN B-PP O
putative JJ B-NP O
serine NN I-NP O
- HYPH B-NP O
threonine NN I-NP O
protein NN I-NP O
kinase NN I-NP O
activity NN I-NP O
. . O O

In IN B-PP O
this DT B-NP O
report NN I-NP O
we PRP B-NP O
present VBP B-VP O
the DT B-NP O
genomic JJ I-NP O
sequences NNS I-NP O
of IN B-PP O
the DT B-NP O
human JJ I-NP O
and CC I-NP O
murine JJ I-NP O
DM NN I-NP B-Disease
kinase NN I-NP O
gene NN I-NP O
. . O O

A DT B-NP O
comparison NN I-NP O
of IN B-PP O
these DT B-NP O
sequences NNS I-NP O
with IN B-PP O
each DT B-NP O
other JJ I-NP O
and CC O O
with IN B-PP O
known VBN B-NP O
cDNA NN I-NP O
sequences NNS I-NP O
from IN B-PP O
both DT B-NP O
species NNS I-NP O
, , O O
led VBD B-VP O
us PRP B-NP O
to TO B-VP O
predict VB I-VP O
a DT B-NP O
translation NN I-NP O
initiation NN I-NP O
codon NN I-NP O
, , O O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
determine NN B-VP O
the DT B-NP O
organization NN I-NP O
of IN B-PP O
the DT B-NP O
DM NN I-NP B-Disease
kinase NN I-NP O
gene NN I-NP O
. . O O

Several JJ B-NP O
polymorphisms NNS I-NP O
within IN B-PP O
the DT B-NP O
human JJ I-NP O
DM NN I-NP B-Disease
kinase NN I-NP O
gene NN I-NP O
have VBP B-VP O
been VBN I-VP O
identified VBN I-VP O
, , O O
and CC O O
PCR NN B-NP O
assays NNS I-NP O
to TO B-VP O
detect VB I-VP O
two CD B-NP O
of IN B-PP O
these DT B-NP O
are VBP B-VP O
described VBN I-VP O
. . O O

The DT B-NP O
complete JJ I-NP O
sequence NN I-NP O
and CC I-NP O
characterization NN I-NP O
of IN B-PP O
the DT B-NP O
structure NN I-NP O
of IN B-PP O
the DT B-NP O
DM NN I-NP B-Disease
kinase NN I-NP O
gene NN I-NP O
, , O O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
the DT B-NP O
identification NN I-NP O
of IN B-PP O
novel JJ B-NP O
polymorphisms NNS I-NP O
within IN B-PP O
the DT B-NP O
gene NN I-NP O
, , O O
represent VBP B-VP O
an DT B-NP O
important JJ I-NP O
step NN I-NP O
in IN B-PP O
a DT B-NP O
further JJ I-NP O
understanding NN I-NP O
of IN B-PP O
the DT B-NP O
genetics NNS I-NP O
of IN B-PP O
myotonic JJ B-NP B-Disease
dystrophy NN I-NP I-Disease
and CC O O
the DT B-NP O
molecular JJ I-NP O
biology NN I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
. . O O

. . O O

Autosomal JJ B-NP O
recessive JJ I-NP O
transmission NN I-NP O
of IN B-PP O
hemophilia NN B-NP B-Disease
A NN I-NP I-Disease
due JJ B-ADJP O
to TO B-PP O
a DT B-NP O
von NN I-NP B-Disease
Willebrand NN I-NP I-Disease
factor NN I-NP O
mutation NN I-NP O
. . O O

The DT B-NP O
differential JJ I-NP O
diagnosis NN I-NP O
of IN B-PP O
the DT B-NP O
genetic JJ I-NP B-Disease
bleeding VBG I-NP I-Disease
disorders NNS I-NP I-Disease
, , O O
hemophilia NN B-NP B-Disease
A NN I-NP I-Disease
and CC I-NP O
von NN I-NP B-Disease
Willebrand NN I-NP I-Disease
disease NN I-NP I-Disease
, , O O
is VBZ B-VP O
occasionally RB I-VP O
confounded VBN I-VP O
by IN B-PP O
the DT B-NP O
close JJ I-NP O
molecular JJ I-NP O
relationship NN I-NP O
of IN B-PP O
coagulation NN B-NP O
factor NN I-NP O
VIII CD B-NP O
and CC I-NP O
von NN I-NP B-Disease
Willebrand NN I-NP I-Disease
factor NN I-NP O
( ( O O
vWF NN B-NP O
) ) O O
. . O O

This DT B-NP O
report NN I-NP O
describes VBZ B-VP O
the DT B-NP O
autosomal JJ I-NP O
inheritance NN I-NP O
of IN B-PP O
a DT B-NP O
hemophilia NN I-NP B-Disease
A NN I-NP I-Disease
phenotype NN I-NP O
due JJ B-ADJP O
to TO B-PP O
a DT B-NP O
mutation NN I-NP O
of IN B-PP O
vWF NN B-NP O
that WDT B-NP O
results VBZ B-VP O
in IN B-PP O
defective JJ B-NP O
factor NN I-NP O
VIII CD I-NP O
binding NN I-NP O
. . O O

The DT B-NP O
proband NN I-NP O
was VBD B-VP O
a DT B-NP O
female JJ I-NP O
patient NN I-NP O
with IN B-PP O
low JJ B-NP O
levels NNS I-NP O
of IN B-PP O
factor NN B-NP O
VIII CD I-NP O
activity NN I-NP O
. . O O

Polymerase NN B-NP O
chain NN I-NP O
reaction NN I-NP O
( ( O O
PCR NN B-NP O
) ) O O
amplification NN B-NP O
and CC I-NP O
DNA NN I-NP O
sequencing NN I-NP O
were VBD B-VP O
employed VBN I-VP O
to TO B-VP O
examine VB I-VP O
exons NNS B-NP O
encoding VBG B-VP O
the DT B-NP O
putative JJ I-NP O
factor NN I-NP O
VIII CD I-NP O
binding NN I-NP O
domain NN I-NP O
of IN B-PP O
vWF NN B-NP O
. . O O

The DT B-NP O
patient NN I-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
be VB I-VP O
homozygous JJ B-ADJP O
for IN B-PP O
a DT B-NP O
single JJ I-NP O
point NN I-NP O
mutation NN I-NP O
causing VBG B-VP O
a DT B-NP O
Thr NN I-NP O
- SYM B-NP O
- SYM B-NP O
> SYM I-NP O
Met NN I-NP O
substitution NN I-NP O
at IN B-PP O
amino JJ B-NP O
acid NN I-NP O
position NN I-NP O
28 CD I-NP O
in IN B-PP O
the DT B-NP O
mature JJ I-NP O
vWF NN I-NP O
subunit NN I-NP O
. . O O

The DT B-NP O
phenotypic JJ I-NP O
expression NN I-NP O
of IN B-PP O
the DT B-NP O
mutation NN I-NP O
was VBD B-VP O
determined VBN I-VP O
to TO I-VP O
be VB I-VP O
recessive JJ B-ADJP O
because IN B-SBAR O
heterozygous JJ B-NP O
family NN I-NP O
members NNS I-NP O
were VBD B-VP O
clinically RB B-ADJP O
unaffected JJ I-ADJP O
. . O O

Recombinant JJ B-NP O
vWF NN I-NP O
containing VBG B-VP O
the DT B-NP O
observed VBN I-NP O
amino NN I-NP O
acid NN I-NP O
substitution NN I-NP O
was VBD B-VP O
expressed VBN I-VP O
in IN B-PP O
COS NN B-NP O
- HYPH B-NP O
1 CD I-NP O
cells NNS I-NP O
. . O O

The DT B-NP O
mutant JJ I-NP O
vWF NN I-NP O
was VBD B-VP O
processed VBN I-VP O
and CC O O
secreted VBN B-VP O
normally RB B-ADVP O
, , O O
and CC O O
was VBD B-VP O
functionally RB B-ADJP O
equivalent JJ I-ADJP O
to TO B-PP O
wild JJ B-NP O
- HYPH I-NP O
type NN I-NP O
vWF NN I-NP O
in IN B-PP O
its PRP$ B-NP O
ability NN I-NP O
to TO B-VP O
bind VB I-VP O
to TO B-PP O
platelets NNS B-NP O
. . O O

However RB B-ADVP O
, , O O
the DT B-NP O
mutant NN I-NP O
failed VBD B-VP O
to TO I-VP O
bind VB I-VP O
factor NN B-NP O
VIII CD I-NP O
, , O O
demonstrating VBG B-VP O
that IN B-SBAR O
the DT B-NP O
mutation NN I-NP O
was VBD B-VP O
functionally RB I-VP O
related VBN I-VP O
to TO B-PP O
the DT B-NP O
observed VBN I-NP O
hemophilia NN I-NP B-Disease
phenotype NN I-NP O
. . O O

The DT B-NP O
family NN I-NP O
we PRP B-NP O
describe VBP B-VP O
demonstrates VBZ B-VP O
the DT B-NP O
recessive JJ I-NP O
inheritance NN I-NP O
of IN B-PP O
a DT B-NP O
recently RB I-NP O
recognized VBN I-NP O
class NN I-NP O
of IN B-PP O
genetic JJ B-NP O
bleeding NN I-NP O
disorders NNS I-NP O
, , O O
we PRP B-NP O
call VBP B-VP O
autosomal JJ B-NP O
hemophilia NN I-NP B-Disease
. . O O

We PRP B-NP O
conclude VBP B-VP O
that IN B-SBAR O
vWF NN B-NP O
mutation NN I-NP O
may MD B-VP O
be VB I-VP O
an DT O O
under IN B-PP O
recognized VBN B-NP O
cause NN I-NP O
of IN B-PP O
hemophilia NN B-NP B-Disease
, , O O
especially RB B-ADVP O
in IN B-PP O
cases NNS B-NP O
where WRB B-ADVP O
the DT B-NP O
inheritance NN I-NP O
pattern NN I-NP O
is VBZ B-VP O
not RB O O
consistent JJ B-ADJP O
with IN B-PP O
X NN B-NP O
- HYPH O O
linked VBN B-NP O
transmission NN I-NP O
. . O O

Somatic JJ B-NP O
von NN I-NP B-Disease
Hippel NNP I-NP I-Disease
- HYPH I-NP I-Disease
Lindau NNP I-NP I-Disease
mutation NN I-NP O
in IN B-PP O
clear JJ B-NP O
cell NN I-NP O
papillary JJ I-NP B-Disease
cystadenoma NN I-NP I-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
epididymis NN I-NP I-Disease
. . O O

Papillary JJ B-NP B-Disease
cystadenoma NN I-NP I-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
epididymis NN I-NP I-Disease
is VBZ B-VP O
an DT B-NP O
uncommon JJ I-NP O
benign JJ I-NP O
lesion NN I-NP O
that WDT B-NP O
may MD B-VP O
occur VB I-VP O
sporadically RB B-ADVP O
or CC O O
as IN B-PP O
a DT B-NP O
manifestation NN I-NP O
of IN B-PP O
von NNP B-NP B-Disease
Hippel NNP I-NP I-Disease
- HYPH I-NP I-Disease
Lindau NNP I-NP I-Disease
( ( O I-Disease
VHL NNP O I-Disease
) ) O I-Disease
disease NN B-NP I-Disease
. . O O

Neither DT B-NP O
immunohistochemical JJ I-NP O
studies NNS I-NP O
nor CC O O
molecular JJ B-NP O
genetic JJ I-NP O
analyses NNS I-NP O
of IN B-PP O
the DT B-NP O
VHL NN I-NP B-Disease
gene NN I-NP O
have VBP B-VP O
been VBN I-VP O
reported VBN I-VP O
previously RB B-ADVP O
for IN B-PP O
this DT B-NP O
lesion NN I-NP O
. . O O

The DT B-NP O
authors NNS I-NP O
describe VBP B-VP O
two CD B-NP O
cases NNS I-NP O
of IN B-PP O
clear JJ B-NP O
cell NN I-NP O
papillary JJ I-NP B-Disease
cystadenoma NN I-NP I-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
epididymis NN I-NP I-Disease
, , O O
both DT B-NP O
of IN B-PP O
which WDT B-NP O
were VBD B-VP O
initially RB I-VP O
confused VBN I-VP O
with IN B-PP O
metastatic JJ B-NP B-Disease
renal JJ I-NP I-Disease
cell NN I-NP I-Disease
carcinoma NN I-NP I-Disease
. . O O

Both DT B-NP O
lesions NNS I-NP O
showed VBD B-VP O
positive JJ B-NP O
immunohistochemical JJ I-NP O
staining NN I-NP O
for IN B-PP O
low JJ B-NP O
and CC I-NP O
intermediate JJ I-NP O
molecular JJ I-NP O
weight NN I-NP O
keratins NNS I-NP O
( ( O O
Cam NN B-NP O
5 CD I-NP O
. . O O

2 CD B-NP O
and CC O O
AE1 NN B-NP O
/ SYM B-NP O
AE3 NN I-NP O
) ) O O
, , O O
EMA NN B-NP O
, , O O
vimentin NN B-NP O
, , O O
alpha SYM B-NP O
1 CD I-NP O
- HYPH B-VP O
antitrypsin JJ B-ADJP O
, , O O
and CC O O
alpha SYM B-NP O
1 CD I-NP O
- HYPH I-NP O
antichymotrypsin NN I-NP O
. . O O

Each DT B-NP O
was VBD B-VP O
negative JJ B-ADJP O
for IN B-PP O
CEA NN B-NP O
. . O O

Because IN B-SBAR O
clear JJ B-NP O
cell NN I-NP O
papillary JJ I-NP B-Disease
cystadenoma NN I-NP I-Disease
is VBZ B-VP O
similar JJ B-ADJP O
to TO B-PP O
renal JJ B-NP B-Disease
cell NN I-NP I-Disease
carcinoma NN I-NP I-Disease
histologically RB B-ADVP O
, , O O
and CC O O
because IN B-SBAR O
both DT B-NP O
occur VBP B-VP O
as IN B-PP O
components NNS B-NP O
of IN B-PP O
the DT B-NP O
von NNP I-NP B-Disease
Hippel NNP I-NP I-Disease
- HYPH I-NP I-Disease
Lindau NNP I-NP I-Disease
disease NN I-NP I-Disease
complex NN I-NP O
, , O O
the DT B-NP O
authors NNS I-NP O
analyzed VBD B-VP O
both DT B-NP O
cases NNS I-NP O
for IN B-PP O
the DT B-NP O
presence NN I-NP O
of IN B-PP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
VHL NN I-NP B-Disease
gene NN I-NP O
. . O O

A DT B-NP O
somatic JJ I-NP O
VHL NN I-NP B-Disease
gene NN I-NP O
mutation NN I-NP O
was VBD B-VP O
detected VBN I-VP O
in IN B-PP O
one CD B-NP O
of IN B-PP O
the DT B-NP O
two CD I-NP O
tumors NNS I-NP B-Disease
by IN B-PP O
polymerase NN B-NP O
chain NN I-NP O
reaction NN I-NP O
followed VBN B-VP O
by IN B-PP O
single JJ B-NP O
- HYPH I-NP O
strand NN I-NP O
conformation NN I-NP O
polymorphism NN I-NP O
analysis NN I-NP O
. . O O

Direct JJ B-NP O
sequencing NN I-NP O
revealed VBD B-VP O
a DT B-NP O
cytosine NN I-NP O
to TO B-PP O
thymine NN B-NP O
transition NN I-NP O
at IN B-PP O
nucleotide NN B-NP O
694 CD I-NP O
, , O O
resulting VBG B-VP O
in IN B-PP O
the DT B-NP O
replacement NN I-NP O
of IN B-PP O
an DT B-NP O
arginine NN I-NP O
with IN B-PP O
a DT B-NP O
stop NN I-NP O
codon NN I-NP O
after IN B-PP O
the DT B-NP O
sixth JJ I-NP O
amino JJ I-NP O
acid NN I-NP O
of IN B-PP O
exon NN B-NP O
3 CD I-NP O
. . O O

As IN B-SBAR O
the DT B-NP O
VHL NN I-NP B-Disease
gene NN I-NP O
is VBZ B-VP O
believed VBN I-VP O
to TO I-VP O
function VB I-VP O
as IN B-PP O
a DT B-NP O
tumor NN I-NP B-Disease
suppressor NN I-NP O
gene NN I-NP O
, , O O
VHL NN B-NP B-Disease
gene NN I-NP O
mutations NNS I-NP O
may MD B-VP O
play VB I-VP O
a DT B-NP O
role NN I-NP O
in IN B-PP O
the DT B-NP O
initiation NN I-NP O
of IN B-PP O
tumorigenesis NN B-NP O
in IN B-PP O
sporadic JJ B-NP O
cystadenomas NNS I-NP B-Disease
of IN B-PP I-Disease
the DT B-NP I-Disease
epididymis NN I-NP I-Disease
. . O O

Identification NN B-NP O
of IN B-PP O
WASP NN B-NP O
mutations NNS I-NP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
Wiskott NNP B-NP B-Disease
- HYPH B-NP I-Disease
Aldrich NNP I-NP I-Disease
syndrome NN I-NP I-Disease
and CC O O
isolated VBN B-NP B-Disease
thrombocytopenia NN I-NP I-Disease
reveals VBZ B-VP O
allelic JJ B-NP O
heterogeneity NN I-NP O
at IN B-PP O
the DT B-NP O
WAS NN I-NP B-Disease
locus NN I-NP O
. . O O

Mutation NN B-NP O
in IN B-PP O
the DT B-NP O
gene NN I-NP O
encoding VBG B-VP O
the DT B-NP O
recently RB I-NP O
isolated VBN I-NP O
WASP NN I-NP O
protein NN I-NP O
has VBZ B-VP O
now RB I-VP O
been VBN I-VP O
identified VBN I-VP O
as IN B-PP O
the DT B-NP O
genetic JJ I-NP B-Disease
defect NN I-NP I-Disease
responsible JJ B-ADJP O
for IN B-PP O
the DT B-NP O
X NN I-NP B-Disease
- HYPH B-VP I-Disease
linked VBN I-VP I-Disease
Wiskott NNP B-NP I-Disease
- HYPH I-NP I-Disease
Aldrich NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
WAS NN B-NP B-Disease
) ) O O
, , O O
a DT B-NP O
primary JJ I-NP O
immunodeficiency NN I-NP B-Disease
disease NN I-NP I-Disease
associated VBN B-VP O
with IN B-PP O
extensive JJ B-NP O
phenotypic JJ I-NP O
variability NN I-NP O
. . O O

To TO B-VP O
elucidate VB I-VP O
the DT B-NP O
range NN I-NP O
of IN B-PP O
WASP NN B-NP O
mutations NNS I-NP O
responsible JJ B-ADJP O
for IN B-PP O
WAS NNP B-NP B-Disease
, , O O
we PRP B-NP O
used VBD B-VP O
PCR NN B-NP O
- HYPH B-NP O
SSCP NN I-NP O
analysis NN I-NP O
to TO B-VP O
screen VB I-VP O
for IN B-PP O
WASP NN B-NP O
gene NN I-NP O
mutation NN I-NP O
in IN B-PP O
19 CD B-NP O
unrelated JJ I-NP O
boys NNS I-NP O
with IN B-PP O
the DT B-NP O
diagnosis NN I-NP O
of IN B-PP O
classical JJ B-NP O
or CC O O
attenuated VBD B-VP O
WAS NNP B-NP B-Disease
or CC O O
isolated VBN B-NP B-Disease
thrombocytopenia NN I-NP I-Disease
. . O O

All DT B-NP O
19 CD I-NP O
patients NNS I-NP O
had VBD B-VP O
WASP NN B-NP O
mutations NNS I-NP O
, , O O
each DT B-NP O
of IN B-PP O
which WDT B-NP O
localized VBD B-VP O
to TO B-PP O
the DT B-NP O
initial JJ I-NP O
three CD I-NP O
or CC I-NP O
terminal JJ I-NP O
three CD I-NP O
exons NNS I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
, , O O
and CC O O
the DT B-NP O
majority NN I-NP O
of IN B-PP O
which WDT B-NP O
were VBD B-VP O
unique JJ B-ADJP O
in IN B-PP O
each DT B-NP O
case NN I-NP O
. . O O

However RB B-ADVP O
, , O O
a DT B-NP O
missense JJ I-NP O
mutation NN I-NP O
which WDT B-NP O
results VBZ B-VP O
in IN B-PP O
substitution NN B-NP O
of IN B-PP O
the DT B-NP O
arginine NN I-NP O
at IN B-PP O
WAS NN B-NP B-Disease
codon NN I-NP O
86 CD I-NP O
was VBD B-VP O
identified VBN I-VP O
in IN B-PP O
three CD B-NP O
boys NNS I-NP O
with IN B-PP O
severe JJ B-NP O
WAS NN I-NP B-Disease
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
in IN B-PP O
one CD B-NP O
boy NN I-NP O
presenting VBG B-VP O
with IN B-PP O
thrombocytopenia NN B-NP B-Disease
alone RB B-ADVP O
. . O O

While IN B-SBAR O
the DT B-NP O
three CD I-NP O
mutations NNS I-NP O
found VBN B-VP O
in IN B-PP O
the DT B-NP O
isolated VBN I-NP B-Disease
thrombocytopenia NN I-NP I-Disease
patients NNS I-NP O
leave VBP B-VP O
the DT B-NP O
reading NN I-NP O
frame NN I-NP O
intact JJ B-ADJP O
, , O O
about RB B-NP O
one CD I-NP O
- HYPH I-NP O
half NN I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
alterations NNS I-NP O
detected VBN B-VP O
in IN B-PP O
both CC B-NP O
severe JJ I-NP O
and CC O O
attenuated VBD B-VP O
WAS NN B-NP B-Disease
patients NNS I-NP O
result VBP B-VP O
in IN B-PP O
frameshifted VBN B-NP O
transcript NN I-NP O
and CC O O
premature JJ B-NP O
translation NN I-NP O
termination NN I-NP O
. . O O

These DT B-NP O
findings NNS I-NP O
therefore RB B-ADVP O
confirm VBP B-VP O
the DT B-NP O
association NN I-NP O
of IN B-PP O
WAS NN B-NP B-Disease
with IN B-PP O
WASP NN B-NP O
mutation NN I-NP O
and CC O O
identify VB B-VP O
WASP NN B-NP O
mutation NN I-NP O
as IN B-PP O
a DT B-NP O
cause NN I-NP O
for IN B-PP O
isolated VBN B-NP O
congenital JJ I-NP B-Disease
thrombocytopenia NN I-NP I-Disease
in IN B-PP O
males NNS B-NP O
. . O O

While IN B-SBAR O
the DT B-NP O
WASP NN I-NP O
gene NN I-NP O
defects NNS I-NP O
responsible JJ B-ADJP O
for IN B-PP O
isolated VBN B-NP B-Disease
thrombocytopenia NN I-NP I-Disease
and CC O O
other JJ B-NP O
mild JJ I-NP O
presentations NNS I-NP O
of IN B-PP O
WAS NN B-NP B-Disease
do VBP B-VP O
not RB I-VP O
appear VB I-VP O
distinct JJ B-ADJP O
from IN B-PP O
those DT B-NP O
resulting VBG B-VP O
in IN B-PP O
severe JJ B-NP O
WAS NN I-NP B-Disease
, , O O
these DT B-NP O
data NNS I-NP O
indicate VBP B-VP O
that IN B-SBAR O
analysis NN B-NP O
of IN B-PP O
WASP NN B-NP O
gene NN I-NP O
mutation NN I-NP O
provides VBZ B-VP O
a DT B-NP O
valuable JJ I-NP O
tool NN I-NP O
for IN B-PP O
distinguishing VBG B-VP O
the DT B-NP O
spectrum NN I-NP O
of IN B-PP O
WAS NN B-NP B-Disease
patients NNS I-NP O
and CC O O
the DT B-NP O
subset NN I-NP O
of IN B-PP O
males NNS B-NP O
with IN B-PP O
isolated VBN B-NP B-Disease
thrombocytopenia NN I-NP I-Disease
who WP B-NP O
represent VBP B-VP O
mild JJ B-NP O
cases NNS I-NP O
of IN B-PP O
WAS NNP B-NP B-Disease
. . O O

. . O O

WASP NN B-NP O
gene NN I-NP O
mutations NNS I-NP O
in IN B-PP O
Wiskott NNP B-NP B-Disease
- HYPH I-NP I-Disease
Aldrich NNP I-NP I-Disease
syndrome NN I-NP I-Disease
and CC I-NP O
X NN I-NP B-Disease
- HYPH O I-Disease
linked VBN B-NP I-Disease
thrombocytopenia NN I-NP I-Disease
. . O O

The DT B-NP O
WASP NN I-NP O
gene NN I-NP O
has VBZ B-VP O
been VBN I-VP O
recently RB I-VP O
cloned VBN I-VP O
from IN B-PP O
Xp11 NN B-NP O
. . O O

23 CD B-NP O
and CC O O
shown VBN B-VP O
to TO I-VP O
be VB I-VP O
mutated VBN I-VP O
in IN B-PP O
three CD B-NP O
patients NNS I-NP O
with IN B-PP O
the DT B-NP O
Wiskott NNP I-NP B-Disease
- HYPH I-NP I-Disease
Aldrich NNP I-NP I-Disease
syndrome NN I-NP I-Disease
( ( O O
WAS NN B-NP B-Disease
) ) O O
. . O O

We PRP B-NP O
have VBP B-VP O
developed VBN I-VP O
a DT B-NP O
screening NN I-NP O
protocol NN I-NP O
for IN B-PP O
identifying VBG B-VP O
WASP NN B-NP O
gene NN I-NP O
alterations NNS I-NP O
in IN B-PP O
genomic JJ B-NP O
DNA NN I-NP O
and CC O O
have VBP B-VP O
identified VBN I-VP O
a DT B-NP O
spectrum NN I-NP O
of IN B-PP O
novel JJ B-NP O
mutations NNS I-NP O
in IN B-PP O
12 CD B-NP O
additional JJ I-NP O
unrelated JJ I-NP O
families NNS I-NP O
. . O O

These DT B-NP O
missense JJ I-NP O
, , I-NP O
nonsense NN I-NP O
and CC I-NP O
frameshift NN I-NP O
mutations NNS I-NP O
involve VBP B-VP O
eight CD B-NP O
of IN B-PP O
the DT B-NP O
12 CD I-NP O
exons NNS I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
. . O O

Two CD B-NP O
mutations NNS I-NP O
creating VBG B-VP O
premature JJ B-NP O
termination NN I-NP O
codons NNS I-NP O
were VBD B-VP O
associated VBN I-VP O
with IN B-PP O
lack NN B-NP O
of IN B-PP O
detectable JJ B-NP O
mRNA NN I-NP O
on IN B-PP O
Northern NN B-NP O
blots NNS I-NP O
. . O O

Four CD B-NP O
amino NN I-NP O
acid NN I-NP O
substitutions NNS I-NP O
, , O O
Leu27Phe NN B-NP O
, , O O
Thr48Ile NN B-NP O
, , O O
Val75Met NN B-NP O
and CC I-NP O
Arg477Lys NN I-NP O
, , O O
were VBD B-VP O
found VBN I-VP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
congenital JJ B-NP B-Disease
thrombocytopenia NN I-NP I-Disease
and CC O O
no DT B-NP O
clinically RB I-NP O
evident JJ I-NP O
immune JJ I-NP O
defect NN I-NP O
indicating VBG B-VP O
that IN B-SBAR O
the DT B-NP O
WASP NN I-NP O
gene NN I-NP O
is VBZ B-VP O
the DT B-NP O
site NN I-NP O
for IN B-PP O
mutations NNS B-NP O
in IN B-PP O
X NN B-NP B-Disease
- HYPH O I-Disease
linked VBN B-NP I-Disease
thrombocytopenia NN I-NP I-Disease
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
in IN B-PP O
WAS NNP B-NP B-Disease
. . O O

A DT B-NP O
T NN I-NP O
- HYPH I-NP O
cell NN I-NP O
line NN I-NP O
from IN B-PP O
a DT B-NP O
WAS NN I-NP B-Disease
patient NN I-NP O
contained VBD B-VP O
two CD B-NP O
independent JJ I-NP O
DNA NN I-NP O
alterations NNS I-NP O
, , O O
a DT B-NP O
constitutional JJ I-NP O
frameshift NN I-NP O
mutation NN I-NP O
, , O O
also RB B-ADVP O
present JJ B-ADJP O
in IN B-PP O
peripheral JJ B-NP O
blood NN I-NP O
leukocytes NNS I-NP O
from IN B-PP O
the DT B-NP O
patient NN I-NP O
, , O O
and CC O O
compensatory JJ B-NP O
splice NN I-NP O
site NN I-NP O
mutation NN I-NP O
unique JJ B-ADJP O
to TO B-PP O
the DT B-NP O
cell NN I-NP O
line NN I-NP O
. . O O

The DT B-NP O
distribution NN I-NP O
of IN B-PP O
eight CD B-NP O
missense JJ I-NP O
mutations NNS I-NP O
provides VBZ B-VP O
valuable JJ B-NP O
information NN I-NP O
on IN B-PP O
amino NN B-NP O
acids NNS I-NP O
which WDT B-NP O
are VBP B-VP O
essential JJ B-ADJP O
for IN B-PP O
normal JJ B-NP O
protein NN I-NP O
function NN I-NP O
, , O O
and CC O O
suggests VBZ B-VP O
that IN B-SBAR O
sites NNS B-NP O
in IN B-PP O
the DT B-NP O
first JJ I-NP O
two CD I-NP O
exons NNS I-NP O
are VBP B-VP O
hot JJ B-ADJP O
- HYPH B-NP O
spots NNS I-NP O
for IN B-PP O
mutation NN B-NP O
. . O O

Evidence NN B-NP O
for IN B-PP O
inter AFX B-NP O
- HYPH I-NP O
generational JJ I-NP O
instability NN I-NP O
in IN B-PP O
the DT B-NP O
CAG NN I-NP O
repeat NN I-NP O
in IN B-PP O
the DT B-NP O
MJD1 NN I-NP O
gene NN I-NP O
and CC B-PP O
for IN B-PP O
conserved VBN B-NP O
haplotypes NNS I-NP O
at IN B-PP O
flanking VBG B-VP O
markers NNS B-NP O
amongst IN B-PP O
Japanese JJ B-NP O
and CC I-NP O
Caucasian JJ I-NP O
subjects NNS I-NP O
with IN B-PP O
Machado NNP B-NP B-Disease
- HYPH I-NP I-Disease
Joseph NNP I-NP I-Disease
disease NN I-NP I-Disease
. . O O

The DT B-NP O
size NN I-NP O
of IN B-PP O
the DT B-NP O
( ( O O
CAG NN O O
) ) O O
n NN B-NP O
repeat NN I-NP O
array NN I-NP O
in IN B-PP O
the DT B-NP O
3 CD I-NP O
' SYM I-NP O
end NN I-NP O
of IN B-PP O
the DT B-NP O
MJD1 NN I-NP O
gene NN I-NP O
and CC O O
the DT B-NP O
haplotype NN I-NP O
at IN B-PP O
a DT B-NP O
series NN I-NP O
of IN B-PP O
microsatellite NN B-NP O
markers NNS I-NP O
surrounding VBG B-VP O
the DT B-NP O
MJD1 NN I-NP O
gene NN I-NP O
were VBD B-VP O
examined VBN I-VP O
in IN B-PP O
a DT B-NP O
large JJ I-NP O
cohort NN I-NP O
of IN B-PP O
Japanese JJ B-NP O
and CC I-NP O
Caucasian JJ I-NP O
subjects NNS I-NP O
affected VBN B-VP O
with IN B-PP O
Machado NNP B-NP B-Disease
- HYPH I-NP I-Disease
Joseph NNP I-NP I-Disease
disease NN I-NP I-Disease
( ( O O
MJD NN B-NP B-Disease
) ) O O
. . O O

Our PRP$ B-NP O
data NNS I-NP O
provide VBP B-VP O
five CD B-NP O
novel JJ I-NP O
observations NNS I-NP O
. . O O

First RB B-ADVP O
, , O O
MJD NN B-NP B-Disease
is VBZ B-VP O
associated VBN I-VP O
with IN B-PP O
expansion NN B-NP O
fo VBP B-VP O
the DT B-NP O
array NN I-NP O
from IN B-PP O
the DT B-NP O
normal JJ I-NP O
range NN I-NP O
of IN B-PP O
14 CD B-NP O
- HYPH I-NP O
37 CD I-NP O
repeats NNS I-NP O
to TO B-PP O
68 CD B-NP O
- HYPH I-NP O
84 CD I-NP O
repeats NNS I-NP O
in IN B-PP O
most JJS B-NP O
Japanese JJ I-NP O
and CC I-NP O
Caucasian JJ I-NP O
subjects NNS I-NP O
, , O O
but CC O O
no DT B-NP O
subjects NNS I-NP O
were VBD B-VP O
observed VBN I-VP O
with IN B-PP O
expansions NNS B-NP O
intermediate VBP B-VP O
in IN B-PP O
size NN B-NP O
between IN B-PP O
those DT B-NP O
of IN B-PP O
the DT B-NP O
normal JJ I-NP O
and CC I-NP O
MJD NN I-NP B-Disease
affected VBN I-NP O
groups NNS I-NP O
. . O O

Second RB B-ADVP O
, , O O
the DT B-NP O
expanded VBN I-NP O
allele NN I-NP O
associated VBN B-VP O
with IN B-PP O
MJD NN B-NP B-Disease
displays VBZ B-VP O
inter AFX B-NP O
- HYPH I-NP O
generational JJ I-NP O
instability NN I-NP O
, , O O
particularly RB B-ADVP O
in IN B-PP O
male JJ B-NP O
meioses NNS I-NP O
, , O O
and CC O O
this DT B-NP O
instability NN I-NP O
was VBD B-VP O
associated VBN I-VP O
with IN B-PP O
the DT B-NP O
clinical JJ I-NP O
phenomenon NN I-NP O
of IN B-PP O
anticipation NN B-NP O
. . O O

Third RB B-ADVP O
, , O O
the DT B-NP O
size NN I-NP O
of IN B-PP O
the DT B-NP O
expanded VBN I-NP O
allele NN I-NP O
is VBZ B-VP O
not RB B-VP O
only RB I-VP O
inversely RB I-VP O
correlated VBN I-VP O
with IN B-PP O
the DT B-NP O
age NN I-NP O
- HYPH B-ADJP O
of IN B-PP O
- HYPH B-NP O
onset NN I-NP O
of IN B-PP O
MJD NN B-NP B-Disease
( ( O O
r NN B-NP O
= SYM B-VP O
- SYM B-NP O
0 CD I-NP O
. SYM I-NP O

738 CD I-NP O
, , O O
p NN B-NP O
< SYM B-VP O
0 CD B-NP O
. . I-NP O

001 CD I-NP O
) ) O O
, , O O
but CC O O
is VBZ B-VP O
also RB I-VP O
correlated VBN I-VP O
with IN B-PP O
the DT B-NP O
frequency NN I-NP O
of IN B-PP O
other JJ B-NP O
clinical JJ I-NP O
features NNS I-NP O
[ ( O O
e NN B-NP O
. . O O

g NN B-NP O
. . I-NP O

pseudoexophthalmos NNS I-NP O
and CC O O
pyramidal JJ B-NP O
signs NNS I-NP O
were VBD B-VP O
more RBR B-ADJP O
frequent JJ I-ADJP O
in IN B-PP O
subjects NNS B-NP O
with IN B-PP O
large JJ B-NP O
repeats NNS I-NP O
( ( O O
p NN B-NP O
< SYM B-ADJP O
0 CD B-NP O
. . I-NP O

001 CD I-NP O
and CC O O
p NN B-NP O
< SYM B-NP O
0 CD B-NP O
. . I-NP O

05 CD I-NP O
respectively RB B-ADVP O
) ) O O
] ) O O
. . O O

Fourth NNP B-NP O
, , O O
the DT B-NP O
disease NN I-NP O
phenotype NN I-NP O
is VBZ B-VP O
significantly RB B-ADJP O
more RBR I-ADJP O
severe JJ I-ADJP O
and CC O O
had VBD B-VP O
an DT B-NP O
early JJ I-NP O
age NN I-NP O
of IN B-PP O
onset NN B-NP O
( ( O O
16 CD B-NP O
years NNS I-NP O
) ) O O
in IN B-PP O
a DT B-NP O
subject NN I-NP O
homozygous JJ B-ADJP O
for IN B-PP O
the DT B-NP O
expanded VBN I-NP O
allele NN I-NP O
, , O O
which WDT B-NP O
contrasts VBZ B-VP O
with IN B-PP O
Huntington NNP B-NP B-Disease
disease NN I-NP I-Disease
and CC O O
suggests VBZ B-VP O
that IN B-SBAR O
the DT B-NP O
expanded VBN I-NP O
allele NN I-NP O
in IN B-PP O
the DT B-NP O
MJD1 NN I-NP O
gene NN I-NP O
could MD B-VP O
exert VB I-VP O
its PRP$ B-NP O
effect NN I-NP O
either CC B-PP O
by IN B-PP O
a DT B-NP O
dominant JJ I-NP O
negative JJ I-NP O
effect NN I-NP O
( ( O O
putatively RB B-VP O
excluded VBN I-VP O
in IN B-PP O
HD NN B-NP B-Disease
) ) O O
or CC O O
by IN B-PP O
a DT B-NP O
gain NN I-NP O
of IN B-PP O
function NN B-NP O
effect NN I-NP O
as IN B-SBAR O
proposed VBN B-VP O
for IN B-PP O
HD NN B-NP B-Disease
. . O O

Finally RB B-ADVP O
, , O O
Japanese JJ B-NP O
and CC I-NP O
Caucasian JJ I-NP O
subjects NNS I-NP O
affected VBN B-VP O
with IN B-PP O
MJD NN B-NP B-Disease
share NN I-NP O
haplotypes NNS I-NP O
at IN B-PP O
several JJ B-NP O
markers NNS I-NP O
surrounding VBG B-VP O
the DT B-NP O
MJD1 NN I-NP O
gene NN I-NP O
, , O O
which WDT B-NP O
are VBP B-VP O
uncommon JJ B-ADJP O
in IN B-PP O
the DT B-NP O
normal JJ I-NP O
Japanese JJ I-NP O
and CC I-NP O
Caucasian JJ I-NP O
population NN I-NP O
, , O O
and CC O O
which WDT B-NP O
suggests VBZ B-VP O
the DT B-NP O
existence NN I-NP O
either CC B-PP O
of IN B-PP O
common JJ B-NP O
founders NNS I-NP O
in IN B-PP O
these DT B-NP O
populations NNS I-NP O
or CC B-PP O
of IN B-PP O
chromosomes NNS B-NP O
susceptible JJ B-ADJP O
to TO B-PP O
pathologic JJ B-NP O
expansion NN I-NP O
of IN B-PP O
the DT B-NP O
CAG NN I-NP O
repeat NN I-NP O
in IN B-PP O
the DT B-NP O
MJD1 NN I-NP O
gene NN I-NP O
. . O O

Evidence NN B-NP O
for IN B-PP O
inter AFX B-NP O
- HYPH I-NP O
generational JJ I-NP O
instability NN I-NP O
in IN B-PP O
the DT B-NP O
CAG NN I-NP O
repeat NN I-NP O
in IN B-PP O
the DT B-NP O
MJD1 NN I-NP O
gene NN I-NP O
and CC B-PP O
for IN B-PP O
conserved VBN B-NP O
haplotypes NNS I-NP O
at IN B-PP O
flanking VBG B-VP O
markers NNS B-NP O
amongst IN B-PP O
Japanese JJ B-NP O
and CC I-NP O
Caucasian JJ I-NP O
subjects NNS I-NP O
with IN B-PP O
Machado NNP B-NP B-Disease
- HYPH I-NP I-Disease
Joseph NNP I-NP I-Disease
disease NN I-NP I-Disease
. . O O

The DT B-NP O
size NN I-NP O
of IN B-PP O
the DT B-NP O
( ( O O
CAG NN O O
) ) O O
n NN B-NP O
repeat NN I-NP O
array NN I-NP O
in IN B-PP O
the DT B-NP O
3 CD I-NP O
' SYM I-NP O
end NN I-NP O
of IN B-PP O
the DT B-NP O
MJD1 NN I-NP O
gene NN I-NP O
and CC O O
the DT B-NP O
haplotype NN I-NP O
at IN B-PP O
a DT B-NP O
series NN I-NP O
of IN B-PP O
microsatellite NN B-NP O
markers NNS I-NP O
surrounding VBG B-VP O
the DT B-NP O
MJD1 NN I-NP O
gene NN I-NP O
were VBD B-VP O
examined VBN I-VP O
in IN B-PP O
a DT B-NP O
large JJ I-NP O
cohort NN I-NP O
of IN B-PP O
Japanese JJ B-NP O
and CC I-NP O
Caucasian JJ I-NP O
subjects NNS I-NP O
affected VBN B-VP O
with IN B-PP O
Machado NNP B-NP B-Disease
- HYPH I-NP I-Disease
Joseph NNP I-NP I-Disease
disease NN I-NP I-Disease
( ( O O
MJD NN B-NP B-Disease
) ) O O
. . O O

Our PRP$ B-NP O
data NNS I-NP O
provide VBP B-VP O
five CD B-NP O
novel JJ I-NP O
observations NNS I-NP O
. . O O

First RB B-ADVP O
, , O O
MJD NN B-NP B-Disease
is VBZ B-VP O
associated VBN I-VP O
with IN B-PP O
expansion NN B-NP O
fo VBP B-VP O
the DT B-NP O
array NN I-NP O
from IN B-PP O
the DT B-NP O
normal JJ I-NP O
range NN I-NP O
of IN B-PP O
14 CD B-NP O
- HYPH I-NP O
37 CD I-NP O
repeats NNS I-NP O
to TO B-PP O
68 CD B-NP O
- HYPH I-NP O
84 CD I-NP O
repeats NNS I-NP O
in IN B-PP O
most JJS B-NP O
Japanese JJ I-NP O
and CC I-NP O
Caucasian JJ I-NP O
subjects NNS I-NP O
, , O O
but CC O O
no DT B-NP O
subjects NNS I-NP O
were VBD B-VP O
observed VBN I-VP O
with IN B-PP O
expansions NNS B-NP O
intermediate VBP B-VP O
in IN B-PP O
size NN B-NP O
between IN B-PP O
those DT B-NP O
of IN B-PP O
the DT B-NP O
normal JJ I-NP O
and CC I-NP O
MJD NN I-NP B-Disease
affected VBN I-NP O
groups NNS I-NP O
. . O O

Second RB B-ADVP O
, , O O
the DT B-NP O
expanded VBN I-NP O
allele NN I-NP O
associated VBN B-VP O
with IN B-PP O
MJD NN B-NP B-Disease
displays VBZ B-VP O
inter AFX B-NP O
- HYPH I-NP O
generational JJ I-NP O
instability NN I-NP O
, , O O
particularly RB B-ADVP O
in IN B-PP O
male JJ B-NP O
meioses NNS I-NP O
, , O O
and CC O O
this DT B-NP O
instability NN I-NP O
was VBD B-VP O
associated VBN I-VP O
with IN B-PP O
the DT B-NP O
clinical JJ I-NP O
phenomenon NN I-NP O
of IN B-PP O
anticipation NN B-NP O
. . O O

Third RB B-ADVP O
, , O O
the DT B-NP O
size NN I-NP O
of IN B-PP O
the DT B-NP O
expanded VBN I-NP O
allele NN I-NP O
is VBZ B-VP O
not RB B-VP O
only RB I-VP O
inversely RB I-VP O
correlated VBN I-VP O
with IN B-PP O
the DT B-NP O
age NN I-NP O
- HYPH B-ADJP O
of IN B-PP O
- HYPH B-NP O
onset NN I-NP O
of IN B-PP O
MJD NN B-NP B-Disease
( ( O O
r NN B-NP O
= SYM B-VP O
- SYM B-NP O
0 CD I-NP O
. SYM I-NP O

738 CD I-NP O
, , O O
p NN B-NP O
< SYM B-VP O
0 CD B-NP O
. . I-NP O

001 CD I-NP O
) ) O O
, , O O
but CC O O
is VBZ B-VP O
also RB I-VP O
correlated VBN I-VP O
with IN B-PP O
the DT B-NP O
frequency NN I-NP O
of IN B-PP O
other JJ B-NP O
clinical JJ I-NP O
features NNS I-NP O
[ ( O O
e NN B-NP O
. . O O

g NN B-NP O
. . I-NP O

pseudoexophthalmos NNS I-NP O
and CC O O
pyramidal JJ B-NP O
signs NNS I-NP O
were VBD B-VP O
more RBR B-ADJP O
frequent JJ I-ADJP O
in IN B-PP O
subjects NNS B-NP O
with IN B-PP O
large JJ B-NP O
repeats NNS I-NP O
( ( O O
p NN B-NP O
< SYM B-ADJP O
0 CD B-NP O
. . I-NP O

001 CD I-NP O
and CC O O
p NN B-NP O
< SYM B-NP O
0 CD B-NP O
. . I-NP O

05 CD I-NP O
respectively RB B-ADVP O
) ) O O
] ) O O
. . O O

Fourth NNP B-NP O
, , O O
the DT B-NP O
disease NN I-NP O
phenotype NN I-NP O
is VBZ B-VP O
significantly RB B-ADJP O
more RBR I-ADJP O
severe JJ I-ADJP O
and CC O O
had VBD B-VP O
an DT B-NP O
early JJ I-NP O
age NN I-NP O
of IN B-PP O
onset NN B-NP O
( ( O O
16 CD B-NP O
years NNS I-NP O
) ) O O
in IN B-PP O
a DT B-NP O
subject NN I-NP O
homozygous JJ B-ADJP O
for IN B-PP O
the DT B-NP O
expanded VBN I-NP O
allele NN I-NP O
, , O O
which WDT B-NP O
contrasts VBZ B-VP O
with IN B-PP O
Huntington NNP B-NP B-Disease
disease NN I-NP I-Disease
and CC O O
suggests VBZ B-VP O
that IN B-SBAR O
the DT B-NP O
expanded VBN I-NP O
allele NN I-NP O
in IN B-PP O
the DT B-NP O
MJD1 NN I-NP O
gene NN I-NP O
could MD B-VP O
exert VB I-VP O
its PRP$ B-NP O
effect NN I-NP O
either CC B-PP O
by IN B-PP O
a DT B-NP O
dominant JJ I-NP O
negative JJ I-NP O
effect NN I-NP O
( ( O O
putatively RB B-VP O
excluded VBN I-VP O
in IN B-PP O
HD NN B-NP B-Disease
) ) O O
or CC O O
by IN B-PP O
a DT B-NP O
gain NN I-NP O
of IN B-PP O
function NN B-NP O
effect NN I-NP O
as IN B-SBAR O
proposed VBN B-VP O
for IN B-PP O
HD NN B-NP B-Disease
. . O O

Finally RB B-ADVP O
, , O O
Japanese JJ B-NP O
and CC I-NP O
Caucasian JJ I-NP O
subjects NNS I-NP O
affected VBN B-VP O
with IN B-PP O
MJD NN B-NP B-Disease
share NN I-NP O
haplotypes NNS I-NP O
at IN B-PP O
several JJ B-NP O
markers NNS I-NP O
surrounding VBG B-VP O
the DT B-NP O
MJD1 NN I-NP O
gene NN I-NP O
, , O O
which WDT B-NP O
are VBP B-VP O
uncommon JJ B-ADJP O
in IN B-PP O
the DT B-NP O
normal JJ I-NP O
Japanese JJ I-NP O
and CC I-NP O
Caucasian JJ I-NP O
population NN I-NP O
, , O O
and CC O O
which WDT B-NP O
suggests VBZ B-VP O
the DT B-NP O
existence NN I-NP O
either CC B-PP O
of IN B-PP O
common JJ B-NP O
founders NNS I-NP O
in IN B-PP O
these DT B-NP O
populations NNS I-NP O
or CC B-PP O
of IN B-PP O
chromosomes NNS B-NP O
susceptible JJ B-ADJP O
to TO B-PP O
pathologic JJ B-NP O
expansion NN I-NP O
of IN B-PP O
the DT B-NP O
CAG NN I-NP O
repeat NN I-NP O
in IN B-PP O
the DT B-NP O
MJD1 NN I-NP O
gene NN I-NP O
. . O O

A DT B-NP O
4 CD I-NP O
- HYPH I-NP O
megabase NN I-NP O
YAC NN I-NP O
contig NN I-NP O
that WDT B-NP O
spans VBZ B-VP O
the DT B-NP O
Langer NNP I-NP B-Disease
- HYPH I-NP I-Disease
Giedion NNP I-NP I-Disease
syndrome NN I-NP I-Disease
region NN I-NP O
on IN B-PP O
human JJ B-NP O
chromosome NN I-NP O
8q24 CD I-NP O
. . I-NP O

1 CD I-NP O
: : O O
use NN B-NP O
in IN B-PP O
refining VBG B-VP O
the DT B-NP O
location NN I-NP O
of IN B-PP O
the DT B-NP O
trichorhinophalangeal JJ I-NP B-Disease
syndrome NN I-NP I-Disease
and CC O O
multiple JJ B-NP O
exostoses NNS I-NP O
genes NNS I-NP O
( ( O O
TRPS1 NN B-NP O
and CC O O
EXT1 NN B-NP O
) ) O O
. . O O

We PRP B-NP O
have VBP B-VP O
constructed VBN I-VP O
a DT B-NP O
physical JJ I-NP O
map NN I-NP O
covering VBG B-VP O
over IN B-NP O
4 CD I-NP O
Mb NN I-NP O
of IN B-PP O
human JJ B-NP O
chromosome NN I-NP O
8q24 CD I-NP O
. . O O

1 CD B-NP O
and CC O O
used VBN B-VP O
this DT B-NP O
map NN I-NP O
to TO B-VP O
refine VB I-VP O
the DT B-NP O
locations NNS I-NP O
of IN B-PP O
the DT B-NP O
genes NNS I-NP O
responsible JJ B-ADJP O
for IN B-PP O
Langer NNP B-NP B-Disease
- HYPH I-NP I-Disease
Giedion NNP I-NP I-Disease
syndrome NN I-NP I-Disease
. . O O

The DT B-NP O
map NN I-NP O
is VBZ B-VP O
composed VBN I-VP O
of IN B-PP O
overlapping VBG B-VP O
YAC NN B-NP O
clones NNS I-NP O
that WDT B-NP O
were VBD B-VP O
identified VBN I-VP O
and CC O O
ordered VBN B-VP O
in IN B-PP O
relation NN B-NP O
to TO B-VP O
sequence VB I-VP O
tagged VBN B-NP O
sites NNS I-NP O
mapped VBN B-VP O
to TO B-PP O
the DT B-NP O
Langer NN I-NP O
- HYPH B-NP O
Giedion NN I-NP O
chromosomal JJ I-NP O
region NN I-NP O
on IN B-PP O
somatic JJ B-NP O
cell NN I-NP O
hybrids NNS I-NP O
. . O O

The DT B-NP O
minimal JJ I-NP O
region NN I-NP O
of IN B-PP O
overlap NN B-NP O
of IN B-PP O
Langer NNP B-NP B-Disease
- HYPH I-NP I-Disease
Giedion NNP I-NP I-Disease
syndrome NN I-NP I-Disease
deletions NNS I-NP O
, , O O
previously RB B-VP O
identified VBN I-VP O
by IN B-PP O
analysis NN B-NP O
of IN B-PP O
15 CD B-NP O
patients NNS I-NP O
, , O O
was VBD B-VP O
placed VBN I-VP O
on IN B-PP O
the DT B-NP O
map NN I-NP O
by IN B-PP O
analysis NN B-NP O
of IN B-PP O
2 CD B-NP O
patients NNS I-NP O
whose WP$ B-NP O
deletions NNS I-NP O
define VBP B-VP O
the DT B-NP O
endpoints NNS I-NP O
. . O O

The DT B-NP O
chromosome NN I-NP O
8 CD I-NP O
breakpoint NN I-NP O
of IN B-PP O
a DT B-NP O
balanced JJ I-NP O
t NN I-NP O
( ( O O
8 CD B-NP O
; : O O
9 CD B-NP O
) ) O O
( ( O O
q24 NN B-NP O
. . B-NP O

11 CD I-NP O
; : O O
q33 CD B-NP O
. . O O

3 CD O O
) ) O O
translocation NN B-NP O
from IN B-PP O
a DT B-NP O
patient NN I-NP O
with IN B-PP O
trichorhinophalangeal JJ B-NP B-Disease
syndrome NN I-NP I-Disease
( ( O O
TRPS NN B-NP B-Disease
I CD I-NP O
) ) O O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
be VB I-VP O
located VBN I-VP O
just RB B-ADVP O
within IN B-PP O
the DT B-NP O
proximal JJ I-NP O
end NN I-NP O
of IN B-PP O
the DT B-NP O
minimal JJ I-NP O
deletion NN I-NP O
region NN I-NP O
. . O O

A DT B-NP O
deletion NN I-NP O
of IN B-PP O
8q24 CD B-NP O
. . O O

11 CD B-NP O
- HYPH I-NP O
q24 NN I-NP O
. . O O

3 CD B-NP O
in IN B-PP O
a DT B-NP O
patient NN I-NP O
with IN B-PP O
multiple JJ B-NP O
exostoses NNS I-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
overlap VB I-VP O
the DT B-NP O
distal JJ I-NP O
end NN I-NP O
of IN B-PP O
the DT B-NP O
LGS NN I-NP B-Disease
deletion NN I-NP O
region NN I-NP O
, , O O
indicating VBG B-VP O
that IN B-SBAR O
the DT B-NP O
EXT1 NN I-NP O
gene NN I-NP O
is VBZ B-VP O
distal JJ B-ADJP O
to TO B-PP O
the DT B-NP O
TRPS1 NN I-NP O
gene NN I-NP O
and CC O O
supporting VBG B-VP O
the DT B-NP O
hypothesis NN I-NP O
that IN B-SBAR O
Langer NN B-NP B-Disease
- HYPH I-NP I-Disease
Giedion NN I-NP I-Disease
syndrome NN I-NP I-Disease
is VBZ B-VP O
due IN B-PP O
to TO I-PP O
loss NN B-NP O
of IN B-PP O
functional JJ B-NP O
copies NNS I-NP O
of IN B-PP O
both CC O O
the DT B-NP O
TRPS1 NN I-NP O
and CC O O
the DT B-NP O
EXT1 NN I-NP O
genes NNS I-NP O
BRCA1 NN B-NP O
mutations NNS I-NP O
in IN B-PP O
a DT B-NP O
population NN I-NP O
- HYPH O O
based VBN B-NP O
sample NN I-NP O
of IN B-PP O
young JJ B-NP O
women NNS I-NP O
with IN B-PP O
breast NN B-NP B-Disease
cancer NN I-NP I-Disease
. . O O

BACKGROUND NN B-NP O
. . O O

Inherited VBN B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
BRCA1 NN I-NP O
gene NN I-NP O
are VBP B-VP O
associated VBN I-VP O
with IN B-PP O
a DT B-NP O
high JJ I-NP O
risk NN I-NP O
of IN B-PP O
breast NN B-NP B-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
in IN B-PP O
some DT B-NP O
families NNS I-NP O
. . O O

However RB B-ADVP O
, , O O
little JJ B-NP O
is VBZ B-VP O
known VBN I-VP O
about IN B-PP O
the DT B-NP O
contribution NN I-NP O
of IN B-PP O
BRCA1 NN B-NP O
mutations NNS I-NP O
to TO B-PP O
breast NN B-NP B-Disease
cancer NN I-NP I-Disease
in IN B-PP O
the DT B-NP O
general JJ I-NP O
population NN I-NP O
. . O O

We PRP B-NP O
analyzed VBD B-VP O
DNA NN B-NP O
samples NNS I-NP O
from IN B-PP O
women NNS B-NP O
enrolled VBN B-VP O
in IN B-PP O
a DT B-NP O
population NN I-NP O
- HYPH O O
based VBN B-NP O
study NN I-NP O
of IN B-PP O
early JJ B-NP O
- HYPH I-NP O
onset NN I-NP O
breast NN I-NP B-Disease
cancer NN I-NP I-Disease
to TO B-VP O
assess VB I-VP O
the DT B-NP O
spectrum NN I-NP O
and CC I-NP O
frequency NN I-NP O
of IN B-PP O
germ NN B-NP O
- HYPH I-NP O
line NN I-NP O
BRCA1 NN I-NP O
mutations NNS I-NP O
in IN B-PP O
young JJ B-NP O
women NNS I-NP O
with IN B-PP O
breast NN B-NP B-Disease
cancer NN I-NP I-Disease
. . O O

METHODS NNS B-NP O
. . O O

We PRP B-NP O
studied VBD B-VP O
80 CD B-NP O
women NNS I-NP O
in IN B-PP O
whom WP B-NP O
breast NN B-NP B-Disease
cancer NN I-NP I-Disease
was VBD B-VP O
diagnosed VBN I-VP O
before IN B-PP O
the DT B-NP O
age NN I-NP O
of IN B-PP O
35 CD B-NP O
, , O O
and CC O O
who WP B-NP O
were VBD B-VP O
not RB I-VP O
selected VBN I-VP O
on IN B-PP O
the DT B-NP O
basis NN I-NP O
of IN B-PP O
family NN B-NP O
history NN I-NP O
. . O O

Genomic JJ B-NP O
DNA NN I-NP O
was VBD B-VP O
studied VBN I-VP O
for IN B-PP O
BRCA1 NN B-NP O
mutations NNS I-NP O
by IN B-PP O
analysis NN B-NP O
involving VBG B-VP O
single JJ B-NP O
- HYPH I-NP O
strand NN I-NP O
conformation NN I-NP O
polymorphisms NNS I-NP O
and CC B-PP O
with IN B-PP O
allele NN B-NP O
- HYPH B-NP O
specific JJ I-NP O
assays NNS I-NP O
. . O O

Alterations NNS B-NP O
were VBD B-VP O
defined VBN I-VP O
by IN B-PP O
DNA NN B-NP O
sequencing NN I-NP O
. . O O

RESULTS NNS B-NP O
. . O O

Germ NN B-NP O
- HYPH I-NP O
line NN I-NP O
BRCA1 NN I-NP O
mutations NNS I-NP O
were VBD B-VP O
identified VBN I-VP O
in IN B-PP O
6 CD B-NP O
of IN B-PP O
the DT B-NP O
80 CD I-NP O
women NNS I-NP O
. . O O

Four CD B-NP O
additional JJ I-NP O
rare JJ I-NP O
sequence NN I-NP O
variants NNS I-NP O
of IN B-PP O
unknown JJ B-NP O
functional JJ I-NP O
importance NN I-NP O
were VBD B-VP O
also RB I-VP O
identified VBN I-VP O
. . O O

Two CD B-NP O
of IN B-PP O
the DT B-NP O
mutations NNS I-NP O
and CC O O
three CD B-NP O
of IN B-PP O
the DT B-NP O
rare JJ I-NP O
sequence NN I-NP O
variants NNS I-NP O
were VBD B-VP O
found VBN I-VP O
among IN B-PP O
the DT B-NP O
39 CD I-NP O
women NNS I-NP O
who WP B-NP O
reported VBD B-VP O
no DT B-NP O
family NN I-NP O
history NN I-NP O
of IN B-PP O
breast NN B-NP B-Disease
or CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
. . O O

None NN B-NP O
of IN B-PP O
the DT B-NP O
mutations NNS I-NP O
and CC O O
only RB B-NP O
one CD I-NP O
of IN B-PP O
the DT B-NP O
rare JJ I-NP O
variants NNS I-NP O
was VBD B-VP O
identified VBN I-VP O
in IN B-PP O
a DT B-NP O
reference NN I-NP O
population NN I-NP O
of IN B-PP O
73 CD B-NP O
unrelated JJ I-NP O
subjects NNS I-NP O
. . O O

CONCLUSIONS NNS B-NP O
. . O O

Alterations NNS B-NP O
in IN B-PP O
BRCA1 NN B-NP O
were VBD B-VP O
identified VBN I-VP O
in IN B-PP O
approximately RB B-NP O
10 CD I-NP O
percent NN I-NP O
of IN B-PP O
this DT B-NP O
cohort NN I-NP O
of IN B-PP O
young JJ B-NP O
women NNS I-NP O
with IN B-PP O
breast NN B-NP B-Disease
cancer NN I-NP I-Disease
. . O O

The DT B-NP O
risk NN I-NP O
of IN B-PP O
harboring VBG B-VP O
a DT B-NP O
mutation NN I-NP O
was VBD B-VP O
not RB I-VP O
limited VBN I-VP O
to TO B-PP O
women NNS B-NP O
with IN B-PP O
family NN B-NP O
histories NNS I-NP O
of IN B-PP O
breast NN B-NP B-Disease
or CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
. . O O

These DT B-NP O
results NNS I-NP O
represent VBP B-VP O
a DT B-NP O
minimal JJ I-NP O
estimate NN I-NP O
of IN B-PP O
the DT B-NP O
frequency NN I-NP O
of IN B-PP O
BRCA1 NN B-NP O
mutations NNS I-NP O
in IN B-PP O
this DT B-NP O
population NN I-NP O
. . O O

Comprehensive JJ B-NP O
methods NNS I-NP O
of IN B-PP O
identifying VBG B-VP O
BRCA1 NN B-NP O
mutations NNS I-NP O
and CC O O
understanding VBG B-VP O
their PRP$ B-NP O
importance NN I-NP O
will MD B-VP O
be VB I-VP O
needed VBN I-VP O
before IN B-PP O
testing NN B-NP O
of IN B-PP O
women NNS B-NP O
in IN B-PP O
the DT B-NP O
general JJ I-NP O
population NN I-NP O
can MD B-VP O
be VB I-VP O
undertaken VBN I-VP O
. . O O

. . O O

Novel JJ B-NP O
inherited VBN I-NP O
mutations NNS I-NP O
and CC O O
variable JJ B-NP O
expressivity NN I-NP O
of IN B-PP O
BRCA1 NN B-NP O
alleles NNS I-NP O
, , O O
including VBG B-PP O
the DT B-NP O
founder NN I-NP O
mutation NN I-NP O
185delAG NN I-NP O
in IN B-PP O
Ashkenazi NNP B-NP O
Jewish JJ I-NP O
families NNS I-NP O
. . O O

Thirty CD B-NP O
- HYPH I-NP O
seven CD I-NP O
families NNS I-NP O
with IN B-PP O
four CD B-NP O
or CC I-NP O
more JJR I-NP O
cases NNS I-NP O
of IN B-PP O
breast NN B-NP B-Disease
cancer NN I-NP I-Disease
or CC I-NP O
breast NN I-NP B-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
were VBD B-VP O
analyzed VBN I-VP O
for IN B-PP O
mutations NNS B-NP O
in IN B-PP O
BRCA1 NN B-NP O
. . O O

Twelve CD B-NP O
different JJ I-NP O
germ NN I-NP O
- HYPH I-NP O
line NN I-NP O
mutations NNS I-NP O
, , O O
four CD B-NP O
novel JJ I-NP O
and CC I-NP O
eight CD I-NP O
previously RB B-VP O
observed VBN I-VP O
, , O O
were VBD B-VP O
detected VBN I-VP O
in IN B-PP O
16 CD B-NP O
families NNS I-NP O
. . O O

Five CD B-NP O
families NNS I-NP O
of IN B-PP O
Ashkenazi NNP B-NP O
Jewish NNP I-NP O
descent NNP I-NP O
carried VBD B-VP O
the DT B-NP O
185delAG NN I-NP O
mutation NN I-NP O
and CC O O
shared VBD B-VP O
the DT B-NP O
same JJ I-NP O
haplotype NN I-NP O
at IN B-PP O
eight CD B-NP O
polymorphic JJ I-NP O
markers NNS I-NP O
spanning VBG B-VP O
approximately RB B-NP O
850 CD I-NP O
kb NN I-NP O
at IN B-PP O
BRCA1 NN B-NP O
. . O O

Expressivity NN B-NP O
of IN B-PP O
185delAG NN B-NP O
in IN B-PP O
these DT B-NP O
families NNS I-NP O
varied VBD B-VP O
, , O O
from IN B-PP O
early JJ B-NP O
- HYPH I-NP O
onset NN I-NP O
breast NN I-NP B-Disease
cancer NN I-NP I-Disease
without IN B-PP O
ovarian JJ B-NP B-Disease
cancer NN I-NP I-Disease
. . O O

Mutation NN B-NP O
4184delTCAA NN I-NP O
occurred VBD B-VP O
independently RB B-ADVP O
in IN B-PP O
two CD B-NP O
families NNS I-NP O
. . O O

In IN B-PP O
one CD B-NP O
family NN I-NP O
, , O O
penetrance NN B-NP O
was VBD B-VP O
complete JJ B-ADJP O
, , O O
with IN B-PP O
females NNS B-NP O
developing VBG B-VP O
early JJ B-NP O
- HYPH I-NP O
onset NN I-NP O
breast NN I-NP B-Disease
cancer NN I-NP I-Disease
or CC O O
ovarian JJ B-NP B-Disease
cancer NN I-NP I-Disease
and CC O O
the DT B-NP O
male JJ I-NP O
carrier NN I-NP O
developing VBG B-VP O
prostatic JJ B-NP B-Disease
cancer NN I-NP I-Disease
, , O O
whereas IN O O
, , O O
in IN B-PP O
the DT B-NP O
other JJ I-NP O
family NN I-NP O
, , O O
penetrance NN B-NP O
was VBD B-VP O
incomplete JJ B-NP O
and CC I-NP O
only JJ I-NP O
breast NN I-NP B-Disease
cancer NN I-NP I-Disease
occurred VBD B-VP O
, , O O
diagnosed VBN B-VP O
at IN B-PP O
ages NNS B-NP O
38 CD B-NP O
- HYPH I-NP O
81 CD I-NP O
years NNS I-NP O
. . O O

Two CD B-NP O
novel JJ I-NP O
nonsense JJ I-NP O
mutations NNS I-NP O
led VBD B-VP O
to TO B-PP O
the DT B-NP O
loss NN I-NP O
of IN B-PP O
mutant JJ B-NP O
BRCA1 NN I-NP O
transcript NN I-NP O
in IN B-PP O
families NNS B-NP O
with IN B-PP O
10 CD B-NP O
and CC I-NP O
6 CD I-NP O
cases NNS I-NP O
of IN B-PP O
early JJ B-NP O
- HYPH I-NP O
onset NN I-NP O
breast NN I-NP B-Disease
cancer NN I-NP I-Disease
and CC O O
ovarian JJ B-NP B-Disease
cancer NN I-NP I-Disease
. . O O

A DT B-NP O
665 CD I-NP O
- HYPH I-NP O
nt NN I-NP O
segment NN I-NP O
of IN B-PP O
the DT B-NP O
BRCA1 NN I-NP O
3 CD I-NP O
- HYPH I-NP O
UTR NN I-NP O
and CC I-NP O
1 CD I-NP O
. . O O

3 CD B-NP O
kb NN I-NP O
of IN B-PP O
genomic JJ B-NP O
sequence NN I-NP O
including VBG B-PP O
the DT B-NP O
putative JJ I-NP O
promoter NN I-NP O
region NN I-NP O
were VBD B-VP O
invariant JJ B-ADJP O
by IN B-PP O
single JJ B-NP O
- HYPH I-NP O
strand NN I-NP O
conformation NN I-NP O
analysis NN I-NP O
in IN B-PP O
13 CD B-NP O
families NNS I-NP O
without IN B-PP O
coding VBG B-VP O
- HYPH B-NP O
sequence NN I-NP O
mutations NNS I-NP O
. . O O

Overall RB B-ADVP O
in IN B-PP O
our PRP$ B-NP O
series NN I-NP O
, , O O
BRCA1 NN B-NP O
mutations NNS I-NP O
have VBP B-VP O
been VBN I-VP O
detected VBN I-VP O
in IN B-PP O
26 CD B-NP O
families NNS I-NP O
16 CD B-NP O
with IN B-PP O
positive JJ B-NP O
BRCA1 NN I-NP O
lod NN I-NP O
scores NNS I-NP O
, , O O
7 CD B-NP O
with IN B-PP O
negative JJ B-NP O
lod NN I-NP O
scores NNS I-NP O
( ( O O
reflecting VBG B-VP O
multiple JJ B-NP O
sporadic JJ I-NP O
breast NN I-NP B-Disease
cancers NNS I-NP I-Disease
) ) O O
, , O O
and CC O O
3 CD B-NP O
not RB B-VP O
tested VBN I-VP O
for IN B-PP O
linkage NN B-NP O
. . O O

Three CD B-NP O
other JJ I-NP O
families NNS I-NP O
have VBP B-VP O
positive JJ B-NP O
lod NN I-NP O
scores NNS I-NP O
for IN B-PP O
linkage NN B-NP O
to TO B-PP O
BRCA2 NN B-NP O
, , O O
but CC O O
13 CD B-NP O
families NNS I-NP O
without IN B-PP O
detected VBN B-NP O
BRCA1 NN I-NP O
mutations NNS I-NP O
have VBP B-VP O
negative JJ B-NP O
lod NN I-NP O
scores NNS I-NP O
for IN B-PP O
both CC O O
BRCA1 NN B-NP O
and CC I-NP O
BRCA2 NN I-NP O
. . O O

A DT B-NP O
new JJ I-NP O
glucose NN I-NP O
- HYPH B-NP O
6 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
dehydrogenase NN I-NP O
variant NN I-NP O
, , O O
G6PD NN B-NP O
Orissa NNP I-NP O
( ( O O
44 CD B-NP O
Ala NN I-NP O
- SYM B-NP O
- HYPH B-NP O
> SYM I-NP O
Gly NN I-NP O
) ) O O
, , O O
is VBZ B-VP O
the DT B-NP O
major JJ I-NP O
polymorphic JJ I-NP O
variant NN I-NP O
in IN B-PP O
tribal JJ B-NP O
populations NNS I-NP O
in IN B-PP O
India NNP B-NP O
. . O O

Deficiency NN B-NP B-Disease
of IN B-PP I-Disease
glucose NN B-NP I-Disease
- HYPH B-NP I-Disease
6 CD I-NP I-Disease
- HYPH I-NP I-Disease
phosphate NN I-NP I-Disease
dehydrogenase NN I-NP I-Disease
( ( O O
G6PD NN B-NP O
) ) O O
is VBZ B-VP O
usually RB I-VP O
found VBN I-VP O
at IN B-PP O
high JJ B-NP O
frequencies NNS I-NP O
in IN B-PP O
areas NNS B-NP O
of IN B-PP O
the DT B-NP O
world NN I-NP O
where WRB B-ADVP O
malaria NN B-NP B-Disease
has VBZ B-VP O
been VBN I-VP O
endemic JJ B-ADJP O
. . O O

The DT B-NP O
frequency NN I-NP O
and CC O O
genetic JJ B-NP O
basis NN I-NP O
of IN B-PP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
have VBP B-VP O
been VBN I-VP O
studied VBN I-VP O
in IN B-PP O
Africa NNP B-NP O
, , O O
around IN B-PP O
the DT B-NP O
Mediterranean NNP I-NP O
, , O O
and CC O O
in IN B-PP O
the DT B-NP O
Far NNP I-NP O
East NNP I-NP O
, , O O
but CC O O
little JJ B-NP O
such JJ I-NP O
information NN I-NP O
is VBZ B-VP O
available JJ B-ADJP O
about IN B-PP O
the DT B-NP O
situation NN I-NP O
in IN B-PP O
India NNP B-NP O
. . O O

To TO B-VP O
determine VB I-VP O
the DT B-NP O
extent NN I-NP O
of IN B-PP O
heterogeneity NN B-NP O
of IN B-PP O
G6PD NN B-NP O
, , O O
we PRP B-NP O
have VBP B-VP O
studied VBN I-VP O
several JJ B-NP O
different JJ I-NP O
Indian JJ I-NP O
populations NNS I-NP O
by IN B-PP O
screening VBG B-VP O
for IN B-PP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
, , O O
followed VBN B-VP O
by IN B-PP O
molecular JJ B-NP O
analysis NN I-NP O
of IN B-PP O
deficient JJ B-NP O
alleles NNS I-NP O
. . O O

The DT B-NP O
frequency NN I-NP O
of IN B-PP O
G6PD NN B-NP B-Disease
deficiency NN I-NP I-Disease
varies VBZ B-VP O
between IN B-NP O
3 CD I-NP O
% NN I-NP O
and CC I-NP O
15 CD I-NP O
% NN I-NP O
in IN B-PP O
different JJ B-NP O
tribal JJ I-NP O
and CC I-NP O
urban JJ I-NP O
groups NNS I-NP O
. . O O

Remarkably RB B-ADVP O
, , O O
a DT B-NP O
previously RB I-NP O
unreported JJ I-NP O
deficient JJ I-NP O
variant NN I-NP O
, , O O
G6PD NN B-NP O
Orissa NNP I-NP O
( ( O O
44 CD B-NP O
Ala NN I-NP O
- SYM B-NP O
- HYPH B-NP O
> SYM I-NP O
Gly NN I-NP O
) ) O O
, , O O
is VBZ B-VP O
responsible JJ B-ADJP O
for IN B-PP O
most JJS B-NP O
of IN B-PP O
the DT B-NP O
G6PD NN I-NP B-Disease
deficiency NN I-NP I-Disease
in IN B-PP O
tribal JJ B-NP O
Indian JJ I-NP O
populations NNS I-NP O
but CC O O
is VBZ B-VP O
not RB I-VP O
found VBN I-VP O
in IN B-PP O
urban JJ B-NP O
populations NNS I-NP O
, , O O
where WRB B-ADVP O
most JJS B-NP O
of IN B-PP O
the DT B-NP O
G6PD NN I-NP B-Disease
deficiency NN I-NP I-Disease
is VBZ B-VP O
due IN B-PP O
to TO B-PP O
the DT B-NP O
G6PD NN I-NP O
Mediterranean NN I-NP O
( ( O O
188 CD B-NP O
Ser NN I-NP O
- SYM B-NP O
- HYPH B-NP O
> SYM I-NP O
Phe NN I-NP O
) ) O O
variant NN B-NP O
. . O O

The DT B-NP O
KmNADP NN I-NP O
of IN B-PP O
G6PD NN B-NP O
Orissa NNP I-NP O
is VBZ B-VP O
fivefold RB B-ADJP O
higher JJR I-ADJP O
than IN B-PP O
that DT B-NP O
of IN B-PP O
the DT B-NP O
normal JJ I-NP O
enzyme NN I-NP O
. . O O

This DT B-NP O
may MD B-VP O
be VB I-VP O
due JJ B-ADVP O
to TO B-PP O
the DT B-NP O
fact NN I-NP O
that IN B-SBAR O
the DT B-NP O
alanine NN I-NP O
residue NN I-NP O
that WDT B-NP O
is VBZ B-VP O
replaced VBN I-VP O
by IN B-PP O
glycine NN B-NP O
is VBZ B-VP O
part NN B-NP O
of IN B-PP O
a DT B-NP O
putative JJ I-NP O
coenzyme NN I-NP O
- HYPH B-PP O
binding VBG B-NP O
site NN I-NP O
. . O O

. . O O

Evidence NN B-NP O
for IN B-PP O
linkage NN B-NP O
of IN B-PP O
bipolar JJ B-NP B-Disease
disorder NN I-NP I-Disease
to TO B-PP O
chromosome NN B-NP O
18 CD I-NP O
with IN B-PP O
a DT B-NP O
parent NN I-NP O
- HYPH B-NP O
of IN B-PP O
- HYPH B-NP O
origin NN I-NP O
effect NN I-NP O
. . O O

A DT B-NP O
susceptibility NN I-NP O
gene NN I-NP O
on IN B-PP O
chromosome NN B-NP O
18 CD I-NP O
and CC O O
a DT B-NP O
parent NN I-NP O
- HYPH B-NP O
of IN B-PP O
- HYPH B-NP O
origin NN I-NP O
effect NN I-NP O
have VBP B-VP O
been VBN I-VP O
suggested VBN I-VP O
for IN B-PP O
bipolar JJ B-NP B-Disease
affective JJ I-NP I-Disease
disorder NN I-NP I-Disease
( ( O O
BPAD NN B-NP B-Disease
) ) O O
. . O O

We PRP B-NP O
have VBP B-VP O
studied VBN I-VP O
28 CD B-NP O
nuclear JJ I-NP O
families NNS I-NP O
selected VBN B-VP O
for IN B-PP O
apparent JJ B-NP O
unilineal JJ I-NP O
transmission NN I-NP O
of IN B-PP O
the DT B-NP O
BPAD NN I-NP B-Disease
phenotype NN I-NP O
, , O O
by IN B-PP O
using VBG B-VP O
31 CD B-NP O
polymorphic JJ I-NP O
markers NNS I-NP O
spanning VBG B-VP O
chromosome NN B-NP O
18 CD I-NP O
. . O O

Evidence NN B-NP O
for IN B-PP O
linkage NN B-NP O
was VBD B-VP O
tested VBN I-VP O
with IN B-PP O
affected VBN B-NP O
- HYPH I-NP O
sib NN I-NP O
- HYPH I-NP O
pair NN I-NP O
and CC I-NP O
LOD NN I-NP O
score NN I-NP O
methods NNS I-NP O
under IN B-PP O
two CD B-NP O
definitions NNS I-NP O
of IN B-PP O
the DT B-NP O
affected VBN I-NP O
phenotype NN I-NP O
. . O O

The DT B-NP O
affected VBN I-NP O
- HYPH I-NP O
sibpair NN I-NP O
analyses NNS I-NP O
indicated VBD B-VP O
excess JJ B-NP O
allele NN I-NP O
sharing VBG B-VP O
for IN B-PP O
markers NNS B-NP O
on IN B-PP O
18p NN B-NP O
within IN B-PP O
the DT B-NP O
region NN I-NP O
reported VBN B-VP O
previously RB B-ADVP O
. . O O

The DT B-NP O
greatest JJS I-NP O
sharing NN I-NP O
was VBD B-VP O
at IN B-PP O
D18S37 NN B-NP O
64 CD B-NP O
% NN I-NP O
in IN B-PP O
bipolar JJ B-NP O
and CC I-NP O
recurrent JJ I-NP O
unipolar JJ I-NP O
( ( O O
RUP NN B-NP O
) ) O O
sib NN B-NP O
pairs NNS I-NP O
( ( O O
P NN B-NP O
= SYM B-VP O
. . B-NP O

0006 CD I-NP O
) ) O O
. . O O

In IN B-PP O
addition NN B-NP O
, , O O
excess JJ B-NP O
sharing NN I-NP O
of IN B-PP O
the DT B-NP O
paternally NN I-NP O
, , O O
but CC O O
not RB O O
maternally RB B-ADVP O
, , O O
transmitted VBN B-NP O
alleles NNS I-NP O
was VBD B-VP O
observed VBN I-VP O
at IN B-PP O
three CD B-NP O
markers NNS I-NP O
on IN B-PP O
18q NN B-NP O
at IN B-PP O
D18S41 NN B-NP O
, , O O
51 CD B-NP O
bipolar JJ I-NP O
and CC I-NP O
RUP NN I-NP O
sib NN I-NP O
pairs NNS I-NP O
were VBD B-VP O
concordant JJ B-ADJP O
for IN B-PP O
paternally RB B-NP O
transmitted VBN I-NP O
alleles NNS I-NP O
, , O O
and CC O O
21 CD B-NP O
pairs NNS I-NP O
were VBD B-VP O
discordant JJ B-ADJP O
( ( O O
P NN B-NP O
= SYM B-VP O
0004 CD B-NP O
) ) O O
. . O O

The DT B-NP O
evidence NN I-NP O
for IN B-PP O
linkage NN B-NP O
to TO B-PP O
loci NNS B-NP O
on IN B-PP O
both CC O O
18p NN B-NP O
and CC I-NP O
18q NN I-NP O
was VBD B-VP O
strongest JJS B-ADJP O
in IN B-PP O
the DT B-NP O
11 CD I-NP O
paternal JJ I-NP O
pedigrees NNS I-NP O
, , O O
i NN B-NP O
. . O O

e NN B-NP O
e NN I-NP O
. NN I-NP O

, , O O
those DT B-NP O
in IN B-PP O
which WDT B-NP O
the DT B-NP O
father NN I-NP O
or CC O O
one CD B-NP O
of IN B-PP O
the DT B-NP O
fathers NNS I-NP O
sibs NNS I-NP O
is VBZ B-VP O
affected VBN I-VP O
. . O O

In IN B-PP O
these DT B-NP O
pedigrees NNS I-NP O
, , O O
the DT B-NP O
greatest JJS I-NP O
allele NN I-NP O
sharing VBG B-VP O
( ( O O
81 CD B-NP O
% NN I-NP O
; : O O
P NN B-NP O
= JJ B-NP O
. . I-NP O

00002 CD I-NP O
) ) O O
and CC O O
the DT B-NP O
highest JJS I-NP O
LOD NN I-NP O
score NN I-NP O
( ( O O
3 CD B-NP O
. . I-NP O

51 CD I-NP O
; : O O
phi NN B-NP O
= SYM B-VP O
0 CD B-NP O
. SYM I-NP O

0 CD I-NP O
) ) O O
were VBD B-VP O
observed VBN I-VP O
at IN B-PP O
D18S41 NN B-NP O
. . O O

Our PRP$ B-NP O
results NNS I-NP O
provide VBP B-VP O
further JJ B-NP O
support NN I-NP O
for IN B-PP O
linkage NN B-NP O
of IN B-PP O
BPAD NN B-NP B-Disease
to TO B-PP O
chromosome NN B-NP O
18 CD I-NP O
and CC O O
the DT B-NP O
first JJ I-NP O
molecular JJ I-NP O
evidence NN I-NP O
for IN B-PP O
a DT B-NP O
parent NN I-NP O
- HYPH B-NP O
of IN B-PP O
- HYPH B-NP O
origin NN I-NP O
effect NN I-NP O
operating VBG B-VP O
in IN B-PP O
this DT B-NP O
disorder NN I-NP O
. . O O

The DT B-NP O
number NN I-NP O
of IN B-PP O
loci NNS B-NP O
involved VBN B-ADJP O
, , O O
and CC O O
their PRP$ B-NP O
precise JJ I-NP O
location NN I-NP O
, , O O
require VB B-VP O
further JJR B-NP O
study NN I-NP O
A DT B-NP O
prevalent JJ I-NP O
mutation NN I-NP O
for IN B-PP O
galactosemia NN B-NP B-Disease
among IN B-PP O
black JJ B-NP O
Americans NNPS I-NP O
. . O O

OBJECTIVE NN B-NP O
To TO B-VP O
define VB I-VP O
the DT B-NP O
mutation NN I-NP O
causing VBG B-VP O
galactosemia NN B-NP B-Disease
in IN B-PP O
patients NNS B-NP O
of IN B-PP O
black JJ B-NP O
American JJ I-NP O
origin NN I-NP O
who WP B-NP O
have VBP B-VP O
no DT B-NP O
galactose NN I-NP O
- HYPH B-NP O
1 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
uridyltransferase NN I-NP O
( ( O O
GALT NN B-NP O
) ) O O
activity NN B-NP O
in IN B-PP O
erythrocytes NNS B-NP O
but CC O O
good JJ B-NP O
clinical JJ I-NP O
outcome NN I-NP O
. . O O

METHODS NNS B-NP O
We PRP B-NP O
discovered VBD B-VP O
a DT B-NP O
mutation NN I-NP O
caused VBN B-VP O
by IN B-PP O
a DT B-NP O
C NN I-NP O
- SYM B-NP O
- SYM B-NP O
> SYM I-NP O
T NN I-NP O
transition NN I-NP O
at IN B-PP O
base NN B-NP O
- HYPH O O
pair NN B-NP O
1158 CD I-NP O
of IN B-PP O
the DT B-NP O
GALT NN I-NP O
gene NN I-NP O
that WDT B-NP O
results VBZ B-VP O
in IN B-PP O
a DT B-NP O
serine NN I-NP O
- HYPH B-ADJP O
to TO B-PP O
- HYPH B-NP O
leucine NN I-NP O
substitution NN I-NP O
at IN B-PP O
codon NN B-NP O
135 CD I-NP O
( ( O O
S135L NN B-NP O
) ) O O
. . O O

We PRP B-NP O
developed VBD B-VP O
a DT B-NP O
method NN I-NP O
with IN B-PP O
which WDT B-NP O
to TO B-VP O
screen VB I-VP O
populations NNS B-NP O
for IN B-PP O
its PRP$ B-NP O
prevalence NN I-NP O
. . O O

We PRP B-NP O
compared VBD B-VP O
galactose NN B-NP O
- HYPH B-NP O
1 CD I-NP O
- HYPH I-NP O
phosphate NN I-NP O
uridyltransferase NN I-NP O
among IN B-PP O
erythrocytes NNS B-NP O
, , O O
leukocytes NNS B-NP O
, , O O
and CC O O
transformed VBN B-NP O
lymphoblasts NNS I-NP O
, , O O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
total JJ B-NP O
body NN I-NP O
oxidation NN I-NP O
of IN B-PP O
D NN B-NP O
- HYPH O O
( ( O O
13C NN B-NP O
) ) O O
- HYPH B-NP O
galactose NN I-NP O
to TO B-PP O
13CO2 NN B-NP O
among IN B-PP O
three CD B-NP O
genotypes NNS I-NP O
for IN B-PP O
GALT NN B-NP O
( ( O O
S135L NN B-NP O
/ SYM O O
S135L NN B-NP O
, , O O
Q188R NN B-NP O
/ SYM I-NP O
Q188R NN I-NP O
, , O O
and CC O O
Normal JJ B-NP O
/ SYM I-NP O
Normal JJ I-NP O
) ) O O
. . O O

RESULTS NNS B-NP O
We PRP B-NP O
found VBD B-VP O
a DT B-NP O
48 CD I-NP O
% NN I-NP O
prevalence NN I-NP O
of IN B-PP O
the DT B-NP O
S135L NN I-NP O
mutation NN I-NP O
among IN B-PP O
17 CD B-NP O
black JJ I-NP O
American JJ I-NP O
patients NNS I-NP O
with IN B-PP O
classic JJ B-NP B-Disease
galactosemia NN I-NP I-Disease
and CC O O
a DT B-NP O
1 CD I-NP O
% NN I-NP O
prevalence NN I-NP O
in IN B-PP O
a DT B-NP O
population NN I-NP O
of IN B-PP O
50 CD B-NP O
black JJ I-NP O
Americans NNPS I-NP O
without IN B-PP O
galactosemia NN B-NP B-Disease
. . O O

The DT B-NP O
S135L NN I-NP O
mutation NN I-NP O
was VBD B-VP O
not RB I-VP O
found VBN I-VP O
in IN B-PP O
84 CD B-NP O
white JJ I-NP O
patients NNS I-NP O
with IN B-PP O
G NN B-NP O
/ SYM O O
G NN B-NP O
galactosemia NN I-NP B-Disease
nor CC B-PP O
in IN B-PP O
87 CD B-NP O
white JJ I-NP O
control NN I-NP O
subjects NNS I-NP O
without IN B-PP O
galactosemia NN B-NP B-Disease
. . O O

We PRP B-NP O
found VBD B-VP O
normal JJ B-NP O
whole JJ I-NP O
body NN I-NP O
oxidation NN I-NP O
of IN B-PP O
D NN B-NP O
- HYPH O O
( ( O O
13C NN B-NP O
) ) O O
- HYPH B-NP O
galactose NN I-NP O
by IN B-PP O
the DT B-NP O
patient NN I-NP O
homozygous JJ B-ADJP O
for IN B-PP O
S135L NN B-NP O
and CC O O
various JJ B-NP O
degrees NNS I-NP O
of IN B-PP O
enzyme NN B-NP O
impairment NN I-NP O
among IN B-PP O
different JJ B-NP O
tissues NNS I-NP O
. . O O

CONCLUSIONS NNS B-NP O
The DT B-NP O
S135L NN I-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
GALT NN I-NP O
gene NN I-NP O
is VBZ B-VP O
a DT B-NP O
prevalent JJ I-NP O
cause NN I-NP O
of IN B-PP O
galactosemia NN B-NP B-Disease
among IN B-PP O
black JJ B-NP O
patients NNS I-NP O
. . O O

Because IN B-SBAR O
GALT NN B-NP O
activity NN I-NP O
varies VBZ B-VP O
in IN B-PP O
different JJ B-NP O
tissues NNS I-NP O
of IN B-PP O
patients NNS B-NP O
homozygous JJ B-ADJP O
for IN B-PP O
S135L NN B-NP O
, , O O
they PRP B-NP O
may MD B-VP O
have VB I-VP O
a DT B-NP O
better JJR I-NP O
clinical JJ I-NP O
outcome NN I-NP O
than IN B-PP O
patients NNS B-NP O
who WP B-NP O
are VBP B-VP O
homozygous JJ B-ADJP O
for IN B-PP O
Q188R NN B-NP O
when WRB B-ADVP O
both DT B-NP O
are VBP B-VP O
treated VBN I-VP O
from IN B-PP O
infancy NN B-NP O
. . O O

. . O O

A DT B-NP O
high JJ I-NP O
incidence NN I-NP O
of IN B-PP O
BRCA1 NN B-NP O
mutations NNS I-NP O
in IN B-PP O
20 CD B-NP O
breast NN I-NP B-Disease
- HYPH B-NP I-Disease
ovarian JJ I-NP I-Disease
cancer NN I-NP I-Disease
families NNS I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
analyzed VBN I-VP O
20 CD B-NP O
breast NN I-NP B-Disease
- HYPH B-NP I-Disease
ovarian JJ I-NP I-Disease
cancer NN I-NP I-Disease
families NNS I-NP O
, , O O
the DT B-NP O
majority NN I-NP O
of IN B-PP O
which WDT B-NP O
show VBP B-VP O
positive JJ B-NP O
evidence NN I-NP O
of IN B-PP O
linkage NN B-NP O
to TO B-PP O
chromosome NN B-NP O
17q12 CD I-NP O
for IN B-PP O
germ NN B-NP O
- HYPH I-NP O
line NN I-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
BRCA1 NN I-NP O
gene NN I-NP O
. . O O

BRCA1 NN B-NP O
mutations NNS I-NP O
cosegregating VBG B-VP O
with IN B-PP O
breast NN B-NP B-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
susceptibility NN I-NP O
were VBD B-VP O
identified VBN I-VP O
in IN B-PP O
16 CD B-NP O
families NNS I-NP O
, , O O
including VBG B-PP O
1 CD B-NP O
family NN I-NP O
with IN B-PP O
a DT B-NP O
case NN I-NP O
of IN B-PP O
male JJ B-NP B-Disease
breast NN I-NP I-Disease
cancer NN I-NP I-Disease
. . O O

Nine CD B-NP O
of IN B-PP O
these DT B-NP O
mutations NNS I-NP O
have VBP B-VP O
not RB I-VP O
been VBN I-VP O
reported VBN I-VP O
previously RB B-ADVP O
. . O O

The DT B-NP O
majority NN I-NP O
of IN B-PP O
mutations NNS B-NP O
were VBD B-VP O
found VBN I-VP O
to TO I-VP O
generate VB I-VP O
a DT B-NP O
premature JJ I-NP O
stop NN I-NP O
codon NN I-NP O
leading VBG B-VP O
to TO B-PP O
the DT B-NP O
formation NN I-NP O
of IN B-PP O
a DT B-NP O
truncated VBN I-NP O
BRCA1 NN I-NP O
protein NN I-NP O
of IN B-PP O
2 CD B-NP O
% NN I-NP O
- HYPH O O
88 CD B-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
expected VBN I-NP O
normal JJ I-NP O
length NN I-NP O
. . O O

Two CD B-NP O
mutations NNS I-NP O
altered VBD B-VP O
the DT B-NP O
RING NN I-NP O
finger NN I-NP O
domain NN I-NP O
. . O O

Sequencing NN B-NP O
of IN B-PP O
genomic JJ B-NP O
DNA NN I-NP O
led VBD B-VP O
to TO B-PP O
the DT B-NP O
identification NN I-NP O
of IN B-PP O
a DT B-NP O
mutation NN I-NP O
in IN B-PP O
the DT B-NP O
coding VBG I-NP O
region NN I-NP O
of IN B-PP O
BRCA1 NN B-NP O
in IN B-PP O
12 CD B-NP O
families NNS I-NP O
, , O O
and CC O O
cDNA NN B-NP O
analysis NN I-NP O
revealed VBD B-VP O
an DT B-NP O
abnormal JJ I-NP O
or CC I-NP O
missing JJ I-NP O
BRCA1 NN I-NP O
transcript NN I-NP O
in IN B-PP O
4 CD B-NP O
of IN B-PP O
the DT B-NP O
8 CD I-NP O
remaining JJ I-NP O
families NNS I-NP O
. . O O

A DT B-NP O
total NN I-NP O
of IN B-PP O
eight CD B-NP O
mutations NNS I-NP O
were VBD B-VP O
associated VBN I-VP O
with IN B-PP O
a DT B-NP O
reduced VBN I-NP O
quantity NN I-NP O
of IN B-PP O
BRCA1 NN B-NP O
transcript NN I-NP O
. . O O

We PRP B-NP O
were VBD B-VP O
unable JJ B-ADJP O
to TO B-VP O
detect VB I-VP O
BRCA1 NN B-NP O
mutations NNS I-NP O
in IN B-PP O
4 CD B-NP O
of IN B-PP O
the DT B-NP O
20 CD I-NP O
families NNS I-NP O
, , O O
but CC O O
only RB B-NP O
1 CD I-NP O
of IN B-PP O
these DT B-NP O
was VBD B-VP O
clearly RB I-VP O
linked VBN I-VP O
to TO B-PP O
BRCA1 NN B-NP O
. . O O

It PRP B-NP O
is VBZ B-VP O
expected VBN I-VP O
that IN B-SBAR O
the DT B-NP O
majority NN I-NP O
of IN B-PP O
clear JJ B-NP O
examples NNS I-NP O
of IN B-PP O
the DT B-NP O
breast NN I-NP B-Disease
- HYPH B-NP I-Disease
ovarian JJ I-NP I-Disease
syndrome NN I-NP I-Disease
will MD B-VP O
be VB I-VP O
associated VBN I-VP O
with IN B-PP O
germ NN B-NP O
- HYPH I-NP O
line NN I-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
coding VBG I-NP O
region NN I-NP O
of IN B-PP O
BRCA1 NN B-NP O
. . O O

. . O O

Brca1 NN B-NP B-Disease
deficiency NN I-NP I-Disease
results VBZ B-VP O
in IN B-PP O
early JJ B-NP O
embryonic JJ I-NP B-Disease
lethality NN I-NP I-Disease
characterized VBN B-VP O
by IN B-PP O
neuroepithelial JJ B-NP B-Disease
abnormalities NNS I-NP I-Disease
. . O O

The DT B-NP O
breast NN I-NP B-Disease
and CC I-NP I-Disease
ovarian JJ I-NP I-Disease
cancer NN I-NP I-Disease
susceptibility NN I-NP O
gene NN I-NP O
, , O O
BRCA1 NN B-NP O
, , O O
has VBZ B-VP O
been VBN I-VP O
cloned VBN I-VP O
and CC O O
shown VBN B-VP O
to TO I-VP O
encode VB I-VP O
a DT B-NP O
zinc NN I-NP O
- HYPH B-NP O
finger NN I-NP O
protein NN I-NP O
of IN B-PP O
unknown JJ B-NP O
function NN I-NP O
. . O O

Mutations NNS B-NP O
in IN B-PP O
BRCA1 NN B-NP O
account VBP B-VP O
for IN B-PP O
at IN B-NP O
least JJS I-NP O
80 CD I-NP O
% NN I-NP O
of IN B-PP O
families NNS B-NP O
with IN B-PP O
both CC O O
breast NN B-NP B-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
, , O O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
some DT B-NP O
non AFX I-NP O
- HYPH I-NP O
familial JJ I-NP O
sporadic JJ I-NP O
ovarian JJ I-NP B-Disease
cancers NNS I-NP I-Disease
. . O O

The DT B-NP O
loss NN I-NP O
of IN B-PP O
wild JJ B-NP O
- HYPH I-NP O
type NN I-NP O
BRCA1 NN I-NP O
in IN B-PP O
tumours NNS B-NP B-Disease
of IN B-PP O
individuals NNS B-NP O
carrying VBG B-VP O
one CD B-NP O
nonfunctional JJ I-NP O
BRCA1 NN I-NP O
allele NN I-NP O
suggests VBZ B-VP O
that IN B-SBAR O
BRCA1 NN B-NP O
encodes VBZ B-VP O
a DT B-NP O
tumour NN I-NP B-Disease
suppressor NN I-NP O
that WDT B-NP O
may MD B-VP O
inhibit VB I-VP O
the DT B-NP O
proliferation NN I-NP O
of IN B-PP O
mammary JJ B-NP O
epithelial JJ I-NP O
cells NNS I-NP O
. . O O

To TO B-VP O
examine VB I-VP O
the DT B-NP O
role NN I-NP O
of IN B-PP O
BRCA1 NN B-NP O
in IN B-PP O
normal JJ B-NP O
tissue NN I-NP O
growth NN I-NP O
and CC O O
differentiation NN B-NP O
, , O O
and CC O O
to TO B-VP O
generate VB I-VP O
a DT B-NP O
potential JJ I-NP O
model NN I-NP O
for IN B-PP O
the DT B-NP O
cancer NN I-NP B-Disease
susceptibility NN I-NP O
associated VBN B-VP O
with IN B-PP O
loss NN B-NP O
of IN B-PP O
BRCA1 NN B-NP O
function NN I-NP O
, , O O
we PRP B-NP O
have VBP B-VP O
created VBN I-VP O
a DT B-NP O
mouse NN I-NP O
line NN I-NP O
carrying VBG B-VP O
a DT B-NP O
mutation NN I-NP O
in IN B-PP O
one CD B-NP O
Brca1 NN I-NP O
allele NN I-NP O
. . O O

Analysis NN B-NP O
of IN B-PP O
mice NNS B-NP O
homozygous JJ B-ADJP O
for IN B-PP O
the DT B-NP O
mutant JJ I-NP O
allele NN I-NP O
indicate VBP B-VP O
that IN B-SBAR O
Brca1 NN B-NP O
is VBZ B-VP O
critical JJ B-ADJP O
for IN B-PP O
normal JJ B-NP O
development NN I-NP O
, , O O
as IN B-SBAR O
these DT B-NP O
mice NNS I-NP O
died VBD B-VP O
in IN B-PP O
utero NN B-NP O
between IN B-PP O
10 CD B-NP O
and CC I-NP O
13 CD I-NP O
days NNS I-NP O
of IN B-PP O
gestation NN B-NP O
( ( O O
E10 NN B-NP O
- HYPH B-NP O
E13 NN I-NP O
) ) O O
. . O O

Abnormalities NNS B-NP O
in IN B-PP O
Brca1 NN B-NP B-Disease
- HYPH B-NP I-Disease
deficient JJ I-NP I-Disease
embryos NNS I-NP O
were VBD B-VP O
most RBS B-ADJP O
evident JJ I-ADJP O
in IN B-PP O
the DT B-NP O
neural JJ I-NP O
tube NN I-NP O
, , O O
with IN B-PP O
40 CD B-NP O
% NN I-NP O
of IN B-PP O
the DT B-NP O
embryos NNS I-NP O
presenting VBG B-VP O
with IN B-PP O
varying VBG B-NP O
degrees NNS I-NP O
of IN B-PP O
spina NN B-NP B-Disease
bifida NN I-NP I-Disease
and CC O O
anencephaly RB B-ADVP B-Disease
. . O O

In IN B-PP O
addition NN B-NP O
, , O O
the DT B-NP O
neuroepithelium NN I-NP O
in IN B-PP O
Brca1 NN B-NP B-Disease
- HYPH B-NP I-Disease
deficient JJ I-NP I-Disease
embryos NNS I-NP O
appeared VBD B-VP O
disorganized VBN I-VP O
, , O O
with IN B-PP O
signs NNS B-NP O
of IN B-PP O
both CC O O
rapid JJ B-NP O
proliferation NN I-NP O
and CC O O
excessive JJ B-NP O
cell NN I-NP O
death NN I-NP O
. . O O

. . O O

Identification NN B-NP O
of IN B-PP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
ALD NN I-NP O
- HYPH O O
gene NN B-NP O
of IN B-PP O
20 CD B-NP O
families NNS I-NP O
with IN B-PP O
adrenoleukodystrophy NN B-NP B-Disease
/ SYM I-NP O
adrenomyeloneuropathy NN I-NP B-Disease
. . O O

Adrenoleukodystrophy NN B-NP B-Disease
( ( O O
ALD NN B-NP B-Disease
) ) O O
, , O O
an DT B-NP O
X NN I-NP B-Disease
- HYPH B-VP I-Disease
linked VBN I-VP I-Disease
inherited VBN B-VP I-Disease
metabolic JJ B-NP I-Disease
disorder NN I-NP I-Disease
, , O O
is VBZ B-VP O
the DT B-NP O
most RBS I-NP O
frequent JJ I-NP O
inborn JJ I-NP B-Disease
peroxisomal JJ I-NP I-Disease
disease NN I-NP I-Disease
. . O O

It PRP B-NP O
leads VBZ B-VP O
to TO B-PP O
demyelination NN B-NP B-Disease
in IN B-PP I-Disease
the DT B-NP I-Disease
central JJ I-NP I-Disease
and CC I-NP I-Disease
peripheral JJ I-NP I-Disease
nervous JJ I-NP I-Disease
system NN I-NP I-Disease
. . O O

Defective JJ B-NP O
beta SYM I-NP O
- HYPH I-NP O
oxidation NN I-NP O
of IN B-PP O
saturated VBN B-NP O
very RB I-NP O
long JJ I-NP O
chain NN I-NP O
fatty JJ I-NP O
acids NNS I-NP O
( ( O O
VLCFAs NNS B-NP O
; : O O
C22 NN B-NP O
0 CD I-NP O
- HYPH I-NP O
C26 NN I-NP O
0 CD I-NP O
) ) O O
in IN B-PP O
peroxisomes NNS B-NP O
has VBZ B-VP O
been VBN I-VP O
shown VBN I-VP O
to TO I-VP O
lead VB I-VP O
to TO B-PP O
an DT B-NP O
accumulation NN I-NP O
of IN B-PP O
VLCFAs NNS B-NP O
in IN B-PP O
leukoid JJ B-NP O
areas NNS I-NP O
of IN B-PP O
the DT B-NP O
central JJ I-NP O
nervous JJ I-NP O
system NN I-NP O
, , O O
peripheral JJ B-NP O
nerves NNS I-NP O
, , O O
adrenal JJ B-NP O
gland NN I-NP O
, , O O
and CC O O
blood NN B-NP O
. . O O

The DT B-NP O
ALD NN I-NP B-Disease
gene NN I-NP O
has VBZ B-VP O
been VBN I-VP O
recently RB I-VP O
identified VBN I-VP O
and CC O O
encodes VBZ B-VP O
a DT B-NP O
745 CD I-NP O
- HYPH I-NP O
amino JJ I-NP O
- HYPH I-NP O
acid NN I-NP O
protein NN I-NP O
. . O O

We PRP B-NP O
screened VBD B-VP O
patients NNS B-NP O
with IN B-PP O
adrenoleukodystrophy NN B-NP B-Disease
/ SYM O O
adrenomyeloneuropathy NN B-NP B-Disease
( ( O O
ALD NN B-NP B-Disease
/ SYM B-NP O
AMN NN I-NP B-Disease
) ) O O
from IN B-PP O
20 CD B-NP O
kindreds NNS I-NP O
for IN B-PP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
ALD NN I-NP B-Disease
gene NN I-NP O
. . O O

Eleven CD B-NP O
missense JJ I-NP O
and CC O O
two CD B-NP O
nonsense JJ I-NP O
mutations NNS I-NP O
, , O O
five CD B-NP O
deletions NNS I-NP O
, , O O
and CC O O
one CD B-NP O
insertion NN I-NP O
were VBD B-VP O
detected VBN I-VP O
by IN B-PP O
direct JJ B-NP O
sequencing NN I-NP O
of IN B-PP O
eight CD B-NP O
reverse JJ I-NP O
transcribed VBN I-NP O
fragments NNS I-NP O
of IN B-PP O
the DT B-NP O
ALD NN I-NP B-Disease
- HYPH B-NP O
gene NN I-NP O
mRNA NN I-NP O
. . O O

Four CD B-NP O
mutations NNS I-NP O
could MD B-VP O
be VB I-VP O
shown VBN I-VP O
to TO I-VP O
be VB I-VP O
de FW B-NP O
novo FW I-NP O
. . O O

All DT B-NP O
mutations NNS I-NP O
could MD B-VP O
be VB I-VP O
confirmed VBN I-VP O
in IN B-PP O
carriers NNS B-NP O
by IN B-PP O
sequencing VBG B-VP O
genomic JJ B-NP O
DNA NN I-NP O
. . O O

No DT B-NP O
correlation NN I-NP O
between IN B-PP O
the DT B-NP O
type NN I-NP O
of IN B-PP O
mutation NN B-NP O
and CC O O
the DT B-NP O
severity NN I-NP O
of IN B-PP O
the DT B-NP O
phenotype NN I-NP O
could MD B-VP O
be VB I-VP O
observed VBN I-VP O
. . O O

The DT B-NP O
mutations NNS I-NP O
were VBD B-VP O
not RB I-VP O
detected VBN I-VP O
in IN B-PP O
the DT B-NP O
ALD NN I-NP B-Disease
gene NN I-NP O
of IN B-PP O
30 CD B-NP O
healthy JJ I-NP O
persons NNS I-NP O
. . O O

. . O O

The DT B-NP O
murine JJ I-NP O
homolog NN I-NP O
of IN B-PP O
the DT B-NP O
human JJ I-NP O
breast NN I-NP B-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
susceptibility NN I-NP O
gene NN I-NP O
Brca1 NN I-NP O
maps VBZ B-VP O
to TO B-PP O
mouse NN B-NP O
chromosome NN I-NP O
11D NN I-NP O
. . O O

The DT B-NP O
recently RB I-NP O
cloned VBN I-NP O
human JJ I-NP O
breast NN I-NP B-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
susceptibility NN I-NP O
gene NN I-NP O
, , O O
BRCA1 NN B-NP O
, , O O
is VBZ B-VP O
located JJ B-ADJP O
on IN B-PP O
human JJ B-NP O
chromosome NN I-NP O
17q21 NN I-NP O
. . O O

We PRP B-NP O
have VBP B-VP O
isolated VBN I-VP O
murine JJ B-NP O
genomic JJ I-NP O
clones NNS I-NP O
containing VBG B-VP O
Brca1 NN B-NP O
as IN B-PP O
a DT B-NP O
first JJ I-NP O
step NN I-NP O
in IN B-PP O
generating VBG B-VP O
a DT B-NP O
mouse NN I-NP O
model NN I-NP O
for IN B-PP O
the DT B-NP O
loss NN I-NP O
of IN B-PP O
BRCA1 NN B-NP O
function NN I-NP O
. . O O

A DT B-NP O
mouse NN I-NP O
genomic JJ I-NP O
library NN I-NP O
was VBD B-VP O
screened VBN I-VP O
using VBG B-VP O
probes NNS B-NP O
corresponding VBG B-VP O
to TO B-PP O
exon NN B-NP O
11 CD I-NP O
of IN B-PP O
the DT B-NP O
human JJ I-NP O
BRCA1 NN I-NP O
gene NN I-NP O
. . O O

Two CD B-NP O
overlapping VBG I-NP O
mouse NN I-NP O
clones NNS I-NP O
were VBD B-VP O
identified VBN I-VP O
that WDT B-NP O
hybridized VBD B-VP O
to TO B-PP O
human JJ B-NP O
BRCA1 NN I-NP O
exons NNS I-NP O
9 CD B-NP O
- HYPH I-NP O
12 CD I-NP O
. . O O

Sequence NN B-NP O
analysis NN I-NP O
of IN B-PP O
1 CD B-NP O
. . O O

4 CD B-NP O
kb NN I-NP O
of IN B-PP O
the DT B-NP O
region NN I-NP O
of IN B-PP O
these DT B-NP O
clones NNS I-NP O
corresponding VBG B-VP O
to TO B-PP O
part NN B-NP O
of IN B-PP O
human JJ B-NP O
exon NN I-NP O
11 CD I-NP O
revealed VBD B-VP O
72 CD B-NP O
% NN I-NP O
nucleic JJ I-NP O
acid NN I-NP O
identity NN I-NP O
but CC O O
only RB B-NP O
50 CD I-NP O
% NN I-NP O
amino JJ I-NP O
acid NN I-NP O
identity NN I-NP O
with IN B-PP O
the DT B-NP O
human JJ I-NP O
gene NN I-NP O
. . O O

The DT B-NP O
longest JJS I-NP O
of IN B-PP O
the DT B-NP O
mouse NN I-NP O
Brca1 NN I-NP O
genomic JJ I-NP O
clones NNS I-NP O
maps VBZ B-VP O
to TO B-PP O
chromosome NN B-NP O
11D NN I-NP O
, , O O
as IN B-SBAR O
determined VBN B-VP O
by IN B-PP O
two CD B-NP O
- HYPH I-NP O
color NN I-NP O
fluorescence NN I-NP O
in FW B-NP O
situ FW I-NP O
hybridization NN I-NP O
. . O O

The DT B-NP O
synteny NN I-NP O
to TO B-PP O
human JJ B-NP O
chromosome NN I-NP O
17 CD I-NP O
was VBD B-VP O
confirmed VBN I-VP O
by IN B-PP O
cohybridization NN B-NP O
with IN B-PP O
the DT B-NP O
mouse NN I-NP O
probe NN I-NP O
for IN B-PP O
the DT B-NP O
NF1 NN I-NP O
- HYPH I-NP O
gene NN I-NP O
. . O O

This DT B-NP O
comparative JJ I-NP O
study NN I-NP O
confirms VBZ B-VP O
that IN B-SBAR O
the DT B-NP O
relative JJ I-NP O
location NN I-NP O
of IN B-PP O
the DT B-NP O
BRCA1 NN I-NP O
gene NN I-NP O
has VBZ B-VP O
been VBN I-VP O
conserved VBN I-VP O
between IN B-PP O
mice NNS B-NP O
and CC I-NP O
humans NNS I-NP O
. . O O

Atelosteogenesis NN B-NP B-Disease
type NN I-NP I-Disease
II CD I-NP I-Disease
is VBZ B-VP O
caused VBN I-VP O
by IN B-PP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
diastrophic JJ I-NP B-Disease
dysplasia NN I-NP I-Disease
sulfate NN I-NP O
- HYPH B-NP O
transporter NN I-NP O
gene NN I-NP O
( ( O O
DTDST NN B-NP O
) ) O O
: : O O
evidence NN B-NP O
for IN B-PP O
a DT B-NP O
phenotypic JJ I-NP O
series NN I-NP O
involving VBG B-VP O
three CD B-NP O
chondrodysplasias NNS I-NP B-Disease
. . O O

Atelosteogenesis NN B-NP B-Disease
type NN I-NP I-Disease
II CD I-NP I-Disease
( ( O O
AO NN B-NP B-Disease
II CD I-NP I-Disease
) ) O O
is VBZ B-VP O
a DT B-NP O
neonatally RB I-NP O
lethal JJ I-NP O
chondrodysplasia NN I-NP B-Disease
whose WP$ B-NP O
clinical JJ I-NP O
and CC I-NP O
histological JJ I-NP O
characteristics NNS I-NP O
resemble VBP B-VP O
those DT B-NP O
of IN B-PP O
another DT B-NP O
chondrodysplasia NN I-NP B-Disease
, , O O
the DT B-NP O
much RB I-NP O
less RBR B-NP O
severe JJ I-NP O
diastrophic JJ I-NP B-Disease
dysplasia NN I-NP I-Disease
( ( O O
DTD NN B-NP B-Disease
) ) O O
. . O O

The DT B-NP O
similarity NN I-NP O
suggests VBZ B-VP O
a DT B-NP O
shared JJ I-NP O
pathogenesis NN I-NP O
involving VBG B-VP O
lesions NNS B-NP O
in IN B-PP O
the DT B-NP O
same JJ I-NP O
biochemical JJ I-NP O
pathway NN I-NP O
and CC O O
perhaps RB B-ADVP O
the DT B-NP O
same JJ I-NP O
gene NN I-NP O
. . O O

DTD NN B-NP B-Disease
is VBZ B-VP O
caused VBN I-VP O
by IN B-PP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
recently RB I-NP O
identified VBN I-NP O
diastrophic JJ I-NP B-Disease
dysplasia NN I-NP I-Disease
sulfate NN I-NP O
- HYPH B-NP O
transporter NN I-NP O
gene NN I-NP O
( ( O O
DTDST NN B-NP O
) ) O O
. . O O

Here RB B-ADVP O
, , O O
we PRP B-NP O
report VBP B-VP O
that IN B-SBAR O
AOII NN B-NP B-Disease
patients NNS I-NP O
also RB B-ADVP O
have VBP B-VP O
DTDST NN B-NP O
mutations NNS I-NP O
, , O O
which WDT B-NP O
lead VBP B-VP O
to TO B-PP O
defective JJ B-NP O
uptake NN I-NP O
of IN B-PP O
inorganic JJ B-NP O
sulfate NN I-NP O
and CC O O
insufficient JJ B-NP O
sulfation NN I-NP O
of IN B-PP O
macromolecules NNS B-NP O
by IN B-PP O
patient NN B-NP O
mesenchymal JJ I-NP O
cells NNS I-NP O
in FW B-ADVP O
vitro FW I-ADVP O
. . O O

Together RB B-ADVP O
with IN B-PP O
our PRP$ B-NP O
recent JJ I-NP O
observation NN I-NP O
that IN B-SBAR O
a DT B-NP O
third JJ I-NP O
even RB I-NP O
more RBR I-NP O
severe JJ I-NP O
chondrodysplasia NN I-NP B-Disease
, , O O
achondrogenesis NN B-NP O
type NN I-NP O
IB NN I-NP O
, , O O
is VBZ B-VP O
also RB I-VP O
caused VBN I-VP O
by IN B-PP O
mutations NNS B-NP O
in IN B-PP O
DTDST NN B-NP O
, , O O
these DT B-NP O
results NNS I-NP O
demonstrate VBP B-VP O
a DT B-NP O
phenotypic JJ I-NP O
series NN I-NP O
of IN B-PP O
three CD B-NP O
chondrodysplasias NNS I-NP B-Disease
of IN B-PP O
increasing VBG B-NP O
severity NN I-NP O
caused VBN B-VP O
by IN B-PP O
lesions NNS B-NP O
in IN B-PP O
a DT B-NP O
single JJ I-NP O
sulfate NN I-NP O
- HYPH I-NP O
transporter NN I-NP O
gene NN I-NP O
. . O O

The DT B-NP O
severity NN I-NP O
of IN B-PP O
the DT B-NP O
phenotype NN I-NP O
appears VBZ B-VP O
to TO I-VP O
be VB I-VP O
correlated VBN I-VP O
with IN B-PP O
the DT B-NP O
predicted VBN I-NP O
effect NN I-NP O
of IN B-PP O
the DT B-NP O
mutations NNS I-NP O
on IN B-PP O
the DT B-NP O
residual JJ I-NP O
activity NN I-NP O
of IN B-PP O
the DT B-NP O
DTDST NN I-NP O
protein NN I-NP O
. . O O

. . O O

Haplotype NN B-NP O
and CC I-NP O
phenotype NN I-NP O
analysis NN I-NP O
of IN B-PP O
six CD B-NP O
recurrent JJ I-NP O
BRCA1 NN I-NP O
mutations NNS I-NP O
in IN B-PP O
61 CD B-NP O
families NNS I-NP O
: : O O
results NNS B-NP O
of IN B-PP O
an DT B-NP O
international JJ I-NP O
study NN I-NP O
. . O O

Several JJ B-NP O
BRCA1 NN I-NP O
mutations NNS I-NP O
have VBP B-VP O
now RB I-VP O
been VBN I-VP O
found VBN I-VP O
to TO I-VP O
occur VB I-VP O
in IN B-PP O
geographically RB B-NP O
diverse JJ I-NP O
breast NN I-NP B-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
families NNS I-NP O
. . O O

To TO B-VP O
investigate VB I-VP O
mutation NN B-NP O
origin NN I-NP O
and CC I-NP O
mutation NN I-NP O
- HYPH B-NP O
specific JJ I-NP O
phenotypes NNS I-NP O
due JJ B-ADJP O
to TO B-PP O
BRCA1 NN B-NP O
, , O O
we PRP B-NP O
constructed VBD B-VP O
a DT B-NP O
haplotype NN I-NP O
of IN B-PP O
nine CD B-NP O
polymorphic JJ I-NP O
markers NNS I-NP O
within IN B-PP O
or CC O O
immediately RB B-VP O
flanking VBG I-VP O
the DT B-NP O
BRCA1 NN I-NP O
locus NN I-NP O
in IN B-PP O
a DT B-NP O
set NN I-NP O
of IN B-PP O
61 CD B-NP O
breast NN I-NP B-Disease
/ SYM B-NP I-Disease
ovarian JJ I-NP I-Disease
cancer NN I-NP I-Disease
families NNS I-NP O
selected VBN B-VP O
for IN B-PP O
having VBG B-VP O
one CD B-NP O
of IN B-PP O
six CD B-NP O
recurrent JJ I-NP O
BRCA1 NN I-NP O
mutations NNS I-NP O
. . O O

Tests NNS B-NP O
of IN B-PP O
both CC B-NP O
mutations NNS I-NP O
and CC I-NP O
family NN I-NP O
- HYPH B-NP O
specific JJ I-NP O
differences NNS I-NP O
in IN B-PP O
age NN B-NP O
at IN B-PP O
diagnosis NN B-NP O
were VBD B-VP O
not RB O O
significant JJ B-ADJP O
. . O O

A DT B-NP O
comparison NN I-NP O
of IN B-PP O
the DT B-NP O
six CD I-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
relative JJ I-NP O
proportions NNS I-NP O
of IN B-PP O
cases NNS B-NP O
of IN B-PP O
breast NN B-NP B-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
was VBD B-VP O
suggestive JJ B-ADJP O
of IN B-PP O
an DT B-NP O
effect NN I-NP O
( ( O O
P NN B-NP O
= SYM B-VP O
. . B-NP O

069 CD I-NP O
) ) O O
, , O O
with IN B-PP O
57 CD B-NP O
% NN I-NP O
of IN B-PP O
women NNS B-NP O
presumed VBN B-VP O
affected VBD B-VP O
because IN B-PP O
of IN I-PP O
the DT B-NP O
1294 CD I-NP O
del NN I-NP O
40 CD B-NP O
BRCA1 NN I-NP O
mutation NN I-NP O
having VBG B-VP O
ovarian JJ B-NP B-Disease
cancer NN I-NP I-Disease
, , O O
compared VBN B-PP O
with IN B-PP O
14 CD B-NP O
% NN I-NP O
of IN B-PP O
affected VBN B-NP O
women NNS I-NP O
with IN B-PP O
the DT B-NP O
splice NN I-NP O
- HYPH B-NP O
site NN I-NP O
mutation NN I-NP O
in IN B-PP O
intron NN B-NP O
5 CD I-NP O
of IN B-PP O
BRCA1 NN B-NP O
. . O O

For IN B-PP O
the DT B-NP O
BRCA1 NN I-NP O
mutations NNS I-NP O
studied VBN B-VP O
here RB B-ADVP O
, , O O
the DT B-NP O
individual JJ I-NP O
mutations NNS I-NP O
are VBP B-VP O
estimated VBN I-VP O
to TO I-VP O
have VB I-VP O
arisen VBN I-VP O
9 CD B-NP O
- HYPH I-NP O
170 CD I-NP O
generations NNS I-NP O
ago RB B-ADVP O
. . O O

In IN B-PP O
general JJ B-ADJP O
, , O O
a DT B-NP O
high JJ I-NP O
degree NN I-NP O
of IN B-PP O
haplotype NN B-NP O
conservation NN I-NP O
across IN B-PP O
the DT B-NP O
region NN I-NP O
was VBD B-VP O
observed VBN I-VP O
, , O O
with IN B-PP O
haplotype NN B-NP O
differences NNS I-NP O
most RBS B-ADVP O
often RB I-ADVP O
due JJ B-ADVP O
to TO B-PP O
mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
short JJ I-NP O
- HYPH I-NP O
tandem JJ I-NP O
- HYPH I-NP O
repeat NN I-NP O
markers NNS I-NP O
, , O O
although IN B-SBAR O
some DT B-NP O
likely JJ I-NP O
instances NNS I-NP O
of IN B-PP O
recombination NN B-NP O
also RB B-ADVP O
were VBD B-VP O
observed VBN I-VP O
. . O O

For IN B-PP O
several JJ B-NP O
of IN B-PP O
the DT B-NP O
instances NNS I-NP O
, , O O
there EX B-NP O
was VBD B-VP O
evidence NN B-NP O
for IN B-PP O
multiple JJ B-NP O
, , I-NP O
independent JJ I-NP O
, , I-NP O
BRCA1 NN I-NP O
mutational JJ I-NP O
events NNS I-NP O
. . O O

Isolation NN B-NP O
of IN B-PP O
the DT B-NP O
mouse NN I-NP O
homologue NN I-NP O
of IN B-PP O
BRCA1 NN B-NP O
and CC O O
genetic JJ B-NP O
mapping NN I-NP O
to TO B-PP O
mouse NN B-NP O
chromosome NN I-NP O
11 CD I-NP O
. . O O

The DT B-NP O
BRCA1 NN I-NP O
gene NN I-NP O
is VBZ B-VP O
in IN B-PP O
large JJ B-NP O
part NN I-NP O
responsible JJ B-ADJP O
for IN B-PP O
hereditary JJ B-NP B-Disease
human JJ I-NP I-Disease
breast NN I-NP I-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
. . O O

Here RB B-ADVP O
we PRP B-NP O
report VBP B-VP O
the DT B-NP O
isolation NN I-NP O
of IN B-PP O
the DT B-NP O
murine JJ I-NP O
Brca1 NN I-NP O
homologue NN I-NP O
cDNA NN I-NP O
clones NNS I-NP O
. . O O

In IN B-PP O
addition NN B-NP O
, , O O
we PRP B-NP O
identified VBD B-VP O
genomic JJ B-NP O
P1 NN I-NP O
clones NNS I-NP O
that WDT B-NP O
contain VBP B-VP O
most JJS B-NP O
, , O O
if IN B-SBAR O
not RB B-NP O
all DT I-NP O
, , O O
of IN B-PP O
the DT B-NP O
mouse NN I-NP O
Brca1 NN I-NP O
locus NN I-NP O
. . O O

DNA NN B-NP O
sequence NN I-NP O
analysis NN I-NP O
revealed VBD B-VP O
that IN B-SBAR O
the DT B-NP O
mouse NN I-NP O
and CC O O
human JJ B-NP O
coding NN I-NP O
regions NNS I-NP O
are VBP B-VP O
75 CD B-NP O
% NN I-NP O
identical JJ B-ADJP O
at IN B-PP O
the DT B-NP O
nucleotide NN I-NP O
level NN I-NP O
while IN B-SBAR O
the DT B-NP O
predicted VBN I-NP O
amino NN I-NP O
acid NN I-NP O
identity NN I-NP O
is VBZ B-VP O
only RB B-NP O
58 CD I-NP O
% NN I-NP O
. . O O

A DT B-NP O
DNA NN I-NP O
sequence NN I-NP O
variant NN I-NP O
in IN B-PP O
the DT B-NP O
Brca1 NN I-NP O
locus NN I-NP O
was VBD B-VP O
identified VBN I-VP O
and CC O O
used VBN B-VP O
to TO B-VP O
map VB I-VP O
this DT B-NP O
gene NN I-NP O
on IN B-PP O
a DT B-NP O
( ( I-NP O
Mus NNP I-NP O
m NN I-NP O
. . O O

musculus CC O O
Czech JJ B-NP O
II CD I-NP O
x SYM I-NP O
C57BL NN I-NP O
/ SYM B-NP O
KsJ NN I-NP O
) ) O O
F1 NN B-NP O
x SYM B-NP O
C57BL NN I-NP O
/ SYM B-NP O
KsJ NN I-NP O
intersubspecific JJ I-NP O
backcross NN I-NP O
to TO B-PP O
distal JJ B-NP O
mouse NN I-NP O
chromosome NN I-NP O
11 CD I-NP O
. . O O

The DT B-NP O
mapping NN I-NP O
of IN B-PP O
this DT B-NP O
gene NN I-NP O
to TO B-PP O
a DT B-NP O
region NN I-NP O
highly RB B-ADJP O
syntenic JJ I-ADJP O
with IN B-PP O
human JJ B-NP O
chromosome NN I-NP O
17 CD I-NP O
, , O O
coupled VBN B-VP O
with IN B-PP O
Southern JJ B-NP O
and CC I-NP O
Northern JJ I-NP O
analyses NNS I-NP O
, , O O
confirms VBZ B-VP O
that IN B-SBAR O
we PRP B-NP O
isolated VBD B-VP O
the DT B-NP O
murine JJ I-NP O
Brca1 NN I-NP O
homologue NN I-NP O
rather RB B-CONJP O
than IN I-CONJP O
a DT B-NP O
related JJ I-NP O
RING NN I-NP O
finger NN I-NP O
gene NN I-NP O
. . O O

The DT B-NP O
isolation NN I-NP O
of IN B-PP O
the DT B-NP O
mouse NN I-NP O
Brca1 NN I-NP O
homologue NN I-NP O
will MD B-VP O
facilitate VB I-VP O
the DT B-NP O
creation NN I-NP O
of IN B-PP O
mouse NN B-NP O
models NNS I-NP O
for IN B-PP O
germline NN B-NP O
BRCA1 NN I-NP B-Disease
defects NNS I-NP I-Disease
. . O O

. . O O

Emerin NN B-NP B-Disease
deficiency NN I-NP I-Disease
at IN B-PP O
the DT B-NP O
nuclear JJ I-NP O
membrane NN I-NP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
Emery NNP B-NP B-Disease
- HYPH B-NP I-Disease
Dreifuss NNP I-NP I-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
. . O O

Mutations NNS B-NP O
in IN B-PP O
the DT B-NP O
STA NN I-NP O
gene NN I-NP O
at IN B-PP O
the DT B-NP O
Xq28 NN I-NP O
locus NN I-NP O
have VBP B-VP O
been VBN I-VP O
found VBN I-VP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
X NN B-NP B-Disease
- HYPH O I-Disease
linked VBN B-VP I-Disease
Emery NNP B-NP I-Disease
- HYPH I-NP I-Disease
Dreifuss NNP I-NP I-Disease
muscular JJ I-NP I-Disease
dystrophy NN I-NP I-Disease
( ( O O
EDMD NN B-NP B-Disease
) ) O O
. . O O

This DT B-NP O
gene NN I-NP O
encodes VBZ B-VP O
a DT B-NP O
hitherto RB I-NP O
unknown JJ I-NP O
protein NN I-NP O
named VBN B-VP O
emerin NN B-NP O
. . O O

To TO B-VP O
elucidate VB I-VP O
the DT B-NP O
subcellular JJ I-NP O
localization NN I-NP O
of IN B-PP O
emerin NN B-NP O
, , O O
we PRP B-NP O
raised VBD B-VP O
two CD B-NP O
antisera NNS I-NP O
against IN B-PP O
synthetic JJ B-NP O
peptide NN I-NP O
fragments NNS I-NP O
predicted VBN B-VP O
from IN B-PP O
emerin NN B-NP O
cDNA NN I-NP O
. . O O

Using VBG B-VP O
both DT B-NP O
antisera NNS I-NP O
, , O O
we PRP B-NP O
found VBD B-VP O
positive JJ B-NP O
nuclear JJ I-NP O
membrane NN I-NP O
staining NN I-NP O
in IN B-PP O
skeletal JJ B-NP O
, , I-NP O
cardiac JJ I-NP O
and CC I-NP O
smooth JJ I-NP O
muscles NNS I-NP O
in IN B-PP O
the DT B-NP O
normal JJ I-NP O
controls NNS I-NP O
and CC B-PP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
neuromuscular JJ B-NP B-Disease
diseases NNS I-NP I-Disease
other JJ B-ADJP O
than IN B-PP O
EDMD NN B-NP B-Disease
. . O O

In IN B-PP O
contrast NN B-NP O
, , O O
a DT B-NP O
deficiency NN I-NP O
in IN B-PP O
immunofluorescent JJ B-NP O
staining NN I-NP O
of IN B-PP O
skeletal JJ B-NP O
and CC I-NP O
cardiac JJ I-NP O
muscle NN I-NP O
from IN B-PP O
EDMD NN B-NP B-Disease
patients NNS I-NP O
was VBD B-VP O
observed VBN I-VP O
. . O O

A DT B-NP O
34 CD I-NP O
kD NN I-NP O
protein NN I-NP O
is VBZ B-VP O
immunoreactive JJ B-ADJP O
with IN B-PP O
the DT B-NP O
antisera AFX I-NP O
- HYPH I-NP O
- HYPH I-NP O
the DT B-NP O
protein NN I-NP O
is VBZ B-VP O
equivalent JJ B-ADJP O
to TO B-PP O
that DT B-NP O
predicted VBN B-VP O
for IN B-PP O
emerin NN B-NP O
. . O O

Together RB B-ADVP O
, , O O
our PRP$ B-NP O
findings NNS I-NP O
suggest VBP B-VP O
the DT B-NP O
specific JJ I-NP O
deficiency NN I-NP B-Disease
of IN B-PP I-Disease
emerin NN B-NP I-Disease
in IN B-PP O
the DT B-NP O
nuclear JJ I-NP O
membrane NN I-NP O
of IN B-PP O
muscle NN B-NP O
cells NNS I-NP O
in IN B-PP O
patients NNS B-NP O
with IN B-PP O
EDMD NN B-NP B-Disease
. . O O

. . O O

Growth NN B-NP B-Disease
retardation NN I-NP I-Disease
and CC O O
tumour NN B-NP B-Disease
inhibition NN I-NP O
by IN B-PP O
BRCA1 NN B-NP O
. . O O

Inherited VBN B-NP O
mutations NNS I-NP O
in IN B-PP O
BRCA1 NN B-NP O
predispose NN I-NP O
to TO B-PP O
breast NN B-NP B-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
, , O O
but CC O O
the DT B-NP O
role NN I-NP O
of IN B-PP O
BRCA1 NN B-NP O
in IN B-PP O
sporadic JJ B-NP O
breast NN I-NP B-Disease
and CC O I-Disease
ovarian JJ B-NP I-Disease
cancer NN I-NP I-Disease
has VBZ B-VP O
previously RB I-VP O
been VBN I-VP O
elusive JJ B-ADJP O
. . O O

Here RB B-ADVP O
, , O O
we PRP B-NP O
show VBP B-VP O
that IN B-SBAR O
retroviral JJ B-NP O
transfer NN I-NP O
of IN B-PP O
the DT B-NP O
wild JJ I-NP O
- HYPH I-NP O
type NN I-NP O
BRCA1 NN I-NP O
gene NN I-NP O
inhibits VBZ B-VP O
growth NN B-NP O
in FW B-PP O
vitro FW B-NP O
of IN B-PP O
all DT B-NP O
breast NN I-NP B-Disease
and CC I-NP I-Disease
ovarian JJ I-NP I-Disease
cancer NN I-NP I-Disease
cell NN I-NP O
lines NNS I-NP O
tested VBN B-VP O
, , O O
but CC O O
not RB O O
colon NN B-NP B-Disease
or CC O I-Disease
lung NN B-NP I-Disease
cancer NN I-NP I-Disease
cells NNS I-NP O
or CC O O
fibroblasts NNS B-NP O
. . O O

Mutant JJ B-NP O
BRCA1 NN I-NP O
has VBZ B-VP O
no DT B-NP O
effect NN I-NP O
on IN B-PP O
growth NN B-NP O
of IN B-PP O
breast NN B-NP B-Disease
cancer NN I-NP I-Disease
cells NNS I-NP O
; : O O
ovarian JJ B-NP B-Disease
cancer NN I-NP I-Disease
cell NN I-NP O
growth NN I-NP O
is VBZ B-VP O
not RB I-VP O
affected VBN I-VP O
by IN B-PP O
BRCA1 NN B-NP O
mutations NNS I-NP O
in IN B-PP O
the DT B-NP O
5 CD I-NP O
portion NN I-NP O
of IN B-PP O
the DT B-NP O
gene NN I-NP O
, , O O
but CC O O
is VBZ B-VP O
inhibited VBN I-VP O
by IN B-PP O
3 CD B-NP O
BRCA1 NN I-NP O
mutations NNS I-NP O
. . O O

Development NN B-NP O
of IN B-PP O
MCF NN B-NP B-Disease
- HYPH B-NP I-Disease
7 CD I-NP I-Disease
tumours NNS I-NP I-Disease
in IN B-PP O
nude JJ B-NP O
mice NNS I-NP O
is VBZ B-VP O
inhibited VBN I-VP O
when WRB B-ADVP O
MCF NN B-NP O
- HYPH B-NP O
7 CD I-NP O
cells NNS I-NP O
are VBP B-VP O
transfected VBN I-VP O
with IN B-PP O
wild JJ B-NP O
- HYPH I-NP O
type NN I-NP O
, , B-NP O
but CC I-NP O
not RB I-NP O
mutant JJ I-NP O
, , I-NP O
BRCA1 NN I-NP O
. . O O

Most RBS B-ADVP O
importantly RB I-ADVP O
, , O O
among IN B-PP O
mice NNS B-NP O
with IN B-PP O
established VBN B-NP O
MCF NN I-NP B-Disease
- HYPH O I-Disease
7 CD B-NP I-Disease
tumours NNS I-NP I-Disease
, , O O
peritoneal JJ B-NP O
treatment NN I-NP O
with IN B-PP O
a DT B-NP O
retroviral JJ I-NP O
vector NN I-NP O
expressing VBG B-VP O
wild JJ B-NP O
- HYPH I-NP O
type NN I-NP O
BRCA1 NN I-NP O
significantly RB B-VP O
inhibits VBZ I-VP O
tumour NN B-NP B-Disease
growth NN I-NP O
and CC O O
increased VBN B-NP O
survival NN I-NP O
. . O O

. . O O

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          growth NN I-NP O

and CC O O

increased VBN B-NP O

survival NN I-NP O

. . O O


. . O O


